0001445305-14-000438.txt : 20140213 0001445305-14-000438.hdr.sgml : 20140213 20140213160205 ACCESSION NUMBER: 0001445305-14-000438 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140213 DATE AS OF CHANGE: 20140213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 14605966 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 10-K 1 a2013123110k.htm 10-K 2013.12.31 10K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark one)
x
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
or
o
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                                       to                                      
Commission file number 001-34912
CELGENE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
 
22-2711928
(I.R.S. Employer Identification No.)
86 Morris Avenue
Summit, New Jersey
(Address of principal executive offices)
 
07901
(Zip Code)
(908) 673-9000
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Name of each exchange on which registered
Common Stock, par value $.01 per share
 
NASDAQ Global Select Market
Contingent Value Rights
 
NASDAQ Global Market
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x    No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o    No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x    No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer x
 
Accelerated filer o
 
Non-accelerated filer o 
 
Smaller reporting company o
 
 
 
 
(Do not check if a smaller reporting company)
 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Act). Yes o    No x
The aggregate market value of voting stock held by non-affiliates of the registrant on June 28, 2013, the last business day of the registrant's most recently completed second quarter, was $48,096,964,775 based on the last reported sale price of the registrant's Common Stock on the NASDAQ Global Select Market on that date.
There were 406,020,079 shares of Common Stock outstanding as of February 7, 2014.
Documents Incorporated by Reference
The registrant intends to file a definitive proxy statement pursuant to Regulation 14A within 120 days of the end of the fiscal year ended December 31, 2013. The proxy statement is incorporated herein by reference into the following parts of the Form 10-K:
Part II, Item 5.(d)
Equity Compensation Plan Information.
Part III, Item 10.
Directors, Executive Officers and Corporate Governance.
Part III, Item 11.
Executive Compensation.
Part III, Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Part III, Item 13.
Certain Relationships and Related Transactions, and Director Independence.
Part III, Item 14.
Principal Accountant Fees and Services.


CELGENE CORPORATION
ANNUAL REPORT ON FORM 10-K
TABLE OF CONTENTS
Item No.
 
Page
 


PART I

ITEM 1.    BUSINESS
Celgene Corporation, together with its subsidiaries (collectively “we,” “our,”  “us,” “Celgene” or the “Company”), is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.  We are dedicated to innovative research and development designed to bring new therapies to market and we are involved in research in several scientific areas that may deliver proprietary next-generation therapies, targeting areas including intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. Celgene Corporation was incorporated in the State of Delaware in 1986.
Our primary commercial stage products include REVLIMID®, VIDAZA®, ABRAXANE®, POMALYST®/IMNOVID®, THALOMID® (inclusive of Thalidomide CelgeneTM), ISTODAX® and azacitidine for injection (generic version of VIDAZA®). Additional sources of revenue include royalties from Novartis Pharma AG (Novartis) on their sales of FOCALIN XR® and the entire RITALIN® family of drugs, the sale of services through our Celgene Cellular Therapeutics (CCT) subsidiary and other licensing agreements.
We continue to invest substantially in research and development in support of multiple ongoing proprietary clinical development programs which support our existing products and pipeline of new drug candidates.  REVLIMID® is in several phase III trials across a range of hematological malignancies that include newly diagnosed multiple myeloma and maintenance, lymphomas, chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDS). POMALYST®/IMNOVID® was approved in the United States and European Union for indications in multiple myeloma based on phase II and phase III results, respectively, and additional phase III trials are underway with POMALYST®/IMNOVID® in relapsed refractory multiple myeloma. Phase III trials are also underway for VIDAZA® and CC-486 in MDS and acute myeloid leukemia (AML) and ISTODAX® in first-line peripheral T-cell lymphoma (PTCL).  In solid tumors, we are evaluating ABRAXANE® in phase III trials for breast, pancreatic and non-small cell lung cancers.  Our lead product candidate in inflammation and immunology, OTEZLA® (apremilast), is being evaluated in a broad phase III program for psoriatic arthritis, psoriasis and ankylosing spondylitis.
In addition to our phase III programs, we have a growing early-to-mid-stage pipeline of novel therapies to address significant unmet medical needs consisting of in-house developed compounds, compounds licensed from other companies and compounds we have options to acquire from collaboration partners.
We believe that continued use of our primary commercial stage products, ongoing internal and external collaborative research and development efforts, depth of our product pipeline, regulatory approvals of new products and expanded use of existing products will provide the catalysts for future growth.

1

COMMERCIAL STAGE PRODUCTS
REVLIMID® (lenalidomide):    REVLIMID® is an oral immunomodulatory drug marketed in the United States and many international markets for the treatment of patients as indicated below:
Disease
Geographic Approvals
Multiple myeloma (MM), in combination with dexamethasone, in patients who have received at least one prior therapy
* United States
* European Union
* Japan
* Other international markets
Myelodysplastic syndromes (MDS)
 
Transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q abnormality with or without additional cytogenetic abnormalities
* United States
* Other international markets
Transfusion-dependent anemia due to low- or intermediate-1-risk MDS in patients with isolated deletion 5q cytogenetic abnormality when other options are insufficient or inadequate
* European Union (Approved June 2013)
MDS with a deletion 5q cytogenetic abnormality. The efficacy or safety of REVLIMID for International Prognostic Scoring System (IPSS) intermediate-2 or high risk MDS has not been established.
* Japan
Mantle cell lymphoma (MCL) in patients whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
* United States (Approved June 2013)
REVLIMID® is distributed in the United States through contracted pharmacies under the REVLIMID® Risk Evaluation and Mitigation Strategy (REMS) program, which is a proprietary risk-management distribution program tailored specifically to provide for the safe and appropriate distribution and use of REVLIMID®. Internationally, REVLIMID® is distributed under mandatory risk-management distribution programs tailored to meet local authorities' specifications to provide for the safe and appropriate distribution and use of REVLIMID®. These programs may vary by country and, depending upon the country and the design of the risk-management program, the product may be sold through hospitals or retail pharmacies.
REVLIMID® continues to be evaluated in numerous clinical trials worldwide either alone or in combination with one or more other therapies in the treatment of a broad range of hematological malignancies, including multiple myeloma, MDS, various lymphomas, CLL, other cancers and other diseases.
VIDAZA® (azacitidine for injection):  VIDAZA® is a pyrimidine nucleoside analog that has been shown to reverse the effects of DNA hypermethylation and promote subsequent gene re-expression.  VIDAZA® is a Category 1 recommended treatment for patients with intermediate-2 and high-risk MDS, according to the National Comprehensive Cancer Network and is marketed in the United States for the treatment of all subtypes of MDS.  The U.S. regulatory exclusivity for VIDAZA® expired in May 2011.  As the result of the launch of a generic version of VIDAZA® in the United States by a competitor in September 2013, we experienced a significant reduction in our U.S. sales of VIDAZA® in the fourth quarter of 2013. In 2013, we also contracted with Sandoz AG to sell a generic version of VIDAZA®, which we supply. In Europe, VIDAZA® is marketed for the treatment of intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia with 10% to 29% marrow blasts without myeloproliferative disorder, as well as AML with 20% to 30% blasts and multi-lineage dysplasia and has been granted orphan drug designation for the treatment of MDS and AML.  Regulatory exclusivity for VIDAZA® is expected to continue in Europe through 2018.

2

ABRAXANE® (paclitaxel albumin-bound particles for injectable suspension):  ABRAXANE® is a solvent-free chemotherapy product which was developed using our proprietary nab® technology platform. This protein-bound chemotherapy agent combines paclitaxel with albumin. ABRAXANE® is approved for the treatment of patients as indicated below:
Disease
Geographic Approvals
Breast Cancer
 
Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within six months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
* United States

Metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease for whom standard, anthracycline containing therapy is not indicated
* European Union
Breast cancer
* Japan
* Other international markets
Non-Small Cell Lung Cancer (NSCLC)
 
Locally advanced or metastatic NSCLC, as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy
* United States
* Other international markets
NSCLC
* Japan (Approved February 2013)

Metastatic adenocarcinoma of the pancreas, a form of pancreatic cancer, as first line treatment in combination with gemcitabine
* United States (Approved September 2013)
* European Union (Approved December 2013)
Gastric cancer
* Japan (Approved February 2013)
During 2013, applications for marketing authorizations for ABRAXANE® for the treatment of patients with advanced pancreatic cancer were also submitted in other countries and regions. ABRAXANE® is currently in various stages of investigation for breast, pancreatic and non-small cell lung cancers.
POMALYST®/IMNOVID®1(pomalidomide): POMALYST®/IMNOVID® is a proprietary, distinct, small molecule that is administered orally and modulates the immune system and other biologically important targets. POMALYST®/IMNOVID® received its first approvals from the U.S. Food and Drug Administration (FDA) and the European Commission (EC) during 2013 for the treatment of patients as indicated below:

Disease
Geographic Approvals
Multiple myeloma for patients who have received at least two prior therapies, including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
* United States (Approved February 2013)
Relapsed and refractory multiple myeloma, in combination with dexamethasone, for adult patients who have received at least two prior therapies including both lenalidomide and bortezomib and have demonstrated disease progression on the last therapy.
* European Union (Approved August 2013)
1 We received FDA approval for pomalidomide under the trade name POMALYST®. We received EC approval for pomalidomide under the trade name IMNOVID®.

POMALYST®/IMNOVID® is also being evaluated in multiple trials in various phases for expanded usage in multiple myeloma and in a phase II trial for systemic sclerosis. POMALYST® is distributed in the United States through contracted pharmacies under the POMALYST REMSTM program, which is a proprietary risk-management distribution program tailored specifically to provide for the safe and appropriate distribution and use of POMALYST®. Internationally, POMALYST®/IMNOVID® is distributed under mandatory risk-management distribution programs tailored to meet local authorities' specifications to provide for the safe and appropriate distribution and use of POMALYST®/IMNOVID®. These programs may vary by country and, depending upon the country and the design of the risk-management program, the product is sold through hospitals or retail pharmacies.

3

THALOMID® (thalidomide):    In combination with dexamethasone, THALOMID® is marketed in the United States for patients with newly diagnosed multiple myeloma and for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) an inflammatory complication of leprosy and as maintenance therapy for prevention and suppression of the cutaneous manifestation of ENL recurrence. Thalidomide CelgeneTM in combination with melphalan and prednisone is marketed in the European Union as a first line treatment for patients with untreated multiple myeloma who are aged sixty-five years of age or older or ineligible for high dose chemotherapy.
THALOMID® is distributed in the United States under our THALOMID REMSTM program, which is a proprietary risk-management distribution program tailored specifically to provide for the safe and appropriate distribution and use of THALOMID®. Internationally, THALOMID® and Thalidomide CelgeneTM are also distributed under mandatory risk-management distribution programs tailored to meet local authorities' specifications to provide for the safe and appropriate distribution and use of THALOMID® and Thalidomide CelgeneTM. These programs may vary by country and, depending upon the country and the design of the risk-management program, the products are sold through hospitals or retail pharmacies.
ISTODAX® (romidepsin):  ISTODAX® is approved in the United States for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy and for the treatment of PTCL in patients who have received at least one prior therapy.  ISTODAX® has received orphan drug designation for the treatment of non-Hodgkin’s T-cell lymphomas, including CTCL and PTCL.
azacitidine for injection (generic version of VIDAZA®): After the launch of a generic version of VIDAZA® in the United States by a competitor in September 2013, we contracted with Sandoz AG to sell azacitidine for injection, which we supply. We recognize net product sales from sales of azacitidine for injection to Sandoz AG.
FOCALIN®, FOCALIN XR® and RITALIN LA®: We licensed the worldwide rights (excluding Canada) regarding certain chirally pure forms of methylphenidate for FOCALIN® and FOCALIN XR® to Novartis. We also licensed to Novartis the rights related to long-acting formulations of methylphenidate and dex-methylphenidate products which are used in FOCALIN XR® and RITALIN LA®. As a result of the grant of these licenses we receive royalties on sales of these products.
PRECLINICAL AND CLINICAL STAGE PIPELINE
Our preclinical and clinical-stage pipeline of new drug candidates and cell therapies is highlighted by multiple classes of small molecule, therapeutic agents designed to selectively regulate disease-associated genes and proteins. These product candidates are at various stages of preclinical and clinical development.
Oral anti-inflammatory agents:    We are developing novel, orally administered small molecules that specifically target PDE4, an intracellular enzyme that modulates the production of multiple pro-inflammatory and anti-inflammatory mediators including interleukin-2 (IL-2), IL-10, IL-12, IL-23, INF-gamma, TNF-α, leukotrienes and nitric oxide synthase. OTEZLA® (apremilast), our lead product candidate in inflammation and immunology, has demonstrated statistically significant and clinically meaningful benefits in recent phase III trials in the treatment of psoriasis (ESTEEM 1 and 2 trials), previously treated psoriatic arthritis (PALACE 1, 2 and 3 trials) and psoriatic arthritis in treatment-naïve patients (PALACE 4 trial). OTEZLA® (apremilast) is also being evaluated in a phase III trial for ankylosing spondylitis and a phase II trial for Behçet's disease has recently been completed.
Next generation of thalidomide analogues: CC-122 and CC-220 represent novel compounds that are in phase I clinical trials for hematological and solid tumor cancers. They have been differentiated from previous compounds and have been developed based on our scientific understanding of thalidomide mechanism of action and protein homeostasis.
Cellular therapies:    At CCT we are conducting research with stem cells derived from the human placenta as well as from the umbilical cord. CCT is our research and development division dedicated to fulfilling the promise of cellular technologies by developing products and therapies to significantly benefit patients. Our goal is to develop proprietary cell therapy products for the treatment of unmet medical needs.
Stem cell based therapies offer the potential to provide disease-modifying outcomes for serious diseases that lack adequate therapy. We have developed proprietary technology for collecting, processing and storing placental stem cells with potentially broad therapeutic applications in cancer, auto-immune diseases, and other inflammatory diseases.
We are developing our cellular therapies, PDA-001 (IV formulation) and PDA-002 (IM/SC injectable formulation), with the initiation of phase I safety and dose finding studies for Crohn’s disease and peripheral arterial diseases. We are also continuing research to define the potential of placental-derived stem cells and to characterize other placental-derived products.
CC-486:    We have initiated two phase III trials of CC-486 that are currently enrolling to evaluate CC-486 in the treatment of MDS and AML. In addition, a phase I trial of CC-486 for the treatment of solid tumors is currently in progress.

4

Sotatercept (ACE-011) and ACE-536:   We have collaborated with Acceleron Pharma, Inc. (Acceleron) to develop sotatercept and ACE-536 to treat anemia in patients with rare blood disorders. Several phase II trials are in progress to evaluate the use of sotatercept or ACE-536 in the treatment of anemia in patients with rare blood disorders and chronic kidney disease, beta-thalassemia and MDS.
mTOR pathway inhibitors: CC-223 and CC-115 target the important cancer pathway that is dysregulated in a large proportion of cancers. In particular, activity is being investigated in lymphomas, hepatocellular and prostate cancers in phase I/II trials.
Epigenetics: The current insights into molecular regulation of genetic information (Epigenetics) has the potential to transform human diseases. Celgene has two epigenetic modifiers on the market, VIDAZA® and ISTODAX®. In addition, we are collaborating with Epizyme Inc. (Epizyme) to develop EPZ-5676 for AML.
CC-292: CC-292 is in phase I clinical trials for the treatment of CLL and lymphomas. CC-292 is also in phase II combination studies with REVLIMID® and Rituxan in CLL’s.
PRODUCT DEVELOPMENT
We devote significant resources to research and development programs in an effort to discover and develop potential future product candidates. Research and development expenses amounted to $2.226 billion in 2013, $1.724 billion in 2012 and $1.600 billion in 2011. The product candidates in our pipeline are at various stages of preclinical and clinical development. The path to regulatory approval includes three phases of clinical trials in which we collect data to support an application to regulatory authorities to allow us to market a product for treatment of a specified disease. There are many difficulties and uncertainties inherent in research and development of new products, resulting in a high rate of failure. To bring a drug from the discovery phase to regulatory approval, and ultimately to market, takes many years and significant cost. Failure can occur at any point in the process, including after the product is approved, based on post-market factors. New product candidates that appear promising in development may fail to reach the market or may have only limited commercial success because of efficacy or safety concerns, inability to obtain necessary regulatory approvals, limited scope of approved uses, reimbursement challenges, difficulty or excessive costs of manufacture, alternative therapies or infringement of the patents or intellectual property rights of others. Uncertainties in the FDA approval process and the approval processes in other countries can result in delays in product launches and lost market opportunities. Consequently, it is very difficult to predict which products will ultimately be submitted for approval, which have the highest likelihood of obtaining approval and which will be commercially viable and generate profits. Successful results in preclinical or clinical studies may not be an accurate predictor of the ultimate safety or effectiveness of a drug or product candidate.
Phase I Clinical Trials
Phase I clinical trials begin when regulatory agencies allow initiation of clinical investigation of a new drug or product candidate and usually involve up to 80 healthy volunteers or subjects. The trials study a drug's safety profile, and may include a preliminary determination of a drug or product candidate's safe dosage range. The phase I clinical trial also determines how a drug is absorbed, distributed, metabolized and excreted by the body, and therefore the potential duration of its action. Phase I clinical trials generally take from one to three years to complete.
Phase II Clinical Trials
Phase II clinical trials are conducted on a limited number of subjects with the targeted disease. An initial evaluation of the drug's effectiveness on subjects is performed and additional information on the drug's safety and dosage range is obtained. Phase II clinical trials normally include up to several hundred subjects and may take as many as two to three years to complete.
Phase III Clinical Trials
Phase III clinical trials are typically controlled multi-center trials that involve a larger target patient population that normally consists of from several hundred to several thousand subjects to ensure that study results are statistically significant. During phase III clinical trials, physicians monitor subjects to determine efficacy and to gather further information on safety. These trials are generally global in nature and are designed to generate all of the clinical data necessary to submit an application for marketing approval to regulatory agencies. Phase III testing varies by disease state, but can often last from two to seven years.
Regulatory Review
If a product candidate successfully completes phase III clinical trials and is submitted to governmental regulators, such as the FDA in the United States or the EC in the European Union, the time to final marketing approval can vary from six months (for a U.S. filing that is designated for priority review by the FDA) to several years, depending on a number of variables,

5

such as the disease state, the strength and complexity of the data presented, the novelty of the target or compound, risk-management approval and whether multiple rounds of review are required for the agency to evaluate the submission. There is no guarantee that a potential treatment will receive marketing approval, or that decisions on marketing approvals or treatment indications will be consistent across geographic areas.
The current stage of development of our commercial stage products and new drug candidates in various areas of research are outlined in the following table:
Area of Research
 
Status
 
Entered Current Status
Multiple Myeloma (MM)
 
 
 
 
REVLIMID®
 
Relapsed/refractory
 
Post-approval research1
 
2006
 
 
Newly diagnosed
 
Phase III
 
2008
 
 
Maintenance
 
Phase III
 
2004
POMALYST®/IMNOVID®
 
Relapsed/refractory2
 
Post-approval research1
 
February 2013
THALOMID®/Thalidomide CelgeneTM
 
Newly diagnosed
 
Post-approval research1
 
2006
Anti-CD38 Antibody: MOR2023
 
Relapsed/refractory
 
Phase I
 
2011
 
 
 
 
 
 
 
Myelodysplastic Syndromes (MDS)
 
 
 
 
VIDAZA®
 
.
 
Post-approval research1
 
2004
REVLIMID®
 
Deletion 5q
 
Post-approval research1
 
2005
 
 
Non-deletion 5q
 
Phase III
 
2010
CC-486
 
Lower-risk
 
Phase III
 
May 2013
 
 
Post HSC transplant
 
Phase I/II
 
October 2013
 
 
 
 
 
 
 
Acute Myeloid Leukemia (AML)
 
 
 
 
VIDAZA®
 
AML (20%-30% blasts) (EU)
 
Post-approval research1
 
2008
 
 
AML (>30% blasts) (EU)
 
Phase III
 
2010
REVLIMID® & VIDAZA®
 
.
 
Phase II
 
September 2013
CC-486
 
Post-induction AML maintenance
 
Phase III
 
May 2013
 
 
Post HSC transplant
 
Phase I/II
 
October 2013
DOT 1L Inhibitor: EPZ-56764
 
.
 
Phase I
 
2012

6

Area of Research
 
Status
 
Entered Current Status
Lymphoma
 
 
 
 
ISTODAX® 
 
Cutaneous T-cell lymphoma (US)5
 
Post-approval research1
 
2009
 
 
Peripheral T-cell lymphoma: Relapsed/refractory (US)5
 
Post-approval research1
 
2011
 
 
Peripheral T-cell lymphoma: Relapsed/refractory (Japan)
 
Phase II
 
March 2013
 
 
Peripheral T-cell lymphoma: First-line
 
Phase III
 
January 2013
REVLIMID®
 
Mantle cell lymphoma: Relapsed/refractory (US)
 
Post-approval research1
 
June 2013
 
 
Mantle cell lymphoma: Relapsed/refractory (EU)
 
Phase II
 
2009
 
 
Diffuse large B-cell: Maintenance
 
Phase III
 
2009
 
 
Diffuse large B-cell: Relapsed/refractory
 
Phase II/III
 
2010
 
 
Relapsed/refractory indolent lymphoma
 
Phase III
 
September 2013
 
 
Follicular lymphoma: First-line
 
Phase III
 
2011
 
 
Adult T-cell leukemia-lymphoma (Japan)
 
Phase II
 
2012
CC-292
 
.
 
Phase I
 
2012
CC-122
 
Diffuse large B-cell lymphoma
 
Phase Ib
 
January 2014
 
 
 
 
 
Chronic Lymphocytic Leukemia (CLL)
 
 
 
 
REVLIMID®
 
Maintenance
 
Phase III
 
2009
CC-292
 
.
 
Phase I
 
2012
 
 
 
 
 
 
 
Anemias
 
 
 
 
sotatercept (ACE-011)6
 
Renal anemia with metabolic bone disease
 
Phase II
 
2010
 
 
Diamond blackfan anemia
 
Phase II
 
2012
 
 
Beta-thalassemia
 
Phase II
 
2012
 
 
MDS
 
Phase II
 
2012
ACE-5366
 
Beta-thalassemia
 
Phase II
 
January 2013
 
 
MDS
 
Phase II
 
January 2013
 
 
 
 
 
 
 
Solid Tumors
 
 
 
 
ABRAXANE®
 
Breast: Metastatic
 
Post-approval research1
 
2005
 
 
Breast: Metastatic (first-line, triple negative)
 
Phase II/III
 
September 2013
 
 
Non-small cell lung: Advanced (first-line) (US, Japan)
 
Post-approval research1
 
2012
 
 
Pancreatic: Advanced (first-line) (US)
 
Post-approval research1
 
September 2013
 
 
Pancreatic: Advanced (first-line) (EU)
 
Post-approval research1
 
December 2013
 
 
Gastric: Metastatic (Japan)8
 
Post-approval research1,7
 
February 2013
CC-223
 
.
 
Phase I
 
2012
CC-115
 
.
 
Phase I
 
2011
CC-122
 
.
 
Phase I
 
2011
CC-486
 
.
 
Phase I
 
2011

7

Area of Research
 
Status
 
Entered Current Status
Anti-Inflammatory
 
 
 
 
OTEZLA® (apremilast)
 
Psoriatic arthritis
 
Regulatory filing and approval
 
March 2013
 
 
Psoriasis
 
Regulatory filing and approval
 
September 2013
 
 
Ankylosing spondylitis
 
Phase III
 
2012
 
 
Behçet's disease
 
Phase II
 
2009
 
 
Rheumatoid arthritis
 
Phase II
 
2010
POMALYST®/IMNOVID®
 
Systemic sclerosis
 
Phase II
 
March 2013
CC-220
 
.
 
Phase I
 
January 2013
 
 
 
 
 
 
 
Cellular Therapies
 
 
 
 
PDA-001
 
Crohn's disease
 
Phase I
 
February 2013
PDA-002
 
Peripheral artery disease/Diabetic foot ulcers
 
Phase I
 
June 2013
UCB+HPDSC®
 
Transplants
 
Phase I
 
April 2013
1 Includes Celgene-sponsored and Celgene-supported studies.
2 In the United States, regulatory approval is based on pivotal phase II data; phase III program ongoing.
3 In collaboration with MorphoSys AG.
4 In collaboration with Epizyme.
5 Filing for regulatory approval based on pivotal phase II data.
6 In collaboration with Acceleron Pharma, Inc.
7 For information on approved uses, please refer to approved product labeling.
8 Trial conducted by licensee partner, Taiho Pharmaceuticals Co. Ltd.


8

PATENTS AND PROPRIETARY TECHNOLOGY
We consider intellectual property protection to be critical to our operations. For many of our products, in addition to compound (e.g., drug substance) and composition (e.g., drug product) patents, we hold polymorph, formulation, methods of treatment or use, and methods of manufacture patents that may extend exclusivity beyond the expiration of the compound patent or composition patent.
Key product exclusivities:
The following table shows the expected expiration dates in the United States and Europe of the last-to-expire period of exclusivity (primary regulatory approval or patent) related to the following drugs:
 
 
U.S.1
 
Europe
REVLIMID® brand drug
 
2027
 
2024
(U.S. and European Patent Office (EPO) drug substance patents)
 
 
 
 
THALOMID® brand drug
 
2023
 
2019
(Use and/or drug product patents)
 
 
 
 
VIDAZA® brand drug
 
2011
 
2018
(U.S. and EMA regulatory exclusivities only)
 
 
 
 
ABRAXANE® brand drug
 
2026
 
2022
(U.S. use and EPO use/drug product patents)
 
 
 
 
ISTODAX® brand drug
 
2021
 
*
(U.S. drug substance patents)
 
 
 
 
POMALYST®/IMNOVID® brand drug
 
20242
 
20233
(U.S. use patent)
 
 
 
 
(EMA regulatory exclusivity)
 
 
 
 
FOCALIN® brand drug
 
2015
 
N/A
(U.S. use patents)
 
 
 
 
FOCALIN XR® brand drug
 
2015
 
2018
(U.S. use patents)
 
 
 
 
(EPO drug product patent)
 
 
 
 
OTEZLA® brand drug
 
20244
 
20245
_____________________
* Generally, 10 years regulatory exclusivity upon approval of submitted application for an orphan indication.

1 
The patents covering these drugs include patents listed in the U.S. Orange Book. The date provided reflects the last-to-expire patent as listed in the U.S. Orange Book, which may not be the last date on which all relevant patents (e.g., polymorph and manufacturing patents) expire.
2 
Application for patent term extension through June 2025 pending.
3 
Patent application pending, receipt of which would likely extend exclusivity beyond 2023.
4 
Application for patent term extension of up to five years will be made upon marketing approval.
5 
Patent grant pending, receipt of which would extend exclusivity through 2024.


9

The term of individual patents and patent applications will depend upon the legal term of the patents in the countries in which they are obtained. In the United States, the patent term is 20 years from the date of filing of the patent application although term extensions are available. We may obtain patents for certain products many years before marketing approval is obtained for those products. Because of the limited life of patents, which ordinarily commences prior to the commercial sale of the related product, the commercial value of the patent may be limited. However, we may be able to obtain patent term extensions upon marketing approval. For example, supplementary protection certificates (SPCs) on some of our products have been granted in a number of European countries, compensating in part for delays in obtaining marketing approval. Also, under the Hatch-Waxman Act, the term of a patent that covers an FDA-approved drug may also be eligible for patent term extension (for up to five years, but not beyond a total of 14 years from the date of product approval) as compensation for patent term lost during the FDA regulatory review process. When possible, depending upon the length of clinical trials and other factors involved in the filing of a new drug application (NDA) with the FDA, we expect to apply for patent term extensions for patents covering our drug products and their use in treating various diseases.

In most cases, our drugs are also covered in foreign countries by patents and patent applications that correspond to certain of those listed in the U.S. Orange Book. For example, patents related to the active pharmaceutical ingredient, uses and pharmaceutical compositions for most of our drugs have been granted in Europe. Although certain of the patents granted by the regulatory authorities of the European Union may expire at specific dates, patents granted in certain European countries, such as Spain, France, Italy, Germany and the United Kingdom, will extend beyond such European Union patent expiration date due to the SPCs granted in these countries for many of our drugs. The table above may also reflect patents in Europe that relate to certain polymorphic forms of the active pharmaceutical ingredient of our drugs.

Patent term extensions have been granted in other markets as well, including Australia and Korea, relative to certain of our patents related to REVLIMID®. Patent term extensions relative to lenalidomide have been granted in Japan. Further, patent term extensions relative to ABRAXANE® have been secured and/or are actively being sought in Australia, Japan, Russia and Korea. We are also considering alternative exclusivity strategies, mostly through international treaties, in a variety of countries throughout Latin America.

The existence of issued patents does not guarantee our right to practice the patented technology or commercialize the patented product. Third parties may have or obtain rights to patents which could be used to prevent or attempt to prevent us from commercializing the patented product candidates. Patents relating to pharmaceutical, biopharmaceutical and biotechnology products, compounds and processes, such as those that cover our existing compounds, products and processes and those that we will likely file in the future, do not always provide complete or adequate protection. Future litigation or re-examination proceedings (including oppositions and invalidity proceedings) regarding the enforcement or validity of our existing patents or any future patents could invalidate such patents or substantially reduce their protection.

In total, we own or have exclusively licensed 480 issued U.S. patents. In addition, approximately 530 additional pending U.S. patent applications are owned by or exclusively licensed to us. We have a policy to seek broad global patent protection for our inventions and have foreign patent rights corresponding to most of our U.S. patents.

Our patents are subject to challenge by generic drug companies and others for a variety of reasons. For more information regarding challenges to certain of our patents, see Item 1A. "Risk Factors” and Item 3. "Legal Proceedings."

Trade secret strategies and intellectual property rights in our brand names, logos and trademarks are also important to our business. We maintain both registered and common law trademarks. Common law trademark protection typically continues where and for as long as the mark is used. Registered trademarks continue in each country for as long as the trademark is registered.
GOVERNMENTAL REGULATION
General:    Regulation by governmental authorities in the United States and other countries is a significant factor in the manufacture and marketing of pharmaceuticals and in our ongoing research and development activities. Our therapeutic products require regulatory approval by governmental agencies. Human therapeutic products are subject to rigorous preclinical testing and clinical trials and other pre-marketing and post-marketing approval requirements of the FDA and regulatory authorities in other countries. In the United States, various federal and, in some cases, state statutes and regulations also govern, or impact the manufacturing, testing for safety and effectiveness, labeling, storage, record-keeping and marketing of such products. The lengthy process of seeking required approvals and the continuing need for compliance with applicable statutes and regulations, require the expenditure of substantial resources. Regulatory approval, if and when obtained, may be limited in scope which may significantly limit the uses for which a product may be promoted. Further, approved drugs, as well as their manufacturers, are subject to ongoing post-marketing review, inspection and discovery of previously unknown problems with such products or the manufacturing or quality control procedures used in their production, which may result in restrictions on their manufacture, sale or use or in their withdrawal

10

from the market. Any failure or delay by us, our suppliers of manufactured drug product, collaborators or licensees, in obtaining regulatory approvals could adversely affect the marketing of our products and our ability to receive product revenue, license revenue or profit sharing payments. For more information, see Item 1A. “Risk Factors.”

Clinical Development:  Before a product may be administered to human subjects, it must undergo preclinical testing. Preclinical tests include laboratory evaluation of a product candidate's chemistry and biological activities and animal studies to assess potential safety and efficacy. The results of these studies must be submitted to the FDA as part of an Investigational New Drug (IND) application which must be reviewed by the FDA primarily for safety considerations before clinical trials in humans can begin.

Typically, clinical trials in humans involve a three-phase process as previously described under “- Product Development.”

In some cases, further studies beyond the three-phase clinical trial process described above are required as a condition for an NDA or biologics license application (BLA) approval. The FDA requires monitoring of all aspects of clinical trials and reports of all adverse events must be made to the FDA. The FDA may also require the conduct of pediatric studies for the drug and indication either before or after submission of an NDA.

FDA Review and Approval:    The results of the preclinical testing and clinical trials are submitted to the FDA as part of an NDA or BLA for evaluation to determine if there is substantial evidence that the product is sufficiently safe and effective to warrant approval. In responding to an NDA or BLA, the FDA may grant marketing approval, deny approval, or request additional information, including data from new clinical trials.

Expedited Programs for Serious Conditions:    The FDA has developed four distinct approaches to make new drugs available as rapidly as possible in cases where there is no available treatment or there are advantages over existing treatments.

The FDA may grant “accelerated approval” to products that have been studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit to patients over existing treatments. For accelerated approval, the product must have an effect on a surrogate endpoint or an intermediate clinical endpoint that is considered reasonably likely to predict the clinical benefit of a drug, such as an effect on irreversible morbidity and mortality. When approval is based on surrogate endpoints or clinical endpoints other than survival or morbidity, the sponsor will be required to conduct additional post-approval clinical studies to verify and describe clinical benefit. These studies are known as confirmatory trials. Approval of a drug may be withdrawn or the labeled indication of the drug changed if these trials fail to verify clinical benefit or do not demonstrate sufficient clinical benefit to justify the risks associated with the drug.

The FDA may grant “fast track” status to products that treat serious diseases or conditions and fill an unmet medical need. Fast track is a process designed to facilitate the development and expedite the review of such products by providing, among other things, more frequent meetings with the FDA to discuss the product's development plan, more frequent written correspondence from the FDA about trial design, eligibility for accelerated approval if relevant criteria are met, and rolling review, which allows submission of individually completed sections of an NDA or BLA for FDA review before the entire submission is completed. Fast track status does not ensure that a product will be developed more quickly or receive FDA approval.

“Breakthrough Therapy” designation is a process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint. For drugs and biologics that have been designated as Breakthrough Therapies, robust FDA-sponsor interaction and communication can help to identify the most efficient and expeditious path for clinical development while minimizing the number of patients placed in ineffective control regimens.

The FDA may grant “priority review” status to products that, if approved, would provide significant improvement in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions. Priority review is intended to reduce the time it takes for the FDA to review an NDA or BLA, with the goal to take action on the application within six months.

Orphan Drug Act: Pursuant to the United States Orphan Drug Act, a sponsor may request that the FDA designate a drug intended to treat a “rare disease or condition” as an “orphan drug.” A “rare disease or condition” is defined as one which affects less than 200,000 people in the United States, or which affects more than 200,000 people, but for which the cost of developing and making available the product is not expected to be recovered from sales of the product in the United States. Upon the approval of the first NDA or BLA for a drug designated as an orphan drug for a specified indication, the sponsor of that NDA or BLA is entitled to seven years of exclusive marketing rights in the United States unless the sponsor cannot assure the availability of sufficient quantities to meet the needs of persons with the disease. However, orphan drug status is particular to the approved indication and does not prevent another company from seeking approval of an off-patent drug that has other labeled indications that are not under orphan or other exclusivities. Orphan drugs may also be eligible for federal income tax credits for costs associated with

11

the drugs' development. In order to increase the development and marketing of drugs for rare disorders, regulatory bodies outside the United States have enacted regulations similar to the Orphan Drug Act.

Review and Approval Outside of the United States:    Approval procedures must be undertaken in virtually every other country comprising the market for our products. The approval procedure and the time required for approval vary from country to country and may involve additional testing. In certain countries such as the EU countries, Switzerland, Canada and Australia, regulatory requirements and approval processes are similar to those in the United States, where approval decisions by regulators are based on the regulators’ review of the results of clinical trials performed for specific indications. Other countries may have a less comprehensive review process in terms of data requirements and may rely on prior marketing approval from a foreign regulatory authority in the United States or the EU.

Manufacturing Quality Control:    Among the conditions for NDA or BLA approval is the requirement that the prospective manufacturer’s quality control and manufacturing procedures continually conform with the FDA’s current Good Manufacturing Practice (cGMP) regulations (which are regulations established by the FDA governing the manufacture, processing, packing, storage and testing of drugs and biologics intended for human use). In complying with cGMP, manufacturers must devote substantial time, money and effort in the areas of production, quality control and quality assurance to maintain compliance. Material changes in manufacturing equipment, location or process, may result in additional regulatory review and approval. The FDA, the EC and other regulatory agencies conduct periodic visits to inspect equipment, facilities, and processes following the initial approval of a product. If a manufacturing facility is not in substantial compliance with the applicable regulations and requirements imposed when the product was approved, regulatory enforcement action may be taken, which may include a warning letter or an injunction against shipment of products from the facility and/or recall of products previously shipped.

Post-approval Review and Enforcement:    Regulatory authorities closely review and regulate the marketing and promotion of drug and biologic products. In most countries, regulatory approval is granted for a specified indication and is required before marketing or promoting a product for that indication. Regulatory authorities may take enforcement action against a company for promoting unapproved uses of a product ("off-label promotion") or for other violations of advertising and labeling laws and regulations.

When an NDA or BLA is approved, the NDA or BLA holder must, among other things, (a) employ a system for obtaining reports of drug adverse events and side effects associated with the drug and make appropriate submissions to the FDA and (b) timely advise the FDA if any marketed product fails to adhere to specifications established by the NDA or BLA. If the FDA concludes that a drug previously shown to be effective can be safely used only if distribution or use is restricted, the FDA will require post-marketing restrictions as necessary to assure safe use. The sponsor may be required to establish systems to assure use of the product under safe conditions. The FDA may require the drug sponsor to implement REMS to ensure that benefits of a drug outweigh risks and that safety protocols are adhered to.

In addition, a sponsor of a drug product has ongoing reporting obligations concerning assessment of serious risks associated with the drug. Following assessment of these reports, regulatory authorities can require product label updates to reflect new safety data or warnings. If the FDA or other regulatory authorities become aware of new safety information, they can also require us to conduct studies or clinical trials to assess the potential for a serious risk. The FDA and other regulatory authorities can also impose marketing restrictions, including the suspension of marketing or complete withdrawal of a product from the market.

The FDA may issue publicly available warning letters and non-compliance letters, which may require corrective actions, including modification of advertising or other corrective communications to consumers or healthcare professionals.

Failure to comply with applicable FDA or other regulatory agency requirements can result in enforcement actions, such as license revocation or suspension; orders for retention, recall, seizure or destruction of product; cessation of manufacturing; injunctions; inspection warrants; search warrants; civil penalties, including fines based on disgorgement; restitution; and criminal prosecution.
Other Regulations: We are also subject to various federal and state laws, as well as foreign laws, pertaining to healthcare “fraud and abuse,” including anti-kickback laws and false claims laws. Anti-kickback laws make it illegal to solicit, offer, receive or pay any remuneration in exchange for or to induce the referral of business, including the purchase or prescription of a particular drug that is reimbursed by a state or federal program. False claims laws prohibit knowingly and willingly presenting, or causing to be presented for payment to third-party payers (including Medicare and Medicaid) any claims for reimbursed drugs or services that are false or fraudulent, claims for items or services not provided as claimed or claims for medically unnecessary items or services. Our activities related to the sale and marketing of our products may be subject to scrutiny under these laws. Violations of fraud and abuse laws may be punishable by criminal and/or civil sanctions, including fines and civil monetary penalties, as well as the possibility of exclusion from federal healthcare programs (including Medicare and Medicaid).

12

We are also subject to regulation under the Occupational Safety and Health Act, the Toxic Substances Control Act, the Resource Conservation and Recovery Act and other federal, state and local laws, rules and regulations. Our research and development activities may involve the controlled use of hazardous materials, chemicals, biological materials and various radioactive compounds. We believe our procedures comply with the standards prescribed by federal, state or local laws, rules and regulations; however, the risk of injury or accidental contamination cannot be completely eliminated.
Additionally, the U.S. Foreign Corrupt Practices Act (FCPA) prohibits U.S. corporations and their representatives from offering, promising, authorizing or making payments to any foreign government official, government staff member, political party or political candidate, in an attempt to obtain or retain business abroad. The scope of the FCPA includes interactions with certain healthcare professionals in many countries. Other countries have enacted similar anti-corruption laws and regulations to which our activities are subject.
COMPETITION
Our current products and products under development face competition from other innovative drugs and, in some cases, generic drugs. The relative speed with which we develop new products, complete clinical trials, obtain regulatory approvals, receive pricing and reimbursement approvals, and finalize manufacturing and distribution arrangements, and market our products are critical factors in gaining a competitive advantage. Competition among approved products depends, among other things, on product efficacy, safety, convenience, reliability, availability, price, third-party reimbursement, sales and promotional activities, product liability issues and patent and non-patent exclusivity. For additional information, see Item 1A. "Risk Factors.”

SIGNIFICANT ALLIANCES

We have entered into a variety of alliances in the ordinary course of our business. Although we do not consider any individual alliance to be material, a brief description of certain of the more notable alliances are identified in Note 17 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K.

MANUFACTURING

We own and operate an FDA approved manufacturing facility in Zofingen, Switzerland which produces the active pharmaceutical ingredient (API) for REVLIMID® and THALOMID® and have contracted with FDA approved third-party contract manufacturers to provide backup API manufacturing services for these products. Manufacturing services for REVLIMID® and THALOMID®, which consist of formulation, encapsulation, packaging, warehousing and distribution, are performed at our FDA approved drug product manufacturing facility in Boudry, Switzerland. We have contracted with a number of third-party drug product manufacturing service providers and packaging service providers to provide backup manufacturing and packaging services. All of our third-party service providers are approved by the regulatory authorities for the geographies that they serve.
The API for ABRAXANE® is generally available from multiple sources and is normally available in quantities adequate to meet our needs. Manufacturing services for ABRAXANE® are performed at our manufacturing facility in Arizona and by an approved third party contract manufacturing facility.
The API for VIDAZA® is supplied by three suppliers. Manufacturing and packaging services are provided by a number of third-party service providers.
The API for the azacitidine for injection (generic version of VIDAZA®) is supplied by a single -source supplier. Manufacturing and packaging services are provided by a single manufacturer.
The API for POMALYST®/IMNOVID® is supplied by a single-source supplier with primary manufacturing services being performed at our Boudry manufacturing facility.We have contracted with a number of third-party drug product manufacturing service providers and packaging service providers to provide backup manufacturing and packaging services for this product.
The API for ISTODAX® is supplied by a single-source supplier. Manufacturing and packaging services are provided by a number of third-party service providers.
The API for OTEZLA® (apremilast) is supplied by two suppliers with manufacturing services being performed at our Boudry manufacturing facility. We expect to utilize third-party service providers for backup manufacturing and packaging services for this product.
The API for FOCALIN® and FOCALIN XR® is currently obtained from two suppliers, and we rely on a single manufacturer for the tableting and packaging of FOCALIN® finished product.

13

CCT currently operates an FDA registered facility in Cedar Knolls, New Jersey for the recovery and storage of cord blood and placental stem cells for LifeBankUSA®. In addition, our Warren, New Jersey facility is FDA registered for production of PDA-001 and PDA-002, which are culture-expanded placenta-derived stem cell products, under cGMP to supply clinical studies. This is a multi-purpose facility capable of supporting other products.
INTERNATIONAL OPERATIONS
We have significant operations outside the United States conducted both through our subsidiaries and through distributors. Revenues from operations outside the United States were $2.632 billion, or 40.5% of total revenues in 2013, $2.338 billion, or 42.4% of total revenues in 2012 and $1.981 billion, or 40.9% of total revenues in 2011. The decrease in the percentage of total revenues from outside of the United States in 2013 compared to 2012 was primarily due to increased U.S. sales of ABRAXANE® resulting from the October 2012 and September 2013 FDA approvals for treatment of NSCLC and pancreatic cancer, respectively, as well as the U.S. launch of POMALYST® resulting from the February 2013 FDA approval for treatment of relapsed and refractory multiple myeloma.
Our international headquarters and a drug product manufacturing facility which performs formulation, encapsulation, packaging, warehousing and distribution are located in Boudry, Switzerland. We continue to expand our international regulatory, clinical and commercial infrastructure and currently conduct our international operations in over 50 countries and have sales in over 70 countries and regions including Europe, Latin America, Middle East, Asia/Pacific and Canada.
Our international operations are subject to risks associated with operating on an international basis including currency fluctuations, price and exchange controls and other restrictive governmental actions. Our international operations are also subject to government-imposed constraints, including laws on pricing, reimbursement and access to our products. Depending on the direction of change relative to the U.S. dollar, foreign currency values can increase or decrease the reported dollar value of our net assets and results of operations. While we cannot predict with certainty future changes in foreign exchange rates or the effect they will have, we attempt to mitigate their impact through operational means and by using foreign currency derivative instruments. See the discussions under Item 7A. "Quantitative and Qualitative Disclosures About Market Risk."
SALES AND COMMERCIALIZATION
We promote our brands globally through our commercial organization which supports our currently marketed brands and prepares for the launches of new products, as well as new indications for existing products. We have a team of dedicated market access professionals to help physicians, patients and payers understand the value our products deliver. Given our goal to ensure that patients who might benefit from our therapies have the opportunity to do so and given the complex reimbursement environment in the United States, we offer the services of Celgene Patient Support® or similar outside services to serve as a dedicated, central point of contact for patients and healthcare professionals who use or prescribe Celgene products. Celgene Patient Support® is a free service that helps patients and healthcare professionals navigate the challenges of reimbursement, providing information about co-pay assistance and answering questions about obtaining Celgene products.
In most countries, we promote our products through our own sales organizations. In some countries, particularly in Latin America, we partner with third-party distributors. Generally, we distribute our products through commonly used channels in local markets. However, REVLIMID®, POMALYST®/IMNOVID® and THALOMID®/Thalidomide CelgeneTM are distributed under mandatory risk-management distribution programs tailored to meet local authorities' specifications to provide for their safe and appropriate distribution and use.
EMPLOYEES
As of December 31, 2013, we had 5,100 full-time employees, of whom 2,110 were engaged primarily in research and development activities, 1,690 engaged primarily in sales and commercialization activities, 470 engaged primarily in manufacturing, and the remaining 830 engaged primarily in executive and general and administrative activities. The number of full-time employees in our international operations has grown from 1,834 at the end of 2012 to 1,933 at the end of 2013. We also employ a number of part-time employees and maintain consulting arrangements with a number of researchers at various universities and other research institutions around the world.
AVAILABLE INFORMATION
Our Current Reports on Form 8-K, Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K are electronically filed with or furnished to the Securities and Exchange Commission (SEC), and all such reports and amendments to such reports have been and will be made available, free of charge, through our website (http://www.celgene.com) as soon as reasonably practicable after such submission to the SEC. Such reports will remain available on our website for at least 12 months. The contents of our website are not incorporated by reference into this Annual Report on Form 10-K. The public may read and copy any materials filed by us with the SEC at the SEC's Public Reference Room at 100 F Street, NW, Washington, D.C. 20549.

14

The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site (http://www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.
DISCLOSURE PURSUANT TO SECTION 219 OF THE IRAN THREAT REDUCTION AND SYRIA HUMAN RIGHTS ACT OF 2012
Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (ITRSHRA) added Section 13(r) to the Securities Exchange Act of 1934, as amended, which requires, among other things, disclosure by an issuer, in its annual or quarterly reports, as applicable, whether it or any of its affiliates knowingly conducted, without specific authority from a U.S. federal department or agency, any transaction or dealing with the Government of Iran, which includes, without limitation, any person or entity owned or controlled, directly or indirectly, by the Government of Iran or any of its political subdivisions, agencies or instrumentalities. Neither Celgene nor, to its knowledge, any of its affiliates engaged in activities during 2013 that are required to be disclosed pursuant to ITRSHRA.
FORWARD-LOOKING STATEMENTS
Certain statements contained or incorporated by reference in this Annual Report on Form 10-K are considered forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning our business, results of operations, economic performance and/or financial condition, based on management's current expectations, plans, estimates, assumptions and projections. Forward-looking statements are included, for example, in the discussions about:
•
strategy;
•
new product discovery and development;
•
current or pending clinical trials;
•
our products' ability to demonstrate efficacy or an acceptable safety profile;
•
actions by the FDA and other regulatory authorities;
•
product manufacturing, including our arrangements with third-party suppliers;
•
product introduction and sales;
•
royalties and contract revenues;
•
expenses and net income;
•
credit and foreign exchange risk management;
•
liquidity;
•
asset and liability risk management;
•
the outcome of litigation and other proceedings;
•
intellectual property rights and protection;
•
economic factors;
•
competition; and
•
operational and legal risks.
Any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements. Forward-looking statements generally are identified by the words "expects," "anticipates," "believes," "intends," "estimates," "aims," "plans," "may," "could," "will," "will continue," "seeks," "should," "predict," "potential," "outlook," "guidance," "target," "forecast," "probable," "possible" or the negative of such terms and similar expressions. Forward-looking statements are subject to change and may be affected by risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update any forward-looking statement in light of new information or future events, although we intend to continue to meet our ongoing disclosure obligations under the U.S. securities laws and other applicable laws.
We caution you that a number of important factors could cause actual results or outcomes to differ materially from those expressed in, or implied by, the forward-looking statements, and therefore you should not place too much reliance on them. These factors include, among others, those described herein, under "Risk Factors" and elsewhere in this Annual Report and in our other public reports filed with the SEC. It is not possible to predict or identify all such factors, and therefore the factors that are noted are not intended to be a complete discussion of all potential risks or uncertainties that may affect forward-looking statements. If these or other risks and uncertainties materialize, or if the assumptions underlying any of the forward-looking statements prove incorrect, our actual performance and future actions may be materially different from those expressed in, or implied by, such forward-looking statements. We can offer no assurance that our estimates or expectations will prove accurate or that we will be able to achieve our strategic and operational goals.

15

ITEM 1A.    RISK FACTORS
The following describes the major risks to our business and should be considered carefully.  Any of these factors could significantly and negatively affect our business, prospects, financial condition, operating results or credit ratings, which could cause the trading prices of our equity securities to decline.  The risks described below are not the only risks we may face.  Additional risks and uncertainties not presently known to us, or risks that we currently consider immaterial, could also negatively affect us.
 
Our operating results are subject to significant fluctuations.
 
Our operating results may fluctuate from quarter to quarter and year to year for a number of reasons, including the risks discussed elsewhere in this “Risk Factors” section. Events such as a delay in product development or a revenue shortfall may cause financial results for a particular period to be below our expectations. In addition, we have experienced and may continue to experience fluctuations in our quarterly operating results due to the timing of charges that we may take. We have recorded, or may be required to record, charges that include development milestone and license payments under collaboration and license agreements and amortization of acquired intangibles and other acquisition related charges.

Our revenues are also subject to foreign exchange rate fluctuations due to the global nature of our operations. We recognize foreign currency gains or losses arising from our operation in the period in which we incur those gains or losses. Although we utilize foreign currency forward contracts and option contracts to manage foreign currency risk, our efforts to reduce currency exchange losses may not be successful. As a result, currency fluctuation among our reporting currency, the U.S. dollar, and the currencies in which we do business will affect our operating results. Our net income may also fluctuate due to the impact of charges we may be required to take with respect to foreign currency and other hedge transactions. In particular, we may incur higher than expected charges from hedge ineffectiveness or from the termination of a hedge arrangement.

We are dependent on the continued commercial success of our primary products, REVLIMID®, VIDAZA®, THALOMID®, ABRAXANE® and POMALYST ®/IMNOVID ®.
 
Currently, our business is largely dependent on the commercial success of REVLIMID®, VIDAZA®, THALOMID®, ABRAXANE® and POMALYST®/IMNOVID®. The success of these products depends on acceptance by regulators, key opinion leaders, physicians, and patients as effective drugs with certain advantages over other therapies.  A number of factors, as discussed in greater detail below, may adversely impact the degree of acceptance of these products, including their efficacy, safety, price and benefits over competing products, as well as the reimbursement policies of third-party payers, such as government and private insurance plans.
 
If unexpected adverse events are reported in connection with the use of any of these products, physician and patient acceptance of the product could deteriorate and the commercial success of such product could be adversely affected.  We are required to report to the FDA or similar bodies in other countries events associated with our products relating to death or serious injury. Adverse events could result in additional regulatory controls, such as a requirement for costly post-approval clinical studies or revisions to our approved labeling which could limit the indications or patient population for a product or could even lead to the withdrawal of a product from the market. THALOMID® is known to be toxic to the human fetus and exposure to the drug during pregnancy could result in significant deformities.  REVLIMID® and POMALYST®/IMNOVID® are also considered toxic to the human fetus and their respective labels contain warnings against use by pregnant women. While we have restricted distribution systems for THALOMID®, REVLIMID®, and POMALYST®/IMNOVID®, and endeavor to educate patients regarding the potential known adverse events, including pregnancy risks, we cannot ensure that all such warnings and recommendations will be complied with or that adverse events resulting from non-compliance will not occur.
 
Our future commercial success depends on gaining regulatory approval for products in development, and obtaining approvals for our current products for additional indications.
 
The testing, manufacturing and marketing of our products require regulatory approvals, including approval from the FDA and similar bodies in other countries. Certain of our pharmaceutical products, such as FOCALIN®, also require authorization by the U.S. Drug Enforcement Agency (DEA) of the U.S. Department of Justice. Our future growth would be negatively impacted if we fail to obtain timely, or at all, requisite regulatory approvals in the United States and internationally for products in development and approvals for our existing products for additional indications.
 

16

The principal risks to obtaining and maintaining regulatory approvals are as follows:

•
In general, preclinical tests and clinical trials can take many years and require the expenditure of substantial resources, and the data obtained from these tests and trials may not lead to regulatory approval;
•
Delays or rejections may be encountered during any stage of the regulatory process if the clinical or other data fails to demonstrate compliance with a regulatory agency’s requirements for safety, efficacy and quality;
•
Requirements for approval may become more stringent due to changes in regulatory agency policy or the adoption of new regulations or legislation;
•
Even if a product is approved, the scope of the approval may significantly limit the indicated uses for which the product may be marketed and may impose significant limitations in the nature of warnings, precautions and contra-indications that could materially affect the sales and profitability of the product;
•
After a product is approved, the FDA or other international regulatory agency may withdraw or modify an approval in a significant manner or request that we perform additional clinical trials or change the labeling of the product due to a number of reasons, including safety concerns, adverse events and side effects;
•
Products, such as REVLIMID® and POMALYST®/IMNOVID®, that are subject to accelerated approval can be subject to an expedited withdrawal if post-marketing restrictions are not adhered to or are shown to be inadequate to assure safe use, or if the drug is shown to be unsafe or ineffective under its conditions of use;
•
Guidelines and recommendations published by various governmental and non-governmental organizations can reduce the use of our approved products;
•
Approved products, as well as their manufacturers, are subject to continuing and ongoing review by regulatory agencies, and the discovery of previously unknown problems with these products or the failure to comply with manufacturing or quality control requirements may result in restrictions on the manufacture, sale or use of a product or its withdrawal from the market; and
•
Changes in regulatory agency policy or the adoption of new regulations or legislation could impose restrictions on the sale of our approved products.
If we fail to comply with laws or government regulations or policies our business could be adversely affected.

The discovery, preclinical development, clinical trials, manufacturing, risk evaluation and mitigation strategies (such as our REMS® program), marketing and labeling of pharmaceuticals and biologics are all subject to extensive laws and government regulations and policies.  In addition, individual states, acting through their attorneys general, are increasingly seeking to regulate the marketing of prescription drugs under state consumer protection and false advertising laws. If we fail to comply with the laws and regulations regarding the promotion and sale of our products, appropriate distribution of our products under our restricted distribution systems, off-label promotion and the promotion of unapproved products, government agencies may bring enforcement actions against us that could inhibit our commercial capabilities and result in significant penalties.
 
Other matters that may be the subject of governmental or regulatory action which could adversely affect our business include laws, regulations and policies governing:

•
protection of the environment, privacy, healthcare reimbursement programs, and competition;
•
parallel importation of prescription drugs from outside the United States at prices that are regulated by the governments of various foreign countries; and
•
premature or mandated disclosures of clinical trial or other data.
The FDA’s Center for Biologics Evaluation and Research currently regulates human tissue or cells intended for transplantation, implantation, infusion or transfer to a human, requiring, among other things, cell and tissue establishments to screen and test donors, prepare and follow written procedures for the prevention of the spread of communicable disease and register with FDA. Through our CCT subsidiary, we are licensed in certain states to operate our allogeneic and private stem cell banking businesses. If we are unable to maintain those licenses or are unable to obtain licenses in other states that may adopt similar licensing requirements, those businesses could be adversely affected.
 

17

Sales of our products will be significantly reduced if access to and reimbursement for our products by governmental and other third-party payers is reduced or terminated.
 
Sales of our current and future products depend, in large part, on the conditions under which our products are paid for by health maintenance, managed care, pharmacy benefit and similar health care management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payers.  Generally, in Europe and other countries outside the United States, the government-sponsored healthcare system is the primary payer of patients’ healthcare costs.  These health care management organizations and third-party payers are increasingly challenging the prices charged for medical products and services, seeking to implement cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products.  Our products continue to be subject to increasing price and reimbursement pressure due to price controls imposed by governments in many countries; increased difficulty in obtaining and maintaining satisfactory drug reimbursement rates; and the tendency of governments and private health care providers to favor generic pharmaceuticals. In addition, governmental and private third-party payers and purchasers of our products may restrict access to formularies or otherwise discourage use of our products. Limitations on patient access to our drugs, adoption of price controls and cost-containment measures could adversely affect our business. In addition, our operating results may also be affected by distributors seeking to take advantage of price differences among various markets by buying our products on low cost markets for resale in higher cost markets.

The Affordable Care Act will affect our profitability.

In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (together, the Affordable Care Act), was enacted in the United States. The provisions of the Affordable Care Act became effective over various periods from 2010 through 2014. We expect that the rebates, discounts, taxes and other costs resulting from the Affordable Care Act will have a significant effect on our profitability in the future. In addition, potential reductions of the per capita rate of growth in Medicare spending under the Affordable Care Act, could potentially limit access to certain treatments or mandate price controls for our products. Similarly, the promulgation of new regulations concerning rebates, discounts, taxes and other costs, or the interpretation and enforcement of new or existing regulations by government agencies could affect our profitability in ways that are difficult to predict.
 
Our ability to sell our products to hospitals in the United States depends in part on our relationships with group purchasing organizations.

Many existing and potential customers for our products become members of group purchasing organizations (GPOs). GPOs negotiate pricing arrangements and contracts, sometimes on an exclusive basis, with medical supply manufacturers and distributors and these negotiated prices are made available to a GPO’s affiliated hospitals and other members. If we are not one of the providers selected by a GPO, affiliated hospitals and other members may be less likely to purchase our products, and if the GPO has negotiated a strict sole source, market share compliance or bundling contract for another manufacturer’s products, we may be precluded from making sales to members of the GPO for the duration of that contractual arrangement. Our failure to enter into or renew contracts with GPOs may cause us to lose market share and could adversely affect our sales.
 
Our long-term success depends, in part, on intellectual property protection.
 
Our success depends, in part, on our ability to obtain and enforce patents, protect trade secrets, obtain licenses to technology owned by third parties and to conduct our business without infringing upon the proprietary rights of others.  The patent positions of pharmaceutical and biopharmaceutical companies, including ours, can be uncertain and involve complex legal and factual questions. There can be no assurance that if claims of any of our owned or licensed patents are challenged by one or more third parties a court or patent authority ruling on such challenge will determine that our patent claims are valid and enforceable. If a third party is found to have rights covering products or processes used by us, we could be forced to cease using the products or processes covered by the disputed rights, be subject to significant liabilities to such third party and/or be required to license technologies from such third party. Lawsuits involving patent claims are costly and could affect our results of operations, result in significant expense and divert the attention of managerial and scientific personnel. For more information on challenges to certain of our patents, see “Legal Proceedings” contained elsewhere in this report.

In addition, we do not know whether any of our owned or licensed pending patent applications, which have not already been allowed, will result in the issuance of patents or, if patents are issued, whether they will be dominated by third-party patent rights, provide significant proprietary protection or commercial advantage or be circumvented, opposed, invalidated, rendered unenforceable or infringed by others.
 
Our intellectual property rights may be affected in ways that are difficult to anticipate at this time under the provisions of the

18

America Invents Act enacted in 2011.  This law includes a number of important changes to established practices, including transition to a first-to-file system, post-grant review for issued patents, and various procedural changes. The scope of these changes and the lack of experience with their practical implementation may result in uncertainty over the next few years.
 
Also, different countries have different procedures for obtaining patents and patents issued by different countries provide different degrees of protection against the use of a patented invention by others.  There can be no assurance that the issuance to us in one country of a patent covering an invention will be followed by the issuance in other countries of patents covering the same invention or that any judicial interpretation of the validity, enforceability or scope of the claims in a patent issued in one country will be similar to or recognized by the judicial interpretation given to a corresponding patent issued in another country.

The United States Patent and Trademark Office and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction.

We also rely upon unpatented, proprietary and trade secret technology that we seek to protect, in part, by confidentiality agreements with our collaborative partners, employees, consultants, outside scientific collaborators, sponsored researchers and other advisors.  Despite precautions taken by us, there can be no assurance that these agreements provide meaningful protection, that they will not be breached, that we would have adequate remedies for any such breach or that our proprietary and trade secret technology will not otherwise become known to others or found to be non-proprietary.

We receive confidential and proprietary information from collaborators, prospective licensees and other third parties. In addition, we employ individuals who were previously employed at other biotechnology or pharmaceutical companies. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential information of these third parties or our employees’ former employers. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and diversion of personnel and resources.

Our products may face competition from lower cost generic or follow-on products.
 
Manufacturers of generic drugs are seeking to compete with our drugs and present a significant challenge to us. Those manufacturers may challenge the scope, validity or enforceability of our patents in court, requiring us to engage in complex, lengthy and costly litigation.  If any of our owned or licensed patents are infringed or challenged, we may not be successful in enforcing or defending those intellectual property rights and, as a result, may not be able to develop or market the relevant product exclusively, which would have a material adverse effect on our sales from that product. In addition, manufacturers of innovative drugs as well as generic drug manufacturers may be able to design around our owned or licensed patents and compete with us using the resulting alternative technology. For more information concerning certain pending proceedings relating to our intellectual property rights, see “Legal Proceedings” contained elsewhere in this report.
 
Upon the expiration or loss of patent protection for a product, or upon the “at-risk” launch (despite pending patent infringement litigation against the generic product) by a manufacturer of a generic version of one of our products, we can quickly lose a significant portion of our sales of that product. In addition, if generic versions of our competitors’ branded products lose their market exclusivity, our patented products may face increased competition for our products.
 
Our business operates in an extremely competitive environment.
 
The pharmaceutical and biotechnology industries in which we operate are highly competitive and subject to rapid and significant technological change. Our present and potential competitors include major pharmaceutical and biotechnology companies, as well as specialty pharmaceutical firms, including:

•
Hematology and Oncology: Amgen, AstraZeneca, Bristol-Myers-Squibb, Eisai, Gilead, Johnson & Johnson, Novartis, Pharmacyclics, Roche/Genentech, Sanofi and Takeda.
•
Inflammation and Immunology: AbbVie, Amgen, Biogen Idec, Eisai, Johnson & Johnson, Merck, Pfizer and UCB S.A.
Many of these companies have considerably greater financial, technical and marketing resources than we have, enabling them, among other things, to make greater research and development investments. We also experience competition in drug development from universities and other research institutions, and we compete with others in acquiring technology from these sources.  The

19

pharmaceutical industry has undergone, and is expected to continue to undergo, rapid and significant technological change and we expect competition to intensify as technical advances are made and become more widely known.  The development of products or processes by our competitors with significant advantages over those that we are developing could adversely affect our future revenues and profitability.
 
A decline in general economic conditions would adversely affect our results of operations.
 
Sales of our products are dependent, in large part, on third-party payers.  As a result of global credit and financial market conditions, these organizations may be unable to satisfy their reimbursement obligations or may delay payment. For information about amounts receivable from the government owned or controlled hospitals in Spain, Italy and Portugal, see our discussion of accounts receivable from those countries in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of this report.

In addition, due to tightened global credit, there may be a disruption or delay in the performance of our third-party contractors, suppliers or collaborators.  We rely on third parties for several important aspects of our business, including portions of our product manufacturing, clinical development of future collaboration products, conduct of clinical trials and supply of raw materials.  If such third parties are unable to satisfy their commitments to us, our business could be adversely affected.
 
We may be required to modify our business practices, pay fines and significant expenses or experience other losses due to governmental investigations or other enforcement activities.
 
We may become subject to litigation or governmental investigations in the United States and foreign jurisdictions that may arise from the conduct of our business. Like many companies in our industry, we have from time to time received inquiries and subpoenas and other types of information requests from government authorities and we have been subject to claims and other actions related to our business activities. For more information relating to governmental investigations and other legal proceedings, see Note 18 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K.
 
While the ultimate outcome of investigations and legal proceedings are difficult to predict, adverse resolutions or settlements of those matters could result in, among other things:

•
significant damage awards, fines, penalties or other payments, and administrative remedies, such as exclusion and/or debarment from government programs, or other rulings that preclude us from operating our business in a certain manner;
•
changes to our business operations to avoid risks associated with such litigation or investigations;
•
product recalls;
•
reputational damage and decreased demand for our products; and
•
expenditure of significant time and resources that would otherwise be available for operating our business.
While we maintain insurance for certain risks, the amount of our insurance coverage may not be adequate to cover the total amount of all adverse resolutions and settlements of claims and liabilities. It also is not possible to obtain insurance to protect against all potential risks and liabilities. For more information, see Note 18 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K.
 

20

The development of new biopharmaceutical products involves a lengthy and complex process and we may be unable to commercialize any of the products we are currently developing.
 
Many of our drug candidates are in the early or mid-stages of research and development and will require the commitment of substantial financial resources, extensive research, development, preclinical testing, clinical trials, manufacturing scale-up and regulatory approval prior to being ready for sale.  This process takes many years of effort without any assurance of ultimate success. Our product development efforts with respect to a product candidate may fail for many reasons, including:

•
the failure of the product candidate in preclinical or clinical studies;
•
adverse patient reactions to the product candidate or indications of other safety concerns;
•
insufficient clinical trial data to support the effectiveness or superiority of the product candidate;
•
our inability to manufacture sufficient quantities of the product candidate for development or commercialization activities in a timely and cost-efficient manner;
•
our failure to obtain, or delays in obtaining, the required regulatory approvals for the product candidate, the facilities or the process used to manufacture the product candidate;
•
changes in the regulatory environment, including pricing and reimbursement, that make development of a new product or of an existing product for a new indication no longer attractive; and
•
the failure to obtain or maintain satisfactory drug reimbursement rates by governmental or third-party payers.

The stem cell products that we are developing through our CCT subsidiary may represent substantial departures from established treatment methods and will compete with a number of traditional products and therapies which are now, or may be in the future, manufactured and marketed by major pharmaceutical and biopharmaceutical companies.  Furthermore, public attitudes may be influenced by claims that stem cell therapy is unsafe and stem cell therapy may not gain the acceptance of the public or the medical community.

If a product were to fail to be approved or if sales fail to materialize for a newly approved product, we may incur losses related to the write-down of inventory, impairment of property, plant and equipment dedicated to the product or expenses related to restructuring.

Disruptions of our manufacturing and distribution operations could significantly interrupt our production and distribution capabilities.

We have our own manufacturing facilities for many of our products and we have contracted with third parties to provide other manufacturing, finishing, and packaging services.  Any of those manufacturing processes could be partially or completely disrupted by fire, contamination, natural disaster, terrorist attack, governmental action or military action. A disruption could lead to substantial production delays and the need to establish alternative manufacturing sources for the affected products requiring additional regulatory approvals. In the interim, our finished goods inventories may be insufficient to satisfy customer orders on a timely basis. Further, our business interruption insurance may not adequately compensate us for any losses that may occur.
 
In all the countries where we sell our products, governmental regulations define standards for manufacturing, packaging, labeling, distributing and storing pharmaceutical products.  Our failure to comply, or the failure of our contract manufacturers and distributors to comply with applicable regulations could result in sanctions being imposed on them or us, including fines, injunctions, civil penalties, disgorgement, suspension or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions and criminal prosecutions.
 
We have contracted with distributors to distribute REVLIMID®, THALOMID®, VIDAZA®, ABRAXANE®, POMALYST®/IMNOVID® and ISTODAX®.  If our distributors fail to perform and we cannot secure a replacement distributor within a reasonable period of time, our revenue could be adversely affected.
  
The consolidation of drug wholesalers and other wholesaler actions could increase competitive and pricing pressures.
 
We sell our pharmaceutical products in the United States primarily through wholesale distributors and contracted pharmacies. These wholesale customers comprise a significant part of our distribution network for pharmaceutical products in the United States. This distribution network is continuing to undergo significant consolidation. As a result, a smaller number of large wholesale distributors and pharmacy chains control a significant share of the market. We expect that consolidation of drug wholesalers and pharmacy chains will increase competitive and pricing pressures on pharmaceutical manufacturers, including us. In addition, wholesalers may apply pricing pressure through fee-for-service arrangements and their purchases may exceed customer demand, resulting in increased returns or reduced wholesaler purchases in later periods.


21

Risks from the improper conduct of employees, agents, contractors or collaborators could adversely affect our business or reputation.
 
We cannot ensure that our compliance controls, policies and procedures will in every instance protect us from acts committed by our employees, agents, contractors or collaborators that violate the laws or regulations of the jurisdictions in which we operate, including employment, anti-corruption, environmental, competition and privacy laws.  Such improper actions could subject us to civil or criminal investigations, monetary and injunctive penalties and could adversely impact our ability to conduct business, our results of operations and our reputation.
 
The integration of acquired businesses may present significant challenges to us.
 
We may face significant challenges in effectively integrating entities and businesses that we acquire and we may not realize the benefits anticipated from such acquisitions.  Achieving the anticipated benefits of our acquired businesses will depend in part upon whether we can integrate our businesses in an efficient and effective manner.  Our integration of acquired businesses involves a number of risks, including:
 
•
demands on management related to the increase in our size after the acquisition;
•
the diversion of management’s attention from daily operations to the integration of acquired businesses and personnel;
•
higher than anticipated integration costs;
•
failure to achieve expected synergies and costs savings;
•
difficulties in the assimilation and retention of employees;
•
difficulties in the assimilation of different cultures and practices, as well as in the assimilation of broad and geographically dispersed personnel and operations; and
•
difficulties in the integration of departments, systems, including accounting systems, technologies, books and records and procedures, as well as in maintaining uniform standards and controls, including internal control over financial reporting, and related procedures and policies.
We may not be able to continue to attract and retain highly qualified managerial, scientific, manufacturing and commercial talent.
 
The success of our business depends, in large part, on our continued ability to attract and retain highly qualified managerial, scientific, manufacturing and commercial personnel, and competition for these types of personnel is intense. We cannot be sure that we will be able to attract or retain skilled personnel or that the costs of doing so will not materially increase.
 
Risks associated with using hazardous materials in our business could subject us to significant liability.
 
We use certain hazardous materials in our research, development, manufacturing and other business activities.  If an accident or environmental discharge occurs, or if we discover contamination caused by prior owners and operators of properties we acquire, we could be liable for remediation obligations, damages and fines that could exceed our insurance coverage and financial resources.  Additionally, the cost of compliance with environmental and safety laws and regulations may increase in the future, requiring us to expend more financial resources either in compliance or in purchasing supplemental insurance coverage.
 
Product liability claims could adversely affect our business, results of operations and financial condition.

Product liability claims could result in significant damage awards or settlements. Such claims can also be accompanied by consumer fraud claims or claims by third-party payers seeking reimbursement of the cost of our products. In addition, adverse determinations or settlements of product liability claims may result in suspension or withdrawal of a product marketing authorization or changes to our product labeling, including restrictions on therapeutic indications, inclusion of new contraindications, warnings or precautions. Although we purchase product liability coverage from third-party carriers, it is increasingly difficult and costly to obtain. There can be no assurance that we will be able to recover under any insurance policy or that such coverage will be adequate to fully cover all risks or damage awards or settlements. Product liability claims, regardless of their merits or ultimate outcome, are costly, divert management attention, may harm our reputation and can impact the demand for our products.


22

Changes in our effective income tax rate could adversely affect our results of operations.
 
We are subject to income taxes in both the United States and various foreign jurisdictions and our domestic and international tax liabilities are largely dependent upon the distribution of income among these different jurisdictions.  Various factors may have favorable or unfavorable effects on our effective income tax rate.  These factors include interpretations of existing tax laws, the accounting for stock options and other share-based compensation, changes in tax laws and rates, future levels of research and development spending, changes in accounting standards, changes in the mix of earnings in the various tax jurisdictions in which we operate, the outcome of examinations by the U.S. Internal Revenue Service and other tax authorities, the accuracy of our estimates for unrecognized tax benefits and realization of deferred tax assets and changes in overall levels of pre-tax earnings.  The impact on our income tax provision resulting from the above-mentioned factors and others could have a material impact on our results of operations.
 
Currency fluctuations and changes in exchange rates could adversely affect our revenue growth, increase our costs and cause our profitability to decline.
 
We collect and pay a substantial portion of our sales and expenditures in currencies other than the U.S. dollar. Therefore, fluctuations in foreign currency exchange rates affect our operating results. We utilize foreign currency forward contracts and option contracts, which are derivative instruments, to manage foreign currency risk.  We use these derivative instruments to hedge certain forecasted transactions, manage exchange rate volatility in the translation of foreign earnings and reduce exposures to foreign currency fluctuations of certain balance sheet items denominated in foreign currencies.  The use of these derivative instruments is intended to mitigate a portion of the exposure of these risks with the intent to reduce our risk or cost, but generally would not fully offset any change in operating results as a consequence of fluctuations in foreign currencies.  Any significant foreign exchange rate fluctuations could adversely affect our financial condition and results of operations.  See Note 5 of Notes to Consolidated Financial Statements, and Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” contained in this Annual Report on Form 10-K.
 
We may experience an adverse market reaction if we are unable to meet our financial reporting obligations.
 
As we continue to expand at a rapid pace, the development of new and/or improved automated systems will remain an ongoing priority.  During this expansion period, our internal control over financial reporting may not prevent or detect misstatements in our financial reporting.  Such misstatements may result in litigation and/or negative publicity and possibly cause an adverse market reaction that may negatively impact our growth plans and the value of our common stock.
 
Impairment charges or write downs in our books and changes in accounting standards could have a significant adverse effect on our results of operations and financial condition.

New or revised accounting standards, rules and interpretations could result in changes to the recognition of income and expense that may materially and adversely affect our financial results. In addition, the value allocated to certain of our assets could be substantially impaired due to a number of factors beyond our control. Also, if any of our strategic equity investments decline in value, we may be required to write down such investment.

The price of our common stock may fluctuate significantly.
 
The market for our shares of common stock may fluctuate significantly.  The following key factors may have an adverse impact on the market price of our common stock:

•
results of our clinical trials or adverse events associated with our marketed products;
•
fluctuations in our commercial and operating results;
•
announcements of technical or product developments by us or our competitors;
•
market conditions for pharmaceutical and biotechnology stocks in particular;
•
changes in laws and governmental regulations, including changes in tax, healthcare, environmental, competition and patent laws;
•
new accounting pronouncements or regulatory rulings;
•
public announcements regarding medical advances in the treatment of the disease states that we are targeting;

23

•
patent or proprietary rights developments;
•
changes in pricing and third-party reimbursement policies for our products;
•
the outcome of litigation involving our products, processes or intellectual property;
•
the existence and outcome of governmental investigations and proceedings;
•
regulatory actions that may impact our products or potential products;
•
disruptions in our manufacturing processes or supply chain;
•
failure of our collaboration partners to successfully develop potential drug candidates;
•
competition; and
•
investor reaction to announcements regarding business or product acquisitions.
In addition, a market downturn in general and/or in the biopharmaceutical sector in particular, may adversely affect the market price of our securities, which may not necessarily reflect the actual or perceived value of our company.
 
Our business would be adversely affected if we are unable to service our debt obligations.
 
We have incurred various forms of indebtedness, including senior notes, commercial paper and a senior unsecured credit facility.  Our ability to pay interest and principal amounts when due, comply with debt covenants or repurchase the senior notes if a change of control occurs, will depend upon, among other things, continued commercial success of our products and other factors that affect our future financial and operating performance, including prevailing economic conditions and financial, business and regulatory factors, many of which are beyond our control.
 
If we are unable to generate sufficient cash flow to service the debt service requirements under our debt instruments, we may be forced to take remedial actions such as:

•
restructuring or refinancing our debt;
•
seeking additional debt or equity capital;
•
reducing or delaying our business activities, acquisitions, investments or capital expenditures, including research and development expenditures; or
•
selling assets, businesses, products or other potential revenue streams.
Such measures might not be successful and might not enable us to service our debt obligations. In addition, any such financing, refinancing or sale of assets might not be available on economically favorable terms, if at all.
 
A breakdown or breach of our information technology systems could subject us to liability or interrupt the operation of our business.

We rely upon our information technology systems and infrastructure for our business. The size and complexity of our computer systems make them potentially vulnerable to breakdown and unauthorized intrusion.  Similarly, data privacy breaches by those who access our systems may pose a risk that sensitive data may be exposed to unauthorized persons or to the public. There can be no assurance that our efforts to protect our data and information technology systems will prevent breakdowns or breaches in our systems that could adversely affect our business.
 
The illegal distribution and sale by third parties of counterfeit versions of our products or stolen products could have a negative impact on our reputation and business.

Third parties might illegally distribute and sell counterfeit versions of our products, which do not meet our rigorous manufacturing and testing standards. A patient who receives a counterfeit drug may be at risk for a number of dangerous health consequences. Our reputation and business could suffer harm as a result of counterfeit drugs sold under our brand name. In addition, thefts of inventory at warehouses, plants or while in-transit, which are not properly stored and which are sold through unauthorized channels, could adversely impact patient safety, our reputation and our business.

24


We have certain charter and by-law provisions that may deter a third-party from acquiring us and may impede the stockholders’ ability to remove and replace our management or board of directors.
 
Our board of directors has the authority to issue, at any time, without further stockholder approval, up to 5.0 million shares of preferred stock and to determine the price, rights, privileges and preferences of those shares.  An issuance of preferred stock could discourage a third-party from acquiring a majority of our outstanding voting stock.  Additionally, our by-laws contain provisions intended to strengthen the board’s position in the event of a hostile takeover attempt.  These provisions could impede the stockholders’ ability to remove and replace our management and/or board of directors.  Furthermore, we are subject to the provisions of Section 203 of the Delaware General Corporation Law, an anti-takeover law, which may also dissuade a potential acquirer of our common stock.
 
In addition to the risks relating to our common stock, holders of our CVRs are subject to additional risks.
 
On October 15, 2010, we acquired all of the outstanding common stock of Abraxis BioScience, Inc. (Abraxis) and in connection with our acquisition, Contingent Value Rights (CVRs) were issued entitling each holder of a CVR to a pro rata portion of certain milestone and net sales payments if certain specified conditions are satisfied. In addition to the risks relating to our common stock, CVR holders are subject to additional risks, including:

•
an active public market for the CVRs may not continue to exist or the CVRs may trade at low volumes, both of which could have an adverse effect on the market price, if any, of the CVRs;
•
if the clinical approval milestones or net sales targets specified in the CVR Agreement are not achieved for any reason within the time periods specified therein, no payment will be made under the CVRs and the CVRs will expire valueless;
•
since the U.S. federal income tax treatment of the CVRs is unclear, any part of a CVR payment could be treated as ordinary income and the tax thereon may be required to be paid prior to the receipt of the CVR payment;
•
any payments in respect of the CVRs are subordinated to the right of payment of certain of our other indebtedness;
•
we may under certain circumstances redeem the CVRs; and
•
upon expiration of our obligations under the CVR Agreement to continue to commercialize ABRAXANE® or any of the other Abraxis pipeline products, we may discontinue such efforts, which would have an adverse effect on the value, if any, of the CVRs.

25

ITEM 1B.    UNRESOLVED STAFF COMMENTS
None.
ITEM 2.    PROPERTIES
Our corporate headquarters are located in Summit, New Jersey and our international headquarters are located in Boudry, Switzerland. Summarized below are the locations, primary usage and approximate square footage of the facilities we own worldwide:
Location
 
Primary Usage
 
Approximate
Square Feet
Summit, New Jersey
 
Administration, marketing, research
 
400,000

Boudry, Switzerland
 
Manufacturing, administration and warehousing
 
266,500

Phoenix, Arizona
 
Manufacturing and warehousing
 
247,000

Zofingen, Switzerland
 
Manufacturing
 
12,000

We occupy the following facilities, located in the United States, under operating lease arrangements, none of which are individually material to us. Under these lease arrangements, we may be required to reimburse the lessors for real estate taxes, insurance, utilities, maintenance and other operating costs. All leases are with unaffiliated parties.
Location
 
Primary Usage
 
Approximate
Square Feet
Berkeley Heights, New Jersey
 
Office space
 
337,800

Warren, New Jersey
 
Office space and research
 
177,600

San Diego, California
 
Research
 
171,900

Basking Ridge, New Jersey
 
Office space
 
95,900

San Francisco, California
 
Office space and research
 
55,900

Durham, North Carolina
 
Clinical trial management
 
36,000

Overland Park, Kansas
 
Office space
 
29,600

Cedar Knolls, New Jersey
 
Office space and stem cell recovery
 
25,300

Bedford, Massachusetts
 
Office space
 
23,000

Los Angeles, California
 
Office space
 
9,900

Dallas, Texas
 
Office space
 
3,000

Destin, Florida
 
Office space
 
1,600

We also lease a number of offices under various lease agreements outside of the United States for which the minimum annual rents may be subject to specified annual rent increases. At December 31, 2013, the non-cancelable lease terms for our operating leases expire at various dates between 2014 and 2023 and in some cases include renewal options. The total amount of rent expense recorded for all leased facilities in 2013 was $42.5 million.
ITEM 3.    LEGAL PROCEEDINGS
See Note 18 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K.
ITEM 4.    MINE SAFETY DISCLOSURES
Not applicable.

26

PART II
ITEM 5.    MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
(a)   MARKET INFORMATION
Our common stock is traded on the NASDAQ Global Select Market under the symbol "CELG." The following table sets forth, for the periods indicated, the intra-day high and low prices per share of common stock on the NASDAQ Global Select Market:
 
 
High
 
Low
2013:
 
 
 
 
Fourth Quarter
 
$
173.80

 
$
142.10

Third Quarter
 
156.04

 
118.15

Second Quarter
 
131.82

 
110.53

First Quarter
 
116.95

 
79.75

2012:
 
 
 
 
Fourth Quarter
 
$
82.78

 
$
71.23

Third Quarter
 
78.63

 
61.89

Second Quarter
 
80.42

 
58.53

First Quarter
 
78.83

 
66.28

 
 
Cumulative Total Return
 
 
12/08
 
12/09
 
12/10
 
12/11
 
12/12
 
12/13
Celgene Corporation
 
$
100.00

 
$
100.72

 
$
106.98

 
$
122.29

 
$
141.95

 
$
305.66

S&P 500
 
100.00

 
125.92

 
144.58

 
147.60

 
171.04

 
225.85

NASDAQ Composite
 
100.00

 
145.05

 
171.14

 
169.83

 
199.89

 
279.63

NASDAQ Biotechnology
 
100.00

 
115.93

 
134.42

 
150.63

 
199.91

 
331.72

* $100 Invested on 12/31/08 in Stock or Index – Including Reinvestment of Dividends, Fiscal Year Ended December 31.

27

(b)   HOLDERS
The closing sales price per share of common stock on the NASDAQ Global Select Market on February 6, 2014 was $149.91. As of February 6, 2014, there were approximately 468 holders of record of our common stock.
(c)   DIVIDEND POLICY
We have never declared or paid any cash dividends on our common stock and have no present intention to pay a cash dividend on our common stock.
(d)   EQUITY COMPENSATION PLAN INFORMATION
We incorporate information regarding the securities authorized for issuance under our equity compensation plan into this section by reference from the section entitled "Equity Compensation Plan Information" to be included in the proxy statement for our 2014 Annual Meeting of Stockholders.
(e)   REPURCHASE OF EQUITY SECURITIES
During the period April 2009 through December 2013, our Board of Directors approved repurchases of up to an aggregate of $9.500 billion of our common stock, including the June 2013 authorization to repurchase an additional $3.000 billion of our common stock. Approved amounts exclude share repurchase transaction fees.

As part of our share repurchase program, in February 2013 we entered into an Accelerated Share Repurchase (ASR) agreement with an investment bank to repurchase an aggregate of $600.0 million of our common stock. The total number of shares repurchased under the ASR agreement was 5,249,137 shares at a weighted average price of $114.30 per share.
As of December 31, 2013, an aggregate 96,774,120 common shares were repurchased under the program at an average price of $76.80 per common share and an aggregate cost of $7.432 billion, excluding share repurchase transaction fees.
The following table presents the total number of shares purchased during the three-month period ended December 31, 2013, the average price paid per share, the number of shares that were purchased and the approximate dollar value of shares that still could have been purchased, pursuant to our repurchase program:
Period
 
Total Number of
Shares Purchased
 
Average Price Paid
per Share
 
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
 
Approximate Dollar
Value of Shares That
Still Could Be Purchased
Under the Plans or
Programs
October 1 - October 31
 
975,000

 
$
154.86

 
975,000

 
$
2,638,566,036

November 1 - November 30
 
1,627,900

 
$
152.22

 
1,627,900

 
$
2,390,759,137

December 1 - December 31
 
1,950,800

 
$
165.47

 
1,950,800

 
$
2,067,961,325

During the period covered by this report, we did not sell any of our equity shares that were not registered under the Securities Act of 1933, as amended.

28

ITEM 6.    SELECTED FINANCIAL DATA
The following Selected Consolidated Financial Data should be read in conjunction with our Consolidated Financial Statements and the related Notes thereto, Management's Discussion and Analysis of Financial Condition and Results of Operations and other financial information included elsewhere in this Annual Report on Form 10-K. The data set forth below with respect to our Consolidated Statements of Income for the years ended December 31, 2013, 2012 and 2011 and the Consolidated Balance Sheet data as of December 31, 2013 and 2012 are derived from our Consolidated Financial Statements which are included elsewhere in this Annual Report on Form 10-K and are qualified by reference to such Consolidated Financial Statements and related Notes thereto. The data set forth below with respect to our Consolidated Statements of Income for the years ended December 31, 2010 and 2009 and the Consolidated Balance Sheet data as of December 31, 2011, 2010 and 2009 are derived from our Consolidated Financial Statements, which are not included elsewhere in this Annual Report on Form 10-K (amounts in millions, except per share data).
 
 
Years ended December 31,
 
 
2013
 
2012
 
2011
 
2010
 
2009
Consolidated Statements of Income:
 
 
 
 
 
 
 
 
 
 
Total revenue
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1

 
$
3,625.7

 
$
2,689.9

Costs and operating expenses
 
4,685.0

 
3,760.3

 
3,399.4

 
2,636.1

 
1,848.4

Operating income
 
1,808.9

 
1,746.4

 
1,442.7

 
989.6

 
841.5

Interest and investment income, net
 
22.0

 
15.3

 
25.9

 
44.7

 
76.8

Interest (expense)
 
(91.6
)
 
(63.2
)
 
(42.7
)
 
(12.6
)
 
(2.0
)
Other income (expense), net
 
(73.9
)
 
(17.0
)
 
(6.4
)
 
(9.1
)
 
59.4

Income before income taxes
 
1,665.4

 
1,681.5

 
1,419.5

 
1,012.6

 
975.7

Income tax provision
 
215.5

 
225.3

 
102.1

 
132.4

 
199.0

Net income
 
$
1,449.9

 
$
1,456.2

 
$
1,317.4

 
$
880.2

 
$
776.7

Less: Net loss attributable to non-controlling interests
 
—

 
—

 
0.7

 
0.3

 
—

Net income attributable to Celgene
 
$
1,449.9

 
$
1,456.2

 
$
1,318.1

 
$
880.5

 
$
776.7

Net income per share attributable to Celgene:
 
 
 
 
 
 
 
 
 
 
Basic
 
$
3.50

 
$
3.38

 
$
2.89

 
$
1.90

 
$
1.69

Diluted
 
$
3.37

 
$
3.30

 
$
2.85

 
$
1.88

 
$
1.66

Weighted average shares:
 
 
 
 
 
 
 
 
 
 
Basic
 
413.8

 
430.9

 
455.3

 
462.3

 
459.3

Diluted
 
430.3

 
440.8

 
462.7

 
469.5

 
467.4

 
 
As of December 31,
 
 
2013
 
2012
 
2011
 
2010
 
2009
Consolidated Balance Sheets Data:
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents and marketable securities
 
$
5,687.0

 
$
3,900.3

 
$
2,648.2

 
$
2,601.3

 
$
2,996.8

Total assets
 
13,378.2

 
11,734.3

 
10,005.9

 
10,177.2

 
5,389.3

Short-term borrowings
 
544.8

 
308.5

 
526.7

 
—

 
—

Long-term debt, net of discount
 
4,196.5

 
2,771.3

 
1,275.6

 
1,247.6

 
—

Retained earnings (accumulated deficit)
 
4,472.5

 
3,022.6

 
1,566.4

 
248.3

 
(632.2
)
Total equity
 
5,589.9

 
5,694.5

 
5,512.7

 
5,995.5

 
4,394.6


29

ITEM 7.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
EXECUTIVE SUMMARY
Celgene Corporation, together with its subsidiaries (collectively “we,” “our,”  “us,” “Celgene” or the “Company”), is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.  We are dedicated to innovative research and development designed to bring new therapies to market and we are involved in research in several scientific areas that may deliver proprietary next-generation therapies, targeting areas including intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.

Our primary commercial stage products include REVLIMID®, VIDAZA®, ABRAXANE®, POMALYST®/IMNOVID®, THALOMID® (inclusive of Thalidomide CelgeneTM), ISTODAX® and azacitidine for injection (generic version of VIDAZA®). Additional sources of revenue include royalties from Novartis Pharma AG (Novartis) on their sales of FOCALIN XR® and the entire RITALIN® family of drugs, the sale of services through our Celgene Cellular Therapeutics (CCT) subsidiary and other licensing agreements.
REVLIMID® (lenalidomide):    REVLIMID® is an oral immunomodulatory drug marketed in the United States and many international markets for the treatment of patients as indicated below:
Disease
Geographic Approvals
Multiple myeloma (MM), in combination with dexamethasone, in patients who have received at least one prior therapy
* United States
* European Union
* Japan
* Other international markets
Myelodysplastic syndromes (MDS)
 
Transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q abnormality with or without additional cytogenetic abnormalities
* United States
* Other international markets
Transfusion-dependent anemia due to low- or intermediate-1-risk MDS in patients with isolated deletion 5q cytogenetic abnormality when other options are insufficient or inadequate
* European Union (Approved June 2013)
MDS with a deletion 5q cytogenetic abnormality. The efficacy or safety of REVLIMID for International Prognostic Scoring System (IPSS) intermediate-2 or high risk MDS has not been established.
* Japan
Mantle cell lymphoma (MCL) in patients whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
* United States (Approved June 2013)
VIDAZA® (azacitidine for injection):  VIDAZA® is a pyrimidine nucleoside analog that has been shown to reverse the effects of DNA hypermethylation and promote subsequent gene re-expression.  VIDAZA® is a Category 1 recommended treatment for patients with intermediate-2 and high-risk MDS, according to the National Comprehensive Cancer Network and is marketed in the United States for the treatment of all subtypes of MDS.  The U.S. regulatory exclusivity for VIDAZA® expired in May 2011.  As the result of the launch of a generic version of VIDAZA® in the United States by a competitor in September 2013, we experienced a significant reduction in our U.S. sales of VIDAZA® in the fourth quarter of 2013. In 2013, we also contracted with Sandoz AG to sell a generic version of VIDAZA®, which we supply. In Europe, VIDAZA® is marketed for the treatment of intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia with 10% to 29% marrow blasts without myeloproliferative disorder, as well as acute myeloid leukemia (AML) with 20% to 30% blasts and multi-lineage dysplasia and has been granted orphan drug designation for the treatment of MDS and AML.  Regulatory exclusivity for VIDAZA® is expected to continue in Europe through 2018.

30

ABRAXANE® (paclitaxel albumin-bound particles for injectable suspension):  ABRAXANE® is a solvent-free chemotherapy product which was developed using our proprietary nab® technology platform. This protein-bound chemotherapy agent combines paclitaxel with albumin. ABRAXANE® is approved for the treatment of patients as indicated below:
Disease
Geographic Approvals
Breast Cancer
 
Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within six months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
* United States

Metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease for whom standard, anthracycline containing therapy is not indicated
* European Union
Breast cancer
* Japan
* Other international markets
Non-Small Cell Lung Cancer (NSCLC)
 
Locally advanced or metastatic NSCLC, as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy
* United States
* Other international markets
NSCLC
* Japan (Approved February 2013)
Metastatic adenocarcinoma of the pancreas, a form of pancreatic cancer, as first line treatment in combination with gemcitabine
* United States (Approved September 2013)
* European Union (Approved December 2013)
Gastric cancer
* Japan (Approved February 2013)
During 2013, applications for marketing authorizations for ABRAXANE® for the treatment of patients with advanced pancreatic cancer were also submitted in other countries and regions. ABRAXANE® is currently in various stages of investigation for breast, pancreatic and non-small cell lung cancers.
POMALYST®/IMNOVID®1(pomalidomide): POMALYST®/IMNOVID® is a proprietary, distinct, small molecule that is administered orally and modulates the immune system and other biologically important targets. POMALYST®/IMNOVID® received its first approvals from the U.S. Food and Drug Administration (FDA) and the European Commission (EC) during 2013 for the treatment of patients as indicated below:
Disease
Geographic Approvals
Multiple myeloma for patients who have received at least two prior therapies, including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
* United States (Approved February 2013)
Relapsed and refractory multiple myeloma, in combination with dexamethasone, for adult patients who have received at least two prior therapies including both lenalidomide and bortezomib and have demonstrated disease progression on the last therapy.
* European Union (Approved August 2013)
1 We received FDA approval for pomalidomide under the trade name POMALYST®. We received EC approval for pomalidomide under the trade name IMNOVID®.
THALOMID® (thalidomide):    In combination with dexamethasone, THALOMID® is marketed in the United States for patients with newly diagnosed multiple myeloma and for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) an inflammatory complication of leprosy and as maintenance therapy for prevention and suppression of the cutaneous manifestation of ENL recurrence. Thalidomide CelgeneTM in combination with melphalan and prednisone is marketed in the European Union as a first line treatment for patients with untreated multiple myeloma who are aged sixty-five years of age or older or ineligible for high dose chemotherapy.
ISTODAX® (romidepsin):  ISTODAX® is approved in the United States for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy and for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.  ISTODAX® has received orphan drug designation for the treatment of non-Hodgkin’s T-cell lymphomas, including CTCL and PTCL.

31

azacitidine for injection (generic version of VIDAZA®): After the launch of a generic version of VIDAZA® in the United States by a competitor in September 2013, we contracted with Sandoz AG to sell azacitidine for injection, which we supply. We recognize net product sales from sales of azacitidine for injection to Sandoz AG.
We continue to invest substantially in research and development in support of multiple ongoing proprietary clinical development programs which support our existing products and pipeline of new drug candidates.  REVLIMID® is in several phase III trials across a range of hematological malignancies that include newly diagnosed multiple myeloma and maintenance, lymphomas, chronic lymphocytic leukemia (CLL) and MDS.  POMALYST®/IMNOVID® was approved in the United States and European Union for indications in multiple myeloma based on phase II and phase III results, respectively, and additional phase III trials are underway with POMALYST®/IMNOVID® in relapsed refractory multiple myeloma. Phase III trials are also underway for VIDAZA® and CC-486 in MDS and acute myeloid leukemia (AML) and ISTODAX® in first-line peripheral T-cell lymphoma (PTCL).  In solid tumors, ABRAXANE® is currently in various stages of investigation for breast, pancreatic and non-small cell lung cancers. Our lead product candidate in inflammation and immunology, OTEZLA® (apremilast) is being evaluated in a broad phase III program for psoriatic arthritis, psoriasis and ankylosing spondylitis.
Beyond our phase III programs, we have access to a growing early-to-mid-stage pipeline of novel therapies to address significant unmet medical needs that consists of a combination of in-house developed compounds, compounds licensed from other companies and options to acquire compounds from collaboration partners. For more information, see Item 1 "Preclinical and Clinical Stage Pipeline."
We believe that continued use of our primary commercial stage products, participation in research and development collaboration arrangements, depth of our product pipeline, regulatory approvals of new products and expanded use of existing products will provide the catalysts for future growth.
The following table summarizes total revenue and earnings for the years ended December 31, 2013, 2012 and 2011 (dollar amounts in millions, except per share data):
 
 
 
 
 
 
 
 
% Change
 
 
Years Ended December 31,
2013
versus
2012
 
2012
versus
2011
 
 
2013
 
2012
 
2011
 
Total revenue
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1

 
17.9
 %
 
13.7
%
Net income attributable to Celgene
 
$
1,449.9

 
$
1,456.2

 
$
1,318.1

 
(0.4
)%
 
10.5
%
Diluted earnings per share attributable to Celgene
 
$
3.37

 
$
3.30

 
$
2.85

 
2.1
 %
 
15.8
%

Revenue increased by $987.2 million to $6.494 billion in 2013 compared to 2012 primarily due to the continued growth in unit sales of REVLIMID® and ABRAXANE® as well as the FDA and EC approvals of POMALYST® /IMNOVID® in February 2013 and August 2013, respectively, as noted above.  The $6.3 million decrease in net income to $1.450 billion in 2013 compared to 2012 was primarily due to a $446.3 million increase in payments made related to research and development collaboration arrangements, a $61.9 million increase in ABRAXANE® amortization expense due to the October 2012 FDA approval of ABRAXANE® for treatment of NSCLC, a $94.8 million increase in share-based compensation expense and increased spending in support of our currently marketed products and those that we plan to launch. The increases in expense were nearly offset by the favorable impact from a higher level of net product sales. The $0.07 increase in diluted earnings per share in 2013 compared to 2012 was favorably impacted by the repurchase of 22.3 million common shares under our common share repurchase program, reducing our outstanding share base.


32

Results of Operations:
Fiscal Years Ended December 31, 2013, 2012 and 2011
Total Revenue:    Total revenue and related percentages for the years ended December 31, 2013, 2012 and 2011 were as follows (dollar amounts in millions, except per share data):
 
 
 
 
 
 
 
 
% Change
 
 
2013
 
2012
 
2011
 
2013
versus
2012
 
2012
versus
2011
Net product sales:
 
 
 
 
 
 
 
 
 
 
REVLIMID®
 
$
4,280.3

 
$
3,766.6

 
$
3,208.2

 
13.6
 %
 
17.4
 %
VIDAZA®
 
803.3

 
823.2

 
705.3

 
(2.4
)%
 
16.7
 %
ABRAXANE®
 
648.9

 
426.7

 
385.9

 
52.1
 %
 
10.6
 %
POMALYST®/IMNOVID®
 
305.4

 
12.0

 
0.6

 
N/M

 
N/M

THALOMID®
 
244.5

 
302.1

 
339.1

 
(19.1
)%
 
(10.9
)%
ISTODAX®
 
54.0

 
50.0

 
30.9

 
8.0
 %
 
61.7
 %
azacitidine for injection
 
23.3

 
—

 
—

 
N/M

 
N/M

Other
 
2.6

 
5.0

 
29.7

 
(48.0
)%
 
(83.2
)%
Total net product sales
 
$
6,362.3

 
$
5,385.6

 
$
4,699.7

 
18.1
 %
 
14.6
 %
Collaborative agreements and other revenue
 
14.7

 
10.7

 
19.5

 
37.4
 %
 
(45.1
)%
Royalty revenue
 
116.9

 
110.4

 
122.9

 
5.9
 %
 
(10.2
)%
Total revenue
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1

 
17.9
 %
 
13.7
 %
The increase in total revenue of $987.2 million in 2013 compared to 2012 reflected increases of $693.0 million, or 21.9%, in the United States, and $294.2 million, or 12.6%, in international markets. The increase in total revenue of $664.6 million in 2012 compared to 2011 reflected increases of $308.2 million, or 10.8%, in the United States, and $356.4 million, or 18.0%, in international markets.
Net Product Sales:    Total net product sales for 2013 increased by $976.7 million, or 18.1%, to $6.362 billion compared to 2012. The increase was comprised of net volume increases of $950.3 million and price increases of $117.0 million, partly offset by an unfavorable impact from foreign exchange of $90.6 million. The increase in volume was driven by increased unit sales of REVLIMID®, the favorable impact from increased U.S. sales of ABRAXANE® resulting from the October 2012 and September 2013 FDA approvals for treatment of NSCLC and pancreatic cancer, respectively, as well as the February 2013 FDA and August 2013 EC approvals of POMALYST®/IMNOVID® for treatment of multiple myeloma. The increase in price was primarily due to price increases on REVLIMID®, VIDAZA® and THALOMID® in the U.S. market.
Total net product sales for 2012 increased by $685.9 million, or 14.6%, to $5.386 billion compared to 2011. The increase was comprised of net volume increases of $559.1 million and price increases of $162.2 million, partly offset by an unfavorable impact from foreign exchange of $35.4 million. The increase in price was primarily due to price increases on REVLIMID®, VIDAZA® and THALOMID® in the U.S. market.
REVLIMID® net sales increased by $513.7 million, or 13.6%, to $4.280 billion in 2013 compared to 2012, primarily due to increased unit sales in both international and U.S. markets in addition to price increases in the U.S. market. These increases were partially offset by unfavorable changes in price in international markets and unfavorable foreign exchange impacts, including the impact of foreign exchange hedging activity. Increases in market penetration and treatment duration of patients using REVLIMID® in multiple myeloma contributed to the increase in United States unit sales. The growth in international markets resulted from volume increases, primarily driven by increased duration of use and market share gains.
Net sales of REVLIMID® increased by $558.4 million, or 17.4%, to $3.767 billion in 2012 compared to 2011, primarily due to increased unit sales in both U.S. and international markets. Increases in market penetration, treatment duration of patients using REVLIMID® in multiple myeloma and price increases contributed to U.S. growth. The growth in international markets resulted from volume increases, primarily driven by increased duration of use and market share gains.

33

VIDAZA® net sales decreased by $19.9 million, or 2.4%, to $803.3 million in 2013 compared to 2012, reflecting volume decreases in the U.S. market due to the launch of a generic version of VIDAZA® by a competitor in September 2013 and the launch of a generic version of VIDAZA® (azacitidine for injection) by Sandoz AG in the fourth quarter of 2013, which we supply. Foreign exchange also unfavorably impacted sales. These decreases were partly offset by price increases in the U.S. market and volume increases in international markets. VIDAZA® retains orphan drug exclusivity in Europe through the end of 2018.
Net sales of VIDAZA® increased by $117.9 million, or 16.7%, to $823.2 million in 2012 compared to 2011, reflecting increases in both U.S. and international markets. The U.S. growth reflects an increase in volume and price. The growth in international markets was partly due to the increase in treatment duration of patients using VIDAZA® and launches of VIDAZA® in new markets, including the United Kingdom and Japan.
ABRAXANE® net sales increased by $222.2 million, or 52.1%, to $648.9 million in 2013 compared to 2012, primarily due to increased unit volumes in both U.S. and international markets, reflecting increased acceptance of the product in the treatment of metastatic breast cancer, the October 2012 FDA approval for treatment of NSCLC and the September 2013 FDA approval for treatment of pancreatic cancer.
Net sales of ABRAXANE® increased by $40.8 million, or 10.6%, to $426.7 million in 2012 compared to 2011, primarily due to increased unit volumes in both U.S. and international markets, reflecting increased acceptance of the product in the treatment of metastatic breast cancer and the October 2012 FDA approval for NSCLC.
Net sales of POMALYST®/IMNOVID® totaled $305.4 million in 2013, reflecting the approval of POMALYST® by the FDA in February 2013 for patients with multiple myeloma who have received at least two prior therapies, including lenalidomide and bortezomib, and have demonstrated disease progression on or within 60 days of completion of the last therapy. IMNOVID® (the non-U.S. trade name) in combination with dexamethasone was approved by the EC in August 2013 for adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy. Net sales of POMALYST® totaled $246.0 million in the United States and IMNOVID® net sales totaled $59.4 million in international markets.
THALOMID® net sales decreased by $57.6 million, or 19.1%, to $244.5 million in 2013 compared to 2012, primarily due to lower unit volumes in the U.S. and international markets and an increase in estimated returns related to the transition of THALOMID® distribution from retail to specialty pharmacies.  The reductions in volume were partially offset by price increases in the United States.
Net sales of THALOMID® decreased by $37.0 million, or 10.9%, to $302.1 million in 2012 compared to 2011,primarily due to lower unit volumes in the United States, partly resulting from the increased use of REVLIMID®, partially offset by an increase in price and lower gross to net adjustments.
ISTODAX® net sales increased by $4.0 million, or 8.0%, to $54.0 million in 2013 compared to 2012, primarily due to increases in price in the United States.
Net sales of ISTODAX® increased by $19.1 million, or 61.7%, to $50.0 million in 2012 compared to 2011, primarily due to increased unit sales in the treatment of CTCL and the June 2011 FDA approval of ISTODAX® for the treatment of PTCL in patients who have received at least one prior therapy.
Net sales of azacitidine for injection, which is a generic version of VIDAZA®, reached $23.3 million after its launch in the second half of 2013. We have entered into an agreement with Sandoz AG to sell azacitidine, which we supply.
The "other" net product sales category, which includes LENADEX® and FOCALIN®, decreased by $2.4 million, or 48.0%, to $2.6 million in 2013 compared to 2012. The "other" net product sales category decreased by $24.7 million, or 83.2%, to $5.0 million in 2012 compared to 2011. That decrease was primarily due to the April 2011 sale of Abraxis non-core assets, resulting in the elimination of further Abraxis non-core product sales. Sales of Abraxis non-core products totaled $21.3 million in 2011.
Collaborative Agreements and Other Revenue:    Revenue from collaborative agreements and other sources increased by $4.0 million to $14.7 million in 2013 compared to 2012. The increase was primarily due to a $5.0 million milestone payment received in 2013 related to ABRAXANE® in Japan. Revenue from collaborative agreements and other sources decreased by $8.8 million to $10.7 million in 2012 compared to 2011. The decrease was primarily due to a $2.4 million reduction in certain manufacturing and management fees and a $6.3 million milestone payment received in 2011 related to VIDAZA® in Japan which was not repeated in 2012.
Royalty Revenue:    Royalty revenue increased by $6.5 million to $116.9 million in 2013 compared to 2012, due to an increase in royalties earned from Novartis based upon its sales of both RITALIN® and FOCALIN XR®. Royalty revenue decreased by $12.5 million to $110.4 million in 2012 compared to 2011, primarily due to reduced royalties earned from Novartis based upon

34

its sales of RITALIN®, which was negatively impacted by generic competition in certain markets, partly offset by an increase in royalties from sales of FOCALIN XR®.
Gross to Net Sales Accruals:  We record gross to net sales accruals for sales returns and allowances, sales discounts, government rebates, chargebacks and distributor service fees.
 
REVLIMID®, POMALYST® and THALOMID® are distributed in the United States primarily through contracted pharmacies under the REVLIMID® Risk Evaluation and Mitigation Strategy (REMS), POMALYST REMSTM and THALOMID REMSTM programs, respectively.  These are proprietary risk-management distribution programs tailored specifically to provide for the safe and appropriate distribution and use of REVLIMID®, POMALYST® and THALOMID®.  Internationally, REVLIMID®, THALOMID®/Thalidomide CelgeneTM and IMNOVID® are distributed under mandatory risk-management distribution programs tailored to meet local authorities’ specifications to provide for the product’s safe and appropriate distribution and use.  These programs may vary by country and, depending upon the country and the design of the risk-management program, the product may be sold through hospitals or retail pharmacies. VIDAZA®, ABRAXANE® and ISTODAX® are distributed through the more traditional pharmaceutical industry supply chain and are not subject to the same risk-management distribution programs as REVLIMID®, POMALYST®/IMNOVID®, THALOMID®/Thalidomide CelgeneTM.

We base our sales returns allowance on estimated on-hand retail/hospital inventories, measured end-customer demand as reported by third-party sources, actual returns history and other factors, such as the trend experience for lots where product is still being returned or inventory centralization and rationalization initiatives conducted by major pharmacy chains, as applicable.  If the historical data we use to calculate these estimates do not properly reflect future returns, then a change in the allowance would be made in the period in which such a determination is made and revenues in that period could be materially affected.  Under this methodology, we track actual returns by individual production lots.  Returns on closed lots, that is, lots no longer eligible for return credits, are analyzed to determine historical returns experience.  Returns on open lots, that is, lots still eligible for return credits, are monitored and compared with historical return trend rates.  Any changes from the historical trend rates are considered in determining the current sales return allowance.  As noted above, REVLIMID®, POMALYST®/IMNOVID®, THALOMID®/Thalidomide CelgeneTM are distributed primarily through hospitals and contracted pharmacies, which are typically subject to tighter controls of inventory quantities within the supply channel and, thus, resulting in lower returns activity.
 
Sales discount accruals are based on payment terms extended to customers.
 
Government rebate accruals are based on estimated payments due to governmental agencies for purchases made by third parties under various governmental programs. U.S. Medicaid rebate accruals are generally based on historical payment data and estimates of future Medicaid beneficiary utilization applied to the Medicaid unit rebate formula established by the Center for Medicaid and Medicare Services. The Medicaid rebate percentage was increased and extended to Medicaid Managed Care Organizations in March 2010.  The accrual of the rebates associated with Medicaid Managed Care Organizations is calculated based on estimated historical patient data related to Medicaid Managed Care Organizations.  We have also analyzed actual billings received from the states to further support the accrual rates.  Subsequent to implementation of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the 2010 U.S. Health Care Reform Law), certain states have only recently begun submitting partial Medicaid Managed Care Organization bills.  Our accruals for these Medicaid Managed Care Organization rebates had been at elevated levels given the delays in the receipt of complete invoices from certain states.  Due to the receipt of more complete claims data as 2013 progressed, the accruals for certain states were reduced from the elevated levels at December 31, 2012 as a result of both the payments made being applied to the accrual and a $20.3 million favorable change in estimate of the ultimate obligation.  We will continue to adjust the rebate accruals as more information becomes available and to reflect actual claims experience.  Effective January 1, 2011, manufacturers of pharmaceutical products are responsible for 50% of the patient’s cost of branded prescription drugs related to the Medicare Part D Coverage Gap.  In order to estimate the cost to us of this coverage gap responsibility, we analyze data for eligible Medicare Part D patients against data for eligible Medicare Part D patients treated with our products as well as the historical invoices.  This expense is recognized throughout the year as costs are incurred.  In certain international markets government-sponsored programs require rebates to be paid based on program specific rules and, accordingly, the rebate accruals are determined primarily on estimated eligible sales.

Rebates or administrative fees are offered to certain wholesale customers, group purchasing organizations and end-user customers, consistent with pharmaceutical industry practices. Settlement of rebates and fees may generally occur from one to 15 months from the date of sale. We record a provision for rebates at the time of sale based on contracted rates and historical redemption rates. Assumptions used to establish the provision include level of wholesaler inventories, contract sales volumes and average contract pricing.  We regularly review the information related to these estimates and adjust the provision accordingly.
 
Chargeback accruals are based on the differentials between product acquisition prices paid by wholesalers and lower government contract pricing paid by eligible customers covered under federally qualified programs.  Distributor service fee accruals are based

35

on contractual fees to be paid to the wholesale distributor for services provided.  TRICARE is a health care program of the U.S. Department of Defense Military Health System that provides civilian health benefits for military personnel, military retirees and their dependents.  TRICARE rebate accruals are included in chargeback accruals and are based on estimated Department of Defense eligible sales multiplied by the TRICARE rebate formula.
 
See Critical Accounting Estimates and Significant Accounting Policies below for further discussion of gross to net sales accruals.
Gross to net sales accruals and the balance in the related allowance accounts for the years ended December 31, 2013, 2012 and 2011 were as follows (in millions):
 
 
Returns
and
Allowances
 
Discounts
 
Government
Rebates
 
Chargebacks
and Distributor
Service Fees
 
Total
Balance at December 31, 2010
 
$
4.8

 
$
8.3

 
$
84.9

 
$
47.4

 
$
145.4

Allowances for sales during prior periods
 
—

 
—

 
(5.4
)
 
2.1

 
(3.3
)
Allowances for sales during 2011
 
16.7

 
56.1

 
192.1

 
191.8

 
456.7

Credits/deductions issued for prior year sales
 
(5.7
)
 
(4.2
)
 
(34.3
)
 
(38.2
)
 
(82.4
)
Credits/deductions issued for sales during 2011
 
(6.8
)
 
(51.5
)
 
(100.3
)
 
(138.8
)
 
(297.4
)
Balance at December 31, 2011
 
$
9.0

 
$
8.7

 
$
137.0

 
$
64.3

 
$
219.0

Allowances for sales during prior periods
 
(7.5
)
 
—

 
(13.3
)
 
(2.4
)
 
(23.2
)
Allowances for sales during 2012
 
15.0

 
64.9

 
208.7

 
212.6

 
501.2

Credits/deductions issued for prior year sales
 
1.7

 
(4.3
)
 
(60.2
)
 
(54.8
)
 
(117.6
)
Credits/deductions issued for sales during 2012
 
(4.9
)
 
(58.1
)
 
(146.4
)
 
(158.5
)
 
(367.9
)
Balance at December 31, 2012
 
$
13.3

 
$
11.2

 
$
125.8

 
$
61.2

 
$
211.5

Allowances for sales during prior periods
 
(1.1
)
 
—

 
(27.8
)
 
(1.9
)
 
(30.8
)
Allowances for sales during 2013
 
10.7

 
74.3

 
262.1

 
290.8

 
637.9

Credits/deductions issued for prior year sales
 
(3.1
)
 
(5.2
)
 
(53.4
)
 
(42.0
)
 
(103.7
)
Credits/deductions issued for sales during 2013
 
(4.3
)
 
(68.2
)
 
(172.6
)
 
(224.9
)
 
(470.0
)
Balance at December 31, 2013
 
$
15.5

 
$
12.1

 
$
134.1

 
$
83.2

 
$
244.9

A comparison of provisions for allowances for sales within each of the four categories noted above for 2013 and 2012 follows:
2013 compared to 2012:   Returns and allowances increased by $2.1 million in 2013 compared to 2012, partly due to a first quarter 2012 reversal of approximately $7.5 million in reserves established for certain products with quality issues which were resolved in 2012. In addition, during 2013 we recorded a sales returns reserve of $7.9 million for estimated returns related to the transition of THALOMID® distribution from retail to specialty pharmacies. The increases were partly offset by a $12.5 million net reduction in the VIDAZA® returns provision, which included a $7.5 million reduction in the returns allowance related to inventory levels held by distributors in early 2013 and a $2.8 million increase in the returns allowance related to inventory held by distributors at the end of 2013 given the launch of a generic version of VIDAZA® in September 2013.
Discounts increased by $9.4 million in 2013 compared to 2012, primarily due to sales increases in the United States.
 
Government rebates increased by $38.9 million in 2013 compared to 2012, partly due to an increase of approximately $21.1 million in government rebates related to U.S. governmental agencies, primarily attributable to volume increases and higher expense rates for the Medicare Part D Coverage Gap, partially offset by the refinement of the accrual for rebates to Medicaid Managed Care Organizations completed in the latter part of 2013. Rebates related to international markets increased by approximately $17.8 million, primarily due to a reduction in rebates recorded during 2012 for an amendment to a price/volume agreement for VIDAZA®

36

in a specific European country that resulted in a reduction in government rebates of approximately $10.9 million in 2012. Sales growth in multiple countries worldwide also contributed to higher rebates.

Chargebacks and distributor service fees increased by $78.7 million in 2013 compared to 2012.  Chargebacks and distributor service fees increased by approximately $46.2 million and $32.5 million, respectively, primarily due to higher sales volumes and contract eligible sales. Rebates specifically related to the TRICARE program increased by $6.8 million also due to higher sales volume.
2012 compared to 2011:    Returns and allowances decreased by $9.2 million in 2012 compared 2011, primarily due to the reversal of approximately $7.5 million in reserves established for certain products with quality issues which were resolved in 2012 and lower returns experience on all products, partially offset by a $7.6 million increase in the returns allowance related to increased levels of VIDAZA® inventory held by distributors at the end of 2012.
Discounts increased by $8.8 million in 2012 compared to 2011, primarily due to revenue increases in the U.S. and international markets, both of which offer different discount programs, and expansion into new international markets. These amounts were partly offset by rebates related to VIDAZA® sales in the Japanese market being included in the chargebacks and distributor service fees category in 2012.
Government rebates increased by $8.7 million in 2012 compared to 2011, primarily due to an increase of approximately $15.8 million in rebates related to various U.S. programs, partly offset by a $7.0 million decrease in rebates in certain international markets. The U.S. programs increase was primarily attributable to volume increases and the refinement of accrual rates for Medicaid Managed Care Organizations and Medicare Part D Coverage Gap. The decrease in government rebates of $7.0 million in international markets was primarily driven by the refinement of select government rebates during the third quarter of 2012.
Chargebacks and distributor service fees increased by $16.3 million in 2012 compared to 2011. Chargebacks increased by approximately $2.8 million and distributor service fees increased by approximately $13.5 million. Chargebacks primarily increased due to $7.7 million of rebates related to VIDAZA® sales in the Japanese market which were included within discounts during the 2011 period, partially offset by a $4.1 million decrease in TRICARE rebates, reflecting lower utilization of THALOMID®. The distributor service fees increase was primarily due to higher sales volumes, including $8.3 million associated with higher sales of ABRAXANE®.
Cost of Goods Sold (excluding amortization of acquired intangible assets):    Cost of goods sold and related percentages for the years ended December 31, 2013, 2012 and 2011 were as follows (dollar amounts in millions):
 
 
2013
 
2012
 
2011
Cost of goods sold (excluding amortization of acquired intangible assets)
 
$
340.4

 
$
299.1

 
$
425.9

Increase (decrease) from prior year
 
$
41.3

 
$
(126.8
)
 
$
119.3

Percent increase (decrease) from prior year
 
13.8
%
 
(29.8
)%
 
38.9
%
Percent of net product sales
 
5.4
%
 
5.6
 %
 
9.1
%

Cost of goods sold (excluding amortization of acquired intangible assets) increased by $41.3 million to $340.4 million in 2013 compared to 2012.  The increase was primarily due to the higher level of REVLIMID® and ABRAXANE® sales, partly offset by the elimination of royalty payments on sales of REVLIMID® resulting from the expiration of our royalty obligations to Children's Medical Center Corporation (CMCC) at the end of February 2013.  As a percent of net product sales, cost of goods sold (excluding amortization of acquired intangible assets) decreased to 5.4% in 2013 compared to 5.6% in 2012 primarily due to the increase in lower cost REVLIMID® sales and the elimination of royalty payments on our sales of REVLIMID® as noted above. See Note 18 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K for additional details related to a lawsuit filed by CMCC against us.
Cost of goods sold (excluding amortization of acquired intangible assets) decreased by $126.8 million to $299.1 million in 2012 compared to 2011. The net decrease was primarily due to the 2011 inclusion of the $90.3 million final inventory step-up amortization adjustment on sales of ABRAXANE® related to the October 2010 acquisition of Abraxis, an aggregate $13.2 million in costs related to the sale of non-core Abraxis products which were divested in April 2011, a $15.3 million decrease in the allocation of prepaid royalties related to sales of VIDAZA® and a $8.6 million decrease in costs related to former Pharmion products to be exited. These decreases were partly offset by an increase in 2012 product material costs resulting from a higher level of sales activity. As a percent of net product sales, cost of goods sold (excluding amortization of acquired intangible assets) decreased to 5.6% in 2012 compared to 9.1% in 2011. Excluding the inventory step-up amortization for ABRAXANE®, the cost of goods sold ratio in 2011 was 7.1%. The cost of goods sold ratio in 2012 was favorably impacted by 0.3% from a reduction in prepaid royalties

37

expensed in 2012 related to sales of VIDAZA® and lower cost products, such as REVLIMID®, comprising a larger portion of total net sales.
Research and Development:    Research and development costs are expensed as incurred and primarily include salary and benefit costs, third-party grants and fees paid to clinical research organizations, supplies and upfront and milestone payments resulting from collaboration arrangements.
Research and development expenses and related percentages for the years ended December 31, 2013, 2012 and 2011 were as follows (dollar amounts in millions):
 
 
2013
 
2012
 
2011
Research and development
 
$
2,226.2

 
$
1,724.2

 
$
1,600.3

Increase from prior year
 
$
502.0

 
$
123.9

 
$
471.8

Percent increase from prior year
 
29.1
%
 
7.7
%
 
41.8
%
Percent of total revenue
 
34.3
%
 
31.3
%
 
33.0
%

Research and development expenses increased by $502.0 million to $2.226 billion in 2013 compared to 2012. The increase was primarily due to a $446.3 million increase in payments made related to research and development collaboration arrangements as well as an increase in general research activity. The increases were partly offset by 2012 in-process research and development (IPR&D) asset impairment charges of $122.5 million, of which $53.4 million related to ISTODAX® for PTCL in Europe and $69.1 million related to an adjustment to the probability weighted forecasted sales of CC-292 compared to prior estimates. No IPR&D asset impairment charges were recorded in 2013.
Research and development expenses increased by $123.9 million to $1.724 billion in 2012 compared to 2011. The increase was primarily due to a $31.9 million increase in payments related to research and development collaboration arrangements, an increase in 2012 research and development project spending in support of multiple programs across a broad range of diseases and the inclusion of Avila expenses incurred subsequent to the March 2012 acquisition date. The expense for 2012 also included $122.5 million in IPR&D asset impairment charges related to ISTODAX® and CC-292 as noted above.
The following table provides a breakdown of research and development expenses (in millions):
 
 
 
 
 
 
 
 
Increase (Decrease)
 
 
2013
 
2012
 
2011
 
2013
versus
2012
 
2012
versus
2011
Human pharmaceutical clinical programs
 
$
825.3

 
$
781.0

 
$
732.4

 
$
44.3

 
$
48.6

Other pharmaceutical programs 
 
530.9

 
428.3

 
406.1

 
102.6

 
22.2

Drug discovery and development
 
202.9

 
166.6

 
159.4

 
36.3

 
7.2

Cellular therapy
 
25.9

 
30.9

 
21.4

 
(5.0
)
 
9.5

Collaboration arrangements
 
641.2

 
194.9

 
163.0

 
446.3

 
31.9

IPR&D impairments
 
—

 
122.5

 
118.0

 
(122.5
)
 
4.5

Total
 
$
2,226.2

 
$
1,724.2

 
$
1,600.3

 
$
502.0

 
$
123.9


We make significant investments in research and development in support of multiple ongoing proprietary clinical development programs which support both our existing products and pipeline of new drug candidates. See Item 1. "Business" for a table summarizing the current stage of development of both our commercial stage products and new drug candidates. Expenses related to collaboration arrangements increased significantly during 2013 compared to 2012 as a result of an increased number of new collaboration arrangements entered into during 2013 as well as higher levels of upfront fees associated with those new collaboration agreements. Expenses for milestone payments related to collaboration arrangements was also higher in 2013 than in 2012. See Note 17 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K for additional details related to our collaboration arrangements.
We do not collect costs on a project basis or for any category of projects for the majority of costs involved in carrying out research projects. While we do perform cost calculations to facilitate our internal evaluation of individual projects, these calculations include

38

significant estimations and allocations that are not relevant to, or included in, our external financial reporting mechanisms. As a consequence, we do not report research and development costs at the project level.
The following table presents significant developments in our phase III clinical trials and regulatory approval requests that occurred during the three-month period ended December 31, 2013, as well as developments that are expected to occur if the future occurrence is material and reasonably certain:
New phase III trials:
Product
 
Disease Indication
 
 
 
 
 
 
POMALYST®/IMNOVID®
 
Relapsed/Refractory Multiple Myeloma
 
 
 
 
 
 
Regulatory approval requests in major markets:
Product
 
Disease Indication
 
Major
Market
 
Regulatory
Agency
 
Date of Filing
OTEZLA® (apremilast)
 
Psoriasis
 
U.S.
 
FDA
 
November 2013
 
 
Psoriasis and Psoriatic Arthritis
 
E.U.
 
EC
 
December 2013
Regulatory agency actions:
Product
 
Disease Indication
 
Major
Market
 
Regulatory
Agency
 
Action
ABRAXANE®
 
Pancreatic cancer
 
E.U.
 
EC
 
Approval

Selling, General and Administrative:    Selling, general and administrative expenses primarily include salary and benefit costs for employees included in our sales, marketing, finance, legal and administrative organizations, costs related to the launch of new products or those approved for new indications, outside legal and professional services, donations to independent non-profit patient assistance organizations in the United States and facilities costs.
Selling, general and administrative expenses and related percentages for the years ended December 31, 2013, 2012 and 2011 were as follows (dollar amounts in millions):
 
 
2013
 
2012
 
2011
Selling, general and administrative
 
$
1,684.5

 
$
1,373.5

 
$
1,226.3

Increase from prior year
 
$
311.0

 
$
147.2

 
$
275.7

Percent increase from prior year
 
22.6
%
 
12.0
%
 
29.0
%
Percent of total revenue
 
25.9
%
 
24.9
%
 
25.3
%

Selling, general and administrative expenses increased by $311.0 million to $1.685 billion in 2013 compared to 2012, partly due to an increase in headcount related costs, including share based compensation expense, and marketing activities primarily related to the global launch of POMALYST®/IMNOVID®, expenses related to the launch of ABRAXANE® in pancreatic cancer, headcount increases and marketing expenses to prepare for the planned future launch of OTEZLA® (apremilast), a $27.7 million increase in service fees attributable to Latin American operations, an increase in incentive accruals and continued support of our currently marketed products, partially offset by a $23.6 million decrease in donations to independent non-profit patient assistance organizations in the United States.
Selling, general and administrative expenses increased by $147.2 million to $1.374 billion in 2012 compared to 2011, partly due to a $72.0 million increase in donations to independent non-profit patient assistance organizations in the United States, a $6.1 million increase in allowances for doubtful accounts related to our European operations and increased marketing activities related to the pre-launch of ABRAXANE® for first-line treatment of advanced NSCLC in the United States and pre-launch activities for POMALYST®/IMNOVID® globally.

39

Amortization of Acquired Intangible Assets:    Amortization of intangible assets acquired as a result of business combinations is summarized below for the years ended December 31, 2013, 2012 and 2011 (in millions):
 
 
2013
 
2012
 
2011
Avila
 
$
47.3

 
$
39.4

 
$
—

Abraxis
 
160.0

 
99.6

 
89.3

Gloucester
 
51.5

 
51.5

 
40.2

Pharmion
 
4.0

 
4.0

 
159.7

Total amortization
 
$
262.8

 
$
194.5

 
$
289.2

Increase (decrease) from prior year
 
$
68.3

 
$
(94.7
)
 
$
86.0


Amortization of acquired intangible assets increased by $68.3 million to $262.8 million in 2013 compared to 2012 primarily due to a $61.9 million increase attributable to the October 2012 approval of ABRAXANE® in the United States for the treatment of NSCLC, which resulted in the commencement of amortization of the related intangible asset, and a $7.9 million increase in amortization related to intangible assets obtained in the March 2012 acquisition of Avila, partly offset by certain Abraxis related intangibles becoming fully amortized early in 2012.
Amortization of acquired intangible assets decreased by $94.7 million to $194.5 million in 2012 compared to 2011 primarily due to certain Pharmion intangible assets becoming fully amortized at the end of 2011, which reduced amortization expense in 2012 by $155.8 million. The decrease was partly offset by the addition of intangible assets obtained in the March 2012 acquisition of Avila, which increased amortization expense by $39.4 million. In addition, the June 2011 FDA approval of ISTODAX® for treatment of PTCL in patients who have received at least one prior therapy increased amortization expense by $15.0 million and the October 2012 approval of ABRAXANE® in the United States for the treatment of NSCLC increased amortization expense by $16.3 million, both of which resulted from the commencement of amortization of the related intangible assets.
Acquisition Related (Gains) Charges and Restructuring, net: Acquisition related (gains) charges and restructuring, net is summarized below for the years ended December 31, 2013, 2012 and 2011 (dollar amounts in millions):
 
 
2013
 
2012
 
2011
Acquisition related (gains) charges and restructuring, net
 
$
171.1

 
$
169.0

 
$
(142.3
)
Increase (decrease) from prior year
 
$
2.1

 
$
311.3

 
$
(189.6
)
Percentage increase from prior year
 
1.2
%
 
N/M

 
N/M

Acquisition related (gains) charges and restructuring, net was a net charge of $171.1 million in 2013 and $169.0 million in 2012. The net increase in expense of $2.1 million in 2013 compared to 2012 was primarily due to a combined $80.8 million unfavorable change in the income statement impact related to the fair values of our contingent consideration liabilities related to the Gloucester and Avila acquisitions, partly offset by a $76.1 million favorable change in the income statement impact related to the fair value of our our publicly traded contingent value rights (CVRs) that were issued as part of the acquisition of Abraxis.
Acquisition related (gains) charges and restructuring, net increased by $311.3 million in 2012 compared to 2011 primarily due to a $368.3 million change in the income statement impact related to the fair value of our CVRs. We recorded a $216.8 million charge in 2012 and a $151.5 million gain in 2011. In addition, in 2012 we recorded a $9.2 million accretion of the contingent consideration liability related to our acquisition of Avila. The increases were partly offset by a $63.6 million reduction in the contingent consideration liability related to the approval of ISTODAX® for PTCL in Europe.
Interest and Investment Income, Net:    Interest and investment income, net is summarized below for the years ended December 31, 2013, 2012 and 2011 (dollar amounts in millions):
 
 
2013
 
2012
 
2011
Interest and investment income, net
 
$
22.0

 
$
15.3

 
$
25.9

Increase (decrease) from prior year
 
$
6.7

 
$
(10.6
)
 
$
(18.9
)
Percentage increase (decrease) from prior year
 
43.8
%
 
(41.0
)%
 
(42.2
)%


40

Interest and investment income, net increased by $6.7 million to $22.0 million in 2013 compared to 2012 primarily due to higher investment balances compared to the prior year, partly offset by a $6.1 million increase in losses on sales of marketable securities.
Interest and investment income, net decreased by $10.6 million to $15.3 million in 2012 compared to 2011. The decrease was primarily due to a $3.7 million reduction in interest income due to lower overall interest rates, a $5.1 million net decrease in gains on sales of marketable securities and a $1.9 million net increase in the cost of amortization of discounts and premiums related to marketable securities.
Interest Expense:    Interest expense is summarized below for the years ended December 31, 2013, 2012 and 2011 (in millions):
 
 
2013
 
2012
 
2011
Interest expense
 
$
91.6

 
$
63.2

 
$
42.7

Increase from prior year
 
$
28.4

 
$
20.5

 
$
30.1


Interest expense increased by $28.4 million to $91.6 million in 2013 compared to 2012 primarily due to interest and fees associated with the issuance of $1.500 billion in senior notes in both August 2013 and August 2012.
Interest expense increased by $20.5 million to $63.2 million in 2012 compared to 2011 primarily due to interest and fees associated with the issuance in August 2012 of the $1.500 billion in senior notes referred to above and an increase in interest on Commercial Paper borrowings, which was in effect for full year 2012.
Other Income (Expense), Net:    Other income, net is summarized below for the years ended December 31, 2013, 2012 and 2011 (in millions):
 
 
2013
 
2012
 
2011
Other income (expense), net
 
$
(73.9
)
 
$
(17.0
)
 
$
(6.4
)
Increase (decrease) from prior year
 
$
(56.9
)
 
$
(10.6
)
 
$
2.8


Other expense increased by $56.9 million to $73.9 million in 2013 compared to 2012, primarily due to a $73.7 million increase in investment related impairment charges, including an $80.0 million impairment charge related to a royalty receivable asset that was received in April 2011 as partial consideration for the sale of the Abraxis non-core assets. The increase was partly offset by increased gains of $18.8 million related to foreign exchange contracts not designated as hedging instruments which were intended to mitigate the impact of exchange rate volatility in the translation of foreign earnings.
Other expense increased by $10.6 million to $17.0 million in 2012 compared to 2011, primarily due to $25.5 million in impairment losses related to cost method investments. The increase was partly offset by a $7.4 million gain on the sale of equity securities, net gains of $3.7 million related to the short period in June 2012 when certain treasury rate lock agreements were not designated as hedges and a $2.1 million decrease in equity method investment losses.
Income Tax Provision:    The income tax provision decreased by $9.8 million to $215.5 million in 2013 compared to 2012. The full year 2013 underlying effective tax rate of 12.2% reflects the impact of our global business footprint. The decrease in the underlying effective tax rate from 2012 reflects an increase in tax benefits from certain collaboration and acquisition-related items, including the $80.0 million impairment charge for the royalty receivable referred to above, and upfront payments to collaboration partners of $227.0 million that were incurred in the fourth quarter of 2013. The effective tax rate for 2013 was increased by 0.7 percentage points as a result of discrete items, including a net increase in unrecognized tax benefits resulting from ongoing examinations and settlements with taxing authorities, partially offset by tax benefits from the retroactive reinstatement of the 2012 U. S. research and development tax credit. The U.S. research and development tax credit expired on December 31, 2011 and was retroactively reinstated in the first quarter of 2013.
The income tax provision increased by $123.2 million to $225.3 million in 2012 compared to 2011. The full year 2012 underlying effective tax rate of 13.5% reflects the impact of our global business footprint. The increase in the underlying effective tax rate from 2011 reflects a decrease in tax benefits from certain acquisition-related items. The effective tax rate for 2012 was reduced by 0.1 percentage points as a result of discrete items, including tax benefits related to the settlement of tax examinations and expirations of statutes of limitations offset by an increase in deferred tax liabilities recorded on certain unremitted foreign earnings previously treated as permanently reinvested in such foreign jurisdictions and tax expense related to the filing of our 2011 income tax returns with certain items being less favorable than originally estimated. The U.S. research and development tax credit expired on December 31, 2011 and was retroactively reinstated in the first quarter of 2013. The tax benefit of our 2012 research credit was recorded in the first quarter of 2013. This change in tax law did not have a significant impact on our income tax provisions.

41

The income tax provision for 2011 included a full year underlying effective tax rate of 11.5%. The effective tax rate was reduced by 4.3 percentage points in 2011 as a result of discrete items which included tax benefits related to a foreign tax credit, a decrease in unrecognized tax benefits for certain ongoing income tax audits and expirations of statutes of limitations, and a net tax benefit related to changes in state tax laws.
Net Income:    Net income and per common share amounts for the years ended December 31, 2013, 2012 and 2011 were as follows (dollar amounts in millions, except per share data):
 
 
2013
 
2012
 
2011
Net income attributable to Celgene
 
$
1,449.9

 
$
1,456.2

 
$
1,318.1

Per common share amounts:
 
 
 
 
 
 
Basic
 
$
3.50

 
$
3.38

 
$
2.89

Diluted
 
$
3.37

 
$
3.30

 
$
2.85

Weighted average shares:
 
 
 
 
 
 
Basic
 
413.8

 
430.9

 
455.3

Diluted
 
430.3

 
440.8

 
462.7


The $6.3 million decrease in net income to $1.450 billion in 2013 compared to 2012 was primarily due to a $446.3 million increase in payments made related to research and development collaboration arrangements, a $61.9 million increase in ABRAXANE® amortization expense due to the October 2012 FDA approval of ABRAXANE® for treatment of NSCLC, a $94.8 million increase in share-based compensation expense, and increased spending in support of our currently marketed products and those that we plan to launch. The increases in expense were nearly offset by the favorable impact from a higher level of net product sales. The $0.07 increase in diluted earnings per share in 2013 compared to 2012 was favorably impacted by the repurchase of 22.3 million common shares under our common share repurchase program, reducing our outstanding share base.
Net income increased by $138.1 million to $1.456 billion and diluted earnings per share increased by $0.45 to $3.30 in 2012 compared to 2011 reflecting a higher level of net product sales, reduction in amortization of acquired intangible assets primarily due to certain intangible assets becoming fully amortized at the end of 2011 and a decrease in cost of goods sold, resulting from the 2011 inclusion of inventory step-up amortization for sales of ABRAXANE®. These favorable items were partly offset by an increase in the fair value of our liability related to publicly traded CVRs, an increase in payments related to research and development collaboration arrangements and increase in marketing activity, primarily related to pre-launch expenses for POMALYST® and ABRAXANE® for new indications. Earnings per diluted share were also favorably impacted in 2012 by the repurchase of 28.6 million common shares under our common share repurchase program, reducing our outstanding share base.


42

Liquidity and Capital Resources
The following table summarizes the components of our financial condition for the years ended December 31, 2013, 2012 and 2011 (in millions):
 
 
 
 
 
 
 
 
Increase (Decrease)
 
 
2013
 
2012
 
2011
 
2013
versus
2012
 
2012
versus
2011
Financial assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
3,234.4

 
$
2,090.4

 
$
1,859.5

 
$
1,144.0

 
$
230.9

Marketable securities available for sale
 
2,452.6

 
1,809.9

 
788.7

 
642.7

 
1,021.2

Total financial assets
 
$
5,687.0

 
$
3,900.3

 
$
2,648.2

 
$
1,786.7

 
$
1,252.1

Debt:
 
 
 
 
 
 
 
 
 
 
Short-term borrowings
 
$
544.8

 
$
308.5

 
$
526.7

 
$
236.3

 
$
(218.2
)
Long-term debt, net of discount
 
4,196.5

 
2,771.3

 
1,275.6

 
1,425.2

 
1,495.7

Total debt
 
$
4,741.3

 
$
3,079.8

 
$
1,802.3

 
$
1,661.5

 
$
1,277.5

Working capital1
 
$
5,607.4

 
$
3,767.6

 
$
2,660.0

 
$
1,839.8

 
$
1,107.6

1
Includes cash, cash equivalents and marketable securities available for sale, accounts receivable, net of allowances, inventory and other current assets, less short-term borrowings, accounts payable, accrued expenses, income taxes payable and other current liabilities.
We rely primarily on positive cash flows from operating activities, proceeds from sales of available-for-sale marketable securities, and borrowings in the form of long-term notes payable and short-term Commercial Paper to provide for our liquidity requirements. We expect continued growth in our expenditures, particularly those related to research and development, clinical trials, commercialization of new products, international expansion and capital investments. However, we anticipate that existing cash and cash equivalent balances, marketable securities available for sale, cash generated from operations and existing sources of and access to financing are adequate to fund our operating needs, capital expenditures, debt service requirements and our plans to repurchase stock or pursue other strategic business initiatives for the foreseeable future.
Many of our operations are conducted outside the United States and significant portions of our cash, cash equivalents and short-term investments are held internationally.  As of December 31, 2013, we held approximately $4.701 billion of these short-term funds in foreign tax jurisdictions.  The amount of funds held in U.S. tax jurisdictions can fluctuate due to the timing of receipts and payments in the ordinary course of business and due to other reasons, such as repurchases of our common stock and business-development activities.  As part of our ongoing liquidity assessments, we regularly monitor the mix of domestic and international cash flows (both inflows and outflows).  Repatriation of overseas funds can result in additional U.S. federal, state and local income tax payments.  We record U.S. deferred tax liabilities for certain unremitted earnings, but when amounts earned overseas are expected to be permanently reinvested outside of the United States, no accrual for U.S. taxes is provided.  Approximately $900.0 million of our foreign earnings, included in the $4.701 billion of short-term funds in foreign tax jurisdictions, may not be required for use in offshore operations and may be available for use in the United States.  These earnings are not treated as permanently reinvested and accordingly, our deferred tax liabilities as of December 31, 2013 and December 31, 2012 included $316.5 million for the estimated U.S. federal and state income taxes that may be incurred should these earnings be repatriated.  The remaining foreign earnings are unremitted and expected to be permanently reinvested outside the United States.  We do not rely on these earnings as a source of funds for our domestic business as we expect to have sufficient current cash resources combined with future cash flows in the United States to fund our U.S. operational and strategic needs.
Share Repurchase Program:    Our Board of Directors has approved an aggregate $9.500 billion stock repurchase program of which we have approximately $2.068 billion remaining for future share repurchases. During 2013, we used $2.765 billion for repurchases of our common stock, measured on a settlement date basis.
Components of Working Capital
Cash, Cash Equivalents and Marketable Securities Available for Sale:    We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency mortgage-backed securities, non-U.S. government agency and Supranational securities, global corporate debt securities and asset backed securities. All liquid investments with maturities of three months or less from the date of purchase are classified as cash equivalents and all investments with maturities of greater than three months from the date of purchase are classified as marketable securities

43

available for sale. We determine the appropriate classification of our investments in marketable debt and equity securities at the time of purchase. The $1.787 billion increase in cash, cash equivalents and marketable securities available for sale at December 31, 2013 compared to 2012 was primarily due to the issuance of $1.500 billion in senior notes in August 2013, net increase of $234.1 million in short-term borrowings and by cash generated from operations, partly offset by $2.765 billion paid under our share repurchase program.
Marketable securities available for sale are carried at fair value, held for an unspecified period of time and are intended for use in meeting our ongoing liquidity needs. Unrealized gains and losses on available-for-sale securities, which are deemed to be temporary, are reported as a separate component of stockholders' equity, net of tax. The cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. The amortization, along with realized gains and losses and other than temporary impairment charges, is included in interest and investment income, net. For more information related to the fair value and valuation of our marketable securities, see Note 4 of Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.
Accounts Receivable, Net: Accounts receivable, net increased by $100.9 million to $1.061 billion at December 31, 2013 compared to December 31, 2012 primarily due to increased U.S. and international sales of REVLIMID®, ABRAXANE® and POMALYST®/IMNOVID®. Sales made outside the United States typically have payment terms that are greater than 60 days, thereby extending collection periods beyond those in the United States.  We expect our accounts receivable balance to continue to grow as our international sales continue to expand.
We continue to monitor economic conditions, including the volatility associated with international economies, the sovereign debt crisis in certain European countries and associated impacts on the financial markets and our business.  Our current business model in these markets is typically to sell our products directly to principally government owned or controlled hospitals, which in turn directly deliver critical care to patients.  Our products are used to treat life-threatening diseases and we believe this business model enables timely delivery and adequate supply of products.  Many of the outstanding receivable balances are related to government-funded hospitals and we believe the receivable balances are ultimately collectible. Similarly, we believe that future sales to these customers will continue to be collectible.
 
The credit and economic conditions within Spain, Italy, Portugal and Greece, as well as increasing sales levels in those countries have resulted in, and may continue to result in, an increase in the average length of time it takes to collect accounts receivable.  Our total net receivables in Spain, Italy and Portugal are composed almost entirely of amounts receivable from government-owned or controlled hospitals and the public sector and amounted to $348.4 million at December 31, 2013 compared to $324.2 million at December 31, 2012.  Approximately $86.4 million of the $348.4 million receivable at December 31, 2013 was greater than one year past due.  Our exposure to the sovereign debt crisis in Greece is limited, as we do not have a material amount of receivables in Greece.  We maintain timely and direct communication with hospital customers in Spain, Italy and Portugal regarding both the current and past due receivable balances.  We continue to receive payments from these countries and closely monitor the plans for payment at the regional government level.  Payments from customers in these countries are not received on regular intervals and several months could elapse between significant payments.
 
In determining the appropriate allowance for doubtful accounts for Spain, Italy and Portugal, we considered that the balance of past due receivables is related to sales made to government-owned or supported customers.  We regularly monitor developments in Europe to assess whether the level of risk of default for any customers has increased and note the ongoing efforts by the European Union, European Monetary Union and International Monetary Fund to support countries with large public deficits and outstanding debt balances.  We also monitor the efforts of individual countries to support their regions with large public deficits and outstanding debt balances.  We have not experienced significant losses or write-offs with respect to the collection of our accounts receivable in these countries as a result of their economic difficulties and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse impact on our financial position or results of operations.
Inventory:    Inventory balances increased by $80.9 million to $340.4 million at the end of 2013 compared to 2012. The increase was primarily due to an increase in ABRAXANE® inventories, attributable to a higher sales level resulting from the FDA approvals of ABRAXANE® for treatment of NSCLC in October 2012 and pancreatic cancer in September 2013, as well as $33.4 million of OTEZLA® (apremilast) inventory that has been capitalized prior to regulatory approval, in anticipation of regulatory approval for this product.
Other Current Assets:    Other current assets increased by $116.2 million to $436.4 million at the end of 2013 compared to 2012 primarily due to a $48.8 million increase in prepaid taxes, a $33.9 million increase in the fair value of foreign currency forward contracts and a net increase in other prepaid accounts.
Commercial Paper:    In September 2011, we entered into a commercial paper program (the Program) under which we issue unsecured commercial paper notes (Commercial Paper) on a private placement basis, the proceeds of which are used for general corporate purposes. The maximum aggregate amount available under the Program is currently $1.500 billion. The maturities of

44

the Commercial Paper may vary, but may not exceed 270 days from the date of issue. The Commercial Paper is sold under customary terms to a dealer or in the commercial paper market and is issued at a discount from par or, alternatively, is sold at par and bears varying interest rates on a fixed or floating basis. Borrowings under the Program are accounted for as short-term borrowings. As of December 31, 2013, $544.8 million of Commercial Paper was outstanding bearing an effective interest rate of 0.4%.
Senior Unsecured Credit Facility:    In September 2011, we entered into a senior unsecured revolving credit facility (Credit Facility) providing for revolving credit in the aggregate amount of $1.000 billion, which was increased to $1.500 billion in April 2013. The term of the Credit Facility was also extended from September 2, 2016 to April 18, 2018.  Subject to certain conditions, we have the right to increase the amount of the Credit Facility (but in no event more than one time per annum), up to a maximum aggregate amount of $1.750 billion. 
Amounts may be borrowed under the Credit Facility for working capital, capital expenditures and other corporate purposes. The Credit Facility serves as backup liquidity for our Commercial Paper borrowings.  As of December 31, 2013 there was no outstanding borrowing against the Credit Facility.
 
The Credit Facility contains affirmative and negative covenants including certain customary financial covenants.  We were in compliance with those covenants as of December 31, 2013.
Accounts Payable, Accrued Expenses and Other Current Liabilities:    Accounts payable, accrued expenses and other current liabilities increased by $4.4 million to $1.357 billion at the end of 2013 compared to 2012. The increase was primarily due to increases of $93.1 million in compensation related expenses, $45.3 million of contingent consideration related to the January 2012 Avila acquisition, $45.0 million related to collaboration agreements, $30.3 million related to sales adjustments, $22.7 million related to foreign exchange contracts, $22.8 million in accrued interest and other miscellaneous liabilities. The increases were mostly offset by the 2013 payment of a $300.0 million liability, which had a fair value of $277.4 million at the end of 2012, associated with our publicly traded CVRs.
Income Taxes Payable (Current and Non-Current):    Income taxes payable increased by $51.0 million to $251.0 million at the end of 2013 compared to 2012, primarily from the current provision for income taxes of $462.1 million, net deferred intercompany credits of $32.6 million and an increase in refundable income taxes of $23.9 million, offset by income tax payments of $291.9 million and a tax benefit of stock options of $171.7 million.
Senior Notes:     In August 2013, we issued an additional $1.500 billion principal amount of senior notes consisting of $400.0 million aggregate principal amount of 2.300% Senior Notes due 2018 (the 2018 notes), $700.0 million aggregate principal amount of 4.000% Senior Notes due 2023 (the 2023 notes) and $400.0 million aggregate principal amount of 5.250% Senior Notes due 2043 (the 2043 notes) and, together with the 2018 notes and 2023 notes, referred to herein as the “2013 issued notes”. The 2013 issued notes were issued at 99.792%, 99.452% and 99.147% of par, respectively, and the discount is being amortized as additional interest expense over the period from issuance through maturity. Offering costs of approximately $12.5 million have been recorded as debt issuance costs on our Consolidated Balance Sheets and are being amortized as additional interest expense using the effective interest rate method over the period from issuance through maturity. Interest on the notes is payable semi-annually in arrears on February 15 and August 15 each year beginning February 15, 2014 and the principal on each note is due in full at their respective maturity dates. The notes may be redeemed at our option, in whole or in part, at any time at a redemption price defined in a make-whole clause equaling accrued and unpaid interest plus the greater of 100% of the principal amount of the notes to be redeemed or the sum of the present values of the remaining scheduled payments of interest and principal discounted to the date of redemption on a semi-annual basis plus 15 basis points in the case of the 2018 notes, 20 basis points in the case of the 2023 notes and 25 basis points in the case of the 2043 notes. If we experience a change of control accompanied by a downgrade of the debt to below investment grade, we will be required to offer to repurchase the notes at a purchase price equal to 101% of their principal amount plus accrued and unpaid interest. We are subject to covenants which limit our ability to pledge properties as security under borrowing arrangements and limit our ability to perform sale and leaseback transactions involving our property. The carrying value of all of our senior notes issued was $4.196 billion at December 31, 2013.

45

Cash flows from operating, investing and financing activities for the years ended December 31, 2013, 2012 and 2011 were as follows (in millions):
 
 
 
 
 
 
 
 
Increase (Decrease)
 
 
2013
 
2012
 
2011
 
2013
versus
2012
 
2012
versus
2011
Net cash provided by operating activities
 
$
2,225.9

 
$
2,018.6

 
$
1,776.1

 
$
207.3

 
$
242.5

Net cash (used in) provided by investing activities
 
$
(528.6
)
 
$
(1,553.6
)
 
$
377.7

 
$
1,025.0

 
$
(1,931.3
)
Net cash used in financing activities
 
$
(553.7
)
 
$
(248.8
)
 
$
(1,622.0
)
 
$
(304.9
)
 
$
1,373.2

Operating Activities:    Net cash provided by operating activities increased by $207.3 million to $2.226 billion in 2013 compared to 2012 primarily as a result of an expansion of our operations and a related increase in net earnings.
Net cash provided by operating activities in 2012 increased by $242.5 million to $2.019 billion compared to 2011 primarily as a result of an expansion of our operations and related increase in net earnings.
Investing Activities: Net cash used in investing activities decreased by $1.025 billion in 2013 compared to 2012. The decrease in net cash used in investing activities was principally related to a cash use of $341.3 million for net purchases of marketable securities available for sale during 2013 compared to a cash use of $1.025 billion for net purchases in 2012, plus the use of $352.2 million for the acquisition of Avila in 2012.
Net cash used in investing activities in 2012 changed to a net use of $1.554 billion compared to $377.7 million of net cash provided by investing activities in 2011. The decrease in net cash provided by investing activities was principally related to a cash use of $1.025 billion for net purchases of marketable securities available for sale during 2012 compared to net sales of $481.8 million in 2011, plus the use of $352.2 million for the acquisition of Avila and $48.9 million for the purchase of intellectual property and other assets.
Financing Activities:    Net cash used in financing activities in 2013 was $553.7 million compared to a net cash use of $248.8 million in 2012. The $304.9 million increase in net cash used in financing activities was primarily attributable to a $721.0 million increase in cash used for the purchase of treasury shares and a cash use of $225.0 million recorded as a financing activity to reflect the portion of a $300.0 million milestone payment to holders of our CVRs that represents the original fair value of Abraxis contingent consideration. These increases were partially offset by net proceeds from borrowing of $234.1 million during 2013 compared to net repayments of $217.4 million in 2012. Proceeds from issuances of common stock under our employee stock plans plus the excess tax benefit from share-based compensation arrangements provided an aggregate $721.0 million during 2013, which is an increase of $195.5 million from 2012.
Net cash used in financing activities in 2012 was $248.8 million compared to a net cash use of $1.622 billion in 2011. The $1.372 billion decrease in net cash used in financing activities in 2012 was primarily attributable to $1.487 billion of proceeds from the issuance of long-term debt, partially offset by $217.4 million of net repayments of short-term borrowing in 2012, compared to $525.7 million of net short-term borrowing in 2011. During 2012 and 2011, we used $2.044 billion and $2.189 billion, respectively, for repurchases of our common stock, measured on a settlement date basis.

46

Contractual Obligations
The following table sets forth our contractual obligations as of December 31, 2013 (in millions):
 
 
Payment Due By Period
 
 
Less than
1 Year
 
1 to 3 Years
 
3 to 5 Years
 
More than
5 Years
 
Total
Senior notes1
 
$
146.5

 
$
780.6

 
$
1,158.9

 
$
3,998.0

 
$
6,084.0

Short-term borrowings
 
544.8

 
—

 
—

 
—

 
544.8

Operating leases
 
54.5

 
87.3

 
52.8

 
44.6

 
239.2

Other contract commitments
 
101.7

 
68.6

 
—

 
—

 
170.3

Total
 
$
847.5

 
$
936.5

 
$
1,211.7

 
$
4,042.6

 
$
7,038.3

1 
The senior note obligation amounts include future principal and interest payments.
Senior Notes:   In August 2013, we issued $1.500 billion principal amount of senior notes consisting of $400.0 million aggregate principal amount of 2.300% Senior Notes due 2018, $700.0 million aggregate principal amount of 4.000% Senior Notes due 2023 and $400.0 million aggregate principal amount of 5.250% Senior Notes due 2043.
In August 2012, we issued a total of $1.500 billion principal amount of senior notes consisting of $500.0 million aggregate principal amount of 1.90% Senior Notes due 2017, and $1.000 billion aggregate principal amount of 3.25% Senior Notes due 2022.
In October 2010, we issued a total of $1.250 billion principal amount of senior notes consisting of $500.0 million aggregate principal amount of 2.45% Senior Notes due 2015, $500.0 million aggregate principal amount of 3.95% Senior Notes due 2020 and $250.0 million aggregate principal amount of 5.7% Senior Notes due 2040.
Short-term Borrowings:    Contractual obligations related to short-term borrowings included principal, interest and fees of $544.8 million related to commercial paper outstanding at December 31, 2013.
Operating Leases:    We lease office and research facilities under various operating lease agreements in the United States and various international markets. The non-cancelable lease terms for operating leases expire at various dates between 2014 and 2023 and include renewal options. In general, we are also required to reimburse the lessors for real estate taxes, insurance, utilities, maintenance and other operating costs associated with the leases. For more information on the major facilities that we occupy under lease arrangements refer to Part I, Item 2. "Properties" of this Annual Report on Form 10-K.
Other Contract Commitments:    Other contract commitments of $170.3 million on December 31, 2013 primarily included $153.7 million in contractual obligations related to product supply contracts and a remaining $14.6 million balance due in connection with our acquisition of a manufacturing facility in Switzerland.
Collaboration Arrangements:    We have entered into certain research and development collaboration agreements with third parties that include the funding of certain development, manufacturing and commercialization efforts with the potential for future milestone and royalty payments upon the achievement of pre-established developmental, regulatory and/or commercial targets. Our obligation to fund these efforts is contingent upon continued involvement in the programs and/or the lack of any adverse events which could cause the discontinuance of the programs. Due to the nature of these arrangements, the future potential payments related to the attainment of specified development and regulatory approval milestones over a period of several years are inherently uncertain, and accordingly, no amounts have been recorded for these future potential payments in our Consolidated Balance Sheets at December 31, 2013 and 2012 contained in this Annual Report on Form 10-K. Potential milestone payments (not including potential royalty payments) total approximately $4.300 billion, including approximately $3.503 billion contingent on the achievement of various research, development and regulatory approval milestones and approximately $796.7 million in sales-based milestones. The more notable collaboration agreements are identified in Note 17 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K.
New Accounting Standards
For a discussion of new accounting standards please see Note 1 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K.

47

Critical Accounting Estimates and Significant Accounting Policies
A critical accounting policy is one that is both important to the portrayal of our financial condition and results of operation and requires management's most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. While our significant accounting policies are more fully described in Note 1 of Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K, we believe the following accounting estimates and policies to be critical:
Revenue Recognition:    Revenue from the sale of products is recognized when title and risk of loss of the product is transferred to the customer and the sales price is fixed and determinable. Provisions for discounts, early payments, rebates, sales returns and distributor chargebacks under terms customary in the industry are provided for in the same period the related sales are recorded. We record estimated reductions to revenue for volume-based discounts and rebates at the time of the initial sale. The estimated reductions to revenue for such volume-based discounts and rebates are based on the sales terms, historical experience and trend analysis.
We recognize revenue from royalties based on licensees' sales of our products or products using our technologies. Royalties are recognized as earned in accordance with the contract terms when royalties from licensees can be reasonably estimated and collectability is reasonably assured. If royalties cannot be reasonably estimated or collectability of a royalty amount is not reasonably assured, royalties are recognized as revenue when the cash is received.
Gross to Net Sales Accruals:  We base our sales returns allowance on estimated on-hand retail/hospital inventories, measured end-customer demand as reported by third-party sources, actual returns history and other factors, such as the trend experience for lots where product is still being returned or inventory centralization and rationalization initiatives conducted by major pharmacy chains, as applicable.  If the historical data we use to calculate these estimates do not properly reflect future returns, then a change in the allowance would be made in the period in which such a determination is made and revenues in that period could be materially affected.  Under this methodology, we track actual returns by individual production lots.  Returns on closed lots, that is, lots no longer eligible for return credits, are analyzed to determine historical returns experience.  Returns on open lots, that is, lots still eligible for return credits, are monitored and compared with historical return trend rates.  Any changes from the historical trend rates are considered in determining the current sales return allowance.  REVLIMID®, POMALYST® and THALOMID® are distributed primarily through hospitals and contracted pharmacies, which are typically subject to tighter controls of inventory quantities within the supply channel, resulting in generally lower returns activity for those products.
Sales discount accruals are based on payment terms extended to customers.
Government rebate accruals are based on estimated payments due to governmental agencies for purchases made by third parties under various governmental programs. U.S. Medicaid rebate accruals are generally based on historical payment data and estimates of future Medicaid beneficiary utilization applied to the Medicaid unit rebate formula established by the Center for Medicaid and Medicare Services. The Medicaid rebate percentage was increased and extended to Medicaid Managed Care Organizations in March 2010.  The accrual of the rebates associated with Medicaid Managed Care Organizations is calculated based on estimated historical patient data related to Medicaid Managed Care Organizations.  We have also analyzed actual billings received from the states to further support the accrual rates.  Subsequent to implementation of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively the 2010 U.S. Health Care Reform Law), certain states have only recently begun submitting partial Medicaid Managed Care Organization bills.  Our accruals for these Medicaid Managed Care Organization rebates had been at elevated levels given the delays in the receipt of complete invoices from certain states.  Due to the receipt of more complete claims data as 2013 progressed, the accruals for certain states were reduced from the elevated levels at December 31, 2012 as a result of both the payments made being applied to the accrual and a $20.3 million favorable change in estimate of the ultimate obligation.  We will continue to adjust the rebate accruals as more information becomes available and to reflect actual claims experience.  Effective January 1, 2011, manufacturers of pharmaceutical products are responsible for 50% of the patient’s cost of branded prescription drugs related to the Medicare Part D Coverage Gap.  In order to estimate the cost to us of this coverage gap responsibility, we analyze data for eligible Medicare Part D patients against data for eligible Medicare Part D patients treated with our products as well as the historical invoices.  This expense is recognized throughout the year as costs are incurred.  In addition, certain international markets have government-sponsored programs that require rebates to be paid based on program specific rules and, accordingly, the rebate accruals are determined primarily on estimated eligible sales.
Rebates or administrative fees are offered to certain wholesale customers, group purchasing organizations and end-user customers, consistent with pharmaceutical industry practices. Settlement of rebates and fees may generally occur from one to 15 months from the date of sale. We provide a provision for rebates at the time of sale based on contracted rates and historical redemption rates. Assumptions used to establish the provision include level of wholesaler inventories, contract sales volumes and average contract pricing.  We regularly review the information related to these estimates and adjust the provision accordingly.
 

48

Chargeback accruals are based on the differentials between product acquisition prices paid by wholesalers and lower government contract pricing paid by eligible customers covered under federally qualified programs.  Distributor service fee accruals are based on contractual fees to be paid to the wholesale distributor for services provided.  TRICARE is a health care program of the U.S. Department of Defense Military Health System that provides civilian health benefits for military personnel, military retirees and their dependents.  TRICARE rebate accruals are included in chargeback accruals and are based on estimated Department of Defense eligible sales multiplied by the TRICARE rebate formula.
Allowance for Doubtful Accounts:    We estimate an allowance for doubtful accounts primarily based on the credit worthiness of our customers, historical payment patterns, aging of receivable balances and general economic conditions, including publicly available information on the credit worthiness of countries themselves and provinces or areas within such countries where they are the ultimate customers.
Income Taxes:    We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse. We provide a valuation allowance when it is more likely than not that deferred tax assets will not be realized.
We account for interest and penalties related to uncertain tax positions as part of our provision for income taxes. These unrecognized tax benefits relate primarily to issues common among multinational corporations in our industry. We apply a variety of methodologies in making these estimates which include studies performed by independent economists, advice from industry and subject experts, evaluation of public actions taken by the U.S. Internal Revenue Service and other taxing authorities, as well as our own industry experience. We provide estimates for unrecognized tax benefits. If our estimates are not representative of actual outcomes, our results of operations could be materially impacted.
We periodically evaluate the likelihood of the realization of deferred tax assets, and reduce the carrying amount of these deferred tax assets by a valuation allowance to the extent we believe a portion will not be realized. We consider many factors when assessing the likelihood of future realization of deferred tax assets, including our recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income, carryforward periods available to us for tax reporting purposes, various income tax strategies and other relevant factors. Significant judgment is required in making this assessment and, to the extent future expectations change, we would have to assess the recoverability of our deferred tax assets at that time. At December 31, 2013, it was more likely than not that we would realize our deferred tax assets, net of valuation allowances.
Share-Based Compensation:     We utilize share based compensation in the form of stock options, restricted stock units, or RSUs, and performance-based restricted stock units, or PSUs. Compensation expense is recognized in the Consolidated Statements of Income based on the estimated fair value of the awards at grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized to date associated with grants that are not expected to vest will be reversed.
Other-Than-Temporary Impairments of Available-For-Sale Marketable Securities:    A decline in the market value of any available-for-sale marketable security below its cost that is deemed to be other-than-temporary results in a reduction in carrying amount to fair value. The impairment is charged to operations and a new cost basis for the security established. The determination of whether an available-for-sale marketable security is other-than-temporarily impaired requires significant judgment and requires consideration of available quantitative and qualitative evidence in evaluating the potential impairment. Factors evaluated to determine whether the investment is other-than-temporarily impaired include: significant deterioration in the issuer's earnings performance, credit rating, asset quality, business prospects of the issuer, adverse changes in the general market conditions in which the issuer operates, length of time that the fair value has been below our cost, our expected future cash flows from the security, our intent not to sell, an evaluation as to whether it is more likely than not that we will not have to sell before recovery of our cost basis, and issues that raise concerns about the issuer's ability to continue as a going concern. Assumptions associated with these factors are subject to future market and economic conditions, which could differ from our assessment.
Derivatives and Hedging Activities:    All derivative instruments are recognized on the balance sheet at their fair value. Changes in the fair value of derivative instruments are recorded each period in current earnings or other comprehensive income (loss), depending on whether a derivative instrument is designated as part of a hedging transaction and, if it is, the type of hedging transaction. For a derivative to qualify as a hedge at inception and throughout the hedged period, we formally document the nature and relationships between the hedging instruments and hedged item. We assess, both at inception and on an on-going basis, whether the derivative instruments that are used in cash flow hedging transactions are highly effective in offsetting the changes in cash flows of hedged items. We assess hedge effectiveness on a quarterly basis and record the gain or loss related to the ineffective

49

portion of derivative instruments, if any, to current earnings. If we determine that a forecasted transaction is no longer probable of occurring, we discontinue hedge accounting and any related unrealized gain or loss on the derivative instrument is recognized in current earnings. We use derivative instruments, including those not designated as part of a hedging transaction, to manage our exposure to movements in foreign exchange and interest rates. The use of these derivative instruments modifies the exposure of these risks with the intent to reduce our risk or cost.
Investments in Other Entities:   We hold a portfolio of investments in equity securities and certain investment funds that are accounted for under either the equity method or cost method. Investments in companies or certain investment funds over which we have significant influence but not a controlling interest are accounted for using the equity method, with our share of earnings or losses reported in other income (expense), net. Investments in equity securities of companies that become publicly traded are accounted for as available-for-sale marketable securities prospectively from the date of such companies' initial public offering.
Our cost method and equity method investments are included in other assets on the Consolidated Balance Sheets.
All investments are reviewed on a regular basis for possible impairment. If an investment's fair value is determined to be less than its net carrying value and the decline is determined to be other-than-temporary, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an other-than-temporary decline in value has occurred include: market value or exit price of the investment based on either market-quoted prices or future rounds of financing by the investee; length of time that the market value was below its cost basis; financial condition and business prospects of the investee; our intent and ability to retain the investment for a sufficient period of time to allow for recovery in market value of the investment; issues that raise concerns about the investee's ability to continue as a going concern; any other information that we may be aware of related to the investment.
Accounting for Long-Term Incentive Plans:    We have established a Long-Term Incentive Plan, or LTIP, designed to provide key officers and executives with performance-based incentive opportunities contingent upon achievement of pre-established corporate performance objectives covering a three-year period. We currently have three separate three-year performance cycles running concurrently ending December 31, 2014, 2015 and 2016. Performance measures for each of the performance cycles are based on the following components: 37.5% on non-GAAP earnings per share; 37.5% on total non-GAAP revenue, as defined; and 25% on relative total shareholder return, which is a measurement of our stock price performance during the year compared with a group of other companies in the biopharmaceutical industry.
Payouts may be in the range of 0% to 200% of the participant's salary for the LTIPs. Such awards are payable in cash or common stock or a mixture of cash and common stock, which will be determined by the Compensation Committee at the time of award delivery. For awards payable in common stock, the number of shares is determined using the average closing price for the 30 trading days prior to the beginning of the cycle. The Compensation Committee may determine that payments made in common stock will be restricted from trading for a period of three years. We accrue the long-term incentive liability over each three-year cycle. Prior to the end of a three-year cycle, the accrual is based on an estimate of our level of achievement during the cycle. Upon a change in control, participants will be entitled to an immediate payment equal to their target award or, if higher, an award based on actual performance through the date of the change in control.
Accruals recorded for the LTIP entail making certain assumptions concerning future non-GAAP earnings per share, non-GAAP revenues and relative total shareholder return, as defined; the actual results of which could be materially different than the assumptions used. Accruals for the LTIP are reviewed on a regular basis and revised accordingly so that the liability recorded reflects updated estimates of future payouts. In estimating the accruals, management considers actual results to date for the performance period, expected results for the remainder of the performance period, operating trends, product development, pricing and competition.
Valuation of Goodwill, Acquired Intangible Assets, Other Assets and IPR&D:    We have recorded goodwill, acquired intangible assets and IPR&D primarily through the acquisitions of Pharmion, Gloucester, Abraxis and Avila. When identifiable intangible assets, including in-process research and development and securitized financial assets, are acquired, we determine the fair values of these assets as of the acquisition date. Discounted cash flow models are typically used in these valuations if quoted market prices are not available, and the models require the use of significant estimates and assumptions including but not limited to:
•
projecting regulatory approvals;
•
estimating future cash flows from product sales resulting from completed products and in-process projects or estimating future cash flows expected to be collected; and
•
developing appropriate discount rates and probability rates.
Goodwill represents the excess of purchase price over fair value of net assets acquired in a business combination accounted for by the acquisition method of accounting and is not amortized, but subject to impairment testing at least annually or when a triggering event occurs that could indicate a potential impairment. We test our goodwill annually for impairment each November 30. We are

50

organized as a single reporting unit and therefore the goodwill impairment test is done using our overall market value, as determined by our traded share price, as compared to our book value of net assets.
Intangible assets with definite useful lives are amortized to their estimated residual values over their estimated useful lives and reviewed for impairment if certain events occur. Intangible assets related to IPR&D product rights are treated as indefinite-lived intangible assets and not amortized until the product is approved for sale by regulatory authorities in specified markets. At that time, we will determine the useful life of the asset, reclassify the asset out of IPR&D and begin amortization. Impairment testing is also performed at least annually or when a triggering event occurs that could indicate a potential impairment. Such test entails completing an updated discounted cash flow model to estimate the fair value of the asset.
Other assets are tested for impairment when a triggering event occurs that could indicate a potential impairment. Such test entails completing an updated discounted cash flow model to estimate the fair value of the asset.
Valuation of Contingent Consideration Resulting from a Business Combination:    We record contingent consideration resulting from a business combination at its fair value on the acquisition date, and for each subsequent reporting period revalue these obligations and record increases or decreases in their fair value as an adjustment to operating earnings in the consolidated statements of income. Changes to contingent consideration obligations can result from movements in publicly traded share prices of CVRs, adjustments to discount rates and periods, updates in the assumed achievement or timing of any development milestones or changes in the probability of certain clinical events and changes in the assumed probability associated with regulatory approval. The assumptions related to determining the value of a contingent consideration include a significant amount of judgment and any changes in the assumptions could have a material impact on the amount of contingent consideration expense recorded in any given period. Our contingent consideration liabilities were acquired in the acquisitions of Gloucester, Abraxis, and Avila. The fair values of the Gloucester and Avila contingent consideration liabilities are based on the discount rate, probability and estimated timing of cash milestone payments to the former shareholders or each company. The fair value of the Abraxis contingent consideration liability is based on the quoted market price of the publicly traded CVRs.
ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The following discussion provides forward-looking quantitative and qualitative information about our potential exposure to market risk. Market risk represents the potential loss arising from adverse changes in the value of financial instruments. The risk of loss is assessed based on the likelihood of adverse changes in fair values, cash flows or future earnings.
We have established guidelines relative to the diversification and maturities of investments to maintain safety and liquidity. These guidelines are reviewed periodically and may be modified depending on market conditions. Although investments may be subject to credit risk, our investment policy specifies credit quality standards for our investments and limits the amount of credit exposure from any single issue, issuer or type of investment. At December 31, 2013, our market risk sensitive instruments consisted of marketable securities available for sale, our long-term debt and certain derivative contracts.
Marketable Securities Available for Sale:    At December 31, 2013, our marketable securities available for sale consisted of U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency mortgage-backed (MBS) securities, non-U.S. government, agency and Supranational securities, global corporate debt securities, asset backed securities and marketable equity securities. U.S. government-sponsored agency securities include general unsecured obligations either issued directly by or guaranteed by U.S. Government Sponsored Enterprises. U.S. government-sponsored agency MBS include mortgage backed securities issued by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association. Non-U.S. government, agency and Supranational securities consist of direct obligations of highly rated governments of nations other than the United States, obligations of sponsored agencies and other entities that are guaranteed or supported by highly rated governments of nations other than the United States. Corporate debt – global includes obligations issued by investment-grade corporations including some issues that have been guaranteed by governments and government agencies. Asset backed securities consist of triple-A rated securities with cash flows collateralized by credit card receivables and auto loans.
Marketable securities available for sale are carried at fair value, held for an unspecified period of time and are intended for use in meeting our ongoing liquidity needs. Unrealized gains and losses on available-for-sale securities, which are deemed to be temporary, are reported as a separate component of stockholders' equity, net of tax. The cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. The amortization, along with realized gains and losses and other than temporary impairment charges, is included in interest and investment income, net.

51

As of December 31, 2013, the principal amounts, fair values and related weighted-average interest rates of our investments in debt securities classified as marketable securities available for sale were as follows (dollar amounts in millions):
 
 
Duration
 
 
Less than 1 Year
 
1 to 3 Years
 
3 to 5 Years
 
Over 5 Years
 
Total
Principal amount
 
$
390.4

 
$
1,351.8

 
$
222.3

 
$
33.8

 
$
1,998.3

Fair value
 
$
391.6

 
$
1,363.8

 
$
229.8

 
$
34.3

 
$
2,019.5

Weighted average interest rate
 
0.4
%
 
0.7
%
 
2.1
%
 
2.6
%
 
0.8
%
Long-Term Debt:   We have issued an aggregate $4.250 billion principal amount of senior notes at varying maturity dates and interest rates. The principal amounts and carrying values of these senior notes as of the end of December 31, 2013 are summarized below:
 
 
Principal Amount
 
Carrying Value
2.450% senior notes due 2015
 
$
500.0

 
$
513.9

1.900% senior notes due 2017
 
500.0

 
499.9

2.300% senior notes due 2018
 
400.0

 
399.0

3.950% senior notes due 2020
 
500.0

 
484.6

3.250% senior notes due 2022
 
1,000.0

 
956.6

4.000% senior notes due 2023
 
700.0

 
696.3

5.700% senior notes due 2040
 
250.0

 
249.6

5.250% senior notes due 2043
 
400.0

 
396.6

Total long-term debt
 
$
4,250.0

 
$
4,196.5

At December 31, 2013, the fair value of our senior notes outstanding was $4.269 billion.
Celgene Common Stock: As part of the management of our Board of Director authorized share repurchase program, we may, from time to time, sell put options on our common stock with strike prices that we believe represent an attractive price to repurchase our shares. If the trading price of our shares exceeds the strike price of the put option at the time the option expires, we will have economically reduced the cost of our share repurchase program by the amount of the premium we received from the sale of the put option. If the trading price of our stock is below the strike price of the put option at the time the option expires, we would repurchase the shares covered by the option at the strike price of the put option. While such a purchase would be at a price above the then fair market value of our shares, it would be at a price that we feel is favorable in the overall context of our share repurchase program. During 2013 we sold a single put option for a premium of $1.2 million that expired unexercised. At December 31, 2013, we had no outstanding put options. In February 2014, we sold a put option on $200.0 million notional amount of shares of stock with a strike price of $142.81 and maturing in March 2014 for a premium of $4.8 million.
MARKET RISK MANAGEMENT
Our revenue and earnings, cash flows and fair values of assets and liabilities can be impacted by fluctuations in foreign exchange rates and interest rates. We actively manage the impact of foreign exchange rate and interest rate movements through operational means and through the use of various financial instruments, including derivative instruments such as foreign currency options, foreign currency forward contracts, treasury rate lock agreements and interest rate swap contracts.
Foreign Currency Risk Management
We maintain a foreign exchange exposure management program to mitigate the impact of volatility in foreign exchange rates on future foreign currency cash flows, translation of foreign earnings and changes in the fair value of assets and liabilities denominated in foreign currencies.
Through our revenue hedging program, we endeavor to reduce the impact of possible unfavorable changes in foreign exchange rates on our future U.S. dollar cash flows that are derived from foreign currency denominated sales. To achieve this objective, we hedge a portion of our forecasted foreign currency denominated sales that are expected to occur in the foreseeable future, typically within the next three years. We manage our anticipated transaction exposure principally with foreign currency forward contracts and occasionally foreign currency put and call options.

52

Foreign Currency Forward Contracts: We use foreign currency forward contracts to hedge specific forecasted transactions denominated in foreign currencies, manage exchange rate volatility in the translation of foreign earnings and to reduce exposures to foreign currency fluctuations of certain assets and liabilities denominated in foreign currencies.
We manage a portfolio of foreign currency forward contracts to protect against changes in anticipated foreign currency cash flows resulting from changes in foreign currency exchange rates, primarily associated with non-functional currency denominated revenues and expenses of foreign subsidiaries. The foreign currency forward hedging contracts outstanding at December 31, 2013 and 2012 had settlement dates within 36 months. These foreign currency forward contracts are designated as cash flow hedges and, to the extent effective, any unrealized gains or losses on them are reported in other comprehensive income (loss) (OCI) and reclassified to operations in the same periods during which the underlying hedged transactions affect operations. Any ineffectiveness on these foreign currency forward contracts is reported in other income (expense), net. Foreign currency forward contracts entered into to hedge forecasted revenue and expenses were as follows at December 31, 2013 and 2012 (in millions):
 
 
Notional Amount
Foreign Currency:
 
2013
 
2012
Australian Dollar
 
$
—

 
$
5.1

British Pound
 
279.4

 
77.9

Canadian Dollar
 
—

 
134.4

Euro
 
3,318.2

 
969.3

Japanese Yen
 
559.1

 
236.2

Total
 
$
4,156.7

 
$
1,422.9

We consider the impact of our own and the counterparties' credit risk on the fair value of the contracts as well as the ability of each party to execute its obligations under the contract on an ongoing basis. As of December 31, 2013, credit risk did not materially change the fair value of our foreign currency forward contracts.
We also manage a portfolio of foreign currency contracts to reduce exposures to foreign currency fluctuations of certain recognized assets and liabilities denominated in foreign currencies and, from time to time, we enter into foreign currency contracts to manage exposure related to translation of foreign earnings. These foreign currency forward contracts have not been designated as hedges and, accordingly, any changes in their fair value are recognized on the Consolidated Statements of Income in other income (expense), net in the current period. The aggregate notional amount of the foreign currency forward non-designated hedging contracts outstanding at December 31, 2013 and 2012 were $878.5 million and $795.4 million, respectively.
Although not predictive in nature, we believe a hypothetical 10% threshold reflects a reasonably possible near-term change in foreign currency rates. Assuming that the December 31, 2013 exchange rates were to change by a hypothetical 10%, the fair value of the foreign currency forward contracts would change by approximately $501.0 million. However, since the contracts either hedge specific forecasted intercompany transactions denominated in foreign currencies or relate to assets and liabilities denominated in currencies other than the entities' functional currencies, any change in the fair value of the contract would be either reported in other comprehensive income and reclassified to earnings in the same periods during which the underlying hedged transactions affect earnings or re-measured through earnings each period along with the underlying asset or liability.

53

Foreign Currency Option Contracts:    From time to time, we may hedge a portion of our future foreign currency exposure by utilizing a strategy that involves both a purchased local currency put option and a written local currency call option that are accounted for as hedges of future sales denominated in euros. In connection with this strategy, we may also sell local currency put options that are not accounted for as hedges in order to reduce or fully offset the net cost of the hedging contracts. Foreign currency option contracts entered into to hedge forecasted revenue and expenses were as follows at December 31, 2013 and 2012:
 
Notional Amount 1
 
2013
 
2012
Foreign Currency Option:
 
 
 
Designated as hedging activity:
 
 
 
Purchased Put
$
—

 
$
228.8

Written Call
$
—

 
$
235.9

Not designated as hedging activity:
 
 
 
Purchased Put
$
—

 
$
160.5

Written Put
$
—

 
$
(216.0
)
1 U.S. dollar notional amounts are calculated as the hedged local currency amount multiplied times the strike value of the foreign currency option. The local currency notional amounts of our purchased put, and written call that are designated as hedging activity are equal to each other.
Interest Rate Risk Management
In anticipation of issuing fixed-rate debt, we may use forward starting interest rate swaps (forward starting swaps) or treasury rate lock agreements (treasury rate locks) that are designated as cash flow hedges to hedge against changes in interest rates that could impact expected future issuances of debt. To the extent these hedges of cash flows related to anticipated debt are effective, any realized or unrealized gains or losses on the treasury rate locks or forward starting swaps are reported in OCI and are recognized in income over the life of the anticipated fixed-rate notes.

Forward Starting Interest Rate Swaps: During 2013, we entered into forward starting swaps, that were designated as cash flow hedges, with an aggregate notional value of $300.0 million and effective dates in November 2014, with $100.0 million maturing in five years and $200 million maturing in ten years to hedge against changes in interest rates that could impact an anticipated issuance of debt. During January and February 2014, we entered into additional forward starting swaps with effective dates in November 2014 and an aggregate notional value of $350.0 million and maturities of five and ten years. A one percentage point increase in interest rates at December 31, 2013 would not have had a material impact on the fair value of our forward starting interest rate swaps.
Treasury Rate Lock Agreements: During 2012, we entered into treasury rate lock agreements, or treasury rate locks, in anticipation of issuing fixed-rate notes that were issued in August 2012. The treasury rate locks were settled during 2012 which resulted in losses of $35.3 million that were recorded to OCI. No material amounts were recorded in income during 2013 or 2012 as a result of hedge ineffectiveness or hedge components excluded from the assessment of effectiveness.
Interest Rate Swap Contracts:    From time to time we hedge the fair value of certain debt obligations through the use of interest rate swap contracts. The interest rate swap contracts are designated hedges of the fair value changes in the notes attributable to changes in interest rates. Since the specific terms and notional amount of the swap are intended to match those of the debt being hedged, it is assumed to be a highly effective hedge and all changes in fair value of the swap is recorded on the Consolidated Balance Sheets with no net impact recorded in income. Any net interest payments made or received on interest rate swap contracts are recognized as interest expense. We may terminate the hedging relationship of certain swap contracts by settling the contracts or by entering into offsetting contracts.  At the time a hedging relationship is terminated, accumulated gains or losses associated with the swap contract are measured and recorded as a reduction of current and future interest expense associated with the previously hedged notes.

54

We have entered into swap contracts that were designated as hedges of our fixed rate notes due in 2015, 2017, 2018, 2020, 2022 and 2023 and also terminated the hedging relationship by settling certain of those swap contracts during 2012 and 2013.  The settlement of swap contracts resulted in the receipt of net proceeds of $5.0 million in 2012 and $22.9 million in 2013 which is accounted for as a reduction of current and future interest expense associated with these notes.  See Note 11 of Notes to Consolidated Financial Statements contained in this Annual Report on Form 10-K for additional details related to reductions of current and future interest expense. The following table summarizes the notional amounts of our outstanding swap contracts at the end December 31, 2013 and 2012:
 
 
Notional Amount
 
 
2013
 
2012
Interest rate swap contracts entered into as fair value hedges of the following fixed-rate senior notes:
 
 

 
 

2.450% senior notes due 2015
 
$
300.0

 
$
—

1.900% senior notes due 2017
 
300.0

 
100.0

2.300% senior notes due 2018
 
200.0

 
—

3.950% senior notes due 2020
 
500.0

 
—

3.250% senior notes due 2022
 
850.0

 
200.0

4.000% senior notes due 2023
 
150.0

 
—

Total
 
$
2,300.0

 
$
300.0

During 2014 we continued to actively manage our interest rate swaps and have terminated the hedging relationships of certain swap contracts and entered into new swaps that were designated as fair value hedges of our senior notes. The notional amount of our outstanding interest rate contracts at February 12, 2014 was $1.850 billion.
A sensitivity analysis to measure potential changes in the market value of our debt and interest rate swap contracts from a change in interest rates indicated that a one percentage point increase in interest rates at December 31, 2013 would have reduced the aggregate fair value of our net payable by $157.2 million. A one percentage point decrease at December 31, 2013 would have increased the aggregate fair value of our net payable by $181.9 million.

55

ITEM 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
CELGENE CORPORATION AND SUBSIDIARIES
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

56

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Celgene Corporation:
We have audited the accompanying consolidated balance sheets of Celgene Corporation and subsidiaries (the Company) as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income, cash flows, and stockholders' equity for each of the years in the three-year period ended December 31, 2013. In connection with our audits of the consolidated financial statements, we also have audited the consolidated financial statement schedule, "Schedule II – Valuation and Qualifying Accounts." These consolidated financial statements and consolidated financial statement schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements and consolidated financial statement schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Celgene Corporation and subsidiaries as of December 31, 2013 and 2012, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2013, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related consolidated financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of the Company's internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 1992 and our report dated February 13, 2014 expressed an unqualified opinion on the effectiveness of the Company's internal control over financial reporting.
/s/ KPMG LLP
Short Hills, New Jersey
February 13, 2014

57

CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in millions, except per share amounts)
 
December 31,
 
2013
 
2012
Assets
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
3,234.4

 
$
2,090.4

Marketable securities available for sale
2,452.6

 
1,809.9

Accounts receivable, net of allowances of $40.0 and $33.0 at December 31, 2013 and 2012, respectively
1,061.4

 
960.5

Inventory
340.4

 
259.5

Deferred income taxes
25.3

 
93.2

Other current assets
436.4

 
320.2

Total current assets
7,550.5

 
5,533.7

Property, plant and equipment, net
593.4

 
578.4

Intangible assets, net
2,839.7

 
3,100.4

Goodwill
2,041.2

 
2,042.8

Other assets
353.4

 
479.0

Total assets
$
13,378.2

 
$
11,734.3

Liabilities and Stockholders' Equity
 
 
 
Current liabilities:
 
 
 
Short-term borrowings
$
544.8

 
$
308.5

Accounts payable
156.2

 
145.6

Accrued expenses
1,001.1

 
775.7

Income taxes payable
16.0

 
11.8

Current portion of deferred revenue
27.7

 
17.3

Other current liabilities
199.7

 
431.3

Total current liabilities
1,945.5

 
1,690.2

Deferred revenue, net of current portion
23.7

 
16.2

Income taxes payable
235.0

 
188.2

Deferred income taxes
804.9

 
1,018.4

Other non-current liabilities
582.7

 
355.5

Long-term debt, net of discount
4,196.5

 
2,771.3

Total liabilities
7,788.3

 
6,039.8

Commitments and Contingencies (Note 18)

 

Stockholders' Equity:
 
 
 
Preferred stock, $.01 par value per share, 5.0 million shares authorized; none outstanding at December 31, 2013 and 2012, respectively
—

 
—

Common stock, $.01 par value per share, 575.0 million shares authorized; issued 511.2 million and 498.4 million shares at December 31, 2013 and 2012, respectively
5.1

 
5.0

Common stock in treasury, at cost; 101.5 million and 78.7 million shares at December 31, 2013 and 2012, respectively
(7,662.1
)
 
(4,823.2
)
Additional paid-in capital
8,680.4

 
7,539.8

Retained earnings
4,472.5

 
3,022.6

Accumulated other comprehensive income (loss)
94.0

 
(49.7
)
Total stockholders' equity
5,589.9

 
5,694.5

Total liabilities and stockholders' equity
$
13,378.2

 
$
11,734.3

See accompanying Notes to Consolidated Financial Statements

58

CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In millions, except per share amounts)
 
Years Ended December 31,
 
2013
 
2012
 
2011
Revenue:
 
 
 
 
 
Net product sales
$
6,362.3

 
$
5,385.6

 
$
4,699.7

Collaborative agreements and other revenue        
14.7

 
10.7

 
19.5

Royalty revenue
116.9

 
110.4

 
122.9

Total revenue
6,493.9

 
5,506.7

 
4,842.1

Expenses:
 
 
 
 
 
Cost of goods sold (excluding amortization of acquired intangible assets)                 
340.4

 
299.1

 
425.9

Research and development
2,226.2

 
1,724.2

 
1,600.3

Selling, general and administrative
1,684.5

 
1,373.5

 
1,226.3

Amortization of acquired intangible assets        
262.8

 
194.5

 
289.2

Acquisition related (gains) charges and restructuring, net
171.1

 
169.0

 
(142.3
)
Total costs and expenses
4,685.0

 
3,760.3

 
3,399.4

Operating income
1,808.9

 
1,746.4

 
1,442.7

Other income and (expense):
 
 
 
 
 
Interest and investment income, net
22.0

 
15.3

 
25.9

Interest (expense)
(91.6
)
 
(63.2
)
 
(42.7
)
Other income (expense), net
(73.9
)
 
(17.0
)
 
(6.4
)
Income before income taxes
1,665.4

 
1,681.5

 
1,419.5

Income tax provision
215.5

 
225.3

 
102.1

Net income
1,449.9

 
1,456.2

 
1,317.4

Net loss attributable to non-controlling interest
—

 
—

 
0.7

Net income attributable to Celgene
$
1,449.9

 
$
1,456.2

 
$
1,318.1

Net income per share attributable to Celgene:
 
 
 
 
 
Basic
$
3.50

 
$
3.38

 
$
2.89

Diluted
$
3.37

 
$
3.30

 
$
2.85

Weighted average shares:
 
 
 
 
 
Basic
413.8

 
430.9

 
455.3

Diluted
430.3

 
440.8

 
462.7

See accompanying Notes to Consolidated Financial Statements

59

CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in millions)
 
Years Ended December 31,
 
2013
 
2012
 
2011
Net income
$
1,449.9

 
$
1,456.2

 
$
1,317.4

Other comprehensive income:
 
 
 
 
 
Foreign currency translation adjustments
27.4

 
25.9

 
(9.8
)
Pension liability adjustment
3.2

 
(4.7
)
 
(1.5
)
Change in functional currency of a foreign subsidiary
—

 
13.1

 
—

Net asset transfer of a common control foreign subsidiary
—

 
0.6

 
(0.1
)
Net unrealized (losses) gains related to cash flow hedges:
 
 
 
 
 
Unrealized holding gains (losses), net of tax expense (benefit) of $2.6, ($13.8) and ($0) for the years ended 2013, 2012 and 2011, respectively
(5.8
)
 
53.0

 
21.3

Reclassification adjustment for (gains) losses included in net income, net of tax (expense) benefit of $6.9, ($1.9) and ($2.9) for the years ended 2013, 2012 and 2011, respectively
(14.2
)
 
(77.7
)
 
2.9

Net unrealized gains (losses) on marketable securities available for sale:
 
 
 
 
 
Unrealized holding gains, net of tax expense (benefit) of $77.1, ($0.1) and $1.4 for the years ended 2013, 2012 and 2011, respectively
128.0

 
1.4

 
2.9

Reclassification adjustment for losses (gains) included in net income, net of tax (expense) benefit of $2.2, $0.1 and $0.3 for the years ended 2013, 2012 and 2011, respectively
5.1

 
1.0

 
(4.3
)
Total other comprehensive income
143.7

 
12.6

 
11.4

Comprehensive income
1,593.6

 
1,468.8

 
1,328.8

Comprehensive loss attributable to non-controlling interest
—

 
—

 
0.7

Comprehensive income attributable to Celgene
$
1,593.6

 
$
1,468.8

 
$
1,329.5

See accompanying Notes to Consolidated Financial Statements

60

CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in millions)
 
Years Ended December 31,
 
2013
 
2012
 
2011
Cash flows from operating activities:
 
 
 
 
 
Net income
$
1,449.9

 
$
1,456.2

 
$
1,317.4

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
Depreciation
96.9

 
84.9

 
71.2

Amortization
277.2

 
198.6

 
291.7

Provision for accounts receivable allowances
6.2

 
12.5

 
6.4

Deferred income taxes
(246.6
)
 
100.2

 
(85.8
)
Impairment charges
105.4

 
148.0

 
118.0

Change in value of contingent consideration
171.1

 
166.4

 
(147.5
)
Share-based compensation expense
325.8

 
231.0

 
217.2

Share-based employee benefit plan expense
32.6

 
19.3

 
20.7

Reclassification adjustment for cash flow hedges included in net income
(7.3
)
 
(79.6
)
 
—

Unrealized change in value of derivative instruments
(1.4
)
 
71.7

 
(47.6
)
Realized losses (gains) on marketable securities available for sale
7.3

 
1.1

 
(3.8
)
Other, net
4.5

 
(1.8
)
 
15.9

Change in current assets and liabilities, excluding the effect of acquisitions:
 
 
 
 
 
Accounts receivable
(101.4
)
 
(30.1
)
 
(263.1
)
Inventory
(89.7
)
 
(69.7
)
 
71.0

Other operating assets
(90.9
)
 
91.7

 
(66.9
)
Accounts payable and other operating liabilities
287.2

 
68.2

 
191.2

Payment of contingent consideration
(75.0
)
 
—

 
(23.3
)
Income tax payable
57.4

 
(455.5
)
 
95.3

Deferred revenue
16.7

 
5.5

 
(1.9
)
Net cash provided by operating activities
2,225.9

 
2,018.6

 
1,776.1

Cash flows from investing activities:
 
 
 
 
 
Proceeds from sales of marketable securities available for sale
3,642.3

 
1,743.7

 
2,175.2

Purchases of marketable securities available for sale
(3,983.6
)
 
(2,768.8
)
 
(1,693.4
)
Payments for acquisition of business, net of cash acquired
—

 
(352.2
)
 
—

Purchases of intellectual property and other assets
(19.4
)
 
(48.9
)
 
—

Proceeds from the sale of assets, net
—

 
15.8

 
93.2

Capital expenditures
(119.7
)
 
(111.5
)
 
(132.1
)
Purchases of investment securities
(47.1
)
 
(30.0
)
 
(59.3
)
Other investing activities
(1.1
)
 
(1.7
)
 
(5.9
)
Net cash (used in) provided by investing activities
(528.6
)
 
(1,553.6
)
 
377.7

Cash flows from financing activities:
 
 
 
 
 
Payment for treasury shares
(2,764.6
)
 
(2,043.6
)
 
(2,188.6
)
Proceeds from short-term borrowing
4,462.0

 
4,494.8

 
1,878.8

Principal repayments on short-term borrowing
(4,227.9
)
 
(4,712.2
)
 
(1,353.1
)
Proceeds from sale of common equity put options
1.2

 
—

 
—

Payment of contingent consideration
(225.0
)
 
—

 
(156.7
)
Proceeds from the issuance of long-term debt
1,479.6

 
1,486.7

 
—

Net proceeds from exercise of common stock options and warrants
551.6

 
476.2

 
166.5

Excess tax benefit from share-based compensation arrangements
169.4

 
49.3

 
31.1

Net cash used in financing activities
(553.7
)
 
(248.8
)
 
(1,622.0
)
Effect of currency rate changes on cash and cash equivalents
0.4

 
14.7

 
(23.4
)
Net increase in cash and cash equivalents
1,144.0

 
230.9

 
508.4

Cash and cash equivalents at beginning of period
2,090.4

 
1,859.5

 
1,351.1

Cash and cash equivalents at end of period
$
3,234.4

 
$
2,090.4

 
$
1,859.5

See accompanying Notes to Consolidated Financial Statements

61

CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS – (Continued)
(Dollars in millions)
 
Years Ended December 31,
 
2013
 
2012
 
2011
Supplemental schedule of non-cash investing and financing activity:
 
 
 
 
 
Change in net unrealized gain on marketable securities available for sale
$
(205.1
)
 
$
(1.3
)
 
$
(3.7
)
Matured shares tendered in connection with stock option exercises
$
—

 
$
(1.2
)
 
$
(4.9
)
Supplemental disclosure of cash flow information:
 
 
 
 
 
Interest paid
$
90.8

 
$
48.4

 
$
50.2

Income taxes paid
$
291.9

 
$
469.6

 
$
93.0

See accompanying Notes to Consolidated Financial Statements

62

CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Dollars in millions)
 
 
Celgene Corporation Shareholders
 
 
 
 
Years Ended December 31, 2013, 2012 and 2011
 
Common
Stock
 
Treasury
Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income
(Loss)
 
Stockholders'
Equity
 
Non-
Controlling
Interest
 
Total
Balances at December 31, 2010
 
$
4.8

 
$
(545.6
)
 
$
6,350.2

 
$
248.3

 
$
(73.7
)
 
$
5,984.0

 
$
11.5

 
$
5,995.5

Net income
 
 

 
 

 
 

 
1,318.1

 
 

 
1,318.1

 
(0.7
)
 
1,317.4

Other comprehensive income
 
 

 
 

 
0.1

 
 

 
11.4

 
11.5

 
 

 
11.5

Mature shares tendered related to option exercise
 
 

 
(4.9
)
 
3.0

 
 

 
 

 
(1.9
)
 
 

 
(1.9
)
Exercise of stock options and warrants and conversion of restricted stock units
 
0.1

 


 
166.7

 
 

 
 

 
166.8

 
 

 
166.8

Shares purchased under share repurchase program
 
 

 
(2,221.2
)
 
 

 
 

 
 

 
(2,221.2
)
 
 

 
(2,221.2
)
Issuance of common stock for employee benefit plans
 
 

 
11.0

 
2.6

 
 

 
 

 
13.6

 
 

 
13.6

Issuance of common stock related to Abraxis acquisition
 
 

 
 

 
0.1

 
 

 
 

 
0.1

 
 

 
0.1

Expense related to share-based compensation
 
 

 
 

 
216.6

 
 

 
 

 
216.6

 
 

 
216.6

Income tax benefit upon exercise of stock options
 
 

 
 

 
25.1

 
 

 
 

 
25.1

 
 

 
25.1

Disposal of non-controlling interest
 
 

 
 

 
 

 
 

 
 

 


 
(10.8
)
 
(10.8
)
Balances at December 31, 2011
 
$
4.9

 
$
(2,760.7
)
 
$
6,764.4

 
$
1,566.4

 
$
(62.3
)
 
$
5,512.7

 
$
—

 
$
5,512.7

Net income
 
 

 
 

 
 

 
1,456.2

 
 

 
1,456.2

 
 

 
1,456.2

Other comprehensive income
 
 

 
 

 
(13.7
)
 
 

 
12.6

 
(1.1
)
 
 

 
(1.1
)
Mature shares tendered related to option exercise
 
 

 
(1.2
)
 
0.6

 
 

 
 

 
(0.6
)
 
 

 
(0.6
)
Exercise of stock options and warrants and conversion of
restricted stock units
 
0.1

 
(10.6
)
 
483.0

 
 

 
 

 
472.5

 
 

 
472.5

Shares purchased under share repurchase program
 
 

 
(2,050.7
)
 
 

 
 

 
 

 
(2,050.7
)
 
 

 
(2,050.7
)
Issuance of common stock for employee benefit plans
 


 
 

 
19.2

 
 

 
 

 
19.2

 
 

 
19.2

Expense related to share-based compensation
 
 

 
 

 
230.5

 
 

 
 

 
230.5

 
 

 
230.5

Income tax benefit upon exercise of stock options
 
 

 
 

 
55.8

 
 

 
 

 
55.8

 
 

 
55.8

Balances at December 31, 2012
 
$
5.0

 
$
(4,823.2
)
 
$
7,539.8

 
$
3,022.6

 
$
(49.7
)
 
$
5,694.5

 
$
—

 
$
5,694.5

Net income
 
 

 
 

 
 

 
1,449.9

 
 

 
1,449.9

 
 

 
1,449.9

Other comprehensive income
 
 

 
 

 


 
 

 
143.7

 
143.7

 
 

 
143.7

Exercise of stock options and conversion of
restricted stock units
 
0.1

 
(69.7
)
 
623.6

 
 

 
 

 
554.0

 
 

 
554.0

Shares purchased under share repurchase program
 
 

 
(2,769.2
)
 
 

 
 

 
 

 
(2,769.2
)
 
 

 
(2,769.2
)
Issuance of common stock for employee benefit plans
 


 
 

 
22.0

 
 

 
 

 
22.0

 
 

 
22.0

Expense related to share-based compensation
 
 

 
 

 
325.0

 
 

 
 

 
325.0

 
 

 
325.0

Income tax benefit upon exercise of stock options
 
 

 
 

 
170.0

 
 

 
 

 
170.0

 
 

 
170.0

Balances at December 31, 2013
 
$
5.1

 
$
(7,662.1
)
 
$
8,680.4

 
$
4,472.5

 
$
94.0

 
$
5,589.9

 
$
—

 
$
5,589.9

See accompanying Notes to Consolidated Financial Statements

63

CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in millions, except per share amounts, unless otherwise indicated)
1.     Nature of Business and Basis and Summary of Significant Accounting Policies
Celgene Corporation, together with its subsidiaries (collectively “we,” “our,”  “us,” “Celgene” or the “Company”) is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.  We are dedicated to innovative research and development designed to bring new therapies to market and are involved in research in several scientific areas that may deliver proprietary next-generation therapies, targeting areas such as intracellular signaling pathways in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.
 
Our primary commercial stage products include REVLIMID®, VIDAZA®, ABRAXANE®, POMALYST®/IMNOVID®, THALOMID® (inclusive of Thalidomide CelgeneTM), ISTODAX® and azacitidine for injection (generic version of VIDAZA®). Additional sources of revenue include royalties from Novartis Pharma AG (Novartis) on their sales of FOCALIN XR® and the entire RITALIN® family of drugs, the sale of services through our Celgene Cellular Therapeutics subsidiary and other licensing agreements.
 
The consolidated financial statements include the accounts of Celgene Corporation and its subsidiaries. Investments in limited partnerships and interests where we have an equity interest of 50% or less and do not otherwise have a controlling financial interest are accounted for by either the equity or cost method. We record net income (loss) attributable to non-controlling interest, if any, in our Consolidated Statements of Income equal to the percentage of ownership interest retained in the respective operations by the non-controlling parties. Certain prior year amounts have been reclassified to conform to the current year's presentation.

The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect reported amounts and disclosures.  Actual results could differ from those estimates.  We are subject to certain risks and uncertainties related to, among other things, product development, regulatory approval, market acceptance, scope of patent and proprietary rights, competition, outcome of civil and governmental proceedings, European credit risk, technological change and product liability.

Financial Instruments:    Certain financial instruments reflected in the Consolidated Balance Sheets, (e.g., cash, cash equivalents, accounts receivable, certain other assets, accounts payable, short-term borrowings and certain other liabilities) are recorded at cost, which approximates fair value due to their short-term nature. The fair values of financial instruments other than marketable securities are determined through a combination of management estimates and information obtained from third parties using the latest market data. The fair value of available-for-sale marketable securities is determined utilizing the valuation techniques appropriate to the type of security (See Note 4).
Derivative Instruments and Hedges:    All derivative instruments are recognized on the balance sheet at their fair value. Changes in the fair value of derivative instruments are recorded each period in current earnings or other comprehensive income (loss), depending on whether a derivative instrument is designated as part of a hedging transaction and, if it is, the type of hedging transaction. For a derivative to qualify as a hedge at inception and throughout the hedged period, we formally document the nature and relationships between the hedging instruments and hedged item. We assess, both at inception and on an on-going basis, whether the derivative instruments that are used in cash flow hedging transactions are highly effective in offsetting the changes in cash flows of hedged items. We assess hedge ineffectiveness on a quarterly basis and record the gain or loss related to the ineffective portion of derivative instruments, if any, to current earnings. If we determine that a forecasted transaction is no longer probable of occurring, we discontinue hedge accounting and any related unrealized gain or loss on the derivative instrument is recognized in current earnings. We use derivative instruments, including those not designated as part of a hedging transaction, to manage our exposure to movements in foreign exchange, on our stock price and interest rates. The use of these derivative instruments modifies the exposure of these risks with the intent to reduce our risk or cost.
Cash, Cash Equivalents and Marketable Securities Available for Sale:    We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency mortgage-backed securities (MBS), non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities. All liquid investments with maturities of three months or less from the date of purchase are classified as cash equivalents and all investments with maturities of greater than three months from date of purchase are classified as marketable securities available for sale. We determine the appropriate classification of our investments in marketable debt and equity securities

64
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


at the time of purchase. In addition, our equity investments in the publicly traded common stock of companies with whom we have entered into collaboration agreements are also designated as marketable securities available for sale.
Marketable securities available for sale are carried at fair value, held for an unspecified period of time and are intended for use in meeting our ongoing liquidity needs. Unrealized gains and losses on available-for-sale securities, which are deemed to be temporary, are reported as a separate component of stockholders' equity, net of tax. The cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. The amortization, along with realized gains and losses and other-than-temporary impairment charges, is included in interest and investment income, net.
A decline in the market value of any available-for-sale security below its carrying value that is determined to be other-than-temporary would result in a charge to earnings and decrease in the security's carrying value down to its newly established fair value. Factors evaluated to determine if an investment is other-than-temporarily impaired include significant deterioration in earnings performance, credit rating, asset quality or business prospects of the issuer; adverse changes in the general market condition in which the issuer operates; our intent to hold to maturity and an evaluation as to whether it is more likely than not that we will not have to sell before recovery of its cost basis; our expected future cash flows from the security; and issues that raise concerns about the issuer's ability to continue as a going concern.
Concentration of Credit Risk:    Cash, cash equivalents and marketable securities are financial instruments that potentially subject the Company to concentration of credit risk. We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency MBS, non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities (See Note 6). We have established guidelines relative to diversification and maturities to maintain safety and liquidity. These guidelines are reviewed periodically and may be modified to take advantage of trends in yields and interest rates.
We sell our products in the United States primarily through wholesale distributors and specialty contracted pharmacies. Therefore, wholesale distributors and large pharmacy chains account for a large portion of our U.S. trade receivables and net product revenues (See Note 19). International sales are primarily made directly to hospitals, clinics and retail chains, many of which in Europe are government owned and have extended their payment terms in recent years given the economic pressure these countries are facing. We continuously monitor the creditworthiness of our customers, including these governments, and have internal policies regarding customer credit limits. We estimate an allowance for doubtful accounts primarily based on the credit worthiness of our customers, historical payment patterns, aging of receivable balances and general economic conditions, including publicly available information on the credit worthiness of countries themselves and provinces or areas within such countries where they are the ultimate customers.
We continue to monitor economic conditions, including the volatility associated with international economies, the sovereign debt crisis in certain European countries and associated impacts on the financial markets and our business. Our current business model in these markets is typically to sell our products directly to principally government owned or controlled hospitals, which in turn directly deliver critical care to patients. Our products are used to treat life-threatening diseases and we believe this business model enables timely delivery and adequate supply of products. Many of the outstanding receivable balances are related to government-funded hospitals and we believe the receivable balances are ultimately collectible. Similarly, we believe that future sales to these customers will continue to be collectible.
The credit and economic conditions within Spain, Italy, Portugal and Greece, as well as increasing sales levels in those countries have resulted in, and may continue to result in, an increase in the average length of time it takes to collect accounts receivable. Our total net receivables in Spain, Italy and Portugal are composed almost entirely of amounts receivable from government-owned or controlled hospitals and the public sector and amounted to $348.4 million at December 31, 2013, compared to $324.2 million at December 31, 2012. Approximately $86.4 million of the $348.4 million receivable at December 31, 2013 was greater than one year past due. Our exposure to the sovereign debt crisis in Greece is limited, as we do not have a material amount of receivables in Greece. We maintain timely and direct communication with hospital customers in Spain, Italy and Portugal regarding both the current and past due receivable balances. We continue to receive payments from these countries, and closely monitor the plans for payment at the regional government level. Payments from customers in these countries are not received on regular intervals and several months could elapse between significant payments. We also regularly request and receive positive confirmation of the validity of our receivables from most of the regional governmental authorities.
In determining the appropriate allowance for doubtful accounts for Spain, Italy and Portugal, we considered that the balance of past due receivables is related to sales made to government-owned or supported customers. We regularly monitor developments in Europe to assess whether the level of risk of default for any customers has increased and note the ongoing efforts by the European Union, European Monetary Union and International Monetary Fund to support countries with large public deficits and outstanding debt balances. We also monitor the efforts of individual countries to support their regions with large public deficits and outstanding debt balances. We have not experienced significant losses or write-offs with respect to the collection of our accounts receivable in these countries as a result of their economic difficulties and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse impact on our financial position or results of operations.

65
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Inventory:    Inventories are recorded at the lower of cost or market, with cost determined on a first-in, first-out basis. We periodically review the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized. Included in inventory are raw materials used in the production of preclinical and clinical products, which are charged to research and development expense when consumed.
We capitalize inventory costs associated with certain products prior to regulatory approval of products, or for inventory produced in new production facilities, when management considers it highly probable that the pre-approval inventories will be saleable. The determination to capitalize is based on the particular facts and circumstances relating to the expected regulatory approval of the product or production facility being considered, and accordingly, the time frame within which the determination is made varies from product to product. The assessment of whether or not the product is considered highly probable to be saleable is made on a quarterly basis and includes, but is not limited to, how far a particular product or facility has progressed along the approval process, any known safety or efficacy concerns, potential labeling restrictions and other impediments. We could be required to write down previously capitalized costs related to pre-launch inventories upon a change in such judgment, or due to a denial or delay of approval by regulatory bodies, a delay in commercialization or other potential factors.
Property, Plant and Equipment:    Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation of plant and equipment is recorded using the straight-line method. Building improvements are depreciated over the remaining useful life of the building. Leasehold improvements are depreciated over the lesser of the economic useful life of the asset or the remaining term of the lease, including anticipated renewal options. The estimated useful lives of capitalized assets are as follows:
Buildings
40 years
Building and operating equipment
15 years
Manufacturing machinery and equipment
10 years
Other machinery and equipment
5 years
Furniture and fixtures
5 years
Computer equipment and software
3-7 years
Maintenance and repairs are charged to operations as incurred, while expenditures for improvements which extend the life of an asset are capitalized.
Capitalized Software Costs:    We capitalize software costs incurred in connection with developing or obtaining software. Capitalized software costs are included in property, plant and equipment, net and are amortized over their estimated useful life of three to seven years from the date the systems are ready for their intended use.
Investments in Other Entities:    We hold a portfolio of investments in equity securities and certain investment funds that are accounted for under either the equity method or cost method. Investments in companies or certain investment funds over which we have significant influence but not a controlling interest are accounted for using the equity method, with our share of earnings or losses reported in other income (expense), net. Investments in equity securities of companies that become publicly traded are accounted for as available-for-sale marketable securities prospectively from the date of such companies' initial public offering.
Our cost method and equity method investments are included in other assets on the Consolidated Balance Sheets.
All investments are reviewed on a regular basis for possible impairment. If an investment's fair value is determined to be less than its net carrying value and the decline is determined to be other-than-temporary, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an other-than-temporary decline in value has occurred include: market value or exit price of the investment based on either market-quoted prices or future rounds of financing by the investee; length of time that the market value was below its cost basis; financial condition and business prospects of the investee; our intent and ability to retain the investment for a sufficient period of time to allow for recovery in market value of the investment; issues that raise concerns about the investee's ability to continue as a going concern; any other information that we may be aware of related to the investment.
Other Intangible Assets:    Intangible assets with definite useful lives are amortized to their estimated residual values over their estimated useful lives and reviewed for impairment if certain events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Intangible assets which are not amortized include acquired in-process research and development (IPR&D) and acquired intangible assets held for sale. Amortization is initiated for IPR&D intangible assets when their useful lives have been determined. IPR&D intangible assets which are determined to have had a drop in their fair value are adjusted downward and an expense recognized in the income statement. These IPR&D intangible assets are tested at least annually or when a triggering event occurs that could indicate a potential impairment.

66
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Goodwill:    Goodwill represents the excess of purchase price over fair value of net assets acquired in a business combination accounted for by the acquisition method of accounting and is not amortized, but is subject to impairment testing at least annually or when a triggering event occurs that could indicate a potential impairment. We test our goodwill annually for impairment each November 30.
Impairment of Long-Lived Assets:    Long-lived assets, such as property, plant and equipment and certain other long-term assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to the estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of the assets exceed their estimated future undiscounted net cash flows, an impairment charge is recognized for the amount by which the carrying amount of the assets exceed the fair value of the assets.
Contingent Consideration from Business Combinations:    Subsequent to the acquisition date, we measure contingent consideration arrangements at fair value for each period with changes in fair value recognized in income as acquisition related (gains) charges and restructuring, net. Changes in fair values reflect new information about related IPR&D and other assets and the passage of time. In the absence of new information, changes in fair value reflect only the passage of time as development work towards the achievement of the milestones progresses, and is accrued based on an accretion schedule.
Foreign Currency Translation:    Operations in non-U.S. entities are recorded in the functional currency of each entity. For financial reporting purposes, the functional currency of an entity is determined by a review of the source of an entity's most predominant cash flows. The results of operations for non-U.S. dollar functional currency entities are translated from functional currencies into U.S. dollars using the average currency rate during each month, which approximates the results that would be obtained using actual currency rates on the dates of individual transactions. Assets and liabilities are translated using currency rates at the end of the period. Adjustments resulting from translating the financial statements of our foreign entities into the U.S. dollar are excluded from the determination of net income and are recorded as a component of other comprehensive income (loss). Transaction gains and losses are recorded in other income (expense), net in the Consolidated Statements of Income. We had a net foreign exchange gain of $22.2 million in 2013 and losses of $10.8 million and $3.1 million in 2012 and 2011, respectively. These amounts include the impact of gains and losses on foreign exchange contracts not designated as hedging instruments (See Note 5).
Research and Development Costs:    Research and development costs are expensed as incurred. These include all internal and external costs related to services contracted by us. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Milestone payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product. Upfront payments are recorded when incurred, and milestone payments are recorded when the specific milestone has been achieved.
Income Taxes:    We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. We recognize the benefit of an uncertain tax position that we have taken or expect to take on income tax returns we file if such tax position is more likely than not to be sustained.
Revenue Recognition:   Revenue from the sale of products is recognized when title and risk of loss of the product is transferred to the customer and the sales price is fixed and determinable. Provisions for discounts, early payments, rebates, sales returns and distributor chargebacks under terms customary in the industry are provided for in the same period the related sales are recorded. We record estimated reductions to revenue for volume-based discounts and rebates at the time of the initial sale. The estimated reductions to revenue for such volume-based discounts and rebates are based on the sales terms, historical experience and trend analysis.
We base our sales returns allowance on estimated on-hand retail/hospital inventories, measured end-customer demand as reported by third-party sources, actual returns history and other factors, such as the trend experience for lots where product is still being returned or inventory centralization and rationalization initiatives conducted by major pharmacy chains, as applicable.  If the historical data we use to calculate these estimates do not properly reflect future returns, then a change in the allowance would be made in the period in which such a determination is made and revenues in that period could be materially affected.  Under this methodology, we track actual returns by individual production lots.  Returns on closed lots, that is, lots no longer eligible for return credits, are analyzed to determine historical returns experience.  Returns on open lots, that is, lots still eligible for return credits, are monitored and compared with historical return trend rates.  Any changes from the historical trend rates are considered in determining the current sales return allowance. 

67
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Sales discount accruals are based on payment terms extended to customers.
 
Government rebate accruals are based on estimated payments due to governmental agencies for purchases made by third parties under various governmental programs. U.S. Medicaid rebate accruals are generally based on historical payment data and estimates of future Medicaid beneficiary utilization applied to the Medicaid unit rebate formula established by the Center for Medicaid and Medicare Services. The Medicaid rebate percentage was increased and extended to Medicaid Managed Care Organizations in March 2010.  The accrual of the rebates associated with Medicaid Managed Care Organizations is calculated based on estimated historical patient data related to Medicaid Managed Care Organizations.  We have also analyzed actual billings received from the states to further support the accrual rates.  Subsequent to implementation of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the 2010 U.S. Health Care Reform Law), certain states have only recently begun submitting partial Medicaid Managed Care Organization bills.  Our accruals for these Medicaid Managed Care Organization rebates had been at elevated levels given the delays in the receipt of complete invoices from certain states.  Due to the receipt of more complete claims data as 2013 progressed, the accruals for certain states were reduced from the elevated levels at December 31, 2012 as a result of both the payments made being applied to the accrual and a $20.3 million favorable change in estimate of the ultimate obligation.  We will continue to adjust the rebate accruals as more information becomes available and to reflect actual claims experience. Effective January 1, 2011, manufacturers of pharmaceutical products are responsible for 50% of the patient’s cost of branded prescription drugs related to the Medicare Part D Coverage Gap.  In order to estimate the cost to us of this coverage gap responsibility, we analyze data for eligible Medicare Part D patients against data for eligible Medicare Part D patients treated with our products as well as the historical invoices.  This expense is recognized throughout the year as costs are incurred.  In certain international markets, government-sponsored programs require rebates to be paid based on program specific rules and, accordingly, the rebate accruals are determined primarily on estimated eligible sales.
 
Rebates or administrative fees are offered to certain wholesale customers, group purchasing organizations and end-user customers, consistent with pharmaceutical industry practices. Settlement of rebates and fees may generally occur from one to 15 months from the date of sale. We provide a provision for rebates at the time of sale based on contracted rates and historical redemption rates. Assumptions used to establish the provision include level of wholesaler inventories, contract sales volumes and average contract pricing.  We regularly review the information related to these estimates and adjust the provision accordingly.
 
Chargeback accruals are based on the differentials between product acquisition prices paid by wholesalers and lower government contract pricing paid by eligible customers covered under federally qualified programs.  Distributor service fee accruals are based on contractual fees to be paid to the wholesale distributor for services provided.  TRICARE is a health care program of the U.S. Department of Defense Military Health System that provides civilian health benefits for military personnel, military retirees and their dependents.  TRICARE rebate accruals are included in chargeback accruals and are based on estimated Department of Defense eligible sales multiplied by the TRICARE rebate formula.
We record estimated reductions to revenue for free goods and volume-based discounts at the time of the initial sale. The estimated reductions to revenue for such free goods and volume-based discounts are based on the sales terms, historical experience and trend analysis. The cost of free goods is included in Cost of Goods Sold (excluding amortization of acquired intangible assets).
We recognize revenue from royalties based on licensees' sales of its products or products using its technologies. Royalties are recognized as earned in accordance with the contract terms when royalties from licensees can be reasonably estimated and collectability is reasonably assured. If royalties cannot be reasonably estimated or collectability of a royalty amount is not reasonably assured, royalties are recognized as revenue when the cash is received.
Share-Based Compensation:    We utilize share based compensation in the form of stock options, restricted stock units (RSUs) and performance-based restricted stock units (PSUs). Compensation expense is recognized in the Consolidated Statements of Income based on the estimated fair value of the awards at grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized to date associated with grants that are not expected to vest will be reversed.
The fair values of stock option grants are estimated as of the date of grant using a Black-Scholes option valuation model. The fair values of RSU and PSU grants are based on the market value of our Common Stock on the date of grant.
Earnings Per Share:    Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, assuming potentially dilutive common shares, resulting from option

68
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


exercises, restricted stock units, warrants and other incentives had been issued and any proceeds thereof used to repurchase common stock at the average market price during the period. The assumed proceeds used to repurchase common stock is the sum of the amount to be paid to us upon exercise of options, the amount of compensation cost attributed to future services and not yet recognized and, if applicable, the amount of excess income tax benefit that would be credited to paid-in capital upon exercise.
New Accounting Pronouncements:   In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update “Comprehensive Income (Topic 220):  Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income” (ASU 2013-2).  ASU 2013-2 requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. generally accepted accounting principles (GAAP) to be reclassified in its entirety to net income.  The amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  An entity shall provide this information together, in one location, either on the face of the statement where net income is presented or as a separate disclosure in the notes to the financial statements.  The amendments are effective prospectively for reporting periods beginning after December 15, 2012.  The adoption of ASU 2013-2 did not have a material impact on our financial position or results of operations.

In July 2013, the FASB issued Accounting Standards Update "Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes" (ASU 2013-10). ASU 2013-10 permits the use of the Fed Funds Effective Swap Rate (also referred to as the Overnight Index Swap Rate), in addition to the U.S. government rate (UST) and London Interbank Offered Rate (LIBOR), as a U.S. benchmark interest rate for hedge accounting purposes. This update is effective prospectively for qualifying new or re-designated hedging relationships entered into on or after July 17, 2013. The adoption of ASU 2013-10 did not have a material impact on our financial position or results of operations.

In July 2013, the FASB issued Accounting Standards Update "Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists" (ASU 2013-11). ASU 2013-11 requires an entity to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (NOL) carryforward, or similar tax loss or tax credit carryforward, rather than as a liability when (1) the uncertain tax position would reduce the NOL or other carryforward under the tax law of the applicable jurisdiction and (2) the entity intends to use the deferred tax asset for that purpose. ASU 2013-11 is effective prospectively for fiscal years and interim periods within those years, beginning after December 15, 2013 for public entities. During the quarter ended December 31, 2013, we early adopted ASU 2013-11 on a prospective basis, and the change in presentation had no material impact on our financial position or results of operations.

2.     Acquisitions and Divestitures
Avila Acquisition
On March 7, 2012 (the Acquisition Date), we acquired all of the outstanding common stock of Avila Therapeutics, Inc., subsequently renamed Celgene Avilomics Research, herein referred to as Avila. The acquisition resulted in Avila becoming our wholly-owned subsidiary. The results of operations for Avila are included in our consolidated financial statements from the Acquisition Date and the assets and liabilities of Avila have been recorded at their respective fair values on the Acquisition Date and consolidated with our other assets and liabilities. Avila's results of operations to the Acquisition Date were determined to be immaterial to us; therefore, pro forma financial information is not required to be presented.
We paid $352.2 million in cash, net of cash acquired, and may make additional payments of up to an estimated maximum of $595.0 million in contingent developmental and regulatory milestone payments.
Avila is a clinical-stage biotechnology company focused on the design and development of targeted covalent drugs to achieve best-in-class outcomes. Avila's product pipeline has been created using its proprietary Avilomics platform for developing targeted covalent drugs that treat diseases through protein silencing. Avila's most advanced product candidate, CC-292, formerly AVL-292, a potential treatment for cancer and autoimmune diseases, is currently in phase I clinical testing. We acquired Avila to enhance our portfolio of potential therapies for patients with life-threatening illnesses worldwide.
Our potential contingent consideration payments are classified as liabilities, which were measured at fair value as of the Acquisition Date and subsequently adjusted for time and probability accretion. The range of potential milestone payments is from no payment if none of the milestones are achieved to an estimated maximum of $595.0 million if all milestones are achieved. The potential milestones consist of developmental and regulatory achievements, including milestones for the initiation of phase II and phase III studies, investigational new drug, or IND, filings, and other regulatory events.

69
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


We estimated the fair value of potential contingent consideration using a probability-weighted income approach, which reflects the probability and timing of future potential payments. This fair value measurement is based on significant input not observable in the market and thus represents a Level 3 liability within the fair value hierarchy. The resulting probability-weighted cash flows were discounted using a discount rate based on a market participant assumption.
The acquisition has been accounted for using the acquisition method of accounting which requires that assets acquired and liabilities assumed be recognized at their fair values as of the Acquisition Date and requires the fair value of acquired IPR&D to be classified as indefinite-lived assets until the successful completion or abandonment of the associated research and development efforts.
The fair value of consideration transferred in the acquisition of Avila is shown in the table below:
 
Fair Value at the
Acquisition Date
Cash
$
363.4

Contingent consideration
171.7

Total fair value of consideration transferred
$
535.1

The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the Acquisition Date based upon their respective fair values summarized below:
 
Amounts
Recognized as of
Acquisition Date
Working capital1
$
12.0

Property, plant and equipment
2.6

Platform technology intangible asset2
330.8

In-process research and development product rights
198.4

Net deferred tax liability3
(165.0
)
Total identifiable net assets
378.8

Goodwill
156.3

Net assets acquired
$
535.1


1 
Includes cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities.
2 
Platform technology related to the Avilomics discovery platform which is being amortized over a useful life of seven years based on the estimated useful life of the platform.
3 
Includes current deferred income tax asset of $14.7 million and non-current deferred tax liability of $179.7 million.
The fair values of current assets, current liabilities and property, plant and equipment were determined to approximate their book values.
The fair value of the platform technology intangible asset was based primarily on expected cash flows from future product candidates to be developed from the Avilomics platform and the fair value assigned to acquired IPR&D was primarily based on expected cash flows from the CC-292 product candidate which is in phase I testing. The values assigned to the platform technology intangible asset and the IPR&D asset were determined by estimating the costs to develop CC-292 and future product candidates into commercially viable products, estimating the resulting revenue from the potential products, and discounting the net cash flows to present value. The revenue and cost projections used were reduced based on the probability of developing new drugs. Additionally, the projections considered the relevant market sizes, growth factors and the nature and expected timing of new product introductions. The resulting net cash flows from such potential products are based on our estimates of cost of sales, operating expenses, and income taxes. The rates utilized to discount the net cash flows to their present value were commensurate with the stage of development of the projects and uncertainties in the economic estimates used in the projections described above. Acquired IPR&D will be accounted for as an indefinite-lived intangible asset until regulatory approval in specified markets or discontinuation of CC-292.
The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition. The goodwill recorded as part of the acquisition is largely attributable to full ownership rights to the Avilomics platform. We do not expect any portion of this goodwill to be deductible for tax purposes. The

70
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


goodwill attributable to the acquisition has been recorded as a non-current asset in our Consolidated Balance Sheets and is not amortized, but is subject to review for impairment annually.
Prior to the acquisition, Avila had a number of collaboration agreements in place to which we are now party. These agreements entitle us to receive potential milestone payments and reimbursement of expenses for research and development expenses incurred under the collaborations and our collaboration partners may receive intellectual property rights or options to purchase such rights related to products developed under the collaborations. We do not consider these collaboration arrangements to be significant.
Sale of Non-core Assets
The 2010 acquisition of Abraxis BioScience, Inc. (Abraxis) included a number of assets that were not associated with nab® technology or ABRAXANE®. In April 2011, we sold these non-core assets to various entities that were owned or controlled by Dr. Patrick Soon-Shiong, the former majority shareholder and executive chairman of Abraxis. We received cash consideration, 10% equity ownership in Active Biomaterials, LLC, which we subsequently sold to Dr. Patrick Soon-Shiong, and a future royalty stream based on net sales of certain products of Active Biomaterials, LLC. We recorded the future royalty stream as an asset and assigned a value of $170.0 million based on its April 2011 fair market value calculated as the present value of estimated future net cash flows. Based on observed industry consolidation in the market that produces the raw materials for the products sold by Active Biomaterials, LLC and the forecasted reduction of net sales subject to royalties, we performed an analysis in December 2013 of the fair value of the future royalty stream. Our evaluation of discounted estimated future cash flows resulted in a fair value of $90.0 million for the future royalty stream and we recorded an impairment expense of $80.0 million in 2013.
In January 2014, we entered into a collaboration agreement with NantBioScience, Inc. (NantBioScience), an entity controlled by Dr. Patrick Soon-Shiong in which Celgene contributed $75 million, the rights to the future royalty stream noted above and licenses to two nab® product candidates. In return, Celgene received 14 percent equity ownership in NantBioScience, an option to license a certain number of product candidates developed by NantBioScience, including the two nab® product candidates that Celgene is licensing to NantBioScience, and the parent company of NantBioScience assumed, and agreed to pay and satisfy when due, our obligation to pay The Chan Soon-Shiong Institute for Advanced Health (CSS Institute) $50.0 million contingent, matching contributions.
3.     Earnings Per Share
 
 
2013
 
2012
 
2011
Net income attributable to Celgene
 
$
1,449.9

 
$
1,456.2

 
$
1,318.1

Weighted-average shares:
 
 
 
 
 
 
Basic
 
413.8

 
430.9

 
455.3

Effect of dilutive securities:
 
 
 
 
 
 
Options, restricted stock units, warrants and other
 
16.5

 
9.9

 
7.4

Diluted
 
430.3

 
440.8

 
462.7

Net income per share attributable to Celgene:
 
 
 
 
 
 
Basic
 
$
3.50

 
$
3.38

 
$
2.89

Diluted
 
$
3.37

 
$
3.30

 
$
2.85

The total number of potential shares of common stock excluded from the diluted earnings per share computation because their inclusion would have been anti-dilutive was 7.2 million in 2013, 12.7 million in 2012 and 25.9 million in 2011.
During the period of April 2009 through December 2013, our Board of Directors has approved repurchases of up to an aggregate of $9.500 billion of our common stock, including the June 2013 authorization to repurchase an additional $3.000 billion of our common stock.

As part of the Board authorized share repurchase program, in February 2013 we entered into an Accelerated Share Repurchase (ASR) agreement with an investment bank to repurchase an aggregate of $600.0 million of our common stock. The total number of shares repurchased under the ASR agreement was 5.2 million shares at a weighted average price of $114.30 per share.

As part of the management of our Board of Director authorized share repurchase program, we may, from time to time, sell put options on our common stock with strike prices that we believe represent an attractive price to repurchase our shares. If the trading price of our shares exceeds the strike price of the put option at the time the option expires, we will have economically reduced the cost of our share repurchase program by the amount of the premium we received from the sale of the put option. If the trading

71
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


price of our stock is below the strike price of the put option at the time the option expires, we would repurchase the shares covered by the option at the strike price of the put option. During 2013 we sold a single put option for a premium of $1.2 million that expired unexercised. At December 31, 2013, we had no outstanding put options. In February 2014, we sold a put option on $200.0 million notional amount of shares of stock with a strike price of $142.81 and maturing in March 2014 for a premium of $4.8 million.
We repurchased 22.3 million shares of common stock under the program from all sources, including the ASR during 2013. As of December 31, 2013, we had a remaining open-ended repurchase authorization of $2.068 billion.
4.     Financial Instruments and Fair Value Measurement
The table below presents information about assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2013 and the valuation techniques we utilized to determine such fair value.  Fair values determined based on Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities.  Our Level 1 assets consist of marketable equity securities.  Fair values determined based on Level 2 inputs utilize observable quoted prices for similar assets and liabilities in active markets and observable quoted prices for identical or similar assets in markets that are not very active.  Our Level 2 assets consist primarily of U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency MBS, non-U.S. government, agency and Supranational securities, global corporate debt securities, asset backed securities, foreign currency forward contracts, purchased foreign currency options and interest rate swap contracts.  Fair values determined based on Level 3 inputs utilize unobservable inputs and include valuations of assets or liabilities for which there is little, if any, market activity.  We do not have any Level 3 assets.  Our Level 1 liability relates to our publicly traded Contingent Value Rights (CVRs). See Note 18 for a description of the CVRs.  Our Level 2 liabilities relate to interest rate swap contracts and forward starting interest rate swap contracts.  Our Level 3 liabilities consist of contingent consideration related to undeveloped product rights resulting from the acquisition of Gloucester Pharmaceuticals, Inc. (Gloucester) and contingent consideration related to the undeveloped product rights and the technology platform acquired from the Avila acquisition. The maximum potential payments related to the contingent consideration from the acquisitions of Gloucester and Avila are estimated to be $120.0 million and $595.0 million, respectively.
 
 
Balance at
December 31, 2013
 
Quoted Price in
Active Markets for
Identical Assets
(Level 1)
 
Significant
Other Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Available-for-sale securities
 
$
2,452.6

 
$
433.1

 
$
2,019.5

 
$
—

Cash equivalents
 
20.0

 
—

 
20.0

 
—

Total assets
 
$
2,472.6

 
$
433.1

 
$
2,039.5

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
  Forward currency contracts
 
$
(9.2
)
 
$
—

 
$
(9.2
)
 
$
—

Contingent value rights
 
(118.1
)
 
(118.1
)
 
—

 
—

Interest rate swaps
 
(49.6
)
 
—

 
(49.6
)
 
—

Other acquisition related contingent consideration
 
(228.5
)
 
—

 
—

 
(228.5
)
Total liabilities
 
$
(405.4
)
 
$
(118.1
)
 
$
(58.8
)
 
$
(228.5
)


72
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


 
 
Balance at
December 31, 2012
 
Quoted Price in
Active Markets for
Identical Assets
(Level 1)
 
Significant
Other Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Available-for-sale securities
 
$
1,809.9

 
$
0.3

 
$
1,809.6

 
$
—

Cash equivalents
 
27.0

 
—

 
27.0

 
—

Interest rate swaps
 
1.7

 
—

 
1.7

 
—

Forward currency contracts
 
17.8

 
—

 
17.8

 
—

Purchased currency options
 
2.7

 
—

 
2.7

 
—

Total assets
 
$
1,859.1

 
$
0.3

 
$
1,858.8

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
Contingent value rights
 
$
(277.4
)
 
$
(277.4
)
 
$
—

 
$
—

Written currency options
 
(5.1
)
 
—

 
(5.1
)
 
—

Other acquisition related contingent consideration
 
(198.1
)
 
—

 
—

 
(198.1
)
Total liabilities
 
$
(480.6
)
 
$
(277.4
)
 
$
(5.1
)
 
$
(198.1
)

The following table represents a roll-forward of the fair value of Level 3 liabilities (significant unobservable inputs):

 
 
2013
 
2012
Liabilities:
 
 
 
 
Balance at beginning of period
 
$
(198.1
)
 
$
(76.9
)
Amounts acquired or issued
 
—

 
(171.7
)
Net change in fair value
 
(30.4
)
 
50.5

Settlements
 
—

 
—

Transfers in and/or out of Level 3
 
—

 
—

Balance at end of period
 
$
(228.5
)
 
$
(198.1
)
The $30.4 million increase in the fair value of Level 3 liabilities in 2013 was primarily due to probability adjustments for two Avila milestones. Level 3 liabilities issued during 2012 consisted of contingent consideration related to the acquisition of Avila. The $50.5 million net decrease in the fair value of Level 3 liabilities in 2012 was due to a $59.7 million reduction in the contingent consideration liability related to the approval of ISTODAX® for PTCL in Europe, partly offset by a $9.2 million increase in the accretion of the contingent consideration liability related to our acquisition of Avila.
5.     Derivative Instruments and Hedging Activities
Our revenue and earnings, cash flows and fair values of assets and liabilities can be impacted by fluctuations in foreign exchange rates and interest rates. We actively manage the impact of foreign exchange rate and interest rate movements through operational means and through the use of various financial instruments, including derivative instruments such as foreign currency option contracts, foreign currency forward contracts, treasury rate lock agreements and interest rate swap contracts.
Foreign Currency Risk Management
We maintain a foreign exchange exposure management program to mitigate the impact of volatility in foreign exchange rates on future foreign currency cash flows, translation of foreign earnings and changes in the fair value of assets and liabilities denominated in foreign currencies.
Through our revenue hedging program, we endeavor to reduce the impact of possible unfavorable changes in foreign exchange rates on our future U.S. dollar cash flows that are derived from foreign currency denominated sales. To achieve this objective, we hedge a portion of our forecasted foreign currency denominated sales that are expected to occur in the foreseeable future, typically within the next three years. We manage our anticipated transaction exposure principally with foreign currency forward contracts and occasionally foreign currency put and call options.

73
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Foreign Currency Forward Contracts:  We use foreign currency forward contracts to hedge specific forecasted transactions denominated in foreign currencies, manage exchange rate volatility in the translation of foreign earnings, and to reduce exposures to foreign currency fluctuations of certain assets and liabilities denominated in foreign currencies.
We manage a portfolio of foreign currency forward contracts to protect against changes in anticipated foreign currency cash flows resulting from changes in foreign currency exchange rates, primarily associated with non-functional currency denominated revenues and expenses of foreign subsidiaries. The foreign currency forward hedging contracts outstanding at December 31, 2013 and 2012 had settlement dates within 36 months. These foreign currency forward contracts are designated as cash flow hedges and, to the extent effective, any unrealized gains or losses on them are reported in other comprehensive income (loss) (OCI) and reclassified to operations in the same periods during which the underlying hedged transactions affect operations. Any ineffectiveness on these foreign currency forward contracts is reported in other income (expense), net. Foreign currency forward contracts entered into to hedge forecasted revenue and expenses were as follows at December 31, 2013 and 2012:
 
 
Notional Amount
Foreign Currency:
 
2013
 
2012
Australian Dollar
 
$
—

 
$
5.1

British Pound
 
279.4

 
77.9

Canadian Dollar
 
—

 
134.4

Euro
 
3,318.2

 
969.3

Japanese Yen
 
559.1

 
236.2

Total
 
$
4,156.7

 
$
1,422.9

We consider the impact of our own and the counterparties' credit risk on the fair value of the contracts as well as the ability of each party to execute its obligations under the contract on an ongoing basis. As of December 31, 2013, credit risk did not materially change the fair value of our foreign currency forward contracts.
We also manage a portfolio of foreign currency contracts to reduce exposures to foreign currency fluctuations of certain recognized assets and liabilities denominated in foreign currencies and, from time to time, we enter into foreign currency contracts to manage exposure related to translation of foreign earnings. These foreign currency forward contracts have not been designated as hedges and, accordingly, any changes in their fair value are recognized on the Consolidated Statements of Income in other income (expense), net in the current period. The aggregate notional amount of the foreign currency forward non-designated hedging contracts outstanding at December 31, 2013 and 2012 were $878.5 million and $795.4 million, respectively.
Foreign Currency Option Contracts: From time to time, we may hedge a portion of our future foreign currency exposure by utilizing a strategy that involves both a purchased local currency put option and a written local currency call option that are accounted for as hedges of future sales denominated in euros. In connection with this strategy, we may also sell local currency put options that are not accounted for as hedges in order to reduce or fully offset the net cost of the hedging contracts. Foreign currency option contracts entered into to hedge forecasted revenue and expenses were as follows at December 31, 2013 and 2012:
 
Notional Amount1
 
2013
 
2012
Foreign Currency Option:
 
 
 
Designated as hedging activity:
 
 
 
Purchased Put
$
—

 
$
228.8

Written Call
$
—

 
$
235.9

Not designated as hedging activity:
 
 
 
Purchased Put
$
—

 
$
160.5

Written Put
$
—

 
$
(216.0
)
1 U.S. dollar notional amounts are calculated as the hedged local currency amount multiplied times the strike value of the foreign currency option. The local currency notional amounts of our purchased put and written call that are designated as hedging activities are equal to each other.



74
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Interest Rate Risk Management
In anticipation of issuing fixed-rate debt, we may use forward starting interest rate swaps (forward starting swaps) or treasury rate lock agreements (treasury rate locks) that are designated as cash flow hedges to hedge against changes in interest rates that could impact expected future issuances of debt. To the extent these hedges of cash flows related to anticipated debt are effective, any realized or unrealized gains or losses on the treasury rate locks or forward starting swaps are reported in OCI and are recognized in income over the life of the anticipated fixed-rate notes.

Forward Starting Interest Rate Swaps: During 2013, we entered into forward starting swaps, that were designated as cash flow hedges, with an aggregate notional value of $300.0 million and effective dates in November 2014, with $100.0 million maturing in five years and $200 million maturing in ten years to hedge against changes in interest rates that could impact an anticipated issuance of debt. During January and February 2014, we entered into additional forward starting swaps with effective dates in November 2014 and an aggregate notional value of $350.0 million and maturities of five and ten years.
Treasury Rate Lock Agreements: During 2012, we entered into treasury rate locks in anticipation of issuing fixed-rate notes that were issued in August 2012. The treasury rate locks were settled during 2012 which resulted in losses of $35.3 million that were recorded to OCI. No material amounts were recorded in income during 2013 or 2012 as a result of hedge ineffectiveness or hedge components excluded from the assessment of effectiveness.
Interest Rate Swap Contracts:    From time to time we hedge the fair value of certain debt obligations through the use of interest rate swap contracts. The interest rate swap contracts are designated hedges of the fair value changes in the notes attributable to changes in interest rates. Since the specific terms and notional amount of the swap are intended to match those of the debt being hedged, it is assumed to be a highly effective hedge and all changes in fair value of the swap is recorded on the Consolidated Balance Sheets with no net impact recorded in income. Any net interest payments made or received on interest rate swap contracts are recognized as interest expense. We may terminate the hedging relationship of certain swap contracts by settling the contracts or by entering into offsetting contracts.  At the time a hedging relationship is terminated, accumulated gains or losses associated with the swap contract are measured and recorded as a reduction of current and future interest expense associated with the previously hedged notes.
We have entered into swap contracts that were designated as hedges of our fixed rate notes due in 2015, 2017, 2018, 2020, 2022 and 2023 and also terminated the hedging relationship by settling certain of those swap contracts during 2012 and 2013.  The settlement of swap contracts resulted in the receipt of net proceeds of $5.0 million in 2012 and $22.9 million in 2013 which is accounted for as a reduction of current and future interest expense associated with these notes.  See Note 11 for additional details related to reductions of current and future interest expense. The following table summarizes the notional amounts of our outstanding swap contracts at the end December 31, 2013 and 2012:
 
 
Notional Amount
 
 
2013
 
2012
Interest rate swap contracts entered into as fair value hedges of the following fixed-rate senior notes:
 
 

 
 

2.450% senior notes due 2015
 
$
300.0

 
$
—

1.900% senior notes due 2017
 
300.0

 
100.0

2.300% senior notes due 2018
 
200.0

 
—

3.950% senior notes due 2020
 
500.0

 
—

3.250% senior notes due 2022
 
850.0

 
200.0

4.000% senior notes due 2023
 
150.0

 
—

Total
 
$
2,300.0

 
$
300.0

During 2014 we continued to actively manage our interest rate swaps and have terminated the hedging relationships of certain swap contracts and entered into new swaps that were designated as fair value hedges of our senior notes. The notional amount of our outstanding interest rate contracts at February 12, 2014 was $1.850 billion.

75
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


The following table summarizes the fair value and presentation in the Consolidated Balance Sheets for derivative instruments as of December 31, 2013 and 2012:
 
 
December 31, 2013
 
 
Asset Derivatives
 
Liability Derivatives
Instrument
 
Balance Sheet
Location
 
Fair Value
 
Balance Sheet
Location
 
Fair Value
Derivatives designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
$
63.6

 
Other current assets
 
$
24.9

 
 
Other current liabilities
 
41.5

 
Other current liabilities
 
84.7

 
 
Other non-current assets
 
60.6

 
Other non-current assets
 
41.9

 
 
Other non-current liabilities
 
4.3

 
Other non-current liabilities
 
25.6

Interest rate swap agreements
 
Other current assets
 
17.1

 
Other current assets
 
—

 
 
Other non-current liabilities
 
—

 
Other non-current liabilities
 
68.3

Derivatives not designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
11.3

 
Other current assets
 
0.7

 
 
Other current liabilities
 
6.0

 
Other current liabilities
 
18.7

Interest rate swap agreements
 
Other current assets
 
0.1

 
Other current assets
 
—

 
 
Other non-current assets
 
1.5

 
Other non-current assets
 
—

Total
 
 
 
$
206.0

 
 
 
$
264.8

 
 
December 31, 2012
 
 
Asset Derivatives
 
Liability Derivatives
Instrument
 
Balance Sheet
Location
 
Fair Value
 
Balance Sheet
Location
 
Fair Value
Derivatives designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
$
35.2

 
Other current assets
 
$
12.7

 
 
Other current liabilities
 
9.1

 
Other current liabilities
 
31.4

 
 
Other non-current assets
 
30.5

 
Other non-current assets
 
13.8

Interest rate swap agreements
 
Other current assets
 
0.1

 
Other current assets
 
—

 
 
Other non-current assets
 
0.1

 
Other non-current assets
 
0.2

 
 
Other non-current liabilities
 
—

 
Other non-current liabilities
 
0.6

Derivatives not designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
45.8

 
Other current assets
 
36.3

 
 
Other current liabilities
 
10.4

 
Other current liabilities
 
21.4

Interest rate swap agreements
 
Other current assets
 
0.6

 
Other current assets
 
—

 
 
Other non-current assets
 
1.7

 
Other non-current assets
 
—

Total
 
 
 
$
133.5

 
 
 
$
116.4

1Derivative instruments in this category are subject to master netting arrangements and are presented on a net basis in the Consolidated Balance Sheets in accordance with ASC 210-20.

76
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


The following table summarizes the effect of derivative instruments designated as cash-flow hedging instruments on the Consolidated Statements of Income for the years ended December 31, 2013 and 2012:
 
 
2013
 
 
 
 
Amount of
Gain/(Loss)
Recognized in OCI
on Derivative1
 
Location of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Amount of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Location of
Gain/(Loss)
Recognized in
Income on
Derivative
 
Amount of
Gain/(Loss)
Recognized in
Income on
Derivative
 
 
Instrument
 
(Effective Portion)
 
(Effective Portion)
 
(Effective Portion)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
 
Foreign exchange contracts
 
$
(9.7
)
 
Net product sales
 
$
10.7

 
Other income, net
 
$
12.6

 
2 
Treasury rate lock agreements
 
$
—

 
Interest expense
 
$
(3.4
)
 
 
 
 

 
 
Forward starting interest rate swaps
 
$
6.5

 
Interest expense
 
$
—

 
 
 
 
 
 

1 
Net losses of $13.2 million are expected to be reclassified from Accumulated OCI into income in the next 12 months.
2 
The amount of net gains recognized in income represents $6.3 million of gains related to the ineffective portion of the hedging relationships and $6.3 million of gains related to amounts excluded from the assessment of hedge effectiveness.

 
 
2012
 
 
 
 
Amount of
Gain/(Loss)
Recognized in OCI
on Derivative
 
Location of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Amount of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Location of
Gain/(Loss)
Recognized in
Income on
Derivative
 
Amount of
Gain/(Loss)
Recognized in
Income on
Derivative
 
 
Instrument
 
(Effective Portion)
 
(Effective Portion)
 
(Effective Portion)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
 
Foreign exchange contracts
 
$
74.5

 
Net product sales
 
$
80.9

 
Other income, net
 
$
(6.6
)
 
1 
Treasury rate lock agreements
 
$
(35.3
)
 
Interest Expense
 
$
(1.3
)
 
 
 
 

 
 

1 
The amount of net losses recognized in income represents $9.0 million in losses related to the ineffective portion of the hedging relationships and $2.4 million of gains related to amounts excluded from the assessment of hedge effectiveness.
The following table summarizes the effect of derivative instruments designated as fair value hedging instruments on the Consolidated Statements of Income for the years ended December 31, 2013 and 2012:
 
 
Location of Gain (Loss)
Recognized in Income
on Derivative
 
Amount of Gain (Loss)
Recognized in Income
on Derivative
Instrument
 
2013
 
2012
Interest Rate Swaps
 
Interest expense
 
$
31.4

 
$
7.8


77
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


The following table summarizes the effect of derivative instruments not designated as hedging instruments on the Consolidated Statements of Income for the years ended December 31, 2013 and 2012:
 
 
Location of Gain (Loss)
Recognized in Income
on Derivative
 
Amount of Gain (Loss)
Recognized in Income
on Derivative
Instrument
 
2013
 
2012
Foreign exchange contracts
 
Other income, net
 
$
34.1

 
$
23.8

Treasury rate lock agreements
 
Other income, net
 
$
—

 
$
3.7

Interest rate swap agreements
 
Other income, net
 
$
0.7

 
$
0.3

Put options sold
 
Other income, net
 
$
1.2

 
$
—


The impact of gains and losses on foreign exchange contracts not designated as hedging instruments related to changes in the fair value of assets and liabilities denominated in foreign currencies are generally offset by net foreign exchange gains and losses, which are also included in other income (expense), net for all periods presented. When we enter into foreign exchange contracts not designated as hedging instruments to mitigate the impact of exchange rate volatility in the translation of foreign earnings, gains and losses will generally be offset by fluctuations in the U.S. dollar translated amounts of each Income Statement account in current and/or future periods. 
6.     Cash, Cash Equivalents and Marketable Securities Available-for-Sale
Money market funds of $1.697 billion and $1.160 billion at December 31, 2013 and 2012, respectively, were recorded at cost, which approximates fair value and are included in cash and cash equivalents.
The amortized cost, gross unrealized holding gains, gross unrealized holding losses and estimated fair value of available-for-sale securities by major security type and class of security at December 31, 2013 and 2012 were as follows:
December 31, 2013
 
Amortized
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
U.S. Treasury securities
 
$
795.2

 
$
0.3

 
$
(0.4
)
 
$
795.1

U.S. government-sponsored agency securities
 
208.9

 
0.2

 
(0.2
)
 
208.9

U.S. government-sponsored agency MBS
 
450.8

 
0.1

 
(6.9
)
 
444.0

Non-U.S. government, agency and
Supranational securities
 
10.4

 
—

 
—

 
10.4

Corporate debt – global
 
379.2

 
1.1

 
(0.6
)
 
379.7

Asset backed securities
 
181.6

 
—

 
(0.2
)
 
181.4

Marketable equity securities
 
212.9

 
220.2

 
—

 
433.1

Total available-for-sale marketable securities
 
$
2,239.0

 
$
221.9

 
$
(8.3
)
 
$
2,452.6


December 31, 2012
 
Amortized
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
U.S. Treasury securities
 
$
902.0

 
$
0.5

 
$
—

 
$
902.5

U.S. government-sponsored agency securities
 
303.5

 
0.3

 
—

 
303.8

U.S. government-sponsored agency MBS
 
387.2

 
1.6

 
(1.8
)
 
387.0

Non-U.S. government, agency and
Supranational securities
 
7.1

 
—

 
—

 
7.1

Corporate debt – global
 
208.5

 
0.9

 
(0.2
)
 
209.2

Marketable equity securities
 
0.4

 
—

 
(0.1
)
 
0.3

Total available-for-sale marketable securities
 
$
1,808.7

 
$
3.3

 
$
(2.1
)
 
$
1,809.9



78
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


U.S. government-sponsored agency securities include general unsecured obligations either issued directly by or guaranteed by U.S. Government Sponsored Enterprises.  U.S. government-sponsored agency MBS include mortgage-backed securities issued by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association.  Non-U.S. government, agency and Supranational securities consist of direct obligations of highly rated governments of nations other than the United States and obligations of sponsored agencies and other entities that are guaranteed or supported by highly rated governments of nations other than the United States.  Corporate debt-global includes obligations issued by investment-grade corporations, including some issues that have been guaranteed by governments and government agencies.  Asset backed securities consist of triple-A rated securities with cash flows collateralized by credit card receivables and auto loans. Marketable equity securities consist of investments in equity securities that have become publicly traded.  The increase in net unrealized gains in marketable equity securities in 2013 compared to 2012 primarily reflects the increase in market value for certain equity investments subsequent to their respective initial public offerings. Net unrealized losses in the marketable securities primarily reflect the impact of increased interest rates at December 31, 2013.
The fair value of all available-for-sale securities, which have been in an unrealized loss position for less than and longer than 12 months at December 31, 2013, was as follows:
 
 
Less than 12 months
 
12 months or longer
 
Total
December 31, 2013
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
U.S. Treasury securities
 
$
316.9

 
$
(0.4
)
 
$
—

 
$
—

 
$
316.9

 
$
(0.4
)
U.S. government-sponsored agency securities
 
78.2

 
(0.2
)
 
—

 
—

 
78.2

 
(0.2
)
U.S. government-sponsored agency MBS
 
358.9

 
(5.4
)
 
45.8

 
(1.5
)
 
404.7

 
(6.9
)
Corporate debt – global
 
135.1

 
(0.6
)
 
—

 
—

 
135.1

 
(0.6
)
Asset backed securities
 
126.3

 
(0.2
)
 
—

 
—

 
126.3

 
(0.2
)
Total
 
$
1,015.4

 
$
(6.8
)
 
$
45.8

 
$
(1.5
)
 
$
1,061.2

 
$
(8.3
)
The Company believes that the decline in fair value of securities held at December 31, 2013 below their cost is temporary and intends to retain its investment in these securities for a sufficient period of time to allow for recovery in the market value of these investments.
Duration periods of available-for-sale debt securities at December 31, 2013 were as follows:
 
 
Amortized
Cost
 
Fair
Value
Duration of one year or less
 
$
391.8

 
$
391.6

Duration of one through three years
 
1,364.8

 
1,363.8

Duration of three through five years
 
233.9

 
229.8

Duration of over five years
 
35.6

 
34.3

Total
 
$
2,026.1

 
$
2,019.5


79
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


7.     Inventory
A summary of inventories by major category at December 31, 2013 and 2012 follows:
 
 
2013
 
2012
Raw materials
 
$
147.4

 
$
79.2

Work in process
 
99.6

 
86.5

Finished goods
 
93.4

 
93.8

Total
 
$
340.4

 
$
259.5


Raw materials increased by $68.2 million in 2013 compared to 2012 primarily resulting from an increase in the sales level of ABRAXANE® , which was approved by the FDA for treatment of Non-Small Cell Lung Cancer (NSCLC) in October 2012 and pancreatic cancer in September 2013. In addition, $33.4 million of OTEZLA® (apremilast) inventory has been capitalized in 2013 prior to regulatory approval, in anticipation of regulatory approval for this product.
 
8.     Property, Plant and Equipment
Property, plant and equipment at December 31, 2013 and 2012 consisted of the following:
 
 
2013
 
2012
Land
 
$
37.9

 
$
36.7

Buildings
 
258.0

 
228.4

Building and operating equipment
 
30.8

 
30.0

Leasehold improvements
 
128.2

 
78.1

Machinery and equipment
 
193.8

 
175.2

Furniture and fixtures
 
46.3

 
41.2

Computer equipment and software
 
286.1

 
239.5

Construction in progress
 
44.6

 
90.1

Subtotal
 
1,025.7

 
919.2

Less accumulated depreciation and amortization
 
432.3

 
340.8

Total
 
$
593.4

 
$
578.4

The balance of construction in progress at December 31, 2013 relates primarily to an expansion of our international headquarters in Boudry, Switzerland as well as the expansion of our corporate headquarters in Summit, New Jersey.

80
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


9.     Other Financial Information
Accrued expenses at December 31, 2013 and 2012 consisted of the following:
 
 
2013
 
2012
Compensation
 
$
261.7

 
$
170.3

Rebates, distributor chargebacks and distributor services
 
217.3

 
187.0

Clinical trial costs and grants
 
192.6

 
183.3

Common share repurchases
 
45.7

 
41.0

Interest
 
49.0

 
26.3

Royalties, license fees and collaboration agreements
 
52.4

 
19.4

Commercial related activities
 
46.6

 
22.8

Sales returns
 
15.5

 
13.3

Rent
 
14.8

 
9.5

Professional services
 
9.3

 
9.8

Other Taxes
 
7.6

 
8.3

Other
 
88.6

 
84.7

Total
 
$
1,001.1

 
$
775.7


Other current liabilities at December 31, 2013 and 2012 consisted of the following:
 
 
2013
 
2012
Contingent value rights – Abraxis acquisition
 
$
—

 
$
277.4

Sales, use and value added tax
 
50.9

 
56.9

Foreign exchange contracts
 
55.9

 
33.3

Collaboration agreement
 
7.0

 
17.0

Contingent consideration – Avila acquisition
 
62.7

 
17.4

Other
 
23.2

 
29.3

Total
 
$
199.7

 
$
431.3

Other non-current liabilities at December 31, 2013 and 2012 consisted of the following:
 
 
2013
 
2012
Contingent consideration – Avila acquisition
 
$
147.5

 
$
163.5

Deferred compensation and long-term incentives
 
127.2

 
99.2

Contingent value rights - Abraxis acquisition
 
118.1

 
—

Foreign exchange contracts
 
89.6

 
0.6

Deferred lease incentive
 
28.7

 
31.4

Collaboration agreement
 
28.0

 
—

Contingent consideration – Gloucester acquisition
 
18.3

 
17.3

Manufacturing facility purchase
 
13.9

 
14.4

Other
 
11.4

 
29.1

Total
 
$
582.7

 
$
355.5


81
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


10.   Intangible Assets and Goodwill
Intangible Assets:    Our intangible assets consist of developed product rights obtained primarily from the Pharmion Corp. (Pharmion), Gloucester and Abraxis acquisitions, IPR&D product rights from the Gloucester and Avila acquisitions and technology obtained primarily from the Avila acquisition. Also included are contract-based licenses and other miscellaneous intangibles. The amortization periods related to non-IPR&D intangible assets range from one to 17 years. The following summary of intangible assets by category includes intangibles currently being amortized and intangibles not yet subject to amortization:
December 31, 2013
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Intangible
Assets,
Net
 
Weighted
Average
Life (Years)
Amortizable intangible assets:
 
 
 
 
 
 
 
 
Acquired developed product rights
 
$
3,405.9

 
$
(1,026.4
)
 
$
2,379.5

 
13.0
Technology
 
333.7

 
(87.4
)
 
246.3

 
7.0
Licenses
 
66.2

 
(13.9
)
 
52.3

 
16.5
Other
 
42.5

 
(18.8
)
 
23.7

 
8.6
 
 
3,848.3

 
(1,146.5
)
 
2,701.8

 
12.5
Non-amortized intangible assets:
 
 
 
 
 
 
 
 
Acquired IPR&D product rights
 
137.9

 
—

 
137.9

 
 
Total intangible assets
 
$
3,986.2

 
$
(1,146.5
)
 
$
2,839.7

 
 

December 31, 2012
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Intangible
Assets,
Net
 
Weighted
Average
Life (Years)
Amortizable intangible assets:
 
 
 
 
 
 
 
 
Acquired developed product rights
 
$
3,400.4

 
$
(814.5
)
 
$
2,585.9

 
13.0
Technology
 
333.3

 
(39.8
)
 
293.5

 
7.0
Licenses
 
64.3

 
(10.0
)
 
54.3

 
16.8
Other
 
43.4

 
(14.6
)
 
28.8

 
8.5
 
 
3,841.4

 
(878.9
)
 
2,962.5

 
12.5
Non-amortized intangible assets:
 
 
 
 
 
 
 
 
Acquired IPR&D product rights
 
137.9

 
—

 
137.9

 
 
Total intangible assets
 
$
3,979.3

 
$
(878.9
)
 
$
3,100.4

 
 

The gross carrying value of intangible assets increased by $6.9 million in 2013 compared to 2012 primarily resulting from the acquisition of $5.5 million in certain developed product rights and the addition of $3.9 million from other miscellaneous agreements, net of a $2.5 million impairment charge.
Amortization expense was $270.1 million, $196.2 million and $290.3 million for the years ended December 31, 2013, 2012 and 2011, respectively. Amortization expense increased by $73.9 million in 2013 compared to 2012 primarily due to the October 2012 approval of ABRAXANE® in the United States for the treatment of NSCLC which resulted in the commencement of amortization of the related intangible asset and an increase in amortization of technology related to the March 7, 2012 acquisition of Avila and its Avilomics™ platform. Assuming no changes in the gross carrying amount of intangible assets, the amortization of intangible assets for years 2014 through 2018 is estimated to be in the range of approximately $255.0 million to $270.0 million annually.
Goodwill:    At December 31, 2013, our goodwill related to the 2012 acquisition of Avila, the 2010 acquisitions of Abraxis and Gloucester, the 2008 acquisition of Pharmion and the 2004 acquisition of Penn T Limited.

82
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


The change in carrying value of goodwill is summarized as follows:
Balance at December 31, 2012
$
2,042.8

Tax benefit on the exercise of Pharmion converted stock options
(1.6
)
Balance at December 31, 2013
$
2,041.2


11.   Debt
Senior Notes:    Summarized below are the carrying values of our senior notes at December 31, 2013 and 2012:
 
 
2013
 
2012
2.450% senior notes due 2015
 
$
513.9

 
$
520.1

1.900% senior notes due 2017
 
499.9

 
500.6

2.300% senior notes due 2018
 
399.0

 
—

3.950% senior notes due 2020
 
484.6

 
499.0

3.250% senior notes due 2022
 
956.6

 
1,002.1

4.000% senior notes due 2023
 
696.3

 
—

5.700% senior notes due 2040
 
249.6

 
249.5

5.250% senior notes due 2043
 
396.6

 
—

Total long-term debt
 
$
4,196.5

 
$
2,771.3

At December 31, 2013, the fair value of our outstanding Senior Notes was $4.269 billion and represented a Level 2 measurement within the fair value measurement hierarchy.
In August 2013, we issued an additional $1.500 billion principal amount of senior notes consisting of $400.0 million aggregate principal amount of 2.300% Senior Notes due 2018 (the 2018 notes), $700.0 million aggregate principal amount of 4.000% Senior Notes due 2023 (the 2023 notes) and $400.0 million aggregate principal amount of 5.25% Senior Notes due 2043 (the 2043 notes) and, together with the 2018 notes and 2023 notes, referred to herein as the "2013 issued notes". The 2013 issued notes were issued at 99.792%, 99.452% and 99.147% of par, respectively, and the discount is being amortized as additional interest expense over the period from issuance through maturity. Offering costs of approximately $12.5 million have been recorded as debt issuance costs on our Consolidated Balance Sheets and are being amortized as additional interest expense using the effective interest rate method over the period from issuance through maturity. Interest on the notes is payable semi-annually in arrears on February 15 and August 15 each year beginning February 15, 2014 and the principal on each note is due in full at their respective maturity dates.
The notes may be redeemed at the option of the Company, in whole or in part, at any time at a redemption price defined in a make-whole clause equaling accrued and unpaid interest plus the greater of 100% of the principal amount of the notes to be redeemed or the sum of the present values of the remaining scheduled payments of interest and principal. If we experience a change of control accompanied by a downgrade of the debt to below investment grade, we will be required to offer to repurchase the notes at a purchase price equal to 101% of their principal amount plus accrued and unpaid interest. We are subject to covenants which limit our ability to pledge properties as security under borrowing arrangements and limit our ability to perform sale and leaseback transactions involving our property.
During 2012, we entered into treasury rate locks in anticipation of issuing the fixed-rate notes that were issued in August 2012. As of December 31, 2013, a balance of $30.6 million in losses remained in OCI related to treasury rate locks and will be recognized as interest expense over the life of the 2017 notes and the 2022 notes.
At December 31, 2013, we were party to pay-floating, receive-fixed interest rate swap contracts designated as fair value hedges
of fixed-rate notes as described in Note 5. Our swap contracts outstanding at December 31, 2013 effectively convert the hedged portion of our fixed-rate notes to floating rates. From time to time we terminate the hedging relationship on certain of our swap contracts by settling the contracts or by entering into offsetting contracts. Any net proceeds received or paid in these settlements are accounted for as a reduction or increase of current and future interest expense associated with the previously hedged notes. As of December 31, 2013 and 2012, we had balances of $32.1 million and $25.5 million, respectively, in unamortized gains recorded as a component of our debt as a result of past swap contract settlements. During 2013, we terminated the hedging relationship on certain of our swap contracts, resulting in gains of $15.8 million.

83
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Commercial Paper:    The carrying value of Commercial Paper as of December 31, 2013 and 2012 was $544.8 million and $308.5 million, respectively, and approximated its fair value. The effective interest rate on the outstanding Commercial Paper balance at December 31, 2013 was 0.4%.
Senior Unsecured Credit Facility:    We maintain a senior unsecured revolving credit facility (Credit Facility) that provides revolving credit in the aggregate amount of $1.500 billion, which was increased from $1.000 billion in April 2013. During April 2013, the term of the Credit Facility was also extended from September 2, 2016 to April 18, 2018.   Subject to certain conditions, we have the right to increase the amount of the Credit Facility (but in no event more than one time per annum) up to a maximum aggregate amount of $1.750 billion.  Amounts may be borrowed in U.S. dollars for working capital, capital expenditures and other corporate purposes. The Credit Facility currently serves as backup liquidity for our Commercial Paper borrowings.  At December 31, 2013 and 2012, there was no outstanding borrowing against the Credit Facility.
The Credit Facility contains affirmative and negative covenants including certain customary financial covenants.  We were in compliance with all financial covenants as of December 31, 2013. 
12.   Stockholders' Equity
Preferred Stock:    Our Board of Directors is authorized to issue, at any time, without further stockholder approval, up to 5.0 million shares of preferred stock, and to determine the price, rights, privileges, and preferences of such shares.
Common Stock:    At December 31, 2013, we were authorized to issue up to 575.0 million shares of common stock of which shares of common stock issued totaled 511.2 million.
Treasury Stock:    During the period of April 2009 through December 2013, our Board of Directors has approved repurchases of up to an aggregate $9.500 billion of our common stock, including the June 2013 authorization to repurchase an additional $3.000 billion of our common stock. We repurchased $2.769 billion, $2.050 billion, and $2.220 billion of treasury stock under the program in 2013, 2012 and 2011, respectively, excluding transaction fees. As of December 31, 2013 an aggregate 96.8 million common shares were repurchased under the program at an average price of $76.80 per common share and total cost of $7.432 billion.
Other: When employee awards of RSUs vest and are settled net in order to fulfill minimum statutory tax withholding requirements, the shares withheld are reflected as treasury stock.
A summary of changes in common stock issued and treasury stock is presented below:
 
 
Common Stock
 
Common Stock
in Treasury
December 31, 2010
 
482.2

 
(11.8
)
Exercise of stock options, warrants and conversion of restricted stock units
 
5.2

 
—

Issuance of common stock for employee benefit plans
 
—

 
0.2

Shares repurchased under share repurchase program
 
—

 
(38.3
)
December 31, 2011
 
487.4

 
(49.9
)
Exercise of stock options, warrants and conversion of restricted stock units
 
10.7

 
(0.2
)
Issuance of common stock for employee benefit plans
 
0.3

 
—

Shares repurchased under share repurchase program
 
—

 
(28.6
)
December 31, 2012
 
498.4

 
(78.7
)
Exercise of stock options and conversion of restricted stock units
 
12.5

 
(0.5
)
Issuance of common stock for employee benefit plans
 
0.3

 
—

Shares repurchased under share repurchase program
 
—

 
(22.3
)
December 31, 2013
 
511.2

 
(101.5
)
13.   Accumulated Other Comprehensive Income (Loss)
The components of other comprehensive income (loss) consist of changes in pension liability, changes in net unrealized gains (losses) on marketable securities classified as available-for-sale, net unrealized gains (losses) related to cash flow hedges and changes in foreign currency translation adjustments, which includes changes in a subsidiary's functional currency and net asset transfers of common control subsidiaries.

84
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


The accumulated balances related to each component of other comprehensive income (loss), net of tax, are summarized as follows:
 
 
Pension
Liability
 
Net Unrealized
Gains (Losses) From
Marketable Securities
 
Net Unrealized
Gains (Losses)
From Hedges
 
Foreign
Currency
Translation
Adjustment
 
Total
Accumulated
Other
Comprehensive
Income (Loss)
Balance December 31, 2011
 
$
(5.4
)
 
$
1.8

 
$
8.7

 
$
(67.4
)
 
$
(62.3
)
Period change
 
(4.7
)
 
2.4

 
(24.7
)
 
39.6

 
12.6

Balance December 31, 2012
 
(10.1
)
 
4.2

 
(16.0
)
 
(27.8
)
 
(49.7
)
Period change
 
3.2

 
133.1

 
(20.0
)
 
27.4

 
143.7

Balance December 31, 2013
 
$
(6.9
)
 
$
137.3

 
$
(36.0
)
 
$
(0.4
)
 
$
94.0




 
 
 
 
Gains (Losses) Reclassified Out of Accumulated
Other Comprehensive Income
Accumulated Other Comprehensive Income Components
 
Affected Line Item in the Consolidated Statements of Income
 
Years Ended December 31,
 
 
2013
 
2012
 
2011
Gains (losses) from cash-flow hedges:
 
 

 
 

 
 
Foreign exchange contracts
 
Net product sales
 
$
10.7

 
$
80.9

 
$
—

Treasury rate lock agreements
 
Interest (expense)
 
(3.4
)
 
(1.3
)
 
—

 
 
Income tax benefit (expense)
 
6.9

 
(1.9
)
 
(2.9
)
Gains (losses) from available-for-sale marketable securities:
 
 
 
 
 
 
Realized income (loss) on sales of marketable securities
 
Interest and investment income, net
 
(7.3
)
 
(1.1
)
 
4.0

 
 
Income tax benefit
 
2.2

 
0.1

 
0.3

Total reclassification, net of tax
 
 
 
$
9.1

 
$
76.7

 
$
1.4


14.   Share-Based Compensation
We have a stockholder-approved stock incentive plan, the 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013) (Plan) which provides for the granting of options, RSUs, stock appreciation rights, PSUs and other share-based awards to our employees and officers.  The Management Compensation and Development Committee of the Board of Directors (Compensation Committee) may determine the type, amount and terms, including vesting, of any awards made under the Plan.

On June 12, 2013, our stockholders approved an amendment and restatement of the Plan, which included the following key modifications: adoption of an aggregate share reserve of 105.0 million shares of Common Stock, which includes 9.0 million new shares of Common Stock; increase in the maximum payment to an eligible employee under a cash-based performance award from $4.0 million to $6.0 million; and extension of the term of the plan through April 17, 2023.
With respect to options granted under the Plan, the exercise price may not be less than the market closing price of the common stock on the date of grant. In general, options granted under the Plan vest over periods ranging from immediate vesting to four-year vesting and expire ten years from the date of grant, subject to earlier expiration in case of termination of employment unless the participant meets the retirement provision under which the option would have a maximum of three additional years to vest. The vesting period for options granted under the Plan is subject to certain acceleration provisions if a change in control, as defined in the Plan, occurs. Plan participants may elect to exercise options at any time during the option term. However, any shares so purchased which have not vested as of the date of exercise shall be subject to forfeiture, which will lapse in accordance with the established vesting time period.
Shares of common stock available for future share-based grants under all plans were 16.7 million at December 31, 2013.

85
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


The following table summarizes the components of share-based compensation expense in the Consolidated Statements of Income for the years ended December 31, 2013, 2012 and 2011:
 
 
2013
 
2012
 
2011
Cost of goods sold
 
$
18.5

 
$
12.4

 
$
9.8

Research and development
 
144.7

 
102.4

 
104.7

Selling, general and administrative
 
162.6

 
116.2

 
102.7

Total share-based compensation expense
 
325.8

 
231.0

 
217.2

Tax benefit related to share-based compensation expense
 
94.5

 
61.3

 
55.9

Reduction in income
 
$
231.3

 
$
169.7

 
$
161.3

Included in share-based compensation expense for the years ended December 31, 2013, 2012 and 2011 was compensation expense related to non-qualified stock options of $197.6 million, $155.2 million and $154.4 million, respectively. Share-based compensation cost included in inventory was $1.8 million and $1.2 million at December 31, 2013 and 2012, respectively. We do not recognize a deferred tax asset for excess tax benefits that have not been realized and have adopted the tax law method as our accounting policy regarding the ordering of tax benefits to determine whether an excess tax benefit has been realized.
Stock Options:    Cash received from stock option exercises for the years ended December 31, 2013, 2012 and 2011 was $551.6 million, $476.2 million and $166.5 million, respectively, and the excess tax benefit recognized was $169.4 million, $49.3 million and $31.1 million, respectively. As of December 31, 2013, there was $463.2 million of total unrecognized compensation cost related to stock options granted under the plans. That cost will be recognized over an expected remaining weighted-average period of 2.2 years.
The weighted-average grant date fair value of the stock options granted during the years ended December 31, 2013, 2012 and 2011 was $40.44 per share, $19.33 per share and $17.09 per share, respectively. We estimated the fair value of options granted using a Black-Scholes option pricing model with the following assumptions:
 
 
2013
 
2012
 
2011
Risk-free interest rate
 
0.68% - 1.70%
 
0.21% - 1.23%
 
0.21% - 2.20%
Expected volatility
 
27% - 35%
 
27% - 30%
 
27% - 33%
Weighted average expected volatility
 
31%
 
28%
 
29%
Expected term (years)
 
5.03 - 5.50
 
1.30 - 5.17
 
1.80 - 5.20
Expected dividend yield
 
0%
 
0%
 
0%
The risk-free interest rate is based on the U.S. Treasury zero-coupon curve. Expected volatility of stock option awards is estimated based on the implied volatility of our publicly traded options with settlement dates of six months. The use of implied volatility was based upon the availability of actively traded options on our common stock and the assessment that implied volatility is more representative of future stock price trends than historical volatility. The expected term of an employee share option is the period of time for which the option is expected to be outstanding. We made a determination of expected term by analyzing employees' historical exercise experience from its history of grants and exercises in our option database and management estimates. Forfeiture rates are estimated based on historical data.

86
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


The following table summarizes all stock option activity for the year ended December 31, 2013:
 
 
Options
 
Weighted
Average Exercise
Price Per Option
 
Weighted
Average Remaining
Contractual
Term (Years)
 
Aggregate
Intrinsic Value
(In Millions)
Outstanding at December 31, 2012
 
42.6

 
$
58.31

 
6.9
 
$
860.3

Changes during the Year:
 
 
 
 
 
 
 
 
Granted
 
9.6

 
131.96

 
 
 
 

Exercised
 
(11.5
)
 
54.23

 
 
 
 

Forfeited
 
(1.1
)
 
73.96

 
 
 
 

Expired
 
—

 
56.74

 
 
 
 

Outstanding at December 31, 2013
 
39.6

 
$
76.94

 
7.1
 
$
3,643.4

Vested at December 31, 2013 or expected to vest in the future
 
38.9

 
$
76.46

 
7.0
 
$
3,595.3

Vested at December 31, 2013
 
17.0

 
$
54.81

 
5.3
 
$
1,945.6

The total fair value of shares vested during the years ended December 31, 2013, 2012 and 2011 was $159.3 million, $144.1 million and $162.8 million, respectively. The total intrinsic value of stock options exercised during the years ended December 31, 2013, 2012 and 2011 was $814.7 million, $293.5 million and $147.9 million, respectively. We primarily utilize newly issued shares to satisfy the exercise of stock options.
Restricted Stock Units:    We issue RSU, under our equity program in order to provide an effective incentive award with a strong retention component. Equity awards may, at the option of employee participants, be divided between stock options and RSUs. The employee may choose between alternate Company defined mixes of stock options and RSUs, with the number of options to be granted reduced by four for every one RSU to be granted. Information regarding the Company's RSUs for the years ended December 31, 2013 and 2012 is as follows:
Nonvested RSUs
 
Share
Equivalent
 
Weighted
Average
Grant Date
Fair Value
Nonvested at December 31, 2012
 
4.5

 
$
66.20

Changes during the period:
 
 
 
 
Granted
 
1.8

 
124.96

Vested
 
(0.8
)
 
60.17

Forfeited
 
(0.4
)
 
63.20

Nonvested at December 31, 2013
 
5.1

 
$
88.15

As of December 31, 2013, there was $246.5 million of total unrecognized compensation cost related to non-vested awards of RSUs. That cost is expected to be recognized over a weighted-average period of 1.5 years. The Company primarily utilizes newly issued shares to satisfy the vesting of RSUs.

87
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Performance-Based Restricted Stock Units:    The Company's performance-based restricted stock units vest contingent upon the achievement of pre-determined performance-based milestones typically related to product development. The following table summarizes the Company's performance-based restricted stock unit activity for the year ended December 31, 2013 (shares in thousands):
Nonvested Performance-Based RSUs
 
Share Equivalent
 
Weighted Average Grant Date Fair Value
Nonvested at December 31, 2012
 
26

 
$
60.80

Changes during the period:
 
 
 
 
Granted
 
46

 
119.02

Vested
 
(6
)
 
60.78

Forfeited
 
(8
)
 
64.26

Non-vested at December 31, 2013
 
58

 
$
106.87

As of December 31, 2013, there was $3.9 million of total unrecognized compensation cost related to non-vested awards of performance-based RSUs that is expected to be recognized over a weighted-average period of 1.7 years.
15.   Employee Benefit Plans
We sponsor an employee savings and retirement plan, which qualifies under Section 401(k) of the Internal Revenue Code, as amended (the Code) for our U.S. employees. Our contributions to the U.S. savings plan are discretionary and have historically been made in the form of our common stock (See Note 12). Such contributions are based on specified percentages of employee contributions up to 6% of eligible compensation or a maximum permitted by law. Total expense for contributions to the U.S. savings plans were $32.6 million, $19.3 million and $20.7 million in 2013, 2012 and 2011, respectively.
We also sponsor defined contribution plans in certain foreign locations. Participation in these plans is subject to the local laws that are in effect for each country and may include statutorily imposed minimum contributions. We also maintain defined benefit plans in certain foreign locations for which the obligations and the net periodic pension costs were determined to be immaterial at December 31, 2013.
In 2000, our Board of Directors approved a deferred compensation plan. The plan was frozen effective as of December 31, 2004, and no additional contributions or deferrals can be made to that plan. Accrued benefits under the frozen plan will continue to be governed by the terms under the tax laws in effect prior to the enactment of Section 409A. In February 2005, our Board of Directors adopted the Celgene Corporation 2005 Deferred Compensation Plan, effective as of January 1, 2005, and amended the plan in February 2008. This plan operates as our ongoing deferred compensation plan and is intended to comply with the American Jobs Creation Act of 2004, Section 409A. Eligible participants, which include certain top-level executives as specified by the plan, can elect to defer up to an amended 90% of the participant's base salary, 100% of cash bonuses and equity compensation allowed under Section 409A of the Code. Company contributions to the deferred compensation plan represent a match to certain participants' deferrals up to a specified percentage, which currently ranges from 10% to 20%, depending on the employee's position as specified in the plan, of the participant's base salary. We recorded expenses of $0.6 million, $0.6 million and $0.7 million related to the deferred compensation plans in 2013, 2012 and 2011, respectively. The Company's matches are fully vested upon contribution. All other Company contributions to the plan do not vest until the specified requirements are met. At December 31, 2013 and 2012, we had a deferred compensation liability included in other non-current liabilities in the Consolidated Balance Sheets of approximately $73.7 million and $59.8 million, respectively, which included the participant's elected deferral of salaries and bonuses, the Company's matching contribution and earnings on deferred amounts as of that date. The plan provides various alternatives for the measurement of earnings on the amounts participants defer under the plan. The measuring alternatives are based on returns of a variety of funds that offer plan participants the option to spread their risk across a diverse group of investments.
In 2003, we established a Long-Term Incentive Plan (LTIP) designed to provide key officers and executives with performance-based incentive opportunities contingent upon achievement of pre-established corporate performance objectives covering a three-year period. We currently have three separate three-year performance cycles running concurrently ending December 31, 2014, 2015 and 2016. Performance measures for each of the performance cycles are based on the following components: 37.5% on non-GAAP earnings per share (as defined in the LTIP); 37.5% on total non-GAAP revenue (as defined in the LTIP); and 25% on relative total shareholder return, which is a measurement of our stock price performance during the year compared with a group of other companies in the biopharmaceutical industry.

88
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Payouts may be in the range of 0% to 200% of the participant's salary for the LTIPs. The estimated payout for the concluded 2013 Plan is $28.9 million, which is included in accrued expenses at December 31, 2013, and the maximum potential payout, assuming maximum objectives are achieved for the 2014, 2015 and 2016 Plans are $19.6 million, $22.6 million and$25.2 million, respectively. Such awards are payable in cash or common stock or a mixture of cash and common stock, which will be determined by the Compensation Committee at the time of award delivery. For awards payable in common stock, the number of shares is determined using the average closing price for the 30 trading days prior to the beginning of the cycle. The Compensation Committee may determine that payments made in common stock are restricted from trading for a period of three years. We accrue the long-term incentive liability over each three-year cycle. Prior to the end of a three-year cycle, the accrual is based on an estimate of our level of achievement during the cycle. Upon a change in control, participants will be entitled to an immediate payment equal to their target award or, if higher, an award based on actual performance through the date of the change in control. For the years ended December 31, 2013, 2012 and 2011, we recognized expense related to the LTIP of $40.8 million, $10.1 million and $12.0 million, respectively.
16.   Income Taxes
The income tax provision is based on income before income taxes as follows:
 
 
2013
 
2012
 
2011
U.S.
 
$
36.8

 
$
279.6

 
$
416.8

Non-U.S.
 
1,628.6

 
1,401.9

 
1,002.7

Income before income taxes
 
$
1,665.4

 
$
1,681.5

 
$
1,419.5

For the years ended December 31, 2013, 2012, and 2011, U.S. income before income taxes reflects charges related to share-based compensation, up-front collaboration payments, asset impairments and acquisitions, which increased in the United States from 2011 to 2013. These charges were less significant outside the United States in those years.
The provision (benefit) for taxes on income is as follows:
 
 
2013
 
2012
 
2011
United States:
 
 
 
 
 
 
Taxes currently payable:
 
 
 
 
 
 
Federal
 
$
352.6

 
$
101.5

 
$
100.8

State and local
 
45.4

 
(31.8
)
 
33.2

Deferred income taxes
 
(245.1
)
 
107.3

 
(67.1
)
Total U.S. tax provision
 
152.9

 
177.0

 
66.9

International:
 
 
 
 
 
 
Taxes currently payable
 
64.1

 
55.4

 
53.8

Deferred income taxes
 
(1.5
)
 
(7.1
)
 
(18.6
)
Total international tax provision
 
62.6

 
48.3

 
35.2

Total provision
 
$
215.5

 
$
225.3

 
$
102.1

Amounts are reflected in the preceding tables based on the location of the taxing authorities. We do not provide for U.S. federal or state income taxes on unremitted earnings of our international subsidiaries that are indefinitely invested outside the United States. As of December 31, 2013, we have not made a U.S. tax provision on $6.129 billion of unremitted earnings of our international subsidiaries. As these earnings are expected to be reinvested overseas indefinitely, it is not practicable to compute the estimated deferred tax liability on these earnings.
Deferred taxes arise because of different treatment between financial statement accounting and tax accounting, known as temporary differences. We record the tax effect on these temporary differences as deferred tax assets (generally items that can be used as a tax deduction or credit in future periods) or deferred tax liabilities (generally items for which we received a tax deduction but that have not yet been recorded in the Consolidated Statements of Income). We periodically evaluate the likelihood of the realization of deferred tax assets, and reduce the carrying amount of these deferred tax assets by a valuation allowance to the extent we believe a portion will not be realized. We consider many factors when assessing the likelihood of future realization of deferred tax assets, including our recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income, the carryforward periods available to us for tax reporting purposes, tax planning strategies and other relevant factors. Significant judgment is required

89
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


in making this assessment. At December 31, 2013 and 2012, it was more likely than not that we would realize our deferred tax assets, net of valuation allowances. The principal valuation allowance at December 31, 2013 relates to deferred tax assets generated by certain fair value adjustments, and at December 31, 2012 relates to Swiss deferred tax assets.
In 2012, we concluded that approximately $900.0 million of our foreign earnings may not be required for use in offshore operations and may be available for use in the United States. These earnings are not treated as permanently reinvested, and our deferred tax liabilities include $316.5 million for the estimated U.S. federal and state income taxes that may be incurred should these earnings be repatriated. In drawing this conclusion, we considered our future sources of funds as well as our global operating and strategic liquidity needs, including common share repurchase activities and expansion of our commercial, research, manufacturing and administrative infrastructure worldwide.
At December 31, 2013 and 2012 the tax effects of temporary differences that give rise to deferred tax assets and liabilities were as follows:
 
 
2013
 
2012
 
 
Assets
 
Liabilities
 
Assets
 
Liabilities
Federal and state NOL carryforwards
 
$
5.3

 
$
—

 
$
12.6

 
$
—

Deferred revenue
 
2.3

 
—

 
2.3

 
—

Capitalized research expenses
 
6.1

 
—

 
37.1

 
—

Tax credit carryforwards
 
4.2

 
—

 
4.1

 
—

Non-qualified stock options
 
183.3

 
—

 
164.4

 
—

Plant and equipment, primarily differences in depreciation
 
—

 
(9.6
)
 
—

 
(13.6
)
Inventory
 
8.4

 
—

 
6.3

 
—

Other assets
 
32.7

 
(0.7
)
 
26.8

 
(9.3
)
Intangibles
 
311.9

 
(1,005.0
)
 
187.2

 
(1,069.2
)
Accrued and other expenses
 
161.3

 
—

 
116.1

 
—

Unremitted earnings
 
—

 
(316.5
)
 
—

 
(316.5
)
Unrealized (gains) losses on securities
 
—

 
(71.4
)
 
17.3

 
—

Subtotal
 
715.5

 
(1,403.2
)
 
574.2

 
(1,408.6
)
Valuation allowance
 
(35.5
)
 
—

 
(41.7
)
 
—

Total deferred taxes
 
$
680.0

 
$
(1,403.2
)
 
$
532.5

 
$
(1,408.6
)
Net deferred tax asset (liability)
 
 

 
$
(723.2
)
 
 

 
$
(876.1
)
At December 31, 2013 and 2012, deferred tax assets and liabilities were classified on the Company's balance sheet as follows:
 
 
2013
 
2012
Current assets
 
$
25.3

 
$
93.2

Other assets (non-current)
 
56.4

 
49.1

Current liabilities
 
—

 
—

Other non-current liabilities
 
(804.9
)
 
(1,018.4
)
Net deferred tax asset (liability)
 
$
(723.2
)
 
$
(876.1
)

90
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Reconciliation of the U.S. statutory income tax rate to the Company's effective tax rate is as follows:
Percentages
 
2013
 
2012
 
2011
U.S. statutory rate
 
35.0
 %
 
35.0
 %
 
35.0
 %
Foreign tax rate differences
 
(28.8
)%
 
(28.0
)%
 
(21.1
)%
Unremitted earnings
 
—
 %
 
18.8
 %
 
—
 %
State taxes, net of federal benefit
 
0.6
 %
 
1.1
 %
 
0.7
 %
Change in valuation allowance
 
1.2
 %
 
0.4
 %
 
—
 %
Acquisition related differences
 
3.7
 %
 
3.8
 %
 
(3.5
)%
Changes in uncertain tax positions
 
0.8
 %
 
(19.3
)%
 
(2.5
)%
Other
 
0.4
 %
 
1.6
 %
 
(1.4
)%
Effective income tax rate
 
12.9
 %
 
13.4
 %
 
7.2
 %
In our reconciliation of the U.S. statutory income tax rate to our effective tax rate, we disclose changes in uncertain tax positions which include the effect of settlements, expirations of statutes of limitations, and other changes in prior year tax positions.
We have operations in many foreign tax jurisdictions, which impose income taxes at different rates than the United States. The impact of these rate differences is included in the foreign tax rate differences that we disclose in our reconciliation of the U.S. statutory income tax rate to our effective tax rate. The benefit related to foreign tax rate differences primarily results from our commercial operations in Switzerland, which include significant research and development and manufacturing for worldwide markets. We operate under an income tax agreement in Switzerland through 2015 that provides a complete exemption from Swiss income taxes on predominantly all of our operations in Switzerland. In 2013, we entered into a new agreement with the Swiss tax authorities which reflects the planned expansion of our Swiss operations and will result in substantially similar tax benefits through the end of 2024. The impact of the Swiss tax agreement is reflected in our effective tax rate. The difference between the maximum statutory Swiss income tax rate (approximately 19.7% in 2013, 21.0% in 2012 and 22.0% in 2011) and our Swiss income tax rate under the tax agreement resulted in a reduction in the 2013, 2012 and 2011 effective tax rates of 25.1, 26.6 and 20.2 percentage points, respectively. The increase in benefits reflected in the foreign tax rate differences from 2011 to 2013 results from growth in our Non-U.S. operations and an increase in the proportion of consolidated income before income taxes from Non-U.S. operations.
At December 31, 2013, we had combined state NOL carryforwards of approximately $485.6 million that will expire in the years 2014 through 2033. We also have research and experimentation credit carryforwards of approximately $10.0 million that will expire in the years 2018 through 2027. Excess tax benefits related to stock option deductions incurred after December 31, 2005 are required to be recognized in the period in which the tax deduction is realized through a reduction of income taxes payable. As a result, we have not recorded deferred tax assets for certain stock option deductions included in our state NOL carryforwards and research and experimentation credit carryforwards. At December 31, 2013, deferred tax assets have not been recorded on state NOL carryforwards of approximately $311.3 million and for research and experimentation credits of approximately $5.7 million. These stock option tax benefits will be recorded as an increase in additional paid-in capital when realized.
We realized stock option deduction benefits in 2013, 2012 and 2011 for income tax purposes and have increased additional paid-in capital in the amount of approximately $170.0 million, $55.8 million and $25.1 million, respectively. We have recorded deferred income taxes as a component of accumulated other comprehensive income resulting in a deferred income tax liability at December 31, 2013 of $71.4 million and a deferred income tax asset at December 31, 2012 of $17.3 million.
Our tax returns are under routine examination in many taxing jurisdictions. The scope of these examinations includes, but is not limited to, the review of our taxable presence in a jurisdiction, our deduction of certain items, our claims for research and development credits, our compliance with transfer pricing rules and regulations and the inclusion or exclusion of amounts from our tax returns as filed. During 2012, we settled an examination with the U.S. Internal Revenue Service (IRS) for the years ended December 31, 2006, 2007 and 2008. Our U.S. federal income tax returns have now been audited by the IRS through the year ended December 31, 2008. Tax returns for the years ended December 31, 2009, 2010, and 2011 are currently under examination by the IRS. We are also subject to audits by various state and foreign taxing authorities, including, but not limited to, most U.S. states and major European and Asian countries where we have operations.
We regularly reevaluate our tax positions and the associated interest and penalties, if applicable, resulting from audits of federal, state and foreign income tax filings, as well as changes in tax law (including regulations, administrative pronouncements, judicial precedents, etc.) that would reduce the technical merits of the position to below more likely than not. We believe that our accruals for tax liabilities are adequate for all open years. Many factors are considered in making these evaluations, including past history, recent interpretations of tax law and the specifics of each matter. Because tax regulations are subject to interpretation and tax litigation is inherently uncertain, these evaluations can involve a series of complex judgments about future events and can rely

91
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


heavily on estimates and assumptions. We apply a variety of methodologies in making these estimates and assumptions, which include studies performed by independent economists, advice from industry and subject experts, evaluation of public actions taken by the IRS and other taxing authorities, as well as our industry experience. These evaluations are based on estimates and assumptions that have been deemed reasonable by management. However, if management's estimates are not representative of actual outcomes, our results of operations could be materially impacted.
Unrecognized tax benefits, generally represented by liabilities on the consolidated balance sheet and all subject to tax examinations, arise when the estimated benefit recorded in the financial statements differs from the amounts taken or expected to be taken in a tax return because of the uncertainties described above. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
 
 
2013
 
2012
Balance at beginning of year
 
$
174.7

 
$
596.8

Increases related to prior year tax positions
 
25.5

 
—

Decreases related to prior year tax positions
 
—

 
—

Increases related to current year tax positions
 
30.2

 
38.1

Settlements
 
(10.3
)
 
(450.6
)
Lapse of statute
 
(0.9
)
 
(9.6
)
Balance at end of year
 
$
219.2

 
$
174.7

These unrecognized tax benefits relate primarily to issues common among multinational corporations. If recognized, unrecognized tax benefits of approximately $198.9 million would have a net impact on the effective tax rate. We account for interest and penalties related to uncertain tax positions as part of our provision for income taxes. Accrued interest at December 31, 2013 and 2012 is approximately $23.2 million and $18.0 million, respectively.
We have recorded changes in the liability for unrecognized tax benefits for current and prior year tax positions related to ongoing income tax audits in various taxing jurisdictions. During 2012, we settled examinations with various taxing authorities related to tax positions taken in prior years. The settlements resulted in a decrease in our gross unrecognized tax benefits of $450.6 million, exclusive of interest, and a reduction to income tax expense of $318.6 million. The decrease in unrecognized tax benefits and the reduction to income tax expense reflect the impact of the settlements on tax returns filed in various taxing jurisdictions for the years examined as well as certain adjustments to unrecognized tax benefits for years subsequent to the examination period.
The liability for unrecognized tax benefits is expected to increase in the next 12 months relating to operations occurring in that period. Any settlements of examinations with taxing authorities or statute of limitations expirations would likely result in a decrease in our unrecognized tax benefits. Our estimates of tax benefits and potential tax benefits may not be representative of actual outcomes, and variation from such estimates could materially affect our financial statements in the period of settlement or when the statutes of limitations expire.
17.   Collaboration Agreements
We have entered into a variety of alliances in the ordinary course of our business. Although we do not consider any individual alliance to be material, certain of the more notable alliances are described below. The summarized financial information related to our alliances is presented in tabular format after the description of alliances:

Novartis Pharma AG:    We licensed the worldwide rights (excluding Canada) regarding certain chirally pure forms of methylphenidate for FOCALIN® and FOCALIN XR® to Novartis. We also licensed to Novartis the rights related to long-acting formulations of methylphenidate and dex-methylphenidate products which are used in FOCALIN XR® and RITALIN LA®. We sell FOCALIN® to Novartis and receive royalties of between 30% and 35% on Novartis' sales of FOCALIN XR® and RITALIN LA®. The arrangement with Novartis will continue until the later of (i) the tenth anniversary of the first commercial launch on a country-by-country basis or (ii) when the last applicable patent expires with respect to that country. At the expiration date, we will grant Novartis a perpetual, non-exclusive, royalty-free license to make, have made, use, import and sell products using the dex-methylphenidate and long-acting formulation technology. The agreement may be terminated by Novartis upon 12 months prior written notice or by either party upon, among other things, the breach of a material obligation by the other party or in the event of withdrawal of the dex-methylphenidate product or RITALIN® product from the market because of regulatory mandate.

If the agreement is terminated by us, then all licenses granted to Novartis under the agreement will terminate and Novartis will grant us a non-exclusive license to certain of their intellectual property related to the compounds and products. If the agreement is terminated by Novartis then all licenses granted to Novartis under the agreement will terminate.

92
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)



When a generic version of dexmethylphenidate hydrochloride enters the market, we expect Novartis' sales of FOCALIN XR® to decrease and therefore our royalties will also decrease. A generic version of RITALIN LA® was introduced in January 2012 and resulted in a decrease in royalties we received from Novartis related to sales of RITALIN LA®.

Acceleron Pharma (Acceleron):    We have worldwide strategic collaboration agreements with Acceleron for the joint development and commercialization of sotatercept (ACE-11) and ACE-536. ACE-11 is currently in phase II studies for treatment of renal anemia, diamond blackfan anemia, beta-thalassemia and MDS, and ACE-536 is currently in phase II studies for beta-thalassemia and MDS.

On January 1, 2013 we became responsible for the payment of all development costs related to ACE-11 and ACE-536 and have recognized development expenses as research and development expense as they were incurred.

With respect to the ACE-11 program, Acceleron is eligible to receive of up to $367.0 million in development, regulatory approval and sales-based milestones and up to an additional $348.0 million for each of three specific discovery stage programs. We also agreed to co-promote the developed products in North America. Acceleron will receive tiered royalties on worldwide net sales upon the commercialization of a development compound.

With respect to the ACE-536 program, we have an exclusive, worldwide, royalty-bearing license to ACE-536 and future Acceleron products for the treatment of anemia. We also agreed to co-promote the products in the United States, Canada and Mexico. Acceleron is eligible to receive development, regulatory approval and sales-based milestones of up to $217.5 million for ACE-536 and up to an additional $170.8 million for the first discovery stage program, $148.8 million for the second discovery stage program and $125.4 million for each additional discovery stage program thereafter. Acceleron will receive tiered royalties on worldwide net sales upon the commercialization of a development compound.

The ACE-11 agreement may be terminated by us, at our sole discretion, at any time or by either party, among other things, upon a material breach by the other party. The ACE-536 agreement may be terminated by us, at our sole discretion, after completion of the initial phase II clinical trial or by either party, among other things, upon a material breach by the other party.

Agios Pharmaceuticals, Inc. (Agios):    During 2010, we entered into a discovery and development collaboration and license agreement with Agios that focuses on cancer metabolism targets and the discovery, development and commercialization of associated therapeutics. We have an exclusive option to license any potential products that result from the Agios cancer metabolism research platform through the end of phase I clinical trials.

With respect to each product that we choose to license, Agios could receive up to approximately $120.0 million upon achievement of certain milestones and other payments plus royalties on sales, and Agios may also participate in the development and commercialization of certain products in the United States. Our option to license a product will terminate on April 14, 2015.

We have determined that Agios is a variable interest entity; however, we are not the primary beneficiary of this arrangement. Although we would have the right to receive the benefits from the collaboration and license agreement, we do not have the power to direct the activities under the collaboration and license agreement as Agios has the decision-making authority for this collaboration until we exercise our option to license a product. Our interest in Agios is limited to our equity ownership and we do not have any obligations or rights to the future losses or returns of Agios beyond this ownership.

Epizyme Inc. (Epizyme):    In April 2012, we entered into a collaboration and license agreement with Epizyme to discover, develop and commercialize novel therapeutic compounds by inhibiting histone methyltransferases (HMT), an important epigenetic target class. Under the terms of the agreement, we made an upfront payment to Epizyme and also made an equity investment in Epizyme and received an exclusive option to license rights outside the United States to HMT inhibitors targeting the DOT1L HMT, including the Company’s product candidate EPZ-5676 and each Epizyme compound associated with such licensed compounds during the option term. If the option is exercised, Epizyme could receive up to $165.0 million in milestone payments associated with each Epizyme compound developed to inhibit each distinct HMT target under the collaboration plus royalties on sales. Epizyme will have the sole responsibility to develop and commercialize compounds in the United States.

The option term expires on either July 9, 2015 (or July 9, 2016 if we extend the option term for a fourth year and pay an option extension fee). Further, if an HMT target or targets are selected, the collaboration agreement will expire upon the expiration of all applicable royalty terms with respect to all licensed Epizyme compounds. Upon the expiration of the collaboration agreement, we will have a fully paid-up, royalty-free license to use Epizyme intellectual property to manufacture, market, use and sell such licensed Epizyme compounds outside the United States.


93
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


bluebird bio, Inc. (bluebird):  In March 2013, we entered into a collaboration agreement with bluebird to discover, develop and commercialize novel disease-altering gene therapies in oncology. The collaboration focuses on applying gene therapy technology to modify a patient’s own T-cells, known as chimeric antigen receptor (CAR) T-cells, to target and destroy cancer cells. The collaboration has the potential to lead to the development of multiple CAR T-cell products. We have an option to license any products resulting from the collaboration after the completion of a phase I clinical study by bluebird for each product.

We made an upfront payment and may be obligated to pay up to $225.0 million per licensed product in aggregate potential option fees and clinical and regulatory milestone payments. bluebird also has the option to participate in the development and commercialization of any licensed products resulting from the collaboration through a 50/50 co-development and profit share in the United States in exchange for a reduction of milestone payments. Royalties would also be paid to bluebird in regions where there is no profit share, including in the United States, if bluebird declines to exercise their co-development and profit sharing rights. 

The agreement has a termination date of March 19, 2016 and we have the option to extend the agreement until March 19, 2019 with the payment of extension fees.  Further, we have the ability to terminate the collaboration at our discretion upon 90 days written notice to bluebird.  If a product is optioned, the parties will enter into a pre-negotiated license agreement and potentially a co-development agreement should bluebird exercise its option to participate in the development and commercialization in the United States.  The license agreement, if not terminated sooner, would expire upon the expiration of all applicable royalty terms under the agreement with respect to the particular product, and the co-development agreement, if not terminated sooner, would expire when the product is no longer being developed or commercialized in the United States.  Upon the expiration of a particular license agreement, we will have a fully paid-up, royalty-free license to use bluebird intellectual property to manufacture, market, use and sell such licensed product.

FORMA Therapeutics Holdings, LLC (FORMA): In April 2013, we entered into a collaboration arrangement with FORMA under which the parties will discover, develop and commercialize drug candidates to regulate protein homeostasis targets. Protein homeostasis, which is important in oncology, neurodegenerative and other disorders, involves a tightly regulated network of pathways controlling the biogenesis, folding, transport and degradation of proteins.

The collaboration was launched with an upfront payment that enables us to evaluate selected targets and lead assets in protein homeostasis pathways during the pre-clinical phase. We will have the right to obtain exclusive licenses with respect to the development and commercialization of multiple drug candidates outside of the United States, in exchange for research and early development payments of up to approximately $200.0 million. FORMA is incentivized to advance the full complement of drug candidates through Phase I, and we will be responsible for all further global clinical development for each licensed candidate.  FORMA is eligible to receive up to an additional $315.0 million in potential payments based upon development, regulatory and sales objectives for the first ex-U.S. license. FORMA is also eligible to receive potential payments for successive licenses, which escalate for productivity, increasing up to a maximum of an additional $430.0 million per program.  In addition, FORMA will receive royalties on ex-U.S. sales and additional payments if multiple drug candidates reach defined cumulative sales objectives. The collaboration arrangement includes provisions for us to obtain rights with respect to development and commercialization of drug candidates in the United States in exchange for additional payments.

Under the collaboration arrangement, the parties will perform initial research and development for a term of four years. If, during such research term, a drug candidate meets certain criteria, then the parties will enter into a pre-negotiated license agreement and the collaboration will continue until all license agreements and all applicable royalty terms have expired. Each license agreement, if not terminated sooner would expire upon the expiration of all applicable royalty terms under such agreement. Upon the expiration of each license agreement, we will have an exclusive, fully-paid, royalty-free license to use the applicable FORMA intellectual property to manufacture, market, use and sell the product developed under such agreement outside of the United States. On October 7, 2013, we entered into the first ex-US license with FORMA and paid the applicable upfront payment under such license.

MorphoSys AG (MorphoSys):  In June 2013, we signed a collaboration, license and equity purchase agreement with MorphoSys to jointly develop MOR202 globally and to co-promote MOR202 in Europe.  In August 2013, the transaction became effective. MOR202 is a fully human monoclonal antibody targeting CD38 to treat patients with multiple myeloma and certain leukemias. MOR202 is currently being evaluated in a phase I/IIa trial in patients with relapsed/refractory multiple myeloma.

MorphoSys could receive up to EUR 511.0 million (approximately $664.5 million) in development, regulatory and sales milestones and tiered royalties on net sales of MOR202 outside the co-promotion territory.  In the co-promotion territory, MorphoSys retains a 50/50 profit sharing right on MOR202 in exchange for paying one third of the MOR202 development costs. Should MorphoSys choose to opt out of its co-promotion rights, MorphoSys would receive tiered royalties on net sales of MOR202 globally.


94
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


The agreement may be terminated at our discretion upon six months written notice to MorphoSys, or by either party upon material breach of the other party. Upon the expiration of the agreement, we will have a fully paid-up, irrevocable, perpetual, non-terminable license to use the intellectual property licensed from MorphoSys to research, develop, make, commercialize, use and sell MOR202.

Acetylon Pharmaceuticals, Inc. (Acetylon): In July 2013, we entered into a collaboration and option agreement with Acetylon. Under the agreement, the parties will support the development of Acetylon's portfolio of oral, selective HDAC inhibitors in oncology, hematology, immunology and neurologic disease indications. In addition, we have rights to receive certain research and development services from Acetylon and an exclusive right to acquire Acetylon at a later date at a purchase price based upon future independent company valuations.

The collaboration focuses on the continued clinical advancement of Acetylon's lead candidate, ACY-1215, an HDAC6 inhibitor being developed for hematological malignancies, ACY-738 for neurological diseases, an HDAC1/2 inhibitor and a yet unnamed project, spanning cancer and non-cancer disease indications. Under the agreement, we made an upfront payment to Acetylon, which included a fee for entering into the collaboration, fees for the exclusive right to acquire Acetylon and the rights to receive certain research and development services from Acetylon. During the term of the agreement, Acetylon will retain control of its drug development programs. If we exercise our right to acquire Acetylon, in addition to the purchase price based upon independent company valuations to be paid at the time of the acquisition, Acetylon shareholders will be eligible to receive potential future milestone payments for approvals, or additional indications, of drugs developed by Acetylon and for accomplishing defined sales targets. If all the milestones are achieved, the aggregate amount of the milestone payments would be $1.100 billion.

The agreement has an expiration date of December 31, 2015 and we have the right to extend the agreement until either June 30, 2016 or December 31, 2016 with the payment of an extension fee. Further, we have the ability to terminate the agreement at our discretion upon written notice to Acetylon.

OncoMed Pharmaceuticals, Inc. (OncoMed): On December 2, 2013, we entered into a collaboration agreement to jointly develop and commercialize up to six anti-cancer stem cell (CSC) product candidates from OncoMed’s biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). OncoMed will control and conduct initial clinical studies. We will have an option to license worldwide rights to up to six novel anti-CSC therapeutic candidates commencing upon the completion of enrollment of patients in a phase I trial (and with respect to Demcizumab, a phase II trial) and ending 60 days after delivery by OncoMed of the applicable data package for each therapeutic candidate, subject to certain extensions.  We will also have research, development and commercialization rights to small molecule compounds in another cancer stem cell pathway, with OncoMed eligible to receive milestones and royalties on any resulting products.

Demcizumab is currently in three phase Ib clinical studies in combination with standard-of-care therapeutics, including a trial in patients with first-line advanced pancreatic cancer. Subsequent to the exercise of our option rights, the parties will co-develop demcizumab and share global development costs on a one-third OncoMed and two-thirds Celgene split. Outside the United States, we would lead development and commercialization efforts, with OncoMed eligible to receive milestones and tiered royalties on sales outside the United States.

In addition to demcizumab, the collaboration includes up to five preclinical- or discovery-stage biologics programs: OncoMed’s anti-DLL4/VEGF bispecific antibody and up to four additional biologics programs targeting either the RSPO-LGR CSC pathway or another CSC pathway. We have exclusive options on these programs during or after completion of certain phase I clinical trials to be conducted by OncoMed, which if exercised, contain U.S. profit sharing and co-commercialization terms, plus one-third OncoMed and two-thirds Celgene global development cost-sharing and royalties outside the profit-sharing territory.

The collaboration agreement also includes option exercise payments and payments for achievement of development, regulatory and commercial milestones, paid on a per-program basis. For the demcizumab program, these contingent payments could total up to approximately $790.0 million, and include a payment for achievement of predetermined safety criteria in phase II clinical trials. For the anti-DLL4/VEGF bispecific antibody program, contingent payments could total up to $505.0 million. For the other four programs, each program is eligible for up to approximately $440.0 million of contingent payments. OncoMed could also receive more than $100.0 million in contingent payments for the small molecule program.

The collaboration agreement may be terminated by us on a program-by-program basis upon one hundred twenty (120) days prior written notice before exercise of that program option, and after such program option exercise, by either party for material breach by the other party. With certain exceptions, the collaboration agreement expires upon the later of (a) the last-to-expire option term and (b) if one or more options are exercised, the termination or expiration of the last to expire agreement with respect to such exercised option.


95
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Other Collaboration Arrangements in 2013:    In addition to the collaboration arrangements described above, we entered into a number of collaborative arrangements during 2013 that resulted in $52.1 million of assets for investments in equity or other assets and research and development expenses of $149.0 million. These additional arrangements entered into during 2013 include the potential for future milestone payments of up to an aggregate $373.0 million related to the attainment of specified development and regulatory approval milestones over a period of several years. Our obligation to fund these efforts is contingent upon continued involvement in the programs and/or the lack of any adverse events which could cause the discontinuance of the programs. We do not consider these collaboration arrangements to be individually significant at this time.
Summarized financial information related to our collaboration agreements is presented below:
 
 
Year ended December 31,
 
As of December 31,1
 
 
Research and Development Expense
 
 
 
 
 
 
 
 
Upfront Fees
Milestones
Extension of Agreements
Amortization of Prepaid Research and Development
 
Additional Equity Investments Made
 
Intangible Asset Balance
Equity Investment Balance
Percentage of Outstanding Equity
Acceleron
2013
$
—

$
17.0

$
—

$
—

 
$
10.0

 
$
—

$
127.2

11
%
 
2012
—

—

—

—

 
—

 
—

30.5

12
%
 
2011
25.0

14.5

—

—

 
25.0

 
 
 
 
 
2010 and prior
45.0

13.0

—

—

 
5.5

 
 
 
 
Agios
2013
—

—

20.0

—

 
12.8

 
—

113.0

15
%
 
2012
—

—

—

—

 
—

 
—

37.5

17
%
 
2011
—

—

20.0

—

 
28.7

 
 
 
 
 
2010 and prior
121.2

—

—

—

 
8.8

 
 
 
 
Epizyme
2013
—

25.0

—

—

 
1.0

 
—

69.4

12
%
 
2012
65.0

—

—

—

 
25.0

 
—

25.0

15
%
bluebird
2013
74.7

—

—

—

 
—

 
0.2

—

—
%
FORMA
2013
52.8

—

—

—

 
—

 
0.2

—

—
%
MorphoSys
2013
94.3

—

—

—

 
61.3

 
—

61.4

3
%
Acetylon
2013
50.0

—

—

4.3

 
10.0

 
35.7

25.0

10
%
 
2012
—

—

—

—

 
5.0

 
—

15.0

10
%
 
2011
—

—

—

—

 
10.0

 
 
 
 
Oncomed
2013
155.0

—

—

—

 
22.2

 
—

43.4

5
%
Other Collaboration Arrangements
2013
149.0

—

—

3.0

 
13.6

 
25.6

30.0

N/A

2012
113.5

5.4

—

0.2

 
13.6

 
27.3

29.9

N/A

2011
103.5

1.0

2.4

—

 
1.1

 
 
 
 
1 Year-end balance and percentage of outstanding equity are presented for the current and prior year.
18.   Commitments and Contingencies
Contingent Value Rights: In connection with the acquisition of Abraxis in 2010, CVRs were issued under a Contingent Value Rights Agreement, or CVR Agreement, entered into between Celgene and American Stock Transfer & Trust Company, LLC, as trustee. The CVRs are registered for trading on the NASDAQ Global Market under the symbol "CELGZ." The fair value of the liability of the Company related to payments under the CVR Agreement are subject to fluctuation based on trading prices for the publicly traded CVRs. Subsequent to the Abraxis Acquisition Date, we measured the contingent consideration represented by the CVRs at fair value with changes in fair value recognized in operating earnings. The fair value of our liability related to the CVRs was $118.1 million at the end of 2013 compared to $277.4 million at the end of 2012.

96
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Each holder of a CVR is entitled to receive a pro rata portion, based on the number of CVRs then outstanding, of each of the following contingent cash payments:
•
Milestone Payment #1.  $250.0 million upon FDA approval of ABRAXANE® for use in the treatment of NSCLC if such approval permits us to market ABRAXANE® with FDA approval that includes a progression-free survival, or PFS, claim, but only if this milestone is achieved no later than the fifth anniversary of the Merger.
•
Milestone Payment #2.  $400.0 million (if achieved no later than April 1, 2013) or $300.0 million (if achieved after April 1, 2013 and before the fifth anniversary of the Merger) upon FDA approval of ABRAXANE® for use in the treatment of pancreatic cancer, if such approval permits us to market ABRAXANE® with FDA approval that includes an overall survival claim.
•
Net Sales Payments.  For each full one-year period ending December 31 during the term of the CVR Agreement, which we refer to as a net sales measuring period (with the first net sales measuring period beginning January 1, 2011 and ending December 31, 2011):
◦
2.5% of the net sales of ABRAXANE® and the Abraxis pipeline products that exceed $1.000 billion but are less than or equal to $2.000 billion for such period, plus
◦
an additional amount equal to 5% of the net sales of ABRAXANE® and the Abraxis pipeline products that exceed $2.000 billion but are less than or equal to $3.000 billion for such period, plus
◦
an additional amount equal to 10% of the net sales of ABRAXANE® and the Abraxis pipeline products that exceed $3.000 billion for such period.
No payments will be due under the CVR Agreement with respect to net sales of ABRAXANE® and the Abraxis pipeline products after December 31, 2025, which we refer to as the net sales payment termination date, unless net sales for the net sales measuring period ending on December 31, 2025 are equal to or greater than $1.000 billion, in which case the net sales payment termination date will be extended until the last day of the first net sales measuring period subsequent to December 31, 2025 during which net sales of ABRAXANE® and the Abraxis pipeline products are less than $1.000 billion or, if earlier, December 31, 2030.
Milestone Payment #1 update: In October 2012, the FDA approved ABRAXANE® for the first-line treatment of locally advanced or metastatic NSCLC, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. The FDA approval was based on tumor response rates and did not result in the use of a marketing label that includes a progression-free survival claim, and accordingly, the CVR Milestone Payment #1, as described above, has not been achieved. This approval resulted in the related $1.172 billion intangible asset obtained from the Abraxis acquisition being reclassified in October 2012 from an acquired IPR&D intangible to an acquired developed product rights intangible asset and amortization commenced in October 2012.
Milestone Payment #2 update: In September 2013, the FDA approved ABRAXANE® for use in the treatment of pancreatic cancer, permitting us to market ABRAXANE® with a label that includes an overall survival claim. This approval resulted in the achievement of milestone #2 and the subsequent payment of $300.0 million to CVR holders in October 2013.
Leases:    We lease offices and research facilities under various operating lease agreements in the United States and international markets. We also lease automobiles and certain equipment in these same markets. At December 31, 2013, the non-cancelable lease terms for the operating leases expire at various dates between 2014 and 2023 and include renewal options. In general, the Company is also required to reimburse the lessors for real estate taxes, insurance, utilities, maintenance and other operating costs associated with the leases.
Future minimum lease payments under non-cancelable operating leases as of December 31, 2013 are:
 
Operating
Leases
2014
$
54.5

2015
47.7

2016
39.6

2017
31.4

2018
21.4

Thereafter
44.6

Total minimum lease payments
$
239.2

Total rental expense under operating leases was approximately $50.9 million in 2013, $41.9 million in 2012 and $48.1 million in 2011.

97
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Lines of Credit:    We maintain lines of credit with several banks to support its hedging programs and to facilitate the issuance of bank letters of credit and guarantees on behalf of its subsidiaries. Lines of credit supporting our hedging programs as of December 31, 2013 allowed us to enter into derivative contracts with settlement dates through 2016. As of December 31, 2013, we have entered into derivative contracts with net notional amounts totaling $7.635 billion. Lines of credit facilitating the issuance of bank letters of credit and guarantees as of December 31, 2013 allowed us to have letters of credit and guarantees issued on behalf of our subsidiaries totaling $86.6 million.
Other Commitments:    Our obligations related to product supply contracts totaled $153.7 million at December 31, 2013. We are also committed to pay the remaining $14.6 million balance due from our acquisition of a manufacturing facility in Switzerland.
As part of the sale of certain non-core assets in April 2011 (see Note 2) we committed to make certain future contingent matching contributions and an additional milestone-based contingent contribution to the CSS Institute. Under the terms of the agreement, we were obligated to make two additional contributions of $25.0 million based on like amounts of other third-party contributions being received by the CSS Institute and a $25.0 million milestone-based contribution contingent upon the CSS Institute achieving specified results related to the collection of DNA data and genomic sequences and the initiation of research and development alliances to be achieved before December 31, 2015. In conjunction with a September 2013 equity investment, the parent company of NantHealth LLC assumed, and agreed to pay and satisfy when due, our obligation to pay CSS Institute the $25.0 million contingent, milestone-based contribution. Subsequent to December 31, as part of the January 2014 equity investment in NantBioScience, the parent company of NantBioScience assumed, and agreed to pay and satisfy when due, our obligation to pay CSS Institute the $50.0 million contingent, matching contributions.
Collaboration Arrangements:    We have entered into certain research and development collaboration agreements, as identified in Note 17 above, with third parties that include the funding of certain development, manufacturing and commercialization efforts with the potential for future milestone and royalty payments upon the achievement of pre-established developmental, regulatory and/or commercial targets. Our obligation to fund these efforts is contingent upon continued involvement in the programs and/or the lack of any adverse events which could cause the discontinuance of the programs. Due to the nature of these arrangements, the future potential payments are inherently uncertain, and accordingly no amounts have been recorded for the potential future achievement of these targets in our accompanying Consolidated Balance Sheets at December 31, 2013 and 2012.
Contingencies:    We believe we maintain insurance coverage adequate for our current needs. Our operations are subject to environmental laws and regulations, which impose limitations on the discharge of pollutants into the air and water and establish standards for the treatment, storage and disposal of solid and hazardous wastes. We review the effects of such laws and regulations on our operations and modify our operations as appropriate. We believe we are in substantial compliance with all applicable environmental laws and regulations.
We have ongoing customs, duties and VAT examinations in various countries that have yet to be settled. Based on our knowledge of the claims and facts and circumstances to date, none of these matters, individually or in the aggregate, are deemed to be material to our financial condition.
Legal Proceedings:
Like many companies in our industry, we have from time to time received inquiries and subpoenas and other types of information requests from government authorities and we have been subject to claims and other actions related to our business activities.  While the ultimate outcome of investigations and legal proceedings are difficult to predict, adverse resolutions or settlements of those matters may result in, among other things, modification of our business practices, product recalls, costs and significant payments, which may have a material adverse effect on our results of operations, cash flows or financial condition.
 
Pending patent proceedings include challenges to the scope, validity or enforceability of our patents relating to certain of our products or processes. Further, we are subject to claims of third parties that we infringe their patents covering products or processes. Although we believe we have substantial defenses to these challenges and claims, there can be no assurance as to the outcome of these matters and an adverse decision in any of these proceedings could result in (i) a loss of patent protection, which could lead to a significant reduction of sales that could materially affect future results of operations, (ii) our inability to continue to engage in infringing activities, and (iii) significant liabilities, including payment of damages, royalties and/or license fees to any such third party.
 

98
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Among the principal matters pending are the following:
 
Investigative Proceedings:

In 2009, we received a Civil Investigative Demand (CID) from the U.S. Federal Trade Commission (FTC) seeking documents and other information relating to requests by generic companies to purchase our patented REVLIMID® and THALOMID® brand drugs in order for the FTC to evaluate whether there may be reason to believe that we have engaged in unfair methods of competition relating to requests by generic companies to purchase our patented REVLIMID® and THALOMID® brand drugs.  In 2010, the State of Connecticut issued a subpoena referring to the same issues raised by the 2009 CID. Also in 2010, we received a second CID from the FTC relating to this matter.  We continue to cooperate with the FTC and State of Connecticut investigations.
 
In 2011, the United States Attorney’s Office for the Central District of California informed us that they are investigating possible off-label marketing and improper payments to physicians in connection with the sales of THALOMID® and REVLIMID®.  In 2012, we learned that two other United States Attorneys’ offices (the Northern District of Alabama and the Eastern District of Texas) and various state Attorneys General were conducting related investigations.  In February 2014, three civil qui tam actions related to those investigations brought by three former Celgene employees on behalf of the federal and various state governments under the False Claims Act and certain state laws,  were unsealed after the United States Department of Justice (DOJ) declined to intervene in these actions. The DOJ maintains the right to intervene at any time. The three actions are as follows: (i) United States of America ex rel. James Patrick Eddins, Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Northern District of Alabama (the “Northern District of Alabama action”), (ii) David Schmidt, by and on behalf of the United States of America and various States, ex rel. Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Eastern District of Texas, and (iii) United States of America and various States, ex rel. Beverly Brown Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Central District of California. The plaintiff in the Northern District of Alabama action voluntarily dismissed that case. We intend to vigorously defend against the two remaining civil actions.

Patent Related Proceedings:

REVLIMID®: We received Notice Letters, the first of which was dated August 30, 2010, from Natco Pharma Limited of India (Natco) notifying us of Natco’s Abbreviated New Drug Application (ANDA), which contains Paragraph IV certifications against certain of Celgene’s patents that are listed in the FDA Approved Drug Products With Therapeutic Equivalence Evaluations (the “Orange Book”) for REVLIMID® (lenalidomide). Natco’s Notice Letters were sent in connection with its filing of an ANDA seeking permission from the FDA to market a generic version of 25mg, 15mg, 10mg and 5mg REVLIMID® capsules. In response to the Notice Letters, we filed infringement actions in the United States District Court for the District of New Jersey against Natco, Natco’s U.S. partner, Arrow International Limited (Arrow), and Watson Laboratories, Inc. (Watson, a wholly-owned subsidiary of Actavis, Inc. (formerly known as Watson Pharmaceuticals, Inc.), which is Arrow’s parent) (Natco, Arrow and Watson are collectively referred to hereinafter as “Natco”). In its answer and counterclaim, Natco asserts that our patents are invalid, unenforceable and/or not infringed by Natco’s proposed generic products.

The patents in dispute include United States Patent Nos. 5,635,517, 6,045,501, 6,315,720, 6,555,554, 6,561,976, 6,561,977, 6,755,784, 7,119,106, 7,465,800, 6,281,230, 7,189,740, 7,855,217, 7,968,569, 8,288,415, 8,315,886, 8,404,717 and 8,431,598 plus two non-Orange Book listed patents, United States Patent Nos. 7,977,357 and 8,193,219.

On December 11, 2013, the court set the close of fact discovery for April 21, 2014. Claim construction is currently expected to be fully briefed by April 8, 2014. Dates for a claim construction hearing and trial have yet to be set.
 
We believe that Natco’s defenses and counterclaims are unlikely to be sustained and we intend to vigorously assert our patent rights.  Although there can be no assurance as to the ultimate outcome of this proceeding, we currently expect that it will not have a material adverse effect on our financial condition or results of operations. However, if Natco is successful in challenging all the patents in dispute or if the court rules that certain of our key patent claims are invalid or not infringed, such events could have a material adverse effect on our financial condition and results of operations.

ABRAXANE®:  On December 14, 2011, Cephalon, Inc. and Acusphere, Inc. filed a complaint against us in the United States District Court for the District of Massachusetts, alleging, among other things, that the making, using, selling, offering to sell and importing of ABRAXANE® brand drug infringes claims of United States Patent No. RE40,493. Plaintiffs are seeking damages and injunctive relief. On December 3, 2013, the court issued an order construing certain disputed claim terms in accordance with Celgene’s proposed construction for several key terms. We intend to vigorously defend against this infringement suit.  If the suit against us is successful, we may have to pay damages, ongoing royalties and may have to license rights from plaintiffs.  However, we believe that (a) it is unlikely that the plaintiffs in this matter will prevail and (b) the ultimate outcome will not have a material adverse effect on our financial condition or results of operations.

99
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)



VIDAZA®:  On September 28, 2012, we were named as a defendant in a lawsuit filed by Ivax LLC (formerly Ivax Corporation) (“Ivax”) in the United States District Court for the Southern District of Florida.  Ivax alleged that we infringed the claims of United States Patent No. 7,759,481 (the “‘481 patent”) by making, using and selling VIDAZA® brand drug in the United States. In December 2013 the parties reached a resolution in which the patent infringement lawsuit was voluntarily dismissed by Ivax with prejudice with no payments by Celgene to Ivax.

THALOMID® and REVLIMID®: On October 2, 2013, Andrulis Pharmaceuticals Corporation (Andrulis) filed a lawsuit against us in the United States District Court for the District of Delaware claiming infringement of U.S. Patent No. 6,140,346 (“the ‘346 patent”).  Andrulis alleges that we are liable for infringement of one or more claims of the ‘346 patent which covers the use of THALOMID® (and, as asserted by Andrulis, REVLIMID®) in combination with an alkylating agent (e.g., melphalan) to treat cancers.  Andrulis is seeking an unspecified amount of damages, attorneys’ fees and injunctive relief. We disagree with Andrulis’ allegations and intend to vigorously defend against this infringement suit. On November 25, 2013, we filed a motion to dismiss Andrulis’ complaint. Andrulis’ motion seeking leave to file an amended complaint, was granted by the court on December 30, 2013. We filed a motion to dismiss Andrulis’ amended complaint on January 30, 2014. We expect that the ultimate outcome of this lawsuit will not have a material adverse effect on our financial condition or results of operations.

Other Proceedings:

On June 7, 2013, Children's Medical Center Corporation (CMCC) filed a lawsuit against us in the Superior Court of the Commonwealth of Massachusetts alleging that our obligation to pay a 1% royalty on REVLIMID® net sales revenue and a 2.5% royalty on POMALYST®/IMNOVID® net sales revenue under a license agreement entered into in December 2002  extended beyond February 28, 2013 and that our failure to make royalty payments to CMCC subsequent to February 28, 2013 breached the license agreement.  CMCC is seeking unspecified damages and a declaration that the license agreement remains in full force and effect.  In July 2013, we removed these proceedings to the United States District Court for the District of Massachusetts. On August 5, 2013, we filed an answer to CMCC’s complaint and a counterclaim for declaratory judgment that our obligations to pay royalties have expired. On August 26, 2013, CMCC filed an answer to our counterclaim. A scheduling conference was held on February 11, 2014 and the court ordered fact discovery to be completed by December 15, 2014. No trial date has as yet been set by the court. We intend to vigorously defend against CMCC's claims. As of December 31, 2013, we consider the range of reasonably possible loss relating to this lawsuit to be between zero and $35.9 million, with the high end of the range being the royalty payments on REVLIMID® we would have made under the license agreement through December 31, 2013, if it had remained in effect. CMCC contends that our royalty obligation continues on sales of REVLIMID® at least until May 2016 and if CMCC prevails, we may be obligated to continue to pay royalties for periods after December 31, 2013.
19.   Geographic and Product Information
Operations by Geographic Area:    Revenues primarily consisted of sales of REVLIMID®, VIDAZA®, ABRAXANE®, POMALYST®/IMNOVID®, THALOMID® and ISTODAX®. Additional sources of revenue included a licensing agreement with Novartis, which entitles us to royalties on FOCALIN XR® and the entire RITALIN® family of drugs, the sale of services through our Cellular Therapeutics subsidiary and other miscellaneous licensing agreements.
Revenues
 
2013
 
2012
 
2011
United States
 
$
3,862.1

 
$
3,169.1

 
$
2,860.9

Europe
 
1,865.7

 
1,617.7

 
1,477.5

All other
 
766.1

 
719.9

 
503.7

Total revenues
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1

Long-Lived Assets1
 
2013
 
2012
United States
 
$
348.0

 
$
343.3

Europe
 
230.4

 
221.5

All other
 
15.0

 
13.6

Total long lived assets
 
$
593.4

 
$
578.4

1 
Long-lived assets consist of net property, plant and equipment.

100
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


Revenues by Product:    Total revenues from external customers by product for the years ended December 31, 2013, 2012 and 2011 were as follows:
 
 
2013
 
2012
 
2011
REVLIMID®
 
$
4,280.3

 
$
3,766.6

 
$
3,208.2

VIDAZA®
 
803.3

 
823.2

 
705.3

ABRAXANE®
 
648.9

 
426.7

 
385.9

POMALYST®/IMNOVID®
 
305.4

 
12.0

 
0.6

THALOMID®
 
244.5

 
302.1

 
339.1

ISTODAX®
 
54.0

 
50.0

 
30.9

Azacitidine for injection
 
23.3

 
—

 
—

Other
 
2.6

 
5.0

 
29.7

Total net product sales
 
6,362.3

 
5,385.6

 
4,699.7

Collaborative agreements and other revenue
 
14.7

 
10.7

 
19.5

Royalty revenue
 
116.9

 
110.4

 
122.9

Total revenue
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1

Major Customers:    We sell our products primarily through wholesale distributors and specialty pharmacies in the United States, which account for a large portion of our total revenues. International sales are primarily made directly to hospitals, clinics and retail chains, many of which are government owned. During the three-year period of 2013, 2012 and 2011, only Amerisource Bergen accounted for more than 10% of our total revenue in at least one of those years and is summarized below. The percentage of amounts due from this customer compared to total net accounts receivable is also summarized below as of December 31, 2013 and 2012.
 
 
Percent of Total Revenue
 
Percent of Net Accounts Receivable
Customer
 
2013
 
2012
 
2011
 
2013
 
2012
Amerisource Bergen Corp.
 
10.7
%
 
11.5
%
 
12.6
%
 
6.4
%
 
9.6
%


101
CELGENE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


20.   Quarterly Results of Operations (Unaudited)
2013
 
1Q
 
2Q
 
3Q
 
4Q 3
 
Year
Total revenue
 
$
1,464.6

 
$
1,599.0

 
$
1,674.4

 
$
1,755.9

 
$
6,493.9

Gross profit1
 
1,348.8

 
1,483.2

 
1,557.8

 
1,632.1

 
6,021.9

Income tax provision
 
63.5

 
79.7

 
69.5

 
2.8

 
215.5

Net income attributable to Celgene
 
384.9

 
478.1

 
372.5

 
214.4

 
1,449.9

Net income per share:2
 
 
 
 
 
 
 
 
 
 
Basic
 
$
0.92

 
$
1.15

 
$
0.90

 
$
0.52

 
$
3.50

Diluted
 
$
0.89

 
$
1.11

 
$
0.87

 
$
0.50

 
$
3.37

Weighted average shares (in millions)
 
 
 
 
 
 
 
 
 
 
Basic
 
417.9

 
414.1

 
412.3

 
411.2

 
413.8

Diluted
 
432.2

 
429.3

 
428.8

 
428.6

 
430.3

2012
 
1Q
 
2Q
 
3Q
 
4Q 4
 
Year
Total revenue
 
$
1,273.3

 
$
1,366.8

 
$
1,419.2

 
$
1,447.4

 
$
5,506.7

Gross profit1
 
1,173.0

 
1,264.7

 
1,313.4

 
1,335.4

 
5,086.5

Income tax provision
 
72.5

 
73.3

 
52.3

 
27.2

 
225.3

Net income attributable to Celgene
 
401.5

 
367.4

 
424.2

 
263.1

 
1,456.2

Net income per share attributable to Celgene:2
 
 
 
 
 
 
 
 
 
 
Basic
 
$
0.92

 
$
0.84

 
$
0.99

 
$
0.62

 
$
3.38

Diluted
 
$
0.90

 
$
0.82

 
$
0.97

 
$
0.61

 
$
3.30

Weighted average shares (in millions)
 
 
 
 
 
 
 
 
 
 
Basic
 
438.3

 
436.7

 
427.2

 
421.6

 
430.9

Diluted
 
448.6

 
445.4

 
436.3

 
432.3

 
440.8

1 
Gross profit is computed by subtracting cost of goods sold (excluding amortization of acquired intangible assets) from net product sales.
2 
The sum of the quarters may not equal the full year due to rounding. In addition, quarterly and full year basic and diluted earnings per share are calculated separately.
3 
Net income attributable to Celgene for 2013 was moderately lower in the fourth quarter compared to each of the other three quarters. The decrease was primarily due to a higher level of expense related to research and development collaborations, an increase in fair value of our liability related to CVRs and an asset impairment charge related to a royalty receivable asset.
4 
Net income attributable to Celgene for 2012 was moderately lower in the fourth quarter compared to each of the other three quarters. The decrease was primarily due to an increase in fair value of our liability related to the CVRs.

21.   Subsequent Event
On February 12, 2014, our Board of Directors voted to recommend a two-for-one split of the Company’s common stock to be effected through an amendment to the Company’s Certificate of Incorporation. Implementation of the stock split is subject to stockholder approval of the amendment at the Annual Meeting of Stockholders, which is currently scheduled to take place on June 18, 2014. Per share information contained in this Annual Report on Form 10-K has not been restated to reflect this recommended stock split as it is subject to stockholder approval.

102

ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
ITEM 9A.    CONTROLS AND PROCEDURES
CONCLUSION REGARDING THE EFFECTIVENESS OF DISCLOSURE CONTROLS AND PROCEDURES
As of the end of the period covered by this Annual Report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) (the "Exchange Act"). Based on the foregoing evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that such information is accumulated and communicated to our management (including our Chief Executive Officer and Chief Financial Officer) to allow timely decisions regarding required disclosures.
CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING
There were no changes in our internal control over financial reporting during the fiscal quarter ended December 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Our management is responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment of the effectiveness of internal control over financial reporting. As defined by the Securities and Exchange Commission, internal control over financial reporting is a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the consolidated financial statements in accordance with U.S. generally accepted accounting principles.
Our internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect our transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the consolidated financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In connection with the preparation of our annual consolidated financial statements, management has undertaken an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 1992, or the COSO Framework. Management's assessment included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of those controls.
Based on this evaluation, management has concluded that our internal control over financial reporting was effective as of December 31, 2013.
KPMG LLP, the independent registered public accounting firm that audited our consolidated financial statements included in this report, has issued their report on the effectiveness of internal control over financial reporting as of December 31, 2013, a copy of which is included herein.

103

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Celgene Corporation:
We have audited Celgene Corporation and subsidiaries' internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 1992, or COSO. Celgene Corporation and subsidiaries' management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the effectiveness of Celgene Corporation and subsidiaries' internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, Celgene Corporation and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control-Integrated Framework (1992) issued by COSO.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Celgene Corporation and subsidiaries as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income, cash flows, and stockholders' equity for each of the years in the three-year period ended December 31, 2013, and our report dated February 13, 2014 expressed an unqualified opinion on those consolidated financial statements.
/s/ KPMG LLP
Short Hills, New Jersey
February 13, 2014

104

ITEM 9B.    OTHER INFORMATION
None.
PART III
ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Pursuant to Paragraph G(3) of the General Instructions to Form 10-K, the information required by Part III (Items 10, 11, 12, 13 and 14) is being incorporated by reference herein from our definitive proxy statement (or an amendment to our Annual Report on Form 10-K) to be filed with the SEC within 120 days of the end of the fiscal year ended December 31, 2013 in connection with our 2014 Annual Meeting of Stockholders.
ITEM 11.    EXECUTIVE COMPENSATION
See Item 10.
ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
See Item 10.
ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
See Item 10.
ITEM 14.    PRINCIPAL ACCOUNTANT FEES AND SERVICES
See Item 10.

105

PART IV
ITEM 15.    EXHIBITS, FINANCIAL STATEMENT SCHEDULES

106

Exhibit
No.
Exhibit Description
2.1

Agreement and Plan of Merger, dated as of November 18, 2007, among Pharmion Corporation, Celgene Corporation and Cobalt Acquisition LLC (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on November 19, 2007).
2.2

Agreement and Plan of Merger dated as of June 30, 2010, among Celgene Corporation, Artistry Acquisition Corp. and Abraxis Bioscience, Inc. (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on July 1, 2010).
3.1

Certificate of Incorporation of the Company, as amended through February 16, 2006 (incorporated by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K for the year ended December 31, 2005).
3.2

Bylaws of the Company (incorporated by reference to Exhibit 2 to the Company's Current Report on Form 8-K, dated September 16, 1996), as amended effective May 1, 2006 (incorporated by reference to Exhibit 3.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2006), as further amended effective December 16, 2009 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on December 17, 2009), and as further amended effective February 17, 2010 (incorporated by reference to Exhibit 3.2 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2009).
4.1

Contingent Value Rights Agreement, dated as of October 15, 2010, between Celgene Corporation and American Stock Transfer & Trust Company, LLC, as trustee, including the Form of CVR Certificate as Annex A (incorporated by reference to Exhibit 4.1 to the Company's Form 8-A12B filed on October 15, 2010).
4.2

Indenture, dated as of October 7, 2010, relating to the 2.450% Senior Notes due 2015, 3.950% Senior Notes due 2020 and 5.700% Senior Notes due 2040, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on October 7, 2010).
4.3

Indenture, dated as of August 9, 2012, relating to the 1.900% Senior Notes due 2017 and 3.250% Senior Notes due 2022, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on August 9, 2012).
4.4

Indenture, dated as of August 6, 2013, relating to the 2.300% Senior Notes due 2018, 4.000% Senior Notes due 2023 and the 5.250% Senior Notes due 2043, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on August 6, 2013).
4.5

Form of 2.450% Senior Notes due 2015 (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on October 7, 2010).
4.6

Form of 3.950% Senior Notes due 2020 (incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed on October 7, 2010).
4.7

Form of 5.700% Senior Notes due 2040 (incorporated by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K filed on October 7, 2010).
4.8

Form of 1.900% Senior Notes due 2017 (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on August 9, 2012).

107

Exhibit
No.
Exhibit Description
4.9

Form of 3.250% Senior Notes due 2022 (incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed on August 9, 2012).
4.10

Form of 2.300% Senior Notes due 2018 (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on August 6, 2013).
4.11

Form of 4.000% Senior Notes due 2023 (incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed on August 6, 2013).
4.12

Form of 5.250% Senior Note due 2043 (incorporated by reference to Exhibit 4.4 to the Company's Current Report on Form 8-K filed on August 6, 2013).
10.1

1992 Long-Term Incentive Plan (incorporated by reference to Exhibit A to the Company's Proxy Statement dated May 30, 1997), as amended by Amendment No. 1 thereto, effective as of June 22, 1999 (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002).
10.2

1995 Non Employee Directors' Incentive Plan (incorporated by reference to Exhibit A to the Company's Proxy Statement, dated May 24, 1999), as amended by Amendment No. 1 thereto, effective as of June 22, 1999 (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002), as further amended by Amendment No. 2 thereto, effective as of April 18, 2000 (incorporated by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002), as further amended by Amendment No. 3 thereto, effective as of April 23, 2003 (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2005), as further amended by Amendment No. 4 thereto, effective as of April 5, 2005 (incorporated by reference to Exhibit 99.2 to the Company's Registration Statement on Form S-8 (No. 333-126296)), as amended by Amendment No. 5 thereto (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2007), as further amended by Amendment No. 6 thereto (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2008).
10.3

Form of Indemnification Agreement between the Company and each officer and director of the Company (incorporated by reference to Exhibit 10.12 to the Company's Annual Report on Form 10-K for the year ended December 31, 1996).
10.4

Amended and Restated Employment Agreement effective May 1, 2006 between the Company and Robert J. Hugin (incorporated by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2006), as amended by Amendment No. 1 thereto, effective as of December 31, 2008 (incorporated by reference to Exhibit 10.8 to the Company's Annual Report on Form 10-K for the year ended December 31, 2008), as further amended by Amendment No. 2 thereto, effective as of June 16, 2010 (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on June 18, 2010).
10.5

Celgene Corporation 2008 Stock Incentive Plan, as amended and restated as of April 17, 2013 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 13, 2013).
10.6

Development and License Agreement between the Company and Novartis Pharma AG, dated April 19, 2000 (incorporated by reference to Exhibit 10.21 to the Company's Annual Report on Form 10-K for the year ended December 31, 2000).
10.7

Collaborative Research and License Agreement between the Company and Novartis Pharma AG, dated December 20, 2000 (incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K for the year ended December 31, 2000).
10.8

Celgene Corporation 2005 Deferred Compensation Plan, effective as of January 1, 2005 (incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K for the year ended December 31, 2004), as amended and restated, effective January 1, 2008 (incorporated by reference to Exhibit 10.4 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, filed on May 12, 2008).
10.9

Anthrogenesis Corporation Qualified Employee Incentive Stock Option Plan (incorporated by reference to Exhibit 10.35 to the Company's Annual Report on Form 10-K for the year ended December 31, 2002).
10.10

Distribution and Supply Agreement between SmithKline Beecham Corporation, d/b/a GlaxoSmithKline and Celgene Corporation, dated as of March 31, 2003 (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2003).
10.11

Technical Services Agreement among the Company, Celgene UK Manufacturing II, Limited (f/k/a Penn T Limited), Penn Pharmaceutical Services Limited and Penn Pharmaceutical Holding Limited, dated October 21, 2004 (incorporated by reference to Exhibit 10.33 to the Company's Annual Report on Form 10-K for the year ended December 31, 2004).

108

Exhibit
No.
Exhibit Description
10.12

Lease Agreement between the Company and Powder Horn Associates, with respect to the Warren, New Jersey property, dated January 16, 1987 (incorporated by reference to Exhibit 10.17 to the Company's Registration Statement on Form S-1 dated July 24, 1987) (incorporated by reference to Exhibit 10.40 to the Company's Annual Report on Form 10-K for the year ended December 31, 2004).
10.13

Finished Goods Supply Agreement between the Company and Penn Pharmaceutical Services Limited, dated September 8, 2004 (certain portions of the agreement have been redacted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment, which has been granted) (incorporated by reference to Exhibit 10.52 to the Company's Annual Report on Form 10-K for the year ended December 31, 2005).
10.14

Distribution Services and Storage Agreement between the Company and Sharp Corporation, dated January 1, 2005 (certain portions of the agreement have been redacted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment, which has been granted) (incorporated by reference to Exhibit 10.53 to the Company's Annual Report on Form 10-K for the year ended December 31, 2005).
10.15

Non-Competition, Non-Solicitation and Confidentiality Agreement between Celgene Corporation and Dr. Patrick Soon-Shiong, dated as of June 30, 2010 (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on July 1, 2010).
10.16

Stockholders' Agreement among Celgene Corporation, Dr. Patrick Soon-Shiong, California Capital LP, Patrick Soon-Shiong 2009 GRAT 1, Patrick Soon-Shiong 2009 GRAT 2, Michele B. Soon-Shiong GRAT 1, Michele B. Soon-Shiong GRAT 2, Soon-Shiong Community Property Revocable Trust, California Capital Trust and Michele B. Chan Soon-Shiong, dated as of June 30, 2010 (incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K filed on July 1, 2010).
10.17

Letter Agreement between the Company and Jacqualyn A. Fouse, dated August 18, 2010 (incorporated by reference to Exhibit 99.2 to the Company's Current Report on Form 8-K filed on August 27, 2010).
10.18

Amended and Restated Credit Agreement among Celgene Corporation, the lender parties named therein, and Citibank, N.A., as administrative agent, dated as of April 18, 2013 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on April 19, 2013).
10.19*

Celgene Corporation Management Incentive Plan.
10.20

Form of Stock Option Agreement (incorporated by reference to Exhibit 10.20 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012).
10.21

Form of Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.21 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012).
10.22

Letter agreement with Mark J. Alles (incorporated by reference to Exhibit 10. 1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013).
10.23

Letter agreement with Thomas O. Daniel, M.D. (incorporated by reference to Exhibit 10. 2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013).

10.24

Letter agreement with Perry A. Karsen (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013).

14.1

Code of Ethics (incorporated by reference to Exhibit 14.1 to the Company's Annual Report on Form 10-K for the year ended December 31, 2004).
21.1*

List of Subsidiaries.
23.1*

Consent of KPMG LLP.
24.1*

Power of Attorney (included in Signature Page).
31.1*

Certification by the Company's Chief Executive Officer.
31.2*

Certification by the Company's Chief Financial Officer.
32.1*

Certification by the Company's Chief Executive Officer pursuant to 18 U.S.C. Section 1350.
32.2*

Certification by the Company's Chief Financial Officer pursuant to 18 U.S.C. Section 1350.
101*

The following materials from Celgene Corporation's Annual Report on Form 10-K for the year ended December 31, 2013, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, (v) the Consolidated Statements of Stockholders' Equity and (vi) Notes to Consolidated Financial Statements.
*Filed herewith.

109

SIGNATURES AND POWER OF ATTORNEY
KNOW ALL MEN AND WOMEN BY THESE PRESENTS, that each person or entity whose signature appears below constitutes and appoints Robert J. Hugin its true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for it and in its name, place and stead, in any and all capacities, to sign any and all amendments to this Form 10-K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all contents and purposes as it might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
CELGENE CORPORATION
 
 
By:
 
/s/ Robert J. Hugin
Robert J. Hugin
Chief Executive Officer
(principal executive officer)
________________________________________________________________________________________________________________________
Date: February 13, 2014
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signature
 
Title
 
Date
 
 
 
 
 
/s/ Robert J. Hugin
Robert J. Hugin
 
Chairman of the Board;
Chief Executive Officer (principal executive officer)
 
February 13, 2014
/s/ Jacqualyn A. Fouse
Jacqualyn A. Fouse
 
Chief Financial Officer
(principal financial and accounting officer)
 
February 13, 2014
/s/ Richard W. Barker
Richard W. Barker
 
Director
 
February 13, 2014
/s/ Michael D. Casey
Michael D. Casey
 
Director
 
February 13, 2014
/s/ Carrie S. Cox
Carrie S. Cox
 
Director
 
February 13, 2014
/s/ Rodman L. Drake
Rodman L. Drake
 
Director
 
February 13, 2014
/s/ Michael A. Friedman
Michael A. Friedman
 
Director
 
February 13, 2014
/s/ Gilla Kaplan
Gilla Kaplan
 
Director
 
February 13, 2014
/s/ James Loughlin
James Loughlin
 
Director
 
February 13, 2014
/s/ Ernest Mario
Ernest Mario
 
Director
 
February 13, 2014

110

Celgene Corporation and Subsidiaries
Schedule II – Valuation and Qualifying Accounts
Year ended December 31,
 
Balance at
Beginning of
Year
 
Additions Charged
to Expense or
Sales
 
Deductions
 
Balance at
End of Year
 
 
(In millions)
2013
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
21.8

 
$
12.3

 
$
6.2

 
$
27.9

Allowance for customer discounts
 
11.2

 
74.3

1 
73.4

 
12.1

Subtotal
 
33.0

 
86.6

 
79.6

 
40.0

Allowance for sales returns
 
13.3

 
9.6

1 
7.4

 
15.5

Total
 
$
46.3

 
$
96.2

 
$
87.0

 
$
55.5

2012
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
10.1

 
$
12.5

 
$
0.8

 
$
21.8

Allowance for customer discounts
 
8.7

 
64.9

1 
62.4

 
11.2

Subtotal
 
18.8

 
77.4

 
63.2

 
33.0

Allowance for sales returns
 
9.0

 
7.5

1 
3.2

 
13.3

Total
 
$
27.8

 
$
84.9

 
$
66.4

 
$
46.3

2011
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
4.8

 
$
6.4

 
$
1.1

 
$
10.1

Allowance for customer discounts
 
8.3

 
56.1

1 
55.7

 
8.7

Subtotal
 
13.1

 
62.5

 
56.8

 
18.8

Allowance for sales returns
 
4.8

 
16.8

1 
12.6

 
9.0

Total
 
$
17.9

 
$
79.3

 
$
69.4

 
$
27.8


1 
Amounts are a reduction from gross sales.


111
 EX-10.19 2 a20131231ex-1019.htm EXHIBIT 2013.12.31 EX-10.19
Exhibit 10.19


Celgene Corporation
Management Incentive Plan (MIP)

Interpretation
This Celgene Management Incentive Plan (the “MIP” or the “Plan”) document, which is voluntarily established by the Company, exclusively applies in respect of the MIP in the Plan Year, which runs from 1 January to 31 December. A new plan, if any, may be adopted for each year and may contain different terms, including but not limited to different terms as to criteria, weighting and/or levels of Bonus Target, in each case, as determined in the sole discretion of the Compensation Committee. Therefore, the Plan does not create any vested rights for any employees to receive any similar payments in the future, even if such payments have been granted repeatedly in the past.

Purpose
The purpose of the Plan is to annually drive the attainment of key quantifiable objectives and reward performance that the Company believes is critical to the success of the Celgene Group. This Plan also drives the overall success of the Celgene Group by rewarding employees who achieve results through leadership and behaviors that demonstrate the Celgene Values.

Definitions
In this Plan document, the terms are defined as follows:

"Active Employee" refers to an employee whilst in Active Employment.

"Active Employment" means remunerated performance of work duties for Celgene and any Employing Entity and, to avoid doubt, does not include extended-sick leave or disability, family leave or other leaves of absence whether remunerated or otherwise.

“Bonus Target” is the target associated with an employee’s position as of 31 December of the Plan Year. Bonus Targets can be expressed as either a percent of Eligible Earnings or as a fixed dollar amount. At the discretion of management, employees who transfer into a position with a lower target will maintain their higher target through the end of the plan year and transition to the new target on January 1 of the following plan year.

“Cause” means (a) a material breach of any agreement you have with the Company, including, but not limited to, the Inventions and Confidentiality and Code of Business Conduct; (b) a felony or any other crime involving dishonesty, breach of trust, moral turpitude, or physical harm to any person (including, but not limited to, the Company or any of its employees); (c) an act of fraud, misconduct, or dishonesty in connection with the business of the Company; (d) failure to satisfactorily or adequately perform your duties hereunder as determined by the Company based upon objective facts, including, but not limited to, your inability to achieve goals, inability to work with others, insubordination or excessive tardiness; (e) an overall performance rating of Below Expectations on an annual performance assessment; (f) your receipt of a Final Written Warning for any reason; or (g) insobriety or other substance abuse during work activities.

"Celgene" or "the Company" means Celgene Corporation and its successors.

"Celgene Group" means Celgene and its subsidiaries.

“Celgene Values” are defined as the qualities we look for in our employees, how we treat each other, the environment we create together and why we come to work every day. Appendix 6 contains the Celgene Values.

“Compensation Committee" means the Management Compensation and Development Committee of the Company’s Board of Directors.

“Eligible Earnings” means base salary, fixed cash salary and any lump sum merit increases earned while in Active Employment within the Plan Year. The term “Eligible Earnings” will be computed before reduction for pre-tax contributions to any non-qualified deferred compensation plan and/or any employee benefit plan of any member of the Celgene Group pursuant to Sections 401(k) (US only), 125 and 132(f) of the Internal Revenue Code of 1986, as amended. The term “Eligible Earnings” excludes any variable

1

salary, salary in-kind, performance-related pay and benefits, cost of living payments, one-time lump sum payments and any vacation or holiday pay if not included in fixed cash salary. Overtime (OT) and shift differentials are excluded, unless employee is classified as nonexempt and on US payroll, or unless required by local regulations.

"Employing Entity" means, in respect of each employee, his or her Celgene Group employing entity as listed in Appendix 5.             
“Management Committee” is a governing body containing key functional leaders employed by the Company at the VP level and above.

“Individual Performance Score” is the numeric score that represents an individual’s performance versus his/her goals. Each goal is scored, and then is multiplied by the weight assigned to that goal. The final scores for all goals (including Celgene Values goals for Associate Managers through Associate Directors (Grades 8-11 or grade level equivalent) are added together to determine the Individual Performance Score. Any earned extra credit points are added to the final Individual Performance Score. The Individual Performance Score ranges from 0 - 150, and with extra credit can reach a maximum of 200.

“Overall Performance Rating” is the letter grade associated with the Individual Performance Score. Overall Performance Rating scores are as follows: S (Superior), EE (Exceeds Expectations), AE (Achieves Expectations), NI (Needs Improvement) and BE (Below Expectations). This overall performance rating applies to Associate Managers through Associate Directors (Grades 8-11 or grade level equivalent).

"Plan Year" means 1 January to 31 December of the same year.

“Retirement” is defined as an Active Employee’s termination of employment (other than for Cause) on or after the attainment of at least age 55 and completion of at least 5 years of service or the Rule of 65 with the Company or any Employing Entity.

“Scope of Role” is a general categorization that pertains to a job’s responsibility. Scope of Role and/or an employee’s grade level determine how the final bonus amount is calculated using one or more of the following measurements: corporate, divisional, functional, regional, sub-regional, country and individual scores. Scope of Role is further defined in Appendix 1.

Eligibility
Celgene employees in salary grades 8 (Associate Manager or grade level equivalent) and above who are not part of any other annual cash incentive plan (i.e., Employee Incentive Plan or Sales Incentive Plan) are eligible to participate in the Plan. Temporary employees (including interns), Post Doctoral employees, leased employees and independent contractors are excluded from participation in the Plan. Employment must have commenced on or before September 30th of the Plan Year and an employee must be Actively

Employed through December 31st of the Plan Year to participate in the program as specified in further detail below. Employees on an approved leave of absence as

of December 31st of the Plan Year will receive their award on a prorated basis based on earnings for actual days of employment by such employee during the Plan Year, based upon performance versus objectives and manager approval.

Situation
Award Calculation
New Hires starting on or before September 30th
Award is prorated using eligible earnings (or a prorated fixed bonus amount) based on the number of days worked in the Plan Year.
 
 
New Hires starting after September 30th
Not eligible.
 
 
Employee target decreases during the Plan Year (through transfer to a lower position, demotion, career ladder placement, etc)
Generally, the higher target is maintained until the end of the performance year and employee assumes lower target on January 1 of the following year. In the case of demotions, Celgene reserves the right to immediately reduce the Bonus Target amount or percentage, as applicable.
 
 

2

Transfer from Employee Incentive Plan (EIP).
Award is calculated using the Bonus Target as of December 31st of the Plan Year. If transfer occurs before the start of the 4th quarter, MIP goals and measurements are to be established. If transfer occurs during the 4th quarter, the EIP goals shall remain and the EIP score will be used to calculate the bonus for the Plan Year.
 
 
Transfer to Employee Incentive Plan (EIP).
Award is calculated using the Bonus Target as of December 31st of the Plan Year. If transfer occurs before 4th quarter, EIP goals and measurements are to be established. If transfer occurs in the 4th quarter, the actual MIP score will be used to calculate the bonus for the Plan Year.
 
 
Transfer to or from Sales Incentive Plan position to and from MIP position (as applicable)
Award is prorated using eligible earnings (or a prorated fixed bonus amount) for time in each plan. Proration is to the nearest quarter, per the Sales Incentive Plan. Regardless of proration, there will be no overlap of plan eligibility. Example: If employee transfers from SIP to MIP on June 15, he/she will be paid out 2 quarters on SIP and 2 quarters on MIP. SIP payout is from Jan 1 through June 30 and MIP payout is from July 1 through Dec 31.
 
 
Involuntary termination during the Plan Year (up to and including work through December 31st) for reasons other than for Cause
Award is prorated using eligible earnings (or a prorated fixed bonus amount) based on the number of days worked during the Plan Year and is typically paid at target at time of termination, and is contingent upon agreeing to the terms of a Separation Agreement, if applicable. Celgene Management, in its sole discretion, may award payments at, above or below target based on latest estimates of company and/or individual performance.
 
 
Involuntary termination after December 31 of the Plan Year for reasons other than cause or gross misconduct, but prior to when the Plan Year MIP payments are made.
Employee is eligible for a MIP award for the completed Plan Year; payment is calculated using actual individual and company performance and is paid according to schedule established for active employees. This means that performance document must be completed and approved for employee (including ratings and scores for each goal).

Employee is also eligible for a prorated MIP award for the following Plan Year based on the number of days worked during that Plan Year and is typically paid at target at the time of termination (see Involuntary termination during the Plan Year section). Celgene Management, in its sole discretion, may award payments at, above or below target based on latest estimates of Celgene performance.
 
 
Voluntary termination after December 31 of the Plan Year, but prior to when MIP payments are made
Employee is eligible for MIP award. Payment is calculated using actual individual and company performance and is paid according to schedule established for active employees.
 
 
Retirement during the Plan Year (up to and including work through December 31st)
Award is prorated using eligible earnings (or a prorated fixed bonus amount) based on the number of days worked during the Plan Year and is typically paid at target at time of retirement. Celgene Management may award payments at, above or below target based on latest estimates of company performance. Employee must meet eligibility age of at least 55 years and must have completed 5 or more years of service or meet the Rule of 65.
 
 

3

Retirement after December 31 of the Plan Year for reasons other than cause or gross misconduct, but prior to when the Plan Year MIP payments are made.
Employee is eligible for a MIP award for the completed Plan Year; payment is calculated using actual individual and company performance and is paid according to schedule established for active employees. This means that performance document must be completed and approved for employee (including ratings and scores for each goal).

Employee is also eligible for a prorated MIP award for the following Plan Year based on the number of days worked during that Plan Year and is typically paid at target at the time of termination (see Involuntary termination during the Plan Year section). Celgene Management, in its sole discretion, may award payments at, above or below target based on latest estimates of Celgene performance.
 
 
Death in Service
Award is prorated using eligible earnings (or a prorated fixed bonus amount) based on the number of days worked during the Plan Year and is typically paid at target to the estate at time of death. Celgene Management may award payments at, above or below target based on latest estimates of company performance.
 
 
Leaves of Absence and Disability
Award is prorated using eligible earnings (or a prorated fixed bonus amount) based on the number of days of Active Employment. Bonus is paid in accordance with schedule defined for active employees. Special rules may apply in different countries.
 
 
Transfers to or from countries with different currencies
Award is paid from employee’s payroll (and currency) as of February 1.   Exchange rates as of February 1 are used.  

Establishment of Performance Objectives
Plan participants’ annual goals are established, measured, assessed and scored against one or more of the following: corporate, divisional, functional, regional, sub-regional, country and individual objectives. The Plan is designed to reward that are established at or around the start of the Plan Year.

Objectives used to measure performance are those that ultimately drive the achievement of our financial and business performance and are established per the following:
•
Individual objectives: Set as part of the performance management process and are approved by Celgene Management
•
Divisional, functional, regional and country objectives: Set by Celgene Management and approved by the Chief Executive Officer
•
Corporate objectives: Set by Celgene Management under the direction of the Chief Executive Officer and are subject to the approval of the Compensation Committee

Determining the Bonus Target
Each position is assigned a Bonus Target defined as a percentage of Eligible Earnings or as a fixed target amount. An employee’s Bonus Target calculation is based on his or her Eligible Earnings within the Plan Year multiplied by the Bonus Target percentage, or is the fixed target amount (prorated based on the number of days employed by Celgene or any Employing Entity during the Plan Year).

Determining Bonus Target Weights
For all Plan participants, the Bonus Target may be weighted as a mix of corporate, individual, divisional, functional, regional, sub-regional, and country goals. These weightings reflect the principle that the greater impact the employee may have on achieving certain objectives, the greater the weighting placed on those objectives. The chart in Appendix 2 outlines the various Bonus Target weightings by scope of role and/or grade.

4

Determining the Bonus Payout
Bonus payouts may be higher or lower than an employee’s bonus target and are determined as follows:

Employees in Grades
Bonus Determined by
Associate Managers through Associate Directors (Grades 8-11 or grade level equivalent)
Combination of individual and business performance and values scores
Directors (Grade 12 and above or grade level equivalent)
Combination of individual and business performance
 
If achievements are above 100%, this will result in MIP payouts greater than target. Scores and achievements that are below 100% will result in payouts lower than target. The maximum gross amount of the total bonus payout for this Plan Year is 200% of Bonus Target. Refer to the “Award Payment” section of this document for examples.

Determining the Corporate MIP Score
Based upon recommendation from the Chief Executive Officer, the Compensation Committee will, in its sole discretion, determine the degree of attainment of corporate objectives by participants for the Plan Year.

Determining the Individual Performance Score for Associate Managers through Associate Directors (Grades 8-11 or grade level equivalent)
The ability of each participant to focus on the achievement of the corporate, divisional, regional, sub-regional, country, and individual objectives is critical to Celgene achieving its key milestones. In addition, how each employee achieves his/her individual objectives vis-à-vis the Celgene Values is critically important to creating and maintaining a culture that fosters strong performance and high achievement. Therefore, there are two key components that determine the Overall Performance Rating. They are:
 
Performance Goals Score (75% of Individual Performance Score : Represents each employee’s performance versus objectives that are set as part of the performance management process. Each objective is weighted and evaluated individually and each employee and his/her manager are required to carry out a final assessment of each score. Each objective score is then added together to determine the final Performance Goals Score. For weighting of corporate, regional, sub-regional, country or individual goals, refer to Appendix 2.

Values Goals Score (25% of Individual Performance Score): Represents each employee’s performance versus goals regarding the Celgene Values. Each goal will be equally weighted and are set as part of the performance management process. Each objective is evaluated individually and each employee and

his/her manager are required to carry out a final assessment of each score. Each objective score is then added together to determine the final Values Goals Score. If an employee receives an overall

Values Rating of Below Expectations (BE) the Overall Performance Rating will likewise be BE, resulting in an Overall Performance Score (i.e., MIP score) of zero and no bonus will be paid.

Determining the Individual Performance Score for Directors (Grade 12) and Above

Performance Goals Score (100% of Individual Performance Score): Represents each employee’s performance versus objectives that are set as part of the performance management process. Each objective is weighted and evaluated individually and each employee and his/her manager are required to complete a final assessment of each score. Each objective score is then added together to determine the final Performance Goals Score. For weighting of corporate, regional, sub-regional, country or individual goals, refer to Appendix 2.

Extra Credit: Each manager - at his/her own discretion - may award up to a total of 50 points of extra credit to an employee who demonstrates results that far surpass the established achievement measurements for a goal. Extra credit is awarded per individual goal and may only be given when the following conditions are met:
•
The provision for extra credit must have been included in the goal at the time it was approved
•
The measure of the criteria for extra credit must have been specified when the goal was approved.
•
The performance and results for the extra credit must be thoroughly documented in the Performance Review.
The intention of extra credit is to further reward exceptional performance that brings significant value to Celgene and drives its business forward and as such should be utilized on an exceptional or infrequent basis. Even if extra credit is awarded, the maximum gross amount of the total bonus payout for this Plan Year cannot exceed 200% of Bonus Target.

5

Employees on Performance Improvement Plans
If an individual’s performance versus objectives is below required standards including, but not limited to, being subject to a Performance Improvement Plan during the Plan Year, whether or not individual objectives are met, an award may not be earned in respect of any bonus element, individual or corporate. Final scoring for each participant is subject to approval by the Celgene Management Committee.

Award Payment
Payouts are typically approved and paid in the 1st quarter of the following Plan Year. MIP awards, less any appropriate legal/statutory deductions as required or permitted under applicable law, will be paid in the manner in which the employee has elected to receive his or her regular salary, subject to the Company's approval.

Notwithstanding anything herein to the contrary, in no event shall any bonus payments in respect of the Plan Year be made after March 15 of the following year.

Administration
Celgene has the authority to interpret, administer and implement the Plan approved by the Compensation Committee. The Management Committee or Chief Executive Officer may make variations to an individual’s level of participation, changes of targets, weights and payouts, excluding changes to their own eligibility. The Compensation Committee may, in its sole discretion, make adjustments to the Plan during the Plan Year as deemed advisable in order to give consideration to changes in accounting rules, principles or methods, or extraordinary events, and make adjustments to financial performance measures in recognition of such occurrences, including varying or withdrawing the Plan.

Any bonus paid under the MIP shall not form part of salary for purposes of pension or other benefits plans calculations, except where mandated by law or if defined as such in the pension or benefits plan documents. It is understood that any bonus paid under the MIP is already inclusive of any additional monthly wages and holiday entitlement that are due to the employee.
Subject to applicable law, an employee’s eligibility to participate in the MIP in this Plan Year constitutes neither a guarantee of employment, nor a guarantee of an award for the entire Plan
Year or any portion thereof, nor a guarantee of entitlement to participate in MIP or any other similar Plan in future years.

The rights and interests of a participant under the Plan are personal to the individual and may not be assigned encumbered or transferred except by assignment to successors of the Company.

Section 409A
This Plan is intended to be exempt from and/or comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the final regulations and official guidance promulgated thereunder (together, “Section 409A”). Nothing in the Plan shall be construed as the guarantee of any particular tax treatment to any participant hereunder.



6
 EX-21.1 3 a20131231ex-211.htm EXHIBIT 2013.12.31 EX-21.1


EXHIBIT 21.1


LIST OF SUBSIDIARIES


Name
State or Other Jurisdiction of Incorporation
Celgene Inc.
Canada
Abraxis Bioscience Australia Pty Ltd.
Australia
Abraxis BioScience International Holding Company, Inc.
Delaware
Abraxis BioScience Puerto Rico, LLC
Puerto Rico
Abraxis BioScience Service (Beijing) Co. Ltd. Beijing, P.R.C.
People’s Republic of China
Abraxis BioScience, LLC
Delaware
Anthrogenesis Corporation
New Jersey
Cabrellis Pharmaceuticals Corp.
Delaware
Celgene Alpine Investment. Co., LLC
Celgene Alpine Investment. Co. II, LLC
Delaware
Delaware
Celgene Ab
Finland
Celgene AB
Sweden
Celgene ApS
Denmark
Celgene AS
Norway
Celgene BV
Netherlands
Celgene BVBA
Belgium
Celgene Chemicals Sarl
Switzerland
Celgene Co.
South Korea
Celgene Edinburgh Finance
Scotland
Celgene Europe, Limited
United Kingdom
Celgene European Investment Co. LLC
Delaware
Celgene Financing Company, LLC
Delaware
Celgene GmbH
Austria
Celgene GmbH
Germany
Celgene GmbH
Switzerland
Celgene Holdings East Corp.
New Jersey
Celgene Holdings Sarl
Celgene Holdings II Sarl
Switzerland
Switzerland
Celgene International Holdings Corporation
Delaware
Celgene International SARL
Switzerland
Celgene International, Inc.
Delaware
Celgene Kft
Hungary
Celgene KK
Japan
Celgene Limited
Hong Kong
Celgene Limited
Ireland
Celgene Limited
Taiwan
Celgene Limited
United Kingdom
Celgene llac Pazarlama ve Tic.Ltd. Sti.
Turkey
Celgene Logistics Sarl
Switzerland
Celgene Luxembourg Finance Company SARL
Luxembourg




Celgene Luxembourg SARL
Luxembourg
Celgene Management Sarl
Switzerland
Celgene Netherlands BV
Netherlands
Celgene Netherlands II BV
Netherlands
Celgene Netherlands Investment, B.V.
Netherlands
Celgene NJ Investment Co.
New Jersey
Celgene Pharmaceuticals Information Consulting Co., Ltd (Shanghai)
China
Celgene PTE Ltd
Singapore
Celgene Pty Limited
New Zealand
Celgene Pty Limited
Australia
Celgene Puerto Rico Distribution LLC
Puerto Rico
Celgene R&D Sarl
Celgene Research and Development, LLC
Switzerland
Delaware
Celgene Research and Investment Company LLC
Delaware
Celgene Research, SL
Spain
Celgene Sdn. Bhd.
Malaysia
Celgene S.L.
Spain
Celgene Sarl
Celgene Services Sarl
France
Switzerland
Celgene Sociedade Unipessoal Lda
Portugal
Celgene sp. zoo
Poland
Celgene Srl
Italy
Celgene sro
Czech Republic
Celgene sro
Slovakia
Celgene Summit Investment Co
New Jersey
Celgene Switzerland Holdings Sarl
Celgene Switzerland Investment Sarl
Switzerland
Switzerland
Celgene Switzerland SA
Switzerland
Celgene UK Distribution Limited
United Kingdom
Celgene UK Holdings, Limited
United Kingdom
Celgene UK Manufacturing II, Limited
United Kingdom
Celgene UK Manufacturing III, Limited
United Kingdom
Celgene UK Manufacturing, Limited
United Kingdom
Celgro Corporation
Delaware
Cenomed BioSciences, LLC
Delaware
CHT I LLC
Delaware
CHT II LLC
Delaware
CHT III LLC
Delaware
CHT IV LLC
Delaware
Global Strategic Partners, LLC
Delaware
Gloucester Pharmaceuticals, LLC
Delaware
Morris Avenue Investment II, LLC
New Jersey
Morris Avenue Investment LLC
New Jersey
Celgene Ltd
Thailand
Pharmion LLC
Delaware
Resuscitation Technologies, LLC
Delaware
Seamair Insurance Limited
Ireland




Signal Pharmaceuticals, LLC
California
VivoRx Autoimmune, Inc.
California
Celgene Brasil Biofarmacêutica Ltda.
Brazil
Abraxis BioScience Limited
Hong Kong
AHI Investment, LLC
Delaware
Abraxis BioScience, Inc.
Delaware
Celgene Logistics II Sarl
Switzerland
Gloucester International, LLC
Delaware
Celgene Avilomics Research, Inc.
Delaware
Deuteria Pharmaceuticals, Inc.
Delaware
Celgene, S. de R.l. de C.V.
Mexico
Celgene Research Investment Company II, LLC
Delaware




 EX-23.1 4 a20131231ex-231.htm EXHIBIT 2013.12.31 EX-23.1


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors
Celgene Corporation:

We consent to the incorporation by reference in the registration statements (Nos. 333-70083, 333-91977, 333-39716, 333-107980, 333-65908, 333-138497, 333-149603, 333-152655, 333-160955, 333-177669, 333-184634, 333-191996) on Form S-8, in the registration statements (Nos. 333-02517, 333-32115, 333-38861, 333-52963, 333-87197, 333-93759, 333-94915, 333-75636, 333-107977, 333-107978, 333-138395, 333-169731, 333-191998) on Form S-3, and in the registration statements (Nos. 333-101196, 333-42302, 333-148777 and 333-168369) on Form S-4 of Celgene Corporation of our reports dated February 13, 2014, with respect to the consolidated balance sheets of Celgene Corporation and subsidiaries as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income, cash flows, and stockholders' equity for each of the years in the three-year period ended December 31, 2013, the related consolidated financial statement schedule, and the effectiveness of internal control over financial reporting as of December 31, 2013, which reports appear in the December 31, 2013 annual report on Form 10-K of Celgene Corporation and subsidiaries.


/s/ KPMG LLP

Short Hills, New Jersey
February 13, 2014



 EX-31.1 5 a20131231ex311.htm EXHIBIT 2013.12.31 EX 31.1


Exhibit 31.1

CERTIFICATION PURSUANT TO
18 U.S.C. Sec. 1350,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Robert J. Hugin, certify that:
1.
I have reviewed this annual report on Form 10-K of Celgene Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: February 13, 2014
 
/s/ Robert J. Hugin
 
Robert J. Hugin
Chief Executive Officer


 EX-31.2 6 a20131231ex312.htm EXHIBIT 2013.12.31 EX 31.2


Exhibit 31.2
CERTIFICATION PURSUANT TO
18 U.S.C. Sec. 1350,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jacqualyn A. Fouse, certify that:
1.
I have reviewed this annual report on Form 10-K of Celgene Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: February 13, 2014
 
/s/ Jacqualyn A. Fouse
 
Jacqualyn A. Fouse, Ph.D.
Executive Vice President
Chief Financial Officer
(principal financial and accounting officer)


 EX-32.1 7 a20131231ex321.htm EXHIBIT 2013.12.31 EX 32.1


Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Annual Report on Form 10-K of Celgene Corporation ("the Company") for the year ended December 31, 2013 ("the Periodic Report"), I, Robert J. Hugin, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that the Periodic Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:
 
February 13, 2014
 
 
 
  /s/ Robert J. Hugin
 
 
 
 
 
 
  Robert J. Hugin
  Chief Executive Officer


 EX-32.2 8 a20131231ex322.htm EXHIBIT 2013.12.31 EX 32.2


Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Annual Report on Form 10-K of Celgene Corporation ("the Company") for the year ended December 31, 2013 ("the Periodic Report"), I, Jacqualyn A. Fouse, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that the Periodic Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:
 
February 13, 2014
 
 
 
/s/ Jacqualyn A. Fouse
 
 
 
 
 
 
 
  Jacqualyn A. Fouse, Ph.D.
  Executive Vice President
  Chief Financial Officer
  (principal financial and
  accounting officer)


 EX-101.INS 9 celg-20131231.xml XBRL INSTANCE DOCUMENT 0000816284 celg:AcceleronPharmaMember celg:ACE536EachAdditionalDiscoveryStageProgramMember 2011-08-01 2011-08-31 0000816284 celg:AcceleronPharmaMember celg:ACE536FirstDiscoveryStageProgramMember 2011-08-01 2011-08-31 0000816284 celg:AcceleronPharmaMember celg:ACE536ProgramMember 2011-08-01 2011-08-31 0000816284 celg:AcceleronPharmaMember celg:ACE536SecondDiscoveryStageProgramMember 2011-08-01 2011-08-31 0000816284 2011-01-01 2011-12-31 0000816284 celg:AcceleronPharmaMember 2011-01-01 2011-12-31 0000816284 celg:AcetylonMember 2011-01-01 2011-12-31 0000816284 celg:AgiosPharmaceuticalsMember 2011-01-01 2011-12-31 0000816284 celg:OtherCollaborationAgreementsMember 2011-01-01 2011-12-31 0000816284 celg:LongTermIncentivePlanMember 2011-01-01 2011-12-31 0000816284 us-gaap:DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember 2011-01-01 2011-12-31 0000816284 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000816284 us-gaap:TreasuryStockMember 2011-01-01 2011-12-31 0000816284 celg:NonQualifiedStockOptionMember 2011-01-01 2011-12-31 0000816284 us-gaap:EmployeeStockOptionMember 2011-01-01 2011-12-31 0000816284 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2011-01-01 2011-12-31 0000816284 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2011-01-01 2011-12-31 0000816284 celg:TotalRevenueMember us-gaap:CustomerConcentrationRiskMember celg:AmerisourceBergenMember 2011-01-01 2011-12-31 0000816284 us-gaap:CostOfSalesMember 2011-01-01 2011-12-31 0000816284 us-gaap:ResearchAndDevelopmentExpenseMember 2011-01-01 2011-12-31 0000816284 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2011-01-01 2011-12-31 0000816284 celg:AbraxaneMember 2011-01-01 2011-12-31 0000816284 celg:AzacitidineMember 2011-01-01 2011-12-31 0000816284 celg:IstodaxMember 2011-01-01 2011-12-31 0000816284 celg:OtherProductsMember 2011-01-01 2011-12-31 0000816284 celg:PomalystImnovidMember 2011-01-01 2011-12-31 0000816284 celg:RevlimidMember 2011-01-01 2011-12-31 0000816284 celg:ThalomidMember 2011-01-01 2011-12-31 0000816284 celg:VidazaMember 2011-01-01 2011-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2011-01-01 2011-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2011-01-01 2011-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0000816284 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000816284 us-gaap:NoncontrollingInterestMember 2011-01-01 2011-12-31 0000816284 us-gaap:ParentMember 2011-01-01 2011-12-31 0000816284 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0000816284 us-gaap:TreasuryStockMember 2011-01-01 2011-12-31 0000816284 celg:AllOtherCountriesMember 2011-01-01 2011-12-31 0000816284 country:US 2011-01-01 2011-12-31 0000816284 us-gaap:EuropeMember 2011-01-01 2011-12-31 0000816284 celg:AllowanceForDoubtfulAccountsAndCustomerDiscountsMember 2011-01-01 2011-12-31 0000816284 us-gaap:AllowanceForDoubtfulAccountsMember 2011-01-01 2011-12-31 0000816284 us-gaap:AllowanceForPromotionsMember 2011-01-01 2011-12-31 0000816284 us-gaap:AllowanceForSalesReturnsMember 2011-01-01 2011-12-31 0000816284 celg:AvilaTherapeuticsIncMember 2012-03-06 2012-03-07 0000816284 celg:AvilaTherapeuticsIncMember 2012-03-01 2012-03-31 0000816284 2012-06-01 2012-06-30 0000816284 2013-02-01 2013-02-28 0000816284 2013-06-01 2013-06-30 0000816284 2013-06-11 2013-06-12 0000816284 us-gaap:MaximumMember 2013-06-11 2013-06-12 0000816284 celg:PomalystRoyaltyMember 2013-06-06 2013-06-07 0000816284 celg:RevlimidRoyaltyMember 2013-06-06 2013-06-07 0000816284 us-gaap:MaximumMember 2013-06-09 2013-06-10 0000816284 celg:SeniorNotes2.30PercentDue2018Member us-gaap:SeniorNotesMember 2013-08-01 2013-08-31 0000816284 celg:SeniorNotes4.00PercentDue2023Member us-gaap:SeniorNotesMember 2013-08-01 2013-08-31 0000816284 celg:SeniorNotes5.250PercentDue2043Member us-gaap:SeniorNotesMember 2013-08-01 2013-08-31 0000816284 celg:AbraxaneMember 2013-09-01 2013-09-30 0000816284 celg:OncoMedPharmaceuticalsInc.Member us-gaap:MaximumMember 2013-12-01 2013-12-02 0000816284 2013-11-01 2013-11-30 0000816284 us-gaap:SubsequentEventMember 2014-02-01 2014-02-13 0000816284 us-gaap:SubsequentEventMember 2014-02-11 2014-02-12 0000816284 celg:NantBioScienceInc.Member us-gaap:SubsequentEventMember 2014-01-01 2014-02-14 0000816284 celg:ForwardStartingInterestRateSwapMaturinginYearFiveMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-01-01 2014-02-14 0000816284 celg:ForwardStartingInterestRateSwapMaturinginYearTenMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-01-01 2014-02-14 0000816284 celg:NantBioScienceMember us-gaap:SubsequentEventMember 2014-01-01 2014-01-31 0000816284 celg:AcceleronPharmaMember 2010-01-01 2010-12-31 0000816284 celg:AgiosPharmaceuticalsMember 2010-01-01 2010-12-31 0000816284 2012-01-01 2012-03-31 0000816284 2012-04-01 2012-06-30 0000816284 2012-07-01 2012-09-30 0000816284 2012-10-01 2012-12-31 0000816284 2012-01-01 2012-12-31 0000816284 celg:AcceleronPharmaMember 2012-01-01 2012-12-31 0000816284 celg:AcetylonMember 2012-01-01 2012-12-31 0000816284 celg:AgiosPharmaceuticalsMember 2012-01-01 2012-12-31 0000816284 celg:EpizymeIncMember 2012-01-01 2012-12-31 0000816284 celg:InstituteForAdvancedHealthMember 2012-01-01 2012-12-31 0000816284 celg:OtherCollaborationAgreementsMember 2012-01-01 2012-12-31 0000816284 celg:LongTermIncentivePlanMember 2012-01-01 2012-12-31 0000816284 us-gaap:DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember 2012-01-01 2012-12-31 0000816284 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000816284 us-gaap:TreasuryStockMember 2012-01-01 2012-12-31 0000816284 celg:AcquiredDevelopedProductRightsMember 2012-01-01 2012-12-31 0000816284 celg:TechnologyMember 2012-01-01 2012-12-31 0000816284 us-gaap:LicensingAgreementsMember 2012-01-01 2012-12-31 0000816284 us-gaap:OtherIntangibleAssetsMember 2012-01-01 2012-12-31 0000816284 celg:NonQualifiedStockOptionMember 2012-01-01 2012-12-31 0000816284 us-gaap:EmployeeStockOptionMember 2012-01-01 2012-12-31 0000816284 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0000816284 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0000816284 us-gaap:InventoriesMember 2012-01-01 2012-12-31 0000816284 celg:TotalRevenueMember us-gaap:CustomerConcentrationRiskMember celg:AmerisourceBergenMember 2012-01-01 2012-12-31 0000816284 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember celg:AmerisourceBergenMember 2012-01-01 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-01-01 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherIncomeMember 2012-01-01 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2012-01-01 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-01-01 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2012-01-01 2012-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2012-01-01 2012-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-01-01 2012-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2012-01-01 2012-12-31 0000816284 us-gaap:PutOptionMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember us-gaap:ShortMember 2012-01-01 2012-12-31 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-01-01 2012-12-31 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2012-01-01 2012-12-31 0000816284 us-gaap:TreasuryLockMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2012-01-01 2012-12-31 0000816284 us-gaap:CostOfSalesMember 2012-01-01 2012-12-31 0000816284 us-gaap:ResearchAndDevelopmentExpenseMember 2012-01-01 2012-12-31 0000816284 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2012-01-01 2012-12-31 0000816284 celg:AbraxaneMember 2012-01-01 2012-12-31 0000816284 celg:AzacitidineMember 2012-01-01 2012-12-31 0000816284 celg:IstodaxMember 2012-01-01 2012-12-31 0000816284 celg:OtherProductsMember 2012-01-01 2012-12-31 0000816284 celg:PomalystImnovidMember 2012-01-01 2012-12-31 0000816284 celg:RevlimidMember 2012-01-01 2012-12-31 0000816284 celg:ThalomidMember 2012-01-01 2012-12-31 0000816284 celg:VidazaMember 2012-01-01 2012-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2012-01-01 2012-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-01-01 2012-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2012-01-01 2012-12-31 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2012-01-01 2012-12-31 0000816284 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-01-01 2012-12-31 0000816284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2012-01-01 2012-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-01-01 2012-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2012-01-01 2012-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0000816284 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000816284 us-gaap:ParentMember 2012-01-01 2012-12-31 0000816284 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0000816284 us-gaap:TreasuryStockMember 2012-01-01 2012-12-31 0000816284 celg:AllOtherCountriesMember 2012-01-01 2012-12-31 0000816284 country:US 2012-01-01 2012-12-31 0000816284 us-gaap:EuropeMember 2012-01-01 2012-12-31 0000816284 celg:AllowanceForDoubtfulAccountsAndCustomerDiscountsMember 2012-01-01 2012-12-31 0000816284 us-gaap:AllowanceForDoubtfulAccountsMember 2012-01-01 2012-12-31 0000816284 us-gaap:AllowanceForPromotionsMember 2012-01-01 2012-12-31 0000816284 us-gaap:AllowanceForSalesReturnsMember 2012-01-01 2012-12-31 0000816284 2013-01-01 2013-03-31 0000816284 2013-04-01 2013-06-30 0000816284 2013-07-01 2013-09-30 0000816284 2013-10-01 2013-12-31 0000816284 2013-01-01 2013-12-31 0000816284 celg:AcceleronPharmaMember 2013-01-01 2013-12-31 0000816284 celg:AcceleronPharmaMember celg:ACE011DiscoveryStageProgramsMember 2013-01-01 2013-12-31 0000816284 celg:AcceleronPharmaMember celg:ACE011ProgramMember 2013-01-01 2013-12-31 0000816284 celg:AcetylonMember 2013-01-01 2013-12-31 0000816284 celg:AcetylonMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:AgiosPharmaceuticalsMember 2013-01-01 2013-12-31 0000816284 celg:BluebirdbioInc.Member 2013-01-01 2013-12-31 0000816284 celg:BluebirdbioInc.Member us-gaap:ParentCompanyMember 2013-01-01 2013-12-31 0000816284 celg:EpizymeIncMember 2013-01-01 2013-12-31 0000816284 celg:EpizymeIncMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:FORMAMember 2013-01-01 2013-12-31 0000816284 celg:LicensepaymentsFORMAMember 2013-01-01 2013-12-31 0000816284 celg:MorphoSysAGMember 2013-01-01 2013-12-31 0000816284 celg:MorphoSysAGMember us-gaap:ParentCompanyMember 2013-01-01 2013-12-31 0000816284 celg:MorphoSysAGMember us-gaap:EurodollarMember 2013-01-01 2013-12-31 0000816284 celg:NovartisMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:NovartisMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member 2013-01-01 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member celg:AntiDLL4VEGFMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member celg:DemcizumabMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member celg:OtherBiologicalProgramsMember 2013-01-01 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member celg:RSPOLGRCSCPathwayoranotherCSCPathwayMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member celg:SmallMoleculeProgramMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member us-gaap:ParentCompanyMember 2013-01-01 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:OtherCollaborationAgreementsMember 2013-01-01 2013-12-31 0000816284 celg:OtherCollaborationAgreementsMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:RegulatoryapprovalmilestoneFORMAMember 2013-01-01 2013-12-31 0000816284 celg:ResearchanddevelopmentpaymentsFORMAMember 2013-01-01 2013-12-31 0000816284 celg:LongTermIncentivePlanMember 2013-01-01 2013-12-31 0000816284 us-gaap:DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember 2013-01-01 2013-12-31 0000816284 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0000816284 us-gaap:TreasuryStockMember 2013-01-01 2013-12-31 0000816284 celg:AcquiredDevelopedProductRightsMember 2013-01-01 2013-12-31 0000816284 celg:AcquiredInProcessResearchAndDevelopmentProductRightsMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:AcquiredInProcessResearchAndDevelopmentProductRightsMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 celg:TechnologyMember 2013-01-01 2013-12-31 0000816284 us-gaap:LicensingAgreementsMember 2013-01-01 2013-12-31 0000816284 us-gaap:OtherIntangibleAssetsMember 2013-01-01 2013-12-31 0000816284 celg:AvilaTherapeuticsIncMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneFiveMember celg:AbraxaneMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneFourMember celg:AbraxaneMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneOneMember celg:AbraxaneMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneOneMember celg:AbraxaneMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneOneMember celg:AbraxaneMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneThreeMember celg:AbraxaneMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneThreeMember celg:AbraxaneMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneTwoMember celg:AbraxaneMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneTwoMember celg:AbraxaneMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:MilestoneTwoMember celg:AbraxaneMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 celg:NonQualifiedStockOptionMember 2013-01-01 2013-12-31 0000816284 celg:PerformanceBasedRestrictedStockUnitsMember 2013-01-01 2013-12-31 0000816284 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-12-31 0000816284 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 us-gaap:RestrictedStockUnitsRSUMember 2013-01-01 2013-12-31 0000816284 us-gaap:InventoriesMember 2013-01-01 2013-12-31 0000816284 celg:AbraxisBioScienceIncMember 2013-01-01 2013-12-31 0000816284 celg:AbraxisBioScienceIncMember us-gaap:SubsequentEventMember 2013-01-01 2013-12-31 0000816284 celg:AvilaTherapeuticsIncMember 2013-01-01 2013-12-31 0000816284 celg:GloucesterPharmaceuticalsIncMember 2013-01-01 2013-12-31 0000816284 celg:TotalRevenueMember us-gaap:CustomerConcentrationRiskMember celg:AmerisourceBergenMember 2013-01-01 2013-12-31 0000816284 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember celg:AmerisourceBergenMember 2013-01-01 2013-12-31 0000816284 us-gaap:RevolvingCreditFacilityMember 2013-01-01 2013-12-31 0000816284 celg:SeniorNotesDue2017And2022Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2013-01-01 2013-12-31 0000816284 celg:ForwardStartingInterestRateSwapMaturinginYearFiveMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-01-01 2013-12-31 0000816284 celg:ForwardStartingInterestRateSwapMaturinginYearTenMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-01-01 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember 2013-01-01 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-01-01 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherIncomeMember 2013-01-01 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2013-01-01 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-01-01 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2013-01-01 2013-12-31 0000816284 us-gaap:ForeignExchangeOptionMember 2013-01-01 2013-12-31 0000816284 us-gaap:InterestRateSwapMember 2013-01-01 2013-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-01-01 2013-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2013-01-01 2013-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-01-01 2013-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2013-01-01 2013-12-31 0000816284 us-gaap:PutOptionMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember us-gaap:ShortMember 2013-01-01 2013-12-31 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-01-01 2013-12-31 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2013-01-01 2013-12-31 0000816284 us-gaap:TreasuryLockMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-01-01 2013-12-31 0000816284 us-gaap:TreasuryLockMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2013-01-01 2013-12-31 0000816284 us-gaap:CashFlowHedgingMember 2013-01-01 2013-12-31 0000816284 us-gaap:CostOfSalesMember 2013-01-01 2013-12-31 0000816284 us-gaap:ResearchAndDevelopmentExpenseMember 2013-01-01 2013-12-31 0000816284 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2013-01-01 2013-12-31 0000816284 us-gaap:SeniorNotesMember 2013-01-01 2013-12-31 0000816284 us-gaap:AssetBackedSecuritiesMember 2013-01-01 2013-12-31 0000816284 us-gaap:CorporateDebtSecuritiesMember 2013-01-01 2013-12-31 0000816284 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2013-01-01 2013-12-31 0000816284 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2013-01-01 2013-12-31 0000816284 us-gaap:USTreasurySecuritiesMember 2013-01-01 2013-12-31 0000816284 celg:AbraxaneMember 2013-01-01 2013-12-31 0000816284 celg:AzacitidineMember 2013-01-01 2013-12-31 0000816284 celg:IstodaxMember 2013-01-01 2013-12-31 0000816284 celg:OtherProductsMember 2013-01-01 2013-12-31 0000816284 celg:PomalystImnovidMember 2013-01-01 2013-12-31 0000816284 celg:RevlimidMember 2013-01-01 2013-12-31 0000816284 celg:ThalomidMember 2013-01-01 2013-12-31 0000816284 celg:VidazaMember 2013-01-01 2013-12-31 0000816284 celg:ComputerEquipmentAndSoftwareMember us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 celg:ComputerEquipmentAndSoftwareMember us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 us-gaap:BuildingMember 2013-01-01 2013-12-31 0000816284 us-gaap:EquipmentMember 2013-01-01 2013-12-31 0000816284 us-gaap:FurnitureAndFixturesMember 2013-01-01 2013-12-31 0000816284 us-gaap:MachineryAndEquipmentMember 2013-01-01 2013-12-31 0000816284 us-gaap:OtherMachineryAndEquipmentMember 2013-01-01 2013-12-31 0000816284 celg:AbraxaneMember 2013-01-01 2013-12-31 0000816284 celg:OtezlaMember 2013-01-01 2013-12-31 0000816284 us-gaap:MaximumMember 2013-01-01 2013-12-31 0000816284 us-gaap:MinimumMember 2013-01-01 2013-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-01-01 2013-12-31 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2013-01-01 2013-12-31 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2013-01-01 2013-12-31 0000816284 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-01-01 2013-12-31 0000816284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2013-01-01 2013-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2013-01-01 2013-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0000816284 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0000816284 us-gaap:ParentMember 2013-01-01 2013-12-31 0000816284 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0000816284 us-gaap:TreasuryStockMember 2013-01-01 2013-12-31 0000816284 celg:AllOtherCountriesMember 2013-01-01 2013-12-31 0000816284 country:US 2013-01-01 2013-12-31 0000816284 us-gaap:EuropeMember 2013-01-01 2013-12-31 0000816284 celg:AllowanceForDoubtfulAccountsAndCustomerDiscountsMember 2013-01-01 2013-12-31 0000816284 us-gaap:AllowanceForDoubtfulAccountsMember 2013-01-01 2013-12-31 0000816284 us-gaap:AllowanceForPromotionsMember 2013-01-01 2013-12-31 0000816284 us-gaap:AllowanceForSalesReturnsMember 2013-01-01 2013-12-31 0000816284 2011-12-31 0000816284 us-gaap:CommonStockMember 2011-12-31 0000816284 us-gaap:TreasuryStockMember 2011-12-31 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2011-12-31 0000816284 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2011-12-31 0000816284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2011-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2011-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000816284 us-gaap:CommonStockMember 2011-12-31 0000816284 us-gaap:NoncontrollingInterestMember 2011-12-31 0000816284 us-gaap:ParentMember 2011-12-31 0000816284 us-gaap:RetainedEarningsMember 2011-12-31 0000816284 us-gaap:TreasuryStockMember 2011-12-31 0000816284 celg:AllowanceForDoubtfulAccountsAndCustomerDiscountsMember 2011-12-31 0000816284 us-gaap:AllowanceForDoubtfulAccountsMember 2011-12-31 0000816284 us-gaap:AllowanceForPromotionsMember 2011-12-31 0000816284 us-gaap:AllowanceForSalesReturnsMember 2011-12-31 0000816284 2012-12-31 0000816284 celg:AcceleronPharmaMember 2012-12-31 0000816284 celg:AcetylonMember 2012-12-31 0000816284 celg:AgiosPharmaceuticalsMember 2012-12-31 0000816284 celg:EpizymeIncMember 2012-12-31 0000816284 celg:InstituteForAdvancedHealthMember 2012-12-31 0000816284 celg:NantBioScienceMember 2012-12-31 0000816284 celg:NantBioScienceMember us-gaap:SubsequentEventMember 2012-12-31 0000816284 celg:OtherCollaborationAgreementsMember 2012-12-31 0000816284 us-gaap:DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember 2012-12-31 0000816284 us-gaap:CommonStockMember 2012-12-31 0000816284 us-gaap:TreasuryStockMember 2012-12-31 0000816284 celg:AcquiredDevelopedProductRightsMember 2012-12-31 0000816284 celg:AcquiredInProcessResearchAndDevelopmentProductRightsMember 2012-12-31 0000816284 celg:TechnologyMember 2012-12-31 0000816284 us-gaap:LicensingAgreementsMember 2012-12-31 0000816284 us-gaap:OtherIntangibleAssetsMember 2012-12-31 0000816284 celg:PerformanceBasedRestrictedStockUnitsMember 2012-12-31 0000816284 us-gaap:RestrictedStockUnitsRSUMember 2012-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2012-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2012-12-31 0000816284 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2012-12-31 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2012-12-31 0000816284 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 celg:AbraxisBioScienceIncMember 2012-12-31 0000816284 celg:AvilaTherapeuticsIncMember 2012-12-31 0000816284 celg:GloucesterPharmaceuticalsIncMember 2012-12-31 0000816284 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember 2012-12-31 0000816284 celg:AvilaTherapeuticsIncMember 2012-12-31 0000816284 us-gaap:RevolvingCreditFacilityMember 2012-12-31 0000816284 currency:AUD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 currency:CAD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 currency:EUR us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 currency:GBP us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 celg:SeniorNotes1.90PercentDue2017Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes1.90PercentDue2017Member us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes2.30PercentDue2018Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes2.30PercentDue2018Member us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes2.45PercentDue2015Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes2.45PercentDue2015Member us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes3.25PercentDue2022Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes3.25PercentDue2022Member us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes3.95PercentDue2020Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes3.95PercentDue2020Member us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes4.00PercentDue2023Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes4.00PercentDue2023Member us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes5.250PercentDue2043Member us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:SeniorNotes5.70PercentDue2040Member us-gaap:SeniorNotesMember 2012-12-31 0000816284 celg:GainAsAResultofPastSwapContractSettlementsMember 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CallOptionMember us-gaap:ShortMember 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PutOptionMember us-gaap:LongMember 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:PutOptionMember us-gaap:LongMember 2012-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:PutOptionMember us-gaap:ShortMember 2012-12-31 0000816284 us-gaap:InterestRateSwapMember 2012-12-31 0000816284 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000816284 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000816284 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000816284 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000816284 us-gaap:CorporateDebtSecuritiesMember 2012-12-31 0000816284 us-gaap:EquitySecuritiesMember 2012-12-31 0000816284 us-gaap:ForeignGovernmentDebtSecuritiesMember 2012-12-31 0000816284 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2012-12-31 0000816284 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2012-12-31 0000816284 us-gaap:USTreasurySecuritiesMember 2012-12-31 0000816284 celg:AbraxaneMember 2012-12-31 0000816284 celg:BuildingAndOperatingEquipmentMember 2012-12-31 0000816284 celg:ComputerEquipmentAndSoftwareMember 2012-12-31 0000816284 us-gaap:BuildingMember 2012-12-31 0000816284 us-gaap:ConstructionInProgressMember 2012-12-31 0000816284 us-gaap:FurnitureAndFixturesMember 2012-12-31 0000816284 us-gaap:LandMember 2012-12-31 0000816284 us-gaap:LeaseholdImprovementsMember 2012-12-31 0000816284 us-gaap:MachineryAndEquipmentMember 2012-12-31 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2012-12-31 0000816284 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-12-31 0000816284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2012-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2012-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000816284 us-gaap:CommonStockMember 2012-12-31 0000816284 us-gaap:ParentMember 2012-12-31 0000816284 us-gaap:RetainedEarningsMember 2012-12-31 0000816284 us-gaap:TreasuryStockMember 2012-12-31 0000816284 celg:AllOtherCountriesMember 2012-12-31 0000816284 country:US 2012-12-31 0000816284 us-gaap:EuropeMember 2012-12-31 0000816284 celg:AllowanceForDoubtfulAccountsAndCustomerDiscountsMember 2012-12-31 0000816284 us-gaap:AllowanceForDoubtfulAccountsMember 2012-12-31 0000816284 us-gaap:AllowanceForPromotionsMember 2012-12-31 0000816284 us-gaap:AllowanceForSalesReturnsMember 2012-12-31 0000816284 2013-12-31 0000816284 celg:AcceleronPharmaMember 2013-12-31 0000816284 celg:AcetylonMember 2013-12-31 0000816284 celg:AgiosPharmaceuticalsMember 2013-12-31 0000816284 celg:BluebirdbioInc.Member 2013-12-31 0000816284 celg:EpizymeIncMember 2013-12-31 0000816284 celg:FORMAMember 2013-12-31 0000816284 celg:MorphoSysAGMember 2013-12-31 0000816284 celg:OncoMedPharmaceuticalsInc.Member 2013-12-31 0000816284 celg:OtherCollaborationAgreementsMember 2013-12-31 0000816284 celg:LongTermIncentivePlan2014Member 2013-12-31 0000816284 celg:LongTermIncentivePlan2014Member us-gaap:MaximumMember 2013-12-31 0000816284 celg:LongTermIncentivePlan2015Member 2013-12-31 0000816284 celg:LongTermIncentivePlan2015Member us-gaap:MaximumMember 2013-12-31 0000816284 celg:LongTermIncentivePlan2016MemberMember us-gaap:MaximumMember 2013-12-31 0000816284 celg:LongTermIncentivePlanMember 2013-12-31 0000816284 celg:LongTermIncentivePlanMember us-gaap:MaximumMember 2013-12-31 0000816284 celg:LongTermIncentivePlanMember us-gaap:MinimumMember 2013-12-31 0000816284 us-gaap:DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember 2013-12-31 0000816284 us-gaap:DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember us-gaap:MaximumMember 2013-12-31 0000816284 us-gaap:DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember us-gaap:MinimumMember 2013-12-31 0000816284 us-gaap:CommonStockMember 2013-12-31 0000816284 us-gaap:TreasuryStockMember 2013-12-31 0000816284 celg:AcquiredDevelopedProductRightsMember 2013-12-31 0000816284 celg:AcquiredInProcessResearchAndDevelopmentProductRightsMember 2013-12-31 0000816284 celg:TechnologyMember 2013-12-31 0000816284 us-gaap:LicensingAgreementsMember 2013-12-31 0000816284 us-gaap:OtherIntangibleAssetsMember 2013-12-31 0000816284 country:CH 2013-12-31 0000816284 celg:MilestonePaymentOneMemberIfTargetAchievedBeforeSpecifiedTimeMember celg:AbraxaneMember 2013-12-31 0000816284 celg:MilestonePaymentTwoIfTargetAchievedAfterSpecifiedTimeMember celg:AbraxaneMember 2013-12-31 0000816284 celg:PerformanceBasedRestrictedStockUnitsMember 2013-12-31 0000816284 us-gaap:EmployeeStockOptionMember 2013-12-31 0000816284 us-gaap:RestrictedStockUnitsRSUMember 2013-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2013-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2013-12-31 0000816284 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2013-12-31 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2013-12-31 0000816284 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 celg:AbraxisBioScienceIncMember 2013-12-31 0000816284 celg:AvilaTherapeuticsIncMember 2013-12-31 0000816284 celg:AvilaTherapeuticsIncMember us-gaap:MaximumMember 2013-12-31 0000816284 celg:GloucesterPharmaceuticalsIncMember 2013-12-31 0000816284 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember 2013-12-31 0000816284 celg:AvilaTherapeuticsIncMember 2013-12-31 0000816284 us-gaap:RevolvingCreditFacilityMember 2013-12-31 0000816284 currency:AUD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 currency:CAD us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 currency:EUR us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 currency:GBP us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 celg:SeniorNotes1.90PercentDue2017Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes1.90PercentDue2017Member us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes2.30PercentDue2018Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes2.30PercentDue2018Member us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes2.45PercentDue2015Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes2.45PercentDue2015Member us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes3.25PercentDue2022Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes3.25PercentDue2022Member us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes3.95PercentDue2020Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes3.95PercentDue2020Member us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes4.00PercentDue2023Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes4.00PercentDue2023Member us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes5.250PercentDue2043Member us-gaap:SeniorNotesMember 2013-12-31 0000816284 celg:SeniorNotes5.70PercentDue2040Member us-gaap:SeniorNotesMember 2013-12-31 0000816284 us-gaap:CommercialPaperMember 2013-12-31 0000816284 celg:ForwardStartingInterestRateSwapMaturinginYearFiveMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 celg:ForwardStartingInterestRateSwapMaturinginYearTenMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 celg:ForwardStartingInterestRateSwapsMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 celg:GainAsAResultofPastSwapContractSettlementsMember 2013-12-31 0000816284 celg:GainRelatedtoSettlementofSwapContractsDuringCurrentFiscalYearMember 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CallOptionMember us-gaap:ShortMember 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PutOptionMember us-gaap:LongMember 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:PutOptionMember us-gaap:LongMember 2013-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:PutOptionMember us-gaap:ShortMember 2013-12-31 0000816284 us-gaap:InterestRateSwapMember 2013-12-31 0000816284 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000816284 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000816284 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000816284 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2013-12-31 0000816284 us-gaap:StateAndLocalJurisdictionMember 2013-12-31 0000816284 celg:ChildrensMedicalCenterCorporationMember 2013-12-31 0000816284 us-gaap:AssetBackedSecuritiesMember 2013-12-31 0000816284 us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0000816284 us-gaap:EquitySecuritiesMember 2013-12-31 0000816284 us-gaap:ForeignGovernmentDebtSecuritiesMember 2013-12-31 0000816284 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2013-12-31 0000816284 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2013-12-31 0000816284 us-gaap:USTreasurySecuritiesMember 2013-12-31 0000816284 celg:AbraxaneMember 2013-12-31 0000816284 celg:BuildingAndOperatingEquipmentMember 2013-12-31 0000816284 celg:ComputerEquipmentAndSoftwareMember 2013-12-31 0000816284 us-gaap:BuildingMember 2013-12-31 0000816284 us-gaap:ConstructionInProgressMember 2013-12-31 0000816284 us-gaap:FurnitureAndFixturesMember 2013-12-31 0000816284 us-gaap:LandMember 2013-12-31 0000816284 us-gaap:LeaseholdImprovementsMember 2013-12-31 0000816284 us-gaap:MachineryAndEquipmentMember 2013-12-31 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2013-12-31 0000816284 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-12-31 0000816284 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2013-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2013-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000816284 us-gaap:CommonStockMember 2013-12-31 0000816284 us-gaap:ParentMember 2013-12-31 0000816284 us-gaap:RetainedEarningsMember 2013-12-31 0000816284 us-gaap:TreasuryStockMember 2013-12-31 0000816284 celg:AllOtherCountriesMember 2013-12-31 0000816284 country:US 2013-12-31 0000816284 us-gaap:EuropeMember 2013-12-31 0000816284 us-gaap:ResearchMember 2013-12-31 0000816284 celg:AllowanceForDoubtfulAccountsAndCustomerDiscountsMember 2013-12-31 0000816284 us-gaap:AllowanceForDoubtfulAccountsMember 2013-12-31 0000816284 us-gaap:AllowanceForPromotionsMember 2013-12-31 0000816284 us-gaap:AllowanceForSalesReturnsMember 2013-12-31 0000816284 2010-12-31 0000816284 us-gaap:CommonStockMember 2010-12-31 0000816284 us-gaap:TreasuryStockMember 2010-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000816284 us-gaap:CommonStockMember 2010-12-31 0000816284 us-gaap:NoncontrollingInterestMember 2010-12-31 0000816284 us-gaap:ParentMember 2010-12-31 0000816284 us-gaap:RetainedEarningsMember 2010-12-31 0000816284 us-gaap:TreasuryStockMember 2010-12-31 0000816284 celg:AllowanceForDoubtfulAccountsAndCustomerDiscountsMember 2010-12-31 0000816284 us-gaap:AllowanceForDoubtfulAccountsMember 2010-12-31 0000816284 us-gaap:AllowanceForPromotionsMember 2010-12-31 0000816284 us-gaap:AllowanceForSalesReturnsMember 2010-12-31 0000816284 celg:AvilaTherapeuticsIncMember 2012-03-07 0000816284 celg:AvilaTherapeuticsIncMember us-gaap:MaximumMember 2012-03-07 0000816284 us-gaap:SeniorNotesMember 2012-08-31 0000816284 celg:AbraxisBioScienceIncMember 2012-10-31 0000816284 us-gaap:RevolvingCreditFacilityMember 2013-04-30 0000816284 2013-06-12 0000816284 2013-06-28 0000816284 celg:SeniorNotes2.30PercentDue2018Member us-gaap:SeniorNotesMember 2013-08-31 0000816284 celg:SeniorNotes4.00PercentDue2023Member us-gaap:SeniorNotesMember 2013-08-31 0000816284 celg:SeniorNotes5.250PercentDue2043Member us-gaap:SeniorNotesMember 2013-08-31 0000816284 us-gaap:SeniorNotesMember 2013-08-31 0000816284 us-gaap:PutOptionMember us-gaap:SubsequentEventMember 2014-02-13 0000816284 celg:ForwardStartingInterestRateSwapMaturinginYearTenMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-02-14 0000816284 2014-02-07 0000816284 celg:NantBioScienceInc.Member us-gaap:SubsequentEventMember 2014-01-31 0000816284 us-gaap:InterestRateContractMember 2014-02-12 celg:Time_Per_Annum iso4217:USD celg:option celg:attorney_general celg:contribution celg:discovery_stage_program iso4217:EUR celg:milestone xbrli:pure celg:performance_cycle celg:product_candidate xbrli:shares iso4217:USD iso4217:USD xbrli:shares 145600000 156200000 324200000 348400000 960500000 1061400000 86400000 11800000 16000000 188200000 235000000 1001100000 775700000 9300000 9800000 9500000 14800000 340800000 432300000 94000000 -49700000 -62300000 -400000 -16000000 -10100000 -6900000 -36000000 8700000 -27800000 1800000 -5400000 4200000 -67400000 137300000 8680400000 7539800000 325000000 230500000 325000000 230500000 216600000 230500000 216600000 325000000 216600000 170000000 25100000 55800000 170000000 25100000 55800000 170000000 55800000 25100000 154400000 197600000 155200000 1200000 1800000 116200000 144700000 102400000 231000000 102700000 325800000 12400000 9800000 162600000 18500000 104700000 217200000 231300000 169700000 161300000 33000000 40000000 290300000 270100000 196200000 12700000.0 7200000.0 25900000.0 105400000 118000000 148000000 80000000 13378200000 11734300000 5533700000 7550500000 433100000 2039500000 2472600000 1858800000 300000 1859100000 2452600000 433100000 2019500000 300000 1809600000 1809900000 902000000 400000 303500000 208500000 1808700000 387200000 7100000 450800000 208900000 2239000000 795200000 181600000 212900000 10400000 379200000 -205100000 -3700000 -1300000 0 0 -1500000 -1500000 0 -200000 -200000 -6900000 -600000 -8300000 -400000 135100000 78200000 404700000 1061200000 316900000 126300000 -200000 -200000 -400000 -6800000 -5400000 -600000 1015400000 78200000 126300000 358900000 316900000 135100000 45800000 0 0 45800000 0 1809900000 2452600000 303800000 902500000 7100000 209200000 387000000 300000 433100000 208900000 379700000 444000000 10400000 795100000 181400000 2026100000 391800000 391600000 2019500000 -7300000 3800000 -1100000 169000000 171100000 -142300000 535100000 171100000 166400000 -147500000 9200000 -59700000 -30400000 595000000 595000000 595000000 120000000 179700000 198400000 330800000 1172000000 378800000 2600000 535100000 3234400000 2090400000 1351100000 1859500000 20000000 20000000 27000000 27000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash, Cash Equivalents and Marketable Securities Available-for-Sale</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Money market funds of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.697 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.160 billion</font><font style="font-family:inherit;font-size:10pt;"> at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">, respectively, were recorded at cost, which approximates fair value and are included in cash and cash equivalents.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amortized cost, gross unrealized holding gains, gross unrealized holding losses and estimated fair value of available-for-sale securities by major security type and class of security at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">795.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">795.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency MBS</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S. government, agency and</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supranational securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt&#160;&#8211; global</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable equity securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">220.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total available-for-sale marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,239.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,452.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">902.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">902.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">303.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">303.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency MBS</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S. government, agency and</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supranational securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt&#160;&#8211; global</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">209.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total available-for-sale marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,808.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,809.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency securities include general unsecured obligations either issued directly by or guaranteed by U.S. Government Sponsored Enterprises.&#160; U.S. government-sponsored agency MBS include mortgage-backed securities issued by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association.&#160; Non-U.S. government, agency and Supranational securities consist of direct obligations of highly rated governments of nations other than the United States and obligations of sponsored agencies and other entities that are guaranteed or supported by highly rated governments of nations other than the United States.&#160; Corporate debt-global includes obligations issued by investment-grade corporations, including some issues that have been guaranteed by governments and government agencies.&#160; Asset backed securities consist of triple-A rated securities with cash flows collateralized by credit card receivables and auto loans. Marketable equity securities consist of investments in equity securities that have become publicly traded. &#160;The increase in net unrealized gains in marketable equity securities in </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> compared to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> primarily reflects the increase in market value for certain equity investments subsequent to their respective initial public offerings. Net unrealized losses in the marketable securities primarily reflect the impact of increased interest rates at December 31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of all available-for-sale securities, which have been in an unrealized loss position for less than and longer than 12&#160;months at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 12&#160;months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12&#160;months or longer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency MBS</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">404.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt&#160;&#8211; global</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,015.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company believes that the decline in fair value of securities held at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> below their cost is temporary and intends to retain its investment in these securities for a sufficient period of time to allow for recovery in the market value of these investments.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration periods of available-for-sale debt securities at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration of one year or less</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration of one through three years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,364.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,363.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration of three through five years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">233.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration of over five years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,026.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,019.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Collaboration Agreements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have entered into a variety of alliances in the ordinary course of our business. Although we do not consider any individual alliance to be material, certain of the more notable alliances are described below. The summarized financial information related to our alliances is presented in tabular format after the description of alliances:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Novartis Pharma AG:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We licensed the worldwide rights (excluding Canada) regarding certain chirally pure forms of methylphenidate for FOCALIN</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and FOCALIN XR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> to Novartis. We also licensed to Novartis the rights related to long-acting formulations of methylphenidate and dex-methylphenidate products which are used in FOCALIN XR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and RITALIN LA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. We sell FOCALIN</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> to Novartis and receive royalties of between </font><font style="font-family:inherit;font-size:10pt;color:#000000;">30%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">35%</font><font style="font-family:inherit;font-size:10pt;"> on Novartis' sales of FOCALIN XR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and RITALIN LA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. The arrangement with Novartis will continue until the later of (i)&#160;the tenth anniversary of the first commercial launch on a country-by-country basis or (ii)&#160;when the last applicable patent expires with respect to that country. At the expiration date, we will grant Novartis a perpetual, non-exclusive, royalty-free license to make, have made, use, import and sell products using the dex-methylphenidate and long-acting formulation technology. The agreement may be terminated by Novartis upon 12&#160;months prior written notice or by either party upon, among other things, the breach of a material obligation by the other party or in the event of withdrawal of the dex-methylphenidate product or RITALIN</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> product from the market because of regulatory mandate.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If the agreement is terminated by us, then all licenses granted to Novartis under the agreement will terminate and Novartis will grant us a non-exclusive license to certain of their intellectual property related to the compounds and products. If the agreement is terminated by Novartis then all licenses granted to Novartis under the agreement will terminate.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When a generic version of dexmethylphenidate hydrochloride enters the market, we expect Novartis' sales of FOCALIN XR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> to decrease and therefore our royalties will also decrease. A generic version of RITALIN LA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> was introduced in January 2012 and resulted in a decrease in royalties we received from Novartis related to sales of RITALIN LA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acceleron Pharma (Acceleron):</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We have worldwide strategic collaboration agreements with Acceleron for the joint development and commercialization of sotatercept (ACE-11) and ACE-536. ACE-11 is currently in phase II studies for treatment of renal anemia, diamond blackfan anemia, beta-thalassemia and MDS, and ACE-536 is currently in phase II studies for beta-thalassemia and MDS.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2013 we became responsible for the payment of all development costs related to ACE-11 and ACE-536 and have recognized development expenses as research and development expense as they were incurred.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the ACE-11 program, Acceleron is eligible to receive of up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$367.0 million</font><font style="font-family:inherit;font-size:10pt;"> in development, regulatory approval and sales-based milestones and up to an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$348.0 million</font><font style="font-family:inherit;font-size:10pt;"> for each of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">three</font><font style="font-family:inherit;font-size:10pt;"> specific discovery stage programs. We also agreed to co-promote the developed products in North America. Acceleron will receive tiered royalties on worldwide net sales upon the commercialization of a development compound.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the ACE-536 program, we have an exclusive, worldwide, royalty-bearing license to ACE-536 and future Acceleron products for the treatment of anemia. We also agreed to co-promote the products in the United States, Canada and Mexico. Acceleron is eligible to receive development, regulatory approval and sales-based milestones of up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$217.5 million</font><font style="font-family:inherit;font-size:10pt;"> for ACE-536 and up to an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$170.8 million</font><font style="font-family:inherit;font-size:10pt;"> for the first discovery stage program, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$148.8 million</font><font style="font-family:inherit;font-size:10pt;"> for the second discovery stage program and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$125.4 million</font><font style="font-family:inherit;font-size:10pt;"> for each additional discovery stage program thereafter. Acceleron will receive tiered royalties on worldwide net sales upon the commercialization of a development compound.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The ACE-11 agreement may be terminated by us, at our sole discretion, at any time or by either party, among other things, upon a material breach by the other party. The ACE-536 agreement may be terminated by us, at our sole discretion, after completion of the initial phase II clinical trial or by either party, among other things, upon a material breach by the other party.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Agios Pharmaceuticals,&#160;Inc. (Agios):</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;During 2010, we entered into a discovery and development collaboration and license agreement with Agios that focuses on cancer metabolism targets and the discovery, development and commercialization of associated therapeutics. We have an exclusive option to license any potential products that result from the Agios cancer metabolism research platform through the end of phase I clinical trials.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to each product that we choose to license, Agios could receive up to approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$120.0 million</font><font style="font-family:inherit;font-size:10pt;"> upon achievement of certain milestones and other payments plus royalties on sales, and Agios may also participate in the development and commercialization of certain products in the United States. Our option to license a product will terminate on April&#160;14, 2015.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have determined that Agios is a variable interest entity; however, we are not the primary beneficiary of this arrangement. Although we would have the right to receive the benefits from the collaboration and license agreement, we do not have the power to direct the activities under the collaboration and license agreement as Agios has the decision-making authority for this collaboration until we exercise our option to license a product. Our interest in Agios is limited to our equity ownership and we do not have any obligations or rights to the future losses or returns of Agios beyond this ownership.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Epizyme Inc. (Epizyme):</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;In April 2012, we entered into a collaboration and license agreement with Epizyme to discover, develop and commercialize novel therapeutic compounds by inhibiting histone methyltransferases (HMT), an important epigenetic target class. Under the terms of the agreement, we made an upfront payment to Epizyme and also made an equity investment in Epizyme and received an exclusive option to license rights outside the United States to HMT inhibitors targeting the DOT1L HMT, including the Company&#8217;s product candidate EPZ-5676 and each Epizyme compound associated with such licensed compounds during the option term. If the option is exercised, Epizyme could receive up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$165.0 million</font><font style="font-family:inherit;font-size:10pt;"> in milestone payments associated with each Epizyme compound developed to inhibit each distinct HMT target under the collaboration plus royalties on sales. Epizyme will have the sole responsibility to develop and commercialize compounds in the United States.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The option term expires on either July&#160;9, 2015 (or July&#160;9, 2016 if we extend the option term for a fourth year and pay an option extension fee). Further, if an HMT target or targets are selected, the collaboration agreement will expire upon the expiration of all applicable royalty terms with respect to all licensed Epizyme compounds. Upon the expiration of the collaboration agreement, we will have a fully paid-up, royalty-free license to use Epizyme intellectual property to manufacture, market, use and sell such licensed Epizyme compounds outside the United States.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">bluebird bio,&#160;Inc. (bluebird):</font><font style="font-family:inherit;font-size:10pt;">&#160; In March 2013, we entered into a collaboration agreement with bluebird to discover, develop and commercialize novel disease-altering gene therapies in oncology. The collaboration focuses on applying gene therapy technology to modify a patient&#8217;s own T-cells, known as chimeric antigen receptor (CAR) T-cells, to target and destroy cancer cells. The collaboration has the potential to lead to the development of multiple CAR T-cell products. We have an option to license any products resulting from the collaboration after the completion of a phase I clinical study by bluebird for each product.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We made an upfront payment and may be obligated to pay up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$225.0 million</font><font style="font-family:inherit;font-size:10pt;"> per licensed product in aggregate potential option fees and clinical and regulatory milestone payments. bluebird also has the option to participate in the development and commercialization of any licensed products resulting from the collaboration through a </font><font style="font-family:inherit;font-size:10pt;color:#000000;">50</font><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:10pt;color:#000000;">50</font><font style="font-family:inherit;font-size:10pt;"> co-development and profit share in the United States in exchange for a reduction of milestone payments. Royalties would also be paid to bluebird in regions where there is no profit share, including in the United States, if bluebird declines to exercise their co-development and profit sharing rights.&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement has a termination date of March&#160;19, 2016 and we have the option to extend the agreement until March&#160;19, 2019 with the payment of extension fees.&#160; Further, we have the ability to terminate the collaboration at our discretion upon 90 days written notice to bluebird.&#160; If a product is optioned, the parties will enter into a pre-negotiated license agreement and potentially a co-development agreement should bluebird exercise its option to participate in the development and commercialization in the United States.&#160; The license agreement, if not terminated sooner, would expire upon the expiration of all applicable royalty terms under the agreement with respect to the particular product, and the co-development agreement, if not terminated sooner, would expire when the product is no longer being developed or commercialized in the United States.&#160; Upon the expiration of a particular license agreement, we will have a fully paid-up, royalty-free license to use bluebird intellectual property to manufacture, market, use and sell such licensed product.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">FORMA Therapeutics Holdings, LLC (FORMA):</font><font style="font-family:inherit;font-size:10pt;"> In April 2013, we entered into a collaboration arrangement with FORMA under which the parties will discover, develop and commercialize drug candidates to regulate protein homeostasis targets. Protein homeostasis, which is important in oncology, neurodegenerative and other disorders, involves a tightly regulated network of pathways controlling the biogenesis, folding, transport and degradation of proteins. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The collaboration was launched with an upfront payment that enables us to evaluate selected targets and lead assets in protein homeostasis pathways during the pre-clinical phase. We will have the right to obtain exclusive licenses with respect to the development and commercialization of multiple drug candidates outside of the United States, in exchange for research and early development payments of up to approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;">. FORMA is incentivized to advance the full complement of drug candidates through Phase I, and we will be responsible for&#160;all further global clinical development for each licensed candidate.&#160; FORMA is eligible to receive up to an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$315.0 million</font><font style="font-family:inherit;font-size:10pt;"> in potential payments based upon development, regulatory and sales objectives for the first ex-U.S. license. FORMA is also eligible to receive potential payments for successive licenses, which escalate for productivity, increasing up to a maximum of an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$430.0 million</font><font style="font-family:inherit;font-size:10pt;"> per program.&#160; In addition, FORMA will receive royalties on ex-U.S. sales and additional payments if multiple drug candidates reach defined cumulative sales objectives. The collaboration arrangement includes provisions for us to obtain rights with respect to development and commercialization of drug candidates in the United States in exchange for additional payments.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the collaboration arrangement, the parties will perform initial research and development for a term of four years. If, during such research term, a drug candidate meets certain criteria, then the parties will enter into a pre-negotiated license agreement and the collaboration will continue until all license agreements and all applicable royalty terms have expired. Each license agreement, if not terminated sooner would expire upon the expiration of all applicable royalty terms under such agreement. Upon the expiration of each license agreement, we will have an exclusive, fully-paid, royalty-free license to use the applicable FORMA intellectual property to manufacture, market, use and sell the product developed under such agreement outside of the United States. On October 7, 2013, we entered into the first ex-US license with FORMA and paid the applicable upfront payment under such license.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">MorphoSys AG (MorphoSys):&#160;</font><font style="font-family:inherit;font-size:10pt;"> In June 2013, we signed a collaboration, license and equity purchase agreement with MorphoSys to jointly develop MOR202 globally and to co-promote MOR202 in Europe.&#160; In August 2013, the transaction became effective. MOR202 is a fully human monoclonal antibody targeting CD38 to treat patients with multiple myeloma and certain leukemias.&#160;MOR202 is currently being evaluated in a phase I/IIa trial in patients with relapsed/refractory multiple myeloma.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MorphoSys could receive up to EUR </font><font style="font-family:inherit;font-size:10pt;color:#000000;">511.0 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$664.5 million</font><font style="font-family:inherit;font-size:10pt;">) in development, regulatory and sales milestones and tiered royalties on net sales of MOR202 outside the co-promotion territory. &#160;In the co-promotion territory, MorphoSys retains a </font><font style="font-family:inherit;font-size:10pt;color:#000000;">50</font><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:10pt;color:#000000;">50</font><font style="font-family:inherit;font-size:10pt;"> profit sharing right on MOR202 in exchange for paying one third of the MOR202 development costs. Should MorphoSys choose to opt out of its co-promotion rights, MorphoSys would receive tiered royalties on net sales of MOR202 globally. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement may be terminated at our discretion upon six months written notice to MorphoSys, or by either party upon material breach of the other party. Upon the expiration of the agreement, we will have a fully paid-up, irrevocable, perpetual, non-terminable license to use the intellectual property licensed from MorphoSys to research, develop, make, commercialize, use and sell MOR202.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acetylon Pharmaceuticals, Inc. (Acetylon):</font><font style="font-family:inherit;font-size:10pt;"> In July 2013, we entered into a collaboration and option agreement with Acetylon. Under the agreement, the parties will support the development of Acetylon's portfolio of oral, selective HDAC inhibitors in oncology, hematology, immunology and neurologic disease indications. In addition, we have rights to receive certain research and development services from Acetylon and an exclusive right to acquire Acetylon at a later date at a purchase price based upon future independent company valuations. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The collaboration focuses on the continued clinical advancement of Acetylon's lead candidate, ACY-1215, an HDAC6 inhibitor being developed for hematological malignancies, ACY-738 for neurological diseases, an HDAC1/2 inhibitor and a yet unnamed project, spanning cancer and non-cancer disease indications. Under the agreement, we made an upfront payment to Acetylon, which included a fee for entering into the collaboration, fees for the exclusive right to acquire Acetylon and the rights to receive certain research and development services from Acetylon. During the term of the agreement, Acetylon will retain control of its drug development programs. If we exercise our right to acquire Acetylon, in addition to the purchase price based upon independent company valuations to be paid at the time of the acquisition, Acetylon shareholders will be eligible to receive potential future milestone payments for approvals, or additional indications, of drugs developed by Acetylon and for accomplishing defined sales targets. If all the milestones are achieved, the aggregate amount of the milestone payments would be </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$1.100 billion</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement has an expiration date of December 31, 2015 and we have the right to extend the agreement until either June 30, 2016 or December 31, 2016 with the payment of an extension fee. Further, we have the ability to terminate the agreement at our discretion upon written notice to Acetylon.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">OncoMed Pharmaceuticals, Inc. (OncoMed):</font><font style="font-family:inherit;font-size:10pt;"> On December 2, 2013, we entered into a collaboration agreement to jointly develop and commercialize up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">six</font><font style="font-family:inherit;font-size:10pt;"> anti-cancer stem cell (CSC) product candidates from OncoMed&#8217;s biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). OncoMed will control and conduct initial clinical studies. We will have an option to license worldwide rights to up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">six</font><font style="font-family:inherit;font-size:10pt;"> novel anti-CSC therapeutic candidates commencing upon the completion of enrollment of patients in a phase I trial (and with respect to Demcizumab, a phase II trial) and ending </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">60</font><font style="font-family:inherit;font-size:10pt;"> days after delivery by OncoMed of the applicable data package for each therapeutic candidate, subject to certain extensions.&#160; We will also have research, development and commercialization rights to small molecule compounds in another cancer stem cell pathway, with OncoMed eligible to receive milestones and royalties on any resulting products.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Demcizumab is currently in three phase Ib clinical studies in combination with standard-of-care therapeutics, including a trial in patients with first-line advanced pancreatic cancer. Subsequent to the exercise of our option rights, the parties will co-develop demcizumab and share global development costs on a one-third OncoMed and two-thirds Celgene split. Outside the United States, we would lead development and commercialization efforts, with OncoMed eligible to receive milestones and tiered royalties on sales outside the United States.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to demcizumab, the collaboration includes up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">five</font><font style="font-family:inherit;font-size:10pt;"> preclinical- or discovery-stage biologics programs: OncoMed&#8217;s anti-DLL4/VEGF bispecific antibody and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">four</font><font style="font-family:inherit;font-size:10pt;"> additional biologics programs targeting either the RSPO-LGR CSC pathway or another CSC pathway. We have exclusive options on these programs during or after completion of certain phase I clinical trials to be conducted by OncoMed, which if exercised, contain U.S. profit sharing and co-commercialization terms, plus one-third OncoMed and two-thirds Celgene global development cost-sharing and royalties outside the profit-sharing territory. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The collaboration agreement also includes option exercise payments and payments for achievement of development, regulatory and commercial milestones, paid on a per-program basis. For the demcizumab program, these contingent payments could total up to approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$790.0 million</font><font style="font-family:inherit;font-size:10pt;">, and include a payment for achievement of predetermined safety criteria in phase II clinical trials. For the anti-DLL4/VEGF bispecific antibody program, contingent payments could total up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$505.0 million</font><font style="font-family:inherit;font-size:10pt;">. For the other four programs, each program is eligible for up to approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$440.0 million</font><font style="font-family:inherit;font-size:10pt;"> of contingent payments. OncoMed could also receive more than </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> in contingent payments for the small molecule program. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The collaboration agreement may be terminated by us on a program-by-program basis upon one hundred twenty (</font><font style="font-family:inherit;font-size:10pt;color:#000000;">120</font><font style="font-family:inherit;font-size:10pt;">) days prior written notice before exercise of that program option, and after such program option exercise, by either party for material breach by the other party. With certain exceptions, the collaboration agreement expires upon the later of (a) the last-to-expire option term and (b) if one or more options are exercised, the termination or expiration of the last to expire agreement with respect to such exercised option.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Collaboration Arrangements in 2013:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;In addition to the collaboration arrangements described above, we entered into a number of collaborative arrangements during 2013 that resulted in </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$52.1 million</font><font style="font-family:inherit;font-size:10pt;"> of assets for investments in equity or other assets and research and development expenses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$149.0 million</font><font style="font-family:inherit;font-size:10pt;">. These additional arrangements entered into during 2013 include the potential for future milestone payments of up to an aggregate </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$373.0 million</font><font style="font-family:inherit;font-size:10pt;"> related to the attainment of specified development and regulatory approval milestones over a period of several years. Our obligation to fund these efforts is contingent upon continued involvement in the programs and/or the lack of any adverse events which could cause the discontinuance of the programs. We do not consider these collaboration arrangements to be individually significant at this time.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized financial information related to our collaboration agreements is presented below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.0390625%;border-collapse:collapse;text-align:left;"><tr><td colspan="27" rowspan="1"></td></tr><tr><td width="13%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="16" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended December 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December 31,</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and Development Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Upfront </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Fees</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Milestones</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Extension of </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Agreements</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of Prepaid Research and </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additional Equity Investments </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Made</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible Asset </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Balance</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity Investment </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Balance</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Percentage of Outstanding </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Equity</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acceleron</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">127.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010 and prior</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Agios</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">113.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010 and prior</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Epizyme</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">69.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">65.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">bluebird</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">FORMA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">MorphoSys</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">94.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">61.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">61.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acetylon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Oncomed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">155.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td rowspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other Collaboration Arrangements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">149.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">113.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">103.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font><font style="font-family:inherit;font-size:10pt;"> Year-end balance and percentage of outstanding equity are presented for the current and prior year.</font></div></div> 544800000 308500000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Value Rights: </font><font style="font-family:inherit;font-size:10pt;">In connection with the acquisition of Abraxis in 2010, CVRs were issued under a Contingent Value Rights Agreement, or CVR Agreement, entered into between Celgene and American Stock Transfer&#160;&amp; Trust Company,&#160;LLC, as trustee. The CVRs are registered for trading on the NASDAQ Global Market under the symbol "CELGZ." The fair value of the liability of the Company related to payments under the CVR Agreement are subject to fluctuation based on trading prices for the publicly traded CVRs. Subsequent to the Abraxis Acquisition Date, we measured the contingent consideration represented by the CVRs at fair value with changes in fair value recognized in operating earnings. The fair value of our liability related to the CVRs was </font><font style="font-family:inherit;font-size:10pt;">$118.1 million</font><font style="font-family:inherit;font-size:10pt;"> at the end of 2013 compared to </font><font style="font-family:inherit;font-size:10pt;">$277.4 million</font><font style="font-family:inherit;font-size:10pt;"> at the end of 2012.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each holder of a CVR is entitled to receive a </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">pro rata</font><font style="font-family:inherit;font-size:10pt;"> portion, based on the number of CVRs then outstanding, of each of the following contingent cash payments:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Milestone Payment #1.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;color:#000000;">$250.0 million</font><font style="font-family:inherit;font-size:10pt;"> upon FDA approval of ABRAXANE&#174; for use in the treatment of NSCLC if such approval permits us to market ABRAXANE&#174; with FDA approval that includes a progression-free survival, or PFS, claim, but only if this milestone is achieved no later than the fifth anniversary of the Merger.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Milestone Payment #2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;color:#000000;">$400.0 million</font><font style="font-family:inherit;font-size:10pt;"> (if achieved no later than April&#160;1, 2013) or </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> (if achieved after April&#160;1, 2013 and before the fifth anniversary of the Merger) upon FDA approval of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> for use in the treatment of pancreatic cancer, if such approval permits us to market ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> with FDA approval that includes an overall survival claim.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net Sales Payments.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;For each full </font><font style="font-family:inherit;font-size:10pt;color:#000000;">one</font><font style="font-family:inherit;font-size:10pt;">-year period ending December&#160;31 during the term of the CVR Agreement, which we refer to as a net sales measuring period (with the first net sales measuring period beginning January&#160;1, 2011 and ending December&#160;31, 2011):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#9702;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;">2.5%</font><font style="font-family:inherit;font-size:10pt;"> of the net sales of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and the Abraxis pipeline products that exceed </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$1.000 billion</font><font style="font-family:inherit;font-size:10pt;"> but are less than or equal to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$2.000 billion</font><font style="font-family:inherit;font-size:10pt;"> for such period, plus</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#9702;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">an additional amount equal to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">5%</font><font style="font-family:inherit;font-size:10pt;"> of the net sales of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and the Abraxis pipeline products that exceed </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$2.000 billion</font><font style="font-family:inherit;font-size:10pt;"> but are less than or equal to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$3.000 billion</font><font style="font-family:inherit;font-size:10pt;"> for such period, plus</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">&#9702;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">an additional amount equal to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">10%</font><font style="font-family:inherit;font-size:10pt;"> of the net sales of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and the Abraxis pipeline products that exceed </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$3.000 billion</font><font style="font-family:inherit;font-size:10pt;"> for such period.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No payments will be due under the CVR Agreement with respect to net sales of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and the Abraxis pipeline products after December&#160;31, 2025, which we refer to as the net sales payment termination date, unless net sales for the net sales measuring period ending on December&#160;31, 2025 are equal to or greater than </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$1.000 billion</font><font style="font-family:inherit;font-size:10pt;">, in which case the net sales payment termination date will be extended until the last day of the first net sales measuring period subsequent to December&#160;31, 2025 during which net sales of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and the Abraxis pipeline products are less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$1.000 billion</font><font style="font-family:inherit;font-size:10pt;"> or, if earlier, December&#160;31, 2030.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Milestone Payment #1 update: </font><font style="font-family:inherit;font-size:10pt;">In October 2012, the FDA approved ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> for the first-line treatment of locally advanced or metastatic NSCLC, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. The FDA approval was based on tumor response rates and did not result in the use of a marketing label that includes a progression-free survival claim, and accordingly, the CVR Milestone Payment #1, as described above, has not been achieved. This approval resulted in the related </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$1.172 billion</font><font style="font-family:inherit;font-size:10pt;"> intangible asset obtained from the Abraxis acquisition being reclassified in October 2012 from an acquired IPR&amp;D intangible to an acquired developed product rights intangible asset and amortization commenced in October 2012.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Milestone Payment #2 update:</font><font style="font-family:inherit;font-size:10pt;"> In September 2013, the FDA approved ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> for use in the treatment of pancreatic cancer, permitting us to market ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> with a label that includes an overall survival claim. This approval resulted in the achievement of milestone #2 and the subsequent payment of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> to CVR holders in October 2013. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We lease offices and research facilities under various operating lease agreements in the United States and international markets. We also lease automobiles and certain equipment in these same markets. At December&#160;31, 2013, the non-cancelable lease terms for the operating leases expire at various dates between 2014 and 2023 and include renewal options. In general, the Company is also required to reimburse the lessors for real estate taxes, insurance, utilities, maintenance and other operating costs associated with the leases.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments under non-cancelable operating leases as of December&#160;31, 2013 are:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total rental expense under operating leases was approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$50.9 million</font><font style="font-family:inherit;font-size:10pt;"> in 2013, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$41.9 million</font><font style="font-family:inherit;font-size:10pt;"> in 2012 and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$48.1 million</font><font style="font-family:inherit;font-size:10pt;"> in 2011.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lines of Credit:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We maintain lines of credit with several banks to support its hedging programs and to facilitate the issuance of bank letters of credit and guarantees on behalf of its subsidiaries. Lines of credit supporting our hedging programs as of December&#160;31, 2013 allowed us to enter into derivative contracts with settlement dates through 2016. As of December&#160;31, 2013, we have entered into derivative contracts with net notional amounts totaling </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$7.635 billion</font><font style="font-family:inherit;font-size:10pt;">. Lines of credit facilitating the issuance of bank letters of credit and guarantees as of December&#160;31, 2013 allowed us to have letters of credit and guarantees issued on behalf of our subsidiaries totaling </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$86.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Commitments:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Our obligations related to product supply contracts totaled </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$153.7 million</font><font style="font-family:inherit;font-size:10pt;"> at December&#160;31, 2013. We are also committed to pay the remaining </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$14.6 million</font><font style="font-family:inherit;font-size:10pt;"> balance due from our acquisition of a manufacturing facility in Switzerland. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the sale of certain non-core assets in April 2011 (see Note 2) we committed to make certain future contingent matching contributions and an additional milestone-based contingent contribution to the CSS Institute. Under the terms of the agreement, we were obligated to make </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> additional contributions of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> based on like amounts of other third-party contributions being received by the CSS Institute and a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> milestone-based contribution contingent upon the CSS Institute achieving specified results related to the collection of DNA data and genomic sequences and the initiation of research and development alliances to be achieved before December&#160;31, 2015. In conjunction with a September 2013 equity investment, the parent company of NantHealth LLC assumed, and agreed to pay and satisfy when due, our obligation to pay CSS Institute the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> contingent, milestone-based contribution. Subsequent to December 31, as part of the January 2014 equity investment in NantBioScience, the parent company of NantBioScience assumed, and agreed to pay and satisfy when due, our obligation to pay CSS Institute the </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> contingent, matching contributions.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Collaboration Arrangements:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We have entered into certain research and development collaboration agreements, as identified in Note&#160;17 above, with third parties that include the funding of certain development, manufacturing and commercialization efforts with the potential for future milestone and royalty payments upon the achievement of pre-established developmental, regulatory and/or commercial targets. Our obligation to fund these efforts is contingent upon continued involvement in the programs and/or the lack of any adverse events which could cause the discontinuance of the programs. Due to the nature of these arrangements, the future potential payments are inherently uncertain, and accordingly no amounts have been recorded for the potential future achievement of these targets in our accompanying Consolidated Balance Sheets at December&#160;31, 2013 and 2012.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We believe we maintain insurance coverage adequate for our current needs. Our operations are subject to environmental laws and regulations, which impose limitations on the discharge of pollutants into the air and water and establish standards for the treatment, storage and disposal of solid and hazardous wastes. We review the effects of such laws and regulations on our operations and modify our operations as appropriate. We believe we are in substantial compliance with all applicable environmental laws and regulations.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have ongoing customs, duties and VAT examinations in various countries that have yet to be settled. Based on our knowledge of the claims and facts and circumstances to date, none of these matters, individually or in the aggregate, are deemed to be material to our financial condition.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Like many companies in our industry, we have from time to time received inquiries and subpoenas and other types of information requests from government authorities and we have been subject to claims and other actions related to our business activities.&#160; While the ultimate outcome of investigations and legal proceedings are difficult to predict, adverse resolutions or settlements of those matters may result in, among other things, modification of our business practices, product recalls, costs and significant payments, which may have a material adverse effect on our results of operations, cash flows or financial condition.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pending patent proceedings include challenges to the scope, validity or enforceability of our patents relating to certain of our products or processes. Further, we are subject to claims of third parties that we infringe their patents covering products or processes. Although we believe we have substantial defenses to these challenges and claims, there can be no assurance as to the outcome of these matters and an adverse decision in any of these proceedings could result in (i) a loss of patent protection, which could lead to a significant reduction of sales that could materially affect future results of operations, (ii) our inability to continue to engage in infringing activities, and (iii) significant liabilities, including payment of damages, royalties and/or license fees to any such third party.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among the principal matters pending are the following:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investigative Proceedings:</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2009, we received a Civil Investigative Demand (CID) from the U.S. Federal Trade Commission (FTC) seeking documents and other information relating to requests by generic companies to purchase our patented REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;brand drugs in order for the FTC to evaluate whether there may be reason to believe that we have engaged in unfair methods of competition relating to requests by generic companies to purchase our patented REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;brand drugs.&#160; In 2010, the State of Connecticut issued a subpoena referring to the same issues raised by the 2009 CID. Also in 2010, we received a second CID from the FTC relating to this matter.&#160; We continue to cooperate with the FTC and State of Connecticut investigations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2011, the United States Attorney&#8217;s Office for the Central District of California informed us that they are investigating possible off-label marketing and improper payments to physicians in connection with the sales of THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;and REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">.&#160; In 2012, we learned that </font><font style="font-family:inherit;font-size:10pt;color:#000000;">two</font><font style="font-family:inherit;font-size:10pt;"> other United States Attorneys&#8217; offices (the Northern District of Alabama and the Eastern District of Texas) and various state Attorneys General were conducting related investigations.&#160; In February 2014, three civil qui tam actions related to those investigations brought by three former Celgene employees on behalf of the federal and various state governments under the False Claims Act and certain state laws,&#160; were unsealed after the United States Department of Justice (DOJ) declined to intervene in these actions. The DOJ maintains the right to intervene at any time. The three actions are as follows: (i) United States of America ex rel. James Patrick Eddins, Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Northern District of Alabama (the &#8220;Northern District of Alabama action&#8221;), (ii) David Schmidt, by and on behalf of the United States of America and various States, ex rel. Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Eastern District of Texas, and (iii) United States of America and various States, ex rel. Beverly Brown Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Central District of California. The plaintiff in the Northern District of Alabama action voluntarily dismissed that case. We intend to vigorously defend against the two remaining civil actions.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patent Related Proceedings:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">: We received Notice Letters, the first of which was dated August 30, 2010, from Natco Pharma Limited of India (Natco) notifying us of Natco&#8217;s Abbreviated New Drug Application (ANDA), which contains Paragraph IV certifications against certain of Celgene&#8217;s patents that are listed in the FDA </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Approved Drug Products With Therapeutic Equivalence Evaluations</font><font style="font-family:inherit;font-size:10pt;"> (the &#8220;Orange Book&#8221;) for REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;(lenalidomide). Natco&#8217;s Notice Letters were sent in connection with its filing of an ANDA seeking permission from the FDA to market a generic version of 25mg, 15mg, 10mg and 5mg REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;capsules. In response to the Notice Letters, we filed infringement actions in the United States District Court for the District of New Jersey against Natco, Natco&#8217;s U.S. partner, Arrow International Limited (Arrow), and Watson Laboratories, Inc. (Watson, a wholly-owned subsidiary of Actavis, Inc. (formerly known as Watson Pharmaceuticals, Inc.), which is Arrow&#8217;s parent) (Natco, Arrow and Watson are collectively referred to hereinafter as &#8220;Natco&#8221;).&#160;In its answer and counterclaim, Natco asserts that our patents are invalid, unenforceable and/or not infringed by Natco&#8217;s proposed generic products.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The patents in dispute include United States Patent Nos. 5,635,517, 6,045,501, 6,315,720, 6,555,554, 6,561,976, 6,561,977, 6,755,784, 7,119,106, 7,465,800, 6,281,230, 7,189,740, 7,855,217, 7,968,569, 8,288,415, 8,315,886, 8,404,717 and 8,431,598 plus two non-Orange Book listed patents, United States Patent Nos. 7,977,357 and 8,193,219.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 11, 2013, the court set the close of fact discovery for April 21, 2014. Claim construction is currently expected to be fully briefed by April 8, 2014. Dates for a claim construction hearing and trial have yet to be set.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that Natco&#8217;s defenses and counterclaims are unlikely to be sustained and we intend to vigorously assert our patent rights.&#160; Although there can be no assurance as to the ultimate outcome of this proceeding, we currently expect that it will not have a material adverse effect on our financial condition or results of operations. However, if Natco is successful in challenging all the patents in dispute or if the court rules that certain of our key patent claims are invalid or not infringed, such events could have a material adverse effect on our financial condition and results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:10pt;"> On December 14, 2011, Cephalon, Inc. and Acusphere, Inc. filed a complaint against us in the United States District Court for the District of Massachusetts, alleging, among other things, that the making, using, selling, offering to sell and importing&#160;of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;brand drug infringes claims of United States Patent No. RE40,493. Plaintiffs are seeking damages and injunctive relief. On December 3, 2013, the court issued an order construing certain disputed claim terms in accordance with Celgene&#8217;s proposed construction for several key terms. We intend to vigorously defend against this infringement suit.&#160; If the suit against us is successful, we may have to pay damages, ongoing royalties and may have to license rights from plaintiffs.&#160; However, we believe that (a) it is unlikely that the plaintiffs in this matter will prevail and (b) the ultimate outcome will not have a material adverse effect on our financial condition or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">VIDAZA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:10pt;"> On September 28, 2012, we were named as a defendant in a lawsuit filed by Ivax LLC (formerly Ivax Corporation) (&#8220;Ivax&#8221;) in the United States District Court for the Southern District of Florida.&#160; Ivax alleged that we infringed the claims of United States Patent No. 7,759,481 (the &#8220;&#8216;481 patent&#8221;) by making, using and selling VIDAZA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;brand drug in the United States. In December 2013 the parties reached a resolution in which the patent infringement lawsuit was voluntarily dismissed by Ivax with prejudice with no payments by Celgene to Ivax.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">On October 2, 2013, Andrulis Pharmaceuticals Corporation (Andrulis) filed a lawsuit against us in the United States District Court for the District of Delaware claiming infringement of U.S. Patent No. 6,140,346 (&#8220;the &#8216;346 patent&#8221;).&#160; Andrulis alleges that we are liable for infringement of one or more claims of the &#8216;346 patent which covers the use of THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> (and, as asserted by Andrulis, REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">) in combination with an alkylating agent (e.g., melphalan) to treat cancers.&#160; Andrulis is seeking an unspecified amount of damages, attorneys&#8217; fees and injunctive relief. We disagree with Andrulis&#8217; allegations and intend to vigorously defend against this infringement suit. On November 25, 2013, we filed a motion to dismiss Andrulis&#8217; complaint. Andrulis&#8217; motion seeking leave to file an amended complaint, was granted by the court on December 30, 2013. We filed a motion to dismiss Andrulis&#8217; amended complaint on January 30, 2014. We expect that the ultimate outcome of this lawsuit will not have a material adverse effect on our financial condition or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Proceedings:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 7, 2013, Children's Medical Center Corporation (CMCC) filed a lawsuit against us in the Superior Court of the Commonwealth of Massachusetts alleging that&#160;our obligation to pay a </font><font style="font-family:inherit;font-size:10pt;color:#000000;">1%</font><font style="font-family:inherit;font-size:10pt;"> royalty on REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> net sales revenue and a </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2.5%</font><font style="font-family:inherit;font-size:10pt;"> royalty on POMALYST</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">/IMNOVID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> net sales revenue under&#160;a license agreement entered into in December 2002&#160; extended beyond February 28, 2013 and that our failure&#160;to make royalty payments to CMCC subsequent to February 28, 2013&#160;breached&#160;the license agreement.&#160; CMCC is seeking unspecified damages and a declaration that the license agreement remains in full force and effect.&#160; In July 2013, we removed these proceedings to the United States District Court for the District of Massachusetts. On August 5, 2013, we filed an answer to CMCC&#8217;s complaint and a counterclaim for declaratory judgment that our obligations to pay royalties have expired. On August 26, 2013, CMCC filed an answer to our counterclaim. A scheduling conference was held on February 11, 2014 and the court ordered fact discovery to be completed by December 15, 2014. No trial date has as yet been set by the court. We intend to vigorously defend against CMCC's claims. As of December 31, 2013, we consider the range of reasonably possible loss relating to this lawsuit to be between </font><font style="font-family:inherit;font-size:10pt;color:#000000;">zero</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$35.9 million</font><font style="font-family:inherit;font-size:10pt;">, with the high end of the range being the royalty payments on REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> we would have made under the license agreement through December 31, 2013, if it had remained in effect. CMCC contends that our royalty obligation continues on sales of REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> at least until May 2016 and if CMCC prevails, we may be obligated to continue to pay royalties for periods after December 31, 2013.</font></div></div> 0.01 0.01 575000000.0 575000000.0 498400000 511200000 511200000 487400000 482200000 49900000 78700000 498400000 11800000 101500000 5000000 5100000 1329500000 1468800000 1593600000 0 0 -700000 1468800000 1593600000 1328800000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;Accumulated Other Comprehensive Income (Loss)</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of other comprehensive income (loss) consist of changes in pension liability, changes in net unrealized gains (losses) on marketable securities classified as available-for-sale, net unrealized gains (losses) related to cash flow hedges and changes in foreign currency translation adjustments, which includes changes in a subsidiary's functional currency and net asset transfers of common control subsidiaries.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accumulated balances related to each component of other comprehensive income (loss), net of tax, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gains (Losses) From</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gains (Losses)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance December&#160;31, 2011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Period change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Period change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="181px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="146px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="69px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="69px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="69px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;vertical-align:top;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gains (Losses) Reclassified Out of Accumulated</font></div><div style="text-align:center;vertical-align:top;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other Comprehensive Income</font></div></td></tr><tr><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Income Components</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Affected Line Item in the Consolidated Statements of Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Years Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gains (losses) from cash-flow hedges:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net product sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Treasury rate lock agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest (expense)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax benefit (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gains (losses) from available-for-sale marketable securities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Realized income (loss) on sales of marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest and investment income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total reclassification, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">76.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risk:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Cash, cash equivalents and marketable securities are financial instruments that potentially subject the Company to concentration of credit risk. We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency MBS, non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities (See Note&#160;6). We have established guidelines relative to diversification and maturities to maintain safety and liquidity. These guidelines are reviewed periodically and may be modified to take advantage of trends in yields and interest rates.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We sell our products in the United States primarily through wholesale distributors and specialty contracted pharmacies. Therefore, wholesale distributors and large pharmacy chains account for a large portion of our U.S. trade receivables and net product revenues (See Note&#160;19). International sales are primarily made directly to hospitals, clinics and retail chains, many of which in Europe are government owned and have extended their payment terms in recent years given the economic pressure these countries are facing. We continuously monitor the creditworthiness of our customers, including these governments, and have internal policies regarding customer credit limits. We estimate an allowance for doubtful accounts primarily based on the credit worthiness of our customers, historical payment patterns, aging of receivable balances and general economic conditions, including publicly available information on the credit worthiness of countries themselves and provinces or areas within such countries where they are the ultimate customers.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We continue to monitor economic conditions, including the volatility associated with international economies, the sovereign debt crisis in certain European countries and associated impacts on the financial markets and our business. Our current business model in these markets is typically to sell our products directly to principally government owned or controlled hospitals, which in turn directly deliver critical care to patients. Our products are used to treat life-threatening diseases and we believe this business model enables timely delivery and adequate supply of products. Many of the outstanding receivable balances are related to government-funded hospitals and we believe the receivable balances are ultimately collectible. Similarly, we believe that future sales to these customers will continue to be collectible.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The credit and economic conditions within Spain, Italy, Portugal and Greece, as well as increasing sales levels in those countries have resulted in, and may continue to result in, an increase in the average length of time it takes to collect accounts receivable. Our total net receivables in Spain, Italy and Portugal are composed almost entirely of amounts receivable from government-owned or controlled hospitals and the public sector and amounted to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$348.4 million</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2013, compared to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$324.2 million</font><font style="font-family:inherit;font-size:10pt;"> at December&#160;31, 2012. Approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$86.4 million</font><font style="font-family:inherit;font-size:10pt;"> of the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$348.4 million</font><font style="font-family:inherit;font-size:10pt;"> receivable at December&#160;31, 2013 was greater than one year past due. Our exposure to the sovereign debt crisis in Greece is limited, as we do not have a material amount of receivables in Greece. We maintain timely and direct communication with hospital customers in Spain, Italy and Portugal regarding both the current and past due receivable balances. We continue to receive payments from these countries, and closely monitor the plans for payment at the regional government level. Payments from customers in these countries are not received on regular intervals and several months could elapse between significant payments. We also regularly request and receive positive confirmation of the validity of our receivables from most of the regional governmental authorities.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In determining the appropriate allowance for doubtful accounts for Spain, Italy and Portugal, we considered that the balance of past due receivables is related to sales made to government-owned or supported customers. We regularly monitor developments in Europe to assess whether the level of risk of default for any customers has increased and note the ongoing efforts by the European Union, European Monetary Union and International Monetary Fund to support countries with large public deficits and outstanding debt balances. We also monitor the efforts of individual countries to support their regions with large public deficits and outstanding debt balances. We have not experienced significant losses or write-offs with respect to the collection of our accounts receivable in these countries as a result of their economic difficulties and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse impact on our financial position or results of operations.</font></div></div> 0.096 0.064 0.107 0.115 0.126 14600000 299100000 340400000 425900000 4685000000 3399400000 3760300000 101500000 100800000 352600000 64100000 55400000 53800000 33200000 45400000 -31800000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Senior Notes:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Summarized below are the carrying values of our senior notes at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.450% senior notes due 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">520.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.900% senior notes due 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.300% senior notes due 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.950% senior notes due 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.250% senior notes due 2022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">956.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,002.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.000% senior notes due 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.700% senior notes due 2040</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.250% senior notes due 2043</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">396.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,196.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,771.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, the fair value of our outstanding Senior Notes was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4.269 billion</font><font style="font-family:inherit;font-size:10pt;"> and represented a Level&#160;2 measurement within the fair value measurement hierarchy.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2013, we issued an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.500 billion</font><font style="font-family:inherit;font-size:10pt;"> principal amount of senior notes consisting of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$400.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2.300%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2018 (the 2018 notes), </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">4.000%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2023 (the 2023 notes) and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$400.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5.25%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2043 (the 2043 notes) and, together with the 2018 notes and 2023 notes, referred to herein as the "2013 issued notes". The 2013 issued notes were issued at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">99.792%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">99.452%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">99.147%</font><font style="font-family:inherit;font-size:10pt;"> of par, respectively, and the discount is being amortized as additional interest expense over the period from issuance through maturity. Offering costs of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;"> have been recorded as debt issuance costs on our Consolidated Balance Sheets and are being amortized as additional interest expense using the effective interest rate method over the period from issuance through maturity. Interest on the notes is payable semi-annually in arrears on February&#160;15 and August&#160;15 each year beginning February&#160;15, 2014 and the principal on each note is due in full at their respective maturity dates.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The notes may be redeemed at the option of the Company, in whole or in part, at any time at a redemption price defined in a make-whole clause equaling accrued and unpaid interest plus the greater of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the notes to be redeemed or the sum of the present values of the remaining scheduled payments of interest and principal. If we experience a change of control accompanied by a downgrade of the debt to below investment grade, we will be required to offer to repurchase the notes at a purchase price equal to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">101%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount plus accrued and unpaid interest. We are subject to covenants which limit our ability to pledge properties as security under borrowing arrangements and limit our ability to perform sale and leaseback transactions involving our property.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2012, we entered into treasury rate locks in anticipation of issuing the fixed-rate notes that were issued in August 2012. As of December 31, 2013, a balance of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$30.6 million</font><font style="font-family:inherit;font-size:10pt;"> in losses remained in OCI related to treasury rate locks and will be recognized as interest expense over the life of the 2017 notes and the 2022 notes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2013, we were party to pay-floating, receive-fixed interest rate swap contracts designated as fair value hedges</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of fixed-rate notes as described in Note 5. Our swap contracts outstanding at December 31, 2013 effectively convert the hedged portion of our fixed-rate notes to floating rates. From time to time we terminate the hedging relationship on certain of our swap contracts by settling the contracts or by entering into offsetting contracts. Any net proceeds received or paid in these settlements are accounted for as a reduction or increase of current and future interest expense associated with the previously hedged notes. As of December 31, 2013 and 2012, we had balances of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$32.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$25.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in unamortized gains recorded as a component of our debt as a result of past swap contract settlements. During 2013, we terminated the hedging relationship on certain of our swap contracts, resulting in gains of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$15.8 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Commercial Paper:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;The carrying value of Commercial Paper as of December&#160;31, 2013 and 2012 was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$544.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$308.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and approximated its fair value. The effective interest rate on the outstanding Commercial Paper balance at December&#160;31, 2013 was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">0.4%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Senior Unsecured Credit Facility:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We maintain a senior unsecured revolving credit facility (Credit Facility) that provides revolving credit in the aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$1.500 billion</font><font style="font-family:inherit;font-size:10pt;">, which was increased from </font><font style="font-family:inherit;font-size:10pt;">$1.000 billion</font><font style="font-family:inherit;font-size:10pt;"> in April 2013. During April 2013, the term of the Credit Facility was also extended from September&#160;2, 2016 to April&#160;18, 2018.&#160;&#160; Subject to certain conditions, we have the right to increase the amount of the Credit Facility (but in no event more than </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> time per annum) up to a maximum aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$1.750 billion</font><font style="font-family:inherit;font-size:10pt;">.&#160; Amounts may be borrowed in U.S. dollars for working capital, capital expenditures and other corporate purposes. The Credit Facility currently serves as backup liquidity for our Commercial Paper borrowings.&#160; At December 31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding borrowing against the Credit Facility.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Facility contains affirmative and negative covenants including certain customary financial covenants.&#160; We were in compliance with all financial covenants as of December 31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> 700000000.0 400000000.0 400000000.0 1500000000.000 0.02300 0.04 0.0525 0.0245 0.0525 0.0525 0.0245 0.019 0.0230 0.04 0.057 0.03950 0.03950 0.03250 0.04 0.0190 0.0230 0.057 0.03250 1 127200000 99200000 73700000 59800000 28900000 12500000 -18600000 -1500000 -7100000 15800000 32100000 25500000 -85800000 100200000 -246600000 27700000 17300000 16200000 23700000 2300000 2300000 715500000 574200000 37100000 6100000 6300000 8400000 -723200000 -876100000 532500000 680000000 93200000 25300000 56400000 49100000 5300000 12600000 32700000 26800000 71400000 17300000 4200000 4100000 183300000 164400000 116100000 161300000 17300000 0 35500000 41700000 -1600000 1408600000 1403200000 0 0 1005000000 1069200000 804900000 1018400000 9300000 700000 13600000 9600000 316500000 316500000 71400000 6129000000 20700000 32600000 19300000 96900000 71200000 84900000 41900000 25600000 700000 24900000 12700000 13800000 36300000 200000 P5Y P10Y P10Y P5Y 5000000 22900000 100000 4300000 17100000 206000000 11300000 60600000 63600000 1500000 35200000 600000 1700000 100000 133500000 30500000 45800000 100000 84700000 264800000 18700000 68300000 21400000 31400000 600000 116400000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Instruments and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our revenue and earnings, cash flows and fair values of assets and liabilities can be impacted by fluctuations in foreign exchange rates and interest rates. We actively manage the impact of foreign exchange rate and interest rate movements through operational means and through the use of various financial instruments, including derivative instruments such as foreign currency option contracts, foreign currency forward contracts, treasury rate lock agreements and interest rate swap contracts.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Risk Management</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We maintain a foreign exchange exposure management program to mitigate the impact of volatility in foreign exchange rates on future foreign currency cash flows, translation of foreign earnings and changes in the fair value of assets and liabilities denominated in foreign currencies.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Through our revenue hedging program, we endeavor to reduce the impact of possible unfavorable changes in foreign exchange rates on our future U.S. dollar cash flows that are derived from foreign currency denominated sales. To achieve this objective, we hedge a portion of our forecasted foreign currency denominated sales that are expected to occur in the foreseeable future, typically within the next three years. We manage our anticipated transaction exposure principally with foreign currency forward contracts and occasionally foreign currency put and call options.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Forward Contracts:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;We use foreign currency forward contracts to hedge specific forecasted transactions denominated in foreign currencies, manage exchange rate volatility in the translation of foreign earnings, and to reduce exposures to foreign currency fluctuations of certain assets and liabilities denominated in foreign currencies.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manage a portfolio of foreign currency forward contracts to protect against changes in anticipated foreign currency cash flows resulting from changes in foreign currency exchange rates, primarily associated with non-functional currency denominated revenues and expenses of foreign subsidiaries. The foreign currency forward hedging contracts outstanding at December 31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and 2012 had settlement dates within </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">36 months</font><font style="font-family:inherit;font-size:10pt;">. These foreign currency forward contracts are designated as cash flow hedges and, to the extent effective, any unrealized gains or losses on them are reported in other comprehensive income (loss) (OCI) and reclassified to operations in the same periods during which the underlying hedged transactions affect operations. Any ineffectiveness on these foreign currency forward contracts is reported in other income (expense), net. Foreign currency forward contracts entered into to hedge forecasted revenue and expenses were as follows at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and&#160;</font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Foreign Currency:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Australian Dollar</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">British Pound</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canadian Dollar</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,318.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">969.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Japanese Yen</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">559.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">236.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,156.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,422.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We consider the impact of our own and the counterparties' credit risk on the fair value of the contracts as well as the ability of each party to execute its obligations under the contract on an ongoing basis. As of December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, credit risk did not materially change the fair value of our foreign currency forward contracts.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We also manage a portfolio of foreign currency contracts to reduce exposures to foreign currency fluctuations of certain recognized assets and liabilities denominated in foreign currencies and, from time to time, we enter into foreign currency contracts to manage exposure related to translation of foreign earnings. These foreign currency forward contracts have not been designated as hedges and, accordingly, any changes in their fair value are recognized on the Consolidated Statements of Income in other income (expense), net in the current period. The aggregate notional amount of the foreign currency forward non-designated hedging contracts outstanding at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and&#160;</font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$878.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$795.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Option Contracts:</font><font style="font-family:inherit;font-size:10pt;"> From time to time, we may hedge a portion of our future foreign currency exposure by utilizing a strategy that involves both a purchased local currency put option and a written local currency call option that are accounted for as hedges of future sales denominated in euros. In connection with this strategy, we may also sell local currency put options that are not accounted for as hedges in order to reduce or fully offset the net cost of the hedging contracts. Foreign currency option contracts entered into to hedge forecasted revenue and expenses were as follows at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notional Amount</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Foreign Currency Option:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designated as hedging activity:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased Put</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written Call</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not designated as hedging activity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased Put</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written Put</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(216.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1</sup></font><font style="font-family:inherit;font-size:9pt;"> U.S. dollar notional amounts are calculated as the hedged local currency amount multiplied times the strike value of the foreign currency option. The local currency notional amounts of our purchased put and written call that are designated as hedging activities are equal to each other.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Risk Management</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In anticipation of issuing fixed-rate debt, we may use forward starting interest rate swaps (forward starting swaps) or treasury rate lock agreements (treasury rate locks) that are designated as cash flow hedges to hedge against changes in interest rates that could impact expected future issuances of debt. To the extent these hedges of cash flows related to anticipated debt are effective, any realized or unrealized gains or losses on the treasury rate locks or forward starting swaps are reported in OCI and are recognized in income over the life of the anticipated fixed-rate notes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Forward Starting Interest Rate Swaps:</font><font style="font-family:inherit;font-size:10pt;"> During 2013, we entered into forward starting swaps, that were designated as cash flow hedges, with an aggregate notional value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> and effective dates in November 2014, with </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> maturing in </font><font style="font-family:inherit;font-size:10pt;color:#000000;">five years</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$200 million</font><font style="font-family:inherit;font-size:10pt;"> maturing in </font><font style="font-family:inherit;font-size:10pt;color:#000000;">ten years</font><font style="font-family:inherit;font-size:10pt;"> to hedge against changes in interest rates that could impact an anticipated issuance of debt. During January and February 2014, we entered into additional forward starting swaps with effective dates in November 2014 and an aggregate notional value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$350.0 million</font><font style="font-family:inherit;font-size:10pt;"> and maturities of </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">ten years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Rate Lock Agreements:</font><font style="font-family:inherit;font-size:10pt;"> During&#160;2012, we entered into treasury rate locks in anticipation of issuing fixed-rate notes that were issued in August&#160;2012. The treasury rate locks were settled during&#160;2012 which resulted in losses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$35.3 million</font><font style="font-family:inherit;font-size:10pt;"> that were recorded to OCI. No material amounts were recorded in income during </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> as a result of hedge ineffectiveness or hedge components excluded from the assessment of effectiveness. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Rate Swap Contracts:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;From time to time we hedge the fair value of certain debt obligations through the use of interest rate swap contracts. The interest rate swap contracts are designated hedges of the fair value changes in the notes attributable to changes in interest rates. Since the specific terms and notional amount of the swap are intended to match those of the debt being hedged, it is assumed to be a highly effective hedge and all changes in fair value of the swap is recorded on the Consolidated Balance Sheets with no net impact recorded in income. Any net interest payments made or received on interest rate swap contracts are recognized as interest expense. We may terminate the hedging relationship of certain swap contracts by settling the contracts or by entering into offsetting contracts.&#160; At the time a hedging relationship is terminated, accumulated gains or losses associated with the swap contract are measured and recorded as a reduction of current and future interest expense associated with the previously hedged notes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have entered into swap contracts that were designated as hedges of our fixed rate notes due in 2015, 2017, 2018, 2020, 2022 and 2023 and also terminated the hedging relationship by settling certain of those swap contracts during 2012 and 2013.&#160; The settlement of swap contracts resulted in the receipt of net proceeds of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> in 2012 and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$22.9 million</font><font style="font-family:inherit;font-size:10pt;"> in 2013 which is accounted for as a reduction of current and future interest expense associated with these notes.&#160; See Note 11 for additional details related to reductions of current and future interest expense. The following table summarizes the notional amounts of our outstanding swap contracts at the end December 31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:677px;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="453px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="95px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="95px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2012</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest rate swap contracts entered into as fair value hedges of the following fixed-rate senior notes:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.450% senior notes due 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.900% senior notes due 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">300.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.300% senior notes due 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.950% senior notes due 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.250% senior notes due 2022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">850.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.000% senior notes due 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">150.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,300.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">300.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2014 we continued to actively manage our interest rate swaps and have terminated the hedging relationships of certain swap contracts and entered into new swaps that were designated as fair value hedges of our senior notes. The notional amount of our outstanding interest rate contracts at February 12, 2014 was </font><font style="font-family:inherit;font-size:10pt;">$1.850 billion</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value and presentation in the Consolidated Balance Sheets for derivative instruments as of December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="30%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Asset Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance Sheet</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance Sheet</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td></tr><tr><td colspan="9" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Derivatives designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign&#160;exchange&#160;contracts</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">84.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange contracts</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">206.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">264.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:681px;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="218px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="133px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="133px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Asset Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance Sheet</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance Sheet</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td></tr><tr><td colspan="9" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Derivatives designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign&#160;exchange&#160;contracts</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange contracts</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">133.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font><font style="font-family:inherit;font-size:8pt;">Derivative instruments in this category are subject to master netting arrangements and are presented on a net basis in the Consolidated Balance Sheets in accordance with ASC&#160;210-20.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the effect of derivative instruments designated as cash-flow hedging instruments on the Consolidated Statements of Income for the years ended December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">on Derivative</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassified from</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassified from</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Ineffective Portion</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">and Amount Excluded</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">From Effectiveness</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Testing)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Ineffective Portion</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">and Amount Excluded</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">From Effectiveness</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Testing)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign&#160;exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net product sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Treasury rate lock agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forward starting interest rate swaps</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net losses of </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$13.2 million</font><font style="font-family:inherit;font-size:8pt;"> are expected to be reclassified from Accumulated OCI into income in the next 12&#160;months.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The amount of net gains recognized in income represents </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$6.3 million</font><font style="font-family:inherit;font-size:8pt;"> of gains related to the ineffective portion of the hedging relationships and </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$6.3 million</font><font style="font-family:inherit;font-size:8pt;"> of gains related to amounts excluded from the assessment of hedge effectiveness. </font></div></td></tr></table><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:681px;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td width="118px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="84px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="118px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="81px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="108px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="91px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="21px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">on Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassified from</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassified from</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Ineffective Portion</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">and Amount Excluded</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">From Effectiveness</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Testing)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Ineffective Portion</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">and Amount Excluded</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">From Effectiveness</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Testing)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign&#160;exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net product sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">80.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Treasury rate lock agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(35.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The amount of net losses recognized in income represents </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$9.0 million</font><font style="font-family:inherit;font-size:8pt;"> in losses related to the ineffective portion of the hedging relationships and </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$2.4 million</font><font style="font-family:inherit;font-size:8pt;"> of gains related to amounts excluded from the assessment of hedge effectiveness.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the effect of derivative instruments designated as fair value hedging instruments on the Consolidated Statements of Income for the years ended December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="29%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of Gain (Loss)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized in Income</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">on Derivative</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain (Loss)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized in Income</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">on Derivative</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest Rate Swaps</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the effect of derivative instruments not designated as hedging instruments on the Consolidated Statements of Income for the years ended December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="29%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of Gain (Loss)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized in Income</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">on Derivative</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain (Loss)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized in Income</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">on Derivative</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Treasury rate lock agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Put options sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The impact of gains and losses on foreign exchange contracts not designated as hedging instruments related to changes in the fair value of assets and liabilities denominated in foreign currencies are generally offset by net foreign exchange gains and losses, which are also included in other income (expense), net for all periods presented. When we enter into foreign exchange contracts not designated as hedging instruments to mitigate the impact of exchange rate volatility in the translation of foreign earnings, gains and losses will generally be offset by fluctuations in the U.S. dollar translated amounts of each Income Statement account in current and/or future periods.</font></div></div> -1300000 80900000 -3400000 10700000 -6600000 12600000 7800000 31400000 -35300000 74500000 0 0 -9700000 35300000 300000 1200000 700000 0 0 3700000 34100000 23800000 55900000 33300000 6000000 41500000 9100000 10400000 142.81 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Instruments and Hedges:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;All derivative instruments are recognized on the balance sheet at their fair value. Changes in the fair value of derivative instruments are recorded each period in current earnings or other comprehensive income (loss), depending on whether a derivative instrument is designated as part of a hedging transaction and, if it is, the type of hedging transaction. For a derivative to qualify as a hedge at inception and throughout the hedged period, we formally document the nature and relationships between the hedging instruments and hedged item. We assess, both at inception and on an on-going basis, whether the derivative instruments that are used in cash flow hedging transactions are highly effective in offsetting the changes in cash flows of hedged items. We assess hedge ineffectiveness on a quarterly basis and record the gain or loss related to the ineffective portion of derivative instruments, if any, to current earnings. If we determine that a forecasted transaction is no longer probable of occurring, we discontinue hedge accounting and any related unrealized gain or loss on the derivative instrument is recognized in current earnings. We use derivative instruments, including those not designated as part of a hedging transaction, to manage our exposure to movements in foreign exchange, on our stock price and interest rates. The use of these derivative instruments modifies the exposure of these risks with the intent to reduce our risk or cost. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have a stockholder-approved stock incentive plan, the 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013) (Plan) which provides for the granting of options, RSUs, stock appreciation rights, PSUs and other share-based awards to our employees and officers.&#160; The Management Compensation and Development Committee of the Board of Directors (Compensation Committee) may determine the type, amount and terms, including vesting, of any awards made under the Plan.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 12, 2013, our stockholders approved an amendment and restatement of the Plan, which included the following key modifications: adoption of an aggregate share reserve of </font><font style="font-family:inherit;font-size:10pt;">105.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock, which includes </font><font style="font-family:inherit;font-size:10pt;">9.0 million</font><font style="font-family:inherit;font-size:10pt;"> new shares of Common Stock; increase in the maximum payment to an eligible employee under a cash-based performance award from </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;">; and extension of the term of the plan through April 17, 2023.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to options granted under the Plan, the exercise price may not be less than the market closing price of the common stock on the date of grant. In general, options granted under the Plan vest over periods ranging from immediate vesting to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">four</font><font style="font-family:inherit;font-size:10pt;">-year vesting and expire </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">ten</font><font style="font-family:inherit;font-size:10pt;"> years from the date of grant, subject to earlier expiration in case of termination of employment unless the participant meets the retirement provision under which the option would have a maximum of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> additional years to vest. The vesting period for options granted under the Plan is subject to certain acceleration provisions if a change in control, as defined in the Plan, occurs. Plan participants may elect to exercise options at any time during the option term. However, any shares so purchased which have not vested as of the date of exercise shall be subject to forfeiture, which will lapse in accordance with the established vesting time period.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares of common stock available for future share-based grants under all plans were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16.7 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the components of share-based compensation expense in the Consolidated Statements of Income for the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2011</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax benefit related to share-based compensation expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reduction in income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in share-based compensation expense for the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;"> was compensation expense related to non-qualified stock options of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$197.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$155.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$154.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Share-based compensation cost included in inventory was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">, respectively. We do not recognize a deferred tax asset for excess tax benefits that have not been realized and have adopted the tax law method as our accounting policy regarding the ordering of tax benefits to determine whether an excess tax benefit has been realized.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Options:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Cash received from stock option exercises for the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$551.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$476.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$166.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and the excess tax benefit recognized was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$169.4 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$49.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$31.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$463.2 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to stock options granted under the plans. That cost will be recognized over an expected remaining weighted-average period of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2.2</font><font style="font-family:inherit;font-size:10pt;">&#160;years.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average grant date fair value of the stock options granted during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$40.44</font><font style="font-family:inherit;font-size:10pt;"> per share, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$19.33</font><font style="font-family:inherit;font-size:10pt;"> per share and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$17.09</font><font style="font-family:inherit;font-size:10pt;"> per share, respectively. We estimated the fair value of options granted using a Black-Scholes option pricing model with the following assumptions:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="55%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68% - 1.70%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.21% - 1.23%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.21% - 2.20%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27% - 35%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27%&#160;-&#160;30%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27%&#160;-&#160;33%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.03 - 5.50</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.30&#160;-&#160;5.17</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.80&#160;-&#160;5.20</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The risk-free interest rate is based on the U.S. Treasury zero-coupon curve. Expected volatility of stock option awards is estimated based on the implied volatility of our publicly traded options with settlement dates of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;"> months. The use of implied volatility was based upon the availability of actively traded options on our common stock and the assessment that implied volatility is more representative of future stock price trends than historical volatility. The expected term of an employee share option is the period of time for which the option is expected to be outstanding. We made a determination of expected term by analyzing employees' historical exercise experience from its history of grants and exercises in our option database and management estimates. Forfeiture rates are estimated based on historical data.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes all stock option activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="18%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Price Per Option</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contractual</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term (Years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intrinsic Value</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(In Millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58.31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">860.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes during the Year:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,643.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested at December&#160;31, 2013 or expected to vest in the future</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.9</font></div></td><td style="vertical-align:bottom;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.46</font></div></td><td style="vertical-align:bottom;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,595.3</font></div></td><td style="vertical-align:bottom;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.81</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,945.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total fair value of shares vested during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$159.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$144.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$162.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The total intrinsic value of stock options exercised during the years ended December&#160;31, 2013, 2012 and 2011 was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$814.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$293.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$147.9 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. We primarily utilize newly issued shares to satisfy the exercise of stock options.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Stock Units:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We issue RSU, under our equity program in order to provide an effective incentive award with a strong retention component. Equity awards may, at the option of employee participants, be divided between stock options and RSUs. The employee may choose between alternate Company defined mixes of stock options and RSUs, with the number of options to be granted reduced by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">four</font><font style="font-family:inherit;font-size:10pt;"> for every one RSU to be granted. Information regarding the Company's RSUs for the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2012</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share</font></div><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equivalent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average</font></div><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Grant Date</font></div><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes during the period:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.15</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$246.5 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested awards of RSUs. That cost is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1.5</font><font style="font-family:inherit;font-size:10pt;">&#160;years. The Company primarily utilizes newly issued shares to satisfy the vesting of RSUs.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance-Based Restricted Stock Units:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;The Company's performance-based restricted stock units vest contingent upon the achievement of pre-determined performance-based milestones typically related to product development. The following table summarizes the Company's performance-based restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> (shares in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="64%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested Performance-Based RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share Equivalent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes during the period:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106.87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested awards of performance-based RSUs that is expected to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1.7</font><font style="font-family:inherit;font-size:10pt;">&#160;years.</font></div></div> 3.50 3.38 2.89 0.99 0.92 0.62 0.84 0.90 0.52 0.92 1.15 2.85 3.37 3.30 0.90 0.97 0.82 0.61 0.87 0.50 0.89 1.11 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, assuming potentially dilutive common shares, resulting from option exercises, restricted stock units, warrants and other incentives had been issued and any proceeds thereof used to repurchase common stock at the average market price during the period. The assumed proceeds used to repurchase common stock is the sum of the amount to be paid to us upon exercise of options, the amount of compensation cost attributed to future services and not yet recognized and, if applicable, the amount of excess income tax benefit that would be credited to paid-in capital upon exercise.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Celgene</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,449.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,456.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,318.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">455.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options, restricted stock units, warrants and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">440.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">462.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per share attributable to Celgene:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.89</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total number of potential shares of common stock excluded from the diluted earnings per share computation because their inclusion would have been anti-dilutive was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">7.2</font><font style="font-family:inherit;font-size:10pt;"> million in&#160;</font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">12.7</font><font style="font-family:inherit;font-size:10pt;"> million in&#160;</font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">25.9</font><font style="font-family:inherit;font-size:10pt;"> million in&#160;</font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the period of April&#160;2009 through December 2013, our Board of Directors has approved repurchases of up to an aggregate of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$9.500 billion</font><font style="font-family:inherit;font-size:10pt;"> of our common stock, including the June 2013 authorization to repurchase an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$3.000 billion</font><font style="font-family:inherit;font-size:10pt;"> of our common stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the Board authorized share repurchase program, in February&#160;2013 we entered into an Accelerated Share Repurchase (ASR) agreement with an investment bank to repurchase an aggregate of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$600.0 million</font><font style="font-family:inherit;font-size:10pt;"> of our common stock. The total number of shares repurchased under the ASR agreement was </font><font style="font-family:inherit;font-size:10pt;color:#000000;">5.2 million</font><font style="font-family:inherit;font-size:10pt;"> shares at a weighted average price of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$114.30</font><font style="font-family:inherit;font-size:10pt;"> per share.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the management of our Board of Director authorized share repurchase program, we may, from time to time, sell put options on our common stock with strike prices that we believe represent an attractive price to repurchase our shares. If the trading price of our shares exceeds the strike price of the put option at the time the option expires, we will have economically reduced the cost of our share repurchase program by the amount of the premium we received from the sale of the put option. If the trading price of our stock is below the strike price of the put option at the time the option expires, we would repurchase the shares covered by the option at the strike price of the put option. During 2013 we sold a single put option for a premium of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> that expired unexercised. At </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding put options. In </font><font style="font-family:inherit;font-size:10pt;">February 2014</font><font style="font-family:inherit;font-size:10pt;">, we sold a put option on </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> notional amount of shares of stock with a strike price of </font><font style="font-family:inherit;font-size:10pt;">$142.81</font><font style="font-family:inherit;font-size:10pt;"> and maturing in </font><font style="font-family:inherit;font-size:10pt;">March 2014</font><font style="font-family:inherit;font-size:10pt;"> for a premium of </font><font style="font-family:inherit;font-size:10pt;">$4.8 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We repurchased </font><font style="font-family:inherit;font-size:10pt;color:#000000;">22.3 million</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock under the program from all sources, including the ASR during 2013. As of December 31, 2013, we had a remaining open-ended repurchase authorization of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$2.068 billion</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> -23400000 14700000 400000 0.129 0.134 0.072 0.35 0.35 0.35 0.012 0.000 0.004 -0.280 -0.211 -0.288 0.016 0.004 -0.014 0.188 0.000 0.000 0.007 0.011 0.006 -0.193 0.008 -0.025 170300000 261700000 476200000 551600000 166500000 3900000 463200000 246500000 P1Y6M P1Y8M12D P2Y2M 55900000 94500000 61300000 49300000 31100000 169400000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments in Other Entities:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We hold a portfolio of investments in equity securities and certain investment funds that are accounted for under either the equity method or cost method. Investments in companies or certain investment funds over which we have significant influence but not a controlling interest are accounted for using the equity method, with our share of earnings or losses reported in other income (expense), net. Investments in equity securities of companies that become publicly traded are accounted for as available-for-sale marketable securities prospectively from the date of such companies' initial public offering.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our cost method and equity method investments are included in other assets on the Consolidated Balance Sheets.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All investments are reviewed on a regular basis for possible impairment. If an investment's fair value is determined to be less than its net carrying value and the decline is determined to be other-than-temporary, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an other-than-temporary decline in value has occurred include: market value or exit price of the investment based on either market-quoted prices or future rounds of financing by the investee; length of time that the market value was below its cost basis; financial condition and business prospects of the investee; our intent and ability to retain the investment for a sufficient period of time to allow for recovery in market value of the investment; issues that raise concerns about the investee's ability to continue as a going concern; any other information that we may be aware of related to the investment.</font></div></div> 0.15 0.03 0.10 0.05 0.12 0.17 0.15 0.00 0.11 0.12 0.00 0.10 43400 15000000 25000000 127200000 30000000 30500000 0 29900000 25000000 61400000 37500000 0 69400000 113000000 49300000 169400000 31100000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Instruments and Fair Value Measurement</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents information about assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2013 and the valuation techniques we utilized to determine such fair value.&#160; Fair values determined based on Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities.&#160; Our Level 1 assets consist of marketable equity securities.&#160; Fair values determined based on Level 2 inputs utilize observable quoted prices for similar assets and liabilities in active markets and observable quoted prices for identical or similar assets in markets that are not very active.&#160; Our Level 2 assets consist primarily of U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency MBS, non-U.S. government, agency and Supranational securities, global corporate debt securities, asset backed securities, foreign currency forward contracts, purchased foreign currency options and interest rate swap contracts.&#160; Fair values determined based on Level 3 inputs utilize unobservable inputs and include valuations of assets or liabilities for which there is little, if any, market activity.&#160; We do not have any Level 3 assets.&#160; Our Level 1 liability relates to our publicly traded Contingent Value Rights (CVRs). See Note 18 for a description of the CVRs.&#160; Our Level 2 liabilities relate to interest rate swap contracts and forward starting interest rate swap contracts.&#160; Our Level 3 liabilities consist of contingent consideration related to undeveloped product rights resulting from the acquisition of Gloucester Pharmaceuticals,&#160;Inc. (Gloucester) and contingent consideration related to the undeveloped product rights and the technology platform acquired from the Avila acquisition. The maximum potential payments related to the contingent consideration from the acquisitions of Gloucester and Avila are estimated to be </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$120.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$595.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:677px;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="181px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="106px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="106px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="106px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="106px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted Price in</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Active Markets for</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identical Assets</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Observable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,452.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,019.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,472.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,039.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Forward currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent value rights</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other acquisition related contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(405.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(118.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(58.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="24%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted Price in</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Active Markets for</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identical Assets</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Observable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,809.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,809.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward currency contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased currency options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,859.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,858.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent value rights</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(277.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(277.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written currency options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other acquisition related contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(480.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(277.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents a roll-forward of the fair value of Level 3 liabilities (significant unobservable inputs):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(76.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts acquired or issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(171.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net change in fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers in and/or out of Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;">$30.4 million</font><font style="font-family:inherit;font-size:10pt;"> increase in the fair value of Level 3 liabilities in 2013 was primarily due to probability adjustments for </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> Avila milestones. Level&#160;3 liabilities issued during&#160;2012 consisted of contingent consideration related to the acquisition of Avila. The </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$50.5 million</font><font style="font-family:inherit;font-size:10pt;"> net decrease in the fair value of Level 3 liabilities in&#160;2012 was due to a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$59.7 million</font><font style="font-family:inherit;font-size:10pt;"> reduction in the contingent consideration liability related to the approval of ISTODAX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> for PTCL in Europe, partly offset by a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.2 million</font><font style="font-family:inherit;font-size:10pt;"> increase in the accretion of the contingent consideration liability related to our acquisition of Avila.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(76.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts acquired or issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(171.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net change in fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers in and/or out of Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of period</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:677px;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="181px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="106px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="106px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="106px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="106px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted Price in</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Active Markets for</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identical Assets</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Observable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,452.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,019.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,472.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,039.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;Forward currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent value rights</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other acquisition related contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(405.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(118.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(58.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(228.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="24%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted Price in</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Active Markets for</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identical Assets</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Observable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sale securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,809.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,809.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward currency contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased currency options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,859.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,858.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent value rights</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(277.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(277.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written currency options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other acquisition related contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(480.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(277.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(198.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> -30400000 -50500000 0 171700000 0 0 0 0 -228500000 198100000 76900000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Certain financial instruments reflected in the Consolidated Balance Sheets, (e.g.,&#160;cash, cash equivalents, accounts receivable, certain other assets, accounts payable, short-term borrowings and certain other liabilities) are recorded at cost, which approximates fair value due to their short-term nature. The fair values of financial instruments other than marketable securities are determined through a combination of management estimates and information obtained from third parties using the latest market data. The fair value of available-for-sale marketable securities is determined utilizing the valuation techniques appropriate to the type of security (See Note&#160;4).</font></div></div> P12Y6M P16Y6M P7Y P8Y7M6D P13Y P1Y P17Y P7Y P13Y P8Y6M P12Y6M P16Y9M 18800000 1026400000 13900000 87400000 1146500000 814500000 10000000 878900000 14600000 39800000 333700000 3848300000 66200000 42500000 3405900000 3400400000 333300000 3841400000 64300000 43400000 2379500000 52300000 23700000 2701800000 246300000 293500000 2962500000 2585900000 28800000 54300000 P7Y 3900000 5500000 -13200000 17800000 17800000 9200000 9200000 -3100000 -22200000 -10800000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Translation:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Operations in non-U.S. entities are recorded in the functional currency of each entity. For financial reporting purposes, the functional currency of an entity is determined by a review of the source of an entity's most predominant cash flows. The results of operations for non-U.S. dollar functional currency entities are translated from functional currencies into U.S. dollars using the average currency rate during each month, which approximates the results that would be obtained using actual currency rates on the dates of individual transactions. Assets and liabilities are translated using currency rates at the end of the period. Adjustments resulting from translating the financial statements of our foreign entities into the U.S. dollar are excluded from the determination of net income and are recorded as a component of other comprehensive income (loss). Transaction gains and losses are recorded in other income (expense), net in the Consolidated Statements of Income. We had a net foreign exchange gain of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$22.2 million</font><font style="font-family:inherit;font-size:10pt;"> in 2013 and losses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;"> in 2012 and 2011, respectively.</font></div></div> 35200000 62600000 48300000 2400000 6300000 6300000 -9000000 2041200000 2042800000 156300000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets and Goodwill</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangible Assets:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Our intangible assets consist of developed product rights obtained primarily from the Pharmion Corp. (Pharmion), Gloucester and Abraxis acquisitions, IPR&amp;D product rights from the Gloucester and Avila acquisitions and technology obtained primarily from the Avila acquisition. Also included are contract-based licenses and other miscellaneous intangibles. The amortization periods related to non-IPR&amp;D intangible assets range from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">17</font><font style="font-family:inherit;font-size:10pt;">&#160;years. The following summary of intangible assets by category includes intangibles currently being amortized and intangibles not yet subject to amortization:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life (Years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired developed product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,405.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,026.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,379.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.0</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.5</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,848.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,146.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,701.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.5</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortized intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired IPR&amp;D product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,986.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,146.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,839.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life (Years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired developed product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,400.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(814.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,585.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.0</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">293.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.8</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,841.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(878.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,962.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.5</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortized intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired IPR&amp;D product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,979.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(878.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,100.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying value of intangible assets increased by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$6.9 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> compared to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> primarily resulting from the acquisition of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$5.5 million</font><font style="font-family:inherit;font-size:10pt;"> in certain developed product rights and the addition of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;"> from other miscellaneous agreements, net of a </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> impairment charge. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$270.1 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$196.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$290.3 million</font><font style="font-family:inherit;font-size:10pt;"> for the years ended December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively. Amortization expense increased by </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$73.9 million</font><font style="font-family:inherit;font-size:10pt;"> in 2013 compared to 2012 primarily due to the October 2012 approval of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> in the United States for the treatment of NSCLC which resulted in the commencement of amortization of the related intangible asset and an increase in amortization of technology related to the March 7, 2012 acquisition of Avila and its Avilomics&#8482; platform. Assuming no changes in the gross carrying amount of intangible assets, the amortization of intangible assets for years </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2014</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2018</font><font style="font-family:inherit;font-size:10pt;"> is estimated to be in the range of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$255.0 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$270.0 million</font><font style="font-family:inherit;font-size:10pt;"> annually.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;At </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, our goodwill related to the 2012 acquisition of Avila, the 2010 acquisitions of Abraxis and Gloucester, the 2008 acquisition of Pharmion and the 2004 acquisition of Penn T Limited.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in carrying value of goodwill is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,042.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax benefit on the exercise of Pharmion converted stock options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,041.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Goodwill represents the excess of purchase price over fair value of net assets acquired in a business combination accounted for by the acquisition method of accounting and is not amortized, but is subject to impairment testing at least annually or when a triggering event occurs that could indicate a potential impairment. We test our goodwill annually for impairment each November&#160;30.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Intangible Assets:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Intangible assets with definite useful lives are amortized to their estimated residual values over their estimated useful lives and reviewed for impairment if certain events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Intangible assets which are not amortized include acquired in-process research and development (IPR&amp;D) and acquired intangible assets held for sale. Amortization is initiated for IPR&amp;D intangible assets when their useful lives have been determined. IPR&amp;D intangible assets which are determined to have had a drop in their fair value are adjusted downward and an expense recognized in the income statement. These IPR&amp;D intangible assets are tested at least annually or when a triggering event occurs that could indicate a potential impairment.</font></div></div> 1264700000 1313400000 1173000000 1335400000 5086500000 1557800000 1348800000 6021900000 1483200000 1632100000 2500000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-Lived Assets:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Long-lived assets, such as property, plant and equipment and certain other long-term assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to the estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of the assets exceed their estimated future undiscounted net cash flows, an impairment charge is recognized for the amount by which the carrying amount of the assets exceed the fair value of the assets.</font></div></div> 31400000 28700000 36800000 279600000 416800000 1665400000 1419500000 1681500000 1002700000 1628600000 1401900000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax provision is based on income before income taxes as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">416.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,628.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,401.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,002.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,665.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,681.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended December&#160;31, 2013, 2012, and 2011, U.S. income before income taxes reflects charges related to share-based compensation, up-front collaboration payments, asset impairments and acquisitions, which increased in the United States from 2011 to 2013. These charges were less significant outside the United States in those years.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision (benefit) for taxes on income is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes currently payable:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State and local</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(245.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total U.S. tax provision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes currently payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total international tax provision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total provision</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">225.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts are reflected in the preceding tables based on the location of the taxing authorities. We do not provide for U.S. federal or state income taxes on unremitted earnings of our international subsidiaries that are indefinitely invested outside the United States. As of December&#160;31, 2013, we have not made a U.S. tax provision on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$6.129 billion</font><font style="font-family:inherit;font-size:10pt;"> of unremitted earnings of our international subsidiaries. As these earnings are expected to be reinvested overseas indefinitely, it is not practicable to compute the estimated deferred tax liability on these earnings.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred taxes arise because of different treatment between financial statement accounting and tax accounting, known as temporary differences. We record the tax effect on these temporary differences as deferred tax assets (generally items that can be used as a tax deduction or credit in future periods) or deferred tax liabilities (generally items for which we received a tax deduction but that have not yet been recorded in the Consolidated Statements of Income). We periodically evaluate the likelihood of the realization of deferred tax assets, and reduce the carrying amount of these deferred tax assets by a valuation allowance to the extent we believe a portion will not be realized. We consider many factors when assessing the likelihood of future realization of deferred tax assets, including our recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income, the carryforward periods available to us for tax reporting purposes, tax planning strategies and other relevant factors. Significant judgment is required in making this assessment. At December&#160;31, 2013 and 2012, it was more likely than not that we would realize our deferred tax assets, net of valuation allowances. The principal valuation allowance at December 31, 2013 relates to deferred tax assets generated by certain fair value adjustments, and at December 31, 2012 relates to Swiss deferred tax assets.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2012, we concluded that approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$900.0 million</font><font style="font-family:inherit;font-size:10pt;"> of our foreign earnings may not be required for use in offshore operations and may be available for use in the United States. These earnings are not treated as permanently reinvested, and our deferred tax liabilities include </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$316.5 million</font><font style="font-family:inherit;font-size:10pt;"> for the estimated U.S. federal and state income taxes that may be incurred should these earnings be repatriated. In drawing this conclusion, we considered our future sources of funds as well as our global operating and strategic liquidity needs, including common share repurchase activities and expansion of our commercial, research, manufacturing and administrative infrastructure worldwide.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December&#160;31, 2013 and 2012 the tax effects of temporary differences that give rise to deferred tax assets and liabilities were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal and state NOL carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized research expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax credit carryforwards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-qualified stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plant and equipment, primarily differences in depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,005.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,069.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued and other expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unremitted earnings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(316.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(316.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized (gains) losses on securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(71.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,403.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">574.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,408.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">680.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,403.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,408.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax asset (liability)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(723.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(876.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December&#160;31, 2013 and 2012, deferred tax assets and liabilities were classified on the Company's balance sheet as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets (non-current)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(804.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,018.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax asset (liability)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(723.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(876.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reconciliation of the U.S. statutory income tax rate to the Company's effective tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percentages</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax rate differences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unremitted earnings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes, net of federal benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition related differences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in uncertain tax positions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective income tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In our reconciliation of the U.S. statutory income tax rate to our effective tax rate, we disclose changes in uncertain tax positions which include the effect of settlements, expirations of statutes of limitations, and other changes in prior year tax positions.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have operations in many foreign tax jurisdictions, which impose income taxes at different rates than the United States. The impact of these rate differences is included in the foreign tax rate differences that we disclose in our reconciliation of the U.S. statutory income tax rate to our effective tax rate. The benefit related to foreign tax rate differences primarily results from our commercial operations in Switzerland, which include significant research and development and manufacturing for worldwide markets. We operate under an income tax agreement in Switzerland through 2015 that provides a complete exemption from Swiss income taxes on predominantly all of our operations in Switzerland. In 2013, we entered into a new agreement with the Swiss tax authorities which reflects the planned expansion of our Swiss operations and will result in substantially similar tax benefits through the end of 2024. The impact of the Swiss tax agreement is reflected in our effective tax rate. The difference between the maximum statutory Swiss income tax rate (approximately </font><font style="font-family:inherit;font-size:10pt;">19.7%</font><font style="font-family:inherit;font-size:10pt;"> in 2013, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21.0%</font><font style="font-family:inherit;font-size:10pt;"> in 2012 and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22.0%</font><font style="font-family:inherit;font-size:10pt;"> in 2011) and our Swiss income tax rate under the tax agreement resulted in a reduction in the 2013, 2012 and 2011 effective tax rates of </font><font style="font-family:inherit;font-size:10pt;">25.1</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">26.6</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">20.2</font><font style="font-family:inherit;font-size:10pt;"> percentage points, respectively. The increase in benefits reflected in the foreign tax rate differences from 2011 to 2013 results from growth in our Non-U.S. operations and an increase in the proportion of consolidated income before income taxes from Non-U.S. operations.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December&#160;31, 2013, we had combined state NOL carryforwards of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$485.6 million</font><font style="font-family:inherit;font-size:10pt;"> that will expire in the years 2014 through 2033. We also have research and experimentation credit carryforwards of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> that will expire in the years 2018 through 2027. Excess tax benefits related to stock option deductions incurred after December&#160;31, 2005 are required to be recognized in the period in which the tax deduction is realized through a reduction of income taxes payable. As a result, we have not recorded deferred tax assets for certain stock option deductions included in our state NOL carryforwards and research and experimentation credit carryforwards. At December&#160;31, 2013, deferred tax assets have not been recorded on state NOL carryforwards of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$311.3 million</font><font style="font-family:inherit;font-size:10pt;"> and for research and experimentation credits of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;">. These stock option tax benefits will be recorded as an increase in additional paid-in capital when realized.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We realized stock option deduction benefits in 2013, 2012 and 2011 for income tax purposes and have increased additional paid-in capital in the amount of approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$170.0 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$55.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. We have recorded deferred income taxes as a component of accumulated other comprehensive income resulting in a deferred income tax liability at December&#160;31, 2013 of </font><font style="font-family:inherit;font-size:10pt;">$71.4 million</font><font style="font-family:inherit;font-size:10pt;"> and a deferred income tax asset at December 31, 2012 of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$17.3 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our tax returns are under routine examination in many taxing jurisdictions. The scope of these examinations includes, but is not limited to, the review of our taxable presence in a jurisdiction, our deduction of certain items, our claims for research and development credits, our compliance with transfer pricing rules and regulations and the inclusion or exclusion of amounts from our tax returns as filed. During 2012, we settled an examination with the U.S. Internal Revenue Service (IRS) for the years ended December&#160;31, 2006, 2007 and 2008. Our U.S. federal income tax returns have now been audited by the IRS through the year ended December&#160;31, 2008. Tax returns for the years ended December&#160;31, 2009, 2010, and 2011 are currently under examination by the IRS. We are also subject to audits by various state and foreign taxing authorities, including, but not limited to, most U.S. states and major European and Asian countries where we have operations.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We regularly reevaluate our tax positions and the associated interest and penalties, if applicable, resulting from audits of federal, state and foreign income tax filings, as well as changes in tax law (including regulations, administrative pronouncements, judicial precedents, etc.) that would reduce the technical merits of the position to below more likely than not. We believe that our accruals for tax liabilities are adequate for all open years. Many factors are considered in making these evaluations, including past history, recent interpretations of tax law and the specifics of each matter. Because tax regulations are subject to interpretation and tax litigation is inherently uncertain, these evaluations can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. We apply a variety of methodologies in making these estimates and assumptions, which include studies performed by independent economists, advice from industry and subject experts, evaluation of public actions taken by the IRS and other taxing authorities, as well as our industry experience. These evaluations are based on estimates and assumptions that have been deemed reasonable by management. However, if management's estimates are not representative of actual outcomes, our results of operations could be materially impacted.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits, generally represented by liabilities on the consolidated balance sheet and all subject to tax examinations, arise when the estimated benefit recorded in the financial statements differs from the amounts taken or expected to be taken in a tax return because of the uncertainties described above. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">596.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increases related to prior year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lapse of statute</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unrecognized tax benefits relate primarily to issues common among multinational corporations. If recognized, unrecognized tax benefits of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$198.9 million</font><font style="font-family:inherit;font-size:10pt;"> would have a net impact on the effective tax rate. We account for interest and penalties related to uncertain tax positions as part of our provision for income taxes. Accrued interest at December&#160;31, 2013 and 2012 is approximately </font><font style="font-family:inherit;font-size:10pt;">$23.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have recorded changes in the liability for unrecognized tax benefits for current and prior year tax positions related to ongoing income tax audits in various taxing jurisdictions. During 2012, we settled examinations with various taxing authorities related to tax positions taken in prior years. The settlements resulted in a decrease in our gross unrecognized tax benefits of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$450.6 million</font><font style="font-family:inherit;font-size:10pt;">, exclusive of interest, and a reduction to income tax expense of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$318.6 million</font><font style="font-family:inherit;font-size:10pt;">. The decrease in unrecognized tax benefits and the reduction to income tax expense reflect the impact of the settlements on tax returns filed in various taxing jurisdictions for the years examined as well as certain adjustments to unrecognized tax benefits for years subsequent to the examination period.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The liability for unrecognized tax benefits is expected to increase in the next 12&#160;months relating to operations occurring in that period. Any settlements of examinations with taxing authorities or statute of limitations expirations would likely result in a decrease in our unrecognized tax benefits. Our estimates of tax benefits and potential tax benefits may not be representative of actual outcomes, and variation from such estimates could materially affect our financial statements in the period of settlement or when the statutes of limitations expire.</font></div></div> 102100000 225300000 215500000 1900000 2900000 -300000 -2200000 -100000 -6900000 52300000 72500000 27200000 73300000 2800000 63500000 69500000 79700000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. We recognize the benefit of an uncertain tax position that we have taken or expect to take on income tax returns we file if such tax position is more likely than not to be sustained.</font></div></div> 291900000 469600000 93000000 287200000 191200000 68200000 101400000 30100000 263100000 95300000 -455500000 57400000 5500000 -1900000 16700000 69700000 89700000 -71000000 66900000 90900000 -91700000 33400000 68200000 137900000 137900000 3986200000 3979300000 2839700000 3100400000 0 25600000 0 35700000 0 0 200000 0 0 0 200000 27300000 0 0 91600000 42700000 63200000 3400000 0 1300000 50200000 90800000 48400000 49000000 26300000 1700000 1700000 49600000 49600000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Capitalized Software Costs:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We capitalize software costs incurred in connection with developing or obtaining software. Capitalized software costs are included in property, plant and equipment, net and are amortized over their estimated useful life of three to seven years from the date the systems are ready for their intended use.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventory</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of inventories by major category at </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials increased by </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$68.2 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> compared to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> primarily resulting from an increase in the sales level of ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">, which was approved by the FDA for treatment of Non-Small Cell Lung Cancer (NSCLC) in October 2012 and pancreatic cancer in September 2013. In addition, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$33.4 million</font><font style="font-family:inherit;font-size:10pt;"> of OTEZLA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> (apremilast)</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">inventory has been capitalized in 2013 prior to regulatory approval, in anticipation of regulatory approval for this product.</font></div></div> 93400000 93800000 259500000 340400000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Inventories are recorded at the lower of cost or market, with cost determined on a first-in, first-out basis. We periodically review the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized. Included in inventory are raw materials used in the production of preclinical and clinical products, which are charged to research and development expense when consumed.</font></div></div> 147400000 79200000 99600000 86500000 22000000 25900000 15300000 -1100000 -7300000 4000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration of one year or less</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration of one through three years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,364.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,363.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration of three through five years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">233.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Duration of over five years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,026.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,019.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> 86600000 6039800000 7788300000 13378200000 11734300000 1945500000 1690200000 228500000 118100000 58800000 405400000 480600000 198100000 277400000 5100000 118100000 277400000 0 0 0.004 1500000000.000 1000000000.000 2771300000 4196500000 956600000 399000000 249600000 696300000 1002100000 0 500600000 249500000 520100000 484600000 499900000 396600000 513900000 499000000 0 0 4269000000 35900000 0 P36M P36M <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Acquisitions and Divestitures</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Avila Acquisition</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March&#160;7, 2012 (the Acquisition Date), we acquired all of the outstanding common stock of Avila Therapeutics,&#160;Inc., subsequently renamed Celgene Avilomics Research, herein referred to as Avila. The acquisition resulted in Avila becoming our wholly-owned subsidiary. The results of operations for Avila are included in our consolidated financial statements from the Acquisition Date and the assets and liabilities of Avila have been recorded at their respective fair values on the Acquisition Date and consolidated with our other assets and liabilities. Avila's results of operations to the Acquisition Date were determined to be immaterial to us; therefore, pro forma financial information is not required to be presented.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We paid </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$352.2 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, net of cash acquired, and may make additional payments of up to an estimated maximum of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$595.0 million</font><font style="font-family:inherit;font-size:10pt;"> in contingent developmental and regulatory milestone payments.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Avila is a clinical-stage biotechnology company focused on the design and development of targeted covalent drugs to achieve best-in-class outcomes. Avila's product pipeline has been created using its proprietary Avilomics platform for developing targeted covalent drugs that treat diseases through protein silencing. Avila's most advanced product candidate, CC-292, formerly AVL-292, a potential treatment for cancer and autoimmune diseases, is currently in phase&#160;I clinical testing. We acquired Avila to enhance our portfolio of potential therapies for patients with life-threatening illnesses worldwide.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our potential contingent consideration payments are classified as liabilities, which were measured at fair value as of the Acquisition Date and subsequently adjusted for time and probability accretion. The range of potential milestone payments is from no payment if none of the milestones are achieved to an estimated maximum of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$595.0 million</font><font style="font-family:inherit;font-size:10pt;"> if all milestones are achieved. The potential milestones consist of developmental and regulatory achievements, including milestones for the initiation of phase&#160;II and phase&#160;III studies, investigational new drug, or IND, filings, and other regulatory events.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We estimated the fair value of potential contingent consideration using a probability-weighted income approach, which reflects the probability and timing of future potential payments. This fair value measurement is based on significant input not observable in the market and thus represents a Level&#160;3 liability within the fair value hierarchy. The resulting probability-weighted cash flows were discounted using a discount rate based on a market participant assumption.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition has been accounted for using the acquisition method of accounting which requires that assets acquired and liabilities assumed be recognized at their fair values as of the Acquisition Date and requires the fair value of acquired IPR&amp;D to be classified as indefinite-lived assets until the successful completion or abandonment of the associated research and development efforts.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of consideration transferred in the acquisition of Avila is shown in the table below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="84%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value at the</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition Date</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total fair value of consideration transferred</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">535.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the Acquisition Date based upon their respective fair values summarized below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="84%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized as of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition Date</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Working capital</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform technology intangible asset</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">330.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development product rights</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax liability</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">3</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(165.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">535.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform technology related to the Avilomics discovery platform which is being amortized over a useful life of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">seven years</font><font style="font-family:inherit;font-size:10pt;"> based on the estimated useful life of the platform.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">3</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes current deferred income tax asset of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$14.7 million</font><font style="font-family:inherit;font-size:10pt;"> and non-current deferred tax liability of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$179.7 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of current assets, current liabilities and property, plant and equipment were determined to approximate their book values.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the platform technology intangible asset was based primarily on expected cash flows from future product candidates to be developed from the Avilomics platform and the fair value assigned to acquired IPR&amp;D was primarily based on expected cash flows from the CC-292 product candidate which is in phase&#160;I testing. The values assigned to the platform technology intangible asset and the IPR&amp;D asset were determined by estimating the costs to develop CC-292 and future product candidates into commercially viable products, estimating the resulting revenue from the potential products, and discounting the net cash flows to present value. The revenue and cost projections used were reduced based on the probability of developing new drugs. Additionally, the projections considered the relevant market sizes, growth factors and the nature and expected timing of new product introductions. The resulting net cash flows from such potential products are based on our estimates of cost of sales, operating expenses, and income taxes. The rates utilized to discount the net cash flows to their present value were commensurate with the stage of development of the projects and uncertainties in the economic estimates used in the projections described above. Acquired IPR&amp;D will be accounted for as an indefinite-lived intangible asset until regulatory approval in specified markets or discontinuation of CC-292.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition. The goodwill recorded as part of the acquisition is largely attributable to full ownership rights to the Avilomics platform. We do not expect any portion of this goodwill to be deductible for tax purposes. The goodwill attributable to the acquisition has been recorded as a non-current asset in our Consolidated Balance Sheets and is not amortized, but is subject to review for impairment annually.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to the acquisition, Avila had a number of collaboration agreements in place to which we are now party. These agreements entitle us to receive potential milestone payments and reimbursement of expenses for research and development expenses incurred under the collaborations and our collaboration partners may receive intellectual property rights or options to purchase such rights related to products developed under the collaborations. We do not consider these collaboration arrangements to be significant.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Sale of Non-core Assets</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2010 acquisition of Abraxis BioScience,&#160;Inc. (Abraxis) included a number of assets that were not associated with nab</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> technology or ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. In April 2011, we sold these non-core assets to various entities that were owned or controlled by Dr.&#160;Patrick Soon-Shiong, the former majority shareholder and executive chairman of Abraxis. We received cash consideration, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> equity ownership in Active Biomaterials,&#160;LLC, which we subsequently sold to Dr.&#160;Patrick Soon-Shiong, and a future royalty stream based on net sales of certain products of Active Biomaterials,&#160;LLC. We recorded the future royalty stream as an asset and assigned a value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$170.0 million</font><font style="font-family:inherit;font-size:10pt;"> based on its April 2011 fair market value calculated as the present value of estimated future net cash flows. Based on observed industry consolidation in the market that produces the raw materials for the products sold by Active Biomaterials,&#160;LLC and the forecasted reduction of net sales subject to royalties, we performed an analysis in December 2013 of the fair value of the future royalty stream. Our evaluation of discounted estimated future cash flows resulted in a fair value of </font><font style="font-family:inherit;font-size:10pt;">$90.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the future royalty stream and we recorded an impairment expense of </font><font style="font-family:inherit;font-size:10pt;">$80.0 million</font><font style="font-family:inherit;font-size:10pt;"> in 2013.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2014, we entered into a collaboration agreement with NantBioScience, Inc. (NantBioScience), an entity controlled by Dr.&#160;Patrick Soon-Shiong in which Celgene contributed </font><font style="font-family:inherit;font-size:10pt;">$75 million</font><font style="font-family:inherit;font-size:10pt;">, the rights to the future royalty stream noted above and licenses to </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> nab</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> product candidates. In return, Celgene received </font><font style="font-family:inherit;font-size:10pt;">14</font><font style="font-family:inherit;font-size:10pt;"> percent equity ownership in NantBioScience, an option to license a certain number of product candidates developed by NantBioScience, including the </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> nab</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> product candidates that Celgene is licensing to NantBioScience, and the parent company of NantBioScience assumed, and agreed to pay and satisfy when due, our obligation to pay The Chan Soon-Shiong Institute for Advanced Health (CSS Institute) </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> contingent, matching contributions.</font></div></div> 1697000000 1160000000 230900000 1144000000 508400000 -248800000 -1622000000 -553700000 -1553600000 377700000 -528600000 2018600000 2225900000 1776100000 0 0 -700000 1449900000 1318100000 1456200000 263100000 424200000 401500000 367400000 214400000 478100000 372500000 384900000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">New Accounting Pronouncements:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;In February&#160;2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update &#8220;Comprehensive Income (Topic 220):&#160; Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income&#8221; (ASU 2013-2).&#160; ASU 2013-2 requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. generally accepted accounting principles (GAAP) to be reclassified in its entirety to net income.&#160; The amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.&#160; An entity shall provide this information together, in one location, either on the face of the statement where net income is presented or as a separate disclosure in the notes to the financial statements.&#160; The amendments are effective prospectively for reporting periods beginning after December&#160;15, 2012.&#160; The adoption of ASU 2013-2 did not have a material impact on our financial position or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the FASB issued Accounting Standards Update "Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes" (ASU 2013-10). ASU 2013-10 permits the use of the Fed Funds Effective Swap Rate (also referred to as the Overnight Index Swap Rate), in addition to the U.S. government rate (UST) and London Interbank Offered Rate (LIBOR), as a U.S. benchmark interest rate for hedge accounting purposes. This update is effective prospectively for qualifying new or re-designated hedging relationships entered into on or after July 17, 2013. The adoption of ASU 2013-10 did not have a material impact on our financial position or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the FASB issued Accounting Standards Update "Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists" (ASU 2013-11). ASU 2013-11 requires an entity to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (NOL) carryforward, or similar tax loss or tax credit carryforward, rather than as a liability when (1) the uncertain tax position would reduce the NOL or other carryforward under the tax law of the applicable jurisdiction and (2) the entity intends to use the deferred tax asset for that purpose. ASU 2013-11 is effective prospectively for fiscal years and interim periods within those years, beginning after December 15, 2013 for public entities.</font></div></div> -10800000 -10800000 1746400000 1442700000 1808900000 239200000 54500000 21400000 31400000 39600000 47700000 44600000 48100000 41900000 50900000 485600000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of Business and Basis and Summary of Significant Accounting Policies</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Celgene Corporation, together with its subsidiaries (collectively &#8220;we,&#8221; &#8220;our,&#8221;&#160; &#8220;us,&#8221; &#8220;Celgene&#8221; or the &#8220;Company&#8221;) is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.&#160; We are dedicated to innovative research and development designed to bring new therapies to market and are involved in research in several scientific areas that may deliver proprietary next-generation therapies, targeting areas such as intracellular signaling pathways in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our primary commercial stage products include REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, VIDAZA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, POMALYST</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">/IMNOVID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;(inclusive of Thalidomide Celgene</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></font><font style="font-family:inherit;font-size:10pt;">), ISTODAX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and azacitidine for injection (generic version of VIDAZA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">). Additional sources of revenue include royalties from Novartis Pharma AG (Novartis) on their sales of FOCALIN XR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;and the entire RITALIN</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;family of drugs, the sale of services through our Celgene Cellular Therapeutics subsidiary and other licensing agreements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of Celgene Corporation and its subsidiaries. Investments in limited partnerships and interests where we have an equity interest of 50% or less and do not otherwise have a controlling financial interest are accounted for by either the equity or cost method. We record net income (loss) attributable to non-controlling interest, if any, in our Consolidated Statements of Income equal to the percentage of ownership interest retained in the respective operations by the non-controlling parties. Certain prior year amounts have been reclassified to conform to the current year's presentation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect reported amounts and disclosures.&#160; Actual results could differ from those estimates.&#160; We are subject to certain risks and uncertainties related to, among other things, product development, regulatory approval, market acceptance, scope of patent and proprietary rights, competition, outcome of civil and governmental proceedings, European credit risk, technological change and product liability.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Certain financial instruments reflected in the Consolidated Balance Sheets, (e.g.,&#160;cash, cash equivalents, accounts receivable, certain other assets, accounts payable, short-term borrowings and certain other liabilities) are recorded at cost, which approximates fair value due to their short-term nature. The fair values of financial instruments other than marketable securities are determined through a combination of management estimates and information obtained from third parties using the latest market data. The fair value of available-for-sale marketable securities is determined utilizing the valuation techniques appropriate to the type of security (See Note&#160;4).</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Instruments and Hedges:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;All derivative instruments are recognized on the balance sheet at their fair value. Changes in the fair value of derivative instruments are recorded each period in current earnings or other comprehensive income (loss), depending on whether a derivative instrument is designated as part of a hedging transaction and, if it is, the type of hedging transaction. For a derivative to qualify as a hedge at inception and throughout the hedged period, we formally document the nature and relationships between the hedging instruments and hedged item. We assess, both at inception and on an on-going basis, whether the derivative instruments that are used in cash flow hedging transactions are highly effective in offsetting the changes in cash flows of hedged items. We assess hedge ineffectiveness on a quarterly basis and record the gain or loss related to the ineffective portion of derivative instruments, if any, to current earnings. If we determine that a forecasted transaction is no longer probable of occurring, we discontinue hedge accounting and any related unrealized gain or loss on the derivative instrument is recognized in current earnings. We use derivative instruments, including those not designated as part of a hedging transaction, to manage our exposure to movements in foreign exchange, on our stock price and interest rates. The use of these derivative instruments modifies the exposure of these risks with the intent to reduce our risk or cost. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash, Cash Equivalents and Marketable Securities Available for Sale:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency mortgage-backed securities (MBS), non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities. All liquid investments with maturities of three months or less from the date of purchase are classified as cash equivalents and all investments with maturities of greater than three months from date of purchase are classified as marketable securities available for sale. We determine the appropriate classification of our investments in marketable debt and equity securities at the time of purchase. In addition, our equity investments in the publicly traded common stock of companies with whom we have entered into collaboration agreements are also designated as marketable securities available for sale.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities available for sale are carried at fair value, held for an unspecified period of time and are intended for use in meeting our ongoing liquidity needs. Unrealized gains and losses on available-for-sale securities, which are deemed to be temporary, are reported as a separate component of stockholders' equity, net of tax. The cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. The amortization, along with realized gains and losses and other-than-temporary impairment charges, is included in interest and investment income, net.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A decline in the market value of any available-for-sale security below its carrying value that is determined to be other-than-temporary would result in a charge to earnings and decrease in the security's carrying value down to its newly established fair value. Factors evaluated to determine if an investment is other-than-temporarily impaired include significant deterioration in earnings performance, credit rating, asset quality or business prospects of the issuer; adverse changes in the general market condition in which the issuer operates; our intent to hold to maturity and an evaluation as to whether it is more likely than not that we will not have to sell before recovery of its cost basis; our expected future cash flows from the security; and issues that raise concerns about the issuer's ability to continue as a going concern.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risk:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Cash, cash equivalents and marketable securities are financial instruments that potentially subject the Company to concentration of credit risk. We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency MBS, non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities (See Note&#160;6). We have established guidelines relative to diversification and maturities to maintain safety and liquidity. These guidelines are reviewed periodically and may be modified to take advantage of trends in yields and interest rates.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We sell our products in the United States primarily through wholesale distributors and specialty contracted pharmacies. Therefore, wholesale distributors and large pharmacy chains account for a large portion of our U.S. trade receivables and net product revenues (See Note&#160;19). International sales are primarily made directly to hospitals, clinics and retail chains, many of which in Europe are government owned and have extended their payment terms in recent years given the economic pressure these countries are facing. We continuously monitor the creditworthiness of our customers, including these governments, and have internal policies regarding customer credit limits. We estimate an allowance for doubtful accounts primarily based on the credit worthiness of our customers, historical payment patterns, aging of receivable balances and general economic conditions, including publicly available information on the credit worthiness of countries themselves and provinces or areas within such countries where they are the ultimate customers.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We continue to monitor economic conditions, including the volatility associated with international economies, the sovereign debt crisis in certain European countries and associated impacts on the financial markets and our business. Our current business model in these markets is typically to sell our products directly to principally government owned or controlled hospitals, which in turn directly deliver critical care to patients. Our products are used to treat life-threatening diseases and we believe this business model enables timely delivery and adequate supply of products. Many of the outstanding receivable balances are related to government-funded hospitals and we believe the receivable balances are ultimately collectible. Similarly, we believe that future sales to these customers will continue to be collectible.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The credit and economic conditions within Spain, Italy, Portugal and Greece, as well as increasing sales levels in those countries have resulted in, and may continue to result in, an increase in the average length of time it takes to collect accounts receivable. Our total net receivables in Spain, Italy and Portugal are composed almost entirely of amounts receivable from government-owned or controlled hospitals and the public sector and amounted to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">$348.4 million</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2013, compared to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$324.2 million</font><font style="font-family:inherit;font-size:10pt;"> at December&#160;31, 2012. Approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$86.4 million</font><font style="font-family:inherit;font-size:10pt;"> of the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$348.4 million</font><font style="font-family:inherit;font-size:10pt;"> receivable at December&#160;31, 2013 was greater than one year past due. Our exposure to the sovereign debt crisis in Greece is limited, as we do not have a material amount of receivables in Greece. We maintain timely and direct communication with hospital customers in Spain, Italy and Portugal regarding both the current and past due receivable balances. We continue to receive payments from these countries, and closely monitor the plans for payment at the regional government level. Payments from customers in these countries are not received on regular intervals and several months could elapse between significant payments. We also regularly request and receive positive confirmation of the validity of our receivables from most of the regional governmental authorities.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In determining the appropriate allowance for doubtful accounts for Spain, Italy and Portugal, we considered that the balance of past due receivables is related to sales made to government-owned or supported customers. We regularly monitor developments in Europe to assess whether the level of risk of default for any customers has increased and note the ongoing efforts by the European Union, European Monetary Union and International Monetary Fund to support countries with large public deficits and outstanding debt balances. We also monitor the efforts of individual countries to support their regions with large public deficits and outstanding debt balances. We have not experienced significant losses or write-offs with respect to the collection of our accounts receivable in these countries as a result of their economic difficulties and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Inventories are recorded at the lower of cost or market, with cost determined on a first-in, first-out basis. We periodically review the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized. Included in inventory are raw materials used in the production of preclinical and clinical products, which are charged to research and development expense when consumed.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We capitalize inventory costs associated with certain products prior to regulatory approval of products, or for inventory produced in new production facilities, when management considers it highly probable that the pre-approval inventories will be saleable. The determination to capitalize is based on the particular facts and circumstances relating to the expected regulatory approval of the product or production facility being considered, and accordingly, the time frame within which the determination is made varies from product to product. The assessment of whether or not the product is considered highly probable to be saleable is made on a quarterly basis and includes, but is not limited to, how far a particular product or facility has progressed along the approval process, any known safety or efficacy concerns, potential labeling restrictions and other impediments. We could be required to write down previously capitalized costs related to pre-launch inventories upon a change in such judgment, or due to a denial or delay of approval by regulatory bodies, a delay in commercialization or other potential factors. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Property, Plant and Equipment:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation of plant and equipment is recorded using the straight-line method. Building improvements are depreciated over the remaining useful life of the building. Leasehold improvements are depreciated over the lesser of the economic useful life of the asset or the remaining term of the lease, including anticipated renewal options. The estimated useful lives of capitalized assets are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and operating equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer equipment and software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-7&#160;years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maintenance and repairs are charged to operations as incurred, while expenditures for improvements which extend the life of an asset are capitalized.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Capitalized Software Costs:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We capitalize software costs incurred in connection with developing or obtaining software. Capitalized software costs are included in property, plant and equipment, net and are amortized over their estimated useful life of three to seven years from the date the systems are ready for their intended use.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments in Other Entities:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We hold a portfolio of investments in equity securities and certain investment funds that are accounted for under either the equity method or cost method. Investments in companies or certain investment funds over which we have significant influence but not a controlling interest are accounted for using the equity method, with our share of earnings or losses reported in other income (expense), net. Investments in equity securities of companies that become publicly traded are accounted for as available-for-sale marketable securities prospectively from the date of such companies' initial public offering.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our cost method and equity method investments are included in other assets on the Consolidated Balance Sheets.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All investments are reviewed on a regular basis for possible impairment. If an investment's fair value is determined to be less than its net carrying value and the decline is determined to be other-than-temporary, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an other-than-temporary decline in value has occurred include: market value or exit price of the investment based on either market-quoted prices or future rounds of financing by the investee; length of time that the market value was below its cost basis; financial condition and business prospects of the investee; our intent and ability to retain the investment for a sufficient period of time to allow for recovery in market value of the investment; issues that raise concerns about the investee's ability to continue as a going concern; any other information that we may be aware of related to the investment.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Intangible Assets:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Intangible assets with definite useful lives are amortized to their estimated residual values over their estimated useful lives and reviewed for impairment if certain events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Intangible assets which are not amortized include acquired in-process research and development (IPR&amp;D) and acquired intangible assets held for sale. Amortization is initiated for IPR&amp;D intangible assets when their useful lives have been determined. IPR&amp;D intangible assets which are determined to have had a drop in their fair value are adjusted downward and an expense recognized in the income statement. These IPR&amp;D intangible assets are tested at least annually or when a triggering event occurs that could indicate a potential impairment.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Goodwill represents the excess of purchase price over fair value of net assets acquired in a business combination accounted for by the acquisition method of accounting and is not amortized, but is subject to impairment testing at least annually or when a triggering event occurs that could indicate a potential impairment. We test our goodwill annually for impairment each November&#160;30.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Long-Lived Assets:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Long-lived assets, such as property, plant and equipment and certain other long-term assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to the estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of the assets exceed their estimated future undiscounted net cash flows, an impairment charge is recognized for the amount by which the carrying amount of the assets exceed the fair value of the assets.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Consideration from Business Combinations:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Subsequent to the acquisition date, we measure contingent consideration arrangements at fair value for each period with changes in fair value recognized in income as acquisition related (gains) charges and restructuring, net. Changes in fair values reflect new information about related IPR&amp;D and other assets and the passage of time. In the absence of new information, changes in fair value reflect only the passage of time as development work towards the achievement of the milestones progresses, and is accrued based on an accretion schedule.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Translation:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Operations in non-U.S. entities are recorded in the functional currency of each entity. For financial reporting purposes, the functional currency of an entity is determined by a review of the source of an entity's most predominant cash flows. The results of operations for non-U.S. dollar functional currency entities are translated from functional currencies into U.S. dollars using the average currency rate during each month, which approximates the results that would be obtained using actual currency rates on the dates of individual transactions. Assets and liabilities are translated using currency rates at the end of the period. Adjustments resulting from translating the financial statements of our foreign entities into the U.S. dollar are excluded from the determination of net income and are recorded as a component of other comprehensive income (loss). Transaction gains and losses are recorded in other income (expense), net in the Consolidated Statements of Income. We had a net foreign exchange gain of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$22.2 million</font><font style="font-family:inherit;font-size:10pt;"> in 2013 and losses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;"> in 2012 and 2011, respectively. These amounts include the impact of gains and losses on foreign exchange contracts not designated as hedging instruments (See Note 5).</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Research and Development Costs:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Research and development costs are expensed as incurred. These include all internal and external costs related to services contracted by us. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Milestone payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product. Upfront payments are recorded when incurred, and milestone payments are recorded when the specific milestone has been achieved.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. We recognize the benefit of an uncertain tax position that we have taken or expect to take on income tax returns we file if such tax position is more likely than not to be sustained.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Revenue from the sale of products is recognized when title and risk of loss of the product is transferred to the customer and the sales price is fixed and determinable. Provisions for discounts, early payments, rebates, sales returns and distributor chargebacks under terms customary in the industry are provided for in the same period the related sales are recorded. We record estimated reductions to revenue for volume-based discounts and rebates at the time of the initial sale. The estimated reductions to revenue for such volume-based discounts and rebates are based on the sales terms, historical experience and trend analysis.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We base our sales returns allowance on estimated on-hand retail/hospital inventories, measured end-customer demand as reported by third-party sources, actual returns history and other factors, such as the trend experience for lots where product is still being returned or inventory centralization and rationalization initiatives conducted by major pharmacy chains, as applicable.&#160; If the historical data we use to calculate these estimates do not properly reflect future returns, then a change in the allowance would be made in the period in which such a determination is made and revenues in that period could be materially affected.&#160; Under this methodology, we track actual returns by individual production lots.&#160; Returns on closed lots, that is, lots no longer eligible for return credits, are analyzed to determine historical returns experience.&#160; Returns on open lots, that is, lots still eligible for return credits, are monitored and compared with historical return trend rates.&#160; Any changes from the historical trend rates are considered in determining the current sales return allowance.&#160; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales discount accruals are based on payment terms extended to customers.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government rebate accruals are based on estimated payments due to governmental agencies for purchases made by third parties under various governmental programs. U.S. Medicaid rebate accruals are generally based on historical payment data and estimates of future Medicaid beneficiary utilization applied to the Medicaid unit rebate formula established by the Center for Medicaid and Medicare Services. The Medicaid rebate percentage was increased and extended to Medicaid Managed Care Organizations in March&#160;2010.&#160; The accrual of the rebates associated with Medicaid Managed Care Organizations is calculated based on estimated historical patient data related to Medicaid Managed Care Organizations.&#160; We have also analyzed actual billings received from the states to further support the accrual rates.&#160; Subsequent to implementation of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the 2010 U.S. Health Care Reform Law), certain states have only recently begun submitting partial Medicaid Managed Care Organization bills.&#160; Our accruals for these Medicaid Managed Care Organization rebates had been at elevated levels given the delays in the receipt of complete invoices from certain states.&#160; Due to the receipt of more complete claims data as 2013 progressed, the accruals for certain states were reduced from the elevated levels at December 31, 2012 as a result of both the payments made being applied to the accrual and a </font><font style="font-family:inherit;font-size:10pt;">$20.3 million</font><font style="font-family:inherit;font-size:10pt;"> favorable change in estimate of the ultimate obligation. &#160;We will continue to adjust the rebate accruals as more information becomes available and to reflect actual claims experience. Effective January&#160;1, 2011, manufacturers of pharmaceutical products are responsible for </font><font style="font-family:inherit;font-size:10pt;color:#000000;">50%</font><font style="font-family:inherit;font-size:10pt;"> of the patient&#8217;s cost of branded prescription drugs related to the Medicare Part&#160;D Coverage Gap.&#160; In order to estimate the cost to us of this coverage gap responsibility, we analyze data for eligible Medicare Part&#160;D patients against data for eligible Medicare Part&#160;D patients treated with our products as well as the historical invoices.&#160; This expense is recognized throughout the year as costs are incurred.&#160; In certain international markets, government-sponsored programs require rebates to be paid based on program specific rules&#160;and, accordingly, the rebate accruals are determined primarily on estimated eligible sales.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rebates or administrative fees are offered to certain wholesale customers, group purchasing organizations and end-user customers, consistent with pharmaceutical industry practices. Settlement of rebates and fees may generally occur from </font><font style="font-family:inherit;font-size:10pt;color:#000000;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">15</font><font style="font-family:inherit;font-size:10pt;">&#160;months from the date of sale. We provide a provision for rebates at the time of sale based on contracted rates and historical redemption rates. Assumptions used to establish the provision include level of wholesaler inventories, contract sales volumes and average contract pricing.&#160; We regularly review the information related to these estimates and adjust the provision accordingly.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chargeback accruals are based on the differentials between product acquisition prices paid by wholesalers and lower government contract pricing paid by eligible customers covered under federally qualified programs.&#160; Distributor service fee accruals are based on contractual fees to be paid to the wholesale distributor for services provided.&#160; TRICARE is a health care program of the U.S. Department of Defense Military Health System that provides civilian health benefits for military personnel, military retirees and their dependents.&#160; TRICARE rebate accruals are included in chargeback accruals and are based on estimated Department of Defense eligible sales multiplied by the TRICARE rebate formula.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We record estimated reductions to revenue for free goods and volume-based discounts at the time of the initial sale. The estimated reductions to revenue for such free goods and volume-based discounts are based on the sales terms, historical experience and trend analysis. The cost of free goods is included in Cost of Goods Sold (excluding amortization of acquired intangible assets).</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize revenue from royalties based on licensees' sales of its products or products using its technologies. Royalties are recognized as earned in accordance with the contract terms when royalties from licensees can be reasonably estimated and collectability is reasonably assured. If royalties cannot be reasonably estimated or collectability of a royalty amount is not reasonably assured, royalties are recognized as revenue when the cash is received.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Share-Based Compensation:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We utilize share based compensation in the form of stock options, restricted stock units (RSUs) and performance-based restricted stock units (PSUs). Compensation expense is recognized in the Consolidated Statements of Income based on the estimated fair value of the awards at grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized to date associated with grants that are not expected to vest will be reversed.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of stock option grants are estimated as of the date of grant using a Black-Scholes option valuation model. The fair values of RSU and PSU grants are based on the market value of our Common Stock on the date of grant.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, assuming potentially dilutive common shares, resulting from option exercises, restricted stock units, warrants and other incentives had been issued and any proceeds thereof used to repurchase common stock at the average market price during the period. The assumed proceeds used to repurchase common stock is the sum of the amount to be paid to us upon exercise of options, the amount of compensation cost attributed to future services and not yet recognized and, if applicable, the amount of excess income tax benefit that would be credited to paid-in capital upon exercise.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">New Accounting Pronouncements:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;In February&#160;2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update &#8220;Comprehensive Income (Topic 220):&#160; Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income&#8221; (ASU 2013-2).&#160; ASU 2013-2 requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. generally accepted accounting principles (GAAP) to be reclassified in its entirety to net income.&#160; The amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.&#160; An entity shall provide this information together, in one location, either on the face of the statement where net income is presented or as a separate disclosure in the notes to the financial statements.&#160; The amendments are effective prospectively for reporting periods beginning after December&#160;15, 2012.&#160; The adoption of ASU 2013-2 did not have a material impact on our financial position or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the FASB issued Accounting Standards Update "Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes" (ASU 2013-10). ASU 2013-10 permits the use of the Fed Funds Effective Swap Rate (also referred to as the Overnight Index Swap Rate), in addition to the U.S. government rate (UST) and London Interbank Offered Rate (LIBOR), as a U.S. benchmark interest rate for hedge accounting purposes. This update is effective prospectively for qualifying new or re-designated hedging relationships entered into on or after July 17, 2013. The adoption of ASU 2013-10 did not have a material impact on our financial position or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2013, the FASB issued Accounting Standards Update "Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists" (ASU 2013-11). ASU 2013-11 requires an entity to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (NOL) carryforward, or similar tax loss or tax credit carryforward, rather than as a liability when (1) the uncertain tax position would reduce the NOL or other carryforward under the tax law of the applicable jurisdiction and (2) the entity intends to use the deferred tax asset for that purpose. ASU 2013-11 is effective prospectively for fiscal years and interim periods within those years, beginning after December 15, 2013 for public entities. During the quarter ended December 31, 2013, we early adopted ASU 2013-11 on a prospective basis, and the change in presentation had no material impact on our financial position or results of operations.</font></div></div> 84700000 88600000 436400000 320200000 479000000 353400000 -9800000 27400000 25900000 -600000 100000 0 12600000 11400000 143700000 27400000 -24700000 -4700000 133100000 -20000000 3200000 39600000 12600000 2400000 143700000 4700000 -3200000 1500000 -1000000 4300000 -5100000 100000 2200000 300000 14200000 77700000 -2900000 -2900000 6900000 -1900000 21300000 53000000 -5800000 2600000 -13800000 0 1400000 128000000 2900000 1400000 -1000000 77100000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent value rights&#160;&#8211; Abraxis acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales, use and value added tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collaboration agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration&#160;&#8211; Avila acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">431.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> 431300000 199700000 355500000 582700000 14400000 13900000 -4500000 -15900000 1800000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration&#160;&#8211; Avila acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation and long-term incentives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent value rights - Abraxis acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred lease incentive</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collaboration agreement </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration&#160;&#8211; Gloucester acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing facility purchase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">582.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">355.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> -73900000 -6400000 -17000000 14700000 10700000 19500000 23200000 29300000 29100000 11400000 1100000 1700000 5900000 2043600000 2764600000 2188600000 3983600000 1693400000 2768800000 363400000 352200000 0 0 352200000 19400000 0 48900000 59300000 30000000 47100000 132100000 111500000 119700000 20700000 19300000 32600000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee Benefit Plans</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We sponsor an employee savings and retirement plan, which qualifies under Section&#160;401(k) of the Internal Revenue Code, as amended (the Code) for our U.S. employees. Our contributions to the U.S. savings plan are discretionary and have historically been made in the form of our common stock (See Note&#160;12). Such contributions are based on specified percentages of employee contributions up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">6%</font><font style="font-family:inherit;font-size:10pt;"> of eligible compensation or a maximum permitted by law. Total expense for contributions to the U.S. savings plans were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$32.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$19.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$20.7 million</font><font style="font-family:inherit;font-size:10pt;"> in 2013, 2012 and 2011, respectively. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We also sponsor defined contribution plans in certain foreign locations. Participation in these plans is subject to the local laws that are in effect for each country and may include statutorily imposed minimum contributions. We also maintain defined benefit plans in certain foreign locations for which the obligations and the net periodic pension costs were determined to be immaterial at December&#160;31, 2013.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2000, our Board of Directors approved a deferred compensation plan. The plan was frozen effective as of December&#160;31, 2004, and no additional contributions or deferrals can be made to that plan. Accrued benefits under the frozen plan will continue to be governed by the terms under the tax laws in effect prior to the enactment of Section&#160;409A. In February 2005, our Board of Directors adopted the Celgene Corporation 2005 Deferred Compensation Plan, effective as of January&#160;1, 2005, and amended the plan in February 2008. This plan operates as our ongoing deferred compensation plan and is intended to comply with the American Jobs Creation Act of 2004, Section&#160;409A. Eligible participants, which include certain top-level executives as specified by the plan, can elect to defer up to an amended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">90%</font><font style="font-family:inherit;font-size:10pt;"> of the participant's base salary, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of cash bonuses and equity compensation allowed under Section&#160;409A of the Code. Company contributions to the deferred compensation plan represent a match to certain participants' deferrals up to a specified percentage, which currently ranges from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">20%</font><font style="font-family:inherit;font-size:10pt;">, depending on the employee's position as specified in the plan, of the participant's base salary. We recorded expenses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> related to the deferred compensation plans in 2013, 2012 and 2011, respectively. The Company's matches are fully vested upon contribution. All other Company contributions to the plan do not vest until the specified requirements are met. At December&#160;31, 2013 and 2012, we had a deferred compensation liability included in other non-current liabilities in the Consolidated Balance Sheets of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$73.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$59.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, which included the participant's elected deferral of salaries and bonuses, the Company's matching contribution and earnings on deferred amounts as of that date. The plan provides various alternatives for the measurement of earnings on the amounts participants defer under the plan. The measuring alternatives are based on returns of a variety of funds that offer plan participants the option to spread their risk across a diverse group of investments.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2003, we established a Long-Term Incentive Plan (LTIP) designed to provide key officers and executives with performance-based incentive opportunities contingent upon achievement of pre-established corporate performance objectives covering a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">-year period. We currently have </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> separate three-year performance cycles running concurrently ending December&#160;31, 2014, 2015 and 2016. Performance measures for each of the performance cycles are based on the following components: </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">37.5%</font><font style="font-family:inherit;font-size:10pt;"> on non-GAAP earnings per share (as defined in the LTIP); </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">37.5%</font><font style="font-family:inherit;font-size:10pt;"> on total non-GAAP revenue (as defined in the LTIP); and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">25%</font><font style="font-family:inherit;font-size:10pt;"> on relative total shareholder return, which is a measurement of our stock price performance during the year compared with a group of other companies in the biopharmaceutical industry.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payouts may be in the range of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">0%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">200%</font><font style="font-family:inherit;font-size:10pt;"> of the participant's salary for the LTIPs. The estimated payout for the concluded 2013 Plan is </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$28.9 million</font><font style="font-family:inherit;font-size:10pt;">, which is included in accrued expenses at December&#160;31, 2013, and the maximum potential payout, assuming maximum objectives are achieved for the 2014, 2015 and 2016 Plans are </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$19.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$22.6 million</font><font style="font-family:inherit;font-size:10pt;"> and</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$25.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Such awards are payable in cash or common stock or a mixture of cash and common stock, which will be determined by the Compensation Committee at the time of award delivery. For awards payable in common stock, the number of shares is determined using the average closing price for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">30</font><font style="font-family:inherit;font-size:10pt;"> trading days prior to the beginning of the cycle. The Compensation Committee may determine that payments made in common stock are restricted from trading for a period of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">three</font><font style="font-family:inherit;font-size:10pt;"> years. We accrue the long-term incentive liability over each three-year cycle. Prior to the end of a three-year cycle, the accrual is based on an estimate of our level of achievement during the cycle. Upon a change in control, participants will be entitled to an immediate payment equal to their target award or, if higher, an award based on actual performance through the date of the change in control. For the years ended December&#160;31, 2013, 2012 and 2011, we recognized expense related to the LTIP of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$40.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$12.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> 0.01 0.01 5000000.0 5000000.0 0 0 0 0 0 1479600000 1486700000 551600000 166500000 476200000 1743700000 2175200000 3642300000 0 15800000 93200000 1878800000 4494800000 4462000000 1456200000 1317400000 1449900000 -700000 1456200000 1456200000 1318100000 1318100000 1449900000 1449900000 1400000 76700000 9100000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment at </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">258.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and operating equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer equipment and software</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,025.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">919.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">432.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">578.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The balance of construction in progress at </font><font style="font-family:inherit;font-size:10pt;color:#000000;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> relates primarily to an expansion of our international headquarters in Boudry, Switzerland as well as the expansion of our corporate headquarters in Summit, New Jersey.</font></div></div> 228400000 193800000 258000000 44600000 78100000 41200000 919200000 46300000 128200000 30000000 239500000 175200000 286100000 90100000 1025700000 36700000 30800000 37900000 578400000 593400000 343300000 13600000 15000000 221500000 230400000 348000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Property, Plant and Equipment:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation of plant and equipment is recorded using the straight-line method. Building improvements are depreciated over the remaining useful life of the building. Leasehold improvements are depreciated over the lesser of the economic useful life of the asset or the remaining term of the lease, including anticipated renewal options. The estimated useful lives of capitalized assets are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and operating equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer equipment and software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-7&#160;years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maintenance and repairs are charged to operations as incurred, while expenditures for improvements which extend the life of an asset are capitalized.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">258.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and operating equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer equipment and software</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,025.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">919.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">432.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">578.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> P40Y P15Y P10Y P5Y P5Y P7Y P3Y 6200000 12500000 6400000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quarterly Results of Operations (Unaudited)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="30%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4Q </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">3</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,464.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,599.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,674.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,755.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,493.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,483.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,557.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,632.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,021.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax provision</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Celgene</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">384.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">478.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,449.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per share:</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.90</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares (in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">414.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">412.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">432.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">429.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="30%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4Q </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">4</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,273.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,366.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,447.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,506.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,173.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,313.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,335.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,086.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax provision</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">225.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Celgene</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">263.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,456.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per share attributable to Celgene:</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.62</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.82</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares (in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">438.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">427.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">421.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">448.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">432.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">440.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit is computed by subtracting cost of goods sold (excluding amortization of acquired intangible assets) from net product sales.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The sum of the quarters may not equal the full year due to rounding. In addition, quarterly and full year basic and diluted earnings per share are calculated separately.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">3</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Celgene for 2013 was moderately lower in the fourth quarter compared to each of the other three quarters. The decrease was primarily due to a higher level of expense related to research and development collaborations, an increase in fair value of our liability related to CVRs and an asset impairment charge related to a royalty receivable asset.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">4</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Celgene for 2012 was moderately lower in the fourth quarter compared to each of the other three quarters. The decrease was primarily due to an increase in fair value of our liability related to the CVRs.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:590px;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="181px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="146px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="69px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="69px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="69px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;vertical-align:top;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gains (Losses) Reclassified Out of Accumulated</font></div><div style="text-align:center;vertical-align:top;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other Comprehensive Income</font></div></td></tr><tr><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated Other Comprehensive Income Components</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Affected Line Item in the Consolidated Statements of Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Years Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gains (losses) from cash-flow hedges:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net product sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Treasury rate lock agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest (expense)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax benefit (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gains (losses) from available-for-sale marketable securities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Realized income (loss) on sales of marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest and investment income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total reclassification, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">76.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> 4227900000 4712200000 1353100000 2226200000 1600300000 1724200000 149000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Research and Development Costs:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Research and development costs are expensed as incurred. These include all internal and external costs related to services contracted by us. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Milestone payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product.</font></div></div> 4472500000 3022600000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Revenue from the sale of products is recognized when title and risk of loss of the product is transferred to the customer and the sales price is fixed and determinable. Provisions for discounts, early payments, rebates, sales returns and distributor chargebacks under terms customary in the industry are provided for in the same period the related sales are recorded. We record estimated reductions to revenue for volume-based discounts and rebates at the time of the initial sale. The estimated reductions to revenue for such volume-based discounts and rebates are based on the sales terms, historical experience and trend analysis.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We base our sales returns allowance on estimated on-hand retail/hospital inventories, measured end-customer demand as reported by third-party sources, actual returns history and other factors, such as the trend experience for lots where product is still being returned or inventory centralization and rationalization initiatives conducted by major pharmacy chains, as applicable.&#160; If the historical data we use to calculate these estimates do not properly reflect future returns, then a change in the allowance would be made in the period in which such a determination is made and revenues in that period could be materially affected.&#160; Under this methodology, we track actual returns by individual production lots.&#160; Returns on closed lots, that is, lots no longer eligible for return credits, are analyzed to determine historical returns experience.&#160; Returns on open lots, that is, lots still eligible for return credits, are monitored and compared with historical return trend rates.&#160; Any changes from the historical trend rates are considered in determining the current sales return allowance.&#160; </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales discount accruals are based on payment terms extended to customers.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government rebate accruals are based on estimated payments due to governmental agencies for purchases made by third parties under various governmental programs. U.S. Medicaid rebate accruals are generally based on historical payment data and estimates of future Medicaid beneficiary utilization applied to the Medicaid unit rebate formula established by the Center for Medicaid and Medicare Services. The Medicaid rebate percentage was increased and extended to Medicaid Managed Care Organizations in March&#160;2010.&#160; The accrual of the rebates associated with Medicaid Managed Care Organizations is calculated based on estimated historical patient data related to Medicaid Managed Care Organizations.&#160; We have also analyzed actual billings received from the states to further support the accrual rates.&#160; Subsequent to implementation of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the 2010 U.S. Health Care Reform Law), certain states have only recently begun submitting partial Medicaid Managed Care Organization bills.&#160; Our accruals for these Medicaid Managed Care Organization rebates had been at elevated levels given the delays in the receipt of complete invoices from certain states.&#160; Due to the receipt of more complete claims data as 2013 progressed, the accruals for certain states were reduced from the elevated levels at December 31, 2012 as a result of both the payments made being applied to the accrual and a </font><font style="font-family:inherit;font-size:10pt;">$20.3 million</font><font style="font-family:inherit;font-size:10pt;"> favorable change in estimate of the ultimate obligation. &#160;We will continue to adjust the rebate accruals as more information becomes available and to reflect actual claims experience. Effective January&#160;1, 2011, manufacturers of pharmaceutical products are responsible for </font><font style="font-family:inherit;font-size:10pt;color:#000000;">50%</font><font style="font-family:inherit;font-size:10pt;"> of the patient&#8217;s cost of branded prescription drugs related to the Medicare Part&#160;D Coverage Gap.&#160; In order to estimate the cost to us of this coverage gap responsibility, we analyze data for eligible Medicare Part&#160;D patients against data for eligible Medicare Part&#160;D patients treated with our products as well as the historical invoices.&#160; This expense is recognized throughout the year as costs are incurred.&#160; In certain international markets, government-sponsored programs require rebates to be paid based on program specific rules&#160;and, accordingly, the rebate accruals are determined primarily on estimated eligible sales.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rebates or administrative fees are offered to certain wholesale customers, group purchasing organizations and end-user customers, consistent with pharmaceutical industry practices. Settlement of rebates and fees may generally occur from </font><font style="font-family:inherit;font-size:10pt;color:#000000;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">15</font><font style="font-family:inherit;font-size:10pt;">&#160;months from the date of sale. We provide a provision for rebates at the time of sale based on contracted rates and historical redemption rates. Assumptions used to establish the provision include level of wholesaler inventories, contract sales volumes and average contract pricing.&#160; We regularly review the information related to these estimates and adjust the provision accordingly.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chargeback accruals are based on the differentials between product acquisition prices paid by wholesalers and lower government contract pricing paid by eligible customers covered under federally qualified programs.&#160; Distributor service fee accruals are based on contractual fees to be paid to the wholesale distributor for services provided.&#160; TRICARE is a health care program of the U.S. Department of Defense Military Health System that provides civilian health benefits for military personnel, military retirees and their dependents.&#160; TRICARE rebate accruals are included in chargeback accruals and are based on estimated Department of Defense eligible sales multiplied by the TRICARE rebate formula.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We record estimated reductions to revenue for free goods and volume-based discounts at the time of the initial sale. The estimated reductions to revenue for such free goods and volume-based discounts are based on the sales terms, historical experience and trend analysis. The cost of free goods is included in Cost of Goods Sold (excluding amortization of acquired intangible assets).</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize revenue from royalties based on licensees' sales of its products or products using its technologies. Royalties are recognized as earned in accordance with the contract terms when royalties from licensees can be reasonably estimated and collectability is reasonably assured. If royalties cannot be reasonably estimated or collectability of a royalty amount is not reasonably assured, royalties are recognized as revenue when the cash is received.</font></div></div> 6493900000 4842100000 5506700000 1477500000 1617700000 719900000 2860900000 503700000 3169100000 766100000 3862100000 1865700000 1419200000 1447400000 1366800000 1273300000 1464600000 1674400000 1755900000 1599000000 122900000 116900000 110400000 56900000 50900000 5385600000 4699700000 6362300000 0 4280300000 305400000 426700000 648900000 823200000 30900000 803300000 29700000 339100000 54000000 302100000 3766600000 3208200000 50000000 244500000 5000000 23300000 600000 0 2600000 385900000 705300000 12000000 0 80900000 10700000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rebates, distributor chargebacks and distributor services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Clinical trial costs and grants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common share repurchases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties, license fees and collaboration agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial related activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Professional services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,001.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">775.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">795.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">795.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency MBS</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S. government, agency and</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supranational securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt&#160;&#8211; global</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable equity securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">220.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total available-for-sale marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,239.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,452.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">902.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">902.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">303.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">303.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency MBS</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">387.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S. government, agency and</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supranational securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt&#160;&#8211; global</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">209.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total available-for-sale marketable securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,808.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,809.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="84%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value at the</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition Date</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total fair value of consideration transferred</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">535.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes currently payable:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State and local</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(245.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total U.S. tax provision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes currently payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total international tax provision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total provision</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">225.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gains (Losses) From</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gains (Losses)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (Loss)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance December&#160;31, 2011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Period change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(27.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Period change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.450% senior notes due 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">520.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.900% senior notes due 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.300% senior notes due 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">399.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.950% senior notes due 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.250% senior notes due 2022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">956.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,002.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.000% senior notes due 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">696.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.700% senior notes due 2040</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.250% senior notes due 2043</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">396.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,196.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,771.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal and state NOL carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized research expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax credit carryforwards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-qualified stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plant and equipment, primarily differences in depreciation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,005.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,069.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued and other expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unremitted earnings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(316.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(316.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized (gains) losses on securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(71.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,403.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">574.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,408.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">680.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,403.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,408.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax asset (liability)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(723.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(876.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">on Derivative</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassified from</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassified from</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Ineffective Portion</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">and Amount Excluded</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">From Effectiveness</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Testing)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Ineffective Portion</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">and Amount Excluded</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">From Effectiveness</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Testing)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign&#160;exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net product sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Treasury rate lock agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Forward starting interest rate swaps</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net losses of </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$13.2 million</font><font style="font-family:inherit;font-size:8pt;"> are expected to be reclassified from Accumulated OCI into income in the next 12&#160;months.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The amount of net gains recognized in income represents </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$6.3 million</font><font style="font-family:inherit;font-size:8pt;"> of gains related to the ineffective portion of the hedging relationships and </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$6.3 million</font><font style="font-family:inherit;font-size:8pt;"> of gains related to amounts excluded from the assessment of hedge effectiveness. </font></div></td></tr></table><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:681px;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td width="118px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="84px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="118px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="81px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="108px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="91px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="21px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">on Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassified from</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Reclassified from</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated OCI</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">into Income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gain/(Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Recognized in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Derivative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Ineffective Portion</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">and Amount Excluded</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">From Effectiveness</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Testing)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Ineffective Portion</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">and Amount Excluded</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">From Effectiveness</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Testing)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign&#160;exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net product sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">80.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup>&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Treasury rate lock agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(35.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:24px;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The amount of net losses recognized in income represents </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$9.0 million</font><font style="font-family:inherit;font-size:8pt;"> in losses related to the ineffective portion of the hedging relationships and </font><font style="font-family:inherit;font-size:8pt;color:#000000;">$2.4 million</font><font style="font-family:inherit;font-size:8pt;"> of gains related to amounts excluded from the assessment of hedge effectiveness.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the effect of derivative instruments designated as fair value hedging instruments on the Consolidated Statements of Income for the years ended December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="29%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of Gain (Loss)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized in Income</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">on Derivative</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain (Loss)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized in Income</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">on Derivative</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest Rate Swaps</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the fair value and presentation in the Consolidated Balance Sheets for derivative instruments as of December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="30%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Asset Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance Sheet</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance Sheet</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td></tr><tr><td colspan="9" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Derivatives designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign&#160;exchange&#160;contracts</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">63.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">84.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">60.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">41.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">68.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange contracts</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">206.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">264.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:681px;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="218px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="133px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="133px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="3px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">December 31, 2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Asset Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance Sheet</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance Sheet</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value</font></div></td></tr><tr><td colspan="9" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Derivatives designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign&#160;exchange&#160;contracts</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="9" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange contracts</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other non-current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">133.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">116.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font><font style="font-family:inherit;font-size:8pt;">Derivative instruments in th</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Celgene</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,449.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,456.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,318.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">455.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options, restricted stock units, warrants and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">440.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">462.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per share attributable to Celgene:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.89</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percentages</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax rate differences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unremitted earnings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes, net of federal benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition related differences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in uncertain tax positions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective income tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of goods sold</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax benefit related to share-based compensation expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reduction in income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,280.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,766.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,208.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">VIDAZA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">803.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">823.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">648.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">426.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">POMALYST</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">/IMNOVID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">305.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">302.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">339.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ISTODAX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Azacitidine for injection</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net product sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,362.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,385.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,699.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collaborative agreements and other revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalty revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,493.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,506.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,842.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.09375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notional Amount</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Foreign Currency Option:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designated as hedging activity:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased Put</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written Call</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">235.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not designated as hedging activity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased Put</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written Put</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(216.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1</sup></font><font style="font-family:inherit;font-size:9pt;"> U.S. dollar notional amounts are calculated as the hedged local currency amount multiplied times the strike value of the foreign currency option. The local currency notional amounts of our purchased put and written call that are designated as hedging activities are equal to each other.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,042.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax benefit on the exercise of Pharmion converted stock options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,041.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">416.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,628.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,401.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,002.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,665.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,681.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the notional amounts of our outstanding swap contracts at the end December 31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:677px;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="453px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="95px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="95px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2012</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest rate swap contracts entered into as fair value hedges of the following fixed-rate senior notes:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.450% senior notes due 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.900% senior notes due 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">300.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.300% senior notes due 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.950% senior notes due 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.250% senior notes due 2022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">850.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.000% senior notes due 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">150.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,300.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">300.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Foreign Currency:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Australian Dollar</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">British Pound</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canadian Dollar</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,318.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">969.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Japanese Yen</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">559.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">236.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,156.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,422.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="29%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of Gain (Loss)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized in Income</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">on Derivative</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain (Loss)</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized in Income</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">on Derivative</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Instrument</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">34.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Treasury rate lock agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Put options sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="30%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4Q </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">3</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,464.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,599.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,674.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,755.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,493.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,483.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,557.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,632.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,021.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax provision</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Celgene</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">384.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">478.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">214.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,449.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per share:</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.90</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares (in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">417.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">414.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">412.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">413.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">432.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">429.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="30%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4Q </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">4</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,273.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,366.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,447.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,506.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,173.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,264.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,313.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,335.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,086.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax provision</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">225.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Celgene</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">263.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,456.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per share attributable to Celgene:</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.62</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.38</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.82</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average shares (in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">438.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">427.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">421.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">430.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">448.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">432.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">440.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit is computed by subtracting cost of goods sold (excluding amortization of acquired intangible assets) from net product sales.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The sum of the quarters may not equal the full year due to rounding. In addition, quarterly and full year basic and diluted earnings per share are calculated separately.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="84%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized as of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition Date</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Working capital</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform technology intangible asset</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">330.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development product rights</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax liability</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">3</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(165.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable net assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">535.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Platform technology related to the Avilomics discovery platform which is being amortized over a useful life of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">seven years</font><font style="font-family:inherit;font-size:10pt;"> based on the estimated useful life of the platform.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">3</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes current deferred income tax asset of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$14.7 million</font><font style="font-family:inherit;font-size:10pt;"> and non-current deferred tax liability of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$179.7 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,862.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,169.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,860.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,865.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,617.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,477.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">766.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">719.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">503.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,493.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,506.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,842.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-Lived Assets</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long lived assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">578.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-lived assets consist of net property, plant and equipment.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share</font></div><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equivalent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average</font></div><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Grant Date</font></div><div style="font-weight:bold;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes during the period:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63.20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.15</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="18%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Price Per Option</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contractual</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term (Years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intrinsic Value</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(In Millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58.31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">860.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes during the Year:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,643.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested at December&#160;31, 2013 or expected to vest in the future</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.9</font></div></td><td style="vertical-align:bottom;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.46</font></div></td><td style="vertical-align:bottom;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,595.3</font></div></td><td style="vertical-align:bottom;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.81</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,945.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="55%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68% - 1.70%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.21% - 1.23%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.21% - 2.20%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27% - 35%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27%&#160;-&#160;30%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27%&#160;-&#160;33%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average expected volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected term (years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.03 - 5.50</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.30&#160;-&#160;5.17</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.80&#160;-&#160;5.20</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 12&#160;months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12&#160;months or longer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">316.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government-sponsored agency MBS</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">404.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt&#160;&#8211; global</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,015.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,061.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedule&#160;II&#160;&#8211; Valuation and Qualifying Accounts</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="32%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended December&#160;31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions Charged</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">to Expense or</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">End of Year</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(In millions)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for doubtful accounts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for customer discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for doubtful accounts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for customer discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for doubtful accounts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for customer discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts are a reduction from gross sales.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percent&#160;of&#160;Total&#160;Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percent&#160;of&#160;Net&#160;Accounts&#160;Receivable</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amerisource Bergen Corp.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographic and Product Information</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operations by Geographic Area:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Revenues primarily consisted of sales of REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, VIDAZA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, POMALYST</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">/IMNOVID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and ISTODAX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">. Additional sources of revenue included a licensing agreement with Novartis, which entitles us to royalties on FOCALIN XR</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> and the entire RITALIN</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;"> family of drugs, the sale of services through our Cellular Therapeutics subsidiary and other miscellaneous licensing agreements.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,862.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,169.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,860.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,865.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,617.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,477.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">766.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">719.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">503.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,493.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,506.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,842.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-Lived Assets</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long lived assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">578.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-lived assets consist of net property, plant and equipment.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues by Product:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Total revenues from external customers by product for the years ended December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">REVLIMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,280.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,766.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,208.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">VIDAZA</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">803.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">823.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ABRAXANE</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">648.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">426.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">385.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">POMALYST</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">/IMNOVID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">305.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">THALOMID</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">302.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">339.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ISTODAX</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Azacitidine for injection</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net product sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,362.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,385.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,699.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collaborative agreements and other revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalty revenue</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,493.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,506.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,842.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Major Customers:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We sell our products primarily through wholesale distributors and specialty pharmacies in the United States, which account for a large portion of our total revenues. International sales are primarily made directly to hospitals, clinics and retail chains, many of which are government owned. During the three-year period of </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;">, only Amerisource Bergen accounted for more than 10% of our total revenue in at least one of those years and is summarized below. The percentage of amounts due from this customer compared to total net accounts receivable is also summarized below as of December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percent&#160;of&#160;Total&#160;Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Percent&#160;of&#160;Net&#160;Accounts&#160;Receivable</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amerisource Bergen Corp.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div> 1373500000 1226300000 1684500000 217200000 325800000 231000000 P4Y 400000 8000000 63.20 64.26 1800000 46000000 124.96 119.02 5100000 4500000 26000000 58000000 66.20 88.15 106.87 60.80 800000 6000000 6000000.0 4000000.0 60.17 60.78 0 0 0 0.35 0.27 0.27 0.33 0.27 0.30 0.0170 0.0068 0.0123 0.0220 0.0021 0.0021 0.29 0.31 0.28 105000000 16674585 293500000 147900000 814700000 0 1100000 9600000 17.09 19.33 40.44 860300000 3643400000 42600000 39600000 58.31 76.94 17000000 54.81 3595300000 38900000 76.46 9000000.0 54.23 56.74 73.96 131.96 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Share-Based Compensation:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We utilize share based compensation in the form of stock options, restricted stock units (RSUs) and performance-based restricted stock units (PSUs). Compensation expense is recognized in the Consolidated Statements of Income based on the estimated fair value of the awards at grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized to date associated with grants that are not expected to vest will be reversed.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of stock option grants are estimated as of the date of grant using a Black-Scholes option valuation model. The fair values of RSU and PSU grants are based on the market value of our Common Stock on the date of grant.</font></div></div> P10Y P5Y0M10D P5Y2M1D P5Y6M P1Y3M18D P5Y2M12D P1Y9M18D 1945600000 P5Y3M18D P6Y10M24D P7Y1M6D P7Y 308500000 544800000 153700000 -200000 300000 300000 12500000 200000 500000 5200000 10700000 11500000 100000 100000 100000 13600000 13600000 22000000 22000000 11000000 19200000 22000000 2600000 19200000 19200000 166800000 166700000 554000000 100000 100000 100000 -10600000 483000000 472500000 -69700000 623600000 472500000 166800000 554000000 3000000000.000 600000000 9500000000.000 3000000000.000 2068000000 22300000 5694500000 5589900000 1566400000 5995500000 -62300000 4472500000 5000000 0 4900000 94000000 5589900000 5589900000 3022600000 7539800000 5512700000 8680400000 5694500000 5100000 11500000 6764400000 248300000 -73700000 -7662100000 5984000000 4800000 -2760700000 -545600000 -49700000 6350200000 5512700000 5694500000 -4823200000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders' Equity</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Preferred Stock:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Our Board of Directors is authorized to issue, at any time, without further stockholder approval, up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">5.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of preferred stock, and to determine the price, rights, privileges, and preferences of such shares.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Common Stock:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;At December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, we were authorized to issue up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;">575.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock of which shares of common stock issued totaled </font><font style="font-family:inherit;font-size:10pt;color:#000000;">511.2 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;During the period of April 2009 through December 2013, our Board of Directors has approved repurchases of up to an aggregate </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.500 billion</font><font style="font-family:inherit;font-size:10pt;"> of our common stock, including the June 2013 authorization to repurchase an additional </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.000 billion</font><font style="font-family:inherit;font-size:10pt;"> of our common stock. We repurchased </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.769 billion</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.050 billion</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.220 billion</font><font style="font-family:inherit;font-size:10pt;"> of treasury stock under the program in </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2011</font><font style="font-family:inherit;font-size:10pt;">, respectively, excluding transaction fees. As of December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> an aggregate </font><font style="font-family:inherit;font-size:10pt;color:#000000;">96.8 million</font><font style="font-family:inherit;font-size:10pt;"> common shares were repurchased under the program at an average price of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$76.80</font><font style="font-family:inherit;font-size:10pt;"> per common share and total cost of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$7.432 billion</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other:</font><font style="font-family:inherit;font-size:10pt;"> When employee awards of RSUs vest and are settled net in order to fulfill minimum statutory tax withholding requirements, the shares withheld are reflected as treasury stock.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of changes in common stock issued and treasury stock is presented below:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="66%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">in Treasury</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">482.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercise of stock options, warrants and conversion of restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of common stock for employee benefit plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares repurchased under share repurchase program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">487.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercise of stock options, warrants and conversion of restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of common stock for employee benefit plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares repurchased under share repurchase program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercise of stock options and conversion of restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of common stock for employee benefit plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares repurchased under share repurchase program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(101.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> 2 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsequent Event</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 12, 2014, our Board of Directors voted to recommend a </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">-for-one split of the Company&#8217;s common stock to be effected through an amendment to the Company&#8217;s Certificate of Incorporation. Implementation of the stock split is subject to stockholder approval of the amendment at the Annual Meeting of Stockholders, which is currently scheduled to take place on June 18, 2014. Per share information contained in this Annual Report on Form 10-K has not been restated to reflect this recommended stock split as it is subject to stockholder approval.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">596.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increases related to prior year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decreases related to prior year tax positions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increases related to current year tax positions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lapse of statute</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of year</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">219.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Financial Information</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">170.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rebates, distributor chargebacks and distributor services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Clinical trial costs and grants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common share repurchases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties, license fees and collaboration agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial related activities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Professional services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,001.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">775.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent value rights&#160;&#8211; Abraxis acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales, use and value added tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collaboration agreement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration&#160;&#8211; Avila acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">431.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current liabilities at December&#160;31, </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;">2012</font><font style="font-family:inherit;font-size:10pt;"> consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration&#160;&#8211; Avila acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation and long-term incentives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent value rights - Abraxis acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred lease incentive</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Collaboration agreement </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration&#160;&#8211; Gloucester acquisition</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing facility purchase</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">582.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">355.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> 10000000 8300000 7600000 114.30 101500000 78700000 5200000 28600000 38300000 22300000 4823200000 7662100000 2050700000 2221200000 2769200000 2769200000 2769200000 2221200000 2050700000 2050700000 2221200000 47600000 -71700000 1400000 30600000 596800000 174700000 219200000 0 0 450600000 10300000 30200000 38100000 25500000 0 23200000 18000000 900000 9600000 198900000 11200000 27800000 17900000 21800000 13300000 9000000 18800000 40000000 46300000 12100000 8700000 10100000 27900000 4800000 55500000 33000000 4800000 15500000 8300000 13100000 3200000 62400000 56800000 66400000 800000 87000000 6200000 73400000 1100000 12600000 69400000 79600000 7400000 55700000 63200000 16500000 9900000 7400000 440800000 430300000 462700000 432300000 448600000 445400000 436300000 432200000 428600000 428800000 429300000 455300000 430900000 413800000 427200000 421600000 436700000 438300000 417900000 411200000 412300000 414100000 19400000 52400000 2 13600000 61300000 10000000 28700000 10000000 0 12800000 10000000 5500000 25000000 1100000 0 13600000 1000000 22200 8800000 25000000 0 5000000 0 75000000 291700000 277200000 198600000 289200000 194500000 262800000 0 0 0 0 0 0 0 0 0 200000 0 4300000 0 0 0 0 0 3000000 0 0 34300000 1364800000 1363800000 233900000 229800000 35600000 0 300000 900000 1600000 0 500000 3300000 1100000 300000 0 220200000 100000 200000 0 221900000 0 0 1800000 0 200000 100000 2100000 8300000 0 6900000 400000 200000 600000 200000 0 2 171700000 14700000 -165000000 12000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash, Cash Equivalents and Marketable Securities Available for Sale:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency mortgage-backed securities (MBS), non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities. All liquid investments with maturities of three months or less from the date of purchase are classified as cash equivalents and all investments with maturities of greater than three months from date of purchase are classified as marketable securities available for sale. We determine the appropriate classification of our investments in marketable debt and equity securities at the time of purchase. In addition, our equity investments in the publicly traded common stock of companies with whom we have entered into collaboration agreements are also designated as marketable securities available for sale.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities available for sale are carried at fair value, held for an unspecified period of time and are intended for use in meeting our ongoing liquidity needs. Unrealized gains and losses on available-for-sale securities, which are deemed to be temporary, are reported as a separate component of stockholders' equity, net of tax. The cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. The amortization, along with realized gains and losses and other-than-temporary impairment charges, is included in interest and investment income, net.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A decline in the market value of any available-for-sale security below its carrying value that is determined to be other-than-temporary would result in a charge to earnings and decrease in the security's carrying value down to its newly established fair value. Factors evaluated to determine if an investment is other-than-temporarily impaired include significant deterioration in earnings performance, credit rating, asset quality or business prospects of the issuer; adverse changes in the general market condition in which the issuer operates; our intent to hold to maturity and an evaluation as to whether it is more likely than not that we will not have to sell before recovery of its cost basis; our expected future cash flows from the security; and issues that raise concerns about the issuer's ability to continue as a going concern.</font></div></div> 183300000 192600000 0.3333 0.6667 0.50 0.50 0.50 0.50 7000000 17000000 28000000 0 22800000 46600000 41000000 45700000 228500000 228500000 198100000 198100000 62700000 17400000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Consideration from Business Combinations:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Subsequent to the acquisition date, we measure contingent consideration arrangements at fair value for each period with changes in fair value recognized in income as acquisition related (gains) charges and restructuring, net. Changes in fair values reflect new information about related IPR&amp;D and other assets and the passage of time. In the absence of new information, changes in fair value reflect only the passage of time as development work towards the achievement of the milestones progresses, and is accrued based on an accretion schedule.</font></div></div> 18300000 147500000 118100000 163500000 0 17300000 373000000 505000000 100000000 790000000 440000000 277400000 0 118100000 118100000 277400000 277400000 250000000.0 300000000.0 400000000.0 300000000 P1Y 3000000000.000 1000000000.000 1000000000.000 2000000000.000 2000000000.000 1000000000.000 3000000000.000 0.05 0.1 0.025 0.14 0.99452 0.99147 0.99792 1.01 318600000 40800000 10100000 600000 600000 700000 12000000 0.9 1 0.1 0.2 3 0 2 22600000 25200000 19600000 P3Y 0.375 0.375 0.375 0.375 0.25 0.25 P3Y -245100000 107300000 -67100000 311300000 5700000 187200000 311900000 0.06 0.038 0.037 -0.035 P120D 52100000 0 0 20000000 0 0 0 0 0 0 0 0 0 2400000 0 0 20000000 0 0 0 0 90000000 66900000 177000000 152900000 89600000 600000 270000000 255000000 73900000 20300000 6900000 1750000000.000 -4900000 0 -1200000 1 120000000 0.197 0.220 0.210 0 1000000 0 13000000 0 0 5400000 0 0 14500000 0 0 25000000 0 0 0 0 0 0 17000000 125400000 170800000 348000000 367000000 217500000 148800000 P30D 2 2 5 3 4 6 13100000 0 0 143700000 -1100000 143700000 143700000 11500000 11500000 11400000 -13700000 12600000 100000 -1100000 0 156700000 225000000 75000000 23300000 0 0.10 0.5 50000000 25000000 50000000 430000000 1100000000.0 200000000 315000000 511000000 664500000 25000000 165000000 225000000 170000000 0 1200000 0 2700000 2700000 1200000 4800000 0 4 217300000 187000000 -7300000 0 -79600000 0.202 0.251 0.266 0.35 0.3 0.025 0.01 15500000 13300000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="72%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets (non-current)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(804.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,018.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax asset (liability)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(723.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(876.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="66%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">in Treasury</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">482.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercise of stock options, warrants and conversion of restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of common stock for employee benefit plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares repurchased under share repurchase program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">487.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercise of stock options, warrants and conversion of restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of common stock for employee benefit plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares repurchased under share repurchase program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(28.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">498.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercise of stock options and conversion of restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance of common stock for employee benefit plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares repurchased under share repurchase program</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(101.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life (Years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired developed product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,405.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,026.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,379.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.0</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.5</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,848.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,146.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,701.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.5</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortized intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired IPR&amp;D product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,986.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,146.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,839.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life (Years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired developed product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,400.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(814.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,585.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.0</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">293.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.8</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,841.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(878.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,962.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.5</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortized intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired IPR&amp;D product rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,979.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(878.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,100.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td width="87%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and operating equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing machinery and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer equipment and software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-7&#160;years</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="64%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested Performance-Based RSUs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share Equivalent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at December&#160;31, 2012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes during the period:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at December&#160;31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106.87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Summarized financial information related to our collaboration agreements is presented below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.0390625%;border-collapse:collapse;text-align:left;"><tr><td colspan="27" rowspan="1"></td></tr><tr><td width="13%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="16" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended December 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of December 31,</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="12" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and Development Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Upfront </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Fees</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Milestones</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Extension of </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Agreements</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of Prepaid Research and </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additional Equity Investments </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Made</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Intangible Asset </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Balance</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Equity Investment </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Balance</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Percentage of Outstanding </font><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">Equity</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acceleron</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">127.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010 and prior</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Agios</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">113.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">28.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2010 and prior</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Epizyme</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">69.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">65.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">bluebird</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">74.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">FORMA</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">MorphoSys</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">94.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">61.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">61.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acetylon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">50.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Oncomed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">155.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td></tr><tr><td rowspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other Collaboration Arrangements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">149.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">25.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">30.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2012</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">113.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2011</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">103.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">1</sup></font><font style="font-family:inherit;font-size:10pt;"> Year-end balance and percentage of outstanding equity are presented for the current and prior year.</font></div></div> P1M P15M P3Y P6M 159300000 162800000 144100000 96800000 76.80 7432000000 -1900000 600000 3000000 -4900000 -600000 -1900000 -1200000 -600000 2050000000 2769000000 2220000000 900000000 45000000 0 103500000 74700000 0 121200000 52800000 0 149000000 155000 50000000 0 94300000 25000000 0 0 0 65000000 0 113500000 7500000 77400000 9600000 12500000 6400000 62500000 79300000 74300000 16800000 96200000 84900000 12300000 56100000 86600000 64900000 P60D 5100000 5100000 false --12-31 FY 2013 2013-12-31 10-K 0000816284 406020079 Yes Large Accelerated Filer 48096964775 CELGENE CORP /DE/ No Yes 200000000 77900000 279400000 0 5100000 134400000 1422900000 3318200000 236200000 969300000 4156700000 559100000 0 200000000 300000000 0 100000000 0 500000000 0 300000000 150000000 300000000 850000000 0 200000000 2300000000 160500000 235900000 0 -216000000 0 0 0 228800000 795400000 300000000 200000000 1850000000 878500000 350000000 100000000 7635000000 EX-101.SCH 10 celg-20131231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2113100 - Disclosure - Accumulated Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Accumulated Other Comprehensive Income (Loss) Reclassification Out of Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Acquisitions and Divestitures link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Acquisitions and Divestitures (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Acquisitions and Divestitures (Details 2) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Acquisitions and Divestitures (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details 2) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details 3) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Collaboration Agreements link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Collaboration Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Collaboration Agreements (Details 2) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Collaboration Agreements (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - Commitments and Contingencies (Details 2) link:presentationLink link:calculationLink link:definitionLink 2418404 - Disclosure - Commitments and Contingencies Manufacturing Facility Payment Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Debt (Details 2) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Derivative Instruments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Derivative Instruments and Hedging Activities (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Derivative Instruments and Hedging Activities (Details 2) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Derivative Instruments and Hedging Activities (Details 3) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2415401 - Disclosure - Employee Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Employee Benefit Plans (Details 2) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Financial Instruments and Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Financial Instruments and Fair Value Measurement (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Financial Instruments and Fair Value Measurement (Details 2) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Financial Instruments and Fair Value Measurement (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Geographic and Product Information link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Geographic and Product Information (Details) link:presentationLink link:calculationLink link:definitionLink 2419403 - Disclosure - Geographic and Product Information (Details 2) link:presentationLink link:calculationLink link:definitionLink 2419404 - Disclosure - Geographic and Product Information (Details 3) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Geographic and Product Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Income Taxes (Details 2) link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Intangible Assets and Goodwill link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Intangible Assets and Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Intangible Assets and Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Other Financial Information link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Other Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Other Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Quarterly Results of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Quarterly Results of Operations (Unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 2422401 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Share-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Share-Based Compensation (Details 2) link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - Share-Based Compensation (Details 3) link:presentationLink link:calculationLink link:definitionLink 2414405 - Disclosure - Share-Based Compensation (Details 4) link:presentationLink link:calculationLink link:definitionLink 2414406 - Disclosure - Share-Based Compensation (Details 5) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2421401 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 celg-20131231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 celg-20131231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 celg-20131231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Inventory Disclosure [Abstract] Summary of inventories by major category Schedule of Inventory, Current [Table Text Block] Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Commercial Paper Commercial Paper [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Debt Debt Instrument [Line Items] Amount outstanding Commercial Paper Effective interest rate (as a percent) Line of Credit Facility, Interest Rate at Period End Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Maximum number of credit facility increases Maximum Number of Times Company has Right to Increase Credit Facility Represents the maximum number of times the Company has the right to increase the amount of the Credit Facility subject to certain conditions. Maximum borrowing capacity, subject to certain conditions Line of Credit Facility, Maximum Borrowing Capacity Subject to Certain Conditions Increased maximum borrowing capacity, subject to certain conditions, under the credit facility. Outstanding uncommitted facility Line of Credit Facility, Amount Outstanding Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Earnings Per Share [Abstract] Schedule of earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of intangible assets by category Schedule of Intangible Assets [Table Text Block] Tabular disclosure of the carrying value of intangible assets, excluding goodwill, in total and by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company. Schedule of changes in carrying value of goodwill Schedule of Goodwill [Table Text Block] Net income attributable to Celgene Net Income (Loss) Available to Common Stockholders, Basic Weighted average shares: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Effect of dilutive securities: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Options, restricted stock units, warrants and other (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Net income per share attributable to Celgene: Earnings Per Share, Basic and Diluted [Abstract] Basic (in dollars per share) Earnings Per Share, Basic Diluted (in dollars per share) Earnings Per Share, Diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Put Put Option [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Disclosures [Abstract] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Approved common share repurchase amount Stock Repurchase Program, Authorized Amount Aggregate common stock repurchased under the program (in shares) Treasury Stock, Shares, Acquired Weighted average price (in dollars per share) Treasury Stock Acquired, Average Cost Per Share Put option premium Put Option Premium Put Option Premium Put options outstanding Put Options Outstanding Put Options Outstanding Notional amount Derivative, Notional Amount Strike price (in dollars per share) Derivative, Price Risk Option Strike Price Common stock repurchased under the program during the period (in shares) Stock Repurchased During Period, Shares Remaining open-ended repurchase authorization Stock Repurchase Program, Remaining Authorized Repurchase Amount Equity [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Pension Liability Accumulated Defined Benefit Plans Adjustment [Member] Net Unrealized Gains (Losses) From Marketable Securities Accumulated Net Unrealized Investment Gain (Loss) [Member] Net Unrealized Gains (Losses) From Hedges Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Foreign Currency Translation Adjustment Accumulated Translation Adjustment [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Summary of accumulated other comprehensive income (loss), net of tax Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance at the beginning of the period Accumulated Other Comprehensive Income (Loss), Net of Tax Period change Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Balance at the end of the period Business Combinations [Abstract] Acquisitions and Divestitures Mergers, Acquisitions and Dispositions Disclosures [Text Block] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of goods sold Cost of Sales [Member] Research and development Research and Development Expense [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Non-qualified stock options Non Qualified Stock Option [Member] Represents the non-qualified stock options granted by the entity. Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Inventory Inventories [Member] Stock-Based Compensation Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Total share-based compensation expense Allocated Share-based Compensation Expense Tax benefit related to share-based compensation expense Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Reduction in income Allocated Share-based Compensation Expense, Net of Tax Segment Reporting [Abstract] Schedule of revenues and long-lived assets by geographic area Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of total revenues from external customers by product Revenue from External Customers by Products and Services [Table Text Block] Schedule of customer concentration risk based on total revenues and net accounts receivable Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Cash, Cash Equivalents, and Short-term Investments [Abstract] Schedule of available-for-sale securities by major security type and class Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Schedule of available-for-sale securities in an unrealized loss position for less than and longer than 12 months Schedule of Unrealized Loss on Investments [Table Text Block] Schedule of duration periods of available-for-sale debt securities Investments Classified by Contractual Maturity Date [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Compensation and Retirement Disclosure [Abstract] Employee Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Collaboration Agreements Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaboration Agreements Parties [Axis] Collaboration Agreements Parties [Axis] Represents the parties to collaboration agreements for which information is being disaggregated. Collaboration Agreements Parties [Domain] Collaboration Agreements Parties [Domain] The names of the parties with which the entity has entered into collaboration agreements. Acceleron Acceleron Pharma [Member] Acceleron Pharma. Agios Agios Pharmaceuticals [Member] Agios Pharmaceuticals, Inc. Epizyme Epizyme Inc [Member] Represents information related to Epizyme, Inc. Bluebird Bluebird bio, Inc. [Member] Bluebird bio, Inc. [Member] FORMA FORMA [Member] FORMA [Member] MorphoSys MorphoSys AG [Member] MorphoSys AG [Member] Acetylon Acetylon [Member] Acetylon [Member] OncoMed OncoMed Pharmaceuticals, Inc. [Member] OncoMed Pharmaceuticals, Inc. [Member] Other Collaboration Arrangements Other Collaboration Agreements [Member] Represents information pertaining to other collaboration agreements not disclosed elsewhere in the taxonomy. Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Upfront Fees Upfront Payments Made Upfront payments made under a collaboration agreement. Milestones Milestone Payments Made Milestone payments made under a collaboration agreement. Extension of Agreements Extension of Agreement Payment Made Extension of Agreement Payment Made Amortization of Prepaid Research and Development Amortization of Prepaid Research and Development Amortization of Prepaid Research and Development Additional Equity Investments Made Additional Equity Investments Made Additional Equity Investments Made Intangible Asset Balance Intangible Assets, Net (Excluding Goodwill) Equity Investment Balance Equity Method Investments Percentage of Outstanding Equity Equity Method Investment, Ownership Percentage Fair Value Disclosures [Abstract] Assets and liabilities measured at fair value on recurring basis Fair Value, Measurement Inputs, Disclosure [Text Block] Roll-forward of fair value of Level 3 instruments (significant unobservable inputs), liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Statement, Geographical [Axis] Geographical [Axis] Segment, Geographical [Domain] Geographical [Domain] United States UNITED STATES Europe Europe [Member] All other All Other Countries [Member] All Other Countries [Member] Operations by Geographic Area Revenues from External Customers and Long-Lived Assets [Line Items] Total revenues Revenues Total long lived assets Property, Plant and Equipment, Net Derivative [Table] Derivative [Table] Foreign currency forward contracts Foreign Exchange Forward [Member] Foreign exchange option contracts Foreign Exchange Option [Member] Interest rate swap contracts Interest Rate Swap [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash flow hedges Cash Flow Hedging [Member] Derivative [Line Items] Derivative [Line Items] Schedule of notional amount of foreign currency forward contracts Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Foreign currency option contracts entered into to hedge forecasted revenue and expenses Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Schedule of fair value and balance sheet location of derivative instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Schedule of effect of derivative instruments designated as hedging instruments on Consolidated Statements of Income Derivative Instruments, Gain (Loss) [Table Text Block] Schedule of effect of derivative instruments not designated as hedging instruments on Consolidated Statements of Income Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Quarterly Financial Data [Abstract] Quarterly Results of Operations (Unaudited) Quarterly Financial Information [Text Block] Cash and cash equivalents Cash and Cash Equivalents [Abstract] Money market funds Money Market Funds, at Carrying Value Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] U.S. Treasury securities US Treasury Securities [Member] U.S. government-sponsored agency securities US Government Corporations and Agencies Securities [Member] U.S. government-sponsored agency MBS Mortgage-backed Securities, Issued by US Government Sponsored Enterprises [Member] Non-U.S. government, agency and Supranational securities Foreign Government Debt Securities [Member] Corporate debt – global Corporate Debt Securities [Member] Asset backed securities Asset-backed Securities [Member] Marketable equity securities Equity Securities [Member] Available-for-sale securities by major security type and class of security Schedule of Available-for-sale Securities [Line Items] Amortized Cost Available-for-sale Securities, Amortized Cost Basis Gross Unrealized Gain Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Loss Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Estimated Fair Value Available-for-sale Securities, Current Schedule of quarterly results of operations Schedule of Quarterly Financial Information [Table Text Block] Income Tax Disclosure [Abstract] Income before income taxes: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract] U.S. Income (Loss) from Continuing Operations before Income Taxes, Domestic Non-U.S. Income (Loss) from Continuing Operations before Income Taxes, Foreign Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Provision (benefit) for taxes on income: Income Tax Expense (Benefit), Continuing Operations, by Jurisdiction [Abstract] United States: Federal State and Local Income Tax Expense Benefit Continuing Operations [Abstract] Taxes currently payable: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Federal Current Federal Tax Expense (Benefit) State and local Current State and Local Tax Expense (Benefit) Deferred income taxes Deferred Federal State and Local Income Tax Expense Benefit The component of total income tax expense for the period comprised of the increase (decrease) in the entity's domestic, state and local deferred tax assets and liabilities attributable to continuing operations as determined by applying the provisions of the applicable enacted tax laws. Total U.S. tax provision Federal State and Local Income Tax Expense Benefit Continuing Operations The sum of domestic, state and local current and deferred income tax expense or benefit attributable to continuing operations. International: Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract] Taxes currently payable Current Foreign Tax Expense (Benefit) Deferred income taxes Deferred Foreign Income Tax Expense (Benefit) Total international tax provision Foreign Income Tax Expense (Benefit), Continuing Operations Total provision Income Tax Expense (Benefit) Permanently unremitted earnings of international subsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Unremitted earnings of international subsidiaries Undistributed Earnings of Foreign Subsidiaries, Not Permanent Amount of undistributed earnings of foreign subsidiaries not intended to be permanently reinvested outside the United States. Deferred tax liability on foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Deferred tax assets and liabilities: Components of Deferred Tax Assets and Liabilities [Abstract] Assets Deferred Tax Assets, Net [Abstract] Federal and state NOL carryforwards Deferred Tax Assets, Operating Loss Carryforwards Deferred revenue Deferred Tax Assets, Deferred Income Capitalized research expenses Deferred Tax Assets, in Process Research and Development Tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Non-qualified stock options Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Inventory Deferred Tax Assets, Inventory Other assets Deferred Tax Assets, Other Intangibles Deferred Tax Assets, Intangible Assets Represents the tax effect as of the balance sheet date of the amount of the estimated future tax deductions attributable to intangible assets, which can only be deducted for tax purposes when actual costs are incurred and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. Accrued and other expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other Unrealized (gains) losses on securities Deferred Tax Assets, Unrealized Losses on Trading Securities Deferred Tax Liabilities, Unrealized Gains on Trading Securities Deferred Tax Liabilities, Unrealized Gains on Trading Securities Subtotal Deferred Tax Assets, Gross Valuation allowance Deferred Tax Assets, Valuation Allowance Total deferred taxes Deferred Tax Assets, Net of Valuation Allowance Liabilities Deferred Tax Liabilities, Gross [Abstract] Plant and equipment, primarily differences in depreciation Deferred Tax Liabilities, Property, Plant and Equipment Other assets Deferred Tax Liabilities, Other Intangibles Deferred Tax Liabilities, Intangible Assets Unremitted earnings Total deferred taxes Deferred Tax Liabilities, Net Net deferred tax asset (liability) Deferred Tax Assets, Net Deferred tax assets and liabilities classified on the company's balance sheet: Deferred Tax Assets, Net, Classification [Abstract] Current assets Deferred Tax Assets, Net of Valuation Allowance, Current Other assets (non-current) Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Current liabilities Deferred Tax Liabilities, Net, Current Other non-current liabilities Deferred Tax Liabilities, Net, Noncurrent Percentages Effective Income Tax Rate Reconciliation, Percent [Abstract] U.S. statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Foreign tax rate differences Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Unremitted earnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent State taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Acquisition related differences Effective Income Tax Rate Reconciliation Acquisition Related Differences The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to acquisition related differences. Changes in uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Settlement, Percent Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Maximum statutory Swiss income tax rate (as a percent) Maximum Statutory Foreign Income Tax Rate Represents the maximum statutory foreign income tax rate. Reduction in effective tax rates due to difference between maximum statutory Swiss income tax rate and the company's Swiss income tax rate under the tax holiday (as a percent) Reduction in Effective Income Tax under Tax Holiday The reduction in effective tax rate due to the difference between the maximum statutory foreign income tax rate and the company's foreign income tax rate under the tax holiday recorded during the period. Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Research Research Tax Credit Carryforward [Member] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] State State and Local Jurisdiction [Member] Income Taxes Operating Loss Carryforwards [Line Items] NOL carryforwards Operating Loss Carryforwards NOL carryforwards for which deferred tax assets have not been recorded Deferred Tax Asset Not Recognized Operating Loss Carryforwards Represents the amount as of the balance sheet date of operating loss carryforwards on which the entity has not provided deferred taxes. Accounting Policies [Abstract] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment by Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Buildings Building [Member] Building and operating equipment Equipment [Member] Manufacturing machinery and equipment Machinery and Equipment [Member] Other machinery and equipment Other Machinery and Equipment [Member] Furniture and fixtures Furniture and Fixtures [Member] Computer equipment and software Computer, Equipment and Software [Member] Represents the long-lived, depreciable assets that are used in the creation, maintenance and utilization of information systems and capitalized costs of purchased software applications. Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Property, Plant and Equipment: Property, Plant and Equipment [Line Items] Estimated useful lives of capitalized assets (in years) Property, Plant and Equipment, Useful Life Foreign Currency Translation: Foreign Currency Translation [Abstract] Net foreign exchange losses Foreign Currency Transaction Gain (Loss), before Tax Revenue Recognition Revenue Recognition [Abstract] Percentage of responsibility for patient's cost of branded prescription taken by manufacturers Percentage of Responsibility for Patients Cost of Branded Prescription Represents the percentage of responsibility for patient's cost of branded prescription taken by the manufacturers. Period for settlement of rebates and fees Settlement Period for Rebates and Fees Represents the period for settlement of rebates and fees. Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Options Employee Stock Option [Member] Share-Based Compensation Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Cash received from exercise of awards Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options Excess tax benefit recognized from exercise of awards Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options Unrecognized compensation cost Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted-average period over which unrecognized compensation cost is expected to be recognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Weighted-average grant date fair value of the stock options issued (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Assumptions used in the estimation of fair value of options granted Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Weighted average expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Period of settlement of publicly traded options Share Based Compensation Arrangement by Share Based Payment Award, Fair Value Assumptions Settlement Period of Publicly Traded Options Represents the settlement period of the publicly traded stock options. Implied volatility of such publicly traded options is used in estimation of expected volatility of stock options granted to arrive at estimated fair value of options granted. Geographic and Product Information Segment Reporting Disclosure [Text Block] Statement of Financial Position [Abstract] Accounts receivable, allowances (in dollars) Allowance for Doubtful Accounts Receivable, Current Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, treasury Treasury Stock, Shares Concentration Risk [Table] Concentration Risk [Table] Major Customers [Axis] Customer [Axis] Name of Major Customer [Domain] Customer [Domain] Amerisource Bergen Corp. Amerisource Bergen [Member] Represents Amerisource Bergen, a major customer of the entity. Concentration Risk by Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Percent of Total Revenue Total Revenue [Member] Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process), when it serves as a benchmark in a concentration of risk calculation. Percent of Net Accounts Receivable Accounts Receivable [Member] Concentration Risk by Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Customers' concentration risk Customer Concentration Risk [Member] Major Customers Revenue, Major Customer [Line Items] Percentage of concentration risk Concentration Risk, Percentage Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Total revenue Gross profit Gross Profit Income tax provision Net income per share attributable to Celgene: Diluted (in shares) Net receivables Spain, Italy and Portugal Geographic Concentration Risk [Member] Concentration of Credit Risk: Concentration Risk [Line Items] Increase in rebates distributor chargebacks and distributor services Increase (Decrease) in Rebates Distributor Chargebacks and Distributor Services Increase (Decrease) in Rebates Distributor Chargebacks and Distributor Services Accounts receivable, net Accounts Receivable, Net Accounts receivable, net, noncurrent Accounts Receivable, Net, Noncurrent Income Taxes Income Tax Disclosure [Text Block] Schedule of Deferred Compensation Arrangement Excluding Share Based Payments and Postretirement Benefits by Type of Deferred Compensation [Table] Schedule of Deferred Compensation Arrangement Excluding Share Based Payments and Postretirement Benefits by Type of Deferred Compensation [Table] Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability. Deferred Compensation Arrangement Excluding Share Based Payments and Postretirement Benefits by Type of Deferred Compensation [Axis] Deferred Compensation Arrangement Excluding Share Based Payments and Postretirement Benefits by Type of Deferred Compensation [Axis] Reflects the information pertaining to the type of deferred compensation (such as equity-based payments, pension and other postretirement benefits, and arrangements that are neither an equity-based payment, nor a pension or other postretirement benefit). The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Type of Deferred Compensation [Domain] Type of Deferred Compensation, All Types [Domain] Deferred compensation plan Deferred Compensation, Excluding Share-based Payments and Retirement Benefits [Member] Long-Term Incentive Plan Long Term Incentive Plan [Member] Represents the long-term incentive plan of the entity. Long Term Incentive Plan 2015 [Member] Long Term Incentive Plan 2015 [Member] Represents the long-term incentive plan of the entity ending on December 31, 2015. 2014 Long-Term Incentive Plan Long Term Incentive Plan 2014 [Member] Represents the long-term incentive plan of the entity ending on December 31, 2014. 2015 Long-Term Incentive Plan Long Term Incentive Plan 2016 [Member] [Member] Long Term Incentive Plan 2016 [Member] Deferred compensation arrangement Deferred Compensation Arrangement Postretirement Benefits [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Percentage of base salary which the eligible participants can elect to defer Deferred Compensation Arrangement, Deferral by Participants as Percentage of Base Salary Represents the percentage of base salary which an eligible participant can elect to defer under the deferred compensation arrangements. Percentage of cash bonuses which the eligible participants can elect to defer Deferred Compensation Arrangement, Deferral by Participants as Percentage of Cash Bonuses Represents the percentage of cash bonuses which an eligible participant can elect to defer under the deferred compensation arrangements. Employer match as a percentage of participant's base salary Deferred Compensation Arrangement, Employer Match as Percentage of Base Salary of Participants Represents the employer's matching contribution to the deferred compensation plan expressed as a percentage of participants' base salary. Plan related expense Deferred Compensation Arrangement, Compensation Expense The compensation expense recognized during the period relating to the deferred compensation arrangement. Deferred compensation liability, non-current Deferred Compensation Liability, Classified, Noncurrent Performance period Deferred Compensation Arrangement, Performance Period Represents the period over which the performance is measured to arrive at the performance-based incentives to be provided to the employees under the deferred compensation arrangement. Number of separate three-year performance cycles Deferred Compensation Arrangement, Number of Performance Cycles Represents the number of performance cycles running concurrently. Percentage of non-GAAP net income as component of performance measures of the plans Deferred Compensation Arrangement, with Individual, Percentage of Performance Measured, based on Non-GAAP Net Income Represents the percentage of performance which is measured on the basis of non-GAAP net income in the last year of the three-year cycle under the deferred compensation arrangement. Percentage of total non-GAAP revenue as component of performance measures of the plans Deferred Compensation Arrangement, with Individual, Percentage of Performance Measured, based on Non GAAP Revenue Represents the percentage of performance which is measured on the basis of non-GAAP revenue in the last year of the three-year cycle under the deferred compensation arrangement. Percentage of relative shareholder return as component of performance measures of the plans Deferred Compensation Arrangement, with Individual Percentage of Performance Measured, Based on Relative Shareholder Return Represents the percentage of performance which is measured on the basis of relative shareholder return in the last year of the three-year cycle under the deferred compensation arrangement. Payouts as percentage of the participant's salary Deferred Compensation Arrangement, Payout as Percentage of Participants Salary Represents the payouts expressed as a percentage of participants' base salary under the deferred compensation arrangement. Estimated payout for the plan, current Deferred Compensation Liability, Current Potential payout, assuming maximum objectives are achieved Deferred Compensation Arrangement, Performance Based Incentive Potential Payout Represents the potential payout assuming maximum performance objectives are achieved under the deferred compensation arrangement. Consecutive trading days Number of Consecutive Trading Days Period of consecutive trading days used to calculate the average closing price of common stock to determine the stock-based performance awards. Payments made in common stock, trading restriction Deferred Compensation Shares, Trading Restriction Period Represents the period over which the performance-based common stock shares awarded to select participants at the entity's discretion cannot be traded by the employee under the deferred compensation arrangement. Other Financial Information Schedule of accrued expenses Schedule of Accrued Liabilities [Table Text Block] Schedule of other current liabilities Other Current Liabilities [Table Text Block] Schedule of other non-current liabilities Other Noncurrent Liabilities [Table Text Block] Nature of Business and Basis and Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation Depreciation Amortization Amortization Expense Amortization Expense Provision for accounts receivable allowances Provision for Doubtful Accounts Deferred income taxes Deferred Income Tax Expense (Benefit) Impairment charges Asset Impairment Charges Change in value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Share-based compensation expense Share-based Compensation Share-based employee benefit plan expense Pension and Other Postretirement Benefit Expense Reclassification adjustment for cash flow hedges included in net income Reclassification Adjustment for Cash Flow Hedges This element represents accumulated gains and losses from derivative instrument designated and qualifying as the effective portion of cash flow hedges included in net income during the period. Unrealized change in value of derivative instruments Unrealized Gain (Loss) on Derivatives Realized losses (gains) on marketable securities available for sale Available-for-sale Securities, Gross Realized Gain (Loss) Other, net Other Noncash Income (Expense) Change in current assets and liabilities, excluding the effect of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Other operating assets Increase (Decrease) in Other Operating Assets Accounts payable and other operating liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Payment of contingent consideration Payments for Contingent Consideration Operating Activities The amount of cash paid during the reporting period for charges associated with the contingent consideration in connection with a business combination of reporting entity. This element represents the cash inflow reported in the enterprise's operating activities. Income tax payable Increase (Decrease) in Income Taxes Payable Deferred revenue Increase (Decrease) in Deferred Revenue Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Proceeds from sales of marketable securities available for sale Proceeds from Sale and Maturity of Available-for-sale Securities Purchases of marketable securities available for sale Payments to Acquire Available-for-sale Securities Payments for acquisition of business, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Purchases of intellectual property and other assets Payments to Acquire Intangible Assets Proceeds from the sale of assets, net Proceeds from Sale of Property, Plant, and Equipment Capital expenditures Payments to Acquire Productive Assets Purchases of investment securities Payments to Acquire Other Investments Other investing activities Payments for (Proceeds from) Other Investing Activities Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Payment for treasury shares Payments for Repurchase of Common Stock Proceeds from short-term borrowing Proceeds from Short-term Debt Principal repayments on short-term borrowing Repayments of Short-term Debt Proceeds from sale of common equity put options Proceeds From Sale of Common Equity Put Options Proceeds from sale of common equity put options. Payment of contingent consideration Payments for Contingent Consideration Financing Activities The amount of cash paid during the reporting period for charges associated with the contingent consideration in connection with a business combination of reporting entity. This element represents the cash inflow reported in the enterprise's financing activities. Proceeds from the issuance of long-term debt Proceeds from Issuance of Long-term Debt Net proceeds from exercise of common stock options and warrants Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Excess tax benefit from share-based compensation arrangements Excess Tax Benefit from Share-based Compensation, Financing Activities Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Effect of currency rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations Net increase in cash and cash equivalents Net Cash Provided by (Used in) Continuing Operations Cash and cash equivalents at beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Supplemental schedule of non-cash investing and financing activity: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Change in net unrealized gain on marketable securities available for sale Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes Matured shares tendered in connection with stock option exercises Matured shares tendered in connection with stock option exercises Remaining Payments Under Terminated Agreement which Resulted in Forfeiture of Entitys Previous Rights. Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid Income taxes paid Income Taxes Paid Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Derivative Instruments and Hedges Derivatives, Policy [Policy Text Block] Cash, Cash Equivalents and Marketable Securities Available for Sale Cash and Cash Equivalents and Marketable Securities Available for Sale [Policy Text Block] Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value and investments in debt and equity securities that are classified as available-for-sale. This policy also may describe the entity's accounting treatment for transfers between investment categories, how the entity determines whether impairments of available-for-sale securities are other than temporary, and how the fair values of such securities are determined. Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Inventory Inventory, Policy [Policy Text Block] Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Capitalized Software Costs Internal Use Software, Policy [Policy Text Block] Investments in Other Entities Equity and Cost Method Investments, Policy [Policy Text Block] Other Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Contingent Consideration from Business Combinations Contingent Consideration from Business Combinations [Policy Text Block] Disclosure of accounting policy related to measurement of contingent consideration subsequent to the acquisition. Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Share-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Income Statement [Abstract] Revenue: Revenues [Abstract] Net product sales Sales Revenue, Goods, Net Collaborative agreements and other revenue Other Revenue, Net Royalty revenue Royalty Revenue Total revenue Expenses: Costs and Expenses [Abstract] Cost of goods sold (excluding amortization of acquired intangible assets) Cost of Goods Sold Research and development Research and Development Expense (Excluding Acquired in Process Cost) Selling, general and administrative Selling, General and Administrative Expense Amortization of acquired intangible assets Amortization of Intangible Assets, Acquired Amortization of Intangible Assets, Acquired Acquisition related (gains) charges and restructuring, net Business Combination, Acquisition Related Costs Total costs and expenses Costs and Expenses Operating income Operating Income (Loss) Other income and (expense): Nonoperating Income (Expense) [Abstract] Interest and investment income, net Investment Income, Interest and Dividend Interest (expense) Interest Expense Other income (expense), net Other Nonoperating Income (Expense) Net income Net loss attributable to non-controlling interest Net Income (Loss) Attributable to Noncontrolling Interest Net income attributable to Celgene Valuation and Qualifying Accounts [Abstract] Valuation and Qualifying Accounts Disclosure [Table] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves [Domain] Valuation Allowances and Reserves [Domain] Allowance for doubtful accounts Allowance for Doubtful Accounts [Member] Allowance for customer discounts Allowance for Promotions [Member] Subtotal Allowance for Doubtful Accounts and Customer Discounts [Member] Represents the allowance established for amounts due that are unlikely to be received and for discounts given to customers. Allowance for sales returns Allowance for Sales Returns [Member] Valuation and Qualifying Accounts Disclosure [Line Items] Valuation and Qualifying Accounts Disclosure [Line Items] Movement in Valuation Allowances and Reserves [Roll Forward] Movement in Valuation Allowances and Reserves [Roll Forward] Balance at Beginning of Year Valuation Allowances and Reserves, Balance Additions Charged to Expense or Sales Valuation Allowances and Reserves Charged to Sales and Expense Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs, charged to sales or expenses. Deductions Valuation Allowances and Reserves, Deductions Balance at End of Year Amortization period related to non-IPR&D intangible assets, minimum (in years) Finite-Lived Intangible Asset, Useful Life Finite Lived and Indefinite Lived Intangible Assets by Major Class [Table] Finite Lived and Indefinite Lived Intangible Assets by Major Class [Table] Disclosure of the carrying value of amortizable and nonamortizable intangibles assets, in total and by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Finite Lived and Indefinite Lived Intangible Assets by Major Class [Axis] Finite Lived and Indefinite Lived Intangible Assets by Major Class [Axis] The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table. Finite Lived and Indefinite Lived Intangible Assets by Major Class [Domain] Finite Lived and Indefinite Lived Intangible Assets by Major Class [Domain] The major class of finite-lived and indefinite-lived intangible asset. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Acquired developed product rights Acquired Developed Product Rights [Member] Represents acquired developed product rights acquired by the entity. Technology Technology [Member] Represents technology related intangible assets. Licenses Licensing Agreements [Member] Other Other Intangible Assets [Member] Acquired IPR&D product rights Acquired in Process Research and Development Product Rights [Member] Represents in process research and development products rights acquired by the entity. Intangible Assets By Category Finite Lived and Indefinite Lived Assets [Line Items] Gross Carrying Value Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Intangible Assets, Net Finite-Lived Intangible Assets, Net Non-amortized intangible assets: Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Carrying Value Indefinite-Lived Intangible Assets (Excluding Goodwill) Total intangible assets Intangible Assets, Net (Excluding Goodwill) [Abstract] Gross Carrying Value Intangible Assets, Gross (Excluding Goodwill) Intangible Assets, Net Increase in the gross carrying value of the intangible assets Intangible Assets, Gross Carrying Value, Period Increase (Decrease) The change during the reporting period in the gross carrying value of intangible assets. The change could be the result of new intangible assets acquired, intangible assets impairment during the period, intangible assets written off related to the sale of a business, or other adjustments to intangible assets. Finite-lived assets acquired Finite-lived Intangible Assets Acquired Impairment of intangible assets Impairment of Intangible Assets (Excluding Goodwill) Amortization Amortization of Intangible Assets Increase in amortization expense Increase (Decrease) in Amortization Expense Increase (Decrease) in Amortization Expense Amortization Future Annual Amortization Expense The annual estimated amortization expense for succeeding fiscal years for intangible assets subject to amortization. Summary of changes in carrying value of goodwill Goodwill [Roll Forward] Balance at December 31, 2012 Goodwill Tax benefit on the exercise of Pharmion converted stock options Deferred Tax Expense from Stock Options Exercised Balance at December 31, 2013 Inventory Inventory Disclosure [Text Block] Schedule of fair value of consideration transferred Schedule of Business Acquisitions, by Acquisition [Table Text Block] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] NantBioScience, Inc. NantBioScience, Inc. [Member] NantBioScience, Inc. [Member] NantBioScience NantBioScience [Member] NantBioScience Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Abraxis Bio Science, Inc. Abraxis Bio Science, Inc. [Member] Represents information related to Abraxis Bio Science, Inc. Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Groups, Including Discontinued Operations, Name [Domain] Disposal Groups, Including Discontinued Operations, Name [Domain] Investment [Axis] Investment [Axis] Investment, Name [Domain] Investment, Name [Domain] Acquisitions Business Acquisition [Line Items] Sale of Non-core Assets Sale of Non Core Assets [Abstract] Equity ownership interest in Active Biomaterials, LLC received as consideration from sale of non-core assets (as a percent) Percentage, Equity Interest Received as Consideration from Divestiture of Non Core Assets Represents the percentage ownership interest received by the entity as part consideration from the sale of certain non-core assets. Fair value of future royalty stream Present Value of Future Royalty Stream Carrying amount as of the balance sheet date of the present value of the future royalty streams included as noncash consideration in sale of non-core assets. Fair Value of Future Royalty Stream Fair Value of Future Royalty Stream Fair value of future royalty stream after valuation of discounted estimated future cash flows. Sale of business Disposal Group, Including Discontinued Operation, Balance Sheet Disclosures [Abstract] Aggregate collaboration agreement payments Aggregate Collaboration Agreement Payments Aggregate upfront and milestone payments made since inception of collaboration agreement. Number Of Product Candidates From Pipeline Number Of Product Candidates From Pipeline Number of product candidates from pipeline. Ownership percentage Cost Method Investments, Ownership Percentage Cost Method Investments, Ownership Percentage Potential future investment Potential Future Investment Potential future investment agreed to under the collaboration agreement. Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Gains (losses) from cash-flow hedges: Gains (losses) from available-for-sale marketable securities: Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Net product sales Revenue, Net Interest (expense) Income tax benefit (expense) Interest and investment income, net Investment Income, Net Total reclassification, net of tax Assets: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Liabilities: Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Balance at beginning of period Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Amounts acquired or issued Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Net change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Transfers in and/or out of Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Balance at end of period Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Potential Milestone Payments by Milestone Achieved [Axis] Potential Milestone Payments by Milestone Achieved [Axis] Represents information pertaining to the potential milestone payments categorized by the achievement of different milestones. Potential Milestone Payments by Name of Milestone Achieved [Domain] Potential Milestone Payments by Name of Milestone Achieved [Domain] Represents the name of the different milestones to be achieved for potential milestone payments. Avila Therapeutics, Inc. Avila Therapeutics Inc [Member] Represents information pertaining to the acquisition of Avila Therapeutics, Inc. Gloucester Pharmaceuticals, Inc. Gloucester Pharmaceuticals, Inc. [Member] Represents information related to Gloucester Pharmaceuticals, Inc. Fair Value of assets and liabilities Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Number of milestones with probability adjustments Business Combination, Contingent Consideration Arrangements, Number of Milestones with Probability Adjustments Business Combination, Contingent Consideration Arrangements, Number of Milestones with Probability Adjustments Property, Plant and Equipment, Net [Abstract] Land Land [Member] Building and operating equipment Building and Operating Equipment [Member] Represents long-lived, depreciable building and operating equipment. Leasehold improvements Leasehold Improvements [Member] Machinery and equipment Construction in progress Construction in Progress [Member] Subtotal Property, Plant and Equipment, Gross Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total Nonvested RSUs Restricted Stock Units (RSUs) [Member] Nonvested Performance-Based RSUs Performance Based, Restricted Stock Units [Member] Restricted stock units as awarded by a company to its employees as a form of incentive compensation. Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding at December 31, 2012 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Changes during the Year: Changes During Year Stock Options [Abstract] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Exercised/Released (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Outstanding at December 31, 2013 (in shares) Vested at December 31, 2013 or expected to vest in the future (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested at December 31, 2013 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Weighted Average Exercise Price Per Option Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Outstanding at December 31, 2012 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Changes during the Year: Changes During Period [Abstract] Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Outstanding at December 31, 2013 (in dollars per share) Vested at December 31, 2013 or expected to vest in the future (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested at December 31, 2013 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Outstanding at December 31, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding at December 31, 2013 Vested at December 31, 2013 or expected to vest in the future Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Vested at December 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (In Millions) Share Based Compensation Arrangement by Share Based Payment Award, Options, Outstanding Aggregate Intrinsic Value [Abstract] Outstanding at December 31, 2012 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Outstanding at December 31, 2013 Vested at December 31, 2013 or expected to vest in the future Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Vested at December 31, 2013 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share Equivalent Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Nonvested at December 31, 2012 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Nonvested at December 31, 2013 (in shares) Compensation cost and expected weighted-average period related to nonvested awards Share Based Compensation, Unrecognized Compensation Cost, Nonvested Awards [Abstract] Expected weighted-average period in years of compensation cost to be recognized Weighted Average Grant Date Fair Value Share Based Compensation Arrangement by Share Based Payment Award Other Than Options Weighted Average Grant Date Fair Value [Abstract] Nonvested at December 31, 2012 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Nonvested at December 31, 2013 (in dollars per share) Schedule of property, plant and equipment Property, Plant and Equipment [Table Text Block] Schedule of income (loss) before income taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of provision (benefit) for taxes on income Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of tax effects of temporary differences that give rise to deferred tax assets and liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of deferred tax assets and liabilities classified on the company's balance sheet Schedule of Classification of Deferred Tax Assets and Liabilities [Table Text Block] Tabular disclosure of classification of deferred tax assets and liabilities recognized in the entity's statement of financial position. Reconciliation of U.S. statutory income tax rate to company's effective tax rate for continuing operations Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Reconciliation of beginning and ending amount of unrecognized tax benefits Summary of Income Tax Contingencies [Table Text Block] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Title of Individual [Axis] Title of Individual [Axis] Relationship to Entity [Domain] Relationship to Entity [Domain] Stock-based compensation Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Stock options, additional information Total fair value of shares vested Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested in Period, Total Fair Value Total fair value of shares vested during the period. Total intrinsic value of stock options exercised during the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Ratio of stock options to RSU's in calculating the number of RSU's for employees Ratio of Stock Options to Restricted Stock Units to Determine Restricted Stock Units for Employees The ratio of non qualified stock options to restricted stock units used to calculate the number of restricted stock units available to employees of a total grant (stock options and restricted stock units). Debt Debt Disclosure [Text Block] Manufacturing Facility Repayment Obligation [Table] Manufacturing Facility Repayment Obligation [Table] Manufacturing Facility Repayment Obligation [Table] Manufacturing Facility [Axis] Manufacturing Facility [Axis] Manufacturing Facility [Axis] Manufacturing Facility [Domain] Manufacturing Facility [Domain] [Domain] for Manufacturing Facility [Axis] SWITZERLAND SWITZERLAND Manufacturing Facility Repayment Obligation [Line Items] Manufacturing Facility Repayment Obligation [Line Items] [Line Items] for Manufacturing Facility Repayment Obligation [Table] Contractual Obligation Contractual Obligation Subsequent Event [Table] Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Stock split conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Cash, Cash Equivalents and Marketable Securities Available-for-Sale Cash, Cash Equivalents, and Marketable Securities [Text Block] Schedule of future minimum lease payments under non-cancelable operating leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Currency [Axis] Currency [Axis] All Currencies [Domain] All Currencies [Domain] Eurodollar [Member] Eurodollar [Member] Novartis Novartis [Member] Novartis Pharma AG. Acceleron Pharma Inc Agios Pharmaceuticals, Inc. research and development payments FORMA research and development payments FORMA [Member] research and development payments FORMA [Member] regulatory approval milestone FORMA regulatory approval milestone FORMA [Member] regulatory approval milestone FORMA [Member] license payments FORMA license payments FORMA [Member] license payments FORMA [Member] MorphoSys AG Collaboration Agreements Transactions [Axis] Collaboration Agreements Transactions [Axis] Contractual arrangements that involve two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity. Collaboration Agreements Transactions [Domain] Collaboration Agreements Transactions [Domain] The collective collaborative arrangements, which are contractual arrangements with a party or parties that both: (i) actively participate in a joint operating activity and (ii) is (are) exposed to significant risks and rewards that depend on the commercial success of the joint operating activity. ACE-011 Program ACE-011 Program [Member] Represents the ACE-011 program. ACE-011 - Discovery Stage Programs ACE-011 Discovery Stage Programs [Member] Represents the ACE-011 discovery stage programs. ACE-536 Program ACE-536 Program [Member] Represents the ACE-536 program. ACE-536 First discovery stage program ACE-536 First Discovery Stage Program [Member] Represents the first ACE-536 discovery stage program. ACE-536 Second discovery stage program ACE-536 Second Discovery Stage Program [Member] Represents the second ACE-536 discovery stage program. ACE-536 Each additional discovery stage program ACE-536 Each Additional Discovery Stage Program [Member] Represents each additional ACE-536 discovery stage program following the second discovery stage program. RSPO-LGR CSC Pathway or another CSC Pathway RSPO-LGR CSC Pathway or another CSC Pathway [Member] RSPO-LGR CSC Pathway or another CSC Pathway [Member] Demcizumab Demcizumab [Member] Demcizumab [Member] Anti-DLL4/VEGF Anti-DLL4/VEGF [Member] Anti-DLL4/VEGF [Member] Other Four Biological Programs Other Biological Programs [Member] Other Biological Programs [Member] Small Molecule Program Small Molecule Program [Member] Small Molecule Program [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Celgene Parent Company [Member] Royalty rate (as a percent) Royalty Rate Percentage of royalty received from sale of products. Upfront and milestone payments received Milestone Payments Received Upfront and regulatory achievement payments received under the license agreement. Number of programs Number of Programs Represents the number of programs. Maximum receivable by Agios upon achievement of certain milestones Maximum Payable Per Product upon Achievement of Certain Milestones Maximum payable per product upon achievement of certain milestones Potential milestones payment per product Potential Milestones Payment Per Product Potential Milestones Payment Per Product Co-development and profit sharing ratio due to reduction of milestones Codevelopment and Profit Sharing Ratio Due to Reduction of Milestones Codevelopment and Profit Sharing Ratio Due to Reduction of Milestones Potential milestone payments Potential Milestones Payment Represents the potential payment that the entity is eligible to pay for certain milestone(s), which may include development, regulatory approval or sales-based milestones under the agreement. Number of Anti-Cancer Stem Cell Products Candidates from Pipeline Number of Anti-Cancer Stem Cell Products Candidates from Pipeline Number of Anti-Cancer Stem Cell Products Candidates from Pipeline Worldwide licensing rights for Anti-CSC therapeutic candidates, term Worldwide Licensing Rights for Anti-CSC Therapeutic Candidates, Term Worldwide Licensing Rights for Anti-CSC Therapeutic Candidates, Term Co-development sharing of global development costs Codevelopment Sharing of Global Development Costs Codevelopment Sharing of Global Development Costs Contingent Milestone Payments to be Made Contingent Milestone Payments to be Made Contingent Milestone Payments to be Made Effective notice period required to be served for termination of agreement Effective Notice Period Required to be Served for Termination of Agreement Represents the notice period required to be served before the termination of the agreement. Investments in equity or other assets Equity Method Investments and Other Investments Represents the investment in common stock under equity method and in other assets. Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as hedging instruments Designated as Hedging Instrument [Member] Not designated as hedging instruments Not Designated as Hedging Instrument [Member] Interest Rate Contract [Member] Interest Rate Contract [Member] Forward Starting Interest Rate Swaps Forward Starting Interest Rate Swaps [Member] Forward Starting Interest Rate Swaps [Member] Forward Starting Interest Rate Swap, Maturing in Year Five [Member] Forward Starting Interest Rate Swap, Maturing in Year Five [Member] Represents interest rate swap contracts, maturing in year five. Interest rate swap contracts, maturing in year 2023 Forward Starting Interest Rate Swap, Maturing in Year Ten [Member] Represents interest rate swap contracts, maturing in year ten. Treasury rate locks Treasury Lock [Member] Australian Dollar Australia, Dollars British Pound United Kingdom, Pounds Canadian Dollar Canada, Dollars Euro Euro Member Countries, Euro Japanese Yen Japan, Yen 2.450% senior notes due 2015 Senior Notes 2.45 Percent Due 2015 [Member] Represents senior notes with an interest rate of 2.450%, due in 2015. 3.250% senior notes due 2022 Senior Notes 3.250 Percent Due 2022 [Member] Represents senior notes with an interest rate of 3.250%, due in 2022. 1.900% senior notes due 2017 Senior Notes 1.900 Percent Due 2017 [Member] Represents senior notes with an interest rate of 1.900%, due in 2017. 2.300% senior notes due 2018 Senior Notes 2.30 Percent Due 2018 [Member] Senior Notes 2.30 Percent Due 2018 [Member] 3.950% senior notes due 2020 Senior Notes 3.95 Percent Due 2020 [Member] Represents senior notes with an interest rate of 3.950%, due in 2020. 4.000% senior notes due 2023 Senior Notes 4.00 Percent Due 2023 [Member] Senior Notes 4.00 Percent Due 2023 [Member] Open Option Contracts Written Type [Axis] Open Option Contracts Written Type [Axis] Open Option Contracts Written Type [Domain] Open Option Contracts Written Type [Domain] Call Call Option [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior Notes Senior Notes [Member] Position [Axis] Position [Axis] Position [Domain] Position [Domain] Purchased Put Long [Member] Written Call Short [Member] Summary of Derivative Instruments Summary of Derivative Instruments [Abstract] Period to settlement dates of derivatives is within this period Maximum Remaining Maturity of Foreign Currency Derivatives Derivative, Average Remaining Maturity Derivative, Average Remaining Maturity Derivative settlement losses Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion Amount of Gain/(Loss) Recognized in Income on Derivative Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Face amount of debt Debt Instrument, Face Amount Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Proceeds from settlement of interest rate swap contracts Derivative, Cash Received on Hedge Gains on termination of hedging relationship, accounted as reduction of current and future interest expense Document and Entity Information Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Filer Category Entity Filer Category Entity Public Float Entity Public Float Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Stockholders' Equity Note [Abstract] Summary of changes in common stock issued and treasury stock Schedule of Common Stock Activity [Table Text Block] Tabular disclosure of the information pertaining to changes during the period in common stock issued and treasury shares. Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Marketable securities available for sale Accounts receivable, net of allowances of $40.0 and $33.0 at December 31, 2013 and 2012, respectively Accounts Receivable, Net, Current Inventory Inventory, Net Deferred income taxes Other current assets Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net Intangible assets, net Goodwill Other assets Other Assets, Noncurrent Total assets Assets Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Short-term borrowings Short-term Debt Accounts payable Accounts Payable, Current Accrued expenses Accrued Liabilities, Current Income taxes payable Accrued Income Taxes, Current Current portion of deferred revenue Deferred Revenue, Current Other current liabilities Other Liabilities, Current Total current liabilities Liabilities, Current Deferred revenue, net of current portion Deferred Revenue, Noncurrent Income taxes payable Accrued Income Taxes, Noncurrent Deferred income taxes Other non-current liabilities Other Liabilities, Noncurrent Long-term debt, net of discount Long-term Debt Total liabilities Liabilities Commitments and Contingencies (Note 18) Commitments and Contingencies Stockholders' Equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $.01 par value per share, 5.0 million shares authorized; none outstanding at December 31, 2013 and 2012, respectively Preferred Stock, Value, Issued Common stock, $.01 par value per share, 575.0 million shares authorized; issued 511.2 million and 498.4 million shares at December 31, 2013 and 2012, respectively Common Stock, Value, Issued Common stock in treasury, at cost; 101.5 million and 78.7 million shares at December 31, 2013 and 2012, respectively Treasury Stock, Value Additional paid-in capital Additional Paid in Capital, Common Stock Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive income (loss) Total stockholders' equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders' equity Liabilities and Equity Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Research and experimentation credit Income Taxes Tax Credit Carryforward [Line Items] Credit carryforwards Tax Credit Carryforward, Amount Credit carryforwards for which deferred tax assets have not been recorded Deferred Tax Asset Not Recognized Tax Credit Carryforward Represents the amount as of the balance sheet date of tax credit carryforward on which the entity has not provided deferred taxes. Increase in additional paid-in capital on realization of stock option deduction benefits for income tax purposes Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Deferred income taxes recorded as a component of accumulated other comprehensive income resulting in a deferred income tax asset Deferred Tax Assets, Other Comprehensive Loss Unrecognized tax benefits: Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Balance at beginning of year Unrecognized Tax Benefits Increases related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Decreases related to prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Increases related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Lapse of statute Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Balance at end of year Unrecognized tax benefits that, if recognized, would have a net impact on the effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Accrued interest related to uncertain tax positions Unrecognized Tax Benefits, Interest on Income Taxes Accrued Reduction to income tax expense Decrease in Income Tax Expenses Represents the decrease in income tax expense due to, settled examinations with various taxing authorities related to tax positions taken in prior years. Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total Inventory, Current [Table] Inventory, Current [Table] Inventory [Axis] Inventory [Axis] Inventory [Domain] Inventory [Domain] ABRAXANE Abraxane [Member] Represents Abraxane, a product of the entity. OTEZLA Otezla [Member] Otezla [Member] Inventory [Line Items] Inventory [Line Items] Increase in raw materials during period Increase (Decrease) in Raw Materials, Packaging Materials and Supplies Inventories Earnings Per Share Earnings Per Share [Text Block] Schedule of estimated useful lives of capitalized assets Schedule of Property, Plant and Equipment Estimated Useful Lives [Table Text Block] Tabular disclosure of the estimated useful lives of the property, plant and equipment for each types of property, plant and equipment. Statement of Comprehensive Income [Abstract] Net unrealized (losses) gains related to cash flow hedges: Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax [Abstract] Unrealized holding gains (losses), tax expense (benefit) Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax Reclassification adjustment for (gains) losses included in net income, tax (expense) benefit Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax Net unrealized gains (losses) on marketable securities available for sale: Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax [Abstract] Unrealized holding gains (losses), tax expense (benefit) Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax Reclassification adjustment for (gains) losses included in net income, tax (expense) benefit Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax Collaboration Agreements Collaborative Arrangement Disclosure [Text Block] Property, Plant and Equipment Property, Plant and Equipment Disclosure [Text Block] Accumulated Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Fair value hedges Fair Value Hedging [Member] Foreign exchange contracts Put options sold Net product sales Sales [Member] Other income, net Other Income [Member] Interest expense Interest Expense [Member] Put Options Sold Derivative instruments gain loss Derivative Instruments, Gain (Loss) [Line Items] Amount of Gain/(Loss) Recognized in OCI on Derivative (Effective Portion) Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Amount of Gain/(Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded From Effectiveness Testing) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Gains (losses) expected to be reclassified from accumulated OCI into operations in the next 12 months Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Gains (losses) related to ineffective portion of hedging relationships Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net Gains (losses) related to amounts excluded from assessment of hedge effectiveness Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net Derivative instruments not designated as hedging instruments Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net [Abstract] Carrying values of the senior notes Schedule of Long-term Debt Instruments [Table Text Block] Employer contribution limit to U.S. savings plan per calendar year (as a percent of compensation) Defined Contribution Plan, Employer Contribution Limit Percentage of Compensation The limit of annual employer contributions to the plan per calendar year as a percentage of compensation. Total expense for contributions to U.S savings plan Defined Contribution Plan, Cost Recognized Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Recurring basis Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value Estimate of Fair Value Measurement [Member] Quoted Price in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Estimated maximum potential payments related to contingent consideration Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Assets and liabilities measured at fair value on recurring basis Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract] Assets: Assets, Fair Value Disclosure [Abstract] Available-for-sale securities Available-for-sale Securities Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Interest rate swaps Interest Rate Derivative Assets, at Fair Value Forward currency contracts Foreign Currency Contract, Asset, Fair Value Disclosure Purchased currency options Purchased Currency Options, Fair Value Disclosure This item represents purchased currency options of the entity. Total assets Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Forward currency contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Contingent value rights Contingent Value Rights Fair Value Disclosure Fair value of contingent value rights existing as of the balance sheet date in connection with business acquisition. Interest rate swaps Interest Rate Derivative Liabilities, at Fair Value Written currency options Written Currency Options, Fair Value Disclosure This item represents written currency options of the entity. Other acquisition related contingent consideration Contingent Consideration As Liability, Fair Value Disclosure Contingent Consideration As Liability, Fair Value Disclosure Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Financial Instruments and Fair Value Measurement Fair Value Disclosures [Text Block] Schedule II - Valuation and Qualifying Accounts Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Number of common shares in the share reserve Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of new common shares issued Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Vested in period, total fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Award vesting period, maximum (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Award expiration period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Additional award vesting period, retirement provision, maximum Share Based Compensation Arrangement by Share Based Payment Award, Additional Award Vesting Period, Maximum Represents the additional award vesting period in case the employee meets the retirement provision. Shares of common stock available for future share-based grants under all plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Collaboration Agreements [Abstract] Collaboration Agreements [Abstract] Schedule of Collaboration Agreements Schedule of Collaboration Agreements [Table Text Block] Schedule of Collaboration Agreements [Table Text Block] Operating Leases Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2014 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2015 Operating Leases, Future Minimum Payments, Due in Two Years 2016 Operating Leases, Future Minimum Payments, Due in Three Years 2017 Operating Leases, Future Minimum Payments, Due in Four Years 2018 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total minimum lease payments Operating Leases, Future Minimum Payments Due Total rental expense under operating leases Operating Leases, Rent Expense, Net Lines of Credit: Line of Credit Facility [Abstract] Derivative contract notional amount Letters of credit and guarantees issued on behalf of subsidiaries Letters of Credit Outstanding, Amount Other Commitments: Other Commitments [Abstract] Product supply contract obligation Supply Commitment, Remaining Minimum Amount Committed Supply Commitment [Table] Supply Commitment [Table] The Chan Soon-Shiong Institute for Advanced Health Institute for Advanced Health [Member] The Institute for Advanced Health. Other Commitments Supply Commitment [Line Items] Number of additional contribution amounts Additional Contribution Number Represents the number of additional contributions allowed under the agreement. Product Liability Contingency [Table] Product Liability Contingency [Table] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Revlimid Royalty Revlimid Royalty [Member] Revlimid Royalty [Member] Pomalyst Royalty Pomalyst Royalty [Member] Pomalyst Royalty [Member] Product Liability Contingency [Line Items] Product Liability Contingency [Line Items] Legal Proceedings: Legal Proceedings [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Children's Medical Center Corporation Children's Medical Center Corporation [Member] Children's Medical Center Corporation [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Range of possible loss minimum Loss Contingency, Range of Possible Loss, Minimum Range of possible loss maximum Loss Contingency, Range of Possible Loss, Maximum Number of other U.S. Attorney offices conducting investigations Number of Other US Attorney Offices Conducting Investigations The number of other U.S. Attorney offices conducting investigations. Duration periods of available-for-sale debt securities Available-for-sale Securities, Debt Maturities [Abstract] Amortized Cost Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract] Duration of one year or less Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis Duration of one through three years Available for Sale Securities, Debt Maturities, after One Through Three Years, Amortized Cost This item represents debt securities, at cost, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments, as defined), and fair value hedge accounting adjustments, if any, which are expected to mature after one year and through three years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Duration of three through five years Available for Sale Securities, Debt Maturities after Three Through Five Years, Amortized Cost This item represents debt securities, at cost, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments, as defined), and fair value hedge accounting adjustments, if any, which are expected to mature after three year and through five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Duration of over five years Available for Sale Securities, Debt Maturities More than Five Years, Amortized Cost This item represents debt securities, at cost, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments, as defined), and fair value hedge accounting adjustments, if any, which are expected to mature after five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Total Available-for-sale Securities, Debt Maturities, Amortized Cost Basis Fair Value Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract] Duration of one year or less Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Duration of one through three years Available for Sale Securities, Debt Maturities after One Through Three Years, Fair Value This item represents the fair value of debt securities which are expected to mature after one year and through three years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Duration of three through five years Available for Sale Securities, Debt Maturities after Three Through Five Years, Fair Value This item represents the fair value of debt securities which are expected to mature after three year and through five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Duration of over five years Available for Sale Securities, Debt Maturities after More than Five Years, Fair Value This item represents the fair value of debt securities which are expected to mature after five years from the balance sheet date which are categorized neither as held-to-maturity nor trading securities. Total Available-for-sale Securities, Debt Securities, Current 5.700% senior notes due 2040 Senior Notes 5.70 Percent Due 2040 [Member] Represents senior notes with an interest rate of 5.700%, due in 2040. 5.250% senior notes due 2043 Senior Notes 5.250 Percent Due 2043 [Member] Senior Notes 5.250 Percent Due 2043 [Member] Senior Notes due 2017 and 2022 Senior Notes Due 2017 and 2022 [Member] Represents the senior notes 1.90 % note due in 2017 and the 3.25% note due in 2022 that are together referred to as the '2012 issued notes'. Gain As A Result of Past Swap Contract Settlements Gain As A Result of Past Swap Contract Settlements [Member] Gain as a result of past swap contract settlements. [Member] Gain Related to Settlement of Swap Contracts During Current Fiscal Year [Member] Gain Related to Settlement of Swap Contracts During Current Fiscal Year [Member] Gain related to settlement of swap contracts during current fiscal year. Carrying values of the entity's senior notes Long-term Debt, Unclassified [Abstract] Long-term debt Senior notes, fair value Long-term Debt, Fair Value Debt issuance price (as a percent) Debt Instrument, Issuance Price as Percentage of Par Value Represents the debt instrument issuance price, expressed as a percentage of par value. Debt issuance costs Deferred Finance Costs, Noncurrent, Gross Redemption price, all or a portion of the notes, as a percentage of the principal amount (as a percent) Debt Instrument, Redemption Price, Percentage Repurchase price, as a percentage of the principal amount, change of control (as a percent) Debt Instrument, Repurchase Price Due to Change in Control as Percentage of Principal Amount Represents the price at which the entity may be required to repurchase the debt, as a percentage of the principal amount, if the entity undergoes a change in control. Losses related to treasury rate locks Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss) Deferred (Gain) Loss on Discontinuation of Fair Value Hedge Deferred (Gain) Loss on Discontinuation of Fair Value Hedge Aggregate value of common shares authorized to be purchased under share repurchase program Amount of stock repurchased under share repurchase program Treasury Stock, Value, Acquired Cost, Excluding Fees Equity impact of the cost of common and preferred stock that were repurchased during the period that were recorded using the cost method. The amount does not include transaction fees. Stock Repurchase Program, Aggregate Shares Stock Repurchase Program, Aggregate Shares The aggregate number of shares repurchased under a stock repurchase plan authorized by the entity's Board of Directors. Average price of shares repurchased under share repurchase program (in dollars per share) Stock Repurchase Program, Average Price Per Share Represents the average price per share of the shares repurchased under the stock repurchase program of the entity as of the balance sheet date. Cost of shares repurchased under share repurchase program Stock Repurchase Program, Cost of Shares Repurchased Represents the cost of the shares repurchased under the stock repurchase program of the entity as of the balance sheet date. Schedule of Common Stock [Table] Schedule of Common Stock [Table] Schedule reflecting the activity related to the common stock of the entity during the reporting period. Equity Component [Axis] Equity Component [Axis] Represents components of equity. Common Stock Common Stock [Member] Treasury Stock Treasury Stock [Member] Stockholders' Equity Common Stock Activity [Line Items] Changes in common stock issued and treasury stock Increase (Decrease) in Common Stock [Roll Forward] -- None. No documentation exists for this element. -- Balance at the beginning of the period (in shares) Exercise of stock options, warrants and conversion of restricted stock units Issuance of common stock for employee benefit plans Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Shares repurchased under share repurchase program Balance at the end of the period (in shares) Estimated Fair Value Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Abstract] Less than 12 months Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value 12 months or longer Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value Total Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value Gross Unrealized Loss Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss [Abstract] Less than 12 months Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss 12 months or longer Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss Total Available-for-sale Securities, Continuous Unrealized Loss Position, Aggregate Loss Other Financial Information Supplemental Balance Sheet Disclosures [Text Block] Milestone and Net Sales Payments [Axis] Milestone and Net Sales Payments [Axis] Pertinent information related to milestone and net sales achievement payments. Milestone and Net Sales Payments [Domain] Milestone and Net Sales Payments [Domain] Represents various types of milestone and net sales achievement payments. Milestone Payment One, if target achieved before specified date Milestone Payment One Member if Target Achieved before Specified Time [Member] Represents the first milestone payment under contingent consideration agreement if target achieved before a specified date. Milestone Payment Two, if target is achieved after specified date Milestone Payment Two, if Target Achieved after Specified Time [Member] Represents the milestone payment two under contingent consideration agreement if target achieved after a specified date. Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Payments for acquisition of business, net of cash acquired Fair Value at the Acquisition Date Payments to Acquire Businesses, Net of Cash Acquired [Abstract] Cash Payments to Acquire Businesses, Gross Contingent consideration Business Combination, Contingent Consideration, Fair Value Business Combination, Contingent Consideration, Fair Value Total fair value of consideration transferred Business Combination, Consideration Transferred Amounts Recognized as of Acquisition Date Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] Working capital Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital Excluding Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital Excluding Inventory Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Platform technology intangible asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles In-process research and development product rights Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Net deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Net Total identifiable net assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Amortization period of platform technology Finite-Lived Intangible Assets, Remaining Amortization Period Current deferred income tax asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets, Current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets, Current Net deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Fair value of acquired IPR&D Accrued expenses Accrued Liabilities, Current [Abstract] Compensation Employee-related Liabilities, Current Rebates, distributor chargebacks and distributor services Rebates Distributor Chargebacks and Distributor Services Current Carrying value as of the balance sheet date of the current portion of obligations incurred through that date and payable for rebates, distributor charge backs and distributor services. Clinical trial costs and grants Clinical Trial Costs and Grants Current Carrying value as of the balance sheet date of the current portion of obligations incurred through that date and payable for clinical trial costs and grants. Common share repurchases Common Share Repurchases, Current Carrying value of the balance sheet date of liabilities incurred through that date and payable for repurchase of common stock shares. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Interest Interest Payable, Current Royalties, license fees and collaboration agreements Accrued Royalties License Fees and Collaborations Current Accrued royalties, license fees and collaborations, current. Royalties, license fees and collaboration agreements Accrued Royalties License Fees and Milestones Current Carrying value as of the balance sheet date of the current portion of obligations incurred through that date and payable for royalties, license fees and milestones. Commercial related activities Commercial Related Activities Current Commercial related activities : current Sales returns Sales Returns Current Carrying value as of the balance sheet date of the current portion of obligations incurred through that date and payable for sales returns. Rent Accrued Rent, Current Professional services Accrued Professional Fees, Current Other Taxes Taxes Payable, Current Other Other Accrued Liabilities, Current Total Business Acquisition [Line Items] Other current liabilities Other Liabilities, Current [Abstract] Contingent value rights – Abraxis acquisition Contingent Value Rights, Current Represents the current portion of the contingent value rights. Sales, use and value added tax Sales and Excise Tax Payable, Current Foreign exchange contracts Derivative Liability, Current Collaboration agreement Collaboration Agreement, Current Carrying value of the balance sheet date of liabilities incurred through that date and payable for collaboration agreements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Contingent consideration – Avila acquisition Contingent Consideration Current Represents the current portion of the contingent consideration payable for the business acquisition. Other Other Sundry Liabilities, Current Total Other non-current liabilities Other Liabilities, Noncurrent [Abstract] Contingent consideration Contingent Consideration Non Current Represents the non-current portion of the contingent consideration payable for the business acquisition. Deferred compensation and long-term incentives Foreign exchange contracts Foreign Exchange Contracts, Noncurrent Foreign Exchange Contracts, Noncurrent Deferred lease incentive Incentive from Lessor Collaboration agreement Collaboration Agreement, Noncurrent Carrying values as of the balance sheet date of the liabilities for collaboration agreements payable beyond one year (or the operating cycle, if longer). Manufacturing facility purchase Other Notes Payable, Noncurrent Other Other Sundry Liabilities, Noncurrent Total Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] REVLIMID Revlimid [Member] Represents Revlimid, a product of the entity. VIDAZA Vidaza [Member] Represents Vidaza, a product of the entity. POMALYST/IMNOVID Pomalyst/Imnovid [Member] Represents Pomalyst/Imnovid, a product of the entity. THALOMID Thalomid [Member] Represents Thalomid, a product of the entity. ISTODAX Istodax [Member] Represents Istodax, a product of the entity. Azacitidine Azacitidine [Member] Represents Azacitidine, a product of the entity. Other Other Products [Member] Represents other products of the entity. Revenues by Product Revenue from External Customer [Line Items] Total net product sales Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Pension liability adjustment Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax Change in functional currency of a foreign subsidiary Other Comprehensive Income Foreign Currency, Change Functional Currency Foreign Subsidiary Reclassification adjustment for the change in the functional currency of a foreign subsidiary, net of tax. Net asset transfer of a common control foreign subsidiary Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Unrealized holding gains (losses), net of tax expense (benefit) of $2.6, ($13.8) and ($0) for the years ended 2013, 2012 and 2011, respectively Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Reclassification adjustment for (gains) losses included in net income, net of tax (expense) benefit of $6.9, ($1.9) and ($2.9) for the years ended 2013, 2012 and 2011, respectively Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Unrealized holding gains, net of tax expense (benefit) of $77.1, ($0.1) and $1.4 for the years ended 2013, 2012 and 2011, respectively Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Reclassification adjustment for losses (gains) included in net income, net of tax (expense) benefit of $2.2, $0.1 and $0.3 for the years ended 2013, 2012 and 2011, respectively Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Total other comprehensive income Other Comprehensive Income (Loss), Net of Tax Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive loss attributable to non-controlling interest Comprehensive (Income) Loss, Net of Tax, Attributable to Noncontrolling Interest Comprehensive income attributable to Celgene Comprehensive Income (Loss), Net of Tax, Attributable to Parent Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Interest rate swap agreements Other current assets Other Current Assets [Member] Other current liabilities Other Current Liabilities [Member] Other non-current assets Other Noncurrent Assets [Member] Other non-current liabilities Other Noncurrent Liabilities [Member] Summary of fair value and presentation in the consolidated balance sheets for derivative instruments Derivatives, Fair Value [Line Items] Fair value of derivative instruments Derivative Assets (Liabilities), at Fair Value, Net, by Balance Sheet Classification [Abstract] Asset Derivative Derivative Asset, Fair Value, Gross Asset Asset Derivative Derivative Liability, Fair Value, Gross Asset Liability Derivative Derivative Liability, Fair Value, Gross Liability Liability Derivative Derivative Asset, Fair Value, Gross Liability Intangible asset If Achieved no later than April 1, 2013 If Achieved after April 1, 2013 and before the fifth anniversary of the Merger Milestone One Milestone One [Member] Milestone One [Member] Milestone Two Milestone Two [Member] Milestone Two [Member] Milestone Three Milestone Three [Member] Milestone Three [Member] Termination date of December 31, 2025 if sales less than $1.0 billion Milestone Four [Member] Milestone Four [Member] Termination date of December 31, 2030 or earlier if sales less than $1.0 billion Milestone Five [Member] Milestone Five [Member] Nonfinancial liabilities CVR milestone payment Contingent Value Rights, Milestone Payment Contingent Value Rights, Milestone Payment Net sales measurement period Contingent Value Rights, Net Sales Measurement Period Contingent Value Rights, Net Sales Measurement Period Royalty rate Contingent Value Rights, Royalty Rate Contingent Value Rights, Royalty Rate Revenue milestones Contingent Value Rights, Revenue Milestones Contingent Value Rights, Revenue Milestones Milestone payment made Contingent Value Rights, Milestone Payment Made Contingent Value Rights, Milestone Payment Made Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Summary of other comprehensive income (loss) Comprehensive Income (Loss) [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Components of share-based compensation expense Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of assumptions used in the estimation of fair value of options granted Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of stock option activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of restricted stock units Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Schedule of performance-based restricted stock units Schedule of Share Based Compensation Performance Based, Restricted Stock Units Award, Activity [Table Text Block] Tabular disclosure of the number and weighted-average grant date fair value for performance-based restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested or forfeited during the year. Intangible Assets and Goodwill Goodwill and Intangible Assets Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Stockholders' Equity Parent [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Retained Earnings (Deficit) Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) [Member] Non-controlling Interest Noncontrolling Interest [Member] Statement [Line Items] Statement [Line Items] Increase (decrease) in stockholders' equity Balances at beginning of period Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Other comprehensive income Other Comprehensive Income (Loss) Net of Tax Period Increase (Decrease) including Additional Paid-in-Capital This element represents Other Comprehensive Income or Loss, Net of Tax, for the period, including the impact on additional paid-in capital. Mature shares tendered related to option exercise Treasury Stock Mature Value Tendered Related to Option Exercise Value of mature treasury stock tendered related to option exercise. Exercise of stock options and warrants and conversion of restricted stock units Stock Issued During Period, Value, Stock Options Exercised Shares purchased under share repurchase program Treasury Stock, Value, Acquired, Cost Method Issuance of common stock for employee benefit plans Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Issuance of common stock related to Abraxis acquisition Stock Issued During Period, Value, Acquisitions Expense related to share-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Income tax benefit upon exercise of stock options Disposal of non-controlling interest Noncontrolling Interest, Increase from Business Combination Balances at end of period EX-101.PRE 14 celg-20131231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 a2013123110_chart-22797.jpg begin 644 a2013123110_chart-22797.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_ MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`%6`G@#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^_BBBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`K M\[/V[O\`@H[\+OV(]2^"7PP_X1/Q1\+O'OB&:2VTFUDFEL=+UB6ROH;;] M$Z_D*_X*G>'O$G[-G_!Q7_P2:_X*`_&5Y;/]CN[\!ZQ^S/??$O6WAM_`7P@^ M+?B/2_CQH&F+XPUJ<'2O"%KXCN_BWX2UG3]]:W` M/WO\1?M/?M5?"SQ#\!].^,'[)7A:;PY\:_BIX/\`A;J_C/X&_'R]^)ND?!C4 M?&L[Q:9J?Q*T[QC\&/A/K5SX?,\1T6V\0^#;77K&?Q'=:99:M;^'M.UJ^ M_5O+=I4@\Z,7#PBX%OO4S>3N"&;RL^885D81F;;Y0D(0L'.VO/\`Q#\5?ASX M=U[X?^$-:\5:-#XI^)NH-9^`?#<,HU36_$TFGZ=/KNH7^E:7IJ7MY)HVCZ59 M3:CJWB1H8]!T>#[-+?ZI:M=V0N/X.?$OCOX^I^Q#\=_VJKJ6[C_X*MZ9_P`' M#>G?!_PQXF%_=Q?&+3]2M=4\+>'/"G[-N@XEBU]?@Y??#RYU72[3X-6]N?`> MO^![J^U>Y\-7\$DM^`#_`$"WFB16=W543.YR0$7'#;G.$7:>&+,,'@X)`H$L M9?RPPW[2VS.&V@X+;3\VT$A2V-H;Y2=W%?PF?MZ?"[P/\4_^"J__``<+Z%\0 M=(_M[0O`_P#P1IC^+7ASPU+KNMVGAK3OB=X8^%'PKUKPYXXET/3M2T[2]1\1 M>'=;CCU?0]2U6RN9--U;RM7MTBU`QSCSC]BK4M5\,?MB?\&L_P`7].\2>)[K MXH?M,_LN?M)>$OC]XZUOQ;XC\1>)?BQX7\)^"-5TCP;X;\:ZEK>JW\VKZ#X. MLK:SM/">CS_Z!H0TS3A8012Z=;-"`?W]--&H!9PH+!`QX4NS;`@8X4L7^15! M+,_R@%B!39KFWMHFGN)HH(47<\TSK%%&O3=))(52,9(&791N(7.2!7\*_BOX M;?!#XG?M^_\`!UEHWQPM]"U/1?AK^R_X/^*/P\T[Q)KLECI_@7QEI'P"U?Q4 MOQ3\(Z9+?P66B^-?#_C>+PY?V/CK3K-->T75M:DMK74[8^*]0M]5]JT3X[R? M$#X`?\&\WA7]KWXF^*_&/[2'Q>^!WQ@U/_AFSXTW?A73/V9OCMX2U'X37_AO M3/C;^V+XI^(&E:I>W-[X'^&D>G>*OA]8Z+X?\9?$CQ_\0-=N-*\,Q^&-5UN^ M\=V@!_:%O7CGKG`PA!KYO_:P^+WQ>^"/P)\:?$KX!_LZ^ M(?VL/BGX=N?#$'A[X%>%?&WAKX>ZYXN36/%&BZ/K4UOXK\61SZ/IH\-:!J.H M>*KB*>VGGO[727M+>-&N5N8O\^?6?BEXU\8_\&CGA2XU?X@ZUK?B7X6_M^Z9 MX`\(ZU?Z[<:IX@\%>'K'XCZA/H6@6=U?7MYJ.F:?INEZ_=0Z5I,]P8+7P_

2U>:$!?-#F%D=K$ES;PR112S1QRSLR01NZK).Z1O*Z0H3NE=(D>5DC#. ML:M(P"`L/XKO^"E:_$?X1_M#ZA^V&='^'G[B?"G]AGX"_M>_`JW\1+H MW[6/["6O7MQX*\4_"7XM_LW:N\SZQX?C^)NO_$3PYKM_'X>AU#3_`(K:KJ&I M>!?'6BWFA:='XC\)XW[;>M>)_%_QN_X.:?%G[2UV+3QO^RG^RM^S=JG[!FK: M[JD^CZA\%_"&K>$O&'BKPSX]_9^U9IM/OO"OB3Q3\9-.\,7>N^+O!US!K.H? M$%(?"EWJ4Y@M])H`_MO+KG&N#M]<'&:1'210\;!T;E64AE M8>JL"58>X)'O7\47[2MG\2?CC^W[_P`&M^E?M66NM6_Q'^,W[,?Q&D_:7T"/ M4]7\*W_B_P`0M\#O"6O^(_#WCN#2+C2KN>UU76KW68/%?A6\"Z=-_;OBCP[< MV7V#4=0M)OO?_@UFUS4YOV+_`-K+P"VHW<_A#X._\%'_`-IWX:UIWA/08[JXN#I^@V6IZQJM]9Z?`RV\4^H7EPBF2ZFDD`/Z8IK MFWMS$LTT<1FE6&$2.J&69U9EABW$>9,RH[+"FZ5E1F5"%)'Y]?\`!0#_`(*" M>$_V&+/]FO09O!EU\2/BO^US^TG\.OV7O@CX*77XO".A3>-?B!?Q6C^)O''B MY](\1W/ASP-X6MY[>XUN]TCPSXFUV>YOM,L-.T2875Q>V/X+?MMO=?$G_@I- M_P`%F/#O[4\>G7OPW_9__P"",EU\1OV,['QMJ+6>C>!;#5?#-UJ7C_XW_#.* M\FLK?P[\1K3XU:6/#UY\5_#:VOC'0YM#\.>'+;Q+:V\5E9O\&_MF^$=:_:(_ M9K_X-6OB3^V;X)T[QE\>/B_^T7^S]\,OC#X@^(6EBY\8?$'X2ZYK?A>ZTG2/ M'MSJ,<.HZI%XQ\+:EI?B?Q)!J0:;4-;\1:E?W3-=ZA-),`?V5?"'X]?'7QQ^ MR8GQR^*/[,.H_L^?&VU\.^.-7UW]G3Q_\2]"ULZ/?^"]4UZU@MG^)?@G1->L MIM(\6:5HL.O:#JX\*?;H;#5[$:GH4$R2J?RP_8A_X+,_M(?\%"/V//%7[8?[ M.'[!/@34M$T#QGXX^'FB_"OQC^VC%X3^)OCKQKX%\-:+XINO#OA))_V8KSP; M-?Z[8:TD'AV/5?%FE_:KRSNUOSIMJB7;_MY\4[>RTKX._$*UMHK>QT[3OAOX MPM[>&,)!:V=E9>$M4AAB0?+'#!;V\2(HRJ1QH.0!7\6W_!JA^S'X^^)G[%W[ M-GQ]T#X\_$G3?!WP`_X*!?M%Z]XP_9X6Z\(0_"'QA;>)?V9+'X=VWBW4(K;P MO;>.;GQSX8U/QOI&J:+#JGC35/"\-E'?2V?A2TU>>'6X`#^LWX'?M'?&[XL? M?"GB7]E#Q9\,O@F?@!\&?BYX.^/VL_$#PQJVE^+_'7Q+T]=1\5_!Y/`MI M8VGB;1]9^&\4J0W^NWSB"[\S2]'M[C09M9^R?-CR!O4$DC!(!R-H((/( M(+*#G&"RCJR@_P`E7AKX+^#?VC_^#A__`(+'?LU_$2.>Y^&OQ>_X)I_![PQX MCTRTNI(!977B;3/@3:OXLTR&.:..R\4Z+?W,/B#2M;A6+4++6;.SU"&YCN`L MK2?\$&/!?Q6^('@SPY^QS^TK\.6;5?\`@BW^U+^T#X1O/B#K.DVXT[XG_&'7 MY=;M_@UJ6A:I(]U>ZG_PBG@7X@_$/QAX@N[B-LC4_@+XE@FU"^(GLP#^LX7$ M!F:W$J&=425HMP\Q8I&=(Y63.\12/'(D#?&-EK/_"'6+OX@U[2+B+2Y?^$;L=6U*RO;BYT]=.NOY&_^"1+?$7]K+XX^ M!_CW\3_VT/A#\$OVX?V>_P#@IK\?(_VB_AGXCT'QAJW[5OQY\*?$2Y\.>%-4 M_9TU.UN?B!IDUS\"=+\+>';[2O`.BZ7X%U3P1\'KSP7J>MKI.AOX;UK4!_=G MKFAZ/XDT/5O#OB#3;+7-!UW2[_1M:TC4[:*]T_5](U2SFL-2TS4+2=)(;NSU M&QN)[.\MY4>.>WGEC=2KD4`?F;\&/^"E5I^T9_P3B^%G[>?P0^&F@>./$?QB MTOPW:^"/@*OQ473KO4/BAXB\:)\/V^#4OQ"D\!W$5KXRT7Q9]KTG6[Z;P4NB MV`TO4M9N9X?#5K)K2_III=Y>266FKK4>FV.O3Z=!<:EINF:C-JEC;7HB@&HQ M:9J%WI^CWFIZ;:7DOV>#4Y](TR2XB,$UQ86$L_V6/^,+_@W.^'D7PE_X*%?\ M%7OV&=+\6ZYKW[.7[!O[3_BSQA^SCX"UJ[CN+?PGXM^)'B#QS\(=:\4RW*NU MY>ZKH_PU\&VOA:P1IETVTNM?\4ZX=/@US7)+B+P;X2S_`!/_`&M?^"@G[?-A M\7_VQ_@O^RE^V!^RG_P5H\&?$GX2ZA\1="\6Z[\>[_\`9\\`2Z]X`^%7[/WP M.L8/B#X3&N_`3XE>&=6:P\7_``Z\)>'?$$?C;4_%6F^)/%FDZ]-XKT:X8`_O M$%S;F=K831FX6-96@#J9EB=VC25HL^8L3NC*DI41LRL%8D$4]I8T4LS!54X+ M$X4$':?C_`#>.]6^"$GP6_9$\2WOPW\%?$GQG\-=*U'QDOA3X-Z_I7BN_NO`6 MM:%J=SJ&@ZO'JNIVMCLZ]<:[JVEW^M66C:A8`']?WQ!\?^#/A5X%\ M8?$SXB^)-)\'>`?`'AG7/&7C/Q7KUTMCHWAOPOX;TVXU?7-;U6[<$6]AIFFV MEQ=W,FUF$<16-'D9$;\R?V5/^"AGQV_;L^&FJ?M&_LM?LDZ9)^S)?:EXDLO@ M[XW^/OQPN/A!\2/V@=.\,:CJ6@7WB_P)\,-`^$'Q0M/!W@O4?$&D7]AX4U/X MH>-/#6LZ^L1O+[PYX>TTK?-9_P""U_[.WQ7_`&DO^"3_`.V7\`_V?M.U35OB M=XE^$-F?!OAS2IY)];\5P^!O%?A7QIJW@C36N'EN=1U;QEX8\+:IX8T^T>?S M]6U#4K>QDF=[QBWD?_!`?X_?";QW_P`$B/V3DTCQ+X?T;4/V??A#I_P9^-WA M_5-1L=&UCX6?$/X43:CX=\7Z9\0M,OWL[KPA?W#Z=_PE.W7X;%Y](UBUU4O) M!.9R`?IE^RO\<]:_:,^!_A7XM>)?A1XQ^!OB/7=7^(.A:[\)?']SI%]XR\$: MO\/?B5XO^'&HZ7XAN_#T]WH-Q?27GA*:_P#.T6^U'1WAO(3IFJZK9^3J-S]" M[TP&W#!(`/.&)Z;?[V>VW.>U?RN?\%HOB1X1US]LK_@W?^.?A'Q/9VOPKUS] MNW5$NOB(T]SX9\.:EX=U:_\`A?=Z;-?:KJB:3'/X56*-AF`4['P3L;"K(C*KJP*.`48'(<,,J4(R'##E2 MN0PY!(YK^!G]FWX%?#&[_P""C?\`P1?^&]YIVL7G@?\`;!_X(9:3XB_:I\/7 M/CGQK-8?M!W^G?"7Q[XATV/XM$^)/M'C72-,U/PUX=.GZ)JUQ-HUII_AK1-' MM[)-%TBUT^&G^SOXD\;>./\`@SC_`&HK6^U?7/$E[\,M:^*>B>#+B[U&^U34 M_#'A/P=^TA\/O$%O;:7?W$]Q>V5AX;TW4]=DL_)GC33=(:6W@\JR790!_?A) M)M5M@#.,*H)(4.V`@=@K;02REN"P0[@K<`_F?_P2\_X*.V7_``4H^%?QQ^)$ M'PCNO@Y/\#_VGOB;^S/JFA7'CB#Q]%KFJ_#33?"U_>>*[#5H/"G@][33]4;Q M*(K?3+G2GN+9+)IY;N03A(?YX/V+?B1X:\9?\%U?^"5T'@WQQHWB>&'_`((, M?">V\=IX;\2VNM6X\<0>$=8FN(/$_P#9U[^%.E>(/^"[?C+PYX>T_X+)X+;Q!\ M9/%AO?A9XCTKX(>);[XAW^E^`]&^&WCRS\/:E-\1-;\8ZE'X9TSPIHM_=ZSI M/C+35N/`OB@`_P!`O5/$>@:)H6I>*-9UO2=)\-:-I=]K>L>(=3U*RL-"TG1= M,M9KW4]8U/6+N:+3K'2M-LK>XO+_`%&YN8[2SM8)I[B6..-F'P=J/[<^O?$G M]DWX0_M7_L5?L\^,_P!K;0OC'XW\#:=X;\(V/BKPW\)]:7X6>)/'U]X.\1?& M![GQ@EY;G1O#>EZ?+XKM-#EBM]3U73;S3O[2D\/6W]K7NE?RD_L_M;>.O`W_ M``=H_LX:QI_P\NOAKX*\$:O\6_AM\"?AGK5QXB^#O@/QE+\)/C9XFU?5OA)I M)TOPU%+?"W@F]G\0:5X/\-Z;K>MZ%HVLRZ!IA>QTZW^;/CIX8^"_@?_ M`(-E?^"[^W0^(Y-`MK.VECU)X+XZ5!:B2(6\<&P`_T3_-0`EF5>7Y9@`0A.XAC@'"@ MLV#\HSNQ@TV6Y@A3S)9HXXRZ1[Y'5$$DDBPQH78A5>29TB1&(9Y66-078*?Y M*OVQ/`7Q1_8'_P""ZGP]^-7P#^'4_C;P=_P5S^`?Q0_9FN/#BZ;#J_AOP'^U MGH=CI>JV?Q'U?3[NG>)/!V@ZE\6-#T&;PQJG@3Q'XGUNX/A7QY\07US2 MY]+\1>*X=18`_LK\5:[_`,(UX8\0^(UL;C4SH.A:QK0TZU#?:K\Z3IMUJ'V* MW"Q3O]HNC;?9X@L$KB610(I&^0_S_P#Q?_X+7?M%_`'XR?\`!//X`?&'_@GW MX;\'?%;_`(*-3V-E\-/#;_M?G4Q\+]4OM7\):0=(^,=]8_LR/;Z7J5A-XSTE M]2B\&?\`":PVYBU"WBN+BYMECF_4#_@F[X$\4?"_]B#]G;X<>,/VB[;]K76? M`G@B7PA'^T79Z=J>G6OQ5T+P]X@UK2_"GB&W.K:WXDO=7AA\+VVCZ/%XK/B' M6[;QE%IV>\-I)J,_B+Q%<*XBT/P MIHVM:W=GRK-8I_QE_P""@?\`PD_Q"_X+7?\`!(_]G_XQZ58>(OV,?&7PZ_:W M\9MX!\76\5[\,?B7^T=X/^&/B5](L?&WAW4HW\-^--9\#^$Y=*\0^`]!\0P: MF-.N]3U[7M+TY+VUDO(?Y9->TQ?C'^SY_P`$G:;XU^$'A_P#X+H?% M_P#9T^$7CWXC7LFOZ'JW[#=O\3O!$FE>#+KQWXDO9UU;X7V.NV7Q!\.:']OU MFYTV+POX2M])L[M-(\/6UO9@'^EM+/]OCQK\0 M?`^C_$"S\=Q:"WPUU#X?6?AN^OKS4_"=QX0U4^)[/4(?%.G+:"T\2:)-%+#> MK.I5+=I_YD_^"TOC#]G"/Q=_P42^$'P9\>KXVU;X)?\`!,#X$ZGX7^'7BR]\ M#Z/\#/V1-"\-^,O`FN_"G4_V/6LK;5OB#XF^-?Q"T#Q)X>UK5+OP;%X-\&^% M/!MS!K/BKXE>,+Z/P?\`#[1/2OC1\0];^*WQ\_X,Z?B/XI\4R^,_%?C/P9J> MO>*_%5YJB:OJ.O\`BK4/@=^SJ?$>IZIJ9GGDOM7N==%__:]Q/+)=OJOVI;QO MMGFK0!_3;_P4A_;.OO\`@GY^QQ\6_P!L%/AE;_%O1/@SIWA_6_$W@C_A.'\! M:MJ6CZ]XM\.^#P^A:RW@[QE8RZC9WOB2UO'LM0LK*"YL[>Y6._CN##&_YH^) M?^"\DOP7^`/[#W[7W[3O[)M]\-?V3_VY+WP#I'A;XJ_#?XXZ9\7-;^$FL?$S M0KKQ+X3M_B[\/M8^%WPIU*VLI-"T[5M5U/4?`>L>-DL+71=3BC@O-1_LW3]3 M]6_X./F5?^")'[>)9E5?^%<_#U=S,%7<_P`;_A6B)N8@;W7($:L M>*^?OC%^U)\'?@;\1/V>/A-X[\1"#XC?M1_$C4/AC\'?"&GK;W>N>(=7T/P; MXA\>>)]:DL6NH)[7PEX4\.^')Y?$/B%DDL[#4-4\/:/^\U37],M9_P"3'_@J M)\2)_P!IK_@KSH'[+WQ._:$^!'PP_90_:#_X)4^*[C]D'XK?'*34-:^!&G?% M/XL:Y)>ZO\?OA5K-AXT\">&8/V@M)\/:&S_#+QM?^))(])TK1M.T_0WLM5\6 M67VWAOVV_@'\+9?^"D7_``;>:=^UAXQ^'_[3&C>)_@3\:_AU\;OVB?B-X>?P MMX3_`&AM&^&7PQL'\%>+O%P\9ZG<0RVVI7.LIXHLIM1U:Z35-3\1R^(+>ZO5 MUZ":<`_N+$J,H8-PV,'U)XV@C(+9R"JDD$$=13BR@X)YQG'.0#T)'4#/'..> M.M?Y\W[9OBW0_AM\=O\`@[*\'Z_XGTKP5;ZO\!OV.[[X4^&-1UVTT*/4K[4M M`\,ZMIEYX!T66[MOMEY<7VI6&J)<^'[6287=U!>R2++*LK?1_P"UEI=[XT^' M_P#P9^Z,/%GBGPU<_$&Z^!GAGQ/XI\)>(+S0_&%[H.K?";]FA=9M+;Q/:3+J MUKZC##JMM[0`_N(6:-AE7##YON_-]UBC?=S] MUP4;^ZX*'#`@*LB."RL&"LRDK\V&5BK+QGYE8%67[RL"K`,"!_&O_P`%?OV- MO@;^R#JW_!"?]F3]GVR\:_#WX3ZI_P`%6+2*2QM_BG\0]2\46NF?%_QOX2\0 M^-]*L/'NL>)+SQK9:?>WNHE+9+?7%GM1!:SBYDU42:C/YQ^QYX-MKCX<_P#! MSW^QOX/_`&@[/]CKX2:/^U^/AA\%_&MWK^K:1\._@1K7QI\3>,/`5K:)<07W MG^#O"'CK7;#PCX(\6ZEIDMLVG:/J=WJ&?,L^`#^Q'XW_`!^^#_[.'PE\6?'7 MXU^.]'\`_"3P+#I5UXO\IW8M'UK5K&SFN8 MK:2"T,KSWLEM:6]S<0_-/['?[?GPS_:MU/Q'\/)?^$=\$?'OPDGCGQ3XA^#. MD>.]+^)]_I'PBTOXT>.OA3\+_BC?>,/">G1^$H+'XOZ7X.MO'6@^'C?G7-/T M37[!Y(;[3'M-;O\`\F/^".^E?$7XF>$O^"DG['/[1OP1F_8E_:T^'=O\(O@S M\??'W['_`(KL?!WPV\5V_CCX*:_9?"[]H']FR/1[#4_#/P>^*>I_#Y[3Q5XB MB\,V)TR/7;GPCX\;PUX;U_6M:\-:;^TG[+?[&/PS_9#O?B(/A/XI^*LWA7XA MV/PJA?X<>,/'$GB;X?>#-6^&'@&S^'UUXK\`Z#-IUM+X=\5?%6STW3O$OQFU M,[^*VUS4=7N=0`/KJBBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`KG/%OA#PIX]\.ZMX0\<>&O M#_C'PGK]G)IVO>&/%6BZ9XB\.ZWI\V!-8:OH>LVM[I>IVVD\+]TKH MZ*`/(/AC^SY\!_@FUX_P<^"_PI^%#:A;K9WS?#CX>^$O!+7EFDQN(K*Y?PWI M&FO-90S?O8;*1FM('`:&!"`0DW[/?P'N/BE%\<+CX+?"B?XSP+&L/Q;F^'?A M"3XEPK%IK:-$(O'3Z.WB>,Q:.\FDQ.NIB6/2Y)--CD6Q=K<^P44`>)ZM^S5^ MSIKWB+QIXOUSX"?!;6?%GQ(T.X\,_$/Q/JOPL\":CXA\>>'+I+"*Z\/^,]:O M-!FU/Q3HES'I6EQSZ1KUUJ&G3)INGI);,MG;"*GI_P"RW^S3I%[X!U/2/V>O M@=I6J?"B*:'X6ZEIWPE^']C?_#6.XU&[UB:/P!>6OAZ*X\&1RZQ?7NJRIX:E MTM9-2O+J^<-=7$TK^\44`?A+\!?^"25_X=_X*1_\%(OVM?VC/#/[-OQO^"/[ M;&H?!C4_`_P[\3>'[CQYK_@'4/@MHZZ+IFH:[H7CKX>/X2GO->0G4GFT?6)9 M-"N8(+6-]7C8W47[&^+?@K\'?'VO?#_Q5XZ^%'PV\:>*/A-J,FK_``M\2>+/ M`OA;Q'K_`,-M6E6T275/`.L:QI5YJ'@[494L+%)+WP[<:=<,MG:@R?Z-`8_3 M:*`/GQ_V2OV5Y?!>H_#>3]FKX`2?#S5_&M_\2=5\!O\`!KX/-0\+/X:;0[WQGJ7GS_;_%%U82ZY=^=*)KYUD8'O/'7P>^$OQ0\(6WP^^) M7PO^'?Q"\!V4NFSV?@GQQX)\,^+O"-K-H\+6^D36_AKQ#I>HZ+#+I=N[P:=) M'8J]C"S1VK1(Q!]'HH`\,NOV8?V;;WQ?X?\`B#>?`#X*W7COPG_8'_"+>-)_ MA9X%E\5^'/\`A%;*TTWPP-#\0OH+:MI8\.:?I]A8^'Q9W<0T2TL;.#2A:1VT M`CU/'O[/GP'^*GB?PUXV^)OP6^$_Q$\8^##`?"'BOQS\.O!_BWQ'X6-MJ,>K MVW_"/:WK^C:AJ6CBWU>K=+"Y@C@U6"#4H4COH8[A?7Z*`/,?$_P`%/@YX MU\:^%?B3XQ^$_P`-?%GQ$\#(J>"O'OB7P)X5U[QKX01;B:[5?"_BK5=)N]>\ M/JMU<3W(&D:A9XN)YIO]9([,_P"&OP8^$'P9LM7T[X0_"KX;_"O3_$&I?VSK MUC\./`WA;P-9ZUJ_E"#^U=6M?"^E:5!J6I>0!";^]CGNS$!&9B@"CTNB@#R' MXG?L_?`GXUW?A^_^,7P8^%/Q5O?"\^(_P\\(>.+GPY+=36MQ=/H<_B M;1]3ETHW-Q8V-Q&]4^*7P>^%OQ* MU/P=*)_"6H^/_A]X1\9W_A><30W'G^'+SQ)H^IW&AS>?;V\WG:5):2>;!!)O MWPQ%/5Z*`,/Q#X8\-^+=!U'PMXJ\/Z)XE\,ZQ:/I^K>'?$&E6.LZ'JE@X"O9 M:CI.HP7.GWUG(JA9+6ZMY8)%&UXV7BN&^&/P*^"7P3MM2LO@W\'_`(6_":SU MB6.?5[3X9_#[PCX"M=4GBC2**;4;;PGH^D07TT44:11RW4F?!;X/:+\1=:^+^C_"GX;:5\6/$EB=,\1?$_3?`OA:P^(>O:<8[*$Z? MK7C:UTJ+Q-JMB8M-TZ+['?ZI<6WEV%B@B"VEN(^PT?PQX;\/7/B&\T'P_HFB M7?BW6V\3>*KK2=*L=-N/$OB-M)TG06U_7Y[."&76-:;0]!T/1FU346N;XZ5H MVE:>9_LFGVD,.Y10!X]I?[/7P$T/XJZO\==%^"7PBTCXV^(+&73->^,6E_#7 MP7I_Q3US3)HX(I=.U?XA6FB0^+M2L9(K6UCDM;S6)H98[:!)4=(8E3UV6**> M*2">-)H9HWBEBD4/')%(I22-T8%61T9E96!#*2""":DHH`\5\#_LV_L\?#+Q M5J7CGX`/&NL?:O[6\7^"?A?X'\*>*-4%[/)>7?*[.;.H?L]?`35OBOI?QXU3X)?"+4OCAHED--T7XR7_ M`,-?!=Y\5=(TT6LEB-.TOXAW&B2>+]/L193368M;36(HA:S2VRJ()'C;V&B@ M#YSC_8^_9,ATV31X?V8/V>(M)E^)$'QCDTN/X*?#1-.D^+MJURUM\5'L5\," MV?XCV[7MXT'C=XF\20M=7)BU)//D#>@Z%\%_@_X7\?>)/BMX:^%7PW\/?$_Q ME;FT\7_$;0_`OA;2?'GBFU9[21K;Q)XPT_2K?Q%KMN9+"Q\^)?B;]G/X%>(OB-J,L$^H^/=<^$?P M_P!5\9:A-:JBV/J.GZEX^TX>'A9^,M0L=0DDOK.\\20:G&6G[,'[->GZQX6\0V/[/GP0LM?\#^&&\%>"];M/A/X!MM8\(^ M#6M=2L6\)^%]3A\/I?>'_#+66M:Q9MH&D3V>DFTU;4[8V?D7]U'+N>$?@/\` M!#X?^!M<^&'@3X.?"OP5\-O$ZZHOB3X?>$OAYX/\-^"/$"ZY8II>M+K?A+1M M&LO#^K+K&FQQZ=JJW^G7`U&QC2TO!-;JL8]7HH`\"\#_`+*7[+_PRU+PEK/P MX_9Q^`WP_P!7\`:/J/AWP)JG@GX/_#SPIJ7@KP_J\VI7.JZ%X2O]!\.6%YX< MT;4[G6-7N-0TS1Y[.ROI]5U*:ZAFEOKIY:+_`+'_`.R;+X*UWX;2_LP_L\2_ M#OQ1XBT_Q=XE\!2?!3X:-X+\0^*])=9=*\3:YX6/AC^PM7\0Z9*B2Z?K6H6% MQJ=I(B-!=)M%?1=%`'EV@_`_X+^%?%7B[QUX8^$?PQ\.>-OB!HNC>&_'GC#0 M?`/A/2/%/C7P]X+?$&GZ1;ZMXCT;0=)ABTO1M+UB[O+#3-.BCL MK.WAMD2)>#A_8]_9+MO`-C\*;;]E[]G>W^%^E^)KWQIIGPWA^"?PSC\!:=XP MU%'CU#Q78^#U\,#P[:>);^.65+S7H-.CU6Y261);MD M^%]2O_#6@7VH^![RYU'P7?WFCZ=7B?BW\!_@A\?=%L/#7QT^#GPK^-'AS2M23 M6=+T#XL?#SPA\1M$T[6(HS%%JUAI7C'1]9L;/4HXF:)+ZW@CN5C9H_,*$J?5 MZ*`*MC8V6F65IING6EM8:?86MO96-C96\-I9V=G:0I;VMK:VMND<%M;6T$<< M,%O!''##$B11(B(JCQWQQ^S7^SK\3O%5AXZ^)'P%^#'Q`\:Z4+0:7XO\;_"W MP+XL\4::MA,EQ8KI_B'7]!U#5[%;.XBCGM1:7D(MIT6:'9*H>O;**`/-OB1\ M&_A)\8_#5KX,^+7PP^'OQ/\`"%E?6FIV?A?X@^#?#OC+P]::E802VUCJ-KH_ MB+3M1L+:_LK>>>"TO;>"*ZMX)YH8I5BFE1\;Q=^SS\`_'_PZT3X/^._@C\(O M&OPF\-2:++X=^%_BWX:^"_$?P[T&3PW&T7AR31?!.L:)>>&=*?P_$S1Z(UAI MEN=*C9H[+R49E;V*B@#Q36_V:_V=O$OB?7?&WB/X#?!C7_&?BCP'/\+/$WBW M6OA;X%U3Q/XB^&-U9R:?<_#G7=>OM!GU75O`EQ8S36<_A&_NI]`FM)I;:33V M@!+:TO(8;JV@\*G28X;F**=`)HT<>Y44`<#\1?A5\,/B]H/_``BWQ7^'/@3X MF^&?M,-[_P`(Y\0O"/A[QIH)O+=UDM[LZ-XET[4]-:Y@D17AG:U,L+JKQNK` M$PZE:7!\"MH9\*^= M:ZC;V^H6TG]D[X+Z&*[B*7$:RCV2B@#Y[\2_LE?LK^,_"O@3P+XO_9J^`'BK MP3\+9C<_#/P?XD^#7PXUSPM\.[HS)<&Z\"^'M3\-7.D>$;C[1''.9=`L]/)F M1)6W.B,O:_$3X)?!KXO?\(E_PMCX2_#/XG?\(%K]IXK\#?\`"P_`?A7QK_PA MGBJP$8L?$WA/_A)=)U/_`(1WQ!9"*,6NL:1]CU"`1H([A=B;?3Z*`/#?&?[, M7[-WQ&\7ZE\0?B#^S]\$?'7CS6/",_@#5O&WC'X3^`?$_B[5/`ETV^Y\$ZCX MDUSP_?ZQ?>$;E_GN/#EU>2Z/,_,EHPXJ:\_9J_9UU"'X=6U_\!?@O>V_P@\K M_A4T%W\+?`MS#\,/(N;:]A_X5W%-H+IX(,-Y96=W$?#"Z48[FTM9TVR6T+1^ MV44`>9^/O@M\'?BKJ'A75OB?\*/AK\1M4\#:BVL>"M2\>>!/"WB_4/"&K-/9 MW3:GX6O?$6DZC<^'M1:YT[3[AK[1Y;*Z,]C9S&;S+6!H^;@_9E_9PM8?B%;V MOP!^"EM!\6KN*_\`BG#;_"GP%#%\2KZ#5)=X44`>??#;X3?"WX-Z#-X5^$?PX\"?"_PQ'? MA[X2T#P;HD^KWD<$-WJDVE^';#3K.;4;F&UM89[Z6%[F6&VMX6E,-O"B>@T4 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!17@? M[3_QYTS]F/X$?$3XZZWX?U3Q)HOPZTNPUC6+'2S-&MEI-UKVD:+J7B37+ZWL M-6GT;P=X.LM4F\7>._$,.DZM)X;\$Z'X@U]=+U$Z:+*?Y9\"?M5_M-^.OV8] M'^-OAGX.?LZ>*;[7?!?A'XB^'?&US^TY>>`OV>/$O@37?"VM^)-7\2R>/Y/A M5X]\2>&1I5QI=EI%G;KX:\6>']2MM>TGQ1)XTL-&&I16`!^D5%?EU\:?^"A> MN_#SX*_LI>.(/A]\/_A5\1OVH=$\-ZY%X<_:R^)'C7X2?"?X97&L:+X>N+CP M3X[^.WPW^#GQH\*Z)\0+_P`2^+-$\,^`M(\0V7AC2O'LL6M3Z=K5I>Z=%H]W MZG\1_P!M1/AWJ/QJU.[\%VE]\-OV6K_X5Z#^T;XQ7Q%U[XEZ-X2\5Z MFG@C0FT*>/Q+I?PS\"^._!_CKQI=ZUJWAJZN=#UM[+P_9WVMZ7-970!]Y44B MG<,^Y!^JDJ?3C(.#CD2PVMK;0H"\L]Q+'%&@+.ZJ":`+]%>;Z+\8_A+XDU"+2?#WQ/^'F MNZI,DLD6G:-XX\+:I?RI`N^9X[.PU:XN9$B3YI&2)EC7YG*CFNU_MK2/^@II MW_@=:?\`QZ@#3HK,_MK2/^@IIW_@=:?_`!ZC^VM(_P"@IIW_`('6G_QZ@#3H MK,_MK2/^@IIW_@=:?_'J/[:TC_H*:=_X'6G_`,>H`TZ*S/[:TC_H*:=_X'6G M_P`>H_MK2/\`H*:=_P"!UI_\>H`TZ*S/[:TC_H*:=_X'6G_QZC^VM(_Z"FG? M^!UI_P#'J`-.BLS^VM(_Z"FG?^!UI_\`'J/[:TC_`*"FG?\`@=:?_'J`-.BL MS^VM(_Z"FG?^!UI_\>H_MK2/^@IIW_@=:?\`QZ@#3HK,_MK2/^@IIW_@=:?_ M`!ZC^VM(_P"@IIW_`('6G_QZ@#3HK,_MK2/^@IIW_@=:?_'J/[:TC_H*:=_X M'6G_`,>H`TZ*S/[:TC_H*:=_X'6G_P`>H_MK2/\`H*:=_P"!UI_\>H`TZ*S/ M[:TC_H*:=_X'6G_QZC^VM(_Z"FG?^!UI_P#'J`-.BLS^VM(_Z"FG?^!UI_\` M'J/[:TC_`*"FG?\`@=:?_'J`-.BLS^VM(_Z"FG?^!UI_\>H_MK2/^@IIW_@= M:?\`QZ@#3HK,_MK2/^@IIW_@=:?_`!ZC^VM(_P"@IIW_`('6G_QZ@#3HK,_M MK2/^@IIW_@=:?_'J/[:TC_H*:=_X'6G_`,>H`TZ*S/[:TC_H*:=_X'6G_P`> MH_MK2/\`H*:=_P"!UI_\>H`TZ*S/[:TC_H*:=_X'6G_QZC^VM(_Z"FG?^!UI M_P#'J`-.BLS^VM(_Z"FG?^!UI_\`'J/[:TC_`*"FG?\`@=:?_'J`-.BLS^VM M(_Z"FG?^!UI_\>H_MK2/^@IIW_@=:?\`QZ@#3HK,_MK2/^@IIW_@=:?_`!ZC M^VM(_P"@IIW_`('6G_QZ@#3HK,_MK2/^@IIW_@=:?_'J/[:TC_H*:=_X'6G_ M`,>H`TZ*S/[:TC_H*:=_X'6G_P`>H_MK2/\`H*:=_P"!UI_\>H`TZ*S/[:TC M_H*:=_X'6G_QZC^VM(_Z"FG?^!UI_P#'J`-.BLS^VM(_Z"FG?^!UI_\`'J/[ M:TC_`*"FG?\`@=:?_'J`-.BLS^VM(_Z"FG?^!UI_\>H_MK2/^@IIW_@=:?\` MQZ@#3HK,_MK2/^@IIW_@=:?_`!ZC^VM(_P"@IIW_`('6G_QZ@#3HK,_MK2/^ M@IIW_@=:?_'J/[:TC_H*:=_X'6G_`,>H`TZ*S/[:TC_H*:=_X'6G_P`>H_MK M2/\`H*:=_P"!UI_\>H`TZ*S/[:TC_H*:=_X'6G_QZC^VM(_Z"FG?^!UI_P#' MJ`-.BLS^VM(_Z"FG?^!UI_\`'J/[:TC_`*"FG?\`@=:?_'J`-.BLS^VM(_Z" MFG?^!UI_\>H_MK2/^@IIW_@=:?\`QZ@#3HK.35]+E=(X]1L'DD941$O;5W=V M("JJK*69F)`"J"22``36C0`4444`%%%%`!1110`4444`%%%%`'%?$*V\=W7A M2^C^&U[X9L?&$=YH=UI[>,;+4;[PY>V5GKVF7?B#1=2329(]1M!K_AR'5M$M M-7M8[U]"O]0M=:?2=:BL)-(OORM_90_8(^(?[.7PD\8?#N/P%^SMKG@'XX:I MX;?XK?LR:]K'BW5?@#X5@L_`&H:+X^\4>$M$O_`GB'0->\6_&;QO+IWBGXH^ M&X/!/@/X>:RME]LM[+_A,KSQ#XL\1_KCKNO:)X8T?4?$'B36-+\/Z#H]I+?Z MMK6MZC9Z3I.EV-NNZXO=1U+4)K>RLK2!?GFN;J>*&)?F=U%?./\`PVY^R%%\ M+)_C;J/[2GP6\/\`PIL[O2-/U+QQXL^(7ASP?HNBZEK]G)J6B:5X@;Q3?:1= M>'M7U;2X9=5T_2=;MK#4;O28WU2"U?3T>Y4`^>K3]CGXC>"/V5?`O["?@.^^ M%WB+]GN/]G>^^`'C?Q/\43XQUSQCI>BZKI>H>&=0A\+>`5M=2\*>*/#5OX4U M6XT?PKX9\4^,=&C\+PZ?HMK>7OB;3K-K22OXT_8*U+5=+^-_PB\/^+K)O@/^ MTX_P-E^+Y\37&HZG\2M/7X1^!_AW\)O%%KH-Z--FTOQ/+\7?A/\`"7P#X5U/ M5_$-]I-YX+U:V\0>*;>V\7OK5IH^C_)=>^)G@32O#OCJ" MUN_!FO7GBK1(M&\56-[80:K;:EX?U3[:;'5M*ETNZMM3_M6RGFTQ-.N;>^EN MTM)X9GTM9^)WP[\.^+-#\":[XW\+:/XS\2Q13:!X7U+7-.L]=U:*XN)[2U>R MTR>X2ZF6]N[2[M-/Q&/[1N[.\M;#[3<6=S%$`=RHVC'NS?BS%C^`)P/:JU]8 MV6IV=SI^HVEK?V%Y#);7=E>V\-W:75O*I66"YMKA)()X9%)62*6-XW4D,I%6 MNO2B@#\(/^"BWA#PIX=_X*(?\$-6T#PSX>T-Y_VP_P!H(3/I&B:7ICS!?V0_ MB/(HE:QM+-'^\B%?W0CT[3_+C_T&S^XO_+M!_='^Q7XH_P#! M3#_E(?\`\$,/^SP_VA/_`%D#XE5^W4?^KC_W%_\`010!6_L[3_\`GQL__`:# M_P"(H_L[3_\`GQL__`:#_P"(JY10!3_L[3_^?&S_`/`:#_XBC^SM/_Y\;/\` M\!H/_B*N44`4_P"SM/\`^?&S_P#`:#_XBC^SM/\`^?&S_P#`:#_XBKE%`%/^ MSM/_`.?&S_\``:#_`.(H_L[3_P#GQL__``&@_P#B*N44`4_[.T__`)\;/_P& M@_\`B*/[.T__`)\;/_P&@_\`B*N44`4_[.T__GQL_P#P&@_^(H_L[3_^?&S_ M`/`:#_XBKE%`%/\`L[3_`/GQL_\`P&@_^(H_L[3_`/GQL_\`P&@_^(JY10!3 M_L[3_P#GQL__``&@_P#B*/[.T_\`Y\;/_P`!H/\`XBKE%`%/^SM/_P"?&S_\ M!H/_`(BC^SM/_P"?&S_\!H/_`(BKE%`%/^SM/_Y\;/\`\!H/_B*/[.T__GQL M_P#P&@_^(JY10!3_`+.T_P#Y\;/_`,!H/_B*/[.T_P#Y\;/_`,!H/_B*N44` M4_[.T_\`Y\;/_P`!H/\`XBC^SM/_`.?&S_\``:#_`.(JY10!3_L[3_\`GQL_ M_`:#_P"(H_L[3_\`GQL__`:#_P"(JY10!3_L[3_^?&S_`/`:#_XBC^SM/_Y\ M;/\`\!H/_B*N44`4_P"SM/\`^?&S_P#`:#_XBC^SM/\`^?&S_P#`:#_XBKE% M`%/^SM/_`.?&S_\``:#_`.(H_L[3_P#GQL__``&@_P#B*N44`4_[.T__`)\; M/_P&@_\`B*/[.T__`)\;/_P&@_\`B*N44`4_[.T__GQL_P#P&@_^(H_L[3_^ M?&S_`/`:#_XBKE%`%/\`L[3_`/GQL_\`P&@_^(H_L[3_`/GQL_\`P&@_^(JY M10!3_L[3_P#GQL__``&@_P#B*/[.T_\`Y\;/_P`!H/\`XBKE%`%/^SM/_P"? M&S_\!H/_`(BC^SM/_P"?&S_\!H/_`(BKE%`%/^SM/_Y\;/\`\!H/_B*/[.T_ M_GQL_P#P&@_^(JY10!3_`+.T_P#Y\;/_`,!H/_B*/[.T_P#Y\;/_`,!H/_B* MN44`4_[.T_\`Y\;/_P`!H/\`XBC^SM/_`.?&S_\``:#_`.(JY10!3_L[3_\` MGQL__`:#_P"(H_L[3_\`GQL__`:#_P"(JY10!3_L[3_^?&S_`/`:#_XBC^SM M/_Y\;/\`\!H/_B*N44`4_P"SM/\`^?&S_P#`:#_XBC^SM/\`^?&S_P#`:#_X MBKE9NK:QI>A6$^IZQ?VFFV%LN9KN\G2"%,\*F]R-TLC82*%`\TSE4BC=V"D` MF_L[3_\`GQL__`6#_P"(KY.^*?Q.\=^!O''_``C6EZ#X0U"TU..RN?#PDT>: M6^N8[Z3[(EI.(-313(4TF&1`3'JGB*)KG:P>#0F&R>OYMOV[?^#CS_@FM_P3 M^_:W;]F'Q+\-/CK\9_B%\(_$EH?B[\0?AOI_A+4]-\'^+=4TR$7>B7FJ>-_& M&@ZO\0O%7AZPO[6^UO3M+2VT30K\VNDV.L2ZUI^IZ1IH!_3[I6FN-,L!K-II M+ZM]CMSJ365C'%9F^,2FZ%K'(T\BVZS%EB#RNY0`LQ).-#^SM/\`^?&S_P#` M:#_XBO/_`(,_&'X=?M`_"?X<_&_X1^);3QC\,OBOX,\/>/O`GB>RCN+>#6O" M_B?38-4TF]-I>16]_83O;7"I>:;J%M;:CIMY'<6%_;6]W;30IZ90!3_L[3_^ M?&S_`/`:#_XBC^SM/_Y\;/\`\!H/_B*N44`55L+%&5TL[174AE9;>%65@"/AE\1_P!G M7X@>"OC!JOC?P[X#\0/X/L]0\7?#@WZ>-?`FL1^/?"MYX-^(F@W%AI6NBPN/ MAYXVM?#GC6XU35M#UGPOI-EH-SJ7C#2[_P`)VNM6TGY.?L/_`!A\77_[,6K^ M"/C%\0_@?X:^(<7ACP-\+/V<_P!N8?"F+4M!^+EYK/PE\3>(;>RU[X;ZW>:; MH/B/XK?!O3K[Q%X?\?6G@CQFOPJ\<76O)I_A"/PS>7?B'X8>'?W\(!!!Z>Q( MZ<]001^=5K:SM+*WAM;2&*UM;=%C@@ME6WMX8D&U8XHH0D4<2#A8T547^%0: M`/P6^`&A>*O@IH7P$UC]I;X2Z7\//"-S_P`$J;7X!:!\+_!FA:W?>"M,^)_A MKQ==:C\0?A?X8\-:A+JFLZ-XB^-_@>3X77_@[X:ZR]UXFU3_`(1#5/!XN-9U MCPG>*/*?#7PH^.'@?]E7]H?]G/XAVGB"?]K_`.+_`,/O^"?VE?!B^FMWO-2U M/6_`O[/G[.7P^?4=#UR"[O+2>/X"?M">`/BY\1/'^H1ZE''X.M[Q?'>K&SM_ M%>FWNI?TC%4`&>`.`#VR",CV/?GK2X7(]2.!D@$#V!P31E+ M?48M-U6*;3;Z2T'9;>RE^TZEK=\ MC/IOAS1X#?ZYJ*JVUI(;-&5;>T1@1-J6H36>F6X!,]XG0\U_PC7B3QC^]\;W M0TG1'Y3P1H-])LN(^H3Q3X@@\FXU0L&(FTG2?L.C\&*XFU:/YR`9MUXGUK4; MNXTCP+J,OBC4K=V@O-5>RTVW\(Z).I"NFIZS%;2&_NX2?GT?0TO+\,"EV^GJ M?.&C9_#N[DU"WU_Q%XFN/$/B"!4:WN+S2M._LG190,.WAO1I$F@TDM@!KR5[ MW5I%7$NHE6:.O1K2SLM+M(+*PM;>QLK6-8;6SLX([>W@B7[L-O;P(D<:#LD: M`=\=37Y`_%O]O#XB_M&Z]XM^#G_!/'6_`^D^%/!^K7OA3X\?\%'/B?9V.K?L MN_`75K.;[-KG@WX+6>H:EI.E?M5_M#Z/&+E9M`T/5H_@G\,M8CMD^*OC34-9 MBD^&^H@'T)^U;^VOX;_9RU_PQ\'/!UAXM_:/_:V^)^F76H_"+]E'X3P^%E^( M?BG2X+A-.N/'OCO7]63_`(1KX(_!#1-1FBB\5_&KXDRZ?X6TY([G3_#T'BWQ M9]B\+WO\D'[87_!IW^TC^UW^TG<_M-_$/]L7]FGX4?%']J?QYX@^(7QK^'?A MCX=_$;4O"O@7Q[X@GOO$.NZ!\$+_`%CQ3_;/Q:M-*T&TDO;O4/%D7PUN=:U6 MQUG7(]+T#1=0M=)TC^J#]E+X8?!S]FW0O%$'[,?P[^*O[1_Q1^)FI6OB'XU_ MM5?%&]CC\7_';QA86XM(O%'Q0^//C73]';Q/::;"[6_A?PE\,?#5[\/O`6ER MMHOP_P#!WA[24-HW@W[2R_MP^,?C;X0\1Z;\*M6N(/@OK$.I^"Y_`&FZO=^$ MKS69_L-]JUS_`&GXAGT_4/$*3Q1_\(QFI?1VFEQP74DUR`?HU^ MRA^RUX:_8^_9M^"7[,/PQ\3:Y<^!O@=\./#/PZT#4-=M-(NMO;VD*011@_0G]F:O_`-#%/_X+-,_^,4GA M36;KQ%X9T#7;[1=2\.7NKZ/I^HWGA_6(3;ZIHEW=VL-U8]!0!@?V9J_\`T,4__@LTS_XQ1_9FK_\`0Q3_`/@LTS_XQ6_1 M0!B1:=JB2QO)KTTT:.C/$=.TY!*BL"T9=(`Z!P"I9"&4'*D$`UMT44`%%%%` M!1110`4444`%%%%`'E'Q9^,_@3X*Z=H.L>/]1GTK2-=U?4]-?55M3-IF@V.@ M>#O%'C_Q/XH\4W[20VOAWPAX7\(>#M?UO7_$6HRQV-A!:109EO;ZRMI^*_9J M_:8\'_M/^"IO&WA+PK\2O!-O'+IDT7A_XK^#Y/`_BRY\/>)-%L?$_@OQ:N@R MZAJ4]KH7C7POJ5CKVBPZE+8^(;&">72O%6@>'/$=AJ6BV?AO_!15GM_A'\/] M2U+X0_#/XZ>`M+^-'ABX^)_PX^,/C/X._#SX=ZIX.NO"WC?2[/4?$'C+XT:? MJ.AZ2NA^-[_PAJ5C::%$GB+Q'?Q6_A9G?PUK7B.&31_8:^+ND_&NP^.WC:V^ M&7PH^&WB"[^+UFGB\_"WXY^`OC^/&6MM\+_A]<0^*?%_C+X>[=)L?$2:1-I_ MANV\.72?;;#PWX?T.Z0C3KZQA@`/TBX\0Z)HNI^*(IO"6F^,=8\(Q^(--\!ZAXRC;P79>-KK MP]<^,`/#46J$?F;^QK\3]<_:J_9675O#?[G^-]<\%?$>P\5>'[ M&\;X6_$#6_!NOZ?K%A^OGQ`\$6'Q$\+7GA74=5\2:'%)='OM.U:Q)DC,&K:19-=V-S%=Z5K%A]JT;6]/U+1M0O\`3[GX M3C_X)L^!K/P-I/A?P]\??VF_`GBB+4/`M[XK^*GP]\?^%?"_Q!\?VGPO\,ZC MX5^&WA?Q/=2_#_6=!@\"^!;+6-5U'P[X(\.:%H7A^+Q)J%UXIU*UU/Q%(-24 M`^:OC'XV_;XT+]C#]G_QO\1;CXN03>$O#/BSQ[^UQ\2?V5=0^"'P_P#VFH?! M?A>2[F\(>*/#?P6^-/PP^)GPV\07.H_#@W'Q!^-GPO\`"=YX6\::;XMTQ/#' MPIAU=XSX1O\`K/BE^UO\1M/\(_MD?M`>`?&]WJ'@']C*^^`NG>!O"-II^CWF ME?'/P_XH^#_P3^/7CKQ%XJN[G1VUR]O_`!WX.^-5CX1\!R>'KWP]!X:UWP_% MK9L;^YOM6TN3["M_V-](E\)>%/`OB?X\_M-^/?"FC^'=?\,>-=*\:?%F+4S\ M9=.\1Z]J.NZB?BGJ-CX8TO5]0D9-4N?#HC\'ZAX)LI/!RP>$;NTNM!@CLAU? MBG]DGX.>+/%M_P")KW2;^QTWQ%)\-+CQUX"TB[MM/^'OQ$O/@U?PZC\*[OQE MX8CT]TO9/!:19Z]I&C:!X>\8VOB3P]X>T32[``^F4)89/9G7Z M[79<]N3C)[9S61XBU>70=#U;6H='UCQ#-I=AA^'[>UN];U5[>,R+8:5; M7M[IUI/?W)'EVT5S?VD+R$"2XB7+#9`QT]_S)R3QW)Y/O00#P1D>AH`_GL_; MS^)NH^-_^"BG_!#V*[^%7Q4\""S_`&O_`-H!TF\=Z-X;TR&_,G[(_P`0X#%8 M_P!D>+]?D>2)9C<2FXCMH_(BE:-WDC,;?OE'K4WEQ_\`$CUS[B_\NMI_='_4 M0K\8O^"EX`_X*'?\$,,`#_C,/]H3H`/^;0/B3Z?05^WOB?5K>1K>]U$ MS-!X4T*9>&&JZU&DHNKN$G+:/HJ7VHDKLN?[/5O/`!LZGXOL]%LKC4M7L=2T MW3[5/,N+R]2PMX(ES@`O)J(W2.Q"1PQAYI7*I%&[L%/%W/B;QCXL$:^'-&US MPOX=N(DD;Q-?Z5:R>(+Z)SDQZ%X>O[F,:660;DU7Q%`^%8/;:-<`I,.#UWQW M\+/!/B&"/QYXS/Q#^*4#/+IO@SPUI-]XN\0:5.(_,5/#GPV\*0ZU?:&CKMC7 M7-:A^UL,&[UV.(D)H_\`"5?M`>._E\(^`="^$>AS$;?$?Q;NT\2>+'MI8O\` M767PU\%:HMA:RHY#1GQ%\0+.XC(`N]%/,1`/1M"LM&\)074MEX>UU9[K_2-7 MUO4_LMWJFI/$A+7>L:S>ZF9IEC7>P$TT=E:(66WAMX0$'S'\=_\`@H;^S)^S MQX!\9?$KQ[XON9/"'@&*+_A*M>T"Q36?#VDZA>2K:Z3X?E\5VET_A6X\6:]J M$D.F>'/!FFZQJ'C+Q)JDT6F>'O#^J:C(EJWS?^U1\8/A7\%/$OA3X3>)+7XG M?M]_ME?$G3)=9^$?[(7A_6]#TY=7L;2YCTR;XA>./">FIH_PI^"/P)T7498H M?$?QJ^,MKJ6F6:QW.F>&I/&_BT6OAF]Z7]G;]@/Q+JGQ!\(_M1?MW>)/"7QE M_:)\'NU_\&?A/X$L+O2_V1OV,4NX0LNG?LY_#O4[:T?Q'\25C8V7B#]IKXBZ M;+\4=>B1K+P98?"WPC,WA)@#YFUKP)^VG_P5@\-PS?&G2OBG_P`$_OV$O$`1 MXOV?-&;[+^V1^U+X3NHHIE;]H'Q/;ZAI4/[-7PFUR!EM+[X%>&_[0^*OB[3I MM0L?BAX@\-Z/>/X0F_2[X6?LM?`?X0Z%X/\`#_AGX47=[8?#_1-.\-^!K?Q! MI^E:GI?@C0=(B6#2]%\">%4GMO!?@'2=/B79:Z=X)\-^'[.,M)*8FGEEE?ZW M``&!_G/)/N2>2>I/)I:`,`:S*.FA:YQG'^BVG&>P_P")AP/8<4AUB0\G0=:) M]3:6?_R?6Z\B(C2,RA%5F9R<(JJ"6+-]U5`&26(``))X-?R_?M'?\%O_`-HW MX3?M!?&7X6^#/AW\`M?\(_#_`.)7B;P?XZAJVCZ-??9;2_O;O2O M'%KIES=3J&,TUC;06KN#Y<,8!4`'],W]M3#IH6N?^`MI_P#+"C^VIO\`H!ZY M_P"`MI_\L*\'_8[^,_B3]H;]F3X+?&KQ?INAZ/XE^)'@?3_$^LZ9X;COX="L MKV\N+R*2#3(M3O=1OTM56W0HMU>W,VYFW2D8`^EJ`,'^VIO^@'KG_@+:?_+" MC^VIO^@'KG_@+:?_`"PK>HH`Q8M7EEECC.C:S$)'5#++;6JQQAF`+R,M\[!% MSN8JC$`'"L>#M444`%%%%`!1110`4444`%%%%`'Y/_MM_$?X3?%?6;?X*^-/ M@5^U!X\3X/?%'PYX@UVXT#]B#XF?'SX2^)[;5/`EW8^(]!T[4H]&/A35K_4/ MAY\2=2LM&\;>'-0N-3^'7C&6"_A%W?:-J_AV][K_`()K:)_8G@OXW(EO\0]+ MM;OXRV\]AH7CS]E0_L@C3]/M?A5\.-*T^[T_XDZ5%HT'(?ME_!7Q9H^MWOCOP#\3OVY/'_P`3OC1X MYTGPQ\,O@-\)OVI-+^!_PST34=/\"/?ZS++K6L:)/I?@3P)IF@^!_$GCCQ1K M$T'C'Q)=ZYJ,^E^%_#NMW^J:/H4/LW["&C:[X4\+?$WPCX]UGXPS?%72?'>E MWGQ!\+?&+XY6O[1-_P"#[K5O`?A>30;+P9\3K31?#3:AX%UG1+6WU^PT[5/# M7AG6K'7+[7Y[[0;2*^L[B\`/H_X]?'#P+^SC\*?%'QB^)%S=VGA#PHV@P:A) M8Q6LES)>^*/$^B>#=`M(Y-0O--TJR6_\1^(M(L9M5UO5-*T'1X+F75=>U;2] M'LKV_M_F[PM^V7X]\4?"[1?&&E_L>_'OQ#X]U^U\,WVB_#;P=K'P;O[+7M+\ M1Z+J^N2Z]HOQ4\7_`!*\"?#>WT/0(]&N-&UH^,-9\(:\OB6YTK2--\/:E'K& MFW]Q]0_&C2=1U_X9^*M!T_X=>#OBY%KMK9Z'X@^&?C^?3X/"?C?P5K&J6&F^ M/?#NJ#5]*UK1+QK_`,$W6OII^DZ]ITGA_6]3%EHVNW.G:3?WFI6?XX?LM?"/ M]MO]C']FR3P!\+O@?\0/B%X+\37_`(!TCX?$.]UK2[/PQKWC9-)3X0?`^RUGQSX>^%%G'JVHV&MZ/X+]3\9_"WQM\9M<^'AT'2/#WQ%^&_@ M7X:>+)O`'CV/QOX?U[7K.WC\8:)\0K+6/`NG>$=`U/7+OQ7XA\/>(F\,WFHZ M'I%QK1WK[]NWX+A;_P`1>'FUKQ=\*?"^D_!O6?B'\8=#AL8_!7@*Q^/MCH.M M?#"?5(=5OM/\1:E!?>&/%7A3QEXGFT31;Y/!?@[Q5H'B#73';7%]'IWSUX)^ M"GQS\):OX3^.7@;]GWPO\-/%'BC]D[5_V7]5^`EW\4_#WBW?@_XB^*?% MWP3\6ZGX[TRWBT/Q9HNH1^,/%-Q\7O\`A'1K'BJ"\OM$N=$3QQ?1:NZ^4:/_ M`,$Z?B+\//@+\6OV,?"]SI7B+X5?M!>#OV7O"GB#XLW&I)IFI>![3X0_!+X, M?L[?%UKWPM=W]QK&IWGBKX??`[0_$'PR30)[NS@\7^*M8T_Q5/XO\_0X_;J,CRX M^OW%['^Z/:OY\?V]/@?\)OAC_P`%$_\`@A[/X"\!>'?"TVI?M@?M`17\NDV; M0O=Q0_LC_$.YBCG9Y93)''<6\4R(3M5UR`-S[OWRC\,Z!Y_Y'_"L/_A&=`_Z!5I_WP?_`(JC_A&=`_Z!5I_WP?\` MXJ@#_Y'_"L/\`X1G0/^@5:?\`?!_^*H_X1G0/^@5:?]\'_P"* MH`W,CW_(_P"%&1[_`)'_``K#_P"$9T#_`*!5I_WP?_BJ/^$9T#_H%6G_`'P? M_BJ`-S(]_P`C_A1D>_Y'_"L/_A&=`_Z!5I_WP?\`XJC_`(1G0/\`H%6G_?!_ M^*H`W,CW_(_X49'O^1_PK#_X1G0/^@5:?]\'_P"*H_X1G0/^@5:?]\'_`.*H M`W,CW_(_X49'O^1_PK#_`.$9T#_H%6G_`'P?_BJ/^$9T#_H%6G_?!_\`BJ`- MS(]_R/\`A1D>_P"1_P`*P_\`A&=`_P"@5:?]\'_XJC_A&=`_Z!5I_P!\'_XJ M@#M+_PC.@?] M`JT_[X/_`,50!N9'O^1_PHR/?\C_`(5A_P#",Z!_T"K3_O@__%4?\(SH'_0* MM/\`O@__`!5`&YD>_P"1_P`*,CW_`"/^%8?_``C.@?\`0*M/^^#_`/%4?\(S MH'_0*M/^^#_\50!N9'O^1_PHR/?\C_A6'_PC.@?]`JT_[X/_`,51_P`(SH'_ M`$"K3_O@_P#Q5`&YD>_Y'_"C(]_R/^%8?_",Z!_T"K3_`+X/_P`51_PC.@?] M`JT_[X/_`,50!N9'O^1_PHR/?\C_`(5A_P#",Z!_T"K3_O@__%4?\(SH'_0* MM/\`O@__`!5`&YD>_P"1_P`*,CW_`"/^%89\,^'QUTJS'U0C_P!FI/\`A&O# M_7^RK0_2-C_(F@#=R/?\C_A1D>_Y'_"N'UG_`(5[XQQY=>_&C]F^TF^SP^-O!VM7(.W[)X4FN/&5 MX6XRHL_"4&MW+,"0"JQD@G!`(Q0!]$Y'O^1_PHR/?\C_`(5\W/\`%#PC=.J> M&_@_\7O%*O\`ZN>S^%VM^'+202=N37-:E\3M6AN MGM(/@MX?T20'"P^/?BQX.TG4F&1@#1?`:?$W5FD*G)BCM7<-E2"-I<`^MLCW M_(_X49'O^1_PKXW2\^.NNOG0_!7PUTJ.1&V._AKQYKL48*'#K?\`B[4?A-!- MA@"K1:7=1MN/[N14VS6$^#WQ_P#$+!M:^,&@^#;60DM;>"OAUX56^1<_=6[U M>VUIH6()`9=0NF`"Y=V#%P#ZLUO4VT?2-2U5+"]U0Z=9SWIT_3UC:^NTMT,L MD-HD\D,:Y93-KMC+H&LRZ#=K/#ID] MS=:E'9K=+!H^G66IW.IZN9I3)8QK8VDKB]@N$D5(H_-:SXP_9:SX.\1W)^+? MQ-\1^+SHE_!H5]XZ^*GB7PGX+T_6;JW^RV.HZKIWP_70E-E8W+QWGV8I<_:I M(8[60[)I'KY:_90_8X\??`[XP:?XOUKXB?!/QGHNHZ9J>A:YI>GZEJ=WXDE6 M\07=IJ6@37NCCR-7M]4M8)+AH[BV:\TZ?4;>27,D94`^HY/&OQJ^,6Y?#?PH MU[1_#$X986^(FIWGPQ\-S0O%O2?6[>&SO_BCXI1PR$:-IOASP?H%R"T%UKFH MQ$N>]L?@/X@U^S@M?BE\3]?U;1XXVB3X>?#"WF^$'PXMK:6,*^GO#X'$5I7TVS"A6DDE924`0%G>24MM`4`E MGD88`))ZU\6?'G]O/]@#]FC0=6\1?&7]H+X1>&+'0YH;/4[/3=8D\;^(8-4O M)&@TS0X_"O@"W\4>);KQ!K%RIM=$\/6NERZUK5W_`*+I=C=SYC`!]B>$/`G@ MCX>Z9_9'@CPIH/A/32PDDM/#^CVFF)[LK']K#]H/1U-RESINCWZ?`KX7:Q';K\4?&6M:W#+\-K M[XZ\96_[:;K/[)GQ<_9R_8"D:W@TWX2^,?B/I?[-OQG_:UTZ=X9 MIKC]IGQ5I-]XD^+_`,#_`("WUM&T,O[/?PW\&_\`"Q_B';32)\5_'?AS0YYO MA_/^FO@C]F_]H33_``AX9\`Z=XT_9]_9?^&W@_2[/PWX5^&O[+WP1L=2'A+P MOI\7DV.@>&?%7Q/=O".AZ?91@K;0:%\$]*@CD=[E(O-=F(!Z5^RE^QG\&?V0 M/#OB:/P2GB+Q?\2/B/J-MXG^.'[0?Q5U?_A,_CK\=?&%E:"V3Q7\5_B'=6MK M<:H;"#S+?PWX6TJVT/X?^`M+&M&06==%XN_;$_9J\&:K_P`([??% MKPWK_BOS'A_X0GX=KJ?Q5\=>>I($)\%_#+3_`!=XFBE9OE47&F0KD_,P`)'$ MVG["GP2U&47?Q4O?B=\?]0\Y9G?XX?$[Q9XQ\/R%"2JCX<65[H/PJ@B!P5@M MO`L4*#Y57;7T=X2^%/PQ\`::-&\`_#[P9X$T@9SI7@KPWI'A/36)ZE['P_:: M=;2$]S)$Q/)/)H`^>5_:,^,WC/:OP@_9'^*=];/*T2^)_CEK?AGX`^&0IR([ MG^Q]3F\8_%DP@?.R2_"^TE(^7Y7.%:/`O[:'CG8WB_XY_"_X*Z>9CYFC?`[X M9W'CGQ.MN_WHQ\1_C-=W>A-*J_*MQ!\'+8@_O%4$`5]4CPQX?&<:39C)R<1D M9/J>>32_\(SH'_0*M/\`O@__`!5`'RPO[$7P>UQDG^+NK_%7]H6\2;SQ_P`+ MP^)GBGQ9X<+DDMM^&NEW/ASX40HS*-3\26_@KP9H'PWTSPCX5AU&831Z#X;T[_A%3]AT73P M/*LK;)\J/Y0:_;#_`(1G0/\`H%6G_?!_^*H_X1G0/^@5:?\`?!_^*H`\S_9W M^"VB_LZ_!3X;_!+P]K.K^(=%^&OABT\+Z;K6NQ64>KZC:V+='\+?`CPY^SAX\^$GCSP=J/@GP MAJV@:GXE^,L_Q;\/ZE:7GC>W\,^%/"VL)9>([]/9?^")OA3K_P M3\(?`WXL?#SXG:_I?QJTGP+\0_&/Q=\+?$3Q_JVA^&?$EK\:=%^*OQ.N;OXM M^/=/^)?@C5_"6HP:A\6;BX\?^&WLI_A[K-YJ,7@VSU*\K_%+_@G=X.^*?Q9^ M(WQ=G_:._;6^'&I_$K4_#FJ:OX5^!O[5WQ5^#'@"UNO#7@;PQX#M;NT\'>"- M5LM);5K[2_"UA+J^M3QOJ&I2K!%-)]GL;2./VK]F+]ESP]^R[I/Q`TC0/B1\ M:?B@?B'XVMO'.J^(?CS\4/$OQA\<0:A;>#?"_@J/3(O&_B^XN]?GT"#3O"EC M<:=I-S<26^EW-SJ`LA'!*?"WB+0O$?AC4;9KS3O$6@ZMI^KZ%?6:E@UU9ZOIUQ<:?(?BXWP*M?&*^$O#^F_%)HM.O+#PUXKU M#QYX6C\$0Z]H^L7-CI/BCPKXB\9C0/"OBWP7J>HZ78>./#&N:MX/N=5TR+7# M?6_\^9\1Z;XH_P""/_\`P4$\'>.?@G\.OAS\8OAA^SG\,8OB1XP^$E_;ZE\% M?B](W@^+Q=\)_B1X:C$=C>^"?B+I^FNL'COX;^*+6Y\:_#VXM?"-G<^+O'?A MB[\'>*M1`/ZE=<\0Z#X9LAJ7B+6M)T+3S-';B^UG4K'2K+SY0YBA^UZA/;6_ MFR"-S''YF]PCE%.UL63JNF+/8VIU"R%SJ<4L^FVYNK<3:A!!''+/-8Q>9YEW M%!%+%+-);+*D,)[CXC?`N\\3_`;P]XS^ M*^@?LR_M)_#/X3_&CX*?'G51;1V^AZ1XQ\`^,;-OB#I6OZK<:/J'P\^''Q$^ M%NJ67B+PMK7C?6?(T/QRUU+X5O?F;XW:SXKU?PY^WSXIN/#M]X2_:=TS7?V* MS^QYX/U2-6\;>!+'Q'\,_@EJ'PR\*^`EM8_-CM+C]IZ_^._A3QF/"H73==.C M^*=.U])-$MI[.W`/WWHIB9V\Y'S.!GCY0[;<>VW&/;%9/B)/$$FAZM'X5N-' MM/$CV%RNAW/B"SOM0T2#4S&19RZK9:9?Z7J%U8)-M:Y@L]1LKF2,%8KF)B'` M!^+?_!3#_E(?_P`$,/\`L\/]H3_UD#XE5^W4?^KC_P!Q?_017\]_[>=G\;;? M_@HG_P`$/C\3->^%NIP-^U_^T`--3P-X4\8:'+!*/V1_B&9GOI?$7C;Q&MU& M]M]H2**WBLVCG\J1II8S+$/WRCB\2^7'_I>A_<7_`)<=1_NC_J)T`=#16#Y7 MB7_G[T/_`,`=1_\`EG1Y7B7_`)^]#_\``'4?_EG0!O45@^5XE_Y^]#_\`=1_ M^6='E>)?^?O0_P#P!U'_`.6=`&]16#Y7B7_G[T/_`,`=1_\`EG1Y7B7_`)^] M#_\``'4?_EG0!O45@^5XE_Y^]#_\`=1_^6='E>)?^?O0_P#P!U'_`.6=`&]1 M6#Y7B7_G[T/_`,`=1_\`EG1Y7B7_`)^]#_\``'4?_EG0!O45@^5XE_Y^]#_\ M`=1_^6=(8_$HX^UZ'GT^PZCG\O[3S0!OT5Q>L:S=>'K*34O$'B/P=H6G0@F6 M_P!9:;2[*(#DF2ZOM8@@0`);71+*ZU' M59_`/A?QE\0+>QL;*-I[NYN[_P`(IJVDV4,$*M)+<7^H6MM$HW2S(N30!]2T M5^7W[,G[;/Q%^-=WX\T&T^'LOBWQ-INOZKXCT6PT_4O#'A^VT[X>ZE>I;Z+; M7]WKGB#29KBZT:Z9+"]GL-/U:9XKF"ZN6$K10W7UU%XA_:KLHD615F:,I-0!]#T5X2='_`&C] M2A99_'?PA\+,Y&T:7\./%OBF:%(Y5<_/#X7\#>`_"4./FPL4UQI'B?4X@,H0?[1=B$=22)!Y8!]# M@@\@@_3G^6:@N+JVM8FGNIX;:%!EY;B1((U!(7+23,B*,D#)(Y('4C/SV?@+ M;W*LFM>.?B-XD#X+QZQ\6OB7;6[X8$%K#POXE\,V&!M0;1:[,QJX42M+)*6? M[-WPPLY!/)\.?AQJTXP?M'B/P]JGBRX)XPS7'B;5M8F=@%50S.6$:)'GRT50 M`=WJOQN^#FB,\>K?%3X=V$\?#6UQXS\.K=Y."%6T347NGI>)O%<@!\M/!WP[^(GBM)3\NU4NM$\+7ECE]\95GNTCVRPN7$ M&)60N[/#=VD<<:L(RS$JJL M$)((6N.U_P"/GPK\*/-'XG^._P`"/#LL#3)-%KOCOP_I4L;P(LLZ/%?>+()% M>&-T>5"@=%="5`9<@%B/XT:M?LZ:#\$?C5JS8;RI;SP[X;\'VS'!V%W\<>+O M#MU&C9C9B;)G19"&B\V&>*-$\:_'34&=-.^".B:.K;Q'-XS^+.E6C(2&\LR6 MO@[PQXTW,O[OS(TO,;S)&DY4).WEM]^VM^SG92M#!^T%\'M.-AX4 M_97_`&E-3CVC9)<'[;/X(L]/7R(V3[0OVEYXVEB5;>5V*@`_-KXN_MC?O MVI]&UZ*WTJUT?X42ZW\/;ZRT"U\9>)/`^J6VM7=O!XVUFX>73_#^I:XVGW5G M8FUELX+%6E\*P?V=(\5Y-)-2"DT+I(I!/RL*_CF^('_!5;]ORQ\9^/;32/VC?%VDZ99>+O M&MKI.G77@GX<6ESI6G6?B'5X-,L+JUOO`TU]:W&FV<5O:W-K?/->VTUO)!>/ M+;4(KF?3-(@AM[@/)8V04V\8!]*_9/VE/^ M@]\#_P#PDOB!_P#-K46?VETRA7X&W.TD?:`_Q$L1,`3B3[&(]0%L2N,Q"^N@ MISB9P>//V^/7QI4,6_9)^."JN2S->?L^JH`ZDLW[20`7W)`]ZS+C]I7XGV9( MN_V8OBS:E2JL+GQ#^S;`59QE0RR_M-HREA@J"`6!!&00:`/4]_[2_P#S[?`[ M_P`#?B+_`/(%&_\`:7_Y]O@=_P"!OQ%_^0*\0D_:P^)#2M'8_LV^,Y5C0F9M M5^(_[.FC/YF]D$5K!;?'G79+P@+EW4P@.T<42S.QVL'[5/QE=B_9?B/(I=1\SIN#(GS,`,9`/*'#!?(C*%I)/M_[1__`$*7P2_\.-X]_P#G7UY,WQF_:S:(-%^Q MU"DI;!AN_P!H/X<1%4&06+VT5XN3P549R"=S(1@T$^+O[:MU,L-O^R%X%L@? M,8W.M?M+Z%#:HB*2JDZ+X(UZ\:>5MJHHLA`/G,EQ&`N\`\9_;<_:!^,WPF^% M5QX:U:R^'?A_7OBA#J/AC1K_`,$^-?%NJ^)=+TU;=&\0ZW:6^I>"=`M[86]G M-'ID%^-2BN+34-5M9[2.:6`A.Z_98^+OQJ_:(^$VFZYI_COX9^&KS0'3PCXD M6?P/XA\4^*AK&CV=LHU6^-QXV\/:/`_B*R:VUJ(PZ;=6:M>3V\3R26DP'X+? M\%H?BM^TA;_%7X'Q^/-+@^#%RWPZ\6RZ=HOPY^,6M^+-/UB'_A++".ZU/4KJ M#P[X)2UO;:18+2W@^QWY>V=I#>1[?LZ^G_\`!&'6?VHO'_A?]H.#P%XN\-ZW MI]AXG^'O]L7'Q2\??$9+FPN;KP_XF%FFA6WA?3-1OYK:YCC:34BGB7PZ1+:V MJB*]++<68!_0_<_#GQNUK+-XQ_:)\$O#4*"&(+@!=3\0375J"J``/'HD`4*NU1 MMKPT?LCZ5=HZ>)?BK^T#XR$HVRQ:_P#M%?&32[*5=R$)+IGP_P#$_@33'C*Q MQQO&UILD53(ZM&6:/XE_'3P4TR'<\7Q! M^,GAZP@&4BD(.AOK^D:5@QRPN4&E_-'+$Q#+(I/.6G[7_P"Q_H$CV'A/XD># M=8<%D-M\*O#VO>/6'/AEH6A2(R2&9&1],2U9664F56!!$A+@[B37IJ0: M_'&D<-QH*11J$CC@T_4EC15&%1$AU(*JJ,`*H`4<``4`?.\_[6GANX8#PK\' MOVG?&>]MD+Z9^SM\2?#EM,<(N%U'XDZ7X$TZ,>>_D,]Q=PQQ.DDTS1VD;7(2 M;X\?&K4HUD\+?L>?&!HV566?QQXZ^`_@>(JQD;)M8/B9XLUB)GC6/9'/I44B MS2B&Y2VV/(/H>1M=1=\U[H,2;@-]Q8:E$NXG"C?-J2C<3PHSDG@9KPCQE^U3 M\`?AP6'Q!_:;_9G\![%A=_\`A,OBIX*\+[$GN9+*!F&M^-[$JLUY%):0L1B2 MYC>!"949``?`G_!3#Q5^TOX@_81_:'C\9?!CX6^!O![^%='_`+0-+\/Z=\']&T"XG:]\L/\`:O%D,:V8FDR)T2&3^8W]@;0=6US] MM/\`9LTC1-?U?P/JVH?%*QMK+Q=H6DZ%?:QX?E;1M=>34-,M?%.B:[X=FNQ; MI/;Q#6=%U.QC^T&:2RFDBC4?TO?MD_\`!<#]AG]F/]G7XR?%_P`+?M,?LR_M M%^,OA[X$U+7_``M\'/A5\5O#7B[7/'WB@W46D^'?#`O/"^M^*8-(M[O6[FWG MUK49;*]GTCP_:ZEK2Z=#OV+I_#?[)/P+ MU[]I_P`8+X#^''QZ\)_!OQQXHU7]GV>XLM6U>[UZQ\!:_P#$G5M%^*&KG1]+ MGTGPK!XKN-&T/2_%-YIWB/Q:NM>&+'4_#EV`?U(?M37_`.S3\$_$7A/X.:SX M=^.'_!1C]LSXBZ=/KOPG_95\0_%W5?%FJ:SI,=U'I\WQ$^)7AR:^T+X"_`+X M$Z/J/?!&G>'XC%<:3X/TSQKXK6U\+7?IW[+'_!-]M%\;>$_VD_V MQKCX<_$K]H+PE+/I7]E/\`8P^'7[(OA[Q';_#K M[1XI^(/Q(U.R\3_&KX^?%2^U'QS\>OCSXTMK)+0>+OBQ\1;FXL[S6[BWC\V+ MPYX8TRTT?P+X"TN4>'_`?A?P[HD*69^L/*\2_P#/WH?_`(`ZC_\`+.@#="A> M@`SR<=SW)/)?\`G[T/_P``=1_^6='E>)?^?O0__`'4?_EG M0!O45@^5XE_Y^]#_`/`'4?\`Y9T>5XE_Y^]#_P#`'4?_`)9T`;U%8/E>)?\` MG[T/_P``=1_^6='E>)?^?O0__`'4?_EG0!O45@^5XE_Y^]#_`/`'4?\`Y9T> M5XE_Y^]#_P#`'4?_`)9T`;U%8/E>)?\`G[T/_P``=1_^6='E>)?^?O0__`'4 M?_EG0!O45@^5XE_Y^]#_`/`'4?\`Y9T>5XE_Y^]#_P#`'4?_`)9T`;U%8L4? MB$2QF:YT9H0ZF58K._61HPPWB-GU%T5RN0K,CJ&P2K`$':H`****`"BBB@`H MHHH`****`"BBB@"CJ>F:=K5A=Z5J]A9:IIE_`]M?:?J-I;WUC>6\@Q)!=6=U M'-;7,,@X>*:)XW'#*17G^F_!;X0Z1\.T^$>G?##P!:_"Z.W2T7X=IX/\/-X) M-O'.ERD4GA>33GT291!->\,WFI)IGC+P3]JT:5]:`/V+OOAO\`#[4]=\,^)]1\#>#K[Q)X+M7L M?!_B"\\+Z%=:WX5LI%C62T\-ZO/I\FHZ#;.L42O!I-S9Q,(XP4(1<:UYX5\, MZCKFD>)K_P`/:'>^(]`BO(-#UZ[TG3[G6M&@U!!'?PZ3JL]M)J&FPWJ*J7D5 ME<01W2*$N%D48KY%^*_QO^)UY\?=3_9[^#TOA71O$?@K]G/4?VB_$>M^,=%O M==T[69-2\::QX$^&?@&""QUC1Y-*T[Q%JO@_QQ?>+O$L3WNI:38:7I%KH]A] MHU2XO+3Y'TO_`(*3>*?'WP0^*7[7O@O0-$T7X(?`+P;^S;XK\:>!]9M+S5_% M_C*#XS?![X0_M`?$6+3_`!-#=:9!X?N/AS\,?C5X6M?"D,=&UV' M6#;Z3J&G'3@#]D**:IW#.,(=>T[POH>K>(M7:[32]%L+ MG4K]K#3-4UJ]6TM(S+,;72=$LM1U?49PBGR[/3;"[O)VPD%O+(0I`/Q;_P"" MF'_*0_\`X(8?]GA_M"?^L@?$JOVZC_U!/B1_P43_X( M>P^%I?%,KZ=^U_\`M`2W)UOX=?$CPC%ME_9'^(=LBVT_C'PCH$-]*);B+S(+ M)[B:&-Q/*B0;I%_?"/Q)I7EQ_/>?<7_F$ZQ_='_4/H`Z&BL'_A)-*_OWG_@I MUC_Y7T?\))I7]^\_\%.L?_*^@#>HK!_X232O[]Y_X*=8_P#E?7\:'_!P9_P< M0_M>_P#!,W]K_P`*?LU?LP^$/@IJNE:G\$O`_P`5->\0?%GP)XL\0:A#>^*] M>\:Z7'I.DQ:9XW\(1F`VOAJVNY[FZMIQ$9_LL(\]9WA`/[3:*_D8_P""8_\` MP_C?XK^..F_$GQ!X4GT[]DS]EGXV^-OA2='TO0/"U M_IT\OB_2K3Q[IVEZY?7&K7]Q>>'[K6+O5],M?LDD]N;2[TZ[O?K'4?\`@N9X MS\2W#0^#_P!ESXJ>`[*7,<=_\1O@7^U-J5]&&5=LTEAHGP/MK>WVEB9`XO=@ M5]L4\B"&0`_HVR!C)`ST]_I5'4-3T[2+26_U6_L],LH!NFO-0NH+&UB`!.9+ MFZDB@08!.6D`P#S7\V[_`/!2;XB>,=G_``D7COQ+X=MY-Q^QI\'/V]/#]K`& M,GR-;_"S]A;1?$,C`/$0A^(A#F"6-;M([F*ZMUB_:<^%>J2K>Z_\4O"MKJ#, M9?[3F_X)P_\`!1'XO>(H90TCPM%XB^._P]^(2I)&QAWS6VBVID`D">4Y64@' M[PW_`.TM\$+2[.G6/C[3?%>IC(_LOX?VFK_$;4O,Z"(V?@33O$,L#7M:O?%L:$'+#_ M`(1$S*.L6X%:_'VU_;)^#TMG;Z?KG[9W[7":;:H$CT[P3^Q?^T7\-M-A0.'+ M0Q>"OV$-(U**)%CB"VPUK[R3,UT+>[EM%Z,?&?\`9.U>WBD\2WG_``4<\?03 M)'*J>+OV1?\`@L)XDTVYMY(X65EL;?PGX?T.XM[R-0\@.B"*:WN)(@I@D18P M#]2]7U;X_&">]\1^*/@/\&-&9"PGNY/$/Q#U.W18GF?=J.M7_P`+O#\,T<<4 MCL[:?J%NJQR.0R1L3X7K?Q._9]M&"_%']OJSUFYA=TN/#WA;XN?#CP!`Q&\2 M0KI7PKCM/&;)&5=72?7[ITVXE$/AMXS^*VL!U:/5M,_9[^/?QFU21M^TSQ>+?$'@7Q! M!E668M.-<0%[>YB5FGA:*ODW_@J1^T3XIU/]B#XD:=X+^#O[1/PLL)M:^'%A M)XW\0^'=!^&VA6FER^.=!2YTF:P?QQ%XV>WUM"NC_8+;PE+;3&;&H^1IRS7" M?1*?M[?LR9_TG2O^"B%[DDL)OV$_^"C5NKC&%4IIW[.EBBA.H\M4+'F0O7Y^ M_P#!4G_@J+^R-\#_`-A;XZ?%&/\`9I_:$^..O>'+'PS'X0\`?M)?LC_MO?#O MX-:IXYU[Q;H^A^%=6^(/C7XO_"OPCX+TW1_#VJZA'K\]G-XET;7?$LNGQ^&? M#5];:WJ]I%-6N?%^J7]OX_LI/#'C/XBZ[X0\ M)ZW8GX?^([RZ@U[7+30O&,L-M9-9PZO:0-X:U1+G5M.TZ/9;.$O;;^L&]\-I/&VE^.-;^%OC']D_P#9 M9\4>(?C1\/O$NC>&]2U>ZT/3?A_X"C\<:YXQ\"ZAX7M=;L+N:UT<:_X:++KF MN>(=0T2*_6V_M='_``42^$6FP,V@_L:?\%";N\'E+:Z9I?\`P3B_:/T2:Z<2 MKLCCU#Q!X`\.Z#:"(,\_G:GK.GVR*CA9_.>**0`]>FU7]HO4X]M[^U!^SGX> M+?%,\1DXPM]K7QTOHIQ;0@2QW+:/%&MW)LNK>:%%AE2W\(_%V M_P!S:E^U]\;+H,'`B^'O[._PRT"W#,%5`DOB+X3^-IP(X-\TZR7[.]RXGA>" M%8[.O)E_X*8QR;8-._8$_P""F=]>2NL=I8K^R%J6B+[UG5]-L(E5C/=QDJ&O#_@H?X^F*PV7_``30_P""DES=S,L5M!K?M/6NFZ?"68&6\U"Y@M+>,-+/(B*30!Z/_`,*.O=2D+:G\ M8OVYO$V=ORGQ_H?P_ADVJ8[4'_A#]%^'3PJC%IV9/+>5B!JQG18X5DG_`&5_ MAWJ0)UCX??'+QAE88R?B)^U3\6]8@ECM\M&LVGW'Q=UFQ93=,]V87L6A67%S M$HE2&-."E_;E^/K1R)9?\$M/VZWO74I:+?Z_^Q'IM@URYVP_;=1/[7ET+"S\ MPJ;F]-K<_9H`\WD3;/+:K+^V-^V*4D6V_P""77QX-R598/MG[2'[%-M9>>05 MB-W=6_QRO[BWM/,*FYN(+"]GA@\R6&RNI52WD`/4]-_8Z^!UJZS0_LI_`*>= M'B(NO&1'C6\W0EI&F>?7/"6M322W$KF2>=[LSW& MFC/AGX6?L\>"O+\H(_ASX8V220B*'U'D7!,L0PH,S-.U MFE"P/9/[1/\`P4BP=O[`7P$WX.W=_P`%`U\O?CCA(_X)Z<@-P2!R.0*Q1\2/^"J7R&3X,_\` M!/U1NC,J)^T3^UDS*NY3*B2G]C@*Q"[E67RQG`<1C(2@#B=?_P"".G[%&L?$ M6WUV^^'%YJ.D:U)XDUKQA9ZA\1?B`+_5]>U.]EOGGA:U\16TD=IJ%WJ5Y=7Z MV/D16;6HB@$,=QMC_1W0?@S\/?#>@:%X9TG2=031/#>C:7H&BV-UXH\5:C'8 MZ3HNGV^EZ7:QM?:U.[?9-/M;>UCF=FG,48#R,68G_('_`."@&J?\%7IO^"L_ MQ,N?BP?CW;?MO-\<]7;X4VOPVE^)4]Y#;GQ--;CP MGX6F\:V'AS]ACXP>/=:TGQ+%X>L/[=T^3Q'J7[6N@>%=8N9=<^V+JU_IW@K2 M-.,JRC0[.TM6@*@'Z9Q?#?P%$=W_``B'A^5@5(-SIEM=D;>0`;M)R!GE@,!F M^9@QYK4@\+>%+(J;7P]X>LRN[:;?2-,@V[_O[3';*1NS\^#SGFOS>7X`_MV: MI*TOB#_@I]K.D!_/G:'X7_L-?!?PS`ES(P$5O!_PLF/XSW*:-;QEMMI<7%SJ M\DXCEE\0-"KVTNA'/V1?AZGF7" MJM[*7\(_L7V5Y()=NVR$MY)-I2%FLKA+DFY(!^E<*6D*A+=+>)0%4+"L:#"C M"J%C`&%'"J!@=`*E+*O9_P`$D;^2D5^8$'_!/KP)?MC_';P;;O81L6FT^1/A-#\.&ECNV+?:+^1VUP(1#;:M;0JD:VKO_`()G M?L4ZUYC>,+/]I3XBO,\1N!\3/VQ/V[/']M=Q6P7[):7^G>)OCE?Z7?V5DZB: MSM+VQG@MK@+%7.XGH#7 MD?B;]H?X!^"B!XP^-GPB\)EKNXL!_P`)+\3/`V@[KZS#-=68_M77K0F[ME5F MN+#X=K/-"'C1RDTDFZ15D$_BA\5IKF[G M($6F6,7PU\!^*WO]:(9';0[,3ZQ'')'+)8K')&[?9OA_PI\(_"8E'A;P'X5\ M-B?[-YPT#X>VVC>;]B#"S\S^S/#UKO\`L@=A;;]WV<,PBV9.>W/B#22<^9?_ M`(:=K@'Y"R`H`_B+_P"#B_\`X+F^&/A/IW[/GA[]DWX$>`_'GCCQYIWCJ_U/ MX]?M7?L9>.##X3\+>&]6T:R/A+X/^'_VE_A;X2T?Q5?ZMKMZ]YXN\165CXET M'PS%8V>D261U_6OM.D>^?\&^7_!9'Q_^TG^SO\3K6\_X)R>*O&?QB\#>/?#O MAWQGXZ_8;^$'P%^%_P`/O'MAJ^AW%[X,O?B#8^-?BK\(?"WAKQMIT<.OV]\^ MCW%YX=.D&RU06GAR34/L5W_0O^W3^P)^Q+_P4@^'OA_X;_M>?"-/B;H_@[6+ MG7_!.L03>.?"7C+P7JU_!#:ZI/X9\9>$Y-(\0:=::S;6UI#KNBM>7&@ZX+'3 M9=6TN\N-+TR>S[3]C?\`9$_9*_8$^#MG\"?V4?A79?"KX=0:M>>(K^QL[;Q= MKNM>)/$^I16\&H>)O%OBOQ(-6\2^)]>N;:TM+%;_`%C4[IK+2[*PT?3(['2+ M"RL8`#RF[_:O_;DU>4#P5_P2\^)^GV\SN+6[^,W[4W[*/P_B"23+%9R7]K\. M/'/QVU:R54$MSJL<6GWES96_DC3X-:NI9;:WGE^(7_!5?Q);*VA_LN?L0_#5 MI4N"DGCS]L?XS>/[^VWN(;9KG1O`?[(.@:=+-:A9+Z>UMO%IM[Z)[>PCU/3Y MS/=P_?\`_P`))I7]^\_\%.L?_*^C_A)-*_OWG_@IUC_Y7T`?GY:>%O\`@K/X M@64:I\:O^"?OPRCECN`B:!^SC^T7\8+ZT,C+!"(]1\0?M+?".QN98H?,U%;B M70(H1=&'3)=/N+:*34+F%OV8O^"@VM3N_B7_`(*9R:!#)O/D_!S]B[X$^$EC M)2.")89OBSKOQ\G6-8A+*XAGMM-B;1YOT)_P"$DTK^_>?^"G6/ M_E?1_P`))I7]^\_\%.L?_*^@#\_[[]@;XF>(RS^-?^"E'_!0GQ`[,2T.@>,O MV;_A+9_+!]FMRB?!_P#9C\$7T;0PM(75-1$%W6ZAM);:1/^"8'P`U M&#R/'7Q0_;=^)R^:92GCG_@H)^VC<6A9(?(MB=+\-?&[POH_F6:-,;:X&GBZ M$ES/+-/.YC,?WY_PDFE?W[S_`,%.L?\`ROH_X232O[]Y_P""G6/_`)7T`?`. MG?\`!(W_`()O6R)LWD\S>]L3`[-&2I^B?\`A)-*_OWG_@IUC_Y7 MT?\`"2:5_?O/_!3K'_ROH`XGXB?`_P"$GQ7^%?CCX(_$'X?>%O$OPG^(_A+4 M_`WC7P+=Z5;V^@:[X6U?36TF\TJ>UT];-K=18LL=E=64EM>Z7+#;76F7-G=6 MMM-%^0W["/\`P;O_`/!-G_@GG^T%)^TU\$?!/Q%\0_%;3X-;MO`>I_%GX@-X MYT[X50^(K2YTS6'^'^G1Z'H8MM2N]$O+O05\0^)9O$WB.UTB[O[2TU:!M2U& M:Z_:_P#X232O[]Y_X*=8_P#E?1_PDFE?W[S_`,%.L?\`ROH`WNG2BL'_`(23 M2O[]Y_X*=8_^5]'_``DFE?W[S_P4ZQ_\KZ`-ZBL'_A)-*_OWG_@IUC_Y7T?\ M))I7]^\_\%.L?_*^@#>HK!_X232O[]Y_X*=8_P#E?1_PDFE?W[S_`,%.L?\` MROH`WJ*P?^$DTK^_>?\`@IUC_P"5]'_"2:5_?O/_``4ZQ_\`*^@#>HK!_P"$ MDTK^_>?^"G6/_E?1_P`))I7]^\_\%.L?_*^@#>HK!_X232O[]Y_X*=8_^5]' M_"2:5_?O/_!3K'_ROH`WJ*P?^$DTK^_>?^"G6/\`Y7T?\))I7]^\_P#!3K'_ M`,KZ`-ZBL6+Q!ILTL<,;W9>5UC3=IFJQKN=@J[I)+%(T7)&7=U11RS``D;5` M!1110`4444`%%%%`!1110`4444`<7\0?#6N>+?"M[HOAOQIK/P^UQ[W0M1TW MQ7H-GI.HWMC<:%K^F:[]CGT[7+2]TS4=&UR/3I-!\0Z?-%#/>:!JFI6]AJ&E M:B]IJEG^;%A_P2]T(_LQ?M)?!+5/B>\/Q`_:M^'GP_\`AU\5?B?X?\!Z/I&E M1Z7\-_"T7@OP[>>'_`,.K1PSZXGA[[3!J'BCQ9XE\1^)]8GEL8M5U6XT'P[X M:\/Z1^K=>`_M$?M)?#;]F7P9!XO^(,VLWT^JW.J6'A7P=X3TI]?\:>,]3T3P MUK7C+6;#PYHR2VT4O]C^$_#FN^(]8U'4KW3-%T?1]*NKS4]4M%\@3`'-?%7] MFMOB%XPL_B/X>\?ZO\-OB%>_"KQ)\$?&WB7PQI%C=KXG^&_BJ_MM;N+>TT_6 M;N[70?%'A3Q#'J&M?#KQ,+G5E\,S^(?$5MJND>*;34A%;^677_!/[X6V]EJW M@3PMJ^L>%O@7XUTKX&Z1\3?@Y:Q1ZAI/C"R_9XT3POX4\`6MMXBO[E]9\/66 ML^!_`W@?P%\2+>!=1D\8>$/!^BV%G<^&[^76]5UCOO&G[9_PL\(>#?"OC"S\ M*?';Q_+XN\5^+?!]CX*^%_[/WQ<\>_$O3=3\`ZW<>&O'%[XD^'FB^%G\4^&? M#GA;Q%%:Z-JWBK6["S\.B\UGP\UEJ=Y:>(-(N[SOM>_:4^$WAOQU+\/]6UR] M@U;3]8\#^&?$FIQZ)JMSX5\&^+?B=)9P_#CPAXQ\56UM+H?AWQ/XWEU'2XM` MTB_NTFFEUSPQ'>-9-XN\)C6P#WD``8`P,D_BQ+$_B232T`YY_P`_Y]J"0!DD M`#J3P!^-`'XA?\%+QC_@H?\`\$,.O_)X?[0GM?MU'_JX_\`<7_T M$5^(G_!2YE;_`(*'?\$,-I#?\9A_M"?=(/\`S:!\2<],],C/H.37["='^'^EZI\)_%_A+PP!X9T;5-;UBWL;V/ M7_`7BW[>KWVO7\_^D%OLSNQL?LOGW8N/V\W#T;_OA_\`XFC6OJ_\`W\D_^*I=P]&_ M[X?_`.)HW#T;_OA__B:`$\M?5_\`OY)_\53L#W_[Z;_&DW#T;_OA_P#XFCCZSI=W9:QH>L65AK&CWUCJ=C:7X>C?]\/_P#$ MT;AZ-_WP_P#\30!^1G[`G_!#O_@G9_P3:^)'BCXP?LT?"'5K3XH>)=*OO#L/ MCCX@^-_$'Q%UWPKX7U*>*?4?#O@R37Y3:>'+/4&MX(=2U*VM)/$NJ6,0TW4M M=NM.>:UE_70JIX*@CT(%)N'HW_?#_P#Q-&X>C?\`?#__`!-`""-!R$0'U"C_ M``IV!Z#\A2;AZ-_WP_\`\31N'HW_`'P__P`30`ZBF[AZ-_WP_P#\31N'HW_? M#_\`Q-`#J*;N'HW_`'P__P`31N'HW_?#_P#Q-`#J*;N'HW_?#_\`Q-&X>C?] M\/\`_$T`1-;6[S)C?]\/_P#$T`.HINX>C?\`?#__`!-&X>C?]\/_`/$T`.HINX>C M?]\/_P#$T;AZ-_WP_P#\30`ZBF[AZ-_WP_\`\31N'HW_`'P__P`30`ZBF[AZ M-_WP_P#\31N'HW_?#_\`Q-`#J*;N'HW_`'P__P`31N'HW_?#_P#Q-`#J*;N' MHW_?#_\`Q-&X>C?]\/\`_$T`.HINX>C?]\/_`/$T;AZ-_P!\/_\`$T`.HINX M>C?]\/\`_$T;AZ-_WP__`,30`ZBF[AZ-_P!\/_\`$T;AZ-_WP_\`\30`ZBF[ MAZ-_WP__`,31N'HW_?#_`/Q-`#J*;N'HW_?#_P#Q-&X>C?\`?#__`!-`#J*; MN'HW_?#_`/Q-&X>C?]\/_P#$T`.HINX>C?\`?#__`!-&X>C?]\/_`/$T`.HI MNX>C?]\/_P#$T;AZ-_WP_P#\30`ZBF[AZ-_WP_\`\31N'HW_`'P__P`30`ZB MF[AZ-_WP_P#\31N'HW_?#_\`Q-`#J*;N'HW_`'P__P`31N'HW_?#_P#Q-`#J M*;N'HW_?+#^8IU`!1110`4444`%%%%`!1110`4444`%?F=_P55^$?ASXT?LQ MZQX5\0?"GXL>-[_37UKQ5\/OB%\#YKM/B?\``SXH:+X7U>'PA\0/#,6@78\7 MROJ,>HZQX,U=#\8:+JFF:_=>'OB%X/U[X?ZYXAM:_3&D(##!`(]QG\?K[ MT`?A;\0O@K\6OCA\"O!O@[X[_![XH^(OV[_"^A_%UOV8_P!LKP)X5\,?"[Q7 M\-9F^)GBRP^"WCSXC?$;X?>)-.\,?"[QGJ?AC0OAQ\1_VBOA5HL&H_#;QXEW MJGAVP^'_`(@BO+SX;Z-Z)\5OV?`.#P_P")M3OOVK/VGOV?OCAX M=^,.F)!'X-\.>$]&\/\`[+NA_%6?5M1FOC=^%=;^'D_[/GB>]\&^&+AKR_\` M$47BKP#9>')KX0>*[SPW^QNU<@[5RHP#@9`]`<<#V%+@9S@9'`.!D#TSUH`1 M!M&/5G;GJ-S%L=^FJZ#S_`()"?]&E3?\`B0?[4W_S[Z/^(>S_`()"?]&E3?\`B0?[4W_S[Z_: M"B@#\7_^(>S_`()"?]&E3?\`B0?[4W_S[Z^6OVS?^"$W_!,'X;?L]^*_%WPS M_9=U/1_&-CXD^$]CI]_IWQT_:(8X[.\^,6H0.MWX:U?6 M;.>0VKO;VUQ-<1/!+$D\?](M!&?_`*Q(_E0!^+J_\&]O_!(0@D_LE3??D_YN M#_:E&`'8``#XW```8`P`,4[_`(A[/^"0G_1I4W_B0?[4W_S[Z_:"B@#\7_\` MB'L_X)"?]&E3?^)!_M3?_/OH_P"(>S_@D)_T:5-_XD'^U-_\^^OV@HH`_%__ M`(A[/^"0G_1I4W_B0?[4W_S[Z/\`B'L_X)"?]&E3?^)!_M3?_/OK]H**`/Q? M_P"(>S_@D)_T:5-_XD'^U-_\^^C_`(A[/^"0G_1I4W_B0?[4W_S[Z_:"B@#\ M7_\`B'L_X)"?]&E3?^)!_M3?_/OIDG_!O;_P2%$$-,M5M/C#8BZL;#3%$-I?3+<7%U'^]FN[ER9#]2?\0]G M_!(3_HTJ;_Q(/]J;_P"??7[08Q_/J3_/^72B@#\7_P#B'L_X)"?]&E3?^)!_ MM3?_`#[Z/^(>S_@D)_T:5-_XD'^U-_\`/OK]H**`/Q?_`.(>S_@D)_T:5-_X MD'^U-_\`/OH_XA[/^"0G_1I4W_B0?[4W_P`^^OV@HH`_%_\`XA[/^"0G_1I4 MW_B0?[4W_P`^^C_B'L_X)"?]&E3?^)!_M3?_`#[Z_:"B@#\7_P#B'L_X)"?] M&E3?^)!_M3?_`#[Z/^(>S_@D)_T:5-_XD'^U-_\`/OK]H**`/YRO&G_!"'_@ MEWIG[6'[/_@'3/V6]2A^'WBWX+_M-^)?&&E1_';]IV6PO_$W@GQ-^S38^!;R M[U!_C')=6=SIECXU\;QV5M!?6L-\FI7DEQ;W;6-N]I]*_P#$/9_P2$_Z-*F_ M\2#_`&IO_GWU^T'^?\_Y_F:*`/Q?_P"(>S_@D)_T:5-_XD'^U-_\^^C_`(A[ M/^"0G_1I4W_B0?[4W_S[Z_:"B@#\7_\`B'L_X)"?]&E3?^)!_M3?_/OH_P"( M>S_@D)_T:5-_XD'^U-_\^^OV@HH`_%__`(A[/^"0G_1I4W_B0?[4W_S[Z/\` MB'L_X)"?]&E3?^)!_M3?_/OK]H**`/Q?_P"(>S_@D)_T:5-_XD'^U-_\^^C_ M`(A[/^"0G_1I4W_B0?[4W_S[Z_:"B@#^>']J_P#X(,_\$LO`/[+?[2?CKX?? MLLZAI7CWP7\`OC)XL\$:G8_'C]I[4+[3O%_ASX=>)-8\-7]G877QEOK6]NK/ M6K*RN+>TN+*[@N9HTAFMIXW:)_:-`_X-]/\`@D9=Z'HUU>?LFW$EWS_@D M)_T:5-_XD'^U-_\`/OH_XA[/^"0G_1I4W_B0?[4W_P`^^OV@HH`_%_\`XA[/ M^"0G_1I4W_B0?[4W_P`^^C_B'L_X)"?]&E3?^)!_M3?_`#[Z_:"B@#\7_P#B M'L_X)"?]&E3?^)!_M3?_`#[Z/^(>S_@D)_T:5-_XD'^U-_\`/OK]H**`/Q?_ M`.(>S_@D)_T:5-_XD'^U-_\`/OH_XA[/^"0G_1I4W_B0?[4W_P`^^OV@HH`_ M%X_\&]G_``2$`/\`QB5-T/\`S<'^U-_\^^OFSX!_\$(?^"77BSQS^UII?B[] MEO4K_2OA_P#M*)X+^'D%U\=OVG;2+2O!!_9W_9[\8'3;"6W^,=J^H6?_``F7 MB[QCJ'VVZDOKC[7J%W9_:Q;V<%K:_P!&E'^?\^GX4`?B_P#\0]G_``2$_P"C M2IO_`!(/]J;_`.??1_Q#V?\`!(3_`*-*F_\`$@_VIO\`Y]]?M!10!^+_`/Q# MV?\`!(3_`*-*F_\`$@_VIO\`Y]]'_$/9_P`$A/\`HTJ;_P`2#_:F_P#GWU^T M%%`'XO\`_$/9_P`$A/\`HTJ;_P`2#_:F_P#GWT?\0]G_``2$_P"C2IO_`!(/ M]J;_`.??7[044`?B_P#\0]G_``2$_P"C2IO_`!(/]J;_`.??1_Q#V?\`!(3_ M`*-*F_\`$@_VIO\`Y]]?M!10!^+_`/Q#V?\`!(3_`*-*F_\`$@_VIO\`Y]]? M-7QI_P""$/\`P2[\-?&#]D'P[X8_9;U*S\-_$/XT>/O#7Q'M+;X[?M.W5OJW MAG2OV9/CKXVTBSU"YF^,=Q-IUM;^.?"WA34HKFTN+&:6]L;6Q>XDMKN>TN?Z M-:/\_P"?7\:`/Q?_`.(>S_@D)_T:5-_XD'^U-_\`/OH_XA[/^"0G_1I4W_B0 M?[4W_P`^^OV@HH`_%_\`XA[/^"0G_1I4W_B0?[4W_P`^^C_B'L_X)"?]&E3? M^)!_M3?_`#[Z_:"B@#\DOAQ_P0M_X)9?"3XA>!OBI\/OV8)=`\>?#;Q=X=\= M^"]=/QS_`&DM6&C>*O"FJVVM:!JATK7/C#J>BZD+#4[.VN?L&KZ;?Z9=>7Y- M[9W-N\D3?K;_`)_.BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`^3_`(G?MI_`KX/_`!2\-_"KQ]?>/='O_$?BGP9X#;QS!\(_ MBAJWP<\->/OB1>Z;IOPZ\#^.?C/I/A2\^&G@GQ3XXU#6=%L/#^E^)/$FGF6_ MU[PU8WTNGW?BGPU#JW8:3^TY\'M7\:3>"8?$<]G, M]'\0Z#XP\#Q7GCK7_B!X&O&/CG4KO1O)N]5\.6-A9W%WIFD M:Y;:I\M7?[&_QF\<_`[X4?L_!_XN_MB>+O$OQRU&ZAA\-^(/"_Q M9^&/[8'@+X7>(-`UFQGO;[Q%XB\;7G[3WAS6_&6B1VD6H>%F\*>/K3Q!Y$LW MA2X\3`'Z.)^V[^SI'X2U[QOJGC.\\/>'M&\'>'?B+I]QXA\,^(])O?&GP]\9 M^(+7PGX)\:?#[1[C3?[8\;:'XR\5:AI7AOPU_8-C(_AOXHA\&?$+P?XGT:]\.^+/!OB2[\-Z%XQ MTZPUK2+Y<^3J_A/Q/X?\1:-JNG7&H:-JNEZI!-8ZC/+%=PVWY!?%SX`?&[XW M_#K297_9ILM33X7?\$^_$W[*OB[X-_$X:,VD_$3QI\4_B)^SG>_$/2O!%N-< MTW1_%$'PN\$_`C7?$'PP\6S>(O#7AW7_`!WXF\$QZ1XATR2S\0W>A?7'_!.K MX0_%/X(Z!\=O!/BW5?'GC+X7R_&&/Q%\#?B9\=;8+^TYXZ\(ZOX`\(0ZX/CY MKLRIKOQ!USP3XETZY\`^!_B1XZ@L?B#XB^'7AWP[I?B6UOXO#FE>*/$@!^CE M%%%`!1110`4444`>5_&'XP>%?@EX1/B_Q58^,]:CGU&VT71O#7P[\!^+_B9X MZ\3ZY>07=U;Z/X8\$>!M(USQ'K5\;.PO]0NC;6(L],TK3]0U?5KNPTNQN[R' MQCPY^W%^SWXT\`>!OB)X*U_Q3XLTOQ_#\2+G2O#^D?#KQVOQ!TFW^"^N+X9^ M-!\8_#?4M`T[QOX)O/A)XF>'POX^T?Q1H>F:YHOBJ[TWPM'IE[XAU?2=,ONX M_:4^,NK_``.^'T7BWP]\'?BY\;->OM=L?#NF>%_@YX&C\?:_I%D_P"$4T*&W>;6!!K=MJ.H-+:Z1IB-=Z@DMO\`G9\$O#/B;P7\2?AU M^T_X4_9W_:3LO"VH_!;]HCX4>(?A_P#$7PSX3\/_`!CN?C+XR^//AWX\7/Q0 MU_P;8>+]6M-!T3X^^-/^$WM[_P`07&HV]IX7ELO!%SK]CHO@ZYBU/2`#]`=: M_:Y^`VB76F*WC:#5=%O/"W@'QSJGC/0+*]USP+X1\%_%:]ETWX8>*_&?C#3H M9]#\-:#X]O(+@>'-0O[H136%M=:[??8/#MM-JZ6X/VIO@]/X^L?`']MZE%/J MWQ`UKX1:-XLG\/ZQ#\/=9^+OANQU+4=>^%^F^.7M1H$_C73(-&UFUETQKF.W MN==T76_"FGWU[XLT;5-"M/R#\)?L1_'SX1?LP?M`?LE2>'M5\:^*?VH_V2/V M:_@MH/Q+TG4(]0\(?#[QIX6^`NG?L\?%&U\2Z[F#XH>"[YM M/E7Q78:E_%3PYX/\"^(?B)IGP"TK]KEOVT_ M'.F^,AH']C:;\2[/Q/KWQ)NO`WPCO9-%A\>WVA^/OCCJUM\4_$\NKZA-X6\. M6/\`PE>@>'-7U&T\6Z=X<\,`'ZC@@C(.0>01T(]:*:J[55>NU0N?7`Q3J`"B MBB@`HHHH`CFFBMXI)YY$AAA1Y99976..*.-2\DDDCD(D:("[NY"HH+,0H)'Q M;X3_`."@G[,GBG7OB'X=NO$WC/P'?_#GX;:I\:+V7XL_"3XJ_"?3?%GP9T;4 M;31M4^+'PSU/Q_X/T&R^)O@2QUG4-*TNZUCP3+K$L%UKOA3QVUI=7$L4T\4%O/-)#;VTMY/+'%$\CQ0VD"23W4LBJ4BMX8Y)9Y&6*-&= MU4_AM\5I/&?[=%C\7+32OV2OVLOAA\4K'X8:-_PJW4?CO\//"WPO^'MIX4^& MWQT^%/QGUGX1Q>*&^)&O&[\7?M':[\-_#.GZY+%I']AZ9H'A_0K+5Y-.M?#N MIZIK0!^GNH?M9_!G0?AG\9?BIXJU3Q)X5T/]GOPQ?^,_C)H6M>!_%P\?^!/" MUAX5G\<#7-3^'FFZ1J7B^[L;[PE;76N:;)I&E:E]K@LM4M`$U/1-;L--Z;Q; M^T%\.O"&G^`;JXN->US4?B=I=WKW@?POX3\-:SXG\7:_X>TG1;#Q%X@U^U\- MZ3;3ZDNC^'-&U33+C6;Z:)$M[S5M$T*W%WXBU[0M(U+\\/CQ\+/BG\5_AU_P M5*^+&A_#GQSI\G[07["FF_LX_![X9ZGI4D'Q!\7>*O!/PW_:7N'U:;PC;O=- MI5QX@\9?M`:?X!T9M1NX'N(O"%]KL[P^%KK2=7N_6#X-\=^!?B=^R+^T,O@' MX@>+M"\(_LA>/_@!XR\$^'M-AF\8^$?%'C:^_9[\?^&]6;PIJ=SIL[1:AJ7P M>UKP!XDN?M,`\/:GJGAC4M9:U\+PZ[K6C@'Z">$?%OAKQ[X5\.>-_!NM:?XD M\)>+M#TKQ+X9\0:5.MUIFM:#K=E!J6DZI87"@":TOK&XAN8),`F.0;E5@RCH MJ^5?V(?@QXI_9\_93^"/PB\;W4-SXQ\(^"X8_%$=M>#4;'3=?UO4]3\3:MH. MFZ@N$OM+\-WNMS>'M+NXU2&YT_2[::&..%T1?JJ@`HHHH`****`"OE3]HS]L MOX(_LL&";XNW'Q#M-'M]'_X2GQ?XF\'?!_XI_$KPI\+O!`N[BP?Q]\6_$GP_ M\)>(](^&G@B*[L[X3>(_%=UI]G!9:7KNM2A-!\.^(-4TSZKK\Z?VYOC')IEC M>_`6\_9A_:S^-/@?XG>"+M/B;XB_9^^$NF>.-'OO!>HW-WHVM_"=M:U3QOX0 M&G>(_'&CC4-.U6\2&]M=%\(ZE>!;NSUO5],N-/`/IB__`&F?A%IWCP^`;CQ! M0^)O!_@74/$=OI&I7/@;1_B!\0])TS7O`/@'5O&D,#:!8^+O&6BZWH.H: M#I+W;&Y7Q-X1M9I[;4?&/A.RUOHO!GQQ^&WQ`^)7Q>^$GA;6;V]\=_`J\\%6 M'Q+TBZ\.^(M(AT6Z^(7AE_&'A/[!JFKZ78Z9XDM=4\/)]N&H^&KK5M,MY=^G MW%Y'J5O=6D'YA:E^SU\6M6T/XV_`ZV\">.-'7X_?MR_`7]J[1OB#/)HT>A>" M?A5HGC#]FSXK>--#UW5]+U6^ATSQS\.KOX(Z[\*M`\&V9N7U5;[P)JWA^\N_ M"X\0:AX;^E/V>O!/C71/VZ/^"@_C?7/!_B71?!_Q#;]E)_`OBC4])NK70?%O M_"$_"/6_#_BX>']1D417W]@:U=0:??<1;Y9!):?:;" MY/B#\,-5O]9\+1>,?B+X"DN]3\/>(?"U]%XI^%'C[Q)\,?'6F7&A^*=,T;7; M-]%\:^$M?TZ;;+>?8?MMGY]C<6UQ-ZI7PI_P3P\*>+O!?P*\;Z-XV\)>) MO!>L7O[6O[M97D5KJ-I>6EO]UT`%%%%`!1110`5YY\4OBAX6^#_@S4O''BX: M_$_!7@_2]:\4>*-=U.[E2*TTS M1M+NYQ&L][<_9M.L[V\MO0Z\4_:!^*U]\&/AIJGCO2OA1\4OC3JUC?:7I^E^ M`?@_X4A\7^,]0O-7NQ8"_BTRYU31;:'1]&AEFU+7[Z74[:2'2K>XAL$O=3N; M+3[L`\H\%_MT?L^_$7P5H/B[P5K'C#7-3\0>.O&7PPA^&!^&_CG1OC7I7Q%^ M&]M+?_$CP9XG^$'B+1-'\=^%=<\!:9"-4\21>(=(TZU@TV^T"]L+O48O%?A3 M^V_19/VGO@D)OV>(K7QE_:L/[5.M:AX?^!VI:+H7B/5]$\7ZKI?P[\4_%6^M M+C7K#29M'\+S1>!_!?B;58X/%E[H=S=7&D7FD6L$^L036,?YT?"+0]=3XE_! MO]K#1/V+3=9 MUJQ#V8TCPCXW^/G@WXLW^OF=_##ZAJ?C71K77-)MK^/0-$B\1?I>,```8```'H!T M]^GKSZT`+1110`4444`%'^?SZ44$X]3R!Q[G'Y#J?:@#X]TG]NO]G/4OB_=? M!6]\1^*_"7B1M*\>ZUX8\2^/_AE\1_`'PJ^)&G?"F$7/Q1G^%OQ@\7^&-'^& MOQ#_`.%?6>_4_$J>&?$M\\6A6VH>(].&I>'=*U35;/T/P%^TQ\*?B+::_=:% MJ.OV\N@>"-+^*#:3K'@_Q1I7B+6?AAK\>K2^&_B%X9\,W&EGQ!XC\,>(AH>J MPZ3-I.FW.IR7UFVEW6EV>J36UE/^;7QOU'5OVW->^*WP,E_9=_:S^'.KZE\% M/VJ?@7\%OBQ\2OA'H7@_X*^`]:^)'PL\6>`=5^,NI>+W\;ZEK,=/%EX2\ M`VNF^$1X@TOPMXEUAKK3K>X\2:NGA[Z!^''@_P"(OC+X]V?[1/B'X;>+/A=H M/PY_8EO?@+=^"-8M8)M]ZI^V)\'K7]G_`.&_[2OA^V^*7Q%^''Q> M\)^&/'/PXM?A3\%OBI\3OB!XH\*^+?#T/BW2M9MOAEX+\*:OXZL;5/#4Z:KJ M7]KZ)ITFE[X=-O4BUJZL],N?;?AA\3/`WQG^'/@7XM?#+Q%:>+?AY\2O">@^ M./!7B6QBO+>VUOPQXFTVWU;1=22UU&VLM2LFN;&ZA>:PU.RLM2L)C)9ZA9VM MY!/;Q_G7^S=X>\7>`O\`@F3^QQ\`/B!X,_:5\"^-=3_9<^%GP-\;77P?3 MOBK\&_%OASX26&C:Y?7&JQRS3^#;ZSUG1+K2-$\7V]CJVDVVKW&FWDMU;:7< MIJJ?7G['?@;XL?#+]ESX"_#SXXZYIOB/XJ^"OA=X3\,>,]:TNPTC3(;_`%/1 M--CT^&6YLO#UO:>'(M7338+"'7W\-VEKX=N->BU*ZT*V@TJ>TB4`^DZ***`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`88 MXR=Q1"V<[BJDY'0YQG(IV!DG`R>IQR<=,GVI:*`$VJ,X`&N#VS[4N`,X`&>OO\`6BB@`HHHH`****`" MBBB@`IJQHIRJ(IQC*J`<>F0!QP*=10`FU<;=J[3U7`P<]>.G-&U2,$`@8P,# M`QTXZ<=O2EHH`****`"BOC_]M']I[7_V4_AY\//&WA[X=Z1\2[[X@?M#_L]? ML]6VB:QXYO/`%KI^J_M%?%KPO\'O#GB2?6K/P3X\EFT_P]X@\6:?J>M6$>C" MYN-'@O#83M?+!;3X/AK]L_2M*_:(\=_LP_'[PE9?!3X@^%_@K/\`M(>&/%%_&GAC0 MI=+T_P`4^%?$.AZIXCT;4[RYTH`^WJ*^7]0_;._9AT_Q%\$?"W_"Y_`=_K'[ M0_CSQK\-/A3#I7B+2]0A\1>-/AUX>U3Q%XUT%KF&Z\FPU+P['IL>C:CIMXT6 MJ0^)M8T'P]]@.I:M;0GV3P[\4OAQXN\2>(/!_A?QUX3\0>*_"D<,_B3PYH^O MZ7J&MZ+;W%]?:7#=:CIEKJ:2MXT7V7^UM+U/2S,-0TZ\MH`#O M*8T:,F64$X],D4^B@!,#.<#(&`<#('IGT]J``"2``3U(`R?J>]+10`@ M`484`#).``!D]3QW/>EHHH`****`"BBB@`I&56&&4,/1@"/R-+10`T(@&T(H M7.=H48SZXQC-*0"02`2#D$@$@^H]#]*6B@!GEINW;$W9SNVC=GUSC.?>GT44 M`%%%%`!1110`4444`,$:`[@B!N>0H!YZ\@9Y[TX*H!```.20``"3U)]<]Z6B M@!NQ,`;5POW1M&!]!C`_"G444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'PA_P4%_9^^*W[1WPM^%' MA3X0Q>!I?$7@']K#]D_]H/44^('BG6?"6C7GA[]G'X[^"OC1J^A6FI:%X-\< M7HUSQ1;>#V\/:.TNC+I]G=Z@FH:A=+;6SP3?-OQX_8M_:5^-_P`3_BO^T]J- MS\"+?XJ:5^S'J7[-7[-'P/UTZAXZ^%>BZ'X[^*/P\^*OQH\9?%/QKXI^'DMO MK?CSQS-\-_"OAOX?Q0?"/6O!GPH;PY8>(]4TSXDW>IWUE8?L#10!^)OPQ_8/ M_:1\"_''PC\9;I/AK>6^D?\`!0CXK?M.W?AV?XN^.]>UF+X7?';]B?2?V;?$ M22^,->^'$MUJGC_P)XVM;KQ!;:-+9Q:#XLT.3;8>(/"7DVFECUW_`()Z_L8? M$K]F631=/^+_`(.^#&K>(O@]\-=?^!/@/]H3PE\1OBOXR^(OQ<^&%_XXT_Q9 MI5[XD\#>/=&L?#_P+N+^+1-%UGXC^"_!WB7XA:'XI^)JWGB?1-6\/:/#!IU] M^JM%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`45SGB_P`8^$OA M_P"&M9\9^._%'AWP7X0\.V4FI>(/%/BW7-+\-^'-#TZ)D66_UC7=:N['2M,L MHFD19+J^NX($9T#2`LH/S>?V]?V'02#^V1^RH"."#^T5\&\@^A_XK6@#ZSHK M\\?CU_P54_8(^`/P6^*7QKUO]J/X$^,],^%O@;Q%XVNO!_PX^,WPJ\7^/?%? M]A6$EU;^&O!WAO3?&,ESK'B77[L6^DZ-9YA@DOKN%KNYMK5)KB/^;W_@GK_P M>`>`/VJ/VO/"_P"S]^T1^S?X=_9J^&WQ4UJ[\/\`@+XP+\:8_$6F>"M<:*YG M\/V'Q8/B7PMX.TBVT37O(&FS^,=&O[.UT'69]/2]T2YT>[N]8TD`_M0HKY+' M[>_[#A`/_#9'[*HR`>?VBO@V#R,\C_A->#ZCM6YX:_;1_8_\9^(=%\)>$/VJ MOV;O%/BGQ)J5KHWA[PUX<^.WPJUW7]=U>]?R[/2]&T;2O%MWJ6J:C=R?);6- MA:W%U._RQ1.W%`'TQ12$@#/4<8QCG/``)(')(`YQSUKX)\)?M;?$OXV>$/C7 M\3/V;O@WH/Q$\!?"CXA?%GX4>$F\4_$2[\%ZY\<_&GP1U^_\#_$B?P$+#P3X MLT;1O">F?$?0?%/@/PQK?B._-UXTUSPOJUW'IGAWPU/HGB#6`#[WHKS+6OBQ MX(T[6KGP7;>*_"DOQ&DT76=3T;P3J.OV^EZOJDVCZ+'KEQ:"T,=SJ2/:Z?=: M?J&K06NGWNIZ5I%];ZM/IS6(];715?P[H&J>([+0G\4ZK:: M193W5Q8K*?4=-L]";Q3=7=CONUCNH[?PLDGB>98)'E3PW%+KYC_`+'BDO5Y[P5^T?\` ML_\`Q(.JCX??&SX4^-AHG@_0_B#JS^%?'_A;7H]/\!^)K2:^\/>-;J73=4N( MHO"6MVEO<7&F>(R_]CWD=O,8;QFB=0`>TT5P_A_XE>`/%>@:OXI\-^,?#FM^ M'_#]WK&GZ_JVG:M9W%GH6H>'T\W7=/UN19@7WQ8^'=AK'@7P]XC\6^,;"_P#&&@V,WAKPMX-E M2W\9>)-8^UWT"66@^#KB2*V\7:M*PL?"US/;VVOSZ=<7$,4G!7_[9?[)6EZ6 MVM:E^TM\"K'2DTK5=>.H7?Q3\&06IT#0CX9&MZ^DTFKJLF@Z-_PFGA)M6UN/ M?I>FIXDT62\NX8]0MG<`^EJ*\OU/XV?"'1M8\+>']5^)O@6PUGQNVA)X0T^Z M\4Z+%/XDD\4F5?"L6C[KSR[Z;Q4]O<1^%XH7:3Q++;7,6A+J$L$R)SL'[37[ M/%Y)XEAL/C?\*M3F\'7UQI7BB'2O'?AS5)M!U>U\62^`[C1=3AT_4+F2VUR' MQQ#+X-DT1E.K#Q2C>'Q9'5L6A`/#WC\3Z5)X:U+X4>"-4TW1=8\9MXDBNSI?]C17^H7,OG07,K+IW MAWQ7J,XM[;P_?2)VL/[0/PATWP]\.=6\4?%KX5V+?$CP_P"#]9\,:E9>-=*; MPSXJA\:)I]OX=U7PEJ][G^#M7E:*#Q%-6O[17P#OO'-O\,K'XT_"N]^(=UXH\0>![?P39^/?#%SXIE\:^$]% MM?$?B;P^/?!?@G^UOM/]E_\)=XJT'PU_:7V+R/MGV#^V]0L M?MGV3[5;?:?LWF^1]H@\W9YL>X`[:BO%/^&D_P!G?_HO/P8_\.GX$_\`E_7Y MO?\`!0/_`(*KZ3^R@?A3_P`*9T[X4?'O_A.SXT'B+[#\3X)/^$6'AP>&SI9E M_P"$1A\0X_MDZQ?!/M_V0'^SF^S&"=)\)7^@WM]\3HXU\2W&OW^O6NHVL9\6VWAZ(G2HM+LIF^Q M27,@^WK]H6)3"9/TU_X:3_9W_P"B\_!C_P`.GX$_^7]`'M=%<+X0^)_PV^(, MM_!X#^(/@CQM/I<=O-JBZC?/:1W+V\Z6[W"QK M,\$RQ%C$X7S3]JK]H;PW^RI\!_'/QY\7V\4WAKP,WA5-8N;R_;2-$T2T\5^- MO#?@D^*_%VN+8ZHWASP%X.D\2Q^*_B#XH&F:B/#'@G1M?U]K"\&GFWD`/H6B MOCN?]I?Q9X2^#?[0OQL\>_#S0]3\"_!CX9:C\7?`WBKX1^.X_B!H'QZ\":3\ M++OXD7FJ>!KF70=(&GWDMUI]_P"&[+3I)MU_QE'X#U_QOI7AVY\-?\)-HMZ=+U6[MK_38V`/L>BOR._9<_P"" MHMU\==7_`&0;#QU\#H?AW:?MKZG^UIX<^$U[X5^)?_"Q7T+Q3^R+XB\4Z7XO MT[XA6&I>!/A_=Z1I/BS0O!7B'Q!X8\3:$?$.GV=^FG^%/$5OI>H:OH]]J/TA MX[_:_GT?]KGX??LH>"-*^#NK>(-:TVQ\0>.4^)?QKU[X2_$*W\.WT5[J4M[\ M#/AW/\&_%>E?M"ZAH&@Z;CG5IDMKR\N].`/N&BO@9 M?V^_`&F>%O#7Q6\7Z!>>'_@=\1+/XYZC\-?B';Z@^KW^O:=\!/"7CCXA>(=1 MUOPJFDV4F@V?B_X=_#+Q_P".?A\UGK&OS:IH.@1Q>((?#>LZI9Z97L?PP_:$ MG\7>/K#X6^./!DGP]\?:_P#"#1/CGX;T+^W5\2+=^!-5UQ/#FJ6.J7L6D:1% MIOC3P5K5[H-CXQT>U35=#@;Q-HTN@>)M>B;4#8`'TM1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`')>//`'@/XI^$/$'P]^)W@GPC\1 MO`/BS3I='\5>!_'GAO1O%_A#Q-I,[(\^E^(/#7B"RU#1=9TZ9XHGELM1LKFV MD:-&>(E%(^2#_P`$PO\`@FH22?\`@GE^PT23DD_LE_`,DD]23_P@')-?!O%^F6 M.O:=<:9_M5Z%X:;5G^'WP<^.7A7X&UU-EU>_P##E]=VNGK9?U844`?# M0_X)@_\`!-,``?\`!/+]AK`&!_QB7\`ST]SX`R?QKH_"'_!/+]@'X>^*O#WC MKP#^PW^Q[X'\;^$=7L_$'A/QCX0_9F^"WAKQ5X8U[3I/-T_6_#WB'1?!-EJ^ MBZO82_O+/4M-O+:]M9/G@F1N:^PJ*`&E01C@8P1QP"I!7@$<`@<9'IFO@/\` M9-_9T^*_[(VD?$3X&>%8/`7BGX%:K\:OC;\7?A)XGN-=U;0_%_@'2?C[\1_$ M7QE\6?#WQ?X/7PSJ%CXJ7PA\1?''C$>#?%6C^,--DUWPA=:)HOB#1]!U30[C M7->^_J*`/RI^'/[%OQ,\"_M)_%SQYX@\)_!3XF^"M1^-OQ3_`&C_`((?$[Q# MX_\`BE:?%[P#XN^+/PWO/!NN?#^3X9S>'-7^&.F/I<^KZ]X+O@A\3/@?X&_9]_9-U7P_^SSXI\5Q_P#!.'X9 M_L9?'&Q\??%_]I#X;^'/C#X_$ZW_:G^'>L>-/B;\3'^,'P+^+6N_`C1OA MKKWPPB\"V?A?4/A-K1T&_M-1TKPE\<--U_2]6T#P/X@UWPO=?#OQ!-!#J6J? M-MW_`,$K_P!HS4O@7\"/A%%XU^$7A34_A)_P3#MOV.-0UW3M:\;ZOH>J?&GP MK\4/@!\3/"^MRZ)8^%O"&JZM\'?$$_P+N=!\921ZWX<\K^"=$^'^IZQKOQ1^(GAGP3XK\8ZWJ?AO0[+2XK^[\(Z*=&\/Z?H/ MAZ/^U/[&_M*YYO\`8G^"GQK_`&8/@+\(_P!E;Q.W@/Q7X*_9[\(>'/A-\/?B MSI>M:K9:WXM^$GP\2+P_\.O^$I^',OAF&WT#XB6O@73=%T#Q7-IGC/6O#.I: MW977B[2I;6'5!X0TS[DHH`_%Z_\`^">7QGUOX(_#_P""^M:U\.;_`%3]G31/ MVQ]$^%'Q3EUC7DUOXK6'[1WPK^,?PI\(67Q+T]/"YD\'"UTWXM6GB7XPW-E> M>.U\5^.OA[X?\4:';2'5)++0J@\#?$#X6?M5_P#!-KX51>&?AMXO\<@$=3CGU&<$\<$C([=30!^*WAC_@FA M\2?!OP6^)7[*,/C+PEXJ^#GQ:\#_`+(^D1_$>_N-9T;XC?"+Q%^S?X&^%/P\ MU<^$_#T>FZC9ZSHQM/A!X<\>_!GR_%6@R_#SQSJ6KVVHV=WI=G9:A>>J>$OV M3_VB_`/PH\7^'-&L/@;K'BCQ'_P44^*O[5DMAJVOZU]FG^$?Q3^-/B?XER:9 MX?\`&UU\+]5O_AU\9]!TWQ%:V$/B?1_"FL/;?V9JFG^&?%V@7NO6/BSP]^JU M%`'XF?`G_@GG^T!\%[CP+(=:^&'BCPQ\=/^">W[.G[&_Q'O;K7_$EV/A-XZ^!7PR\9 M?"C4/'OP\MKCP?:R^-?!?B#2?&+>./#FAWLG@77O#/Q#T"*\>6:W\6ZAJ/AC M]MZ*`/Q\NOV%?CN/%'B#6;#4/AHMOJ?_``58^'7[IIU%`!1110`5YUX]^$'PE^*O]E_\`"T/A=\.OB1_8?VS^ MQ/\`A/?!/AKQA_8_]H_9O[0_LO\`X2'3-1_L_P"W_8[3[9]D\G[5]EMO/W^1 M%M]%HH`^=O\`AD']DS_HU[]G;_PR?PU_^9FOAS]LO_@D9\%OVHC\._\`A7MW MX+_9E_X0D^*3JW_"L_@OX.3_`(3/_A(1H0L1K/\`9%]X1R-`_LBZ-AY_V_G5 MKOROLWS^?^ME%`'Y!?L;?\$?_@Y^R_JWC[4?B#K'A']IB#QEIWARQTO3_B7\ M%_"#V_A"70[O6+F\O=(_M;4O%RB;6TU.WM[WR(K%O+TVV\R2X&Q(?O3_`(9! M_9,_Z->_9V_\,G\-?_F9KZ)HH`\U\!?!GX/_``KGU.Y^&'PH^&OPXN=:BM(- M8N/`7@7POX/GU:"P>>6QAU.7P]I>G27\5E)=74EI'=-*EN]S.\(1II"U/XS: M;\2-7\$2:?\`"ZS\!:KK]SXA\(QZQH/Q,DOH/!WB7P`_B;2X_B5X;U"ZTW0? M$]U:7FN^`G\0:=HET=!U6SAUN?3VU2SFTO[;&WJU%`'X87?_``35^*_PWT5[ M']EO2/A/\*O@WJO[8WPF_:$\9?L*7/CWQ?I/[/'B;X=>&OAYXV\-_%;P#H^I M:'X&UC2/A]9_$KXCZ_X'^,MS\,O#?PVE^$-]XF^$^DV6KZ=&GCGQ9-%],_LC M?LV_M'_LQ:W_`,*VO-+^"'C;X#^&+'5=/^#/C:Y\=>/'^,WP@^$,MW>>(O"7 M[)UKH&H_#J31?&'@SX<:_&/C/=_$#P]K6L^`]&\.:=XG^%]QJWA?1[J MOTVHH`_-W_@F]^Q`/V1O@/X'\,_%#P?\(=1^/?A/4?C?:7/Q2\#6\FO7MUX/ M^+'QU\=_&2'0M.\7>(O"7ACQ58V.SQ9I%AXCTB.SMM/U'6/#EM?2-?PVVF26 M_M?Q>^#WC_XZ>,/"6@>-O#_PLT_X4_#3XU?"7XX>"?&5GKOB37OBH_B'X2ZS MI'C#2;&U\,W_`(,TKP[X"N]1\0V=_P"&]<\5:3XY\3S:O\-]5U[PY_8-G/XF MO)]-^MZ*`/RNO/\`@G4_B_X3_#W]FCQOKN@0_`GX+Z)^T9X>^'MWH,4USXQU MG2?C?\,?BG\$_"T.NZ3J.BVVA^';CX7?"SXR^,]'>YTO5M='C;Q!;:'X@$'A M.UBO-$E^E_A9\"?'%M\8='^.GQ=U'PG<^-_"?[/^E?L^Z!;^"9-2N-*O;";Q M3IWC'Q_XWO9-9TG2[W2KCQOK/AKP7_9_@R!M6M?"5IH%Q'+XH\2SZH)K#ZZH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***3(] M_P`C_A0`M%)D>_\`WRW^%>8^"OB_X&^('BWXE>"O#.I_;==^%6O6/A[Q7;E` MJ17U_IL5^CV;!V:YMH+C[;H]U-LC\G6-*U*R*GR%DD`/3Z*3(]_R/^%&1[_D M?\*`%HIKML1WVEMJLVU=H)V@G`W%5R<8&2!D\D#)'QAX!_;J^#_Q%T/]J.ZT M/2/'=KXT_8\\1>*O#OQM^$VM:5X?TOXC:0?#6EW^N66OZ'9R^*7\,^)/!OC7 M1])UBZ\">,=-\4MX=\07FA^(?#[7]CXH\-^(=$TH`^T:*^>/BU^T]\+/@7\/ M_AU\2/BS>ZEX,\/_`!,^('PA^&6BK?64-]:AI M6E:;9ZMKEH?$FOMJ+_B M/\3M+\<^(/"7@WPX_AVUU"]\,_#0^%8_'7B&74/%GB'PQH,%CH%UXX\(:?); MG5FU*\OO$-@MG8S6<.J7VG`'L]%?#*?MX>";GQU^SQ\-=.^$'QWOO&W[2OPK M^*7Q<\$Z!-X;\!^'M0T'P[\%M7\%:'\2M.\>6WB_XE>')O#?B7PWJ7Q#\(P- MHT2ZHVHMJK+I5S>OI^I+:^W_``)_:.^%G[1'A#Q)XN^'NK:@J^!/&WB?X9?$ MKPWXJT74?"/C'X9?$CP4UJ?%?@?Q]X9UR*VO_#VNZ/;7VG:LIE\_2M9\-:MH MGBWPYJFL^%M=T?6;X`]WHKY:\!?MF_L\?$']F?6/VO-/\=PZ%\!/#>F?$O6/ M%'C+Q;8WOAX^%]/^$/B3Q-X5\?R^(-(NHGU;3KC0M7\(ZU#)ILEFVJS^7;1V M]C)#_'W@SXC?""]_:'.HVGP3O?B5HVB:99>./$>E M^$[CQ[/X%N$T3Q)X@U#P/\1)_`^G:WXLT[P-\0;'POKVJ:3X=\26]C;S:]X< MUW1-.`/JFBO!_B;^T)X,^&WCWX(?#&DZCXB\1ZYIUO=>(?%/AOPQH< M.L>(M;L-+FZ;X9_%*W^(]EXON)_!OCGX?7O@GQOK'@36M(^(>DZ=H]\^H:19 M:/J0U?2KC2]9US2=8\,:M8ZY876A:_I^IS6FJ0N[QB-D*``]2HIGF(.IQG&, M@C))P!T^]GC;U!X(S2[UZ@Y&[;P"?F].GKP?1OE^]Q0`ZBHFGA1/->5$CX_> M.P5/F957YVPN'9E5#G#LRA,_$]GXPU;0?!^I:AIEQKFJ:#X)U73-,U MO7K.'2[R^@FTNU7Q!X7NKN99]VFCQ-HUCJ26FIW#64?9))')NV.K[&*-M.=K MJ<,C8Z.IX=#\RG`8#(H`?1110`444$X]?R)_E0`44F1[_D?\*\\^(OQ$L?AO MIEEJ^IZ1J^I6%W>?89)M*2S?['.\32V_VI;NYMBL=SYCZSIUAI]U'9"YU2.S5+NZ:+SIHK7['-%W,'">D9'O^1_PH`6BC.?7\01_.O#_VCOCOX>_9F^#7CCXX^+O" M_CKQ;X1^'>E-K_BG3?AQHECXF\76WA^WFBCU+5M,\-76L:->>(CID4HN9=%T M"34?$VHQJUOH&B:QJ+0V$P![A17@FD_M&_#WQ3=_`J3P(][\0O"7[0_A[5?% M?P\^(W@ZY\.ZCX&N?#FF>'+/Q7'K%WJ%UK]AJDEEJVC7]M-I4FC:-K#2S.UO M>)8R1R!;>E?M$_"K6?V@_&O[,-EKTA^+_@'X6^"?C%K^@S6-S!;?\(3X[\0^ M*?#.EW6FZE*JVNJ7NG:EX7SXCL+)I9M`M?$?@^XU$Q+XFTY7`/<**^5(?VMO M!FI>(;S3/#'@OXC^,O#6E?'B/]F_7_B#X5T?0=3\+^&_BG'?V^CZSI^OV3^) M[;QAIWA_PWKUW;Z!KOBM_"SZ+;:NXAMY[JRD@U"7Q6W_`."F/P0A\$?&/XK> M*?!'QG\#_"#]G_XX^//@%\8_BKKWA/PQJOA+P#XN^&7B./PIXY\0>(+;P-XY M\8>+['X;>&-8N+0Z[\1YO"J^%M$T>:7Q+K-YIWAO3-9U73`#]%:*\)^.'[2' MPE_9X\*>#/&_Q/\`$7]D>&/'GQ.^%GPE\/ZQ:6LFI6,GBGXP>+M)\&>#Y[VZ MM2UMIWATZIK-G9)\4?C_X,^&'C'X:_#.>TUOQ M9\5/B^_BR3X=_#?PI;Z?/XAUS2/`.GV.I^._%-W=:SJ>B>'O#G@[P;!J^A6^ MO^)_$6M:;IT6K^(_#/AO3VU+Q-XDT+1M0`//_@OXRC\!_%OX;>*[6UT_QIX`\17WA_2O%^@C5;.PO]4TS4M"\6>#]'-6UKPQXET:^+:;JLFH:?K&GZ;\QP_P#!2;X+PV'QH\3>(O!'Q@\( M?#C]GO\`:&G_`&9?B]\4]<\/^#;OP7X-^)$%YX)L)+K4H/#'Q`\1>-5\#17/ MQ&\&&^\>+X./AW1K36&U#7;K3-/TK6[K30#]#:*R;;4;J:_U6VN=)NK"QL/L M?V/5[BYTU[35Q/!)+>&U@M[R:_M5TR5/LURVI6MDLTC>;9&YME>89U_XU\)Z M7XA\->$]0\0:5:>)/&5OKEWX6T2:\B74]>M/#-K97OB"[TRTR9;JTT>VU+3I M=0NHU-O:C4+%99%>\MEE`.GHJ,31-O(D0B,E9"&!\M@`65_[K*I#.K8**0S` M`@GPVZ_:`\)VG[2'AW]F632/$A\7^)O@=XO^/6F^)%AT<^#'\+>"_'_@;X=Z MMH[78U@ZZ/$AU?X@:%?6T/\`8(T>?27FEBUF2\C-DH![M132Z@@$X)(`!!!) M()`''/`).,X"L3@*V,_4]4BTVQU&\$$]_+INGW6H-IUB;;[?7 M-G:K-=-`]O:O=W5K:M/\LMS#&LDD8!I45X[\`OC9X7_:'^!GP:^/OA*RUG1? M"GQN^&?@;XI>%M*\3Q6%KXCL=$\?^&[#Q1H^G:U;:9?ZIIT6MV]AJ$46H6NG M:GJ5K'=Q3I:7MY`BW#^O&6,,$+C>5W!!RQ0%07"C)**64,X&U2P#$9%`$E%- M#*>A'7'OD>W7N/S'J*=0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!S_BKPW8^+_#NK^&=2NM M8LK'6;.2QNKK0-:U/P[K,$4C*QDT[6]&N;/5--N04`2ZLKF&=`6"N`Q!^?#^ MR3\.R2?^$Q^///I^T'\7L?\`J65]1T4`?(/B7]DGP[_PC^MCPAXS^,B>*FTJ M_7PY+KO[0WQH31H-;>VD33+G5/L7B2ZNGL;:\:*XN8K>"26>.(P*!YA9?C+X M,_\`!.WXR^!/B):>(O%_Q1TG4/#6JO>0^.(?!'CGXH^#/%>MP7:7%REZNNZ/ M!I=S>7MKK3PZL;;4KUK6]E^TBX=99A.O[%T4`?+G_#)/P[[^,?CS_P")!_%[ M_P":RMGP]^S)X%\-:]H_B&Q\5?&>ZO=$U&VU*UMM9^-_Q0UO29Y[5]\<6I:/ MJ?B6YT[4[-SQ/97UO-:SK\LL3+Q7T510`UQN1E'4J0,^X(YZFOQ5^.?['WQH M^(OPS^)_QF^!/AO_`(5[^UWX.\6_M<^&_!VD>/+VST'PM^TC^SQ\;/%_BK6] M0^!WQ&U70+_5/LWA7Q6FKZ=X\^$_B;52NL?![XP:9IVMW&EV?A[7/B1X>\3_ M`+648`Z#%`'YF?M)?LM^*/VQ/#OQ<^!/C#5OB#\)OAA8?L^WGP&UT>QMO"OQD\-26`O'/QPUCX'_LD?ME_"OXZ?$[PG#\*K'4W\9_&GQU^S;`]2\&>,5_9G^`O@_X(>`/@AI.M^-;O5M1D\) MZ[X_\9>#OA,DGCB/P1#XXTC1/$WQ(TW1]/?Q9X>\%ZEXINOV(P#U`/X4M`'\ M_GQ,_8!^/_C;P;_P5&_8CL;CQ!/\)?VN?#_A;]I+X(?M`>(+/P/H?@GP]^U# MK,.D2?%WX2^(O#W@:_LO%6E^#O$GC3X4_#7XDWNKZ7X`?2;X_$KXI0?;]6\2 M63VNK^^?$_6?^&ZOC[^RI\$]3\,>*?@9X_\`V.?VA?AI^V;\/\`8?`SG`SZ]ZHW.F:=>3V=U=V%G=7.GS-<6$]S:P3S65PZ M;'GLY)8W>UF=/E>6W:.1U`5F*C%`'YV?%SX._$?P'_P4"^$'[:GA3PEKWQ2\ M"2?LM_$G]DWXH>$_"UYI2>+?A^NN_%3P'\8O`_Q5T'P]K.IZ;!XPT&YU#PMK MO@OQ_H^A72^+[#[=X+UW2=)\1:98:Y%I/6?M%^'?B7XO^('[,OC9_A=J7Q`^ M`VA^+/B5I_QQ^#,?A^-&^&OQ.U7P3J.HIH?C'3?`GB*WU?2]8 M\&&]UG6+"R\=V?C2PT:]U;PD]KIOWH0",$`@]01D'\#00",$`CT(X_*@#^83 MXC?L'_M6KX"_:(\/V?PM\<>/?$J?L(>%_`O[-FLW/C?PUJVN>$?BSX4_;2_: M,^+7P4\$Z+XLUWQG876D?$7X!?`_Q]\'?#5I\5);JSL;<^$KG3]"\=:E<:8T M-QZG^TK\-/&GPZUWXNSWWPIU[PS\$_'?_!6[_@E_X]^#/A73#X8TK3/%FE^) M)OV?O`OQKE\/^'-,\1VZZ9>^)?'^C^-%\::=XEAT$^+K[4+_`%J6/6!XBEOK M[^BC`]!^5%]-_LCQ%!X8Y7X5_LP_M,?# MWQ]^R))KGA[Q1\2=3^%5E\+?"_CV3XKOX<\:^"M)^&VG>(OC)J_A_P`1_#7X MO:?XJMOB=X2^.O[/W@3Q?H?PZ\>_VK9^*_`7[1L,.DV8\/7FJG4?B3X?_=(@ M$8(!'H1D=<]/KS]:,#.<#/KCG\Z`/YTO@M^Q=^T5H6J?LS>)YO@S<>"/B=X7 M^!__``5P^#6B?$G7O^$&UW6/@1XW_:#_`&F]%^,'[*OCC6M4M/$FK:Q'X0@\ M#VOB&2QN_!]SXCU?PQJ6K3>&+_1]-O-7ND7[U_X)P_";QOX+T#Q!XS^)7PO^ M/OPC^)?B'P!\'/`GQ.\-?&+QW\%/$OAO5O'?PLT76]+U?Q5\.+#X&O-H&M:? MJC?$'XHZ3;>%U\4Z/#-X8MX[/\`3C`]!QTXZ4H`'0`9.3CN M?7ZT`%%%%`!7+>)/"6G>*?L?V^\UZT^Q>?Y7]B>(=8T'S/M'E;_M/]E7=K]J MV^2OE>?O\G=)Y>WS'SU-%`'EW_"I?#W_`$%_'?\`X<+Q?_\`+6LK7/@CX:UG M2;_37U3Q>[7-O(MN=0\9^)=3M(;Q5+6=S-87NHS6MR+:Y$)-)LKG4'1#?7<.GV-_!;6RW M%P'=42,,$V!V=P6.U_PJ7P]_T%_'?_APO%__`,M:]1HH`Y3PWX/TWPO)=R6% M[X@NFO$A20:UXCUG7400-(RFW35;RY6V9C*PE:$(TJJBR%A&@'CO[6.B^*/$ M7P&\;:-X,\-:UXN\37S^%ETK0?#[:='JMW):^,_#FI7$MM/J^I:/IT'V&RL; MJ^DEN=2M2%M]EN9;IX()/HVB@#\J?"W[*GQ+_9V_:ML?&'P@TC_A(OV.-6T[ MX_?&QOA%::A:VOBSX)_M">.M*TI_$WA;X1Z9K.HZ=IC_``K_`&@]3O=>\=7/ M@Z2YTVU^&7QGC\2ZCIMW;>$/B7+8^%/,?&7P"_:3\'?%W]C']M3PAI/Q&^)' MQ%MOB-XZ\-?M%?`VUTOX/>&=0\*_`/\`:OT:SU/XLZ=-XA_M/0W\4I^S]\1? M`7P5UWP]ILWC7Q9?:YI'@'4=/\,0:S?ZS;3K^TE&!Z"@#\;=8_9F\<2?M6Z7 M^TK\"OAW\8OV8OCEKG[1>F:9^T9!HGBW0;[]ES]K/]FWPOXQD\*7/Q&^*_@& M/Q7KOAF3XJWOP6T^TO?ACXQTGPQX5^/OA_QPNB>'O%-SJ7P\M[N2'POPK\!/ MVL+C]DS_`(*F<+?B M;X%^#WPQ_90T?]F;PWX\D\+?#7Q+?_%BY\1>`-'TO7?B9H"_!4>DW30^$]7A\51Z]?:3>:C8W&G:Q%Y9X"\)_M3VWC3]B;_@H1\<_@ MSXWL_BI\*?V,OC9^RU^V'\%-%;2?&OQ!L]6\6ZS\'?B++\:_@_X8^'^L^)]) M^(]IJWCGX'3F?P-X9U6[^(&H>%/B)I":-H^L>*?"5[X6N_VUI,#&,#'I@8_* M@#\QOV%/"FE_$GXQ?M;_`+?7AS78)_!_[8\7[/WAKX=>%BE]::_H/@']G'P' MXD\,6FJ?$30M2@LM2\#?$WQ#XS\>>-X?$?PYUBP@\2^!M'T'PUHOB]-/\6C7 M?#NA?F;XR_8M_:9\5?#O_@HSX;\+_`[XT:5\;OC/_P`%"O%'[2W[+&OZ_P#% M;PO:?LT7%E:-\!A\,?'_`,+_`NC>(_A]K?B3QG\.O&/P=\4 M^--=TG2=-ETKPZ/%T?A._P!(_I>MM,TZRN+RZM+&SMKK49$FO[F"V@AN+Z:. M-8HY;R>.-9;J1(D6-)+AY'6-50,%``NX'H/RH`_$CXB_`W]J:/\`:3_:L^)6 M@_#K6_$?PP\1_'S]@7QYKOA*SUC0K*W_`&A/A+\*_AOK?@_X\>&_!FE:EXI$ M<=WX9\2ZAX7\9/X1\;S>&;#XEV?@B7PM;7.O0ZV_VOB+7]B?XNZ-^U;\)_C! MX6^&4EEX#MO&/[?MI\&;K4[?PEK.J?LGZ1^T%\-/V<+KX7WDNAZIJMMJ7ACP M"WQH^&?QS^(VG^%_!KZG/\/F^)FD>&XM!TAM2N[/2/WNP.>!SP>.H]#2X''` MXZ>W&./3CCZ4`?SW?"WX"?M7>&_V?4\^ M#/%GQY\5OV0=>\?^)-1N?"'[(?BKPU\+M3_X)O?M MS>"_"OP^\9:IX%UV?PG^T'\<_CG\/_B[\.?"CZ=)\1/$VF^%O$-YK/A_Q#XL M\+6GA[5;KX>_!J9M!T30_$7A%K&QTK2OWTP.>!SG/'7/7/KGO1@>@Z8Z=O3Z M4`?S?3_LN_M9ZMHGQX^(WB'X'^-M<^.FHZW_`,$@O&WPS\2W^M>!+KQ;#XV^ M`J?"RR_:SUOPKKE]XT:'PKK6FZ%HWCWP[XJU*.\T;_A8^E7LVEZ'/XRTC5XD MN/K?1/@5\#/$&O>`?$VE_%GX2_ME_M%?%#Q;\;-.OM&NM-^.'[)GQ! MB^-M[X,^&UM<'7AJ^JIJ7@[QA\(?AE#\)_$=E86GPZ\;?"RT\8V!M=(\.^$] M?UW]BL#T'Y"C`R3@9(P3CDCT)]*`/Y^_A7^R[^T!I?[-'P$^#?QF^!/BKQ/H ML?\`P2J^%W[-6D^'=.\3^%SKG[/7[77P[TO7],\6ZX]]:^*&TSPS=>.H;_P! M-X.^-_@?4M8?P;??"`3OJVAC5]$?577]C\2Q\4;?P/\`%7PW\=_C_H'@3X^? ML8^+OB'^T1\,=8_9Z\0^%_#_`,5/@E\'OA?X1^)?P[?PKJ?[17A_XR1>!_%7 MCQ(O&'CCP;8?!'4?$OF^./B!<:1X:\76WBC2;W1/Z`B`<9`.#D9`X/J/0\FO M/'^$/PI?QX?BF_PS^'S?$UH8K8_$5O!?AD^.S;06RV<-L?%YTO\`X2(P16J+ M;1Q'4MD=NH@0+"`@`/@_]E;X#77P^^,'Q)^&MG:>'-2_9X^`OQ-\5_%3]G74 M]-O+:_O]%\5?M)66J^)?'GPYU-5M?/MY?@QJ.N^/CX8OWO[Q;SP!\:/`_AT) M9S?#YFNOTTKG_#'A+PMX)TE-`\&^&]`\)Z%%=ZA?1:-X:T;3=!TF*]U:^GU/ M5+N/3M)MK2S2ZU+4KJZU"_N%@$U[?7,]W GRAPHIC 16 g286883kii001.jpg begin 644 g286883kii001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V2BBB@`HH MILDB0Q-+*ZHB`LS,<``=S0`XG`R>E9.G^)]*U75KC3+*X$TULFYV7[IYP0#W MQ7FOC;X@RZLTFG:5(T-@#M>4'#3_`."_SK(\#75QIWBJQN8X96B=_*D*QDC: MW'Z<'\*ZXX9\CE+\76=ZDR6]]*F MG0G9/<0G8)&_N*W5C[+CW--*TZTL@.DC()I3]6;/Z`4S_A*->+;AK-X#_LS$#\AQ M7LNG^$Q;(#>:I=7$M!U2+9=:9`QQ@2(H1Q^(Q6GUFG?8GV M&[6:P@NFFMS*9(EDQNC!ZC/ M<9%;%<4K2>-/$UUXDUY?#VG3&.S$PA8@_ MZU\X)/\`LCT]LUZQ+N\E]GWMIQ]<5X#X=S_PDT`;[Y:11G^\58#]:Z\-%.\N MQE4>R&7LK:MJ<&G60VVT;BWM(_8G&X^['DFO6YF3PK8Z7X=T=$^V7C;$=QD+ M@9>5AW/M7EG@I4/C'2_,P`LVXY]@37I'BJ==.\;>'=4N"%M/GA:0]%9NF?S_ M`$K:O\2AY-DPV;-)=*\066JV4ZZ[-?6K2;;F&6)%PN#\P('3..*6[\;Z1:3% M9%NGMEE\E[Q(28$?T+?X5H:]=K9Z!>S^:$;R'$;9ZL0=H'J2:Y'PKH^GZ]X! M@M[K4[H6R@BXA6555&#$\\9'KUKEBE)A;V/!Q4S>--%^TSVL4L]Q<0 M`;HH;=V9OH,<_7I7/>$])L->\!0VUSJ=T+=0RW,"R*JH0Q;GC(['K4O@F&"' MQEXACMR6BC6%(V)R2H''-0X07-Y#4GH;\/B_1[C1QJB32>49?)$9C/FF3^X% MZDU)I'B6RUB[GLDBN+6[MP&>WNH]C[3W`[BO,;%O+URSDN)WM[3^V;@&52!L M<@8.3Q_DUZ5;:!I]IXA34Y+VXGU!X3&OG2`Y3OP`/\FE4IP@$9-FW1117.:! M7D'CKPU<^'=<&O6$9-I),)<@?ZF3.<'V)Z?E7K],FABN(7AFC62-QM9&&0P] M"*UI5'3E9'@ZF+3/$]EJ47_'E/*L\9]$)PR_5>1^%>I:/+8>)M'N-"U: M))KBQ?R9XF/)"\+(._(QR*S-6^&T!]N?^`GI^=%_\7Y&B*Z=I0C2.WI6!>>'?#U_:*/"MOJ$6I; ME\IAYJ+%R,ER_``'IS6Y\.5O+S3;K7=1E::ZU"7AV[(O``]!G/%=C4N;INU] M@Y5)7.?3P1H9NEO)K,/<$`R[798Y7'\3(#@\\U=L_#NFZ?J$VH6T,B7-QGS7 M\YCO^H)Q_A6H.E+6+G)[LNR,)?!F@K;7%M]AW0W+;I$>5F!;^]R>#[CFK.C^ M'=-T)7%A`59P`TDCEV('09)Z>U:E%#G)JS860W%%.HJ1C:***`"LG7/#MIK= MM*&S#<,@"3H<,K`Y5OP/\SZUK44TVG=`U<\(U*X6#4)K'Q+I>^[A;:US;-Y4 MK>C'C:^>N<9]ZBMK#PY>W,4$.HZG'),X14:T1CDG`Y#5ZOXR\'6_B>T#H5AO MX1^ZEQPP_NM[?RK@/`_AJ]B\=QP:A;/"U@#,X8<9'"D'N,G]*]&%6,H-IV:. M=Q:=CUK3-/BTK3+:P@YCMXP@)[X[_C5JBBO-;N=`4444`%%%%`!1110`4444 E`%%%%`!2;1NW8&[&,XYQ110`M%%%`!1110`4444`%%%%`'__V3\_ ` end XML 17 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property, Plant and Equipment (Tables)
 12 Months Ended
Dec. 31, 2013
Property, Plant and Equipment, Net [Abstract]  
Schedule of property, plant and equipment
 
 
2013
 
2012
Land
 
$
37.9

 
$
36.7

Buildings
 
258.0

 
228.4

Building and operating equipment
 
30.8

 
30.0

Leasehold improvements
 
128.2

 
78.1

Machinery and equipment
 
193.8

 
175.2

Furniture and fixtures
 
46.3

 
41.2

Computer equipment and software
 
286.1

 
239.5

Construction in progress
 
44.6

 
90.1

Subtotal
 
1,025.7

 
919.2

Less accumulated depreciation and amortization
 
432.3

 
340.8

Total
 
$
593.4

 
$
578.4

XML 18 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Divestitures (Details 2) (USD $)
In Millions, unless otherwise specified
 12 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Jan. 31, 2014
NantBioScience, Inc.
Subsequent Event
Dec. 31, 2013
Abraxis Bio Science, Inc.
Dec. 31, 2013
Abraxis Bio Science, Inc.
Subsequent Event
Feb. 14, 2014
NantBioScience, Inc.
Subsequent Event
Dec. 31, 2012
NantBioScience
Jan. 31, 2014
NantBioScience
Subsequent Event
product_candidate
Dec. 31, 2012
NantBioScience
Subsequent Event
Sale of Non-core Assets                    
Equity ownership interest in Active Biomaterials, LLC received as consideration from sale of non-core assets (as a percent)         10.00%          
Fair value of future royalty stream         $ 170.0          
Fair Value of Future Royalty Stream         90.0          
Sale of business                    
Proceeds from the sale of assets, net 0 15.8 93.2              
Impairment charges 105.4 148.0 118.0     80.0        
Aggregate collaboration agreement payments             75      
Number Of Product Candidates From Pipeline                 2  
Ownership percentage       14.00%            
Potential future investment               $ 50.0   $ 50.0
XML 19 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]  
Schedule of future minimum lease payments under non-cancelable operating leases
 
Operating
Leases
2014
$
54.5

2015
47.7

2016
39.6

2017
31.4

2018
21.4

Thereafter
44.6

Total minimum lease payments
$
239.2
EXCEL 20 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`&:?(5D@(``#LU```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,V\V.FS`4!>!]I;X#8EL% M!P.V4R6917^6[4B=/H`+-P$%,+(]T^3M:\C,:#1*,XH:J6<3%+#O/7CQK;C+ MFWW71@]D76/Z59PF\SBBOC15TV]7\<^[KS,51\[KOM*MZ6D5'\C%-^OW[Y9W MAX%<%';W;A77W@\?&7-E39UVB1FH#T\VQG;:A[]VRP9=[O26&)_/!2M-[ZGW M,S_6B-?+S[31]ZV/ONS#[6,22ZV+HT_'A6.O5:R'H6U*[4-2]M!7K[K,'CLD M8>>TQM7-X#Z$&#$[V6%\\O<&C_N^AZ.Q3471K;;^F^Y"#+9OV6]C=[^,V27G MBYQ(:3:;IJ3*E/==.('$#99TY6HBW[7)=$TZW?1/N<_TGQ8[-EW2*P<9WV\J M?&$.#I(C`\F1@^0H0'((D!P2)(<"R;$`R9'.48*@B)JBD)JBF)JBH)JBJ)JB ML)JBN)JBP)JBR,I19.4HLG(463F*K!Q%5HXB*T>1E:/(RE%DY2BR9BBR9BBR M9BBR9BBR9BBR9BBR9BBR9BBR9BBR9BBRYBBRYBBRYBBRYBBRYBBRYBBRYBBR MYBBRYBBRYBBR%BBR%BBR%BBR%BBR%BBR%BBR%BBR%BBR%BBR%BBR"A19!8JL M`D56@2*K0)%5H,@J4&05*+(*%%D%BJP215:)(JM$D56BR"I19)4HLDH4626* MK!)%5HDBJT*15:'(JE!D52BR*A19%8JL"D56A2*K0I%5H6W)6_9SX6?:MSK2U5/[P-0SQ7#_"R]KD<8<3E MUIK!A6$?2Y>?PM,TS[A[-H1"9'U#S_,\I^9BGCN&0:'+&[X:S*%Q%*FBZD1O M-HT^K?\```#__P,`4$L#!!0`!@`(````(0"U53`C]0```$P"```+``@"7W)E M;',O+G)E;',@H@0"**```@`````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````C)+/3L,P#,;O2+Q# MY/OJ;D@(H:6[3$B[(50>P"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I5!\< M8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NHLHN+ M&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&74"T\U<%J"`=[!ZH^ M^CSYLK$SO+=N5#9@NIS]NHFD++28,5\YS3$$X4UD^&'!Q0]4 M7P```/__`P!02P,$%``&``@````A`/0T>"4V`P``@C4``!H`"`%X;"]?64[C*OE7&[]_\V'[?:PCI^&]?=3[/-?[E'_',:WM(\QETV[<1=S*Z:E5%]? M46Y1,HOZ'W$D.XY$<8PBQS$*QO'L.![%<9HRN2,A=R2;.Q)R1[.YHR%W-)L[&G+'LKEC(7SN>,A=SR; M.QYRQY(I:!$$FS(.4HW5+&&<63^C8#'20@8[-0`<9R'Y6\%%9]N1EX>3EV=3QD#J! M;8@`#1%F-<1T-'"WP[1T.RT(V)^S0C"74Y5XCW*]K*\_8<7,FF%Z__<@IPQXJ#%2$98^C%H^C;$DX*`G/KAT/:\>S)>&A)`);$@%*(K`E M$:`D&G:C-[#1V6E@&+8_H3XENZLD["K%[BH%NTJQNTK!KM+LTM&P=@Q[]#)P M]++LTO2P6A(.2\&Q) M>"@)SY:$AY(([$8/L-$#VUD!.JN9E3LI7X[E+\/N7Z)=K]&W9[/>?CJ"O">8 MEFZGDI!Z;']#?4MV5TO8U9+=U1)VM68_*PT?EF;7L8:%;-F^M-"7ENU+BWW) M1K"'"&:/Z7!*]VQ;>FC+ACV'-G`.9:?!8=@(5!"!BHU`!1%HV`@T$(&&C4`# M$>C8"'00@8'-P``AZ-@0=!""@8V=`+DCV=R1D#N2S1T)N:/9W-&0.YK-'0VY M8]G2 M3!$@,U3-A.S"9BY="A:@BK$9R2;)VV_;WL"1VU$--TD$T:&[]74?`5=?7O=1 MXRBU44E\W?0^M9L-&:^34,7;Z^:_J[N_ALV&244/K=:9KV3>V$^)0<9TS.;1.]%2DN];9F#EB(T.RG3 M?=3RV^U^:R]4W"P5/NO?T4@V&[66TV2=[66=-^;+Q^E/%8?*2_RN5]NVTZE`` M+\53/U68[NCY=KM]>NR;5-M=^OX@R;=`OZ@@O4[QNQ$7Z;U7)*"3"F9QJM*W M8!Z7U5<)'6%>]3EEYC4;^K.B/_0\]/+`466RN%\NOL^GX]5L&MR.OX_O)[-@ M^6TV6RU!8M0!#?\"C>!!H$P79(IJ?QC*I@N1-:XEX:0:?#\1BT=RH6\5J)B(`WJ2X&0YG,G5`:=4:H MP\"=2JV.-$B.D@E]DR'H4*>B$$=7F%TPR7_,J#A'$=&D*@/Z(?2S)61U(Z-W M'A]I:Z+?K#T^OCAC]4'3Y-74_0^1B--R'%`4AWQ<6C+8Q!YC=9'NZ"2PM.^S MA.;U"7>OC=WG,5;G,3G'5CU%,A@;(_^OPM9=$(;E`<0BI74*$D<9R90J.U^0N&7F*#(.R#I-D3]ZUD[%11RMJ M)--G9!8@4T>13JY`VPN?LA2029\Q.=L?HN1-RN!6QG*CTN)4L:\\ZJ5S<_B, MQ3EY^5X&*_%JM:-';03;&'F3)(K$4Z*+>(/Q5DMR/:(80_<01)^!2!GO55KL M*BB<).1*\98N%ZH2"I)8FBE.S:\RV6IQV*EU(4-\A]DZ?3VJ()D^)W.]DV%& M_3"?!X\BRLH"YZ9-X5D=0=UT/J$.@]0]O]&3/&HG4&*4NI7HD,]=2IT&2HQ6 MIQD$*)3?A4XCO<.HY79`!-,4L2I-_08:#&&<7=P6K`)1WX$2(]EM#+82LMQA M4[4PA0^=P59"F#L,YI,UU!4&\>TP?%T.$:RL4T*6.XQEAT=05)80LMQE++MM MPBX+LMQE+.<^45<1Y+;+N*VQBQH1ZL$S)5W&K-LUK"0ZM#K1WV7D?F`;=2$A MN%T&+@[_NMT(:Y?#^H$'E$IXO!UDMWI2A<_3DUKQG%V/L>M6HA*?E'IX[+1@]Q?'G3RPD\/&Z-4P M[5*RK(&Z&I)C3-=,]*E,A8JLD4X-#2*,9_=(M\.Q2L38=BOAJ?6LXV=LN[W! M#@G;KGATZA53V:/5!AAK3+0Z<2A6CT@!`CVNVA M>%1]JRPU1).%UE2$!A:\?@V^YVT!OIQG3:L^H[7.?/G+#S![6E2H<)LOAC/` M-&AQD1!R.D!.:5$1^LC$R]2L@\6Y,&"8NH5PF@]P+-#BHHBL&N%4&#!FW1%9 M-<*A,&#,NH6PEP?(+"TJJ=6_3:ZA>(!M38N+=*Q:8UL/&-36S8O3/$2::5$) MHVZWU5-#A)@6E?T?O7LO"V*QA\@,&<1N(:S'$"&F!8O(\6&`?27I(7Q#1K'[ M,HD4>SVD;\@P=BLAQIYU"1@RCMWW4HQIB!S3HE(FMQ"&-$20:7&1$';6$$&F M147(?5'&U$;(-"TJ0NQ#DYKN'"'6M*A*.#\[01I'%-CI?00M2*A5W)[I6Y.U MB-;T=4[^*_\^I`BT]?YEULU_````__\#`%!+`P04``8`"````"$`WZ9UQ"X& M```L%P``&````'AL+W=OH)N+(8H]&D"SN]*NM%KMY9E@;*,Q8`%)9OY^J^F&[BJ(,WE(XJY#]>FZ M'=Q/G[XU5^NUZH>Z:_6__\_>7A]BVAK%HC\6U:ZN]_;T: M[$^'GW]Z>NOZK\.EJD8+/+3#WKZ,X^W1=8?R4C7%X'2WJ@7+J>N;8H2/_=D= M;GU5'*>'FJO+/2]RFZ)N;>GAL?\1']WI5)=5WI4O3=6.TDE?78L1^`^7^C;, MWIKR1]PU1?_UY?90=LT-7#S7UWK\/CFUK:9\_.W<=GWQ?(5S?V-!4GJ8`_5M7 M;X/QOS5]U6$&W(D\C`<]=]%=#?CF()'G973W^9,O!G;QVK4_%R M'?_JWGZMZO-EA'2'XI&RN\).\-MJ:E$#M:WR91B[YC\)8LJ5=,*5DP!H*CMW>!RR,/K8BRL932?)B[$X//7= MFP7E`7L.MT(4&WL$S^H(BL=R*(AM*="?!7QZ".@.L/IZB-F3^PI!*A4DE1"H M\05"$-F,$($27G-CP05>"SDX,B4'^9RY""OAP@F7-80@LC7"][&3?`V)-03Q M]1'?F:=8A8P;`8D#O$4J(1#_)6811F0?(O)[",02MC&B.K,4JWL;SKI0B$/, M(9609$I[Y$?<(C]2<(W/BZ#@@DA$B.<=1K!)R^I#3[JF$*'(L#U&0^,8.DB%"A*$7K4*($$$< M<(=Y^D>?"#$6PJB'T1Q1L4KZAT0LE1"HKJ5X24%D'R+R>PC$,D$LI^(,PF4J M"2N.;^*1^$J(S+\?K/*;F78.36)&SB,#+#?!`0^-5"'2D,VMV$[+A"X9UZG" MJ'K@G$<.2_0/J9X,P]F.!P[E3""1YQFC!-,6TK`N"285PYQ6"=DD51A%FT5Q M8#2R+&,"\7<^A>0$(@ZOIQZF*G1"4Z5#BTD9092U)SD8%$96!HDQ6J,4=LE),$%G=LXKL+#AB2K`=]8>)"0C3Q>48PJ2R(L![;BK#$[*:Q%D14WC+E0Q6,OXO,JIQ0D,V>$II03S)J$KA%5*,D+EP8R\VFGKBD1'(+H@,'HHJ]A)`?+4. M8:I"3S:H2IF!)"Y#-=$>5$AG*=(8`GM07Q(^V0LEE_1#L])(R^.V48$/E&:RN. MR,.=?`O)V"`IE<0D"<)#I(N9]9;)1_!&2F?''LS:QAEG6]KU[2, MM8L98T-6J`+-S11%(>V4C$)BME(!`@G8NR^%?%NPIF7*E11AJD"J1*$*R03+ M,`#$G@A(C@#,@Y>N)7\XHI#EC1+@8IFR)'ND"C1'-`B2U7BBD#!:%2N!^&QG MY`5S%3*BRY7J*I:1+5(% MFAGZY`09M2\-+8<^,@-#75V8X;8P<2D9.-_ZD*IY9EVYD^\/(;G::KMJ,-=M M?>(;^L1(NZ8*)'LY8/[J#1H#?(_.KAP#0G/&(I9P'V&.I?E%=%HF+<_T%)81 M52#%$DB0&9MA`'Q%)%4CKC5E#XJWA0"^*>BRD2SEI:6\ZFNJ_EQEU?4Z6&7W MTD+7,G@'7E;E96D*EZ73A:.[&.`*\U:3G]>X%;Z0JN]CP'P*>N&^<^_`\``/__`P!02P,$ M%``&``@````A`(7"3('>!```11,``!D```!X;"]W;W)K&ULC%A-CZ,X$+VOM/\!<1_`)B0A2C*:9-2[(^U(J]5^G&GB)*@!1T!W M9O[]EEV&4."&SJ$[J7HNGJM<#]O;SS^*W'D359W)EK M(=Z>^ROMO57;Z(RL%9!OJI"KP+.6+@GX[*1,,]D>C MGW0%_JRGYKIS MPZ47K8*0\X],$0:P\'H,AH57W@$3/JP[8A::R2+DWJ.D.EW'OC]< M!-ZZ(TJ(+`F1MN3*2@FP]:(+@/5`#!*(XM`;^(_$OUKW_(3`RDI`62D!Z+0! M`<1`PKMZ#1?$%(*04.^$1Q^V65#6V66)H"D64PC"(K:R4-9A*H;+$C%8BW#E M#=Q'XEYZJZ#_>2P<0H:!(%MRHLV4#N?#RAC05%(F(90(%;9GM YA@(#M96A6JI=WZL(CH2,YAOZ#HFL;IBZ3) M!_5W`D0)V#64C44T8@.%.AB0?9J&0RND-IVC1.Q:RE`&YSIE2BP-DRD(96(7 M5(92V%^FXU>L`6%-&+0"B_N?K@:&4ZNN:GL$;YF@CXT?[R1*SZZTS":UHRYJ MQ=16#L-I"D*(<+O(:O-L%QG4U-J9A%`F=I7E*([3%3,@4S'8"@S5C0)6T7N[ M(@[/L8B*-@_>.;TMK$[ZP8`FLZ'"OR<[-!MVF>4HCS.=9%"33#"0'4*9`,:6 M$F6F*1EW$D<0UF6Q'&T1J9^]6Q6[P*ICSX`"#Q\-9ZK2"NC[W6+B?"07=J'E M*)!S59F24>Q;$^@C3.Q*RU$@9[JE55&E6'R]]%A_-_8X+QA.!!W&WF.O1=>) M77&Y37$'[7DP(/N\#8U69FUUI$3LVLI1$^>*-*6&^KBPVU^-$?!][CL(H4\-8"S_J%J"[B*/*\=E+Y6L)IA<.IK;/B M;WDX@PA`V\%K5;A-0C^:.1- M']N?90.W&OKK%:ZK!)S/`P_`9RF;]H>Z:.DNP/;_`P``__\#`%!+`P04``8` M"````"$`EEJY]7\&``"7&@``&0```'AL+W=OI=I:MT.MV?URPA"6H($;#=]MO? MF#'@L1VV^Z+=]3RQ'X]G?A!X?/^]N7C?JJZOV^O>9T'D>]6U;`_U];3W__G[ MT[O4]_JAN!Z*2WNM]OZ/JO??/_WZR^-KVWWMSU4U>###M=_[YV&X/81A7YZK MINB#]E9=(7)LNZ88X,_N%/:WKBH.XX>:2\BC:!,V17WU<8:'[F?F:(_'NJP^ MMN5+4UT'G*2K+L4`_OMS?>NGV9KR9Z9KBN[KR^U=V38WF.*YOM3#CW%2WVO* MA\^G:]L5SQ?8]W<6%^4T]_B'-7U3EUW;M\1?N0ICIZ?%0PPYD MVKVN.N[]#^PACV,_?'H<$_1O7;WVVN]>?VY??^OJPQ_UM8)LPSG)$WANVZ]2 M^OD@A^##H?7I3^,)_-EYA^I8O%R&O]K7WZOZ=![@N!/YD;*]P$KPK]?4L@9@ MZ\7W\?_7^C"<][[8!,DV$HPGOO=<]<.G6G[6]\J7?FB;_U#$U%0X"5>3"+"I MXCS@:<*2S=NSA.AHW,G'8BB>'KOVU8/R@#7[6R&+C3W`S'(+(H)4EC+X049' M#0SW,/KMB?&8/8;?("NE$F4H@J*>19PJ!=^P8$OCN1YGVRBXDV:H.LV`>>HR:AI)Z$(9:F(TPK;: M0F.V1E86F_:O1PU%T^-Y*-&+;ZCP5P/\LV]G>_(XF8% MR*AIPE@G0PV:2'A@5&H^A9=J7LZ(I($!=[4\F%;&\%M>E`BJ?^Z=934LR%DR M4FP7B!WYF9-(O5$\3F?$$&BD587)"R52I[2Q2I3$.0^60Z86),CL,F'(-VIA M*30L4B5""RP)C";.:?QNES`)-H<%Y!VU8')Y_.S>5Q9B;9?J6"9HRF/9:0YI M$B37'`X0=]3!@CR5!!2A`SCWB/P8?9TSJDZ).%K4U![EZ5PF#I`*HT\RN&&0 MO8;VMG:5Z.'TOGOJQPU6YB"K,&HB4R+TDZ:V(1VM::R1CUIPHY79;&6IE1(4 M0<>.O1I%+#`J.U?SJ*QM=0!3&V[(,H0DU-[,B\2JFPFDB\9BRIJ$^ECG+;.! M"S=:5B]-3)5I,7"3JRDP(WP+5V2=;W?@PBE[I\(=APWFBF4*["LEP@63*#"N M#SF-;[0XR0QW(W8,:79DI#2PT-[;="7<@U>I;)5))X5O[8'2F0M*6@Z->W$SE-E,=K8(B])#N+*RK23`>:6'J MP(U3CAPDU^'8I+H2X0H\M2MC@JFD&Q3&\GEJ@9)T1I9-4$=[Z@#E!M!RKD<7 MU)#5X;NQ"P[CL`&'>.EP!*82J3(0%JUH/+Z7`.$&YCAL6+`N[DJD+.@YQNXD M<2#$;#5;[$,I.5$+1+]%I8ZDY-:NPJ0G'8O1CIE3NO2H?$SA=J*=.W.P4B,7U8YG0 MZ5I$^5B34!]N@@J;H(YCT0D)^=+:4]G0!?<(YN:GL/D)1V+>WRC5ZI%,%'5E MBZ0B=K-T''[C$J\T:SY6)=2'&ZBQ_27?/A(E4IT"W\]H)^4TKC\FHQ;<0(T= M0+7QI52KR<")W!+JQ`W2&$%*^L38:Z8T[D6P0%76Y]%[9OESA1I/# ME]5Y%-\_9.PAX_*)M#&>PWN)<3R<`_"VX%:ICC!E%&R!LQV^ M6,`_AO8V/@A_;@=X3S#^>H870!4\\8X"$!_;=IC^D*\NYE=*3_\#``#__P,` M4$L#!!0`!@`(````(0#,A>;5-PH``,$W```9````>&PO=V]R:W-H965T3M]]J5HGLJBXU&5^,Q\W/U8?%ZCI-6GS\^<=A/_E>G9M=?5Q-H_OY M=%(=M_7+[OBVFO[OOU_O%M-)<]D<7S;[^EBMIG]7S?3GIW_]]/A9G[\U[U5U MF4"$8[.:OE\NIX?9K-F^5X=-:W/A\T%?CR_S9K3N=J\M+]TV,_B M^3R?'3:[XQ0C/)S'Q*A?7W?;RM3;CT-UO&"0<[7?7$!_\[X[-==HA^V8<(?- M^=O'Z6Y;'TX0XGFWWUW^;H-.)X?MPR]OQ_J\>=[#>?^(TLWV&KO]P0M_V&W/ M=5._7NXAW`R%^N>\G"UG$.GI\64'9V#3/CE7KZOIE^C!%-ET]O38)NC/7?79 M./^?-._UY[_/NY=?=\<*L@W7R5Z!Y[K^9M%?7NP0_/+,^^VO[17X_3QYJ5XW M'_O+'_7G?ZK=V_L%+G<[W[;>PTSP[^2PLS4`I[[YT7[_W+UH#( ME$[*29=@N,Y;2W^Q^&H*BPE2U\#H]ZX9%N"U@K$B?)*V%S;N,89 MF(&R3AXDWI%W56%'K8KKKZ]Q`()TLF(QHT\D"4>,CRQZA*F""^FH:I.6S+L< MV:-0;8Z8+%WRN=;(0,([P3DGRD'"A`@F%Z:1IJUH[ZJF5*PVAHE5[%T5IGBE*2D8MBL52@0Q"(^0N M5;EV5,K-1-[6"*'\&7_R42D$52ZV^#5'ZB7/) MUE<4R6@WO.]ZY1`A1?6P2):%*MFEDF@^5U<;Q1HCV5I++UD:7(3.(Z1'/(]K MHE!ZKBVHDA!=$6T,1KM/C;D3ZVB M,AI$3!#AHJW!]**[HD#?$2F6.[3(M;!XGL:J;3-1=9B>KU>DM&! M7-W9PNL2KI?=1;E2IF4[SZUE1:)'NUVLNUT[[+4)N?2(HJ4W3R-M69624B^% M(4J_%*PN8MWTVF$N.Z\.R2B7$7PC$#1EF>,%::,$JM/ M`)=NG:=O=5V>T9"$9+GOC)'"KI&D\TSU/TGIFSBBW!.[)9E;8"<9'4M(EG=- M,5(H^2Z:Q[FVI2PYMHA2;>=DB!JC67?`6'5`K]4Q!TR*I2:FI%C4PK.%>C$, M46,D1`Q-I4?AFL.NEXQR/:+6*UO*LN)YW-8P2JT\`EZZ[7C+*]8@BUTL2 M]4>1YBT)U/`[!0R3EAL40-$:P;GC)*,,C MBJPLS;7DE1Q:)EKC-@2-$:S;78(V!?VINZ'.O)/7+JNY^R1R;*%0U[9+''*U5*WD`:A;JQ M^%+K3KT)7KMR.\S3K'1EHES)_318&\.("2(\SV'W2T>Y'U&N:"W/&(M3?IY] MJD\`EPZ1M#S;8;XQ@CS+75R*%/:,7'TL6'(FU=J*(<8]J5MRN?]U9:'ZGJC1 M-=R&VY.BGASI3PX%U'9D^5C?$#1&L.YZJ>9ZW@-[HE!P%FNY*SES([^C/2_5 M/:\=YN60)?)FFB`]*;3JT#L#B`E&X:7+[<[KR&A[L!)Z%_&>#J4(!025PX@) M(EPS=SRO(_O.IW5DW]>B.!.O-`VP*6`4NVQOB%HC&!@ M-,%V6):$UY$SI%!PK-^&<$8])T/,&+FZXV7H9:R[>7]0)TB?!3OR,&*""%]U MNMEEJMG)S011F%K=FPD)G(\)(ERL;G69?WN7Y5[=#OI827&"6D-1N%9N=5WO M52PN]_(Z;''9(&*""-?*+:[3JEE;+O^VFR&%11#!8U>E.95C($.0GG\F.->- MK1T6#6&^[+M@NW[61.G3X!(;1DP0X6*YL5VSF^.M7+@=$!34BG$"B`E&X5IU M)\L5)_,^ET`0-5IZ0BQCX;MWIZ'$W,K0C_SW4$ M!;5BG`!B@E&8UD)WN798N)S7C`G"3^G"!TGQB]\RE`2%U`81KI;;G.QK!=H4 M*X&A9EP@%-0\B)A@%*[9NI'0['Q< MI4"S@AF[ARA*GR#*%0U]0K3`4J'$%3-!A.N&R1S=UWU088=YCI5F3)2K5R@I MAQ$31+C8L./!*T[^K:?W616B7-%:DC&62XE3LV]4V>ET!'7C&U/X;L^A.K]5 M9;7?-Y-M_7&$.HCA\^_=:/>FUI?8OD(CQM?P!E?[%M2L.P#O59TV;]5OF_/; M[MA,]M4KA)S?6U5G?`4+?[C4I_:-HN?Z`F]4M?]]AU?E*GC#9WX/\&M=7ZX_ MP,2S[N6[I_\#``#__P,`4$L#!!0`!@`(````(0"06`Q0_PX``"9V```9```` M>&PO=V]R:W-H965TU,$N(D. MRQ/)?=_W&RU1%J,E44'2[>Y_/PFB`*$6X4O/Z&!+Q<>L0J$>$H7UZW_^?GVY M^6M_.A^.;_<9+YO+W.S?'HZ/A[;F?-F]/>Y>CF_[^\P_^W/F M/]_^_:^OOXZG/\_/^_WEAB.\G>\SSY?+^Y?;V_/#\_YU=\X>W_=O_,G3\?2Z MN_"?IQ^WY_?3?O=X_=+KRZV?RY5N7W>'MTP8X/#S]?]V^7 M,,AI_[*[#X^7;(<[C9LJ+W,E=O*+4?Z]O7Q MP$L0=/O-:?]TGR'O"RV]WF=16,3S>/^Z?=SY?+]/BKO3_\>+[P^BX&7WDX MOG!-_._-ZR$8!+SLN[^O__\Z/%Z>[S/Y4K98SN4]OYBY^;X_7YJ'X+N9FX>? MY\OQ=15"G@H5!O%5D#PW4WU>R/IW1:]8^HTH!16%ZU51_)*X"4Q>EZ,KI(ORY>#AW_8&1\+\C_TAA_TZN\OE1S/GK$^_V% M\J*N"7[Y?YK#77OMG<)''_OEWU^L0M3+P2_1BJZ(X]R&`_@Z\.N[R^[;U]/Q MUPUO3GB(GM]WP<;)^\*A>8P'I104WV>X*A[%9R[]ZYOGE^Z^WO[%]CPHJ&I# MOD[4;"*?UY%ZB/"_<4U&D(9-F$&:-F($:=F$&:1M(T:0CDUX7MZ`NC9D$#U( M]&W";.W`1HQJAI`8V83GE4OZ"AH[(+_LZ=#$AHS63&W"7*29C1A!YC9A!EG8 MB!%D:1-FD)6-&$'6-F$&V=B(W;M;&S)J(N4B@[$A9E6D5$PR9ACE8A*QPF`9 M26`C81U)X"-A(/\IF;IN@KVU0C%.8<''00H+]MZ" MG%8U"VIF03TL2"KBY?)E?5/7D$!-"=220&T'Y-T9F]^.$_KHMNOR=R50SP'Y MI8K>!7T)-'!!Y9P>:>B`O++1XR,)-)9`$QO*5XR%FPJ8F8"9"YB%S11R1A2,G5]RB&M##G%MR"&N#3G$+>0*NI+D$->&'.+:D$-<&W*(:T,.<8MW MQF:"'.;:D$/=XITQL2&'NS;DD->&'/9Z?OEC:&H)C>?/R806S<6"8BV1F04U MLZ`>%H2'&X+HRQJ:E4K%^J53L M9"H5BYI*Q?:F4B*E2>0TB:0FD=4DTIJ0UUH>X0.HKCP2%&MYQ"RHF07UL""1 M1\R"IEG0,@O:9D''+.B:!3VSH&\6#,R"H5DP,@O&9L'$+)B:!;.H(#&PK/G@ M7`(M(BC*6DNS8!45I-6UED";"(KJVIH%1%9)-2I)JY[4`-&VJU:'D#5JJ!%% MCYI$\;A)K2\>3*F4-<+(&F(4C['42/'`2Z6LT4C6<"1K/%(\(%-CQZ,TE;*& M+EECE^+!&_=Y/%+C$FM84CPN/ZE?V\[P"9;D=N9Z`":?BP_`!!_SB;'$<4O> M]35F0-40XO$1']PTCC_7(%&'1`,234BT(-&&1`<274CT(-&'Q``20TB,(#&& MQ`024TC,(#&'Q`(22TBL(+&&Q`826T@0801;1U@[PMX1%H^P>835(^P>8?D( MVT=8/\+^$1:0L(&$%23L(&$)"5M(6$/"'A(6D5)-U-(3G[A/IJ?H<$I0?)_A M`Y1QQN&T9!P$JX90Z7KFN^!52L5<\*,?*:LE(;]<]O(.J!Y"*0FN`8DF)%J0 M:$.B`XDN)'J0Z$-B`(DA)$:0&$-B$A+A&"AZ^8IC[4XUQL]Y#F8&:YI#8I&L MIU"IN-JR3#(\7DN.MJQ@36M(;""Q3;:$3[!<&V+(0Y2$S`^5?RG6D+(O#5'N M*8OO"JX>(:6?@CYI+#:0L(*D'`RKJA1+SO8H#4.(QY/O&E.$523L(F$92=D8 M-J=4*;FV<:2$#"%S76(7"+L.TU'AEQ;;<(^DA(R7)Y\Q;VB-"?- MA58RND>GEJ7XLC!7E@J*C2SE5\ZU!H@Z)!B2:D&A!H@V)#B2Z MD.A!H@^)`22&D!A!8@R)24CXN?QU+X4OE0R'>[BUS>6\QA\?YYFNHV'ZV]^8 MP5;,(;'0:_6R%:MA2XRL8#UK2&ST:OQLWFK)%B-$`J8*&T/835)R1JLXGZT4 MK1:3\C,=PHH2=I24I!]5^6C(D;+V=[Z"-2;L,2F1HXIS6?M$M[X>'802.24& M%IFPR62H7,R6(XG#_WU[K1LN2[ZB9(Z6IICE#)G\N;-K47;_SE<,W26U*/W= M>4Q+EGQ!LBM9!L5&LO3+17VV5@VAW<(H1!C!ZA%VC[!\A.TCK!]A_P@+2-A`P@H2=I"4A.%ZC*PA81$)FTA*Q=3A2]A&PCI2JH]:?O+X9FC7U.E:;F0HW[P' ML*JHE.ZM8:2.D09&FAAI8:2-D0Y&NACI8:2/D0%&AA@9862,D0E&IAB9862. MD05&EAA9862-D8U"HH,EN6RE4E9'&<(<9MS;LL4Q^>;/P%N^KRUQNMJX0(IO M_L2,0$\2^,FW?^*Z!(;R_9\XCL!1O@$4QQ%8RG>`XCB1I\D5K!]S-PXY\=V@ M.*K`6Q*(2P)S2:`NWQ"*VQS)F^R)C]W?8+";/2%PF00R\^,_TEJG9SR^3-69 M\8)R*^,9E\17O9!*\:Z&D3I&&AAI8J2%D39&.ACI8J2'D3Y&!A@98F2$D;%" MU"1.G='0=U(G.,P4(S.,S#&RP,@2(RN,K#&RP<@6(YSDH&RRX&;JQ#-ZS`<=>.'-UL85C<:]G%5%I?1C#2-UC#0P MTL1("R-MC'0PTL5(#R-]C`PP,E1(M%MES!=&.,(8(Q.,3#$RP\@<(PN,+#&R MPL@:(QN,;#'"N2RT,<4SSF68$C(N0S'$0C)N0S'$2C)N0S'$4A) M`BLYE^&Z(B_3UJE`3IZBX;H$>O(4#<<1"$H"0SF7X;K2'=5S67#_=EHN"^_O MYCJ35^<;CVBI>B&5LCYJ&*ECI(&1)D9:&&ECI(.1+D9Z&.EC9("1H4+B7)8U M'^TRPD'&&)E@9(J1&4;F&%E@9(F1%4;6&-E@9(L13F=0-4YGF!'XR.D,QQ$8 MR>D,QQ$XR>D,QQ%8R>D,QQ%XR>D,QQ&8R0^@PW$$G(ZPW$$@G(Z MPW$$BO(QQK0X>CKC%)1,9]$]9L$S;*UCC'?&30)51:6FL3!0"E+'41H8:6*D MA9$V1CH8Z6*DAY$^1@88&6)DA)$Q1B88F6)DAI$Y1A8866)DA9$U1C88V6*$ M\Q@4B?,89FH"1F`DGT?#=0FEN$X`C?Y M$"..(["3#S'B.`(_^1`CCB,PE*=E.$[D:'AF(V_>$*HGLN"A`8EY69S(PH<) M:/,QKV1>P!@\SH:%"V\T>BN!O&+'<(??PDE-:M%2?#D&>FF$F$E.=L/ZDW1]NNOI0H"5/RW!; M(C'3^OG#R\^76Z`G3\O2VJ-GL^#9`HEL9CZ9*GBGASD]\RKF,T`4E;)L-8S4 M,=+`2%,AX3KW?=?S'UH:XTS!;5Q3!R-=C/0PTL?(`"-#C(PP,L;(!"-3C,PP M,L?(`B-+C*PPLL;(!B-;C'`B"Y5,D8WG9Y@1&,G)#,<1.,G)#,>)I$Q;+H&5 M/#_#=0F\Y'2&XPC,Y&2&XPC&N#DCC(PQ,L'(%",SC,PQLL!( M\.8_,'Q7&%EC9(.1+48XI<'VSDE(;C"/SDE(;C"`SEE(;CI#L:IK3P M[9OA2PA?]Z5\\W#\^<;'!8.'&<6E'Z_]+`2O<3+*J]X7?FRU75[S MOO"#JKG\-OX"O[OS??=C/]B=?AS>SCN*I<-7G)Y"E_S&?YQ.;Y?7XGX M_7CAMW9>?WWF]['N^14:N2S#3\?C)?HCJ.!7](;7;_\%``#__P,`4$L#!!0` M!@`(````(0!5,'V0P@,``/H,```9````>&PO=V]R:W-H965T;R[!`GL1HPPDZGY^^W M"@.-`9'D@4OYU/%QE2E7=L\?66J]LU)RD0?$G3G$8GDBCCP_!^3']]>G-;&D MHOF1IB)G`?G-)'G>__G'[B;*-WEA3%G`D,N`7)0JMK8MDPO+J)R)@N4PHAG0 M9SPIA10G-0,Z6PL=KGEC;VQ@VN^.'%:`8;=*=@K(B[N-W3FQ][LJ0#\YN\G. MLR4OXO9WR8]?>$?CFB"9SM@?=KE8%_2^O(3O2:JO_$[1_& MSQ<%Z5Z@2R)2F`FN5L9Q#\#2Z4=UO_&CN@3$7\X6*\=WO06Q#DRJ5XZ^Q$JN M4HGLEP:Y-94F\6H2N-7`9M@Y) M%)FP?Z$1]=;>SGZ'="0U M*-0@N'Z"3$34(#`ER!MW##8(:%5`4$=4H!55-.ZA-G1G[&F*&I>.)F\]-V7% M0Y#OMQ!#%^1K1!=:#5W:T-4%X?JDK-8>];WBCL&8%/([,BE:8>-VHKWH+RS4 M&+BV&5FVZ](B[B+B*80A$S;NB$RT!@0BW$J`4"Q,%:$&+:N-M9C/UP[^3$RD M,1-KB;LLOK->F"R&UN6H5K0.M/8B%FK0A([H+B*>0A@ZH:*,Q!2M]U*O,5,R M[R+B*80A$T_08=%`ZR"<*S.MH0:M=$W1*1OFW@!5:<6+R11KT/B*#;4;0ZV% MQX3OM*4.1P>JU^9:-V8 M>L(:58=XU<381$4U:CQ\=;%&-0$9AYBZL:X/-X2KR[U9##:]/(8U2E>#WF!4 M#XYKJ&7J6?K^ID`L^2,"]4G0$]A+<.AJU(2&Z#XDGH288O%@&!&KSXOI$\#5 MH$FM=R'Q)(NI%68:TXKF_D[=]`[K$)K#"N7XU8%X M![O=.D!#6M`S^T;+,\^EE;(33.7,L/\K=>^J7Y0HJJ[L(!2THM7C!?YC,&B? MG!F`3T*HY@4G:/^U[/\'``#__P,`4$L#!!0`!@`(````(0`=.\G=L@8``"0C M```9````>&PO=V]R:W-H965T*+WM\T-V.VV\O_^*/JR\45DEMT-RR6_IQON6 MEM['IY]_>GS-B\_E.4VK$2CD@H_% MR2_O19H;Y`W%_5+-DW MVO6'GOPUVQ=YF1^K,*']F-?^V@>EI\=#!A$8VT=%>MQXG]1#'*P\_^FQ M-NB?+'TM._^/RG/^&A?9X;?LEH+;,$YF!)[S_+-!?SV8)CC9[YT=U2/P1S$Z MI,?DY5+]F;_^DF:GG[/,+]`2_1]?,S`$(/?E:_WW-#M5YXTT7X_ER M,E7!W!L]IV459>9<;[1_*:O\^B]"RDJA2&!%X*\54;-QL)JK^>('5*96!?XV M*L$/7\K,BL#%-R+_XU(65F7YIA*,EVJRGBY%5WQTN!Z9,*F2I\P>`UZ85L<+9P)O$8%^6KO<>2$2H4AH)*P7RV$W MOH.)N9Z('[#1=ORH]\39O-T"S5'J"VR!,SHZ6X06]?A-\S1GCW.NMDBQ-DC$J%( M:"30GO5B14.JLW(DBL0<06Q9]VWI+"MSM&>+DU:W"'&VB$0H$AJ)=;UXEXNQ ML^M%HD#,$<02!34T,U7JPSU3G.O96HIS149"&=$6P5UM.9O:5=`N`IPQLE#, M(M0@4]&]OY84%GR0]=L,!)NQ6[Y8BC4(A1@DE%6TC$0R$K,(=<<4?XP[6!MV MRQD%.82.UU8AQ82^DY%01K1%<+OY,%NO9D,;CBP4LP@UR-2#C$%8+G8-6DS< M/4=Q-64]Y7?Q:2W^R#$3A]$ M;&!SW#9H7*$29;2,1#(2LPAUQQ2,S.3!>K([>6!U*1K7%NYO&`]9>T0DE%6T M11J3E1JR.:+4.VLP9KNC'IF:\+-R:QP+L=9P):F];2`B6NXH MDI&81:@IIEA\,Z7^`M$I`!76DE+20HIU1T1"VQ>CHF4DDI&81:@[IF!DW,%Z MDDR=@:3%59UV4Q:14(F(MHB4M%"HH5;+H=06.UHK^S6BW3&H3::(9&S"&K-K MTT#JX@I1ZY*(A$I$M$5L_'"7=C"SHTX#398#4$R5W%Q!'`KXXKD^3+.76KO9 MRT+,^MC)2"@CVB(V>/PFWPY\/121C,1L1]0EWDM>#M5;B]0F<*"SRIK\%9AF9^ZLW,+00JP[J,,@H:RB9222 MD9A%J"E\U1Q@02SD+TLQH>]D))01+2.1C,0L0MV!D#I3QLWN@3GL3)U^_K(4 MZPX*,4@HJVB+V)6U7`UMNA&%9FN\3T:WIYA"2CFWBZA'?.ELGK\Y'O63EX68 M^'L.7S@%6O-VTU?]&:B%VXLB5LZRB+6(G3A`,9W7LJH%6>*/?75L$ MFJX<)6J1J37?+PSA`;Z[MH8RNUCY[JP08V,H(]HB-GPU&;ZK0:GA781L-.^50_P M2+K?KN$EB;K=;T^`5Q?NR2G]/2E.V:T<7=(C=#49FZ?R!;[E@!^J_%X_<'_. M*WAIH?[W#&^CI/#T>S(&^)CG5?,!.O;;]UN>_@,``/__`P!02P,$%``&``@` M```A`-H)=X2;!```3!$``!D```!X;"]W;W)K&UL MC%A=CYLX%'VOM/\!\1[`0,@0):D:JMFMU$I5M=L^$^(D:`!'0";3?[_7'X"O M86CF82;Q/;[W^/CZ@&?S\:TLK%=:-SFKMC9Q/-NB5<:.>77>VO_]^[QXLJVF M3:MC6K"*;NW?M+$_[O[ZL+FS^J6Y4-I:D*%JMO:E;:]KUVVR"RW3QF%76D'D MQ.HR;>%K?7:;:TW3HYA4%J[O>9%;IGEERPSK^I$<['3*,_J99;>25JU,4M,B M;8%_<\FO39>MS!Y)5Z;UR^VZR%AYA12'O,C;WR*I;979^LNY8G5Z*&#=;R1, MLRZW^#)*7^99S1IV:AU(YTJBXS7';NQ"IMWFF,,*N.Q634];^Q-9)WYDN[N- M$.AG3N^-]MEJ+NS^=YT?O^85!;5AG_@.'!A[X=`O1SX$D]W1[&>Q`]]KZTA/ MZ:UH?[#[/S0_7UK8[B6?DK$"*L%OJ\QY#\#2TS?Q]YX?V\O6#B)GN?("XB]M MZT";]CGGX6M`?4;*XI;S:RALQJ"8I'ORC0-N/H3QPN)@'=!D9?=R3P_(W["C)E"K27 M(.CR`80128?@Z@*1G@VL46/3%>6CN&A@EAQ##$0R1@1!SPJ1`!DT$D*2<-DK MP*.P?_KB`F_()&3:2U"H@:*^ED`DB&OL)2@6 MV[0(8V>%XPF*1[XSK`(Q@!:=8,!',8,H,`KL)2:4?1(&3A3K/P8;!/:=03!$ M)IHDPT;YF!2.80 MB`5_@!B'5NM0'OUCATK0')LY!&(3(S9=A_+1D2:&ZGL)DENR()Y#\)8E*+YT MANF(``'GUO3H&(AA3&'HN3Z9A6!&\Y[K/^2Y"C7+Z&'/ M];DO#D^!SG/%\&B73,]5J*Y35IJMJE[AV;>V`D0K)]3L".[#?6MAE:9=F%^D MC.?`1//J+NQ#P;Z$8J3'@_B]-UFXF4[*\I`+B\E;6[W;>V,.,HN*`\G!+:4. M\E(KKX(EK<\TH4716!F[56!6!-X:^E%YF=[#95I<2-T^`%?<:WJFW]+ZG%>- M5=`33/6<%:R_EK=A^:5E5W%].[`6+K?BXP7^:T'A0NDY`#XQUG9?^(VP_S_( M[G\```#__P,`4$L#!!0`!@`(````(0#S[,BZ@P8``/PC```9````>&PO=V]R M:W-H965TUJ>VJ4;]BJ MK:W]N*816VI$+*"G9_[]GA!$$AW>[KD8VIPGAR1OU%^JPYI M6H_(PZE::X>Z/C^.QU5R2/.XTHMS>B++OBCSN*:?Y>NX.I=IO&LRY<>Q,9F8 MXSS.3IKP\%A^Q$>QWV=):A7)6YZ>:N&D3(]Q3>6O#MFYNGC+DX^XR^/RV]OY M(2GR,[EXR8Y9_;-QJHWRY-%_/15E_'*D>O]@LSBY^&Y^W+C/LZ0LJF)?Z^1N M+`IZ6^?5>#4F3\]/NXQJP)M]5*;[M?:5/49LJ8V?GYH&^C=+WZO>WZ/J4+R[ M9;:+LE-*K4TZ<05>BN(;1_T=3Z+,XYO<3J/`G^5HE^[CMV/]5_'NI=GKH2:Y MYSQ+4ASI3?3_*,]X'Z"JQS^:YWNVJP]K;6KJ\\5DRHRY-GI)J]K)>%YME+Q5 M=9'_)R#6NA).C-;)E(K9V@W=6,[9W/R$EUGKA9Z=EP\7@0K;U(.>7>9/U\-L MG2SZ3CY=#QI#35'HV17EP_58M9GIV67^=#T8]1>A*BES=?/1FHQ%'VGZEA77 M\?-36;R/:,!2+ZC.,1_^[)&1Z[97M5VCZV?4W1..?^5\DXMZ4$6IWY_9E$V> MQM^IYR8MM!$0-=858K.9#&TO$._`W+6E)MAJ@J,FN&J"IR;X:D)P2>B532Y8 M>"$N!8MZ"6-JMJ[MJ+GZ;7=I(IXL-]'4D%^QN4448GM+,#9;R6ZLNY`I0_8] M:*XHYMQ"TZGLQ[U%&)LS&?+N0;.E#/GW(*84.[B%E"8*;PFUS-$MLKQ62]*2 MXEQ?RV8U_`RV#DR6N-^D&GR4H911N!#,D&"0L2-B0<2+B0\"#A0R(0 MQ*H)[@\KIBN=.)3LYE17QF4DV6>&ONB&OR083>OW!./)LF#F7)DZ-H*9B1(: MNA)?MI+97.GSK@!BHI'LBU6O@(W=ENQ4026_(]F-A=H`KF2?&_HUY#3^/+(\\LR;R"F8(=T@84'"AH0#"1<2'B1\2`07@@?.56^F:F)9 MV+8FD_+!*":5+9:&^:9D!@;88L3!B8\3!B(L1#R,^1H(.:=:B M$S5HAI)].=%7D_X_91T?2?1U%2FKR/?Q]U04^_O!_3D;.@-H)H$M1BR,V!AQ M,.)BQ,.(CY&@0[B*#]/>Y"9F1MG.;C:!DOU7NM'8N:L;3Y=GQ-MM.A/0X/"# MB(6]V!AQ,.)BQ,.(CY&@0[APYLT^4#(_,-4>R7:C9Y>''-_D]X93A-^N=6WL!<;(PY&7(QX&/$Q$F`DQ$@TB,AJ\KV_ MJF9O1\C$V0"%RNZ\A=2\'NLT(6'34H-J"D<#B(6]V!AQ,.)BQ,.(CY$`(R%& MHD%$5I,?!/34[!8UXH"@/QW>":M#IPCM?`@1BT'$QHB#$15;<53TN%9L`O?S37-SH#7&PO=V]R:W-H965T2C$J`W9%FI=5H9O::$"=!!8RPT[3_?H]MH-@@F/8BE,/#RWG/L<'> M?7DK]^;/'_'3VC0H2\ISDI,2[\UW3,TOAS__ MV#U(_4)O&#,#%$JZ-V^,55O+HND-%PE=D`J7<.5"ZB)A<%I?+5K5.#F+FXK< M"UPR*5+C/&&0/[UE%6W5BO1WY(JD?KE7 M3RDI*I`X97G&WH6H:13I]NNU)'5RRL'W&UHF::LM3@;R19;6A)(+6X"<)1,= M>MY8&PN4#KMS!@YXV8T:7_;F,]K&")G682<*]"O##]K[WZ`W\OBKSL[?LA)# MM:%/O`,G0EXX^O7,0W"S-;@[%AWXMS;.^)+<<_:=//[&V?7&H-T>OR4E.3P) M?HTBXV,`K"=OXOC(SNRV-UU_X:UL%SF>:9PP97'&[S6-]$X9*?Z3D$B]$W$: M$3@V(LA;+!UOM?Z,BMNHP+%5<1;.VD.>_XE1@PSJ%XM$KXK$%;$&QZT12TZPX,DI33SQS?FS`3H>X4 MHJ\'Y*+ESGJ%?J<-%$@(?C\@A!P5.K80;SN7#MM`[R[UED@2RL,'NG$+\1$( M'CNC4**>T=8/CW(_;19!&^AEX2)/3>0XA#1WH20@EZX$&A$-":BD]J!X%/*[ M;!2#,#1'#/*H8E`/'/5`*`/]W/V-VSU3-"L:,LC>;%0HGH&4[&%*C&3/HS#K M>V7T?2V50#+PVY7ZHT`BV>,L$_L MP+A8J94-)+22$]#V;/&G,D?)0%:=D%:7<):(9HEXBE!5UEHAFB7B*4+RN1KWRZ,"K-F<""4TX.0Z2'U0-(2T*1%/$8KM MC6*['[ZHT`;YTNM>V;!8'FG[8%4DJ4GW$FG>Z[Z_ M6GIKK:EA\[`)F6@>X>M[GO*XBO0NU^]RL5C@^HJ/.,^ID9)["5^4);COHMV^ MX=GE*RDM'O']Q$@\<+;!&']TMK`HX>NW3@AV!55RQ?\D]34KJ9'C"Z1@+U;P M]:GE!D*>,%*))>V),-@/B']OL-'#L+ZT%P!?"&'M"7]`MW4\_`\``/__`P!0 M2P,$%``&``@````A`$A4YFTS`P``0@H``!D```!X;"]W;W)K&ULC%;;;J,P$'U?:?\!\5ZN(0E1DJI`NENI*ZU6>WEVP`2K@)'M M-.W?[Q@G*!A*^D+"S/'QG)DQX_7]6U4:KYAQ0NN-Z5J.:>`ZI1FI#QOSS^_' MNZ5I<('J#)6TQAOS'7/S?OOUR_I$V0LO,!8&,-1\8Q9"-"O;YFF!*\0MVN`: M/#EE%1+PR@XV;QA&6;NH*FW/<>9VA4AM*H85^PP'S7.2XH2FQPK70I$P7"(! M\?."-/S"5J6?H:L0>SDV=RFM&J#8DY*(]Y;4-*IT]72H*4/[$G2_N3.47KC; MEP%]15)&.[#ZL2W`3V9D.$?'4ORBI^^8 M'`H!U0[DDI26L!,\C8K(%@#EZ*W]/9%,%!O3GUO>,G"#N1>8QAYS\4CD8M-( MCUS0ZI]"N6*=66#%F<7U/LUBJY!:*0D2:+MF]&1`>\">O$&RV=Q5`"E, MI?%!6EL?1,7!^KIU/3]8VZ^0CO0,BA0(FKD#>7U$/$3X?A^2#'?22'93"!M4 M=%(@02-2I+4OQ==VB!1DV69;RH]U0S(D@7S,^U)VHZ!%!^K%ZH_&*JW0'%<9 M#1QMETAA9E<8#1'?1"0W$;LI1$\(!#*2=&G=F)"0KC4"9]EEHNVQ2&%"U5VS MA37K^^-K_R*TM*(ER@W/;@LM#[LI1$\#G*@1#=*J:PC[,48*,VLUA*&E11!? MNY=S2SM`R<7]L80I1$_"?%2"M&H27$>3H#!G"?Z@"II;*V)R<7\L80K1D[`8 ME2"M?0GN4NN42&&4!'_F##1<^[T@'-3AXO]8Q!2B)T*.]N'G5%K[YQH^'UHJ M(P6::.CX)B*YB=A-(7I*PE$ETJJ5P_/U4Z%`4TIN(A*%4%^'^5(__3#691S* M[5]WK=*@9K8:=!5F!QSCLN1&2H\U?"X\.*^=55T5(G<%8P!&MV:/W15,`WD+ MZ!PPV1MTP#\0.Y":&R7.@=*Q%G!6F;H$J!=!FW;N[*F`D=[^+>"NAF'`.!:` M&PO=V]R:W-H965TP.;2 M$(54S:INDS9IFG9Y=L`D5@$CVVG:?[_/-J&!$*UY"/!Q?,YWM5G=O32U]\RD MXJ+-$?9#Y+&V$"5O=SGZ_>OQ9H$\I6E;TEJT+$>O3*&[]<Y2Y0G62TM(N:.B!AF`8-Y2UR#$OY M'@Y15;Q@#Z(X-*S5CD2RFFKP7^UYITYL3?$>NH;*IT-W4XBF`XHMK[E^M:3( M:XKEUUTK)-W6$/<+CFEQXK8/%_0-+Z10HM(^T`7.TC[S4^QQ% MJ9_A*X]B28^&21X"3]/TO@/+*1 M/%!-URLICAZT!VBJCIIFPTM@-B'$":2R,"_OS5N+`;,"Z_,:DRA>!<^0E:(' M;1P(FGH`D0$1@,R@!?QG6B<-8QUK1&_KK1L;!UG88IP31K.$Q@H9/O,'$Y(, M+CE*!XK/0.F`&#D-D!FGC35'X-<0`#I@1,-:I0#00 MN!@N,%$:7Y-(9R6,=2HQK:W#Q%:!1)&?#2Z,DG0[*V"L4X%I'1S&"42) M?Z4(9L=\Z])3YQCKF!\OI@$X3)\C$I+4Q_,A9+,2QCKNI1A/Z^PP[V@E\&(N M#&L>QW'93#VH3Q1TTY5,X?%`GU)ES5.-:3_UH#Y9.$JC:PV%YT?9FJA-NZH']=F*?9*=_V[G.P".BMGR7,[Z99O9M3ERPTY" MG/EO+KE)<:>(VWL;)G?L$ZMKY17BT,(>@F'"!JL[O39P>A&[Y0TOX$SIZ(Y] MIW+'6^75K(*EH7\+&X%TQX][T**S.^I6:#A-[.T>/A,8;.FA#^!*"'UZ,`?< M\.&Q_@<``/__`P!02P,$%``&``@````A`%]:+P!4!0``!A@``!D```!X;"]W M;W)K&ULC%C;CJ,X$'U?:?\!\=[<#+DIR:A;H]X= M:5<:K?;R3`A)4`<<`=WI^?LMNTP,=C&0A^ZD\WV24OT\;CM[R";TZ\+M,6/M9GO[G5>7J4%Y57/PJ"A5^F M1>5BADT])P<_G8HL_\JS]S*O6DQ2Y]>TA?MO+L6MZ;*5V9QT95J_O=^>,E[> M(,6AN!;M#YG4=FG_'\OCNUEY[*%ERP#%D:)ZQSRIGTMQ+6ND[TW+2__0U"H4F&2 M2"6!_RI)N/#B*%FN9F3Q\8YD)5_3-MUO:WYW8'D`9W-+Q6(+-Y!9E!`GT,I, M?/DLOI48"#<0_=B'$0NW_@=T)5.@%P+T0/A`\^""_#VNCD-$AQPL>EPO;^/% MAFC$@(&1#"(*+7>=7A71RN!`4-P#+1Z(`0=`B"I$=.?"C?8XK#H0M,9&!F'B MQ30%+`J"0D0M"O;(@*U"4"PIXL3350YJ6)`$(FH0K/0=8G[$A(&J81%Z(U(L M20H1M:18&C4@:(848I#JQ=LM*!$URH@L*1"$?5J,M6E-YA=1*[^I`X(P?^@E MCPH',D`;J0)DV&"PA%`@9'A:>2P8O'1/AXQ#OW4;+_7Z1^D5:(8N MH3"L+8P,6^KK):IHT.US:&B[AVCE?C$PM?0R532=X<548S!*5^O>2]_4L'W" MP41A(FP(%C%S282(0L6"D15!6Q]V%8O`7A%][\^NB!X%(?H<>M2;9Y%>5*J' MB)HC%3T.0K3ZE%3=0!!2!6-#,Z2G@0Q/:].?!V/:T.,@).:!K4U_'CR-UA`- M!X+GE*CL[Q:$4]5`=C,J+=+L-&LP@U!FZGQV1$>UV�);C;[5P8IC-0S= M;EG1=GV\TH-#6;%SO9ZB>E,==`Q,3BTO&9ZTHD+-T)[1CI=AHV_VCJE0N(Q9 MLO+6M#B,]KL,6R2F%Q4*2<8?8!GM=QDV.*P%H$"*(H@]O:T--:$MST38TD3G M0.D5:HXFM.T9VG["CPJ%M8S^GF"TY678Z);M1X5"BM%'649;7H8-"EN0ON.? M%J/KBC8]0S\;C3*MJ%!S]!@:O]M[&7K9>"(R-U^%FD$3TXZ78:-AMA452FG" M$D__)A\LX9CVNPQ;)*85%0I)=#^'!+378Q$V""S9%6BZ"-KKL0A/^E"AY@@" M&&*'CT78*(40!%&J5][(E(>3%9*"M+HE!Z)^+@=M])C8VVTY^EL[[(MC-=!& MC]'#?1?&*YT"AZ("S1&#]GJ,7I\PH4+-H:&]'J/7^\40OR`52JW?:.%IQ08> M26BGR["QL"Q1%&B:@S9Z(L*3'E&H&?U*:+O+L%&*[1&%ZCPR\MP%![:41V38 MH+"[A2,!#]B(1SL\R<7SSUMZSO],ZW-1-PYGHX$'X!/G;?=!G!0_3O#W_P,``/__`P!02P,$%``&``@` M```A`,A0H_D=!P``F2@``!D```!X;"]W;W)K&UL ME)I9CYM($,??5]KO8/$><(/QI?%$X3YVI=5JCV?&QF,4VUC`9))OGVH:>N@& M=SGSD-C5/XJB_GT5[J?/WR_GV;>\JHORNM.(/M=F^75?'HKKZT[[]Y_@TUJ; MU4UV/63G\IKOM!]YK7U^_OVWI_>R^EJ?\KR9@8=KO=-.37/;&D:]/^67K-;+ M6WZ%EF-97;(&OE:O1GVK\NS07G0Y&^9\OC0N67'5F(=M]8B/\G@L]KE7[M\N M^;5A3JK\G#40?WTJ;G7O[;)_Q-TEJ[Z^W3[MR\L-7+P4YZ+YT3K59I?]-GZ] MEE7V@:9]5 M^7&G?2';U+0TX_FI3=!_1?Y>#S[/ZE/Y'E;%X8_BFD.V02>JP$M9?J5H?*`F MN-@871VT"OQ5S0[Y,7L[-W^7[U%>O)X:D-NFE^S+,]P)_IU="MH'X-&S[^W_ M[\6A.>TT:ZG;J[E%3%N;O>1U$Q3T6FVV?ZN;\O(_@TCGBCDQ.R<+"+-K-W5S M;1-[^0M>X'YM*!ONQ23ZVK87R_7J\5@(Y(H]$4T:B\8T?_F1"$\,?.@S,]<7 MIKU:/Y`:@Z6YEXI_H7Q[ M%8A0@_7;,X&_)^,;B+_O((=!,'8_()%P>X)V`.K7DPW^Y(U,T4TP"5DB%,JN M(]D0]V[Z:!+9D`X,!F2.IP]ZVC!]?9:H6$^-HDDEH)4:3CJ&/:`2)K&F)J)E*U&ON M,,.:&US9X,D&O_$V&*@P2-0^`@4/0+%CT#))+06`T\GH0V'A"3#3#LU M#JA92#(S#)(L&SS9X,L^`MD0RH:H-PQTF6\^(F]GG/@1*.FAOI>D`X.0`%@0 MIA)`S;"$#6="8LYY#MM('`:!9SY=2D//10D/)7R4"%`B1(D()6*42%`B51&" M+$M1EG9YL^9\-:/-.PVF$IYY8DL3C<.89;O62(-Y#U$.$$C%*)"B1J@A!C=6$&@N;JT&;)36(*>\M&*1(FXL2'DKX*!&@ M1-@3=)-D;Z1E(5*VQLK6I&_]Z+;2A)'V1+M!&TPX@ARTN!KL_?K-"S6/YBRI M9SL,4LF`$AY*^"@1H$2($A%*Q"B1H$2J(@19H-Z8DH6:Q=%AKJ1.Y3!&I0I* M>"CA]P3M7-;2TN7=9-]^MWN&*!&A1(P2"4JD*D+0A%9Q4Z*T=ED5>07I()4L M..+AB,^1=MBOB"Y%$G#@OC0X$N%(C",)CJ1*1-2'%FB#N4Q>Z&EI.QH]TH;7 MZ2"E3LR/`O%P+SY'VJ7!LG5ID0LXH-`)C23"O<0XDN!(JD1$G6C9IM*)E772 MAEFJ:1W"*(4*+HYX..+C2(`C(8Y$.!+C2((CJ1(1I:+UWT"J?GM`6%TH;)J) M*:T!3D_$YPK8ZX@8\X*V*@82&$>%>8AQ)<"15(J(ZD+9)=:A= M6I#D=T(.89`B\RZ.>#CBH6/9$XLZWJX836@@$>XEQI$$1U(E(NISY]T"'$&:T$?J<$Y'*9+OXHB'(WZ'L-_W MR&HS%@A]=Q#BMXEP),:1!$?H":_[A243B)W@8D>$+GGUFKOY^5S/]N7;%7XC MI;_5<2L[.>:0+1S>@=_')7M(MG#09FQWS*VSF+"[YM:=LGOF%LX$@!^#WP#. MB]VRU_S/K'HMKO7LG!\AM+E.#V55[&@9^]*4M_80SDO9P$FQ]N,)C@#F<-YH MK@-\+,NF_T)OP`\5/O\$``#__P,`4$L#!!0`!@`(````(0#T\2'5T04``(`= M```9````>&PO=V]R:W-H965T:=T#< M=U@2LBFI5A-V9J31:)9KBI`$58`(J*7??HXQ)MA0G)2F+BK)\>UF2I+21X7QS0_[^6__W*^K66IJJ/\&%V+/-G+/Y-*_O[T MZR^[]Z)\J2Y)4DN@D%=[^5+7MZVB5/$ER:)J5MR2'$I.19E%-?PLSTIU*Y/H MV%3*KHJNJDLEB])5%&SU>X[P]M$<5,N_DQD,_2N"RJ MXE3/0$ZA#1W>\T;9**#TM#NF<`=HU"?HG3=ZKWG>I MNA3O;ID>?TOS!+(-/A$'GHOBA:#^D82@LC*H[30._%%*Q^04O5[K/XMW+TG/ MEQKL-DB5N+C"E>"_E*6D#\"M1Q_-YWMZK"][>;Z<&2MUKNF&+#TG5>VDI*XL MQ:]5763_4DAKI:B(WHHLH)EMN3[3UX9F++^@`M=KF@*?3&7S=95EJ[+J5'3] MRS<$PZ!I"GS^CZ9L6A7X9"J/YU0#SZDSQ/PVJZO9VC`6R_7J"SJ=P_#EKO.H M.PKM+TT_LZ(Z>MJ5Q;L$@Q?4JEM$I@)MJ\&/MH>UW:3K<]#U8X+_('Q3"WI3 M!=&W)TW3-SOE#7IQW$(FA2#K=X@G#HP@/9GH6F+`9A=BA,.(3T5=1K`J'M/H M5=&T.=\4GT&L5L`"4[5"!D$M!5+9Y1/&4#^?+&TDS*=MKO/M,"G23YI`'(;$ M7+@9:XBL!<0>-@5RHO*-<8:0T!@7);PA`1<29/PA)-Y3,$2�Z'4$^'6.0>#E_%!+Z1/`( M%"(0EV1XA(P-`Q+FDDP#O22+`4L,V$SCGN3-6NA5#F.8F2X+3%3R'F!\QC#A M@`4FA,-IALL;/!#&\D;"7-YHH)"+@8`%[K)<"<_XL9LE85B_])X>:%<%2[18`I'@OPW3;91X<-_CDFQ2:L@"CAHT2`$N$4P9D#RX.^.6QY0<(#4X0185)HRA24L%#" M1@F'$DNZ>%P)*P\7K>^AA(\2`4J$4P1G"6P+QBPAX8$E*V&<4&C*$I2P4,)& M"8<19#V_$1UAA?<1+_0L#R5\E`A0(IPB.$?(GFO,DB;./UE@[A*67F9+39F" M(Q:.V#CBX(B+(QZ.^#@2X$@XB?`6D?U3;]_))C*R!16'C3'87E)H02=U?D@= M6@5:J!DSP5Z+*]_,9\+2T>[*/^WN#HZX..+AB(\C`8Z$DPCO"ME%C;E"=U?< M0W\X;BC4)EXU9L(R\*!QP&)@#%$[+IZEC3+L?E].:;171G<>7\]-A@QE)J&8%.!).(KQ+D)-)ETBYN!I8"-W/U"@UD=\#CE@X M8N.(@R,NCG@XXN-(T"'$:V&^#KO",:MYD\@^M#>4NF<.W9_R0V@A;!5,>.U. M+)PT!T4L7,5ND=ZF9:%R?T++'%S3Q1$/1WP<"7`DG$1XP\B>='Y'JMI+AXS>'Q8\""K(O2`S)3V\*K?7CQ(\0=;0NOZX=Q4]^:S?F6P!_T M[6$L;NE;>--%7BQU%>!8[!:=D]^C\ISFE71-3M`T=4;.6DIZ@D9_U,6M>2/_ M7-1P(-9\OH,X%-1U.P'N4!W=OKT'P```/__`P!02P,$%``&``@` M```A`.+8,(:#"@``5$0``!D```!X;"]W;W)K&UL ME-Q9<^*X%@?P]UMUOP/%^P"VV2O)5(/WW:Z[/-/$2:@!G`*ZT_/M1T*&6,=J M_;OSD.7XEV-9/MB6C'GX\\=AW_M>GJNO18AN/YL?]VN;POA\/S M]JTZ;,Z#^KTZLB4O]>FPN;`_3Z_#\_NIVCQ?_^FP'YJCT71XV.R.?9%A>?J5 M'/7+RVY;V?7VVZ$Z7D224[7?7%C[SV^[]_,MVV'[*^D.F]-?W][_V-:'=Y;B MZVZ_N_Q]3=KO';;+X/58GS9?]VR[?QCCS?:6^_I')_UAMSW5Y_KE,F#IAJ*A MW6U>#!=#ENGIX7G'MH!W>^]4O3SVOQC+TISTAT\/UP[ZWZ[Z.+=^[YW?Z@_O MM'N.=\>*]3;;3WP/?*WKOS@-GGF(_?.P\]_N=0_DI]YS];+YMK^4]8=?[5[? M+FQW7]>WK?=L3>Q[[[#C-<`V??/C^O-C]WQY>^Q;T\%D-K(,UKS>U^I\<7?\ M?_N][;?SI3[\7R"#K_V>Q&R2L)]-$L/\[216DX3]_$PR,T8+:_;K+1DW2=C/ MSR3F?&),IK^Q/6Q]UTZ9MK/\;E-F31)#VJ#?[5KCMD5&JS'CP6]ODG%O#GN) MW[IF]LMYAJ)LKN5F;RZ;IX=3_=%CKV%6&.?W#3\B&$N#I6X*K:F6>^FQ5\"6 M\R_+ MR%9[7<'J;B&G\96(M#I0HG'56O\[#4ZS2PI@&; M!AP:<&G`HP&?!@(:"&D@HH&8!A(:2&D@HX&/K2ABVLON1GKS>UU#84#A0N%!X4/A0!%"$4$10 MQ%`D4*109%#D4!10E#HAU2"[JE35(`\_]MEA^EY?1J<&A='5(!0V%`X4KA#3 MZ\6D:8S'(_XEGT>]MK%FYD1A_+89S^:&P@1M8\W'"X4)V\:<6JH\4=N,S3$; M';,ON092B[J!!(4Q:E M3DC%R<8LJN+D8?D`R4:)MA-&T8@V%#84#A0N%!X4/10!%"$4$10Q%`D4* M109%#D4!1:D34@WR&;'6`/Y_^LT>=T M'U].CY,3,N6VNF9Y[.OJ$1,;$P<3%Q,/$Q^3`),0DPB3&),$D[0AXBQB3%57 MFIEDE->9N424U[0%;DRI)7*!\NE.Q?G;$-.@T@C'(+-OJP9IZU+DT1`;9W$P M<1O2G,7-N>JLZ5&D.I7Y!"U4YZE`1I:I.@&'%*DR101-52B6T7BB'.P0I.R" M5$;62+6Z3$;CD:J?3GN1'Y#[.JD':LA1Y-,3&61Q,W(8LKB.BT8#>GO#(66B)7($NCK$`>)Y>9G4$/OY7.D*8E:TQL3!Q,W(;< M*U"N&8\LGI,7DR\M9Q4HAN+7<2O[1BYC`DF/.KLH),NGY/\CLGQ!6A.3Y?2V M4T*6DPI)I<76P"+I,[I<[JM<6LP*D!1PT2S7[/922^0"Y!/KJD.@F'"7SLS& MA#1EQ=Z!`RL0$AMG<3!Q,?$P\3$),`DQB3"),4DP23'),,DQ*3`IM42N2SZG MWJK+ZY7C>/(Y#A=S[O)P9]*Y=-3-S%_?9+/F;T/2'T1M3!Q,7$P\3'Q,`DQ" M3"),8DP23-*&B'&@FU!*Y0OF,.ZW0]DR1F)$G M%4K.!2O^-C9]^:T;(CI(C/[XB5$^:]B2$F/I#G(D]+-4+FZ3AXF/28!)B$F$ M28Q)@DG:$+$C%F+"J-/'&4Z48U)@4FJ)7*I\"EY7JF**GI0JN3!>\7=#HE*% MQ&ZRB$Z#5N)AXF/B8!)B$F$28 MQ)@DF*289)CDF!28E%HB5:=);@G=9HFN<3)&9_=^Y?/RJE'B>*>\5;UNB&9` M9V/B8.)BXF'B8Q)@$F(281)CDF"28I)ADF-2-$04PU@U25]JL\AU^9,[0:;J M3A"=`UDU2E-T:TQL3!Q,W#OACT^0%Y!W7_CYUCTRS/,Q"3`),8DPB3%),$GO M1-$CV7WA3WLDQZ3`I-02N1;9N;E]!K\?(WF\)CXF`28A)A$F,28))BDF&28Y M)@4FY9U<'P<2R6?+5?\264PWCY4I]=J7>WWY]ZV_G9DQF4OV:%PWGIM+]H1<-^Z;2_8$7S<>F$OV(%\W'II+ M]CQ?-QZ92_987S<>FTOV=%\WGIA+]I!?-\X^?.&+*KXRENR9\:YWC25[7KL; M3XTE>P:[&U^9RY4J_]IO7MB^'@WX)RJZ21O3^FWWNIZ\OM#[Z"^^>!//T#``#__P,`4$L#!!0`!@`( M````(0#[=O6/;@8``)D<```9````>&PO=V]R:W-H965TQ1=D?:D5:KO3P3C&T4`Q:09.;OM_K" MI;K;;>FZ'(KTXYZV_BGOK\\A&&7GXHJZX+F M4M1PY="T5=;#U_88=I>VR/;BINHXZ,Y',J\^-KD[U51 M]]))6YRS'OAWI_+2#=ZJ_!YW5=:^O5\6>5-=P,5K>2[[G\*I[U7YP[=CW;39 MZQGV_8/$63[X%E\,]U69MTW7'/H`W(62J+GG-$Q#\/3TN"]A!SSL7EL<-OXS M>=C%*S]\>A0!^K7^C[(N(-J0)YZ!UZ9YX]!O>VZ"FT/C M[A>1@3];;U\_UO?R]ZYOJ/PDBRI5T0I43!C35=1K0=4*2Y6TO MH60D=O(UZ[.GQ[;Y]*`\8,WNDO%B(P_@F6^!11#*G%]\YE<%!LP=6#^>"%DN M'\,/B$JN0%L)@J(>010C=B:"L1$2`I.1#FQR1F>@P:V8!M.6V$K(6D2,4]_- M#&@%V*1E!6[=^'#/N`?8Z&KD***QE:!X!M)"L7,A$`MP8F'!K1#_V0*,$8V$ MQ+A(N!"(!-2>A02WXE`P(]H2DXJ*H'%"`ST0-LX<3.N'&;T+Y$@%:@X-=1K!-P. MC5U#80HP:"2ZC"B0LW"D'\4T":)Y9-+T6KZPJAH/=8N\QOKSE,PE=$'I.M#J M?H<1))UG%J?*KK3$E-ID2K;JK;F0+N(H";3'P$YY&7*YCF;)Q"RPW(J@Q`F( MAUCIF9BZ"Q.`P6?055MAJ')V03`CN_P2J9S0%>,L8DX!"N2LG4&!)S]7ZH7: M55B8M5XR)@$%DO&/&3/:&P&B8%(A%`MJ%V!AQA2,!X'".!C(\5,"KC.P*R^5 MRHNSH;7"5H%:<_.';XZ34(X#G:!I5(842<9,X("V:.M$C((+&=(KHVX\#9M M:QUAQJUC3G0*Y"(Q0@2)JY,^L^NK,.LL](>>`CE9S"7VZK3/[!(KS)B$(?(* M,Y8E,\L20V#:7U][[6%VA17F6].^`CF#(97:#D$%R@!CD55AQ@&QU`:_=]35 MF].^\GD/*2RL0],R4U#-R5J!E)1;)NL18-,Y'!N[FC(IE*AYCR;E)!)CY=5#(R[CI#'C-4B!AMG$\AJ$$8[7 MH-@NP<*,:1BUHS`N%G,!7KA8V#4XYF;,@A"BIT>A7.EQ0E"#QW85%F:LPE"Q M^KRD4$XF=\MP#&YF,JR_&HK+>FRHP8@[&?0X2;70[903.V$<%[O^PKNJ)4/Z M0*M0]F6DSC@AF(E=@F,IP?-.MF5(HIQ,7!#,!.NND2%SLB7$S)!$+<4_#`G5 M1)"?%,D$7A<6>1(DST^JHCT6N^)\[KR\>:_A79V"X]$J3Z"VY&%+^9F$9M_! MR92PA^,%."^Z9,?B>]8>R[KSSL4!7$;!"M+>RJ,E^:5O+N(HY+7IX:1(?#S! M$6`!9QY1`.!#T_3#%WYX-1XJ/OT/``#__P,`4$L#!!0`!@`(````(0#M)>A( M=@0``%$1```9````>&PO=V]R:W-H965TT[W(!OOU M\'@\GK&S^_Q>Y-8;J>J,EGL;.9YMD3*EYZR\[NU__WE9;&RK;I+RG.2T)'O[ M)ZGMSX<_/NV>M'JM;X0T%E@HZ[U]:YK[UG7K]$:*I';HG930U[H%DE6VL+"MOH=&_1RR5*":?HH2-D((Q7)DP;XZUMVKSMK M1?H[YHJD>GW<%RDM[F#BE.59\Y,;M:TBW7Z[EK1*3CG,^QTMD[2SS1\FYHLL MK6A-+XT#YEP!.IUSY$8N6#KLSAG,@+G=JLAE;W]!6^PCVSWLN(/^R\BS'GVW MZAM]_EEEY^]92<#;L$YL!4Z4OC+IMS-K@L'N9/0+7X&_*NM,+LDC;_ZFSZ\D MN]X:6.X5&Y+2'-X$GU:1L1B`J2?O_/\S.S>WO1V$SFKM!6=\3 M%FQH"Y;;*;0<_:3`MRE3?V%R/@AP:VA].R"T]G?N&[@I;45'(8(H'T2R(NX4 MS%7,+AXUN$#6X\&D1W@=!6N5*0*582I1%/%4$00R)IY*-H-$X@RTG*P5UGKD MB"!8R>\X"@VXOG=6*"OB604V*21,>(W&G:QU;\-D>X1@I6(*3<27?(&BC8,4 M2DFP#IW(&_\I<\)"#9_]*P>%1`S[0T/,6E7BM0QT%)HE)_;DOGC8Y0NU?*Q5Y8MDAJ/0"+[`A0: MO0,-?;CKFT5C=7#(/=WF9JTR&J288=OQ?'$4(CV;H0]W?;-LD9:-M/9>':\!NOA\G&X$K M;K;B/EB0ZDIBDN>UE=)'"0D*04'N6\6-^@@W:GXK=?L.N.?>DROYD537K*RM MG%Q@J.>L(=55XDHL'AIZYU>V$VW@ALN_WN"G"P*W/SC=VM:%TJ9[8)?N_L>0 MPR\```#__P,`4$L#!!0`!@`(````(0"C:$963!$``.F#```9````>&PO=V]R M:W-H965TQ_WIXX_W\<SOWY\?GF#D[Y]?9KP,X@O M^]IL_+Q3HV@['$7MVL:WK\LK=#,9_YP7_KXV?YW^W)M-GHXF'V.^W#Q0\1!\ MGT[_BM'A4USB+]Y07SU8#L'9;.UI_#SZ\;:XF/[<'T]>7A<\WLOC/4[?^$C\ M_[7W23P)^+F/_EG^^7/RM'C=J34WU]N=>C-JM&MKW\?SQ6`2?VUM[?''?#%] MOTV@*#YZ'M)(0_C/-"1JK3>VVE%[\S=2FFE*:Y72^/T4/NOE$^(_LW-IK'>B M>K?9\3^AS>RJ=/.41F>]U6AWMG[KNO"X+4^FP= M%=_SEA=GZPWLXL<_R6[.G6O2AN)EDN=^Z/%Z-O7V?3G&M\D^5K- M/T?Q+3?:CI-3D5,;<[7Y%O,8XQ3S.S5^3BSMG*M_?XNB3OOKQM]\LWA,H6!` M9:*7$;'E<6Y?%G:30G(?B(F!+.S)PKXL#&7A0!8.9>%(%HYEX4063F7A3!;. M9>%"%BYEX4H6KF7A1A9N9>%.%NYEX4$6*!W?U66G=#`+E73P"I5T]`H5-7RD MQH_4`%(Z@J7959XXE([IUO+U83DCU:"2&E52PTIJ7$D-+*F1)36TI,:6U."2 M&EU2PTMJ?$D-,*D1)C7$E(]Q4="H*:YB/O`%JHR$?"84D$@&!:QZ4*X')7M( MI\MJ5(.:+D%-EZ"$#\KXH&9'4+.#.Z7E36TY?3?XOIC?'/GUL7ASS.Z!<3F^ M!V8WKY`55I>J4;Z:/4TTQ9CT-;(ED-T$X;,MWGPWRX<::$BZ50CXDAGFI`AYQH1(1>:T*=[ MJ2%YI"N-B"-=:T*&W&A$A-QJ0H;<:42$W&M"ACQH1(00:42F4*IB41$9D[I8 M1%1,*F.1D3&&C"H&NT@.&0G;2`X="?M(#B$)&TF&DNK:&$;*2VP8J6(,)V6, MX:2*,:R4,0XG"4M)#BL):TD.+PF+28:9_"(OGSJ6,QARZJ"`]0R&GN)T`K8S M..P,V,[@L#-@.X/#SH#M#`X[@V%G%&VMOD$K]3?\':G5W\3E4G\C"SU9Z,O" M;E(HWD#Y5:XC6A4--;O=,K/G8/8UTZJ+WFGH8`XLIEX^GT,'J`[#W3O@1X\$)&+ M"BXJU;$DF[J>E#H**$M>J1X:]!&08;E.&P01D6 M&Y3AL4$9)AN4X;)!&38;E.&S01E&&Y3AM$%95NMQM+36E.6UIBRQ-669K2E+ M;4U9;BLJ6&YKRG);4Y;;FK+[I.42>;.>KXC'#Y>Z)5GHR4)?%G:3PFK]=)`52BL] MXA5RSP/M>Z"A!SKP0(<>Z,@#'7N@$P]TZH'./-"Y![KP0)<>Z"J#LH7&:UFX MR0JK>:(ZZ%L'FA*S2JV-*VZA%+;RI#HD"DW M<'4A6W4)&5:VZN+&2(:5&K*LK*M%"4M+35E>:LH24U.6F9JRU-24Y::F+#DU M9=FI*4M/35E^:LH25%.YH:MIPQVN^-:37 MV\'E=LC=YE>34G_#GW,H]C?9NUQQN=37R$)/%OJRL)L4"GV-+.S)PKXL#&7A M0!8.9>%(%HYEX4063F7A3!;.9>%"%BYEX4H6KF7A)BL4[@QJF>S6`]UYH'L/ M]."!B%Q4<%'I1"J^0O/WEZ+;I71V`2J?5?(:O+E$4R=D;\EE?2;E,""X30FX" MGVGI%8T_`FF]HL7ETBN:+/1DH2\+NTFA\(HF"WNRL"\+0UDXD(5#63B2A6-9 M.)&%4UDXDX5S6;B0A4M9N)*%:UFXD85;6;B3A7M9>)`%(E4)JI(.WFIH*!V] M0D4-'PU4CAI`4B-(:@@I'\/5[&\6%I22^U\^KE50/M9%2-[_\O&O@M2<(#4I M2,T*4M."U+P@-3%(S0Q24X/4W"`U.4C-#E+3@]3\"&I^!#4_@IH?00>(`$$48"1K!VA+TC+!YA\PBK1]@]PO(1 MMH^P?H3](RP@80,)*TC80<(2$K:0L(:$/20L(F$3":M(V$7",A*V,6`;`[8Q M8!L#MC%@&P.V,6`;`[8Q8!L#MC%@&T.EC:5O\>*?))4_MU1X4S9^>*?&'QC. M.Q5>01;?^H<$JFIG(-&'Q"XD!I#8@\0^)(:0.(#$(22.('$,B1-(G$+B#!+G MD+B`Q"4DKB!Q#8D;2-Q"X@X2]Y!X@`011K!UU,,IV#O"XA$VC[!Z9+C'-QNY M(&OX9U#80<(2$K:0L(:$/20L(F$3":M(V$7",A*VD;".A'TD+"1A(PDK2=C) M@)T,V,F`G0S8R8"=#-C)@)T,AI-BJ2(80DH$VQBPC:'2QE)3PS\^7VQJLG=B MX[)L9C;E6^L)M+G\D>S.9K-=7_Y7?BNGET`5'4\?$KN0&$!B#Q+[D!A"X@`2 MAY`X@L0Q)$X@<0J),TB<0^("$I>0N$J(9)HUFLDDJXL/EEP7H5\P-P[FMLB( M8]P5']M*9[M@[HL,[Q"3_%=6XJ'(_.);"=#*QXIJEXZ4$ZW99U MFJE["=3IF">2VF>?2"I>\F#4;)E'*;G7;/*GJZQS*PF1A]A(G!`D>#P-^)0SXI3#@U\)0 M,G*KD]ZIRL,12D9VNFUK^$/)3/FDRT)NUA/UQ6&J?`PE'[\THLWEY)+'*0G) M/U>80"NJU,Y$O(]/L9^1GYQ?/BX;F^XJ;/FF:4BIBLG3PT@?([L8&6!D#R/[ M&!EBY``CAQ@YPL@Q1DXP#P@S#B')820YE.1]A?#Y.*3DO8=PCD-+,`GG.`SE395PCL-1WG@)YS@LY8LF%^9PEC=NTE'BY'DK)\PXG.7MGG".PUG>$@KG.)SE M;:-P3K6SY=Z(/\=<[(VRM9XHKJN>2/Q,1DBIBOMT#R-]C.QB9("1/8SL8V2( MD0.,'&+D""/'&#G!R"E&SC!RCI$+C%QBY`HCUQBYP<@M1NXP$:]T28<0C)/1'.<2C)/1'.<4C)/1'.<6C)/1'.<8C)VSCB'(>:O-4CSG'( MR=M!XAR'GKQE),YQ",K;2N(FW!#!'.Z&,./PE+>K M3'(ZRW=2FFUK_8P;(7PPAZB\RR7.<8C*.V'B'(>HO%LFSG&(RCMJ5N64&Z%X M5[_")WGR1BC9[:_\$9ZN?-6X'\*,PTONAW!.9F;%+8#[(9SC$)/[(9SC M4)/[(9SCD)/[(9R3Z5EU?1QV\AH1/I;#3W((ROT0/I9#4.Z'<(Y#4>Z'<(Y# M4NZ'<(Y#4^Z'8`[W0YAQ>,K]$,YQ>,KK0CC'X2FO"^$\+H1S')[RNA#. MJ?:TW`[%.^M9[5"RXQX?J_")YJ[X"?(0)52%ZSV,]#&RBY%!BC3JS64GW5AO M9>\6)F\:1KM?1#>W]_M?LB^^I+G>0$<9_OZ7'(@OB=:[ZN0/'G0!B4M(7*5$Q=R]QL@-1FXQ1>XP\ M8(2[*6@L=U.8<6C-W13.<8C-W13.R52N&$WNIG!.)FM53F9G%9/96<5D=E8Q MF9U53&9G%9/96<5D,J+2SC'X2DO+N$\N(1S')[RXA+.<7C*BTM5.>5N MBN=SL9M2GT"*'U?OMHDM_4*44!5N]##2Q\@N1@88V<`(]T/0->Z',.,0DOLA MG.-0DOLAG..0DOLAG./0DE>7<(Y#3%Y=PCD.-?G=-ISCD)/?;<,Y#CUY=0GG M.`3EU2674)YG`_A!F'I[RZA',R3Y/U>OMG#7AY M*0E*H'0-H/P>!#=$^&`.4;DAPCD.4;DAPCD.4;DAJLHI-T3QQH>%Y:5E0]1J MYYN91\G&B&*927ZD+*62'U?HIA\5+U_L7HG9;%H_/-`O,:V&]:,FNRG#SS!? M^!(?.1M@9`\C^Q@98N0`(X<8B7]U,_@<[C%&3C!RBI$SC)QCY`(CEQBYPL@U M1FXP".".". M".".".".".".".".".9P3X09AZ?<$^$G_(X;SJGV-&F) M-@J_#?U]/'L9]\9O;_.UQ^F/#VXUXD8RKZ[-QL_Q+S_?YHTF>4-%40_1-O]* M8UWGN]=V_`NK]2.\5KC-XV,]TMCFK2OU5_0:V[R!I:[W&]N\C277-_*3FG_[ M^CEZ&1^/9B^3C_G:V_B9GTY]O<-7;39YB7_!>_*/Q?1S^?O?OT\7B^G[\J^O MX]'3F'_9.O]>^=K:\W2ZR/X1'^#G=/;7\I)]^[\`````__\#`%!+`P04``8` M"````"$`3G$J;3T&``!R&P``&0```'AL+W=OM3H\F&J.>_"?_[^ M\F$3!OV0-\?\VC;E+OQ1]N''YY]_>GIKNZ_]I2R'`#(T_2Z\#,/M,8[[XE+6 M>1^UM[*!R*GMZGR`/[MSW-^Z,C_*B^IKS)-D'==YU828X;%[3X[V=*J*\G-; MO-9E,V"2KKSF`_#O+]6M'[/5Q7O2U7GW]?7VH6CK&Z1XJ:[5\$,F#8.Z>/SM MW+1=_G*%=7]G65Z,N>4?5OJZ*KJV;T]#!.EB)&JO>1MO8\CT_'2L8`6B[$%7 MGG;A)_9XR%9A_/PD"_1O5;[UVN]!?VG??NFJX^]54T*UH4^B`R]M^U5`?SN* M(;@XMJ[^(COP9Q<AW^:M]^+:OS98!VR_F*]@HSP;]!70D-P-+S[_+_ MM^HX7'9ANHY6#TG*^"H,7LI^^%*):\.@>.V'MOX/04S,/B7A*DD*-%6<1WRS M8JOU)@(])T@L3`9*(#B]3HC#3$**61&E/L$;*1 M%1/4#]H`F0$6Z9A!C,+*M37`0A\FCK(:>P1E&L@HQ<&'("P@B8.%&-V%P'RJ M)+#8&"P0M);=X(G)`*-;[%6:1JOI:C(_R,XQOQBUYM].&;`*",IP_G46&?P. M>IRQ=91-UQ,&:\)`"@_VZMAQ$368@+E-F9`)@F#%4[G,:O@0A,T#83.R$*.+ MJD"0CX4/05B(@V'>C",+,6K4PE8%@K`KZS0R"Z&'TU4$M=1^[NS%K9.-&+78 MF!I!D-)(%AGA@QYF/)KW&:D&`T/6RF%*1(8-)CQAAD84RM<>+X0RHFXY-HBA MORVXAT)YF6`B-X0R$?9F2X6AZRTXB$)A>S*F>83<5P<2WT9S22D%878."NB! M!@5#`7LV.J4X4S:9)@%%08^G[)Z),"B5QL&2B`A;$C&/#IED%[JKKNA@(C>$ M5L7MK'!;\`XK42CW-(K):*\NTZ-,J,-.8G58JVTG;'1.T9]U8OD)B:>))B'* MP>VK#!UQ22.C;PH.(%-#0P>5!67,4NT@HARHJUH:<=@K3V9+E&7?L]%`7657 MG?%!*".WLS*T15#^=)XY;D(4RJN1T5_G1/-Y0)AP:K&C1N2PL6]LC2B4LI'( M*-EA"B^S<-LJ1S=<4(E"J;-F92EUBB_3@)D\9L)%V"@*3^:[&Q2*0OG:XX70 M]@@7M"V6HSDN"$6AO$PPD1M"F0#&Q40,&S5Q"`51:J,^1$R[]TC,$_O`=71R M[_01CSP:(7-7R[!!C"?SS;!JEL],<5>K1,!IVI3W]I+;;SDZZ5*S1K]U3:.8 M^""T66[7Y4[7-6[?]PKE7K!BHAOS_0Y1WYV\Q>&W;&MX^Y[[S%2Q&"'B>$BB M^52GM:!>:^D$K9)XC/50M><^0U5L?!#""!ZO=>6.=9'#BP\;"N7KCA="F;A] M-WV7[RH4;NKUQK)_$M=O("@%O^>F3L^=GQ=D[?<*Y2T*)G)#*"/AB;;GIFB5 M"]M8H=S3H%"\$,H$TKB8B&'#VFS/31&E/)?9[='CV>K>S5-*;782*QHGV3;V M)I87BQMKW*%&VPXD#"_$^%;_F=&T*-1ES?VK?; MIFZWEI`E]Q['4FJVDUH<)NM0 MR^B@0BUL8ST2RN2CFOC=1\*,VJLI$!DV=@]/S.-'H7P"\4)(6S*WSZ@RQ(FG)GO M_3)$N1>LV/@@E!&D<=5$#"]W!U%>)CX(9>+V6G@K^@Z_5RCUXE=['E?UP"1C MV#17_,2!'P;JLCN7A_)Z[8.B?6W`(3D8^#2*GU;V[''/Q#P% MX$/(+3^7?^3=N6KZX%J>(&42/0"C#K^9X!]#>Y/O^%_:`3Z!R%\O\&VKA)?Y M\'XA#$YM.XQ_B*\RT]>RY_\!``#__P,`4$L#!!0`!@`(````(0"F64!GA@@` M`!(\```9````>&PO=V]R:W-H965T'?Y^1A)EG]8PET M+VEI>?SKSV&?^>V=@YU_?,J:1CZ;\8Y;_W5W?'_*SJ;.726;"<+-\76S]X_> M4_8?+\C^]?S?_SQ^^>=?P8?GA1F6X1@\93_"\/20RP7;#^^P"0S_Y!U9RYM_ M/FQ"]N?Y/1>K:__3QXQU`D M.7O[3DV"#_^K>=Z]=G='CYUMUD^\!UY\_Q>G M[BL/L8USRM;.I0>&Y\RK][;YW(=C_ZOE[=X_0M;=);[)UM^S5V+_9@X[/@;8 MH6_^7/[_VKV&'T_90MDHW><+IE7*9EZ\('1V?-ML9OL9A/YA(9!Y32626--Y"B+9=R;^6KA7O^`S.HUC<7R M16G*1M$JW5/:_,FS$L],8G#:\?LP'GOK:+==S&W<4 M&R];SO_F_K(5ZX*`17\_FY9I/N9^LZ[?7E%-(':\WT@6]4CP[N=Y[1MY3;,@ M;]6(MOHQKQ.)*&^3!EHTX-)`FP8Z--"E@1X-]&E@0`-#&AC1P)@&)C0PI8$9 M#ED=(P9+[L29(1E7%70)&V5D"0=5=`D7960)#TH^JJ@+S-0 M"7F9H2IHDI%*2)*Q*FB2B4I(DJDJ:)*92DB2N2IHDH5*2)*E*FB2E4I(DK4J M$DFD`F47OUL%RL.\0*/WR)H(5.)`G0;L:)/$&Z]Y7Y&KNJ&#'!W4U$$M'>3J MH+8.ZNB@K@[JZ:"^#AKHH*$.&NF@L0Z:W$*5HCQ4ICIHIH/F.FBA@Y8Z:*6# MU@!)-#NKKH($.&NJ@T0UDF>0J,=9!$Q45RWFY?Z<:9J8: M,U^XEQ/-==#B!C(K9.:WU$$K%17+9.RNTXU4I^R36K).H\DN#TOU*0*)^J0! MFV[2H`$G"GQ7L-(M30W3TC"NAFEKF(Z&Z:I&'2:]&T@9`7T=--!!0QTTNH&4 M\3W601,5%0M5N5"F&F:F8>8:9J%AEAIFI6'6Z4:J-G8CXE:U\;!4;2*0J#8: ML.DF#1IP:*!)`ZTH\%V/E9+<9RXF;94H7=_1,-W(1-/W'@WT:6`0!;X/H%@D M%XRAAAEIF+&&F40F.H0I#DNJ)A"[D,2WNLKRT*A#84/1@,*!H@E%"PH7BC84'2BZ4/2@Z$,Q@&((Q0B* M,103**90S*"80[&`8@G%"HIUFI"*DJ_[T!O3B0]&O/DIR^Z%Q'5GFE4R=ZT) ME%:<4-BJ,,T\J?&&#G)41-(TH6A!X4+1AJ(#11>*'A1]*`90#*$803&&8@+% M%(H9%',H%E`LH5A!L4X34HFR):FT$N7-I$0MD]P)J@F45J)0V%`TH'"$J%Y6 MM.ZJ1KDJ_9!/H,VDOB\:9#;8@B_G0M&&H@-%5XCRY:#(>V,OI:TOVJXGHU`R M+.EDD`_V`[@?0RA&4(RAF$`QA6(&Q1R*!11+*%90K-.$5*4F6ZI7RK18BF\Q M7MJ5.B5#NG95:86*B8U)`Q,'DR8FK9A<%K'S!AG6KM1>R1O5?/*'7+K;L?Z> MD!#2P:2+20^3/B:#F/"#ORL8Y&UY*+>;!GD#',7M/Q[N&),))E-,9IC,,5E@ MLL1DAZ1RX_+TX8(J5>6D2;)EDV-6N*K5R1:(48N,L#4P<3)J8 MM#!Q,6G'1'R)Q2#GK2.UWY5I>S=N_[$$>ICT,1E@,L1D%!-^N`635OQ8:K\W MR.+N)&[^\6BGF,PPF6.RP&2)R0J3=2J12Y6ORM-235YDQ:H]*55RR:F90A7% M+-0L&.0F73T&/_:"C4D#$P>3)B8M3%Q,VIAT,.EBTL.DC\D`DR$F(TS&F$PP MF6(RPV2.R0*3)28K3-:I1*Y:OE)/JS9QD\D4*_FD:LE;8^VJ1-66Z52I+C7? MD<4>.V[]L:(;F#B8-#%I8>)BTL:D@TD7DQXF?4P&F`PQ&6$RQF2"R123&29S M3!:8+#%98;).)7*YL@FJ4J[)BRQO5S[)DHJKF4+]6*[)9HM.D^QXZY1ZC3+\ M2!RQ3<"Y!56B]RHK+&'1'A5LZ**EWK(1[4Z)C8F#4P<3)J8M#!Q M,6ECTL&DBTD/DSXF`TR&F(PP&6,RP62*R0R3.28+3):8K#!9IQ*Y;OD7)=+J M5GR10IX66^3+=37V,!FL6TALG*6!B8-)$Y,6)BXF;4PZF'0QZ6'2QV2`R1"3 M$29C3"97(A:F"D6##+FIU&X5Z$VLF=2NW/&?DV9RSWMQ;;ZYG+:4MBW0Q825 MU&S2^SK\P4M>*S2UJ$KQ2*5X:N_@G=^]NK??!YFM_WED5T0^CXVCXE'.FOG` M'K!C7ZXB\09_Q/-&O&8]U"Y/?A)?MQ[JEW@N;F`/:IXV[UYO*/T#_Q+^IE7OR0/:)Y^?6#/7OKL4?]\@;#;[X?1G^P'KP!@``2AX``!D```!X;"]W M;W)K&ULC%E;;Z,X%'Y?:?\#XKV`#;E534<31K,[ MTHZT6NWEF1*2H`DA`CJ=^?=[[&.PC^V0]J%M?#Z./Y_+9Q,_??C1G(/O5=?7 M[64;LB@)@^I2MOOZFM[;[U MIZH:`O!PZ;?A:1BNCW'J*?JHO587L!S:KBD&^-@=X_[:5<5>/M2<8YXD MR[@IZDN('AZ[]_AH#X>ZK#ZUY6M3709TTE7G8@#^_:F^]J.WIGR/NZ;HOKU> M'\JVN8*+E_I<#S^ETS!HRLJ'S[7XMDP*%_[ MH6W^0Y"D/CGARDD*-)6=1WR]8(OE?2\Q,I(K^50,Q?-3U[X%4!XP9W\M1+&Q M1_`LEI`M()2E,'X45HF!X1Y&OS\SSOE3_!VB4BK0#D%0U!/(0N0N(DTG)S$P MF>C`(@TZ(PTQ2FFDUA0[A*QE\`7UW!@@,\`B/3.(4=K",=+T)AY:4@1AT*UC)W",H4!1;9'$Q[&NETDOG%CJ"[<`R!&'7F MURO`1"`(YW]81VE"?BQT3M`\8E/`")V-EXX8=>BL)P](!T$JY#Q;\,@*6$X0 MD)2-$3+"`ISXHB*'*8]L94VR4Z"Y^IR%4"(>D33ZA:&\F>+A:1B%FF6$COP0 MRDBHFULP#$7/DA"[:10*2V:U6426EN8$L$FTF7(04`M(8!TO3+*F;+P M"ZQXWW%9V!VC4&-+V/)*S,PXIE`&5%RG.+BBZMEC^"B90L$?EHYP4#LSPD0Y M4#V=.*#\W=EF^"B2@D.6V=L<,4,FIN,<94#UTVD8KXY:,KGCB)JMSSD(942U MU&&$P$0!<:RJE"W9@=7=A&.KN0-E>P4E0\ M:^UZ7U"SC[HHFL07?M-^._Q^S4Q]FIG:^XE"S77'+(0&@^JFW1TIZBJHO9\H%.8_76V,[4*5IRFTXHBF/5`6?B5-O4KJ-(BI MI"QBY$4[L;<7Y5/5K"']E!`5UJEGO(+J],RHEG)[28PM3$7%LM]XD4NIE$X< M4/GN=Q]<<#F_[-UAD?OF4PU0]LK6=&07RER'&8A9"4I)1 M$;5[1YKO?CVF4+.,4)7]$,I(R)\K;1FJHI4@7?DH;0J%=' M4$$/#Q1'BX>3(U-"+?'+L]&H!4D_3V,!/'T?EG-7%G-C+.=JHQ1-'VSJ-J8@]"\4&5U MN@:U$](\M^-DH\)JE"X#Q6@.0AGYI37S2JO3-:9T:756NI.H;!,.'=?N`E`MQ1AL/#+JAR^VR\*A0ST!!@!8H1FTAL@)4#E=.P4 MN)=[1Z74^]T'9OEZ@#CFX MG4;QRG#''G=<7")9XSE<)#+`!=^U.%9?B^Y87_K@7!W`91*M0`(ZO`O$ M#T-[E7=7+^T`5WORWQ/-TRWP\_\```#__P,`4$L# M!!0`!@`(````(0!J["S.D`0``&L1```9````>&PO=V]R:W-H965TP)"0$"6I&M#=K=1*5;7;/A/B).@"CH#< MW/[['=M\>$QDFH=[@^=X.)X9S[&S_?1>%M8;K9N<53N;.)YMT2ICI[RZ[.S_ M_GWYN+:MIDVK4UJPBN[LW[2Q/^W_^K!]L/JUN5+:6N"A:G;VM6UO&]=MLBLM MT\9A-UJ!YF]>O]]C%CY0U<'/,B;W\+I[959ILOEXK5 MZ;&`=;^319KUOL7#Q'V99S5KV+EUP)TKB4[7'+F1"Y[VVU,.*^!AMVIZWMF? MR2;QB>WNMR)`/W/Z:)3O5G-EC[_K_/0UKRA$&_+$,W!D[)5#OYSX$$QV)[-? M1`:^U]:)GM-[T?Y@CW]H?KFVD.XEGY*Q`MX$?ZTRYS4`2T_?Q?]'?FJO.SL( MG>7*"XB_M*TC;=J7G,^UK>S>M*S\)4&"^N#$[YPL@&9G]QU_O23+<-Z+*QF) ME21IF^ZW-7M84![PSN:6\F(C&_#<+:'C,2P*8IMQ]&<.%Y.`;@.C;WL2^,NM M^P9ARCK008*@RD<01L0]@H>*^TV4`1>8#?1@T0J]G@4?Q2P"'[_A,(5HB'B* M"`+L))E"UB,$\0R>\N2CD&LU$($?XI<<)`AB/T1+0\2SB,2$0#SA-4H\1;H# M;\@NM^YL6/5(944TNA(3B=Q#ZITUML?2'@J['VBS$W6V3U;.F!1$$W:%@2:W MZC1'1Z*@#A*S$#2BA:.5:*R:0^*,697EJ)J72R<:UHA8AHAE7YQ\5&>G^3]( MC&0'0=+?'ZMV$D;.:B`@^6$[S/>4SQASQ';UE"T?Q6P#+:,'"8',C56!Z<2S MB,2$0"RY-H[]J(\I'YW=2!)DXCF+2$P(Q#-"//6-Q*TXJN%D(TF,K`$RV4;8 MJE5WTEN?I031)"!J3^(IAC'!53A6N=Q"'<@4T'E(8H1@KEP$IKDG4AMFNFB' M,I*5C@R0Q.@%D^7:,)+5"X!(Z3"WT@[4E4"T5REZUHJZ@IB%),0$P52YDCRA*@4&ZFH0*3B8 M:OOI0$PRU)&=A21&+Y@LEY.1[*0@I-JH\9W*!.DE21RV%PLG5%N`UK-CC/:> MU`=RYRV4HP6FSB5FI#Z4A%0>E7*DB=.!F-2IB_(L)#%Z053]YQHGAF=[1(-5=`S M3/6<%72P6EZ6Y4/+;N(R=V0MW'W%URO\J$'A7N@Y`#XSUO8/_#H^_$RR_Q\` M`/__`P!02P,$%``&``@````A`#Z#'T()!0``(!,``!D```!X;"]W;W)K&ULE%C;CJ,X$'U?:?\!\=Z`@9`0)1E-\/3N2+/2:K4S M^TR(DZ`&'`'I]/S]EFTNOC"D.P])J7.#-I[>RL%Y)W>2TVMK(\6R+ M5!D]YM5Y:W__]_EI95M-FU;'M*`5V=H_26-_VOW^V^9.ZY?F0DAK@8>JV=J7 MMKVN7;?)+J1,&X=>2066$ZW+M(7+^NPVUYJD1SZI+%S?\R*W3//*%A[6]7M\ MT-,ISPBFV:TD52NX*]/ZY79]RFAY!1>'O,C;G]RI M;979^NNYHG5Z*&#=;RA,L]XWOS#6@?;8C5WPM-L< MV1!,=HW9SSP"?]?6D9S26]'^0^]_DOQ\:2'<"S8EHP7<";ZM,FHC7H+."_SV7OP/4PD[)_#;.WD_%5>(PT7%:9ON-C6]6Y"IL/SFFK*\1VOP MW*G923+H"V'.&/HS@_-)H%P#HZ\[%/C+C?L*$@2+&O.+ MI0$7F`WT0'>=7N`-;)A59;/RU3OM38B&2$Q$$*A.L`E9C1"%+T18XMNKQD8A M_21!HFATP!78"PR$8!`M4EDD#Q%X#J'0A-M,T&2C6QL6.U"`X*Y4%GL!BGGL M%PODZ"QE>[B,'$UN+-M1!!4Y^%<80HE*#'E>2H%G5H-I/'@2B@I0*+(TBIU0 MM2>R/8P=+2!8-@?(0<-LA6>D\.P#SD9U?H$W>!#\!$@H&4:!KE0B[*#7$`Y- M:SR'4%@N%990&O,<\)M*1)#(2_\I2/ M%C(\,4&*"?P=PZ(N@S60,5V&98B^(F]I4:S7(>I`_3+4,DWFS?B79I4?:R$C M/WT_0Z+#R#PA,0R]!4K.#$#IR='YDE$:!,]"5-ZLI8R\!UU%IU'X>K%VFSV: MZT<\A9+'$#P+4M`)+X%&9[YS=%!\V,O5C3,$?FJ*NC36HB;6)OJ6L;:5M M'7O4@?JJ=/3'S.0A`L\A5**L+4T0%=U*)6IDN=G2H"JU4"5H$C7N9KP<\#3J M%ZT&L98T05IT*IDT@B"KN]J>3][:LVDN',U`\*P756'6D4:R1FV*A@4;QO"P M,]$9T5Q;ZS:4AQ`\ZT4A[4\W1SZL-4>C-GM0E[_(62J-ST-?GO2G)V.*'Q@@ MK(%\!ZGU&\M3U-5,]TA_HD<:U=B#AFK4FU-B(M2,PR9@W)M4GI"Z4JKT/0<. M%?1GOFBE%V,'DG,6!:'6\9-IE+8#L5,,=D/-UQ@T05H<5(AWZI+49Y*0HFBL MC-XJ2&4$3T;#J#@@V<,!"3]D<`<#'%M=58!3G!5,]9PEY=BQ,. M<='2*W_=/=`6#BSXWPN<1!%X@_8<`)\H;?L+=H;"3E;X*__N?P```/__`P!0 M2P,$%``&``@````A`!W@/"5V"```X"@``!D```!X;"]W;W)K&ULE)K);N-($H;O#,GYD_(R._3,I\^/G[Z;CX5E[K0W5^7+I@O5R4 MYWWUK]>WDJZJ"ZE&>(O%;74]'`G]>W57VYEL5+>]'IN`K7ZW1U M*@[G)?9P?YW31_7Z>MB7OU;[CU-Y;K"3:WDL&O!?OQ\N==?;:3^GNU-Q_?IQ MN=M7IPMT\7PX'IH_VTZ7B]/^_O>WGP_Y:U=5K M$T!W*S2J[WFWVJV@IZ>'EP/<@4_[XEJ^/BY_6/P[F$;,,\^1EXKJJO7OK[BV^"BU?JZB_M#/SSNG@I7XN/8_.O MZO.W\O#VWL!T)_Z2?76$D>#[XG3P-0"W7GQO?WX>7IKWQV64!LEF';DP62Z> MR[KYQ)E*(*U,HBX(N\4?H[`2.\&,B3=1.M^CFTMW009NE##7Q6,-]YE,*9@(Z&9EHYV>4$1]] M7,(M#9F.XIB/E:$H;FU/#('&].!;U4.Q%UF*$('=\X% MPF'>Q6]Z\/O0L&J[J?"MRL-&9`%%G8?`K=F7X^J\4]]TM#,=^5;E:,O'R%"$ MCM8\EG>QF^,[V`-&*9$+I0TK)SL^6D8JM!+I&F%QMI18A3@#JG'28ZP-2R^) MN/.,5.1E&PBO>1^_G1J/O*%:5&J0B!PBB2B$S*$*[3A15'D?O6W&DV_"#((1 MOO>H<%$B&)ZY*7PB4"8E?+8\`"<<(1]%>B3A'*IV+623;1")_.4DL!G(_=B< MA>.)7TOCS&C0DL@>A1(S&[7.9FW;K,I7;CJDPH2XR`4[`<.<%+97GA$;N9V% MWD2LVXQ4E)PTV"@?LP$<3@.X#:NJD5L!J2A):;"3?IB`KS-6,N$T@MNPN-^;";[9T#M M1Q*(5+?\:"Z#ZQ_YX6B66WJ(AUF^9Z622*1BOIP3=98;JJ$CGB0;TZ&%Z522 MB%3,3)0*/N2&ZD=F;%:'R&I1RVKAHVIL9AB&:GE*PM-B`SJT`)VJ6D85KO)M MN@Y4&<\&-#PV6FNJ;59K2M8PJ>``[)_YH2[A`PQ^>,Y)@B=$;I7E(S+0#-=V M:[P-*S\B_1FI.C_)+E&9(8D]B=P1YW'OQ#+$_5H29(Y3CQ$ M!Q+W3I"MX_5L?.AP&\#1E(2G!,R.C+2`&3W"1#[,#Z,NV@AT9*2R[QN7T:2$ M.[(1'%D(CI23#JZ^>N,T"L0ZRZD;VRKW8:!WG!D+O1NY64:H&@_GHDB9TJIA M'7!3-GHCC=Z-$^LV(]'8RS`*S1+V8TNX$1N[D<;N)A2C9"2R1R$CLZD;<>K* M';(-R[6]$1.0D0J1%JN/:_KP\+`ZW!-+2VRSMVV6+F+)7E+1HW<@]\0^?-L% M)V]'E]@W2Q<;L=%DI$(7=VMM`WNQ9X\GP\9M;.$VEK@E56]#5'/>QV]G@[-6 M5DBLF0N($\-EI$([2;`>/=+!KT,U8/GVZMOF((\3_(U]^"9_265/"3G"CFP) MGS6;OX`^73R*OZ3"-(4Q_`M%'!YZP>W,3/,WGL5?4HUO&R97F9K-WYCS5]42 M\A,JJO]4:Q.JRIZ"+,W6E(3/%N>P,H0<'1\HX/Y%N68QJO#PF:9JTZ3X.(M# M%]P.IW%/'CR\-L%9VYM` M-G*6J%-,TA'4F[@;;I,RT45OF^!\[4U87%5GF`15=(81RRGOH[=-<*JJVK#H MJDXP2<=.GY%$F>FB-\VDG*RMF=%S41OF*\=X8B25O2YPCB8EK%I3F[%MLV2] M.K&0"J$&G]:+=5TA% M/N!?<.GXG0.QC^>DGF.*0U@5C05CF8,,7C/SI46SM4Z#K4BC?Q'-*Z8,X8MF M^&+5J;R^E7EY/-:+??5QAA7DX,/-OA5?<,O@!;?V);%5'X#7SB[%6_F/XOIV M.->+8_D*EZZ##=3<%=]0PS^:ZM*^!/5<-?#"6?OK.[Q)6,+K6>L`Q*]5U71_ M^/>K^G<3G_X"``#__P,`4$L#!!0`!@`(````(0!16YK5[P(``*D(```9```` M>&PO=V]R:W-H965T#"20-`JI MFK!NE39IFO;Q[(`)5@$CVVG:?[]K#"1`1)J'!"[G'I][KO'-^N&MR*U7*B3C M98AL/(0HC^_G^Z6R)**E`G)>4E#]$XE>MA\_K0^45+>))R41`%M^*`924H2>JD(L>>XP2X(*Q$AF$E/L+! MTY3%-.+QL:"E,B2"YD2!?IFQ2K9L1?P1NH*(EV-U%_.B`HH]RYEZKTF15<2K MYT/)!=GG4/>;.R=QRUW?C.@+%@LN>:ILH,-&Z+CF>WR/@6FS3AA4H&VW!$U# M].BNHB7"FW7MSU]&3_+BVI(9/WT5+/G.2@IF0YMT`_:;J%S]]H^R0*>BVKU-BGL-*\&T53&\!J)R\U;\GEJ@L1+/`]A?. MS/5\9.VI5$],YR(K/DK%BW\&Y#94AL1K2.8@LWGNV=[2=_W@-@LVBNI*(J+( M9BWXR8+=`6O*BNB]YJZ`69JIF5U7I:(B`I1,!WOC]1;8&!$YWH*"/V-U$1%.(GDY8YHI[.@I= MOI``.@ M1".$=W:CIS.XJE-'1SJ7`YT&-.7G340TA>CI7%S5J:,W^VY`4SIO(J(I1$^G MGH/GPZ=]NW5TY.>@J]L&U/0]L.=.[^-^N1N>`/V,>SOH)3C>*`-&AQ9RW0M3 MAQD-YD`MJ#C0'[*+=1'KT]+DUB&]A4M7'/>X>P`"IR('^ M(.+`2FGE-`5*QU[`;A5FUI@;Q:OZ&-]S!:.COLS@+P&%8]6Q`9QRKMH;6!AW M?S(V_P$``/__`P!02P,$%``&``@````A`''Y)DY.!@``JQH``!D```!X;"]W M;W)K&ULE)E=;ZLX$(;O5]K_@+@_@/FF:GIT""&0 ML-)JM1_7E)`$-80(:'O.O]\!)^`9HM+VHDD\#V-[WO%@P^/WG^5)>LOKIJC. M"YDIFBSEYZS:%>?#0O[G[_";*TM-FYYWZ:DZYPOY5][(WY]^_^WQO:I?FF.> MMQ)X.#<+^=BVEP=5;;)C7J:-4EWR,UCV55VF+?RL#VISJ?-TUU]4GE1=TVRU M3(NSS#T\U)_Q4>WW198'5?9:YN>6.ZGS4]K"^)MC<6ENWLKL,^[*M'YYO7S+ MJO("+IZ+4]'^ZIW*4ID]Q(=S5:?/)YCW3V:FVR2 MXIQ#M$&G3H'GJGKIT'C7-<'%ZN3JL%?@SUK:Y?OT]=3^5;U'>7$XMB"WU5V2 M52?H"?Y+9='E`$P]_=E_OA>[]KB0#5NQ',U@NB5+SWG3AD5WK2QEKTU;E?]Q MB%U=<2?ZU8D!P[S:=45W+6;97_!B7KW`Y^#ETT.`P?;S@,_AXB_/P[XZ<40G M7YX'K*%^*/`Y#.73\_"N%\/G=?B/CN^O@@QJH/7MB5FF]ZB^0>9F M5\CG$`1KA)AI8FAY@[H$[EP'M&%%&T+:L*8-$6V(:R-N`TN$ M!A7"-L0.PC6)G:$-H>K,.%2NCKORIP@AEE.",1KOX"YDX[Y6]R!+PU`XA0P# M(^LIPIC%,!3=@TP70_$]B)%A;Z80"=%V2M`Q)U/$':>%-(5Z)VIZ2_NN&>JH MD-&>31+:YPR4NB'KR5R6LT0P2ZQFB7"66,\2T2P1SQ*;66([2R0?$4@W"/L] MW;KFA0SR#YJX)`M]CGB\ECF6I9!JMD2`[9@*$3[@@'VMAAZY?H6N-VU3(6D1 M8L!T:`=K##!/(4L@0H!AVPJ99(P`W3&4,?W[XKL1`=OT#!J%K0A8EF8K#E[- MB0B8KJDK3!O_QI`AU>#6?D^UKAFKQJ!+W)_/(;@O]CHC)(1A3>0C!#,H$6%"AQPAT8TYX?#),H?*AQS8FLXF^B'" MTES8$N)P)9P`&8>U,B8J4@WV5/=4ZYJ):AI)5)\S9C\-G89R*5IMCPXP$,V. M1T.T$LVV0:\.1;/N4*'7HMG2Z?J(1/-T^<3(K-.^-Z)99Q:U;Y%=MVCOB6AG MFICI2!C8Y-X3IFNFPA#Q?<[P*JBS28U;BG;#F/CG:+`)8)98S1+A++&>):)9(IXE M-K/$=I9(/B*0?G"F$_6[;1>[9KKB2$7W.<-7G*98I%(NL9GL*0+1RA0X$:`_ M7-A7(JPI'NDIQ&:;F-?83'H<`*,$^T] MK`E@TRXB#)B30UQ,@,DT-Q@`-<@8MA@PH7W( ME_GIU$A9]7J&HJC#J6IHY>\D?/8`3T#A029IWW3O*OJW#8,!WB!),=VG%CA58% M3I,11EPQ70G5%/CWK^>[.4;645713BM>X'=N\4/Y^5.^UV9C6\X=`@9E"]PZ MUR\)L:SEDMI$]US!GUH;21TL34-L;SBMPB;9D?%H-".2"H4CP]+$==9"_;45OCVR2W4(GJ=EL^SNF90\4:]$)]QY(,9)L^=(H;>BZ M@[K?TBEE1^ZPN*"7@AEM=>T2H",QTA.#0;QN0'L-9ZXZ$OE0_!9G*Q^SD,X(=!%:_I MMG,_]?X;%TWK8-I!C^D.E.")I/`6@,KI6WCO1>7:`D]F278_FJ3C#*,UM^Y9 M^+T8L:UU6OZ-H-2K#R3C`PF\#R1IEDS'V?W\!A82,PJ5/%%'R]SH/0)W@*;M MJ?=:N@3F0PF'/(:BH+7,HU<>7F#P+Z1K(;HKTRQ+<[*#-K$#Z#&"X'D"I>EX M`!&0'O1!\TS_*..C7L;7[W4?8^`CY3R[3CFY2NFC!0:>(:G%_)135(F8Z1EF M=ET"(%>R]E$8[=EV:,[_&A%T@P8XXXJ&CWXL`S0F0Y:QC@B:AOF<]&/?HYNC M!R0W#?_"N\XBIK M@[APN@\.6VL'K@Z?+=Q6'"8Z2@!<:^V."W_0AONO_`<``/__`P!02P,$%``& M``@````A`(^FWG/G!0``^!<``!D```!X;"]W;W)K&ULC%C;;J-($'U?:?\!\3Y`@\$FBC,::&5WI!UIM=K+,\'81C%@`;G,WV\U MQ:6KNX.3AR3N.EVF\SQ[.MHLZ;0UF?]O8_?S]^ MV=E6UV?U(;LT=;&W?Q:=_?7AUU_NWYKVN3L716^!A[K;V^>^O]ZY;I>?BRKK MG.9:U&`Y-FV5]?"Q/;G=M2VRP["INKB^YT5NE96UC1[NVL_X:([',B]XD[]4 M1=VCD[:X9#WP[\[EM9N\5?EGW%59^_QR_9(WU159MTS7'W@%W+A+5SQR[L0N>'NX/)9Q`A-UJB^/> M_L;N>,!L]^%^"-"_9?'62?];W;EY^ZTM#W^4=0'1AGL2-_#4-,\"^OT@EF"S MJ^U^'&[@S]8Z%,?LY=+_U;S]7I2G7.!)\%OJRI%#L#1L_?A[UMY MZ,][.XB<<.L%S`]MZZGH^L=2[+6M_*7KF^H_!`W49R?^Z&0#-$>[[_B[D(71 M;2\N,AI.PK,^>[AOFS<+T@.>V5TSD6SL#CR/1QAYS(>"V.8"_4W`ATU`MX/5 MUP<6AIM[]Q7"E(^@!$&0Y0N((M()(4(E_')IP05F,STXM$1O8B%6*8O`IT]( M=(B"2'5$$%`G7(?L%@CA&1">0Q@#;XZ:L,*=RP$)PY`^+$$0W,$!38*@S4`VCAPU!V3S;N/$=#>7S=M8.BJA%QGIB55* M+XZ5QR>(078[A7HJ&Z/(V7CRCW(IG(#C#\&$]];(6ZQ2WI`#RBTF"$+B8>@H MJ9S*9CU%N&PF*4+H"95<.M-4^F*5THMCY?$)8B#3YC16PI7>1/`U!*$9$YIJ MY0OKS0Y3"HK8-])V M2E&H@7[U#$5":4]*V20C"BDR7RI:[$^J74D>3NQ0=O,)*$4A#0:*J!@R1;WJ M&8*0H=Z3B-F38C0JI;R;.4SN"IZW!)S2%<)@H(MZ(=,U%#N;5$7(/=2KTB53 M:M>2@A,[20K*44B#@2,JALPQCI5Z3AB"UDKH-H2O0BA7H0P+5[7JX27P$V4_ MHE9)3PKT82OCJUXH:2$2"^FIHS+4#CG`ILJ7%88Q34E'+YC4.R2IOR%;ACXHYPH_!!4@E)1\X\1;&$E]CC(6 M*F)@C.(B,S9TB4F!1-5M@P\E?>QJ,CKRI;8U=@W9#HJ]A(<2%C)B((SJ(A,V M]8E)@X:O!;X4E)$CL6LIQ)EL7TDAPM@WR]FP3.4L9$KC2D;06@'>AO!5".5* M=4WM&C[J&W3;^;T%HJSH4S*B5DFCHQ4(7_5"2<.M&U+"%\LTP(:N,:*P*ZA? MKU)B93M-ZJ@]D!**,C2+FV\4MR7QL2^,J+%O18Y2Z2FQ;[?K9<@)&LIPN3S* M&*[&%%.Q3&.J]P4?04@8OI2$I-,NKRM8$J=Y-TB'F M#@IA0U\84)$UU!3A).])$4H/[.T^;JTQ;&6`9.R+66G)<%- M"!\?9:XYRI7*F-8%4(AN=8%)KE9(WX1P?PU"20O]T(7!1UE1A$$)7S*B,`%8 MH&DOL2M-FA/CAU\9?*$=!GXH*0H_+0-DX8GU%B";MU)-#PG,AT?O[?%T'Y80 MC(-,#(?E6S4_@L::5\4])6:]QHD9OA$MUT.N&":E1H(H)DH(ESZ!;738O+=Q M*L3TB0"U:RD@QK2BDT0XJ)E;!!+$`2R.+:NB/15I<;ET5MZ\U*"4#/;,JSCX M36#P.PQ/W=D`X]AK=BI^9.VIK#OK4AQAJ^=LH?NT.+G%#WUS'2:+3TT/@]CA MWS-,V`L84GH.@(]-TT\?Q&QXGMD__`\``/__`P!02P,$%``&``@````A`/MB MI6V4!@``IQL``!,```!X;"]T:&5M92]T:&5M93$N>&UL[%E/;]LV%+\/V'<@ M=&]M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/ ME(<8E@HFVE[5_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R M^@;`U#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_2JM9 M=_$&%#(:3Y?0VJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z M`-!`AA6-D9HG9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW]N\ M*1R5D1SBB!4-?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7[ M'IM'+E(H.BVC>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@! MQRO=?9<2Q]VG%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF M%.JVY?"N;+>];=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E M\L77Y44IABJM&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV M&_H<8BN'Q&J/C^WPNA[.CALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E; MS8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO8 M9=Y[$R]E$;SP$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;` M?9.OA`W[4Y/99/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_ M6@/,>E$*E%2CLTFQO@'!\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T M8C-Q@,'].E1!GS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI) M6@8,[F3\N>]I!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2 MI*QIT]9)6RW;K"^XT\WYGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9 MDRD*0Y/L(&,<8[Z4%3]F\=%]6QE MX?..*7*&\^!HNZG1K"2+=\Z<C@>4$ZW#C!@]7@[_?K4XN!E:#X?Q^M'Q[?@TW#D!_&8;1KZ=P-/H81CO(L?>Q.0BWQM. M1J.SH6^[P2"S\-I?\QCQ[>CC?G>R#OV=G;CWKN6O7[][",+(OO<` MZM-X9J\+V^F3FGG?74=A'&Z34S`W#+=;=^W442Z&BR%8NKX,]O[*3V)K'>Z# MY&HP*5^RLM^\VUP-S@96-N5EN`$0?_AQ'R9?_B[[Y]6?7KT:_?N++__YK;/Y MU_=_K/_N^R\&PV(89!,T:+=Y.FHU"[_.+`_S&5Q?;L.@FLCT#&9"7KF^C'^Q M?K(]\(0Q0;(.O3"R$A`4II*^$MB^D[UC:7ON?>22MVUMW_6>LYYO9=#5=G2N=&>6+==W(@-.52BH9`Z[>G+_MC4[U@S7-+D_#?44`"3BU++H0 MNBWQ?;XB/WWX2<\%38]BJ54JZ:>A5^7&.]=W8NN]\[/U;>C;`2$6%[7TW51- MIAR/:?Y=\.A$;D+,4E9*A:4MG!/;;3-L@D`YFC2,,;)0EJ)Z;#2!(:P:`=19 M_ST@5:?>0E2]`D):HT3D+PR@4G0XXILD*PS4^\47(=9D`.LM;*1`4>\D.5$0 MSRN,2*-`!@2"`+L6LL0K2YI@8LA?KN>5RZ_IC*Q:X)7K2U@))DX4K.")E3^^ M>][!FB6`12OQPV'V/L:['R+[>3Q)^>:[(`X]=T-0/"S3E5+.S/+L=K6\3<=% MR'A1-!A=K9;G&HS>WBR6ZI$N%VGX#Q5.?[*"'\5(W\S)CV*C*_C?4AFG>8C, M5($L[5F)2S8Q1J?GB\7B8GQV<7&QF$W'LUE*\GWNT6ZP<9XN*D)@2%6$P)"J:3.J4%78 MJC<ATD"=P6O+S>N M_1`&M@C5('MWU1QB,VLK(\&9#Z!JAS$0STN'/SF>C M\]E\.?=!7@$;"+7OBB,.@'"1WAVJ_>$A4R.7CO"*5 M.E6:\P+PB<(E.*]0,.*^CP9%QR8)>,*WCG2?G-PQN5V`DG/!Y"\X)MZNQ@,&"B[L,#S(@GF^8G< M(LANH'&[[^'I,LVS9VT2$DQ*LH*^D%#U9)CF$;^=)\/M(V@0[FO:_#=O5:#S M63N>]X'T(M]MR_8'=OFN+Y^VZ)`1G/PB1W/(&2;R$+;2\X=9JY,]@>DW731I MO,BR=SOO^?W>OW>B57H<+!TB?95LV5?/;M(>K7K^QG,?`M])]RD'F9EOHC!Q MUDEZ7"V],=>$9]J`9YP;XL$C,_ZL87S@B9L/F?%A'^R@B,"+T?'!N;C'5^D/ MY&!>[M0@`7;J-CPJ$O:(8G+0"D MAFQ*L:92#)(=(JVB`)ZT4+""JJNFY(V;-7?H[LW9WS!&O1[)[;TU9J@@Q,U?BP M\3VPN@RNG!\)+!Q*,XA@SCQ=U3-WYJW"L;+AZ-UMIH@6,)T3%\N/.C,1BNT2K<*.^E%#D2(BZ4;77KX0AP> M<$JUZ6W<N&KKF\F^CM(D M*UV(M*IV9,FC6/MT"2E4J?:)(M01W52PA:#+"79#TM% M$T'N.+5I17<10LK)N7KO<$7JJ,[\+DCR86!^4=KJ!B%)VV-#%=7+GV' MD:[^#$AT?>4"6(_)4D;V61*\4E5.77=DZ-8U1L:@\/`-=.E[E;S)A`MT?1>T M.VJAE*UV%K6<>&2S`!\NSCY@!Z)<>PR"M:4%(9KKOL[,6@1KGK48#B[MRG5T M@CG"(-#TJ^[;ZP!BE%(ZQL5W(`Z-4%-XVO6 M4<+#X$]VM+H8-T]XY[D>M5UR"I!UG]X&)6=>M>#C+2U$3L:!-)V>U5"?*7YJ MGL53U[CRA@!)C96KAI(N#%QXZDY5EH(&_^?A3ZR]$8H*7D*Y8`OU,UIAHV#! M?O"B:C`\P4C5:('+R(Z?'UQ>)\;>H/.3"?6L(%YJX#-;;=V64/3(G@F@P^?3 MBA[]:$6\D7BF_.J%VQDZ]8_Z#\O([%:ASU$!B?=5C\80FILKW$,6@:,%\-%$ M>B.E.FZX9+E2!Z$Z'$`>;5,TU7L^NAT5\M<\%"U\7E^I55.3(%L:J3.$DA=8>K M1O;JFS_'44B0VKK9E:_2C6!99=K,XKL9;FU+AG:&_N#B#:1FN+4.DV?G4,$D M>-,%WRQJI!_9+*`8;/,MY$D'+92[#B_K?'AKK!\#7O(5)R(-J6!WP.JEM,(I M5L==>N1&0%K*&#="_$T5'2#RQ+G00HX;.`J5#KCI2#D"A,>R%]+((?#[JT9KE"2[OBUHI-?[6%X M_?BI:!'7C4X!ERA!?6:.F(6)J+0465KZ,P7B`LBBWZ9=D76$7\$J4FD6>H&> M4=X5H/_$R5<`'U:0A>]0O@Y/I)L]@=#3"4>H]]29.)4"TI*A8G:XLS&^ M5X1/[;>'+<^MH@Y5A$D;%\KZJH0'ID1@,V&3<(OYEFHL^\'7*\$V`M&3X@L%."-%Q>(8; MTIK2N9)+807=8R-:5DFBXLB,@JF8Z`1P>F'1C4BLU*YNLS3"2]B4Y.X.A(A*XT+)6[.[@QH M*E=F**0I]ECWW(WC@_V,H^B^>R50;PDGZ=W^DEDNIU)H+NF1W?G]2=-^OHRIVVABQ`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````__\#`%!+`P04``8`"````"$`4Y%<9J,9`0#.;@0`%````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`Z'J-5IXOIX,<'Q>E5.:^: MXO5R898`:ONOI4W/=^8Y.KNRH+OK5*W_>A"=]0,\_TM_]H/7KTY?OSAZMG]V M^*SX=O_%_JN#P^+T^\/#L]--AN%H4KRL1R-,1_,`LS.JFJ:8+JZJ^77=5$4S MJP;U17V[P7B\0D:0SK)IJD7S^Y6OR^;*S-=`?U1_6]9ORE$U6:RPZ&4Y_[%: ME.+4_`?LOR]D4\VI0,3@#/"@FU:*87A3E M:#2]+B<#!N)?GWSZ:/>1T?+)DR?Z:U%@"JOQ>35/YM"^9K,>/V`\,611OZE& M*[)W-'G#&M8(Y;/JHD);AT6-.QE7Q:)\NZI'K\7R@C6:6COC^LLZFR[0]=N? M.9[C=.:+FP?%;"1[*2\A#L]D8(P)_5&/T-O)92TF^[1KG_IN.AU>(R?]MYWN MV^A=_UU4^U%=GM3%='+I'!]6YRXOMEK^SKO,#&+*L"Y2@:6?$'Q6?H^]A-GW\$BV0I;S\ZU93C&&JU@`6YOE'+O"H(-IL_BJV'NTM_M9FE)$?/'E[A?I@U]. MP_YPB&&83C!ZL[(>[D#&H)S5&,&^:)S@)6H!%W#09(.56(Z7(T,$4S>UTS%0 M_`J;@#6/IOG>:-HT*]+H4FZ;E\1/-G6QX@-6],&$?ILW;_7OGQ=&K M@]'F2EQRXAYUQ;2_`L#-YM/AQ[7^@W>^F1Z4XX(I#=\[6J]X)/3RV(N)OI&+PXDOYO7YTF.KQ51@9V<`-INC0LY19\CFH5>&.*A& MDK-;WDC8:].[*_OR;=D0GV]G6I_5HZ4"_NV>_E-57U[I\9*47TG.P&WQ+13X M`RO*F$^[X9&.;^\:74SN\O3H_^>/@!$]SQRGB&60M?@E1L]LNN"PA9 M]I*+R,J*GR."]250RV+1P0W0KYPT*+0,53G\Z])U8\7Z'@M*\4B,!FZRA_M" M<7!%R"E!+RZ6$^)IPWAI0FQF64@31$:S/&_J84UJJ3^(A-F"2Z>0(%O6M@2= M6LHFB/.6`RTG`-R1D']A(+#";)GUPF"Y,4-++%]Q0?Z@N*J&&+05WOW0CB*D M*$WR0>*8*6A#N6-(6MP[1V\NZL5]T?_)X]W/'Q3W/ME[LOOE?;-']SYY=%^K M*$"`Q0V6ORE(&$*H$DB6=WULS_%/$KBWI2A.JL$(CI'0&?2WTR:(]EHF`G.- M@."LF(A]PDX'F])90C)KV"Y;@RWA\]W?V1)V?Q=7\%A__BIKT*YGF]5E;X'\ MC;=,&FV]>9T%!Q?2V[,OOMB%]6S4[IZO^),]HK%?9;T?VK.P5W'K?O:>/=XE MOZ4%F"SQQY-?AW[WYIMCKKY6=PV;VZC;G_E%#FW==)OKN^71RW MA1%9:SWZY'U(*FO?GNLW%[9]^7SQ_\?I/&U/0!TH#RZPVQ<5\ M.BZ4P71@1XA9OUF?'-QO/5&!:2;>G!*EDL1L+94^U[_,;!M:DC$[O]EN@F<5 MOI*X5]ZIO]P<)O>_(P/KL,STIUQ-16.F?M/M)[3\UEX M##DZ/`T9`OV)LS3NK1)]JK37SGG9P`0A`?RU>X%@T_I3Y<]7X]EH>E,)HKJ9 M5W8Y.K#^BQ\2O+X;W>!H^L-F>@%S`GY(7;/HM\B/F(,2PI&-_C)/HY'MF M\R?XC?Z0!JW6HOIVKV+FU7/A9F$C3"(/^@!&QK!0/KZZN*#(8&"F#:I6P<:: M7,M:VG)QMX),_ZDT4$A_&WUNL5M5S.CMOW])2R[IMR[OUT=W]2 MX8"M%+O_8M_:>+@GJ':+M4&I!U5%&&\&2C4G*Q]MBS7Z-!PO"=]1Q%\VB+,= MFL"&ECX(X3#1"`)=D#+":&&,R(XJ? M7236UW.Z#)(4BTDFPR9SZQ7$L[EN1\CU+@&O'Z`MA>9M0;#_ABDD-D6/=K>U M_V22H7M+&<5Z0^`E MNBQ7W4U.T,:Y](3A.MI,@8*8%.MVN?_28;+B*;!51X*28?@N-%_5#"DEFF5_ MB+\;"N%B#KLJ4;&H>>L7#S;-`,:%,9?U1.42<1@UITFEOXA;WR<*W?SFZ7(V M&QD[D40U1`V7;@\LU22R,O5BH!66KM;V6G\JH]8+`G]*Z-=?Y4L:3I1Z;20< M"(W":T_%"E%-L(5*;%S7BRLZP&@$"1*(W7()79&^SN*'%$^!&\Q@DJRE6PZA M;KNV5F+1E%U4X:M/;NL\(7;=`[>@\=.SUP=_^/[UBV>')Z<44?_K#T=G?]F4 M\[?0K3_YJ1B0RF!>A>T_0U"5FF;ZWYU%>V<#];_-2G['H>1W\(&2WV$H^17W M@`SU@#3*RJ`#6N9"\<^=0S?J"_R\]V)=\>]5+S,:=Z8_R; M]7C4?Q\B7+WO#2O_ZSX:XO*6V+V^ZNAK$J1O,X)8"S+*_4E*8^&F.W:5,\L'532NR579_7@X6TS%2(#L=5JWWJ"C@+\&B( MDJ.)3J_<6?A&,"N:NW&(C$?[Y_/R;I^30*PW0G)*'9ES6A%_]5UOM3IYK.6,ET=B(FQW6]P=X5C>S*>A+#VZ; MU\^EMV/6^W*[4JW;^LV5+K&MWWS27^$KL]=:W[2&#[$3K+JX'$W/V?3S>CI#B\;EH%I:OX#%^CR)TM0PI6;2:G)) MR+R<5#1P7(Q*=D9=N,\2,/*WE).G1MBJ4FH M2'!$40DHN&))X_*&N49LW5PV"([2>,):)M7;Q8Y760TJI)F1!I4^/0ZQ<9KE M`,RGY+HZ*(BT<$Q8.'@'CR%\5BZNKLL;/;#*P4(O-`^Q3(`>ZJ!6X;M=M5BKL;SUTNM62)T(Y$*8H$I4O4, M9J@NGVH&QOO\_&\?;>_1S!GQ0_)%NV?^VOW'8WPJ9^]^> M[/]Y_]7A;Y[0X]D]^^H MNY/$M&XZ[,G9%>9L.!V3C2Z"__IU67WV-?M_,\!W?W)G)=>NF/[>TG\0[6O#_9?'+TJ_GSRV][]I^_?"5!!/2AN0<-8<7)T)LI_ M\V1?E#1;&R0?SI>7@!BM(2:))<6U=G9Q-9\N+Z]HO)Y'NZ'_=I1T9H#.\$L& MJO/D-)!&;2C@J+;]+X`9L$=V'HZAE-NA*Z^F.Q8<&/)/@GZQ^[5%,R*UC)4\ MA"]8M!SWFP+VP?XN1\UBQMH0W:BF'9[9Z!M=T)/77-4SCUB4=5>,W!37++(J MKJOBBM8D1K7C&V3@XQ,2_L\>_9M"`3NL(W$8JH.+M"QT^KD=?U$QR0Y@+>:LDAX\OGZL8KQH0UT^&N4+K*K?.A%1<\T^!=,S0_ M;-E8!H:E5V="R`%TM01KJ2G3;L"3\XO.;,;+DT MCRWAC*\78&XXNA/K84RH]>K+?IBL[<&4[++1,,QN+S MJIJ(&:&M!BY"'UR'E^-(:BS^Z>V[).QDLZ%<@4(0S?:8YIF6IKR]!Y/::]'W M84F=:Z\8F1!E`B"W>IQ%/3^RC=1!"+KX4K)"_68Y]OP]8Q/4E)ZH9E8Z4EE! M7*`)5LI=6GRV[U4AYEF.8`%G0FAJ'=8,,'>SBX"0H4X39C$=?5QR1L:?P-1Y MW?SH--$$YI_9`:\V:<)I`Y(XY*=A@D02Q<9PA&"#2"RUOJKOZ5+!D")+0AMJ M\.7H00KZ.`\XHZMVP*D/0MV9)6()M-@&8PF/IU!NKKY`)B'$F1&W:9<>Z!@( M__;\+0T)WDE[J9AY(DXCE@RATH43>+A4V0S5)9%'6:O00K%WU>!J0L!SJ2[^ M4`:(TUM3/H\M>$?M>7MD#=6;-4+KWX>!M*Q&_UO%/O<9J2: M.JR^4`(#40FZ=9#K;DCK%*&AIP=SM9YY4921#D])K!QOA+IA MA3>@3UOV)#A$ZVL\1P@LP8!=R!0]Z9N)4U97**;GX6",@2(4"*,=C%NAU-FE MF1?E*&7?K7/.3HOT%R1#E,Y=[F#==LQSKU\!J"M;`%DHDD=Q*K9]Z4LP==`I M=_9+3$<#(2,:S06GK#5I*//>%/=.Z3YYQ7FQ]^\^O;_&I9N2/&N;0#(M,:Y\ MGW=L_EH*LQZ+1RW:)Z5"^GI-6TH207*3:CEU/%J0O[/TM5T/(,G$["%NK5SA MD$+U,&A>^Y68]8')YD.FJDJDW(M]4M_HG/!-=G!*L,)%5`:P7T\(7EYY0MJ' M9.U$.HC%['.YG@"E)ST[R/ZB<*I9S0$KZM55'ZV)AGJ,U7_!R-,`D8<&PX2LT4 MZM(XA^>K%!HSX/#.Y51,HG5+#(GLUCP;=MS].H8D%JS-[*;.Y1['X1&/7N'X ME!LV-*`#-$C'].*"$]R6O=1L@U;XTH!FZK)E`9K`A[ZNP'GL6!Q4/2D2F5([ M!-J8,Z,M*_#34*6F4E^O05R=5F@!@3$W&Z\09M&&;I3^%F@*F87SU5':P><7 MVNEDKAA?B$A8N&*)DE=K?P^BB21/IM;(`!S!9IV;\6;N*27&N9]HT7!*J*LI M#Z=AK(E.3HPW#$8Z/BYJI8X-KM>B6=3&'99*R8,%\[%&CVT7V/T-$B+8W;:< M";,I?O@)6HI>*J)6(B.]Y2#3:O=Z0+.`^J`2 M:+9D:L4>>D;")B"P6Z1(.H6+YEL.#+_H/^WL<<`O1OK+MN7\M+VG8/]-?D_! M*>U0'PNNH7#>3!&V@D`:<"Y*82\^6G$W6P&4KFZBE^?@Q1!C\L/N*:Q698+# MO=';PLWP38MQ=R@J$BZK+8(]GW`NI.W`VN)AG2M3T8D"Z.!'QFA?+NZ]_/:4 MY)MB,*.FG1/$YU-)/NBIP$D8=B@)TA.?.=[FE2]L!]9`&&+(V?7L"5%DT.H]VU@&X*(M,.UY0QX>"0'_Q6 MX$7AWM_MS2)EGMG]+0@W-EK81F4IK$NHCJLS6C52V0;;S>LKFLLQSQ:Y8P4P M-V9V%+&GDZ.\WZ:.S#%R_\ZT9QJS)>9+ZBB\L7/5EBR>OFSY<^O+-OF`OC2N M7Q&[6JSW`*]"X(UI18+HD4BWM$1@)V$58\W7((9F]<0AO2*CJFTB/),_$HN) ML0UAN!YHIR;J=MTMLIYK/VFC$4/OM#@55]R&!.V24D@%`4,=Q<673NEI(!`> M2U'M,@&^:Q,/`FN-)S^4\^"IB8PUJ[$M[;7!I-Y6FOS<75B6BJ?[^H^W](-K M@0,D%3IG;V?S:EPOQSS%ZHA'R1U%3"%/OE2ZQ]R=68,;GRP?!$.E[D87,Y35 M#Y*M<$S#&[C>D29SST;@`_7IM>VF#Q M=!].#*@JVWY+85QN0T@+H]06L'D/@68<+;XNE-64'-Y(7!3`L86"25"83$7< MV[7+N[8\D6>-M!9B6;+R(`>8&J&8\3ZV/NDAT1N$Z8:T68^`H>ZKXG711JU? MP)6\+=G(3L,Q;8S][R[1^9";9<8P+$3 MY&6])38B24(/;J$_+8R(`K4#*RG]%#-"/*;CS]9,[=$*2H=RQL9MH4M+6$*- MYP#MV/_\*R19-9P.&!>KO/M@%+<8_.DV5*STU(:>\D%"!K1JO@KV.V(B:5@N MZ:X0K*4-VW%CL#W&(!:CX1)1XU']HQI:S$<)3)J(8&UU:Y"A2S.[O-NHU2`< M=1:(93E6%C`Q4Y[9`@(G34=3+--TL52+IGO0[*A0+B2P1JJA&U($!A'0>:GV M85A!,HAD+W<#A%C/V8!4^>5#4&U96T?L%C.Z/0RO]A3+X:!&50]'-!4'GNL[ M`4M^+)SG$'0MBMC@D6#9^C24\6=&.H4PQ6+F26ZA+<24,1<3%^<(0P$7@CC$.U M&.4'=9'L#(SRA&Z-M-)$4UY4V`[)?G+?YJ$0_6QT3WJ^J:MK#)@G.92'1F/U MIAJ;SH5M+98R&[`H*1U@;.BNMR`/*S0GYV-EK)L:_.'NLA>VK0,\K-MT7D@# MLQ8;AUD1BNQ+0GF`V8K:,D!-5^9X&,N6@VU&/7=BC8UG4T M6IGWOH'YC`>DJK%-0B(;AZ']"D\4WJ.UZ0K&,H%GI1UC%>&9-M>@I5BP8LB3 MK8NI:R=-_>EAI7QG%X1QVU6;P=S['>)P)`3:!C2LD9=1V)8)8U`MZV;TA2SK MM*"Z8O`TW^]A_KT?8X&UP944SX`Z<=*E\ MBS$01L2FDG0,1T<`:W.`$8-HC8`Q/X!^B7RZB]:Y2]H\!I!-U"D;S?MF=8%- M0%=?TP6-"9-+4P%M%IF1Z;)A3<#U&N]LHN"6Y1HF4^>Q/)&'%]R=N`#BS%E9 MGK30).UJ^#*MQ$32;HT*39[0?EG.AX(O<;#HB*T@BZP@HP`(R_LS4'M$TP1@ M.%V>+RZ6HR@5N:#BK.`96%BN*!C'6]=PA1QSQQBZEW@\HVHJ#\4:+!O*WK42 MA3N,G>5L573SB>VPTQU]ASTI,DKH#MX9"G%W=0NYAG=MXUC1&,4E)C;>(M!O MV`#^I;C#FAD55B$:UM/8ON<5;-[&MK@\%)0+G;>1_TW/IRZ>L@-!-,P"1LGX MP$+%=3HY,9Q<(LA\33/5F5VVQ$*^(`I:-/P.8RF[H?<:00]+3EG`,"`-9*"; M9DBO^K9U/,4`+LSL03:)@+O:'L/^M[[6_;$S3L8BXKI=+@]M[WF,G\KP5DH# M!.6);T,.J>]@I]'_53.:6P<,AY_\0K%:S0AZSIZ)O;K@!>9DAB19"0`6EW-% M:Q/;7.%*:".VO9PBM!1IB8A\)ZULB2W<=RE?@C2XJ0+3E+NR44:<7]5IG MB4*ZJ)4JLLGS"6Y01JW%EA%DVUI=,;(3%TD8[=X&8R?-CB[ MQFN]0D%S3,/"W99G.\J.Y6PR!>B0;"7$4*_,5%1<"+(.9;'5FZ7LTHE.`TQ) MQMN*"^WB%=H[NI6?,W@-\3*AT?`YALZUXUS*XFWD&MN];FPC$#Y=7YDZ:VV4 MK.4:W3*U00Y/"4@G=,11VX;>8XSR\A(-TEO?D7]2*`-.OA:4Y[^1.]D#&5A? MPTBE>7,;WA'0&@?S-1X*PF#-H3&%/_+UI5A17\?A4Q@;[^SATMA+ZB8*D)3M M(!@1:#$.!NZT%KLUJ"ZX"[M,58ZZ_<8(SE=NM+6+9W,M*R$Q+T=CQ2IH`AKC M0A@;)]H!O2DBDRLUJN`MUNNBS2:Y=>NMZ%>^4?SQH7D5,4T02U7,O*4ZK_G/ M+\^_N?/\N>ZS?F2=T; MRLM]M(4^_K2].O-?O=#W[\(=ZX_).\\P6MYI@/AL1O*V.M26Q&[;"@9\1M3:I*(=32 M[XW`PTVK$FNA43!8V=C@9\:SQ%H"%W4CIYL%&<"65C-B/I#!VA0H!E M7LK&N1S@A8%"`TP1&&3.I^<-NC:Q1=96PM;J8I%5$T4^9/0E9YE'`P;Y?`V8 MOWAJ/=96\G#"_84.U,KJ1I2H>74EB5^&$&,7=DU?0*/CO]804[O!0>T6QYVI M6H>;D%CKN`1P)N2U`I6&^;WI3!40-H0.]>(8(XE0I8@BR:@3W,]81FP3R MU&%<%V,;U_0/:B@`5S)1(^>@1,#`U*\OAB<5XD(JG@-ZQOB)U4@]CH M9`T;L2Z[QD9N0'D\S1![8Z!\C5`A])TV`48#!69)E>FD%93MHO"2Q"A)Q*(R]-L1-T:SH`35$A; M$"\+GU,]AKX):$QMJBD>(6NBML3T[Y<8'CN(9E_86-WL0GK@..04SZS0-VG_IJ#$M;J8T,$Q\BY6Q738#ZIAZJ>;>= M+2.!Q\DWN"B&2MW/)6/B-:)5\D19ECZ6KCB<25Q3[:C!Q2-%$*=2 MS>*-Z(_HFL`N*-*:/D66IH=S\X1,4-X(\-6UC,4EH*U>V7J@"`&8JBTGIAAZ M\[:GNC6_K2*C3QBP>]O5.EH\CO-2RXJ?"#4##U<5K2HF;:-5>C>LTU7(U&FW MLD.X_0=M7!-A8`;"#QY\K'1WG"`FD3!E-)U+5]PD8&8JN_/1ZWYS_*)^+P(3 MHIL:[,-HIWB)1=/74\^;!>=0'X2_5!"PL^EY0[)Q08340.$.W3"RDG#6RDKVLQKJ=9")LO8A-8,1 M3=.)M/JQ)5`84(=\W$8@;S@B=T8$((X9Q4]$)K8B*:MIYW$4VK5T&+WS\CHA ME\9S!:X_,54::JXSAK/D9H@WTS]BD,^JO%=7\9@5$LVD(;C4W-3#BUYE1MN, M`3_]H*(5#8](\Y):=)!H8JC6LZV/5)28\CLHZ-7,UB0!0XE[&:>8.XK$*IW+ MWB,@[EF(Z,AB"/O#1-F6^"#-#J@D_Y]V+WS%QL,G'6@.CXI/2JCZSV:(&ZS+ M>[&L[S^Z3]S+(K;U\:HWJZ7MA,T[B8XXIU3-Y.4,[V&`Y.4_P M4'D:E`B.G!'M^.I=57I,.S*HYUS#0>G#4HB6=C'TX/8V%?HV<$EB'98O/JUR M0O4+C1<77]%$JFEE*BWUJSR&1K%4P06W1Z@T:>E+ER9]%\V%+Q)(80B"4V/B MBZ&G2`,,"'\Z>QP*&/O9TX@(H%3>*">>05L25W?'&B0BYP5JC`*S7>LZ)L$/ MNJ*UH8,42\;CFBX>,EI,:12A?G^A4RN@IK0I<1$2.)>C&T,C?$XX0Z,4;+-^ M!A&>9(1OU5@FMMX4_H-1H?;$./A[X@BZPEB<55LYIA&KBY1/E.UB1+OZ;'. MD=BO^1P3W"Q,H`]IA[+KWC^6VVTG543EDZH'RR8U2XX2"SCC%\S)DK1D-[-+ M=N@.QX;[U9F[9'G:?YG!6S,JDNL>BF';FCED&A:2(#W84H/GYJI3)P,DT(`77)M%*GP'>I-J9R547:MKR>!, M83J"++"E@/RE%PW[]V)03.@N)E>++@%:>7B MI2<[7[Q_9Z73/E]>(IP47NWN*.$9$\*H`:3673@E()G<_7^[N"MR-ECYR`$WL]T[V@+VDSRA=7X$2O^(0W"*)EM,_#0, M+%8$KVJX"Q,33/`::^@MB`8SI&+>5I@9'X5^JXH:S8_Z>/%22A=-7#GB(4I, MF4"]#$9SPRD$M28R`366X8WM+]\PMDF.`B)LP!H\JSJ016GAQG[QRC7D$/.B M$/0C;IV94E`'^0OL3CV5:1+*S&B1>I.H:CM&3>,B@&X?UH\$#*GJ*!`1&T+T MR[H%E_E.:KAR:ME/*TL"S$G%P\M'71JLWF`MPGHPU'U7IC9GXFI$P&[1=9Y5 MT+U&2R4;#(4)@NFTGA=;)7B6'F3EZZA/A_`"-YQ.%%LQK*+TA@C'_%5J*(32 MD,=(K;/L;(!2?K%NNK#;)%11V0224VCL=Q>5EO%KORT-@%ENAZ))L>UF%<*/ M,0KC8CS.E7($?K%EO`7\543?ZY65?=)Z4@"_9A!;?[?E-<1++2F:72@%`HPF#ZOA,JMAV\6=R$ MO$<^2,%BO`4/UBVD7?DD]"\K]^IGMF!CD(/?`QR4/XKMT1B5MP30Q.\H=@!J M&3-2Q!M,C[^\\[W!XWX*J<-DQ[_MN%\A9-LT M\)H]JZJM6WC5'$STQIJU3(@/51-C,38]-$"6`F_:I"R*;/FD\+"G^>9C7]NP M1S1*AA]2W1?D_VC>-9LH&"QS%DK7JYNR&Q&8O4[`A%V!U@XL`3)ZDA& M")PZ#W6"#,E'LFV6L4KV2^WTT8L*UJ#0\JMV\L^*)QW59B?\HC^9KX7I0C)= M;6DSH53MD9PK-B\(E)*6SKY[==]5H7^[/FX[E*(-#B=\G3MDD=VW@!9D''>@DYB"KJJUHSZ&ZLAARL"R!J8PB5IZ\;<$24XY]BC=(@N+A M!9-,*!J!$V"6Y3A+6I#KRTO#`)Q),`>B@[NR@!$YF%7L8/I M/X\&LF4;,S11A_SL5*^C`YZ>!@\#C2PVPS>$*^/0A()L'L8#+P M,/X\WA'1ANZ,W*;N8#@G@^%N=U[[9JQ]WX]2C MJZD,%>M'%2U1G82D9XCLG@-N_+(&(WHV'JT!C1X@M0N!$_8#R"^`I\-B_Z,: M<9M(-XDB\#81Y:)P->BM(:=M4#2Q[L^4JO4?;8["@3)M,M!2)%0'N)X(((,2:#Q("!:,Z,21&R?2>,8>T!N8RC$9!>AS$C)-X!'WI3%N[[_6>U&A;.SN)(;B M-]"EC\-BI?H,Q"<=7QMHZ-#EJ)X#W7;V22GX7`$]3R2US8RQ],$FL_NJ1&Y; MYUC#K[5T]>Q/^\PZ%$2X)#,@J\R?[>\0>9CWK=*ZLG0'K8GZ:`CIE!\-))X6 M*6&_<[NGW`H!MC+*)E86JP?*`98[,WO4O&:S3<'+ M@D$45RMJ;N\/9^/H84<8XH]R^99Z.(2[Z/UD:N<>F'8F[;]=S635PASF^M&W M.$GKB*5D;D2BZ>`#;?.,?\=C/U1F!+)#) MUPPM3N356@Y/_,BN"6K(KRO=0Y+[! M'V0DXN&(#2,)^(D`0KE.%L$,L_N4K?$`O\%\;6+[7"'E)7]CBXW2#/^8G/@LL)\GX20)E0."-9PC8INU* M-NOM&'ME/U%K9CDVWGVDM>T]VOWR7[HV"[\`NN_?I,>VR:M_H*P MF61"=\_&6.%16FJV41'@P%SRRD47V*X5V09988Z4XE5L.:Q40#'(@^KJDBS9 ME_RZM'17K&2!A-/5:[$Q&X?(I)D0P;BUXQE)CHK6QL/5HNP,/*6#I#(97"D#J:W#(U=^5U' M8'FHN*...-=PO>,[[!6YO%3I:-]0'<+2>0'DKFM+]"R%1PUGY=N/6K7URSI= MORTB<.-=QT@]%E4[*2-A,UBBJ(:K>'3R_@>KR=JYSEC/)#M=J65!CZ`5RH]W MQA82$]NR+&7"[V*>.J?I?+4B:W;1XAKPT<\&^#R:5@.:-]XPOV,DFC'L*@&] MX5`,=:&_3=WA6JJ?@.>S-IYN;_)IR6Q5Q4=3`RAHDDI]L6\E)LS="M[4NT:.+TG7$?I5G:>DW`;0#+/;;>8R&=YF0KC0L6:^3-S]&)YG-T)( MB?S:.R'CHV M>IA.`:HP&]IFN5>8T+D:#TWH).Z48`FAC=V9O0785>V#85;MMD3,@XHUT>3?$?*):+EV1!BH!X8`.]$=QG02]X M.BZ#]F26,[?S#F8U;O\Q+54C^14S3G*([FQ;">(Y>6&561G(03E2=[QW>+%-<1_(J/A9(#0&.4!# M8SXO-A&X&;5&=O64>,8M*EWK2OP4$*;>X%_0R:!MR7%YN:$U&<80F&CON#"8 M5@G!LB"4)HR0VK/C.50(]1\1P#BS_A7OKTOOZ2:!`8H`?NS+`:S-DAO!%,JG M:9,UX$GP'GQD!S])=/"-N`!1NA+9I*&]F9=F\TMKK)&DN!R$JUDDA(B,:90N MWF8SHLGL;%@4T5;J>G2P/TY?GPH7P0]2$,[*!;.M+`5TA4M+,L$)Q-O-2^%B M7/BQKW.$(=F:G%#V5O:X+1>L'\]3LI5QP3''Y3DA+DS-#(7W;@B6:-T>Z,;. M],734WLRVE;+K:+7#GB2F0O.)5P@Y-VGSO%H.J)!BP,+Z*Y/)7RGI@3[J06V M4YYJPYQ1D>B_B0=[0R=_>_07`V2WR@IP2CYBV34(?K1=C`"PXAGWE_6PA]\BNHS%,]Z+2!1+UF_A:@)`@E^7:&O6[W0I&C6F MI%=%B_\#M3D-8:A%LNWP8;E8!UE7I4O5H@3ZTYT@0<+S_4^#T_O-TT/:<1G\ M]?R2KC__E4DS.2\5V;]_1U+BD810/MDR^S`^..V`6A1.=&[]V6H"72D9S'!6 M*HA\YXJ<_)XF)(&0UG8G(A5,QQ;SB'*\L4%E.]J=3$]PAN=*R/&S)NR/[A"# M&TFC+9T*()R2Z>92++8FGMK5[D9>6(BB:;I%+[(SX>>WS:X'CATC*%K)\9S6 M",-/AC/V=;0B\Q MC?:KN!?/SZK/T\]=V>>F)_F()[J@;5R\**])I<9H(RSLY,"U%(CZ\%?PR*K^=*4:])C$=N.MG/4 MF"/?EL<*=]ZT5Z/9.:#@/2U57=4S8Y',O4Z(HB-OIM8G:'O>7;XH?0:F9?NU M#28>_KI%A&D,[F2NZ0]WR]%XQM4,$\56G1#(9,57VYT&KXSR&9S.9:^_*AQM M_[86Q/`W>+].U3-ND*4)[/K]YG.STX')O:<1PBO MLS(F^PIKL?NII]DU04&&%S*#X@:^9PBA.(P_`'O(!^?)1,\V>/_FVK!#;R\XNJ`,'RS-SR M_/,?_U.HNG&!H9*D;,>,]7+/F)UOHAN-7X>#V<+'25Q<-Q'48[SR^W?/Z"(` M$)(5B;[-Q8?X;J,$@&N]J'KWLIQ)?)W5=H&<@=1@ MHEVEQ/Z$YE;("*MBURP''ES$EN\`TVR-J=6_E0%E2HAD4#"M(7-%T6)HS6=\ MGMKP^!,3$3OQPO69\;Y;NY.&P=H$=4QA!MY%FQ#RT;+G&%5O.VZX83_AK^QG M`,S(@'Z8U[HI^6]IESFL7XB^7N?;37JUM0_??_.&@/PN'-^=$!*C(.V)*&$TW):J(22O;@_ M^TMY.C/V:2,7]E[,4NF]5I_DX"0)""2"*A%EVS,[@4/G=GG#9?8]2>?L=_\0 M/C.M6$H/`FRFE@RL@Y6HTFTV2=+;7`JQD4FMD1&"1T^%.3'QDKY(*:ODI`"' M=[!O:4[,R1KU'_Q],!NBU#^L@6`TNUD MIFRC0J5!C<.JSOBO.C&)99GRIJUPR,,MG?KKPB7#X8)BOY^DM9W2<>=68$6P MD=Q='Q,6R2"XDV*7//R\8#M)6\$M_V4K17E0Y-&G@&*6I,6PO-&1%8S`AE5& M.I2,,U.!5D6+S9]B0EH+A1=L8HCIRY8VQU&(3PXO<$:2G64>')5P8'I MUQ=K2A-ACE"O<&!+6_#?+G!S)MX2C%O. MF3-/,SI??FJ"W)($$5UF,R.6^18>!/RIGOR&T\QM00?:@%L=J M&J_D'."H>TPC]B6L[(>=A\#$A:J$7$#[^]3)V/B/%2.3=\-RF4SGZ8*I`;"F MBTYT7XYHT]<$[N%W1`4"3M+O7DL`,P@(W*/*H^M&$5HWC%9F-'0A%DR#;"QP$M\6 M;HI064^VVU""?Z-,(#?1GYS^H-]!9=\PE7I7DL%/)S/KN!7 MMML9%X./0-/!A[KANFZWE:>VH3FZ#1W+0U/Q!#@33\2!H=:2DFE`"-AE[)*T MQA$G2[MX5B+E8VLIQB@D11F+PWO#NH#:-]N.`\*-*> M78GT?]D[UZ6XLBR_OTI&A<9&$1(-Z#[N(0(AJ88)2I(%W=7CB?F00$K0!0F3 MEU)I/O4'OX']T8ZH\`/,0^A1^DG\^Z^U;V>?DY`(,JM+4^&.L8KPTU;YS$$U!Q*V)CAF76.1NCV,2R`\.0NV6*5^G8!0(A6BP*4'EC M01R_-I@P=Z'D2L?[,=L#(JJFB@@+U@+'I^YRHX9DV])51 M#RIKZ_4W#/-B`RXQ*?)%NA(>)IO[HOHTYLB<&R7Q1X@;?,`#KW5!)H#Q0HYH MC3@]N7#I]YZ?HAK?WSLT13:PD2)7Q;K4N_RO/@U#L6NLH)E$G3[9*&)F&ZHX MAH2QDQC_86PK9SQKF[:U+C[\,LZJ?0LN&%->%`>&UU.8+C$*(2&8^9YS8M!3 M*$`'&(L,6X-+T9JR>M$TE)@3%+F/Y#\?L^Q^M(+1)IH3RJK,L_9:``>13Y" M>@(%"63G@C$W"T.`ESVZ1K/?Q9Z)>T`%-Y&2)B=AK[XE4A9IBL M-8%'W.83&%HP*OY,WRFD8,I@"!&#]*%0H!JPVM+HJ"!\KV;[XF(IUS4X M&$W-58^?_H$?_I4J4PBOGI;[V4/Y/S(UY/FYRJ!77FWM/;^+2*-=`<6B>>-Y MX1\NC,W^]2__9YO;RF4(.\XA5O;/F>W1V]A8N_OWV/#O!A?*Y>/H7.^6P7_, M'^/,33[R9FIN<[XUE34HYO,&K#`VVGK]7__R?WLK6_!EG>O^QEV9Z?D_HSK@ MRI%7](`UGL)CN!HR'ME+V>H&U#D%^YFXZT%`XUO:,!9&VI33JC`TGSG@#\@M M/);77?%'N(7U=K,>J%)F"P8*5A8H'Y-ZXN:#Z2T6L!K\!V4RDY23.;OX.,0$0 M\\B0,VX#_M/3,_X$S,'\>Z53*X^@<_K7"8H3R5\_/RR1,(*Q5;S8[::O(U+0 M[.(&+`^WW,7D_(,I4NHXU^-Q\F?\-DD,]#Y*X9K(QS*?I>[!@K*FFWG:50:( M+N*"&^7HP`[-"36C&.2I/!%R'=&)]3F]"CX$^`&J_J,C@]?],4T0FR*3XFL< M+2(0D@>M&SA&ZG&)*<\=-076^,]5^1B_)"CWR*)R&^DFCX)0$N$EBD&@.L!]B MSR8.Q=__,911!,;R=/W1W;\G,H9CPYS+G$X`?\4EO8)>QD6\NE7;$9=[7/2L(\E)_D=F,A:LF=U#]K#H&2';T-9X3<% M-UI?PY),D"9?@#LCHN]"$EDJ(IACJY90@947$LO5D-T>F[U_P_@X7CABH'.- M%.(RAWIOY0][^VXB4ZE_!#W840_ZPQ]Z;RP3_2C`:W?G^9MW)"\89.Q5."4# M>"R<)O#(!V]HJDH76$?!CP)XI%9#1U,7&?S+^:\X9!O9W0EL\UA5A6OX=O]H MD$IJ]!4Q._.A*TGV^.2"-]IEB;M!>IR(QYPR#/_6GQA1/'#]OM]%$ES4HF@B MN]!VAKTOI8<@5_=5A-`+1/#D(=(59<+84_;I#6VT<8J7\HBPVM2:[]5.N=][ M#<,/);A`UX)Z!U/YS&W\7*E+Y1._E3[C2 MQPTZ6&_0P3H79D9Z)94O?/<2+],A`B,Z6DIES-`O^6)-BN#@CJ3!!I':G$@D MVC=A%HIK.9LEHJ^\?K-[%X6M/"%KQSZTRJHV;!U_TV==VZO6@^721M`+`:`8 M1:Q'56P$H*ZL(VWA0#/J"N*88.(LI+VPCBT)HD&=*+86HB):H\V[UPNRA!Y;D@!TIUXO(G#69%Z^+,UA(,@I8N>F49*O]"^*8 M4*%OB]R];!W*N M'4[^M5Z_14"IC[R"[KS#?[W@S9"9_^#K0-^_H^5-._L$R@\;W//\/&5I4"'\O?N*<114DR.+<' MIU)O[3E-W92!X'5[F@E/K;7F=$:B-WEH7P@\/1^25=)/>"-/^"8.E/=DU@=* MC<)_IY_N^[04[829,AA)_AY_UEQ)@8D@80PI_4U2U5"R%4&V]TM+DN\TE49G ME2DIE46@O(9L0CSC8(X!D;$H05=*FX'1]#1+RQ./+"9%$.MCS]'@:+BN7"'M M_&1CRRE'QYE1]U;@#=H(70ZZ010TWM;7+`4ON3G-?,++<5_HGZ6*#V-"RV8?V>G+*R_8EVGI'6ZU[LQK(O7FG'"JP$[7 M_VYMZ-RC7Z`D79$>K]H'<2SL$XG669S29LY\]C$2W!.A4D(CCWB=*Q).+,C= MJF=]>CZX:V4UFN4MCU[AQ]92VN09^VI.>="],;FC;'Q."D7X4-BI>2 MT-"].;G.+/]/^15*DY?E0N;8AV.1]D2,?$RA)*X*C4V.&[7F*3:3^Y!-Q6T3 M2$4M9Y_W>MO;]S>>;3#=AKU8`='6'W?]+V4W//NPF?+:+H\?HK7I6IG\=0[; MF0*"N"TL)GS=UII$"=CLB\RT\0`IE>Z1`#*D$,8[1V(*/)E;&`Q1&.1'0`Q< ME.V@+Z+SV!@;KD*`H`VEI$ICNJTQLJ1QJY$4BVD5=$H7N*/8_#JJ#'(G=K.S M-[:'V!6P0'$Q>UZ$!JLTK(C)%J,I_#,HM87DB9$W8]^I.(Z+S1)&:G#03%M< M7P!O"'E/:>)B!01+^](2;IG)+4IC05V+78R"(#9%C/=G2+:I4?=GCG>4LW`N M.7QIII/,[/00U(GLCK7HLH^_=CZ'XQ)/V0P`.)0[@*OH#_CB6>_,Z7Y0D0 MZS,K=.?U"\VXLM(2EVNNN!2,6]DIU-5),@T#J9^DF]EM@=`/=9E)0C"@6 MV'L_AL($!D7(L-5&YP`HTE&*U^N+Q8,&`>A!<./K(;*1KR52JZY+R)ZBHK%B MU5@=OZ1P9.G1/AD2QC-ER>=L6>$!;$Z;"+$@D>'D>"JU+FA0$F.[DHITEDPL M`2LWFG,-B-&^;"0+HJ$^ZS#%&3-P3"6Q-G]>FB'WJ9S720I1WQ_^Y&ZE="H- M!K4&ULHXL_$A"$,TU:DG@E8ZGX>0C5V'T69)Z@7W5.!$?I4"1[FXLQ.$=T1( M3@P/<\OO`+R2900P"R;J&^13J*>%:\.#9.EG5HHLS(F=R:$W<#57:&$>2T'2)\-$<&'%85C^0%_+J/:Q`WH:$: M'S1PY>"_].[4J*9@&/(>(!(C%48!5H?WA?9-"84Q.QP'0R\@:WD[K$\*UY@9 M4&K&8'M2OB\JE]J'AZ!Y_N8K$N_W:G_ ML)WURL:1ZG7[-J`[7_^E,&@]+`X2H[T>RH7/AR@'>):-7UW4>QN,(XJ,49E0 ML^2/@)P@2[C1N7#9P=?R$00&9"%>7C?;+(5D(67&S8DLNJXJA`?K8[_+OD&C ME>;O%F7]GO:*.FD(S?J*#KONR3>_V_P]"7A21>8U)C;7T^L*8?+VL@DJ'3M\ M&W7IPBK`;]9(O4S?JV=X=6MP6'@9CC0E?IX4KFB#-IR(C>< MBI'S?4J?O)43/$BO*TZPLOX8N]%_R41\M_Z#$QK*+TSN/9U^X`^*[;F+HUZL M`T7G1^#HS25V[(P']>G*&?7SX]7GG_TCO*TX'WXR^9A0QI2\*2%M_Y#+PRU! ME*0@RBS.2GFM3H=^Q)=5?$,_(I>0$'6Q%'W"H*`W-I?&VY/#M>/8&8\6=VS! MM]NVZ:*;9A&%R00W6$V%^%$C&9+IZL);:I(-4H05HD6(!5D*8E].\G)\6KJ1 MR\YZS3*<8A327*^?&X.Z(9850EY4:+S52?5CA%*'NJP;V!DXYM[O9A?& MS[[Z3`D!IQ//":JVHB1&MI*BH(&\DX'=DB0JEC MV<+.^^39H@Z\V8%DM49HFG`\NC-DJK'"[1=LRJW'RR1PL#)PH1&"5[F`K'Y9 M9M['5M(?1>7@_/P''XQ3<[YZ9\*PDF+P#B7G7BW&K5&$VR\H:5)Y<#&A3Z>T MV\(8,A]&M/V"W$V>+\LF09T/JC6GL.7:1X>33JBCGPKE$A#2CS*#:-8RDWIC9$)70K2 M>+B\>2?\.LA`]E"P\:4.ZO5>'(]A#Q"O@[J)3G M$0\N^\8WVX"3P=G*LMJ`-M=?@H&*7Z.>\TA&(6R'4($^0XC33 ME-KB;*=23YU)AU1>8%79QJ;A"9@E1PP9J#43,F["@>+A15T-@1-RHPM?F=Z< M![9X9G%F`HGX"P>&HTYZ)L=S8<,XMZ*,*9X0/Z6R0%A)2 M1@(AI/7U]@2>\B3)#U<>FZ2=0MEQE@Y6B$ZWR]AZ\'M%'J&39`E!2XZ3+@R#" M4M(CS@ZF5-1$%A%9EQU[MHLN,#CV:@I6K,G6M37.Y6Q&-]+XLQU#N`?A*I/# M=POQT^$#::0B;-@,_)0`3T!-8!O2_G7`1*S&N<.2PK(+DB"-T8!%D-Z)A=O> M88G:43YI&?!M[ME*+[P:+.I6A=.\A0][:DX`7WDM'%7#VBWS^KJE$7T/9BCM M`S527=<:&,^36P+8A(R>I,J^>+7$:?_V/F^[[(Q3'#0"UT9W!BZ_F[K3]MO7XY\]-_ MPT>A*&_8VT*'/@T-D:#SL2JO'?N,N0EQXG52A1E:[AFU*S:.X=A$Q$0)\#;UT+4NGC9W6#6U&E/,'\4> MJ$@Z#`5,=/943:PP.B"?$4Z@W>!GBO1CDO?>0JSJ]27U:)++#.Z3122290MA M!E>%'F,:DG+3=G>W8[A.%UCFJ/EMGE]R"X(R"4MQ(.HGVD30'5;9"&?9%2.% MT)1,09_$!#5]CLJN::(S-Q;OR%._[,H[/^7JF(M0VU*T_?IN/>C#,TFLI.YK M^TB>K"TYCR?I\TJNS]3G>EXP1,S8Q)I*S1"!CX#7U,"!2;0'DC78U-U7>\^M M@%PJ$JF+(\7/4MLB$8OG_TF%XD;UA;`!3Z\U(\:H7#;#1W[$(V$M6*24^(;, MDAX[WX#>9V*"T;,A`"P%.U'!TT9N=$8R4%@VH2D2L6&`I7(BD(UC@+(DQ(86 MS-KY"R2X%8^K8D.X8A_*0>?XER[<6[7F@]B!IUEAC^80>VQ!N+!QRZ`51-3X MWIUG!6*9-F-[ZMJ!@0;2!2XA19+KR",0@TJD8]UY6KZ4@^N\0?(CRI,CWL3Z M#EG[WO-.RQX:!&'L:E5"L840=T2^XUEG$A^A$6AZN]E>9?56212ISF MX_RZ+U0L2DF7& M)]%KN!7E)\ANA92;,)..-26;W%UK9E?QH&6'&4:KJ\GX?:C9H'\RWAYLFMQH M,Z[=AX5OJ]:C4+4@7'*2)I"7L:&M(UQ>RE4,39U6MO?V\I*[O3N/2AXCVN1L M;%[],B?,_>.@B6#-OY7DD9I5HEHE?ZY'Q]F/_)_00P.=O]/)Q#_[NE?/,GJ[<(XMWB.22'YX(/8+])%OB";)J-U2?+V'V4[(N\AN7@DVA_+HA= MTQ[9>+3Z;*[WWA"/EG$3MYUQ,D//[:;XHO0.E4@C;>"@9FVI??W:,_B?I_8W M3`<7J]Y,@O4O:#7@,2#Y?]WSC^#$C1[RV,SX3=4G_0\HT.3^FMMMKEN\)G;< M>;;Z:&W-NJ;#S.;ZPDWQ!"BX]S3+GC)GFM=3&DS:NAE>U"HN\2ZJKT_]W=[,)WFX];\AQV\\=;:7W[&A>.YH_7 M"A7TET)SCW?5BEE0QS)BEXY](%H"=$$ZTZ,ESXP-1\;JT<`D;YV56C/A/292 M!)>8ZYJNR^_626%ZL#;7JV_*Z)`23FXW(6`2-\1, M9(IR$6M5S;1W&7BJ/Z((65WH51\1PU%R[F$,-LP#B[#(?F'LGUU1UFS MV\55%%]3MB6LF495I#M8S,YNM$GU>K^C@37R$]=G_9%LP80`>0UN^]3N2[[D MM`GAB9[-N^?#]A*S>&;L_N;YY&DK3"(]H4[4W6_UM)<00FON^0H06!TY?@'@3+Q4C]X""&Q, M>68Z_EJS@3D[.:/``3],`<``U\L_G3H4F/0&!!8OH$\0%TOPL+@F^7O5@<"! MM3!R7S)G,U>.HYK8>.Q_1VN_K3Q;A7(BGQCRP+`Q]%0H.PAD.(W-/Q?[EV6W M:X!K7JB,.B:L%&).,5*4NOYI;*,+D`/GU;\,JXRJK2=I@Z1(]-Q8?;IN#@E\ M--YT`@7A.RMOD>_7'#^-^[OS,$_GOA;'^]XX1]!_%V0$;>3),TOA_1G.#2:: M(_9![7)VK.K$-#^QZ>J4`G#D\!=)@4=F(20;HX5)FM43)R&3;S"\[_U!"DJ/ MXL)UZD51WL;JVN.GBS$LNE-G2='^#XI?#0,?I5+GK[SZ9;ZS?$@NP^+ M52](N*(/#KEYXYDNQ"N\;Y:5Y`P["$5E@BK6Y&#W'G$A#B[;O\RN,BZ".S*6 M-A*)F#2"06K>@B%))K`$)O$_I`.Z(7?90@R#@-AX#D=-E*M[\F]33@>';B3M MQ01A@KYDK^;XDYJH&8`LCJ@D%*(^GDFI$*J,:0+\K8".MO(&[2%^+L`0#W*LU?67V0V$ MH$7VSLY_D(WZ($7E:/-,VG1LH33C1MLG-5^O15!MH^TW9C"T7\_K(L02KL#M M:?,\4OVX0-H$TT:$9003U\$;+!/[O0\VW%=[]2G/9V#=\U_R<(MB,!!:Z?#P MFHN_>[Y'4PXR-JIF;,0H_&T"RM[T@K)'HQ)0H-S,AU.*Y%6228\F2P\]&AR0 M1I`\[[S&VE]I;(-TX>('K@@[@WX7ECS/OOF#&GSQ,I_6,:;;2A)!K=51,=;^ ME-,E3[[7Y8[54R^]9'[L>E!CUW18X%<@(?^!A M'Q9+TO@@K'O*8X>H_XXVCB-D@VC#R-\CSX/T'HA$DYRV'@2D::+2>B)&:<&ME.H)U2NM/@S[A MZ;<^T@9N)KZEMMD3S6_F`G!],U(1 M6]3=PX1E]=A?CRQE&F7,]V4Q-XE]:ZX"3&+D,V7XQ2SNK@Q9HI^?D4<)RX8]QBY2O96\!/<+*#K/G@3:2_:EUVB)R0H;[9L+$U)6<-JR MER$7Z:WNZH@MLFVZFGWD";6 M'[FM2+X!H6FOFF1[ZZ.F']5_C9_::'WJ#X5DF/74@]93?J!6,'KK1T:_2^.X M#S.\/Y8[(LO)^NU__K(5B4']YI">[V-Q\^6WU3\K#]<>K3YLK7WT=/5I_<<6*8289'[9_'!] MF]2OI1^TK6%E_UG$Q*P])0FN!?1^Q MD'LV>$N+Y&'$W.DI)5A8;'I<4!:RQ2+1&=68PGKHK109[@C`EM)UMX6VF4,A M3F*W:=[N4<`6T)X\C@'7?#NADX.GP\NUAN+F/>5;CZ\_68^A\_S\:U7"I8Z< M^9"MIQ^LM2\L3Y!LX?M^:#!B58I(F-^QK]">/'"^D(.0MU)``\^"H-P%A\NM MXSO:9A$P5@,V$DBP:J0+Y./-ND,6NG\1FS<;,F$(/`I6;J5U].?IV(;0>=,Q M)8ZYII!;,ZTZFI0]?J3BA9;_[GNQ`>4;KN!9GBG'GD7\B3N@?N@X)>/@,?N\ MJT=^>\H9N;WT%^5:I7S'N3[`'F^2/V)M)(X&U[_"`%/E`86;ZR]*P5E4#7=W MH@`(8$5BEAQD*#`352)CBI:460N&-!>@,2).%+"SM__FQ=:?9E[FWW`]B%EU M;_>W=T7;+Z,Q-V9:+_30D!QVV#CZ4^ M?KI$7>KUT$`&=2?O2(4NR2?9*]U MF0^#/R'>;+'"_;.PSKC52I4M->$^K9GM&$O!&MNG`BU!.'R]#)%HE<@5T=[QL/!@81/R@8\(DQ3I8F M4/1_),`[X0E-W+6^_L9;`DO1QI3RS!PBNUY#(?$=()@0&NU5@XK2>]O[YT!- M1[7A&MLEZ",V`P]KG5E186&:]AN3.BI$DH*^^:HF4_Y@']N.1GDPAJ[048'9 M?"KDIEP`$+N88&O7_*$Z*??BHU1"6X1#>RC<=`%/Q:.NH"-YOL5]E$F2Y4./ MZ<@%C]#=7T'IQ!@`;*:I>)/F`V\?J112<(%8"'-#;L!U)-FOB^S60XVIVIG5 M%GI$ZVH2UDONE>BP$_(P$YR_(-('.#/ACH(UE&C=.G/!!J"B`56.ZIN)'[VGS$7(;TB%*%`B,T267R%R]2\JCIVD'8K'6P:2UHPB4 MR%REO9E$E85,!($"*F*OL)+HG+'1&TDY$\G<4DF#;-VYWCLW'78CC*$V']OH M*24%Y9S(D=0;FR.:QIC,M9/+G-#[))V-F;SSD;'6$*5:4+[O8X_34ZA_^@_? MK.L/OS/8T7'M,4K6<'(WQ8>ZSV^(,!]GDO@@5H43V'@[BEA">V=9AGI( M#?MH7LK>O1N;^7-]HY'@9")88I?$'$X:DR#22K*F'$C:4I-R#))\4.+#C$^ M1EAN7!BV)RW(11CG"T50Z:WDIG`HNHO%`6YJX!Y.,A]4B5>V#XN`5!]I9K<; M&5,?2EWO:N]5D%V)_B.]9CH%Y);'AF+)-419(D(/(B3J3V+IB4M8NRC3K&D, M^Y%S9@KW2,2-"6!G2(#@9%+B^3))?&'U2K=<*+.9E8\D[2:;KV-2F_M4_3*R M>AS18CM8'BUO[A8.P1%4AT7YPO36^@W/5<:'C?J6?MQ']8_;*!$,R9GUK%P< M]2/_U+_H0PF#WC\/ALW?+A7=H+'-*JBT=FF5ZO1L6HCY%*;"EN>3!#\JELSE13SILH#-)=?8=' M4@/5&5`2O=!P00>J80N$D,I00#$0YW9JF8&0WJ.B-CB4H,`=%WQ)ZG<*0BD% M1M+&[R9!FKM*FZO'.$N="6SH6H,ZRE#IV,6QYU:!?TV$W:T#"DE_+0)RQ@E, M@7%) M=KZ\\;0W.(+;F5G]T37.LB7GWM8,;'G5K@>"'ZN)G7$ZU6CDEH@FT;SA3(M- M1[DBY[SG%)M]K%H5N-H'U9*@2E,+>'[*2!MZ#=,0E9>G;`0-;B"Y,WJ,Y68>FM9>-J M:9D"96+8UHLI]&C5?[<8AO9M'X@B3*?_@&&]HZ6'VS:2@V%Q>X M)LN4-V6N]\Y-QEU6D?&3UU'&EX91AP#XHG!QKKQ/2NI,#M8RN5XT'"419RT$ M1PIR:WE.4'H[;24%QNRC;5S;#MAL^P&!RBESY;?BZSJ^M+*Q_K@>K&&`SK"H M^?*S+QBG,H,MEX&58;Q9+S1$^82;P/<.IZ?1^Q29`1RO8D7^3.],CM@+ZC3Q MXIC_34_`T%3VY:ET\$;]K<77G7^X1EF]N[4QWB$1D9FZ&*'8=V3>QJU3`*90 M,0./-I&A^@4+5'N41G/0S0:516H.L`Z3:;*Y$]/[W@&4WA4!1UA\<@G&7QEE7 MVC_SV`QPM1R.RZ1#L@R!81E2%X MU(2Y?:YT*>(<=76B:8PA?H-UE9ID:R*ET$(T49ZB0`_0OQ6@-0[Q*FP&>\[K M#)JXN2=T6(YV]R*7#H:H<.$2[8893FLI:F&2P&4N;M[(*#R@0XPH]BE)+"$Q ME=_;[.X.053FWEQ3K))`^$ODWR?/=HB(@#:OE0)R@.*&I'\8`+*0$Z\O_<1E MX>\BCO1>O0$L;#[7VR'$^>RO&1)U8:8D1==+M8D7?2^$JI9X+3>26F(]18I% M%%KBVRZS`O^+74N%`^U:^H9!5+04ZN:/SO2N8@4N97X)SE@V6UP:83E.VLP- M8&^4O2AZ6Q!Z=A65FS!/=;&F5^XJ-6XKI<8M4XI[PG1;C'&,,;"^H MK\^#1TON\)"5)#GU\=V8OHM^N8I.@/\,/8N^UFG6J($JK00>0=\,4?>Y"/6: M2M+28LJHWPO:_RW[3F9I!EC4A&:4JR3)838-]Y-8O.M,'NM\`ID\[+:53/0)MN5,L:GP4%^\>Y.?YPBFU$((]L[A>5]\QO!0^AX)>B_ MA3$,J+3.P'1@XS5M_P0]B1Y;AP[KR"Q?Q@%&9>^8:GC\NPE+P@5(<"IQL]A^ M\S[29BQ?)C"?KGABK-7:.QYHHK%9:T-*_2F["&9_FR-Y%H\MB3Z#.'H=KG;$ M*95W;.-MJ/X2'RL\"]6%!_.[B!SGY2'?)F3,$AVP?B+RNNAX`IR<,1;>18#9 M2*<"%9OYYPHYF!C2(WH\.[O9+3^:AJ]@ZAW$[ M75L`XFFCW"MQABF>-79]U*M3N.J\Q71K<7,&G3-O2,.-<^OI-O"&B2/%,B(= M/,1WM2RZ:"+D`RB58][(E-07+\AQ.CF?CL$S1T:GE0X/FGA1-X/\GOOH8ZLU M].3J!K(X+,BW$7BQV)%\:]XXPTE6E5\(0T35HWOZOT_L_S[5_]U8L_]+YQ*. MS'\^<)7Z=(P;*N(*)#@+64J4B`S,"%246FT^"&&^'[]&IR408I^7%VF0/%X] M6"HXVHD1QH5)$5$0*;3>MHXG%R$A[S#Y>:FFIU^5`VDA!]K86'WV"YSH01[7 MV0H=W@XA@G2&\4*KW/9DW>.3N8LM?96HSV^X4!,;,%?L''S`]?6Z=#I-FY?" M;YN!K18**B@J"BUSFRMDQRFH)Q%]7UG*\R(P6;QDKO<"TOG<6EV!OR+J80&+ MZL8:#!MF7*@1)@P,HW2G&5D*]S:=/#7_S]"V%:3;6'WX:.WOX(YYC97QBI/[ MN7-<;GWUV=J,M:%)?%Y+H[Y9:UM=$1ZL/INQAXVU>@\/5C=FK0WWE/?P4%V? M.\^VT2J'#PXFCOU0*K1D.W,Z73>LBPQ%7VUUR75.$[!SR#5G`F&>2G7=$I2- M*]<$6:TI;?RF>.[$".VSO%AG*.!!R3&D[=8,HWFXJ.=PP$GVNJUOF(@'6B#D MG?75IX]2^_&@E,2+F*V0[#=0UEM#5/RM.)C`@AJDQK1>P(<4$])OEZEWE:J, MZP\]OK/RDFUS]%CT\75DO"U$.UD6"]RRIF\OTFV%6I&(1I/-W30G_I)%N6ED MS3H:J%'_B#_0D*K^^ZO4<[+^I=@#*%;&UZ+%4=3Y5GS7_`5$%Y4@^_GG6#/U M^>=$:OXQENE_9"JH?_T2Z"?$06I0:K&U$O-C7MAAX)W@P_G M([+01E@I><#=F0IAN:!@X39FO(H5:GE@AX@I+'CFK&*K>!/1.5@C2SSO6>D! M[E/8VMO&[[N^=I^N:`D#$\H(-MV&Y1Q\W)TCXKA'B<`;X&B2D+(0[JN[0#+? M2]!U^4B(T;=SKL7^)2(L.BF-%TC]QO&IRQN]0L'Q.KV.!.&E<7R?+G[^OF8C MWU*J^KN5717"U3^]RP4,8#!^^N8"(V#P(Q-=0N2:F&^/E4;A`7HW=S/99+NY M>$_5\_6"K<+UU#K-9-,<73M605`_V8!$_:,_`ENH?Z@!D\7KRLN8ST/-E$U/ M;P%_92=[T^.B^@/B39ZZV'L9_.KU$O-:IZ_)+5^OV%?WQ^&'U@9:,C-[_NI7 MT'>N996XS/.0C=4?-A\RY)EM[GT1]R^*$!(GG6RF8*0)5=+QRCX=S4T5MF%P M$-:_KSQH-PL#4%=FN#7?8X>_9='7=7A]IUN,O$9\S1%>+*[AFI&T.[@#K^XE M5+P?V3&?4=]]()/1*2//PP6X%IL,0;-XDO-9>6U&\HZC_-N]/.I/L;[Q^6'_>([@;O'ZFX*? M\\:SNF^?*Y`Z4,0$RZH(_11U]S)@X9;]5PJ/F(M\50S4'$TYQB6FW14)G6QV M"-]"QCQN-XA<4""OC!3<(D"Z>,)-:""QA23=+T?$[*+M]'==TTXJW&.1<_UF M*'UM94%XOH)W2O:S;*/>/+:1FP`UX]R*-M=E+TH^GW<*Y._)]=Q\SV)Q?#B/ MYT@N#TGLAOOW-R]`I:S=(#E_65Z`8-/-=/=E[8'JKM@&S0:2-7$2JTJZ'7/4 MZ7:5V+S,T6A4='0/3*Y%Q<>N]N.2&9"D:)'7(SPL6#$?__+F"KCUF$)!BY^B M9I0D""GNN+.:O3%=N\U')*G4$C;E&[2B5M1ZSVR#9UC)553TFVUX/'Q-KI+W M@%8W9HNS#!AX]OTQ>>2$Q"PBQ>/HT*U]7!>*O&-&L\?D\S7#F!KCZ[9UJT&" M9Y-S98@>*+\K=JRMFX_J'LN*/6N4Y!<>=03NUEJJ.'?-K1[,F3K%J0:DDT/= M.W&'/)\`VRHZ-MGD@8P$U?YJG]+\RK9DZNZ(C1LOVCF.+Q)8XA/+W_3EC$]_*!Q@GJ!I5J.8_/3]48Q_TH]WHS M?P\B5KN5ZU;'(,%1P=-40-AOL*TQ;(OL!%BEEP@CXL[Z?R9>$_Y&)NFG"Y5L MLC4YS"31TT_`[K5D]V033S:Q.QS3FN(%\0<1 MU'_[5FA8__$/"2OK7V02U7_;[7C#RXB9]>)7(&K]MS_V3Z9_2M M'U[IF-]AS\XW@Z_C=:WLIBM?QY2^UGLZ9IJ\OGR.7_V*66/]ZG7;C>E^GW_^ MZU_^5\\'_]4K@55K:(SG@AS4`P#K1PO]J#4ALEZ[?SY1FF2;";D&8TK6)1?Z MM/8W,E6*K*?Z*QPFQ%"RV;*R4?]MME)UY:WF+4J5EW(?E5O8MOVH;("#4W52 M5\)];T!M-WD$H2;LB.'9AQK;`+^%V7Z8]NFV-AGP#'^PCW^KTOFAE;[L72BU MBL35WDLE@=#+EZH89;Y>N4MP+VU/A/^!ELWW6]<9-\6GI7F_&AS)[.F]MIWS MC^_"DYKJ91GQ'$AE[7GI/ZJEZ.XY]:-I;40\UIKTT/+B3)>^7&>[@AYFSK54 M)#).+G4H-ZX!\17J1&394&:0P&RBC?ZS=EMNI)&%[\Z-/PQ/M-C<&FX2E%BV?N.[U' M1."?BC25L M!8W\WSZ@5,VBV>T,)E->)(U5+IBQMF6U#N4H4D^8,?W+AV`%\EPLL:_[;5VRP$F MUFNWFN.YVOO\\S[4`-]0^Q+]P]P*A;KGUC-_+YAB^T/\[GSO=LT\5/`0![KB MO9#TC2PBE?Y!#5;XM:"#S,XB*.W@FQXD=UK5'O`[;*>,*) MU:&[9(!&.S+S1,"/%*FNA7CWF%M$-@H78$?&2EU2GM+L%TW!A$].-B@!_FO* MDMX$(M@D5Y@ENPD"^<2U3I=_DQZ60``6`\$5;EJ]1:$="8;TVE[RGH3\U29>/ M^&R@^%#=\2B;>N4S0A%OH5(T1\I+=U!["::`M'-,8IN-+5L@[1E"7OU%#;O,6_:N_Y';0^]!WVHYPKX_'_T@ M)F9ER6T_V2OTM#'9()@]YT?5P[/QJ/%%WNXF@KD%%@'E.X^?SI&*>9NZ,@!; MQ$&6AN]?I='2F"N%MAKQ3N@M)4=1@C%JZH\#&Z&Z]?S=UI^V7K^<>9%?TA2W M6]'X_!_SH0N[O(DM&M5V4U45`OK1O3$Z_*L76Z9NJ&6316G%XN6>VCM37Y%M M#?S8G1*<89H)K1%Z*Z_WMG>W[PIV;PXGYZ&;H5?YHT2*HAEC1\&1K6;5WN`" MU2FL>V`-LV/;M'OSG?ZZ"<`/2%6_,MOO-JD>B+W9?_D_=K=N%64V/__'S/?= MYNY7^A>C`2.U*`4+I1`P;;S6Y>#1ARL?;4UYJYL)+H[6F)CRP<#-N%#O4RICM2/TE<;.H`N>"$=#-L:X-[T8*)H M5_V\.3LH^DSE)D<#^,OAB9N;4JC)_#T9`D4MH#O.B@*CYQA@?4;5*\VU[F((GI)1H*.,_\87!ITXV M^`9<'O6P$[@S.71WAG@U,#?8];R73M'22.TQ0DE:PRW[%7B9?O7&90A&SLNZ MY&9DN&H'"JB$]0!+E$C4-A6'$;36Q63U^OEWYY_Z M#$O0SD_9#L'QWOM!B+]9M.X`GZ&QTMG]#(#+V6!D1!(S?\.\"]Y;?U"9F&KY M-)F.AJT?WW5K&.]AWY`=X)@%-2?6_?Y/[0_:3\U=S&;3_IZ8FLK@Q`/-5)>G MZ.OR'/[G(UVU*B+!V>KYZ<,WHAWE9.P9-UL'H_Y/*,7]0W1,#_PT\66R:5A[ MST9Y"W3NQ,8,A'5,^C_5J[<5YFX33GM9VI1QHB,"XR*UL*L?,6EF[^DJ'!X6 M/4M^P^/>-8T!3*[E!*>O*8)>#`@G*R@O1U>416:A*>+F">NXA\!SY@VTV.NV M->QJ44'O?F\.$DB?/@UI$>$K%59W6PDS*"(8>Z^+2]EO*Q21Q6Q]R`BC)/CN1+Q`N@ M7F+F*`C\DN0DQ0KM[U&C5[\.L_O>HH.<2:=7@M-J;R7^-T.LRXN#?79@&_K' MSMMW_Z5_=O'?7M0?35^H7U-S2+^ZR>#P>'A^>LX4OLNVNU4_33-@]5N%?+P: M2!H5,+%Z#]+RQIPZJ$C^G7,S$,Y.QH?X&)EZ3.-9'H[(-%ZUCJJEK9ABE5%+ MPA@2F\X'SX_'VBB4O@^H9(*QHZ+0H_)ME1AR33Y'1'"NUW+4FSAP9?;-]9UK M;G\]-"^Y`BAS[W[S\\\6AO2[2XZ,9O0PWG"\(F*(*7H8D*>!"+'22?FDUB@[ MX`3X)%TBW_G8RNL^D294=+@J$2@SB10A5V74:*2Y]36G*CIFU#]EOE7_8ME^ MXWOUGTE=JO_T/45VQV1%UG_?(J!+EF7]YUU-F%KYYT%_U.Y6M!7\*6+!&1H! MO.',641L24N3")S%I.I/KZS?6]MXW.[^LI_X1.N)IT_:RW?=/&H)U17ZI3QK MO6']:9W"HE3H>^L/'[?3712MR#AQ#0ADQM%DT_5N/*N[]>)ZV-9U%$92M9[G\5:2^HKFZ%;P@5QG=+?9QTWFY3-DA!I:Y]*8UO[%JBU'G&-[9O0RKE MCWQWSLQW]4]\WR>B]4G(_P_?K.L/O[-PUF23-NC+G4J-"SVVE)_%<4V.(61[ M,3"Z?*C`@Y<:,C5J<)$OV;8TA'_\$[&\M&!)(L3T96\^*.S:[6 M1K-9>Y3RYDP,'G%+/KTQ^70"YPDU1LO$B`7E`JP_>[SD%*!%N0;O;#Q;FZ.S M66G,S*VWSV#B2D,56_HZ.YLN!N.6YOE:%)YQ@-D-&F\1NYJ%ZS@/BJAPC/@M M04-]LFS)%Q-2RE0[(4VA,FG0#1:_2*^98W6AZ#YA'(3B0K+4EI5R!`QTN&;A M8>0VS4PT99N%AC.N26*YAL>!(-+TT+(=3$\H,0@0Z1/1550;/Z9R5;F`P8;T M<)V>3P9N>DVXE>_Z(P9Y^?PA4M]RW,-NQAUC=FN9I2TY#U^$K@#R M/ISKO6SV9DZPX]'Y],/Q0K1!#A'*K*^P'&]Z".)D>.!#[PK0Z<"*:PQ5S57) M/?=%YMZE`Q-F+M!>TYZ]L_%HV=.@%N3!O+.!HKKUH^(*X:PRS)"&=$]\/6HL%PV-OO[9Z0^42_LD23A1]Y M'U;LG%SRJ>U^2V>$`W@UC>6GMDH'LZ?V>&5;;LB+]O/@WH_+P8'+9^W M_C9O(=+FGD^+>JUIG4LE)>6WD6RG?D4'5@>H0);@V;Q30S8A[[@<:]6ZJX0J MES&!:[)O[C_`>\'":H$VQBVG!W0//'NT^F3&<*Z':S7"/IHY].MA"[D]()!3 M!HY:R"Y)T&U5PZF;J=*_9@QQMMHL#19-E),!2T)>G,/JX>K&XV=+[]Z76MG# M+/J]787]&6[3"X-:S=>G0;K!8"G@5*XX/B'DAT$Q2Z/HQJ.=81B\;O4-E/B@ M2&)4:",4,^0ID8M`+WHE/EI;;H-!4J#)([[`^,T&48/SAO0+V53(NX6<^N': MTG7-#^3>TV1)4YC:YU_$(7VFXEQO1B;>R)YK,`;Y/)!K3WLK$K7VKZ%$/]DO M(9T'A6B MZ*%OI-1&"6:KO_$LHM;?O<5IE'6+L7N?,=?IV<92@+T8_L8!'CY:S@$61M2< M8?WADZ5<@E0&NG4U8Q+>REK(2>')H7EAL=U;.6AD,V9M"^>K]Y&*$5IKT*%W MA%XO%O@6\EHI6VSV05V4>M1^6NV]"0VO0N4*^UJ".W!]V;'PW$!*;6Z\5?&8 MC#3\`PDV7KJ#+T,&Q38^BO/3DR-4H:->=$3L'0^4>"LK53;Z-6]F.I:NJ*OQ M>2AD?,O%GMN`H<9/CL^IR\1A8NOFO,*=^)+@AS%NIA9"%_U/H0/HV?UQ_9R;:F'Z;CB?VG]827(Y^C?C@9#K7_H,!(!XY3 MJ=OMB`#./GNOO=Y/6D]9!?8U):PXJY1;+6*DQ)!'U)?*FB/IW[;8>_-822&F M%G2,PTOYU`(BS4Q^G!SX*K1SWN#YHLJ5.G#`1$&JE1(*-ILK$C'T2+CKQ8S, M8VT&79OS8KUV8S\,\$7\UQ_6RD6Z/0F9O7R28AU@VV8RZ)A^/1Y[2+<30OUX M)N/5+(BWI8(?\W;I85H%D,$ND*Y&]'_9S``^>&T5QWHR05603CN@[<-;6:CB MBC0.4A7O,'I+>-@;SZ^OO%]G.).Q"-NZ^F3E[E?< M'5T]S0HV1[(A7DATY>?61E`QU5SB9S?NH##4BJ5_`;$,_8Z/RM/II7IF)1[0ECJ M@F"E?SB\O0G:#;0WAL"H[5K.KXTNEY:A[^@CE&E?<[)4V-0ZM1A3M!H:%892 MYDG=LLHE$1#"A_GL@]:5S`A;N)M;A>9:>AZMD]GSPECC$L8MB,@K779#!3V% M9A.:]*DP59RGUCI"(DR+B%[>3G^:C`_L]X'N+D$WZSP65%@6J9$)/ M0R8Q)A(#:FA@,^70!SX"1!\'1JBE=%/8*N0LUB;7-K`PZTJ$ID,LR:!GNX3CJ[6#=#:Z MY;%Z8RNPX`@=;[5ZV/O*TH))X;6<%_TO0$4,DQXA*M/5:'$1E"&%*/URNI"R M%!-KP]MJ9T&"4)BU-OFO54S*P"J@+UC0C9.VE@5E3$3HU_H[_1!B1/W05"1X MR8@&YJJ\MAM%*X3!N!JA+:)KV+L0W#97!\8I84;F!B!79@MW8.I+:*S!)S'[ M7K"*%=/"Q3#)IX''E)E9?W(6E$_9`+-83CY,*9SB,L(%&)/9RD2,>2;>=CE$ MS'J0T7C.)_.4.R5BG]"Q?J_,1L`E\R&G_=;-/;C1YBJDTP!E[U-=&BCH+.BK M%'UY0HXPW!22<+E*=-=M+FBE5"6L$CD.>UG&P-5+9'=&]`]ANYTE)-IS#M\[ M>]GOG0X>'C[IYDZW]39FM$?JGO!JB,JQUUCQN=A*H]*FOB41/U<1F:FW+I%, M3^3875SLX>EI5U?2'I>R,WTRUK7EI)\_7=GV? MFT590D?X,$710D>H/V<8=3,9#2=)I.2//#(O-4JL1V^O;=H;EZMBF[GO]+*6GJ+WI'Z-!++-H?1( M>IDMC!/JB7WTA,D6S+:@!=@/S`/0]U$30W4"5%+13+*9GT\OMWXA^F$\E0,D MY;:V;;!/%R"=DQ19`NN(7/)[I0\2WU8G9O,*P?!A.%>;]_=[FX76EQ>(W$G< M&%N@_?AA"ES;?`[;PHJGS%OEEBFPX+TV@&:L7B2XYJ3#7=,3U_1#[R_X`-9O MC08]79US;W"9&/_SRJ;<0POG`CWQ<:5947O])H+VAQ*G_CQ:`C3:41CVN>-U)3V+AB&4&ZG=;G53^&_G8D2#O"Y\X^,WD!/42X( M6[+YPMMA:IG[06M(T&)S;C?RSEO(648+G`SDH;V\-5K#GRV)=:4$`CFWL_L& M(J1'@Z$R/AKQOQ$^9FHG<6W@3PT=V]+O126:JR4@2+(AM.%)CF+*2ARJN-OAWMB88#'FZ!(RQE&0C^]*$(4H='0R MIKL3,[BC5K+O!'5K`6=Z.D9UB%+;F8$+5`24QA/W2KA/`N$[`F;>".L!PG]* MI<<$3XW_WA>1I]O67&TH&/%7;*%T,V10$O>/)85GZ[??5='4#A_LT$3Q+M'U M\:^'L#!D:V+H"=T$6DR'S`A=^3YXG:UW*WI.)Z0[&'15=+O5LDCS,O=//\&= M(Q56T2U%C*G/@R%(.3]ZBL;J=4O1_C>5W0L?6IBSNEB;D:DF[3E<95PDJ+B8 M*\F2Z.+^[CW=>WHG$)-R6V)J.95/L/W+!J7?#.$HO+Q2#\ZG`+="P^E\_=#2'3(^'Q?K.JN\F&XAQ'V>S;QY6Y$K#3F^ZH M%W&6X^-DPN[TAL^`?BGR:2I1".,:QU-[\.%[V6.I]V7J=D-WGU^.W// M/E<.\"LT`WB`0R4:J$5\WSHKUT-;OWV-U416I_*<'B@=166VH&,4X^JJK3[S M^$5*4>5)("7WP'LJP4VB';WO9$OA6T#H=<%1[CT&&D<[K?RI?%/.R1(4P9#4 MB'";*MC9"0]/3XZ[J87:JG];Y^^].#=ZWU].R&?$!S6_F>#BNL:_8=KQZS?? MK7JX3X5+!&I`.@_)RP5FCF0EFMH,&!(?W]*JZ*RQ=I?/ZO,TQOAT,9M M(`D:D<4,N6"HF?,A9L"X]%4JJ2?G\4:K40V`S^7`+!8M(D?U_%4?ZZPQ4OY% M42OL+PF%P=C3Q#?Z18_:/ M6IH_'E-/U3C.X(CZN?JG+T`T'(K;?(EK>JN>%5-5C-XL?78Y@1Y6+;X5K17S@#T1H>]97O>5M(.7.8XB+R:+DK#+D(*WROR4`?QA2/=V&IH> M$'9-V?34B;4LYA#.W)H?C M'W"%!WIW1XI[RZ'08@V-<;U8$9G!9?Y[HD.;*TM!%&>/J^JM`@;GXK_V#MR* M!OE`YW+9+TE[34N1+1GX1494W1NI1&F<3DK8*4YLR=WI'`]C M1Y^V\\LNO8^_78=3#3?V+;SC[=U?P+QO'5?_V3Q:Q,(2E MU,]2P>H_H==.1)K?6H;9GUO2Z-;/OG)0[5)0JK?WDKS<9"A^@Y2IDC02G/U])_U-)RM_^HA?N\5XW)] M-_W3)J?L'[=\N'5GC<84_0&=!!OO&3QJZ7][_+@IF,3F&\R[?]S2/G?KEIH, M^*3E[544ZKUF\G7B2-]N+*^KX+_U`VUGQ_5?%HOTMC]EG-T2S1KB](P*(1.Y M7VLR]TN&*TIUD#;]'':=BF3>H-.XWB)^X&A6WXOUD^Z]L.!_Q#'%Z>J_"[") M3-SR!,1EE>EZ';AL0P4)F"V-*C8FZ8>Y1&HV\'1T54+L1?];D@")V_$\_&HI:[E8TQ[0)W7:$[D+4%*-/)>4BBY#H%. MGJ:W\%*395-2B%'E63W0AH#M+/0CI7IW=&>_A6WLM"X@^)2(T8%5B<;#B/B0 MO/@Q.CD4V8/[.%-H0VP7)@RI8`,,/2.G]G-.CE71*I@CR=Q^,?\ MZ61I3&IS%?`3%R3U/%/UFU':H549ZY6,W0O.(+DJ/C#L#";B%.`\3#\*O.EZ MOF$@:Y"-D37POIU`=4>T@L8GDYT6_D2\*F.KWE$40A&:>6)C1#@G,D]9=+&[ MA5\H%:FXN)A%BKT[F4'85DJ4((V+3,W@1V;)2^<-]C/23@5.J1!8E^#,:([= MC$"VO\HK]71/7N')JXE?12YB[FC\`BI&&GM!8'&S0J##WI_GUPAQ6@9(A)K@ MX2CS-":+(AV3:H8`5W`_P492T=08K1;Q-[V=1?!)PB4+B"`5WDXLL32**:MZ MFPT7+G>`%%[-G(NGA25F+V;3%74DF9_I*'XM@?7#V%+WPNWL_XW[[L#;"D-. M.K?=<:A8,B`$@68L>A5%'<>2+`JA@)T0]8X4@#WY.$K&G=8'4)_"8-M3]%M` MNWYVSI5D=4974_A:O/`V`G,G5+LC*CW?")"_SL`_C_^ MHZ7H:%\!<,L;;R7V@C(T[,X:6IB;W$WK*+(ZTBSN#9X^WF]->#>(>&]`QVL: M,Q+U0V?;!T$9/]WI17?D#QSE]/!TGT>IUL$=5EQ$%9RUJ':RXXT=JW!G3EE! M5\5KE$7M-[=!QE0WU[IO_.RF==JO([XZHS:I1CM=]\[R]UF=G'"ACC7)=(U] M&3I98.9@T/BH8CG0/88HMR:94>9#R5YU7+@@C$!A5[]&EY4%(B[3T"?E,D#6%5Y_WE[41 MUY?>#A`?3W.O[%(=U(H-MJC,TM>\VJ;WK5N/027E"_V_CEOI/\N*3^]5(^P"F^X]?#CX MEU#I3LGD^U=1Z1XQU_;74^GDQ/*X2PO+3D()EQ;^Z=#/;;G:>N%)V9G[2+2_JUI"F:`@&8SDCH]-')GKFAU,"YDIF5 ME9=:L#4-PL*#42I2JY:8@'F)%4O``V_&9$N/-POCF7:IF"0J6FY)>1V&JA^D M3/)4C]<%)E&)L].RNYL&O_QLKMHM2G&[IG..:MXXN/G?/<20&]28XLZOVV^A M"'24_N*=3OAOA?99YUU=_ZW0:IAWBX_VWBD=C/8S@I`(F@<*NC&.\+8>GH1T MQ6Z-7<4"_23=J1"#QX='3W=B'SLSR'8.F`]3UR)PK1`-C=,687U59AB=Y\8M MD23>$GS8^V)&]YV#-R,UI$8/,2>$I:?(^T$RTF266S#FT!Y.FHTWIXYIT]QA MBK&NG[V>KGX\>$NDGB@5,60V9BTP'4(Y+$8/UB>_ZQWT!@RO"GVYRB^/!_[E M\#1MHP MKN+XY7'CR?3F,8T\QL1*>S?323W4R85N&>LE*;QLOV`E.7B:%]DBH+HWEHKE M.;V_3Y;S`SQO1(!5//!A\EW)=E=RNV8MVF*$I0GF4D`^OFD]N8>O=WO7@G(KZC#K":_K33LI_*&\CS6U^2`Z(+ M4DMXCM,"&:GE#CV[!]U2R'$P2M%3:C+-?*\&U+@V`16]-S?AB.:T_+:KE247 M68NXEC=S@=;7C/(H)2[2Q,F:-?'"F%9AU6">'$=MV14Q>,N@NYR"#U1?H8#G M*_9S)D(S*M+>BX(Y"W1'IL;;==:0L,,O+>=%CN9&0I,P+1(P'E_R5(HF5]:. MP#)(Y;G6:]6]5^E1K)D?4W(BG7?)C)W=_%W,-"9%TE&I.$]TL=J3H5^\)^K1 M<-%_=Z.%0Y:)H!T?L3HZW4?@VF39#'6Q)N9(L(PIN9%HP(RO4HZ-MR2V:ICX MO3KDKD0C5^4&M6J+DO[19`\E^%2I6$@5V[OI)L3Q>MLR-1JI&=^Z?[S.!<]( M3%(A[8O@JJY__\H*;%^A`O@"]>_C\Z]CL__Z#T@]@7>,UDQ7J']UKCON_R^. MT:Q!.XMESO6'7K(NBVN2C%&20\T780=,)L M;)CWC8J4YZ$4K#!XM-T&WMHM`=`U5MRQB/5^BR MX0+Z)N4#TOM+/J+\WE'4-%!B+RIV-R;"O^,G5_C1INO_^(,L;H4"MRADW7G: M!@_W[.7M!I/N#6@-O?\.[%T0^+T!E8Y[30.I&YKG<%3G>=AV0931('%C^F8I M\:5$>?QX*PMLLJM:AF9WJ/UD0*WG/@,8':'V\=.3_<;3.O2BG#X^?-K-E;1E MHF!G4)8SQ059&_1D<6Q MG[U&:0F-(]Z8>?.=&D?L-W]%JKNC M@0+JFP`9C!;93+&_25&)LGH@JVML_@DU_EA?*Y.F`G##0U4X!D,PKJ(:+-Q9 M]*!.SPUGF&DV8N4Y6U,50ZRA>,_,(@N_M2]-)4*7I?4@I7_R:_ILW4V,7(Y6^$/#'3-,G9-&'MF0C[1[_[B`%$!#YJ2! M,@$@T;&)13PRQD80*:&F?R^"DI/Z_TF+S?R*^TJ[<2>88A;-?D]69`9>6.HH M/(4NRW!!B;/AZ'(*VS3_)UB$@_,@.@<1"LWU2<_G#;!8Y,C-0JY--(\B?0`! MK%H?!!6.V/E"Z_KM.'\4A%OKJ^Y\)G?V[NR7Z_6#7F2^%>9QX8Y:W<_J3+KE M];/,PUHN>QO_-HVAG6&G($OTV64.SE05)C^V.]0>-?AM&[=-C*#%K?;/SVY/ MNM*;MT0A/Q>S;=*%:0X>0/AG9+PAT/;9&6^32ZZ?O8@:[1>4_K]E*H\J?1M: MCP@^E4TJ//`Z5VX7K5"VM341,VZ_9*R&%=QMA6.U$E,9:NJH]P$IB\2+]A:Q M<"L6Q=+,2MKB+S^?'@WZ/](9#5$-R\03+JU\QHXIG<%_\)QPLU4X6S,-V&9? M/].G]TV9E,UBDVJBQ8#J_RV?67'TE!$ZO,34*+_6`-9V;3>/RIC7_TW1+B_82X&XX*.[U,MI-$' MU=V@DN:PBEI+>.,W$%^V%)$+LS[B@6H/=S=RXM'O$L8)ESNJ,Q#04E,0()<1 M54B5NX@HAD9;&#.>*-9`T%FRG?SY*@)&--<`@TG2>L<=EEW?8XCC7B?&=N0O M4MY--SZ6=C9B1+83LMTQU'&/SFA[=>`IG(2A>E)S4=;]H^FLA2H$+QUJ_EAD MJ-']4/**T#>`E\3>$."]=6]D^K*9V["[5[%9AYG?SI^@$$LFE0%=]%,0@>C) M60^24NP;BT;)O\6:Q\I$1S\>E,@9UO)%L MN74V%D^8QLS%(\:&:&&+MYS.]E/$XLG('XJYL"W ML`:Z>7GKY4+E=J\%[6XP\)=3H-!FR^_>'.BE[O[H:.LLB]P+*I>S53B>SN\: MO/YE?FWB_'_'JY4=;+@_X)AU<_WHU(L6F+4U'/O(.8Y3@;^BGUY%!YK1_N5* M'AL38<8I.;J_GHY\RXWXK&L444`+M&$SOCEU#-8+IA++P?\C6_?*>;1^#U3? ME\^'0CM+2@CXA0')O@*O9ISZR)J-ZHB%1O#TS-H;?36Y6&XDDX'RP^U0+BK[ MGD]FZHF$?L#`N=!`10\#OU!.6%&-7IF"4H?U7X97>BOR6U2M-PO5HOZA`+G:$(VOUAIH*$[W,XP"8$?6P4I:E!\$=MO5?VH3E&1I"-O6<\7!S/9 MEO)HCU"=L-OE?LLJRH4[O'5&NMZRD]1$QDX6AQ"&UF><,S&^VS2*.S+YIS$- M[W-IW%N$%#"URX[L]6J-%].2:6B0"()T(XP'1_L[GEJP]2[F5R2&.3\-WO\* M=N*%H-=/;'56P2^AG4`D=?R0_[H?O,JR(!/D*1IG+(%4NG>^OY)E/!Y&<74+M'JO(^ MM>9N^,V^3]&=[K]OU;_PS(H);N=PIO_L8"6<&RLU)@H]H*2.+L67T<^9V``7 M"W$)3Y56"F+P;S`4!MW,V[7>RH1--QE[LP4M1MR7*+>Q\"SCRYD/]O+W$]S, M9VT^4+M+Q>G@N&J$BY:T!0RI67ZT(VS$L&]9(9?`JE-3?5K!RRAQX5*T=8Y= MKM]<6E="&((IV8P\1MT"1)W0^>.3/1N5TC<[.0FI6QWE"=62*:((3MUP=).% M+`>_376$33O=8+UPF:98Z>X%@:"8>+_D@->1+J1,EWJ&/4`6ZY7Y(1$NB1J] M%;#IL28^L'M(7T9=$;49082\!E(SR?P@>H%9[JD!IO_*T:3-OZ?7[<9'H6BG MY;OT=7Q-<4;KRCA9AN0*`T"R]WPUG:+RLHIG$)_D9HFA*R2WO4U(S.`/IBUX M$KS4?LR:<(JLILJP3\D4J`PK(D_0)A\2$%&5!O&=)1,N1*V<<8FSX!TS&A=: M?&K1=(66XBP&M.SDM>#?6SS#;@N?&".`LZ0.C,/>UQ@_!^=*BWZ9R=SM M?WW^\M5];FK%.`H0@9W&%!-U/>9LUE#:KS8;)&8.H>S5@G-@&IM6(LI\@>VW MUBP689*;K%B%(3#7$I0K]XON8)8CN)%?T9O;I'?#!XV%)L.-B^N$1/?6R]1[ MY')('">F-V5MV=S?7?"?O1V.T4<0(F0.TE-QELX:<:8WNAFIMFVYN1+'$)+D MXP<-M>YR&6!=(^L>1J'W",];@2*!/WB*BWG0H"8C^N)'X;45,M=O<@!7II96X)OH6ZRSZ.!9@T0QQ,%1`4C!_\ M\;=_;,\Y28=?AE#6]A-W)>^/]W?5I@R+^_KA+2'`I\63P2`YEC0"B9V:,)6+ MS)/M<`^.JJRW5BAA3C'HAVXLRL(;9LGERJ3H9WA5J(\7T_F")+#WP]$$CY9< MW].K\89$CILMV9GMWB!F0:C>"ZU+W>..W%L\ MT=ALUG]0$MU#9]&#R%E6KO(A[$-!-(,*N-+T&\D`1D2`63+5O&DV#MDN8'./ M.6T=)36W8V]!?$DCQ[RBY9VY_D-0%',,PQ#J8B37)5,W\CN:8_(?P1YA^`^F)Q*P`&8'BV?2T6I"!=F-5NK'FO=QGL3^W MDW-*>LS)DYJEP)QI6M[B02^*/8*JXT79QX2='.ZW*YG;+4&UG=5;5+TXT M'MYH4&@1;KR8,//$]/V@FILZ[F)ARZU(W"?P<4'<$N`W\QA61S&$D*6X!.-> M19ZH11S49T`[$G"'(5;=E=*P/Q,K9`?7^6&FVV M46&6A4MX5=X4)I@`-&3-9+[9[QS)[872Y&+7`AP^"D8&T:Y'I5)Z+%/K%(FX MA3X9WOR=\G5;!VM4G#F1HB7YUC/W5_#2/#PG((9*:-@;:A68C,-E/5R^(T7! M"7K.Q`S&>%Q.WU'&*<$:/D]5]EY57G$^`(/YYAU1,:A6KBL=3_\>U2>!.)?0 M5V5)<<../6DDJ^"\+1+88XI5S;\MZZPKK%4/HXX3O>CODLGI/"IB1UE,^ MBKD8+4>HY![A!Q<3>+05M86?RQ5=KS_*6U$^:7U[9+@?M'W^55!\=R%-U[A1 MD,;?H0&:.K+HC$75^JDL\%4!W^ MY["_?,?]D-7DR<+L%(.@E35^]]5DK!EM M]6T:=(Q\+1^O_G6?!J2-D@1&T=+7J?%39M\V/O1D6<.="M+7'P[YUI;\/&OL M?Q=[ M'$B"UO0/`=]@"&K`<=*-";'*SC(7PK-\'193@[/@:92'VVX+O0]^2KD1"^2,W"@BN*-6_`%>%?U&%C7%1ZIL85Q`'CNI#J9EH%Z)AHIH=,U%-WAU#87%_J?AQ.(+D@+:4/WK0 M^_%J?HTJ"Z*2T(,P(6U(A"L#8)8]?IA\*5H M@`<#?8045TZ(H.+,MDO\>93,*248DD10D2LK1A":BWGXB]'K?%EY482WB*_Q M-E&[9U"ZXNRC$NKOH_;$Z3;-P+M!HEHA24I1"BSI^<`@K-USF+D=&\(D]_&I<`/&^B(-'.=XD%@`'9^8[)A&_PV MN)&D<[K!:J`%;:Z9)Q*N$03],)RB>SD/V'C@4*1!/J0`A=19;`A&JW@M$*O%L0*4WW;L$E M&,&+V@T2Y-_./N0DLK=QDS3HEO7YU*"K]X?,DQ<`1IN`->\N::9AIMKZJ9!]M5EI=61^*)5#D2X7)_@9K1 M;8;3TZ.CKLR]=OL[NFB@"2MG270GAUMB#1@;BO2)WTINP2U)"EFAB"G)(PQ( M=1H(8;E,4L4S8A@5$R):(.FE$N>&N9*%+CU8'B8$+2!CLFAW;&B@@(<0*FH1F`>I/)&':;Q00\W"(`LJ3%F7D/0YSD\T1> M>(:1UD)<4(>#Q=31C!(@4A0-KFLO._Z^N?`(FB`MRXJ#TXL5Q9V MST<_QOX^]265QX9R+`0`@ZPCPP/)J]!#JM"!Q;S(?D?C`,_!D_I*?8*3C<]P MEC0_),VY\4/J-^N?8=EKQCOJ10,0_<$#RIH.0S@FWY@^9Q)-HYG-60@3ZYRN M;`07<6/E[YK6;7U?>#;@8?5/]6"XQ_Z[(;U0[V.)2^63O;.B&,EM[_IC_<># MP]/&AX,'IT=,`VG]O,4K\;>F%MMX](1NVXT/3^E17O_0/1:ETM&$_S?8`>4O M3/-:]_J1NFX:+;_[CX_;#O2$$5`-S\OM7$$U&$V%J)6V1S,T0B]-YQ(D!)Y; MGUE3(4TO`8$XCH1 M1BW\H__DZ/3P:?U"A-3XHAI8\IHR$=1*UC.;Q(T=%VX2:!L;VXDF'])[_\'')J,M%^%32H]/Z"Z=0? M[Y-WTO`JWF\LJ9\UF<,Q(Y'J"[XQ'Q>OEHVB0EP)X.`""Y[7^B//4]2J19NO M__@L^YOA[U*W\8L$UP7ROO[S/FT/ZY_Y^ZR:8$-(J-FJNH'+Z^ M3/^XN72_A?F\*#OCE;A37Q"%7WJ"7`'_"!KJV2;RF8JD?A8PSQ@@O.WHP8T1 M=593].P`NLC<"I_+A>-/P4@DERD2CJ:N<!&(J)& MRE]?A?S.UA'.#_.B%%H_R[J7H,#_TCYGSZ'*U8K4I=(5,1T81, MKFDJ6!C$BVPY&8`U7A`7D-X)S0<8)CW;JWK+Z@MVYFY#Q:"*>JU$956NC`WK%_UPQR0":,$]@]FZY7!G6B(FP: M4]'%ROZNZL9L,6N_W/3R1\2'><%";74HJ\#GD&^V-WQ'NH#[.2J;`N`>0T`D:GD)_HU;Q"+->P0'R% M8E,2\N9Z\WO5O2G(@)JH5#[.LH*0*6PV&@U8([K(V0/XZ/C4<4OQP408 MP0MB>\[W('^312CMR(;E3;[EJV6*PC/HW3UUPIA2F$5C_6*<(/O54C"X^./? MZ9`.>>>_GS>*@4C<4Y*K'^/8"*63DQ#N#WK`1T#$C7Q2>I:?9'#?CB*FTGZ9 MU#BA&>KZJ_CDN.NX-`2UHG>?9?5COVO^ZZ#B'X,6,6DBC/1#W(6=`/-1--LZ MAJ4HNI,#'$7KJ>,#X&4++:\(#L`0$=I#1O=,G#_>$>:2Y69])MH<*E)?H[%Y MR]F]WB3PG6VD*MYS9\3<$L)K=_^D"'4U.BW7VZ_*/DX8*;3_QG2ZNQW@;4K$ M'GCHPZZ:#SPS\8IO3+6:*3J%TX^R&[U&M@/?D#FKU(["XI(=7]W?` M[,^1+ZO>-]B`K^<8P!KK\W:(%4:S#XU['11S?I[=&SS>LQCH1CV^]_#A?I.] M[#JLL-S0>A:071&\NG%U.H-B5 MQR'-6^9R3[%*"*'H[9)73R%!7"&MX4@$ZSU%:2*8[#+:E[(X0+E,SK5@E4XN MD"&]'0F89RT,;_WL6^P+<=C8VT-193=U\;*0\R,?%/0?AD<"=/-Q\H3NH.+> M=-MH-<+!HPN%2\')BX>31Q*;2JEH*$#26LQ9RZ6OYYZ91''Z%.[#"C)]>)$E M)"TD__"6^[67[WU@O\MLF`>CGF.I>/X]H:,I:7D-25KZ_%R=9G=Z,=BV(!2C M5[H+C,KJ%7$JN8Y'.OMRHWX-K@J]LVPMN1[UM_@S^#BCM$WA=XW\2W]@Y(14 MX.3#K$"?+=)SGZR#+STB+\>!:7GN^S:;KX!IV!LOM%@-(58E,N=FU6\FRP^J M7^^_?/TF9)PGTP/?&6"O%^,DX_M))1,TT52*%+))2Z(+:)-4-BNT8:5 M&[31]>EM>KZZ5!3KJPN(C=.AIW_)32[*B[:F@;QX687$( MW"&Y')]+L.6-N;W%S[WU[<;ZJBB#RLY`7%&"#UU^0PFWJ9YZ![N*KG1+F\BY MV$6FAF-Y'<7?TP;J;4"UVM;*PF`"\/CP6O8H;9` M=0:]@'BY58BA6#*D6,1H/!_K0T99E$0,Q*:8( MSFB7L^%UKV]$9(GQC/")),93U0P57!Y7@&ED;G86);,0"H4(X!GDU6,M\^%D M/3J\#R8A$F(6(":?9SBO)Z/+*VO$H':FA!><>R5("1LNF&]QW9I=:`C$UY92 M:B\0^P@%@G`$R(,-Y\]X`X5)+V_EMFFALOP%N6AVA7! M@D..I''8%+7DF!EB"Y)VXFA>79CEE=KU`A;W'_A!`[!UX2*TT'9M9%]:922- MS$"*P]X7(5E;IRGNPTY3='2NOL,0R<^_#HV2/38E=+9X18J!&OM?(3+R@:RC M*UGL\QDF+C.\N!Y(01Q>W'GRD^[:LDA!Y@MKG;"Q+"7U-^$>=2;E8!.HO>E= M3FBSS__"DF-*N_\"]-^$,?'.#$!T=`&:12\KEZX6E/H5*.V8;:)>A)'0A[T_T^;U@ZI2 M*5#-GZM36X8X;Q:+32U;\8R!*\!!26TP`;!"BB,`U7EKD((&W'[[C($0GE$KRS<,W6DE=` M6W&$>-&P'[VGD%]"#\N,,X-69!LAHF/X'`[MTKQ!P6)L*:(@0=ABSB&@JG6B M=N)H8[J+G-\F>HXM$@B:>MW1CNU$8TA60(:_0#^G/$8 MQV^DNN1J>!$N)&'8F5+_52O3"G@Q%/!V6]K?%R$S"-:?WP""R`%;O]R7P;-? M*5K;D)O>V3@W$R![??GX!*H0IHB<+-9D&J6 M9]FNH"7*!D41*!WF^X:R8V,\98`0T'YK6$6])JF7FA^Y#5G$&A:=YZ\/GNZY MH4Y0:XR[*H:/?15"X>XP:@MQHRJ&FBG30MJ5OQ*9$V$;0RHT260:W8Z$%^*R MELE@QH^4&Z1?RG.!^$/J9GY9JY$N#B#;QVB[AT%.)[5?"9I^SLTM6RX5TJU&"=,ITP8XR2* MF""%3'B-`Z_67T)9`JX$B[8##,Q.]R1,VS:+Z*YH9APZ8O-.;T#`?DJZ@Q+G MS!OA6E(D0Q0*T*",/XD')\KE(714%QL[[?*N<#A1=78WHQ2A76_``L9.(E*?" M5@Y)HT55F-2S[:<2N?MRRJ_"\)2QP1-Z34&#H1"PU4]XSD]WY2[H8\*7J#:" M1J87Z>1ZX]7DIW5O,L9N,U4IVC M@./8P=L!4E1L<2PC<\M:FJ?0"2L'I7!)W227XBQ*MW.ASF)D`(`N,ZQW]2NZ MIG+8VR3(^K*Z7CE:,'(UPEO68EP\6#L1;HR6"20'0/1.*S.]8OZ;K-;X$%8( MUF@V=R[D,PJ":,.(IZ55!66H4UI5S*B>QFA(2V?H*5BS9NE7UHBT=_:G\*N/*%&\9S?9DR;8DHY3^&CZ)H[,U'N.Z3\>WH?WOJ.T2@PA0IUN64L.1$^3#1#6 MT0WOY):YF2T($5F*DW'.K[Y]?O;URV^V"JG'"F#28P9F4D;YEKGG MZ/45PZY?M\`UGOQT4/\<\T/I//*9R_LFHMP(_V!MOW'HZL2O7YX+P7M?G_US M(PAJ%\2_4LWK;YDF"X0VN8U;0=TU>LOYC0='A)D7(3E\ZXV47.*.JO')GM*@ MA5N=[']_+;\CY_F]NBU[H.#?!(^"2-[.RRL"+M-UF;WSRV<6:L'.HCI:9596 M\V**>+P5U')X`9H7S)V!C1O^=V920)H/$PG?$O"[_\O/TF74J07&37,1W/\K MZ79\JR_>3I>$M>04]%)VXH3XI"YE:"F?A#67-P<7-P?AGPI*H.4@Z_M3K9VT M5PI)T9U21!/OE36',3,`Q+%]HWS+AG$["54KK(D^R6?L)=L,U@33HO1VQ'<` M8)W$(!M#F5[0TOF-&B$1/L*LYLQ3)RS\F2O^ M@Z%)'Q9C0\97DZ#+373;Y*$H>XM$4P6"_KI6=V>.C:@SP>T:8-*`)XV&43J M5N[WSZQPQ6.8\2<8>F5:&9()P=HY9$04;0RJMUKX>-#U?,8`**=Z^QN_)F@- M0@[8NL)U!KI+O2^4.\^XJ"YGM)$6-"Q.Z%30S08SJDHF\55Z0[0(_&)I9BL' MUFP&GX0VDHT%#:I[;!PY[9#??99S!]!'R]C, ML>]M;0\?,C)8/,\RA]0EZZ>Z=GMY,U[.1Y<8,!BP1,F`*/>4+M[8D'M?$K7^ MZ\A#,"!Y8<36.#>>.+)Q/+J;=#+#)\OHB3^';;B36^Q&-7R"@HP@\9P]?W$P"(6.^O?#$T9&^8>*L^6$.23JPIH*O7R9 MDE:@LJ(U(_QWJ?0PWDSWT"%5'%,)=92$V7#TX]LAO#)\@6TT/"`O2KT[]%/; MZU^_?.,1A["-W5Z_;:E6_N^*^CJ)UXSL0UZ_?Z`X;*`!;I[L-6O,(PD; M#5S`X".-MZI%GV#4WCNA1W!'\=5VF$A++""M&*RE%$HKLGP`S"2[#F-S!Y[- M1-T#KG1RU%UQ"".>P>U71R)"K=)R#3Y7#[F+2>) M"8QP)'+1T:6(%:U)*9-R*-0G((!?RG0#X[2FN([F!WS]GBE"IDH%1$&B1EU1 MZ/,-QM=E+\R\AW$F"C)M(](-.4]*T\S"%3&3F;X2,UR0F@4E;M[*MQ5MRNP] MZJ\MC.[N7`"N'V%ARJ*GC)`5&>/"?!J[O&4+]0*&):=L8:26G"^TO&PPTVD98*15^F%\J#G(0,7*9.?IJ-Y>2U;&%L!V#MS@6Z9XC'% M'P^["8)O(19=3GF->^-PJAS;ZWR-).;=A;2%.7147S:`G_\ZIZ53G;2R+<@.L<+?8XBVH;!*L$,[;CLV[\#2IP+OD%[\F&_>I(%&M MC.%Q_#4VW#%Y3GN0.070475Z!`;2M]V9B7F1#FJF3!7 MS+UCACV:.3I!4FED;12"K&Y"\FT4U,F<=*^VG\[J5-[.1[B5<8^K0)K,?KJ< M8ZM=T#!D]9X$3PV)K8+]K)EH'^T*3"XJ$K4-%S;LU)6OAL81NIG* M_$C;!HMSCDQ2`VSC[M)P3X7VYF=JGB&96;2D6B/J.%6S=U0P='M55+O;K/&Z MP65\*.R9=T*LW.6(;OBDI^0S8H09JA%8H/P@ZH]!!"]XO-L6VX/C/1=OF_.? MC.-+E4I9?`AU*CIT:Z96Y#IALMV"8LI>1:4V)1I^!OXY%,4J3:M77(`",(5T MI+4;\NZ"L7$G"=?:5$Y/[9I[FDV^2@5Y/.O`HUR)88NXS@B.S'[Y.8X7;5'B MK6K/J"*-]I-O$[SQLZ')>@Z4Y1O%G$UQ!UI$_[%W&>MDP#)E.UQ9SWM9/$JH MEP1120@U_F:;$>@L1:/T"^C#E*Z6H@XU%U8;_S&& M-O;\J[3\@JWC5\*M2V-U!=M87>D?H9-UCB/L\`)Y31Q>B(]P[R.&0Q%R"Q5S M,9W8TZ,-#M5U"2`2E!3C_4D!1F63(65ON6['AW0CH$RZL5S8;(NH'S.1"<:2 MX+"_G"X,=7E3"1&)[ASNLL!E2)$!0@)-,+-B)V(5-%'PYATP_<47DQLI?':V M]*ZVH,.+Q?3O4%?/Q5KXZW,+MG9=[9>?_?]>!MHP9W6;O*M>CF@]B8>D?%BL M-A[&$,G-_B2G#-"EC!*!(,$$T"B7),,6'B%"[9E>74XOT$0P=QE#(?]/R#UB MS(45@5N13__/?SV_+PX4XK(*^DX64Q6!P7^"`$6LX/<\I-W_6'C.%8HU6/:: MH7H\AIW>AQXQDFD!7;%:]$ARJGA`P<"X7/QM0"L?]1,;39:_#G*%QPH3OP6E M`Z)MG=PD(N7$$3B:@^(Z@L"DLWSY[?G@:_VD+$/5%\^!+9C]__[[_RB7T7*S MI'",/6GOQ:O_??#PT>-'=DTF../NXYU`UZE`V6[;>X-'M'H?*]&/DPI2=>(4PB4&E#; M01]T/510KC_0A3L*40BA$%BVD"*,%-W&KK>(;YIT!29DIE<2"BM9-?)?FXN> M8G'XIBC;I;@A2I6>(Z:DG."*FZA5X)Y7D<2S.5P9#@D+?]G,;G[YV7L+/.SU ML3W*3QZI*-4$!0D/XK<5G#-OPY#_;N0R5.J][1J"YG\COGK@M;$D7W5MVBRR M[[&>'8/5DC8@T=N,_X,MI#J$R19DSGA2A*71V$58^DR5C4143"=":F^9^-@F M3B]F_Y^]&P*V%A[K6]] MY^.T>]ACF-)A;Y",Q?CA=8M5TJN1V[0)4`S)>TT)%94+D(W%^7@!2L:=N>JU MJ,2$YE7@ND+F(]ED\'T).]TY#FKZWJ3H[JQJ,^F0U2UCGKTM92ZT%6I4D, M75FA*KZ-%B\/[XZ2#UW@I]#$(W,"K>99\AP`NS(D5CI3 M@)F[4+)9J^8#F`+\)V)JBOF$]S7PR4NB"\HT(@&%0]35%4$V.*Z",NOB0]SO M!D.*Z[@<;U>PDFL4[RU%BD0#G5.8\*GLSXPP0?F`T[M/);D;!*TB%CDKJ5?S MC9GF%Y$QJCC4F'^FQ2M<2VK4XD@7G2B=&\D7WGJPD-H%SB_F+MZYO]!Z5U3C MKGN7S882LGVE9"W"%>[IA&%W8YO_!+*)^"OJCC"06)Y/M1"-EU6=8DXQJ)UT MP55Z_<5L=C?_#=$.E1/1,QZ7>`9K@ZSH+*JN4'("K^>_T:G[ZG60MU8:`4V[ MM*8>:5FRM/#T0AIPPJB<:VD2_"X'@7BC6RZKGSZFBTZ5U.Y6SRY0T0YC,4-. MJU0OI4/**6*R%">-ZWMNC2!3DTZ:J\KW]=A$FW0>^-V#=AU=<_C`/+.>@C`5;W'#SC8!7=43<@%NA'D>O$^ M&F`4-KI"/V/4*XVK<"6FH)EN`6:Q@G[27>EW3TGR!7A--KGA*<%TA#%:HT1X M_1:3EAIFL,5MY=NW1DS)S_99+*X)[W3N-]Q(DK=Q)X:0?7G.(#M3_\9 M)XHOT*6S8911IJY?.Y[(=VD%?H$?NXM3W\T#X<(;3]GO8>E`M4H-1Y`=,B[X M-"HRW"J,HV)D6?V4]E%A-@+G',5?>ELZ30.XP?;/U/T3LER;\A\@TJ38/WWY M^GE;*!-]16/Z$IT=`RP4T&?/=EM+]L1UJ_AS!,)^X3+;6,!EEKV\SHS\-(Z. MN3-UA=1CI.!67PGCBIH[5$86L%N;FT2&K,WG[0=Q1M2@C]@Y*194QWNV-, M;/G\AK'N@EV,*%*-0VM!-SIJWJZ1@EO)&!CB'6^=)/)[*T.7(#]F/#-E.@*E M/"_B]QBM,3)7!WY4^U^Y9>F"*3)Q=$7==)%3^^FC'$8G[M.*\TX36I47D>S0 M9(LDSF+J4=Q_4Y;JK24L;:S=MG4IBHTZ5%0@->=0I(QX!P]_1<#!K>5R3Q),ZJQ-%KZ[NS<!)24-!^50<8H5.4Q\[Y8#1\.SA`,6]_UUI*_[KW^\*SO[R-9,+@VXD M-PGK\1B&/I=LQ0CA"7B@-P$Q`BS]`8-9O8QKTCL<$"!P2TV">7=O@YE*Q#>0';MUN[<$]*0"%\YZC`R=OM8JNI.B?7Y,`L`\)& M2U/$E>A1U(4<1AB#>JLMI02;;M+\P'(KXQ>^V0XSY*&_FP#^=0(2*=RK'!7^13'S]&Q`NW"-HDRH-#?<,5L^$.H&ZO&" M<>]G20-U8YP-&:23TD-])@'?3='8**_HX"'*B5F\M&28JW[IN:2DF4HLDC4E:6T6KPSBPEN2REQK&ER([>/F"6`K`TEY[FP("1@QN]OSX^L M;*:LZY@)@;(30CP5C:3"EQM.A^5)U)25M03%Q M*?K[ZQ$Y&?ZPU]YEFY:BJ2Q$Q$!V%:,"=B:6@`*R MG)]/O;>-'<"\R!KA<*1BAC"_]9CJ$FE-T#7,/)J1AH:F]P=+UO#!&W]%+2?B MAZU='F7L,W,WG`]510H=O^\LK:^MB47HETGR73Q/F?B4+*ITZWZE)8.Y>I, M.S^RT31:;!M-5<_E*^ZLG:?=N+I/>9%P3R?8#_UZ0E@D?6_D%<' MK@&[OJ1"R`O2HVK<%/[9B#V-Z(\).2])!HR*$(K^LN!:D<%!FH@=R*A2.S&R M=,!73!'+)]'1]5VR4"_#+=D8/'MMB)VZ>VM5\>`H00LV$$\*S\!MX,J0H1#1 MER@LS0%2TE%PEH&YQ*F!9,H+D%O%Q3I`K!./A0$B'9OYPK;FT\[E1*/?QRP( MB-!.2*)9.J$(=XQ/2)5WZ8R6F?&6\)$:\]B!6>)RCVJ@X*2K9G>OKA8/PHB& MK4IXT[]R[P$UK@WLBZ_H%D14CID>GB8+0I/LE78E'+;%CLS+WZ,$`;2*#D'W M`J8HG1(#N"B=-^T)Y95$CU"]$U)/8/^0F]@FXLY"YJZR#2FE4BQC%VD4UK)'GF(YW*S;'@3DBV8 M$1&^(K$D8?(E>24I(QDM=8/*0`S_A\*%^NH/72CK"HJ,$]A?)>FDR#0N-S(W MXR01XYB&/2SM M'NS>2_[()-^#XA/NT9)V":R;XH5FUQO""OOHS2[MG`F='_5^P2-UV%IZ^?S5 MROK:\[5',%2]=._9LTU2XR/.)">U!(=#NJ^P$JNY:SYI(TIW13^H1:XAA9S( M%:V$U.VB$(HWEZ=Z6W?F-4YV<]R3V'),8"D3-PQ3T:20!193%.LP`9'JLKM] MI4A$K2YYY-"ZD],N..R6C+75>@_M=>/EHH?%K.1]_\4]N\(N4HS7+X3(E]'' M5287/WRPT.N^E&XL!\\'R1^#]M:,!J$8.8(JR;%!NA1'QR$UZ4*EBP#PKD4\9,6PZ3)M$#[+. MW@U>WLE.QK29;F+6?2@BWV$V60*3@'L(Z0_CE%O;,9E+],H<':\,3F!]J#[% M+:")9?8UUU]MP9,5<3N4-DNUP,;`;)$_'2/4(88_J6$D1RP^]7E*@67YA308 MU?B9@M*'0A?)S6C+LX3=91050[MR[VB&.Z(CUQ?]V>3ZBIZ\,>>867RE,M^,8L0HL/2!YE5QI,E9%B+9\W;7H(HT M2[O"#R#]/T/4(5\UBU,X_.8$Q@E\XU:XU1!79##F5Z1=RDEH#;16O(%6(<5# M*ZW?1Y0Q*6^R1@+[_H]/OGN*-IY:<>D;BRX)#6X04EB&MP*IP@:;!4H10@MZ MNX3JZX-7+U>>??>Z)6$<>*.95*!@LC:^UGUF?Q=@LAQ";3#V"T*+<9`Q<('DEE++N_`BK3WX?(AD^P1AV M7+K:G<;IO1V[<\<^E/(*0.16!;HPMYG#M%;$TJ0OZ&V%J"C(WK>5'N3M,6*3 MD"-YS*_B`BOL($VU2*0?V'.$4C2]/."4LG/<^*[TOB@8Y$ST*D.Q,,&!H:+M MQK;Q?BM,K'PB;W..60<2"-,=8$U[K:#FRN@&WIK>.QS0J/0LT"; MYG"XV>8CVX]O.?]*7D!YMRU[29JH'S_X1"K7`A\LVG",.R>:`AQ3<*0K!&*: MH:9\`PNPPG0SB]U)0MWK=)ML/;CEI,8,(=<:+44J0`(.8=IN1&K2%9*V*.() MB8)RAMTL;FYNWC)NRFW6@`79['42-34^A@O/U?2:C/#^EQM.^[.S(;[!G7;+ M20JF@Z,G4(Q28XRQ-E5221J_2SWR%YVM M.L/4$(F(B#Y$PLQCA8G?DLVD,NO)!S9ZT5JZ"*?9"E&C07=APINA>::].XLBSW-D(*(H>M&(7#&&9:8):9WT(%ELC(9 M,'<#]RRO#$5E"E5()BP=DDJ"H<75`AJCJZAMR>R+4`DN[X@U;$R/%R[?8,WK M;;(;PMOR1LW&P9:-0T4,AFGUL*T&RU8JRLY+#C*BDTJ)T>U;.%5/3OB9IPC+14K:,BK59QB-*31ZK1B M@)/@'X`B82$+4SZ@PO-\)4\"&4[8G^YMX]=]/<&$YZO M2W1R7)OMGUYX\N0XD)I-VOH`BT5S1/F$6[(YM/(B@;]YL@\O/T&NBE]SJ<$O M9'X\#,Z@$QB'=SUI:M3^?G`6&@E"^7:?P2\AOGZ?&]5GFD=@!(4G$3<<05G6 M?P]Z$)RUND-7KHXZ,5/(W!YZZ=2JH]AZN;09Y\>U*:*^ZTMX'\?#S,Z#1LF\ M47)QCZY\F`J*JUG#-K5M;9``DYV#*\X/K6TEQJO@'RK<`,3DH!,?UH#2VGS0 MR[SV8F^T-HLI;>$;<\94#H^!%86?C%,G],4YRK[V\>?UO?A&VU5ZM[` MEKZE"H\ZSZOL:@947\>V7N&'Y-X4'`/Q%(A0D*8Q>OC%%^D@F`7:9"<-.?`O M(TN<[/QS_0-TU`=F8YC95?_6&G;6/PQMR.H?QY8']<^M#J?^8%D>1E]#*%7)-V=*2Z-@WL79W0O,1%K1;E17 ME)Q8A\^E#[?V"+?0V'7*EOZM?:CI4$>3?Z\N,9_-I?=.6C]V:/#5>FWCM7\_ M2[=?!/R=?45*^WW2)&4`FTDK[^'GYB;27U.CN,,S>C5%*W4*8T=)O'4P&:']O M0MO63Q__4^=\^%_XMZJGN(TAX>7E3Q_IXH%S@V"(/N]VO036MBS\4+\C/M8+ M#4'H_R".$[P-+]H'>^T_MKZSK'QU$7IG&:4ZG0`SOC@_)%7E=[M/GGWWKZN_ ML]8S)QW:&BDSU[B8GF*B?6CW`_#T0=@;[TZZ>?+7.^CLJ1(LEIY7I`2.P>?@15=M^'EXWG**)'Z&4ZGO.J;,W!:;CO;9SXF-K#^/!;/ES M4JI!7M/A2WR(@]8WZ]O;><3%[-/K#?QB/OT^48VL)XV:L:(KD+(.JO"W`V)'?;"'X7M5!M;YUV]YZL\6?[K53%/+PYV:9N$R]5+EA70@1O*58`HC9UMSIV3MO.2 MQA,JKS3O7PK#XFR0^:]F%.3J6\]8^-'['FN;$'GU](#X]5FG1S3T4$5:?1@> MNS#+.WDN1'0QR5D][<1_QQBAC3$(XT7P3=A7\ MX2O'KLU;CP4M<2US+B$.4_!P6Z=&SH3 MG,>J7J"_'G348BP(PF(4SK4PJF:=0++Q*;=K`MZZ4D0_?=Q8B_E9(E@D2:J.DGY7&#GNBJ8<@]X&DC<4 M-JE:/)>FNW:MU8-+?2D97]ZDXY)'#[%@O*`M3,2ESZGQSS5C*0V[]F^+&HPD MSM"?_L?_<1A6K/SUU:W@_A"2W*#N&)2_?-R[SM-DL`H[HG$52R2DSEBVL[0/ M1HL0#\<.6`A]KT@5E$\]N*GRJ69J-P5,QC5\!KM;VI5H_[]-T0/!_1LYY/JM M'U+2RC,E+`KF&9#I;(FDH)8Y_G_`4L8WO<;N1J'T&Q'#NIYB3GK\9S8;8`X^ M?P5$?/OX+2OJEHF8X/@M5BO_N"#[7+M"3TJ%%* M%3+SP$H0B^+&0R5Z:I(7*O849S)J*)=BN9P4<B?N$T&4XG74#=;XI! MX,03\=]$(#=V`"6T1>L#X7?V%4(&=]Y1F"C6:W`K,8@SFHC99))8F`OWT_1K M$@14FVLA"N,GA/RJ=<'4`A\.AH0%>L2O"&\,^0MZ5S8A3AM,VCXS1,IF"*Q\ M-`US"W#!$26`G]#!AC`R/U50UDKSZ9#VIG(%F,**2N80V93$*_Q#UF4=1Q%8 MX25F#&&PE_(5==(QY"(W*6Q%<]T5DY;GZ*Q#QA^OPYNP2-0D!DMDVW1H&S.2 M<^N,BFX!5OZK)GRU0/I,JK?F[@@NAUUB>M&SKP,KVA(#0+Y_,"\$C6*<-I'0 M]0JBM>WUF^D8,X=9T,(I9GI9RC;IK\JTY;QIN%MT`97I%-XM5:6Y_(J$48=/ M2;O^>_D*O)'8<6O_U6O+=-@#E.FE\BD6SX1\7I8+?J;8_:+XB>_3[K],^H,F M2,TXFMW)'&[7&/Z*C&VAVP7C%O/'SH']/JD@5)-X*QZ%\O\1^=T5`B,>:S6F M,+4BX%JX=>ZE?,W!(;,XU#BO@C;FUM\]4W_%(O_B,M:],'%;`H4" M130VH<.$"3@RZ(,81'R@B)%&<](YTNPT#21UX_0]%>,#\#PG"_FO4VV6Y1CI M*BL39>R"X8;=$56""&H$LI/)V(H`K!PS+#2=T*^;%*ZPE53#1L;QT'#'11H[ M'M-J,"_3GLSHC)$WI8:#X+-:FMIY%4'*:5NU\VBNM56X(=_CD:4[HD.$'#DX MWZ:="F-T(QS/"Z)'S#WZP`%#Y9MUPR2?1A4;0=Z'CI(2V*I^'V'F4$T7$I-Z MYX=3%58(AK)1U9=3QBGVY%F+;&MV05N$G[MCJ4PH0/=EY.IV0D`;1]FVRB(,P M.3$<-VI@SF_T=16&@YCKBCVE9ZAZ,Z43+^-^G?AC@&RR\\S(H?[I&\[8-5_! MS#=6C=^\\>JS\X,';VP-+E:%_:$`+!#$S"FE:-Y"U3]I2H]OM9`.LG-I[T`3 M%[HD-'E59\;FVM_E."YY;N9$10+D0B^`3+](,?,+*C+M$OD*L7>>H1\;`>[" M:GJ3G,]WV35^X9YB=2M"QKB2VIVHB9/M@PP3]N&)S[&B[;#3?V=*5&QNK"RV MM]UC@NY$ZXN2-/F$@G`RA@BS[(W'JI-'6,7Y5N4[Y"KJK).Y<[<608-/APM=6>\RK+'O:1,7J+ MF167OD=^LS[31WURA45%M4GXG(ZY$-Y>E=2W5Q]N;-VFN;C:JM]DPAP=$AS_ M#-R9+\PJEVUW\:N(*-3EKBKX*!0K\?&&;^71P]6'-R-/FKJ^&D>*A?BI[.-6 M>5*U:G:,?J7\5%/"HA4O@B>Q-9.F$0;/W`A=K&UMK&[?S!7,,>51;F>YE2OD MZ'JFF\H_T8.-.EQPWXM:1G2&1Q&\*0:QMGE3J#@'#K'.23$X)! MSK_^%,:!'JR3!Q9"VC/^$%CV+]T1Q5*,Z$JX41&_S6^&C0]IZR'Q([BJ[9[^ MCC:/*=1J3F/.([.L+(U5BMA::VG<[;9>,-:PM7Y/;9`K5Z7Y"FF=4(U?I/;3 M0N3(NE8;;O?(/D`"H+?*/5E)E$E6^HH[3XLURI]*'.L$NP<'K?W^F$*+Z83B MGQ_2(`.$$=96.&II]<4?;0B7&A93G*%ZEB1:91 M"24#P$(;N.*YOEF_Y>93V95^U@/1O&6Y'<^M36N"R50WM:RI0B#Y8+OT8K2^ MZC-XXVB8">D:$>#V`=5$0*-`<&6Q3>JY4R&AX.`7P\GM(]RY7Y%8@J$:%81B M0NAL[T5;H6X?)X;[87!.+,8#JM'+HQ]YLV>+G?"CY/<1(ZATJ:!ABQP*IL`> M,3`U5K+W*@.6(]]5-Q2.H6$9PF? MS=E[DQS4'7W;&QQ0L&M.*2%8\TWFIV[N)K\I*[D*4I.'K$GZS8NX[,[M%'7- M^FKIDYVUX:)2,)=&YS4JL3`B5:-@1`QYO4!K('%]N]4YI*(!*2R3TWBVW;C< MO65HTPA#/67$AZ#%N)6"0PBHI7HD(K38U@@GXUEL<1&;T22/XZ]T#=(JWICT M@HV%C*G$*6L!A2&SUN4?I?YVC&U>\B]Y7L/\>DTZ9%FUM,G[BZ/>[W(OG3V4 MUZ"%X6.7LY:;@@)Q)9?=G)R_!HTP@S]!5V%W)OO@.^A/L'W@WMV18JN!T^;8 M-6Z#)/<-6RT@K9+BD3)_8CY5?D5X9^W6?(=A7(J8B.O>@?,+X7;13!E@)3?( M<2LTX&!RG$WU;;1@3'^`2Q5E@15=?(<5G3NJL\`-$C'!,TE)*>?)_95\]J"? MBHE.N9YC)8Z%X=XZ/CD.)O[Z2#4")"\ENMP=;DHZ-X1C0/.5=.'=_OO>:&!= MIG!.GW4^N!H?T%UJ/?1MW9EZY\,!V'#6PZ*S*`P*FY=BJD\3O8#9"S@SA-]- M"77CBC(GE;BXRNQ%C!_8IO^5**UEC2#H[IZ#*2D]A,;ZS'>T,_)CWL(&V"0O ML1NU)=]V?N''BBGA.2?"8O8GH^EZW0_&=WSXJNF65@#0=$*=PP1\`25>>#XX M[J$$U+\)_GD*]SF-O:ZX*,=_\[P(!C`O\8FAJS_.*-7!OQ@T\.L7T"!9)CL_ MA<$U@_[I0&A^1,.$@7H['V.,P8`%[A_;;P@W=*RWIAEHT$<,1]%K"X]A8M5& M@AK!!4H<@B#F/\0<_9;8GGF6!(5W_<$'*N#]GG6O5L/K[Y)IZW\=]49,-=>U M!H5/I+<,O:NM8^0IR%!0@>U6.G'!5=FB84SL[0;C`&&/U8+"5#0VEQI8LE=M MBTGJO,M!C9"1-AI`5H9]3KF*5Z.!2G>`5Z3;X@E9(D@A61Q2&P6:P$_8(]`= M:8)"@+KGB=`CS'BF_C=T@U7*C,)Q\0J@M.&`:)J#)E@W%T/6!A2]/FR.T[!A M?D^R(E,MW8-P*N+VUF^=Z>3M@+;9<<6X!>.7!2$7=^&OX4+LT@O/E*!U.!W+ MA)H*-KQHL/S$-%HC* M6`!?`)5MV.Z63ECPU*?3D2!O!"!ZG,4[?M^@`8*L(+D\7H9;B(&X!Q-?VL.< M-[8QU0;3T[XQ;(J(7X9;S]X^X1T^:@6AA$,##]>0.9,QB03,-I'37T MX%*/*3LM^@H9LN<;GKC5';'.?T;,V]A=IX*AT!.M9/1BP"UW7U"T_3<12=&[ M.B6^094"5Q8 MAG5*0HH-7F!98O#*:[";#NT\V/MQYYR%^3;/#6`I:=5Q%)2-4V0[`J\)[HQ= M%S/W"4L_P8:JQ75QI#W^WX+2[OW7`?&UYQO)O"^^4/[VAJFJ76$.Z(>-$2%D2!!!^6.Z6A@X2`YLSOS7R;"D1SIV=DIQ'\.W%^,>5@QQ-+@",)II[><" MGSW=&5:GP]YEP9()C;(<4!^M#-Q!,5/AQEQ)^05IQ;<5870[JIDRQI"&4-?2 M>9=$02]H$H<0HG"Q((PVF(T69RJ@'GHB]TOMF3=X'\9HO:!!]#N@N,.J(A6. M6]]Y:BO0A8[$3:3@0D3&0@!U05HB>.=\3[N'(_*P+BR8("HG@-,Z,M4+XQMW M+/,D3$^N1;ED7U87;!V.9&50#Z/9H^7 MS?>8^*SGGY(2@9*GOF=CQD%/#"[1_G*XR#NUS!D-&M,^:=3J..A%K%JB>F-[ MM'L>6&2,V04ZXJOE8W`R-UDV39QEV$<#CE4[\``[- M4_R_6!L\7CU+JS\%XZ6+6V-TJX]R<$4XBPUB2+EV/?Z]63O5W;+%T`T4IY3N M=[7U/2G8ZFXD;ONN]80&T7(WO@)"2(B3D_NOE50#33?? M4_1U`9)8>30^!RED$6.3[^ M''?XBJ"X94CK?>]T``<9ZV%#1J92B(H@'MX'.P?18[:3,ZA(>4E\I.#"9`=* MD-O'T)Z7_HH)>I$,I'GU07KP,4XHZ^J(MUY19TB)M5S3^_)CA$ILCNULOLI.T-P!H5&6^Z(M M,3YJ+H'F,H&#(1N5[QY_]*RC"6I)^HVKM(@H!?#P6(_C"UX1M3WO'!G!HYSZ.Q*/ MPVZW305FI9CRO<*A>:8ONB]!@`X#/.6P)Y<@F-[9=\GO>#-:O6A-G5E2[`,+ MG/W)J=RGX#W&(WQ@'+'!MS#9@4&F"`9X@WXP)%.5 MM;UVKXI#09J_&("E6\M4+2QOK6TOMQXN/]CDSP>X)QXN;ZQM+6^O(\0>+F]M M\>G6IOWY<&WY\?;#_*?];)L'MA_QP/;RVMKCY;4'/+"]O/EP:_G1`UMA_=': M\OH&?_+`H\?+VYOVYR-^MJX7;R\_?OAH>>OAX^76H^7U1X^6-WDY?VH/CQZQ M&)\\V%S>5F(/2,B_-M:6MQX_\G'!TF6445SPY"BP@B"K*^'E^7GW]O;RQE9< M>NWQ!IMZ/./)?YF[X[3DP,'KM.'Z`"B!)J^Y+")QS6$3T#MD"4!HJHB[TB"%T0]A%5,U8[B$*+#P)-"[^L]LLVP MW!XZ@BNHH3BR)F/"82P8V*59H%\96A%H!F_5UI&_>P1J&=X:%(XD>/T2AVXDG MO4,:!)AZX+'D3MIKA161X#*E3)I=*K;#[1(P_'Q(Z,J;0?$O]^7 MC9XR.[/I58=?/&!AP=;_7/<79?%76!E<&U8&2]KM#@G@RWEA\EQWUB9W9RAJ M"Y^YK@)S4>(0U(SC)>@7&"U@I?"P*FF26K)KZ!G='>EC5(+G$#VY4,\*SXRZ)W/H#]R#"$BX'V]&'QNV4(,8TB?[I MIX_20<*\`,<]60M??6`%X+I^""U*9IB)6(5TDFFKZ,K(U\W'&ZO9R^$\.45M M/PIY#A8FSI#$&\1 M9!7\%E6I&)U1WZG(0V%,+*(5"T/W.D=K02PU"I`95P>,-<+.=.OQM#>1--EW MKJE_5I"XY,,F(5*N#0BES/J4(!#SVRJ)`N!E2,WA\9@Q8#[+D#^5/#_F,4Z" M`(%8$;.:2\S.V'V6HY),0OV\A-,<#WE*`9$J$'Z(MZ!#J%\$K+G%^LF,.+0G M;TB\);JJ\O4?]_?:_QJ&?WVU1'>WN7K1O\B50@\.F<^^CT<;ASV,(/@#<4X+ M?]0,YX.1@7-WU,K]]YV?K1AE*=EG]E'AX<;KM)@6D^`KI35MT_J=/I&/_*@_<7M[>>KR\^8AR0OV"S?[MK_^A M?[H.9+OFJ!4Q8B03)$GK3J!KF;/AS*`F@%<1YJF(R3BYLQ`,?Z5MDJ]QI)*" MCM2SD`"I==R5*,`%E;'"0R/"R//9[)2.2&1,'H;T%_*L\-;9/]'88SZC;)@@ M`B2OA4X-QJUIA7\@S?``.<`)8F)NOI51JE!P<54W1V4EM1U M*NHL[3[)3/BN@_<]N9,HO4BQNM92?`HOKOGB,D>\!NUVCT#A!_-`B6=)1ZJ0 M$NJH>>(*[>WA\AKJV\;F0V.QSKS^0__,G,O,X7@V9Y7!Z(-5NK_>&D))>:J_ MSI+=:62IZL;,1V=>DZ()C7XDC-PL.;OE[?.DXC<,%[U(@? M[Y*X'`$=SSW+X@^FQ*YZ<$YW61B@/`-ZT/_@A=I\5O%:)*>%`1PG`_ZVV9KL MAIF<32'**[9(6+N=.0ZQ6A6$NQN:3#/R%#WT,9.[JB80U[J9J[FU>5?%Y;QZ M^;S][,\';^9J5U]'UO#]_>W_E@+"3&S3DW9F3*!+UNS1P`8O`$CI+XYD>6%\(V M`6V.X*"7>EB]Z@E-SN4%?<[F\`RY.PU:`Q+>P[\!L!9T3L(^'!_QGL+"%NJ+ M\%!9/M;OJ>%"NL4L'.P,\BMF-Z*72EB;UN-R;^L$0ATF=BU!DI7;$X*4.T&1 MH08/`Q\C2-[901_GN.7-2$-YVR6H`S]/J!'"FIMV)N$$:TEI41T(&%P+:`(. MXF\&B&Y0=/:Z1ZY]*7S+5M%%7DC?5'VB4J0((4GU;BGDZ%6B^@.G;GR7Z2Z+ MJ(""`/+>#1B.:0[Q]'JBPQE[Y$[6;'%[BZ?M(+^]4@4KB:A8S(JW"CBKN)`WRSL;5Z0\U;=]"J8QW&6W*` M*22U+#JACE^J-V"R?P\NZ*=3=-:XZTH+)LR''((]5T6>21Q#Z5DF&UMJ-M`# MP6+""F\IX71.;((I\EYG]]"+W(WX23$SYY#D^&A3TT9@C8C.?BRE1LA3`E5Q)JW@)4@"0<(L)%?U>YNGPQ M9E@`V>KL)^M)),;>X/N<['S796`Y69PD`$E,O@H5X_M6\F/RUBDYQM`G.P== MES:ONR'JV?JW-F7)JCK_]^JSYEE]R:Z"`0XK+E[7AD?.N@.;3!:(;D$O76R< M^]J5;QHQC2CIMY1FX].69@I[OF,H!7>Z$_$"LN/N1O";6HO?#)E_::KZ+/6+ MQ>EN^8Z4YLVQN,3Y]@_>O-QK_VFNWO)U&+;HHA0+R0Q"YQTC/=5JQO1-]S:$ MA$RY'%QP2]7,UJ+I.#@Q%9^3E+'^1IAP/9IFDPM@UD*V%*2\O]QM/]M_T?K3 MZZ\;,)=V,L":X:X).:@*C\5]- M.N`5;5WINPNMN[",:X;+C>U^_39V;_BVT(NN#OY,-Y==ZQ>"WTN(2E^KH;5M:K+[MQE;OZNM\49R0!2%6%RHVG+51?=]/*:GK;9*?] M"[/,)I18$1/UA`]UT$0!=5*+TBG*Q"#5C/6;E5U]S*CQ>>%S8KW)Y-X>,V*;],4 M)?I-.`*H7N?31[-I/GT,IE557M4>?=&=?/K8=E0=ZR?Q[NN_BL*M_GD#YBM9 M=+7^W!^GN&BLG\AK&ZEM"%2XTI=^Z'=(>B8P>F_^3Y^F_L"4;G;FNNDG.VM_ MK"^R/O/)1NT32?)F+K7YQ_DBXK-,\"P9"KWDSPBEZJY-M_ANI#ZC&)\GO8E_ M+2E5,RP_:Q?9H$F[L#>"$S`C`M6(9\+`8Y2".);SNEZ=:2*]6HVPU:L(OD3" MH/4*MS>/Z<[3C].PQC7DT'YOZMVN9 M+J:C28(!/ER`UDW9JC/B3*7EN`3R5\(Q_XH)52'Z=TSRC\X.:6E,&704$=JT MSZ/.&1VNK5/,6!VX^.MLMB=M00]S[M5$O#PTELE*,VM%"%7+K7&/J1/ZB;)# MWL9=5\2P$HLB8-R!:8IJ?';L4OZXRP#*#AJ!LE&RYAR`U&DISL_KSM"ZL0=. M+*E5R566HN'RGK(58,'+!+%B;`>[P5MJ32K4&X:<;W4*#J^#_DBCHGD7K4Q- MP9"&'UL#JSV$@U!X_N-KU]+YN7D0U2&1GUHV#RJ[+(7B<K*S^&VO_UUO^[/N1X2G.ZJ!EQ@X3O20_/8$ MFVW6\SOSP"72M_YL5:J1RUSF4%%R!^5052VD^G;`"`BA[IX9@K)0WS.BQE15 M4(09A/A;"071PF(%M7I%>O)X2,/K2#R[UA_9>X+J<65;3`:TI`,Y#PF;6#=M MK1?""L)3K>GI9IX=5ZZQBS/;^T`9XE/IG2MAX$:4=5O68N*3`K"_T+=E&GL: MT6'?^-AW'PT-1<6=YVU@!6B9=K\OAOB<^2;BUP#E0"<)4^.C+6Z*O4T)@=V$ MW#6'UT23__#"'['SD`*^EEI?H"^Z8(?*`23UL)`]3,!Z8?%[,_]9.VS"4R,L M^8V'L6%6_JOEIO5I^&"):?"5B?%1<>ONB7K'<`@62+?&HB5@X&!>KXM,BA-, MFL`SBZF>G]=M[>^W5EH_6G=E[5T,#263'J_6%2SJM'7<^]4?7(;7X=7TN=G_ M]/%O?_WO5W^]E+RFF$%]F]^JIM\F:PY.ZM_%@.FXM6L<];C^`'?PA$XH8OV# MFDH)IAE>-DV_M<)UF;^,=3F8'NPRLH$6%QE:D M]F\T)M&NGW=&[_"AJ:WQ09=^+C8XI-56GI9]J/L2DM2O:'=``93:*ANK`"J[ MP!(:?MT;OYMYMF.N.W-3'`Q.)E;1MSM@*DK]R7UK`VV'%M/Q,I(A4/L3YU^ M9F-/J0X$`W`!BQ4?76@,0'^,6L3#U4.8)G/9X_-MA,_*9&FVCF+TLS#``;Z: M0EEU):!PK!#-B(/;)"^3">JJY(,#8CC`F938>V'%TQ#`(=RBY]12JQC M8H%Z=*%?2L+-60F9[.O(?#DF5YK.>.J,1@Q6]&L#H7BAB5J4!LDW#)3X([*< MST$T]..N&O8Q4$BU>]"!C6]Q11II18&7N2`4KO8[-24^@>!8^C"':#AL!3K0 M@UTT^S-TF?V!>]/AR09:7U>I*>(/.D.T=A,P93O@NS.?M4$5+68"-0<7]Q!? MP,\VUT?9$;H?/XPERWO:*YK.X#"TC_(7D-,,JX9&J&_X;EI#/"KXSVTK5@HH8R!PWF"!>IK;IY&V]*L(O8Y?3. M@C)C@^]#O+*"_Z@LWLH'K1.DTNM9P\8'@FP,&!V3.1%_O:3D>'I%OLEP;%GO M'P3EZX7W8XV;#*>+G^_*;AMFA:T>AN`=2.=*P)!R>NYM;96PW+&? M)>C\C/FE%IS:A/;N;$F6U"7&U!6#'M^LKZ^N1U_-0B\`@(MEPC;S,8D,L[MU M68*XX_%"K[[JV=8>K#ZZU;/I3#=RDHW5M5L]B%_2NF$^MT6&#.2N3GW67C+H M7:!A886_+OT4>W)H#"R%"`D]HT282+W\!]\Y`TG$!%ZH$?`N^EA+C9*LI1=T% MXQ0F_<,0W@ECT@)IUF_N'6(!5N.,/6QLO%W6T82[8:7*A`HN9Q$?T=S3M:9# M[?3_T79NNW$<21I^E<)@L*0!419%RS9F`0,M'K0$2)'+ICQKSX70)%M2K\EN M@LV6S,%<[?/L4^V3[/='9E9F9=:A:=$7!F1V5AXC(^/P1X3XZRT5#8U3ID57 M]8"A^#ZOCHD(1^=#AZ^#\=HGB8X8K!-TW-*7S85,LO(7F]"I/?`V3#9(-?C\ M6QE2>*^64^DCJ(LF/FBR89>9GKS]'73I8*EG"$5(_*5\)P/2EX8*P)E@OB30 MBT>C$!P/&[%[FL7!:/P:P6>Y8MZ))@&K)S^^BFN^N]5[7?W%L?OJ?/([3&_S M?'&+S9-$H=_\#1P=)XB0K-EYV>C=7.\,,Y;CD$_P4LZG>!2H%BA?)2EP[RLO M#/(&'\GEL$NUV`>>#V1WY8"HQJ3C,/"EDAW1`(L-*5ZM,Z\)I%^@@8(S6/Z% M="'C=\:CM[:W>0^3_V/#56!1[V`0WD0WMV[V^N,JG?4]XU[X6=M3'%4YGC.7 MI0GIFUNB?$@26$RB<\^@%_-8FUZ):O/MR=$WB(7I"EG-TB]1/5@[_J9_8P>5 MIM-LCYBFU]^_FI&%>Y)5?5SJ<&YIPG# M23`\06VP+9/`54'(\Q'JQ.E8&DS(I&;WA,>YCN1*<43@MFF/[:0_&1MTD8=' M;QKC8=\6K^FNNTG.[ESS@=,%>/XE;G!X)1*QBN!>S+<9ZB;I$(]FKJ2@Y'U^ M7Y$5+>]X/WA79%4:JD?1 MX&^':`_++,:M2>C)PD0,%TJ*@\*]5-5M6.1E_<9+A/58'OBCIOGG3/'`Z]6U/A_H/4B>!96FDYY; MZB">`P=&LDORZ`[#%%#D(L.-\9"93/7E6P61H5 MA2V8TF,6C M:YR5L^QD>^CL52M$!/B%Q$%]V!Q$VGX'^GF&V7ECWVI?) MSK6DR^4"DX#4[41E2%-Q1D%TWL9@)/MF[_A80]U+$T1)2?SE:J^F%RHL$);L M:"9*7O(U8!N\>^C>S>C1474Y-9;<4V\=[]V4,E$/><^G==C3:1WV)+^+LUET MOO-+._-=(\M'+30ME:" M2=ZQC:ZIJY%9\^VE$OATZ,`F4E]AI MBMX2DXC3<#`GG-2I#_NZ=]`)+\W(+8.H7W"AE+#1)8$@FGG0?;O"6E527K(" MV(]Q$>1[OP?K]9'9H8;5UP9!8`"0\,5V&95@X&BY'^DLL1VB/2-S;WICD"LF M9A_*H>4ZZMM+&5&^/*GS\TN*B]7ZF#D;Y2Q3G(_, M/V%[G@5M M[J:(Q&H4$L1UFT@Z/^A*Y]*4<;H^SU>\"ZN=>;>E=.)=VR;@`P[HT<4D$QK^ ML#)@"<[IV0V`6&7124S@*^7&,U^\I9QUH(S$?JG6Q68E:6@T)^01"UA+LMYT ML^]D9B%@RUY@26G-8&\>U8])>AW>EGQS4A;4C`%SCMWHV%C!EK+0ZK[.:DB0 M"!W!S,N#7,[?9*+Q-\:BV!N+D.L4<4?Q:FEH2S[4(\(3UMI(CVX&DP<3+;$& M^?!/:K_Q;OI!7(TV(X8B:AX/L#!%Y/+WQQ737\+ M/J]\UQ`2\G,U7_FZ[6C,$IQDFW_S9YQ(A4F^XTP.O&UDUV;3!!`5>ZD#U*,I MQ%%M&I'.5?(%++(Z(Q\8!BTB[E#2GI<"$5-,_I87@P8\,)="S7"*%R`6KKA/ MR('+R[N9L[@(3$K],*F0\Y42&V)QO2M(Y]AQM'POF02`#QL.V9S,+&:K9:A` M"&)9RHB=?[B!GUJZ8?[WXPD`F-5-_N>-[5<=NF2O?E;L[[Z3V=B#8>N^1:>8 M+Z.X9QO?O7#.D+9YVB?E#UU?O&KOB;=(P1U`2FME4WNY#)"[?^%CM4>F&&GG M#W?8L?<_M'[XS]G$N?3+_UP[\O[E2J+'C2\GXQL-S# MN&ZH;'7Y:8ZWX*,Y-QOJ?_Z-&&9#_@XR>Z%",>L8]X1&)+[%G('1YX/F8SC. MG8R3B-QFD\@_2/:AS0_H;T;/FT$B^YKZ?&Q,I.^WX!ZAO%["(Y'M\TJA%PK` MR*?7["#_%7.5!,SWB*A7!D;+&\CZQ1.C"/R[Y:?9+>^^#.\\,0@`YJNB&O1L M@=&*3;8@_Z.C72^6P'@AE08].NG13)HCF!63[I-Y]OS?( M`7GOIS5_\#LCPZ>#9>9-V_R\0PQ\IY=%D[D-$O:%'?+AJ%K0_:/1[DL7S[+3 M]V7!ERGZU=UMRNZ+;M,OBV[=9=IIOTRGJ_M\CB?.6&18N!9+#7!?("!<8L<; MG&%-D;!FI"K1"2/X^):%.\IFT6T#5[N69ADV5K:!5000E9YZ$WNZIF(`+RXQ MO2"^^3@C0.!@M4EHS:VUIR'?D/2")(%;\3O$,5.-91>!_Y#E]:9O&D4X,1&3 ME]@AV<,`PN96N-D5/(,#\^8YR<$WLU+8C"UXU:)#+E_5VZ8?-/\97D+57\98 M?VJR/VA7+:RM?W=PF^@EM0US;UD/!9U9JGFUQ]@PW\)PPQ'&_JL)9>APA[B8 MX'P=J2\"ENI!#Y)%$U;:0&H,,0[DAA2!4?TKZ2D?O6S[GRL+&SRU?8TOCHM] M<36?'>[E$L%HY%P&FPZWL5T00]E]&N[C#.A[^<6QE!PKD3SVJV8";T`*J8B5]27U%;'Q9;-5Y<#A9%R"$?BLFSC8BC0^@ M:HH=,EG5!POG/];SMMW"+F7(Z,YE)BZT=BK*^S]US!-]*;%?"(5K"LU538F0 M?X)RY-\\,&@0>7<;.]]WV"GB=,@\_9G()+`ID2^[PRS]/O&K='[M!J$#Q0.[ M!UBW4Q[S?'KU;MH1]LO6&%94'MX7ZTUVA[YG0>)OH:9\S#?8'-E,G!X6[56[ M,0+>RE16O#Y2)0`C.\.?TQ,,0AN@SMZ:9_;K6IZE3RD>'5Z\9/<.$\">N*AB M*W5Y3%_QV+IAO:RI;US5U,&&U$]COGY[@H#L!)Z6_W[D_>X//6T&.9'>T-QL MB)9EEV7)C^XEJ[>P%;WZQ(/TO%-/-%(*0G`/9+ZW?\)`7[FLY@TT/ERGO'[* M@UIOG*?9P<>/U;.);]=Y0IZ"W/^$@9Y@6>OM9?]%7G=EZXVU#HT$WH9P4_-! M8]1];':GVV42`=L&XBSDC,A-4\[K`B#U..9\`-O?RD4KZ37ZUJ->$OLE,M3) M[J%>J:3KS7W+*2*Q2HXRWJA"2N_L.+K[+>JU`7IAH)D"60\]?.8KA@GV5^;O M>\N6<$@LT`<7CQ<680?C)[YO::%X;5)[)8LWO0#?1#+(6] MO09&8447%E.>K9TG/4*1PMHC[("],#5VC@.YZH0,9H,F=FZ,8_4*07L$<:%- MO"CHHKM7)T<1%1,VR(Y1K\QR&7Q<1ILQ;J;--)A04R(B""OV>#FYD]8&B""_ M#$^"61U2NO#M3.525$(*A=I?%7L_^OPUD%9)N`'MFB^0C9*E'ZI62&G^J\NB MIJ@Y#VD5$0PV$DXN;[1?.Q.CLIZW>1L2+\36HF3^U.[D!QL3@?;'/I8VC8/`(X7#YR]4Q9'\&J!^((?=!(= MAOGF)'V@CT0O9-*)N6M[ND!,"2Y`TZ66X=F!6[3;98R?==BUY)O# MT[-_F]S<_ON>'N8PF%,I,(YX,)<,K!UP`*CZD$C:MWXH=*CIKY.@9;IY'YZ6F[DR][8[L#>,'M(_EM$VYG MY(YYH^SD^P%*VJ`.GZ,URDL:@*+HXT??X`??`*J\FCP4S]=&:-=%M/T4Z.$G MJ&+F[E90:;Q&6'H-I>@X1C'#;9MA_F>/_?EC/7:`5!R@?XA%2`10Y=01)CEA M^B1=G*H`HLRS!@-5`%@UKB%.Q69:#V>1J\2FZJO1S3)DK=_UD1<'+KKZ%QE> MN^RWJ1&[(-.QBT!X*R.VI0:'EG\P,1\[;M&Z/E9SG)N=4_=:4))[P9&7/?$, MEG'K'D->JWG1SV.N>3Q+(F?S@[9#42B#19QZ#UFOH[_YA?!LQ0F<3:^`>YOX M;STB9JEV@A(9)&J!5NKGEP[H473ZE8_!^]XBC<&-I#7VFTG/HO,S#,L#)?.P M$`L]_3X3,!+V)?HP4]WB>F`HR:`<*\5D`<`8W8+=Z@(&\)1IRWN\ MKF?3SXOKSS+=>DPJ9F_#/.9$%K@)F6_O%E_T`0'\J@_RT-62R5[@-M9YP,W( M"@$:TL$IH0@3W@JBZQ[DF:J7A?27(4T$.TZ_,G;G M9R0(>('@]S>X0>J1YOT0""!?52`/=+\.'_FZ/=E*X?9A)@+@:$2<,S6:9ZR@ MH>*D@O/&L2V(Q8;4M0Q]#:UJ3:""E%<1XZ/[SW=M-Q&34H3!VL%DB1@D#AG# M0)B=L4SSA?4A-K(>0"!H9>M]FXJZ3I^!^&\[0]F&J#61'U/+U(+)]"9\<[G: M-.O)[_D.9\OKV*"!KXI-R=N?*@\=K/LH>(SR!@)#9H8-$'3NV?C&F?@<3,)" MTL>=T;1K]"/#;GDW@@_*239-K'N2%#"?]^-.&+-M,[`0WBEJ>EPO@]IO,4Q, M:A@`$&N.V&<6T*/,&0[;'&OO9'J`E6R=DI0@M"7="^$Y_EQP'=A(69AM=2!PX:A?J;S@#@(`^@EK:5+[8@+#<"BEL/;E8NCV7K;81[5ET M*+B,##A-SY"?N!0#(Q/ M'>M]ZH0C3K>)H7&)SPC$`Z0A/*:?;[$W7=:9#1\X5+T(9I[M%^UV'F=MJ7;J M=C_VM@MVI6J[HUT8>'!FX3BK;0U8K"ST$YN];)W8\,W[KM.5G.I5;1:_/J'U MC7@/)].#K-WWE_?J6VP_"H+L;8UX]&&J0EC]7<*C^YL,+&JGKWO_%+7LQ8Z, M)>F=U>NC-TMBNF?-/5O1UW'/9^%JUZ"XL*5H9$).?@5UX:;LP MC`=/3WFX=9B=.\+A]LTC'VZ_KQ?:G_YPZX$M<(0PW$W?T:U'$U\WQGJ\N:"4 M")_<]5`W)4(_EW5R4\;4,I1B8+\*4^F&MRK#P,S6WF5)#R9Y.+"SR5]_)W`:BVKTQ/9V_.Z/--3TGKWMG?$=5E46!9Y MVLWI):10FU-K6%9X-2RE.^.@%\CP(UPYHRW,)2FIE%\9*\V92:/N="M'*>T? M8)[UUZ8VGC;EUVD0,0)0(%K-\A[/I-I)"F[V`"V?C=_AV8'D"8JY5%HHV+AY:@_7W_0YUB6IB$935H2O'?N;PS5J!:&N@U*9G):>BK M9RPG,NJ#JZ=+*:>:*18Q*-G(N>&$T1+3*UNP%W<68B>JE*0UF8=%I;'%COR@ M53IFOI<#:^U1*&N/2SI%TI@C37XT=3D?JOV#`"8%^C&/V=;6^U:;F+=$D$H\ M4K(Q51>+.6D0B&OX-+O\9.1`K.G'F>H'61)YN<&D?1,*7"'>X@'EM"S:NNA< MIQ:XL]_WO$W[,NV\26;0;C9H3EK98#@T4I4K$??7SKFF2O`P++_%'9AL`KU0H=:SCS@VXI07&%-U88S+,!WS>4N%%4=IX\@;.^UJ MZ>GD0;8C50F]LMPQ7!=XN^-=&,A\EXKO0!%H4P"Z=A!S:1=[OXFW>O^OQF-3ALU;%S]5TMQ M)WX(:=3'[)-?UZY]W;'BU)M#.'MD/5"=*O=I1S$.(4*WA]&72W3%W70F8IA_ M?$$ZF^&=[B$.8`M<0UYY=PUX^&4-$ET'N^O"/+HL`!)2CH++3S,2@A.[0P5(E3*QG-76F+(ONY;MR3R*S+K0$[P*#80BY9, M@]Y_C2CJ,L%#HN:)CEA7*G\0KT[%^Y(CR5CY51W4;XW2WM4OJ?#]7!*77UI8XK/2L\:O9U[+M7M2ZO[TTPL,==P^P.=(>.'9#(DQ(BF#U\[3)&>_CJ+ M(H;H^R]3\D:%FS$T`<7<-1?6/E%GZ%=+C0Z'(`7)PP`NAM#:^]))0\T-`S!R MX')?%/Q/13D:#>S9OP3JIB(],%@[0.PA<''Q"!6`3K#Q?/M^:/&-;@QCY MPH`F%#78\B2)YNCQF?-L@Z,3[V052067.(R[#/E\&FX*[7Y84$'ZG2VAL\G] MLVJF)&3!XT'.C<6*.NAVB*YNC,I7(]'Z"U=2?3XS/*V663GB:2+:#\1.2R&8 M@N3B/>,R)3O1(3"?X7ZL*WJK#1578+".!!Q$*9_D+K;#K)Q-,8NV-D]"^UUI M-J."F$]73K+-,HTA6XVZ074EGS6K.IQ?YI^.=O>W*#@6<#M=/V\YH!L!UP\4 M618]G'ZO@N"E&03\`4O8H"`)O6*$'`_1MND]//![`[+ M>CV@N#<3ZQK0]\D3`WKLL5_MJ_Q\PEC6'?3C;+%<+V?9:U)J7U!W+%_L[O2: MT(&"+\NG7A-U6E41K(J8S&]1/LGE!4R];^_ MXV.J?G]:C!\`_[[)EW#"*WI4%7)$*28E'\?7PC M=_;Q`KUZA<+=03)`U,ETUX%P.!N?GFP=O3FK=L>[P`#O/WWAK41WF\P=9T[^ MG"]M;WIS.?OGZF9RD?^B-$);>T='WWW[\_Z;@_S7_17(;E=`M0NJO/_NK-K\ MO__YW\(JD_`'GM)1-(@@34/9V`FWD@1:S29IMH";F\UI![!LKJ!3]] MO@=1W_97MCC;():Y'@Q`<_$`LE"7:G4+7_.:0X@D#*]'3)B2CQES><4V(>V? MFI\-#V*H<1XEG@\O"2*OQY'R7EMF$R93 M[$7<+:,L$IRQ6GCQ]*:"1=B]T9A+PF%\PCF?325?T,;W[4:*;/O"GK$Y+O`.R2L6 ML&R%IV7[8O5H%LH6JO%`&?YR\4KG/*2]Y;X1?8VX^`^>+O&/\22$2:Z1\%51GQXQQ66Q4N,0';0;KWU'I#3/)AL2Y MY4,!*U;`:"U;GX+E10`'=)>\57OQI(OOHX/`)T=,M[+U=-W>QF9=JVM::5+W MH1LIG\JN(<>=84V7O28_E\)\4.$7C-(9-=!U*@7)^3J((_#.UQ4%7C$\[.2C M'B:?N6)_C>;&WKT10:K=A]F'>Z22^1Q+RMU2UER.1S\<3\D476#9\2)"EQB& MJI-2GH@_GG]9Y/-*?I1!-/]9UIEP8PQ+Q#2RF+"7KZ1(8`Q$*^(_7^GFK]O/ M7U2D6I9S\P]TBD64^XH8=#UC>Q_9?UVUWL*N?,G)O@?1.4,H?D#:;\-WR"?B M].RAW//)';3;GZ_UB(`HI09CWYP^8B?]<34QY`Q;YL%7<(:+Z:?)-84QV,P> MPP]2D!X#VMS>8DA"XL4.+"V-(I%DV&S9[O!%#8I.2/ZA5U!`WOB@(O(61)&8 M8_)%[OY\%I_"\,SEC029=E3BC:_VM$ME*Y-$I1)*W@_A+=,Y-6JZW]Y(TUZP M-0-ZWL]Z?*"'-T_N$;:)X7\O(?ZN)<3\T^SZ"J+"5(Z(;!+P+B0&/8=0]9;# M,DBNS]M<,!&6+I<@;-=E8\V7=$I*V>L'%*>.W\]A(+N$.E3C!9+D^!/C*]L: M0?I4RG!>P-'59STA2O\TN2Z3CQNY>2=A/OH)9PD!TN51:YD&55VTB^#4Z\)< ML0D(_D.YB:ZFL5) MCM'F;BULH,29/\C#J&)#:I'+3O#+00,4N!H.(\\]'6*2CP^'`O__O/AWNC7PN#PNG)\>CHE_'Y MMX?';T]HDG]U_A^CHY.6W@['YR=[H__*FX_^J=!"_!FEA)+LCR2R\&`U"K@$ M65D0\A&!?;,EU@6$_M<2B%2$].[V.74&5XA!JJRR(7*7^]*4-VS#U$HIU&TO M.NK)=2*`W\-\ZL=6.K#N._^Y*8&6XW:TU[!Z%+'EN4H>9W5=DOR+1U5H&:)- MESSAUG3A*_F.QGWF#7H8XMO"&Y2W5.'16DG-YCYRR74PK ME.DY/*RV##WG-!%1"WM#(?L',:-Z)P?Q-L?`]$W^0(L3&,]U-[JF**V>/V=N MD7)#<`M\726/E3Y0;I(B<6@2VO:Z+NC-V0I@F2]DY/4@7@ZK^6)*ZKY'X2#Q MCB5&YQ\E`^RSX*+K;Y?+^Y_^7P````#__P,`4$L#!!0`!@`(````(0`_*[JQ M&@,``!$)```8````>&PO=V]R:W-H965T&ULC%;;CILP$'VO MU']`?E_`N9%$258+JVTKM5)5]?+L@`G6`D:VL]G]^X[MA&+GTN4A@9GC,V=F MC(?5_6M3!R]42,;;-<)AC`+:YKQ@[6Z-?OU\NINC0"K2%J3F+5VC-RK1_>;C MA]6!BV=94:H"8&CE&E5*=#ER7+Z2//]PUME241M"8*],N*=?+$UN3OH6N(>-YW=SEO M.J#8LIJI-T.*@B9??MFU7)!M#7F_X@G)3]SFX8R^8;G@DI1$M M(F#:K`H&&>BR!X*6:_2`EQG&*-JL3(%^,WJ0@_M`5OSP2;#B*VLI5!OZI#NP MY?Q90[\4V@2+H[/53Z8#WT50T)+L:_6#'SY3MJL4M'NJE^2\ADCP&S1,[P%( MG;R:_P,K5+5&XUDX3>(Q'DU1L*52/3&]%@7Y7BK>_+$@([TG&1U)QB#SZ!^% MH_D43V?_9XFL(I/)(U%DLQ+\$,#V@)BR(WJSX24PZQ3&,90RU\X'[348,$NP MOFR2>!6]0$WR(R2U$-C2/63D(K)SQ'C<0R+0T8N!%&^(T5Y/#.YYC-[40N:F M!3J!;&!P(D&J-R)I+]1AD%/B)95:R&0`F;E:LEL(1PN0W-"BO6L$>?3U3?Y5 MSV9M(3/3GXG7GVSHO%9WV(0W%&BOIV#BYII:R,(HB,/8:TMVU>W48>:H.&U! M;?6B3[WH%I*8Z-/87"XBNX5P-"07-6BKI\'K=FHA$UL!+_IEGQ-7CX3KKZ'V M>O$3-T9J(5<[<-7MJ%@X*DX=T%8O^MR+;B''#B27>W`;X^C` MDH6GY(@Y2L$81B)<+BAS0)/%?.*"7"WN"=EKL:?:\+V<>V%2F#VZ`7.J(SOZC8@=:V50TQ(HXS"!=U;8D68?%._,X;OE"B:4N:W@TX/"*1N' M`"XY5Z<'/33[CYG-7P```/__`P!02P,$%``&``@````A`)@K%/Q@!@```1@` M`!@```!X;"]W;W)KF_=H=JZKWP,.E6_O'OK\^KE;=]EB=RRYHKM4%5O9->RY[^-@>5MVU MK^'?'^MK= MO)VW/^+N7+9?7ZX/V^9\!1?/]:GNOP].?>^\??QRN#1M^7R"VWOU67RJ(-N3)9."Y:;X:Z)>=,<&75[-O?QXR\$?K[:I] M^7+J_VS>?JWJP[&'=&OSE6US@IW@MW>N30W`TM\]5UW^NS7=];_O2]R0D;#23Z5?;EY M:ILW#\H#]NRNI2DV\0B>S1%4"*')EB!>.@>P`1US8P5CAW,X9 M5#0R'"*1(R1R(#%%%.\A"`=PLL#!6-<^\![CJ#3=(4=(AGF0*@H8R<(%R#`+ M'0!A`$6WP,!8&0-VQAPAPA3(ZT9&6@8,41"$2,,LR,93$`XQX3`47J3'PC.K MC$LR^L&,(,1R$6$L@BB-O?6-G^4U0Q&@C!_:4.I@;#[=WE3`53_Y#39XN[ M&RO=/0K9Z1&"NT>@;;PPW74EPWO[0S*7CC^8&0.6W]QB;#DD6KLIQAA0B-9* M!5--D3@(JHJW-`QFQF.*).;!8C`4&D+-0T$!2>H`*`1A=6^"!6>5 M4S",2$#@I\Q2)E0\Q_I$D8.0CL^0:*IP&XN;$$X81K80[T$HCV6Y%'.]C*:L M6AZN(.HH"I+,^6$9+*Q'F\$PO2>?8ED_!S-KW"G)EI`KD7"G"H3#)V/HPGI$ M0B+2SG.01FA94L5<4S775(NYU4P8BH")7F$AR"))M-/FA(5[\IE/1W,;'_6%;G%X/XR<4XXI*T@ZR*YUS'2Z-U-.EM\6"0F22W&^9 M9?F4"_+)'S`68WDD"=0`Z^R"0N(0[DF3%Q(/>"5V6Y>WS+#,$L7+Q6*@,<:' M<\PDOW@?0QDM2ZK"EVWW"A!S2;<8PH1EZ%T(Y4&%=8A,/`T0E%FFD8DG64*! MM1@LX5E(T`%?I!RHL`XPY,9(TD6,CB:PY.7'%.>:[:0U54IU/G;9N7"XBGA"'. M:,5);RX>P`1XL*_&!9C+7LM#]7O9'NI+YYVJ/;@,`]`+K\41+G[H MF^LP='QN>IC(#O\>8=1>P7011@N^MV^:_O;!#(G'X?WF/P```/__`P!02P,$ M%``&``@````A`!J-]WZR"```U3H``!D```!X;"]W;W)K&ULE-M=K*]J#?BAPP\2`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`=K!LR'4=&NROB)S"OVE<+`K6`J06A6A"I!;%: MD%P+!MLF;UAZ%=<-RP8%2SIL_;&CPS4\=M=#Q(OE0V1;\E=LQT01N[$P36F$%!P=]JG@>/'#G/+O,]FX:F["Z'*#PH#8'C;3:+VR&70J-+^C"T]JIC&_U%AB^6PULK MW[05A+ZOSU<1.RA\*`(H&!0A%!$4,13)5;179&=PW$5RTF)#79Q)BS<+M^_@ MI-1H+#5,[7J]X\5*6K?8VZ_?"J)+"PH?B@`*!D4(101%#$5R%6U:IK=0+NRI MO-Q8*&.G3%IN68/UI0ME5V-96"M;[?82 M27C.QE8/1BH)US6\40N3A+-VK(5IW/Z[Y2OEQV_=!X/S:X/CQ7)^-`97=FLK MD*[)0>%#$4#!H`BAB*"(H4B@2*'(=$(*CF[UIH+CQ7`T*9`N."A\*`(H&!0A M%!$4,10)%"D4F4Y(P?';[*GDVG*YS8W'DQW218>)CTF`"<,DQ"3"),8DZ0A] M\*N)8ZT-M8M-96*OJ)]6QG.90BQC/>CLY1#Y#?M$OVF*&_GA30%UG,IU:=LI M;8JB(@WQ<2T!)@R3$),(DQB3!),4DTQ+Y!3YS?M4BN*FGFX0^Z$_I:B../E< M%O6UFHAVF/B8!)@P3$),(DQB3!),4DPR+9%3Y#?R4RF*&_QA6YSH4'6S`&(8 M:D+B8Q)@PC`),8DPB3%)>L+[T[4Q&K&F,K#L04_9'K9,`BO#'73(7:O*/G4*"W]3$),&&8A)A$F,28))BDF&1:(J?([_JG4A2S`:`K MO4X9:$*$Q#G M`*;B$U,#P_A,UU$>T&Q-H;1=*20^KB7`A&$28A)A$F.28))BDFF)G"*?`YA* M4C3$Q[4$F#!,0DPB3&),DI[P+M5RG,&3V?9"DTK`-N2G2H;:J\K:WBQN M7:*<)9]4F;@\6KQ']JGM[^MYUJM>CUBY5[L0S:5W;^.QV MW^)3)5-]J)A"&=YB4!^J_-)JVZZM?WR!B8])@`G#),0DPB3&),$DQ233$KGU M?3)I8XFY%C0VA3,RNZXB;?.#M02X%H9)B$F$28Q)@DF*2:8E#T$YI>L<=)CXF`28,DQ"3"),8DP23%)-,2^04/YFBH??=\""T0]H0 M\0P-KB7`A&$28A)A$F.2=$3\WMX:S'&*46BWV&M_-*5T;_Q%0W[@NW7'O[,7 M;Q&*-[V.Q>6UV!6'0SW;5^\G>M1K49U]J7A[<6O>T;M2],J34I[06XUM^;)? M0.\:GO/7XL_\\EJ>ZMFA>*$JZ3?E-&J^B-<2Q1]-=6Y?@WJJ&GK+L/WG&[T^ M6M"[7L:"\$M5-=<_Z(N7_0NIC_\"``#__P,`4$L#!!0`!@`(````(0`>F0FR M4P8````B```9````>&PO=V]R:W-H965T5M_K4Y8U$GBXU!OYU#37)U6MTU-6)+527K,+E!S*JD@: M^%H=U?I:95B8:I%DE]DYN&I^HB/\G#(T\PNT[Z]%>E'W!5)]?WM^B4MBRNX>,W/>?.K=2I+1?H4'"]EE;R>H=T_B9ZD MO>_VR\A]D:=569>'1@%W*@MTW.:UNE;!T\OS/H<6T&Z7JNRPD;^1IYA8LOKR MW';0OWGV7M_]+=6G\MVK\GV<7S+H;=")*O!:EM\I&NRI"2JKH]INJ\"?E;3/ M#LG;N?FK?/>S_'AJ0&Z#5DG+,SP)_I>*G(X!:'KRL_U\S_?-:2-KIF)8"XTL M#5EZS>K&S6E=64K?ZJ8L_F,0Z5PQ)\O.B09A=N5+9;DRB&%^PHO>>8'/P3?V)&3RD#,%&0L>0IO&(-T8(,0@/^5.0ON*A8`HB0MCA&!*Z*!H38LSQ M&%G=FL5I">O4"WQ`=X/$#6BC`)?`[03%,1)QL'+"U-N4V`=MD- M[P%37VMB+T3W@&$L3,7BQW]\#^@K?:F0Q>W?K4WZ85NMU'"00FW)^@6:%@K,0JO+W\8A8\2`4J$/=%&,>Z+ MB"L?1QGWY5-1]247M0LZB4,T2UC8)`,4U'08X<2-DHX*.&BA(<2/DH$ M*!&B1(02\1S!Z0;OO5.Z43.ZKS%H3CB4L%'"00D7)3R4\%$B0(D0)2*4B.<( M3CB:MM^]F/E&S6+NHD;&V/8QJ:);\V[OO3A,FJC MA(,2;D^T7:6/WA:\OOQA%#Y*!"@1]@2+0GBEB?C248QQ7SX5(Z<53:JGQ&KM MHEK">].V@^:F&8[8..+@B(LC'H[X.!+@2(@C$8[$LP@O(DW/)U9*PM)V2"2& M]PXXJA#7RHZ:59$YFD%LW(N#(RZ.>#CBXTB`(R&.1#@2SR*\BC15GU*1I?#S MB1P]N(+5=4:A'8[8..+@B(LC'H[X.!+@2-@A,)?H0DI6IB'F;I&`F,02D5A` M=,M2;K.(%Y%F[5,BLFR>%U'<_4B?\M-8E]I"S*AV`W";T$(B8>.(@R/N@+21 M+,E=<]L,TQN`AY'X.!+@2#@@#_HDXH%QJ/$`3(7*BP?39U(\:A.`]CA"MPX M(4NMC2,.CK@XXN&(CR,!CH0X$N%(/(OP*M+T?DI%EO;SZ^AM+6X5VI*YLX%. M1!2Q<2\.CK@XXN&(CR,!CH0#0M=2"TY*Q220!^"L53C.C3G`6&AW.R4O'TWR MI^1CR3\OWV@;9%!_ILPGJCNX8$:G'XHXN!>W0[K#<4T\N?9P%SZ.!#@2=LAT M?T1=Z:,PZ87\X_YBHK$+=W8I6F35,=MEYW,MI>7;!1*');PZ#59VT;\E3W"M M"+>#@CVD/P!HK_"'`KB6OR;'[(^D.N:76CIG!W"Y4"Q81"MV@\^^-.6UO3%\ M+1NXD&__/,$O+3*X%ETH`!_*LNF_P(/5X;<;+_\#``#__P,`4$L#!!0`!@`( M````(0`V+"(06P(``#H%```9````>&PO=V]R:W-H965T\O<=DK:B MQ`7JBR3.O'EO-FIY?Y0=VG-CA58ESI(4(ZZ8KH1J2OSKY]/-#"/KJ*IHIQ4O M\0NW^'[U\Z#8B$ZXET"*D62+YT9I0S<=U'W,;BD[%WBAVRQGF"R6H;^_!;\8$??R+;Z\-F(ZJM0')H-8_(# MV&B]]=#GRIL@F%Q$/X4!?#>HXC7==>Z'/GSAHFD=3#OH,=V!$CR1%'X%H')Z M#.^#J%Q;XF*:3.[2(LLG&&VX=4_"QV+$=M9I^2>",J\^D.0G$GB?2+(\R6>3 M;#+]/PN)&85*'JFCJZ71!P3;`9JVIW[7L@4P^Q*F*722>>>#]P8,F"U8]ZML M4J1+LH>NL!-H'4&PTP,H'Q`$9`8MX!]IG36\]:U&\1H?TEA'R"P,8TQ8_)/0 M6TL,,4,^D'0VI!0I(^AV!)H.B#=)`V24=&A0\=H@[X5ICFA`ZWWZ$72%%BS# M2.O<(&^]J*<8LHWU1-`\SN@V>5],W.$X>0VB:W(&TB#OU[#7V_U%P``__\#`%!+`P04``8`"````"$`RX(C@.D"``#R!P`` M&0```'AL+W=O"#[G\^?O7'Q8W;\VM?5" MN*"L39!GN\@B;<9RVI8)^OWK\6Z!+"%QF^.:M21!;T2@^_7G3ZL#X\^B(D1: MP-"*!%52=DO'$5E%&BQLUI$6/`7C#9:PY*4C.DYPWF]J:L=WW9G38-HBS;#D M'^%@14$SDK)LWY!6:A).:BQ!OZAH)TYL3?81N@;SYWUWE[&F`XH=K:E\ZTF1 MU63+I[)E'.]JB/O5"W%VXNX7$_J&9IP)5D@;Z!PM=!IS[,0.,*U7.84(5-HM M3HH$/7C+=(Z<]:K/SQ]*#F+T;HF*';YPFG^C+8%D0YE4`7:,/2OH4ZY,L-F9 M['[L"_"#6SDI\+Z6/]GA*Z%E):':D=J2L1I.@J?54-4"$#E^[?\/-)=5@H*9 M'2-7\UR#M2:1+_2!*"S*/?M_U%Y$6S]UD<'2SH#CA3=%CUFK<$YF,(1QU#4)#:3*$?%+S?!'(%6%_67K!P5\X+ MI"D[@C8:!$U^!IF([0FA4J5XTY'!`66#/`AZ).^D0EE-%8%OGK"90BX0VRDB M"$R2=`I9G"&&SN"J3F5-$+`,B9C%9X(^\HW&0.K/&%/%]EU$>@MAR(1CKJ13 M6:$E1Q*@J)ZI8J-!MW2^BTAO(0R=<"NNZ%16,YV@\Z*L&PV*=6]&L1VXH]]% M4%L#'(;VA3\U_#/?7HRXW#/8T#XSM/T*#=`P++[3G9BVV M8[\?!W9D^M.QWPOG=CSX#:7SJ=(P&I0J[T1I.##I[M6@L,_VA6][\OVWLV$V MJR.N]Y16JF>OGE@-X279DKH65L;V+=P7#\X=K'KD;V#D]W/3&1PPB3M5P'QR;0`7C,G30GT6AJ_U M^A\```#__P,`4$L#!!0`!@`(````(0`H5M0]I@(``)@&```9````>&PO=V]R M:W-H965TS*6D2112-4'=)FW2 M-.WR[(`!JQ@CVVG:?[]C.R%9\%.D8TD(YIL-U*(2.=\4BG M36,<]%DS5JCY("%W4U\[AX$2]$E;C-7LWT5D;R%&0TMX2BX`M?2C1:WT**SK7\0&B:%_:SA#T#A M%@4^@$LA]&5AAE?_3]G^!P``__\#`%!+`P04``8`"````"$`UWU(5B\'``#9 M)```&0```'AL+W=OKA5;MH7:EB$I3?OV2VJHPPR987*1Q.+GT<_A M<'[&T>/''Y?SXGO9M%5]W08BC()%>=W5^^IZW`;__/WYPSI8M%UQW1?G^EIN M@Y]E&WQ\^O67Q]>Z^=:>RK);J`C7=ANFK+8]V^ZG)=Q%-TM+T5U#2#"0_.>&/7A4.U*6>]>+N6U@R!->2XZ MI;\]5;=VB';9O2?\? M(BUV0^S^A17^4NV:NJT/7:C"+4&H/>?-]Y6:@4[[HBD/V^"3>)#I M)E@^/?8)^K72M>`FGKQH__Y6NV[ MTS9([L+5?92(>!4LGLNV^USI]P:+W4O;U9?_`!(F%`2)39!4R33C<1BO5V)U MYX^R!$7]3&31%4^/3?VZ4.6A[MG>"EULXD%%-E,P.L9)J=SN-/U)X_V;E-Q6 M7?W^))+U^G'Y7:5I9Z`,(%7E$X2)?"!TJG1<.;NP5,I&>6K2,WF#"GT5JTAB M?(?,1@B1VT22X"#21M83@G0F3IWZJEKK>2*2]0;?)`-(Y7[,UATF9Y;-?[B0:5U>/;@,UZU&*2#815I,!M('%C^]#FM?Y^&9#AR4,J^_C/:;I M(JEJ9\RD#DNOKUH2!9$(D/L>?;WE7D)R!-)YY]2IKWJ7'B!.IY>0'(%TWB.= M=.GUJ)57LK29@:($%A]G/8=19C:2(Y!6[9!35QK67E^U-$X;LE_9#*"T5QB% M4VW!NK.C$H_>C_-#VC9(&\VC'K4TTBT$$&B\3\+I1B!R/KS:A*2]RF'8NX.$ M;EE!A.,EZV*ICLJFR/L@V8!3E?D2R",ZS-I`IST,/4^=#+5;-??0_ M=8(B*YX9BA7+&52_=24;!8O5+C*)M>H83,97%(8:BX+8")NQ')(M@L=I9'&+!<'S%,-C25#)D/^;"BT@6P6*U MP3C$@N^0(J#V*P9WTG\;I%%XOYE_D4V9(UI$(:D8B<>G)H/TQMCFADKH+UMM M@>XT0\UWFA`1J9?<09$ED"R"]6*'HYLM!H-">4XC>H0P%)PAR"+DX^";%2-9 M!,M52ASE$.O+)+UI1!8P,Q3(C->6M8WCC%*XT7R%IMQCI=I1[,*-P6A(0J=B M@G..H>:W$6ED919BS:E)#+0P1Z`)P7I5F)E>JQ#TL)5A>CZ+@9HK9ZB9+[%2Y"<3,1[(($JL^EIG7+2V%?MAJ#K04!FHXDN&_/'(S MS`EF$2R8M[7$:6O$:#-#,8IR/R)9!(O6YF)WAP0\QU,2AF+%0B`&D6P4+%:; MSR2V+XET-7YZE^AAJR3H@6>@AI((DWO2HG.#L*+A7FX$BU8,)UH/4]&"GG82 M0W&B`5'?QS^LR&Z0)HH;P:*QPUF9=CF=H&>?Q%"CZ-A*-!!N0>#*)H@;P9JQ MT5D-`ZP,MV1!S"%+_(;G1R2+8-'8\(:S>P(6YMM_0+ES`^YL`C&(9!$L%IN= ME6&7Z0ER@LP2H,R).+8^H1S'F3H>0K@0K-CM>`EX&:D%>K(T%).[W(](%D%B M4^QX0RWTE[V?F!B*$^M')(M@L0ZWF_7BU.EVM!DD6P:.U& M;QM("F9%RH+VXH'B1$,@5C2'8-&\ZZ4NU[-Z\4"-HJU>;`A6\[M-+U5A:*+5 M26HL:3ULF1YQAZP/PG]BZ47JQJGT])29]N1^1+(+%\FZ7 M.MV.]F)#02\6F_`NFG\1/\]'VM5VP:U9!.O'QD>])`5K(UN1'&@R0[%)]WJD M9*-@T=@`QPH!/_)5".=:X-:I%Y$L@L5B[[,R[/1`JT*`@O]VQROZW^Q3>H2H M5$]A1*&"#W7=#2_TPR_C0TE/_P,``/__`P!02P,$%``&``@````A`-%;I82H M$0``\G0``!D```!X;"]W;W)K&ULE)U;<]NZDH7? MIVK^@\OOED6*NJ62G-J\WZ9J:NJSL\^\'(,`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`.)%A(=)/HY@NFFE_23 M2?LX\=2;>;UMY=PK-*JCI&2`7>;[6(YG;#NKQ=.+J9>SGM& MS\@L\]F282T.F5IH5DT39P;)<90"(R5&*HS4&&DPTA(R3#?5."K*H./`5DPG M>M:\V2SVDZ)4-C--<+B2>GGO4](L^]42DA8#V_7U;#`3&&UVJ;%W1J8,(SE& M"HR4&*DP4F.DP4B+D0XC_2S"1=0K?9^(Q@'@Y2AFNFDT9Q,,.F<8R3%28*3$ M2(61&B,-1EI"=#ENDN#`.'11Q^BU?MJ021`B,E1BJ,U!AI,-(2,EPEG>EGQ]NW\AK:\_9(N0!L8+U>N7OJTGC M"/":O'HY=F`UT*R4$,G5G2TP/!<8*3%28:3&2(.1EI"A)MV5!FM/=NYL9^P1 MO?]J_\YV5PZAN.87 MK'VSDDNKDK7'VX4P%2O6KJ8<8JY6L_;M2K8WO#V6QV]9>QRM)=!Q(%[+(_0, MB)1_%JHWO?*?J#3WU_FQK3R(%'208)02(Q5&:HPT&&D)T8.?TR<=-0<_33^+5"HB@L>I,=)@ MI"4DE$H'B9X(7[),R3C@VPS;A<.]D0M$"\T,EQE&>IQN-FT*J*#:=48:3#2$O*>M+K?HGNB M?1^""QXP/,B74;,O"ZLPM((*'*4D1'?EREE/5]0> M3*3&2(.1EA"=B-,A'6MV\^RIW9I]N-J+PT-I"1+9$KM(R: M?5E8V<8(0:3`44I"=&])NVLO+@H5T<%CUAAI,-(28M(2HUPGFOG="YEU3[0O M:RZI=@HF$U@:>HV#,)VX;C=BE9CJIWL'7USG'.V<97-&@"\/*^H8(X@4.$I) MR)")K([&1_ M93:$JCBZ+R)*(\=(@9&2$-U?&VF+5-0/K$ MWG"4BMJ#1ZDQTF"D)40G@OJG8[2;=D_MOK2YIMI#\0VBQEMA@^C6$74T8(:D M(_44PG2J*,HVBT?:EY05%2(%CE(2HM.*=JZE2D`PDQHC#49:0M[301VC/7GW M!/CRYK(*IL9(@Y&6D/=T4,=I-^^>`%_>3%9EEGNK==@N9K$[T3VIA'!/NIG$:ZR-EX\E]&5,62FE]&UD%K(UJVYE"R`CP)>'K5)L]^`H)2%#9221O$==$1#,I,9(@Y&6 MD"$3MT\Z#KBI]@3X4N7B:<_%5Y/&BYG6Y'8GYT`K`QGQ-CMQ?%E6Z, M$$0*'*4D9*A(M3`0)U%%0/`P-48:C+2$Z$R<'NE8\]I-M"?`ER@7+F#LK(S? MHDJ"%O;;C>B/U$*J\PD2J_\,(SE&"HR4&*DP4F.DP4B+D0XC_2S"110&CS/O M<8V>[5:46;J:.CUWZMMWXMXRM0?%SC%28*0D9!BWHI7,I"(@F$F-D08C+2%# M)DZ7=+S=S;0GP)X?=8QE[\EO**DU&[+PL[@&*'!TON=K<"?OGG!?WEQ5[;'X+HO&>V&71^)'2*" MJ=08:3#2$A)*I8-$3X0O629@$O!QANW2QY%34PO1N90LU?>[Q(71,G-EB)$" M(Z6;C/,5[`J'J3'28*1UDW%ZIG,9)^%^]E!<2.'NC#YKXKHZVYVL1`O92MS& M3K(9$;XSRE0B1@J,E(0,I_]NZYJK1`13J3'28*0E9$C%TRL=)SS)]D3XDN4" M:H-F/R:O2/BZ+7H$\]]S#VS069$SC%28*0D1">R=T:%BMI]9_

?]GV MAU>$>-CM=Y<_3-#QZ+!=__9\[$^;ASW&_3,K-UN*;7Z(\(?=]M2?^Z?+!.&F MEJ@<\VJZFB+2W'IW8R;HO[ON_1S\>W1^Z=__ M=MH]_F-W[##;6">]`@]]_UV[_O:H(32>BM;?S`K\ZS1Z[)XV;_O+O_OWOW>[ MYY<+EKO23;;]'CWA_Z/#3N<`AK[Y:?Z^[QXO+[?C(IODRRJKYGDU'CUTY\NW MG6X\'FW?SI?^\#_KE;E8-DKNHA3@Z:+,)]5B5F1?"%*Z(/CK@LRO=@IZACK^ M.O_,]RG)3NW(S8RUF\OF[N;4OX^0AAC:^76CDSI;(Y:;*C?<8?*PAEOM?:_= M;\?8*)B5,]`?=_F\N)G^P&ILG4\M?3+NT9"'7A$=MHT!%0!3,!WH8JZ_0E>[ M:[K444U`P#_B1A[4I(T!%0",&];_*]RT.Q*.367)R=36)UL%3G/NT@PN`V&! MJ!!AE)%M7Z&LW6_'.3;DE>6W3E&K6](L12# M.%>$_RI7W22:5P=QKN(0'+R(6)L)2#&(<]6J[N>5A#"S8L_FSD&<3Q[/W>#E M^0A(47@SPYR/5NP$'RODC(_3=G\N-YF`6@DI!O'.M4@G.G?:'2:2A3`.&F:# MVE`O80"U$E(,XIUK74YT[N0Z[-Q"A2T@=>G39`[BBQ/55*WW(M:*09R/UF#/ MQQ5U9L==7G;;[W4/C<]\3>2U,^5I`BJ)!*/)8Z13AC+4B)Q@[ MH0X96PB,:2(:71(AS0*H)6@^>"F"S.9@G>NZ*]&Y@;D`.:ADA=HB/B?)2V?" MC[MLD4TBC]9[T"`406;[<'H)G<^J#[,NEQKO(-"F[AJ"`D&7D"+(3#8GI155 M+ECNA-;W5#LH2K'XU":OZRE&7C;%JJ*:1.*OR$.F6*XUUS/^;/,:]VCUK6H' M>=8XK](^!)M'+H*"U"-H(?(^U_(!L9B?F]?PTEQK2/6%K%UQ,1;-:X M^*"&X?H/#2E+%//BZZ^EW1,GB=%59W1H.PA[G\(V$FHEI!C$.T^?"[D\%QP4 MG$"-A%H)*0;QSK7L)D9NU1C;F(99YTZ@@T.)(+8XRZC::KT7Q5(,XGS28I]+ ML7=0>/@0Q/E$FZKU7IZ/.Q)DN9)S*?]TGTF)-Q'T*Z-A*AN"KA^2WLOS=&># ME-4BK?H&YCO*006&['?4,B[SR.NZ@I&75;`L"J+(+.4+LY%*.P-'=.T!`+HT M"XWS"I2K)2B0*8+D"5EH69%YR!!/M=:"2F"$IUS`1\Z=UH:J($^`'65PK,H*I$: M\IK;(JJ83:*3LO4>?FZ&T("8.!1IF39PM'!6N5G6.,BG2.L:%AY2!"6R)BW3 M:!R?$0Z*LB8N0\G+U56K95Q@MM[#SXWMK4PL75K("RGD#F)Y8[V0P=132UX> M4@0E.M?ZZ7?49RJILR8Z5PD"D4"5HIW4.*\2,AAXQ?6H]Z+1*()XNOIDY&G& M-7_8!5+;"PM%*QU7)\ZKFME=L%C*76#CP,,S=I"9?T9/]Q9,-M$S,-\%#L(? M"ML0Y)>UE9`B2*XT4B39N2S3C:=YCO%K5<8"04Y6('"A,BEFP7_QT>W=:4"* M(+EA2R[SGR6E<8_FS\I_<-`TS@L92`Q:"2D'5;*>P,Y-SI^4=^,9GSVKJ+AJ MG%>%]GY'+*)]TY*7S<#4DP9Y)-*-GPF?3J,\*TH+L32T4.6?>UOG5?F'#T60 MT6>^!_A)($A%#Q9XHHD%QT$8-RUD(Z%60HI!G%3ZA"CE">&@L)!G$`_+E=V, MM?+O94JI\`ZJF)BNHLW4D!?3Q)6OX3@)KO"#Z$@E+RW$QA9"/*Q6N>C@L&]] MAQZL#H:%CY9_'!_1\.*JC+S0M]\9*R]`C`>4-^1!G1N8:X*#PN$QB(?E:FF6 MSCX0#SU(X<3:)H87EP_DQ8?G-S[GD9#"O)I@5WQTJ0+IBG<,0;`$$QH=OHWW MHGW52D@QB%/E`FFF+)]!+CYD*J53JZ&N+SA3?]J;V^3&>WFF0T."%//B3+6& M1;G[R240]$[,JH,XU[B$H(;!"PX)*09QK@F]7.#S@RO3*B43TBRF%<=U=$'@ MO6@.6PDI!G&J:16MI(HZJ((<#`E9S&*9\UZ>CXV%A@0IYL7Y).0W0PUW;>ZD M)&NQBE.RF'FQ=2DY>!&QUC%.5G,8H&E MAF%.#@T]V1"R9.T7.?;[DD-W>NZ:;K\_C[;]VQ'K.%^B3!Y@^RE072WP+9!Y MX2@L2_I**+:4U5H?UF`26ZH<;0QM82E@,26!L)2PF')%6-`/TCG5SQP64[S$ M;59KW-HF6F2SM;XC35GP-11N)%,6C`;W?RD+1F,/JKC_'*/!ZU#9!A]=W:=C M(53"OT;G27]TG9K'^W)];S_JBBF!48I0K66O!JB1+14;N"]$Z*E+`H6_8XGP2U'HN$E?EKYOG[I^;T_/N>![MNR<<>S-S2)_L9ZCVQ\7>CHT>^@L^*M479:,7 M?"[&ULE)O;;ALY M$H;O%]AW$'0_DEHG6XTX@TCJ\P&+Q>SNM2++L1#;,B1EDGG[_=GL:C;Y,Q[G M)HZ_*A;95=5DD4U_^/W'\]/@S\/Y5P-_SKGD\'*X#6'BYW`T?K]?7<#R^ M[!\/S[O+Z/1Z>('DX71^WEWQZ_G+^/)Z/NSNFT;/3^/I9+(&X/VQ/^V_/AY>K-G(^/.VN&/_E\?AZ$6O/^_>8>]Z=OWY[_6U_>GZ% MB<_'I^/UK\;H M*#_S:KP:P]+'#_='/(%R^^!\>+@;?@K">C89CC]^:!STW^/A^Z7W_\'E\?0] M.1_OR^/+`=Y&G%0$/I].7Y5J=J\0&H^I==Q$X%_GP?WA8??MZ?KOT_?T$6X%ZK)_O2$GO#OX/FH<@"/OOO1_/Q^O+\^W@VG-\/!Y\/E&A]5F^%@_^UR M/3W_3PN#UH1N/&T;XV?;>+8<+6XFLV"Z>+>166L$/V4$^.\;O<[;!OC9-IB/ M;A>+^?+V!KV^T1#2YEGQ4WJ:C*:WBV"Q5.-]H^6R;0G72,NWQXCWJ.D*/W]M MC*NV(7Y*3^\<8X`DT:%$T*3MVZ,,)(#J/[\VS@"6=6_XC_3VWI%*!`,3PJEW MI&.=K4V6;W?7W<O+U2_Z3T[X:( M!G+Z`OKGQ]ED_F'\)UZA?:NS9IW`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`RMO-8+OI;^-6I'<%URCN:F/HE:KA^(6+::=K81MI=PP8Y2SK8)M ME=RP8E1;MNPD57N"G@.[)4?O%2Q':;1$I6N2-)C8";<)M-;<;)ZV+5I,])*# M=<&9O".C(3&(!>GS>E4W)6PZ%:W6]'SBKF:9T1#3N2!CNF#3I6BUII?3D;.Z M5D9#3->"&M.VH]4&H>?HO\U4O:&P`J`1`B#];;![5YEJ>5NC1;\X(A2W#1=F M84C85BI:QE;&*!=D;!5LJQ0M8ZMB5`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`=[K($7ZXJOR(B/3X*/R8B/3X(OQHB/3X*/E!BU;T[$)T>,P"?! M!T18\TEJE6Z^B7<;!.C&]_K@G@*Z\4EPZP#6?)(U'F?M?1Q<#$#@_`^*J=U0@+X!&N4";XTV]Z&N(S&AM+;$-?)F)4,%-FEM09_TW M-_J7J[[,,_A\NN)/:=2]GL$C_C;J@,]R$[4#?CB=KO(+W#'N_MKJX_\!``#_ M_P,`4$L#!!0`!@`(````(0"HJ#_/:2```-.>```9````>&PO=V]R:W-H965T M'I^=G!X?W7U[__#A_MNGM\?_\Z_R'Z^/CYZ>;[]]N/WR\.WN[?%_[IZ. M__GNO__KS=\/CW\\?;Z[>SZ"A6]/;X\_/S]_SUZ]>GK_^>[K[=/)P_>[;Y!\ M?'C\>ON,_WW\].KI^^/=[8==HJ]?7IV?GEZ]^GI[_^UXMI`]_HR-AX\?[]_? MY0_O__QZ]^UY-O)X]^7V&?X_?;[__B36OK[_&7-?;Q__^//[/]X_?/T.$[_? M?[E__L_.Z/'1U_=9\^G;P^/M[U_PW/\^N[A]+[9W_T/FO]Z_?WQX>OCX?`)S MKV9'^9EO7MV\@J5W;S[_S;639=7QZ_>O=F5T#_>W_W]U/P M[Z.GSP]_5X_W'_K[;W#WAX<_G&KSP2$D?D6IRUT$QL>C#W&_1U_O71W`H]_^^^WQ.7*X__#\^>WQXNKD M\OIT<79^>7ST^]W3"OX:1`PDO?$+\ M]0E?GUR?G=XL4#:',H1TYS7^2H:7)Q?GE]>O=VX?R/'*I\1?G_+JIW*\]NGP M5W(,RNE`AGBC=J[B[R\]XHU/A[\^W?G/>7J&RK++T?WCEY[Q3"J#^\>O/>49 MZL^]P_)]">#>2;UQ_WCUQY5:A!>"DD95OP#`3V3*N3^X3/] MR4>52G2FM>AG@RK5Z$SKT<'J\&I^SW?M0W[[?/ONS>/#WT=H=!':I^^WK@D_ MRYPQWS+XMVW?5J#)>N_4?W/Z;X^AB%;@"?2O=XNSJS>O_D+C\][K+%GG+-98 MB89K-9S9/`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`P^Y8^ MPRVX)"^<1U$`9ZT`Y5X+@UK)O6!4,JK8?.U14AD6<65H5$MR;!EU;+Y7K;`X MDSG46K7$_,!HP^9'U3I@?JM:8GZ*4!PM-WD,HN772G9#KN?/]^__6#Y@%'6F M2R7S9!/3$#&^=.MB"&P0LA6CW*/KBWW"@E')J&);M4<+S*UTB'=^D49Q]@M: MXFJK"05U;+Y7K=!\,H)KTON]RCQ;S"[A:X"D8EHXIMU:S5,&H9 M=6RK9ZTUHX'1AFV-K+5E-$4HCH.;3EIQF*>941QF=(5A2Q"'I-]8N47?^-W* M!84+`>?728]0>"W,G-QRYOG%Y?E)HE**(7T_*D:UH(/9-:+E&HJ_WETL%B=) MC6I%0W/K&/6"#N:V]EKR<*=G-R?)8&800YK=AM$HZ&!V6]&*IOB+I-.81&N7 M8UPKW'S7JA5^'ARVI3-"K9"W?N56[],JX)$F++P6BD02EIRP8E0+4EN-H/D' M,/>FMX*T.#M&O2"UM?8H\&L0+;6U830*4EM;0>K7),@H=#>GM0K=SW75[M+] MR($2OL*?X%5,NI.5UUIH:')!5_-+EC3AA8HU)G-6@9%*M-1N+2AV**EPC6J) M^5:0VNH8]8)LM]&6T139BH/AIMA!,/:CC'GJ'17ZC*[#JG"1=$`K]]-(UNG+G1OEUG%NO=@Y^'!KKW7M M'^YT871NE-V&LQM_*KNM:(5=X(([MS#'N%*XF7Q0*7[XALXS_ZBRS`B51=_0 M&05SBMS]J(':!K5JTU%8C2#O05I#:ZMA6+UIJ:^W1 MM?HUB);:VK"M4;34UE:0^C4)VMF*@H%2/1R,?SU\#V=S._UX4<4C-YK9OX&+ M13*\6DG"8'[@T570@C(J&55LJV:MAE'+J&-;/6NM&0V,-FQK9*TMHRE"<7Q> M6!LYY[41CR[B]S)M0D5+QU*YH#`A-Z&B%8]IDY6*4K0B6Z^3F7`E6NI$+2A* MF$Y2&M&*G4C&.:UHJ?F.42_H8(YKT8IS3!Y[$*W(5OK8&]%2OT9!4<+TL;>B M%3N1//8D6COS<2U*UFRD'S[GM1F/4(OV3:L@=3L7I%J%(.T_2T&J50E26[4@ MU6H$J:U6D";L&/6"U-9:D-H:!*G61I":'P6IUE:0VIH$[1+&A>Y61()^;E_H M?J5$[2[/9Y3,)Y*W9N6UPD&HH'#4M%@DJ[&%:DE,2T%AHWV>5MA*M+1;J@4= MS+%1+4)QC4OG7JB4Y#H+4UH;1*.B@^:UJB?E)T,Y\''FW M!F-%WO&D\YQ1.->D#7:Q$;NDV\2(.\4K:13(97WFM M8!28"XK:X8MDX:I0+24@JA$SBGJ]&47AGU&PG%9X6P$J/;K6 M663E46"KYH0-H]:C8+6N8UL])UPS&MC6AFV-G'#+:/)H?L8X&&Y!XU>",2^` M1,'P:R)ABWQ)8T^?3BM@?N[380ZA+UDZ=2E$*US"6EPD2^6E:$6VN'\D)VHS M8>I$(UJ1$^DPN16M@TYT7@LAD=>G-Q.F3JQ%*W+B(EDG&43KH!,;=F(T$Z9. M;$4K=B)I4B?1>LF)J`HN,`8X6`63):2=?MPM>X2512G3%:.<4<&H9%0QJADU MC%I&':.>T9K1P&C#:&2T931%*`X&WN(P&#+I7#B>%/J,HD(GE/N$@5;!J&14 M,:H9-8Q:1AVCGM&:T:T@IKE'^+5*&\V2@ MTZB6Y-@RZMA\KUIA<28_"ZQ52\P/C#9L?E2M`^:WJB7FIPC%T<*L,'S=?C1M M6SC]I!V=41"RE=<*4.Y1N&^34:3 MN<]:M<3\P&C#YD?5"LS3ODW5$O-3A.(HNC4+J]&^RR6+E:N$3 M!K_+>H2J)`X5C$I&%=NJ6:MAU#+JV%;/6FM&`Z,-VQI9:\MHBE`+5YD?0;*RQ6T(#$HVB--9W1%3ZAW]IX]OKTYB1IU4NV73&J!1W, MKA&M>=_FZ4G2HK8BUP%NQZ@7=#"OM=<*'RWI#P5.=?<+A+QB*X^BEG1.&/P66WBM8'=DR0DK M1K4@=:(1I$O`K2`MSHY1+TAMK3T*_!I$2VUM&(V"U-96D/HU">)"=]L=K$+? M\;C[\BA>AUXD2U$KKX4P2VAR07[[8]++%RJ6%*4@-5(QJ@5%Z[5IA6M42\RW M@M1\QZ@79+N]5K'8'02IW0VC4=!!M[>J)>8G03OS47-ZX18>C%=GQY,HSFL4 MX=JQUXI"-FNA(Y7<"]%25`K2YZT8U8(T8<.H%:2V.D:](+6U9C0(4EL;1J,@ MM;5E-`DR"MVM,EB%/J\^A'W8Q8SB/HQ^,?5:81,F:.XNSD[HW9D-PTF)4RE) MM-VH&-6"#C;6C6J)^5:0FN\8]8)>\'NM@C0H!:-2D#YOQ:@6I+8:1JT@M=4QZ@6IK36C M09#:VC`:!:FM+:-)D%'H+ZQ>7/#JA4=QOW.1O`DKKQ4U8K,M-&+N&YFSZY-D M9E)(&FT!2D':=%2,:D$'F_!&M:06MH+4?,>H%_22XVM5$,N#(+6\830*.NCX M5K7$_"3(:`9?6,:XX&4,CZ*^9]:*PN:11J7P"8/NJ!2DSULQJ@6IK891*TAM M=8QZ06IKS6@0I+8VC$9!:FO+:!)D%#H":+99CB<=_HR2OB=Y%587LQ9>6`EY M+FANP\^Y[_%)M`DH)8E:J1C5@@ZVX8UJB4>M(#7?,>H%O>#W6N5B>!"DAC>, M1D$'_=ZJEIB?!.W,QP.W9#WB1ZM*%[Q.X5'4)\U:43`]T@]I"I\0':,X6@K2 M;6N5("V:6I`F;!BU@M16)TAM]8+4UIK1($AM;02IK5&0VMHRF@3M;,7!<`L& MUD!@7DB(!@(SND*I[N>ZZ5+YZF)6BMHVC]#$[=/Q7G&?\&HQ=URO+V_2KSM+ ML:UKO94@;7EJ00>S:T1K_@"&UR1$KGEU@C2O7M#!O-9>2Q_M==HK#V)(L]L( MTNQ&00>SVXI6&"?^V$:T=CG&52)9D_CA^\EK%=ALXYID5!5YS58>117#KU4$ MBX:24"M]Z1&JL-BJV%8M6FJK$:3]32M(;75LJQN2^?]R_?_RQC234ZI9[=*6^%XQ* M1A7;JEFK8=0RZMA6SUIK1@.C#=L:66O+:(I0'!]TC%;[>>EX$H<9Q6/Z13HH M\0G#]T00AO;[`'(#*EI1F"_2=5W1BFS1KBG1TLI0"XH2IBO+C6@==*(5KX%KVPK()= MA52+_+**MAXKKQ55F5D+/\1*HUF(EB8L!:E6)4A+I1:D6HT@M=4*4JU.D-KJ M!:G66I#:&@1IP@VC49#:V@I26Y,@H]!?6`-Q'^JFK^Y^#43?P,5ENOO?)PR' MH(*BX?-E\H-:H5H2K5)0]/-#^HI4HJ4#PEI0E&-:^1O5DAQ;06JK8]0+BLRG M#[16+3$_"#KX0!O14B=&05&.Z0-M54MRG`3M;,6O&]YFL]%V/&FT9Q3.-/!Q ML-.*PNR13@L+T5)4"M+?+2I!^KRU($W8,&H%:<*.42](;:T9#8+4KXT@-3\* M4EM;1I,@H]`Q:C4+W?&DT&<4]Y2T^_]RUHJ:/8^B=O@R^=VTD(3:2I2"$$?M M8OEUHQQK21CEF-;.1K6D=K:"M(WK&/6"#II?JY:8'P2I^0VC45!D/BVOK6J) M^4G02^45OVXP'T:>QK#)\5^73C^I$3,*5]&\5A3^60NC:7&T\%H!*CT*=_^S MK9H3-HQ:C]#)2(X=V^HYX9K1P+8V;&ODA%M&DT?&[O]+MR@23/A_&(QY$25< M"-B9>'M\';;(M/O?*P5[WG-)A[&)OF3IZ*T0+72Y>ZW%9;)GH!2MR!:_L-YY M?0MJ,V'J1"-:D1/I8+H5K8-.=%XK*(G>3)@ZL1:MR(FTKQU$ZZ`3&W9B-!.F M3FQ%*W8B:5(GT7K)B;@]<`M"AZI@.J>=%Y"B*CBC8-O?ZI)0SJA@5#*J&-6, M&D8MHXY1SVC-:&"T830RVC*:(A0'(UGMD2VUE[RJXQ$&/N&;F6Z&4"UI$G-& M!:.24<6H9M0P:AEUC'I&:T8#HPVCD=&6T12A*`Y7R4*/Q&''X\[0H^#[BA6C MG%'!J&14,:H9-8Q:1AVCGM&:TVB,='*Q$2U'N$;83[\ZX/#U+1B*%*DA[5S*JV'*M M6MYRTJDVJB"6VPC%!>*FH$&GNJ_*\]0T[#RQBNW*(MGEFWSWL?):^,Y7OCN^*,?F]))U&E:&&*LG>"OR_W6L%8L383IL.T1K1B)Y*MKZUHO>1$7,)N M-F65\#S+BDIX1O&$_3+=KN+$J'?AC$T0)/M2H=^J"M62JE@*TFA5C&I!D?ET MJM*HEIAO!?W4_-;](FH6E)]]Z+K*Z.P54LEIY%)7*G##8^E&(5K!F(2@L M`I]042U:FK!AU`K:K:7&M2`9K._;%1Z4N^T6B&^\Z^(R^05BY;7"Y3-!T0MZ ME2RO%JHE95<*.KBH6(F6+F;5@N;]$I>GZ=&^C2I(9JT@7MK"<71V!>`Q]$XU MWL7M450@<\)@BV,A6KK\5@K2^E4)"A^5;#6BI;9:0?QPUR\,3'<\'D9XY%X> M?9NODM7NE=<**[R@*&&ZBE:HEL2D%*05OF)4"SIHOE$M,=\*VIF/7@NW^&&] M\SN>E,H\)D2IB-V5UXJ*8-8*WWG1TH2EH/!Y?4)%M6AIPH91*\AXN!=&CM<\ MATFY.&7:$613D^P*44KLD7K MA>Q$;2:DX9=H14ZD8\!6M%YR(FYAW+`R&'[M2O[\\@1XOE15KRD[VEVBD:R: MX;L:UQN'PS1!>*F"2*0+.*HEE31G5#`J&56,:D8-HY91QZAGM&8T,-HP&AEM M&;F[IG>ENGN?YGC-=T?/=\-^O7O\=+>Z^_+EZ>C]PY_?4,H+-/+OWNSY?&OU M\OI2KJU.)+C/^K>=[80O<<_UKKM.^7DVF?J+;-HU`XG^;Q?9;W@&1#81+"^R M:??ZIQR>FOI7V;3K7U+]Q2ERW@U)4LGE:YC:-7V)!/ULYKHCPZOK\VR)UHDE MZ%,RUWBR)(?$-9@L0=^1N7:3)>A",M=\L@0]2>::3):@JX#7EF2)YUF:SX/! M#[RVGC2'I#`E&.3`:RL-QCKPVI)@R`.O+0FF-ID;[O/S+*]>9TN,`UF",7NV M,B4Y)&YHRFDP-L_<")4E&(]G;J#*$@S+,S+(N>#WX$S]\,B2_!S<.9^7V0)?A7.W&^*+,'/OGB#+4-TEB16UZAI<"H@//!G@]X8$4!FSI@S9(LX=O2]&T%R^>0QNIVL(4.:2P)=M)E;LL6 M/REVSR':E@0[YA!M2[*$;TO3MQ4D*U.20^*VY;`'V&V%:%L2[+!"M"T)-D1F M;FL<6\,F2$3.DF#C(R)G2;#9$9&S)-CSF+EM+V);+7.22Y*2D@<;L4.4T)B=NLR)(* M$K=GD278=9^Y;=LLP6;[S.W>9@GVW&=N$S=+L/4^8^)&"O M?!=V;PVGI2?&X& MWRP)OBJ#;Y8$'Y>A[E@2?&.&&F))\!$9:H@EP;=DJ"&6!-][PIKUI/B@$]8L M";[KA#5+@L\[4:LL"3[B1*VR)/B6$[7*DN!3:UBS1G;XHAK6+`D^K(8U2X+O MJQ%M2X(/J!%M2[*$;TO3-WR4BVA;7N>0N*\ZN;[A"UQ$VY+@0UQ$VY+@2`5X M;8VX<&8"O+8D2SS/TGR>%20K4Y)#XC[EMKS&;,J4X.-[>&VEP3?XJ%66!!_9 MHU99$GQKCUIE27`:!JQ93XKC+F#-DN#4"UBS)#C\`K7*DN"0"]0J2X*S+E"K M+`F.F29<;CAM)G/'FK`$A\YD[G03EN"@FD; M#BQ!M"VO<6X)HFU)<#X)HFU)<$P)HFU)<#Y0YDZ18:]Q)E#F#I-A"4X#RMR9 M,BS!H4"9.UJ&)3@;*',GS+`$YP%E[J`9EBPA<6?JL`3G*F7N:!V6Y)#DI@1' M*F7NH!U.@Y.4,G?>#DMPH%+FCMUA"4Y31`VQ9@4X5!'1MMX%G-8'B352Q7#V&R16N>'X2]0=2X)3,.&UY0&.5X3$\@!'^4%B>8#CX2"Q\L%) MZYD[IYO+#4>I8PW/DBP7F/_@#%E.LX372S,?'%.*VFMY@--*$5/K27$,)B36 MD^)\14BL)\69?9!8^>`D4]1K2X*S\C-WACH_#P[#S]Q1ZBS!F?B9.U&=)3@: M/W.GJ+,$9]]G[C!UEN`(_,R=J&W5`]Q< M`Z\M"6Y&@=?6\^`V%'AM27`I"KRV)+CU!%Y;D@H2=UD&>XT+3U"K+`EN-$&M MLB2XV`2URI+@MB)8LYX4UQ'!FB7!%42P9DEP$Q%JE27!54.H598$-PZA5ED2 MW!F&--9L%_>$(8TEP75AF;N7BLL-5X0AVI8$UX(AVI8$UTXAVI9ON&H*T;8D M.23N[B'V`%=*(=J6!-=((=J6!+>^9>[^+[:&F]X0.4N"V]T0.4N"2]X0.4N" MN]XR=S<8YX/[W1!32[*$9&E*5I"L3`FNTLO2X(K#U'?+$D+#]P5F>P![C[-W$V9+,$5J)F[,),EN/8T<_=FLF2`Q%V? MR1)<>IJY6S19@JN(46[6J`9W#:/<+,D2UI:F-5Q4FZU,20Z)NYB4/2@@*4Q) M"8F[II33X(;:S-U6RA)<5)NY2TM9@LMI,W=W*4MPBS0DUI/BFFA$SI+@MFA$ MSI+@TFC$QY+@G:DL<8NN*4=:2P)+FO'6V))<$$[HFU) M<"D[HFU)<.DWHFWYAHN^$6U+@ON^$5-+4D+B+H?F*.!Z;\34DM3PS=V^SFD: M2-PE["QI(7%WL;.D@\1=RH`U;1 M]#?98!5-CZ(9S*+ID?U@9M\C^\',98G)DE73ES>H3)9;JQO4)4N0WV2EY6\. M?TO3WQS^EJ:_.?PMS5RJ&U0Q*_OZ)FNM[&MDW\[9O]H'_^G=F^^WG^[6MX^? M[K\]'7VY^XBM):9ZO7C[Z_>'Y^>&KNX7YZ//=[8>[1Z<- MY8\/#\_R/ZCUK_Y^>/SCZ?/=W?.[_Q<```#__P,`4$L#!!0`!@`(````(0!R M:(_V1D@```UV`0`9````>&PO=V]R:W-H965T'+9WC+KKVA=>SSG/&ED>*\82'9)F//O?GX5"9B$S M%]B4_3#4?,P$4+D2*"2JV/WC?__GT^^O_OWAR]>/3Y]_>KTX.7W]ZL/G]T^_ M?/S\CY]>_Y_']K^N7K_Z^NW=YU_>_?[T^<-/K__GP]?7__WS__Y?/_[Y].6? M7W_[\.';*[3P^>M/KW_[]NV/']Z\^?K^MP^?WGT]>?KCPV?\YM>G+Y_>?O=>VI_]#S7_Z^/[+T]>G7[^= MH+DW>:!\S==OKM^@I9]__.4CKB"%_=67#[_^]/IOBQ\>STZO7K_Y^</O^P^?OZ`<$.H),'?GY[^F4R'7Q*"\QOR;B<);K^\ M^N7#K^_^]?NW^Z<_^P\?__';-^A]GES>/_V.GO"_KSY]3$F`:W_WGY]>+]'# MQU^^_89_79R<7YXN%V?GKU_]_K,[.+Z^F[H]X7H@G?FJ7)U?GYZN+JTLT=L3Q4ASQ M4[MGW]7DMGOBI?7[G92Z@_-1I^H?V:@0Z M,MR%2IO^(:[7WQ???MW<\_?GGZ\Q76;J34US_>I3O! MXH?4F*PO,GWF%07'^XYM_8PE[+S9OV6;A M+=9JD9:QU.PF@B:"-H(N@CZ"(8(Q@FT$NPCV$1PBN(G@-H*[".XC>(C@T8`W M4&J6"]/X+\F5[)-<&NBW"HI^9T$;M5"7301-!&T$701]!$,$8P3;"'81[",X M1'`3P6T$=Q'<1_`0P:,!3ANLDZ3-\G2>.>G7T^W9S)P+'_NWV2:M![-1,%G/ M)K,^1!HB+9&.2$]D(#(2V1+9$=D3.1"Y(7)+Y([(/9$'(H^6.,%P_;'14PMEDEI!(0Z0ETA'IB0Q$1B);(CLB>R('(C=$ M;HG<$;DG\D#DT1(G(=2R$NI=*N%)*8WP6R%85Y_7;CT;J=N&2$.D)=(1Z8D, M1$8B6R([(GLB!R(W1&Z)W!&Y)_)`Y-$2)PRV8%:8:5]Q=GX"^^=F5_+PF@G! M>FLTN_1+YGHVFC4CTA!IB71$>B(#D9'(ELB.R)[(@<@-D5LB=T3NB3P0>;3$ M:8:]K]5,)U/"7IA,SNUM:GEQ%829C69AB#1$6B(=D9[(0&0DLB6R([(GR(/1!XM<<)@NUT3)F$OC!`_8ZZ#,+/1+`R1ADA+I"/2$QF(C$2V M1'9$]D0.1&Z(W!*Y(W)/Y('(HR5.&,P`*\QWK'+)PVLFQ&EV>1HTFXUFS8@T M1%HB'9&>R$!D)+(ELB.R)W(@+7&:I0,8*YHN*D[:[3`60,BJ#\ MR#^'45J]6Q7%@-"KBBTN'J+6+F[C?#`@*RT0\!E*K,FDWBK!: M/+\`-,5*8],6D7V6J7Y@GJU*FT-C$9%E8M+N[=*+I_E71VBHA%Z*RC, M^3!CUVI5LG0C")N2Z:GDH5Y3G^?4%UA/?]%`LM.E1 M427[G]DMHH1,D]:%(R,[M<7*KG>"<.W:>\.H9<>.4:_(3&U&HZ+*Q87=XIS( MO"L\RRA,[7A>I58E'S>*\MP[/[\^"45Y4RPT(JVBTD['J%>4FS[#2S0ABX9B MH4V/BBJ9G_9@)O-?VCNGNC:F0$9NN@LJE[(1QU79R#2,6D'G9W.B=(+,TM&S MX\!H=&WYM2QMT,Q%SRF0-VXNOS-RTWUQ%5;2]9E8V>F>T;FM%7@3*(Z7>4NV MPKM!)^'.T8K)>IH=X/O;K$Z.SL)V3QJ0U-W/FIIDV:B]F*JY$V= MBV9&;K409$.7T7G9P35G&5V6A&H%G9K4I;`[HZE@R?\.H8=0RZACUC`9&(Z,MHQVC/:,#HQM& MMXSN&-TS>F#TZ)!/W;1#C*E[_''?6=Y4NNP5Y(4,*_M:':V0LZ.NR`U;M8PZ M1CVC@='(:,MHQVC/Z,#HAM$MHSM&]XP>&#TZY(3$^RI_5[@.NV.KGM'@D+^XM`4W M^3Q?7-Z:NS4FHW3D6>[62 M@O?LZB0$WZMBI56FK5U3:&A15KB3L8.NS52H[&E^>Q0AW48FK:R9TNIC8G)NZW@((0 M))5H+0@_%&T4E=J[450NK&74*2IM]8I*6X.BRI4\LSU*0H2[CZ#T6+!(=!7F MR%JL3$IN,6D&HD#4J'5OUC`:'O$S/[)A6O&,2%'(Y+EUBE<(YAX`R:Z-6 MQW-9K:R^>5QFV>_4ZFB/O5KE7%YZWB6%"G5J6M7E%I:U!4N9*TKZGV9^M>'\FR-[` M!-D;F*)RTVD4V1#DYLUJT:F5N8$I*FT-BB8K?R6(2C4+$@]9D-$"F\@RGY?7 M\:!E5,'A@].N2E25OCFC1YR^RDR("6UDM8Z=S:,&H8 MM8PZ1CVC@='(:,MHQVC/Z,#HAM$MHSM&]XP>&#TZY-0Z#P7$=!AT_#G!Y.+O M7XJP;9RWH\OK<`*T+E:SD(P:1BVCCE'/:&`T,MHRVC':,SHPNF%TR^B.T3VC M!T:/#GDAGZF?TI8B[#8$V161T891PZAEU#'J&0V,1D9;1CM&>T8'1C>,;AG= M,;IG],#HT2$O3:C^OF>.<6&(-P0F(5&NF#D6G\L7JS+'9D=%#5NUC#I&/:.! MTOBY6JMF'4,&H9=8QZ1@.CD=&6T8[1GM&!T0VC6T9WC.X9/3!Z=,@+F:KN M*.0+?\."ES-H(17DE8QG->I8#A@VC!I&+:..4<]H8#0RVC+:,=HS.C"Z873+ MZ([1/:,'1H\.>27#<<'W3$D^23@7A)72K*WQ`+E8E2DY.RIJV*IEU#'J&0V, M1D9;1CM&>T8'1C>,;AG=,;IG],#HT2$OY#.G)7C;B::='(.4XYNU6)DGYAM& M#:.64<>H9S0P&AWR%_?,2<(YGR0(,H_'UXPVC!I&+:..4<]H8#0ZY"\NU.+3 M%#SR$/V<:W1!5^7(?:U61>2-6L&_S-++4&4TQ4JG9,NH8]0S&AB-#ODXA,+W MQ3AP09PJ86P-7!S$RL9!K*[SWU+P7QYI,Z5B;AEU@LPCVKY837^E<;H(M?A0 M##2XHT,N(!?5VA+UR+,?.)$PX,!I=6SX0S]1F%UR;";HN`UH+7':_+]3;J6%"KJ!Q@ M=]Q6KU;%<6`T*N)C[HM47IB]E#ZVF7@0,UWUG!*\ MA;[(Z-JNZ:NHW%JLW!00Q[P(DMB--FS60&ZE8]07Q[0&+N)8AO)[E6-TK?A( MI/UA36;9-UJ9,T(DM-WU14;NLL6J7%8C5M<%M>S8,>K9<6`T.D=_<6D?5KNX MO#^S-6]ZOHF5W=ER*QVCOC@>F6C\3>7WEU(8OLY';82:[%RR9T=,>>FGZ,7``R2J/4ZVLNF+7"C&O'J*]X#A4V.E=W@9=A M!Z>B3]S?VP6%&1XVYVNQ,KFZ$;0XS>^,7)W'*6X,-"@MM],QZHUGWL^&I@=C MH$V/KAT?C6>V<9>\C1-DY[<@=^G9,5VZ=M^(F64MNW:,^HKG4&&C<_47^,Q6 M[C+OV^R"+BC,\7@:+58F3S?JF._;"U9;]HCF;L:M=(SZTO"Q"5ZL-.*C:\O' M(VS27JKH+GGS)LC.>T$N*-EQ<6JJ%3&SK%57LZ-75+;O?<5SJ+!177E/?_G, M!F[B8=[G?=CB%)N+G[,F[>O%FI-Y\N:6]F;@R[EIE5&*IN;G.GVH"VZG M+G1J5FJ"1LP6IV9K(`SO46AK';?6SYZEM6%F):BC:\U?>=@)TI6'OQF\Y!VB M(DS_.1E6I_&I2+'2"]HP:ABUC#I&/:.!TH9S0P M&AEM&>T8[1D=''*!N@J[?5K%PZ>*3?9^-R!H@8\/U"F_5K.2?9O9+'_$U6IQ ML0RG@(TQT9;:"NLJK*^PH<+&"MM6V*["]A5V\,S'UM8.Z2\7\M"'H) M]B+4F8V8F<<,[>R)NY_Q#*Z8`5U/X&]#IK@5O[7$MS%SY9C9SVY-%.&YLV+.=/4L'787U M%39P<^-L=G0@6_;SV=E4UEXL3\)FO>=!#8S& MN1UWA6&<6W;<51UIG/O9+(_S;!7_&/+@VO9"V2K4KOA<;5YEM(!092')S`1W M4S%KA!FSMF+6S:Q4.CV[#HS&V;.,;G8=&(VSI\U/&MMN-BN=[BOLX'KP\4IU5BU>N?YR\9*2S,4K M,Q.(S54Q*_F)SR`+#Q7%S'BVLZ>LGZ=Q_>R,A>9"SPT-C,;9TR8HC6K+GKO9 MG8= M&(VSI\E0-MO-9J73?84=G*N/%Q2KQBOQ$*^,3&S6>,DG61FT$92B6A+T/-RJ M&W9L9T?)A/AQF)TQT$3HN9V!T3A['AO3EAUWLV,>$_ZJ*%S(WECHH`ZN(1_M M9RJZ:Z[H!)G0KAEM!-D<;MBLGT@(8;XU1.IM_@O%6F?L-55Z;G9@-*KGT2%NV7&GCNFS1.=KHY>\]L9,1W9P MK7E54KU4N:E=YSK*WM0$+:"*-KP6YB30"JP\JFG8K)U;*Q5E5V$]NPZ,1O4T M?T2V9;.=FB&$>@G["CLX5Q^O5/+4XI5+(1Q:S(RFLL M.;;2UN)X/G3&3*^YYV$,C$;U=)D:1[9EQYTZRF2ZN(K+_]Y8Z*`.KB$?]&#U32>'-+8J75E+(KWE162W"\>Q:/--W=6L@-A765%A;85V%]14V5-A8 M85MAYKAW-YN5&]N^P@Z>^3BF,J(VV7-YX2:[E#YNKJP6X7!YG5Y0B?._ZDFW M+')LI:V4G-,M:Q%G661S`P&M737TX8U)8==^HH@SJE&M48Z)@.KAVO M0*J0:@KDRLDI(,64F5UKO(1*X6:SALU:07[FBZN9F#V[#HQ&;PK[.!<7;RF%PIK`:$<-WFHGST7'A>\[(%5]T)JXR+GP9 M0%CS\,5GQ42'AJ\^LVV%V*<"JI*LZ>6YN.XJ"['/AB:`B'UFUA"1)D-$6@Q- M]B"\#!%>\D9XB2&\XFSR`\$D0P13#$W7"!]#A,]ZA_`]4T^E5\XX?)DMTJ>E MF_M62"]D,Y4RB*CZ8BS%-RQNB#&Y(L;JFFO(T_BU`@AXL="D0<"I*02<&`*N MSL=&!@G(%1*H*W[.%\75@;73\4$5VV!0Y9FR;7K#+FR^E"55M'%(D*LY4TU" M`JWPRLT9`2=#!%P-2]V)&#-$C,D;,2:&&*MSZ1H1)4-$5`U+UTAJA@B?]0[A M>Z:^6IQR@:7,'@`@?-G0AT]J+';=RD^I MZQ#65$29L.J)3GHWEA?L4G&5]8E?S%5??PLLOJHW(IJA,41$Q1#"E4[HJ1X6 M$+73OUD-]PU$7%HO.R-$G'I$Q*4E?XLD0T1<#(\/#2*HG0SM8A4_;A>:2/O3 MX((FH?1[.=6Y)DSO[.IV3^.-=2A#$V\LXVP(8<@0PHBA*="@@D!\2+UV@\!G M:-X11N"I101>G'W@R1"!%T/3-:(LT'2-L&:8NPYA3>67274*:WBC>'&:ZS6_ M@DBE5UY70%2)(:K$$%1B""HQQ)080DH,(26&D!+#,DT,$26&@!)#/"T+\4RE ME(EG63IRC>7C)G67.7=W)L-2W+BJXVE`,*G/Z03AM7B[#*\ M.X+O.BXV.HGQ;<<,\7W'#/&-QPSQG<<,\:W'#/&]QPSQS<<,\=W'#/'MQPZ& M4*=*Y2^%.CF$"EN^[3AUI-%9+_0KD%VHL_/BA=FE1?\VHB0I\KIT7Z.E/C&]^;M'8:)ZA1G!5" MC0S-"*&&&AX=(=3(=F:$$$-]CXX0^A0['0ST<3#HDZH>H\_+:U$ND[QN4D_9 M5R@76&_23#(AP%JDAAB1"71X+H?UB'PADOJ6_3/F!T,HPA"*4)-01`V/#@>* MD"\44=\R'(2?(<+O8`A_JG=,^,OTR(60#[-43"^\4;E([\%.!WUN;6*(.#-$ MH!DBT`P1:(8(-$-$FB'"FJ%]M5+9PEPXPBK>!B*L#H:PIGJG&M9<")F&WDZK M=0I7J,/#31(KOA1190>#A,XL^-(I%+LBS#772IDSV^52'U_E@$\L,/^%-^&@ M"HT3HA"#)K4!K,+8H1*Y(OEKKC1V"*=V MOA!=&@6B2PS156=[?XTC0[S)%?%65YECB_@MSXA^,=&A(?JVK1#]5#=5HY\+ M*A]]*;+LJX;3B_-T`V5#)&^&1B;$6@U+LB"\#!%>\D9XB2&\ZNR2EPP13#4L M72-\#!$^ZQW"E\JG:OAR7>7#)[66#U^&)BI8KHMA2=[*D:O8&5]$5'TE1^AK M2!#?8J(Y@OC2.!!?8HBO.MOTI;$A?\D7(5=?66>7\;@)`A03'1L$L&UY`1#@ MN@#3+T*%),RO'@)-$#?IMCYM38Q2C4)CV"I;X.NU=;A=#?8*C?=08:,R.\:M M0N.\4V:[WM?@06'V#N&#BM7\3;L,S&H$0J_K[;1[F'8@V"F:;7$XSURKG3N] MD_8F*8MON(LCQKE;XXH89Z;O'E2>@QD+'2T"3DTAX,00<&D^)=FS(X,$Y`H) MQ!6/(HMKY3F8L=/Q017;8%`E54*U546^Q=VK(F63?54N)462S\0122V&N%`= M!0).A@BXMEAJ!B0U0\28O!%C8HBQ.)NN$5$R1$3%T#W,D;X26&\(JS&2.REPP12S'$3^T:X6.(\%GO$+Y4 M:53#ETL0'SZI7,S0$+X,??B*8^'XE`DJN"*BXIC'/"R2M!R`1M/Q1SF,QBV-(4+*$#%EB)@R1$P9 M(J@,$56&B&J&YH`;457#4I,@J@P150=#6%,94@UKKD]\6*60B7/..A`(9!M.>B3JA35!V+,AZ3Z#?=N+RUUCIF16+@S]*L&&R+% MR1"A%T,S=1%LA@@V>2/8Q!!L<39C1&C)$*$50],U\ILAPF>]??BFKX^OA4^_ M5]Z&3U@J)U2;]4*@"Y\Q+,M+/&UI*JZMLG2O3O>5Q6D\;>FLB0ZC5VB&,538 MJ,R71'%H6S4SS>V4Z=#.*@=!>N%&DX/ZY;9"^%,Y4@U_KE/'WQ8T M[U]]^>GU9E$Q1+#)$,&6%LUP$5Z&""]Y([S$$%YQ-F-$,,D0P11#T_6^!A$^ MZQW"E\J1:OARG>+#IU4.[J'FGA?V+4CH;&?*?D14?3&6XAM60,287!%C=@G4L-S.$7`R1,#5T)X.52"2FKP18V*(L;98ND9$R1`1 M5!\-(P$%YB"*\ZNQ3F0II]$7'U?2F'BYT.$"+8P0014IUB1'CQ MT?G,R".!EZ<=@0N4V&4$(-RUN="#Y#!%^\2S6#X%.+"+XZEP1";I,A M(JV&I6OD-D.$5;RGKD-84_UBPCKOUI:YL/'AR\S?JBLOE(JON5=CP2Z^JC4%/*Q%DM9//$5XNXR>&(.;2?MD>(>;4)V(N;?F;)!DBYF)X M?'"00>UD<(N+N&N"*M+^-+B@2JI_C"HO)WLNF+Q:4D29B\)*E*&).*1A0TA# MAI!&#+'[5PVA@T#LM!0B\!FZ5TJY101>G,T8D>P9FC$B\&)HND:4!9JN$=8, M:Z^4HL7C88VOE$X.X?A?V")]2>!\DUXMPL=N(-)2:,%.XX)0,T2H&2+6#!%K MAH@U0V0Y0T2;(:+-$.%FB'`S1+@9WM3@;0W>U>!]#3[4X&.`81*E(LM,HK*T MY>K+3Q9A3M2SL)^$J+.9T908)"4&18E!4&+0DQCD)`8UB4%,8M"2&*0D!B6) M04ABT)$89"0&%8E!1&+0T#(OXLX33+\+$%(;'U*K->L%L4V%-A;45 MUE587V%#A8T5MJVP787M*^Q083<5=EMA=Q5V7V$/%?;H6=`K58:U*;=*OXAZ M9887[HQ>Q*`7,>A%#'H1@U[$H!AL2@%S'H10QZ$8->Q*`7,>A% M#'H1@U[$H)=E0:]4,QJ]7MQGK))#U#&S="Q@A!3#,ADAI!J>3R=)9_RU==9$ MVX*PQ4\AE&4(:1E"6X80ER'490AY&4)?AA"8(11F"(D90F.&$)DA5,[0[(6@ MLAI.VXT@ZK1QCIJJV,YU%+#]%I5V0B=T>O! MQDX;A*;2"YP50M,,S;O4D%0-D<6FE_"!;5"9?"&R^AX=(70O=CH8Z,X0NE,O MD%T-CXX0F4"^2`3U/3I"Y$:QTQ$B-Q@B-S+$#S5$;H@AML:`(3=2R5W-C5R+ M^]R0HMWGABW:-3?$,+WP:%0+#]6QCA<['2YR@R%R@WI!;JBACWSH!;E!OL@- M]3TZ0N1&L=,1(C<8(C>H%^2&&AX=(7*#?)$;ZGMTA,B-8J%+"!?9('ZNA%&7V1!L=,1 M(@L8(@NH%V2!&%:S()T,5;,@'QGYNX<<(_F)3U_`L%AE.Y\8XIN.HHH8R[`- M0+(4.[U49`M#I$N&IA>D2S$\T@O2A7R1+M_EBW0I=CI"I`M#I`OU@G110VSW M3!S"C17I0KY(%_7%S^=]D2[%3D>(=&&(=,G0Q!#IHH:UC6@Z!JJFBYP/E?/E MMXM59ND/:G08N*%D:'K$HB&&R`TU1"(P1"(P1")0DT@$-H3J9`C5V1`2,X3$ M#"$Q-0F)U=!+'.Z/D)A\(;'Z0@0C?=&JL5]8I-$WVRJSAH-`8CLJLX;8&=S6X M5VB:/"B;'D@;F4+!>Z-VQO=6V70L_KSOG;730-S7X(-"T\NCLO2D!=Z^G$3M M[F;QBR=*DT.4/C62/ONN/"M=+\30C&2C+!TAZW4T-0CII4EC">DS-$U">C:$ M]&0(Z=D0TC.$]`PA/34)Z=40-9F1+]0=D)Y\(;WZ8OX][POIBYV&#-(SA/34 M"Z17PYKTZ02JMH"G)V5QUR=L^J,<,]RPC8;JV=?,6*@N1UWI<'_VI2?$2`2U MP\_9;K4,&SSDAMJY]JZ"'=(EVYFQ(%UJOE=ALB*!R!4)5'.ERT!.J9V\[$$? M\(D,D^;+-$""49=(,&W*7NDJ?O,:$HQ\D6`U7QHN$DSM9+AG\3/?D6[2?!DN MLHVZ1+9I4VX^F#]Z#FM/.N:J)F`^_W(;SO/,_*N3`HW"R#8QQ#&Z3ABDEL)R ML($\4E@LD309FB:1-&*(OQ[1)I$B9(@4X1:1#PJ+-S(@0WS5B[:(#*`6D0'B M;+J&W&0(N<707#:T55BZAIH9FJZA)K4(-=6Y\AK*>3J%JDJ7CZ>\=)E-?SI6 MYO4JE$58.[*=6=ZAIOK:LHBR&`*+73H"F?N@5_&@.?4!R8E!\EJ_JU6H49`% MY(LLJ/G2F)$88N?&O%J%_3]RI=I>7.^0/S06Y(_ZEAQ'_I`A\D<,,1C-2.0/ M0^0/>2-_B"%_Q#F_61>F?CJIJN9//L+R^2/'6NX5O?,,?;*H89E5R`R!YL*0 M!N2--""&-.`6H3D90G,VA,`"3==0DRTA'34)Z=3024>&D$X,33>0CB&D(V]( M1PS2B7-5NG205)4N_2+N##/S;Z"M5J&&P=3/=F;5Q=07W_0W>_.4IFD$@<4. M)USIA?>+^%H9U*;6H38QJ%WKL3;IR1<)4/.ET2(GQ"Z=Q\U710L5TH3Z0)80 M0Y80P_PFAB0AAAPAAA0AAA0AAA2Q+$SN=,A4S9!\^N0GMYQ(F3?*D`X9^G00 M0W,GA/8"$4U=M2`W>4-N8I";6\3D)D-HRX804J#I&JJ1-U0C!M6(035B4(T8 M5",&U8A!-6)0S;*@6CKKJ:J6#X&\:IF9U1>B$<,<)@;-B$$R8I",&"0C!L6( M03%B$(P8]"(&O8A!+V+0BQCT(@:]B$$O8M"+&/2R+.B5#FZJ>N43':^7GO+, MTP1Z6>;;OD@'+Z;MZ50`+^Q>IC=!ID?&?UM,-F&Y%S8=,\^+VVH5RJNU^D[G MB\:N%,YA.*F*-<,I8\CEK;O4"RUYS:4Z%MI.-8MI>[K4B\L3>Z6YK/&]:*F# M"66N(#SPP96J'80T=J5N#J-)>VXSFG*E>3/NQR`;=&S4=?%#APPW-=C48%N# M70WV-3C4X%B#VQK"^!@\U>%.#MS5X5X/W-?A0@X\!!@G3MKPEE MCUP..*$@,0A(#/H1@WS$H!XQB$<,VA&#=,2@'#$(1PRZ$8-LQ*`:,8A&#)H1 M@V3$H!@Q"&99T"OM=:MZY4VPUTLVQF[&$8->Q*`7,>A%#'H1@U[$H!AL2@%S'H10QZ$8->Q*`7,>A%#'H1@UZ6!;W2QM/H]>*)]47>J7H=,_/O M0*IAF8P04@WG=R##$0!T+2:Z#$-8AE"6(:1E"&T90ER&4)0?R(NU4CW2$R(UB MIR-$;C!$;E`OR`TQK.;&1&.*K%O:#8Z74A-Q@B M-Z@7Y(8:^LB7LF@JO9`;Y(O<4%\?^>"+W"AV.D+D!D/D!O6"W%!#/\+P'B-R M@WR1&^KK1QA\D1O%3D>(W&"(W*!>D!MB6,N-RU#6SO>4Z1>AEA7F!> MH1GA05D887R/\4;MC.^MLH6/8?2]LW8ZPOL:?%!H>GE45GT1XA(97;VG3+^( MN9&,\<*#>S]6#$V/FX4P<[B)/!#G\C05:4`,69"9:0]9('8OO0/)OL@"]?59 M$/(465#L-,;(`H;(@@S-")$%:HB?)4_C>XS(`O)%%JBO&V'T1184.QTALH`A MLH!Z01:(876%"*=!986HG`%=RMF.3UI^!U+L3)B0&.*+(VX;IG`K1[(4.[U4 M9`M#I$N&IA>D2S$\TLN@=L87Z?)=ODB78J87F,AVVU3:BTR_BHB$G)\I.1JC4LY M9O(29VCT@,1BZ"5F"(D90F)J$A*S(20F0TC,AI"8(21F"(FI24BLA@BDD3@4 MO)"8?"&Q^GJ)@R\D+G9&8H:0F'J!Q&I8DS@=-AF)7SQ1PF,0>M(MS+\#*=!+ MKT=;Y?Z/VFH3T:H@`&^E#W0'I MR1?2JR_V[,_[0OIB9Z1G".FI%TBOAC7IL=.PTI?[??I%7,`S>_$=R,ML9^8V M)KSXOO0.Y&R7W\:[7/';#-I\R1]D!76)K*AUR:\ZLBORI.9:>9EAMLNCO3H] MN3;?G7)Z&K(`:27C+&-'5M'8D56U`51>?&1?9%7-EP:/K%([W.!+]JU"/8K; MB-K9ES#/XNM7R+UL9V1'[JFOFQWF@:@_V[Y,AUYF)2KIF$_#_,U&3LA,<;%> M3"V$3U`7ECY80*2S%Y\(W)J-!QA"YL^R7A.6TIO""Q]X*TPD][GX0DU-->Q M(%5+>S&]D0?9SN0+\J#FNSH/A]5(#?)%:M1\Z3J0+6(7KB-42DB@:GOQ.I!4 M-!8DE?J6#$!2D2&22@S=JW85B*0B;^04,>24M%A[U>XRG655EX-\R.67`SGX MT(P;MQ+FFW=5S9XW3+\)Z(,S$=+U@MJFPIL+: M"NLJK*^PH<+&"MM6V*["]A5VJ+";"KNML+L*NZ^PAPI[],S?>J_2J5!MKDV_ MB'KI$=)\0X5>EH6VTQ&":;ORCM%5/F5P,UK8BV]3S7982N85?&4^DCF,)E6[ M9C3S)N,JE\%^#,+<'ND\U-^X^-E,=QA(5F)(5F)(5F)(5F)(5F)(5F)(5F)( M5F)(5F)(5F)(5F)(5F)(5F)(5F)(5F)(5F)(5LN"A*F:K4J8RUPO86;N<]:N MB$$O8M"+&/0B!KV(02]BT(L8]"(&O8A!+\M"/%*)5XU'KOU\/+0>M).7&.)! M#/$@AG@00SR((1[$$`]BB`\?IH9N:C* M&/!D0@9PMM"9.9&`*9F7DQ#(&<[:3U4.TA MK+.%MHZP6N;#>OW<;OS_4W:N2XX;1QI]%84?P.*EFSW#T"I"N!)@-WV17D`K MMR3'RA[':+S[^GL^@FR"J#,K[1_,=!X4D/5E`D@`A>(9+*J[BVWQG.]Q\:*T M7E_6FST9::ZV1=OE=X/M=;U9V^YJNV];W!'WM_6FR:JWQ<]H'*ZKS+Z>']YL MMW"/5]MO[/)X6V_:Y=/R]W&>KVM,>UR(_[G2^OU4,M_E[L5V_YWOQ3A3"Z4O M]?;L\1>R3L;9BLAZ69&9+JZY@H87(U-,7(VH-AFY1%QMJ%9L$=7*+2)1N454 MF6]QH2O=; M1UL1[Q*FS$J[`1K\)&O`H;\2ILQ*NP$:_"1KSFMH4>J=!5 MCZETOS_0+^7\[?)._A8V]"ALZ%'8T*.PH4=A0X_"AAZ%#3T*&WH4-O28VQ9Z MI$)7/0*65YW)=E<"O;_8;AJAQZ4M_]PN[H]%&5XV1:*IZ:*@+,KPVVK7TR"J MO36]VE"ML*%:84.UPH9J<]M"M53HJMI4NM]GT62[5^UBNU/MTI;=SE1;U-(D M5M$4U2;;0K5%4W+M;;6K0JA6V%"ML*%:84.UPH9J<]M"M53H,]5^LPQ_/Y7T M]VI.MGLU+[8[-2]M[]1NTNMH0LO`"(=_6^UP9?EOCNB5D?6N%;2%K*O29K+<+YE2ZW\LW MV<[SU]_TVRU>8''1F-:;U7SHIVV7$^>0H45;,M3:6AE^76]Z^;U]^./BO1=" M7S9_JSP1NM@E0E\W=?>*^6EQCB&+K^M-N]P4OT2/^O-=WJF_67WF)F@"]Y>C MJRV_F'P-;7TUSJ6^VN8KME?C;,7N:IN_ANYOQMMN#E?CO`Z_VF9;'*^V^1:/ M-^-MB\]7X[3%A2HIT24GN:<%+%6Y%/GY&=E;3A93V5S;SH[5YFJ[?W%;C&E` MNVD?L[9H9_LM<_)M/=YQW?PK9I=`X6(?@]A0^'?M%]$OZ['?G"KX4ORK+_^; MH_^'RQ%.!.9[7$0@=P`:@5DG$F&W.6*:%NLB+;EBN3E MQ3A[68AJ16M4*VRH5FX1BIRUVN2%X6*Z)MN2)Y>3'>GRF+UFA7V-"NW")"E5M$ ME7GKA2JIXU65J<"_5V6RS9X:DH.%C8.UL*%)84.3PH8DA8UL*FPH4MA0I+`A M2&%#C\+V(K:3V/XDMC^+[2]B^ZO8OA7;=_>V1;QR@S"+U_E6=?/(E"M?_/#O M7S]]^,?A]>\__4QYM7Z;;6:SNMR>W)4"%QO7T%LMMELP$=W"1G0+&]$M;$2WL!'=PD9T"QO1+6Q$M[`1 MW<)&=.>V*;I?_OKSZ^NGYOM/WW_]U3]>/_[T6K_^\LNO7_SPX=__)#I/?#0_ MLW_Q\?7'__A#19;LSZE"9-[:O+%W8>>[XB5CPN3]^<<$I1V3"X>=;[F*=H]I MQZ1*UFZWA3%]CK%W*Q@CLI2EW70OO=S?XV;_'9.B2JM'&DWS]A1M'B#G`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`MC31@+8_GHC-Q5E@_-.,:4Y>,RCC%ER+R+UM8_9,[QH`R9=]': MVI&VN^2N,=)VE]PU1N[N]BR,(7/.9WQL7,86F7,NT';(G'.!,F3>16O;'S+G M/*$,F7?1VMHA\RY:&^,PV>58,<9ALLNQ8HS#9)=CQ1A2;J*GZ8*4F^2U70-@ MVS"[=L`>PNR\"WL,L_U]F_VQ<+9["K/S/(\%N"5V5F6;+&R;A'63V!HCK)O$ MR!CAV21&Q@C/)C$R1G@VB9$QPK/)L6*,PV238\58Y@!,_$R7S`6(UDS55^9\ MYH(+L^M?Y@(+LW,(\5LE?E:[P=9AYDMF3J1_ZDMFS@LS7S)S6ICY@F:I;=07 M&/<([DOF7(R>YF?#3)CINUW#J[0CEZQ='48N&6.;3^22]AV6\Z[V'48-[7TG M/U,3:=]AW`>X+\QL]Y3<-3\SXV7RTUA^R8!S,A/4E[F47S0@!Y7EEPW04QES MJN?:J(S'@+DV*B,./&W)I,&E+_F5"(X_;<=<]#E'*LLO1'".5)9?A>`:IRR_ M!$&>*TB>&2/%'I)GQI!Y$ZU-%V3.M5$9,N?:J(RTW21W M;9ND;>H>9>3NACI267YT-5K;.1*94VMH.V1.K:$,F3?1VOQ$YDVT-H;,J5&4 M(7-J%&4<)JE1E'&8I$91QF&RR;%BON1G<*.GZ9*?PR6O]1 M$R-C^8'DQ,A8?A0Y,3*6'T?.L6(L/W.<8^4S;`O3OA/;+;%51OQR'S`-6%B\ MC8'E//]@UVE8[@.F40EEN]0,^O:+=JEIU1?TY/FU,S3C'8,S-,MS,.T#+.=Y M[0,LSQ6U#[#4!=H'6&IA[<.)24LY9TV37RYTJ1AKF_RTVIL\R[7CP>[5:,<[ M!M\?NU: MC)2IEY0A9>HE94B9>DD94J8F4D:ZI\94AANY'O$]0EGKXT:N1\IP(_6$,GQ) MS:`,-U(S*".LJ:743\*:6DH984TMI8RPII921EA3+RFCVWD?L+5S.=W.^P!E M]'V5OEL[NKU*WXW1[=0VJ@O=3FVCC&ZGME%&MU/;**/OJ5^4D;:I7Y0=UPPH M8&'UQ'/8B[-3&`MK1[?SOD-UH=MYWZ&,;N=]AS*ZG?<=RNA[WFDHH]MY?Z2, MPR3OCY15Z\T3^;*QXP1@)9_B2FD^WB1O;^&+[(QWRCE;])!WRCE89Z<#X M"6>D0][?:CMR@C$NSN@V8PC6&ZM[Z#9C")S1]W7Z;NWH]CI]-T:W4TNI+G0[ MM90RNLUX#6=TF_$:SNA[:EK=)FG+F!IG1[[03]^M5GP.H^_&3F'TW1C=9CR# MZT*W&<_@C&XSGL$9W68\@S/ZSI@39W2;,2?..$P8<^*,ON?9[_29]^)XI^\Y M#RJKH@M]-UWJ,/INK`FC[\;:,/INK`NC[\8.8?3=V!!&WXV-81PKQNAVSCW3 MS-@+7>A[GGNK+O0]S[V5T?7ZH(S\S#VE,M(VUPYE;"[U[MKJ M9#:7FE8984T]O[;S/.U2ERNC7:X!Z@OID&N`,M(AUP!EI$.N`DRA+$P-H:Q,'8,8V'L.8R%L9ZGE=5A+*Q=$\;"6!O&PE@7QL)8'\;"&%+F?IJ/@\H\0\K<3RM#RAQ_RI`R M]]/*D#+WT\I(Z1RWRG`C.<''=:6?N)'[:66XD?.+,GS)_;0RW,BY1QEAS?VT M^DE8WRG`CQZTR?,G] MK3+2*,?TYUCN__A5%R@IR4#.^Y-=)1O2-D5'*$')4\0UZ4G"`G)16^5>I;#:F5 M-)!&20MIE7207DF%;Y7Z5D-J)0VD4=)"6B4=I%=R@!R<9+@O,Q=*[D`&)2-D M5'*$')4\0UZ4G"`G)0-#F`<=I3Q"1B5'R%'),^1%R0ER4E+A6Z6^U9!:20-I ME+205DD'Z954^%:I;S6D5M)`&B4MI%7207HE!\A!R?".,[F./A\AHY(CY*CD M&?*LY`7RHN0$.2EY?D<9Z%]A,DA_U#'ZSY"3DHK]5+J?&E(K:2"-DA;2*ND@ MG9(>TBLY0`Y**H91G_A!B?+8;OB`]:3?KS;O.%,P=WW99H2V)0,0BYTO'"-:16TD!:)1VD4])#>B4'R*!DA(Q**OI3:7]J2*VD M@;1*.DBGI(?T2@Z0006DD# M:95TD$Y)#^F5'""#$X9)'72DUP`9E%0,=:ITE%<-J94TD$9)"VF5=)!.20_I ME1P@!R4#9%!R8`J.@XXB&R"#DOJ!NYSIM]H6;X=ZR*"D0M%*%:TAM9(&TBAI M(:V2#M(IZ2&]DHJ>5MY32*VD@31*6DBKI(-T2GI(KZ3.<*_IM\N76D,&)=66 M^Y)I.K-%FQI2*VD@C9(6TBKI()V2'M(K.4`.2@;(H*3:DE4ZDJ7>\@Q%Q_[4 M&4JUM>1ACAFSY>11CA@WP>V5NUP>?X/+`W MPB\?\4C>"-_.\RK/"#]_PJ-Z(WQJC]=&^-H>KXTP+`1BHX48T0RQ,Q*?>^"; MG4,8]$\;(WSWACJF&U\?HHX1OB'D98:1%L('RO)D@4\.\LS&ULE);;CMHP$(;O*_4=(M]OSAQ%6"U$VZ[42E75P[5)G,0B MB2/;++MOW[%-`@8$VQN2C'___CSC`XO'MZ9V7@D7E+4)"EP?.:3-6$[;,D&_ M?ST_3)$C)&YS7+.6).B="/2X_/QIL6=\*RI"I`,.K4A0)64W]SR15:3!PF4= M::&E8+S!$CYYZ8F.$YSK3DWMA;X_]AI,6V0U##OMR#&6>^M M/R[L&YIQ)E@A7;#S#.CEG&?>S`.GY2*G,`.5=H>3(D%/P3R=(F^YT/GY0\E> MG+P[HF+[+YSFWVA+(-E0)E6`#6-;)7W)50@Z>Q>]GW4!?G`G)P7>U?(GVW\E MM*PD5'NDNF2LAI'@UVFH6@(P<_RFGWN:RRI!T=@=3?PH"$?(V1`AGZGJBYQL M)R1K_AI1<+`R)N'!!)X'DV#LQN%H,OT?E^C@$@\N8>A.`G\63>ZB>&9:.ATI MEGBYX&SOP!(#<-%AM6"#.1BK/,0C*$>F&I]4J]9`6$#T=1GXT]'">X749@?1 MZHK(5JQ[A4JO\DU/`AZ`##20H!.:GD)%;8HHM$=8&0ELS@'T3+&^-#E3I)>* M*!J&L3"A$EQ7K:ZUYQI(1TCH^<-R5ZT)@G4PH`#O[(S7B&9Z-X2^>UPBIL:F^<9TTEL*"W9BP?:[047/ M(6?^&:01W:!8]PJUJ:-XZL:V0VJUA[%[W"T6H[H/C^='SZBB%XR!/<+*B&XQ M&H5)]11.3-L`[@/;OUCNGBL7#8O&0 M[&[=_?IC_SKY/AQ/N_%P/RUNYM/)<-B.C[O#\_WT7[]__F4YG9S.F\/CYG4\ M#/?3/X;3]->'/__I[GT\?CV]#,-Y@@B'T_WTY7Q^NYW-3MN78;\YW8QOPP&6 MI_&XWYSQS^/S[/1V'#:/IM'^=5;.YXO9?K,[3&V$V^//Q!B?GG;;H1^WW_;# MX6R#'(?7S1G\3R^[MQ-%VV]_)MQ^<_SZ[>V7[;A_0X@ON]?=^0\3=#K9;V]_ M>SZ,Q\V75XS[1U%OMA3;_$.$W^^VQ_$T/IUO$&YFB+J??BINU;*8SA[N3(+^O1O>3]'_3TXOX_M?CKO'O^T.`[*->=(S\&4< MOVK7WQXUA,8ST?JSF8%_'">/P]/FV^OYG^/[7X?=\\L9T]WH)MOQ%3WAOY/] M3M<`AK[Y8?Z^[Q[/+_?3:G'3M/.J*)OIY,MP.G_>Z;;3R?;;Z3SN_V.=#'4? MI'1!\-<%*=N;NFS:I8ERI67E6N+O_]]][8+@KPNRR-&=V:&;E/6;\^;A[CB^ M3U"'&-SI;:.KNKC%H%VNW(!]]C")6^W]2;O?3[%2D)<3T.\/RU5U-_N.Z=@Z MG[7T*;A'1QYZ2G38/@54!,S`U--%EO\7NMI=TZ6.U@0$_F7"C3RH29\"*@(8 M-\QCRJV:^\QI*PJ,9:[F?:^M3[&*G!;KG+V+YRP0%2.,,_A%G*D.-6JH4D4P+T3MYD@)1,<)(ZJTVJ`Y-JD8Y$XL4E5_`78RPD%@T44@[.T5]TS9^ M!6H/'MXBQ0I3&(VT3::#O)#RR&OIO1B-`JLEXD%#,S#OW$'QX!C$PVI!#!F+ MBL_W8"43JY4F9%U8Z*/Q>3<^P-6%`6KY"TQ\]U856?<68@.,(3Y`+5HAK!G@ MB%95G$4-\ M@%I70E@SP*8(H]/FI$`L5*RPC'SAK>9B,R4W+(W(+>QKG(86CD##CT[#2?<6 M8M,70SRL7NHAK!G=HHI77^'$(*Y/"WTX0.O6\/&%4P/:DM>D#"P8"Q`/UX<-$BN;@%F29\8@G" M6HR(I9M0\"(]Z26D&,2YYA3+"O)ELE+#2@=A"4=DT\TH>`6ROB%!BGEQLEJ7 M0M70XKQ,U.H81D_!UZ6#.-%T+PE>U+"7D&(0)ZJE+"':XM)R^0Q26O%C5!W$ MJ88-S9S).VH8U*V7D&(0I\IUU.3T^DFDE!)+$*_5L#4YJJYAZ:>C#PTIT8I! MG*J6T)!5$@U]"TQ$T4%%N%)T$NHEI!C$.\\KUJMB]5XD2MQ3PU#OBD&<)]\/?,7(?:"T4%5CJ__^4,Z+ MH.VN>)V#'B)=JLLV4;B>PK0F3%/?)'JMR&&EUP#CBDMH;HX-S'<&!X$K357G MH&6`>H+L(Q5="8J@A>R<;P.4*$Q/NK0<5.LKLTE4,L*.'/3T?W^HVYM$7/O@ M0/050692>5:T7LO*KYR,1\KN(!"CL!U!83'T$E($93K7"ISIW`ESZ&FMBQ8: M%,HG*8R.'!8F*]7J)G'H@P/15P09%>-9X:+MITLJ,Q@Y8A2V(\A4@5W\$E($ M93K/RW`E9=A!H5:24NC(P=9*5=PDJZX/#D1?$929KKQ$5U*B'<1JQ7K5<:T( M2%'#3.=:+#.U8C4TENC*R:J7FG1+)P=;*V4F*RY"F$%%;3+3Q;7:UXK4Y,H) M3EQJ>4RLI&C:5341LZ9 M[BR:LX^V,>/.I=A!^$/UV1$4G7(DI`@RN69K&]1C4C1?!DXZM^JL5ZK?DE9% MN''9E+F&>MEX+[EQD9?=N$H(5))Z11YRYZJY1G^81JG=)H*1SY!&ZU6'[:MW M7G4H1D50*W:TFFOWE7.M/;+\/K[%1Q;3/$FWDWT0\XEDT2GF MQ:>?2[M-YAQ]7GIZ64O1)PC]1DS3C3IX$:U>0HI!G"G?!PS3:JF?!5WF*O<( M3+`Y8G"NR>[8!:_`U3@:N+9>322(AB7IPKWUP,U^L7W5KN.P1Q MJNGM,7@%JBY63#6&.%6^%1FJ>#9TN5;E'E4[B,U_F=RDNN`5B/J&!"GFQ8@V M?%>B#<#`7)$.<9:2[+U;5CS4)*,T$\4>FQ)GCY1$E(,8AS1?AH5JFD%AI.$F6AN*2<5P3U M$E(,XIUS:?:=2_5=.`A_(O5-STW!*R3#-R1(,2_.)Z^^"ZF^#HI&WDFHEY!B M$.^E9-GB%1'F9)T@Q+\:US:NU@;D($13RWTFHEY!B M$.\\H]8?'*1;J=8$\42E!^G@15GI):08Q+DB?$:M6PTGB;)07%'.*X)Z"2D& M\DD MU$M(,8AWGI'RZ_=O_8XNG4$'\3RE9VQJ&)+22T@QB%/-*WDKE=Q!+$]2R:67 M8A#O/*/DQ<*^L;RDYJU4['."WSJFU@+D8.BD;?2:B7 MD&(0[SRCVF5=7A4C?#>?+C*">.FDA^S@17GI):0_RS?AS5*T9.UG]O:;\?UP M?!ZZX?7U--F.WPXXQF)T#W<>MM_WKY?^`__4TC:W>B&#@K`L8#'/WX6EA<4\ MAA>6)2SFU9"PK&`Q)9!:EG/\^,!(>6I9H`WV]QPWM,'FF[-@I-CJXH64L#=K@ M7)VSH`T>N.4LR#6>;N4LR#4>/>4LR#4>`N4LR#6>T&0L-=K8EU#I;-=H@Z?X MN3;(-9Z9YRS(-1YDYRS(-9X)9RP- M:T8Y7,]]#M>K+(=K/ECT6U*9%;R]13\YR[IJ;M?XK$&VP=<9MWW6@F\P,"NY-NNJ1;1< M@7>PZ&\'9#_X=@'1OY_\M7]^>3@\?3RM MG5V7F]>_I\]_WPM/]X^N_]R^D_/_WO_WSX M^_#\Q\NW_?[U!`I/+Q]/O[V^_LC.SU_NO^T?[U[.#C_V3[!\.3P_WKWBG\]? MSU]^/._O/N>%'K^?UR\NKLX?[QZ>3@N%[/EG-`Y?OCS<[SN'^S\?]T^OAJ/=[_C-SCW?,??_[XQ_WA\0@:Y\V)#=9]OSV_/H?3IP^<' M[$$X["?/^R\?3W^K9;O+R]/S3Q_R`[1[V/_]4OE]\O+M\'?_^>'SY.%ICZ.- M.(4(_'XX_!%'OP?[AZ[=7A#NO[_[P M'37A_R>/#Z$-8-?O_O7QM($:'CZ_?L.OJ[/+ZXM&K7YY>O+[_N6U]Q#*GI[< M__GR>GC\O\*I%FH_BC1+$?PM1>H_71:UY!N`OV79F[-:\^+J%ZI'H\TE\/>7 MJ[\MR^+O?UM]#3N;UQ]^_/(&U'#DB](6@E\^`K4KBN#'KV_"-4OCQW][%.IH MH_E^A!^_O`EUML/PXQGVJO'A_"^<9_>E3TM]:K%'FQ[A M!`FRG11T4]!+03\%@Q0,4S!*P3@%DQ1,4S!+P3P%BQ0L4[!*P3H%FQ1L4["K M@'/$\AA0Q/"7`AK\0T`9BA:!1;B>1(\>+-))03<%O13T4S!(P3`%HQ2,4S!) MP30%LQ3,4[!(P3(%JQ2L4[!)P38%NPJ(HH?^[9>B%_SS"U/E=&S&X6H5/C7T MWD>GJ]BE?70YAE1(5TA/2%_(0,A0R$C(6,A$R%3(3,A,80>UU"Z=WPWQT.8992%=(3TA?R$#(4,A(R%C( M1,A4R$S(7,A"R%+(2LA:R$;(5LBN2J(P8[A6#3,OH0'GT6046B5!E_YV?-M' M)Q;K".D*Z0GI"QD(&0H9"1D+F0B9"ID)F0M9"%D*60E9"]D(V0K954D4/`P2 MO>`%'`>O(#6[@K:%=(1TA?2$](4,A`R%C(2,A4R$3(7,A,R%+(0LA:R$K(5L MA&R%[*HDBA0&Y%ZD`HXC51#<3/`,:@OI".D*Z0GI"QD(&0H9"1D+F0B9"ID) MF0M9"%D*60E9"]D(V0K954D4J9`YT9N-LVNG+TJ4I?QUL]/3I1>B9D+M*+HT]5^B:67AZ=*+T2LA;IS=&G*GT; M2V^/3I3>54G47#!BK3877C\#CIM%01JA&?&N]";9I7;I4VD:3JGZ=1*_;N%T MU79\E>K:2JM52U^9FJME%55\W;1EK5KEI5U-!J M&%E[+2WG<5,K4:-Y#'>;J-*T2G1C7MT2U2[-K4>WJZ-87\4&]#*QH2,VHIN) MC55L0B\3FSIB,[J9V%S%%O0RL:4CMJ*;B:U5;$,O$]LZ8CNZY6)Q%$-*I')Y M87]1*U(EN'UBE],J43.Z+%Q?Q%U5V[Q8L%,B7+%"ZJO6:-Z<)1U-UUQ8JJ=" M?44#*YAK-V\:9TGF96@NU!ZIT%C1Q`KFVI>7U^EV3\V%VC,5FBM:6,%<^ZI1 M/TOR?4MSH?9*A=:*-E8P:%]=U&OI6;TU%VKO(J&XC83$B]=&BH1,U$8*A#9" MW79(7N/24T&=$J%!T*NKJ*<%^XH&6G"H:*0%QXHF6G"J:*8%YXH66G"I:*4% MUXHV6G"K:!<5C`,8DBI>`(MD2Q3``J&KMF%![2(YI=KAV0)BVK!NN4-4##.O M&F?I>-$<&/0>D*%D3EH#OM-Y9FI_"*R(37BC9$I7#M,MWFK7E0>D>42\B MEE&@Z")>(MOD3JU$=MGJ*NH16<&^H@&1:0T5C8A,:ZQH0F1:4T4S(M.:*UH0 MF=92T8K(M-:*-D2FM56T(\JUX@"&7(P7P#)'4[U^%ZA9S8C6+I+3M(V'N=)= MERC<9/[UJ7'33"\G718JGMZ&AU,](KL2]!4-B`KIYC4>4,;CB:%YL#F/B$QZ MK&A"5&[U=3T]4Z;F0>D9D4G/%2V("NEZ3>X%EN9!Z1612:\5;4K$L5*S>9L> M[*VY4'L7"<7M(V2`O/919(:B$[Q`:!_4;8?'O^FUNT06ZBZ]#/6(;&?[B@9$ M5G"H:$1D6F-%$R+3FBJ:$9G67-&"R+26BE9$IK56M"E19:RS5;2+"L8!#(DA M+X!%PB@*8(GPYWA+?WN=G%#MVM&+8>Z4J-*U=Q7U%/55:Z!>0T4C16/5FJC7 M5-%,T5RU%NJU5+12M%:MC7IM%>TB%,[.+M-1GH].E@C[RL:$+U;V9!>164US,:YC?Z+>_X1 MW:WJL:()T;M53^EUW,^XKAGM5M=T9[7%3?"D-GQ&F&1\8D:89DFLJ%,.SPR3:\,);+K1Y=>UI'VB&SG M^XH&1*8U)#*M$9%IC15-B$QK2F1:,R+3FBM:$)G6DLBT5D2FM5:T(3*M+9%I M[8ARK2B`B)`;P)S'";@27>':;;U(+4W=E%[5NSHBC.J/!;47H5=Q4W)Q=I/D M*WMTL`;45S0@>K>R(;V*RM"+U"ZJ_R67NQ'=K>JQH@G1NU5/Z77ZUHHV1._6M:5745?CK)'LV(X.>65Q*WPC@5C7 M!&*)T`HY\FB7*&IR1<'J8(1>5K!'9'O?5S0@LO3HD,BT1D2F-58T(3*M*9%I MS8A,:ZYH061:2R+36A&9UEK1ALBTMD2FM2/*M>(`OI'="Q,;T<,C\HQ6JT1A ML'KL#6ZOD\M;FP5MLSLEJMQ:=!7U%/55:Z!>0T4C16/5FJC75-%,T5RU%NJU M5+12M%:MC7IM%>TB%,?TC81?71-^)8HO#3+`++VB\[3,`19]1K-VG=ZH=EG( MFF&/R-I&7]&`B-)-R0J8!QOGB,BDQXHF1)2NGR6/PZ?F0>D9D4G/%2V(*%U+ MGT0LS8/2*R*37BO:$%&ZD284M^9!Z1U1+ATW#UP-O*%?/?#DE"]0U&<7*&H+ M);)(=TNMAJ$>D>UK7]&`R`H.%8V(3&NL:$)D6E-%,R+3FBM:$)G64M&*R+36 MBC9$IK55M"/*M>(`AHR<,W8/[S:D`2Q0?`.I0[\RQ651X]0\*#TC,NFYH@61 M22>S&I;F0>D5D4FO%6V(>*POT@.R-0]*[XARZ;AYA!R=USR*W%UT22\0F@=U MV_4"51_8$=E]25=1C\CVM:]H0&1:0T4C(M,:*YH0F=94T8S(M.:*%D2FM52T M(C*MM:(-D6EM%>V(A.(`A^^8%L,C*16=@@?",S@(H MJ%,7U%744]17-%`T5#12-%8T4315-%,T5[10M%2T4K16M%&T5;2+4!S`D,RJ M!+!\Q^O-:9?U(OD5!;9$Q:`-$R^3ZV>;9>S4[93H/TR]-"\VF9ZBOLH/S*MR M`W>57,:&YD7YD:*QRD_,JRJ?Y!*FYD7YF:*YRB_,JR)_G8S?E^9%^96BM*!=HO?G8]*ITF*(,(`[WI-KAJ[TXI3, M^C5R/'$*O$>ARIQ,(JMN0/1N=<.DNL;557K#,J*0539W.!5U1R*I;$UEU&Z)WJ]O&U5U>7ERE,V!V M%,JKBUO@&^FYAJ;G2E1)O+6);)L[):K.TBQ1-$N3;G:'TU>Q`;TL=S5TQ$9T M,[&QBDWH96)31VQ&-Q.;J]B"7B:V=,16=#.QM8IMZ&5B6T=L1[=<+([B&SFZ MAN;H2O0?9FF:%WNQ3HDX\Z"6=JQ=0M=13TMV%TT()+12LMN%:TT8);1;NH8!S`D$*K##@Y$1O=L02PS+;A MS_&2KW,TRX+5-!U1,2+5&5%=E=T2Y M=-PT,#YPFT;@R2BR0-"B;CN,*.$5M8,2V56K2R]#/2+;U[ZB`9$5'"H:$9G6 M6-&$R+2FBF9$IC57M"`RK:6B%9%IK15MB$QKJVA'E&O%`7PC'X?DN`2P3+Y5 M9WWH),VR8*4+[Q"5*<2+6GH]Z9H'VT:/R'(/?44#HD*Z<27#W:%Y4'I$9-)C M11,BYE2;Z4DX-0]*SXA,>JYH051(US$C/9HHD-R,+\V=]:R(K)ZUHDV).&YJ M7EZE^[`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`^;FCPL476V3XFB M-E84K(XXZ&5W2#TBV_F^H@&1W;`.B4QK1&1:8T43(M.:$IG6C,BTYHH61*:U M)#*M%9%IK15MB$QK2V1:.Z)<*P[@&[D]].72;Q3H/\S09$';[$Z)T'FQ*^DJ MZBGJJ]9`O8:*1HK&JC51KZFBF:*Y:BW4:ZEHI6BM6AOUVBK:12B.* M>'(Q+U!\+9!19+/PBL[3$A5=1K-QDZ:ANBQDS;!'9&VCKVA`1&EY)#4T#S:H M$9%)CQ5-B$KINN3EIN9!Z1F12<\5+8@H74O7I5F:!Z571":]5K0AX@&1:^K6 M/"B](\JEX^81,G25>\CC6*_(W%63`,T"17UVF=^S3>Z47D@[L/:NHAZ1%>PK M&A"9UE#1B,BTQHHF1*8U530C,JVYH@61:2T5K8A,:ZUH0V1:6T4[HEPK#N`; M*;^FIOQ*%-\EZEBO3`S:$+53%L25/SQ#:F)9E60F1]<\&/4>D>GT%0V(*"U/ MOH;F0>D1D4F/%4V(2FFL"I[,1)B:!Z5G1"8]5[0@HK0\+%B:!Z571":]5K0A MX@'!2T[QF'EK'I3>$>726%K\,C:Y('#:+E$_4_Q?HLIHXK-\F MMR+MLB`6TJJF%^V1<[01E]5,0UC%K:@\Q_'8I$35?8M0+%N]_RWW#6GY/'-> MUJ!WPMCY,"!*=B_I,MKTBG?/NL-X.ZHW1)7=T_NARP)%NU=%L6P8>R>AJV'X M8FG?RV)T7HU>B9+=L[CDQZ5-KWCW[-XVWHXP[+/M.$:O&`U&E1M>8M6#-0\CSL]!/J`5=?Q:Z"[7@"I"%+D(M MZ.:ST%.H!1_C^*WN\!8^TI%W/,EVM>H9%CE7G58CP[K8RG]K9K_AX*FAU<06 M.1R7Z"QTW%H"5^HL]-]JP04["WVV6G!5SD+7K19@#4O;M6"HE87KJ6XUQE-9N*RJ M!<.J+%Q=U8+151:NJ&K!+1+BXVTU[I00'\^"&R;$Q[/@K@CQ\2RX.4)\/`ON MD1`?S]*"I>5:VK"T74L'EG"?H7N*^TP<-\^"VTT<-\^"NTX<-\^"[!C:@7?J M("^&=N!9D/+`%GBG%1(8B()G03H"1]2S(+F`UNM9D"K`%G@69!X1!6_;D(#, M0@I*CQN2CHB/9T&V$5O@69!TQ/GC69![S$)Z2NM!VA;'VK,@7XNCXUF0MD4; M]2S(WF8A/:?U(&.+UNM9D*K%L?8L>-2"K>!<]5$`7/TD(] M+;>>-BQMUX(T>]9Q+4BMH\5[6XVD.MJ;9T%N'2W>LR#%GH44J1XW/`'#T?'V M!P_"T*H\"YZ'H55Y%CP#0ZOR+'CXA5;E6?`,#*W*L^")(K;:L^`I(EJ59\'C M0[0JSX*GB&A5G@4/$]&J/`L>(*)5>986+"W7TH:E[5HZL'1<2Q>6\,Q,X].# M)3PZ4PL>P2+:G@6S2[(P(4'+8)))%B8AJ`4323`V\"R8&)"%Q_Y:!H_YL_`0 M7RUX:)^%1_)JP2/X+#Q@5PL>J&,+/`LF_&1AXH>6P;R?+$SV4`LF]V`+/`OF M^&1AZH>6P52?+$SW4`NF\&"K/0NF[>%8>]<2S-[#L?8LF**'/?4L+=33BV8<96%B;BJ`73LA`YSX+965F8EJ-E,$DK"U-QU(*96(BV9\%T2\3' MVQ_,ND1\/`OF5B(^G@53+!$?SX*9EHB/9\%\2L3'LV#.-.+C734Q=1KQ\2R8 M'HWX>)86ZFFY];1A"5,D];AU8`G3(M6".;&(CV?!U%C$Q[-@ABSBXUDP#Q;Q M\2R8[X[X>/N#:>^(CV?!U';$Q[-@ACOBXUDPT1WQ\2R8S([X>!:\NY*%]QKT MZ.!]%<3'L^`U%<3'L[103\NMIPU+F)ZN]>"%!<3'L^"U!,3'L^#M!,3'L^`E M!<3'L^!%!,3'L^"E(AQK;W_P;A&.M6?!*T99>+E$]P>O%2$*G@5O$R$*G@4O M%>$L\2QX42L+K]=H/7@Y"WOJ6?!.%O;4L^#5++1$SX(WM++PYHW6@[>RT$8] M2PN6EFMIPQ)>.E*U#BSAW2.U=&'INA:\TH9VX)7IPQ+>1U(UO+"?A9>\U8+W M]K/PKK=:\/I^%M[O5@O>T<<=O6=IU:]A\7IEO`.:A=U:.K"$]6)T M3[%>$(Z;9\&R03ANG@6K!^&X>18LMRP>!SBXUFP;!RV MP+-@]3B+\>%8>Q:LNX>CXUFP_![:J&?!*GQ96&9-Z\'* M>VB]G@5+[N%8>Q8LH)F%-195#8MF9F&I1;5@N4QD9CU+"_6TW'K:L(1U[%2M M`TO'M71AZ;H6+)6(]N:I8<5$M'C/@H43L[#4G6X!UC7-PLJ6:L'RIEE8X%(M M6.4T"^M-PLKHJH%J^QF86%4M6#5!:LF8PM\"Q8NQV1\[8-2[@C/IX% MZ[1C"SP+EFM'N_8L6+4=K=>S8&EV;+5GP1<8<*R]:PD^Q(!C[5GPM07LJ6=I MH9Z66P]6W4>K\K:@`TM88%W;`5;81^0\"Q;:1]OQ+%AO'V>69\&B^HBV9\&' M,Q`?;W_P_0S$Q[/@*QF(CV?!QS(0'\^";V8@/IX%G\9`?#P+OGZ#^'A737P$ M!_'Q+/C0#>+C65JHI^76@P^>(#[>%N"[)XB/9\'731`?SX*/G"`^G@7?.D%\ M/`N^:(+X>!9\N0CQ\?8''S!"?#P+/E*$^'@6?*L(\?$L^&01XN-9\%DBQ,>S M;)"HQ[>GM/%ND:=W#3OG$!S/@B]/(3B>!5^70G`\"SXR MA>!X%GQK"L'Q+/B>%(+C66:X+W-W9XXDO6M8($?O&I9(T;N&%>[P7,,:"7K7 M,$!^WC4,D9YW#2/<>;J&,9+SKF&"W+QKF"(U[QI:R,R[AC82\ZZA@[R\:^@B M+>\:>KBW=@U]).5=0POY=:];[.#*[26]!QBA>'R"D9C'%Q@Y>7R#D6C.SX_/ MN%X^??AQ]W4_O7O^^O#T'[Z&F4+%/UX//\(704]^/[R^ M'A[SG]_V=Y_W^"S+!>9KG'PY'%[Y#YR:YW\?GO]X^;;?OW[Z?P$```#__P,` M4$L#!!0`!@`(````(0#(*N9''Q<``%]I```9````>&PO=V]R:W-H965TR?]\\O#Z>G M#^>SBZOSL_NGN]/GAZ>O'\[_^Q_%WV[.SUY>;Y\^WWX_/=U_./_W_'KY+TX_X)DB^GY\?; M5_SZ_/7RYWG(='C]\OYU=7Z\O'VX>E\M)`]_Q4;IR]?'N[N\]/='X_W M3Z^CD>?[[[>O*/_+MXZOF'N\??[]CQ]_NSL]_H")WQZ^/[S^>S!Z M?O9XE^V_/IV>;W_[CGK_:[:\O1/;PR]D_O'A[OGT@%SEV-!N<[O+M]= MPM+']Y\?4`/G]K/G^R\?SC_-LGZU/K_\^'YPT/\\W/_Y$OQ\]O+M]&?Y_/"Y M?7BZA[?13JX%?CN=?G>J^\\.(?$EI2Z&%NB?SS[??[G]X_OK?YW^K.X?OGY[ M17.O7)*[TW?DA'_/'A]<'T#5;__UX7R.'!X^OW[[<+Y87ZRNKQ:S^>K\[+?[ ME]?BP:4]/[O[X^7U]/B_H]+,FQJ-++P1_.^-P-Q/])=>'SEX_9N+V?)J[;+\ M23)TSJ&L^/\O9?/.Z^-_R>:G]F=P\Y"!^\&GF*DS?E*R&>H[IE0__MP%,_&9 M^T%*]U><,%M+5OA!"GEUL9ROKF_^0IM=CNT_])O\]O7VX_OGTY]G>!C1PB\_ M;MVC/N6=5]H8 M2K'&5C1GESL'#ZF&,PK$Y>Q6B1]-G-J/53 MWT\JD^^)[(@41$HB%9$]D9I(0Z0ER(%$1*(A61/9&:2$.D)7(@E#$GD/,YOE/8=C[XT$L[/X M2]:]M[#L?>&\ELM1Q6!LO9 M>I$,M-M18ZG^S4>RP.`^#1++=9)L-RE)LQ1$2C)=33IJ>I4./_M)24S71!HR MW4XZH>E%/&4<)B4Q?232D>E^)&Y1/#EDM=+9*&H9%[@%RS<9%1R.6V8DKF6D M+-L1A4TQDJ@I5NGB;C!^4A+3-9&&3+>3CII> MK99)4TQ*8OI(I"/3_4B2IKB>3$=-@;5#V!1^)7UQ[=KQV\/=[YL3FG,VK4J< M>MQ$(YFMQGC-K8JW(PJ;:"0+3-%3YUA>KZ82#7[<34I2V8)(2::KD5QK#]D3 MJ8DT9*<=253$U2HIXF%2DB(>B71DNA_)'`/55/O5ZF:J?=0>+IH+&T2>C8'' MGO=HALDWL)N,05M)>#T]0KE'"VVR':."4]%"/;6_K),HN!:MR-:-]M:ASHUH M:;E:05'"M,X'K^7K/%]D!N;$,[K)!8WMHN^K,8>H[*H ML4>$QI;VW[J=$@QWX4@F2+5V'J%*DK`0+:U"R:@2I+;V@L8M*S>:UH)4JQ&D MYEM!JG7P*"C74;0T8<>H%S04(G:G"[(L=X[!5^3.$2VBT6F=1%%;MZ$$#R]T MW9\+6H]/Q6)QH5/7.%&HACJ<[)2BI:8K0=%(O-:N,YC?JY:8KP6%E9GS0T&% M:"7A6)GYMX-&P'^^8@5'#"DE$E2&WM&=6"M%R-('50*TAM'1@=!6G"CE$O:+`5N].% M:I8[QQ`NZO\C2N:.9(&W=?L0Z0CCT3BPK=<7R3.SDS0Z1A2"]+DN&56"X@D@ M&7[WJB7]H!84#>W<_:DNK20`TRSV MY3QH6C_@>,OZK!>21LV4C"I!:,)@!90LR_:J)7VR%H21;DIHC/^^7%J(5A+Z M\9_FLH,J2&9'06JF8]0+&BW?7&@MX@9SP6#08+\*\+`#1Q/#B**)P2,M8NX3 M+M]-T\>.4>'1:CYIE1X%2X"*$^X9U1Y=:XX-VVHYX8'1T:.@7!W;Z@49$X.+ M\0(W3V&;C_W"YX("Q*W;14YG@1%=7X^KH)OE33IV[GPJJ$C7*3Q:Z2!0LNU* MM,+A?+76%81?!HTE6&G1:TF(=<[/'@.J3>L3^MK,KZ]F%TE$<5`5JD)\)PN$B>A(PU)M--/!X*>11D,N64>[1;*4=<&>PPK-WNH`IV5HE M*=?J[[W!ZHFI5QHVUXI:4+B#P8Z>!87KV%HOB">$^1O1],`3KXX!MEM=3;UG MM4[ZP582:J_./0H&H!VC@E')MBK6VC.J&35LJV6M`Z,CHXYM]1[!.>C^<;]] M(X2=3Q+`2IG9)1)2A<="X6212T M5RTQ7PM2\PVC5M";)3^HAI@^"E+3':->D-'I7:`7C/:_FE3G8V"(ITB*L/$H M7&P*TE+E@G2ZW#$J!(4#S)AC,()5HJ6V]HQJ06JK$:3E:@6IK0.CHR"UU0E2 M6[T@P\TNL`S<+)/J?`PX(W>.*%YL7J<[=3YAL-3(!2$.F08EWJGS6NO%.!N_ MNZ&HK!!#.AF4@G255`GZ:79[T<)Z7ZS>)=NQ!S%D-:Y$Z39]8)XU>1>480-_,OGR.DGD\J(@KEA.UB-]Y0\6NH6 MWK85B_(<+,+ M68/GB-S\C]./\"6/>U.1NGE$6`#+"+;U6@'*&>T8%8Q*1A6C/:.:4<.H971@ M=&34,>HC%$_4+OP+W#P-5V-8&`U7(PI\MYT3RAGM&!6,2D85HSVCFE'#J&5T M8'1DU#'J(Q2[,XE<)W=RA#H?$79$M7<2REEKQZA@5#*J&.T9U8P:1BVC`Z,C MHXY1'Z'8G2XJLWKG&*U%O7-$>B!B?IWN6\XIQLL]BM[#\Y$(U9*F*AB5;+Y2 MK6!.I&,1JB7F:T8-FV]5*S2?+%,/JB7FCXPZ-M][Y,9HG='?.AZ!4X!F4PT\ MGOX\BDY(>!:L_7*/HK;A,Q*J);4K&)5LOE(MK1V?DU`M,5\S:MA\JUIJGL]* MJ):8/S+JV'SO4=(VNAT2/4:+)-ZEN30Y,#'H)VWFX^#PR(17B]IL5(M.)/"A M"9\06E+K@E')YBN/PH,3C&I&#=MJ/8J*RHF34L?G>(S?S!@^/;AS$ M#?1&N.SZ?K*H\2C>D%BEX;(DU-57[E%X@()1P:AD6Q5K[1G5C!JVU;+6@=&1 M4<>V>H^,#0G7S-9,,O"DJ_LP--YI3,,RGS#J_$9"#LM\0CU`@4\+IM=`PRYF MP;9+1I6@L)R4W5ZTPJV,U75Z@$*T(EL4EHF6/K>MH"@AA65>2PY0K&[HT,A1 M#*GMCE$O2'9.)L?%C],;,;B+M-/':43AEH;7BEJ6M'9>*SBH4'#"DE$E2/=5 M]H)T=[06I%J-(/50*TBU#AX%Y3J*EB;L&/6">$L#0X;]['!D.Z@BC(6_=-2C M`Q2BI8%9+FA\,X2]-GISH!HR$A>"U$[)J!(4C<37R0OJO6J)^5I06!E^@29: M6HA6D'^!]FZ1O@T\J(;D=A2D=CI&O:#1]%OSO0M\C67S8@R(PV6S1V@P*,`7&RF9V,[UN?,!IA?,)Q8%LON?M/"M)0!9LI&56"X@D@"1+VJB7F M:T'1T,YS@B^7#BZM)!SKLJ*Z'%1!,CL*4C,=HUZ0'_[7P0NY>`)X(PS')BI- M`".*)@"/M"RY3Q@>H&!4"-*$):-*D([V>T:U(!W:&T%JOA6DM@Z,CH(T8<>H M%V1,`&^$X0L.PSV*)P`Z0"%:^D3F@L:!;;E(%T4[59!.4PA2,R6C2E`\_B?/ MY%ZUQ'PMZ!?C_^@$>$\2MI+0C_\W03<=%G@'59`T1T%JIF/4"QHMWP3S2M3_ MW?@33@"_"O@&_7@D\RB<&`1I$7./P@,4C`J/@H,*)=NJ..&>4>U1>("";;6< M\,#HZ%%0KHYM]8)X8L!P$+E9=OL&GKAS#(R#(7_KM0*4>Z0'*&;T&*B*=)W" MH_``!=NN1"L+<.CSF,#X*J2'9' MR4Z'M(YM]X+\3!!:CI^$-R+K)4?6'@7ML664>Q0=H#!8X5EP1J%D:Y6D#`]0 M&*R>F'JE87.MJ(4'*`QV]"PH7,?6>D$\(Y1\$`M&-4,"K95L5:>T8UHX9MM:QU8'1DU+&MWB-COV()?X4C^#2T M.)X,+2-RP]3T?*[2S_JV@\'XLP!!_ADR#E"HAC1+(4C7$B6C2E"XZ.0#%*HE MYFM!:KYAU`IZL^0'U1#31T%JNF/4"S(Z?1(&_W)2Y?`8[W)=ZZ&II%1;05JJ M7)`>5-@Q*@1IA%0*4EN5(+6U9U0+4EN-(+75"E);!T9'06JK$Z2V>D&&F]\( M7I<2.L^N:'?R*(:TSIT@S:X7 M9*R:7,08[$[\\CD:(\QH4AE1,#=LEQYI$7*/T-7D:=MY%!Q4*$1+IYZ2;56B MI;;V@G3SH1:D6@W;:EGKX%%0KJ-H:;DZMM4+,MRLO!:`8#CE<2'H5'$ACE MC'81BC,/0Z0@\S$<"I]IA"_.&?%@?I.^=K&T:.3.O=9Z/AQ]FU_A>PQ]\S;X M?B>&AO$B+G(8,@1%YH@!@:,OLO3S+:/<(Q1&M':B960>KJPQ5+M+HMQQ$^N[ M]A6OMCU:A^NNU4WRMF?KM=SZ?GJ&5S?)CGBN6EKN,4?WJ5>2TX`7BUG]"V:&!HFL+C(L#U-3=[[L]6;%PO@ M97CZ_'H4SDP>!=-0[E$PW.]$:QCNXT*%"R*C4'X<1R.-E]6-EXX]WC]_O=_> M?__^6L2380X1W+`FV$N$=2X(=17C'DF`G"O6Q'GKL*Z%-+0EVB5`"2X*-?DB& M#8!DR,%^/\IF2;#MC[)9D@U*O3%+C>UEM)Q='SS;I@0[R:BIE::$Q.U?IC>0O&;N]1]+&DC<6T"6 MX)UKYM[\L01O5C/W`I`E>,&:N?>`+&D6*^1C3?XXVH!\+`G.+R`?2X)C#,C' MDN`T`_J!)=F@;!NS;'AYGFU-20[)SI3@37GF7LYR3?'"/'/O:%F"`TFHC[4T MPKDDU,>2X'@2ZF-)-JCIQJSI%A)WY()+@#,QJ(\EP<$7U,>2X/P+ZF-)<`P& M_Y@5#;]AA/F:!_+HSAH MGKDSXYP/CCG#;U8^.%\+B64-7V#!FC77XT.LS'TEQ/G@>RRLQRW)9HZY9'QO ME,RG&Y1Z8Y9@"\G6E."#@,R=[><2X#@ZVL>J:8Z:NO/+G`:?!*#E+`F^J[;+);@VSFTMB5I('%?:G$:?#:7N0^V6'*`Q'VWQ9(-)!M3LH7$ M?:G&:?!)8I:;DATD[KLU3H.O#^%K2X*/$#/W%1NGP0>V\(&UKL)WMO"!)<'G MMJBI)<$WM>B)E@2?UJ(G6A)\88O^9DDVD+A/9+G4^'H9?K,D^(@9WK$D^%(9 MWK$D^&`9WK$D^&X9?<>2-#,\V^-N6_*4X)H#>,?JU[C*`-ZQ)+C1`-ZQ)+C8 M`-ZQ)/@@'O6QGP6,2*8$'ZNC!%8:W#>2N?LOV->X=B1SUV"P!+>/(-:W)!N4 M>F.6&K=69(.R M;2X)9$ MU,>2;%#3C5E3W,F'^E@^P-5\J(\E*2!QE[YQ37$-'^IC27`;'_J;)<%U>^AO ME@0W76;NVD3.![=;PIHEP8V6L&9)<(LE>I4EP666F;M2D?/!!9;H;Y8$MX7" MHY8$-X3"HY8DAR0W);@<%+ZVTN!.4/C:DN!J4/C:DC08#JR56(NAW]IA:V\R MW#3,M6\QC5EV.DP4%L=5LRBK->+BXEBTBB7!-;#HYY9D@T':6LEL,$1;N6\Q M0%L\QR!LU3J_R7`K--'IY>S[_1>\=;@:WIX\CW\@9_SE=?QR_^RWTRO^WHW[B/_L M&_Z0T3TN#KVZP`N.+Z?3J_R"C"^G/XWT\?\$````__\#`%!+`P04``8`"``` M`"$`^%]"W_`(```_)```&0```'AL+W=OWMFZN]U-OMIA.JNNQ>:JO+_?3_WY- M?]M-)VUWN#X=SLVUNI_^6;73WQ_^^8^[]^;VK3U553>!A6M[/SUUW6LPG[?' M4W4YM+/FM;I"\MS<+H<.?]Y>YNWKK3H\]8,NY[F_6&SFET-]G4H+P>TS-IKG MY_I8Q?SLVEU>8>*S/=?=G M;W0ZN1R#XN7:W`Z/9\3]PUL=CF2[_X.9O]3'6],VS]T,YN;241[S?KZ?P]+# MW5.-"$3:)[?J^7[ZQ0M*?S.=/]SU"?I?7;VWH_]/VE/SGMWJIS_J:X5L8Y[$ M##PVS3>A6CP)A,%S-CKM9^#?M\E3]7QX.W?_:=[SJGXY=9CNM1AR;,YX$OZ= M7&JQ!A#ZX4?_^5X_=:?[Z=*?^;NUM][XZ^GDL6J[M!:#IY/C6]LUE_]++4_9 MDE9\906?RHJ_F6V]Q7ZY_;R1E3*"3S+RX4-AN7<=GTI_-_-6B][O#WS%$N^' MX?-3C]DK?7Q^XC%SF=]^7N)#=WBXNS7O$RQV)+!]/8C2\0(/\ZEF1&5UF",L ME:-0_R+T[Z=P$LEO0;\_>(OUZF[^';-^5$JA0\G4B$A#S+RP&]L@L4%J@\P& MN0T*&Y0C,$<"ABQ@@?Q2%H2^R`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`\BLLS%H@/,1@2X*9"H2C7(()PO=>+@F^$/O25X1E*\079;V# M-O=AR/&$HF$`N`2Q)( MQ#K@$I1(()8#EV20B%7!)3@!$;T[+3Z\=B4@\GUX[9)@TX=O+@EV=OCFDF"# MAV\N"?9Y3+Y+@HT<7KLD(>()G?&@'8'7KDC1E(=XN"-&9\>>@9PXBIP2MB/`]$S()G?'@K0Y>NR+%RQV\=DGP!@>O71*\R,%KEP3O<_#: M)<%%#+QVKA`/U8@77!XI+AW@M4N"NP=X[9+@@@%>NR2X9X#7+@FN&^"U2X); M!7CMDH2()W3&@WLQ>.V*-(9$7`GQ2'$+!J]=$ER&P6N7!'=B\-HE*;!T7.NC MQ,)Q\=!#C>+BD/N%ZUS$XI+@5A>QN"2XND4L+@EN#R_5OPZWE_K:3L[5,P[N1?\UU4W^`$3^T,/STY^$O````__\#`%!+`P04``8` M"````"$`82$*>EP*``#B*@``&0```'AL+W=OSNM=M1$J-M*[#=AWG[ M_>M`U8'L)'TS/?E(ELBJ8I%2^>[W'\?#Y%M_ONR'T_TTF2VFD_ZT&Q[WI^?[ MZ7_^;'Z[G4XNU^WI<7L83OW]]*_^,OW]X>]_N_L^G+]<7OK^.L$(I\O]].5Z M?/C#$\/>UW?37LOA[[T]4,&.V_.7KZ^_[8;C M*X;XO#_LKW_I0:>3XR[_X_DTG+>?#XC[1[+<[FAL_0<;_KC?G8?+\'2=8;BY M<93'O)EOYACIX>YQCPC4M$_._=/]]%.2=]G-=/YPIR?HO_O^^\7[_\GE9?C> MGO>/_]B?>LPVUDFMP.=A^*)4_WA4",9S9MWH%?C7>?+8/VV_'J[_'KYW_?[Y MY8KEUL_;#0<\"?^='/=J#R#T[8_[:8HG[!^O+_?3;#6[62^R)+V93C[WEVNS M5[;3R>[KY3H<_V>4$O7T<9"E'03_VD%6;^JOK3[^M?K)VP_`MM1>XE]KD,[6 MR6*3K>$D=VQN@M234VVOVX>[\_!]@AV'IUQ>MVK_)CG&LK-B1QCG"[\RKHI=60M#@9_;ZZC4(W6 MFZ&.*F.HC-2,-(RTC'0^"4)%SGJA4K(IJB,B1PI#$KTP5$/\4!FI#,G<=-2,-,RJ'75<7*O%39B!W:@4QX7CQXN+_%GL[.ABL9(+#2@A9XS!FBU30M*]*R_PP+;HU?8VJK#6AU6C8<,.6M)QA1VBI M#$.W5:5U30.ME.I8HJ6R:.D?RJM%=":7I.5V6T4HT0MVPY:+Y,ZDX:@E!,?& MQK,0)KM8UV&<6X=@=#=G$UMRP MX:@EM-)+O8B7NB.YSN9P>50]%0(U938(U"`$ZI;'(N^02"QRJ5(3A*>"!VP:YTK59L-6T9=]MN"JQB(K7>K82=2RPT[0D(!4T5:<-O4[L!M@Z(49`7,:KDM5*DW#)."YB5Y M%MG4I.!L&HY:0G[V+=ENH(D2%*.H3:I*[[=IPU!+"<33F M#RN-'6GIL8+3))5[#HVC0$WKX!0,.T*"UZHAX!F5 MFCX!RTIUM[`HRJCX&"0MMX,J0GXJL(FM2T5-JT?K:=J/(-TLKOK2.M#12U5 MG81;R3%TTV`$>]F@H*AIZ[!;ML@O:H1<Q338(0 MO.D=@N`-"K+,(N=UE5KD:E--R&DU'+6$G&%'2"AJJFX+7IMR'GAMT'M%S6JY M_*A2BWY:U)A)0R9NE);0.T7-'RLH:IG<;:M+RBAHA-PTM(6?86205 M-7S/],.ADUWCR&W3N+BBMLJBIKNT5GY1(V2*VDV2Q!\S:M+PBAHAMW%;0F%1 MB[\TDM:'BIHZ.7YE)4WCX1]!>@1<$_J?("T+YL"V+"[#:JNU7(]=8,,-6])R MAATA7?_"U%3M@TM-MC'_'%[5W2:Z3G,A;.X\C_WYN2_[P^$RV0U?3^C/D\42 MGYU&;JZBNRS#7;3>>)$$E]2?]%:+>('+:_VTF*(4E<] M%GX"KZ6)*;,$7DN2"I)*E-20J..">]!`TH@2');P6K+!`0FO)4F!>`HQGA*2 M4I2@_L)K:0YJ2%31$KR&1-4N+D$=AM>2!!TN=II.G7BNTW5>H`7AHZ'#RTM1 M@D8O5RT0MT&'EZM.B$O0Z.6J(>(2]'NYZHNX!#T>O)8D!>(IQ'CP,@&OI4@K M2"I14D-2BY(&$M5Y<]_P9@&O)0E>WN&UO$.0C7BIXJ.5*;)1E."]%EY+-GB7 MA=>2!*^T\%J2X,T67DN2#I).E!2(IQ#C*2$I10D^EL!K:0[PF01>2Q)\+8'7 MD@0?3>"U),'G2)RLX@Y)D(VF/D4[OH2D%"7X*@>OI?S!YSAX+4GP50Y>2Q)\ MG(/7DJ2#1'W+XON@0#R%&$\)22E*\`$X5Q]&^6CX\)O7HJ2!1'TFY3;X#)RK MKZ5<@IL6S+6T=XH$V8@OX-RFA*04);B$@->2#2X>X+4DP?T#O)8DN(:`UY($ M5P_P6I(4B*<0X\&5%KR6(JT@J40);K/@M62#2RUX+4EPMP6O)4F'#8(+5CZA M18)DQ-T>E^":%$Y+$MR6PFE)4D-2BQ)]S?'K!ZSL?!3@AX>OV^?^G]OS\_YTF1SZ)S2E"_UCCK/YC:+Y MXVKZV&ULG)U9<]NXLL??;]7]#BZ_']M:+-FL)*=&"Q>1DJC%NL\>1TE< M$ULIV[.<;W_^$-'$\N\HR9V'L?/K1C>(!K$1@-_]^Y^GKV=_[5]>'P_/[\\[ M%U?G9_OGA\/'Q^?/[\_OMNF_;L[/7M_NGS_>?ST\[]^?_V?_>O[O#__[/^_^ M/KS\\?IEOW\[@X7GU_?G7][>OB67EZ\/7_9/]Z\7AV_[9T@^'5Z>[M_PSY?/ MEZ_?7O;W'X^)GKY>=J^N!I=/]X_/YXV%Y.5G;!P^?7I\V$\.#W\^[9_?&B,O M^Z_W;\C_ZY?';Z]B[>GA9\P]W;_\\>>W?STG[V])`4 MGY\/+_>_?\5S_]/IWS^([>,_R/S3X\/+X?7PZ>T"YBZ;C/(SWU[>7L+2AW[_?O5^/WO]WG\6#T^[U': MB).)P.^'PQ]&M?AH$!)?4NKT&('ZY>SC_M/]GU_?UH>_\_WCYR]O"/>U2?)P M^`I/^/_9TZ.I`WCT^W_>GW?AX?'CVY?WY[W!Q?7PJM?I7I^?_;Y_?4L?3=KS MLX<_7]\.3__7*'6LJ<9(WQK!S_^_$;@[Y@0_K9'^1:=_-3#Y..%[8)/AITV& M1SFA/[3Z^&GU3]O'&W',%G[*LUT,.U>WO>'I=+P@V$>/ MYI=?+?_?BYOJZ/[CYP?-U>I(4OUAGPY][0*DN'5=? M?M8IRKS)+WZQ3F'D5&E*_>AX%>2B>W/=N?Y1S>I(53&_6&\-658)M?;(J;GWEANA)S\XM-V#U9(I=-FW%L:R;W;_*GFA(DDD, MIC%(8Y#%((]!$8-9#,H85#&8QV`1@V4,ZABL8K".P28&VQCFA-VX;UD&W M$[:KTU9)0IX2RMCF\Z&MO-6R4QO2"R M)--UJ^.;CD8MCC-]W8L*Y*Y5$M,[GP11-VMK?MB/ M2Q?=ZPMT\)HY?VY7R<832SR:P6CE%'&MG+6*AC-&)5LJV*M M.:,%HR7;JBT*:VPOZ@M73DLBM&:T8?-;I^7B/^C%;[W3$O.[`(4UP"R!\.+5 MA5GV?/OR^/#'Z(!>O>/6KIHE$TRCQ/C(++.B1@3A)S2Q6L/C:O]QO6K**&64 ML?FIPQS9ASTVY)H),]9'5S>XPZDZGHH5Q M2:O5OXV:WU2T`ELWT4`J$RV7B5Q0D##.1"%:PV8)]B(R/!.YZ\9*0BD MK[EH-;YN+@:WP7]16!>B[EPO!3G7M:"3KE>BY9?U(.XTUJ(5V(K+>B-:+A-; M04'"N*SO1"O,1%0M=J(5V/(R$=9FLS*DU>9FQ2AHH1J$VBQOR=A\MT&=#ZIN M@VZRK(:65L*V>M0I"S-1,T:/-5LJU*M)S'N2!G:R'(V5JR MK5JTG*V5(&=K+U M%V/S(2WLB":"T!^U#E7QV(-EHN7FQ[D@TV7^]:%[ M$;69A9.+KYD@9Z5D5`D*'R6:3&;EM,3C6M!)CQO1 M4F#)* M!;FW*K/(&ZGDHN6ZV8+13)!KADJV58F6LS5GM!#D\K5D6[5H.5LK1FM!SM:& M;6U%R]FZ8[03I+0<9JE+:SF:);"@Y6C0CT875LNU;A.SOP4Q[=L.,GZ/ITXN ME3`5Y*QDC')!MG_L]2ZBYJAP&F)Z)LB9+AE5@H)A1#]:0YH[+3&_$/2#8025 M4BT)FX?I#N,ATL.+WI7W7Y2;F:A[`Q%!SG4EZ*3KN6CYSS_H1].ZA6@%MN+G M7XJ6RT0M*$@8/_]*M/Q,](=1)M:B%=B*,[$1+9>)K:`@89R).]%J@G`;C69V M(CX6>M!,=9P+-2Y-,C_.&A.LI@!KROA":,IH]2BS@`UWC5>_6@U-_/4)(2YP@J% MS116*JQ2V%QA"X4M%5:'+"QLLW[D-074$41?:+O->E/01#3(*_&QU?+0A-&4 M46K1#>9Y7@RB9>C,:;D0-)E`0D$%:\T8E8PJ1G-&"T9+1G6`PI(W2S:_4O)& M/ZK^#>H,T(2XXKJ.>N5QUZ9T93.Q*$X9#<>GG#*UZ"9X2^*]09G3DG#DC`I& M,T8EHXK1G-&"T9)1':`P0F:UX5V,::005;'GF$EK+T:INZ13$3,5HSI873LM:CNK8TBF( MY3I`84C,Y-\+23MR:18%@J)O4.6]HV)6IVF_(F6H.=JJ MV=IR=1$M9^1LNV`T$SNGW96B9MW=7%W<>@M(./$>KL-6[&G.:"%63SM?BAJ< MN[+LQ1NEZL!!&/%HHMU&O)U0RSLS,OOZT,&;B`L;6Q:$5]3=,UI(2L_:4IAGK0Z2AL5JIJ72#^#36UNL MAD?-4X,Z0[QC[>O0C[_`CLU6.*3T6J*)16$/<,+7H%N,NSV/4\V1. MRP6CR<0M!K-M0OKF6[#'F46=J^`AXV%9Z:F)SZIE\/U]IW-VNFA3^D[IY5AZ M:N*T#JR%D?4GTWYD>3)M%L[-"X/(BN&Q94$8K9K7/TU9+;4(01-C&:-PWJ#-T7D+%E M03,D:G[+.+B.UI:GG#(5!WC3S9!PKRX#KJ^TI/ M31Q4PL(.(5Z#G[/3A:3$\_A.HWYIZ:F)TUK8=YV&031S7*W1:^:^P>BA06$0 M&Q8$4=1!H5CWT%\B<48163:_Z!"2TI_ M['L;K>%-.6%JD:GB_DM,39.U[U6V7))^]R4^[N8LV.E,4H9.XS%^Z:E)+:F$ MG78Z9Z<+20FGIOF-&NRE)Q9G=6`E#*J9/6M!;6;505`;%`YO&Q9$4-3\X2VI MI3VKY@4B4U@NS&M$"LL\KS-1\\R5"JN$>>;F;&XA:IZYI<+J(&E0L&:[D%:P M1QX.<"WJ#-T@8FP9`B=!G%@4C"T'@V@U9LH)4TG8?#W&+3;!].LJ6BG*G+JX MSMEHP6CF$IIZ>15O2BJ=7`Q7;&7.:.$2-H:C@?C2R<5P'5@)`V.FZEZ-_]&" M.;9OQ3,2B\*`-6I!P!J$@$FVIC:EIY6VQMP']DQAN677;E17L+69DK)46,76 MYFQMH:1<*JP.K(6E[4^?O7$K]C-1J;IYL=>"#Z+J.;8IO9=_8E$'I])<23?6 M/+6T5<,`R4V4XLT66:MV8+RSRO,U:,R>]E:U:XVTXB!=C M*G8W9W>+ULY)=\M6K7'7B7?;U8&W,)1F;OLK+TXS%_:[$)3/<<(W<'W#V#*O MZ":B%L2S2>JII:V:&WQE+7,>%1?@A%6;6IG36RI8Y:Y5EGK6Y1?@A MUA9M2F=MV3)GK;:LL186=S2/IG;*[O"`R^:"P^;2L:?]R^?]>/_UZ^O9P^'/ M9]3S+F:5']ZUO+E:$?4E,9E$ZDB"*I*8K+($=2,Q&68)+FK\[=@N1;9&N,#Q M^);$O)O@>B:V,^HEN-&'^6]]V%<-]7%#I):@VTU^4[.*MSV\34%9;@[4U,E6')")*1*D&KEY@WA=.@\4O,"\.2 M*21358*6,#%O#Z=!XY>8=X@EZ/!1.EH,T.^C##0)NG>4@29!+X\RT"3H[%'] M-`GZ=%0_33*"9*1*,(Y"N6EI,)Q"N6D2#*%0;IH$(RF4CB;!"`FU2I-@VI"8 M`2N7*&8/B1FCL@23@\2,5%F"^4!BQJLLP;0@,4-4EF#TGYB!*DLP&4[,K)8E MF,0F9HK*$DQ)D3=-@@DF_&B2$7(P4G.`*6`R5B432":J!+._9*I*,`E,S"2" M!ZML\!'&SR/)AGA24?JD^(K`9Y'*P-\+,#S:!)\ M(,#S:!)\)\#S:)(<$K/4S#41B_^H;YH$WP!0WS0)/KXAC?:D^`:7F&\[[`>? MW6!-D^`#&VJ5)L%W-M0J38+/;8GYZL-^\#D;UHX+;-'[@Z_:L*9)\'$;D=,D M(_@QW]'8#SZ4(G*:9`+)1)7@&RDBIZ7!I]+$?&%C/_@ZBIAJ$GP514PUR0C/ M8[Z.LS7L.D`.-`DV'\"/)L%V`_C1)-AU@'J@2;#Y`-'6)*/N,!EA/P;G#7N( MDHDJP1ZAQ&RKX338P9+D:AKL0$G,CA).@QTDL*9)L*\],=N>.0VVM&.$J$FP MH176M!'*J(M6#-NUV-H8$K.EC2786H@RT"3889B8#6Z;(#TMPG@OS$4TR@I^1Z@?'=U!WM!Q,(#'G'M@/ M3NZ@[F@2G-9)S"D(3I-!8@Y#L`0'=?#.:1(D^L&1>L1'R\$$$G/(F3X+X,Q$>3X(X,Q$>3X*H,Q$>3X$(,Q$>3X.:< MQ-RAPD^*VW(0'TV"&W(0'TTR@I^1Z@?7HB`^6@YP.PKBHTEP_0GBHTEPY0GB MHTEP\PGBHTEPP0GBHTEPT1'*6GL>W'>$LM8DN/8H,??8<+GAJB-$09/@>B-$ M09/@2B.\)9H$MT@EYAX?]H.;H_"DF@1W1N%)-0FNCD)-U"2X02HQ=_RP']P: MA3JJ24:0C%0)[N1"M+4TN)HKF:@27,>%>J"EP15:!-=NH1YHDLT0!:IU M9MMA@HM(^3&WZ+.UP>/V-L'-A8I^!T-'W&BG2?8%?SYJCYO'KLRMG)\.AS?YAW'0_D&J#_\5````__\#`%!+ M`P04``8`"````"$`EN9HY'(=``"*AP``&0```'AL+W=O/PK(2@!_DNH.]T5+^G)!(;%4`J<*]?X__OGP[>P?=T_/]X_?/YS/ M+B[/S^Z^WSY^NO_^Y;[IYMOC]_O/IS_Z^[Y_#]^^?=_ M>__'X]-OSU_O[E[.X.'[\X?SKR\O/XIW[YYOO]X]W#Q?//ZX^P[)Y\>GAYL7 M_//IR[OG'T]W-Y]&HX=O[^:7EZMW#S?WW\^]A^+IS_AX_/SY_O:N?KS]_>'N M^XMW\G3W[>8%U__\]?['LWA[N/TS[AYNGG[[_^[Z M'3S]\O[3/6K@PG[V=/?YP_G'67':K,[?_?)^#-#_W-_]\1S]_>SYZ^,?W=/] MI_W]]SM$&^WD6N#7Q\??G.KPR2$8OR/K=FR!_WPZ^W3W^>;W;R__]?A'?W?_ MY>L+FGOI3&X?OZ$D_/_LX=[U`53]YI\?SNKB^7Z\FHV7YZ? M_7KW_-+>.]OSL]O?GU\>'_[7*\V"*^]D$9S@S^!D=G6QF"_7F[_B!>6-EX(_ M@Y?5FZ5".NKCS_]'J>O@!7\&+U<7\\URMERY`+Q1:0R5L7C\&0SG".(;!M?! M`'\&@^N+S7*Y6&W6;Y:6S*['`7X+% MVVTQDR[@_A(L-A>SQ>4K47SGN^'8?>N;EYM?WC\]_G&&.0$U?/YQXV:868$. M>Q8Z;HCKU)4QHFZ=^D>G_^$<;8!.^@SZCU]FEZO9^W?_P."X#4JEH91J5*+A M!HCS6^>@R4&;@RX'?0Z&'&QSL,O!/@>''!QS<(K`.T1U"BU:_R^%UNF[T$I, M2@$:ZWD61M$0DSH'30[:''0YZ',PY&";@UT.]CDXY."8@U,$DC!B2%`8%\NI M0SHQ)M&H0ZY6BS1,I=>982*8>NTJ5:DFE2F41!HB+9&.2$]D(+(ELB.R)W(@ M^T\=M"W?&*888^5F'++W6FY&>5*9($VF(M$0Z M(CV1@R('(,29)9'"/LR+CD)S(0V1+9 M$=D3.1`YQB2)#+*-.#+AMGSA$I>7K_>WOY6/8Y(H?HMT0Z\MI/.BXY@-=LBA@FN7C=$MF1U_VD$[QF*<=ADHO7 M8TR2V+HU5Y3R2`P=3F/HR14&]C3EK=:7:9"JH*2!K@-Q324YTGR=W6^:H+3V M*=3F8IFZ;8/\>NKQ'174_YF"AK2@^45V;]Q203LJ:/]G"CHD!2'3ODS^6Z?U M.\;%)JV#F[35.@ZGK>,)6D=:O`HD:@I/-JK3!.*79B[S;`,9%X=C+MJ1GY[\ M#.1G2WYVY&=/?@[DYQC[22(SP[W7"LW(T]@$M(COUM?9D*E$26?56M#,=\O% MXF)U'?^7-F*CZM(&K2!UVC'J!85R+JE;#JHAKK>"U/6.T5Z0N%Y<9%WOH!KB M^BAH=)T&W67WQFSAEH99APP(01>_E2"]Y%J07]&['M@P:@6I8<>H%Z2^!D9; M0>IKQV@O2'T=&!T%&8%R^;L5*)_7(W&4J)1N78S8)1/K=7:;J$0I&LV"5KYW MKN87^:RJ&E)8*TC]=(QZ0<'U;'617<^@&N)Z*TA=[QCM!077Z.O4(4,\=`HZ MBM'H.NV0+J./XORSU,#M+>0=U:-XZ@Q:5UJ5.J"%WH(:1FU`R_G4O!W[ZMEP M8+1E7SOVM6?#`Z-CXBL-H$O4HP#*_=_MI.2!\BB91E=KFD>#EHZO.OA:7HX] M]6J^O-CD4Z7B>"M('>_8\5ZT@N/9 M.A\"!]40UT=!H^LTS"[KM\+L5P/)?.!1,G$&I!6OW>(4[3-;:<@:@[6!7>M- MOPLH"2-[&PQO6_:V8V][P_)@L&/B+0V76PI8X?)+A"1<'B73YVJ=S5?5+&C% M(SH@/Q-=+_*DLQ$;G8A:0>JF8]0+\IY7LXML*3&H@G2=K2#UO&.T%^0]+Y<7 MU^E`.JB">#X*&CVG47:+@BC*/YT\_2(BB7Y85VCWJF8!:4WJ@)+)TVM%J`U: MR>1)OGKV-3#:LJ]=0-&DOF?#`Z-CXBL-H,O;HP!.DZ?/YY-`>91-GEG'J+#; MX49U-#3K@):X2[VQ@!*M:1[,^UPK&CKM=5Q:+UIOEC:(EB]MMKK.;^);T=#2 M=ES:7K3>+.T@6E(:QE.\F,JF_*.H&Y.P6TQ$S?73_NX7'TDS>I1,S@'%D[-' M2QT5C=L$1,LNHZ66()U?NH"B]N]%2WT-@M375I#ZVK&OO6BIKX,@]744-/I* M^CLB\78`__[XP_V((N-@U!_78MIWL4V:]?HRJ+ERIRZ>Y;*5ZLC$5C-J&+6, M.D8]HX'1EM&.T9[1@=&1T2E!:>!?67?->=T5$$:!!*IB5#-J&+6,.D9]@M++ M?F45Y'ZJS)++@)"HZF5[K0C5K-4P:AEUC/H$I9?M5@1_89Z8._UTRT%0W`I! M2U$M6OYV;NPYBH+:M((FFRS5Z41!;7I!DXW.F6G%71H>57P:QSX]1_^4QBGG M'KF,5\?L.EO+54%KOIX,:S'Z>9E&P27# M5A1\DIQ$0?+F.`H;C>ZX@U:YG_)=_]`6J05!HN';9$W9B)8:MH)2PVQ&[41+ M#7M!J:'N?Z8A<+FQ%0*?,R:!\.X(P3#C=^;NKS(%V\-&[4! MS2:C>;:S2I&@@GO#1[RK=WVM?3$-BDM&K:#X)#4)BD,@77_]5>.Z3//0$ M;7;D.SK(QDJ70>WM?,>[@HY,N;6:"6H8M8PZ1CVC@=&6T8[1GM&!T9'1*4%) MY*^R1%-N1"-/[[0!Q?D.HYI1PZAEU#'J&0V,MHQVC/:,#HR.C$X)2F/W2JYX MQ;EB0%&&53&J&36,6D8=HY[1P&C+:,=HS^C`Z,CHE*`T=J\DK%>M<37P&C+[G]62R@V,MNQ^%U`6]"S) MVK/A0=WK=:TOLW3_J%IR7:<$I4''<#-RC%>?;;ER^MD=T*,H\E70BE`=$)I? MKJIAU+)A%]!:-XUZ1@.C+?O:!>0R\&F.647Y]I@?[=GPP.Z/C$X)2L/LE@%1 M*C=-*&%Y$*ULKSQR339=X_HR6YI5HJ69="W(/\6RX-]C14%SNE:0NND$Q?,P M/3'3BY8O;+FAU=,@&EK:5I"6MA/D_:SR'Q3V(E>3@Z`W+_`H6M[Q9H7U77I' M.(G&>(%I:[E5D-5:8744MY9':"WIUM550'K)=4`;W>5L!.F.:L@6EKB49`:G@3Q'BU^W[!C%U9:<>P\6B$QC'IZUDS5 MZ##=O0@HV@5O&+5LV+%6SVA@M&5?NX"PQI:6W[/6@7T=&9T2E';%;`TX31S3 M4D]*+Z\\6L63V_HR2Q6JH(42Q;`6Y+?GKNDY#I&K2T:N* ME#T(4M];1CM!<:Q];:-Z'%CKR.@D:"PQB;7[<T%J>!"D6D=&)T%&[%Y9\2$<>;X; M4#;/9NE[%;22Z<#[V29'+2B>C*^NLAFS$2T=J2VC3E"8>5<7:^JL MX0)T>`]BI*ZWC':"U'`O2`T/@E3KR.@DR)@]W)HM"OC/GNQ8^#5>TA`>)3.R M1Q@C,D+K8(AY3%`C2!/V5I`:=H*TACVC09`:;AGM!*FOO2`U/`A2K2.CDZ#1 M,)T`7EF$+7@1%E"V9,YV`"O1TH%6"_*+Q"M.?45!%[&M('73"<(,,TWLO&06 MK3`_8ZV;]?)!--3UEM%.4/!SD>W_[$6N7@Z"WKS`8]!:S?USLJL%7F//ULSB M:/2=-E>V[OOI$.#UX,*C:#JN!&E=ZH#0<70(>$-L=1`M+?$8T$I'ZTFTQA+3F&:+/XII]KP3GF:D9,4CE[A/77,] MRW*.*A@F,XTWG&U";]CD6S--,)IM=-"W[*@+:(49?+H"8W"DQ:U7%XNWLI?! M*'S+A>\F-5^++$G;L\4AH+TO[2I,-S&QXT_TOWBU$_78$& MA(:5/E\)TO:H`XH>^VL$:==MV;`3+>VGO2#MS8,@];5E7SO14L,]:QU$2TL\ M!K36T7\2K;'$9+`LLQ7HSP;+J)_%U"]6T_O(+)M?JV`8YY8!S;#!-Q["D/6S M9I)KH%IVTP6TPEAX8ZA,SGQA6*CF3_P,DXJ6M^7R=I-:\)1WX3W;'`)Z^QJ/ MDV=_9YU=+Y;YMM)ITC':,EO)4EMF;]SBF>U\X@LHOID(TNY4!Q3?3`3I#:!E MPTZTM$_W@C3F@R#UM65?.]%2PSUK'41+2SP&%-],1(MO)NX)[C=SU.QF,NJ/ MXT,[(QXFR?9IRJ#VYL,DJB-S598EQ%;3B#"J@ MV0;9:629#:`F4I/1T;*W+E)3;_1\1!^IB;!M2EE;:+1>L;NR7$4DW]BBIM$=) MI3V*'I9KEH3:@"+#3K2R+D+U"\ZB:`V1*>J77`44_S3>,6C;L`IIMX',:&HO\<(H^4M-V]9?A3/-ZXUW$I-XRJ$>> M9GH!N1_LI_+7LWS;2[2TD]:"?%[#+^V)/-HP$*1>.D%Q\;PF$BU?UHK?@A8% M(Q19,CR%PF>X<5.[GU\Q4\>)DB"]XCJ@^!=L09JVM&S8B9:F];T@S60&09P* M8C?";E1.^495]TYJTJCY-E#0PB.XTJ?J@**U5,.H9<..M7I&0X*2D;K*?6:3EE$G*'B9+_C77561P`Z" MQLM):_Y*4H1<-D^*`HJW]P-*JND-44TIO6&MEE$G2`U[1H,@HR8NTXEFVZD- M?0:4M*%'Z6;[/-^,<5L/&)#Q1"L(0U6GJWFV,&U$*][KX5^.1$MW"3I!?O\= MC\K,\CN0:DAT!T&\N^'ZJ!D13JY&U0_G\:YW0$GUO6'\.Z1HZ?9'*RBN&!GV MHJ7;TH,@HR:OI$,]T2[=7!6W:V$TZ;%TF$G7VGZ46KJMGCPL&A$!)>55`252\ M(?;01*L)6FM%+1MV@M1]SV@09`QGEU]$-9R&L\\[DN'L4;JW.L_B6[F=DGPX M>X2]+#R:C/>R39:J<,:F_ND:B.U+EFU#!J&76,>D8#HRVC':,]HP.C M(Z-3@M+`OY+EK3G+"RC:$*D8U8P:1BVCCE'/:$A06I-74KHUIW0!Q7LDC&I& M#:.64<>H9S0D**U)EJ+18,@V8;$,S.=Z0.[W6I&O0;2,N=\E/59-?#(4W_C7'OUDH1FT MXH5F0-'MKV'4LF''6CVC(4%IA\WR-LEJ\-,:=5B/LD0V7V@&PZ3EO&%8:"ZH MPP:Q-EG+3CI!89TYN[[(7WWH545':NP[K;A+M:Q6]2E8TJH>Q8DIT2!HC%)2$W=@@563D:O, M;%NL$:TDTZ0G;$5+\[I.T+3.S(]=Z%5C:EM!G(_B#6V-R#6FR?'UG8\CS@+B M---E9M!*:N^UXF6F:$7+3$%QOJ""<_>!ICK`@F-FU9 M6F4&K;C;"DH,Y]G>6"-:;Z\R14M';[S"9">=H&3:."88&)2_!?M_&?!WFX>_IR5]U]^_9\=OOX M^W<,?1Q!A@EOXN&[.NM9\1%EPSJ38`E:N.472S[.+XN//D?);2!Q9T)9-M?% M1SQIP!*<+0&;<;ADWCXNKXJ/6'D;-I"XG\]9@N\$?31+066LNI1S%&[X*5&` MZ7]1?/0_VF476RX*?$&`+VC8S`LWD%E2;A9%:8:^@L1U0;;!J"QJ4])`TIB2 M%A+7+]D;AF?ANB=+>DAZ4X*1B/I8-B5J6IHUK2"I3$D-26U*<&-!?:RXM9"X M.96O&O<47+4I66\*ESNQS0")2Z%84FXN41^KTU205*:DAJ0V)4B!4!_+6PM) M:TJ0_:`^ELT`B488$,95V!)L*^,*[`DV%Y&3[0D^"&H<#^A<#GE:EV46(2P!+^# M%&[7GR4U)+4IP4\@A?L-@&U:2-Q/`2S!KQ^%V_YGR0")^Q6`)27J4YKUJ2"I M3$D-26U*\*,[J'R\'C-)!8;8H'3B"Q9I<2$2W-B%:05*8$#X$@!E8K-)`TIJ2%Q#T>85PU M).XI"9;TD+B')5B"9V>1,IEMNL0LAB?XV*97BO3"_<(\_LK8?$ M/?G,$KSX`1NK/CTD[FT"ML%K'6A32X*7.]"FE@3O>*!-+0E>[T";6A*\0U6X M=WCX"O#V5.%>Y6$)7J(JW!L]+,&+4X5[L8!D';6I= M=0V)>Z.#O>%='+2I)<$;.6A32X+7&7%MUL@J<=6E>=5XAZYP[V3Q%>!5NL*] MFL62!I+&E.!5NL*]J,4V>*.N<.]KL:2'Q+VVQ1*\/5>XM[=8@I?H"O<2%TOP MYBF\63'`ZZ7P9DGPEBF\61*\;(I>94GPSBEZE27!JZ?H.Y8$KUZC'&LFQQO8 M*,>2X$5LE&-)\#XVRK$D>`<;_<"2E+BVTKPVO!",?F!=-=X+1C^P)'@7&/W` MDN"58/0#2X)3$E`?:W;!80FHCR7!`0FHCR4I4=/2K"G>UD=]K!C4D-2F!"_J MHSZ630N)>Y'*00U);4IP M<`;J8]G@L`S4QY+@S`S4QY+@8`S4QY+@?`ST:TN"8S+0KRT)#I=!.58,<(`, MRK$D.$<&Y5@2'">#X`(O:&HX3@S9+@Y!_T`^O:<-H/^H$EP:$_Z`>6I('$'5/# M5X!3?]`/+`F.`ROAOE@2?44*OLB3XTAQB M8/7X$M$IS>A4D%2F!!\^0PRLB.+K9HB!)<%'SA`#2X)OG2$&E@2?-$,,+`F^ M;(886!)\X`PQL"3X_"-B8(X?1**K?")&_Q&E.\Q1M,\!9O,;U;O,/D/O)W4R+Z_,O['S=?[@XW3U_NOS^? M?;O[C-^;+\?G+9[NO[BG+_P_7OS'ELY^?7QY>7QPWUTZ^WIW\^D.'U&]O,#O MZY\?'U_D'QA^[_YX?/KM^>O=W3K>]WQ'X'A>Z'(@@0`!&V)X0^'W&(V3/7LDS;"DNB0Z1___/V>Q6Z$EE5 M*P%:OK"D;V5EG8_HKO[A/__]Y?.;?SU^>_[T]/7'M[.;V[=O'K]^?/KET]?? M?GS[__ZK_(_UVS?/+Q^^_O+A\]/7QQ_?_N_C\]O__.G__I\?_G[Z]L?S[X^/ M+V_@X>OSCV]_?WGY<_/NW?/'WQ^_?'B^>?KS\2N47Y^^??GP@G]^^^W=\Y_? M'C_\<@KTY?.[N]O;Y;LO'SY]?3MYV'S[)SZ>?OWUT\?'_.GC7U\>O[Y,3KX] M?O[P@O0___[ISV?Q]N7C/W'WY<.W/_[Z\S\^/GWY$RY^_O3YT\O_GIR^??/E MXZ;Y[>O3MP\_?T:^_SU;?/@HOD__(/=?/GW\]O3\].O+#=R]FQ+*>7YX]_`. MGG[ZX9=/R($K]C??'G_]\>W[V>8XFRW>OOOIAU,)_?>GQ[^?@[^_>?[]Z>_J MVZ=?^D]?'U'7IR_],1C/O:G*R\$[PIW=R?S-;W"Z=BRO! MH)[BQI\^V/J?!%OZ8/C3!YMIBJ]$M_+A\.?WI!)]XI1*_.F#S6_NUO>S^]>R M]^`#XL_OR=X,E7V*T/WE>Q(ZD[IT?_F^I,Y0_5.J/^8>7#S_]\.WI[S<8Y5`7SW]^<&/F;..<^9[HR_;<-S%&?'3F[YW]CV]A MB%[W#/JOGV:WR]4/[_Z%WO[1&VT-H]@B$PO7XYW?/`5%"LH45"FH4]"DH$U! MEX(^!4,*QA3L4K!/P2$%QP"\0T6<:P/MY;MJP]F[VI!BW`K0ZKE+2EXL)$B> M@B(%90JJ%-0I:%+0IJ!+09^"(05C"G8IV*?@D()C`**2QS#Q727O[#$9!?U@ MM;B-BWH[VR([(D< MB!Q#$M4.QN+OJAUGCT4#9JASR6.86L>%OYVLKM;/V>1YV-H^'@.*L2ZF71"KR6I]MW/H'7I,YMCGKXK4ETI'7_FSCO<[BM`YG M7;R.(8G*%NNSL&RE#!V.RW`BK9*YK?!& MJU/98]NV>@C_2]:,I;=^.+?_BJ*M_TFT313MW>KA9GD;_)?DK:5H.XJV_R?1 M#E&TB]GR)IEMQC"FJ+*P/K`JR^&XLB:"RI(&D'D2U,Q$UFI3>#+MKMU:N_1D M>?93D9^:_#3DIR4_'?GIR<]`?L;03U0R;HMI%+I+MG8J6C M;.X1AIW39F9YM[Y)&[*:2,&7[*AB5&O`D^_%[>SF(>[4C9J([Y8==8QZ#7CR M?7M[=Y-TJ4%-Q/<8.8K+VNU)>"=X<3QVN_BD?7J$.I#X,D%A@4\!9P]J5GBS MD)425)MR)4B]U4;(QF"M!%5OG2#UUALA!X.-$O3D+2Y&M\$(BE&&7G>$D1;7 MA*+!=W:;C/J9#S@/^KB@Z\.OMUI.<]]LN;R_6<2-KQ1'P:`K2*.K!5V-KDFC M6^,\(HZN%4<:72=(H^L%78UN2*);S![2Z$9Q=(HNKB2WT0@JZ;6UASM-2BMO M0N%@[*VBFIJL%CKX%MYJJ0VQ]&BQ.O>;BGW58J6^&O;5BI7ZZMA7+U;J:V!? MHUB=?,4%Z'8"UPKPOY[^=&=+Y]8_[1S2#5DR&&[=F1O*^>J.3&UDD,D9%8Q* M1A6CFE'#J&74,>H9#8Q&1CM&>T8'1L<(Q36&[A36V+EF'$^FT@F%FS20C%'.J&!4,JH8U8P:1BVCCE'/:&`T1B@N*+?[.!<4>NYT='QYP3#M5J(" M]$B;5>:.PEU[5)1[='D3IP92-26CBCW7:N6W7,GNH%$#\=PRZMASKU;>K09&8X3BLG.["ZOLIEU'5'833QH>+>.R2_;` MF;<*ETB"P@;+9PEBM9P.$^[OTDU:*18Z<%2,:D%78VO$:HH-:_)T;=F*A<;6 M,>H%78UM$"N)[9:.#L3B%%M<0]&N;7%><-WQ[LPCU)",.)E'475,`8-U;2%6 M&K`4I-FO&-6"=*G;"%)?K2#UU3'J!:FO09#Z&@49!17MRX*"XGW9W826&".# M82!9JV;>:J&3?R[(K7O_]=."]EN%&D@5E(+43<6H%H3*T23=)[\W-6HE[EM! MX;'(W3KIEIU8:2)Z05->YGBF(#A$N[U-#E8&-9>H1T$GIW&CC;9?05WP-NMN M0J@+\9MY%!6\WV9-CWVX,ZY"K!25@C27%:-:D`9L&+6"=#78"5+WO2#U-3`: M!1D%A8'#FKON'$_&WPE%APES:K/>2$LS]Z[FT;A]GZQ6"K62:B@%P>6Y25++ MJL1*8ZP%R7"WNDD:4Z,6$ELK2/UTC'I!<6:21=V@5N)^%'0I,W'SC;92"/+* MPM<]9I36UH2"43;S5M%8/%DM]+RD\%8!*CU:J57%OFH.V#!J/;J_.W>WCGWU M''!@-'HTI2LN0-2/V:P=3YKUA.)CW?NDP61WWDJ[7N[1_>UI+)YAP9!TAD(M MI!F4@K2_5NRZ%BOO>I4L$!O5Q7$K2!UW[+@7J\GQ^>K8:&(T1BLO.[8^LLO-;*9U%MW<3BA=?]\E)9YN M`P8U$,^CH)/GJ,SG%_9N)QX/LAZ%BRR/P@(6I"56,"H%:58K1K4@]=4P:@6I MKXY1+TA]#8Q&049!)5NHUZ;S.6^M/%J&JVQ:?$FXH+][A-E?6D>5_?)G#FHE<0X MOA9CW-HO;._FO+WS*%E2)(6>B96VO=PCOZ18TA%$H0:2B5*0-LZ*/==B-4W\ MBS6MB-5`/+>"U'/'GGNQFCS/[U_9QJFYQ#,*.L43EWFTC4-3?&4=C`/<=*;T M*%Q2"`H+WF_O=.HNQ$I1*4B7`94@]54+TH`-HU:0^NH$J:]>D/H:&(V">$GA M-FLZ+:[/AS*L4I%-( MQ;YJL=*3_$:0^FH%J:^.??5BI;X&0>IK%'3R%1=@M-4S"C#YH=B=0TP%J,UU M=KM*3KJVWLR=7)];=3*)96HC!9\S*AB5C"I&-:.&4$X(S_P822G\61"X8_.WBI`.:."4?#.X>A8.[1]HI\OF$L!#P/P8GYU>%&DA' M*AE5C&I&#:.64><1MNP28Z]6]H_A@QI(F)'1CM&>T8'1,4)11;FE^O=4U,D^ MKBA!044)TB+(/5ICO7F>5E;+].A`K:0<2D85NZ_5*G2?G&TT:B7N6T8=N^_5 M*G2?I'Y0*W$_,MJQ^[U:A>Z3U!_42MP?(Q17;+3UUKEFP5MLC]Q2+:B:=,X7 MJ[!.)U]NB7(.R+\O2\!ID4@+TE)T79!6@C2N6M#5N!JQPNQY3M%\GHP)K5AI MC)T@C;$7=#7&0:S\$IAVKJ,8:&0[01K97M#5R`YB=35[1['B-?Q0^$R](E[6E(%W65NRK%BL=1QI!ZJL5I+XZ]M6+E?H: M!*FO49#ZVK&OO5BIKX,@]744=/(5]\1D+R\+$!P`IG.>1ZY7GYLO?E^)G_7- MQ$JWR[F@Z7SS[N8N.J"E8R\UE\HM!:G3BE$M"!W_G$#J7XU:B?M6D+KO&/6" M_EDV!C67>$9!&L^.T5[0U6PU?.'`83&=+N`Q$W&R]0BU+"@3 MI,G.!>DA5,&H%*0!*T:U(/75,&H%J:^.42](?0V,1D'J:\=H+TA]'1@=!9U\ MQ86.X3)MXQV@NZFO"#6HG[ MHZ"3^[@BD[.,SRS$R78QH?#01Y`F.Q>DQ58P*@5IP(I1+4A]-8Q:0>JK M8]0+4E\#HU&0^MHQV@M27P=&1T$G7W&ANS.&8)-V+O3I["$:LB8434RK]*7O M#&]9N-Z#05)J*QB+FV0N*U27(*4@]5(QJ@5='<(;M1+WK2!UWS'J!4FZ MXU\\'Y+%\:#F$L\H2./9,=H+NIJ-@UJ)^Z.@D_NX6B\<>"SXP,.C:"::K*(Z M]$A'Z4("*BH%:7XK1K4@#=@P:@6IKXY1+TA]#8Q&0>IKQV@O2'T=&!T%&87N MSB&LON2/+'2NW[J?)-T<$V^WTM\;Q$J'@%R0?[IK/4_/]@NUD'92"E(_%:-: MT-4AO5$K<=\*4O<=HUZ03SF>(*"MLR\4'.)X4^H7@R2G_'R'S`<"`3='6P+=1* MVDHI2,>0BE$M*'2_6B6_B#5J)>Y;0>&VCQ\`$"M-1"\HC)&V8X-:28RC(/6U M8[07%+I?K9(I_*!6XOXHZ%*&XIJ_<"B!)R6IYB<4SE?>*JIF;Z5C>2%6BDI! M6@05HUJ0!FP8M8)TE.\$J?M>D/H:&(V"-.".T5Z0^CHP.@HZI2LN]`N'$O=\ M*.%1-%_-TVYV MQ4J'\8)1*4CS6S&J!:FOAE$K2'UUC'I!ZFM@-`I27SM&>T'JZ\#H*,@H=+11-58OD7#\3(^WQN:!I^S''_1/1X\K)@7:AYM)F2D'JM&)4 M"XI'^,1]HU;BOA5T:80_W3S8B94FHA?DC_CH+I=!#22R49"ZV3':"XKSDBPT M#VHE[H^"+N4E[G'HO6;E.YZL4R84S58>:4[R>X]T)"\8E8(T8,6H%J2^&D:M MH'"VHG3U8J6^!D:C($W7CM%>D/HZ,#H*,F:K"R<5]WQ2X5$T6ZU6U.6F@-'( MY]$T[,]GLYMU>(B>3'B%Q*.#2"E(1Y^*42T()7X^]ENE3XTU:B7-M!44[AN- M52+EK)>`?O>U7J6G,(-:2&RC(,W,CM%>4)R9Y%3UH%;B_BCH4F;B/G?A1..> M3S0\BF:YR2JJ:X^T\@H)J*@4I$50,:H%:<"&42M(?T3J!*G[7I#Z&AB-@C3@ MCM%>D/HZ,#H*.J4K+O0+)QKW?*+A433+K59)C\G$2H>*7-`T&H%Z2^!D:C(/6U8[07I+X.C(Z"3K[B0D<%FH7N>%+H$TIFL/1\ M<.FM=!#(!86#,;7R0JVDK92"U%?%J!84NE^MD\='&[42]ZV@2V/]M%84*TU$ M+RB,D3(TJ)7$.`I27SM&>T&A>\K00:W$_5'0I0S%-7_A>&/)QQL>A9.7(,U) M+D@']H)1*4@#5HQJ0>JK8=0*"B8O0>J^%Z2^!D:C(`VX8[07I+X.C(Z">/+" MS6QV=^/CC9,I?K0*5_^K=3*`9V*EHT0N"!WQO)"CUEFHE32?4I#ZJAC5@D+W MJW5R^-:HE;AO!849XG6B6&DB>D%^&J.7QPIFQV@O*,P+%=5!K<3] M4=#)?=RMT/G"`?6U-V1P*1P-M!.*9C>/-#NY#XCG>R15!:-2D':12I#ZJ@6I MKX91ZQ$^,W&.LA,S==8+4F<#HU&0)FPG2'WM!:FO`Z.C(*._73@26?*1B$?1 M]'8_H^EM"A@NVB7@]*3=BE^D*=1"JJH4I$_?58)T!*H%8>]T[LJK=7H,HE;B MOA6$U)X#&GV-,M-+0/]0Y`J_C(51T&YJ ML5)?#:-6D/:3CGWU8J6^!D:C($W7CGWMQ4I]'1@=!1E]SNWTC6/(Y70"$!Y# M>I3,<4DCR\1*QX5<4#APK];)TP^%6DGS*05=G80JL=(8:T%AC#15-&HE,;:" MU%?'J!<4NE^MDP.+0:W$_2CH:H9V8J6)V`L*8Z0,'=1*8CP*.OF*NUMR'O+J MW,?G).X2`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`T]'0HG>8*L9K6L'QC2RD&NH2M!&EDM:"KD35B-47V@+MGXY<+6S$X M11:7F-N&&><-JVE[%IXW>!0M52>KX&`F]U;14G6R"LY]2K'2)6$E[L/<^X`Z M^S424.>B5M#)5YRY"WLX7+%)G7]"\9(PO00O\P'#YU(%3>?K]TMZ(E(-I`&7 M@G0FKAC5@B;/BX?T]^=&#<1S*^CD.2J+-9925D6?>#P0>A0NA@1IBG-!NN@H M&)6"-&#%J!:DOAI&K2`CA3V;4&:[%R0]MJ" M42E(`U:,:D'JJV'4"C(R]]HZ,YG[W!T5R83O4?3Y@O1JOTS":6YRC]S+X>>6 ML$K?'BO42JJJM"*D'Q8JCK%67V&,R0%GHU828_M:C'%[21:"KRTG,,93D4XH MNO5PM4YWUA)0K]+*/7)=_%RF?.N$6,6;QV0W7(I5Y"O8/)YVPQ4GHC8#IE-[ M(U9Q(I(-2RM6EQ(1E[Q;9P;C%Y5\LFG"5.I+7DL+FZ9DVM]ZLZN;)K611I,S M*AB5C"I&-:.&4V%EO>:5M4?!IBECE#,J&)6,*D8UHX91 MRZB+4)Q?M_0,ZI=Z9#J]3$O5:*4QH=E#/%#08.A#AA/,A"YOM]9G`^FTI4?! M!5656ME[JUH-Q$W#;EJU\FZ2H:Y3`[B)2_'"`GS-"W"/HIEC?9L,[9D$#&>. MR1?N*W;)FRU'L4+7;6M\F,D4G`H#%*0'3TH`"3C7(A5N'R=7V;_(I2 MLOM*`L;NDUJLQ>JJ^X;=MQ(P=I_\UMV)U27W<:&[344P-)P+W?&DT"<4->K5 M*AT!W`#A`FHCR3UR7]T[%SIO-L0*BZZS%;=M=E])0/\-WW5ZB7W(^T.VC8 M<2L!7VG:9H%HNN."1B+,H<3Q9"B94-*T:2CQ`<.F[0-.+6.>?O2Z>#`=:X)/ MY5%ZJW!Y(0'%<5+IM>B7FIPO:$IQ*P&C,7N6+`4ZL8K=ZXP3%[3;,%ECMN-) M04\H;M&SI#RR!Q\P'+-]0&EX27D4/DCL.!T!2G9<24#XUV%^EDS=M5BA/-4J MG8$;=M]*P-A],L%W8G7)?5S)'!N3ID^1.JXDX.1XELX1M>@(&51`TG`:3G$K`>/VGJ2[$ZO8 MO5K%%0!?WU4!SCZI@`G%S766+,RR!Q\P[`<3PKFDFTMG_"$I'R8ZZS%J@#Q7 M$M![GO/8[J,.#UW(<\-I;F//]"YE)_HEQW'AN]U9,-A0ZT].' M#&KLO.!Q/.D6$PI/L/#TQF"Y MP0J#E0:K#%8;K#%8&[,DG\G&C/I=SE,YK`0OHB M2N,<2AA*PZ="8T1IG.W\F4LRVZ-LSA;B"643LJ1L+FRB\'D/HPPF%OU&MKY+ MQB,4BS?3A*-8/`L7$WR.?S;SE$@V+"@J[RGX@?S,-$84U3^)$>7ES:88 M[Q^6-ZOP)H!D7D-9AM$G9>F6^,9H,;N=UO[A(:"P\)>U,]-LH."FL/C90.H3 M_*9_FZ&%C2QX&=X%`OY0QF0/^0S])?DTRW-S7SZ-7MPR#V[G5CT M`_KZ3I& MK%-8Y),8\AF&3?+IUL%F/OT".6H#$TO&C:0VT0:\6=3\/<,?Y\4SU1)*XVPF MM832('O40%-+!X,/(M*PS/M MY,@Z,62=PB+KQ)!U"HM\$D,^P[!)/I-%K2R19K?GU:N4UU98,A@DIZYH"%/0 M\'&:,YL&@_DM'0P%%A(A"H(\H2"(H2`\\][7]$Q-8"'>42RAIZ18+JP<9[>\ M=!06CP.375P&GD7C`#'DFL(BU\20:PJ+ZB>&?(9AXWS.+JTA3T(RWGD6;1WG MRV0GG,TD:+!W%.8^MW0>!]9WR>*@",RDEDIA4:S\=(68!6>1M;`DUN0`IPG, M)-96V,58DV)T*[1@M'AUB3J;EG31DL*S^`3C+CT*G$G0<&#Q+'IT93U/CM90 MO%.LP>O1*-Z)1;%:Q>L3K+&B>,_NM%+Y#LW`+"C>5V)-BMC7^%ADM>F-N=6ZLTT0_G,NWOEQ:VSV;3FO)L]I(,92M5[#U>YPC1&%*&W MPTQ]3BRMJ]%"O=G%=34:;!AC4GQN+7@N/O3X5SY0.<,ND18[GD5SG##-$X\TWD/)>29CA*5L&C!*W;J#\5!_I#_T%^2?[?>NY9_?W"#!+][ M_OWQ\27_\/+AIQ^^/'[[[3%[_/SY^Q<]@I^#3!+.=C;N>(*5]_/EYCW>MF`%W_3;N,_2L?)^-=^\GS82:3Q0W)L` M1ICU_>8]3KE8P5-$&_<@#"NN56[P/\N?:XJ;4P5P.-<&-Z>*8.W];//>S.UL M'R9VG(W\+EP=*0_(7+@Z5M'QXV[DB4)ZGZDA/M?[3`V%Y7J?J2&)KO>9&@K+]3Y30Q[')YXYY+YE+!$\8;]_PP*WA\<>.>"V0E7Z-+XMDO5O#DV<8]7,8*'B:#-U-9 MH<;PDQ"'V:YGFRT>!&<%C^EO,E/!T_I(FQ4&C^-OW"/J[`U/Y6_X-FX%UU8V:+\.K*2@=2\$;*B@=2\&+*B@=2\'+OAOW]BC'@Q=\L1"QE.T* MG1KO\W$8O(6V<6^5L8*WR!#&4K8HMZU9;GBU:Y.9"M[PVKC7F#@>O-6U*4P% MKW,A;588O)N-M%DY[:"XMWDY'KR6O7%O\+*"5[$W[D5>5O!&]L:]S\L*7LS> MN-=Z#67Y`,6L.2CN]7L.@YL04'.6LD4\6S.>#$IF*CD4]PXUQX.WZ%&BEH*7 MZ=&S+`7OU*-G60K>HT?/LA1<9H'ZL?*#"RQ0/Y:">RPV[NX#3C7NKD#-60KN MK$#-60JNKD#-60JNF=FX6TLX'MPCLW&7E["RA;>MZ0TWD*`6K'AR*.Z."?96 M0"E,!=>.H'ZL,+A]!/5C*;B$!/5C*0T4=PT%IP!W!VW.N M_V$%UP`BU=9XC7O^D&I+V2(_6S,_&93,5'(H[KHP3@&N@T.J+06WPB'5EH++ MX="J+`6WOZ%564H'Q5T?QBG`M8[P9N44]S;"FZ5T4-P%@.P-5S:B55D*+F9$ MJ[(4W,^(5F4IN&\5WJR1#Q>JPINEX%Y5>+,47*^*VK84W)^*VK:4+=*V-=.& M"SA1VU:J<0\G:MM2<-$F:MM2<-\F:MM2<.$R4FV-+KA1&:FVE"WRLS7SDT') M3`67]2+55AG@-EZDVE)P*2]2;2FXFQ>MRE)P^2Y:E:5T4#I3P779\&;E%/=A MPYNEX%IL>+,4W(Z-5F4IN`(;KBL;)&VK9DVW'".VK92C8O.4=N6@@O,4=N6 M@GO,4=N6@B]=(-76Z()/62#5EK)%?K9F?C(HF:GD4-R]^%P&^-3!QEV/SPJ^ M>+!QM^2S@@\?;-S-^*S@RP8;=T$^*QT4=T\^*_AR";Q9.<6G2>#-4O`Y$GBS M%'R5!*W*4O#M$;0J2\$G2-"J+`5?$((W:W3!AX+@S5+PO2!XLQ1\-@BU;2GX M+A!JVU*V2-O63!L^-H/:ME*-;\Z@MBT%WY)!;5L*/BF#VK84?#L,J;;&'7P< M#*FVE"WRLS7SDT')3`5?F4*JK3+`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`RFLH6R-94,2F8J.93<5`HHA:F44$I3J:!4IC+.%YO1_+UX.\?\ M,[=^J2+6Z3-'OUO40N6TB/,:"I[*$=3J9&?VLQ/`Z4Q ME19*:RH=E,Y4>BB]J0Q0!E-IY_@1$T_@+?(?QX,X:7;8HG:U9.AF4S%1R*(6IE%!*4ZF@5*920VE,I872FDH'I3.5'LI@ M*N,=9HP[JV=M43I;LW0R*)FIY%`*4RFAE*920:E,I8;2F$H+I365#DIG*CV4 MP51JE$%MED$#I3&5%DIK*AV4SE1Z*+VI#%`&4]E"V9I*!B4SE1Q*;BH%E,)4 M2BBEJ510*E/)9^ZQ+&O_4T-I3:6',II*/L/X-K/62#64UE1Z**.I='A\K3.? M>NNA]*8R0!E,980RFLIVACTM;G'A%4H^P[X1]XVP4D-I3:6',IK*%D\I'O$, M.GL;\2#B>.%Y0O=`DS6^9)P+)6"-;GB8"R5@*7B4"_FT%#RLA7Q:"A[50CXM!0]J(3>6 M@L?0D!M+Z:!TIM)#&4REQ@-95@DT>`+2XBTZJ,4[/+YE\7Z]Z2T^K#>#Q;?N M`-YHK3DZA=DGT"4LWJ-#6'R+ITRM>#,\86KQ?+W)+5[@$3>+EQC:+%[A:=,3 M?W=>(#[_],.?'WY['#Y\^^W3U^&ULE%W9FL=?9]>U.# M`%D#PB3U],S?7X]3F:JH=*<:YF%0NT=$965Z+B>J*O/MO_[S[>O1OV\?'N_N MO[\[;IR<'A_=?O]P__'N^^=WQZMEY_\NCX\>GVZ^?[SY>O_]]MWQ?V\?C__U M_G__Y^W?]P]_/GZYO7TZ0H3OC^^.OSP]_O'C\\.7VV\WCR?V/V^]@/MT_ M?+MYPG\^?'[Q^./A]N;CP>G;UQ=GIZ>O7GR[N?M^7$3('GXEQOVG3W/]IZ<3A'M1 M%)3O^X`ZOVHX?;3^^.KQK9U?7+QO&+]V\/-;2^N_W[T?U] M]/CE_N_NP]W'X=WW6U0W&LJ:X(_[^S_--/]H$)Q?D'?GT`33AZ./MY]N_OKZ M-+__NW=[]_G+$]K[I;E\N/^**^'_C[[=F0AP[S?_.?S[]]W'IR_OCL]?'1_] M7;Y^^;AO_/KN5!:]Q?!T<\6\L[._? M,;K9X>KX]_GJKQNG;\Y_H]8:T$31 M_Z)K;/)&V>:-7[UL;.A&V=+UK=2(K6M_A(*BXFN:!QH/M^9:]A\N$INT4;;I MK]9&;,A&V9+_<+$WL7SX(]R17;?FELYB:]D?O]?09[&U[(_?:^BSV%CV1RSH MV:]TK;/8:/;'A M5U63YK/)LW8(:1/2(:1+2(^0G)`^(0-"AH2,"!D3,B%D2LB,D#DA"T*6A*P( M61.R(61+R(Z0/2%75PR5S9R*"K/[;XG*[-\=GV&U^JP7S%J)9*X+JUI5/9L\ MJXJ0-B$=0KJ$]`C)">D3,B!D2,B(D#$A$T*FA,P(F1.R(&1)R(J0-2$;0K:$ M[`C9$W)UQ5#9S*FJL/3SJHHK'H,/XHEM?AT0#(+/`W6E1!DY`6(6U".H1T">D1DA/2)V1`R)"0$2%C M0B:$3`F9$3(G9$'(DI`5(6M"-H1L"=D1LB?DZHJA:P]5UL3X):=T87!5%P6" M;,2S+@AI$=(FI$-(EY`>(3DA?4(&A`P)&1$R)F1"R)20&2%S0A:$+`E9$;(F M9$/(EI`=(7M"KJX8NO9011?XO>QU$7YEGUC.[>G+W8<_K^\QDS2>?V2;>54O M`7'C""&M`FE8PLK-2V^J\U*[M(K2ZS#49:C'4,Y0GZ$!0T.&1@R-&9HP-&5H MQM"O2*CIN&-HRM&-HS]#5E<"N*UA%;?A= M]#MJ,_.JV@)25D.3D%:!-"SK6:KM=:-:,>W2*E9,AZ$N0SV&Z@B M)TOW>SW%A?$!KPHG0DXY#+4"U+#LL]-.DOUI.[-G\0BL&[$WE07YZ_.J%'O. M+(;+!=:/6%*Z),=KUN]*R_0"^:X0*'?'[2 MK#E'[D>7^LB#:%9?]"%?8!0]ZR\PCF;U%YCP!:8,S6*P^FO.HUFLKJ3A%QQY MR=`J1JF_V#J:U=_@AB^PC9[U%]A%LW@W9Z]/DG%XS\'1Y4(GB&[)O(^^IGM) M:5?M?I905MVO2#17NE\!6?>+7;)I3X2M2Z*O1:P5,6?7CAA*'>TZ`:OT&[Y$ M3[CF[-J/9NZJ@XBYJP[9=13-G.LX8LYUPJY3AF;1TT6;1\Q%6[#KDJ%5]'31 MUA%ST3;LNHUFSG47,>>Z9U>H+#2$LX.R*JU3E9$ED96,BN1R148%=%$JIFGO M!H1IQ,9!C-A)3VA%BPN_Z*6AN.W,2IG1];K.K)Q(*%K/F<5H>@[&)SY^?[R\F2+ MS'=%\@7D1-.T7$&0?"QT*V(H8,3:`NL$S(7K"K.>P')V[0NS@<"&[#H29F.! M3=AURM!,>,X%MF#7)4,KX;D6V(9=M\)L)[`]NT)DH5U=&T)8`82PT+#5@=.2 MWTI%AB<_\0K(S9=-RP&$Z3<,G*58P]L=P0(#^<$BZ3SM&,$-])V`N0MUG=FA M[URDO;#G+*)X<%AE@%R/7;%T)JA#4-;AG8,[1F"-@LMN%)`FAZK*A.CH%2FX8DR"\@)IFF_ M"(,R8\6T(N:TUA98)V`N7%>8]026LVM?F`T$-F37D3`;"VS"KE.&9L)S+K`% MNRX#Y%INQ=":H0U#6X9V#.T9@GZ*-G6E@'X\5M6/Y>35R%;DZBOS8P&YP$W+ M`9E^++[[K9_,V:UH%N;T"QK>0A@W''>"C[M:-PF3)@QZCH]JSCE,WYF5A:9U MY<"9Q6A#CC9R9C71QLXL1IMPM"E#,^=I@]O+=$R?.X,8>L%QE@RM&%HSM&%H MR]".H3U#4">)".KT6%6=EL17ZBR2^Q5U%I#32]->_0WJC!73BIB36EM@G8"Y M<%UAUA-8SJY]8380V)!=1\)L++`)NTX9F@G/N<`6[+ID:,70FJ$-0UN&=@SM M&8)^J)FA'X]5]6-)>Z6?(IE?T4\!I6G+)(W8M->?PHQY6&J(M&6PP/Q9,R"T M8R`WS78"5IE2?RE:3T3+.5K?F16EKV:H!XZ//6;(84;.K.86Q\XL1IMPM"E# M,^=IY<1G#$GR>^XL8NP%!UHRM'*>-85?.[-X@0U'VSJS0TG326GG#&*! ML,N&/@1*YDBH/!@@4526^Z>_>R%MJ?P#7ET7!JB2,8R8SQA&S"FV+;!.P+R* MA5E/8#F[]H790&!#=AT)L['`)NPZ96@F/.<"6[#KDJ&5\%P+;,.N6V&V$]B> M7?%B69I:#*`'/)%1D=%V,V8S6-GRL!AN*&,8+3`= MEZ*FM5C;F<5.U`F8NU[7F=5$ZSFS&"WG:'UG5A-MX,QBM"%'&SFSFFAC9Q:C M33C:E*&9\ZRYP-R9Q0LL.-J2H97SK+G`VIG%"VPXVM:9F3;.7Z?KVIVSB('V M'`B:CL]:0L8P>3X'?<=G+7Y&_OG(:?ES)?DBKX[.$DMS;=]N83'@)-@,D$D^ MFK4BYM><`NMPN*XPZPDL9]>^,!L(;,BN(V$V%MB$7:<,S83G7&`+=ETRM!*> M:X%MV'4KS'8"V[,K1!:>JK@VA+`"*#*&-DM+%179ZXJ*"LC-E\V#=_'`+@R< M:<8P6OS#*M.913EV`N:NUW5F-5V[Y\QBM)RC]9U94?IDE>GX&&;(84;.K*90 M8V<6HTTXVI2AF?,\E//R)!DZYLXBQEYPH&6`W#BP8FC-T(:A+4,[AO8,0:*% MCEPIH%"/56=VRW:K8:[(@E<$6D!.,$W[@#3\#(H5TXJ86UNT!=8)F`O7%68] M@>7LVA=F`X$-V74DS,8"F[#KE*&9\)P+;,&NRP"YEELQM&9HP]"6H1U#>X:@ MGZ)-72F@'X]5]6,I::6?(E5=T8_/7A\>>#3M.^*0FBG[]N5EFCB,9AAUK8,FNP6'73*T8FC-T(:A+4,[AO8,0;:D M+LC68U796B9V9(>B'FAGZ\5A5 M/Y:K5OHI!:F6M+ ML\/UDD13SUTM:CSG,'UG5C-H#9Q9C#;D:"-G5A-M[,QBM`E'FS(T<)0E0ROG65/RM3.+%]APM*TSLV*^>G-R41FIDY>6=\X^AMUS6(B\ MVNAI'@:*#P:V8'1/\LJ?'=5>8!EWU0N*3'RE%Q10-;L8L$IV,6!.O6V\Q7WH M&@[K!*RB:#;K"=><7?O";""P(;N.A-E88!-VG3(T$YYS@2W8=#,8K0A1QLYLYJRC9U9 MC#;A:%.&9LY331=SQ\?("PZS9&CE/&N*OG9F\0(;CK9U9JJ<.\?','L.`PV7 MK7B8*!+-0,_!P-8(_SQ2GO_D._,:J(-G%F,-N1H(V=6$VWL MS&*T"4>;,C1SGC47F#NS>($%1ULRM'*>UDRG:8)D[0QBZ`W'V3JSFH+NG%F, MMN=H4'A\*.-'26ITB%[+]2?KSG-+N(L%PP%/^D',S;LO&()9Y3N8B+DU9EM@ MG8!5A!V?"93/>GK"-6?7OC`;"&S(KB-A-A;8A%VG#,V$YUQ@"W9=,K02GFN! M;=AU*\QV`MNS*\3�%E5010'4XM*ZYD5&3+_;KSO(`:R6R?_`YK1K-R+9J\ M.-2*%F$M^I)>:6D[B]BU.@%S:X*N,ZOIJ#UG%J/E'*WOS&JB#9Q9C#;D:"-G M5A-M[,QBM`E'FS(T$@>BW7GPVGEMU7_:#(^E?Z00%9/X@%;9X'S#_KCIBKGK;` M.@&K"#N$1,!L+;,*N4X9FPG,NL`6[+AE:"<^UP#;L MNA5F.X'MV15BXX:`LBH"J`ZGEFU7,BJR\!49%5":$TT>0#3/@UG-ZC18A-7I MFXN39,!MQQAN8N\$K#*)EX%J>E9/1,LY6M^9U40;.+/8FX8<;>3,:J*-G5F, M-N%H4X9FSM-&NU>-M!;GSB+&7G"@)4,KYUE3^+4SBQ?8<+2M,PLE3?+H.V<1 M`^TY$-1=-KA%2F0#H0?^US*AMB6[U'[Q!*&B_0*J9$(/[LF7V1%SPFT+K!.P MBIC#)9QK3[CF[-H79@.!#=EU),S&`INPZY2AF?"<"VS!KDN&5L)S+;`-NVZ% MV4Y@>W:%R+@AH*R*`*I#J*7?U1!:I.4K,HJ9>D1S^:?D!>GF>3"K69$&B[@B M339J:,<(;C[N!*PR;9=ARO+0+[V>B)9SM+XSJXDV<&:QLP\YVLB965^G26+L M#&*<"<>9,C1SGA:ZD=3>W/$Q\H+#+!E:.<_#`/7RY'7E&5`R8JV=?;S2AL-N MG9F%/4LR0CO'QS![#@-IE^VM;APR#P;)3Z:?K4'M\8!2?O'8H*+\^"3!KT$# M5EF#!LP)MXU1LGB45&;<.@&KB)G->L(U9]>^,!L(;,BN(V$V%MB$7:<,S83G M7&`+=ETRM!*>:X%MV'4KS'8"V[,K5,8-`64%4&5(+2NO9%1DZRLR*B`$BSIO MGH>3-]$BA:866O&I;8SB\$[`7/7ZSJSFF@]9Q:CY1RM[\QJH@V<68PV MY&@C9U83;>S,8K0)1YLR-'.>-H`DX]#W;%/M[Q@5(Y-5Y=1U`\>;_XR0.E`YZHJ,C0NUFR&:S<=SWEY%YL M:!$M,`77=,6V,XM]J!,P=[VN,ZN)UG-F,5K.T?K.K";:P)G%:$..-G)F-='& MSBQ&FW"T*4,SYZG&C[GC8^0%AUDRM&)HS="&H2U#.X;V#$&G)";(U&.57T47 MEL(7D_H!3U1:9/N=:IK!JO+P/&)^:2BP3L!^,!L(;,BN(V$V M%MB$7:<,S83G7&`+=ETRM&)HS="&H2U#.X;V#$$_U,S0C\>J^K%LN-)/D27W MBT*T].'W03())WMD-J-9N5!,?HVUHD6<[E\FZX:V,XC]M1,P-U-WG5G-N-)S M9C%:SM'ZSJPFVL"9Q6A#CC9R9C71QLXL1IMPM"E#,^=I8][96?I4>^XL8NP% M!UHRM'*>-85?.[-X@0U'VSHS*^D%CJ>KOEJZYB7?)'FQIJT(PR<4AZ[-+QY%"_Q[6/!<)(-P MVQE$<78"ADX2H:XS*PO$B4EG%EUSCM9W9C71!LXL1AMRM)$SLWM,)I&QHV.4 M"4>9,C1SGH?*.S])7E68.XL8>\&!E@RMG.>AZ5ZFL=?.(L;><*"M,SO-CF#V'@9J#ENQ?)[ER2#S\&('`"[M"'-5ATE+R2M]%JKZB[P+"-VC/$FMB MV(MBC@5M10P7C5A;8)V`510;PCG7GG#-V;4OS`8"&[+K2)B-!39AURE#,^$Y M%]B"79<,K83G6F`;=MT*LYW`]NP*87%#0$4%J%1D&6^EHB(37E%13(Y[%06L M?%239A\O@@6$<>C5C?-TMX2V,XFRZP2L(K%JI)?IM,-L);,^N$!8W!(;$`E0JLJ2V4E&1[*ZH*.:_ MO8H"5@Z)B8);%\$B#HFG8D@L36*?Z02WBL1*L\,(4?W]UG,7BE%RCM)W9H1YN]Z11>;I\FE3TW-G'*RTX M[)*A%4-KAC8,;1G:,;1G""HMVM(U+T3JLKZPI6%9"EKL4HA].N['>!'^4"U'B#']ONMTJR MTFLZL]C;6@)K"ZPCL*[`>@++!=87V$!@0X&-!#86V$1@4X'-!#87V$)@2X&M M!+86V$9@6X'M!+87&`162,-T$!L8"JN`A<1>/'ZYO7UJW3S=O'_[[?;A\VWS M]NO7QZ,/]W]]AWXN<(",PX\>;C^].[Z^R##<6=QGAT"\!''X/4I$PYC#S)M0 M&.0SZZ<<#6-]9MV5&0SYF?5'9C"F9];AF+%!V\H@.93N3/A<6ZE5H:_/0$B/ MH,WG_F-$S&T2YQ)BV,QM*F<'LG=GHR0PFY\S&4&8P1VF.F"L1],S.!7?68_FYC!C_O,?BDQ@]_NF?U>8@8_X3/[B<0,DHNH M576GR#&B5A6#5"-J53%()T+YBD%6$`Y)-I(,7@'L"=ZOF*-RHS6N2 MLYO5]XIGTE"#NA*>14,-BL$#9ZA!,7CN##4H!H^5H0;%X.DR>I%B\/`8O4@Q M>/D%[:!J`>_`H!T4@U=AT`Z*P0LO:`?%X+T7M(-B\/H+E*H8+!1L18+7IUAU M>%L%[:"\\%84VD$Q+3!MR>!E)[2#\L$[3V@'Q>"5)K2#8O!F$]I!,7AQ">V@ M&+R_A)ZB&+QAB9I3=8`7+='[%8/W*%&GBL'KE.C]BL%+D^@/BK%W)ZWW*PYO MKN*.%(,76'%'BL'[J="<8O":*C2G&+RM"LTI!B^E0G.*P6OSF;W4S.JQM^=Q M1YK#B_-0G>1,D%J/>'49JE.E:(&Q]SBY%'@C&:I3#%Y,ANH4@_>.H3K%X/5C MJ$XQ^$8BLS?/N03X$B*S]\^9P0<1F;V&S@R^B\CLS7-F\+5#9N^?,X./'C)[ MY9P9?'N2V5O\S.`3E,Q>W&<&7YAD]OH^,_C0)+,W]IG!UR29O;?/##XJR>SU M?6;P_1ON1\V[^`P.]Z,8?.H&S2D&+#5M28!1C[ MUIM;")NFX([4O(N;P2K0]K1@+ZC.5HB2,T':5]KLU01C'^LS@UTIH#K%8.<) MJ$XQV(`"JE-,#B:7#+:9@.J4#S;(0=VI>\7^-Z@[Q6`;'*A.,=@-!ZI3#+:\ M@>H4@YUOH#K%8/LAW(]BL`L1[DV%/VLPV]&0&6\YFMJTG,]AY-K/= M/9G!!K29;>C)#/:9S6Q;3V:PFS9J0PMGMALK,UTPM@$K,]A(.+-M6)G!?L*9[;S*#+9'1SNH>\7N MYV@'Q6`3=+2#8K`7.MI!,=CA'.V@&&QT#@4K!JH]V4`SVM$<[*`9;VZ,=%(.=Z]%3%(/C M-M`.JA9PZ@;:03$S,'8\`M\/#MA`.R@&YVR@'12#XS;04Q2#)K`5$TYJX2OA M=`RT@_+"`2QH!\6TP-BI%AP-YZJ@'12#XU70#HK)P>22P2$J:`?E@Z-2T`Z* MP8DIZ"F*P7%.J#E5!SC5"6.P8G!H$^I4,3B["6.P8G`^$_J#8M`?;%4K.1R7 MA3M27C@U"W>D&!R*!X[7`"%C2G&)S5ASM2\YH=V6=W M)#FJ4YP)4NL1YZ5!=:H4+3!MR>`8-*A.^>`T-*A.,3CL#*I3#,X\@^H4 M@R,947?J?G#L(NI.,3A]$:I3#`YAA.H4@S,6H3K%X*A%J$XQ..D2]Z,8''B) M^U$,CK6$YA2#TRVA.<7@\$IH3C$XPQ*:4PQ.XLWL-%76'`[DS>Q0569P+F]F MIZ8R@X-W,SL6E1D[61>*DYR)46L1QYE"<:K<+3!VNB-?":>40G&*Z8*Q8QW9 M!V,H-CE#,[Z989 M'#^NA*,3C&'KI2#$ZSAZX4@^/JH2O%0%>VGI1<#LK.W, M#,'8(>[,C,#8N>W,3,#8Z>W,3,'8(>[,;!I8$3347+@%LY/,'LQ>,J@%RS)I M[MJX:\E=HWRZ[II@FK+D+3!MR73`="33!=.3S`2%F\BR3<%,)3,#,Y?,`LQ" M,DLP2\FLP*PE@TJSM5E#S3=6J;I.FV":,EX+3%LR'3`=R73!]"23@\DETPS%XR$+:MS20W!365S`S, M3#)S,'/)+,`L)+,$LY3,"LQ*,GTP?9'(P MN61:N-6.O-,NF%PR?3!#R8S`3"0S`[.0S`K,1C+7K]`*:NIH768+-1FO+N&@ MB!:6A6_$'#3#PECA*RQQ%;[%3PV%7UW9CXD#\^+Y[<7']V]_W'R^'=T\?+[[ M_GCT]?83W@H]/7F-3QT?[CY_>?Z/I_L?V%_R^.B/^Z>G^V^'/[_&ULE%C;CJ-& M$'V/E']`O*]Q`[XAVZOA,LE*&RF*-LDS@[&-QM`6,#.[?Y_3-Z#IWLGNRWA\ MJJ@Z755]NO'^X]?ZYKR6;5?1YN"2Q=)URJ:@IZJY'-R_OSQ^V+I.U^?-*;_1 MICRXW\K._7C\]9?]&VV?NVM9]@XB--W!O?;]/?*\KKB6==XMZ+UL8#G3MLY[ M?&TO7G=OR_S$'ZIOGK]J*%-:O-1ETXL@;7G+>_#O MKM6]4]'JXD?"U7G[_'+_4-#ZCA!/U:WJO_&@KE,7T:=+0]O\Z89U?R5A7JC8 M_(L1OJZ*EG;TW"\0SA-$S37OO)V'2,?]J<(*6-F=MCP?W`<297[@>L<]+]`_ M5?G63?YWNBM]^ZVM3I^KID2UT2?6@2=*GYGKIQ.#\+!G//W(._!GZYS*<_YR MZ_^B;[^7U>7:H]TK]DA!;\B$OTY=L1G`TO.O_/.M.O77@QNL%ZO-,B#^RG6> MRJY_K-BSKE.\=#VM_Q5.1(8207P9!)\RB+]9A/YJL_V9*(&,@D\5Y=VLH?3' MI_1?V_P]L6)>J33O\^.^I6\.Q@]KZNXY&V828:VR1'*=0]'0NX)Y/S#W@XL- M@G)T0%^/9+G9[+U7M*&03K'%2?=(E`=K!8N;SH%L`GB@.O!%=7^&+W-G?%6B M6`'C`OP9-^6A'DGG0#8!-&[HV9Q;L!Q*QZP8K$GIMKM0SQT+'[*;.*UUEV1P M&?@92#9%-(:8DCE#;(CO=INY'UP?&V_:[JW.*!9>[Y(>7`;2!I)-$8TT"$Y( MJTED*.>F0L8"(6.S$P-)#22;(EI:["-+6H;J:05"N([Q84X,)#60;(IH:3?6 MM`S5TPHD$!K$]E`B$4SGT*T=6>K-2@6?2ON-'TE2R"/:/A2:'=9X2`E&U]D1"VQ%* M%21.,M;Z3$%K,SD3TK&+JD9$Z"NVMLH42RADBO5Z1)5F"TR4`^$.X68QT_UT M=%!!,P7QW:'UCC`5M1`3XJH1$Q"(J;`)?_C@AN/TIR:4*ZJ2674CKHS.RD3(AT$+/B6ZHR M.(Q5D9"E74P7+<2$7&K$I(*.(I+@F)1CJS*E)I0IR)*W6.05]:5"P((`V#?#P1OK`VSO#8[RI\I!SW,<;+$LUQX,(EW`3 M?PBC!ZS,-,1AA`NP!2>[*,9(F98$%C9_I@7[`JQLEM@GB&;+CV&*$JLEA84U MR)('%M8GTQ*3511#44T+#H8HM5HR6)@*F\_$9(-H7()F98:@(IK-DL'"U,L6 M#37`S<"TX(*#:#8+KC&(9K/$)$`T6^=P,4`TFP7'/Z+9+#%*P+?%;)TQ"F!; M2X)%\@TR\T^V46;SCS%,N"I:EKZ+V$W3-*08,JLAPXP)@S&PO M=V]R:W-H965T3/V\>GVX?[M^>SL]FIR:OA\??G[[>W#R?0.'^Z>WIU^?G[\GY^=/UUYN[JZ>S MA^\W][!\?GB\NWK&/Q^_G#]]?[RY^C0DNOMVOIC--N=W5[?WIZ-"\O@S&@^? M/]]>W^0/UW__@'R=_=7C\^/#U\?CZ# MW/EXH5SFW?GN'$KOWGRZ10E;SZ_/7T_3RXWB]/S=V^&`/W?[/C=N3:?'$+B_Z?A[_JF]LO7Y]QN]U3X(7O\]&D79Q?SV6YY\?-%V'D-_/Q/BS#''1ZN MP_WRRX68RUUTO_S'Q9@OY!KPBZC\=!V8HP:-)="JM#M;+=87VZ$JO5)]YE)_ MW"\^X^6Q$KR64"H/JK8DG,^T^KZ6=".7BU]\GJN?2RG5;:[U[;6K/1];W-!2 M\ZOGJW=O'A_^.D'WAWOU]/W*=:;SQ&GY-NH;VK'5HO.X=N[OG?_;4U14M,$4>F3BX?H"IYO'H(A!&8,J!G4,FABT,>ABT,=@ M'X-###[$X&,,+B?@''$_!A]5_)>"[_Q=\"5JJ0"]&XLHT.(A2?(8%#$H8U#% MH(Y!$X,V!ET,^ACL8W"(P8<8?(S!Y00$@49O\$N!=O[#X^A8RW?+N)*//G/T MMT>G313\H\LQ^D0*(B61BDA-I"'2$NF(]$3V1`Y$/A#Y2.1R2H)[@>[UE^Z% M\W][NL`CZ1CG^6P["T.=CEZOWHVCR_%N$"F(E$0J(C61ADA+I"/2$]D3.1#Y M0.0CDX&GEG3NR'=O,-#T"56Z4CFVOED1'(B!9&22$6D)M(0:8ET1'HB M>R*'*0DB@T>R%1F'P\B,!$,/B55&)"=2$"F)5$1J(@V1EDA'I">R)W*8DB`R M&"9,(^/'#&=NL/K\]?;Z]_0!+75^'#(X]S!B(YGO\%P\MNG=:AXVZH0V1[NHMD0Z4NV//EXU*MW^ M:!?5PY0$\7;SX'PKHQDN3K&)?-D<@M&LE6?8B3SM3J5WFES%*I(J":AAH5: M$NI(J">A/0L=ID)!<-P,THK.P,/P>+2:/N!WJZAI9^*EO6SN$;J=81JRW:S/ M+J(.05VDE94L5#&J->&@O9E?Q-J-NHAVRT(=HUX3#MJKBXNS=7C=>W41[4,@ M%,;:32^,_L'-PZ.JZ!%B+;J9H&E@QX0(K'@5WFN"2DY8,:HY8<.HY80=HYX3 M[AD=@H1AH-STP`K4.&W`$%/*F[IE",0.C7;:E:["VY2)E[;17-!FJ)07FTW< M=Q7J(;F5@E2G8E0+\M+S7=Q7->HATJT@E>X8]8)&Z?5L&=?VO7J(]$'0(!T& MV@W^)X'^T0C!+=O$-75$TU[3>RVU*+E'*WWF%(Q*C];#4N>PW%"Q5LT)&T8M M:W6LU7/"/:-#H!4&T(W7)P&41[Y;FXH#-:*H^XPZE,PG7$U;^9APC4`?1PO\ MV/<)+RZ&^KQ9[99QK2N]RWIO5[/9A=JOM"J.:F?X7M?>#B`Y9AS?,32,F-^R'-7Z<=@1=SHB"OMFCZ5T; MT7HR4G#KCJ@4%]HN2H_6DZ&"1Y,:4(N7:C6LU8J7:G6LU8N7:NU9ZR!>@U88 M0#?;>"V`_WCX/IU4S,?921!`/V'1.&3>:S)KS1D5C$I&%:.:4<.H#5!8:#?D MGQ3ZV,S'J4!0N!&ARY#^-W/+M;CO$Y0S*AB5C"I&-:.&41N@L'!NY#PIW`^; MQ#C2#@H]HGBB&$U-,MS>H5?4&Y][]/)441TDGB6CBI5K]?(3NVA^U:B#*+18-]UOQ&'(+(H:0F!$;>#BS\&@ZAA"DEYQ[-)U[ M"=(!<"E(>\&*M6KQTEZP$:1:K2#N!1G(+WD7)`.'0I&I2!-6#&J!:E6PZ@59!3.#7"-EK]P/+K5(_K!9,0GG+9\ M0>.P?AX-"@LUR\TH!6G[J!C5@KSN\BSJD1MU$.56T*` M!2U]]`K",:+I;,$GG*#2H^EL0>0U*C4G;!BU@598:#=HLV[_.)A#%R&12]TF M!-2(J*5'2QV9>&FMS3WZP0A?O&9#?[#&`#_J#TKQT*I><6ZU>+TZXF[$R^=V ML8US:\6#!]F+'XT1HX7GP3]J2N,8,>@G/)H&;D330;;76FLW7@J:/A)(JQ:O MZ2/!RZM6*U[&(R$:(U+KB`;&"QX[>C09*&8!"BNF-6Q;K,_<*MNX!6#!`S6/ MULA;'_N[:($X$R^D/WKM)@.-\#K<>&320'RY90L0[TQ8C`,8]W`]JN-%8701 MJ7=S`XRC6]1]9>HCC3!G5#`J&56,:D8-HY91QZAGM&=T8/2!T4=&EP$*[L_R MA7'8P,-&YQ%&P1+.C%'.J&!4,JH8U8P:1BVCCE'/:,_H$*`P4"^,Z9;C`&[: MTWLT;:B,D9[1H<`A8&*AGO4TT7=^Y*'@8*F-F!RJ@RBWC#I6[M7+*T?]VEX=1/D0H##4P>!S M=>S:$9)X\.D1QE':7^[6T?:+3+TD]US0JU/!PGOY]XJKQ786SP5+$9K,/`7I M3:T%O9I=$V:W=.OS4>??BI!FUPG2['I!KV:WC[);S+9GT7+!081XINO&^_H$ MG-PD'O\.KL&L/V.4>S2=Z7H4O&84M\FXAL5J\9J,:PRQ5MQ4K&.Q7KQ4;&^( M'<2-1TEN5<2,E>/1TVA$F!)/*W34G+)!$(/NR:A0T#B[W>(E233;+M1#6D$I M2'4J1K4@+[U8QM6D40^1;@6I=,>H%S1*7\S6\57OU4.D#X(&Z;#G<&/7X[!L M4BG',6WP-*/!<+8DE`O2R47!J!2D9:T8U8)4JV'4"E*MCE$O2+7VC`Z"C$`% MX_9)H'A\OAQ1U,5&'46F7G*;IER3,!8V]S=+U-KO)?]&B=QDC')!VB<5C$I!6M**42U(M1I& MK2#5ZACU@E1KS^@@R`A4,$72FKGB*9)'KI8?I^^[=;1BE:F7W*9V+VZN' M2!\$<7^P"N9;DZCSO&IP#<>7C')!VD$5C$I!6M:*42U(M1I&K2#5ZACU@E1K MS^@@R`C4"[,EUSU&@TN/HHXSJFF9>LEMR@6-'4]'43Y(,CH`%Z8ZJQXJN,1M$0W8Y0+TAZI M8%0*4JV*42U(M1I&K2#5ZACU@E1KS^@@R`C4"_.<%<]S/')SIDE/&T7$;#BD:]1+X5I/(=HU[0J_)[]1+Y M@R"CZ;L)BS'=68T3F>ETQR/$6W0S07K9N2#MBPI&I2!-6#&J!:E6PZ@5I%H= MHUZ0:NT9'009@7IANK/BZ8Y';CAPK`7K)?618\)).\\EX=CG+.+!6:%VN0.E M(&V5%:-:D.\DPW%!HU:1;06I;,>H%^2O=Q=O9=NK@R@?!!E-/YKG_&AY=,7S M'X\0>"UFSA'O7FC+J+=BI!J=X)4N]>$3GNUV1F5=8P)BB;: M!Q'BM93S?M/`6-G=%\%7=&A3K(_2T% MZ2VO&-6"O/(L5F[4091;0:K<,>H%>>5=/&7;JX,H'P0-RF&0@_G.I$[R?`>; M/]S(?MI1"M(KS@7I8*Y@5`K2A!6C6I!J-8Q:0:K5,>H%J=:>T4&0$:A@OC,) M%,]WW-X2MZ(V'61NXWY2G*;-V:<;QYCS^2:>/Q222!MR*4AU*D:U()&F_6V- M>DBM:06I=,>H%^2E%XOXJO?J(=('08-T6"<_&.^/A"R]^2(G]*/%\TZ.@ M\QR]ID\E[X7N6JZJ8%1ZA'HA7I7(:UAJ3M@P:EFK8ZV>$^X9'0*M,(#!;&A2 M47DVA(T[OD7KH',;+4=FXJ3-*_?(W<3C8)4WSWJOU[Z2$"%ME!5G5XO7J]DU M87;F5Q(BI-EUG%TO7J]FMP^S^^%7$B(Z9!W>KV`V]1,5GF=9^*2!>F:/IG=M M1*@Y4I4+GW#ZE81'TZ\D1%ZU:O%2K<:CB58K7MI==:S5BY=J[5GK(%Z#5AA` M-RDZ3D>-`$:;P=R&K'&%2FLO]D1%*Y*I=WMU3Y3Z2$AS1@6CDE'%J&;4,&H9 M=8QZ1GM&!T8?&'UD=!F@\/8$4[1)?\13,7S7Z^[,=$\4HYQ1P:AD5#&J&36, M6D8=HY[1GM&!T0=&'QE=!BB,\`MSN/4X.9FNQW@TW4S%*&=4,"H958QJ1@VC MEE''J&>T9W1@]('11T:7`0HBO(EF;C\:E`S^X13%(WSW)%U%)EXZD,@]H]POY5N8B]>DVN?A,MKQ_42Q)^8/21 MT66`POL3315_>'_X'=IF1-%G59MX"XQWFY0Z]VC[X@DN$X=1*9GF;UZ>9EHQ>:@#B+S@64^JI==J$MU@$QX3U^8F>)P M1O_XEHQ3C]R7J-IJ-M$#/9.$%\<*FWN$?:KN\G!`731+*R0->M*C\C;>/EV* MERI7D3)]]%-+FE>5&_%2Y392IA7?3M*\JMR+ERKO0^5-_!'"09*\*OQ!O%3X M8RB\BU?HW'F;PRU]27BL%^.1FN-!?7]6:#/?/?F MR,?#/--55L@5#Q<0-@-B" MOB$I4,79@N:>N!;-%K3@Q#52MJ!1)J[=L07M#*>66A8<9_K>O&8DL/S3!8IO MY)`ND\MA_!_%Z_T*^L,C(#)@9I6XT3Y?+"98B1OTLP63JL2-_=ER@,5-`=B2 MKK<(OG4%>)@BD,.R?G1M>%`A7)8%"Q/(QZHR*:X@-:\`,^0D,RV8*">Y:2E@ M<;,O+D\)2VE:,#5.*M."&7+BIF2LAEEQXF9F;&EA<1,TMF"U$#$P*P&BDYK1 MR6#)3$L.BUM8X7RP=(626A:L8*&DE@4+62B/9<%J%`B$&5D3QI@[2`&E@6O>!`#RX(W/8B!9<%;<,3`:B4IHI.:TS2;N)2);\(8V<2\.V8)7L8E[?\@6O)%-W&M$ MMN#%;.)>';(%6U00`ZN5I(A.:D8'6R@0`RMNV$F!&%@6[)=`#"P+MDT@!I8% MNR<0`\N"[1&(@67!+@G$P+)@LP1B8%FP8PPQL%I)BNBD9G2PHPDQL.*&C4V( M@67!!B;$P+)@'Q-B8%FPG0DQL"S8MH086!;L7D(,+`LV,2$&E@6;.A$#JY6D MB$YJ1@>;#A$#*V[8>X@86!9L,$0,+`OV&2(&E@7;#1$#RX)MA(B!9<%N0L3` MLF!3(6)@6;#E.G&[B;F58'LP8F!%!UN"$0/+@IW!B(%EP8Y?Q,"R8.,O8F!9 ML/\7,;`LV.>+&%@6;/=%#"P+=OTB!I8%'T(@!E8K21&=U(P.-NHG;ELYQPW[ M]1.WE9PMV)2?N!WE;,'>_,1M+&<+MN@G;C,Y6[`//W%[RMF"[?B)VUK.%NS* M3]QV8D[XXTM."]L26=;Q)W'AI;<&)7 MXD[@8@M.W$(:RX(3*)&/M523X@I2\PIP$F*2F98).X&,+#CU$#"P+SH5%#,SE+40G-:.#?+;PS/^@I4[RO+D*_XTV0V.2\4?"SH]^?SP\"S_\7``!><```&0```'AL+W=OF6L: M8YMH`PZ@#_OM]Z\JY/CW?/3Y\ M.%PW#[_CRX?!__U7\X^SPX/GE^N'3];?'A]L/A_^^?3[\Y\?_ M_J]?_GI\^OWYZ^WMRP$L/#Q_./SZ\O(].3Y^OOEZ>W_]?/3X_?8!DL^/3_?7 M+_CGTY?CY^]/M]>?QD3WWXZ7)R?;X_OKNX?#R4+R]",V'C]_OKNYS1YO_KB_ M?7B9C#S=?KM^0?F?O]Y]?Q9K]S<_8N[^^NGW/[[_X^;Q_CM,_';W[>[EWZ/1 MPX/[FZ3^\O#X=/W;-]3[[\7Z^D9LC_\@\_=W-T^/SX^?7XY@[G@J*-?Y_/C\ M&)8^_O+I#C5P;C]XNOW\X?#717*U71\>?_QE=-#_W=W^]3S[_>#YZ^-?Y=/= MI^[NX1;>1CNY%OCM\?%WIUI_<@B)CREU,;;`Y=/!I]O/UW]\>_F?Q[^JV[LO M7U_0W!N7Y.;Q&W+"_P_N[UP?0-6O_QY__G7WZ>7KA\/5^O#@M]OGE^+.I3D\ MN/GC^>7Q_O\GX<*;F!(O?>(5BN<3;X\VIR>KQ7+SPT:0W5@"_/1&%ALU\D;N MR&),B)\^X7)SM#S;+#9;E_T;*;<^)7Y*RK,?RO+4)\3/GRLKQM585OST"<]^ MK*CG/B%^2E%_L)(+=)JI:5WO\+.'AYM%YN3L_&`?!& M#UQ(3W*__%")CZ>!.P[X[/KE^N,O3X]_'6`611,]?[]V<_(B<=;\4/?]?S_X M,0?=./5?G?Z'0W1$#.]GT#\_GJ_.?CG^$[/)C=?9L#/@9##"YB_':3H`V MQC)RM&A(DBP&>0R*&)0QJ&)0QZ")01N#+@9]#(887,3@,@97,Q`X&G/"3SG: MZ>-1%G3R\]"SNTEG@9EU/Q*VH4JZ5]E[GTA.I"!2$JF(U$0:(BV1CDA/9"!R M0>22R-6R$#D@L@ED:LY"1H#3ZUY8\@D[_#H<_'5SA/,9*^W0KI7DF09D9Q( M0:0D4A&IB31$6B(=D9[(0.2"R"61JSD)7(RG^]S%XP,6*Q/H3P]X?L2Z%*'W M/<&84N^O3Z+99J^T]SZ1G$A!I"12$:F)-$1:(AV1GLA`Y(+()9&K.0F\CQ7- MW/O2P1T.73R1A3Y<4R(9D9Q(0:0D4A&IB31$6B(=D9[(,">!9URL/EOXB6<< M#CTS$2RPI5^E1#(B.9&"2$FD(E(3:8BT1#HB/9%A3@+/X)$^]XQ?$A^=8LB^ M?+V[^7WWB%&XV*^(G7KHL8DLSH/9[^72 M$@61DJQ6>QVW6(?5:(E8[^5BM2'2DM5NK^.M1K7K]W*Q.LQ)X&\7:LX=+EUQ MY*%G/5JYIMC''^NH1JEHS5PK:)YP>1HMV'*OM9U:8'6V71Y%]2K$T/E^.)2" M-+M*T)O9U5%VB^UYG%TCAC2[5I!FUPEZ,[L^S&YYMCTYBA:U@Q@:LPL;R04Q MQGSA@OVH^WN$G2!I^U20ECGSZ$RU8 ME-P`7)QM-T>GT72A*I)=P89*1I4F'&UO%Z>Q[5I5Q';#AEI&G28<;:]/3X\V M8;E[51';0V`H]+4+-"Q?3P%(X.L)P==B-W7;1L[]<\=."(X5K=QKS5#!"4M& M%2>L&36T1`D#!WE@@#+45-P$#AJ0FXK=S;+KL-F2MUN&7RWTL&: M"=J.G?)TBZV[,%&N&N+=0I#:*1E5@KSIQ7D\=]6J(:8;06JZ9=0)FDQO3E9Q M;^]50TP/@D;3H:,Q"\\=_=[ZP6T=QC/HA((9U".M2N83KO79D#,J/-HL]_VY M]&C6Z<\?4832BI:\U$^ M)=Q@L.^[N+$>F+1.3\?^O%V?K^)>5WC;F^G5AMO++#F[2K3>S*[V6CZ[S>9D M&_?$1@QI=BUGUXG6F]GU87;KLS56.R?Z7S3>!S$Z9ATVF`LR9@WV;H^?@I)@ MRIE0,#=[-&^U"6WTR9R[/6OT@%,=%X5'&WW*EQ[-YOE*M-16S;8:T5);+=OJ M1$MM]6QK$"UCP>!BD;<<^*_'[_.0`V$J31D^G%$_I%YK%M-FC')&!:.24<6H M9M0$*.PU+B"857J_[)\"A:!W3`@/-YE_4[?7AW:?H8Q1SJA@5#*J&-6,F@`% ME4/I@\J]-R1&_3#6\2@.(Z.8)964VO"91Z\'DJH@_BP8E6RY4BT?]D6A5ZT* M8KD)4.BD5V**)<<4'KT3^(G6W!>3K2`A3_22<)KH5^OHC58A"=/HI&56"O.GE(@YL:M40TXV@T70X.-SRVO+&M.S&J!(CN^6$ MY@]/05KD3)`N'7)&A2!-6#*J!*FMFE$CR*B<6\U:E9M6N4'E_,(7==P/JO-U MU&JI.[*!#A%T;8^F9?TB6A3FDD+[="%(AW3)J!+D[:Z.HAFY5@5IH4;0:#EL M9K?$G'GBW0?%M"0-/#2A8*1[I#7)EA.:1PN,"H_FT8)',]=6G+!FU`2VPDJ[ M1=NLTO+H7TZ+N:!R$XHV2**MCM0G#$;ZE/"=%;Y/N#D9YX,-%OA1SRI$0[MZ MR;E5HO7FBKL6+9_;Z5F<6R,:O,A>OK=&C+:E1_UHUIS6B,$\X9$.]\PGG"^R M!>DT7@C2X5-Z-&N$2K3FCX0IQXW::D3+>"1$:T0:'='">,EK1X]F"\4T0$'' M7%G+MO%MG73142-TJT<;=+C]#+4\CW8^4M%"]?=:Y[.%1EB.5U9&*UX9"9KW MO/-UM+&;JI;,21FCG%'!J&14,:H9-8Q:1AVCGM'`Z(+1):.K`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`I MN-ZNS^(7+KEJ2*)"D$YF):-*T&1ZO:27*[5JB.E&D)IN&76")M.KLTU9KGO6$G--GC_)H-SU5 M+6FF3-`T\6RB#IVK6%(4@G1HEHPJ0=YN%+?5*A:[C2"UVS+J!$UV\68HVD/K M54$L#X*,">"54&?-H8Y'\+#831EE@G1&RAD5@M16R:@2I+9J1HT@M=4RZ@2I MK9[1(,APU"MQSIKC'(_<)L"L*T;1;BI:.H(R07ZFY#!'%:0)"D%JIF14"4*K M[HNT6D7+BEJUQ'PC2,VWC#I!;YKO54O,#X*,H>^B$VOH3U%+,/0G!'^+W73M MD18[$Z1S4GO.G555Q/8@AGCO$J_$;5]SZ#.J8J-2 M&S\5I`7,/)IO5.8&*SP[TWFL9&N5D;(V6,/66K;6&2E[@PV!M;!K!@&0SI[N M?7P4`'D4S)YG43](14E'3R9HFHP6ZW@RRE5!VK<0I&9*1I4@;_DDMERK@EAN M!*GEEE$GR%L^CT.V7A7$\B!HM!PZ.8AW9D[F>`>O\YW?@XG2(RUQ)EJZF,L9 M%8(T8T2#(<%00[\P'WBB_Y)?*DBKDGF$M85HY8P*CS!+B5;)MBI. M6#-JV%;+MCI.V#,:`ENA`X-H:-91.1IRYTVF$:V+SK-H.S(5)1U>F4=N5MDO M5ODMIM=ZZ],',:2#LN3L*M%Z,[LZS,[\]$$,:78M9]>)UIO9]6%V[W[Z($;' MK,/V"J*I'^CP'&7A:T>:F3V:M]J$,,5)5\Y]POFG#QZA?XE6*>;55B5::JMF M6XUHJ:V6;76BI;9ZMC6(UF@K=&`498TQ@'T_PO3U=73B:\/1F*!Y%SC?T,CP M"=4OF284[^6,"D8EHXI1S:AAU#+J&/6,!D87C"X9704H:)QM%*!)?#'R,+[P M:'XBBE'&*&=4,"H958QJ1@VCEE''J&CN*V]S89MAS/>80/X&1> M2$5KMB3QR)T&VS]7SS?1)G*N6F*K8%0RJAC5C!I&+:/.(YR[E4+TJC4K_3;: M7!]42Q)>,+ID=!6@L'W@+]V/?/\)BHT(][B<[U-Z%'TIM8T/P$A*K77FT=FK MY^9402I3-1#5I5$#,=F^E5RYN)]FL&51`S M%VSF4K7L2EVI`LR$;?I*7(H[2ZGM)N0^I]91LXW\ETK"TWV'S3S"L6I7O`7% MZ+FDP7-^;_GL+')I(5IJN8PLTW<\E:1YTW(M6FJYB2POX]VN5M*\:;D3+;7< MAY:W\7<%@R1YT_"%:*GAR]#P>5QB=PWMV*2O&9[ZQ733['3QY/WMTY?;]/;; MM^>#F\<_'M`VR_'$#ZPV MW<$[.],[*21N>X6M99"X+1668-,*-;4DV+M"32T)MK!0'TN"?2K4QY)@NPH] MT9)@UPK]S9)@_QX^L'K(#M[9F=[!UC)\8/D-.\SP@27!/C)\8$FPG0P?6!+L M*L,'E@1[Q_"!)<$6,GQ@2;"3#!]8$KQP@P^LD;6#=W:F=U)(W#L*;NT,$O=: M@B5XQP,?6!*\ZH$/+`G>^,`'E@1O=>`#2X*7._"!)<$['OC`DN#]=^)>[7*I M=_#.SO1."HE[>!L+'U@2O)2%#RP)WLW"!Y8$+V'A`TN"=['P M@27!*UGXP)+@<`I\8(V2';RS,[V#PQ.)>\=O^0`SGRG!28G$O=[G-#@PD;BW M_"S!N8G$O=EG"0Y&).X%/TMP/B)Q[_E9@F,2B7NWSQ*<%8,/K%&R@W=VIG=P ME@D^L/R&(TWP@27!T27XP)+@!!-\8$EPD`D^L"0XL`0?6!*<6X(/+`F.+\$' ME@3'.>$#:Y3LX)V=Z1T<-X0/++_AU"%\8$EPM!`^L"0X80@?6!(<-(0/+`D. M$,('E@3G".$#2X+CA/"!)<%A:_C`&B4[>&=G>@>'@>$#RV\X$PP?6!*<]84/ M+`F._,('E@0G?^$#2X(3OO"!)<%!7_C`DN"\+WQ@2?`)1.).]_,HV<$[.],[ M.*(/'UA^PTE]^,"2X#@^?&!)<"H?/K`D.)P/'U@2G,"'#RP)#N+#!Y8$Y_'A M`TN";Y/@`VN4[."=G>D=?#B3N,\\V&\9).[3#I;@(YG$?>'!$GPKD[@//5B" M3V82]W$'2_!=3.*^\6`)/H])W*<>+,%7,HG[O(,E%7S@OG5B";XE0PDL"3XA M0PDL";XD0PDL"3XH2]QG4)P//B)#V2S);K5$^UB]%Y\XPJ/6V,8GBBB;)<$G MAK!F278HP).X#?TZ#JP\2]YT_2W`#0N(^ M]V<);CU(:E."VPY04RO-#C[8F3[`31^HJ>6=#)+2&A)WH1Y+<(:RNYPO+5XAT"$HOOD//.S!G7FJ.5K3)E MD+C[M'FLX49SM+\EP47F:']+@OO,T?ZCY'B_S,`???M^_>6VOW[ZGJ:_#S?]XV6ZJ/+@M\<7_-DW=V?EP5?\';];W(MZXO[FQ>?' MQQ?Y!XI[O/_+@!__(P````#__P,`4$L#!!0`!@`(````(0#4S.+/]Q4``/9E M```9````>&PO=V]R:W-H965T_FVW[^>P<+3R_OS;Z^OWZO+ MRY>[;_O'VY>+P_?]$R1?#L^/MZ_X]?GKY_EX>_]T M'BU4SW_&QN'+E_N[?7NX^_&X?WJ-1I[W#[>O\/_EV_WW%UI[O/LSYAYOGW_[ M\?UO=X?'[S#QZ?[A_O7?D]'SL\>[:OCZ='B^_?2`N/]8K&_O:'OZ19E_O+][ M/KPP-QE=%3'?'-Y'=U$'_ M>[__^3+[_[.7;X>?_?/]Y_^Z?]JCMS%.800^'0Z_!=7A?7 M;^_/5]N+S>YJM5ANSL\^[5]>W7UH>WYV]^/E]?#X?U%ID4Q%(^MD!#^3$9A[ M0Q^6IX/B9]*_OEBLK[;AD&\TP^2Q?QBZ9NK*]?;W] M\.[Y\/,,\Q-!OWR_#;-]42TP!*D3DXO';L7HW@7UCT'__3F\0X>]@/[^87&U MWKV[_!T#=9>4:D,IUVBH$08KV&U+T)7`E:`O@2_!4()Q!B[1`<=>P%#^I5X( M^J$7Z'Y-(-VR+"*F!INT)>A*X$K0E\"78"C!.`-9Q*N_&''01][,QGVS+$*L MH\X"4_$X.;9%+QQ5CMV@2*>(4Z17Q"LR*#+.2=8;2.J_-/Y!'^<3Y,LQ4J3! M=1YL';7>[(^CRK$_%.D4<8KTBGA%!D7&.H>7\P^0.>PJ:W=20+R81& MD5:13A&G2*^(5V109)R3+"*<%:V(`LXCBF2Q.N9VHTBK2*>(4Z17Q"LR*#+. M21;1+H\HG;DO=NB"UV_W=[_5A^F:QK$+ZGFDB=VLHA"N6*%-/$\IH36\Q/V9KDI1I]:DOLMT2(.[6)7=G@G&NPO M1R1V>HT\432]N"[FS"!R&AZ))L-Y7X3*QLB#1:QX<*6BD3HA]`510R0.MT2Q M"`X#VFGDB*1AKY$G$EN#1B.1$5PH8JS@8G&3!1=1D>9%OC:+I#6;T43;6-/> M+"^*1IUHL-\2(I&&OD2<26X-&(Y$17*AJK.!BM9,%%U&1T46IW2R2 MELS.EBBFW?HF'XQ.Q!P,1R1&>HT\4;2[W.IL3KY(#HQL8TSX4-E8/1$KGJPG M4A$D5]UFD9!XW!+)T3N-')$T[#7R1&)KT&@D,H(+U8@57*Q2LN`B*K*Y&+0& M-QK3');9V1+%G-LL+XJ:KA,%&6AEIJ>66/9$Z0)]<[&ZR?[E$VH0=1YG)#(2 M(%0U5L_$:B?KF8BR[$Y(G&W#76:9W0HY:DG#7B-/-,]N96NDE@X.WIO!33PO MS!+*LWMUE7=M0RV9K2U1RNZMNER+`H?#$8F97B-/E/)[>5&<:P91H.612*?` M\D1A-O&B+V*M-K]:)ZWYU9I(7ZOBBMD0RV9GRU1RL+-15&U=Z+`X7!$8J;7R!,ER[HL$P5:'HF,27^B+%OJ MLBRA>483B<=>)`H?#$8F97B-/%"W?E#-H$#D-CT3&G`]EE''F#NOZQ9UT0EE" M1ZTLH1.2).S84)`CFD>J;'EJ2<-!HY'(""Z4+E9PL:3!:8X]5"\C*A*Z6(YH MJ"73LR6*:8>KZE7VKRC@.U'GH1V1&.TU\D0\SG5VF*OB.(.H\S@CD9$/)ZJV MI:[:$LJ2/6JMQ?^66I*@G4:.2!KV&GDBL35H-!(9P87JR)H$L6K*)D%$1;(7 M%5BS3%HR=UNBF)([??5.360B.S81*[U&GB@:OO[%[!I$749][FUVY[T,19#5 M,;$XRCHFHBSU$Q+_V\E@>!IY3*M.(TB70&K(JB M[5=KZY-^T4>QVIJG?=*:ISW14B:`1HY(;OQZ(ND53R2V!HU&HLE6/@%.%',K M7VK)O&V)<.5Z8SD]:6WC4X?%U=7BHB@4'0W-5M2)Y'">Z,W# M#=2*R_>[G5H0&JDQ'2WOM*+J^^5,T=4@'JZ$PF%^JB"24-J$UK+`WB6TE6GA MJ+4[SJ=>V_+4$EL#D9P]1J+)5AYT40VJH/]Y^![>+.##F#!/8FDDHX['I<7- M?9W4PGWE<7(4B["-Z#"-6XTZC9Q&O49>HT&C,4-YSX22S+A"K&*I-K]")(0E M`D;2:-1JU&GD-.HU\AH-&HT9RH,[41SB\E56O@EAG5>"BUHSU&JM3B.G4:^1 MUVC0:,Q0'EQ1T:DY73Q.7>E*CV@^HDE+4)NTD%WIX6=1,G>BP+YS&O7Z8%ZT M3CQ6%05:'C.4=T@H@ZRI',NC;"JGB@EI?DS8Q'-G[PFK6LYFSLB.9OWVI:GEAQQ(!);(]%D*YLAH?ZS M@IMX7@TE%'X M1(&61Z+)MI3GQH1@BW8;(O&X)9*;N$XC1R0->XT\D=@:-!J) MC.!.5(9K71DF%*Z0QX%>;\OU7&K-)C91O&_;;,KAZ$2!W>:(Q$ROD2>*EE>K MB^4\EV^*T]0@ZCS.2#0=)Q_VHOP[#KLN\U#V3Z<_R;:&2/QOB21S.XTITH ML-L/-E`K'FV]6I1S9Z2&+N8W18WW MJXDRZ1=]&1TZC7R<:#1F*$^A$[7? M1M=^"C1J->HT0TZC7R M&@T:C1G*@PLUV5\XXV]B#3<_XQ/)":C1J$WH]%J/*'"*.XUZ;=F+UHFU'E&@ MY3%#>8>.6NEJL-Z5#^L=->97`U5S>FJ] M>;2!6NEHVU5YM)$:QM7@1'VXT?5A0ME9/Y6,\PZ*:+ZTDQK.EW:(Y.3=T[S8 M\M22(F(@D@O!2#39RB?$B?IPH^O#A/+Z<%W4>@VUI(1IB=(]VG*G"D31X!QV M1&*GU\@31=,H*0IW!E&@Y9%HLIQW1E$@\DY@HPO!A.:%()%XW!+)35NGD2.2 MAKU&GDAL#1J-1#JX[8E"<.)Y\9)0D?I%[=U02V9C2Y1NTQ;X$#8OV#O1X'@X M(K'3:^2)<`8XUIAJ;7@0+9H?B2;SV7!OBS*/PSWQHD=T.9>TYN4;S`ORU!);@T8CD1%<4=N(LL362WG4DEG:$L7LN[Y13_E%@I84SKY75YX]:QC4Q61R13NM?( M$T7+N$DKO!E$008Z>6/,^:+<.\YY7=9M(YI?J8G$XY9(XNHTXT\D=@:-!J) MC.!.5&5;794E5"1U^38%M62*MD3I6HT7Z,I+=3P8GJ2SCQS;B)E>(T^4+*LO M*0=1H.61R)CW)XJRK2[*$LJ2.FIE9[.$)*Z.#04YHGFHRI:GEC0<-!J)='"[ M$T79Q/,2)*$BJ8L''@VU9'ZV1#&I%ROUP$T4.!R.2,ST&GFB9'FMSMZB0,LC MD9[TNQ/EV,2+OHCUTCRCD]8\HXDD"SN-'-$\U&1>D*>6V!HT&HF,X$Z48SM= MCB649_2J/'M32^9G2Y3R3EU,.U'@<#@B,=-KY(FBY>5-6=8/HD#+(Y$QZ8MZ M3*TT%F_@['2=EM`\TXDDDC8A+([3JTXCEQ#6_ZC5:UM>-QPT&C-;V:H+C._UX?VU'KST`.UXJ%7>/A?'&VDQG2TO`.+XNZ7LT87?6''C/#IW.R% M#"))]38AK"IR/G1$LJ3BB.3,WVM;GEIB:R`26R/19"L/NBCZ5-!I41Z>QMVS MXI9/C_OGK_MF__#P/M1 M2SYNEM5'.*PE6.JOPBJZEF!_L(\6K[%OF'ET&#+U5W#*LH\PL/2J#UPC"BL( MG)RP8YG98K>N:C.\!I+&E+20A%FCC]]!$B:/EB"MJC"'M`39586II"5(LBK, M*"U!8E5A8FD)$@J16I(:?5";?=!`TI@27&(0C]5ON)`@'DN"ZPGBL22XK,!K M2X)RL`I5DXZGWEW!:VO2H/2!UY8$%1"\MB2H<^"U)4&Y`Z\M":H>>&U)4-N@ MKRU)C7AJ,YX&DL:4H$"O0F&J^P!E>!7J4RU!-5[UI@1%>15*4]UFW&*&X+93 M2^KM%EY/3PJ+TT,#26-*<`L)KZTVN%6$UY8$=XSPVI+@QA%>6Q+<&<)K2U(C MGMJ,IX&D,24M).'.7O&U)<%*,+RV)%@0AM>6!.O"\-J4;+95>#RB>Q1/@ZKPE$1+\!0(ES!+4F^0 MP5A?%1AO5^WP=.-*BS[:PD>K:*-):EQG-H\3@-)8TKP%@SZS?*M@Z0S M)7CC!;Y9;7I(>E."-]E0U%@]6J\Q1^/-3GF^AJ0Q)7AYJPHO)^E^PRM:57A' M24OPIE857E72$KRP5877D[0$KV7!:TM2(Y[:C*>!)+Q?IZWA34-X;4GP/B&\ MMB1XK1!>6Q*\70BO+0E>"(;7UJS"B[#PVIH[>/D57EL2O`,+KRT)7G:%UY8$ M[[S":TN"5U_AM27!*Z[PVI+4B*SX;4E MP4O:\-J4K*ZK\*6"]@!?:53A@P4MP0<9N".P)/4:&1Q7DE4N((--";Y!0*16 M-N)+`T1J2?#!`2*U)/CN`)%:$GQ=@/&Q)#7BJHV^*0:7EL2?%D-WRP)OI^&;Y8$GU'#-TN"KZDQ M[*L"KZU(L;T*O+8DV$0%7EL2[*4"KRT)ME2!UY8$ M6R'!:WN&+.&UE0O8]@=>6Q+L_@.O+0GV^('7E@1;_&U)L*T<5LK,&;)` M-N+E6IT+V$*M:DP)=E*K.E/B(`E;AVEKV#:M"CN(:0EV3ZL&4X)=T>"UU:9& M/+49#_;W@]=6I-CF#UY;$FSG!Z\M"7;U@]>6!)O[P6M+@@TYX;4Y0Q;(1FQU MJ/L`FT_":TN"/2CAM27!3I/PVI)@PTEX;4FP[R2\MB387Q)>6Y(:\=1F/-@= M%5Y;D;:0A*U!=:38"15>6Q)LB`JO+0GV1877EF3`U+'FQXB)8_%Z@1S%]K': MKP:2L+NMEF!G7\1B2;!]+V*Q)-C%%[%8$FSFBU@L"?;LQ0A8DCK<9EJ>H="Q M9J!'F6/Q&JEN]4J#1+=XB\+0XAW2W^(.R6_Q'JEO<8^"?>*7QQ(;?XSC^^W7 M_7_?/G^]?WHY>]A_P;.'JVFK\N?X=SOB+Z]QWXBS3X=7_!F.Z8]3?,/?5]EC M]^&K"SRE^7(XO/(7#.GE\2^V?/A_`0```/__`P!02P,$%``&``@````A`/^2 M=R4C!@``^Q8``!D```!X;"]W;W)K&ULE)C?;Z,X M$,??3[K_`?&^`1+2$*OIJH3?NI-.I[V[9TI(@AI"!'2[^]_?&-N`/5:V?2G- MQ\/7S(P]'GC\^J.^&-_+MJN:Z\YT%K9IE->B.537T\[\YUOTQ3.-KL^OA_S2 M7,N=^;/LS*]/O__V^-ZTK]VY+'L#%*[=SCSW_8U85E>?[9XK(HR:(JWNKSV3*0M+WD/ MS]^=JULGU.KB(W)UWKZ^W;X437T#B9?J4O4_!U'3J`N2GJY-F[]3KJFB;KCGV"Y"SV(-BG[?6U@*EI\=#!1[0L!MM>=R9SP[)G`?3>GH< M`O1O5;YWL_^-[MR\QVUU^*.ZEA!MR!/-P$O3O%+3]$`1W&RANZ,A`W^UQJ$\ MYF^7_N_F/2FKT[F'=*_I+45S@9G@KU%7=`V`Z_F/X?I>'?KSSEP]+-8;>^4L MUZ;Q4G9]5-%[3:-XZ_JF_H\9.5R*B2RY"%RYB.,N-HZ]76T^+N)R$;AR$9"[ M,RDH#T\.5V[_<-<>EO9@#]?B@*UIU$0C^\+,(5EJ7@L+,0M M@0I"%40JB%60J"!5038#DL>K3WI,[6'7S?*^MA]D%WUFX\!2'!>'8K(?3<8P M(!(B$B$2(Y(@DB*2S8D4#=C-G\H_M=^92]@OHZ>P#5PE'LSJ;CQ&DS$>B(2( M1(C$B"2(I(ADUF?$F7;"'I$`D1"1")$8D021%)%L M3B2/H.KJ/*)8]H@19S7N[3TB`2(A(A$B,2()(BDBV9Q('FUDCWCE7M"SK#]7 MQ:O?#">BR!TUESWE9)8[1`)&5JNATB]M1ZGTX3@N5D2$2(Q4D]&&GA^@JM3* M=!P7JMF<2%&@K>#L_!+>4BQ[R\@*EORX9=>V)^_8/3>:0A)P0H,J#KSE1JEJ M(3?:L//0W2R42A!Q@^VXJ&(T4_*1F5)IILUVH40NFT\DQ0F*LBY.%,MQ8@3B M)&*_YV06%$:\R2;DA/5N]$"/.!FZQ^&(CY%.@G12I)/-=22/:+>B."@$B(^1Q`+@?8"34\<",0Z:)K0$*-(H.G&&*-$H$DK MQ2@32.,<[6%TSK'>1G*.(7F7.[8'0;P"D\7W7IV&@@T.PXXFB4A$5:35BK0I)4) M-&C)3M-FZ9[3WYH;?>6%C<:^2;!7X;IL3^6^O%PZHVC>KI!_EY;E$8\?0YZ' M=:YPGWXDH9(J7Q)X^]+P%8$7$);,(]#5 M8.X[-OBB6TI[&*&G-+X'.A3P13<"?0CXHAN!=@1\T8U`5P*^Z$:@]X`,Z$;\ M-8&W+LV3;0B\"V">;`AT\YC['O%U4=E[!#I0;!]X)-#QT"/0C6+[R"/0DV(> M>P0Z4\P3CT!_"MP:]S5\D;SEI_+/O#U5U\ZXE$&UL MC%3;CML@$'VOU']`O*^QGP4VHCJ8.EJ8AM#:=% M=T@V)(WC,9%4*!P8IN8>#EV6@O%GS;:2*Q=(#&^H@_QM+5I[8I/L'CI)S6;; M/C`M6Z!8BT:XMXX4(\FF+Y72AJX;J/N0#"D[<7>+*WHIF-%6ERX".A(2O:XY M(QD!IOFL$%"!MQT97N9XD4R78TSFL\Z?/X+O[=DWLK7>?S6B^"X4![.A3;X! M:ZTW/O2E\!`<)E>G5UT#?AA4\))N&_=3[[]Q4=4.NCWR1YAN0`F>2`H_`E`Y M/73OO2A/T,1H]QH,D'6&TYM:MA#^+$=M:I^7?$)0B2!]Y%D,+Z7 MA(2$ND*>J:/SF=%[!,,!DK:E?M22:0H&,@\N/)ICF%)(R@*ZFV>3>$9VX`4[ MQBQ###S[F*2/(,#>2T"^-R0\ZB6\65YS&8!SOO0VW^`FGT=S#,\^G6SRGE"0 M"#'#LYCQ;0D(N9&R1Z%S,"9G&I>VA*`[-*#Q-S0\VFGTO@0D.35K_]D3P@"7A_5M+@PI0P_V%L)#<5_\*;QB*FMPI.>?H>[:_=(O6= MO<2'TT5W'4F_`;>DI15_I:82RJ*&ET`91X]0M0D7*BR<;KMA76L']Z/[K.&_ MQV%RX@B"2ZW=:0'"I/^3SO\!``#__P,`4$L#!!0`!@`(````(0!5X6693Q<` M`#9K```9````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`=0"O_G[WC$,G>__/VT;T+&1_CE;]_UZ)97XY>?3?O< M5]^NVL_OW^X_?7@Y_'F"O@3%\/KCWO5,HVR$((0*'VIMWP30$A^<^R_._^,I M'%&Y7T'_^#2YN_IP_@?:U$/PF6J?4>PQHX=K5TYVGH)%"O(4%"DH4[!,P2H% M50K6*=BD8)N".@5-"G8I:`?@'''H@X$*^+>"X?Q=,%B,4P*)SC@I>7KPDGD* M%BG(4U"DH$S!,@6K%%0I6*=@DX)M"NH4-"G8I:`=@*CDT8Q5R5]>]+7>F='# M1[7^.B[9J?<9H3/JF\9-[#+K7?K25V2A2*Y(H4BIR%*1E2*5(FM%-HIL%:D5 M:139*=(.210,C$$J&!B$_[)/-EQ+U-Y>C27S9HG=B]')%"B5=]C[#KBR1 M7O9.E%XI4BGI=>\SD)XDT[9-[T3IK2*UDFYZ'Y%6!;+KG2C=#DD40,QMK``Z M'`?0$P20FK-`!M'R)(K6Y.XNB5;O1*%4-RF)LGR?"%>U,HU*C0J-5IJM-*HTFBMT4:CK4:U1HU&.XW: M",5Q<*M"*PY^M8B%!0MJ.@H+R'&W]3&^&"5-=A8$B>`U0KE&A MM4KMM=1HI5&EM=;::Z/15J-::S7::Z=1&Z$X!&XQ:(7`+Q*C$'AT@XF<]#^3 M9#4^Y:,#RT= MNL3BJ@!ELRHXGHQ8'J$JL('.1AY%<0](NND%O>3"G$CNOM"H)!*M)9%HK8A$ MJ])H321:&R+1VA*)5JU10R1:.R+1:HF,0G<+3ZO]^05IU/X\NL$LL6]&DTG2 MC&9NOP;1BB8.`;E)R!^?1J.T`BYXC7](XO:%^?8J;49+<6!% M61&)O7!K8W3N<>:5X;4+L^N+H;_)26Q$7>FO262M&N-&J)07N.S9!*T M$PRR4#G@!W78-[C(96Q:\HGNFLR62=&HB M2:A)))J,W,/W=*X>73GGSN[?G`1 MO`8H)Y+^O=!:);U$:ZG1BDBT*JVUII=H;33:$HE6K;4:>HG63J.6J-.*2]VM MA*U2]RODJ-0]2@:L=#O)/1E(>[*`0@=\F0XK"UXCG4Q.)'U%H5%)Y)4GN@'U M*;,"KGB)"%]6)NW+T]4ZVHMS.QK4ZLUJ@A"N5S?99,PG?B0.66J+N- M**((6131]P:HSC^>#P8T'*`"&LY#B*01+C3*B60<*(@D!"61:"TU6A&)5A50 M-$#13<0V&FV)1*PFDHPU1**UTZ@ET@/4^"_V)CJ>E#JW*X8#U"A]*V`6KAS. MS(DP,>Q'-KTBHU?HK&_29IC30?K\@DCZ_)+H:&)+>OG$)FJ5M**#)%8126)K MHJ.);>CE$[M+NJ0MS9)4321)-41'D]K1RR=UK=IJ2P<]P(W=_L6@JWVW8?K] M#M0MMOII)^%JC53'66!1??!77LF@L`A>5S*:Y$0R;RFT5DDOT5H2B=:*2+0J MK;6FEVAMB$1K2R1:M=9JZ"5:.R+1:HDZK;B;=+L8QZ+QK\./X4;OV.]Z1-'P MZ*[?Q$IV`F:\1FK9/*`;R?9"HURC0FN5VFNIT4JC2FNMM==&HZU&M=9JM-=. MHS9"<6C<1L,@-)S4C_T&1!0"C][9Q`H71DVDW\PXVF4&K["O=)$N'7.M7&A4 M$D'MK_OG);WZ3:QD&K"B@U2G2J,UT='$-O3RB>%MR?B1R99V2:O6J"$ZFM:. M7F$32VT%MG3H$HNK`GICLRHXG@R?'@TWL=PKI,F:@$A&_061=!LYD=Q]H5%) M)%I+(M%:$8E6I=&:2+0V1**U)1*M6J.&2+1V1*+5$AF%[G8>K/;G=R2B]N=1 MLB9(UK&S<=C*D'G5G,C/>>_.;H;KT\DD76.+.\?"G$A$"XU*(I_.S=799+C' M=)'D="GN3&=%).E4`;VW8."5(>VQ6C&(`U/;$DEJM48-45@QJ"W`G3A0N27J ME.-&YO8W!O%^=V+"G93!Q,2C:,7@4;1B"$AF+XNQ0CF15-^"2$JE)!*MI48K M(M&J`HI7#"H7&UXI^ELB$:N))&,-D5RXTZ@EZK3B:+A=BT$T^M&/FQZ#4B<: MKACTEA8>HJEN,"`_C1W=I?W_@M?()"PGDFET023]44GDE6^Q3#[>X/J,L**N MJ"#I5$22SIK(IW-SF>Z";\2!RELB4:Z)1+DA\LKI=M].S-1MB8PYO]L3L(+I M]PJBKI1(*LYL[%DT,AE=:K0B$JU*:ZWI)5H; MC;9$HE5KK89>HK73J"7JM*(FA#>.S5+O>#QK""@9P)(5Y"QX#?LR(M\%)X_E M%F)E)^/3)3=2I*<,:#@^!13%U%]X)2UP02]!.9$, M`P61E$I))!OFD MK]0V84L'/=JY=]F&5>/=AJKW5#J)9(54O4I1,W,K?G,(BW&AB3=_S1GE2G[%&TGO`H"GI`,M5>!*W! M$B,GDNI;$$D9E42BM=1H121:54#Q>D)E;,,K17]+)&(UD62L(9(+=QJU1)U6 M'`VWH3&(1M_ZN!_2]US32Z+A>D+O=P4W),G*,"?RD]K19=HL%N+`:W(BF507 M1*)<$H69^EBOV'VF41VIO.(UHEP1B?*:R"NC*2?/:#;B0.4MD2C71*+<$(72 M4+M_.W&@,+K5722V;1 M2XU61*)5::TUO41KH]&62+1JK=702[1V&K5$G5;4;*Z231$VFXXGI>ZW-9)! M*^FJ9^'"8?]%Y#MA-3=2#J+0J"3RPB-5M9?B0.45D2A7`;TW2O'* MD-HX?4UL(PY,;4LDJ=4:-41>.=D0V(F5LBU1)QO',]E6>6]0P@B2#DH!#0>E M@**@^@L'(]""7M(J3&W&CBR0..%H;/&)E?\ MJ#1>0^5TEQ&@()(1H"0ZFO227CYIO$: MV?*BNR1=$TG2#='1I'?T\DGK?<26#L;@AZ7@BY/V]O>G6-`_>Z:IU8T$5EKM[CQA,+NJ7,57]M M07\$-&2NU]&6+2RN\]$6#!>9ZX.T M!=,Z%+Q5+)B_X38MRQ1J4U-M!HOKSW4Z7ULP18?%NE-,Q!$YRX+Y.")G6=:PN,F<3@<3;<3'LF"^ MC?A8%JR,H=:]%IW40JQ_H699L`R&FF7!:AC1MBQ8\R+:EF6*O$W-O&$9A6A; MN9[#XF;:N@RP:$),+0O63HBI9<$&6>;V6;0:-K[0=BT+]D^0:^M^9K"XA;A6 MP\X)R*H598%6R.H598%FYV9VP33N<:6 M9N;VPK0%.YN9VQ+3EC4L;A=,6[!EF;G-,&W!SF7F]L2T!0\4<$TW:4GJ*)XK MX!K+@L<+F=O,UFIXI(!H6Q8\2T"T+9N:>/*)="P+WG^`FI4#O`:! MR%D6O`V!R%D6O`&!R%D6O.R`O%D6O/.`EF59\$(2RLV:`.&U(]R/99E";6JJ MS6"9F98Y+'/3@G=54$.LO.$E%<3'LN!=%=00RX)75M"R+`M>4T'+LBQXM0P6 MZT[Q!ADB9UGP(ADB9UG6L+AWD'3=P2MBB(]EP9MBB(]EP=N&=46 MO.&;N3='M04O^F;N!5)MP?N^F7MI5%OP'F_FWAW5%KS.F[E72+4%K^M#S;I3 MO(8/-,T>MIF;>\(4%HFWE&A]:(-J6!1]0(-J6!=]1 M(-J6!5\R9>ZS%WT_2UCC^]%$6W+ M@D\%D8[9D\/B/NO3><-G?*BCE@4?Y2$=RX+/;A$%*P?X^A91L"SXXA91L"SX MV!8YL"SXYA:MQ++@TUNT$LN"S]R1:VON/\4U[G-870;X0!K1MBQS6.:F90&+ M^T16J^&C:$3!LN#;:$3;LN`3:;02RX+/HM%*+`N^AT9,30O*P'WYKO.&@PL0 M.$9.Z@"IT.3@O)W'D5VH)# M0S)W1H6VX'`0[%)9EBER,#5S,(-E9EKFL+@#"70Z.%P",;4L.&,",;4L.&H" MD;,L."L(N;;F\5/YK"X4TJT!8?*9.ZP$FW!V3*9.[-$ M6W#$3.;.*=$6'"23N>-*M`7GR63NU!)MP;$RF3NI1%MP"A34K#+`85!0LRPX M_PEJE@7G.J%6618<[X1:95EPRA-JE669PC(U+3A<"U&PKIG#XDY;TG>*D[00 M!RX``YU%[+@M/X<#^6!8?R9>X$-YW.$A9WD)NVX`0^U!#+@H/X4$,L"\[C MR]SI;EH-)W0BU]8L>C[":@KG(^IK<.8CTX+3$E'?K&MP3"+NQ[)4F$3C3%1]HVNLF$Q#C063:6BP*K*: M=8/1UYJFX\16%(N5]A0K%:NB3[%.,2^889EB&N98BUAYFJ/OMO(T1Y[&FRJUBBXI?QN&XLGBH>LKOINY^^ M'_:3;]WIO.N/]]-DMIA.NN.V?]H=7^ZG__OOEQ^7T\GYLCD^;?;]L;N?_MV= MIS\]_.N'NX_^]/7\VG67"2(OW6%SGO5OW1&:Y_YTV%SP MZ^EE?GX[=9LG[738S]/%HIP?-KOCU$18G_Y)C/[Y>;?M?NZW[X?N>#%!3MU^ MGK^]N/V_[PAA"/N_WN\K<..IT[IYVF(&"?7+JGN^G M=;)NJWPZ?[C3`/VYZS[.H_]/SJ_]Q[]/NZ=?=\<.:*-.J@*/??]5F?[RI$1P MG@?>7W0%?C]-GKKGS?O^\D?_\9]N]_)Z0;D+Y;+M]Q@)_TX..]4#F/KFN_[Y ML7NZO-Y/LW)65(LL28OIY+$[7[[LE.]TLGT_7_K#7\8HL:%,D-0&P<\A2#%+ MET52E"I*Q#.SGOAI/9>S*EFLLDKTFYOL]:Q_WEPV#W>G_F."5D)^Y[>-:LQD MC5AJNAE`,R,[`%"'K;*NE?G]%,T.NS.DWQY6J]7=_!L0W5J;)K1)J$4[6*A" M(`^7#&#@R0#[J\DH4H*"46Y4$RL MA&*2,TR<$4\AP2+@.20%@EUE-.5`,]`Q(`)9N/64)@5+P5L%.0BDFB9E%(?$ M<"+6,*(9-AM$-`W.(=XJ2$.1W2?Z(S'DR&F$M6-CS:(=XFV"I%"*(*E5,O/; M7=@CB?)A);(B_!B5B%%P.SAF"E2RTR0"PZ;+16SU:A>6A25>6J$E;Q1G%62A MV(Y5Z&:C6(8<-XH5T338MMPJ:E`HIB$8`K=F!6CGZIIQ[(H9V6:U(I)#RK:@ M-G%6`12*Y3@4-[@CL7& MD4G*(LXF(:WJ,"@_63$I8__66_$"*5H(TD!+7>L1;:^7BU^A!=_N&VL5A<;; M!#D)1)ODBRB9I"'1#B(*#=]RO%60!KIM!(U=$K7:/QAM61$:`C'TPFF)B'"4 M*I445HDI#VE+G.`US]FPQLJ(:%A*?2Y;RU*CQ90:D2(^3[(IWP<'*_3"R,IO M4W1P14)^F;O!+3>-!S;`0K16=N6]+,G/U,#NJN7G`7489 M0KO0!3:(R+:2^1XW:\Y;<8;()*(">-?(4]LS\L03'4.BL691]O0V05*4MC0T MRU4JM@BPHR^DL8D\QF:,_O^@`C2^_.8]8LS@TEB-7P8DH M4\SGF<(D=6//U3ZL;0R!TCV7'P_:P3$\I6:*W5@:V8WF52XL"RNBS$DMR**#-^BO560A*(]ED225M$L ME`NKCQ4A&=^C-G=60182Q<:`L%S*5K0_ZAG>SXU9O#[.)DA*426'Y@;O MY\J'86-%F/P(&[9%M8-CR/NYP+@QMM/V.@4_'GJ747QCS>+8&`J&38"-0,'I M*HN>%W)'PXAF"V1%8VR21<*W@L%3`$=@W2@XCG+'X"2,8)O>/<>!+-#7]BC_+@6!$#)V`]9\;S*"3FC:PJ;<\ZI\IXXUBK*#;>)LA)8N(; M'P\<&3MH"BL:0Y/F;/FWWBK(0J#>6-L4CGA)VS":;:Q9'!H32EA3ZL5TT#8W MH%$NE&YT%(@H-*R(K;<*H!&H^,;+T,*QL2^0%9$-H>#K>G`,CWCJ1,FQ2(O8 MKJ0]&!26>6D2;*VW@Z.0!&7>X5FUL`?3T5(=1#J&.8P0$7D*52]3^=SRQ6J& ML->.1-J%30OI96-)[<6$0G)W'?C4VS"+EO$-'9 ML?76>BO>Q26EOF%V6DQQ'$2CV1$1F5TIL=>-#Q;:AXUIZ8O.CAV[V\$QK%T) M1]Y!T2.U=F`YJ!@0T1SXL61P%'*0V"I^<"Q#MAI$-`O^<.&M@CH+;!4C\M)1 ME2?RLF1]U5BK*(][FR`GB;OBGY-*RU0C2AE$A,<+]@32>JL@"TI>^DFPS*(? M"LJ0V`81K0_?:+U5D(7`=='Z6%8;'^RSX%57::SB]7$V04Z4^IY&SZYE M2(N#B!:(;[3>*DA#8DKTP;4]H'0LZ5L79V7&&HTUBV-C0@EGD(KRIL8F6T1V M)NU`F640$6!*OO=[*PY,14EVX&XM9B,9'C7S,-NNM9*FI@B/GFE:[O]_CS9]N]'//8N*]P/Z]2!ECCT"!I@#4V\E!3%XMUC6>U4--`T^)94M(@`]&G M+E+@)HV#QS/XB+D5R`V/1-(XJ"D>4R0-:HIG!TF#FN+X+VE0.1S)0TV=E^L: MKSE"#5[4K%N\K)$TB";ZU/D2T<2:0M/B[884#7T@^M1Y@F@B.M"T>,$I10/6 M>.LH:8"U&*W.L;+P'DSR017P,D_2H`JB3YUA_>!%N>`#38N7_9(&Z(@^=0:N MPOMER0>XX>VWH,G1O:)/G0%1?`43?*!I\95.T@!1T:?.,D03.P2:%A^_I&A` M%-^:)`T0Q?I$_2;V::%M?6)`T0-?`8)$,4=`AP.5W?+7SN M^\OP"\">N[\.>?@_````__\#`%!+`P04``8`"````"$`_XF;V0P*``!5*0`` M&0```'AL+W=OI,=HNQL\V[H##8??N=9JZ33!)7"3I=/;;[U^6:%DBMS,[+[;;'VF:I$2) MEGK_Z_?3VW/S M,/ZCN8Y_??SG/^X_VLO7Z[YI;B-8.%\?QOO;[2V:3J^[?7/:7B?M6W.&Y*6] MG+8W_'IYG5[?+LWVN7OH=)R&L]EJ>MH>SF-M(;K\C(WVY>6P:])V]WYJSC=M MY-(7K^]LON_;T!A-/A^/A]D=G=#PZ[:+J]=Q> MMD]'Q/T]6&QW9+O[A9D_'7:7]MJ^W"8P-]6.\I@WT\T4EA[OGP^(0*5]=&E> M'L9?@JB>S\;3Q_LN0?\[-!_7P?^/KOOVH[@KR7(]FP?A'8]V[]=;>_J_5@J,*6UD88S@ MIS$"(=,74&_/0:SQ?)^^@TCM#-* ML:#D:B2DH49)V4U]D/D@]T'A@]('E0_J`9@B`7T6,(9_*PM*7V6!W(\)V+2$ M7L2D08^D/LA\D/N@\$'I@\H']0`X$<^%B%&E-,Q*C/H8#/,RF+L1Q5HGP,SK MY\+*54EZE3YJ1C)&%6^E@W4!Y]I)CU7K"QUOHT M'[U*GP]&,D9R1@I&2D8J1NHAQ)H&=^`DC*2,9(SDC M!2,E(Q4C]9`X$6&1E2)2V(U(DV#>EW+"2,I(QDC.2,%(R4C%2#TD3D1K-R*S M4$_62,%M?]A]C=MN[Z*Q4^INI(8,QHZ15)/YO%O8PYE?\EDOIQF1,U(PJV6O MH[8+6/66QJJ7D]5Z2)PLJ*9ML%U1M`J[T6HRQY3O2W89>/M48I1L2E)#5%)I M?PO77J%G1FG=96F^GFS<52\W\DT_IPKVHO)G7E2Y+UI-UK/A/V\]KH>O=9*& M%5I*FL)NTC1!TF@@$D,&&=+DSNIDANB62VWFN2&KWD[![)3,3L7LU$,[3D2J M4Y%"ZK@;DT&+X>(=AOY,("V[#J2$`ET,RSMWE#,KIVSEA*R5@J.2D#$`MT4E@M.SL3`GIL@M0 M=L%F^,\=G,RJT^#DA*S1@J.2D'[/^FXR&[YEPVK=>&HKI"8+0CFHAD?*DVZ$ MG#QIY-2Z0=;_%!_*:EXL[-LSCG)"]L&"HY*0M55Q5!,2@E.]CQ2<[HFZ]AQYW9*I^@+U:YJAG+3L@P5')2$;2<5138@' M!^_%X#KN-FH&.34=SKWE,B$M.S]30KKPPKO5)!BVR5X59E:]'W9"UFC!44G( MO&>^F7A=9&4UR'1-B-=`^!=]6\>]U.A6;KBA&ZWAAD[(%F7&44YH&*LQ;U%) M6M96Q5%-2`A.M4S"I`YU*X6L4(9B@YP"7P9>#Y:0EIVN*2%3AHN)UP1D5H%> MEA.R9@J.2D+:\F8V"=SFH+(*9+DF)-2`U[G]Z-,]Y!V=0'UGVV:T*= M:3<=JL^2TJ'[+R<=&B$=Y'*B[B>\[MV@8&E]S@26&W9GK17<6DE:]AN^XJ@F MU-ERPU,=DA2>[IR<\#1RRSV<@V=*M!F(-L*"EIV2+-.,H)#0N>V2I) MR]JJ.*H)"06O>AYI"NA>R)D"&CD[?7#'=GJC92=X&AJ$\]Y6DX:P*JBV;)"S'TX4W<8YN=3(:0T, M&B9.HX6M[RPTR"X,.2&[HA4&#=J,DK2LK8J0M543ZFPYU8%;IL^#_JU]4_>2 M*#1]YZOO*T_-Y;5)FN/Q.MJU[V>,_T9=5_587S9CT"+E(1[V)!BH2#G*)1B@ M2/G+);BZ_M+5@VG`)04D:E9P"78_1-_-"I:6%;SN9H(GP3H/ MKR4)EGOX)DFPIL,W28*E';Y)$JSP&'Q)@F4<7DN2&/'$8CSH1>"U%&D*B=J& M>7;0=L!K25)`HO9D_DP)B=J'N02?%?!:GH(AO)8F&UIH>"U)T$G#:TF"?AE> M2Q*TS?!:DJ![AM>2!#TRO)8D,>*)Q7CPP0>OI4CQW0>O)4D.B?K.X7G#9QV\ MEB3XNH/7D@1G-*AV<88$J$9\^_+WX#PB2D0)CB6B3)3@\"%27^7<&LX@(O5Q MSB4XBHC4!SF7X,`!7DN2&/'$8CP)).KDB%O#N1F\EB0Y).K0B#^#,S)X+4EP M5`:O)0G.O^&U.$,"5"/.#OE[<-8+KR4)CGSAM23!42Z\EB0XT877D@0'N_!: MDN#`%EY+DACQQ&(\N(B`UU*D*23J))Y'BEL'>"U)CI_:& MOW+K_@1LCS]?;'#1-YN@V7UIVQO]@D1,^S^(?/P3``#__P,`4$L#!!0`!@`( M````(0`@RNH?5`,``-()```9````>&PO=V]R:W-H965THV:9.F:9=G!TRP"AC93M/^^WW&0#"E M6_L2PLGQ.=_%]I?M[5-56H^$"\KJV$:.9UND3EE&ZU-L__IY?[.V+2%QG>&2 MU22VGXFP;W][2K3"M;:T0\;=HL#RG*;ECZ;DBM=0BG)180ORBH(WHU:KT M+7(5Y@_GYB9E50,21UI2^=R*VE:51E].->/X6$+>3VB!TUZ[?7DA7]&4,\%R MZ8"^I6FM;Z5E(5OW1)-1) M:1&_$X%G+Q(Z_CI$X?(=*D&G`L].9>VLD+<)5O^-Q-59M=6XPQ+OMIQ=+-AB M$+=HL-JP*`)=588`BJES&0H#_4D5>Z_HL0V'`'@"T,<=\M!RZSY"J=..=)@A MF8RD9Z@.02!#-%"?:330E%>C4705C>J:"N_0`]?P_(ESSY@Z0^[O<59TJ-2H M#KZW,JT.FH,V(]*D4LE`F8:S>%\XBA[;/C1NW)=I0)KUSX`&RC0@Z,*H/OUV M4&CK.W1`(^C:DV2,&,U>SDHJU)34"`J&-B=CQ)!51J&FL$00)C#0G?4HZ$OB/2.LA.L,8=M>,L4)- M8XU,,MX,FNWQ23J2D7'@#23#&,%FFW%N8=.Z@\RD`S3(:N^>960=7(^O:6Y> M6WV]D;Y7X!P,^[&#S,2#8&JN%ZJ[YEKR5\W-6VHPUU>+8:ZA2>:+J7G',C._ M[D:=N9YD^NZN"#^1A)2EL%)VKB'D%=S%`ZHGZ"&,X.Q!(28X3-9].U@G^$%- MW!G^P8^267X0P?TUH[^(]GIR3PT64;)0"]SA!QBT#3Z1;YB?:"VLDN20B^>H M><;U3-8ODC7MJ#HR"2.V_5K`?R<"=[[G`#EG3/8ORF#X-[;["P``__\#`%!+ M`P04``8`"````"$`'!A%Z0D*``!/*@``&0```'AL+W=O?O]*;)$D<5-)WO3Z7Q5_"D5BV21RNWO/X^'WH_J?-G7I[N^-QCU>]5I M5S_N3\]W_3__"'];]'N7Z_;TN#W4I^JN_W=UZ?]^_\]_W+[7Y^^7EZJZ]J!P MNMSU7Z[7UV`XO.Q>JN/V,JA?JQ,L3_7YN+WBU_/S\/)ZKK:/3:/C83@>C6;# MXW9_ZDN%X/P9C?KI:;^KUO7N[5B=KE+D7!VV5SS_Y67_>B&UX^XS?MPP'O_=.;;'>DW?S"Y(_[W;F^U$_7 M`>2&\D'Y.]\,;X90NK]]W.,-1-A[Y^KIKO_-"\KQN#^\OVT"]->^>K]T_M^[ MO-3OT7G_F.]/%:*-<1(C\%#7WX5K\B@0&@]9Z[`9@7^=>X_5T_;M7*X9[*IKLZ@-ZPK^]XU[D`%Y]^[/Y^;Y_O+[<]<>+P=P;W?CS:;_W4%VN MX5ZT[?=V;Y=K??R/=/*4E!09*Q'\5"+^;#"=CWQO_'F1B1+!3WJ23S\`>FG> M`C]5V\7`FXQF7^@>F=](X.>7N[]1;?'S_^W>HQB*_WSY`3Q?/8'XSQ5U*R:[%W@8%95#*A':K$)R[X3[-^%_UT?\D"\7 MT!_WWFCLW0Y_($]WRFGI<#(]5N0A2N+IV;UB9,W( MAI&0D8B1F)&$D921C)&:.3YYGJW:>T4]9"1B*G&K8_8YZ%J+0A):R?5E)&,J>:MCU*UJH>B MM9-JV25&;,5)IE.]T'P4V(RA)#XF=F>!L_:-E7+2@5XK(H:*RIWQW-I+-M)I M)F/O328W@QLS^J&2N6ES/F)=Q9_I*K&ZFLX&UI"DK*N,=95_IJO"[,KW4&N; M;U5VNS)&!1MO=U1^E?'"W1PM23!:E`$K13I#(\E$'G=$";F19*9;A"4+.!1[%!V M+16:F;&;F_F^4EY^-W92RY\UZ^[$\P<+L]&&&LW:WD)"6B?B*":DI/V1O:HD MVH->)"6DI3..CH=6-M%H3U(NB342)N!%K6]*]"RYC<"+1$"3;HK<13& M]#>BJI#VVI"71B$A_:X11S$AW3#A*"6DM3*.&HY"CB&O%W"OA*.4HXUHY]RHX*@UD M)IFHR5VQD[6Z$3N)9J@:.K&S]N25N.RP\TXA.2\\W&[9D[EUH/0-N4S$44Q( M*K,"(=%V$DX)Z;'-.,H)2>'Y8&(^<:'M)%P2*><.$HY1K95PKYPT+CDI#RTQ2 M<0CH!)#J4;$I6R6.0C,443I)O9$Y?"OE-=&GI;5"TY'<C.S=+-$>))T2TM(9E\[)2TG/Q@-K=RVT!TF7A!II,]#B M1-`)]"\S59X@C%5"(@P`];?R)#*B+=&T6QPQ%*J&4[TQ1%PK)B^ME7"4$M): M&=?*R4MK%1R5A!HM,X"B>+<#.,:;-4=2N]J4E;X1/8G$6M*FK\>K3=50KP9K M7(F(J3#K3GV&0NX5*81GI/&*N5?"4^K/F- MV*F#`5Z[C9T_LN;#2ERS(5!&,BK4O:;CQU%J**X4?MS[]B86DEVO*1%',:$/ M^TK(B_KRK0HE)0?=6<913NC#S@KRDIV-!PMK2R_)H>G,&!V$WSDZ#3?/40IU MUP6%ND-!J%-F$=(+84A(OWW$44Q(:R6$M%9*2&ME'.6$M%9!2&N5A!R!^A^' MIC$_-"ED'IK8#J:\NKL_H>[:P=.8O&1EXP]\:X*$Y*`7\(BCF-"'G27DU79F M[L,IV75?&4XTE@NLWD96 M"AE#H4Y:^LYD0UZZ84A(OWW$44Q(:R6$M%9*2&ME'.6$M%9!2&N);^MBB90O M).>[_%8NOW`>J_-SM:H.ATMO5[^=L-8N%E@36RP_TF,@`_$(B)QEP7@&XDFX M!6,8B`?B%@P>??.WU/#'`-]<+99HT$Q-RW\YAI"CAZ4?X+L/[_G;!/K.!I,` M'S1X`RR7Z*%)&=:U%X@$XFU6>#V11]RRAF7MM&Q@$5G%VV`*!R*YN`4S.1`Y MQBV8T(%(-6[!)`Y$QG$+IF\@$H];L,U!S14#;&U0>S67!+0B> MS67!90B>S67!]27&QS5/<8N)\7%9<)F)\7%9<&.)\7%9<$F&IW8MHKCRPA.X M++C`@IK+4B+=FM.,E5-K;X1>7+,'U^3HQ67!I3=Z<5EP1XUQ<[T-[J4Q;B[+ M&A9Q<^H:-ZR\3@NNHC%NKC:XD<:X.2V+`)]1>"_)(L#'%,Y33%T7SQ8!/JQP M_WP1X/,*Y\4BP$<6SI?3`!^J.5_/`WSVY#R>!_APR7D^#_#ID?/E(EBZ^ETM M`GRHXO[K1;!V\D*9,VH^+I_E'P3*7Z[R^U'OH;[B[_N:/_MZP1]N5K@)&@UP&_=4UU?Z1730 M_BGH_7\!``#__P,`4$L#!!0`!@`(````(0`6IY2_&PO M=V]R:W-H965T?DY4YBG/B.,HJONB!7['PV/-V"OSI__^GZ]? MWOS[\?OSYZ=O/[\=O#MZ^^;QV\>GWSY_^^/GM]=7^7^=OWWS_/+AVV\?OCQ] M>_SY[?\^/K_][U_^___[Z:^G[_]\_O3X^/(&'KX]__SVT\O+G]G[]\\?/SU^ M_?#\[NG/QV]0?G_Z_O7#"_[Y_8_WSW]^?_SPVR[0UR_OAT='I^^_?OC\[6WK M(?O^=WP\_?[[YX^/TZ>/__KZ^.VE=?+]\O'O^/NZX?O M__S7G__U\>GKGW#QC\]?/K_\[\[IVS=?/V;5']^>OG_XQQ?D^W\&HP\?Z7OW M#W'_]?/'[T_/3[^_O(.[]VU"-<\7[R_>P],O/_WV&3D(Q?[F^^/O/[_]=9`] MG!^]??_+3[L"NOG\^-=S[^\WSY^>_BJ^?_YM_OG;(TH;]11JX!]/3_\,IM5O M`2'P>PF=[VI@_?W-;X^_?_C7EY?MTU_EX^<_/KV@ND]"D(]/7Q`3_O_-U\^A M#2#K'_[GY[=#Q/#YMY=//[\]/GUWO'WSC\?GE_QS"/OVS<=_/;\\ M?;UMC0:=J];)J'."_W9.X.Z`/3SO(L5_._OS=X/1T6F(\D`P-,Y=,/SW;T5S MT=GCO_])-`.4]BZ>\$<7<&!E#HXOCL\.E.3AEG/CC;Y7GX(PA\,=_5**LN8%5W=\KT2'K(OSQMQ(Y MW+=H_/&?)'+(D@Q_,*IWH^')V?GN63A0[Z'=[NH]_-$%/5SX0Q9^^*,+,7AW M?G(R.CWWZ^U]^^#N'OCIAYFO-^A%DQ-]JU`R$Q(+J004@JIA-1" M&B%S(0LA2R$K(6LA&R%;(9="KH1<"[D1&<6MUL+WL3?;M1YM^JZ3 M"7NU-Z+K6D@CKN=[FP.N%WLCNEX*68GK]=ZFY_KL."Z0S=Z(KK=]$M4>%BQ> M[04IJ25)=YW'J9GLC.LJ%%.*ZW-OT,YZ,E-7>B*YK(8VX MGN]M#KA>[(WH>BED):[7>YN^ZV0^N-D;T?6V3Z+JPIRQ7UW=JO1=6-N^?/K\ M\9_C)SPG@_UL-)C'U=B2P4F[:156F),6]:NQ)6=6U3,AN9!"_)0M.<9TR9[> MLT'<'*J]$7-?"VG$]7QOTW>=+*46>R.Z7@I9B>OUWJ;O^B1.]69O1-?;/HGJ M+.QW]2N-H_R.Q[73H>-0G=Q&&)VEBP-:V6Q@2M0/.$P#SFAUMNN!SRY.WB4E MEM/B8O^4%T066TET,+:*5FUL1^^27JJF;G$U1!;7G.A@7`M:H9_K%5PR4"QI M%?DZ3_JG%:TL$6NB*&!:O!M:6?$F;7U+BUV6XT82=AQZ^TW[1M+N1&")P(8V M'K3HV![/"9$E>=JA<[.:$=FSGQ.=[MT7ZJNDE?FJB,Q7362^&O4UIY7Y6A"9 MKR616:W4UUJM-D3F:TNT2U=-HCD1&EKO M:4K2O3`KNE\2]4MIJ`^8E-*:`5\MI8U9,+8MT2XS<<6&%;I7L>W*/:K8%J%B MZ7<2C@W26NQ0>T`3ALT9K0SE1%:ZA:*2R`)6BFHB\]4HFA.9KX6B)9'E<45D M[M=$YFNC:$OD%'I8YGJ%WBY_HT)O$;JP7@,[3V9SDW#V@GHX[O=J'3IMUQ`G M1^^21W#&0-8+Y43FIU!4$K6NC]XE?7=E.AM*362.&T5S(JR@[&DZ3]POS(KN MET3]4G*>)BFE-0-VI31*)YRF,ZXMT2XK\;.$0<^MUL"3Z4N+HI&I0U9$T[`A M%JK5:FBF*">R@(6BDLA\58IJ(O/5*)H3F:^%HB51?V22/*YI9;XVBK9$3J&' MY;;W++7+\.A9ZE;F,2R] MO9ILE^113;8H^.IU%$FQ3<)Q<5J3';**FM'*4$YDN2\4E406L%)4$YFO1M&< MR'PM%"V)S-=*T9K(?&T4;8F<>@AK:J\>VK5V5`_=\KO?[X[.DZ=C$@[=0S=F MGF[7YU$]=TMV MZ\HGX9`EK=0.65<^HY6AG,A*MU!4$EG`2E%-9+X:17,B\[50M"2R/*Z(S/V: MR'QM%&V)M-!1JFZA[W@\1^A0O)`Z3[\_4CB?5&TRQ`K:EQJ2SZB^*B:PSGRG*B2QCA:*2R'Q5BFHB M\]4HFA.9KX6B)9'E<45D[M=$YFNC:$OD%'I8)3L=V;!=/:.V6'/C#B7+J:0; MG=#*GOLI4=OW#@=#V9PP"\:6$YF?0E%)U+D>ZO:$6=!U362N&T5SHOX8)=/+ MA5G1_9+(W*\4K8G:E(^.C].EX,8LZ'I+M',=/SQAZZ!7CS_:LQ^V6PU1_;:H MOZ[JK/JSCPZ-;#]UIBCOT,EPWWP*]55JP$I1K;X:]377@`M%2_6U4E]K#;A1 MM(U\Q941%LN]RN`V:[B#M/#T+PS.+'^H]#(2EH=C*RB5;BGA$W(X2!]SFM:6&R-QC:GU<'8%K3J M#UNC\V2\6](J\B5[A9J(M1M0-N,[*Y;OZ&28SA>V=+3+<]Q,PHJ^UTQ^^,RV M.P!1\VE1-!!VR`:):;C9BG;7.U6==>C,.JF<5C8]*SK4:WKE<4NK7;KBR@C[%(F-(],.);=XDM7$S*Q8H;FB0MV79F73H]%I,CNHS(KN:T6-NI^;U0'W M"[.B^Z6BE;I?FU7/O5S`,BNZWT8HJE#<'GO78(>2&DRF MKC.S8B)S186Z+\VJ7P;)Z5UE5G1?*VK4_=RL#KA?F!7=+Q6MU/W:K/KND^=B M8U9TOXU07(/)_LB/IHO'[29)_U'M4'0QJV-1S;8A^U>S.JL>RA45ZJOLT`^N M9YD5"Z)6U*C[N5GURSDYEUJ8%=TO%:W4_=JL^NZ3C>J-6=']-D)Q-;ZRXQ*> MHV1"V:$?7-2BE4T[IT28]Q]8'-*J71Q>'"6EEE.WI7Y!9'&51`?CJFC%:UI) M$=;4+:Z&R.*:$QV,:T$K3+?VN9>=FR6M+,85D<6X)CH8XX96^Y)\E^1O2XM= M;'%[P-+4&VG#$Y.VAQ;U=V@ZJ_X.38?Z=[*(;%65$]D*K5!?):UL[541F:^: MR'PUZFM.*_.U(#)?2R+SM5)?:UJ9KPV1^=H2Z6HO;&*ZA:X[-#O3W5ZSM2:] MDT4KFWE.B=KM\>.CX[11S,R"_49.9'X*1251ZUHN/5:FTW%-9(X;17,B#`"O M/SH+LZ+[)9&Y7RE:$UF1)-.%C5G0]99HYSI^=/!4NK48>#*G:5%_HR1TJ["* M!KX.V?[4C%:&K)1PC4P;MI(H;WYF1QQ,Y!U$SF1]=Z%HI*H M=2W'>Y7I;(`UD3EN%,V)D'3+[$4R7UV8%=TOB?JEI&?:M+)$K(GVI93<'C>= M<6V)=E[B9REL3C@+ON-VTR*:1;8(U4J_D\XJJL/.RFIH1BM#.9%EJU!4$EG` M2E%-9+X:17,B\[50M"2R/*Z(S/V:R'QM%&V)G$(/.Q%>H;<[%%&A=YL64?,Z M3Z9L$U2`]&D=:OO>=%9X?AG5E,AZ[IFBG,@"%HI*(O-5*:J)S%>C:$YDOA:*ED26 MQQ61N5\3F:^-HBW1+F![.9.:&6=P)2(*YGD`9R9 MSJK+BO=`D]ZMQ8EPU:RBIZ,.BOK#*9$6.'NGU"]+])9G1[OKG`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`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`.1$#T`ZU#_,)K*<3(ELOC!3E!-9P$)1262^*D4UD*;H@LX*VB.R+S=:_H@!:6;K9/:&4]\)2H'?L'QR=R0]HLV*1S(O-3*"J) MHL'_/-D_J,R*[FNBUP;_W4?;&EI9(N9$_1B=:5A;?+CYQQB7#&B^5HK61`?= M;\R*[K=$YOY2T171JU5Q;19T?4-DKF\5W1'U4SY*J^+>K.C^@>BUJH@ZKU-8 M>>UUQ^.AMT/]>1B1Y61*9#4U4Y036-(8 M6I3,P]*]N)W#^%V@1.UP/QB>IE?H9F;!)IT36=]=*"J)HN%>UI!F1?5PVB&<3#.A,T5Y MA[#73:M"?94:L%)4=^C,8FS4UUP#+A0M.]1+UTI]K37@1M%6?5VJKRL->*WH M1GW=JJ\[#7BOZ*%#;7G%C>25`P;<:)5.K471C$RN/TRZ@/U]L0Z%S5M;R*4; M[+/.JGOUVN!H<)*^6CRG(^O!"XVNI-7!Z"I:]>5XU:%>`:]I%:4RC6Q#JSC'R>)U2ZO(5YKC M2TW$E1LP3<1U9[6OY=-!NDMZ0T>6YUN-[HY643K3Z.YI%>4Y?:G@`ZTB7[T\ MQT\,.M_^-.!'1\6X?BQ/4HNBN6*'K`E-NX#8TV:'.>M0[PUX.:UL259TJ-=" M2EJ9KXK(ML]K(K-JU-=T4+14M%*T5K11M%5TJ>A*T;6B&T6W MBNX4W2MZB%#>K?ZM*4:$QEF;5+YITX\^LK&CVZ0**BN;LE:VE'8^? MZPY%NPDGZ=N])K3J+V4'YDQW8#K47[D269*G'>K?Z""R83XGLBE#H;Y*6MF4H2(R M7S71SE>GH[2N9V;" M1IRKHT)1:0$[W\>I[\I,Z+N.',7E@=FX-_"=!9X\("WJSZ<[JUZW,>T0,L_8 M9XIR#5@H*C5@I:B.`L:92Q81^\K6Q0)>T1CRFSS]R67:":WZC;L+V&Y@#?%% M@F1U.V,@:]@YD?DI%)5$G>OAA5;U/G(6=LU`.]=Q:22SY7UI[&?%=#(.WRQN M2X-H0F1)GA)9QF:*ZV28F="J_URW MOG``%)X]''DE?>J,86Q-G1.9FT)12=1Y'KT;]BY]7L@QOIFS>FJB73QQM2>S MOQ_-#K!I($]^BZ(GOT.6KVD7$*]/8*IFBG(BZ\`+(O-5$IFO2E%-I"M#K$7] M;DUGA3O3Y,G7#3=:62N>$AT=%38_=I]W.,)A0_+KY9R.^@-_F\[>OCJ]+H!A?IBW9J.G)&_C"/ZAT<_["IM/.N_L\KL?DI/4>'^D77(OQ.W)I* MB[#8)\H[7_C9)U%!]^:KI)7YJCK4\U732G^2?IY,$273W28"TO#^^=/CX\OT MP\N'7W[Z^OC]C\?)XY=8W/ M3I'J76-,2@`##U+M*5,HH4?5>##*(&V>@L$&:?,4C#EH%IZ"L02I]I0Q\A/F M!IH"S(R0:D^90@G3`@V#61!2[2F8#"'5GH(Y$5+M*5C0(-5NXSP;(M5>,\3D M':GVE"F4,&_U4CU$JCT%TW6DVE,P:T>J/04SJ4SA1)6:!K/#,K,5;!411EX8;!B11EX"A:NZ*`\!8M5E(ZG MX$0B"_O&FC8<3&1A^U@5'$9D81=9%1Q`H//TE/$I6CSVSS3,&+4P=LL:6T?9 MQ%6P@Y2%S2#U-D7-Y6X8[!1E84M$P^!`*0N[]:K@$"D+F_:JX.`H"WOWJN#\ M*`M;^*K@S"@+._FJX*@H"QOZJC10PMF%*CB9R\(1ABHXCMZF4,)1D<:#$]4LG!BI M@H-4U+:GX#P5M>TI.%;-PC&2>L-1:A9.DU3!\2E:KZ?@#@9:B%<&N(J!%N(I MN)&!=N`IN':!=N`IN'V!Y]13<`D#3Z.GX,(+4NTI#91PT4!SBKLN:#N>@LLL M:#N>@CLM:#N>@JLM>+(\!;?CD-/=W:1D=,8E.>344W!7#CGU%%R&0TOTE#%2 M,'93,($R<94IE'#Q0TL'-Y30WCP%%Y70WCP%]Y70JCP%=QM1HEZJ<<41)>HI MN.F($O447&5$2_04W&A$2_047&Q$2_04W(W.POU7+0-<:$6)>F%PB14EZBFX MRXH2]11<6$6)>@KNK:)$/0775U&BGH+[J6CQGH([J6CQGH*KJ6CQGH++[EFX MFZQE@`ON6;BBK`KNN6?A6K(JN,R>A=O)JN!.>Q8N*:N"J^U9N)BL"GY4D(7[ MW*K@AP19N-:M"GY/D(6KW*K@5P-9N-&M"GX\D(6+W:K@-P19N,RM"GZ!A)QZ M8SU^B(2<>@I^CX2<>@I^<(26Z"ECI&#LI@"_#,DFKH(?B&3AFKVF&K\"R<)M M>U7P8Y`L7+I7!;\)R<)%>U7P\S&4J)=J_(H,)>HI^#$92M13\&LQM$1/P8_& MT!(]!;\=0TOT%/SZ%"7JC69CA`D_Q-+\3*!,7&4*)?P&2\/@-X$H44_!3P-1 MHIZ"7PBB1#T%/P%$B_<4_.P/+=Y3\.L_M'A/P0^)L_"[3DTU?CR,4)93P*U<-@]]@H^UX"GZ*G87?O&H8 M_/P:K_+H=->\>P//CA<$K"/#\>`I>Y(,6XJ4:[_-! M;7ME@+>H0/'*`.^Q@.)YP^M\T$(\!6_UP5/BQ8/7J4#QXL$++:!XWO`F);0= MSQO>7`/%\X9WAT#QO.%%2FAOGH+W*>&9\^+!*VR@>/'@)2)0/&]C>!N[R@3* MQ%7P5BK4MI<"O`((BI>"*5(0WJ>BK0HOI4(+\93-:)2%-XIJ&+SA-0LO%E5E M/,)LL-TD3F;KTQ%F7.V%Z43!"]'@S5MOX_UC\.8I>(EN%MZOJBG`NW2S\)I5 M5?#^W"R\;545O#,W"R]=564%);Q[516\+C<+KV!5!2^M1GZ\?:0QPHS=,'C? M<39Q%;SV.`NOL]5X9E#"6VU5P1N.L_!R6U7PHN,LO.-6%;SO.`NONE4%[SC. MPAMO5:FAA!??>@J>++<,\"IRU)Q7.G@C.>K'4_#*<=2/IZR@A/=9:PKPMG&T M7D_!)P'@S7M*5E#":^@];T?PYBEXY3]JVU/&2,'830%>(X_:]M*&M\FC3CT% M+XU'G7H*WAV/.O44O$(>->447Y1`JCT% MGXU`JCT%7X]`JCT%'Y%`JCT%WXI`J_(4?#("K$[2XC'4_`Y);0#3\&'>+*)F[8IE/#A%HT'G]W)PO=; M5,'7=[+P&1=5\!&>+'RZ115\:PVI]GH7?%`-J?:4,?(S?B4_.,MQE2G"A`\[ M:0KP02[DQU/P72[DQU/P>2[DQU/P%2ZT-T_!Q[C0WCP%W\F#-R^G^!P>O'D* MOHH';YZ"C^.A57D*OGZ'5N4I^`@>6I6GX/N3"./U+O@,)<)X"KY&F85/'VI9 MXPN4J&U/P9,D;:QF[:)E`FKH*/&J*VO?S@RX6H;4_!!PQ1VYZ";X=F MX1.3FA]\+Q0UYRGX4BAJSE/PP5#4G*?@NZ%9^/RDQH-OA:)./06?948M>#T? MOLZ,I^(IV%CZ(K3G%UYE1"UY.\<%?*%Y.\1UMU(^GX'/:6?@RML:# MSS3C*?'BP9=_H7C>QO`V=A5\AQPEZH7!Y\BS\&5Q3<$4*0A?K/84K!=<;_@@ M.4K4BV90YF[R@+*PE660_260Z^-KJ"L7&4-9>,J6RA;5QDC!6,W!1,H M$U>90IFZR@S*S%5R*+FK%%`*5]D.T;L,O58U1G[&;GXF4":N,H4R2NTH! MI7"5$DKE*ML!9L0#KW<9(S]C-S\3*!-7F4*9N4H.)7>5`DKA*B64RE5J*+6K M-%`:5YE#6;A*C3*HW3)HH#2N,H>R<)4EE*6KK*"L7&4-9>,J\P%ZV($W_BRA M+%UE!67E*FLH&U?90MFZR@1IF[AIFT*9N4H.)7>5`DKA*B64RE76`XP+[>_" MDKVT+92MJXR1G_$K^<&XX"I3A)FY2@XE=Y4"2N$J)93*56HHM:LT4!I7*9'3 MRLUI#:5VE09*XRIS*`M764)9NLH*RLI5E@/TR@-OG%M!6;G*&LK:5390-JZR MA;)UE3'2-G;3-H$R<94IE)FKY%!R5RF@%*Y2(FVEF[8*2N4J-93:51HHC:O, MH6\$GN/@W1N5 MYABRO7/E.18DGI\5CND]OL:DVO._QB#N^5]C">GY&8<#:&<&,<81O&<_P0&\ MQZ7EZ>O MNS\_/7[X[?%[L(;Q[T]/+_P'IE[O_WKZ_L_=[?9?_D\`````__\#`%!+`P04 M``8`"````"$`QYRZ:@=$``!I8P$`&0```'AL+W=OZ2=:E4 M)JDO\^_W!"(\PMV/$Y3Z853S\7A/+AW>_'(P^_?;F[/3T\LVG=Q]_?YU;^-.7 M[VGC\]_^]O']A]7G]__\].'W;[F1+Q]^>_<-X__ZZ\<_ODIKG]Y_3W.?WGWY MQS__^*_WGS_]@2;^^O&WC]_^Y]#HZU>?WO]I_/OOG[^\^^MOF/=_NL6[]]+V MX?^AYC]]?/_E\]?/?_MV@N;>Y('RG&_>W+Q!2W_^Z9>/F$%R^ZLO'_[V\^N_ M=']ZZFYN7K_Y\T\'#_W?CQ_^_57]]ZNOOW[^]^;+QU_FC[]_@+L1J!2"OW[^ M_(\D'7])",9OR+H_A.#NRZM?/OSMW3]_^_;P^=_#AX]___4;XGV13-Y__@T] MX?^^^O0Q)0'F_NX_/[\^1P\??_GV*_[K\N3BZO2\.[MX_>JO'[Y^ZS\FV]>O MWO_SZ[?/G_Y?%G6EJ=S(HC2"?TLC9VA>_Q;+*]/KB\N M%I?75T!'#"^+(?Z5+H_JKXH>_Q;]Q"(.`\2_Q:[[/L.;8HA_ M?VQF'8)]Z#+]A\RM^Z[!=A+-]!_%=/%]_NS.I%?\A_1ZU*,=4B:/L^7.][FF MDWQ)_U'ZZJZ_;X:2,$CF:@H_'EQ(L:>^3_"])__-K3!*+Q%?0?_VY M.SV[_.G-O[`XO2^BMX'(*I:B2`M4:G?EP=J#WH.-!X,'HP>3!UL/9@]V'NP] MN/7@SH-[#QX\>/3@28$W"%6-%Y[6'XI7TJ=XB:/?"F@!/'.Q$868K#Q8>]![ ML/%@\&#T8/)@Z\'LPW'MQY<._!@P>/'CPI8&*#=?&'8I/TAS>Q?I:N M;#3>9E%:&ZK*/6[+*JD1([(FTA/9$!F(C$0F(ELB,Y$=D3V16R)W1.Z)/!!Y M)/*DB0DA7E`_%,*D__EU6CAK=+`>7KL89M71&%9)C2&1-9&>R(;(0&0D,A'9 M$IF)[(CLB=P2N2-R3^2!R".1)TU,#/&ZU3&4-U?"AU")A]\6@L>Y!F]QZA^N M*A*S%9$UD9[(ALA`9"0R$=D2F8GLB.R)W!*Y(W)/Y('((Y$G34Q@L!^+`I.P M#4PFV$J)SY=$5D361'HB&R(#D9'(1&1+9":R([+7Q'@&^\W(,PE;SV2"K7CU M#)$5D361GLB&R$!D)#(1V1*9B>R([#4QGL%.4WNF[$]/4A7W[=>/[__Q]C.> MW:YN3Y/<>BR3#COJZK(B:NFU$M'Y84>[Z"[/;^P2OFX*::9GM&$T,!H938RV MC&9&.T9[@XPSL8GX$6WG;5#*&F=&.T=X@X^)4N6D?R]OGP*TS"^I2G:H'=M.R61L>\ML0%(EQ17NLRM(.DIQ65]0A^,+Z7%9F)KYJLK,AJ+K M?%1R!\JRKY:M@TW`AH"-A:GFIBH[.I`M6\[5L@UD%["]9=;?J3I2_JX/0.+N M`06WH]9IC)E%5O2.D*&?6AX=N4V MSYLJ.SN\6"_/3YQB*`HUJ)'15-LQ,W3CW++A'!K2.'=5EL=YMCAQJ_#>M&T# ME0J1*%"Y0#&!*C4+`B5IL4QGH@B>R365GU71@TY'15"U; MIUN6S8%L5UGK=&],K;]2?1#YJ]0-[9%YFPY]2V*+(Y:%&7\U65M'+MPRLF;# MOK:?P[[H3B[L,[-1"AG!P`V-C*9JJ5/6#VK+AG,US(.Z7IRXK=-.*610>].0 M]7>J.B)_YVK$Y& MSY6,\7@I;DR&9F96!):MTR[#!J8OR&:HF+8$&MAT9#35UG2&4J=SE;4.=@'; MFQZLOU+Y$?DKER7&7QDIWRS3,:3UPZH@NX&X<*_J-1OVU;!DPHE;=#=*((DP M<#LCHZE:ZO3T8]JRX5P-\YC.+OPSLU,*&=3>-&2\#7>&WCYPNZ$M2'N;T:H@ MO6JL6=976X"MC>FUEV(5Y2<>&)3VL%0?/ZV MH.X,^TNU_W=YMRRR<[7]%\L4M6;I]H-K-NS%\"RMZ_CL\NJD.]7_<\7:1NEE MV`,W.S*:Q/+H$+=L.(LAAMCF=G[NGJR=DLG(]J8U&Q5=E:F7&EXL%)52;B$J MTO"RR$P(I"H[W&HY?(B[9EE?4(?92&N;@`UL.C*:Q!).E=:V+)M%ICK=!6QO M3*V_4LD3++$I57T69]2I,2V+S/BKR5I8_7JV9L.^H.3!9DCYL%$R<I'MF7#60PQLL/NY-HO_SNED$'M34/6Z:D4BIR>2R2S=&1DG9Z9<3K+ MULF/"*&2]079)"VF^)D,?6#3D=$DK:F$V+)L%AG^E0YV`=L;4^LO74GIAYHK MJ70'!9,^7,]J"V;G*HNEDLF85@%;!ZP/V"9@0\#&@$T!VQ:F3GKG*FLOMEW` M]I99/Z8R(LJ[7%Z8O"NECWE6%IT[6%Z>99G*L55!*6/;8[R@5Q89]F*(/#B\ MLCK_E&V40J(V\`A&1I-8'AW4E@UG,2R#.J4:50ED3'O3CHU`JI"B".3*R42@ M%%/JZ5KBZ,T]TJN"]`*Q9EDO,LQ#AKD)V,"F(Z-)+-78MBR;1:8ZW05L;TRM MOU)9$?DKEQO&7Z6>46-:XODA?S592T]_7+%FP[Z@M'8>7@+N`$7]6!P\<"LC MHTDL36[Z$6W9#LEDY'M36LV#,\48N= MNN!QS@58038:66:B40HP1$-9N`#6+:-@ZCH%8X3]6R=;IE MV5QEK=-=P/9B>NC4^C&5*U'VYC+&9&^I;,R+M;OV'Q>>9YE^;Q6D7V]KEO4B M0Z2\QMA>',(&PI; MM/0;N;5)+-78MBR;1:8ZW0E3G>X+RYU:/Z8J2"4S^?'I\Q_ZUM=YKII,DF>$ M0W29Y+*H%%HQ6C/J&6T8#8Q&1A.C+:.9T8[1WB#KP&?JJ7.NIPK"Y]O-4:7$ M:FC%JC6CGM&&TT8[0VRCDIES[%,<_<+\0RFRLEDFE1.[7E: MBJQEWZJ@#HY.==*B.[MR*^Y:2206?<`V`1L"-@9L"M@V8'/`=@';6V9]FTJ5 M'_%M+FV,;Z50TKXM,NU;D6%5;!LMNG)XWF3-O\PV@6X(V%B86NNGR89&I#=*J6MH-I#_)*C)UP:^OEEA? M6I@Z?_E0R<0Y0\#&PM38IBH[.K9MD:FQS=7RZ-AV2B9CVUMF`X)Q_,@CL$AZ M%ZB,S.7#(E,S7Q74I1MERK>NN%VS95\MVTYV$[`A8",W-U79T8%LV7*NEFT@ MNX#M+;/^3K6'6G+D[L8BUR1Z:2GHI+/(U&QW`=M;9OWHJK+J1ZZ^D(0I95/UI1//O=N61692-K2D=22KE&$? M=LGU197E(OK\X@1_E4#]SWVB.A2]ZFED--56S7S=J+=L.(>&-.I=E972_\R? M7NY-VS9LSQ2!"RX""S)%MN5];5587+MT4I MWXR[,S/N9MFZF"I97UMK6;$)V,"F(Z.I6NKTI+'-5=8ZW05L;WJP_DIU6)2> MN3XSZ9F1?9PS4XY8H=:.%FM_$['(E&5?+4LNG-)56:607!BXH9'15"UU@M(Y MZ98MYVI9%LMS?UBS4PH9U=XT9#WNRL&:H5SV+4K99S(T,^6W52!;%Z9D?96U M9-D$;D=%4+76&TMCF*FN=[@*V-SU8?Z7J* M19:AK)1PK0IZX9-S-NS%L'P0R!_U*('T-G`[(Z-)+,T9JO_X:9.K#PDW`!C8= M&4UBJ3K=LFP6F>IT%["],;7^PD(3I2T*0E]^%:2/O)>%&7]E2Y>C=,6;+7OI MX-DD50*)V,#MC(PFL;1)Z@>U95@O2CE@6IARQ4K*V[/@[?FLV[,40DVF&M%YME$SR8>#61D:36)HD]2/; MLN$LAC5'W:MDIP0RIKUIQ_K\F=KI@FNG@JS/L\SX/",M6Q=3)>NE-94NFX`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`HJ)U73M*0?K.Q M;!;9\6'MJJP,J[OTFYJ]-,X7$B]UD98ZRG_>]]D_?G30NW=B^41+S6999'H/ M49"-1395LEYDJHC:"%-W`X?"<%(OZ\E8D&IM$DLUMBW+9I&I3G?"5*?[PG*G M=EG015KD1W[+,1C;5.K)0MVR)"9+=KN@&K9-"W2I?1J*\R:53VC#:.!TT0.C1T9/!MG`IB)2!58^RKO,Q27B)TY_6Y"Z&+QDM&*T9M0SVC`:&(V, M)D9;1K-!U@6IG(I82AH9-7$:,MH-L@Z*M43ZJ%Z:4MUE>L/_;`59!R856KGOQ)#X\"%NTF\ MEK:T`W-;Z7>%6J9YPTTQA$J\-3`:&4V,MHQF@ZP#4[WQ(P[,]8EQ8$'89;49 MGOJ=U%51M:WYJB`\!C+I=4'*\WU!U_FF_MEIYVX*;II`FAD8C06I7>?45.EW M`-"R^UQUVP32\FR0]:0NLO0SRT7652FRTEWEYK)+MVM9%IG:8Z]B2_K[R&S9 MAY9<=U59N5FT\%??!FF[;8I&02VV4VU'3Y&ZVU99[NZ,K@S-TC:74^FO3NO4 MK6^3Q-W;)"-SS^)@;DO8@K1LS;)>9+CZ+'FQJ4P_P;G7Z_9[O".W-E7+UMJV MLM;:7%ANS6:>JX>J([CNNTNO`IB.C22S5V+;"5&NS,;6.>&9K?\5;^X)> M^A-C16;6O=R8L^3LRS)EV8=]4B9L1(;[GRD3Z$^H##RHD=$DS9A[==3;5F2U M-_=.FTW3UMW/E!%77$84I)>S96'*0ZM`MF99'\@VPC"/EG=Y(*J'D5N;Q%+= M?-L*4ZW-QM0XXOJ98N+`[?)?D%OU+OVJ5V3ZF8PM*>_8L@\M*1,V(BLK4'?B M]B`#-STRFJ29%]8[D:&W(VOL;#JP3D^[>K5=E%7ONM07;2OWMB#SN5%AQL/9 M4LO6+.N#UC;"U#HUL.G(:!)+O>H)4ZW-QM0Z(BX\GC^INBZ5AW(\#JI<"KXM MJJ,'54TCS]R*T9I1SVC#:&`T,IH8;1G-C':,]HQN&=TQNF?TP.B1T9-!-JYQ M/70DKKFNP?^MFQ:<([N3A+>H7@Y7_;$V5IDKHI=-T^):S02M6=4SVC`:&(V, M)D9;1C.C':,]HUM&=XSN&3TP>F3T9)"-JZO.RD'!D;C6LJU%#`^L6Y[?7I=2 M[FA@JT:BN&IF@M:,>D8;1@.CD='$:,MH9K1CM&=TR^B.T3VC!T:/C)X,LH%- M15;T1LK%ESZHN,Y(GRPS6C%:,^H9;1@-C$9&$Z,MHYG1CM&>T2VC.T;WC!X8 M/3)Z,LB&YIFZ%"6L+]`+TB?>C%:,UHQZ1AM&`Z.1T<1HRVAFM&.T9W3+Z([1 M/:,'1H^,G@RRH7'5ZTOGIM=53E1U.U6U$GRG#K[D, M+ZC#7ZP1AR\+,SOS4G.GKPJHFY;%F=NRKJ4UR*2U/F";PO![*2(;J@PU@.K! M?7XSLN54+8^.;:MDTND9'9O[D.N6+>^JI1V;L[Q7,AG;0\`>N8#^%,&Z=)#^H)%,IP_8IC#5PU!EZ$FM-ZZB'MER MJI;6U:]D,K:'@#UR#T\BB]+` M'5;)J=U-.9-2IW8%V33(,A6DE:]D,K:'@#UR#T\BBP*> MSHV"7;>I/=*)F-["-@C]_!49;P_ MO''G8'4IJ,==TMG;@Q1_2TJMXWKS(;35=7WK+E7;6T MT726]TK6HLF>>^0>GJII$$V\*O2J_=*AS$W2NUU<1N;O$Q:9"LNJH`Y_O5+& MOPY8'[`--S<$LI%E4R#;!FP.V(Z;VU<9%B"U`KM=_RU;WE5+E+;/6]XKF7CI M(6"/W,-3E0513D=IT;LY<1?-C#J\K_4XW89V>9-EZO%<%=29&V;TZ?.ZRK## M4XYP6Z^^RO0XSJZ=;,/C&$++:_Y,)Q[RP.[X];V8JDZO679G5M4X?"E.=/G)K3]62?SWO)IVP M12M"/GDSN_5R&&?_OB?=WSNT:+_&NB![!X;R="VRXS=$>NY@PVB0QLRME,7" M'^RQY11:TFBW(C.C72S<5GH6F1D'K5\['L>^6K8TOF79G&V0M7U7*&ZM+,3J)K<"]/3OA6HA'?".M7-?00?!"KKQX`]"2M=N]#A M#"%ZS+O3]`,?NLS2S`M75B":6:??_<+L94EZ>-955VXA7OK?L$6TJ75$ MFQBB749KKCWR@RXZ-5HD0&1+HT5.%!U&VSQ"]X.1)C0^9`DQ9`DQ)`DQ)`DQ MY`@QI`@QI`@QI(AF+D.>.:?#A:(@0S(S+VP1*@>OA.EKH(A]L59W+1'N#)4U MPDT,X2[&Z@6*AYN$B"T+$<@"5=>(&EDC:L00-6*(&C%$C1BB1@Q1(X:H$4/4 M-'-12X=JP>L;MX6"J&6F%A(\P\00-&*(&3&$C!A"1@PA(X:($4/$B"%@Q!`O M8H@7,<2+&.)%#/$BAG@10[R((5[$$"_-7+S2@548KWR2I?=;W6EF^F**9:[M M=`B@VCZ4\/C;!?CE#3EIZT[S08'MIAP>I#^&VPJQA2N4D"JB,^<3BU;SNN&X M$X4V!CXZZ$[+V4';VJ(_S5S;J>KT4[V\.M$SS86IG6EFG9NI_]VG[E1T=J:M M]G6C2>6+&DV;::YK[!@RZ_#W!Z5.P%09XC%DB.>0(1Y$AG@2&>)19(AGD2$> M1H9X&AGB<62(YY$A'DB&>"(9XI%DB&>2X4,$\52R$H^E@2Z$SY1!W2G70<+T M7;Z`(8"E8&HE-.)'#.$CAN@10_"((7;$$#IBB!PQ!(X8XD8,82.&J!%#T(@A M9L00,F*(&#$$3#,;K^ZY4N3P`[>?+`/0;LR3(7K[3Q5$OD2\?+7?I`UMED,(@[ M0\2=>D'818BH/#]"9`+9(A'$%EL;9>LN5-YKG8P0N=&,!2(W,E21P@I0A,&U M@/1U=\_D1MXNFUW208S/?_4UT=R"SXUL[*X0G+EC/CSO32=3P//.$+F1H9H7 M'G<16L^[7I`;9(O<$%ML9Y7GG2URH^EDA,@-AL@-Z@6Y(<*C(T1ND"UR0VR/ MCA"YT70R0N0&0^0&]8+<*,(P-YXKB[J@+"K,Y486JJAAW2CUD[LOYDYHD1M- M)_-";C!$;E`OR`T16L^WLNC]JR\_OT9ND"UR0VRMYYTMH% MN2%".T)W#1"Y0;;(#;&U(W2VR(VFDQ$B-Q@B-Z@7Y$81AKGARMKV3@EJV:[4 MJ';=R-#F1A':W/!_&P6YT70R+^0&0^0&]8+<$*'U?"LD)3?(%KDAMM;SSA:Y MT70R0N0&0^0&]8+<$*$9H;\;B-P@6^2&V)H1>EOD1M/)")$;#)$;U`MRHPC# MW$#/\7XC_<"7`9FY=2-#FQM%V#X-11X00QH00Q90>\B"HDN[*?4&Q.XMRMI,:;,.E/QG4IR1;I\ERW2I>ED,$@7AD@7Z@7I M(D*\TIL/Z?ZAZ%0@D2YB:WWH7LI(EZ:3$2)=&")=,E2](%U$R'=@#M_S&:=+ M/B"RZ5(.C9`N,HQE;L%O1(M0Q1RK!D,D`D,D0H9J$D@$%B+J)$3468@0,T2( M&2+$U"1"+$(;8O<9(%8$LD6(Q1;_JO1PM@AQTXEO$6*&"'&&RCL(L0BC$*>3 MHW!%R$=*-L3EF,F&.$/5X^KP>2B6!/U8(\3%6L4=(6:($%.3"#$+$6(2(L0L M1(@9(L0,$6)J$B$6H0VQ*W@18K)%B,4605`A=K8(<=.I$#-$B*D7A%B$08@1 M0A/B%T^4#@9N2U!8VG_*\):'&V]^Y1>AOK0H0GV3L8_@1J#*ID&8MAX%*N$D M3`NW$9PCN!.HFMP+Z\ZQ[U;AB4[9VP-)PCMO=:)[Y]B."C0-7+D[`N M>M^G"TCATWWX@0]Q$J=O);:WZ]PV&E'/.O48KX2]=).QZ?(%NZL%WV:0YMN> M$EE!72(KRG#-Y4FZM"@R-5KD260:7&:HNCS:Z].3&_5=R*>G+@N05F6<;>S( M*AH[LBH:`%]D%)T:/+(JLJ7!(ZM$AY.FEKD+5X\BT42GPT[7KI![6:?&@MP3 M6_-TJ`]$[:'G63KTBEXVAQ_X="PG9%C:Y*E`[F6H!H'<*T)U`W#=8/OP$"M. M5JH[@$@M:A&I55HT-R=8B$3BKK'@"&Q=(S,R5%TC,S)3DT%F%&/5-187$B(- MBE#-&C$7V+I&@`6VVW&()C6):(J0+S\>;BG%H130/ MI$9D2X\ILJ7HW#SL!!!)R&"SD)$N$#5-\+)2L2.FD3L1-CFC=B1$+$K0M4-%@2&B!U9 M(W;$$+MB',8NG36%L!%#O(@A7L00+V*(%S'$2S/K#WSA3NR/PP_4'_LH5/>*%Z6\.2/=BZ,A:;+&& MJJ7`K49P$9G"19FYKU]PA3.\5F42&7B-&+Q&#%XC!J\1@](P6N:.:^E#:SRVHNG9^D[).`YZ\VR,S;>+*P]IW@FBZWQ)G_46F1J/P5O M9M/T3_.F-X4WJTQYDQB\20S>)`9O$H,W-7/>3%O*'_)FWH-:;Q:&'4F;*G\N ME8[L4B#:BP$.SDQ_F84PZ\VLPU\J+=?BW*]ZQ3QQ/P7VCK?U<0SSO9 M(D,C6ZJ(X5G1Y6_O.Z'6(EPT9\"'!5ZT%0=> MRU"=0<%KU"*\QBW"1=PBO*);=%Z)BH)T0^']/[]^^_R)OR0N'6`?[BE2TB2':Q!!M M8H@V,42;&*)-#-$FAF@30[2)(=K$$&UBB#8Q1)L8HDT,T2:&:!-#M#6ST4X? MK^EHUZW%X0=NGUL8+AQ(;):'CP3Q9).LR3&.9)#/,DAGD2PSR)89Z:N7FF4D?-\\5Z M9I%K(SO_PO1E`-&UV&/^I:[2R_SYE7NEPR55)FD#EQ"#2XC!)<3@$F)PB6;. M):E>^2&7Y`+'NB2S])T5]8UV?N66.#P-Q=1XJ9@^5VS`056A'$0,#J+6X:"J MBXL-N*LJI'6X2S/GKE2'*'>U)R47*-8MF:7:1;G%G:K`+45FW%(8]HS5E,H% M^*;(L'NJ,OJ#`\BG(FL[0KB+>H6[OJ=7^*SVFKQZ<7)Z8_[G-J3PI^[>^3.5 M%J$_<\UA_9D9_"FQ@O,*,\[+#-_((#IXJK#V]6-P2V'MPS*XA=J#6Z@]^(#: MPSQU>VZ>J5@(YYFK"#O/S-(+I475%VZ8>I'I0Q1A7:[=KVY.SG5L7)T+MY0V MV@=L<`NU"[<0@UNJ;4J#JZOC%T3@LJJ7L,!ENEWGLE02A"[+M8)U669PF;0- M_Q1F_%-8FR]\0`P^(%OX@!A\0+:8)S',4]NZ>:;=9CC/O`VU\\S,+2FN=,#4 MB\P\%87!XRVK?(D);U29>!+>H.;@#6+P1K5-&8%#FQ/W#H!SJD2:AW-T4\XY M:7,6.B?OVJQS,K/K0V'&$X6UYQ[3)H9IDRVF30S3)EO,DQCFJ6WM/'%6$<_S M\`.WTRS,K0_NV5YV(M/Y7]CACSW@VR3/NVO_=6YKL8-&0M0+PYM1V"9@0V5Y M_;FYQ/KSTYM_X?+#^_*F')5$FIHJ.S3O/).VMMR(`BT\DO+'^+Y,7%C?_Z7'BBF+7G`YZ@II``Q."):GO8<9U?^OR"8ZI$ M)8!NRCDF[<:48U[0+>9/#(FAVW/S3[LG-?^ZY;S(VRJ;&)F9I:&[=JLP$J/(S#.161I) MS:E@RUE,\6VK*<"+[N+2?R4MO%.::H\#O$-=PCO?TR4%` MW:5S8-J6*0>^G$!Y'V<=FYE=60HS7LP,PY'$0`)EAF],%087%5U[QN`B:@\N MHO;@#VH/\]?MN?FG/=:Q^3]]_@/U/.)Y^#W#OR"D^0%2B8##:%>WO!79\?/) MTI8Z\L=#EMM7##XB!A\1@X^(P4?$X"-B\!&Q;<#F@.T"M@_8;<#N`G8?L(>` M/0;LR3(7Z[3/Y%@?.8R^R#M3_=1'A]%%]D*PC[2IV/-I9]T*TJTB6-42;&*)-#-$FAF@30[2)(=K$$&UBB#8Q1)L8 MHDT,T2:&:!-#M(DAVL00;6*(-C%$6S,7[50]J&BWY3J7%?9UE9DZ>,9+GQCB M10SQ(H9X$4.\B"%>Q!`OS>R<+I\K>PX_<&5/8>;@F=FJ8[8.6!^P3<"&@(V6 MN3FE/;Z*TXO;CNOL+TWHE1_JXWJ9?N!3.S-[@,[;]F***E*&@$EG4\40 M;F*8=.FVN123)AVF20S3U,Q-,^V[PVGF#;D-:V;FE^K/_:^M(=)9IJIN3),8 MIDD,T\Q,73G"-(NN'0YBFL0P3VF>E#=2Q;3S#)S MED<%%V9>9*8U/K<368LOG%%,&X,SOJ=7^*?V>G@>SJ[]M2"X2[?NW)5VVJ&[ M\A;Y@BM84 M=VAV3IE=XG6N4H#.:2^SS)3K40H4&5;=UEJ0`D765GXX@QB<\3V]PC^UUWR4 M<^&K;KA+M^[Z*S.X2Z5`9JKB1@H4UA9`I$!A9M;$,&MJ#U.D M]C`G;>OFE'8RX9SR%L?.J6Q[L*BTH/G?64.F9YDYA6*&:9(.P2W='G[Q_5"\ M8YJDPS2)89J:V6GBAF@\S<,/W*NKL.0U-4U:[(KLI4P7V0N9+C(=)9FL*`SN:IE>F,ET83K3A9E9 MYS[4NQ*S+DR_[X2U]C`G;>OFE#8VX9SRCL?.*;.T=JH4<$=TR^XJRUYZWXG, MM,:+GC%OJ*P7,X,7 M569D9EZ#5X4UW;H3UB8.9Q1=8W`&M8>94WN8IM:Y.:5-4CBGO'NR<\KL\+E' M2XT;]TO$2(VFD\FO(HB9LA)398BY,L1D&6*V#*<(;B,X1W`7P7T$;R-X%\'[ M"#Y$\#&"3PZZJ*:]G(IJ*5J/G!OB<[)#&:.>>9PDN1W.VZ[(CI\D-9&*?FY? MG24B^,00>V((/3%$GA@"3PQQ)X:P$T/4B2'HQ!!S8@@Y,42<&`).#/$FAG`3 M0[0U<\%.F]P?"W:RP"5]$VR^L7R592\$NXI4L(DAV,00;&((-C$$FQB"30S! M)H9@$T.PB2'8Q!!L8@@V,02;&()-#,$FAF`30[`U<\%.6_0?"W;>U&,A;Z]S M/-KN0T0\VEGW0K2K2$6;&*)-#-$FAF@30[2)(=K$$&UBB#8Q1)L8HDT,T2:& M:!-#M(DAVL00;6*(-C%$6S,7[52\J&C74R=\^$BG3L*PIZDO9P2:+I(TG8IA M::]]`(X8$D,,B2&&Q!!#8H@A,<20&&)(##$DAA@20PR)(8;$$$-BB"$QQ)`8 M8D@,,=3,Q3!59F$,<\EF=UB9F8/^*V*KCAGB13K$BQCB10SQ(H9X$4.\-+/S MO'ZNS#S\P)69A9G#?V:KCMDZ8'W`-@$;`C8&;++,S3.562J>+WX@<)WK,A/G MPJY;J;_L1-=V^)A_MKU&>M5G.KAUWF3R2,,EU5087$(,+B$&EQ"#2S1S+DEE MU`^Y)-==UB6969<4G7%)T>7?;SP[[=Q')DB0JI"9PQO$X`UJ'=ZHNOB#`_BF M*J1U^$8SYYM4>WG?X,_0//_+@_A(A-;VPF[T2_S\AI;V(E/'!TBAW-R-7MJ9 MP4-9ISYY@(?$(,/M'M.9^D"DWYI+[6<,>;IY[933OJP*.2F1H7 MYEET[3@%F4`,\RRL?1:'>5)[F"?98I[$,$_=GIMGVK2'\\R[>9O_F:6OZVZ/ M^@T=NUQGF3E@+"Q]!W0UI7,Q>*/TD.]ZG9^ZXQ"XAMJ&:XC!-:6AH_W!6[6_ M-BSZ=08X4/?@')@VPJ$#\P[9.C`S.%`>3"1*9M9;1:=/7(H.7W8LMO`&V<(; MQ.`-:@]3+ZRUAWEJ6S?/M`4,YYGWAG:>F:7O]ZW17OA@8NI99I^18EI^'=T; M(46J0/F!&H(?B,$/U38MG?AF4G]5N`FD<3A%-^2!G M9E:)Q2F=P%UGFM;AFBJ3+N`: MW9QU37K?A:XY_,#M*0LSSW]AQ@^B:\_FNF/6"U.VFX`-PM3:,09L$I;;<_-, M>ZLH!?#6HQ=B8>[Y=Q<PO+'UK<'I&+S@'E$(B!$_D4:BFX`EB\$1F MAR\EKDM3D`5*)YW`/;I!YYZTO0K=D_==_Y^Q.UUN',G.,'PK%;X`M[AH8\QT M1&$C-J+4*MU`V59W3[AGRE%=#M^^WX\0)8IXR^,_C!`>`3Z071X.S_SAMGL2<;^HB,3G/TL3,)V#O M$_-R4G9^+G`_+WN?A7E9LG`J!($O%Q+X8FT"7RPC\.7*-(+E0F(]7_LBUIP2 M::SSN=+[6.=E%_W!Q?T]&L'\;V>MF$;PLNI\/L"\G?>';%+Q^@^G])")Q8;( MQ&(9F7A=]ZUQ6F?P^F^GKR`UYYN[2$W.HLY2\T\OOW-6?#E`ZV79N[.%EV7O M\S.OFYM\\YF7<"3SK)+AJ>5_5M(_Y_][O'J=U::JO'8Q<6;RLF[?W'O=V MN;8X;?[M)(L$+;Z2!/V_OI*B.;3 MM_>)G9>MHB25ILD22=5G[; M(ADY+7Q+,4DXW^)%$G+>]7\EX64B"47YZ<_?GY^_5U^^?_GY+W]__O;;<_G\ MQQ]_?OCWK__]#YK%+6\`/%O^X=OSKW_]%WY0N-YQ8_18PM=U7NTF=KP"N["/ MW`_??4RY^=X+RX\46>^8GJ7=Q6R]CSP5A&TRJ<:VB1T?&V)VG7(RT40M96$\ M_]+XJCN^CQ^BEY;1^%G/RDE\6TS7^WA#6K@')UM$GABZ)7*WWCUQ;\ID@QP; M[D4>/]YM*3I/P[*5*!VW.T38"2CXO"=<;+#@'ZCAK5B#=L6>=#_I]2:!'(PC]RX^.*"#&@""$.#N*$!Z99RD-L=>WD+ M_?YV5_@^D(YZ=^QGENMQ0+_=\6&IIL>YW1V[G>5Z=#RWNV/OL[3TTKMC+[2T M]-:[8V^TM/30NV.GM+3TS8G=RDG8UXG=&B!A7R=VLYS,)#XS0KM.?&:$=IWX MS`CM.C&84?Q58M!FQ7EL8K"60O$WB<&,&#:)P8SB;Q*#&<7?)`8S8M@D!C.* MOTD,9A1_E1@L/HJ_2@QFQ+!*#&84?Y48S"C^*C&8$<,J,9CE%A(Q<']EV!=[,K>'[A.#&3>3[Q.#66Z))`:SW!I)#&:Y19(8S'(/)/5@1@SI M"S2^W.0C!C5BR/ZN1@S9W]5R;X\8U'*/CQC4B"%MZ0>'A[OLT]P`7=81Q<\^ MK48,U_1G:KF=G?ALFX26_5V-T+*_JQ'?-?V9&F&G+U`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`/WB]`C1'FRMSQ#-P>@)HL:-6H@*-^H@ZMNHAZANHP&BMHU&B,HV M.D#4M=$O_`S\B_X*_(@\JGQ&/JL\(4\J!46@25D12H@6951!-"BC&J(]&340 MSD`>5)WXD?M+?P`O6*72=$BE5 M*J12J9%:I4$:E3VR5VF15J5#.I4>Z54^D8-/FH,'Y)%AJ\LKHX=[3A;TM_4' MAA4\,L;1UN%$0;_G,]_SV>7N#K$^Z@EY4BG86J%;*Y%2I4(:E3VR5VF15J5# M.I4>&54.R,&%2`\:Z2?DD\H#\JB_93_P<_PCTQ*L?CA)U]_I'QBB\,@8=EN' MDTTM04<).I4>&;5L/64;M6S]_15YL]ZEIVRCEJV_Y^132U#PD_834[.6\50, M`GADWLY2"DI=Z-9*I%2ID$8CK8BTT4@K(FTTTHI(&XVT(M)&2["G!/L?"+?O M]=?Y]HX?KU4ZI%/ID5YE0`:5$1E5VMN[7:NC"CJD4^F17F5`!I41&54*RE9H MV4JD5*F02J5&:I4&:50*RE9HV4JD5*F02J5&:I4&:53VR/X'PL\*.E*UO;VA MYFS_Z9!.I4=ZE0$95$9D5&D99MKJR-P.Z51ZI%<9D$%E1$:5@K(56K82*54J MI%*ID5JE01J5@K(56K82*54JI%*ID5JE01J5/;)7F1@F,/$\3NEA;]@;==Q! MP=")@N>9+=58HB,T&@:UC/H]S2UG`?H]/3*J MM.2@U1QT&42ATB.]RH`,*B,RJAR0@TJ!%"HE4JI42*52([5*@S0J>V2OTC(D MHM61#5T&2ZCT2*\R((/*B!Q4)F12Z6XX-NHHCQ[I509D4!F1@\J$3"H%92NT M;"52JE1(I5(CM4J#[%5ZAO_W.@IF0`:5$3FH3,BD4I"#0G-0(J5*A50J-5*K M-,A>I45:E8%I%8/.G!B1@\J$3"H%.2@T!R52JE1(I5(CM4J#[%5:I%7ID$ZE MN.8G;1UI,R*32D$."LU!B90J%5*IU$BMTB![E19I53JD4^F17J6]YK@POUOG MXLYIAW0J/=*K#,B@,B('E0F95+IK;HG.+X2Z*%N/]"H#,JB,R$%E0B:5@K(5 M6K82*54JI%*ID5JE0?8J_99[@;QC;GD6,""#RH@<5"9D4BG(0:$Y*)%2I4(J ME1JI51IDK](BKF03J5'>I6) MH5G3/+WWHC\HR$&A.2B14J5"*I4:J54:9*_2(JU*AW0J/=*K#,B@TI*#5G/0 M(9U*GR%M*@,RJ(S(J')`#BH#P[D&7A9N^REG@RI%ANGI*+T1F50*2E!H"4JD M5*F02J5&:I4&:53VR%YE8MC3M-'KQ@UG3SH6K&(XVZ2CV2HFQK8;NPO:(Y-* M02T4FNL2*55JI%9ID%:E0SJ5-L/"-`<=TJGT2*\R((/*B(PJ!^2@4B"%2HF4 M*A52J=1(K=(@CV:NT#,-K=:1=AW0J/=*K#,B@,B('E0F95+H-M:VC!WND M5QF0065$#BH3,JD4E*W0LI5(J5(AE4J-U"H-LEI45:E8XA ME)V.H.R17F5`!I41.:A,R*12\`R"7A]!,"*32L'6"MU:B90J%5*IU$BMTB![ ME19I?R!8?Z ML;&QS,>@?DR8N$/]F#!]@Q%E)@?DH#(ADPICTQ"[.F0(-&6SW\T8=,PZ)DR/ MH1:L;$R.H19,F-Y#+9@P:89:,&&."V/)3)C80_V8,"6&^C$I.$&Q>JLX=;*V M5M%)Z-4?7:LM9X0=6;$<,\".K)@PB([831A#1QPF#%RDG9DP.)'6=)2?7F_2 M_/GS7_[KRV_/AR_??OO;/_[\\,?SKSRRZNI?^>'UP[>__?;[ZQ_?Y]>F?_BW MK]^_?_U[WJ#^X??G+__Q_"W_S3__^O7K]],?W&3XZ7^^?OO/XV.Q?OY?`0`` M`/__`P!02P,$%``&``@````A`%FK=TE2"```QR```!D```!X;"]W;W)K&ULE%I=;]LV%'T?L/]@Z+VV)5G^0IPBDMAMP`8,0[<] M*[8<"[4M0U*:]M_O\$OD);DD[4/3G'O)>WCOY2$E]>[CM\MY\K7N^J:][J)X M.H\F]77?'IKKTR[Z^_.G#^MHT@_5]5"=VVN]B[[7??3Q_N>?[E[:[DM_JNMA M@AFN_2XZ#<-M.YOU^U-]J?II>ZNOL!S;[E(-^+5[FO6WKJX.8M#E/$OF\^7L M4C772,ZP[=XS1WL\-ONZ;/?/E_HZR$FZ^EP-X-^?FENO9[OLWS/=I>J^/-\^ M[-O+#5,\-N=F^"XFC2:7_?:WIVO;58]GK/M;O*CV>F[QBS?]I=EW;=\>ARFF MFTFB_IHWL\T,,]W?'1JL@*=]TM7'7?00;]DBB6;W=R)!_S3U2V_]>]*?VI=? MNN;P>W.MD6W4B5?@L6V_<-??#AS"X)DW^I.HP)_=Y%`?J^?S\%?[\FO=/)T& ME#OC0_;M&9'P]^32\![`TJMONRA%A.8PG/"OY31;S=,XR:+)8]T/GQH^-IKL MG_NAO?PKG6(UE9QDH2;!3S7)\MUC$440P$\U-GYO_)EIO$6\ZK%JQ6,Z4!5]MS[@;OO(K0^%MH#_7H?S^/UW>PK$KQ73GG` MB7H4VH,GF<];N@"S@!FHCGR3'^/+W3E?'2C7@%E`XG#3'GI(Z0+,`@@W-,:/ MY)*[BVX:1L(VSDC/IO M**-<>KU*>G0927L(LQ%"&GUJD=:MR5'!34^92R0VU2\\I/009B,D+#9J("Q' M:5B)Q.G8=(6'E![";(2$707#Q6LDJI<4J1R>=-F8C MA`D_\3RMF*Z0L.'4[+_D+<+$HU1P;\I0(C9#A:`]+8;.'BA'IY&AC1"&V"<6 M0]T9'*5,))*BPZRX&C%-"1V``W.]=744FPH+W&]$!#37B+9E!1744-JS)D45Q)<0DY_.<=D`87@?9F^WF#:2W98EF;3 MF.:>:8]`BW$)-8S?3*-47+(2"9'6D]!"7I'DZ:T@N_44M.+YIVGD`OL*J<_M MS9817,74[C7;,)XGN@8']T3I0\Q`E'F7*,-\[$!I'23M"DUMXZ> MV(-*'V($HL&Y+`>"2[4FP25D'T"Q!Y4^Q`A$@W/%#0270DR"*VVVCB$,D*Z=`I;&2Q>'$8CRX:H:X"/%EO!1^FOS41#EX^RJDG<2WYVV--@0X8.( M-I^W-IIPIQJO(/MPU!!DPN1MY9POI?$:\T8@RC,L^XDO^PI*43L3?.W=E>7` M-R1,SR4E+'8F8=KLZU?"Y=DOLX"=]$DA!UV=A4)Y6=)5:LC2*0WY1V3"Y3D0 M7*HV)(Q=3\PTY!^0"9?7`#FINH2<$F+# MMQ"#P=?LB=*'F(8"P:F":QWD3\'./4M!3AJ6F14GL9B&DHT#5AF4Y\F5:0TS7N)51[J8O59NU> M,$OC87(CHRT"I>-:'.@;*=&D;R1D7Z`2!=E]XT%,>P6"<_TTP=]422FWA)2" ML#Y+E9R=5"32:X$?EI=[(35>)F]J(!9E#33-2-HLI9JO=X&`J3@IR*FT\]1< M**]L+G?!:NWM`N,Q,M:0*`FE%Y9Z'##N)E6076D-697V(:8AO](X->U*C[F1 M*FU75'CBF(5*C2E?N`*AG:1`Q-ERFLZM/^[1;=Q-GNSS@>:)ROQ;39GZ\J\@ MZZ`I%(0.U`Q*'V(*RL05@Y(*RSO/DJ.P"J*]M7$N5X7RRD!^S++_+*N]9`>& M'C6T1Z#=Z)GP9AK]LX)?(K`XTH82RLR#;ZF\,O/TP30D])FFD9X$'BGG40.B M[Z570E))Q0-BH;PLJ/0A1B!**GQ"I/X)H2#[(D\@.BU78D=<,_,VAA_!;NM( M*"-BNG$V4Z$&9D03-^8.1TEP`34DQGTO=97L>PF1M=D0F99WMS6MJ"->M>#- MDXX@/*CJ*LA9GGLKTUYT>4:`*(^PIN(BY>960?;R"$2GI6HIEI>NI[CTC,OS MA1.O,7A09WGN]4%[T>69`U/RD-]&Y'>!2]T]U45]/O>3??M\A5Q`->[O1EA_ ME,FV#_)-BF/!D_B6/T-#^%Q+NMSR?>%;\(GG08B@.P*??H34N'BRQ4MX?YX\ M18``_K#8/L1"1-R)%OBV%!B0I\DVASS[(0I8N);[%@8+EW3?DJ<+S!9*"81Y M6P0M)2Q<[/S9&"Q<\WQ+GJRV.:Y?OJ6`I0Q:&"S\RA8:L\$8<8*Y64OG6$^H M,+C$@'7(PF#A%P8_#AZ?P#I4!3PR@4'(@BP\(=< MGUL)"W_6]2UXUD:;6P'?%<6'VU/ M^`\#-3[RS*>X(QW;=M"_H("S\;\@W/\'``#__P,`4$L#!!0`!@`(````(0`Z MA%3`%!\``+:5```9````>&PO=V]R:W-H965T__/?#]]._KA[>KY__/[A].+-^>G)W??;QT_WW[]\ M./V??U7_>'MZ\OQR\_W3S;?'[W5'<7;V?/OU[N'F^<'_/GTY>_[Q='?SZ9#H MX=O9Y?GYU=G#S?WW4V^A>/HK-AX_?[Z_O2L?;W]_N/O^XHT\W7V[>8'_SU_O M?SR+M8?;OV+NX>;IM]]__./V\>$'3/QZ_^W^Y3\'HZ3^"*_>3I M[O.'TU\NBN'Z_/3LX_M#`?WO_=V?S]&_3YZ_/OY9/]U_ZN^_WZ&T$2<7@5\? M'W]SJNTGAY#XC%)7APCLGDX^W7V^^?W;R_#X9W-W_^7K"\(]U0$\^LV_/YQ>(H?[3R]?/YQ.KM[,KL\G%Y>STY-?[YY?JGN7]O3D]O?G ME\>'__-*%\&4-S(-1O`W&+E\\W8VFUZ]O8:1(PDA/>2.OR'A!1PYDN`J),#? M,:?+M[.+V95S]TA"5.Q#3O@;$D[>7$S/?Y;L74B&O^+@^5])=X&('?)S_Q@] MG5[.KM\>"O:(IZX$?%*-R:6&Y%C*B:3$/]3=,9K'DDH(+Z(8'BW0"PF%^\?? M?,)K\1/_"$FOW_RUPI$X7F@@+X[6M3-?X0\-I;QYN?GX_NGQSQ/T/JC2SS]N M7%]V43AKH8F$2C0V&K3=6Z?^B]/_<`I%-(=GT#\^7IQ?3MZ?_8%F>!N4YH92 MJK$0#=<4G=TR!\L<5#FH<]#DH,U!EX-5#OHR!"3)#KHCO]6=)P^1G.,.F/)HYN: MIH4_]UI'XS.JC/$ALB12$:F)-$1:(AV1%9&>R)K(ALB6R([(GL@0DR0^F'7$ M\9'!PN%#&*3TYIY@H!&R(%(261*IB-1$&B(MD8[(BDA/9$UD0V1+9$=D3V2( M25+"F%Y8)>QP6L*>7$RTA(F41)9$*B(UD89(2Z0CLB+2$UD3V1#9$MD1V1,9 M8I*4,&9A5@D[G):P)].HA(F4GDPPVHP=T.3B7=K_+$Y'G=AT M-L%8CTIB>D-D2Z9WHTYL.JN^^U%)3`\Q2:*%*9`5+8?3:'D21XM(Z0F&;J%9M_FW8(:]42\QM&6S:_4ZW( M_"3K;_:J)>:'!*51="O*:!TO,[`+O]+$3%B,S`-R6QQ:=I-L`%E(PNLQ81G0 MQ&^@N57[DE'%J&9;#6NUC#I&*[;5L]::T8;1EFWM6&O/:$A0&@>WOK3BX->= M21P\ND*G&<4A&QH6;A\,S2UJ6Z6@>'5S>9UU_,N@A6;L-FDNI[/+-YE*)89T M)E,S:@0=S:X5+==1_/%Q.L&^8MI<.M'0W%:,>D%'W74OO!&EQKACU@M36.J#(KXUHJ:TMHYT@ MM;47I'X-@HQ"=ZM5J]#]*C8I=(^NL#:(XIMM%RQD&VVVL5B]V-(+6[9;03=-3MO6J) M^4'0P7S:=-R*.(KB3ZSVHA4/@9-)UM<,HG4HSK12N#5Z M5"E^VD+]FCYIH1ZALF@+]2B9]W@TBQ<0(:%V2]5%T%);=4"1K4:TU%8K2`?0 M3I#:6K&M7K34UCJ@:_5K(UIJ:\NV=J*EMO:"U*]!T,%6&@RW!#\6C'\]_DA6 MM-:,-HRW;VK'6GM&0H#0^;AT>Q6?L0?WZ/(F#1].T75(7&K1T+E6Z'S1< MKQHG-+K0H)7.:;,]BLJT]39;"=>BI4XT@HXZT8I6ZD36]W2BI>97C'I!1W-< MBU::8_;8&]%*;.6/O14M]6LG*$F8K\WVHI4ZD3WV(%H'\TDM0C4Q:]&!I^-P M0*@,8]%VJEL2T$A1WVI=YA:U%2X>E1M#1'%O5DAP[04=S7(F6YM@+2G/,*O]:M23' MC2"UM66T$W34_%ZUQ/P@Z&`^C?PKFSJ7O*D34+S6""@)LT\XT;G`4K0458)T M+E`+TB)H!&G"EE$G2&VM!*FM7I#:6C/:"-*$6T8[06IKSV@09!2ZV^(P1LI+ MO_6!=BJ1FP>4[J1-L\7X(FA%L\!24-(/3[.-JZ5J28Z5H*2;Y^;F78UR;"1A MDF,^V6Y52W+L!&F'MF+4"TK,YP^T5BTQOQ%T](&VHJ5.[`0E.>8/M%ZV/ZQ"]]LB27/S*!W=IOG&M3N)BF@E MW5Y`2=<\S7K^I234CJ,2A-".PZ(QNE&.C21,8'0:^55SJZP7P<^9^MWR^=?M8,/4I&/8^2 M\'L4;:B==2)5="ZU)+HS82Y$VO1 M2IR89OLD&]$ZZL26G=B9"7,G]J*5.I%UJ8-HO>9$6@7=GLVQ*IAM(:'DJ#_P M"-L@TB4M@E:$2D9+1A6CFE'#J&74,5HQZAFM&6T8;1GM&.T9#0E*@^%V::)@ MR'[1I=^]2=J]1U$)+X)6A$I&2T85HYI1PZAEU#%:,>H9K1EM&&T9[1CM&0T) M2@I]\LKVRH&G(U]`^!5RK.F,2D9+1A6CFE'#J&74,5HQZAFM&6T8;1GM&.T9 M#0E*"QWCE573)XYGA>Y1-,5?!*T(E0&EY[OH#*9J20`K1C6;;U1+A\L)G<-4 M+3'?,5JQ^5ZU8O/9Z+)6+3&_8;1E\SO5.F)^KUIB?DA0&D",+F8`'<\"Z%$4 MK84+$[0B5`:4!C#_#7&I6N)CQ:@.*#+?J%9:'!*4!Q"3"#*#C60`]BHISX<[BY0'T"/O8 MDOLR:$6H8E2SK28@Y_TX.YWD+YZUJB4Y=HQ6;+Y7K=A\]K/`6K7$_(;1ELWO M5.N(^;UJB?DA06FTW#Y'-#/XV4IAXO=%XAE#0$D4O5:$RJ`5G]MD5#&JV7P3 MD'NJ*(K9ZJ%5+2F'CM&*S?>J%9O/UCYKU1+S&T9;-K]3K<@\G=M4+3$_)"B- MHMNSB*(H\SLM=:,-HRV;&O'6GM&0X+2.+B]"2L.?L\B:34>I;O-DVS<6&!OG[K#@)(] MUGQ%MPP)P]'&B[?G[]YDO7K%MFM&C:"CV;6BY<]MGK_)EHZ=R'6"NV+4"SJ: MUSIHQ8^6C8<;,:39;1GM!!W-;B]:\48('VP1+=X2G;CM":M.A&T+W9"='U0_ MG,;[T`$E/:E/&/T6NPQ:T>G(BA/6C!I!ZD0K2+>`.T%:G"M&O2"UM0XH\FLC M6FIKRV@G2&WM!:E?@R"CT+/=A[%#Y%T&[`>Z)I;N0T^RP601M*+-PU)0./Z8 MC?)+%4NW5PG2#8V:42,([5Q'-]IM5BTQWPE2\RM&O2#;[;6*Q>Y&D-K=,MH) M.NKV7K7$_"#H8#[M3E_9MICPMD5`\=YQ0#`O696"]$>!):-*D":L&36"U%;+ MJ!.DME:,>D%J:\UH(TAM;1GM!*FM/:-!T,%64NCNP(_57QUX.G\/*!W#Z!?3 MH!5W88+\<''Q)F\[*I?058*TWZ@9-8*.=M:M:HGY3I":7S'J!;WB]UKE8G@C M2`UO&>T$'?5[KUIB?A#$7>#4;6\8X\Z!9W%TJNFX$[22H'DM2"3WI6@IJ@3I M\]:,&D&:L&74"5);*T:](+6U9K01I+:VC':"U-:>T2#(*'2W_V`5NM^7B">` M4X_2<6>:M81%T(H[,4&^`[^X?I.M3):J((&J!&G743-J!!WMPEO5$O.=(#6_ M8M0+>LWQM2J(Y8T@M;QEM!-TU/&]:HGY09#1#;I=!RN2?C`LK$G:PJ+H(4<)>2E(-^'7_+8$_8NM`NH)(E:J1DU@H[V MX:UJB4>=(#6_8M0+>L7OMM<3\(.A@/IU#9/L1/]M5 MFO(^14#Q6BB@))@^(9JQ>+44+465(#VV5@O2HFD$:<*642=(;:T$J:U>D-I: M,]H(4EM;06IK)TAM[1D-@@ZVTF"@5S1[,L>SB8!'5UAACDN/?*M\,?5*2=\6 M$*(QIN.SXB'AU>3P_LO%V]F[_.W.2FSK7F\M2'N>1M#1[%K1\B_`\)Z$R#6O ME2#-JQ=T-*]UT-)'>YN/RALQI-EM!6EV.T%'L]N+5APGWI,0K4..:95P6PC1 MX/;3]NFW'))!SR-4%6EYBZE'2<7P")53M)9!ZTHK?140_HA6S;8:T5);K2`= M;SI!:FO%MGK14EOK@"*_-J*EMK9L:R=::FLO2/T:!!ULI<'(]BHH&-E)B2GO M803DWJX:VQ^_;",)M;J5`5VI[TM&%:.:;36LU3+J&*W85L]::T8;1ENVM6.M M/:,A06E\7MF%P'$SZC\]2N?T$YJ4>*VDG02$N<<80*,##5I)F*?YOF[PR_U: MH+;HU)1H:65H!"4)\YWE5K2..M&)5F(K=V(E6NI$+RA)F#NQ%JW$B7R/;"-: M:G[+:"?H:(Y[T3J:XR!:AQR36C1[95OEP--1.*!X/1%07&4$:3^Z%*3=3B5( MM6I!6BJ-(-5J!:FM3I!JK02IK5Z0:JT%J:V-($VX9;03I+;V@M36(,@H=+=E M$8USLIZ8^:V,>#P+*%U/S/+3_T$KGH(*2J;/L^P'M:5JR1!7"4I^?LB;2"U: M.B%L!"4YYI6_52W)L1.DME:,>D&)^?R!UJHEYC>"CC[05K34B9V@),?\@?:J M)3D.@@ZVTN;VRD8,#O'FG79`\4HCH"3,/B&V?B3WI6@IJ@3I[Q:U('W>1I`F M;!EU@C3ABE$O2&VM&6T$J5];06I^)TAM[1D-@HQ"=UL<5G/S6Q])<_,H'2GI M]+][H3[;1A&4],.S['?3I6I)M"I!23?/S8UR;"1ADF->.UO5DAP[0=K'K1CU M@HZ:7ZN6F-\(4O-;1CM!B?F\O/:J)>8'0:^55]K>_\/8]-4./ MDE'/HV34\PCCK#BZ#+8B5`44G_X/*++5<,*641<0:KWDN&);/2=<,]JPK2W; MVG'"/:,A(./T_PR+Q[\5#*>?34$\NHY[9#K]?\@'Z;0"E@']Y/2_:*&MC3/4 MR2P[,U")%CK>48M?UV$G&C-A/H5L12MQ(I],=Z)UU(D5.]&;"7,GUJ*5.)&/ MM1O1.NK$EIW8F0ES)_:BE3J1=:F#:+WF1-H?H+LY6@6S->W,Z1^JH,8:GUK. M#JK.@YI[I7VL$MG9CX7J2'LM&2T958QJ1@VCEE'':,6H9[1FM&&T9;1CM&1>\#+&:$2D9+1A6CFE'#J&74)2A]N&R+95P'\%;* MS*/X*#ZCDM&24<6H9M0P:AEU"4H?SNT*1)'[Z=CK=Q&2B`:D/?EB1J@,",NRE*DC3JQC5;+E1K6`YZWQ:51#+78*2`KEZ9:E]X.DX%U!V&C+K M=A:24/M:*5.9,-$ M)UJO.9&6,`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`Y>6Y(2DJ4IP=P-7EMI,%^#UY8$TS9X;4DP.8/7E@0+ M^,(MR+GK.6'9BGPLR1SE-C?+;0')PI1@^8/2L6X"AO MX0YVL@0G>@MWOI,E.,5;N&.>+.D@<:<]68)CO(4[],D2G.8MW-E/2S)%N5FC M)D[1H]PL"0[3H]PL"<[4HW0L"0[-HW0LR1R^S4W?<.*Z<(=KV>L2DM*4+"%Q M1VTY#E*\@@'?+`G>M(!O ME@0O7*#N6!*\=X$:8DGP8@5JB"7!^Q6H(98$[T#!FO6D>,D)UBP)WG6"-4N" M5YY0JRP)7FQ"K;(D>+\)MEY"X-YVLFHB9G2G!RVF(MI4&KQD7[GU6MH;WB+'Z MLB1S/,_/68)/KV`-%;O@B\P((TEP8<8"O?&/UO#QQ<0;4LR0.+>_^"&<)7MTOW'OA+,$W,PKW9066X#L9B)PEP1!]\3@\1Z'GR["A+K M>?`])$BLO+0_PR3%(+`_P>2M(+`_PR21(K'SP]>'"?;N6 MRPV?%\8>ER697V+]@^\J#3?:B]E@?X@A]B:CTI/@T'B?6D)9[4 M?5&,/8V/N<.:)<$'W&'-DN`[[HBV)<&' MVA%32S*';W/3MP4D"U-20N*^^LS/@X]\%^[CSRRI(7'?@&8)+GN`UU8]P&T. M\-J2X+8`>&T]#VX(@->6!!<%P&M+@IL`X+4EJ2%Q'Y!GKW$)`&J5)<%7_E&K M+`D^]H]:94EP@P>L64^**SI@S9+@6@Y8LR2XG0.URI+@^@W4*DN"6SA0JRP) M[M%!&FNUB[MSD,:2X`J=PMW5PN6&:W,0;4N"JW(0;4LRAV]STS=JG#W!7$^2TCXZ-+:&&^L*=RL:2W!+'7[WL23E!6:#_MQC]KL,KAHKW$5B;`T7 MAQ7N6C"6X!HPY&-).GC@KHWC-+@/L'"WQ[$$UP(6[A(YEN`JP,+=)<>2#23N M2CF6X"+`PMTLQQ)PU;FTLW`U^+,'EC86[R(\EN+"Q:0S$T);NE&Z5AI<%DWVH(E MP07=*#=+@GNY46Z6!-=SH]PLR?8:%<3L1J^+P6H(._1@5@>VPTAJ3>!Q:3TJ MC94#[H6'N]8T';>\(S"6!'>VHZI;$MS`CGPL28,QT?*L@6>=Z=GJ&M&W7.ZO MBXU5*#TZ?*M0>DQCK*Q[9+TQ3;W6<<\S@_'"MZNO_B#AGY_WGQUX^>_/KX\O+XX&XB/?EZ=_/I#E>,X_SB MZ_YZ=_?R\?\%````__\#`%!+`P04``8`"````"$` MWA<&UL(*($`2B@``$````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````E)%!2\,P&(;O@O^AY-ZFZ89( M:#-0V/-^7'"M!1<4^"22C*?" M5F@?@J48>[$'S7T6&R:&N]9I'N+1U=AR\7V$-@4L>.#X"4SL1T8B4 M8D+:#]<,`"DP-*#!!(])1O!W-X#3_L\+0S)K:A4.-LXTZL[94IS"J=U[-16[ MKLNZQ:`1_0E^V=P_#J.FRAQW)0"QXWX:[L,FKG*G0-X<6/_FFL3[?8E_9Z44 M@QT5#G@`F<3WZ,GNG#PO;N^V:\2*G"S3O$C)8EL0FB]I05Y+?&Z-]]D$U*/` MOXC%C'@&L,'[YY^S+P```/__`P!02P,$%``&``@````A`/PA))MT!```6A0` M`!``"`%D;V-0&UL(*($`2B@``$````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````G%C?<^(V$'[O3/\'AO<+))?I]#(.-P2<"S,)T-J7 M/FH4>P%-A.239%_H7]^U'0@TR[;AA3'6?MIO?WT"15]?UKI3@?/*FNON^5F_ MVP&3V5R9Y77W>WK[Z?=NQP=ION!GSWZ^#77Z*YLP6XH,!W<`OCK[NK M$(JK7L]G*UA+?X;+!E<6UJUEP*]NV;.+A M_8UIN^AVGJ2'FLYUMY).21.05FW6?FF>=>&#&_QEW;-?`00?]="@?=D\[MON M/ZO+P9>+Q@*?#BWK'5HFN'#(,55!@Y\MYM(%@O*7`\X-BY9Q2VA;18&](6(3 M,%]B8MIJ*[O/?!?#:#9-9O>3\3"-Q^)F>#^IO*I'HS4>JPH\UA,W.NC`71UCZ0RVNA=S<")928>3L%NL>[KM MD%MEI,F4U-@7V-?-S+<>;G%(2,@8G*IP2BMXA[F#G(2,I%^)YB/&."H<4!-: M+P_2/9.0B:G0R+H-N?HJ;!LQUSBD;7OCSD4M621@%E:8A_UHMU-@2/N)03U= MJB<-8N@]CGGCXYNU^4^E48YV"7Q+Y1B>:-])L-GSRNH<%5S4"0AT4,,,-;?4 M,D`N6KXCNRX29X MNJQ!I/+E2'>-K-;RR;K&FQ@N'4"=>GHW9+96H5EOLCBRJ$1FB4<8'DPDU6]@ METX6*Y4U`*QV7F9A*UTDY(\2%1*8NX M;C::2X)'95YB'TPFXE'JL@VY%E1T27<"/^"T]/"8]N!X/65VO<>J@B#3]%X6 ML,K8Y73L^_/R7AWH0'AYH#&\/M"8G4!P`7`Z(5(R0XQ2H"<2PHL%3;]6"XXY M(1J<.:\=-(4CXL&YV1<&SNZ8/K08,HFL2M#-S,L$'32O$S2&G\W/9#@\YI+$ M\/-,<^,QM&X0(C"&()4^105H%[QRT"GCE8/VPV-.\4.7AE%8_KW)"^%=)X:*>2H[QL(>@]*+KDM>;VD??`8NI['-+;E M1F:=A]`JP&/H<'C,*>'0[4G_[A1<=7@(G8*#HXG;G#(\TE5'C[%F?[)Z/(2F MSA]]IV#HBO-^Z(KS9RSMA\>7./^ZMKE7 MYME_+U([QC]WVWNIPY=1,XXYWMALU]]>1'=X)>5TO MVZO"P?GE6?]S'R_(]MY%O=>#`/][#?X!``#__P,`4$L!`BT`%``&``@````A M``9I\A62`@``.S4``!,``````````````````````%M#;VYT96YT7U1Y<&5S M72YX;6Q02P$"+0`4``8`"````"$`M54P(_4```!,`@``"P`````````````` M``#+!```7W)E;',O+G)E;'-02P$"+0`4``8`"````"$`]#1X)38#``""-0`` M&@````````````````#Q!P``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"+0`4``8`"````"$`A9+O^E0&```0&P``#P````````````````!G#``` M>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``&``@````A`-^F=<0N!@``+!<``!@` M````````````````Z!(``'AL+W=O&UL4$L!`BT`%``&``@````A`)9:N?5_!@`` MEQH``!D`````````````````81X``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%4P?9#"`P``^@P``!D````````` M````````NSX``'AL+W=O&PO=V]R:W-H M965T$FP0``$P1```9 M`````````````````)U)``!X;"]W;W)K&UL4$L! M`BT`%``&``@````A`//LR+J#!@``_",``!D`````````````````;TX``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`)^(J?D9`P``O0@``!D`````````````````M5P``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/3Q(=71!0``@!T` M`!D`````````````````Y&P``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.TEZ$AV!```41$``!D````````````` M````2X0``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`*990&>&"```$CP``!D`````````````````[Z```'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#Z# M'T()!0``(!,``!D`````````````````FK4``'AL+W=O`\)78(``#@*```&0`````````` M``````#:N@``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`''Y)DY.!@``JQH``!D` M````````````````K<8``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/MBI6V4!@``IQL``!,````````````````` MW=4``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`*_2$HN@0 M``".QP``#0````````````````"BW```>&PO&PO=V]R M:W-H965T&UL4$L!`BT`%``&``@````A`!J-]WZR"```U3H` M`!D`````````````````&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,N"(X#I`@``\@<``!D````````````` M````=2,"`'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`-%;I82H$0``\G0``!D`````````````````V#`"`'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-1= M=5&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!Z=9-(L!```*@\``!@` M````````````````;7("`'AL+W=O&UL4$L!`BT`%``&``@````A`(YPBT4B&P`` M#8(``!D`````````````````=WP"`'AL+W=O?F=)46``#R:```&0````````````````#0 MEP(`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!R'`VT_"P``]#```!D````````` M````````7<<"`'AL+W=O&PO=V]R:W-H M965T`@!X;"]W;W)K&UL4$L! M`BT`%``&``@````A`*AHGWQU(```BIH``!D`````````````````8O<"`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`.N"G]["-0``.$T!`!D`````````````````54H#`'AL+W=OU!7[O4*``!++0``&0`````` M``````````!.@`,`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$PV/PEX*0``FL\` M`!D`````````````````W9(#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.*+0;P. M`P``FP@``!@`````````````````0\$#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+?,;-$W"0``SBD``!@````````` M````````$-@#`'AL+W=O0H``,4L```9`````````````````'WA`P!X;"]W;W)K&UL4$L!`BT`%``&``@````A`$-UJDC]"P``LC4``!D` M````````````````+>P#`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`++:N$X$`P``=@@``!D````````````````` M?F$$`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`,@JYDI00`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#%%@:[<(@``E+(``!D````` M````````````,AD%`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`-"">J'O%P``7G```!D`````````````````M%D% M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`+R/T=AA`@``C@4``!D`````````````````8HX%`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!:GE+]R)P``,L$``!D````````` M````````I,L%`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`#J$5,`4'P``MI4``!D`````````````````%$`&`'AL M+W=O XML 21 R70.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Details) (USD $)
 1 Months Ended 12 Months Ended
Jun. 30, 2013
Feb. 28, 2013
Jun. 30, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Stockholders' Equity Note [Abstract]            
Preferred stock, shares authorized       5,000,000.0 5,000,000.0  
Common stock, shares authorized       575,000,000.0 575,000,000.0  
Aggregate value of common shares authorized to be purchased under share repurchase program $ 3,000,000,000.000 $ 600,000,000 $ 3,000,000,000.000 $ 9,500,000,000.000    
Amount of stock repurchased under share repurchase program       2,769,000,000 2,050,000,000 2,220,000,000
Stock Repurchase Program, Aggregate Shares       96,800,000    
Average price of shares repurchased under share repurchase program (in dollars per share)       $ 76.80    
Cost of shares repurchased under share repurchase program       $ 7,432,000,000    
Changes in common stock issued and treasury stock            
Balance at the beginning of the period (in shares)       (498,400,000)    
Exercise of stock options, warrants and conversion of restricted stock units       (11,500,000)    
Shares repurchased under share repurchase program   (5,200,000)        
Balance at the end of the period (in shares)       (511,200,000) (498,400,000)  
Common Stock
            
Changes in common stock issued and treasury stock            
Balance at the beginning of the period (in shares)       (498,400,000) (487,400,000) (482,200,000)
Exercise of stock options, warrants and conversion of restricted stock units       (12,500,000) (10,700,000) (5,200,000)
Issuance of common stock for employee benefit plans       (300,000) (300,000)  
Balance at the end of the period (in shares)       (511,200,000) (498,400,000) (487,400,000)
Treasury Stock
            
Changes in common stock issued and treasury stock            
Balance at the beginning of the period (in shares)       (78,700,000) (49,900,000) (11,800,000)
Exercise of stock options, warrants and conversion of restricted stock units       (500,000) (200,000)  
Issuance of common stock for employee benefit plans           200,000
Shares repurchased under share repurchase program       (22,300,000) (28,600,000) (38,300,000)
Balance at the end of the period (in shares)       (101,500,000) (78,700,000) (49,900,000)

G5:AC2.ZNWB@CCYQNOP8=/$0&8<76^< M!P*HW9>&'47'$$&DP%%*0G1_)7OG!A6U!X]28Z3!2$N(3L3MD8ZUNXGVU.Y+ ME`L7\&K4$.H*)Q8+J86,<&+MGU&C+P>KFCF(TB[D]10X2DF([BR1146-P4/4 M&&DPTA+BR:*;:^RIT9S%E9+FC`K9K=,Y'>?,R)\>5C!QB!! MI,!12HO0!'BIOO`G'YK"86J,-!AI"=&ZW7GZI;/$7+H]1?%U#-]2 MYK]?49A9G6^/Z3,'RZ58IO6>/2+Q3#F985SQ@%>S]G@U6SGP6FA6<1-G!LEQ ME`(C)48JC-08:3#26F147$R?.]F\B.2=]EXB`?&$3S-.7=?&GU%_TA)@)V_J MI!::42;#2(Z1`B,E1BJ,U!AI,-):9!1OL^"5MXR*.U%]G=A%_2+^Z2._ZM_% MG1@L>[&+^OU5_(<=A5=LP,Y9NW;.;BE&EM1"LZ*/CL_UY!'+GAQ'*3!28J3" M2(V1!B.M14;1HT7L2-8)1GW5B/\PR8:I>"]VN0X$7%$EA\_G6>OM\JKKC,$& MFE44(KD]U$R4`B,E1BJ,U!AI,-):9%14/9S`:W+G$=CTTW47?I7VEC'?Y4[] M)A-^4JRFA^&J!TRBM6L2[2+YV+*%9O3*,))CI,!(B9$*(S5&&HRT%ADEW,D: M567M#-ZVO^T$6TW/(NF"]R+LG7KBC,NL:O\ZPG.9`_;2VF,OR:E]:J%9F:%[ ME.,H!49*C%08J3'28*2UR"CS.X;B3NP2+393R>QP;3493P7U1/D4XKIJ;V-R MCXSF7L;S8'.O2"S9TO6<,3+DDF$DQTB!D1(C%49JC#08:2TRZJI*4?XFH\Y% M5ORQ?S%4]F('];UN?B%8AR46II1\6F]M?*>IU.HVJ#!=4TO-UC`TL'(???Q1"=LX.L2!ZEP@-RL*I&I3=7F]PKUW'2BGK5+&A M9I6%2&Z/-1.EP$B)D0HC-48:C+06N2H;RW?%="ZR"?UV0CLT6T7(!HN7[&L8 MDY<+L&%Z$W"TANU\;JT4%@N=U%(SVF08R3%28*3$2(61&B,-1EJ,=!CI9Q&N M8L"EVAAWB=T><'X+MX5F1<0N%8Y28*3$2(61&B,-1EJ,=!CI9Q$NHG:E/#.F MC=[NE*)X!CFUE+DMGNS6\F'SC("P;X&1`B,E1BJ,U!AI,-(2HN_2>7JE(R#8 M*_TLPA44UI.<$*E7('J4E!Z4I>R[AM07Y,6*++/`3,'F&"DP4F*DPDB-D08C MK46"O=+A&/H5E+K__1UGE#2OF#2O`7P^OGT_9L>GI_/-P^GGB_**8W6/B;:: M5UNFT0?U(CWU/CRQO56OO!RVWU.#>A'EZ^'[\;\.;]\?7\XW3\=O*J1ZB%\M ML-_,.RO-?RZGU^$=>5].%_4*RN&?/]2[18_J18#+A8*_G4Z7\3_JP/>_QK>5 M?OY_`0```/__`P!02P,$%``&``@````A``:\9T.0!```M!```!D```!X;"]W M;W)K&ULC)C;CJ,X$(;O5]IW0-PW8(XA2C(:0+T[ MTHZT6NWAFA`G00TX`KK3\_9;=G&R03!]T9U0/\7GVH__/WZ\M.UYHVK2YIP2IZU'_01O]R^O67PY/5;\V=TE:# M#%5SU.]M^]B;9I/=:9DV!GO0"B)75I=I"U_KF]D\:II>Q$UE8=J6Y9MEFET:C%)38NT!?[FGC^:/EN9_4RZ,JW?WA\O&2L?D.*< M%WG[0R35M3+;?[M5K$[/!8S[D[AIUN<67V;IRSRK6<.NK0'I3`2=CSDT0Q,R MG0Z7'$;`RZ[5]'K4OY)]8ENZ>3J(`OV;TV:W^XM3+?';\E8`4^"WUJ9 M\QZ`H:>?XN\SO[3WH^[XAA=8#K$]73O3IGW-^;VZEKTW+2O_0Q'I4F$2NTOB M`F87MPU[YQ'/W\YB(I$829*VZ>E0LZ<&[0'/;!XI;S:RA\S=$#J.85!0VXRK MOW*YN`EP&[CZ<2*N'1[,#RA3UHDB%$&7CR)9$?<*7BJ>-YE<,(%LP(-!3_!Z M"GY5IG!L^0G17*(HXKG"<>0DR5RR&R42I[/(R:_"7$\*$3AJL5`#I1^*Y,+D\>M1AT`,*<1U+IHE0Y./[,/ MCV49$TC3'D\5)+UX:L\3+_5+9HYRQ'WA4Y7;E1T6H M06[H.X4DGH:5CD[ZV"9EN$K)HRJE@A&A!BD5C'@EEO2Q340"%K=221%6(94^ MC#H14CJ6H71R+,=WDS6.JVF(;]-R4QCGO5]/!+UBNDTYOKK^.Q%2OA!+7=2Q M+'`]RU`&F@R*;5#N$PN@:!]3T-W<*U'4@5J&8@\QD>+AG+*/;U-REUB@1/.0 M*)U9.7N'X8YODW`^ZU/!PLZ0D*E@96N0%C[A?C$BJWXEPG*_PM:J[EF="BM, MPMV\Q.A**YMO,N38KC)W"P5YLEG!ZZ&Z#P"RNEUU*D2VG7FU>TL2+V"JR0YW M;\-RRQAAAQ6&3C)M"8!4=RO2^PV'<,C.\*<>.]L6>O425+*7ECW$J>C,6CA$BH]W^.\`A0.698#X MREC;?^'GVN'_#:?_`0``__\#`%!+`P04``8`"````"$`/!+6^R4.``"=:@`` M&0```'AL+W=OGKFV]\CVS+6L=I_)=,/'7+X(6\ZQ[)1X-L? M?Q_?4G_MSY?#Z?TQ[=QETZG]^^[T='A_>4S/9XW_E=.IRW7[_K1].[WO']/_ M["_I/[[_]S_??IW.?UY>]_MKBEIXOSRF7Z_7CX=,YK)[W1^WE[O3Q_Z=GGD^ MG8_;*_UZ?LE]EMX.-NT<7I^/NSVM=/NYW'_ M?O4;.>_?ME=:_\OKX>.B6CON;)H[;L]__OSXW^YT_*`F?AS>#M=_O$;3J>/N MH?WR?CIO?[S1=O_MY+<[U;;W2ZSYXV%W/EU.S]<[:B[CKVA\F^\S]QEJZ?NW MIP-M@=SMJ?/^^3$MG`?1!?D2W:G M-UH2_9\Z'F0GH&W?_NW]_'5XNKX^IG/%NT(IFW/<0CKU8W^Y-@[RM>G4[N?E M>CHN?>2M>MB(&S22I]4,GL_?N>6"4RA^HA5:GK'CI@=JBPN=W MJJ..L$/[,FC'<;_0#O40O[O=NLH7^AOUY*"96U_)%>Y*3O8^5Z*09;=U5%^1 M#]3>H16S?;GJ+<[M0#M?Z/>..M;N[5A_9>=2/?'WBGR@-J=\5RX4\L7R)W:+ MJPZV?!"TD_O"P7:IKW@'6S[X%YW&59U&/E#;99_3L@+YJW$[RE_:O>IPN[?J M0.U\MM.YJCK(!VJOE+YPE,)>0P_47K'OO#GJ:]Y>D0^"EW\A$W.JS\D':FO< MN[Q;*)4_H>=.*] M4/2O[TX^=_\M\Q>=\':/!`4P4BJ^(X.7U!+874 M@MH\T.&!KA_P1Q%RW7I*1!:D+Z6OA%K*@`>&/##B@3$/3'A@R@,S'ICSP((' MECRPXH$U#VQX0(2=0&VN"(XXR5NW[9E@]HVJ&.#NG'$MJL'11^*`11#*$90C*&80#&%8@;%'(H%%$LH M5E"LH=A`(00FAAQT\D5'[]?"D(>LIPE#'G*"\U#@1!2&3.0+,N3AC6B5BH8) MT4KEG9EI0*0JEGQ:JUA^(%JQJ`ID];U5M4$U&U0W(G9P&C:H:8-:-JAM@SHV MJ&M"!;8S>T;$=D'?!@V,B)TJAD:4UP_PR(C8N6!L1$6]I8D-FAI126]I9H/F M-F@11^5[=E26<4.7WFSC5C9H;41LK+NQ04)8J8J5,N5P]IZMEC`E<5R9LCBN M3&D<5Z8\CBMC(A=O'50K@70]DE0"Y=-:"?0#MY%[E0=J/%!7@!"?%3T-`& MC6S0V`9-3(BO^%0A-?R?J4"T6_!7S8V(':>%"?%]LC2A`CN8*R-B?6=M1*RE M31R5R^Q$(H0)L8T3E3AR\@6V3B),0VUO&#*`S,>F*M`TG%8**0V9\D#*Q6(-E-D%7JM MD&IFHP+15_%.((25JAB4D^/5H&I0^3Q786^-KE>1G26$L0L7V>E4&/MPD2_1 MJA,+8R\N_B:'Z4Y\-(?5]98,:[GK!R*YRP,U'JCS0$,%HON+[]6F0NKHMWB@ MS0,='NCR0(\'^CPPX($A#XQX8,P#$QZ8\L",!^8\L."!)0^L5$#;BSR'%%)[ M<<,#0L0BE5BD&HN$1UE;.N^GX:'7%%M'8>X/7,4ZA(CV".U\1.\&1?NR=P\A M7PCO(&OWECC>\+@*10V*.A0-*)I0M*!H0]&! MH@M%#XH^%`,HAE",H!A#,8%B"L4,BCD4"RB64*R@6$.Q@4((3'#6"9QV`N>= MP(DG<.8)G'HB,?>THD5O+D:+ECH!R_!CFFX;AW6([@:S"Y**CY**%10U*.I0 M-*!H0M&"H@U%!XHN%#TH^E`,H!A",8)B#,4$BBD4,RCF4"R@6"HAWV+/WK'1 M\4H]>TL&=E)>*Q&\_G:'S3MG;]33OVU`"$QPNHDJ;@4GG,`9)W#*"9QS(C'I MM"I%,UNB58J_/2.?CE4K=A^FXJ.D:@5%#8JZ+XK>9(U9*O(OXI* M/G-4,:EA4L>D@4D3DQ8F;4PZF'0QZ07$+WZNZU\*LR%R'[ZHO%84VV#^4:U#1N+I*3:AMNQ2$NJ;;@= MB\2DVI;4CE[;Y`S'I-KFSX"D]B(W^4OLDJXB_]`3U39(:KB5.B8-3)J8M#!I M8]+!I(M)+R!N-N<-[;)W['JAC\``+V2(R0B3,5J3"0)3O)`9)G-,%I@L,5EA MLL9D@PG5,YA`5,^PJ5H8BTRDOP+#R[+(1?I+,=Q.IIN%V++*1:AIN)SD?]8HF9^\F531_=B^K:&P'5.0G\J"*!DD-MU+'I(%) M$Y,6)FU,.IAT,>EATL=D@,D0DQ$F8TPFF$PQF6$RQV2!R1*3%29K3#:84$6# MB405+6ZI:U<[P2"TR6F*PP66.RP83*'LQ#*GO8 M6"0KU3SH63DX^3*IP_.5FO<&5V>[HB/\0553A( M:KB5.B8-3)J8M#!I8]+!I(M)#Y,^)@-,AIB,,!EC,L%D:B!.OLRF5\X,*C9X M@QUO@5M98K+"9(W)!A,J<'"3J,!A4[4P%DE)!0XORR(MJ;CA=I(34RMM\C-K MHZ5-O77JQ?E;IV4^O2U0](Y'.%&$]:PJ)C5,ZI@T,&EBTL*DC4D'DRXF/4SZ MF`PP&6(RPF2,R023*28S3.:8+`(2O`?G^L,M?8RPQ,VL,%ECLL&$/JH3S^ZO M6!B+C*2/ZL3+LLA)^K!.W(Y%5M(7822UHQ)@,%G M&Y,.)EU,>ICT,1E@,L1DA,D8DPDF4TQFF,PQ603$[\1./KB2TOO=$K>SPF2- MR083*FRP;PJ5F@F)0A]!C-M1:9G4CD524F'#R[)(2^\;?GZ?EWYA\[_!Q_^Z M@./^_+*O[M_>+JG=Z><[C;KDQPB%T=M7!Q7E9ZBS>,5YH`]MC\>;S@-]_'X\ MWJ.O(!*F)^A='/IR(N^93+@,^LJ@C^W+OK\]OQS>+ZFW_3.M7?9.?JO(V?]V M(?^7Z^G#^[Z#'Z&ULE)S;;N/($8;O`^0=!-VO)9Y$:F![,6+W)`LD0!#L M)M<:F;:%D41#THQGWS[=7<6VJEFL[OAB=LW^6*R_3_63LGC_Z\_C8?:C.U_V M_>EAGMTMY[/NM.N?]J>7A_D?OW_YI9G/+M?MZ6E[Z$_=P_S/[C+_]?&O?[E_ M[\_?+J]==YV9"*?+P_SU>GW[M%A<=J_=<7NYZ]^ZDVEY[L_'[=7\>GY97-[. MW?;)G70\+/+EG.43X=$Z)T3\_[W>=ZG??C]WI"D'.W6%[-?E?7O=O MER':<9<2[K@]?_O^]LNN/[Z9$%_WA_WU3Q=T/CON/OWV[Y_V1H'M]MFY>WZ8?\X^Z74Q M7SS>NP[ZS[Y[O]S\_^SRVK__[;Q_^L?^U)G>-N-D1^!KWW^SZ&]/]I`Y>3$Z M^XL;@7^=9T_=\_;[X?KO_OWOW?[E]6J&N[*G[/J#N9+Y=W;@#$-!D!R#%"9-;"_O M\J;*JM7_$:7$*.:Z0Y0\.MG;*9I],9.P( M5..[QHS0SM*?+?XP-\O`B+Z8HS\>L[(I[A<_3&?O$-HP$"7:@;`=;N.J\("^ M.;`PJ?I\35_>Y#ND98_:M(9X&SA@@O@\\R"%,5$$.M08":7J,6+ZH_27(JF; MX;])W75U6?F>M:UF=MUDG)6KVD=RW;0!R,P$+VM%B39*J"BA)8(H,HG<*!H& MPQY]F)N>\4F:/JEHGAN`5FX*Y4VQKI?VAT+M+51DRV7)0`H@\Z^_7-`G6B*( M'K,`&#WV*-73-$&F&V"$)-HHH:*$E@@B9$6$A%/-MD:G&D"2HBBAHH26"**H M)HJ&J6:/TJ$Q4RT8_@U`I9MJP;BU0IN"MAJF:.6F7G"ZOD7*$"'Y6^?PL<\. M^=NC-/^F#G:A#3"01@;+)$BC!815J,CIF"-=9IH@12"4J%BS*NQ1JL*,0KAU M`<3FV`IM2FC3?!O).#/>X*;CW5(HEG[7=B79)*M$,TAN$W<"K)UD=&DCT<+HUU1K/=9$@M"]A?[[*`:,=$8,44$GRJ MJ`8NPR-4C2V2C!JHG;<#U(1N;F-N`:QD_BHX.E%$Q:-H$:%R;(7\D!.6\@P* MJ)D.WOTPMA$I49=4B7'211$M7HCJLJ7S0]=0$#.HJ+?#Q%1TI";V`@C!-BKI M3(V-P_+,@N5)\[=%D\D?:NEM_N.*G@'$9MA*C4IJU!.--&U;,IFTH9+>ILV4 M\`PHK`83Y82OR3B#X@$T7B3L'*(BEXNZ:PYWKB8LZDB%%X)E+C4JJ5%/--+\ M^:*>)Q5UI(99VG`U!!E6FR(!\H:[\]*$,;<[]L?O_%2+F33,C,KMX=$8A$4= M*3;/5FI4OO%CXPM\OQ81JL&6T_&JR*'*TE4Q*NI(X7ADH7_&^02A`"IJMJAC M(&&7UB)")9DPG"1[.!R645'/D?HHZL'`M6,B\/L*"5$-7(9'J!J^J-NG9X&: MYN;IB^OZ#4+\57!TXD4]'D6+")4C%_4\J:@C)>J*5FP5CZ)%A.KBBWJ>5-21 MFM@+(`2LGU5XI^U&4?D`PI8P>`,.H5+X^IZGU'>$(-F<3;9%AE6K?".7IA.K M180JL467V=R@%M/-;737G@OEO)4:E6\4-`S!.81H,'?LMQK"NWC7'.YJHX*/ M%-OEK=2H?".7*(R'B%`M?/$ODHH_4EAL7%G^J,NPF1&$GWT*&6'OT")"!?$. MH$AR`$A-#`J$8!N5/U,8E.%\#J$:>`=0)#D`I'!S6G-/J5O"3(T*7$T<%0FA MBDP89MD7]G"X5$8&8*`^#$!PS]Z.B<`B*"1$-9`,CU`UO`$HQ@8@*ZO@"<0& M*?XRN&CB#B`>18L(U2,[@"+)`2`EZHH[@'@4+2)4%^\`BB0'@!2LH[KD;DQ: M9`3-*HYH$:&">!]0I/@`A-CMJ_6-W-[D)J6*(UI$J!#>!A1)-@"I"252&4$.-S(#2/&*?".7"RB*(UI$J"+>$I1)E@"I"2400EHN M_OQ)L5I$J!+>"Y1)7@`I],WTF0-LTTB(*O@G+B7B`>18L(E2-[@3+)"R`EZHI[@7@4+2)4%^\%RB0O M@!3L!54>/('$@8)(@F:%801$BP@5Q'N!,L4+(#2Q&4`$(4OES^=6NNL.+2)4 M".\%RB0O@-2$DFBA5_Y\08D4A2BI9"_@FL/M;>0%D.(5^<;)=%4 MH$KR`DA-*(E[`7_^I%@M(E0)[P6J)"^`E.`%D)`631S1(D+E\%Z@2O("2$T, M3+30*W^^,#!2%*K$]!GC!2I[.%PL(R\P4!->`)O%48'K"(@6HU`MO!>H."\0 M?$2Q04A(I(TC*HYH$:%R9"]0)7D!I$1=<2\0CZ)%A.KBO4"5Y`60@KU@7<(G M;($'14;0K.*(%A$JB/<"58H70&AB,XA[`7^^L!E(4:@0W@M425X`J0DE4A5W MED7Y\P4E4A2B9"5[`=<<;F\C+X`4K\@W3J:KXH@6$:J(]P*K)"^`%*R:%7XN M':P:9*15$T>TB%!!O"58)5D"I":&!D*(2J*(]I?@!I@JX=W`*LD-(#4,#?N! M`3*B(*GBPSV!&(4*,E=B3,'*'@Y7S<@4#-1@"NZ6P5\QMTB(J*^X)X%"TB5!?O"U9)O@`I M6$;X,7OX:2@R[*:AI$;M&^-[`>\%5BE>`"$VOU9J5%*C]HWQY/GZOTJJ_TA- M9#]4;OLUL6!$#X&0$K(I(TC*HYH$:%Z MY')?)Y5[I$1=\7(?CZ)%A.KBRWV=5.Z1PBW.?=,HW`X@CJ!881`!T2)"Y?"% MOTXI_`BQ6U?K&[E]"6Z=XX@6$2J$-P%UD@E`:D+)8`($)5%$^TMP48B21C8$ MKCGD6_D$/0 MC`U!,_I"!T)"KFT<47%$BPB5(_N!)LD/("7JBON!>!0M(E07[P>:)#^`%/J! MV"5`AO"YHD6X#4A)*AYG//!O!,T)!S,K4/'M6PE@V!:PXWN)$A M0`HRXK_A19#@FZ/@"I!@.T3[QK@@W@^LD_P`4C@]BI6;('0UM`F,H@P\**!A M-"()ZV7->P)W>#0T0679((63I>(5@35`IN8^0%08AT\7[D=%A"P<\^XJKIJZ MPZ&B4?U!"MZ-@Y,MW-8(DZ]A[Z,#H)`1%4DN`Q3!.[3@G5''[OS2M=WA<)GM M^N\G8]5R\ZU_?]2_N^MS;M_$%!S?F'=ZN?=B+7R#>=/6V_:E^^?V_+(_76:' M[MF$7-[9^^0SO)0+?KGV;^Y-55_[JWG'EOO?5_/RM,Z\.6IY9^#GOK\.OY@+ M+_SKV![_!P``__\#`%!+`P04``8`"````"$`:Y1EW5H(``"A-P``&0```'AL M+W=OU=\ZOR. M;LDQOCQV26_0[4270_QRO+P]=O\5ZC]FW4YRWU]>]J?X$CUV_XZ2[E]/__S' MPV=\^Y6\1]&]0S-$].N^37GR-+O0OK_'MO+_37V]O_>1Z MB_8OZ9?.I[XR&$SZY_WQTN49%K+7U^,A4N/#QSFZW'F26W3:W^GZ)^_' M:Y)G.Q_:I#OO;[\^KC\.\?E*4SP?3\?[WVG2;N=\6%AOE_BV?S[1[?Y#1OM# MGCO]I9+^?#SHVS_OS/LWT]/!RI%O`=GOG%KT^=G^214AF MW?[30[J#_GV,/I/2SYWD/?XT;L<7YWB)Z-ZF[<1:X#F.?S%JO;`0_7*_\FT] M;0'OUGF)7OW]3IM[S+YRB$]T2?3_SOG(:H!N^OY/^OEY?+F_ M/W:'D]YX.A@29=SM/$?)73^R[W8[AX_D'I__PQ')4O$D2I:$?F9)B-*;DL%\ M.&V?9)@E&963*+,Q&4^^L2IT>>GVT,]\5<:]D3*>SKZS09,L"_W,LTR^GV6: M9:&?>1:E]^TMHETRW2+ZF649CKZ]<^=9$OJ9)_E^,Q-:AKQ82GMW]/W]0O+= M2TI[9MR;C<>CR>P;%4,[4+8^_]=F*?EFL1^RO:,H;3M!GW>HM".J^_O^Z>$6 M?W;HZ$:[3'+=L[&2+%CFK`MF_:CHE'1L.##^D_G'+MTDVMT2&OW]1$9SY:'_ MFW;S0X:6-4@4JURPKL[RJG)`XP'Z_]>""!F*:?0:)`HC%_F"3!Y(![5TR98< ML/-`:VU+BCN;B7]2J25L:H"GEE MS"J1DEA0V%"LH7"@<*'80+&%PH/"AR*`8@=%6!6$D&E1`4+UTF-N7?6RL%"] M*%68'##D@"D'+#E@RX%U'B@5Y6`NM:U3BZ1=Y.8H/YO9Y(&FU-M:)*7V M$"D@N9HDEZ4C@?S`?LGDE69C$@=404R(S59-$X: M>HX.A0&%"84%A0W%&@H'"A>*#11;*#PH?"@"*'90A$U"J&EZDZ14W\):9RHX.X^&TMKYYJL;Z MAD3+%M6010X@RD0.KA&YQDBXE768XTI^?C'`$F M.TS"1B*6.IL`JBMU/C$DECJ1#MM+]C`Q*G5(5)Q%PT3'Q,#$Q,3"Q,9DG9'L M`J+H">)YD2.H;$ZC:D/+]D#\*CD(5%Q%BTC_`F`HBW$?:/C/`8F)B86 M)C8F:TP<3%Q,-IAL,?$P\3$),-EAPMY<^M]UQ^N;OYG$7X@X1[>W:!6=3DGG M$']XSM]8RK]\9V^"A?19TD'/8I?X_B>_\(64+Q<]_1?````__\# M`%!+`P04``8`"````"$`/%)YH74'``!H*@``&0```'AL+W=O(N)\$DY"3.CUJ`L9(N])JM8=K.B$) MFB1$0$_/O/V6L3G8>%W=?=$DQ4<9_Y0+E^.GKS]NU\GWK*SRXKYSR-1U)MG] M4!SS^WGG_/T7_;)V)E6=WH_IM;AG.^=G5CE?GW_]Y>F]*+]5ERRK)^#A7NV< M2UT_MK-9=;ADM[2:%H_L#F=.17E+:_A:GF?5H\S28W/1[3KS7' MMN5'?!2G4W[(PN+P=LONM7!29M>TAONO+OFC:KW=#A]Q=TO+;V^/+X?B]@`7 MK_DUKW\V3IW)[;!-SO>B3%^OT.\?9)$>6M_-EY'[6WXHBZHXU5-P-Q,W.N[S M9K:9@:?GIV,./>"R3\KLM'->R#;QUL[L^:D1Z)\\>Z\&GR?5I7B/R_SX6W[/ M0&UX3OP)O!;%-XXF1VZ"BV>CJVGS!/XH)\?LE+Y=ZS^+=Y;EYTL-C]OGEQR* M*[0$_R>WG,<`=#W]T1S?\V-]V3GSY=1?N7/B^<[D-:MJFO-KG@MQRW4^F6MF\%5ZJTD+<&'+VC2"0.#9R!,VW]NY?UO&PA:0]^` MIL9>$-!,)]E\KMY#.':RUI!H[$5KAXX)>#2^VE+\$8B-(?V.$RNBZ`CY8Z!C M$V!SMXLG?E;14S?LA6$H'W1+4R?4KXJ,5RU4,:@16JI0;(16*L2,T%J%$@-$ M!L(JJD&^'*C61A^W*FKIAKTP],,FU(E()ZANB'4#:PU]!,,CV&B]:R%]'$%J M,O2$6^'=-A@4Q/=Q1(D2)""4H2L0HP5`BL1%*;,!+RZ`H MM^X-F(O5RB2F0&QBHD2$$A0E8I1@*)'8"$5,7J[TDXDV:W'K M0$QM#`?BM!!SOEF:Q!2(34R4B%""HD2,$@PE$ANAB`FS,8.8W#H04WL1!>*T M%),L3&(*Q"8F2D0H05$B1@F&$HF-4,0D4+(9U&S,`SFU5W8@SPL]/;.>DK$) MBB,1CE`QY/.*)F%3#)+%[4>^-/>]Q*R*!?B M2(0C%$=B'&$XDE@155P^&>_%U;1]'\DKZ`L7=Y+1Q8D MQ)$(1RB.Q#C"<"2Q(JJVO&#H0[C35M01:NAZVF)!`(N/_`F(L%PMYZ(@&&4( M6TTB%VY0)))M61X2Q9$81QB.)%9$E9>7$+V\HPPA*@Q59G>4AP4E9%XOS>\X M6ZTB14:1B*`(Q9$81QB.)%9$%9F7%KW(70R+BD-;'AB):ZM+&N'V!$5"'(EP MA.)(C",,1Q(KHFK+*PV#MJ(`T0)77RX@@A*!2_RYL<:5D&5@AS@2X0C%D1A' M&(XD5D15EY<>!G5%1:)%[DA=6]TB(Q=%0H(B$8Y0'(EQA.%(8D44;3VU6--3 M;W.:%VU]=0&+A_H:C:0LP;G'D1!'(ARA.!+C".L0_K.+]D)/NI.]*/U"BZJN MN6;SQC4;(0NMF4!25E71@BS$O40X0G$DQA$F$9'I/.,\*%$8B?1S)55="$M# M7O"X68O9Q4K/"Y*RJBL<69`0]Q+A",61&$>81.SJVKJDBLN+J3[ICA*#J+74 MY.N.$H.@+`KN/10)<23"$8HC,8XP'$FLB*HQ"#/0N)V2>=RL!_!27R^3E%5; MXSUF;QI)N!;)^!A6#3:)$DM3=908T$)L+QU9@CK$D4@BXH?.N6]:;Z.XFQA'&(XD5D055RW61F\V M4]'F:3_!!["##4T++6*80X;X]1&.4!R)<83A"-^P]__=%>J*#7EBP],M*\_9 M/KM>J\FA>+M##O#A!]S.VFT$?%GPW3V:/2!;V*,TME.RA4U'8WO@;0.3G]#; MPI8,OD>B:P"V_SW2<_9[6I[S>S6Y9B>X-7?*-[:58J>@^%(7CV:[UFM1P\:_ MYN,%=G1FL#G*G0)\*HJZ_<(;Z/:(/O\'``#__P,`4$L#!!0`!@`(````(0`> MG632+`0``"H/```8````>&PO=V]R:W-H965T&ULE)=MCZ,V M$,??5^IW0+R_@$E"-E&2TP+:]J16JMK>];5#G`0M8(J=S=ZW[YCAR3;BMF\2 M&/Z>^7GL\,5*^'+A=4$EO-97 M3U0UH^>F49%[@>^'7D&STD4/N_HC/OCEDJ4LX>F]8*5$)S7+J01^<J\^I;RHP,4IRS/YO7'J.D6Z^W(M>4U/.?3[G:QHVOEN7BSW19;6 M7/"+7(`[#T'M/F^]K0>>COMS!CU0:7=J=CFXSV27D(WK'?=-@KYE["%&SXZX M\<R[_Y(]?67:]28BT5LU3GH,6?ITB4Q,'\D7? M$2,[R]O!78:+]<9?DF#M.BA>2%_^@B+2NT$G0.H'_!WX/X/&# MC9=M8_AO&Y-@$3RMR3K\'PBKU@O\=U[6'_;B85*:Q"94TN.^Y@\'IC5T6U14 M%0G9@>&PQ3VBHB5,!OKR"Z(NX4 M:JB4TV1D\`"K9X,,C]@Z!&55"%WS"`WCB($1T58L=45B*U:]0F.",9Q@4E:8 M5Z-.K_OF31\C5$"&^[2$NB+^H2*94VB0$&8"4ED/+O2T1]CH"!$JQI!/NB*V M%48WDCF%!@G%-P&IK#KD5D>(4#&&),8M9LP:&*46 M3V@L5@PU=C-(=%:U%4RPX@ZAL1KU'!'4C(,0*Z^V9@!IM\,YB=U"-+D+/ZQ)&DE M(2YU3_XVW(:KS68(IN.J'6)(;7,P6JIC:Q/O&4Z:%K;!%+6:66QTLT$F/_3A MYK$QIDPRZT>'5OO%`-W#XC:BS0=C98J(O=4$QKH13VB,/B>S$IU5[1L3K+B= M:*Q&0B*XBZCDCQ.[--:->$)CL=IN!@FRXDT$#\P%JZ\L9GDNG)3?2SA$$1BV MWMI?E=H[3/\![B(5O;+?:7W-2N'D[`)-_<4&AK[&:PN^2%XUQ_$3EW`+:1YO M<"=E<$+V%R"^<"Z[%W5)ZF^YQ_\```#__P,`4$L#!!0`!@`(````(0"N,=7Y M<04``-89```9````>&PO=V]R:W-H965T&\Q%U__JC/T3MONTHTFY@LTCCB32GV57/?OK+^NK:%^[$^=]!!&:;A.?^O[RE"1=>>)UT2W$A3&I_)H8X'*J2,U&^U;SI59"6GXL>^+M3 M=>ENT>KR9\+51?OZ=OE4BOH"(5ZJ<]5_'X+&45T^?3TVHBU>SK#N#W)7E+?8 MPPC$H5]`N$2!NFM>):L$(FW7^PI6(-,>M?RPB;^0)Y9E<;)=#PGZ MM^+7SO@[ZD[B^EM;[?^H&@[9AGV2._`BQ*N4?MW+(;@X<:Y^'G;@SS;:\T/Q M=N[_$M??>74\];#=2WE)*(\[AH;E;CL^(G'6RN1Q7K'9=B])LR&>ZL.9S->]9#_,I$.T#HKT] M0W+4H;1RME,B#T4>5#"?`G%*6YQ:T8U3C@9W7XE\G$$%\RD0YPIQ#KN?I>/N MRUDGKP_6[BN1R0L/G/7(Y*[(VA[F4R!D`MXVD]MAV(%=6;!:9=):('E8PKP2 M#"O-P"T$HCP"=U.G#VB5%U8%\DB8-PJ&E1XQP=K50)2%6*W5+@>M,HD(25.\ M#_F,RMH'YI5@;FD9$_?M:2/*24Q>2JW>M-,B$]<"R<,2YI5@5KC3'*L\#)E>('*T"HOK`KDD3!O%`PK'6DJ8Z?S^8XGB5L?KZE"ZYNV1Y_Q\[J)2O#5PED?@8&4< M5&UL MG)U;<]PXDH7?-V+_@T+O(ZDN*DD,VQ-=]_N]:I_5LFPKVG(Y)'6[Y]_O`"DU/;,P[3\9>(`9((@F`11[_[]]^/7D[_NGYX?#M_>G];.+DY/[K_='3X^ M?/O\_G2W[?_K^O3D^>7VV\?;KX=O]^]/_W/_?/KO#__[/^]^')[^>/YR?_]R M`H5OS^]/O[R\?,_.SY_OOMP_WCZ?';[??X/ET^'I\?8%_WSZ?/[\_>G^]F-> MZ/'K>?WBHG7^>/OP[;10R)Y^1N/PZ=/#W7WWGKR>)>-/G\[/-W^_A7' M_7>M>7M'[?P?(O_X#Y\>CF#W'G14#WFF_.;/?Q`4<03OO)T_VG M]Z>_U;+]Y<7I^8=W^0G:/]S_>*[\??+\Y?!C\/3P'_3QX? M0A_`H=_^_?ZT@1H>/KY\P5^ML\NKBT:M?GEZ\OO]\TO_(90]/;G[\_GE\/A_ MA5.ME"I$FJ4(_EN*U'^Z+&K)&X#_EF6OSVK-B]8O5(].FTO@O[]<_4U9%O_] M;ZNOX6#S^L,?O]R`&LY\4=I"\,MGH-:B"/[X]29/1U^G&!\@=3S]]LP6M6R.F)37@1E3SY> M%K@Z[X+[;\'__2EZ$3K\,^A?'VH7UXUWYW_A0KLKG=J.4^S1H4>XV()N-P6] M%/13,$C!,`6C%(Q3,$G!-`6S%,Q3L$C!,@6K%*Q3L$G!-@6[%.PKX!S!/$84 M0?REB`;_$%&&HDU@(:XGT:,'BW13T$M!/P6#%`Q3,$K!.`63%$Q3,$O!/`6+ M%"Q3L$K!.@6;%&Q3L$O!O@*BZ&&`^Z7H!?_\SG2\'F]:S3A<[<*GAN'[Z-2* M73I'EV-(A?2$](4,A`R%C(2,A4R$3(7,A,R%+(0LA:R$K(5LA&R%[(3LJR2* M,B8!OQ3EX/_^--PUCA'$L)O&N?!Z,\Y'EV.P)*U\]EJ_J"6SUTYIMVNQ M6Y`&AO/C\'O3NHQOH;VC$SM&7\A`I(='GZIT'9TH/18R$>GIT:G9THO1?JO1U++TZ.E%Z+60CTMNC3U7Z)I;>'9THO:^2J+N$;$WE M`8=#<,!QMRA((W0C/MI<)X?4*7TJ7<,I5;]*XM)1[]4N;F M.*H,I*KASU0UBJNZO$G.W%@JFDA%TY^I:!97U+IJGB73D;E4M9"JEC]3U2JN MZNKR\BPYJK54M9&JMC]3U2ZJJM6\::15[:M511T-TVNOHP4<=[2"-)K'6'=* M4NE6!;DVGUY!:I?FU"^=6D>A@0@-16BD0F,1FHC05(1F*C07H84(+45HI4)K M$=J(T%:$=BJTKPI%X:IA,NW%*^=QP$K4C,;_JXMX3.J8%P>E;HEP:\H3)8WF M]5DRHO3,A:7Z*C10-+2"N7;SNG&6/*:/S(7:8Q6:*)I:P5S[\O(J;??,7*@] M5Z&%HJ45S+5;C?I9+3Z3*W.A]EJ%-HJV5C!HMR[JM?3RW9D+M?>14-Q'0H[% MN7G4BMP+GL*)H2E6V^ M2=L\,P:%H253.KM-Q8V5V"J^)3'BC:$M4"MZ)<.NX9 M(3?C]8PB9Q/UC`)5;]CAA43:#4ID=^,>O0SUB>Q8!XJ&1%9PI&A,9%H315,B MTYHIFA.9UD+1DLBT5HK61*:U4;0E,JV=HCU1KA4',"1=O``6R9@H@`5JQNFS MY#+MU$HO&\&[1.%I\J\/C>MF>COIF0?[7)_(=`:*AD2%=/,*K[/BN^#(/"@] M)C+IB:(I4=GJJWIZI*%H2%=+UFDSZ5^9!Z36126\4;4O$N5*S M>9.>[)VY4'L?"<7](Z1ZO/Y1I("B_E$@]`_J=O`>.%S@E=MYEZAXK1M>6O44 M]8GL8`>*AD2F-5(T)C*MB:(ID6G-%,V)3&NA:$ED6BM%:R+3VBC:EJ@RU]DI MVD<%XP"&#)`7P"(S%`6P1$@"')_=;ZZ2"ZH37@"'1[&K8YB[):H,[3U%?44# MU1JJUTC16-%$M:;J-5,T5[10K:5ZK12M%6U4:ZM>.T7[",4Q#6D:+Z9%^B:* M:8%:>-X^QK1QDK.R M$;V*RFI8NW$3_2\>^<=TMZHGBJ9$;U8]H]?Q...ZYK1;70M%2Z(WZUK1BW5= M)N=T30>K;*-H2_1F93MZ%97)K'M/>UY7W`E#"L?KA$5J)^J$!4(GM#M#@:(> M5R*[?_3P)B>_?]A`VB>R@Q\H&A*9UHC(M,9$IC51-"4RK1F1:$5/ M=27"I/!8T!E%2J_BH>3B[#I)3/;#R]CX06&@:$CT9F4C>A65812I753_E]SN MQG2WOCM1-"5ZL^H9O8['F8S#AF;B_,>9Q`+!%ZX7$8*5&URQ%5DKY$5K!/9$<_ M4#0D,JT1D6F-B4QKHFA*9%HS(M.:$YG60M&2R+161*:U)C*MC:(MD6GMB$QK M3Y1KQ0%\);M7U^Q>B<+$YC@:W%PEM[<."UJSNR6J/%KT%/45#51KJ%XC16-% M$]6:JM=,T5S10K66ZK52M%:T4:VM>NT4[2,4Q_25A%]8VACF_G;+:9N&?2+K&P-%0R)*-R4K8!X<2L9$)CU1-"6B M=/TL>>\],P]*SXE,>J%H243I6OHF8F4>E%X3F?1&T9:(THTTH;@S#TKOB7+I MN'N$))TSQ0H&K/+%)\UN5L6;%BD>XKZ1%9PH&A(9%HC16,BTYHH MFA*9UDS1G,BT%HJ61*:U4K0F,JV-HBV1:>T4[8ERK3B`N)V[`0P\N;X+%#]` MRM2O7GA5I_-$Q9-%$R^HDH&^9Q[LE%X3F?1&T9:(Y_HB/2$[\Z#TGBB7 MCKO'*TF_\*%$VCT*5'VT*[VBOE#F`>VYI$HK&B@:*AHI&BN:*)HJFBF:*UHH6BI:*5HKVBC:*MHIVDHKZB@:*AHI&BL:*)HJFBF:*Y MHH6BI:*5HK6BC:*MHIVB?83B`(;,526`_[2^LEYDNJ+`EJB8M&&%97+_[+", M7;K=$OW#&DOS8I?I*QJH_-"\*@]PK>0V-C(ORH\5351^:EY5^227,#,ORL\5 M+51^:5X5^:MD_KXR+\JO%6U4?FM>%?E6DLK:F1?E]Q&*>U'(>U5Z$9==UHM\ M6-1;RA09[K3'9VM9>%F6BQ[#G'*:H2L+K.Z75S=Y>5%*UT!LZ=07EW4`QNOI.=R'C\IE*CR M%K!#9&WNEJBZ)K-$T:),NMD3SD#%AO2RW-7($1O3S<0F*C:EEXG-'+$YW4QL MH6)+>IG8RA%;T\W$-BJVI9>)[1RQ/=URL3B*K^3H&IJC*Q%F[S:.W,@J3?/B M*-8M$5<>U-*!M6<.+--7F8&BH17,USK6L?`[N2>,S(7:8Q6:*)I:P5R[46ND MU^+,7*@]5Z&%HJ45++0;EZGVRERHO5:AC:*M%0S:EQ?7^)0^'I!WYD+M?204 M]Y!7,GX-S?B5J/)\UU'4+5%EW4)/45\+#A0-M>!(T5@+3A1-M>!,T5P++A0M MM>!*T5H+;A1MM>!.T3XJ&`(FL MR=VR8#5=JZA/9`4'BH9$UF5&BL9$IC51-"4RK9FB.9%I+10MB4QKI6A-9%H; M15LBT]HIVA/E6G$`,<%SK^W`DTE8@?YAD6;X/`L%*T-XEZA,(5[4TOM)SSS8 MY_I$EGL8*!H2%=*-EDQW1^9!Z3&124\438F84VVF%^',/"@])S+IA:(E42%= MQXKT:*%`\C"^,G?6LR:R>C:*MB7BO*EYV4J/8627WAZM5.DN! M*J]5.Z57U#-*+TM&]NAEJ$]D!SM0-"2R@B-%8R+3FBB:$IG63-&HKVB@6D/U&BD:*YJHUE2]9HKFBA:JM52O ME:*UHHUJ;=5KIV@?H3B\26;P&%/-`")/$R[9^-V;O%LOO:)+MB@8W04DR])C MP6*$K&R=-N-,1VLLHFB*=&;EA55(9Y65QQWLEF=C0 M9&*)JF_U2A3ULJ)@Y?;1HY>-HWTB._J!HB&1O9D:$9G6F,BT)HJF1*8U(S*M M.9%I+10MB4QK161::R+3VBC:$IG6CLBT]D2Y5A3`<#E7;PP<.7(>3P-+%*_* MD;?VI1>Z#(?^+A$F_4#!RQ*F'/NTF/%`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`R]KL@<-C7+ M5*++:N:P?I,\BW3HA?+'!\.;*WOG'+>BFFH(^[65E6NFH5F@Z."J*)+%-O9V M5\/D).RRC;Q\GCHO:L@]XOM;B9+#2\:,#KWBP[/QL&A'L0E^L?/WX_W3Y_O. M_=>OSR=WAS^_H2D-K*C^\.[(B^WW,3YDH4_A2DLL&":RT+74@M$B"]U)+1@2 MLM"KU()M_G^K.[R-[?_S3IK4WJYGV#U9==J-#!ON*O^MF?V&DZ2&=A,MU=&$)8Z^V&O?>+`S!:L$M.`LC ML5IP)\["Z*L63*<1'Z_5F%4C/IX%DVO$Q[-@!HWX>!9,I!$?SX+Y-.+C6=JP MM%U+!Y:.:^G"$N:D>J1X)L%Y\RQX-,%Y\RQX0L%Y\RS(I*`?>)<4YX6$74?`L>'3%&?4L>!!%[_4L>*Q$"SP+LE2(@M+C69"90@L\"Q)4N'X\"_)464AE:#U(\>%<>Q;D]G!V/`M2?.BCG@69OBRD M9/?0>ST+TGHXUYX%:?DL)&Y5#:GX+.1OU8(" ME&S6=2T]6'JN!0E8]#?O>)"'18_W+$C'9B&=IL>#MR592)>K!2]-LI`U5PO> MG60A>:X6O"_)0@Y=+7A1DH54NEKPOB0+&76UX.U3%EX>J`5OG++P#D$M>-64 MA5<):L$;IRR\45`+7CQEX<6"6O"R*0OO%]32AJ7M6CJP=%Q+%Y:N:\'KNBR\ M7]%Z^K"$URQJP>NZ++QM40M6(N",>O<%+$A`O_8L6'2`?NU9\!(9+B]G@7+/=!JSX(E7CC7WKT$*[UPKCT+EG/A2#U+&_6TW7HZL(0% M'!IMK.Y!W_$L6,*#R'D6K.1!W_$L6-"#*\NS8-4.HNU9L#0/\?&.!ROT$!_/ M@G5XB(]GP7(\Q,>S8%4>XN-9L/8.\?$L6%^+^'AW32RS17P\"Y;2(CZ>I8UZ MVFX]'5@ZKJ4+2\^U8/TDXN.U&LLH$1_/@M64B(]GP9I)Q,>S8&TTXN,=#Y9( M(SZ>!S8.$SXN-9\)T#[L'>LP>^;4!\/`L^:4!\ M/$L;];3=>CJPA*7,WO530WP\"Y:P(SZ>!2O9$1_/@@7MB(]GP:)UQ,>SX`,4 MG&OO>/`="LZU9\'G*+@'>Q9\@H(H>!9\>8(H>!9\@(*KQ+/@HQ[<@ST+/N3! MD7H6?+^#(_4L^(P'/=&SX&L>W(,]"[[@01_U+&U8VJZE`TOX0,6)-BSA.Q6U M]&#IN19\_H1^X)49P!*^75$U?-R=A0^"U8)OO+/P7;!:\*EW%KX%5@N^Y\83 MO6=IUUNP>*,ROA?,PJ=_JH9/_;+PU9Y:\)5>%CZX4PL^L,/Q>!9\&X<6>!9\ MEH]ZO%;CZ_PL?+.M]>`C_2Q\IZT6?(F/MGD6?)"?A:^VM0R^R\_"E]IJP>8: M.!XO&8(]-A`?SX*M-A`?SX+]-'`./$L;+6B[+>C`TG$M75C"-_3::NRA@)AZ M%FRED(4OZK4,=E3(PE?T:L&V*(B/UVKLCH+X>!9LDH+X>!;LA(+X>!9LB(+X M>!;LBX+X>!;L/8/SYEDZL'1<2Q>6L+>('BGVEL%Y\RS88@;GS;-@IQF<-\^" M+;'0#[RK'GMAH1]X%FQSA!9X3V#8M`A1\"S8@@AGU+-@0R'T7L^"[8'0`L^" MW<80!:]MV'0L"]M.Z7G#1F.(CV?!%F-H@6?!3F.X?CP+-AS+PI946@\V;L.Y M]BS8HPUGQ[-@JS;T4<^"'=NRL"67UH-=VM![/0NV9\.Y]BS8;#$+^_&I&C98 MS,*V?&K!UHK(S'J6-NIIN_5T8.FXEBXL7=?2@Z7G6K"M'OJ;=SS870\]WK-@ MD[TL;(NFQX,],+.P"Z):L!5F%C9#5`MVQ,S"GHAJP2Z86=@:42W8_C(+.R2J M!;M@9F&C1+5@@]$L[`FI%FPJFH6M(=6"_4.SL$.D6K"-:!8VBE0+=A/-PGZ1 M:L$.HEG8-E(M;5C:K@7;LF8=U]*%I>M:>K"$;3.U'FS%FH7=,]6"'5FSL(FF M6K##-,ZH=U_`1M/HUYX%FTFC7WL6[!.,%GCS$.SZBW/M6;"'+WJ59\&.O.@' MG@7[ZZ(%G@7[?"-R7MNPW3?BXUFPIS=:X%FPM3?ZM6?!#M_HO9X%VWBCU9X% MN_7C7'OW$FS:CW/M6;`S/X[4L[113]NM!SNTHU=Y+@[G@6[L2-RG@6; MLJ/O>!;LS8XKR[-@`W9$V[/@1Q80'^]X\%L+B(]GP2\J(#Z>!3^L@/AX%OR^ M`N+C6?`S"HB/9\$OI2`^WET3/YB"^'@6_"@*XN-9VJBG[=:#'\=`?+P6X#IG.'-+W']W@D\7@;-83?H=$: M\-M$B(QGP4\4(3*>!3]#A,AX%OP:$2+C6?"C1(B,9\$/#R$RGF6.AS+O:!9( MT'M\B?2\QU=(SGM\C4<[CV^0F/?X$&EYCX^0E/?X&(^;'I\@(>_Q*=+Q'I\A M&>_Q-E+Q'N\@$>_Q+M+P'N\A">_Q/AZD/3Y``M[C;:32O1&PBYNTE]\>8C+B M\2DF71Y?8I+D\2TFG3D_/R;JGS^\^W[[^7YV^_3YX=OSR=?[3UC+<)'_$N33 MP^>PQJ+XQ\OA>_Y#Y[\?7EX.C_F?7^YO/][C)QPNSK"Z[-/A\,)_X.(Y_W%X M^B/_I?0/_R\`````__\#`%!+`P04``8`"````"$`3>?F=)46``#R:```&0`` M`'AL+W=OG^^N+@Z/]L_W1T^WS]]?7_^KW^ZOUV?G[V\WCY] MOGTX/.W?G_][_W+^]P__^1_O?AZ>?WOYMM^_GL'"T\O[\V^OK]^KR\N7NV_[ MQ]N7B\/W_1,D7P[/C[>O^/7YZ^7+]^?][>>IT>/#Y?+J:GOY>'O_=!XM5,]_ MQL;ARY?[NWU[N/OQN']ZC4:>]P^WK_#_Y=O]]Q=:>[S[,^8>;Y]_^_'];W>' MQ^\P\>G^X?[UWY/1\[/'NVKX^G1XOOWT@+C_6*QO[VA[^D69?[R_>SZ\'+Z\ M7L#<9714QWQS>7,)2Q_>?;Y'!*';SY[W7]Z??UQ4X^[F_/+#NZF#_O=^__-E M]O]G+]\./_OG^\__=?^T1V]CG,((?#H`T/A2M7;3"/S/\]GG_9?; M'P^O_SC\]/O[K]]>,=R;T.3N\(`CX=^SQ_LP!Q#Z[1_3SY_WGU^_O3]?;L_/ M/NU?7MU]:'-^=O?CY?7P^']1N$@F8N-E:HR?J?%J>['97:T6R\V?-K).1O"3 M'KQY4%B>/,;/I']]L5A?;<,AW_`5,WMJAI]_ZC`W21\_DS[Z1=N_C/TYC4-[ M^WK[X=WSX><9)C=Z[N7[;4B51;7`^*412":.8X*I<1?4/P;]]^?P#KW^`OK[ MA\UR^>[R=PSR7=*IMA*X$K0E\"78"C!.`-9Q*N_&''0?W^.?]\8 M]JBSP$P\*FV+<3^J'+M!D4X1ITBOB%=D4&2$:_(H,@X)UEWX`PU[PZF?L!3U/2V3@1I=;H?FJ,2 MF[6*=(HX17I%O"*#(N.<9$'B-&D%&7`>9"+(I%F0JV)B'Y6.02K2*>(4Z17Q MB@R*C'.2!;FS@PPX#S*2A9S2&D5:13I%G"*](EZ109%Q3K*(0N4WNUYQ;@:< M1Q3)8G4\23>*M(ITBCA%>D6\(H,BXYQD$>%\.8\H78$O=IBYK]_N[WZK#YAW MB^,%.*CGD28R&SM%VDA6J^F*O;Q:%/.W.\HY?YTBO;+JCSJA#H#5XJ(W'.6T M.LY)U@NA]IAW`P=VXGF\":UP_IIEY+K(2&I)M[1$H6=9O2QWQ36JH]8N]M5V M<;'+33MJ3(7Q5+_T1'(T3_3FT09JQ:,M=E<7Q=",U)B.EO=9J&>,9%C$.@?7 M)_9[G1#ZC*@A$I?;A*Y%JR.*17FHU1S1]FBKU[8\M<360"2V1J+)5AY<*%VL MX&))DP47T3J_'F_R46L624O.""U1R"Y,X,6N[/Q.--AOCDCL]!IYHFAZ<5W, MH4'D-#P238;SO@B5B]47L:+)^B(B]`7M-C@'AE/&6AQNB>)]4AC53B-')`U[ MC3R1V!HT&HF,X$(=8@47ZY,LN(B*S"\2N%DDK?G$3F@[#?3B9GE1-.K82":U M(Q([O4:>*)F^7I5S:!`-#LE(-)G.ASH4+%9O!%Z*>=A`Q[8Y$QJ0/!8[5$['PR29]1%E&)R3^MHN$)`L[ MC1R1-.PU\D1B:]!H)#*""[6.%5RL@;+@(BHR^KH\=2WV3 MM^A$S,%P1&*DU\@3Q71>;G4V'P],RR/;&!,^U#M63\0Z*.N)5!K)];()]XXA M=<7CED@RL-/($4G#7B-/)+8&C48B'1R\-X.;>'ZJ2JC(YF+0&FK)[&R)8LYM MEA=%F=>)`H?#$8F97B-/E"[0-Q>KF^R_?$(-HL[CC$0Z`98G"K.)%ST3:[5Y M=B>M^?6:2#*RT\@1S0-/Y@5Y:HFM0:.1R`CN1&&VU(590GEVKZ[RKFVH);.U M)8I9N-ZJR[4H<#@ MMT22DYU&CD@:]AIY(K$U:#02&<&%HLDX>2UC,87ISQZJ$\KS>U5<(1MJR61L MB5(6;BZ*JKT3!1[,$8F97B-/E"SKLDP4:'DD,B9]J**LOHC55=87$649G9!X MW(;'`*$HERSL-')$TK#7R!.)K4&CD<@([D19%AZQ%#5G0D5&%_?]#;5D?K9$ MJ4Q>EWG7B0*'PQ&)F5XC3Q0MWY0S:!`Y#8]$QIP/990USK&\RL8YHBRA$Q*' MVV5"DH2=1HY(&O8:>2*Q-6@T$AG!A=+%"BZ6-%EP$14)72Q--,ND)=.S)8II MAZOJ5?9?4N;'EJ2<-!HY%(![HT\431\_8O9-8@ZCS,2Z>Q8G2C:)EYT3*RJYJF?M.:U M.I&D:Z>1(YH'GLP+\M026X-&(Y$1W(FB;:6+MH2*U"^NRPVU9+*V1#$EKZ_U ML,>#S:YYCFW$3*^1)TJ6U^4]_2`*,M#I8$8&%$7;KU;7@83FJ<]D432 M$BV/A5*GD2.2&[^>2&QY(K$U:#023;:R=:60Q-:Y?^+%[$Z+9?AQ7"9?7*NT M3UHR2=MD:X72YMA0KZ\GK6U\%K&XNEI<%(6BHZ'9`CN1',X3O7FX@5IQ@7VW M4PM"(S7T`GN(9-YIOYPIL:B;7T@G$[B'E]%MB"24-J&UK(QW"6VEH:/6[CB? M>FW+4TML#41R]AB))EOY3"FJ017T/P_?YP^DL+*HTB,B+!TP'9ND-4.M1IU& M3J->(Z_1H-&8H3SH4*89I=$JEF_9B$:$Z[O,\LVJ6$]N4L-Y%:!1IY'3J-?( M:S1H-&8HC_=$*8CKEQK,B+#()8.I4)L:SK0ZC9Q&O49>HT&C,4-Y<*%JL@8S M5E/98$:$IQ,2G$+M2J%.(Z=1KY'7:-!HS%`67+@NSX-3Z5D\+Y[T\Q,\T6Q$ M-6H3PB4E/=TMJO].%-AW3J->6_:B=>*YL2C0\IBAO$-.U&TH,\JIG%`XX1\O M4)M5<:_04$NZIR5Z\U+340LGB*/YU:KH-D#%[8F$UOZ(E+60DQZM-:/XHF4@N3(Y(+DR]MN6I M)9?"@4ALC423K7R&%`4?WRT(I_!B?2.A,-N.0[A9%?W84$O.&BU1+%$W5Q?% MXG8G"NPC1R1F>HT\4;*\+2T/HD#+(]%D.>^+4+89Y\9U+.?FY\:$T!>TVQ") MQRV1W(]V&CDB:=AKY(G$UJ#12&0$5]1KQX'6=1E*K3#VV:E@O2V7IJDUG]BI M8;P%W6S*X>C81N:T(Q(SO4:>*%I>K2Z6\UR^*4Y3@ZAS>$:BZ3CYL!=%W;%G M=/&VCBC+[X3$_Y9:$F6GD2.2AKU&GDAL#1J-1$9P)XJWM2[>$BKRN\C5AEHR M6UNBF(7%6'0BY5@X(K'1:^2)HME%87<0,>V.1,;L/U'3K75-EU"6VE$+9PX> MJJ66I&.GD2.2AKU&GDAL#1J-1$9PH02SSENQ-,O.6Q%EJ;U9J]1.6C(UVW5" M,0&WRW*9H1,%]I$C$C.]1IXH6@[O&66I7>7[H3 MFJBN-OHXBZA(K7+=2MJR6QMB6(. M+G'>S1]0=J+`X7!$8J;7R!,ERU@-SRT/HD#+(Y%.@4U1H_VJ\I_TBPF0%L5F ME_2D-<][(EEKZC1R1%*5]432*YY(;`T:C423K>S"M3E1NTV\""Z6ZW6K MU'!>JQ+ARGXL^O2Z%;72FYHW-^7IP5%C5MD3299XHC>/-E`K'FV]6I1S9Z2& M+N8W18WWRXFB:[_)1+YL122AM`FA[.#T[8@DX1W1;-E*V_+4$EL#D=@:B?2R MU2;49;,+A`JZ6+::](L)%$N[\+C_.`\VZV)QLF%#F=&M1IU&3J->(Z_1H-&8 MH3QA3E1Z&UWI)31;LVDT:C7J-'(:]1IYC0:-Q@SEP9VH]#:ZTDMHOK*C4:M1 MIY'3J-?(:S1H-&8H#ZZHW]0,+E9V-KJN(Y(<;31J$SJ]LB,*S&NG4:\M>]$Z ML;(C"K0\9BCOD%"/S5+Z6-G$.FU>\VU2Z88SV2QURYJ/6M(]+=&;9^..6NG< MO]Z5;QDX:LS/_#$\]-=0O-JD$A< M;A.:+^00R:G:$V/+6D9!B(Q-9(--G*)L3V1#4X\2*X6"#FU>"ZJ.R: MU'!>_!"E.[+E3I6#HL$Y[(BD\.DU\D31-`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`4!7D&U)#M(IF<:A;,X,6$'/K/-;E?5IK\-)(TI:2$),T9[T$$2 M)HZ6(*6J,'^T!)E5A6FD)4BP*LPF+4%256%2:0F2"9%:DAI]4)M]T$#2F!)< M7A"/U6^XB"`>2X)K">*Q)+BDP&M+@E(07IO3;+>"U]:\0=D#KRT)JA]X;4E0 MX\!K2X)2!UY;$E0\\-J2H*Z!UY:D1CRU&4\#26-*4)S#:ZL/4(+#:TN"2AQ> M6Q(4Y/#:DN!>&HEESI#M#;R>%HF*_&D@:4P);A_AM=4&MXGPVI+@;A%>6Q+< M-,)K2X*[0O2U):D13VW&TT#2F!*L;E3AKE[G#]8PJG!SKR58RJC"/;Z68$6C M"O?U6C)N,4.P7J*IS7BP,@ROK4A;2,*2J.X#K`+#:TN"Q6!X;4FP)@RO3'QE/8:S^L0CR7!`)MVZ#Y[)5>,ZJ)7BNBC:6 MI-Z$(L2L0N!!;7K00-*8DA:2\%*']J"#)+S;H25XZP5>6Y(>DMZ4X&TV>&WU M=;W![(TW-^69')+&E.`%+OAFS2J\I@7?+`G>UH)OE@0O;6%,+0E>S8+7EJ1& M/+493P-)8TKPMB&\MOH`[Q3":TN"5POAM27!&X;PVI+@I6"4K]9\J]>X_N"- M2SVF>`&V:DP)WH.MPDN@N@U>>*W"NZ!:@O=>J_!*J);@]=VY)%%;Y6T,?!EQIH M8TGP408BM23U&AF,E]VU-7R`@$@M";Y#0*26!%\;(%)+@H\.$*DEP;<'\-J2 MX`L#>&U):L13F_'@PQIX;46*[VNJ\,6(CA3?U"`>2X+O:!"/)<'G-(C'DN"3 MT2I\'ZF/@\]$J_"9I);@\U#H6S MVHP'NQG`:RM2;&H`KRT)]BZ`UY8$6QC`:TN"G0S@M27!YB18M[#6`NKE=55C M8P<=#S;BJ!I3@OTXJK#7A&Z#?3:JL.6$EF"[C:HW)=AUHPJ[3>@VV$T#7EN2 M&O'49CS8)@9>6Y%BMQAX;4FP)PR\MB38&@9>6Q+L$`.O+0EV=H+7Y@Q9(ANQ M8XZ.%+L8P6M+@LV,X+4EP99%\-J28.&U)L($1O+8DV*8(7EN2&O'49CS8 M9`M>6Y%BKRUX;4FPHQ:\MB386`M>6Q+LKP6O+0EVR<,ZG3U#D(W8;\SJ:V2C M*<'&_?I>+!K M817VZ],2[$Y8A6W[M`2;%%9A]SXMP5Z%5=BQ3TNPORCZVIPA"V0C=F[4;;"7 M)KRV)-A2$UY;$FR<":\M"?;/A->6!-MHPFM+@NTRX;4EJ1%/;<:#S5[AM15I M"TG8Z51'BHU=X;4EP?ZN\-J28)M7>&U)L(,S)-8,P<[-B,>2U`OD:7PSN:@< ML$LQXK'R!YL5(QY+@AV)$8\EP<;$B,>28']B>&U)L`TQO+8D=5B@-?JSQ>V* M-0L];O(L7J-?PH;4>F0:2,*^U%J"O;NKL#VUEF"_;O2+)<$^W>@72X+MNM$O ME@2[=E=AZVH45Q-.[0_Q[]9$W]Y MC1MCG'TZO.)/T4Q_6^4;_K;0'MLK7UW@T>F7P^&5OX0#'/]:T8?_%P```/__ M`P!02P,$%``&``@````A`!)B[42*&```%7,``!D```!X;"]W;W)K&ULE)W=?@Y(9"6`D[(]-Y;\92(!)$``"8+0+W__Y^/7LS_OGU\> MCD_OSV<75^=G]T]WQX\/3Y_?G__O/XJ_W9R?O;S>/GV\_7I\NG]__J_[E_._ M?_CO__KEK^/S[R]?[N]?SV#AZ>7]^9?7UV_9Y>7+W9?[Q]N7B^.W^R=(/AV? M'V]?\=_GSY3A>SY9VP/W7 M:/3\[/$NVW]^.C[?_O85]?[G;'E[)[;'_Y#YQX>[Y^/+\=/K!@M_/7KX<_RJ? M'SZV#T_W\#;:R;7`;\?C[TYU_]$A)+ZDU,78`L/SV'_]_4IIY4Y.1A3>"G][(^F*VO%H[$]])MO3)H.63 MS5>:]W<2KGW":TUX8VWQ\S\IZ#N?##^EH,N?J>`,[3;F MYW[Q*9<7-ZO5E/%E=::\W+JPV/?SV]?;S_\\GS\ZPP#"ESU\NW6#4^S MS%GSO=[WP=-S@,?QSJG_ZO3?GZ,SH(>_@/[Y8;6\^>7R3SQ8=UYGPSJS6&,K M&N[A^%4T)$F>@ET*BA24*:A2L$]!G8(F!6T*#BGH4M"G8`A`Y%<\ M>>37Q=6IQSHQANBHQ[Z+_;:9=&88K$[=>AVK;$\J)]\2V1$IB)1$*B)[(C61 MADA+Y$"D(](3&4(2.1H#%CG:#5[3M,-CA=/'-(F!_.15'BPFI>^Z_J1RE@\L_$$8]#;/M^> ME"193F1'I"!2$JF([(G41!HB+9$#D8Y(3V0(2>103'6A0\=YSRVEWN[-+D7L M:T_PO*BO5U?)N'%2.OF:R(Y(0:0D4A'9$ZF)-$1:(@R!"2R-=8=PV'KG&D>)L/0N;PZ.H/5:K)/;8J9;8*AB5;+Y2+:W=;*&U&R.9O6J) M^9I1P^9;U5+S"'N3=E$M,=\QZMG\X%'2-M?)HMIJV4%R4M_4L:K,IY2*<1)?7JU.Q1J?N?$)H2:T+ M1B6;KSRZUHZS9U0S:MA6ZU%4U-4J*>I!M:2H':.>S0\>S3&-!@^/QM9Q`[E@ M*&@@F17<1D;:$!-RVPV!W624VDK"ZY.';0T>P3EHK=C#+@RR/#R%1XAJI'TW;N\'3E]&@T)H;&G_K7NT7/MK27)!JK7S"%62A(5H:<*2425(;>T%37O*;FRM M!:E6(TC-MX)4Z^!14*Y.M#1ASV@0-!8B=J<+NRQW.IY,[1-:P(4Z.JV3A<[6 M[3(@X4(C@US0>GHJ%HL+GT:#H,FT^BAN,!>[60WF8SKM+ANW M2>R:0F?4K2`M2"Y(?;]C5`C2A"6C2I#:VC.J!6FY&D%JOA6DM@Z,.D&:L&YTP9SESBG(BX:3"25S1[+JV\Z\ECZ0N:!I8%NO+Y)G9J<*TF,*06JF M9%0)BB>`9/C=JY:8KP5%0SMW?ZI+*PFGNJSFW/M]&AWO.DFC=>D9#8+\\(_W M=*>59=QB+H"T6FP*+*,6FU`T`7BD942U( MG]5&D)IO!:FM`Z-.D";L&0V"1ENQ.UT@:+G3!XA:QHW;^9W&DV`"6&@SC8/M M5K3TB/Q/EF5[U=('P*B+,?Y[+2U$ MJ[;<*F5.<]E!%22S3I":Z1D-@B8OW5QH+:(&0P>/&NQ'`=^H'\_D'H43@R`M M8N[1\MUI4MXQ*CQ:C:_[Q]8LV5;%"?>,:H^N-<>&;;6<\,"H\R@H5\^V!D$\ M,"<+B(GX0W(NLY1]8>!>VQ991[-%MI!]P9K/#LG2Y@2K962/^ZT+0JVAQ?'$PQ-* MUIS)GL)V[K5T#9`+\L_0XCK=B-BIACR>A2"U4S*J!(6+SL4BB8+VJB7F:T%J MOF'4"GJSY`?5$-.=(#7=,QH$&9W>!7I!D_QP4IT"0TP?4H2-VZY%ZX6+34%: MJER03I<[1H6@<(#QYM56)5IJ:\^H%J2V&D%JJQ6DM@Z,.D%JJQ>DM@9!AIO? M"%[=3FK:\T_!:S"V7*<[=3YAN-L@"/XZ#4J\4^>UUHMI-GYW0U%9(89T,B@% MZ2JI$O3=[/:BA>#H5"B:H&O1BFQ15"9:6HA64)20=NJ\EJ_S_&;Q+MV(Z<20 MUKD7I-D-@HQ5DXO^_I/G:(H6H^=H0L'+6H M;2:UJ&WX`(5/B!]2NX)1Z5%@OE(MK1T?H%`M,5\S:MA\JUIJG@]0J):8[QCU M;'[P*&D;W0Z)'Z,DWOW1TM\=*DC6JAY%!R@\"YR:>^1^G+H,'Z!0+:EUP:CT M*#!?>10>H&!4,VK85NN1^W$J*A^@4"TI:L>H]R@HZN"16T<&YG7C(&Z@-\)E MK!"I(284;TBLTG!9$NKJ*_3X6E"R89$&I:-!N/7[(+"+4H.R[R6'J"XND@FJD(,Z=*@9%0) M^FYV>]$*MS)6U^D!"M&*;%%8)EI:KE90E)#",J\E!RA6-W1HI!-#:KMG-`B2 MG1/[_=GBC1A\Y$EC3S%XN*7AM8*'.1>D>R$[CX*#"H5H:15*1I4@M;47I+NC MM2#5:@2I^5:0:AT\"LK5B98F[!D-@GA+8Y%$O!(CC#QQYRFR#48].D#A$X9; M&H*F-T/8:Z,W!ZHA(W$A2`.\DE$E*!J)KY,7U'O5$O.U((RXIR&P8%8(T8 M`)9OA.$C3]PY1>9N(78:,U=T@,(GQ",G3L\%30/;'Q7[2T$*T@/_[?!-UT?$U]4`7)K!.D9GI&@Z#)\DTP MK\3]/PG&?Q3P+:=0.]Q/\2B<&`1I$7./P@,4C`J/@H,*)=NJ..&>4>U1>("" M;;6<\,"H\R@H5\^V!D$\,6``MX<9CI]'U2A9K06&@;#P&4[F@+`E;GU`.4+Q;A\<<_(-`M>DD M.QW2>H\"VX,@/Q.$EN,GP87+QO[VTO%DZ)I0D,O6:P4H]R@Z0&&PPK/@C$+) MUBI)&1Z@,%A]8NJ5ALVUHA8>H#!8YUE0N)ZM#8*,">&-:!KOJLBK$XKW*]:Z M#S+V@ZTDU%Z=>Q0,0#M&!:.2;56LM6=4,VK85LM:!T8=HYYM#1X9^Q7+-T+8 MD2?]]A3"!E-N^N'?UB>,NK)/Z)\AXP"%)-)>5PC2Y[QD5`D*%YU\@$*U9,RH M!:GYAE$KZ,V2'U1#3'>"U'3/:!!D=/HD#/[AI#K%PM&D.B&LM*14VZ5'6JI< MD&YI[Q@5@C1"*@6IK4J0VMHSJ@6IK4:0VFH%J:T#HTZ0VNH%J:U!D.'F-X+7 M)0>O'L6+33I`(5KALL5'O1B;3JM4WJGS"4\'*/#93Q(V%6);#Q.4@C2[2M!W ML]N+%CK$J5`T0=>B%=FBJ$RTM!"MH"@A[=1Y+:GS[(IV)SLQI'7N!6EV@R!C MU>0BQF!*_N%S-$68T7,TH6!NV&().FYD:!%RCS#(RM.V\R@XJ%"(EDX])=NJ M1$MM[07IYD,M2+4:MM6RUL&CH%R=:&FY>K8U"&(WKY(8F-R<'*`8]>.9Q2.< MVA8';AGEC':,"D8EHXK1GE'-J&'4,CHPZACUC(8(10M,K+JCWBQ[;2-/W#G% MQNY<:O"`ZQGX:2DD"764S1GM&!6,2D85HSVCFE'#J&5T8-0QZAD-$8H];`6S MW[\=!1%=N@X5%#M?-U"]\WW"T/F$=FI+GHN"4_B-"!6G(Z@/>Q3WX?3=KR0,^_`IH3A]QUH%HY)1Q6C/J&;4 M,&H9'1AUC'I&0X1B#V/)8_9AQY,A>D+!@;8MKHQP6@'*&>TB%.?^1B2WFJ*O MZ`F:4'@DS&L%*&>TBU"*T.+ELZYU\(-J>,G M9%?X("X9"'9B:%RPQ65^(P)8<03@4;@09)1[--W7.@[T.]$R6I^ZXLZ6-XD+R5SU=+G=C+O/O<])0QWXR)/8EO) M;/V1QSW?HZ3UDWAG*UIX)C3W-(C(O9:] M.$TT?[Y\_ MWV_OOWY].;L[_O$$G^%S>CP3)S[=)KQ9+3,W@"%U*H'`Y"LDL/37N)?8XO.; MS!T#-G)87<'4N".1YKW")<=8EW$:=-_,=4Z6;-97V09N9`GZ3K8U)>@OF6L- M3K.#Q#4*2W#_\J_C!)>6&46V]#=S5-^PLUEDN&+2L+_,?C4S1OB;N=B,DR`* MSER(QA($PVA%2[)9K3(W=W":S>HZVV"48LD6DJTIP;"+9K'28+1%/I9DLX)G ML/[C?#8K^`;K%I9@0R-S$3%+L(F1N<"8)=BXR%Q\S)(&$A.>+LED2O/I% MV2S)!J7>F*7&*T:TG%V?!5K.DN!M(FIJ24I(W#LL;FV\6T3+61*\/(1W+`G. M''S)VX8PG.0&;NX!U+@>).S[,$AS\ M1JDM"`;"T@L:_@*-W.?B+(/\#%NYKX490F^R<4:WI)LYIA+\%$>I]F@U!NS!%M( MMJ8$'X6A%:R:YJBI^[J(\\&'+Y!8-<5G86@Y2X+OJC/W82Y;P[?4F?L^ER7X M?CISG^FRI('$?:W+$GPZG;F/=EER@,1]N\N2#20;4[*%Q'VMS&ER2-Q'RRS9 M0>*^768)OD#/W"?,+,&'Z)G[DIDEN&0!/K#65;AK`3ZP)+AR`36U)+A7`3W1 MDN!Z!?1$2X);%M#?+,D&$G=-`I<:-UC`;Y8$%UG`.Y8$MU7`.Y8$EU;`.Y8$ M=U>@[UB29HYG&R^?N&RXZ@;>L22XS@;>L22XU0;>L22XW`;>L23Y'$\)+@WA M$N"*$[2I)<&%)2B!)<&=4Y!8\S:NGD+9+`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```#__P,`4$L#!!0` M!@`(````(0`&PO=V]R:W-H965T^TX2F*T;06VT^EY M^_UY*%%D,>G.S7CR5;'$*A:I(L6^^?W'\3#ZWIXO^^YT.PXFL_&H/>VZQ_WI M^7;\UY_%;^OQZ'+=GAZWA^[4WH[_;B_CW^_^^8^;]^[\[?+2MM<1+)PNM^.7 MZ_4UGDXONY?VN+U,NM?V!,E3=SYNK_CS_#R]O)[;[:-L=#Q,P]EL.3UN]Z>Q MLA"??\5&]_2TW[59MWL[MJ>K,G)N#]LK^G]YV;]>R-IQ]ROFCMOSM[?7WW;= M\14F'O:'_?5O:70\.N[B^OG4G;[6E>R_/ M^\=_[4\MHHUQ$B/PT'7?A&K]*!`:3UGK0H[`?\ZCQ_9I^W:X_M&]5^W^^>6* MX5Z()KON@"?AOZ/C7N0`7-_^D+_O^\?KR^TXG$_FX6*U#L+%>/307J[%7C0> MCW9OEVMW_)_2"K0M92745O"KK43+R6(UBZ213QI&NB%^Z?'A9!7,-M$*3_^D MX5PWQ*]N.)^L%XOY+8+$4#G_RR*5NN3(M?ZVOF%3R MD?C]6E\WNB%^O]C7`!FCQE6DCA[83WL[58DA$RK;7K=W-^?N?819BI&_O&[% MG`]B85:GDHY4GUS(\9U0OQ?ZMV/XBJRY@'Z_6ZSG-]/OR-:=UDFX3F!KI*0A M,E:8S5R0NZ!P0>F"R@6U"YH!F,+_/@A(["\%0>B+(%#W$P(F*J'C,6E0D\P% MN0L*%Y0NJ%Q0NZ`9`,MCS,@O>2ST;\?X[V#8%[:+B=()D,Z]TM)627N5/@R, MY(P4C)2,5(S4C#1#8D4#R\R7HB'TL91BNO2>\EF@E#X-1Z_2AX.1G)&"D9*1 MBI&:D69(K'!@H1R&@Z:^P-)KZFVB":;5QW%(>R5JEC&2,U(P4C)2,5(ST@R) MY236>Y^3`MM.:H+D&3CI)G:OU#O)2,Y(P4C)2,5(S4@S)):3>)GYG!38=E*1 MP"QI*2,9(SDC!2,E(Q4C-2/-D%@>B1)V\+ZBW!38]DB1(.H7Z921C)&#CW2;^")*'2N+_O=MZ1#W@7]"UBHVYYJ,A@[1C)%HDB^ ML<-9$-D+<][+*7\+1DIFM>IU1!T`J\Y+K^[E9+49$BL*HO88AH$&5G+;7XTB MK%_]C(PV&]NCE+1,6#)"(K)4O80K9RKGI+52U4T031S3!6EL^MPJ"9FG580^ M?5I-6OIIX6SBU$H-:*>:(28$4H)F2YG&JV-5DY( M[2Y$K580DAL<6;Z5W%9%6L963;#]_%\-G,3 M0FN9%2$+-!*SZ_O=?+-QASHW&A2W@I"Q4W)4$5*F%[/9Q,FSVFB0Z8:0-&U' M0]0NOFBHFL:*AD*(!ME-L0J*16-NNIP14CL],:XY1P4AT[#DJ")D;-4<-80\ MSHE*Q.>`?W MBTH4.>MK;;1H4!I"TKP]V*)H\<5#<&*%9]SNH@Q:9L$"CGSVGG)I*1ENY.OMQH MT'@4A(R=DJ.*4+]DV*M,;>1DN"'D27Q1YOABHGC"X%&EJ_A1HO,-X1X]HW%>F6OFBEIF2S-"*FI'HI M:Z@5LF;V8KUVAUIKF73,0HW4S(XPLYU:.3<:-!X%(6.GY*@B]).9W7>`S#?4 MT)/\HI@:1.1G&W;QW<&IVC2R9KS2LF:\1F91SJFA004A\[(H"9G05(1,PYJC MAI"T9>?X!U5;R*LVC9P9[^RA4](RV9L1@MM])UTY`AOD$/13GVE511Y9LUJ12R5@R-C"^9?!`V M>&9GG6NT-'E1D-:J7YY+C09U145:QE;-;36D)6W9J2)*H,^<_K-['1YHA:ID MLIS6"*^3/A,6&W=#3PU-3F<#T-!![Z1X,[0*V07%AMWRZ`; M#EZJ&4=S@)>/.+^7L;$'WGG]I4;+#'S?D%#. MM0J.2HXJCFJ.&@O9@1#%UA?G@*K/K#F@$1P;O"*BQ(@XRCGJ."HY*CBJ.:H ML9`=B`_*2YQ8,G\ULN>`N\N@AF:ERSC*.2HX*CFJ.*HY$E?`]'1%T)6_ZDJ7 MNH%S;,_/;=H>#I?1KGL[(8W7XBM0C]5=LB2*<)E,)C"3S"&1]1V3+""1!1R3 M+.EJFBN!0&X271ZN8U'EP`4FV4`BJUY7$LWP%'D*P"3B:IP\=V"2$!(Y7HX$ ME7HLJE+>`U3GL2A.N01%.?KFD^!NWKWO*0DZYNT7NN75%\/B>?+]/+['P/,N M)1@M[V!AK+Q#!1<2KPO8/,6I5X(]5"PV`_SI.21B3\`EV"[%8FO`)24D8H?` M)3@-051\[B?A'+WV^9-"DGHE.`!`WWQML,M'WWP2;/;1-Y\$>WXDA4^"33UZ M[9/@F`J]]OF#HRGTVB?!"15Z[9/@&`J]]DEP&H5>^R0XE$*O?9(FP`3$T2L? MA22^I,7Y*7KMD^`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`WC^C^79'8_=_L.&/ M^]VYNW1/UPF&FVI'.>?-=#/%2`]WCWLP4*]]=&Z?[L=?HK291^/IPUW_@OZ[ M;]\NSO^/+B_=6WW>/_YC?VKQMC%/:@:^=MTWI?K'HX)@/&7653\#_SJ/'MNG M[??#]=_=6]/NGU^NF.Z%,MEU!SP)_QT=]RH&0'W[L_]]VS]>7^['23)9+Q;S MY7JU&(^^MI=KM5?&X]'N^^7:'?^GM7K?AU%B,PI^:93E9+&:)5'\^4$2,PA^ MS2#QS''EQN/GQA*_QC)*)JMHMDD4AQN&D/;LEX/A9Q^Y,I;XI4?BZ3<>AD7V#7&[J9ZG?GZ+[77[<'?NWD9(&DS$Y76K4C!*,9:96//D8:H1<3NE M_46IWX^AB#F\`/WQ$*T7=],?B)V=TA, MV&*S\?W/M$ZT<926ODH^J`P<&5(RI&)(S9#&13RBB/]?(:K4[\_UCN'/_[-21>3*"NUR&^BB@#GYI!$`P#M>5L%@3AH#108TC)D(HA M-4,:%_&H83W^-6K*P*=F$)]:%%`;E`9J#"D94C&D9DCC(AXU+.(AM27*W(UI M4Q8^-X/XW,+E<5`:N#&D9$C%D)HAC8MXW+"4A=QN1Z0R\*D9Q*>6!-,V*`W4 M&%(RI&)(S9#&13QJ$58XAQNM%CWL,R`(E<1)JGE`P6H-'#A4+-!39HIQSJ.!0R:&*0S6'&@_RO59U6?!:EVO/:PU% MR4`DCQA4<*CD4,6AFD.-!_E>(XPEKQ4>S MQ3Q-)L(*7I+$90KDBR(Y3$X2*,P3%:2QQ/I8&&BM]ZYJ[U$2M!P,*VY8DY8U M;`B:*T/?;55T!;=-+7;=UM#<;5N7L]7P-OKM41X9+1MZ!4$JL'\\+/B4,9.* M3.PH-4%N2YDD0H^7&F8$0 M@8,A>[$E#6\-*P[5!"W[J9Z%4]V0O!_%FQZU&Q*(]K"_[!L(1(?I(<@Z5Q!D M4Z4DR&I5'*H)LH8-08+7DFLL/];' MPD!N`2/()E?%#6O2<@H80;R`J6-6R6W=/'AN:RA(P;"`]>-A7;47-0"XK`]GT*6.F57&H)L@:-@0)7JN& M0/!:]PF>UQH*,HHM@T;+1E`1&\A-!?9B2]*RAA6':H+W2]J!G+3C2#+IB#(UJ:2(*>H$60-:X*L86,@J:@E>#7"A/9PX+;2 MQ!:4=F51O`KJ4VZLW(6>(%/4-FM6U$C#*6H$V?"N"4+N#NFVC((=7D-:6"<' MK7<72+7MEZCKGL.-Y5Y34Z<:GQO,XZHMW:)FM-8VN2IN6).64]0(XD4-.W?1 M;=Z&])HH5VY<+Z-@NEAG(>ET80W>G1I#5JCA4$^04-8)X44M4W>:K9@\'7NL* MKX8:`ICOU(RA%WO&\+VBQDTJ#M4$W2YJI,7+0Z)Z!(&H;AV\Z=$0B-J,,I#- M^J(?#YVC39^2(*M5<:@FR!HV!`E>JX9`\%KW"9[7&O(SBO7VZ.#[[;^-H((@ M-Q5X42,M:UAQJ";('6L9!2G:D-;GTDIU"O8-?%C4=&/AO1D->>EF(,NF0,3V M;\;6II(@&P@50=:P)L@:-@82BYIJ(2P=VJDENK/PW-:0+6K+)&BZ!FR?1F%1XVD]:FBID+3H?[13/;J_A)D M(&\'9S#']\)`DYX+4G0>L)K28*>$UY+$K2>\%J2H`.%UY($72>\EB09 M^&0B'VQOX+7$M("D$"4E)*4HJ2!1>P$^"]CKP&M)@N,$K`YBA,3(1FSS^&@Y M)+DHP4X;7DLVV%W#:TF"33:\EB38:\-K28+]-=ZU),G`)Q/YY)#DHJ2`I!`E M.+A)U9D'?P7X!@G52<@7((#4KQK,4)B9"-.L+A-#DDN2G!."*\E M&QP0PFM)@G-">"U)<%P(KR5)`XDZ7>.^X5`:7DM\`H&EY+ MD@H2=7#+/<#!-+R6)+C[@==RA"`;<2;/1\MC9*,HP;4(O)9L=W*:$1-UZ<@EN<%-U^CX5L!>"U)\(T`O)8D^%0`7DL2?#$`KR4) M/OF!UV*;%R$;\:T$]RV'1'VWP27X7`6^21)\CP+?)`D^2X$'4N.([SD@Z6VF M0RN$;^!?M\_M/[?GY_WI,CJT3^B=<:>!K<=9?RZO_[CJMGOTM;OBXW?5@8]> M\,\:6EQ8S]07DT]==Z4_0&0Z_$.)A_\#``#__P,`4$L#!!0`!@`(````(0#X MC%5:=A@```YU```9````>&PO=V]R:W-H965T_^_<_CUY._[I]?'@Y/[T][9Q>G)_=/=X>/#T^?WY_N MMNF_KD]/7EYOGS[>?CT\W;\__<_]R^F_/_SO_[S[^_#\Q\N7^_O7$UAX>GE_ M^N7U]5MR?OYR]^7^\?;E[/#M_@F23X?GQ]M7_//Y\_G+M^?[VX_'1(]?S_L7 M%Z/SQ]N'I]/60O+\,S8.GSX]W-U/#W=_/MX_O;9&GN^_WKZB_"]?'KZ]B+7' MNY\Q]WC[_,>?W_YU=WC\!A._/WQ]>/W/T>CIR>-=DGU^.CS?_OX5S_U/;WA[ M)[:/_R#SCP]WSX>7PZ?7,Y@[;PO*SWQS?G,.2Q_>?7S`$YAJ/WF^__3^]+=> MLA_>G)Y_>'>LH/W#_=\OWN\G+U\.?\^?'SX6#T_WJ&WXR7C@]\/A#Z.:?30( MB<\I=7KT0/-\\O'^T^V?7U_7A[\7]P^?O[S"W9'TP;P*/? M_O/^M(\<'CZ^?GE_.AB=75Y=#'K]R].3W^]?7M,'D_;TY.[/E]?#X_^U2CUK MJC4RL$;PTQKI]\_ZUY>]RY&Q\D;*H4V)G___[)'%\1GPTQKIH<+>R'5D$^"G M33`\N[Z\'(ZNK]XN[I5-B)^24_^L-[SXT6.B6QU+B)^_EN&-38B?DN'0N>>- M1S0U<,S2_/)K>?:D39A?)->?>LP>6E&;J6M./UFS/6E#YA>7Z;!_>75];(IO M/:NTHIYK1C^;K;0==`[)]N;LJG=Q,_A!4^A)(S*__&(%2S/J!>WHYYY5FE+/ MM:7!SQ58VE+/-::?[:9]:4WFEU][V+ZT)O/++SJV+^W)_&+3OOFPY^WH=AP5 MI[>OMQ_>/1_^/L&K!GF_?+LU+ZY>8HS9\=`.$MT(B8'ZSJC_9O3?GZ**,?:] M@/[UH7=S\>[\+PRY=U9GK.B$&A/1,,.N,3N-P2P&:0SF,5C$((M!'H-E#(H8 ME#&H8E#'H(G!*@;K&&QBL(W!+@9[#YS#EYU#X<-?#O0<" M[V&,_R7O&7W,3+SN..I=A>X:MSIF<.OZ["A4F70JG4N)S(BD1.9$%D0R(CF1 M)9&"2$FD(E(3:8BLB*R);(ALB>R(['T2>!EOXU_RLM''3!2OF,Z#/.JV2F^Z MN5/IW$QD1B0E,B>R()(1R8DLB11$2B(5D9I(0V1%9$UD0V1+9$=D[Y/`S9@Y M^6Z65ZC!1V^*%\:68$CO_#OJ74=]M%.29%,B,R(ID3F1!9&,2$YD2:0@4A*I MB-1$&B(K(FLB&R);(CLB>Y\$SL/DU7?><6+4OSR#?COAYJF121'ZU1(,]IY? M;R*_=DJ=7XG,B*1$YD061#(B.9$ED8)(2:0B4A-IB*R(K(ELB&R)[(CL?1+X M%2L+WZ_2*0T.G6=)X+Q^--6==$J=\XC,B*1$YD061#(B.9$ED8)(2:0B4A-I MB*R(K(ELB&R)[(CL?1(X#^L.S7D&A\YK"9:"XI<)D2F1&9&4R)S(@DA&)">R M)%(0*8E41&HB#9$5D361#9$MD1V1O4\"3V&VJ7G*X-!3+<'F1NY\$GC+[8)JKCCSTE45# MSUF,IA8-PI&S%[[V9DY+')\RFK/YA=/RWJK]06@^T9/.%TWK#?.FT MQ'S%J&;SC=/RS4=SO973$O-K1ALVOW5:SGSO>AA6SLYIB?E]@,+V878:O"TB M>6.:3="H+UL4M(]6RT-3JQ6UCVB38>:TI(PIHSGGN'!:K@I&_:@*,JQE:^S`\&C]:Y#6&B=D9AY:'IA9A)2NYSQBEC.9L:V%1U-8NP_Z0 M.2W),6>T9/.%TW+5.>I'&S"ETQ+S%:.:S3=.RS,_B.:@*Z,-FQ^Z[2< M^,IA8%C<'?5SEN'Z>L M-6=;"];*&.6,EFRK8*V24<6H9EN-16$C'40OS)73DBI<,]JP^:W3#:C/ MM[6*0HCYO4L(%+K9['EX;K;'!F?F:.CUR\/='^,#5KP]=VK0[I$$[F^1U_$G MYI0J;!%3BZZ&7:EFC%)&<[:U8*V,4R0D7YLM$L_7W?O?;IWX7;I%`]CRO1-SH@@W M#]SB;"H(DBYA_RIZJ.06QO!=TM!PV)+-WY36D M'\YAVKVN8`[3(C0PR6]BOCZ)6Y-%;F8U$RV'4HOP95AG;"YJKEH6@ES*C%$N MR'7%I2!GJQ#D;)6,*HO\@M6BYHPU@IRQ%:.U(%>PC2!G:RO(V=HQV@M2Q@BS MV>6YMINRM)M@@0M;%$Y9AM$2:V).5>-QWR+T^&XR,AI&D_:9)+SJG)H*^M[K MRHX1E.-"$K:S@>%9-(//G%Q:8R[(S0B6@MS+N!`4/DIDOG1:8KX2].:CU*+E MS'$C6B['K:`PQVB8W3DMR7$OZ'LY!F,*6I;:\(X\ M?#E9Y,\N!+EB3RWRIA(S1JD@UZOF;&LA6NXUFS'*!;EA:,FV"M%RMDI&E2!7 MKIIM-:+E;*T8K04Y6QNVM14M9VO':"^(1XZ^V:Y41HXCCQQH=S;]%R3/+FQ" M;YD[%61?D'$_GCFY-,)4D!LCYXP6@NS[<3`XBX:CS&F(Z5R0,[UD5`@*IA'# M:*NH=%IBOA+DUQ)/(T3+%:(1U#Y,_RJ>$JV<@F2V%N3,;!AM!=EJ&@ZB=56X M.;ASZI+/7M`QGW``B#9#?S2I,)]<1K-6B_Q)A2#W7%-![A4Y8Y0*8Q[MNMM&`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`"78_RC7S*6O-&*4676.(\7P0'1'-G99S09LC M$@K*6"MGM&14,"H958QJ1DV`PIK_Q>T9\TE.],JUJ#?"RL95UV5\8B`I7=U, MOY,R6BK/.&5JT7702^*O]N9.2]RQ8)0QRADM&16,2D85HYI1$Z#00V8+1,9U MQ%+SJEF#L%5^VM M::01E+'EW"6TEJ,3EZ53$#,%HY(M5T[+6H[:6.T4Q'(3H-`E9@WON416&>;, M+*[Z%O4N4`%>YXBJ;&)3&C7)?ZJPF67>)D`J:B.WOI\K;"%)W893)LBU@5Q) MN518(4F=M5*0LU8)T_:ZB>9$^L(MTKP8G"ILJ;&994*O6 MW,AM,LPEJ<<6G#1CE"LIEPHK.&G)J&)4,VH"%-:JOTCV:Y47R0.[2![YK\+A MB,;V5LU[^4Z[E)A%=@W_.CH?F5DM+V$J":^"`Y)XIV\N:A<7[6=G%V?15N." M;6>,@&#O5RC-X\EBT]--6M?S;/M MFCCPK%TFP[-B>#)H&>P+FEKDO^%GK)9:!*=)RCFCA2#WI=N=/)B67^,-2I^2/CZ#(Z M]YEQRE12HJ>;*>'H+.I1)FE>X6F&-L-9<6+'^4MQ[20]Y MR6U1^$X8748SH(FG)LZ>*FPF.;A!)[7(&\'FC!:,,K:5L]:24<&H9%L5:]6, MF@"%E6P6HEKK;1>H_L".MF<:="^8^XXNHZVXB57S6NJT2XG70/<&O8D2SCAA M*@FC3DQ#DRV9U]@6DO2[G?CX%67&F>:2,LPTGN,O/35I3(6PMS,M.=-*4B)3 M,_Q&`W;MB26S)K`2.O4[Z_$AK\LEHJ:YXBYPA;" MO$$D8W.YJ'GFE@HKA'GF2C97B9IGKE98$R0-*_8[ZV]\O4!CO5TP7[E:G%@U M;Q"96A3,+4>C:#=FQ@E32=A^V8&8H<'RZR+:*9H[=?'I@HUFC'*7T+3+B_B# MP:63B^&"K92,*I>P-1Q-Q&LG%\--8"5TC%EP>\/8CS8%A^T"/1C>6M0+'-:R MP&$M@L.D6#-KS--*+>IYUQ+G"EM8=NEF=1E;RY642X45;*UD:Y62LE98$U@+ M:_L[R^./&J*OIEGEJJ61P!;]T[Q:Z&3CO MU*Z/X^M-W(X75N'23>8S+E3>F7DSMV6GUN9V-8HW8PK.KN3LJL[.F]G5G5J; M72_^$K8)<@M=:=:VO])QVK5PT'%:9%PLCIH,6^8Y:FI1+_`GJ:6=FIM\S3OF M38`6,LFD2K&>1CR89HP1CM018<<(_6MFP\$39-`D6F_"/)L&:$_[1)%A2 MXGDT"3:]X!]MB,+>%_RC2;"UA3K0)-C-@G\T"3:UX!]-@CTKU)LFP4YR8G8T MN3=B\S@Q^YHLP1YR8K8R68(MXL1L:+)DC!*,U1)@GQ+^T![M!88S(CR/)AGC2D9CM;9;@6"(Q6]HL64!B=K99@K.&Q&QPLP1'#HG9TV8)SOJ01GM2'/DE MYBB)T^"4#]8T"<[ST*HT"8[UT*HT"4[W$G/(Q/G@]!S6M# MTR1CY#-6\YE`8@[ON`0XGH7G-`F.9.$Y38*3V<03X.L&Y*-)\)$#VH$FP;<.\+8F&0_ZJ%%M2H5/ MEE!J38)/DN`?;23'!S,HFY8&'[R@'6@2?+`":YH$5UP23X$M&U($FP0>-\)PFP7>->)[C_GXTJ<7' M=I!H:7`5*3&W2[ALN)&$Y]$DN(64F+LFG`8WCQ)SY80EN&V4F)LG+,&EH\1< M0&$);GLEYJX-2W"Q*S%7;EBRA,3_$ M$ES/2\RU)Y;,(3&WGUB"FWF)N03%$MS815UKSX.+NZA138*;N:A135)#4JL2 M7,I%>]/2X.HMVILFP65\^$?K"[B3#_]H$ERZAW\TR1CYC-5\)I!,5`DN7,,+ M6MEPKQI>T"2X7@TO:!+")"5_#$H0Z M2DS(&I8@HE%B(M>P!)'-4-?:\R#`&>I:DR#.66("5[$UQ#:#%S0)XIG!"YH$ M,UM(@%E\R526(OX=VH*5!S#VT`TV".'MH!YH$T8M1H]K;#$&, MT7JU?HKPM9!HLR?$,H5$&WL1_A(2;6Z)8(F0:"5`X&:T*DV"^,UH(5K9$+D7 M$JUL".,*B58V1/Z$1"L;@D)"HI4`\8W1=K1\$.P6$BT?1#Z%1,L'03$AT?)! M;&RT1$V"$-GHC5H=(#@R)%K9$"D7$JULB*0*B58V!-F$1"O!^#K9:^/$&"4; MJRDFD)CXHMQ[$*X<;5=[&@2JAD1[&H0HAD1[&L2KA41[&H0RA40K`8*.93OO%A+X(Y7?;C_?E[?/GQ^>7DZ^WG_"Z0&^!\:)]'/[]RS;?[RV M-[U/?C^\XL]3FDO?)U_P=T?O$8[PPOP9DT^'PZO\`]5RWOTETP__%0```/__ M`P!02P,$%``&``@````A`*AHGWQU(```BIH``!D```!X;"]W;W)K&ULE)W;SZYNK=W;>/#Y_NO_WZX>I__M'\;7OU[NGY]MNGVR\/W^X^7/W[[NGJ M[S_^YW_\\,?#XV]/G^_NGM_!P[>G#U>?GY^_%^_?/WW\?/?U]NGZX?O=-TA^ M>7C\>ON,_WS\]?W3]\>[VT^CT=/OW^]^_;LG3S>?;E]QOT_?;[__B3>OG[\,^Z^WC[^]OOWOWU\^/H=+GZ^ M_W+__._1Z=6[KQ^+_M=O#X^W/W]!N?\U6]Y^%-_C?Y#[K_'GYYOH:[ M]_Y&N/=[]\N/II5EQVVZOW/_XP!NA_[^_^>(K^ M_>[I\\,?[>/]I^'^VQVBC7IR-?#SP\-O3K7_Y!",WY-U,];`?SV^^W3WR^WO M7Y[_^^&/[N[^U\_/J.Z5,_GX\`57PO^_^WKOV@"*?ONO#U=S7.'^T_/G#U>+ M]?5J<[.8S5=7[WZ^>WIN[IWMU;N/OS\]/WS]/Z\T"ZZ\DT5P@K_!R7QVO9G= M[!8;.'G%N/KO>KE;+]?8-2_@=[QM_@^5L>3W?KF:KM;OQ5ZZY#I;X M^Q>ON0F6^!LLEW^JE.A4X[WB[U^\XBY8XN]?+.4,36:\J/M'L/V3E3*3-N'^ M(3<<-8I78CM#,_)7U?;TYV(TDS;D_O%7RRK-:*;M:+;[@L>=5M\^W/_[P^/#'.PQGB-;3]ULW.,X*YS;TN=`6IUZ(P>"C4__)Z7^X M0J-`_WH"_>>/Z_7BA_?_1+?^&'3VK#-+-4K1<%W;N:UR4.>@R4&;@RX'?0X. M.3CF8,C!*0?G'%PB\!Y!G2*+QO27(NOT760E)GL!&NIY%D;1$),J!W4.FART M.>ART.?@D(-C#H8&\4@; M;:I23BI3*(G41!HB+9&.2$_D0.1(9"!R(G(FCG`Y*8E91:0FTA!IB71$>B('(D8))%%0AA'5AJFPVGX/$&OELB41"HB-9&&2$ND(](3.1`Y$AF(G(B< MB5QBDL3*S3#S+.GU5N@LTC`&DK;"==8*)R6)=46D)M(0:8ET1'HB!R)'(@.1 M$Y$SD4M,DLCBH4R176RO=3K$CR)GDH8VD#2TFRRTD](46B(UD89(2Z0CTA,Y M$#D2&8B1I`06D$MUD$56L*(:.:4<.H9=0QZAD= M&!T9#8Q.C,Z,+@E*P^D2_6@0F,+I)P!(C20J>S<'=4TT#>D)8:5&@JJ M&36,6D8=HY[1@=&1T<#HQ.C,Z)*@-)P(CAE.Q[/6Z=%,YT:EF[-#*T(5HYI1 MPZAEU#'J&1T8'1D-C$Z,S@E*`^5R>*O=^=P^:7_Y\__&W_0/RO]DT=70+ M+WE+"RAN:82J8+A8C.L?\YM9M@!2JX)TXX91*]?7BW6JY596X#F;\?>J()X/ MC([L>5"MX#E;DCFI@G@^)R@-M9WE](PJ:OK:"]&*=H%B?/\Z6R^OU+OY? MVBUJ\>!_N?!A):>M:.EU.D'A.C?45'O5D*H^"%(_1T:#('&-I?+TKD^J(:[/ M@D;7:=#=U,`*>I@RQ*W3(P1=_)9(`-P@L=1;K@1IS&I&C2`U;!EU@M17S^@@ M2'T=&0V"U->)T5F0$2B7Z%N!"A,`CK<"YH3,>K:^SNZG5PUQ?1"DMWAD-`@*KM'6J4'279_%:'2= M-$BWQAG'^:TT8M1/$]:`XF%4D!:E"FBI#XN:41/0:CXU^I9]=6S8,SJPKR/[ M&MCPQ.B<^$H#^,)$:8`?V=F1O@V%Y,M@Y M\9:&ZX5IU)RG40$EP^=ZDXU7I6C%/=K[6OB1:+?,D]%:;#2/:02IFY91)\A[ M7L^NLRE'KPK2=`Z"U/.1T2#(>UZMKK-EBI,JB.>SH-%S&F4W6XH>4F\.GF%V MI4UN/_Y*MC7SVC`_LZ!K30^QK8\,3HG/A* M`^AF/5$`96;E%D3S7NU1-GAF#:,,AG&&%-`*K?65F95H3>-@WN8:T=!AK^6K M=:+UZM5ZT?)7FZUW^4/\(!IZM2-?;1"M5Z]V$BVY&OI3/+G*AORSJ!N#<#:W M>K.]\YQK[E$R.`<4#\X>K730K8/A2N/@>+^*,]EGVY6=([E$P->_U M)INJEV*H>57%J&;4,&H9=8QZ1@=&1T8#HQ.C,Z-+@M)A)IMUO1+V:03B"=D\ MH+BSK3?9"DRI6O(`J1C5C!I&+:..4<_HP.C(:&!T8G1F=$E0&FDW]X@:^!1. M/R=!&BU1V<\#2AMN-@4K54L,*T8UHX91RZACU#,Z,#HR&AB=&)T971*4A'.1 MSEMNRE!U'C?>KPM_!0B;M2"XEH(6HHJT?)9J+&D+@IJTPB:;+(, MO14%M>D$33;ZJ$\+CB$M+OC4S!S/FIE';K$\>MQD2Q`E?BP8#3=3K58!S;;Q M(N)ZDT]DV;)YP3++W%NV[&S+K2['IU%PN7)4_5,4?`Z=5+-';G%5H[#5Z(ZO M>99N2N7"IS52"8H7P]?;K"IKT5+#1E!JF*6_K6BI82 M-02/TH:PS9^&[O<,9Q@WA&"X]4NJ-]?YFD/-1DU`L\EHGOU`0)&@"W>&CW@Q M>K?3MI@&Q26C5E!\DIJT"X^R=I$_TS!CIG81$.XZ:E!9MZK9L!&4&FI)QI;8 MBE;<+LPK:J=*0Y#EK5/7",EG]%A?>)2VBYUVN=`U@F'<+H*A5'&ZS%X'OU%+ M:N12MD7+%MV+%FEIK73QC==T,"NF'A)0DN#0SR9B&&7FC&I&#:.64<>H9W1@ M=&0T,#HQ.C.Z)"@-]0OYXH+S14%I.+.ALU0MR2\C7JB6=O6%?K6JIK]4J>RAWJB6^>D8' M=G\,R*V:3;=*[@`DGKP6A&J M@A;J0:Y>,VH"B@Q;U8H+IVGGF`9TJB7N>T:'@/!'M(X!)4%?[[(Z'=CP%%#2 ML#8W67IR5BVYXB5!:=!?F#=X0$'R)WY)1%5`2=.\K0@T;MFH8!SW+R3O5 MDIOH&1W8_3&@+.A9DCJPX4G=ZWUM;K+ITEFUY+XN"4J#[O+[:,1Y:ZZ.CZBH M!WB45`:A*AAB*BEW53-J`HI\M0%M=*VX8]0S.K"O8T!N87D:8];1?&7L30,; MGMC]F=$E06F8W2PA"K,D_LLP>X@'=H_H.N$RU_L=669I^]:.C5#H+T:D=!WL\Z_QUQ$+F: MG`2]>H-GT?*.MVO,C],GPD4T^-VWI9M"6;459EMQ;7F$VI)Z*$=KO$>CMUP% MM-4?-VI!^D-)PX:M:*G[3I#ZZ@6IKP/[.HJ6&@ZL=1(MO>)9D!I>!/%/,\ML MTC>U=)[8C:H?KM9(#*>6AL_QTVHJ@U:\^A,0LVH8<.6M3I&/:,#^SH& MA#4*N8F!M4[LZ\SHDJ!TX'AA8H??JVD<]F@=#VZ;FRQ5*(-ATCJ](18WW.N% M.WI]BTT:1JT@[V6VF%WG>42G*A*R7I!VE@.CHZ`XUN&FU?#$6F=&%T&C81)K MO!=D=ON1I[.^@!!K*4D94!Q80:I5"]+;;ABU@M2P8]0+4E\'1D=!ZFL0I(8G M0:IU9G019,3NA5G?BF=]`:TQ($3=/LNNRJ`590*5H'2\R)+56K3B]?'Y-EO) M:T1+TY%6D%]/76&/C6PHZE1#:KT7I'X.C(Z"]"V$09`:G@2IUIG11=!HF+;? M%V:/>)$E'RL"0AU(2D%J>&!T%*2^ M!D%J>!*D6F=&%T%&[%Z8\;G77;(5^X"R<39+W\N@E0P'WI=;1)X:_GJ=S9EJ M,8SS/Z/]!E]:@:T8^@%XL[C>K>)U^>Q!T*FZ5&XO2)T>&!T%Z5`Q"%+#DR#5 M.C.Z"!H-T\;L9FI&#H9W6:A"/$H&8X^2Z`>D-U0'7U'RU@C2DK2"U+!CU`M2 MPP.CHR#U-0A2PY,@U3HSN@@R8N>F7U;L_+0L_J4%[P&Y<&:#<39:ED$K&1N\ MH5O+FAKS8I&-F#4;-HQ:06'D75_G[]UTJJ&--=R`#@('T5)T%*3CPB!(M4Z" M5.O,Z"+(&#WA`6439FS%M]=R_'K]>+O)/U2[B:/2=CM?9O._-+L#SP95'T7!<"M*R5`%A M]B[MO1:DOX(V;-B*EDYC.T'JJQ>DO@[LZRA::CBPUDFT](KG@-;:6R^B-5XQ MC:F;X[PVK&2O-:[\G"@95CQR/]=,31/;U65S[&"8C#3><+8-K6&;+\W4P6BV MU4[?L*,VH#6&Z^D.C,Z17FZSOEZ^EKWTQL4/?/'CI.9+D25I`UN<`GK]=L^3 MWZ7O*ZO=BM:7)AT>V_!AQ.L5FWUT/.JG,]"`HC604I#61Q40GEQ39Q&D3;=A MPU:TM)UV@M17+TA]'=C74;34<&"MDVCI%<\!;;3W7T1KO&+26=PRTE_I+*-^ M%E,_64V?([-L?"V#89Q;!C3#`M_XA6;6SNI)KH%JV$T;T!I]X96N,CGS%\-$ M-7]CJI]4]'H'OMYQ4@N>\B8\L,TIH-?O\3QY]D_6V6ZYRI>5+I..49?93/:M MAPD>6?FD(*#X82)(FU,54/PP$:0/@(8-6]'2-MT)TICW@M37@7T=14L-!]8Z MB99>\1Q0_#`1+7Z8K+,9[AC3O_#._&B?]913J;;95B M&#\`)D-]`!!JV+!EU#'J&1T8'1D-C$Z,SHPN"4HC[2:$$ND=!N+QU[R?W),\ M6\$)*'YGAU'%J&;4,&H9=8SZ!*4%<9,\HR!^[A=G=VX-"F6+7Z!A5#&J&36, M6D8=HSY!:4'B*5Q4(SR#6WN4ODXPR^9'9="*T]2`9MMD-7F6K2;7D9KT@X:] MM9&:]C-Z":6+U,1;G[(T#/'4*`H#SX#<,@SJ,WH]H0PH*;/7RLN<+X0'2Z^I2E97;YO-&&?9J?M&&/DC)[E)39(WR`+U>O70KB M&K^B)J#(L!6MK(%0\8*S*%A]9(J+)L7;Q`D\3/T&R"]N&C2JI\_.@*+W(?J@9-6S8!C3;XN:F)\8R?S9WD9K$M4]96NPXQ]:6O/%YH3E%:2RW1X$$)ORC." M@-RC3,M&OYT'K7CF)RC\ZDT;2HA*?^(5+>WZC:"X7&38B9:N^/>" MC(*X),:H69_;)#7K4=8WLRB66"0:4RYV]`BI:VR2H@O*7B M5N%6US?Q[]^[_'6D6M2UO3;LM!64]/Q\1\%.M'PWWVZO\RE(+QK<%?#=E4;& M[;/"40!$D4Z7PNKEHR:%2,:D8-HY91QZAG=&!T9#0P M.C$Z,[HD*(UTG%DBTM-HQJDE-KQT$8X7FQA5C&I&#:.64<>H3U!:DCA5C$O" MN2(F)V-)=,0M&56,:D8-HY91QZA/4%H2E\C)$U1:_VSUXJ1\ZQ._^!$J*,X8 M-O-L,:D4K2C5",A]*!_UF7Q%1K6DSS3LJU6MV%>6MG2J);[Z!*6AB;/&N))] M$I>$P*,W)N[;H!6'("`_F9Y3V8,X2C+822L(+6V*(\_;12O,VV_R65I1U%:40>M"#5LV+)6QZA/4-)@=W&R MND:>)04#9]"!_7`6M**&M!/G\?9DW6!%K.!I&K:`P<\=9;/FG.IVJ2`OI M!8V^TX)GN:#4ZLXG>'&M!A3G^P$EI?2&\=2=M1I&K2!MQ1VC7I!1DBSGFTH2 M$CF=7NYW'KTQ=P]:<4(K"&6#IC7#1TJ=;*VB:N^?;K'2J MH77K"^-O,ZW;+#V;(L(YV,ZC>/(>4%)\KQ5/WD5+H]L(B@M&AIUHZ62H%\0S M%NSB:8X](\^ZIT]_LNZ9/#._[)G?J;I6=+A!H^EG.=5;$[H=YUH!)9W;:R4Q\BB>S`?#>#(? M4&38"HH[=W"OJ!10_5>2[;QP MJP>&S1;>,-LU)+NM'-^<>]M!8%G,;@IW()+A:X:CH'&VCR&9;PJW[Z0EP?5] M2II??XX;P)9_;(,3IW\R2^DN;^CO$193'T&Q8O+3LO@)M<@7WB/R9N!7!)=V; M)2TA<;]`L#?\2(,[L"3X/09W8$GPLPSNP)+@UQFT1$N"WU`+]_,CW\%^LRWV M/C_.'BGX$;$H30E^2RPJ4X+?#POW"QI?IX'$_9#&$OQT6'2F!#\0XJXMFSW* MLS?+4T+B?MKEZU205*8$OV?CKBV;!A+W>R][PT_9N&M+TF]FN&OK$5IM%KB. M.89`XE[=X.OL-QCC\4H`2TI(W.L)+*D@J4Q)#8E[68%M\"(&2FI)\#X&2FI) M>DC_1%>Z%.$N"40SODAF2#48*O&[%DCTBNCH2KO@T]DBM*45)"XCR[8&[Z10?U8$GPI4[A/ M,-@&'\P4[DL,EG20N`\R6(+OT6!CE:>#Q'WDQ#;XV@QU:DGPS1GJU)+@TS/4 MJ27!5V>H4TN"3SL+]VDAWP$^ZBS<%X8LP;>=A?O0D"7XGK-PWQNR!)]Q8D)B M2?:XM[UY;R4D[@LS]E9!XCXT8PD^$42=6A)\*(@ZM23XRAKW9N8[N.N]>=?X MM+=PGXKR'>`+W\)],+0J2X)/X=&J+`F^ MB$?;L238$0+7L7)8;`R!ZU@2[`^!ZU@2;!.!ZU@2;`V!=F!)]KBWO7EOV*<` M[<"ZZPJ2RI1@BP*T`\L&.Q6@'5@2;-Z"\EBC"_9P07DL"?9M07DLR1XEW9LE MQ28B*(\5@PJ2RI1@_Q"4Q[)I(''[6W#;P=8A:&^6!%N"H+U9$NRCA/)8/7B/ MDN[-DF)3'Y3'B@'V]D%Y+`GV\T%Y+`GV\$%Y+`FV\D%Y+`GVZT%Y+`FV[4&[ MMB38O0?MVI)@SRMH;U9 M$FR`5[B=V]@&&]]AF][05*:DAL3MGL5W@,W(T`XL"78I+-Q^>6R#W0E1'DN"30H+MWL>VV"O MPL)MHL<2[%)8N+WT6(+-"@NWI1Y+]I#L34D)B=M$D&VPQ6/A]A)D20V)VU*0 M)=CBL7`["[($.ST6;H-!EF![7L3`RM:Q_RY*:DFP#2_:@=5+L%28)]C1,>28+MCM!"K/-B3%Q*K M/-@X%A*K/-C%%!+K.CB.K'!'9'$MX%2RPIV4Q1*<1%:X`[-8@D/'"G=N%DOV M"ZQ7X:@90[+$@KW_Z2E;#]DOT+?]SX8DP>B/_=/9&X[YPQU8,=CCWO;FO>&X MN:(T)14DE2FI(7&'F?$=X(2YPIUIQA(<-%>XH\U8@O/F"G?"&4MPQESA#CIC M";%^Z@;I;@C//"'<[-D@XQ<&?6LZ2' MQ!U=SY(#).X$>Y8<(7$'V;-D@,2=9\^2$R3N6'N6[&=SU(_5>JL9UD=Q_@S; M=)`<3,D`R=F4['$'>_,.2DA*4U)!4IF2&I+:E#20-*:DA:3UDO?3X^SIQQ^^ MW_YZ=[I]_/7^V].[+W>_X!?WF_&=X[1Z>`-V=^>7AXEO]`P-[_\?#XV]/GN[OG'_]?`````/__`P!02P,$ M%``&``@````A`+3T$*"L`@``U`8``!D```!X;"]W;W)K&ULC%5;;]L@&'V?M/^`>*_Q+4D3Q:G25=TJ;=(T[?),,+91C;&`-.V_ MWX=IJ)UD6E\L^W`XY[O`Y_7-LVS1$]=&J*[`211CQ#NF2M'5!?[U\_[J&B-C M:5?25G6\P"_BP5UCI]VBHJA*,WRFVE[RS7D3SEEJ(WS2B-T)':B%?9E$,5(LM5#W2E-=RWD_9SDE!VUAX\S>2F85D95 M-@(YX@,]SWE)E@24-NM20`:N[$CSJL#;9'6;Q)ALUD.!?@M^,*-W9!IU^*Q% M^55T'*H-?7(=V"GUZ*@/I8-@,SG;?3]TX+M&):_HOK4_U.$+%W5CH=TSMX6I M%IS@B:1P9P!2I\\%3L%!E+8I<#:/9HLX2](91CMN[+UP>S%B>V.5_.-)R>#N MM888[JBEF[56!P2-!;;IJ3LFR2J%Y)D#MPXM,)PPT#.`/FT66;HF3Y`&>^7< M>@X\`R<)#`+JP0+BO6#A4&?A\G2>MQX8Z[TY3O2RB1YR]RG/R$6<>&!,KH%P(W:'0!NAT2/V\/)[T#@_HW04/APX>H3X>2<8%&KM. MXIY/-(<2I7$>+6:A3(XQU?=(`FT8995?KLOB7#_)DR#NEJ?B'CD1GUT6=X/M M[4@.P>?Q,IH'>4>8RGOD1/X?/5V>RZ?7201WZ'CZ'6.J[Y$3_<7E\&%6_"?^ M@3$U>(5.'*Y/'/P,\?=7I:=`:UO`+-V)T9I/U4\A]6]#OP>$.QQ&0*Z7L M\0.<2?@?;?X"``#__P,`4$L#!!0`!@`(````(0!XHO;0+2\``)'N```9```` M>&PO=V]R:W-H965TE M21I39MQO>;'9W6#N!X)LE^D-3?<7@`[@C<*C+B MI__\[X]_OOKW\^_OGRZ?GGU__S_.7U__YR__^7S_]_?+YGU_>/S]_?04/G[[\_/K]UZ]_ M[=Z\^?+N_?/'MU\>7OYZ_@3E]Y?/']]^Q?_]_,>;+W]]?G[[V[70QS_?S!\? MUV\^OOWPZ?7H8??Y>WR\_/[[AW?/VO_W-U^OK5QW>[^H]/+Y_?_N-/ MM/N_9\NW[\3W]?^0^X\?WGU^^?+R^]<'N'LS5I3;_/3FZ0T\_?+3;Q_0`A?V M5Y^??__Y]:^SW64VW[Y^\\M/UPC]WP_/?W\)_OO5E_?/_S6??CTC'`C M42X%_WAY^:_/?_^]E]_?KV\_%T]?_CC_5?D>^6* MO'OY$U?"/U]]_.`Z`=K^]K^O__[[PV]?W__\>O'XL)RO-MO9?/7ZU3^>OWPM M/KC"KU^]^]>7KR\?_]]H-?.^1B]S[P7_%B_KA]7F"?ZM3N;;U6RU M=E6Y<_FE+XE_^Y+SL!%W2L+OM?GXMUQS_C!;/G[KBFM?#O_VY=;?4VSCB^'? M/UA1W)G7BN+?ON1L_K!=K9;K[>9^<)Y\2?S[AYHX0Z<;NX;K?6/6OS>LLZE; MX3]^L+XSZ4SN/WS9S<-F]OBT^$9+9]*#W'_\6%NE!\VT"WU70G%/^2`%/6C] M\%V]=B:=R/W'CS54^M%,.Q)NV^^*D72DF?:D>RU],XX7UW$F>_OU[2\_?7[Y M^Q5&;R3VRU]OW5PPVSE??H3QM^DTYF#L>^?,?W7V/[^&(0:3+Z#__F6S>/KI MS;\QB+WS-GNVF<46![%P`YESFZ4@3T&1@C(%50KJ%#0I:%/0I:!/P9""8PI. M*3BGX!*`-\C#E`S<*3^4#&?ODB%AW`O0[,R3R(N%%,E2D*>@2$&9@BH%=0J: M%+0IZ%+0IV!(P3$%IQ2<4W`)0!1YC#0_%'EGCSDVO`V6CW&H]Z/-#`/V=*^L M8Y/#9#*E@TA.I"!2$JF(U$0:(BV1CDA/9"!R)'(BF2HX*13X.^3"?DR6@*.I&<2$&D)%(1J8DT1%HB M'9&>R$#D2.1$Y$SD$I(HZ%BG64%W.`[Z2+"@DG@>B&1$B)#2*+(8$5H1<;A.#(CP=)^B@R1C$A.I"!2$JF(U$0:(BV1CDA/9`A) M%!G,_V%D_`K[P6V"OK[_\.Z?^Q?W,XXAY$O0E(ME(%HOKBGS^.%O$ M"XU\TB7J!9&2O%:3C5OGPVNRF*PG7;PV1%KRVDTVWFLR%O63+EZ'D$2Q=9O; M,+@R]5QY'$6/%IC%@G$P:=%!K#38F2"7+]GSS#?)2BX7J\TU`XOUP^8I_-\F MSDNA:K\=+SS=/#^C'X7]+$1LSUTJT@O70GZ.ZE>[$: M+[V+G4/@ID#N!!T$:94SC[9J ME0L:C\S<3K,0M)Y\E>RK$BOU50M27XT@]=6RKTZLU%85!R-^5L/=\^4`\?2\%$DE"PHY)1 ME?A>/LX>DA.#6DW$=\..6D:=%KS6^_%Q_I#<:KV:B.\ADSGAX`[TW`@0WNX>W1VA8I&_V=6>?3*HCB@9FC[0MF3M==>.-CARY1VOMB(58 M;:;[IO0HR'HE5NJK9E^-6*FOEGUU8J6^>O8UB-755]S+W3XAZ.44P/]Z^2M< MVKD#XC2`TU9#%Q>;9=)##U)P/H4F8Y0S*AB5C"I&-:.&4)3#,`Z&7![(RL/XYXIRH/?1NGH<7!_E4#0@[UT MQBAG5#`J&56,:D8-HY91QZAG-$0H#I3;Z%B!&C=`4:!&A"E85QF$,G>ZZ6*G M5CFC@E')J&)4,VH8M8PZ1CVC(4)1H!")*%`T\B:;ZJM]/'4)"GH:H\RCVQMK M-9`\%(Q*]ERIU8W-M1J(YX91RYX[M;JQP58#\3Q$*`[UC6W:G+=I'KD51S"( M)ON(@Q34N3GS:*$3<[?CR6`[(F1(1IS# M?$11.CS234$N5EJP$*3-+QE5@M17+4A]-8+45\NH$Z2^>D'J:Q!D!,KM?ZQA M8-P78>R5J.S=$U*(W1IKGF`82(Y+#MXJ/,`1Y`Z2__W+DG:YN1K(Q0I!NCHH M&56",-YKE5;)'[MKM1+WC:#P,&J^36[+5JRT$IV@L2V+Q0,>.PS^EQQG]6HN MEQX$79W&G=9MN*Q<^(U8F(L1(1?B]S`?411XC\8GZ=P18RY6B@I!VLJ2425( M"]:,&D%:U5:0NN\$J:^>T2#(")3;V%B!\AL>O?I^/J+H""=]*.@@1AK-3!`B M&/2LY.@G5RM)0R$(X\54D'I6*59ZQ4J0#'>;AZ0SU6HA5VL$J9^642DJ5>ZL` M%1YMU*ID7Q47K!DU'JUT<]VRKXX+]HP&C\9ZQ0%T.Z(@@-.R8MPI18$:47R8 MODHZS&'NK?36RSQ:/8Z'Z5@P)`-XKA;2#0I!>K^6[+H2*^]ZDRP0:]7%<2-( M';?LN!.KT?%Z_?`4C+AXZCL^Q.S57*XS"+I>)XKYX@=W:U?[>`'A4;#*/0@* M`B](NU#.J!"DTWDI2'U5@M17S:@1I+Y:0>JK$Z2^>D:#H*NO.(`W]F`+WH-Y M%._!5NF!HA0,]F`>A7LP1@6CDGU5;%4S:ABU[*MCJY[1$*$X=C?V8`O>@WD4 M+[Y6Z2&@MPK7`(+&!51%."QX%+'L%RL M%!6"M*DEHTJ0%JP9-8+45\NH$Z2^>D:#("-0;L<3S$;?FL[=$BO96GFT#E?9 MM/B2$!<*=Q1=?L9*"X14WJV1FJ=5*.EKC M432FT7*OY2MVZDNKNEDET=AE)*UHB2)442](,O&-T` M8T&_I%C3$43NR\!`&E$(TLY9LN=*K,:)?[FE%;$:B.=&D'INV7,G5J/GQ>H; MVS@UE^L,@J[7B6/N=ET_;<84;2D\$AO^DRL=.K.&16"=!E0"E)? ME2#U53-J!*FO5I#ZZ@2IKY[1(,A84MS8WBUX>^>1NR>F&WZS2I:T!['275(F M"'UW*LC':V+E'U^:K=(#KT(L@EV&(+U:)>CNU6JQ\E>;K]+^WHB%7JT5I%?K M!-V]6B]6X]5F>#HEV=T.8G&]6MS%W0[L1[KXN&.+NOB(D#FYI0[8XZ5;/8_" M/\\+TN.M0I!.(27[JL1*3_)K0>JK$:2^6O;5B97ZZ@6IKT'0U5<<0+D. M:B7W1<8H9U0P*AE5C&I&#:.64<>H9S0P.C(Z,3HSND0H3E"R#;VN5NT;:DH1 M[U"QB+\NB^(4)0=E![72%$T%!>5L53`J&56,:D8-HY91QZAG-#`Z,CHQ.C.Z M1"A.D=O5!F/>E`?'DUO%HS@/Z?'6,D8# MHR.C$Z,SHTN$XCS"I$('[Q5@#)&.:."4"<*=.N64M_)B-6YW:6M=B*Y;ZU*07JL2=/=:M5BAD5.-%HMD3&C$2J_8 M"M(K=H+N7K$7*[^9IS.X00ST8D=!>K&3H+L7.XO5W>9=Q(I/#Y;)Z<$T%_(I MP=4T_G65(*UVYE'XZRI!ND$O!.D&O61?E5CI.%(+4E^-(/75LJ].K-17+TA] M#8+4UY%]G<1*?9T%J:^+H*NO^$Y,3ARFH/-)@CMWQX+<;;:F[CM;T2[(6^G! M7R8%Q[_4S!_FT9^:Z`!?S64D*02ITY)1)0B;KJF"='_5:B7N&T'JOF74"?J^ M9O1J+M<9!.EUCHQ.@NXVXZQ6XOXBZ.H^RC+.V*,5CV3YRN,]ED?(LO@]"-)J M9X+T.#UG5`C2@B6C2I#ZJADU@M17RZ@3I+YZ1H,@]75D=!*DOLZ,+H*NON*@ MN\V_L;%UYT/)QM:C9))+_NIS$*M@B!,T/AV$URG%#SWDJDLV"T'JI614"<): MZ#<3S($@]'QF=!-VM^%FMQ/U%T-5]G$AW MH&`ETA\TZ*VRQZ-`+K?A\;4@K78F2(?VG%$A2`N6C"I!ZJMFU`A27RVC3I#Z MZAD-@M37D=%)D/HZ,[H(NOJ*@W[C.&+%QQ$>11/39IW^B5*L]*;/!(TC^O(A MFITC MHY.@N\TXJY6XOPBZNH_3>N/`8\4''AY%,]%HA?,4N50F5CI*YXP*05JP9%0) M4E\UHT:0^FH9=8+45\]H$*2^CHQ.@M37F=%%T-57''0LW,T!S/%D^A]1,A.E M?SE=>2L=`C)!_CG5[2+]*V6N%I*\0I#Z*1E5@NX.Z;5:B?M&D+IO&76"?,WQ M+%2Z=58+<3T(4M='1B=!=VM^5BMQ?Q%T=1_G$K[,7#J>Y')$T63DD58[6WFD M`W7.J!"D!4M&E2#U53-J!*FOEE$G2'WUC`9!ZNO(Z"1(?9T9701=?<5!OW%> ML>+S"H_BR6B3_KU5K/2^SP3='6QSM9*^4@A27R6C2E#H?K-)UHNU6HG[1E"X M[>-'F<1**]$)"J](V[%>K>2*@R#U=61T$A2ZWVR2*?RL5N+^(NA6@^+,WSB4 M6/&AA$?1?#5:1?.51SJ6YU)042%(0U`RJ@1IP9I1(TB7J:T@==\)4E\]HT&0 M%CPR.@E27V=&%T'7>L5!OW$HL>)#"8^B^6I!2[^Q')Z[D$Z02;EQT-^F0WZN MNA0I!*F7DE$E"*/JO8V3KY$.2(T45/XO@J[NHS2Z!SRMJ>K*XZG*HW"J$J35S@1IU')&A2`M6#*J!*FOFE$C M2'VUC#I!ZJMG-`A27T=&)T'JZ\SH(NCJ*PXZQD,SZ(XG01]1-%71"R36WDCO M^$S0N/U8X/U%T0\OD@/M7,VESQ2"U&G)J!*$&DRWTF:3N*_52MPW@FZ-\-<7 M.+=BI97H!/DC/GHW6*\&CX?"'IW\*>T@5CI09(+&87\QFSULPT/T9,++ MU5SZ42%(G9:,*D'A++!)WQQ8JY6X;P1A@S[=J[Q*%"NM1"?([[ZVF_04IE<+ MN=H@2/T<&9T$Q8U)3E7/:B7N+X)N-2:^Y]R9A'$ZB!=%T8`[HFB6\TA;DOF" M>!!:*I0S*@1IP9)1)4A]U8P:0?I'I%:0NN\$J:^>T2!("QX9G02IKS.CBZ!K MO>*@WSC16/.)AD?1++?9)'?,0:QTJ,@$C9/!;#U[6(3S7+)URM5-((S#4[V,B6N,1+"#[*1@ M>$5J4*]6-X8\W'&Q[%D]#';S*)S=!&ES,D'ZNYV<42%(;Y%2D/JJ!*FOFE'C$3Z- M-DVHK9BILTZ0.NL9#8*T8D=!ZNLD2'V=&5T$\?VV06:M-<65)U%WILD&;35+ MIS=?,)@-,D'CDW8;_DE@KA;2@0I!^O1=*4A'H$H0IJ!IAMILTV,0M1+WC2"L MB:>"/+6)E5ZQ$^0?BMS@+^/ARC?9K_9J+I<>!&G+CH+T.B=!<>I)\?W_!64:Y'JZT^8)=[JP`5@O0^*=E7)5;JJV;4"-+[ MI&5?G5BIKY[1($CK=61?)[%27V=&%T'&/7?C4&3#AR(>)7-$5::JHU4JNV`A27RVC3E#H?K--#BQZ MM1+W@Z"[#3J*E5;B)"B\(C7HK%9RQ8N@JZ_X=G,G&L%YR#?GOO$$)/S-ZF9$ MT=SGD=8]$RN=%G)&A4?A?%6*F3JK!*FSFE$C*+P/J6*=6*FOGM'@45BQHYAI MQ4Z"U-F9T460<2/>."EQ'W-)5O@>Q7N[].UW!['2<3P3%`W'Z:EA+E;CK+). M-V>%Z#IGE(+T6I6@N]>JQ2J>69(YLQ&KR%?:X%:LM!*=H*A@VN!>K/PTBC^4 M)(/:(!;:Y*,@O=I)T-VKG<4J;G(RF5[$*O(5-#F^E;'Y#&]E>6QXXW@RBN=H4KV54E!O1=K03II-8+4JF5?'5OU@M37($CK M=61?)['2*YX%J:^+(..&10+-H#N>!'U$R&9T$195( M&W06J[A!R<[\(E:1KZ!!\>WFCBU^9.81T+#(W77D\3'H4_#;]P"ACE#,J&)6,*D8UHR9" M<>,PJIB-4;Q$ M?TK6M0=?,%QY"8K6?>FDEHO5N&+E-TT58J`+UE*0YJ(2=/=BM5B-%WO".[/C M'R\U8G"]6!PQM^D*9LKIYA\W8U%7&5&X,,7RT\4U"L^(PH6IMPH7IH)T`5BR MKTJL=*ZK!>G,TPBZ^HH;A["9C7,\N?E'%"\`TY=W'M`$5S`X3<\$C:?IJS4] M_Z@&TH$+03KOEHPJ0:/GY5/ZU^9:#<1S(^CJ.8Z%VPI8B1ZW"%&B1Q0N?;8> M:8TS0;K$R!D5@K1@R:@2I+YJ1HT@HW%N%6XU;ER=1XT;47+?)]O)P]9;Z:V8 M"4(DIC4('?#D:B4Y*02IKY)1)>BN^UJMQ'TCZ.H^3KE;G%I1&1>M451&%-W; M'FFULZU'>M?FC`I!6K!D5`E27S6C1I#1N&^M*M.YCU>5VQ%%GUU)7TEZ\$;! M:SXRC]P+@*:>L$E_*Y:KE:2JL"Y(?T8H^8J5^@JOF!QGUFHE5VR^=<6HO^#3 MDU%_^=9RXFH?#Z,>16]KW6S3?;04U%<`9AZYA=P44W['A%AA6399T=ZW$*O( M5[!5O.Y]2ZY$919,I_9:K.)*)/O51JQN52*.O%MG!GH9#8R.C$Z,SHPN$8KSDRRT997T MQ`MJC\(M$J.,4U'FD?N>9Q#`9%N3+ZB=)//(?6QX"B=O+<0*(\AD9?1M]6O!6K6^[C>+L]AA7O<>\1=?(1)9T\614?GGS!L)/[@N-YR6/Z M2;_<%TD<)P-AP8Y+*3@ZGCW,PH=]'M-QJ!+SN",FUZGY.HT4E`8D;6Y%O^4X MCKC;!ED1=SSIX2.*>OCVD1:9OJ!VE.S)%_1=,#V@RD6_U46N2_;"6P4]L)2" MH^/']/2E$OVNXYH=-U+P&UW;#(AF,`HT>H,=Z5&(0RTLZ83I>D+,POVI,`SB MUTGR(>D>^61PJW^,X1:SP'?6;(J:">S^`HZ M^R1!3_96,FOBZYK4OX7%'7RF^;P&YB!F04?,A&$0=T&G;VDBZ./U8M_IF%"( M6>`;0?=%P\ZXG273.4)O7D$#(9GW$?IO7"$)?;)MHFUM MLJS&-Q*,E(PLN@]6Z<(/*?%%@V%>F.^K-#@@)89OGE+%+.BK2(DO*D-]LLA` M,K['-Y)!]48R)M_!3#]+\HADF%=0LR09R9[NV\G@S=[L<61Q'YXEZS369`S8L@9,>2,&')&##DCAIP10\Z((6?$D#-BR!DQY(P8 ML>I&TR"])&#&DC MAK010]J((6W$D#9B2!LQI(T8TD8,:2.&M!%#VH@A;<20-F)(6\B2M+G]:[`; MN8Z.][\S,GOT>UY]T\%^8G'6>/GLBP;/#`5%)9/(&MDA:\20-6+(&C%DC1BR M1@Q9(X:L$4/6B"%KQ)`U8L@:,62-&+(6LB1K;D>=9NV;-YO?F4=I\RQ*VSS9 M`N!FF\PD19C7B"%MQ)`V8D@;,:2-&-)&#&DCAK010]J((6W$D#9B2!LQI(T8 MTD8,:0M9DC:W?4W3=G]>\WO[*&>>Q3GC3=-D%N2,&')&##DCAIP10\Z((6?$ MD#-BR!DQY(P81;^H=!@F<&0![\-U\TN\D`,>2"&/!!#'H@A#R%+VHGN9+?3"6D7 M'%GX!\+9C!C:20SM)(9V$D,[B:&=Q-!.8FAGR))VNGU=D$_:J:7G%V@DM]\S MS17N-V)H_\AN_QDPL)"[%-&82@E#-,@[HC'9N=WW_#$]/$)L)@OQA-B$+(F- MV[D%L=&^[K=TX0SAS@O0+Z*'KK;SY'0)8?%F&BJ$Q3.LVJ>-+C\8,IGYXQC\ MT#;95R%4WE/PQ.7$](H(U?=<$?'R9N,55T_KATWX(JGD3`2Q#"^?Q-+M8LQ8 M^NU-%,N1A8]JS=Q?CEQ\M1D(W,CP=*3D$_>39_KT),+BF3Z(A1Y$_A`6\H<8 MD#^T,_27M-,M^\UV^OU`U,Z114]D;N=ZNN6/8MVY()H>/I(Y$S8>-;G-0_P\ M+`+A2^D#AP@$>4(@B"$04UGMD?37.L1F,I/X(S:ANR0V;G%MQL:ONJ/8C"Q\ M0G/F3LTI$)YI,]%T8F@ZE473B:'I5!;M)(9VAF63=KK5J-E.OTR-VCFR9-Q( MLHEQPYM%W=\S1'P:-RA+B,9D)EE"-,@=HD$,T9C*WKD$`C29R240H-!=$B"W M]#,#Y->$48!&%@\&GD71\$QOV\ M"LDBPK-D,*#C3C'3IXVSF;!Q,%@\TM\>`PM)4#$Q]50:K)J8][ZEA[0#"_'> M3(R?9)[-W;++2O]52,,RKM&B<<#;10.BL'`<8(96>W]1JXFAU9ZIO]I@:&=8 M-DF_6W:9[1S78TB;Q&L_F_LU&J90O9G7M,/T9L&?SI#^L:C[&/I4=#M/%@=Y M8"97132,J_+CNF(67!4!,J^:G!DB9I.97!4Q^\95DS"Z%5H0QF\N4>?CDBX. M[\C<[!3$B,[*I&@XL'@6/0N]723G-0CO>`6824,17N.J5GA]A?6J"._D3BO, MKV`/S.2J".\WKIJ$URW:@O!.J]SYN)J+P^A7>&$OW2ZXEWHS;1!ZJ6=8.TT9 M,%:Y8C:N.>>SIW0P0U2]IW"5*TROB!!^SQ710[W9S74U(AI>,0F?6PL&X?MV M[QP7CW%81Q;-<>X0/UWP>H:/8$JVT>]&.WP_41@BY)G^<1)#._E#A+R=^D,X MR!_:'_I+VN_6>VG[[<-L\ROTL[ESD`[ZGF&.L>19GC3:A>#*$LT8,62.&K!%#UH@A M:\20-6+(&C%DC1BR1@Q9(X:L$4/6B"%KQ)`U8LA:R,:LO?GR_OGY:_;VZ]M? M?OKX_/F/Y\/SGW]^>?7NY5^?,,(M\>+V@+_Z_/S[SZ_W^+/&[N+^MH&1;"HS M:4].NTZ!I,T>H>%PVRHW7T/#8&5J&Z==)PWR.7=U0<.,TZ*5$]'EW]\<=5LYRK/_Z$9V@H99=Q[FS%.3-]+=#> MA=G>)0(_[E32>B\1B?&UPHF"7K_E_3K;_7H= M79-K[5$),QOSW<6T7Z"A1C1_7>Y^O=$7D%4SI\BH55.W>=EAT+"NCJ#,7>LM M#>46KIQ5.Y1;N'*6MG=1PS^LNARRM71NL3*+ZCZX-EH;J/[IZ6AJJ^.CJ:6FHXJ.K MIZ4AUH\NUI:&SOGH>JBE[5W[\`^K?>ZP"VTP-9SY;M$&4W.G6FB#J;G3+;3! MU-PI%]I@:L#N#L2!+^"U<7ZQ[#]1:NG*7!I[O_S)@A M).[^,S5KI7AOR,Z]/8.O@W>%X#J6@I>$X#J6LD?<]F;<\$(,1,>**-Z+@>A8 M"MY^@>A8"EZ"@?98"MZ%@5I;"MX>MG.OH^*6XHUA6'E9RGZ+H1>_-.-$- MZF;U1+RH!F4L98^X[TQB(X5T0Q*9BIX<0SB9I7!&V-0-TO!R]YV[KU@ MW)X6BGL]&"MXS]O.O1*,%;S;;>?>#,8*7O&VMNY]X19R@J*G;D5 M,F+4B,FUQG;U[G`.5@*GA%W\Z]E(WKAM?R[=R[V5C!V_EV[A5MK.`E M?3OWIC96\&*^G7MA&RMX.R;R8[4';\1$?BP%+\;\#!.9LQ2\!!.9 MLQ2\"Q.9LQ2\MQ99L'H57DR++%C*'M[VIC>\TA19L*Z#-YON,E/!VTR1'ZL, MWF.*_%@*7F>*_%@*WFJ*_%@*WF2*_%@*7D8,Q6HIWC:,S%D*7CJ,S%D*WCV, M_%@*7BZ,_%@*7BB,_%@*WB`.;]:X@S>#PYNEX`7A\&8I>$\XLFTI>!$XLFTI M>]1M;]8-;Y)&MJU:XX72R*FEX(W1R*FEX"W1R*FEX+L"J+4U7N/#`:BUI>S1 MGKW9G@.4@ZG@U?.HM14#O%\>M;84O&8>M;84O&T>O+*6%XKXHP-[P#0CT*DO!EQ[0JRP%'WQ`K[(4?,!EY[X! MPM?!%UIV[E,@K.!#+3OW11!6\+V6G?L*""OX(`L.*BQEC[KMS;KABQ[(ME5K M?-@#V;84?+D#V;84?,`#V;84?,$)M;9&%WRB";6VE#W:LS?;7 MFPH^[[-SGX/AN.$K/SOW51A6\+&?G?L2#"OXFL_.?1"&E19*:RKX_A:\62W% M![;@S5+PG2UXLQ1\;@N]RE+P32WT*DO!I[70JRP%7\>#-VMTP2?PX,U2\"4\ M>+,4?!`/V;84?/$.V;:4/>JV-^N&3Z8AVU:M\>4T9-M2\$4T9-M2\&$T9-M2 M\.E,U-H:7?!M3-3:4O9HS]YL#SZNB%I;+<4W%E%K2\&W$U%K2\$G%%%K2\&7 M%-&K+`6?2D2OLI06BOOP'O=>?`H5WJR6XENG\&8I^+XIO%D*/G.*7F4I^)@I M>I6EX)NFZ%66@D\2PYLUNN#+P_!F*?@`,;Q9"KY#C&Q;"CXTC&Q;RAYUVYMU M.T`YF`H^8HML6^W!QVF1;4O!-VJ1;4O!Q\AW[A/7G#E\;1S'I):R1WOV9GL. M4`ZF@L]6H]96#/!U:M3:4O"1:M3:4O"M:O0J2\''J-&K+`7?I$:OLA1\87[G M/C_.,<`GY'?N*^2LM%#JV-^MV@'(PE0R*^S@\MZ>`XKX1 MSTH)Q7TJGI73"J/_^#KL)`87*!=3V:,]>[,]!R@'4\F@Y*920"E,I812FDH% MI3:5!DIC*BV4UE0JM+0V6]I`:4REA=*:2@>E-Y4!RF`J1RA'4^E6&)57UN@R M0!E,Y0CE:"HG*&=3N4"YF,H>==N;=3M`.9A*!B4WE0)*82HEE-)43DN,_BMK M=+E`N9C*'NW9F^TY0#F82@8E-Y4"2F$J)9325"HHM:DT4!I3::&TIE*AI;79 MT@9*8RHME-94.BB]J0Q0!E,Y0CF:RK#$V+NT1IE, MI8?2F\H>RMY4#E`.II)!R4PEAY*;2@&E,)422FDJPP)]9_RM1S+_[)>8?\8G M?Q,E6V*,'Q^-2Y0.RL54LB7^I#8^.I>4J:`TIM)!&4SE!.5B*OLE_L0^/AJ: M7@59H&(CE]G36K=0FE-I8/2F\H` M93"5/6JP-VMP@'(PE0Q*9BHYE-Q4"BB%J9102E/9H]9[L]8'*`=3R:#DIE)` M*4REA%*:2@6E-I5F@;_8X-=TO'YKH;2FTD'I366`,IA*ML#?*,>'4Y-^4$&I M3:6#TIO*,,=<@K=0;3A?7WY@I*8RH=E,%4]FC/WFS/`E,9YA@/["?1$)V]&9T#E(.I9%!R4RF@%*920BE-I8)2FTH# MI3&5%DIK*AV4WE0&/*HTX.EROA?VB,[>C,X!RL%4,BBYJ110"E,IH92F4D&I M3:6!TIA*"Z4UE0Y*;RH58E"9,:C=@URFTD!I3*6%TII*!Z4SE1Y*;RI[*'M3 M.4`YF$H&)3.5'$IN*@64PE1***6I9'.,EN;35164QE0Z*(.I9'C8KC"?M:N@ M-*;201E,I<7C,ZWY]$P'I3.5'DIO*@.4P53V>'1KP"\-^?[)W`-MXX/.Z9SE M'DLSE0[*8"IX1AC7L6;:/>JV-^MV@'(PE0Q*9BHYE-Q4"BB%J9102E.IH%2F M4D.I3:6!TI@*7@&"&%BS,QY&1`RLZ.!11,3`4O`T(EIJ*7@,$2VU%#R$B)9: M"IY#1'LL!0\@HCV6@F?&T4780E@/9-683*W>(?EF<7WN#(> MW3/:@9<5N0?W#`6O+'*/[1D*7H+C'MHS%+P*QSVR9RAX(8Y[8,\I;Z:;^LLO M/_WU]H_G_NWG/SY\^O+JS^??\4#]XX/[=NGG#W^\G_[/UY>_?GZ-'VO^X^7K MUY>/U_]\__SVM^?/SAK&O[^\?)7_XR[P]\OG?UX?VO_E_PL```#__P,`4$L# M!!0`!@`(````(0#K@I_>PC4``#A-`0`9````>&PO=V]R:W-H965TV(MMYE,GCUVEGU/RL:!^^N__^?C'DW^___+UP^=/ M/S_=/'OQ],G[3^\^__KATS]^?MK4P7_=/GWR]=O;3[^^_>/SI_<_/_W?]U^? M_OW79Y__ M?/])OO+;YR\?WWZ3__GE'\^__OGE_=M?3XL^_O'\ZL6+5\\_OOWPZ>GG7#_(=3#_V)U_>__;S MT[O-W^[N-YN;I\]_^>GT(VH_O/_KJ_KSDZ^_?_YK_^7#K_&'3^_EYRU':CH& M?__\^9]3:?CK1++X.58'IV.0?WGRZ_O?WO[KCV_EY[\.[S_\X_=O//R]Y,DU>RM.;JZDR86%UV:A M_-SJ]F9S\^H__'#>F)7RWQ][JAN)RWQ0I]S,!^3[?JZ;]8?#L+%IF/[P M8S]AFX?-CP=B8Q-QM1S7[WRA7=D#._WAAY[PE3VLTQ]^,!)7]KA.?_BQ2%S9 M`SO]X<>>L#VLT\O+K)0][7NVHRN[.TQ_^,'G:Q-QM21B\^K[7NA7-A/3'\S# M2H@WUR\>V2*>SYOX:?/?OOWV]I>?OGS^ZXF<4^7@?OWS[72&WOQM:F:V?;,A MGD\$*_BO[[E]N7-S\]_[><6=Z9FGO6;-R*!ULQG1*F MMMLU[-80K&&_AL,:PC5$:SBN(5Y#LH9T#=D:\C44:RC74*VA7D.SAG8-W1KZ M-0QK&-=P=SZ\]L#(18#N4Z)[.(_E)*I_N>G\O\O;"]SS71J.Q>]6B7G7'*.#F0'"2![ MR`$20B+($1)#$D@*R2`YI("4D`I20QI("^D@/62`C)"[.]*])F?GD=/[#V5J MJIZU^2$2J[\=*CLY<[$I^S88WYO1$Z+CZ?IX5QDEVTA M.T@`V4,.D!`208Z0&))`4D@&R2$%I(14D!K20%I(!^DA`V2$W-V1E@,MQ]") MBESI^Z(RL1L5(W*V5%%9GZK.1>>H0':0`+*''"`A)((<(3$D@:20#))#"D@) MJ2`UI(&TD`[20P;("+F[(]UKG=]U7 M-\]D%YH'D7S?/:UP(V-$+I/4[O)Z=2%\+K*YVD)VD`"RAQP@(22"'"$Q)(&D MD`R20PI(":D@-:2!M)`.TD,&R`BYNR/=:W)2).^`=(KL-K762I.F\CI!TI(.U)!U)(BDA'4DQ*2"DI(^6D@E22*E)- M:D@MJ2/UI($TDF2\-R5#$G!UOLZ0`9\V-T?3[$\-A^T&,WWFL]IA#.DMAK0E M[4@!:4\ZD$)21#J28E)"2DD9*2<5I))4D6I20VI)':DG#:21)*&9#[MB`MJ0=*2#M20=22(I(1U),2D@I*2/EI()4DBI236I(+:DC M]:2!-)(D-#B0$AIM;FBF^9XO-//FUO'^Z?K'>?,Y5=J?93O<-3+O6 MR_-&MB,%I#WI0`I)$>E(BDD)*25EI)Q4D$I21:I)#:DE=:2>-)!&DN0(1TUR MI,W-T30/].7(S`GU26PF=79\F&X3D80HVI)VI("T)QU((2DB'4DQ*2&EI(R4 MDPI22:I(-:DAM:2.U),&TDB2T.!`2FBTN:&9QH"^T)CQH`[->6*H-Q_<)7&N M6C8?T&X#"DA[TH$4DB+2D123$E)*RD@YJ2"5I(I4DQI22^I(/6D@C23)$0Z1 MY$B;FZ-I;.C+T3Q.=$YB>L)HKGQ`V^F6,W<_VI$"TIYT((6DB'0DQ:2$E)(R M4DXJ2"6I(M6DAM22.E)/&D@C24*#HR:AT>:&9IH2^D)CIH=Z\S$DE][JRF=] M\\UTM^'\YFS9?$`[5@6D/>E`"DD1Z4B*20DI)66DG%202E)%JDD-J25UI)XT MD$:2Y`A'37*DS-CJ;CQY`FLT'M)6K(&P^H(!5>]*!%)(BTI$4 MDQ)22LI(.:D@E:2*5),:4DOJ2#UI((TD"0T.D81&FQ,:284W-"=W!\Z6W,WG MY>IMUU)UWGQ(.U)`VI,.I)`4D8ZDF)204E)&RDD%J215I)K4D%I21^I)`VDD MR9V">KA\VB/N[AUS<_3(P/F*`V=#DDF;D`?2EK0C!:0]Z4`*21'I2(I)"2DE M9:2<5)!*4D6J20VI)76DGC201I*$1@^7;6BTN:&91HB>,Y9\R'&Z@%%7/I;< MS>=ZO?F8ARQOY?9W^J:YH&T)>U(`6E/.I!" M4D0ZDF)20DI)&2DG%:225)%J4D-J21VI)PVDD22AP;&5T&AS0S.-$'VA,:-% M'9KSM%&_[5K]W9F'Z2\ON=/E+6E'"DA[TH$4DB+2D123$E)*RD@YJ2"5I(I4 MDQI22^I(/6D@C23)$0ZDY$B;FZ-IJNC+T3QM=#8?/8"?-;W(D]_B7$U\R'M2`%I3SJ00E)$.I)B4D)*21DI)Q6D MDE21:E)#:DD=J2<-I)$D.<*!E!QI09O,!;:>_T>KN M1SM20-J3#J20%)&.I)B4D%)21LI)!:DD5:2:U)!:4D?J20-I)$EH<-0D--K< MT$PC1%]HS&A1;S[G::/>?-:W*E^=J^QU]I:T(P6D/>E`"DD1Z4B*20DI)66D MG%202E)%JDD-J25UI)XTD$:2Y`@'4G*DS-CJ;CQY`FLT'M+T" M[4@!:4\ZD$)21#J28E)"2DD9*2<5I))4D6I20VI)':DG#:21)*'!49/0:'-" M\W(UEZKPOD7:D@+0G'4@A*2(=23$I(:6D MC)23"E))JD@UJ2&UI([4DP;22)*_8VQFTV06_9*S:$-Z%DW: MDG:D@+0G'4@A*2(=23$I(:6DC)23"E))JD@UJ2&UI([4DP;22)+0Z+FSF44[ MYH9FFBYZ3F8OS=117119DJ^HS6=]\_-2M6P^>H)Y>D8[5@6D/>E`"DD1Z4B* M20DI)66DG%202E)%JDD-J25UI)XTD$:2Y`A'338?;6Z.IH&C+T?S(%)?%+W4 ML\GYHHBT)>U(`6E/.I!"4D0ZDF)20DI)&2DG%:225)%J4D-J21VI)PVDD22A MP;&5T&AS0S--%WVA,5-'O?F8#VKX$[4@!:4\ZD$)21#J28E)"2DD9*2<5I))4D6I20VI)':DG#:21)*'! M49/0:'-#,TT756B^9QQD!I)Z7SK/*/6^M+XO^N6Y:MF70#M6!:0]Z4`*21'I M2(I)"2DE9:2<5)!*4D6J20VI)76DGC201I)$#$=-(J;-C=@TBU01LW\7_N4\ MHW3V)3VV-/L2:&L6JJ'1CA20]J0#*21%I",I)B6DE)21,@V[6]T4O5>?-A[0C!:0] MZ4`*21'I2(I)"2DE9:2<5)!*4D6J20VI)76DGC201I+\TX2>6;1C;HX>F45? M5\443:DG:D@+0G'4@A*2(=23$I(:6DC)23"E))JD@U MJ2&UI([4DP;22)+0X-A*:+2YH9D&CRHTW[,OF5FEWI<,N?O2^F[JZW/5LB^! M=JP*2'O2@122(M*1%),24DK*2#FI()6DBE23&E)+ZD@]:2"-)(D8CII$3)L; ML6E,J2)VWI?F\:6S+^F)IMF70-MKT(X4D/:D`RDD1:0C*28EI)24D7)202I) M%:DF-:26U)%ZTD`:21(:'#4)C38W---,TA<:,ZO4FX\AV>/41='Z;NKK<]6R M^8!VK`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`RDD1:0C*28EI)24D7)202I)%:DF-:26U)%Z MTD`:21(Q'#6)F#8W8M,L4D7L?%$TSRB=?4F/+@':D@+0G'4@A*2(= M23$I(:6DC)23"E))JD@UJ2&UI([4DP;22)+0X*A):+0YH7GUR)CZY.Z8VI)[ M4;2^FWJI.F\^I!TI(.U)!U)(BDA'4DQ*2"DI(^6D@E22*E)-:D@MJ2/UI($T MDN17,GO&U(ZY.7ID3/V*8VI#ZNW7`VE+VI$"TIYT((6DB'0DQ:2$E)(R4DXJ M2"6I(M6DAM22.E)/&D@C24+C&5,[YH9F&CQZSEBOS$!27?E8?]2W32]6R M^9A>RX1HQZJ`M"<=2"$I(AU),2DAI:2,E),*4DFJ2#6I(;6DCM23!M)(DASA MJ-W=.^;F:)I%^G(TSRCUE<\K/;:M)`&DD2&AQ;"8TV-S33=%&%YCO>D;TR`TF]+YUGE/H= MV?J6:;MPV82VI!TI(.U)!U)(BDA'4DQ*2"DI(^6D@E22*E)-:D@MJ2/UI($T MDB1BY\-M3S`2,6UNQ*99I(J8?4?V:IY1.ON2'EN:?0FT-0O5I=..%)#VI`,I M)$6D(RDF):24E)%R4D$J216I)C6DEM21>M)`&DD2&AQ("8TV-S33X-$7&C.0 MU)O/>4:I-Y_U+=.OSE4VLUO2CA20]J0#*21%I",I)B6DE)212!M#6TV4\9_?OI5POWO7VY?KVZ!VZDR^_P#C^T]=O!8Z+'(8T>/ MQ1Y+/)9Z+/-8;DQ%IS`D?_'"?KW^HCQJ,ILN]ACB3+][%:?#*2JS+;+/)8;<\)H?YPR M`E+?_VK\5YZ[O3J'MO)8S4=H5)E^A-4;^5:5V>^A\UBO3+=;O9\;5)EM-WI, MXNS_`:Q.EQ+QI4X:NAF?QK"^C,_C66??G&DS_=[2Y<=]NSIM/$P7!:=?T_;R MM&5>O=BL`KFU%4ZCJ]>KX[:S9=,_BG!^O)WMRLL/<+!E M\@#3YKY9'=:0G2.[Y'+GHRV[_-1C/D!B5UY^@-2677Z`C`^0DPK;[/)CEK;, M_KA6![YBYYK4V"Z7'ZRU99>_P8X/T-N5EQ]@L&7VN[EZ_6RU#X]L+B\YDVZ[ M;'4](*\U_ZMDJ7-??M/TVO?R,U-M?8J9:7KYV:`_O#;V9K&M-56WLR;/VJX- MC#FO&S[$P;,TY-+(EJE'/5I3CQIS:6++U-+4FEJ:<6E.*NQ*U:VTIKI57%J3 M&KM2=6NMJ6X=E_:V3"T=K*FE(Y=*RLR!4'62+.?HN#&:YMF^&,US;F<7GTG^ M)36;A(?7,VTV\SXH._;JE;"U%=._<_3X5KQ39;9Y8$P]WEZ57>AV4&6V6\AN MD2J[T.VHRFRWF-T257:A6ZK*;+>,W7)2H59>>(!2E=D'J-BM)C5JY84':%69 M?8".W7I5-ITC7[YXMKJ`&U2%;32RD63:I$PR=#K;KC(F^38%TZ^4/8?L]O:Q MG7.:K_LB;^;N>N><247PX?5,4^3MD]Y:DR=H;>>QP)AJM_>4'3P6BSCTIQ4>%:6'JNXM"8UGI6MQSHN[3UE@\=&+I60F>.JCJ$$RZ`$ M2PZLNW%.TW5?BLS47:=H)G6^?'@]TT9.OU.D9>-J"]*CN]=J[7K\*#JK"-0C:*5-GR&L,U]5&5V6XQNR6J[$*W5)79 M;AF[Y:1"K?3]^$KU==NY8IO:D'K%-J26U)%ZTD`:29+-.2WJ64@TM3G)O'WD MTYV3NY_N&%*!>3`T)=/^8+;6U$7%SF,!V^T]90>/A5P:>5F_Q#^KKMDW(-I$J6YXT M-S=59KO%[):HL@O=4E5FNV7LEI,*M7+ZKF_6>WJI"FSKBGUJ4D-J21VI)PVD MD23IG'.E0G1W[YB;SFG"[SGOWLZ3?_V&Q9!J_&#(N7JSIL[\.X\%;+?WE!T\ M%G)IY"D[>BSFTL13EGHLX]*<5'A6EAZKN+0F-:26U)%ZTD`:29*?^;F9QK:^_(S#_.=_,RT'ENN]IB'6U.V7,NM*K:V0LZ?%S:$G2JSK]K`F#I# M[U79A6X'56:[A>P6J;+3A=)J-G=47[=M8K9)5-F%)Y6J,MLM8[><5*B5IYW^ MZMEJ^%VJ"MN[8J.:U*B5%YY\J\KL`W3LUJNRTS-=3[$'56#[C.PCP3;!,F\! M-JMSI*3<']#EK82;_&F6[TO^/.-WDF_&_FH"]7!KS+DP-.9<&-("L]9),LM1C&9?FI,*SLO18Q:4UJ?&L;#W6<6GO*1L\-G*I MI(P'0I)E<`Z`&Z-I3.V+T3R^=F(TD]J9'VYGNC`QM!5R.K[P8MRI,OLB"HRI MQ]NKL@O=#JK,=@O9+5)E%[H=59GM%K-;HLHN=$M5F>V6L5M.*M3*"P]0JC+[ M`!6[U:1&K;SP`*TJLP_0L5NORJ:-\^7K]77MH"ILHY&-)-,F9>;=Q?KS.'M-#_W17[RU3OJF50$'TZKY28G/3&TYEQSSDLWR@)3I]KM/4L/'@NY M-/*4'3T6#*K.OR)#=(E7FO\KDDXK9)E%M+NPWJ2JS3RICMYQ4J)6GYWG[;/71 M?JDJ;.^*C6I#ZH7;D%I21^I)`VDD243G'ZMZ%I)0;>Z9?9IV^P(Z3\&=@,ZD M`O-P:V;ESO6A,96UG:U3%AA3[?:>LH/'0BZ-/&5'C\553OYT=/K^:_- MW<[T'P>'ILR>VJ\VZ[LO=K:3W5G2!WW!T/.U9TU%<"=QP*VVWO*#AX+N33R ME!T]%G-IXBE+/99Q:4XJ/"M+CU5<6I,:4DOJ2#UI((VDNSN/W3OFYN>1STO> M\/,20^N)XNI&V0=;MESKK2>*MN(_7.NI,ONJ#8SILM1C&9?FI,*SLO18Q:4UJ?&L;#W6<6GO*1L\-G*II(P' M0I+E!,#=3*>1MN<:4K;"]:C%D',R-@/QQ^]'-(NF(6W@`^.#*K/=0G:+5-F%;D=59KO%[):HL@O=4E5FNV7LEI,*M7+Z&5ZM M?H:E^KKM7+%-36K4R@M/O55E]@$Z=NM5F>]Y#NKKMLW(-I)ADRK[EF/U_4J> M3<'W31/?3+-U7\3GF;M^FW0J_?FI$W$SF=?31%.F)X<[CP5LM_>4'3P6BSCTIQ4>%:6'JNXM"8UGI6MQSHN[3UE@\=&+I60F>.JWC-( ML`QZIHEOI@FV+T7S9-M)D1UV2TS5[;&K&#^<.CH31EQUFD;FDN'U]7HZMK,] MU'DW,.:]T.VHRFRWF-T257:A6ZK*;+>,W7)2 MH59>>(!2E=D'J-BM)C5JY;3OO5@/2%I58%MW[-.KL@M/=%!EMMO(;I+PY6A> M:">A-W7?>=TY#=Q]KX-Y$.^\#NQL?KFU\>&-,=G"[9/?6E,AWGDL,.8$V[13 M2P^>I2&71IZRH\=B+DT\9:G',B[-285G9>FQBDMK4N-9V7JLX]+>4S9X;.12 M"1L/A"3+"8![W3E-Q7TQFJ?E3HQFVJS.]JOW80]O3-ER+8KMU%28ZXH;W-*R MLSW422$PIJX)]JKLPBOKH,ILUD-VBU39A6Y'56:[Q>R6J+(+W5)59KME[):3 M"K7RP@.4JLP^0,5N-:E1*Q_93I?C:%MW[-.K/A>>Z*#*;+>1W23ARZ->:">A M-W6KN"[C#O=U,$WW?:^#>>KOO`YFFEX']HD^O#'F7)T:4R'>V3IE@3$GV%QZ M\"P-N33RE!T]%G-IXBE+/99Q:4XJ/"M+CU5<6I,:S\K68QV7]IZRP6,CETK8 M>"`D609]5Z?3M-T7HWD*[\1HIO5,=/4!Q,,;4R8GZM.;.?[E<%MAKD[?7#]; M;;@[56$3&QAS3N+FH:31A5?6P=,M9+=(E5WH=E1E]KG%[):HL@O=4E5FNV7L MEI,*M7+Z.;_:K'^*I:JPO2LVJDF-6GGAR;>JS#Y`QVZ]*C//=#5''U2%;32R MD:1[.>!3IU5L).C^B#ZRA6Y>//*!TOP%=Q9JS1F&GE%?E9Y175ON?!A8U)FV M-HU[[<_BX,/0HEH=6=.KCSZ,+:K5B36].O5A9E&MSCU66-,=2Q]6%E7'VF.- M-=VQ]6%G477LK>G5@P]'BVKUW9U%O?SN_JR>FS`W+Q[YT&G^PCIC9M2_N@18 MW4#]8->JFS-7+X7MN<1>LZYN%Y=`VH\5EK\+*X&<49_:K4U#JPN;@624#26C M:"@970HO-)38+G7VE2"Q14.)[5(X;0LXGTB&EPK;2C*,5I)AF&1X63RUWZQ^ ME)+GI%I_V-/DWUYR/C59'5K*^++"/)EE'9\GZ4CAU7H]_ M)?=+@>TDN4>G*?=+I>]',+T&3,4JNH]NO=,G"Y[KCLV+^2,'?>%AS;F`/:.^ M@CVCNER5I-N/-IRDS^@FG842:Z+$&JLEUBR4#!,EPU@M&6:AQ)8HL<5JB2U, M8LO%$E6B1!6K):HPB2H72QR)$D>LECBR4")(E`AB]11!5DZQ,^JYM-V\F*;] MWHS-'P.X&9M-;?>RSVG2&N;`Y M2BS94&*)AA++I?!"0TGJ4F>?H205#26I2^&%AA+>IOFZ;2X[12'(,DQPOBR]\!Q+MIUP]78GY4F`[ M2!^6S#O<8UJ*Y2)>1$ M"3E:2LA9*(DF2J*Q6A+-0HDO4>*+U1)?%DI6B9)5K):LPB2K7"P!)4I`L5H" M"I.`",V?T+@1FPV=>*5 MC78V=3V[7#?,]\R?2RY?A4H&32MU!2`9Q&-*!I?""YN`Q'*ILR]=B24:2BR7 MP@L-):E+G6TH245#2>I2>*&AA'>ILPTEO&@HX85)>)?%OOU&@KP4V.X29'22 M(,,DR##),4QB#),8PR3%,`DQ;`HQ43*LT9FF;EY,GSAX(SQ_%.%&>#8WPK,Y MMY?.7>636A5&2:BI5"@)14M)*`LECD2)(U9+'%DHV2-*]K!:LL=""1I1@H;5 M$C28!(V+)5Q$"1=62[A@$BZ8A`LFX8))N&`2+IB$"S:%BRCATK@*US39]X9K M'OF[X;(?`\AI7MT$L/H7/V7/-'6/SUG/)7*2GB]+5M)2N#PKW@B@Z^QN(?%$0XGG=S64Q"YUMJ$D%@TEL4OAA6DFD81+I9?&%;T)BOM39!Y&LECRR4#9>HB00JZ<$LG**G5'OM>GT MD8`W8_-G!6[&[.<',LQ:]MXWJX&?Q,[4/7[+P+E$SO*GO?=ZM8%+(DT3]SI@ M1G5I(7OO4K@\*]_>N]39%[*$%`TEI$OAA8:2VZ7.-I3DF\E\+3#V*5'(GZ4F`[2=31:8KZ4KDQ1;4ZL:97IS[,+*K5N<<*:[ICZZRQICNV/NPLJHZ]-;UZ\.%H M4:V6U'D.CD3,Z%RZBM@T]_?MKYOY`P%G?S6VBICYY]#%EM>OL9KIYN?X7 M)R1_IHV;OQG5][C7A=-K]&9]121A9"L)(UI)&)?"Y36*G5GRN=395[WD$PTE MGTOA]-QP1ZB$=:FPK22L:"5AA176IG!,[>7'B*W4TU^BBUX279A$=S;;7_[! M]=6I0(*\E-CG+T%&+PGR4C@]UZLWSU9G4(GU4F)[2:S1:XKU4KD<*-]FZJQ> M)7WZJ,&;]/DS"#?I]G,)9S,UZ&ZF!E5N)B,TS?S=B]G,`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`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`$%U"L@$,T2TD_C=$HZ.6_C)5#/H=M;24J82F1BV-92JAMU%++YE*:%W4 MTE&FDG0PPOC*:"35TIFG1M%/JJ493R6TBVIIR5,)7:-:.O-4LH>D&4\E](9J M:B55F$EI!XS@@='_&<$1H_XCDC=*IE/7:NIF$M MZS%"6UH\9P2[I8!S1F/:>,[B8D=W(WU`\9P=^1*21HC5"_3XQ'-&UI!T0*PQ M-!M&.SLV>@ZCG9$])*U=Z[O18!C/&:'/,)XS0KMA/&<$T5(6TJ>Z_J2(ZIHN M(`M]OR4D'7GKN]%<&N6,K"%IQ5MC:"&-NXW021IW&Z%1-.XV0K]HW&V$WO8H M9QK0XA[EC-#!'G<;H9$][C9">WK<;01CIWA7QLP`5F11C`Y@14:8#(#GC#`@ M`,\984X`GC/".``\9X2A)ZA@YUVFFK!6(QE;$L\9BQW=C3#"K!KR8(21->3!"(-H MR(,1YM'@8",,U6H9>517FJE9Y$$94V3(@[W?`K)0LH1D^DO]22M(9L!4PFPB M\F"$T4/DP0@3B,B#$08,L5.,,!6M9995/0*&H[6,M*J$&6DM4ZPJ80Y:RRRK M2AB'UC+2JA*FHK7,K*J$%*1B8J!>90PQ:YXAYN2UC"*K,4M(AH]5POB[EA%D ME3`%KV7J6"4,N6N9/58)L^Y:QHU5PD2[EJ%CE3#8KF7.6"5,W40YTX#AFRUC M#FL,LS71U`@C-EOF&]88QFBR'XRP'U+5*F.J*2NR*(:;LB(CS"[%,ZBXLAW8^,M<5U=A1+R)D2IM7B M.HMA:"VN,\),6EQGA-&TN,X(D[/1SM;#=&RT,\*0;%QGA%G9N,X(H[!QG1$F M8N,Z(PPD9SU&F$O.>HPP?1S/&6$(.9XSPHQQ/&>$4>-XSLCA#6=WYLC7O7(' MN5-R#\EP^QKS",GT^DHP8FI-93&C>Y&I\SC.CIMI\SC.",/D<9P19LKC.",7 M'-RE'ML6LE5R!;E6LH/LE-Q`;I3L(;=*3B&NVP*RT)@EY$S)"K)2LH:<*]E` M-DKV(]7*&SOG'B`')7>0.R7WD`_>@?"5'<,&M%%R`;E4LH5LE5Q! MKI7L(#LE-Y`;)0\C%<%HY\)'R`0:R7O$>&]:O``>5#R"'E4 M\@'R00,R4K MR$K)&K)6<@XY5[*!;)0L6>I*5[J&;)1<0+9*KB`[)7O(00@Y)[R(.21\B3$OR3:XLC^^[;D\!_?O^? M/SY^_G3U\_YO?_GCUY9?//W_[R]?G/^CY]:]7/SQ_ M_?K\V_3'GS]]_/'3E_QO_O-/S\]?__X+9>9W?SU_^>_T"R;?_P\``/__`P!0 M2P,$%``&``@````A`'M05^[U"@``2RT``!D```!X;"]W;W)K&ULE)K;CN,X#H;O%]AW"'(_26SG:%35H'VVL0LL%K.[U^F4JRKH M)"XDZ>Z9M]]?EFA9(OLT%Y.NCQ1-2J)$2W[X_<_S:?*EO=Z.W>5Q&LP6TTE[ M.73/Q\OKX_0_?Q2_;:>3VWU_>=Z?NDO[./VKO4U_?_K[WQZ^=M=/M[>VO4]@ MX7)[G+[=[^_Q?'X[O+7G_6W6O;<72%ZZZWE_QY_7U_GM_=KNG_M&Y],\7"S6 M\_/^>)EJ"_'U9VQT+R_'0YMUA\_G]G+71J[M:7^'_[>WX_N-K)T//V/NO+]^ M^OS^VZ$[O\/$Q^/I>/^K-SJ=G`]Q_7KIKON/)\3]9[#<'\AV_PKMVM M>[G/8&ZN'>4Q[^:[.2P]/3P?$8'J]LFU?7F'OH/^>VR_WD;_ MGMS>NJ_E]?C\C^.E16]CG-0(?.RZ3TJU?E8(C>>L==&/P+^ND^?V9?_Y=/]W M][5JCZ]O=PSW2C4Y="<\"?^?G(]J#B#T_9^/TQ!/.#[?WQZGT7JVVBRB(%Q- M)Q_;V[TXJK;3R>'S[=Z=_Z>5`F-*&XF,$?P:(^%B%FY7P6JMK'RGY=*TQ*]I MN9PMP]5FVS_^.PUAMO<;OZ9A$/W<(]>FY69H^;/.(CGZ9^+WUYS=F8;X_45G M`XQ\_TSU#]/V!^[.]0CW,R/;W_=/#]?NZP3IAC&\O>]5\@:Q,F?FA!F>899@ MLAZ4^@>E_SA%L!C_&^B7IU40/LR_8-H=C$["=0)7(R4--?64V\/DE)@YID/LA]4/B@]$'E@]H' MS0@X$2,I6<318AAE)4;2.Z,8"FM7)1U4AJ@9R1DI&"D9J1BI M&6G&Q`D>ZPH+'NO@-^>\TL=BB.P8(N637BM]MSL&E:$[&,D9*1@I&:D8J1EI MQL3I#D0^[@[*=(7[J,G;Q!!DT;?[(1V4J%G&2,Y(P4C)2,5(S4@S)DZ06."E M(!5V@S0$B3,*TE!*NP&J4E@5["4 MD8R1G)&"D9*1BI&:D69,G(A4Z3G:GFAN*NQ&I$D0#6MRRDC&2,Y(P4C)2,5( MS4@S)DY$6"_'$9D-=[;!S+V_'0^?D@[S+AA68J7N1FK(:.P8R32)HGZ##A>! MMW;G@YSF;\%(R:Q6@X[:]F'5V^/J04Y6FS%Q>D&5&N-NH('MN1NO01'6KU%& MKKR,)"W;+1DAU;-4K(0;;X_*26O3]U6TF>US%C(STH4+<5W$S)446(++N^U%9,=AM" MO7ON,*O"1>H)Q;WU4",GGPT:AVV0S=1&MV2EIV=F:$=-H%2+M@-_[/'9S;%8SO_JQ&F2Z(22DA*J,I-[0%9/3&Z:(LKMIJMXR M529;_S)"-D=SC@I"MF')447(VJHY:@CQX."]&%S/W<7,("??P\BK@U+2LC,T M(Z3S<+F>>6URJT##41"R9DJ.*D+&T`E9ES-"-BESC@I"MF')447(VJHY:@@)P:F221IW74HYXZZ1 MD^"KP*O!TM!HV;F9$3)IN)QY14!N%6@X"D+63,E114A;WBUFWNET;17(2G9J&XQW-H+4^Q`@6X6KFE0"Y M5:&!*LC0Z&V=D,V)BI!^#]\%.[[(:[>CS;"$-=2(OXV'JLX:S0$ZS>BYUQVZ M)$-WD,NIT7)BUUK!ROJ<&[4Q*PS;6FLEMU:1EGWYKCEJ"/6VW-%6%9(4GJZ< MG'37R$WW<.%6WVEHM.R,S`B9=(]"OJ&;1G:S*JB1M5-R5!'2IJ,E>P6LK08- M2D-(2'BO=/MAPO.2+M3(27B#;"@9:=DDS3DJ"(T3GMFJ2,O:JCEJ"/&$Q]V0 M.`5Z[LYP@YR=/MCZ.SUIV0F>$<(Z-ZP4_+R.M'3JKE#C>Z8+TA@M`83LTRI" MWWU:35KF:7C?\Y[6D`9?%2*O]/O11.GUO;[4-=NX-#!:X]7"H*7-[YR071@* M0G9%*[FMBK2LK9J0M=40ZFTY:P6^7W`F2A\TEFYTL[ZXMU?*^KS[C^Y]?-[= MM_Z#?WW@G=+_IK#'WG M?FZOKVW:GDZWR:'[?$$T.[6[#5A_!I*L8USQ8"7R>132]R&>!),Y5B/'VV`" MQVH`N003%]8D"3Y#^=`'X#TEP>4D*@LXA)4"^B5/C_\ M;@RW<8*5EK?!OABGH@3;8ZP6?]X&>V"L]@`NP588EZ($.V*LEG_>!ML>O)8D M">))Q'A0N\%K*=(,$E6V\.>@3(/7DJ2$1-4PO`V*-G@M2?`:!J^EJ9:$2W@M MS1V\*>`UY($+\OP6HH'+\CP M6I+@/1E>2Q*\_\)K28+78'@M2?`V#*\E""U)<$"#OI8D">))Q'A22-1)&X\'YXRQ.EWC MD@(2=1N M2Q)2)-G$^-Y"\&P7XRL`SJM=C'M\SA/TB[I< MYI(4$G7'S"6XDX_553.7X!X>_2))<`&/?I$DN(='OT@27,?'ZAH:SYD/VR^^ M<'W?O[;_W%]?CY?;Y-2^H`!;]%]>7/7'L/J/NZY()Q^[.[YM[3^1?,-'RRVN M2A>JCGWINCO]H1XP?`;]]'\```#__P,`4$L#!!0`!@`(````(0!&ZIZ2+`<` M`.$;```9````>&PO=V]R:W-H965T'KC\MY]#VOZJ*\;BU[/+5&^34K#\7U96O]]2WXLK9&=9->#^FYO.9; MZ]^\MKX^_OK+PWM9O=:G/&]&L'"MM]:I:6[N9%)GI_R2UN/REE\A.9;5)6WP MM7J9U+Z*2__<"U;V.)69L(*/H65^7+LK*9S>P8C=P;.Q4!\ MRH&+WO1W1B[$2'R*D:L/S8CUM`[C4XR;S<8K>[J9,W_O3+@4`U?=P/D'EXI# MU4Z)ST\M=2/&X?-S2[61+WQ76>+P#?O)8B<\+]I\\M(F?7RHRO<1#BDVOKZE M[,C;+K,K,DE$JLLMI'C&U)^8_M:"JTB:&O3[XWS],/F.7,V$RHZJV+K&7FJP M?&56O2'PAR`8@G`(HB&(AR#I@0G<[V*`M/Y4#)@^BX%<_DX"%939P&.I(8=X M0^`/03`$X1!$0Q`/0=(#FLX=5JN=B<(3M7_AF'?Z8DGF0F M)QG6G>3$5@5M3XA'B$](0$A(2$1(3$C2)YI'K'WM/:QD:C*L>\2)/>]*])X0 MCQ"?D("0D)"(D)B0I$\TCU`M^QZ)Q^^8]2K-J=R7RSNZ>ODQ=]U20WMX1 MXG$RG[>/Z]G4GNOYZW=RF;\!(2&Q&G4ZK`F`U<$C+^[DTFK2)UH46./1#X/< MV);K_@HT1_GJGQ,-_JF[6VAI0J")Q$[7-\?-YLQ204QAE^%N/?$3"C-*,N11-SR&CV0$N^T?/AB?;E&)73 M@43*3$A1)%%G>5"&8J4@-R21J+6L;S3K5GJQ^-FS`/?]X<-`(.VDV6&KQV6;.9E@D M$JG1SJ;'C/5'O9C]-%%X/Z4=)HZT2B%0/W`<.:J,^[9`JHP'$JGC$PK4JSJ1 MU%*V8HF4K40BPR.!M5#WG/Y6WOJ=$KI9&5#^M'"?L%`JV"U<7*L-W'%Q%37P MI8O;FX';:ZRTK;+#I=H;^6)Y(,&#!1+C+/;2W>%@T7E0+-V]48*:Z7I&B0\) MJP+4&NJCRXH!E:!,NJPF4`FJIA(W"]@_BX;_.#2OH(_X:>T M'/>K*2OMQ[)LY![@[9O'KQ^??OGT];4-/'Q] M_O'M[R\O?R3OWS]__/WQRX?G=T]_/'Z%\NO3MR\?7O"?WWY[__S'M\7QZ\ODY-OCY\_O*#\ MS[]_^N-9O'WY^#WNOGSX]L]__?$_'Y^^_`$7__CT^=/+_VV=OGWSY6-2_?;U MZ=N'?WQ&O?^S./[P47QO_X/G;]__],.V@6X^/?[Y[/W]YOGWIS^+;Y]^:3]] M?41KHY]<#_SCZ>F?SK3ZQ2$D?D^I\VT/#-_>_/+XZX=_?7X9G_XL'S_]]OL+ MNOO$)?GX]!DYX?_??/GD8@!5__"?']\>(H=/O[S\_N/;H]-W)V<'1XO#D[=O M_O'X_))_7IR^WD]%B=C4Y.9J=X%_#R9Z$QW-"_#LG/-?,]Z1# MT;:EQK^[#/>6\'1.<.8E^*Z<\(/8YH1__U8)+^9T^/?[2KA`'V]SG)UONV)/:RRD$]T?N]R^JWH+]/N4JP;`]W7!0CK=_3%G>KCXS@)+OR^T MX[^WKM+UB&;)UH_8?<\@CMM*<]#R5V#C4"OK,K#B4`W!]_KYS2_VYX MFE,NSMZ=+0XNCLZ`]I57^O]0^W]_U+V?!LOM()M^>/GPTP_?GOY\@YD+;?3\ MQP7N?<=P,NQOV/SOQG9__C6T0"AM)GT'__='QZ],/[?V,$_SC; M+-EF$5JLQ,*-XLYM&H,L!GD,BAB4,:AB4,>@B4$;@W4,NACT,1ABL(G!&(/+ M&%S%X#H&-S&XC<%=#.YC\."!]XB'75#@Y_"W@L+9NZ"0[EP*T"@YC")`+"1) M&H,L!GD,BAB4,:AB4,>@B4$;@W4,NACT,1ABL(G!&(/+&%S%X#H&-S&XC<%= M#.YC\."!(`(P#E($'!WL1@$G8WT5C`+'80\O)QLW\N^&BM/09+4SV44!D8Q( M3J0@4A*IB-1$&B(MD361CDA/9""R(3(2N21R1>2:R`V16R)W1.Z)//@D"`[, M=!0<;A$SS5@\9SA[K,LQD>\B@2>-R6AON.Q,=N%")".2$RF(E$0J(C61ADA+ M9$VD(](3&8ALB(Q$+HE<$;DF+K"0?!($`:XYK2!P.`R" MF81!$*\>=D:[(""2$=C&,UJ<'$^[)8O3HXMH-IM-CK4?TAD= MA2/@69@P4ROIP)Q1P>Y+M?)GV:A]ROU4K<=XQZ=C^HE>\^VD'8 MJ)6X'P,4]J#;RO!Z<-[)?.>V4E]^__3QG\LG+"@7NRT,=[\@[MD)+4ZFVTMN M8W(UFP4].YF=:?]GLY6'OM5AAB>8U7#2Y=&(5^#J/!K!>K+00@Z`@ M8=R\&['2YHVB?A2+;97#('%[#5:03'L009!,Z$A_K"MWJ\[%C18YG=&Y6F6" M="S(!6WO=F_O6Q3LJQ0K]54)4E^U(/75L*]6K-376I#ZZ@2I5<^^!K;:"%)? MHZ!MN<)&1W^:C>YXM.:9T'&PXW<6A<[*;1DB83"TSL@-T__^Z?#@_%VT)LDD MT73;W@W1N2!=/A6,2D&3ZX/XQURI+@-,+4@=-XQ:09C)O5]35.ZU6HG[3I#? M2H?\`Z-6&B3AJZVT40O);12TK4S8L>YZW?HUS=?Q_I`[(72L^%VY6]!Q+\Y( M^R@3*T6Y(&W=@E$I2!-6C&I!ZJMAU`I27VM&G2"M8R](W0^"U->&T2C(:'1W M?6PU^GS=K+DO%Q/"$.8%V'FTU%N)E3^JS0E/IRN/DX-WT4\PDT0Z"N6"U$_! MJ!0TN3YX%XW=E>H2*+4@==PP:@4AA/37=!ZY7ZN5N.\$^:UD_)KF)M%"#))P M;J5C6H7N6E'R&B7)UDOX6W(7Y5:W3A?KP@ MT>=+^C"\HH7=RMV%BL>T&4UC[N+@710FF:31`2$7I,-&P:@4Y,\?1T?1^J]2 M*XG"6I"Z;QBU@O:Z7ZN5N.\$J?N>T2#HM7;9J(%X'@7QJ(BN,GMRR\,UQHS< M".L-%%&SK68K?XTA2#LJ8Y0+TMH7C$I!ZJMB5`M27PVC5I#Z6C/J!*FOGM$@ M2'UM&(V"C'YPVQ+&+^K0\:@?)A3-3M&O8S4G]-?<@J9Q]^CL(EZ296HAH9,+ MTL&I8%0*FEPOWBT.@O]%LTFEYI)/+4CS:1BU@L(8C*Y_UVHE[CM!^RJK8E0+4E\-HU:0^EHSZ@1I'7M!ZGX0I+XVC$9!VX3!&L$=,C0;G;JG8%0*VCNA5&HE[FM!ZKYA MU`KRW1^?Q9=3:B7N.T%^6_$"4*RT$(,@;:MH]-JHA>0V"MKZ";O7;2]88Z?C MT=@Y(?]RRATCC98>@G0PSQCE@K1B!:-2D/JJ&-6"U%?#J!6DOM:,.D%Z0=,+ M4O>#(/6U830*,AK=725;C3Y=/6.FDYY;NN.V:.%HPHJ&T958Z>\^%32-O8>+ M0]J<4`O)+1>D?@I&I:#9]2%O3ZB%N*X%J>N&42O(GZ-H>;E6*W'?"5+W/:-! MT%3RXZ.C^%)PHQ;B>A2T=1W^>%!,OQ__:A??'5F.?U03"B:J&6E5TCGAL>ZG M9HSR&9UX]V)FY*UD2DY8,:K95\.^6DZX9M2QKYY]#9QPPV@,?(6=X:Y\K1_5 M=$4<_*@F%$U4T7;#ZG"VTA]^.J,3S'V[93SOQ<]69]-F\>%A?`LU%SS.KQ,H==\4F)!X%B6:?6BPTMX9S:\5J;VYKL?*GK>/S*,=.K`)?M%?( MA1C,A+09/UM)^QZ?',;KA5$<;>L59,2/O*K`4*UWJ58)T-[P6I+X:]M6*E?I:"U)?G2"U MZMG7P%:;&7EU',5J6ZZP,]P^Q;[.N'KZP[\->CCM:P2=,2'LM\B`O9JM/)0R MRACEC`I&):.*4T/)+.R/VS6[\>Y+M?+=1ZN#2JW$?M6NUQOU8K<=\QZMG]H%:>>SJH MI5;B?@Q0V*%8`>U^11B5=K\BQZ.A:T+!02UWT`9F7A.G,W)9>CT8+5TSM9)" MYHP*=E^JE>?^++I[5ZF5N*\9->R^5:L][M=J)>X[1CV[']3*=Q_]+C9J)>[' M`(4]Z.^/H`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`(*5`F5HIR05KY@E$I2!-6C&I!ZJMAU`I27VM&G2#UU3,: M!*FO#:-1D-$/;I?"6!"@'>-+X1E%B0 MVD8M)+=1T-9/.%"Z'0FK8QV/9J<)!;/3C+1\Z?&,=.3.&.6"-&'!J!2DOBI& MM2#UU3!J!:FO-:-.D#\[41T'L5)?&T:C(*/1<=%K-KKC4:-/R,UTNO@YCW9S M5\>SE0X"J2"YDHE^@)GJ$B6Y(/52,"H%[9T^*K42][4@==\P:@7Y[H\OH@.2 M:[42]YT@OZ5XM2=66HA!D+14-&5L5)>\1D%;+^'OR>TD>+^GO]I+/';V49=/ M"%TN^:UF*_R,!:6"]"!(QB@7I/%<"%)?I2#U53&J!:FO1I#Z:@6IKS6C;D8+ M[YYX+V;J;!"DSC:,1D';@H6]\9K;1]+^))?A1'O%-X['8G M_LZ/=MK-\+=!MB["'41!6I=T1A@^Y'>A4?U6Y6)WMK`KV58J5^JH$Z;Q4 M"U)?#?MJQ4I]K06IKTZ06O7L:V"KS8R\.HYBM2U7^)OUMT'<4;#I!:#ZV'QT M7@0'YF@$G1">ZI!F7LU6'DH998QR1@6CDE'%J&;4,&H9K1EUC'I&`Z,-HY'1 M):,K1M>,;AC=,KIC=,_H(4!!D)SXFRH2)$?G[]PYSM=>^K=-$TZU@H([K1?1 M`F"E5A).*:.,4Q<>,POB(EM(K2:BKE)11QBAG5#`J&56, M:D8-HY;1FE''J&`A3&A]L/DM6`'Q_3 M/I$_Z^,8M@L9;$S)R+!BE#+*&.6,"D8EHXI1S:AAU#):,^H8]8P&1AM&(Z-+ M1E>,KAG=,+IE=,?HGM%#@,)@\#>^_&#@C2]W8MP%@UZ_K!BEC#)&.:."4,;AG=,;IG]!"@,!C<5I`W,M#2 M-'JC$\Z%TXPR(UWNK\1*!Y%T1N'9GHMX.U2M9/3)&16,2D85HYI1,R,<]I8< M6[7RK_ZB9_O6:B4).T8]HX'1AM'(Z')&7E&OU$J+NCB/9O-KM9*BWC"Z973' MZ)[10X#"Z,+:U8^NW;K$\6A=,B$]&6;2 M`KG!BIEA(A6STC/3)CX^C4^'>F:2M#98,S.O#JUGYN40UV'MF4D.G<'ZF7EU M&#PS+X>X#AO/3'(8#78Y,Z\.5YZ9ET-X] M,\GA(61A@/I[F_YE M6GFM0"==U4K\^&D_6:B7N.T8]NQ_4RGZOU,IW'Y7^6JW$_0VC6W9_IU:^ M^ZCT]VHE[A\"%,:EOWWLCXN\37PR(7=H5??*X\WLE5CI,BL5Y"?DNPQB-6_[ M+T[?G5]X_XON9N1BKONDA2#-NA2T-^M*K/";\&H6W>.HQ2KP%=\%:,1*"]$* M"A+&#;<6*[\0=,JR$RNM=B](WP6]?`6^O#X.?SO1;O]NTJK%J16#?MJV6HM2'UU@K17@%-*/P7`0='AJK9S0(VNM^HU;B?A2D[B\970EZ MK2>NU4`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`5U_B2"W%E)HP+<3U;[7KY=!'ODMZ((ZWS+6=W)U9!.>/L[L4JJ'/\PM$' ML0I\>74.?S'1;86_'%;Y=L/IA(*UXHS\G\V$O',.V9S0>SMF/B/Z,G3;;VX=PK"+M\NU'S MY"#>RU,KZ?Z44<8H9U0P*AE5C&I&#:.6T9I1QZAG-##:,!H973*Z8G3-Z(;1 M+:,[1O>,'@(4Q@VN9_VXD0V2,\>C^)A1&!_1TZPK2:BKKI11QBAG5#`J&56, M:D8-HY;1FE''J&`A3&QROW`L[X7L", M_`<(&*6,,D8YHX)1R:AB5`QJI7,#SFC@MV7:J73SW%\ M?K)2*W%?!RAL`K?OY#7!7ZV,XWZGK:O5;!4TS605GK$[C5:ZV9S0.U"7 M,RK8?:E6?M/$V\!JI4VS*Q=0V#1N$\1KFMVX/VV.^`\&G4THV%LZB=\#N1(K M[S)=$`JQ6U#P.2^QFL\`72SBNV>Y6.C%=R%(!\#EQLNDOQ]#$%:Y'1&_OD>0;KHRP7I`K)@7Z58Z0*R$J2^:D%; M7V'E7KDNQU*6?A/SU:=_C7-R$#]I.B<,?B930@2J^_;#XNCT..[K;$X%$PGB MG!T5C$I-./L^BGU7:B*^Z\!1V![NFL;Z@4S7.L$/9+[\T1WO%38^7*L%E9^0 M5[-LMO)0S@D+1B4GK!C50<*@<`N:MC,/ M\>V::*\C4POICUR0^BD8E8)FUX<7U-5J(:YK05O786OX:^"%VQK9[K+\?,YK MX!GYOVM!6N14D/YB,T:Y($U8,"H%J:^*42W(J)R_@/,KQPNX\PD%^VTG!]$T MLQ(K;^-`T'3;#3=`HS$U4P/ICER0NBD8E8)FS\?O#KTCP!=TJ$/-)9]:T#:? ML-O]U1]:YJ]6!^>\*IR1OZ\B2.N5"M)+HHQ1+D@'\$*0^BH%J:^*42V(]PDP MU^BPYH<#KPJWIMLY3*=OWGX5*XWB5-#>F3B;K7#O?OH:.6X]1=>2N3CR)GY! MFETI:&]V59S=XB)^)5LMCGCF/X?OW63P/:'B[*-Q=$+!R#$CK4NZS0CSADY_ MV8QP&UEB.A7B%:EYRTE%.O]\^^/CR_I MAY3J\2-R'6HP\CJ%,]X]B7R):G15$6^(:GY6?%\G/VY]WE,L2V9NM*N`;EL&93,5'`QC#:P MTN":&&U@*;@T3MSU(>>#RV&TCJ7@#ECB[E-P&MP(2]SM"E9P\RMQ=RU8P0TO MC-R6LCQ#Q&.'CM,LT0M+LZVQ.846M7H!>U1H':OG4O2$2NX7YFX6T:LX!YEXNXCDA7)N8K*",S^($*L-$IQ(ZEX`P58L=2<)0*ORQ+P6E, MU-3Z->)0)FIJ*3B;B9I:"@Y?(A(M98D2+,T2X)0<(M$J&P[+(=XL!2?B$&^6 M@H-QB#=+P?DX1)6EX"PM6M0J-8[4HD4M!2=KT:*6@J.SB$1+P0E:1**EX"`M M(M%2+.HW*\X8`T6M12<$X:+6HI."Z-%K44 MG(=&Q%L*SD`CXBT%1Z$1\9:"ARO0HE8;X($*M*BEX+D*M*BEX.$)1+REX!D* M1+REX%$*1+REX"$6U-12\.`*:FHI>'X%-;44/*6"2+04/*R"2+04/+."2+04 M//&&FEHK2#SXAII:"IY_0TTM!0^X(1(M98D2+,T2X$DD1*)5MA2*>ZS#BD2L M\$T%#Q\A$JTT>`8)D6@I>%P1+6J5&D\MHD4M!0\OHD4M!4\G(A(M!0\I(A(M M!<\J(A(M!4\[XT+/FLV62+,TTZR@K$P%3Z>B1:U\\`PJ6M12\"@J6M12\$0J M6M12\,@I(MY2\)@I(MY2\+0I(MY2\.!ZXIXCYCC`P^J)>YR8%3R7GKBGBEG! MX^F)>[B8%3REGKAGC%G!D^F)>]28%3SLG[BGJEG!,_^)>[B:%3SZG[AGK%G! MX_Z)>]2:%3SBG[@GKEG!D_Z)>_":%;Q9(7'/F+."MRDD[E%S5O`&A<0]<&%"XAY#9P5O%4(O6#,M7BZ$B+?&>+SS!8JUV82W M;D"QO"U1@J59`KP%(UF9"EZ&D;CG_+G4&93,5/"NB\0]]<]I\,J+Q#W\SPK> M#H4(L4J-ET2AMZTVP%M[H%AM@/>F0+&\X1U1B!!+P:NB\"NQ\L'K>Z!8^>`% M*E`L;W@]%V+'\H8W)4&QO.%=-5`L;W@[%^+-4O"2+OSFK'SPRB0H5CYX:0T4 MR]L2WI:FLH+BWM[#/9="<>\LLQ2L.LT2I"B!>W\/I\&;SA`AEK(Y/DO:@=OEH(7NB?N7=]< M`KS7/7&O_&8%[W)/W)N_6<'[VQ/W`G!6>BCN/>"LX-7MB7L=."OX@`):QXJ# M)=(LS31X]WZR,A6\@C]QKU;G?#(H[@WKK.!M^XE[T3HK>.E^XMZWS@K>O9^X MUZZS@O?M)^[MZZS44-Q+V"T%OT:S#?!9#/2+.BJH?2FPJ^3`-O5AI\?@:];2E+E&!IE@"?-$%O6V7# METW0IY:"#YB@3RT%WS%!GUH*/F>"GK,4?)4*I39WV5"?I5D??-8(I;9JBJ\; MH=26@D\8H=26@B\9H=26@@\:H=26@N\6(:HL!9\O0E19"KYBA*BR%'Q1#-ZL M-L"'Q>#-4O!],7BS%'Q`#%%E*?B.&*+*4O`Y,425I>"[@,C'NNF$#_\A'TOI MH;C/S1F_!2CN$W.LX--^B`-+P4?AT-M6V5(H[B-B[`V?@$-O6PJ^!(?>MA1\ M$`Z];2GX[F?B/C+)^>#CGHG[UB0K2]1G:=<'RLI44BCN(X/L#1^'1'TL!=^( M1'TL!9^*1'TL!5^$1+Q9"CX,B7BS%'RS-7$?`.6RX=.LB?L.*"OX0FOB/@?* M"C[4FKA/@+*"+[$F[DN@K."#K(G[("@K^!8RTEBC"SZ)C#26@B\C)^XSO.P- M7T-&;UL*OH*,WK:4)Q5E;P M'>O$?>Z8%7R[&CUG*?AJ-7K.4O#Q:O2`;UHG[%#+G@^]6HT\MI3_"CLQT MO"!:BPU01AS;96_X`CT4:Y\"'S6'8HVC2Y1@:99@!<5]:YKSP;?&$_?):58R M*)FIX,OBZ!\K#3XPCOZQE!(UK8G0Y-",>]5F:]5E!69E*"B4SE1Q*;BH%E,)42BB5J=10 M:E-IH#2FTD)9FTJ--JC--FB@-*;20EF;2@>E,Y4>2F\J`Y2-J72'6,,>6O-" M#Z4WE0'*QE1&**.I+%&"I5F"%925J:10,E/)H>2F4D`I3*6$4IG*N,"*>#K, M'8UO2]1G:=9G!65E*BF4S%1R*+FI%%`*4RFA5*920ZE-I8'2F$H+96TJ-=J@ M-MN@@=*82@ME;2H=E,Y4>BB]J0Q0-J;2+C#"3H^41?W30>E,I8?2F\H`96,J M(Y315%8HV\HL6PHE,Y4<2FXJ!93"5$HHE:D,"\P+^!8TSR4CE-%4EJC/\I7Z M8%XPE11I,E/)H>2F4D`I3*6$4IE*#:4VE09*8RHE:EJ9-:VAU*;20&E,I86R M-I4.2F5+H%1N6%-<_U4'I3&:`,IK*!LC&5$2FTH!I3"59H%[E`MK#FZA=#AVS;_Z=H%Y>V'=O6P7N"XQ MO?7PUIO*`&4T\QF0SVCF,R"?T?2VQ*U#Z\IYB5R69HH5E)6II%!RLV0I2I:; M)4M1LMST5L!;82HEE-K,IT0^M9E/B7SJR=O[W<3T_-,/?WSX[7']X=MOG[X^ MO_G\^"M.OQ]LO_;Y[=-O[MN?TW^\//V![S:\??./IY>7IR_;/W]__/#+XS=G M@(<"?GUZ>I'_0/>___/IVS^W)^Q_^G\!````__\#`%!+`P04``8`"````"$` M509+CH$$``#N#P``&````'AL+W=OP9OOWR6A?'!ZR87UNQN*@O;=9RE7:9Y96*&3?TC.<3IE&<\$=FMY%6+26I>I"WP-Y?\ MVCRRE=F/I"O3^OUV762BO$**0U[D[?;;N1)U>BA@W)_,3[-'[N[' M)'V99[5HQ*FU()V-H-,QAW9H0Z;]]IC#"*3M1LU/._,KVR0L-.W]MC/HGYS? M&^6[T5S$_9!)]&F,Q-S"-`V_: MMUS>:QK9K6E%^2^*6)\*D[A]$A\P^[AKN>N`!HYA4.!M)M5?I;R["7`;N/JQ9\S=VA_@4M9K(M3`(A\U M5!$_%-(IF391+M@`-M#!F!6Z!X2\2B$\G6$JT13Q5.%Y%#.92M:CA'!ZA+-S MT7,&TV04IEPUA(V).@!$7-7YGJ:O:T85C$@YTOQ,UO`BMM4/^5L.S"/2* M0#^VE;RJPVK.1:A!6$^?VUB-+GQK?'HWE(2$F34:0>!D=]0JDK*79%2'U)X3 MH08AG<$!M%.-,<]B-)RHX?%6PA?.\LFHSK>F#XE0\YR/Q"S-_D2-+AR%GA`R MZ&0S%G9A?1-I^SCJ17.[Z+4DF9509MD"M&E?CB6488<@Q! MI?D>DWB@E;:$1%UFC7$**KN"!KH*AEK/L&E04&V51;VH!V7^9"-1P6HUV4I$ MX"I5@;+*CJ"Q^@HK-@SX'"HE<[5Z';&YKH)[ZK4DF9509MD@-&9U(6#_H/Z. M4]4O!!2AO\R=K`,25AI0=W?"U/#_>RM;A,:IK@/L()13[U3PLBBK!7(&EA.2 M/VWSQT2M+:F$!*'VCI90=V6_&*D?I9]A&Z&T8WWN755[#?,]:TEP:9&+^Y2/ M.9B4,AIGRBQ08-DTG@!C+Z'`FF$10Q$4H>Y%-0@!6:>D$G^YUJM&HF7Q7%5" M667W&%GUEP&&S84RZ[VK%Z%M6H&+YX()#2H5@S+*%C+#B!V&,FK[)X(SE5RV M_5O@4UN)XJFK1.&YX>1U`(]=>%@I>7WF,2^*QLC$K8)RQ6!.AZMXW(OD<:\[ ML`T!.(1=TS/_/:W/>=48!3_!K8X%^]2H\;R&/UIQ[0X4!]'"\:O[>H%S-8>S MB6.!^"1$^_@A3X3#27W_'P```/__`P!02P,$%``&``@````A`.*+0;P.`P`` MFP@``!@```!X;"]W;W)K+=%.(Q10+N"EZP[;M'O7X^3)0JD(EU)&M[1+7JE$GW:??RP.7/Q M)&M*50`,G=RB6JE^'46RJ&E+9,A[VD&DXJ(E"A[%,9*]H*0T26T3)7$\CUK" M.F09UN)_.'A5L8+FO#BUM%.61-"&*-`O:];+*UM;_`]=2\33J9\4O.V!XL`: MIEX-*0K:8OWUV'%!#@V<^P5/27'E-@]W]"TK!)>\4B'015;H_9E7T2H"IMVF M9'`";7L@:+5%#WB=+U&TVQA__C!ZEJ/O@:SY^;-@Y3?643`;RJ0+<.#\24._ MEGH)DJ.[[$=3@!\B*&E%3HWZR<]?*#O6"JH]TRD%;V`G>`]:IEL`3DY>S.>9 ME:K>HG0>SA9QBI,9"@Y4JD>FZ)[#:^!^7*$BX[A4&!MH=$/&FZ20*Z$U><= M3E:;Z!E<*BZ8S&*@QV\8%[&_(K13FC8?+40@;%`'9QZINXK0JZZ(-'%WR.XA M'F)_CTA3ER2_ARQO$$=GZN@T+J;Q8)J.0LG'AF#?-(N!"@RFS5TU^W<1^5L( M1RYL,[+5EZNC6P2''Z3@-';%9!:S,AV0A+[4<72"TW#I9N"HCOH2L;M)9C%3L\D\]/S>CZ,3[(=S)YR,PH[(^9LB==0K>^)U868Q MX,?@M>_ENXC\+80C=W$O=]2E.NI[>BN.^9UF%F,]72S">#5^3=T"[,?@B5>= M?!S$X2W5$:SGI'IXM"_ M".R0L%=K2\61[FG3R*#@IPY*BZ$+AU4[FS*83>:"CX8`C(R>'.EW(HZLDT%# M*TB-PP4TH[#3Q3XHWIOK[\`5#`OSM88_`11NTC@$<,6YNC[H^37\K=C]`P`` M__\#`%!+`P04``8`"````"$`O!L6YZ()``#]*```&````'AL+W=OJH='A8K$-=[G_Y>3ZM?C37[MA>'M9B MFZQ7S>70/A\OKP_K__S[VZ98K[I^?WG>G]I+\[#^H^G6OSS^]2_WG^WU>_?6 M-/T*,ERZA_5;W[_?[7;=X:TY[[MM^]Y<(/+27L_['OZ\ONZZ]VNS?QY..I]V M,DFRW7E_O*PQP]WUS^1H7UZ.A\:TAX]S<^DQR;4Y[7O@W[T=W[LQV_GP9]*= M]]?O'^^;0WM^AQ1/Q].Q_V-(NEZ=#W>_O5[:Z_[I!./^*=+]8<`UN_>]+39Q!YG=$!R/:5"@[<&B?[7PX22@V\'1'X]"R?O=#U#I MX#`58J#(/88BZA%AE;)I37!@!\0F=C#F@-U(PAZE)"(.,82QK&.$4I2FB2&% MAQ">:I:G/0I3'0K!KU$A!I2?Q,HHB_I+A%E"$)IPF1DY[=&'-0QVHB`2/\YA M@BK$E#CC:5IN2\:2`G2V97H;`E`BWZ93!L(1%D3`<2C(5$_U9Z-<4I\(N2(& MKC>-ATOZ)<(L(0C=C-`=*]0>99(J/8T7:2(F'20MLTC0,%RD/&S"<"X"M0F[ M?):=/?!!0;V=1@79;%EYYLP+DNQS:?1$X+6"EG[4Q619:$XSC%]BCEIMB:J!""U#8RS;A(=0@0 M2<)%-F%\4^AM,2^B`.<*5!P9#H`(1DV(LV#>J!T;>?W="=! MT1!(ITP3RJ(2"$(62H:3YFB&`*G8*`PY7T*?](V41X6"/53 M;G49_C"/,`3NIY`J;$U@@39Z!*7-%*I@.VC;A*,MXM45QJ&F67TTI#^Z!\6?.N M1.@Q:;"6W3H+PQL1,'#=((P+'3@L5=9ZA&<8K3.T$%AMTVY#I'Z27/&./N-! M#%*++R%F$4(Y6^/PG"=5T4^HJJSB*D%,1R0S-4L0*N&-V-`4,E.T6/S2)J3E MO(L-AZDW1";F,&Z5%25?1C4%9!'`$$#NBYDRI"XVRBK1=ZBLW@BQ!!S(42R3 MH-RP7`F`;)BP7$E\`^Y6DO7GZXE2!E9!)?#JE39,Q14I-UX'0NJR"!W)4<"W:=]!B$E[+/\U9RBF&>$)"*^ M2:%91)YG02^CG*U9Q!U5HH>0[J^YKSH03-]D$7ZU.JZC%]V$F,4LE.NR8TET M&EB3$QVAV7JI',B)I[)4!O7F.&,>!Q%YJGB]&)H%-K-Z*X)=F>^1E#]UKZAG MS;B89H)6$D&.W$:5A0JV3FX`%"-S:%V>TH`Q+(_(2A7LX0AMV'R')<)I#V'6 M:C4W7P?"+L':5$V"&Z7AZ1^]]S`$X4^G-*F)131GS$PS52J%(-=L[8U!,*OP M*Z554WA:\*5J".`6;VLB\0I4Z"VTFAF!RH%NR(H9,`C[0#980TZ&Z?>B4UWG MS4O-F%?FASA46>5`HYX@*"N,FB-$9`\,H>2M5J:LC\P(B?9"A,RXBPWG3K&(!D,Y^OEP8C(76KY1J16#,^4-C8^AHAFBY[UA!FGI7Y!7%7`L]:2+ZB:0XKHAL,X"/+W@Z-LJ9]%;&=\+?>I7`TC M"*^CM8BYAH`4[A.BB@T!`F[/_3Q1MM39(K8S#A<\CG!L0\N"+6FP(QT`-;PP M\T\=X64=,QI#XBI\DDZY4D\;VU@ZXV4YTZ-R(%=YUJ?R\'F%5\5,GRI%D"N[6-XP+-+`8(?!&'*Z?9[@ M[9-2I:X649UQM]RGT16*X9F`6^X6!/I#1][!$6(J*O1>/@T@I)==C<]XVXY6S25`[D&P1R9!.$Q MF&]4V!YH'%[MAXTQ2?R*H+2MP2QHC/X#Y*+@%UXVIW+H@3I\MTXISGLA'SQ*S3\=NO<7%^;NCF= MNM6A_;C`C`LX:3J*7[]5\/7;\`79;@K`-VGO^]?F]_WU]7CI5J?F!4Z%U[8@ MU14_7\,_^O9]^+[JJ>WA:[3AUS?XS+"!3[62+8!?VK8?_[`?R$T?+C[^'P`` M__\#`%!+`P04``8`"````"$`P+1D['L)``"P,P``&````'AL+W=O,T#U'"^6E(_CFB.)3T\-NOXV'RLSI?]O7I<2KF MR^FD.NWJE_WI[7'ZYQ_9;#V=7*[;T\OV4)^JQ^E?U67ZV]/?__;P59]_7-ZK MZCH!#Z?+X_3]>OW8+!:7W7MUW%[F]4=U`LMK?3YNK_#O^6UQ^3A7VY?FI.-A MX2R7P>*XW9^FRL/F?(^/^O5UOZN2>O=YK$Y7Y>1<';97:/_E??]Q:;T==_>X M.V[//SX_9KOZ^`$NGO>'_?6OQNETGIXV4,/I.R3<_7Z./U=;$K7FRZ>'AJ!_K.O MOBZ=OR>7]_HK/^]?_K$_5:`VC),<@>>Z_B'1\D46PJM?M MY^'Z[_JKJ/9O[U<8;E^>LJL/4!/\GASW,@:@Z]M?S?%K_W)]?YRZP=Q?+5WA M^-/)MZ(`L?6BSM?^[X7K%?WJQ)H+W#47AQHUIV2KO3)<&Q/ MOK]FN(J;]L-1G_Q_#&JHG<"Q;8%SMP@+%69->";;Z_;IX5Q_3>":AT"Z?&SE M#"(VX%G'I0XN$ZEPP>PD_;O$FY,@!B]0^O-)K-V'Q4\(_9UF(L5`7SN,AYEX MB/$QDPPQ`6;2(6:%F6R(66,F'V)"S!0#3+C$3#G$",,L0'2C/%R<'>5;@64I M%MAUS/G-&$0*63=7O!R4F!8DM""E!1DMR&E!00O*3@'J!TP0G7XT$>0N36R%I"]G!)1RIOK:,U%"W1A(.@P5"VYB$' M2$-81'0TI%.FM%(MR8P8*49I.1-S:D-0\UM!F,M"6:6/#FX1+]D)'- MNC2YAO+6-EI7P1*EC4#"RG2)K&8Z]R)II<*2&3)2C`[2(*!WDYBQ)UU[+\32 MUMH1@ZP@LA9I8@P:0&XF>6OON,#K@X(E2AN!](05H45/::5ZDN9&BM%3Z,QQ M'#$7X>V'W*SC[^&)PFV3Z_<<9JS#G"4*EBAM!-(?=+,-0&.F(T`DC32D0]JE MRY^8L2?&/AIQJ4'4Q(CC,4-6A]:?&_.H_X)'2BN"-95K]/%)0J@E/%ZQDODU MTI#2M'>9QW9S8LRC/4YY)#.(%+W7AMR81RLI>*2T(EA6F1]89%7I0U=6V(+" MD1()!2E9'1'06(DY(#'`:*]3'LD,(J4=:$=N@-%J"AXIK0@65Z80%G%5AH'% M)0O12"A(B^O3Y4_,V!-C'^USRB.901II>ZW(C7VTEH)'2BN"E95IQ$W9-CL0 M*KO`BI*\,-*04G0FEKW%@@%&.Y/P2,HC&8_D/%+P2&D0.7RXRUA6F4S<9*5+ M7-CZI$L'IY=]:0AF=EF9[PN'+H9B'DDTH@:)6\FFV.',607=1*A9&V>8"5:! M1S.!'".P91I0I$#MF@4.W54H$7";*;',,N6PR*PR$ONN@;"E+2HUXY&$1U(> MR7@DYY&"1THK@B66R<=-8C-!J)RD.T&(?@0K2$>P\/R`[BW%@D42C=A6N3R2 M\4C.MZ7@O916!$LK\Y`!:55Z@J3M;2:(-H=1$]%#Z($E-]T,V7LMR(UYM(:"1THK@E1U[!E:8Z89&AG# M2$/Z%K5R.CO$:O[E@`0!O5P@169YUR8MR!#@T2`A)FAQ_DT\T;YN5O^DRXUWF/%+P2&E%\$C`?&"9 M-!QIIN%-E(TTI,);/D3&65_,V!-C'XV^E$ M*:T(5M:>V,E70WK*DL<%D8;:Q"X(O7[@*C\6)-%>]/C@.27%5/2>2?# MS,IW0SK&.4;2BN" MI1W.YIQ[LCD-Z26"!P\I.BNUL*=R-_<3#)T8WT/7G\HY>"3CD9Q'"H,TBQ"F MY:6AAUJ.M;?G=LY0;D=R@$A#[?V.3-JQW9P@\T`&@A+'H#=+9NC\`&9KTKS< M`$-B-,-8\$AI19"D\-S8MO)MS'3E2W,0#9D<9`4=IZO?.YA$,[8YXPXW&>\F MYY&"1THK@E6V9WKN4*9'\PL-JOHJ%\/6Q)P[&E4ICV0&:=:_I`6YL8[6 M4?!(:46PIO:WG;/TG<1I2JKD.V0>*[>;$F$=[G/)(9A"I:J\-N3&/5E+P M2&E%L*SVA,T=2MC(-F2D(26K6)%\+K:;$V,>[7'*(YE!FGL0;4-NS*.5%#Q2 M6A$LJ\S%QK^C]7YK8JK MP^$RV=6?)W@?<0U/UDRI^A"B$!MX]1>^2R#E)7P@,50>B4TT5!Z+33Q4GH@- MO)[<]Y^*#;REW"_/Q`9>5NZ7YV(#[RQ#^<(T%#ZC^-B^5?_\O-\ME=WBK3OMNT5RJ,S0O37O:]_C9OBZ[2UOMGZW3 MZ;A,5ZMR>=K7Y[F+<-/^2(SFY:4^5+\UA_=3=>Y=D+8Z[GO@[][J2Q>BG0X_ M$NZT;[^^7WXY-*<+0CS5Q[K_PP:=STZ'F]]?STV[?SHB[^])OC^$V/:'"'^J M#VW3-2_]`N&6#JC,>;O<+A'I_O:Y1@:F[+.V>KF;/R0WN[*<+^]O;8'^4UC_L^ZM^?A+6S__K3Y7J#;Z9#KPU#1?C>GOST8$YZ7P_F([\(]V]ER][-^/ M_3^;C[]6]>M;CW87QN70'#$2_IV=:C,'D/K^N_W[43_W;W?SK%P4ZU66I,5\ M]E1U_9?:^,YGA_>N;T[_=4:)#^6"I#X(_H8@Q2+=%$E1FB@3GIGWQ%_ON5FL MD]4V6ZM^2X?>9OW;OM_?W[;-QPQ3"?BZR]Y,S.0&L4RZ&8KF1AX*@#X(93#@>-(&7)RT6$ZTQ#A;1T!LO0>L_Q[@;C#B`4@)(MLDB+A(Y M58T+A>`EF`,C"!O:MMU@Q"&L"82P((R4CN(EZ3`M=V,)F>]FTV"++\E7DUD9 M%SJ>E]"LMBRKP8AGA>DY@A"R,E(ZBI>,LAI+2%8)YN$HIN64I"P6D9EDLZP/ M'3&(2&+)BB46K7AFB6&96-V0FA6SD1P?86D@AF62G;=R(IJ=H9`8UF5WI6F) M\6%C>A'-3A#E8"6R,]P180S9.4H!%814'I,QR_CLQB*:G<8\Z\W44D\&]HE# M>A&&B2LM27GK!BN1G.&!F)S;E3;I)`K).&;K,%6G*#*.8K`2*!322-9Z$3@7["XMAY*R>BTYXRXA!6DE[J1-B&8]BQB(:E M##>$E226.I'9?>,>FW)*#U;HY<@J,BX9W#SX*:6R8LI=7F2VME%8SJ#!"G4= M646&HX-3.@N99Y*QO(AESADK6)',L\@I='!#0'*29$;,,GLE$`C/!4)I:$ M=Y2'BLRP#ZO%M:;`GW^[%"128(,(H(ACP3@*^$=)8:CYS2HD61K)#39Y6P#@R#YU"*(1*"JT1PE%,SQW!\:J[QLG,"A/%@(+R( M@N#<98>"HP("CAQ$DJXG41@7AL*+`"82<\Y)+!^L1#LH7;IV7#GBY9)+@PCC MC&!$EO0=\8Y*,0SE,;+(LF2R&)XE1P>>W(LH"DZC%8"A<:; MTT^FN63.("*+I.#,&:TXBD)CSNG7Q<:#KE0;!"(*@A-GM!(@*'&&@TTASY-! M9+<`M_*(B!Q9"D-C;.7EJ^T"\_HS1K8N+#D3123'&3DXRKW)O/X9H1B2,V(V MDA>-DQN+:'+_![L5DMV"B+:.4WVT$JVC[#9D)QG,'`E<'1'#MVXLHMEI='7E M[5$A^2J(:'9\"XE6(CN-KZ9V=/,RA7?5BR@&OG\$1V7^:&PUO9D6DJV"B*+@ M^T>T$I7X>;8J)%L%$69UW$L+OG]$*XZB5-BJS"9?;5H7NLZ"B-:"[Q_12J"@ M=.5.FWDZ^1122BX+(EH,OH%$*P$#^$?$8F%DJPER*XT#*X47$0PEWSZ"HSS< ME(:?(L6&Y6_%;"1CB2_7HP\WWDKY<%,JY';M?:GU86-ZOB.-+OF^%!SETBMU MSXQM3;N88-/MC, M-0VJ@RU2TZ`ZV/@T#:J#C4?3K*%9:YH3PP:.QIH$/'E@U#6J-ITA-@UKCR4[3H-9X)-,TJ#4> M@!1-BKKAK;.BR>"#MTV:!CYX3Z1I4&N\S=$TJ#5>IV@:U!HO.11-BKJY;SQ\ M)J:H&[[E:#ZH&P[;F@9UWX1[T6`BEV#^:)FMR#*VMC(?\YL'=MN.0S(K1 M`J&':MO10;6!R,PFMAP&P"6[R_ZU^ON^?:W/W>Q8O6`#6=GS6.ONX[D??7.Q MU]>>FA[7Z^Q_WW!OLL)%,/LI]J5I^O`#E5L.-S'O_P<``/__`P!02P,$%``& M``@````A`,K^)2=Y"@``Q2P``!D```!X;"]W;W)K&ULE%K;;B.Y$7T/D'\0]+Z2^J8;;"_/;O M;\CH];U^ZP^8\Z5^[(RQ/_>FPN>#GZ7EZ?CUUFT?3Z+"?YK/9?'K8[(YC M&V%]^C,Q^J>GW;9K^^W;H3M>;)!3M]]

 XML 22 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share (Details) (USD $)
 1 Months Ended 3 Months Ended 12 Months Ended 0 Months Ended
Nov. 30, 2013
Jun. 30, 2013
Feb. 28, 2013
Jun. 30, 2012
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Feb. 13, 2014
Subsequent Event
Feb. 13, 2014
Subsequent Event
Put
Earnings Per Share [Abstract]                                  
Net income attributable to Celgene         $ 214,400,000 $ 372,500,000 $ 478,100,000 $ 384,900,000 $ 263,100,000 $ 424,200,000 $ 367,400,000 $ 401,500,000 $ 1,449,900,000 $ 1,456,200,000 $ 1,318,100,000    
Weighted average shares:                                  
Basic (in shares)         411,200,000 412,300,000 414,100,000 417,900,000 421,600,000 427,200,000 436,700,000 438,300,000 413,800,000 430,900,000 455,300,000    
Effect of dilutive securities:                                  
Options, restricted stock units, warrants and other (in shares)                         16,500,000 9,900,000 7,400,000    
Diluted (in shares)         428,600,000 428,800,000 429,300,000 432,200,000 432,300,000 436,300,000 445,400,000 448,600,000 430,300,000 440,800,000 462,700,000    
Net income per share attributable to Celgene:                                  
Basic (in dollars per share)         $ 0.52 $ 0.90 $ 1.15 $ 0.92 $ 0.62 $ 0.99 $ 0.84 $ 0.92 $ 3.50 $ 3.38 $ 2.89    
Diluted (in dollars per share)         $ 0.50 $ 0.87 $ 1.11 $ 0.89 $ 0.61 $ 0.97 $ 0.82 $ 0.90 $ 3.37 $ 3.30 $ 2.85    
Anti-dilutive securities                                  
Antidilutive securities excluded from computation of earnings per share (in shares)                         7,200,000.0 12,700,000.0 25,900,000.0    
Approved common share repurchase amount   3,000,000,000.000 600,000,000 3,000,000,000.000                 9,500,000,000.000        
Aggregate common stock repurchased under the program (in shares)     5,200,000                            
Weighted average price (in dollars per share)     $ 114.30                            
Put option premium 1,200,000                             4,800,000  
Put options outstanding         0               0        
Notional amount         7,635,000,000               7,635,000,000       200,000,000
Strike price (in dollars per share)                                 142.81
Common stock repurchased under the program during the period (in shares)                         22,300,000        
Remaining open-ended repurchase authorization                         $ 2,068,000,000        
XML 23 R78.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefit Plans (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Compensation and Retirement Disclosure [Abstract]      
Employer contribution limit to U.S. savings plan per calendar year (as a percent of compensation) 6.00%    
Total expense for contributions to U.S savings plan $ 32.6 $ 19.3 $ 20.7
XML 24 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2013
Income Tax Disclosure [Abstract]  
Schedule of income (loss) before income taxes
 
 
2013
 
2012
 
2011
U.S.
 
$
36.8

 
$
279.6

 
$
416.8

Non-U.S.
 
1,628.6

 
1,401.9

 
1,002.7

Income before income taxes
 
$
1,665.4

 
$
1,681.5

 
$
1,419.5
Schedule of provision (benefit) for taxes on income
 
 
2013
 
2012
 
2011
United States:
 
 
 
 
 
 
Taxes currently payable:
 
 
 
 
 
 
Federal
 
$
352.6

 
$
101.5

 
$
100.8

State and local
 
45.4

 
(31.8
)
 
33.2

Deferred income taxes
 
(245.1
)
 
107.3

 
(67.1
)
Total U.S. tax provision
 
152.9

 
177.0

 
66.9

International:
 
 
 
 
 
 
Taxes currently payable
 
64.1

 
55.4

 
53.8

Deferred income taxes
 
(1.5
)
 
(7.1
)
 
(18.6
)
Total international tax provision
 
62.6

 
48.3

 
35.2

Total provision
 
$
215.5

 
$
225.3

 
$
102.1
Schedule of tax effects of temporary differences that give rise to deferred tax assets and liabilities
 
 
2013
 
2012
 
 
Assets
 
Liabilities
 
Assets
 
Liabilities
Federal and state NOL carryforwards
 
$
5.3

 
$
—

 
$
12.6

 
$
—

Deferred revenue
 
2.3

 
—

 
2.3

 
—

Capitalized research expenses
 
6.1

 
—

 
37.1

 
—

Tax credit carryforwards
 
4.2

 
—

 
4.1

 
—

Non-qualified stock options
 
183.3

 
—

 
164.4

 
—

Plant and equipment, primarily differences in depreciation
 
—

 
(9.6
)
 
—

 
(13.6
)
Inventory
 
8.4

 
—

 
6.3

 
—

Other assets
 
32.7

 
(0.7
)
 
26.8

 
(9.3
)
Intangibles
 
311.9

 
(1,005.0
)
 
187.2

 
(1,069.2
)
Accrued and other expenses
 
161.3

 
—

 
116.1

 
—

Unremitted earnings
 
—

 
(316.5
)
 
—

 
(316.5
)
Unrealized (gains) losses on securities
 
—

 
(71.4
)
 
17.3

 
—

Subtotal
 
715.5

 
(1,403.2
)
 
574.2

 
(1,408.6
)
Valuation allowance
 
(35.5
)
 
—

 
(41.7
)
 
—

Total deferred taxes
 
$
680.0

 
$
(1,403.2
)
 
$
532.5

 
$
(1,408.6
)
Net deferred tax asset (liability)
 
 

 
$
(723.2
)
 
 

 
$
(876.1
)
Schedule of deferred tax assets and liabilities classified on the company's balance sheet
 
 
2013
 
2012
Current assets
 
$
25.3

 
$
93.2

Other assets (non-current)
 
56.4

 
49.1

Current liabilities
 
—

 
—

Other non-current liabilities
 
(804.9
)
 
(1,018.4
)
Net deferred tax asset (liability)
 
$
(723.2
)
 
$
(876.1
)
Reconciliation of U.S. statutory income tax rate to company's effective tax rate for continuing operations
Percentages
 
2013
 
2012
 
2011
U.S. statutory rate
 
35.0
 %
 
35.0
 %
 
35.0
 %
Foreign tax rate differences
 
(28.8
)%
 
(28.0
)%
 
(21.1
)%
Unremitted earnings
 
—
 %
 
18.8
 %
 
—
 %
State taxes, net of federal benefit
 
0.6
 %
 
1.1
 %
 
0.7
 %
Change in valuation allowance
 
1.2
 %
 
0.4
 %
 
—
 %
Acquisition related differences
 
3.7
 %
 
3.8
 %
 
(3.5
)%
Changes in uncertain tax positions
 
0.8
 %
 
(19.3
)%
 
(2.5
)%
Other
 
0.4
 %
 
1.6
 %
 
(1.4
)%
Effective income tax rate
 
12.9
 %
 
13.4
 %
 
7.2
 %
Reconciliation of beginning and ending amount of unrecognized tax benefits
 
 
2013
 
2012
Balance at beginning of year
 
$
174.7

 
$
596.8

Increases related to prior year tax positions
 
25.5

 
—

Decreases related to prior year tax positions
 
—

 
—

Increases related to current year tax positions
 
30.2

 
38.1

Settlements
 
(10.3
)
 
(450.6
)
Lapse of statute
 
(0.9
)
 
(9.6
)
Balance at end of year
 
$
219.2

 
$
174.7
XML 25 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Divestitures (Tables)
 12 Months Ended
Dec. 31, 2013
Business Combinations [Abstract]  
Schedule of fair value of consideration transferred
 
Fair Value at the
Acquisition Date
Cash
$
363.4

Contingent consideration
171.7

Total fair value of consideration transferred
$
535.1
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
 
Amounts
Recognized as of
Acquisition Date
Working capital1
$
12.0

Property, plant and equipment
2.6

Platform technology intangible asset2
330.8

In-process research and development product rights
198.4

Net deferred tax liability3
(165.0
)
Total identifiable net assets
378.8

Goodwill
156.3

Net assets acquired
$
535.1


1 
Includes cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities.
2 
Platform technology related to the Avilomics discovery platform which is being amortized over a useful life of seven years based on the estimated useful life of the platform.
3 
Includes current deferred income tax asset of $14.7 million and non-current deferred tax liability of $179.7 million.
XML 26 R79.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefit Plans (Details 2) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Deferred compensation arrangement      
Deferred compensation liability, non-current $ 127.2 $ 99.2  
Deferred compensation plan
      
Deferred compensation arrangement      
Percentage of cash bonuses which the eligible participants can elect to defer 100.00%    
Plan related expense 0.6 0.6 0.7
Deferred compensation liability, non-current 73.7 59.8  
Deferred compensation plan | Maximum
      
Deferred compensation arrangement      
Percentage of base salary which the eligible participants can elect to defer 90.00%    
Employer match as a percentage of participant's base salary 20.00%    
Deferred compensation plan | Minimum
      
Deferred compensation arrangement      
Employer match as a percentage of participant's base salary 10.00%    
Long-Term Incentive Plan
      
Deferred compensation arrangement      
Plan related expense 40.8 10.1 12.0
Performance period 3 years    
Number of separate three-year performance cycles 3    
Estimated payout for the plan, current 28.9    
Consecutive trading days 30 days    
Payments made in common stock, trading restriction 3 years    
Long-Term Incentive Plan | Maximum
      
Deferred compensation arrangement      
Payouts as percentage of the participant's salary 200.00%    
Long-Term Incentive Plan | Minimum
      
Deferred compensation arrangement      
Payouts as percentage of the participant's salary 0.00%    
Long Term Incentive Plan 2015 [Member]
      
Deferred compensation arrangement      
Percentage of non-GAAP net income as component of performance measures of the plans 37.50%    
Percentage of total non-GAAP revenue as component of performance measures of the plans 37.50%    
Percentage of relative shareholder return as component of performance measures of the plans 25.00%    
Long Term Incentive Plan 2015 [Member] | Maximum
      
Deferred compensation arrangement      
Potential payout, assuming maximum objectives are achieved 22.6    
2014 Long-Term Incentive Plan
      
Deferred compensation arrangement      
Percentage of non-GAAP net income as component of performance measures of the plans 37.50%    
Percentage of total non-GAAP revenue as component of performance measures of the plans 37.50%    
Percentage of relative shareholder return as component of performance measures of the plans 25.00%    
2014 Long-Term Incentive Plan | Maximum
      
Deferred compensation arrangement      
Potential payout, assuming maximum objectives are achieved 19.6    
2015 Long-Term Incentive Plan | Maximum
      
Deferred compensation arrangement      
Potential payout, assuming maximum objectives are achieved $ 25.2    
XML 27 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 28 R73.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Details) (USD $)
 0 Months Ended 12 Months Ended 0 Months Ended
Jun. 12, 2013
Dec. 31, 2013
Dec. 31, 2013
Options
Jun. 12, 2013
Maximum
Jun. 10, 2013
Maximum
Share-Based Compensation          
Number of common shares in the share reserve 105,000,000        
Number of new common shares issued 9,000,000.0        
Vested in period, total fair value       $ 6,000,000.0 $ 4,000,000.0
Award vesting period, maximum (in years)     4 years    
Award expiration period (in years)     10 years    
Additional award vesting period, retirement provision, maximum     3 years    
Shares of common stock available for future share-based grants under all plans   16,674,585      
XML 29 R89.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic and Product Information (Details 3) (Amerisource Bergen Corp., Customers' concentration risk)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Percent of Total Revenue
      
Major Customers      
Percentage of concentration risk 10.70% 11.50% 12.60%
Percent of Net Accounts Receivable
      
Major Customers      
Percentage of concentration risk 6.40% 9.60%  
XML 30 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Fair Value Measurement (Details 2) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Liabilities:      
Balance at beginning of period $ (198.1) $ (76.9)  
Amounts acquired or issued 0 (171.7)  
Net change in fair value 30.4 50.5  
Settlements 0 0  
Transfers in and/or out of Level 3 0 0  
Balance at end of period 228.5 (198.1) (76.9)
Fair Value of assets and liabilities      
Change in value of contingent consideration 171.1 166.4 (147.5)
Gloucester Pharmaceuticals, Inc.
      
Fair Value of assets and liabilities      
Change in value of contingent consideration (59.7)    
Avila Therapeutics, Inc.
      
Fair Value of assets and liabilities      
Change in value of contingent consideration 9.2    
Avila Therapeutics, Inc.
      
Fair Value of assets and liabilities      
Change in value of contingent consideration $ (30.4)    
Number of milestones with probability adjustments 2    
XML 31 R76.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Details 4) (USD $)
In Millions, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Options    
Outstanding at December 31, 2012 (in shares) 42.6  
Changes during the Year:    
Granted (in shares) 9.6  
Exercised/Released (in shares) (11.5)  
Forfeited (in shares) (1.1)  
Expired (in shares) 0  
Outstanding at December 31, 2013 (in shares) 39.6 42.6
Vested at December 31, 2013 or expected to vest in the future (in shares) 38.9  
Vested at December 31, 2013 (in shares) 17.0  
Weighted Average Exercise Price Per Option    
Outstanding at December 31, 2012 (in dollars per share) $ 58.31  
Changes during the Year:    
Granted (in dollars per share) $ 131.96  
Exercised (in dollars per share) $ 54.23  
Forfeited (in dollars per share) $ 73.96  
Expired (in dollars per share) $ 56.74  
Outstanding at December 31, 2013 (in dollars per share) $ 76.94 $ 58.31
Vested at December 31, 2013 or expected to vest in the future (in dollars per share) $ 76.46  
Vested at December 31, 2013 (in dollars per share) $ 54.81  
Weighted Average Remaining Contractual Term (Years)    
Outstanding at December 31, 2012 7 years 1 month 6 days 6 years 10 months 24 days
Outstanding at December 31, 2013 7 years 1 month 6 days 6 years 10 months 24 days
Vested at December 31, 2013 or expected to vest in the future 7 years  
Vested at December 31, 2013 5 years 3 months 18 days  
Aggregate Intrinsic Value (In Millions)    
Outstanding at December 31, 2012 $ 860.3  
Outstanding at December 31, 2013 3,643.4 860.3
Vested at December 31, 2013 or expected to vest in the future 3,595.3  
Vested at December 31, 2013 1,945.6  
Options
    
Compensation cost and expected weighted-average period related to nonvested awards    
Unrecognized compensation cost 463.2  
Expected weighted-average period in years of compensation cost to be recognized 2 years 2 months  
Nonvested RSUs
    
Share Equivalent    
Nonvested at December 31, 2012 (in shares) 4.5  
Granted (in shares) 1.8  
Exercised (in shares) (0.8)  
Forfeited (in shares) (0.4)  
Nonvested at December 31, 2013 (in shares) 5.1  
Compensation cost and expected weighted-average period related to nonvested awards    
Unrecognized compensation cost 246.5  
Expected weighted-average period in years of compensation cost to be recognized 1 year 6 months  
Weighted Average Grant Date Fair Value    
Nonvested at December 31, 2012 (in dollars per share) $ 66.20  
Granted (in dollars per share) $ 124.96  
Vested (in dollars per share) $ 60.17  
Forfeited (in dollars per share) $ 63.20  
Nonvested at December 31, 2013 (in dollars per share) $ 88.15  
Nonvested Performance-Based RSUs
    
Share Equivalent    
Nonvested at December 31, 2012 (in shares) 26.0  
Granted (in shares) 46.0  
Exercised (in shares) (6.0)  
Forfeited (in shares) (8.0)  
Nonvested at December 31, 2013 (in shares) 58.0  
Compensation cost and expected weighted-average period related to nonvested awards    
Unrecognized compensation cost $ 3.9  
Expected weighted-average period in years of compensation cost to be recognized 1 year 8 months 12 days  
Weighted Average Grant Date Fair Value    
Nonvested at December 31, 2012 (in dollars per share) $ 60.80  
Granted (in dollars per share) $ 119.02  
Vested (in dollars per share) $ 60.78  
Forfeited (in dollars per share) $ 64.26  
Nonvested at December 31, 2013 (in dollars per share) $ 106.87  
XML 32 R86.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies Manufacturing Facility Payment Obligation (Details) (SWITZERLAND, USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
SWITZERLAND
  
Manufacturing Facility Repayment Obligation [Line Items]  
Contractual Obligation $ 14.6
XML 33 R81.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details 2) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income Taxes      
Increase in additional paid-in capital on realization of stock option deduction benefits for income tax purposes $ 170.0 $ 55.8 $ 25.1
Deferred income taxes recorded as a component of accumulated other comprehensive income resulting in a deferred income tax asset 71.4 17.3  
Unrecognized tax benefits:      
Balance at beginning of year 174.7 596.8  
Increases related to prior year tax positions 25.5 0  
Decreases related to prior year tax positions 0 0  
Increases related to current year tax positions 30.2 38.1  
Settlements (10.3) (450.6)  
Lapse of statute (0.9) (9.6)  
Balance at end of year 219.2 174.7 596.8
Unrecognized tax benefits that, if recognized, would have a net impact on the effective tax rate 198.9    
Accrued interest related to uncertain tax positions 23.2 18.0  
Reduction to income tax expense 318.6    
Research and experimentation credit
      
Income Taxes      
Credit carryforwards 10.0    
Credit carryforwards for which deferred tax assets have not been recorded $ 5.7    
XML 34 R87.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic and Product Information (Details) (USD $)
In Millions, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Operations by Geographic Area                      
Total revenues $ 1,755.9 $ 1,674.4 $ 1,599.0 $ 1,464.6 $ 1,447.4 $ 1,419.2 $ 1,366.8 $ 1,273.3 $ 6,493.9 $ 5,506.7 $ 4,842.1
Total long lived assets 593.4       578.4       593.4 578.4  
United States
                      
Operations by Geographic Area                      
Total revenues                 3,862.1 3,169.1 2,860.9
Total long lived assets 348.0       343.3       348.0 343.3  
Europe
                      
Operations by Geographic Area                      
Total revenues                 1,865.7 1,617.7 1,477.5
Total long lived assets 230.4       221.5       230.4 221.5  
All other
                      
Operations by Geographic Area                      
Total revenues                 766.1 719.9 503.7
Total long lived assets $ 15.0       $ 13.6       $ 15.0 $ 13.6  
XML 35 R77.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Details 5) (Options, USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Options
      
Stock options, additional information      
Total fair value of shares vested $ 159.3 $ 144.1 $ 162.8
Total intrinsic value of stock options exercised during the period $ 814.7 $ 293.5 $ 147.9
Ratio of stock options to RSU's in calculating the number of RSU's for employees 4    
XML 36 R71.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accumulated Other Comprehensive Income (Loss) (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Summary of accumulated other comprehensive income (loss), net of tax    
Balance at the beginning of the period $ (49.7) $ (62.3)
Period change 143.7 12.6
Balance at the end of the period 94.0 (49.7)
Pension Liability
    
Summary of accumulated other comprehensive income (loss), net of tax    
Balance at the beginning of the period (10.1) (5.4)
Period change 3.2 (4.7)
Balance at the end of the period (6.9) (10.1)
Net Unrealized Gains (Losses) From Marketable Securities
    
Summary of accumulated other comprehensive income (loss), net of tax    
Balance at the beginning of the period 4.2 1.8
Period change 133.1 2.4
Balance at the end of the period 137.3 4.2
Net Unrealized Gains (Losses) From Hedges
    
Summary of accumulated other comprehensive income (loss), net of tax    
Balance at the beginning of the period (16.0) 8.7
Period change (20.0) (24.7)
Balance at the end of the period (36.0) (16.0)
Foreign Currency Translation Adjustment
    
Summary of accumulated other comprehensive income (loss), net of tax    
Balance at the beginning of the period (27.8) (67.4)
Period change 27.4 39.6
Balance at the end of the period $ (0.4) $ (27.8)
XML 37 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaboration Agreements
 12 Months Ended
Dec. 31, 2013
Collaboration Agreements  
Collaboration Agreements
Collaboration Agreements
We have entered into a variety of alliances in the ordinary course of our business. Although we do not consider any individual alliance to be material, certain of the more notable alliances are described below. The summarized financial information related to our alliances is presented in tabular format after the description of alliances:

Novartis Pharma AG:    We licensed the worldwide rights (excluding Canada) regarding certain chirally pure forms of methylphenidate for FOCALIN® and FOCALIN XR® to Novartis. We also licensed to Novartis the rights related to long-acting formulations of methylphenidate and dex-methylphenidate products which are used in FOCALIN XR® and RITALIN LA®. We sell FOCALIN® to Novartis and receive royalties of between 30% and 35% on Novartis' sales of FOCALIN XR® and RITALIN LA®. The arrangement with Novartis will continue until the later of (i) the tenth anniversary of the first commercial launch on a country-by-country basis or (ii) when the last applicable patent expires with respect to that country. At the expiration date, we will grant Novartis a perpetual, non-exclusive, royalty-free license to make, have made, use, import and sell products using the dex-methylphenidate and long-acting formulation technology. The agreement may be terminated by Novartis upon 12 months prior written notice or by either party upon, among other things, the breach of a material obligation by the other party or in the event of withdrawal of the dex-methylphenidate product or RITALIN® product from the market because of regulatory mandate.

If the agreement is terminated by us, then all licenses granted to Novartis under the agreement will terminate and Novartis will grant us a non-exclusive license to certain of their intellectual property related to the compounds and products. If the agreement is terminated by Novartis then all licenses granted to Novartis under the agreement will terminate.

When a generic version of dexmethylphenidate hydrochloride enters the market, we expect Novartis' sales of FOCALIN XR® to decrease and therefore our royalties will also decrease. A generic version of RITALIN LA® was introduced in January 2012 and resulted in a decrease in royalties we received from Novartis related to sales of RITALIN LA®.

Acceleron Pharma (Acceleron):    We have worldwide strategic collaboration agreements with Acceleron for the joint development and commercialization of sotatercept (ACE-11) and ACE-536. ACE-11 is currently in phase II studies for treatment of renal anemia, diamond blackfan anemia, beta-thalassemia and MDS, and ACE-536 is currently in phase II studies for beta-thalassemia and MDS.

On January 1, 2013 we became responsible for the payment of all development costs related to ACE-11 and ACE-536 and have recognized development expenses as research and development expense as they were incurred.

With respect to the ACE-11 program, Acceleron is eligible to receive of up to $367.0 million in development, regulatory approval and sales-based milestones and up to an additional $348.0 million for each of three specific discovery stage programs. We also agreed to co-promote the developed products in North America. Acceleron will receive tiered royalties on worldwide net sales upon the commercialization of a development compound.

With respect to the ACE-536 program, we have an exclusive, worldwide, royalty-bearing license to ACE-536 and future Acceleron products for the treatment of anemia. We also agreed to co-promote the products in the United States, Canada and Mexico. Acceleron is eligible to receive development, regulatory approval and sales-based milestones of up to $217.5 million for ACE-536 and up to an additional $170.8 million for the first discovery stage program, $148.8 million for the second discovery stage program and $125.4 million for each additional discovery stage program thereafter. Acceleron will receive tiered royalties on worldwide net sales upon the commercialization of a development compound.

The ACE-11 agreement may be terminated by us, at our sole discretion, at any time or by either party, among other things, upon a material breach by the other party. The ACE-536 agreement may be terminated by us, at our sole discretion, after completion of the initial phase II clinical trial or by either party, among other things, upon a material breach by the other party.

Agios Pharmaceuticals, Inc. (Agios):    During 2010, we entered into a discovery and development collaboration and license agreement with Agios that focuses on cancer metabolism targets and the discovery, development and commercialization of associated therapeutics. We have an exclusive option to license any potential products that result from the Agios cancer metabolism research platform through the end of phase I clinical trials.

With respect to each product that we choose to license, Agios could receive up to approximately $120.0 million upon achievement of certain milestones and other payments plus royalties on sales, and Agios may also participate in the development and commercialization of certain products in the United States. Our option to license a product will terminate on April 14, 2015.

We have determined that Agios is a variable interest entity; however, we are not the primary beneficiary of this arrangement. Although we would have the right to receive the benefits from the collaboration and license agreement, we do not have the power to direct the activities under the collaboration and license agreement as Agios has the decision-making authority for this collaboration until we exercise our option to license a product. Our interest in Agios is limited to our equity ownership and we do not have any obligations or rights to the future losses or returns of Agios beyond this ownership.

Epizyme Inc. (Epizyme):    In April 2012, we entered into a collaboration and license agreement with Epizyme to discover, develop and commercialize novel therapeutic compounds by inhibiting histone methyltransferases (HMT), an important epigenetic target class. Under the terms of the agreement, we made an upfront payment to Epizyme and also made an equity investment in Epizyme and received an exclusive option to license rights outside the United States to HMT inhibitors targeting the DOT1L HMT, including the Company’s product candidate EPZ-5676 and each Epizyme compound associated with such licensed compounds during the option term. If the option is exercised, Epizyme could receive up to $165.0 million in milestone payments associated with each Epizyme compound developed to inhibit each distinct HMT target under the collaboration plus royalties on sales. Epizyme will have the sole responsibility to develop and commercialize compounds in the United States.

The option term expires on either July 9, 2015 (or July 9, 2016 if we extend the option term for a fourth year and pay an option extension fee). Further, if an HMT target or targets are selected, the collaboration agreement will expire upon the expiration of all applicable royalty terms with respect to all licensed Epizyme compounds. Upon the expiration of the collaboration agreement, we will have a fully paid-up, royalty-free license to use Epizyme intellectual property to manufacture, market, use and sell such licensed Epizyme compounds outside the United States.

bluebird bio, Inc. (bluebird):  In March 2013, we entered into a collaboration agreement with bluebird to discover, develop and commercialize novel disease-altering gene therapies in oncology. The collaboration focuses on applying gene therapy technology to modify a patient’s own T-cells, known as chimeric antigen receptor (CAR) T-cells, to target and destroy cancer cells. The collaboration has the potential to lead to the development of multiple CAR T-cell products. We have an option to license any products resulting from the collaboration after the completion of a phase I clinical study by bluebird for each product.

We made an upfront payment and may be obligated to pay up to $225.0 million per licensed product in aggregate potential option fees and clinical and regulatory milestone payments. bluebird also has the option to participate in the development and commercialization of any licensed products resulting from the collaboration through a 50/50 co-development and profit share in the United States in exchange for a reduction of milestone payments. Royalties would also be paid to bluebird in regions where there is no profit share, including in the United States, if bluebird declines to exercise their co-development and profit sharing rights. 

The agreement has a termination date of March 19, 2016 and we have the option to extend the agreement until March 19, 2019 with the payment of extension fees.  Further, we have the ability to terminate the collaboration at our discretion upon 90 days written notice to bluebird.  If a product is optioned, the parties will enter into a pre-negotiated license agreement and potentially a co-development agreement should bluebird exercise its option to participate in the development and commercialization in the United States.  The license agreement, if not terminated sooner, would expire upon the expiration of all applicable royalty terms under the agreement with respect to the particular product, and the co-development agreement, if not terminated sooner, would expire when the product is no longer being developed or commercialized in the United States.  Upon the expiration of a particular license agreement, we will have a fully paid-up, royalty-free license to use bluebird intellectual property to manufacture, market, use and sell such licensed product.

FORMA Therapeutics Holdings, LLC (FORMA): In April 2013, we entered into a collaboration arrangement with FORMA under which the parties will discover, develop and commercialize drug candidates to regulate protein homeostasis targets. Protein homeostasis, which is important in oncology, neurodegenerative and other disorders, involves a tightly regulated network of pathways controlling the biogenesis, folding, transport and degradation of proteins.

The collaboration was launched with an upfront payment that enables us to evaluate selected targets and lead assets in protein homeostasis pathways during the pre-clinical phase. We will have the right to obtain exclusive licenses with respect to the development and commercialization of multiple drug candidates outside of the United States, in exchange for research and early development payments of up to approximately $200.0 million. FORMA is incentivized to advance the full complement of drug candidates through Phase I, and we will be responsible for all further global clinical development for each licensed candidate.  FORMA is eligible to receive up to an additional $315.0 million in potential payments based upon development, regulatory and sales objectives for the first ex-U.S. license. FORMA is also eligible to receive potential payments for successive licenses, which escalate for productivity, increasing up to a maximum of an additional $430.0 million per program.  In addition, FORMA will receive royalties on ex-U.S. sales and additional payments if multiple drug candidates reach defined cumulative sales objectives. The collaboration arrangement includes provisions for us to obtain rights with respect to development and commercialization of drug candidates in the United States in exchange for additional payments.

Under the collaboration arrangement, the parties will perform initial research and development for a term of four years. If, during such research term, a drug candidate meets certain criteria, then the parties will enter into a pre-negotiated license agreement and the collaboration will continue until all license agreements and all applicable royalty terms have expired. Each license agreement, if not terminated sooner would expire upon the expiration of all applicable royalty terms under such agreement. Upon the expiration of each license agreement, we will have an exclusive, fully-paid, royalty-free license to use the applicable FORMA intellectual property to manufacture, market, use and sell the product developed under such agreement outside of the United States. On October 7, 2013, we entered into the first ex-US license with FORMA and paid the applicable upfront payment under such license.

MorphoSys AG (MorphoSys):  In June 2013, we signed a collaboration, license and equity purchase agreement with MorphoSys to jointly develop MOR202 globally and to co-promote MOR202 in Europe.  In August 2013, the transaction became effective. MOR202 is a fully human monoclonal antibody targeting CD38 to treat patients with multiple myeloma and certain leukemias. MOR202 is currently being evaluated in a phase I/IIa trial in patients with relapsed/refractory multiple myeloma.

MorphoSys could receive up to EUR 511.0 million (approximately $664.5 million) in development, regulatory and sales milestones and tiered royalties on net sales of MOR202 outside the co-promotion territory.  In the co-promotion territory, MorphoSys retains a 50/50 profit sharing right on MOR202 in exchange for paying one third of the MOR202 development costs. Should MorphoSys choose to opt out of its co-promotion rights, MorphoSys would receive tiered royalties on net sales of MOR202 globally.

The agreement may be terminated at our discretion upon six months written notice to MorphoSys, or by either party upon material breach of the other party. Upon the expiration of the agreement, we will have a fully paid-up, irrevocable, perpetual, non-terminable license to use the intellectual property licensed from MorphoSys to research, develop, make, commercialize, use and sell MOR202.

Acetylon Pharmaceuticals, Inc. (Acetylon): In July 2013, we entered into a collaboration and option agreement with Acetylon. Under the agreement, the parties will support the development of Acetylon's portfolio of oral, selective HDAC inhibitors in oncology, hematology, immunology and neurologic disease indications. In addition, we have rights to receive certain research and development services from Acetylon and an exclusive right to acquire Acetylon at a later date at a purchase price based upon future independent company valuations.

The collaboration focuses on the continued clinical advancement of Acetylon's lead candidate, ACY-1215, an HDAC6 inhibitor being developed for hematological malignancies, ACY-738 for neurological diseases, an HDAC1/2 inhibitor and a yet unnamed project, spanning cancer and non-cancer disease indications. Under the agreement, we made an upfront payment to Acetylon, which included a fee for entering into the collaboration, fees for the exclusive right to acquire Acetylon and the rights to receive certain research and development services from Acetylon. During the term of the agreement, Acetylon will retain control of its drug development programs. If we exercise our right to acquire Acetylon, in addition to the purchase price based upon independent company valuations to be paid at the time of the acquisition, Acetylon shareholders will be eligible to receive potential future milestone payments for approvals, or additional indications, of drugs developed by Acetylon and for accomplishing defined sales targets. If all the milestones are achieved, the aggregate amount of the milestone payments would be $1.100 billion.

The agreement has an expiration date of December 31, 2015 and we have the right to extend the agreement until either June 30, 2016 or December 31, 2016 with the payment of an extension fee. Further, we have the ability to terminate the agreement at our discretion upon written notice to Acetylon.

OncoMed Pharmaceuticals, Inc. (OncoMed): On December 2, 2013, we entered into a collaboration agreement to jointly develop and commercialize up to six anti-cancer stem cell (CSC) product candidates from OncoMed’s biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). OncoMed will control and conduct initial clinical studies. We will have an option to license worldwide rights to up to six novel anti-CSC therapeutic candidates commencing upon the completion of enrollment of patients in a phase I trial (and with respect to Demcizumab, a phase II trial) and ending 60 days after delivery by OncoMed of the applicable data package for each therapeutic candidate, subject to certain extensions.  We will also have research, development and commercialization rights to small molecule compounds in another cancer stem cell pathway, with OncoMed eligible to receive milestones and royalties on any resulting products.

Demcizumab is currently in three phase Ib clinical studies in combination with standard-of-care therapeutics, including a trial in patients with first-line advanced pancreatic cancer. Subsequent to the exercise of our option rights, the parties will co-develop demcizumab and share global development costs on a one-third OncoMed and two-thirds Celgene split. Outside the United States, we would lead development and commercialization efforts, with OncoMed eligible to receive milestones and tiered royalties on sales outside the United States.

In addition to demcizumab, the collaboration includes up to five preclinical- or discovery-stage biologics programs: OncoMed’s anti-DLL4/VEGF bispecific antibody and up to four additional biologics programs targeting either the RSPO-LGR CSC pathway or another CSC pathway. We have exclusive options on these programs during or after completion of certain phase I clinical trials to be conducted by OncoMed, which if exercised, contain U.S. profit sharing and co-commercialization terms, plus one-third OncoMed and two-thirds Celgene global development cost-sharing and royalties outside the profit-sharing territory.

The collaboration agreement also includes option exercise payments and payments for achievement of development, regulatory and commercial milestones, paid on a per-program basis. For the demcizumab program, these contingent payments could total up to approximately $790.0 million, and include a payment for achievement of predetermined safety criteria in phase II clinical trials. For the anti-DLL4/VEGF bispecific antibody program, contingent payments could total up to $505.0 million. For the other four programs, each program is eligible for up to approximately $440.0 million of contingent payments. OncoMed could also receive more than $100.0 million in contingent payments for the small molecule program.

The collaboration agreement may be terminated by us on a program-by-program basis upon one hundred twenty (120) days prior written notice before exercise of that program option, and after such program option exercise, by either party for material breach by the other party. With certain exceptions, the collaboration agreement expires upon the later of (a) the last-to-expire option term and (b) if one or more options are exercised, the termination or expiration of the last to expire agreement with respect to such exercised option.

Other Collaboration Arrangements in 2013:    In addition to the collaboration arrangements described above, we entered into a number of collaborative arrangements during 2013 that resulted in $52.1 million of assets for investments in equity or other assets and research and development expenses of $149.0 million. These additional arrangements entered into during 2013 include the potential for future milestone payments of up to an aggregate $373.0 million related to the attainment of specified development and regulatory approval milestones over a period of several years. Our obligation to fund these efforts is contingent upon continued involvement in the programs and/or the lack of any adverse events which could cause the discontinuance of the programs. We do not consider these collaboration arrangements to be individually significant at this time.
Summarized financial information related to our collaboration agreements is presented below:
 
 
Year ended December 31,
 
As of December 31,1
 
 
Research and Development Expense
 
 
 
 
 
 
 
 
Upfront Fees
Milestones
Extension of Agreements
Amortization of Prepaid Research and Development
 
Additional Equity Investments Made
 
Intangible Asset Balance
Equity Investment Balance
Percentage of Outstanding Equity
Acceleron
2013
$
—

$
17.0

$
—

$
—

 
$
10.0

 
$
—

$
127.2

11
%
 
2012
—

—

—

—

 
—

 
—

30.5

12
%
 
2011
25.0

14.5

—

—

 
25.0

 
 
 
 
 
2010 and prior
45.0

13.0

—

—

 
5.5

 
 
 
 
Agios
2013
—

—

20.0

—

 
12.8

 
—

113.0

15
%
 
2012
—

—

—

—

 
—

 
—

37.5

17
%
 
2011
—

—

20.0

—

 
28.7

 
 
 
 
 
2010 and prior
121.2

—

—

—

 
8.8

 
 
 
 
Epizyme
2013
—

25.0

—

—

 
1.0

 
—

69.4

12
%
 
2012
65.0

—

—

—

 
25.0

 
—

25.0

15
%
bluebird
2013
74.7

—

—

—

 
—

 
0.2

—

—
%
FORMA
2013
52.8

—

—

—

 
—

 
0.2

—

—
%
MorphoSys
2013
94.3

—

—

—

 
61.3

 
—

61.4

3
%
Acetylon
2013
50.0

—

—

4.3

 
10.0

 
35.7

25.0

10
%
 
2012
—

—

—

—

 
5.0

 
—

15.0

10
%
 
2011
—

—

—

—

 
10.0

 
 
 
 
Oncomed
2013
155.0

—

—

—

 
22.2

 
—

43.4

5
%
Other Collaboration Arrangements
2013
149.0

—

—

3.0

 
13.6

 
25.6

30.0

N/A

2012
113.5

5.4

—

0.2

 
13.6

 
27.3

29.9

N/A

2011
103.5

1.0

2.4

—

 
1.1

 
 
 
 
1 Year-end balance and percentage of outstanding equity are presented for the current and prior year.
XML 38 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Results of Operations (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2013
Quarterly Financial Data [Abstract]  
Schedule of quarterly results of operations
2013
 
1Q
 
2Q
 
3Q
 
4Q 3
 
Year
Total revenue
 
$
1,464.6

 
$
1,599.0

 
$
1,674.4

 
$
1,755.9

 
$
6,493.9

Gross profit1
 
1,348.8

 
1,483.2

 
1,557.8

 
1,632.1

 
6,021.9

Income tax provision
 
63.5

 
79.7

 
69.5

 
2.8

 
215.5

Net income attributable to Celgene
 
384.9

 
478.1

 
372.5

 
214.4

 
1,449.9

Net income per share:2
 
 
 
 
 
 
 
 
 
 
Basic
 
$
0.92

 
$
1.15

 
$
0.90

 
$
0.52

 
$
3.50

Diluted
 
$
0.89

 
$
1.11

 
$
0.87

 
$
0.50

 
$
3.37

Weighted average shares (in millions)
 
 
 
 
 
 
 
 
 
 
Basic
 
417.9

 
414.1

 
412.3

 
411.2

 
413.8

Diluted
 
432.2

 
429.3

 
428.8

 
428.6

 
430.3

2012
 
1Q
 
2Q
 
3Q
 
4Q 4
 
Year
Total revenue
 
$
1,273.3

 
$
1,366.8

 
$
1,419.2

 
$
1,447.4

 
$
5,506.7

Gross profit1
 
1,173.0

 
1,264.7

 
1,313.4

 
1,335.4

 
5,086.5

Income tax provision
 
72.5

 
73.3

 
52.3

 
27.2

 
225.3

Net income attributable to Celgene
 
401.5

 
367.4

 
424.2

 
263.1

 
1,456.2

Net income per share attributable to Celgene:2
 
 
 
 
 
 
 
 
 
 
Basic
 
$
0.92

 
$
0.84

 
$
0.99

 
$
0.62

 
$
3.38

Diluted
 
$
0.90

 
$
0.82

 
$
0.97

 
$
0.61

 
$
3.30

Weighted average shares (in millions)
 
 
 
 
 
 
 
 
 
 
Basic
 
438.3

 
436.7

 
427.2

 
421.6

 
430.9

Diluted
 
448.6

 
445.4

 
436.3

 
432.3

 
440.8

1 
Gross profit is computed by subtracting cost of goods sold (excluding amortization of acquired intangible assets) from net product sales.
2 
The sum of the quarters may not equal the full year due to rounding. In addition, quarterly and full year basic and diluted earnings per share are calculated separately.
XML 39 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Tables)
 12 Months Ended
Dec. 31, 2013
Debt Disclosure [Abstract]  
Carrying values of the senior notes
 
 
2013
 
2012
2.450% senior notes due 2015
 
$
513.9

 
$
520.1

1.900% senior notes due 2017
 
499.9

 
500.6

2.300% senior notes due 2018
 
399.0

 
—

3.950% senior notes due 2020
 
484.6

 
499.0

3.250% senior notes due 2022
 
956.6

 
1,002.1

4.000% senior notes due 2023
 
696.3

 
—

5.700% senior notes due 2040
 
249.6

 
249.5

5.250% senior notes due 2043
 
396.6

 
—

Total long-term debt
 
$
4,196.5

 
$
2,771.3
XML 40 R75.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Details 3) (Options, USD $)
In Millions, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-Based Compensation      
Cash received from exercise of awards $ 551.6 $ 476.2 $ 166.5
Excess tax benefit recognized from exercise of awards 169.4 49.3 31.1
Unrecognized compensation cost $ 463.2    
Weighted-average period over which unrecognized compensation cost is expected to be recognized 2 years 2 months    
Weighted-average grant date fair value of the stock options issued (in dollars per share) $ 40.44 $ 19.33 $ 17.09
Assumptions used in the estimation of fair value of options granted      
Weighted average expected volatility 31.00% 28.00% 29.00%
Expected dividend yield 0.00% 0.00% 0.00%
Period of settlement of publicly traded options 6 months    
Minimum
      
Assumptions used in the estimation of fair value of options granted      
Risk-free interest rate 0.68% 0.21% 0.21%
Expected volatility 27.00% 27.00% 27.00%
Expected term (years) 5 years 0 months 10 days 1 year 3 months 18 days 1 year 9 months 18 days
Maximum
      
Assumptions used in the estimation of fair value of options granted      
Risk-free interest rate 1.70% 1.23% 2.20%
Expected volatility 35.00% 30.00% 33.00%
Expected term (years) 5 years 6 months 5 years 2 months 1 day 5 years 2 months 12 days
XML 41 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Tables)
 12 Months Ended
Dec. 31, 2013
Cash, Cash Equivalents, and Short-term Investments [Abstract]  
Schedule of available-for-sale securities by major security type and class
December 31, 2013
 
Amortized
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
U.S. Treasury securities
 
$
795.2

 
$
0.3

 
$
(0.4
)
 
$
795.1

U.S. government-sponsored agency securities
 
208.9

 
0.2

 
(0.2
)
 
208.9

U.S. government-sponsored agency MBS
 
450.8

 
0.1

 
(6.9
)
 
444.0

Non-U.S. government, agency and
Supranational securities
 
10.4

 
—

 
—

 
10.4

Corporate debt – global
 
379.2

 
1.1

 
(0.6
)
 
379.7

Asset backed securities
 
181.6

 
—

 
(0.2
)
 
181.4

Marketable equity securities
 
212.9

 
220.2

 
—

 
433.1

Total available-for-sale marketable securities
 
$
2,239.0

 
$
221.9

 
$
(8.3
)
 
$
2,452.6


December 31, 2012
 
Amortized
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
U.S. Treasury securities
 
$
902.0

 
$
0.5

 
$
—

 
$
902.5

U.S. government-sponsored agency securities
 
303.5

 
0.3

 
—

 
303.8

U.S. government-sponsored agency MBS
 
387.2

 
1.6

 
(1.8
)
 
387.0

Non-U.S. government, agency and
Supranational securities
 
7.1

 
—

 
—

 
7.1

Corporate debt – global
 
208.5

 
0.9

 
(0.2
)
 
209.2

Marketable equity securities
 
0.4

 
—

 
(0.1
)
 
0.3

Total available-for-sale marketable securities
 
$
1,808.7

 
$
3.3

 
$
(2.1
)
 
$
1,809.9
Schedule of available-for-sale securities in an unrealized loss position for less than and longer than 12 months
 
 
Less than 12 months
 
12 months or longer
 
Total
December 31, 2013
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
U.S. Treasury securities
 
$
316.9

 
$
(0.4
)
 
$
—

 
$
—

 
$
316.9

 
$
(0.4
)
U.S. government-sponsored agency securities
 
78.2

 
(0.2
)
 
—

 
—

 
78.2

 
(0.2
)
U.S. government-sponsored agency MBS
 
358.9

 
(5.4
)
 
45.8

 
(1.5
)
 
404.7

 
(6.9
)
Corporate debt – global
 
135.1

 
(0.6
)
 
—

 
—

 
135.1

 
(0.6
)
Asset backed securities
 
126.3

 
(0.2
)
 
—

 
—

 
126.3

 
(0.2
)
Total
 
$
1,015.4

 
$
(6.8
)
 
$
45.8

 
$
(1.5
)
 
$
1,061.2

 
$
(8.3
)
Schedule of duration periods of available-for-sale debt securities
 
 
Amortized
Cost
 
Fair
Value
Duration of one year or less
 
$
391.8

 
$
391.6

Duration of one through three years
 
1,364.8

 
1,363.8

Duration of three through five years
 
233.9

 
229.8

Duration of over five years
 
35.6

 
34.3

Total
 
$
2,026.1

 
$
2,019.5
XML 42 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of Business and Basis and Summary of Significant Accounting Policies (Details 2) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Foreign Currency Translation:      
Net foreign exchange losses $ 22.2 $ 10.8 $ 3.1
Revenue Recognition      
Percentage of responsibility for patient's cost of branded prescription taken by manufacturers 50.00%    
Minimum
      
Revenue Recognition      
Period for settlement of rebates and fees 1 month    
Maximum
      
Revenue Recognition      
Period for settlement of rebates and fees 15 months    
Buildings
      
Property, Plant and Equipment:      
Estimated useful lives of capitalized assets (in years) 40 years    
Building and operating equipment
      
Property, Plant and Equipment:      
Estimated useful lives of capitalized assets (in years) 15 years    
Manufacturing machinery and equipment
      
Property, Plant and Equipment:      
Estimated useful lives of capitalized assets (in years) 10 years    
Other machinery and equipment
      
Property, Plant and Equipment:      
Estimated useful lives of capitalized assets (in years) 5 years    
Furniture and fixtures
      
Property, Plant and Equipment:      
Estimated useful lives of capitalized assets (in years) 5 years    
Computer equipment and software | Minimum
      
Property, Plant and Equipment:      
Estimated useful lives of capitalized assets (in years) 3 years    
Computer equipment and software | Maximum
      
Property, Plant and Equipment:      
Estimated useful lives of capitalized assets (in years) 7 years    
XML 43 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets and Goodwill (Details) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 12 years 6 months 12 years 6 months  
Intangible Assets By Category      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 12 years 6 months 12 years 6 months  
Gross Carrying Value $ 3,848,300,000 $ 3,841,400,000  
Accumulated Amortization (1,146,500,000) (878,900,000)  
Intangible Assets, Net 2,701,800,000 2,962,500,000  
Total intangible assets      
Gross Carrying Value 3,986,200,000 3,979,300,000  
Intangible Assets, Net 2,839,700,000 3,100,400,000  
Increase in the gross carrying value of the intangible assets 6,900,000    
Impairment of intangible assets 2,500,000    
Amortization 270,100,000 196,200,000 290,300,000
Increase in amortization expense 73,900,000    
Summary of changes in carrying value of goodwill      
Balance at December 31, 2012 2,042,800,000    
Tax benefit on the exercise of Pharmion converted stock options (1,600,000)    
Balance at December 31, 2013 2,041,200,000 2,042,800,000  
Acquired developed product rights
      
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 13 years 13 years  
Intangible Assets By Category      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 13 years 13 years  
Gross Carrying Value 3,405,900,000 3,400,400,000  
Accumulated Amortization (1,026,400,000) (814,500,000)  
Intangible Assets, Net 2,379,500,000 2,585,900,000  
Total intangible assets      
Finite-lived assets acquired 5,500,000    
Technology
      
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 7 years 7 years  
Intangible Assets By Category      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 7 years 7 years  
Gross Carrying Value 333,700,000 333,300,000  
Accumulated Amortization (87,400,000) (39,800,000)  
Intangible Assets, Net 246,300,000 293,500,000  
Licenses
      
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 16 years 6 months 16 years 9 months  
Intangible Assets By Category      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 16 years 6 months 16 years 9 months  
Gross Carrying Value 66,200,000 64,300,000  
Accumulated Amortization (13,900,000) (10,000,000)  
Intangible Assets, Net 52,300,000 54,300,000  
Other
      
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 8 years 7 months 6 days 8 years 6 months  
Intangible Assets By Category      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 8 years 7 months 6 days 8 years 6 months  
Gross Carrying Value 42,500,000 43,400,000  
Accumulated Amortization (18,800,000) (14,600,000)  
Intangible Assets, Net 23,700,000 28,800,000  
Total intangible assets      
Finite-lived assets acquired 3,900,000    
Acquired IPR&D product rights
      
Non-amortized intangible assets:      
Carrying Value 137,900,000 137,900,000  
Minimum
      
Total intangible assets      
Amortization 255,000,000    
Minimum | Acquired IPR&D product rights
      
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 1 year    
Intangible Assets By Category      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 1 year    
Maximum
      
Total intangible assets      
Amortization $ 270,000,000    
Maximum | Acquired IPR&D product rights
      
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 17 years    
Intangible Assets By Category      
Amortization period related to non-IPR&D intangible assets, minimum (in years) 17 years    
XML 44 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Cash and cash equivalents    
Money market funds $ 1,697 $ 1,160
Available-for-sale securities by major security type and class of security    
Amortized Cost 2,239.0 1,808.7
Gross Unrealized Gain 221.9 3.3
Gross Unrealized Loss (8.3) (2.1)
Estimated Fair Value 2,452.6 1,809.9
U.S. Treasury securities
    
Available-for-sale securities by major security type and class of security    
Amortized Cost 795.2 902.0
Gross Unrealized Gain 0.3 0.5
Gross Unrealized Loss (0.4) 0
Estimated Fair Value 795.1 902.5
U.S. government-sponsored agency securities
    
Available-for-sale securities by major security type and class of security    
Amortized Cost 208.9 303.5
Gross Unrealized Gain 0.2 0.3
Gross Unrealized Loss (0.2) 0
Estimated Fair Value 208.9 303.8
U.S. government-sponsored agency MBS
    
Available-for-sale securities by major security type and class of security    
Amortized Cost 450.8 387.2
Gross Unrealized Gain 0.1 1.6
Gross Unrealized Loss (6.9) (1.8)
Estimated Fair Value 444.0 387.0
Non-U.S. government, agency and Supranational securities
    
Available-for-sale securities by major security type and class of security    
Amortized Cost 10.4 7.1
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Estimated Fair Value 10.4 7.1
Corporate debt – global
    
Available-for-sale securities by major security type and class of security    
Amortized Cost 379.2 208.5
Gross Unrealized Gain 1.1 0.9
Gross Unrealized Loss (0.6) (0.2)
Estimated Fair Value 379.7 209.2
Asset backed securities
    
Available-for-sale securities by major security type and class of security    
Amortized Cost 181.6  
Gross Unrealized Gain 0  
Gross Unrealized Loss (0.2)  
Estimated Fair Value 181.4  
Marketable equity securities
    
Available-for-sale securities by major security type and class of security    
Amortized Cost 212.9 0.4
Gross Unrealized Gain 220.2 0
Gross Unrealized Loss 0 (0.1)
Estimated Fair Value $ 433.1 $ 0.3
XML 45 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaboration Agreements (Tables)
 12 Months Ended
Dec. 31, 2013
Collaboration Agreements [Abstract]  
Schedule of Collaboration Agreements
Summarized financial information related to our collaboration agreements is presented below:
 
 
Year ended December 31,
 
As of December 31,1
 
 
Research and Development Expense
 
 
 
 
 
 
 
 
Upfront Fees
Milestones
Extension of Agreements
Amortization of Prepaid Research and Development
 
Additional Equity Investments Made
 
Intangible Asset Balance
Equity Investment Balance
Percentage of Outstanding Equity
Acceleron
2013
$
—

$
17.0

$
—

$
—

 
$
10.0

 
$
—

$
127.2

11
%
 
2012
—

—

—

—

 
—

 
—

30.5

12
%
 
2011
25.0

14.5

—

—

 
25.0

 
 
 
 
 
2010 and prior
45.0

13.0

—

—

 
5.5

 
 
 
 
Agios
2013
—

—

20.0

—

 
12.8

 
—

113.0

15
%
 
2012
—

—

—

—

 
—

 
—

37.5

17
%
 
2011
—

—

20.0

—

 
28.7

 
 
 
 
 
2010 and prior
121.2

—

—

—

 
8.8

 
 
 
 
Epizyme
2013
—

25.0

—

—

 
1.0

 
—

69.4

12
%
 
2012
65.0

—

—

—

 
25.0

 
—

25.0

15
%
bluebird
2013
74.7

—

—

—

 
—

 
0.2

—

—
%
FORMA
2013
52.8

—

—

—

 
—

 
0.2

—

—
%
MorphoSys
2013
94.3

—

—

—

 
61.3

 
—

61.4

3
%
Acetylon
2013
50.0

—

—

4.3

 
10.0

 
35.7

25.0

10
%
 
2012
—

—

—

—

 
5.0

 
—

15.0

10
%
 
2011
—

—

—

—

 
10.0

 
 
 
 
Oncomed
2013
155.0

—

—

—

 
22.2

 
—

43.4

5
%
Other Collaboration Arrangements
2013
149.0

—

—

3.0

 
13.6

 
25.6

30.0

N/A

2012
113.5

5.4

—

0.2

 
13.6

 
27.3

29.9

N/A

2011
103.5

1.0

2.4

—

 
1.1

 
 
 
 
1 Year-end balance and percentage of outstanding equity are presented for the current and prior year.
XML 46 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of Business and Basis and Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2013
Accounting Policies [Abstract]  
Nature of Business and Basis and Summary of Significant Accounting Policies
Nature of Business and Basis and Summary of Significant Accounting Policies
Celgene Corporation, together with its subsidiaries (collectively “we,” “our,”  “us,” “Celgene” or the “Company”) is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.  We are dedicated to innovative research and development designed to bring new therapies to market and are involved in research in several scientific areas that may deliver proprietary next-generation therapies, targeting areas such as intracellular signaling pathways in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.
 
Our primary commercial stage products include REVLIMID®, VIDAZA®, ABRAXANE®, POMALYST®/IMNOVID®, THALOMID® (inclusive of Thalidomide CelgeneTM), ISTODAX® and azacitidine for injection (generic version of VIDAZA®). Additional sources of revenue include royalties from Novartis Pharma AG (Novartis) on their sales of FOCALIN XR® and the entire RITALIN® family of drugs, the sale of services through our Celgene Cellular Therapeutics subsidiary and other licensing agreements.
 
The consolidated financial statements include the accounts of Celgene Corporation and its subsidiaries. Investments in limited partnerships and interests where we have an equity interest of 50% or less and do not otherwise have a controlling financial interest are accounted for by either the equity or cost method. We record net income (loss) attributable to non-controlling interest, if any, in our Consolidated Statements of Income equal to the percentage of ownership interest retained in the respective operations by the non-controlling parties. Certain prior year amounts have been reclassified to conform to the current year's presentation.

The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect reported amounts and disclosures.  Actual results could differ from those estimates.  We are subject to certain risks and uncertainties related to, among other things, product development, regulatory approval, market acceptance, scope of patent and proprietary rights, competition, outcome of civil and governmental proceedings, European credit risk, technological change and product liability.

Financial Instruments:    Certain financial instruments reflected in the Consolidated Balance Sheets, (e.g., cash, cash equivalents, accounts receivable, certain other assets, accounts payable, short-term borrowings and certain other liabilities) are recorded at cost, which approximates fair value due to their short-term nature. The fair values of financial instruments other than marketable securities are determined through a combination of management estimates and information obtained from third parties using the latest market data. The fair value of available-for-sale marketable securities is determined utilizing the valuation techniques appropriate to the type of security (See Note 4).
Derivative Instruments and Hedges:    All derivative instruments are recognized on the balance sheet at their fair value. Changes in the fair value of derivative instruments are recorded each period in current earnings or other comprehensive income (loss), depending on whether a derivative instrument is designated as part of a hedging transaction and, if it is, the type of hedging transaction. For a derivative to qualify as a hedge at inception and throughout the hedged period, we formally document the nature and relationships between the hedging instruments and hedged item. We assess, both at inception and on an on-going basis, whether the derivative instruments that are used in cash flow hedging transactions are highly effective in offsetting the changes in cash flows of hedged items. We assess hedge ineffectiveness on a quarterly basis and record the gain or loss related to the ineffective portion of derivative instruments, if any, to current earnings. If we determine that a forecasted transaction is no longer probable of occurring, we discontinue hedge accounting and any related unrealized gain or loss on the derivative instrument is recognized in current earnings. We use derivative instruments, including those not designated as part of a hedging transaction, to manage our exposure to movements in foreign exchange, on our stock price and interest rates. The use of these derivative instruments modifies the exposure of these risks with the intent to reduce our risk or cost.
Cash, Cash Equivalents and Marketable Securities Available for Sale:    We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency mortgage-backed securities (MBS), non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities. All liquid investments with maturities of three months or less from the date of purchase are classified as cash equivalents and all investments with maturities of greater than three months from date of purchase are classified as marketable securities available for sale. We determine the appropriate classification of our investments in marketable debt and equity securities at the time of purchase. In addition, our equity investments in the publicly traded common stock of companies with whom we have entered into collaboration agreements are also designated as marketable securities available for sale.
Marketable securities available for sale are carried at fair value, held for an unspecified period of time and are intended for use in meeting our ongoing liquidity needs. Unrealized gains and losses on available-for-sale securities, which are deemed to be temporary, are reported as a separate component of stockholders' equity, net of tax. The cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. The amortization, along with realized gains and losses and other-than-temporary impairment charges, is included in interest and investment income, net.
A decline in the market value of any available-for-sale security below its carrying value that is determined to be other-than-temporary would result in a charge to earnings and decrease in the security's carrying value down to its newly established fair value. Factors evaluated to determine if an investment is other-than-temporarily impaired include significant deterioration in earnings performance, credit rating, asset quality or business prospects of the issuer; adverse changes in the general market condition in which the issuer operates; our intent to hold to maturity and an evaluation as to whether it is more likely than not that we will not have to sell before recovery of its cost basis; our expected future cash flows from the security; and issues that raise concerns about the issuer's ability to continue as a going concern.
Concentration of Credit Risk:    Cash, cash equivalents and marketable securities are financial instruments that potentially subject the Company to concentration of credit risk. We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency MBS, non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities (See Note 6). We have established guidelines relative to diversification and maturities to maintain safety and liquidity. These guidelines are reviewed periodically and may be modified to take advantage of trends in yields and interest rates.
We sell our products in the United States primarily through wholesale distributors and specialty contracted pharmacies. Therefore, wholesale distributors and large pharmacy chains account for a large portion of our U.S. trade receivables and net product revenues (See Note 19). International sales are primarily made directly to hospitals, clinics and retail chains, many of which in Europe are government owned and have extended their payment terms in recent years given the economic pressure these countries are facing. We continuously monitor the creditworthiness of our customers, including these governments, and have internal policies regarding customer credit limits. We estimate an allowance for doubtful accounts primarily based on the credit worthiness of our customers, historical payment patterns, aging of receivable balances and general economic conditions, including publicly available information on the credit worthiness of countries themselves and provinces or areas within such countries where they are the ultimate customers.
We continue to monitor economic conditions, including the volatility associated with international economies, the sovereign debt crisis in certain European countries and associated impacts on the financial markets and our business. Our current business model in these markets is typically to sell our products directly to principally government owned or controlled hospitals, which in turn directly deliver critical care to patients. Our products are used to treat life-threatening diseases and we believe this business model enables timely delivery and adequate supply of products. Many of the outstanding receivable balances are related to government-funded hospitals and we believe the receivable balances are ultimately collectible. Similarly, we believe that future sales to these customers will continue to be collectible.
The credit and economic conditions within Spain, Italy, Portugal and Greece, as well as increasing sales levels in those countries have resulted in, and may continue to result in, an increase in the average length of time it takes to collect accounts receivable. Our total net receivables in Spain, Italy and Portugal are composed almost entirely of amounts receivable from government-owned or controlled hospitals and the public sector and amounted to $348.4 million at December 31, 2013, compared to $324.2 million at December 31, 2012. Approximately $86.4 million of the $348.4 million receivable at December 31, 2013 was greater than one year past due. Our exposure to the sovereign debt crisis in Greece is limited, as we do not have a material amount of receivables in Greece. We maintain timely and direct communication with hospital customers in Spain, Italy and Portugal regarding both the current and past due receivable balances. We continue to receive payments from these countries, and closely monitor the plans for payment at the regional government level. Payments from customers in these countries are not received on regular intervals and several months could elapse between significant payments. We also regularly request and receive positive confirmation of the validity of our receivables from most of the regional governmental authorities.
In determining the appropriate allowance for doubtful accounts for Spain, Italy and Portugal, we considered that the balance of past due receivables is related to sales made to government-owned or supported customers. We regularly monitor developments in Europe to assess whether the level of risk of default for any customers has increased and note the ongoing efforts by the European Union, European Monetary Union and International Monetary Fund to support countries with large public deficits and outstanding debt balances. We also monitor the efforts of individual countries to support their regions with large public deficits and outstanding debt balances. We have not experienced significant losses or write-offs with respect to the collection of our accounts receivable in these countries as a result of their economic difficulties and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse impact on our financial position or results of operations.
Inventory:    Inventories are recorded at the lower of cost or market, with cost determined on a first-in, first-out basis. We periodically review the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized. Included in inventory are raw materials used in the production of preclinical and clinical products, which are charged to research and development expense when consumed.
We capitalize inventory costs associated with certain products prior to regulatory approval of products, or for inventory produced in new production facilities, when management considers it highly probable that the pre-approval inventories will be saleable. The determination to capitalize is based on the particular facts and circumstances relating to the expected regulatory approval of the product or production facility being considered, and accordingly, the time frame within which the determination is made varies from product to product. The assessment of whether or not the product is considered highly probable to be saleable is made on a quarterly basis and includes, but is not limited to, how far a particular product or facility has progressed along the approval process, any known safety or efficacy concerns, potential labeling restrictions and other impediments. We could be required to write down previously capitalized costs related to pre-launch inventories upon a change in such judgment, or due to a denial or delay of approval by regulatory bodies, a delay in commercialization or other potential factors.
Property, Plant and Equipment:    Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation of plant and equipment is recorded using the straight-line method. Building improvements are depreciated over the remaining useful life of the building. Leasehold improvements are depreciated over the lesser of the economic useful life of the asset or the remaining term of the lease, including anticipated renewal options. The estimated useful lives of capitalized assets are as follows:
Buildings
40 years
Building and operating equipment
15 years
Manufacturing machinery and equipment
10 years
Other machinery and equipment
5 years
Furniture and fixtures
5 years
Computer equipment and software
3-7 years

Maintenance and repairs are charged to operations as incurred, while expenditures for improvements which extend the life of an asset are capitalized.
Capitalized Software Costs:    We capitalize software costs incurred in connection with developing or obtaining software. Capitalized software costs are included in property, plant and equipment, net and are amortized over their estimated useful life of three to seven years from the date the systems are ready for their intended use.
Investments in Other Entities:    We hold a portfolio of investments in equity securities and certain investment funds that are accounted for under either the equity method or cost method. Investments in companies or certain investment funds over which we have significant influence but not a controlling interest are accounted for using the equity method, with our share of earnings or losses reported in other income (expense), net. Investments in equity securities of companies that become publicly traded are accounted for as available-for-sale marketable securities prospectively from the date of such companies' initial public offering.
Our cost method and equity method investments are included in other assets on the Consolidated Balance Sheets.
All investments are reviewed on a regular basis for possible impairment. If an investment's fair value is determined to be less than its net carrying value and the decline is determined to be other-than-temporary, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an other-than-temporary decline in value has occurred include: market value or exit price of the investment based on either market-quoted prices or future rounds of financing by the investee; length of time that the market value was below its cost basis; financial condition and business prospects of the investee; our intent and ability to retain the investment for a sufficient period of time to allow for recovery in market value of the investment; issues that raise concerns about the investee's ability to continue as a going concern; any other information that we may be aware of related to the investment.
Other Intangible Assets:    Intangible assets with definite useful lives are amortized to their estimated residual values over their estimated useful lives and reviewed for impairment if certain events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Intangible assets which are not amortized include acquired in-process research and development (IPR&D) and acquired intangible assets held for sale. Amortization is initiated for IPR&D intangible assets when their useful lives have been determined. IPR&D intangible assets which are determined to have had a drop in their fair value are adjusted downward and an expense recognized in the income statement. These IPR&D intangible assets are tested at least annually or when a triggering event occurs that could indicate a potential impairment.
Goodwill:    Goodwill represents the excess of purchase price over fair value of net assets acquired in a business combination accounted for by the acquisition method of accounting and is not amortized, but is subject to impairment testing at least annually or when a triggering event occurs that could indicate a potential impairment. We test our goodwill annually for impairment each November 30.
Impairment of Long-Lived Assets:    Long-lived assets, such as property, plant and equipment and certain other long-term assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to the estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of the assets exceed their estimated future undiscounted net cash flows, an impairment charge is recognized for the amount by which the carrying amount of the assets exceed the fair value of the assets.
Contingent Consideration from Business Combinations:    Subsequent to the acquisition date, we measure contingent consideration arrangements at fair value for each period with changes in fair value recognized in income as acquisition related (gains) charges and restructuring, net. Changes in fair values reflect new information about related IPR&D and other assets and the passage of time. In the absence of new information, changes in fair value reflect only the passage of time as development work towards the achievement of the milestones progresses, and is accrued based on an accretion schedule.
Foreign Currency Translation:    Operations in non-U.S. entities are recorded in the functional currency of each entity. For financial reporting purposes, the functional currency of an entity is determined by a review of the source of an entity's most predominant cash flows. The results of operations for non-U.S. dollar functional currency entities are translated from functional currencies into U.S. dollars using the average currency rate during each month, which approximates the results that would be obtained using actual currency rates on the dates of individual transactions. Assets and liabilities are translated using currency rates at the end of the period. Adjustments resulting from translating the financial statements of our foreign entities into the U.S. dollar are excluded from the determination of net income and are recorded as a component of other comprehensive income (loss). Transaction gains and losses are recorded in other income (expense), net in the Consolidated Statements of Income. We had a net foreign exchange gain of $22.2 million in 2013 and losses of $10.8 million and $3.1 million in 2012 and 2011, respectively. These amounts include the impact of gains and losses on foreign exchange contracts not designated as hedging instruments (See Note 5).
Research and Development Costs:    Research and development costs are expensed as incurred. These include all internal and external costs related to services contracted by us. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Milestone payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product. Upfront payments are recorded when incurred, and milestone payments are recorded when the specific milestone has been achieved.
Income Taxes:    We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. We recognize the benefit of an uncertain tax position that we have taken or expect to take on income tax returns we file if such tax position is more likely than not to be sustained.
Revenue Recognition:   Revenue from the sale of products is recognized when title and risk of loss of the product is transferred to the customer and the sales price is fixed and determinable. Provisions for discounts, early payments, rebates, sales returns and distributor chargebacks under terms customary in the industry are provided for in the same period the related sales are recorded. We record estimated reductions to revenue for volume-based discounts and rebates at the time of the initial sale. The estimated reductions to revenue for such volume-based discounts and rebates are based on the sales terms, historical experience and trend analysis.
We base our sales returns allowance on estimated on-hand retail/hospital inventories, measured end-customer demand as reported by third-party sources, actual returns history and other factors, such as the trend experience for lots where product is still being returned or inventory centralization and rationalization initiatives conducted by major pharmacy chains, as applicable.  If the historical data we use to calculate these estimates do not properly reflect future returns, then a change in the allowance would be made in the period in which such a determination is made and revenues in that period could be materially affected.  Under this methodology, we track actual returns by individual production lots.  Returns on closed lots, that is, lots no longer eligible for return credits, are analyzed to determine historical returns experience.  Returns on open lots, that is, lots still eligible for return credits, are monitored and compared with historical return trend rates.  Any changes from the historical trend rates are considered in determining the current sales return allowance. 
Sales discount accruals are based on payment terms extended to customers.
 
Government rebate accruals are based on estimated payments due to governmental agencies for purchases made by third parties under various governmental programs. U.S. Medicaid rebate accruals are generally based on historical payment data and estimates of future Medicaid beneficiary utilization applied to the Medicaid unit rebate formula established by the Center for Medicaid and Medicare Services. The Medicaid rebate percentage was increased and extended to Medicaid Managed Care Organizations in March 2010.  The accrual of the rebates associated with Medicaid Managed Care Organizations is calculated based on estimated historical patient data related to Medicaid Managed Care Organizations.  We have also analyzed actual billings received from the states to further support the accrual rates.  Subsequent to implementation of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the 2010 U.S. Health Care Reform Law), certain states have only recently begun submitting partial Medicaid Managed Care Organization bills.  Our accruals for these Medicaid Managed Care Organization rebates had been at elevated levels given the delays in the receipt of complete invoices from certain states.  Due to the receipt of more complete claims data as 2013 progressed, the accruals for certain states were reduced from the elevated levels at December 31, 2012 as a result of both the payments made being applied to the accrual and a $20.3 million favorable change in estimate of the ultimate obligation.  We will continue to adjust the rebate accruals as more information becomes available and to reflect actual claims experience. Effective January 1, 2011, manufacturers of pharmaceutical products are responsible for 50% of the patient’s cost of branded prescription drugs related to the Medicare Part D Coverage Gap.  In order to estimate the cost to us of this coverage gap responsibility, we analyze data for eligible Medicare Part D patients against data for eligible Medicare Part D patients treated with our products as well as the historical invoices.  This expense is recognized throughout the year as costs are incurred.  In certain international markets, government-sponsored programs require rebates to be paid based on program specific rules and, accordingly, the rebate accruals are determined primarily on estimated eligible sales.
 
Rebates or administrative fees are offered to certain wholesale customers, group purchasing organizations and end-user customers, consistent with pharmaceutical industry practices. Settlement of rebates and fees may generally occur from one to 15 months from the date of sale. We provide a provision for rebates at the time of sale based on contracted rates and historical redemption rates. Assumptions used to establish the provision include level of wholesaler inventories, contract sales volumes and average contract pricing.  We regularly review the information related to these estimates and adjust the provision accordingly.
 
Chargeback accruals are based on the differentials between product acquisition prices paid by wholesalers and lower government contract pricing paid by eligible customers covered under federally qualified programs.  Distributor service fee accruals are based on contractual fees to be paid to the wholesale distributor for services provided.  TRICARE is a health care program of the U.S. Department of Defense Military Health System that provides civilian health benefits for military personnel, military retirees and their dependents.  TRICARE rebate accruals are included in chargeback accruals and are based on estimated Department of Defense eligible sales multiplied by the TRICARE rebate formula.
We record estimated reductions to revenue for free goods and volume-based discounts at the time of the initial sale. The estimated reductions to revenue for such free goods and volume-based discounts are based on the sales terms, historical experience and trend analysis. The cost of free goods is included in Cost of Goods Sold (excluding amortization of acquired intangible assets).
We recognize revenue from royalties based on licensees' sales of its products or products using its technologies. Royalties are recognized as earned in accordance with the contract terms when royalties from licensees can be reasonably estimated and collectability is reasonably assured. If royalties cannot be reasonably estimated or collectability of a royalty amount is not reasonably assured, royalties are recognized as revenue when the cash is received.
Share-Based Compensation:    We utilize share based compensation in the form of stock options, restricted stock units (RSUs) and performance-based restricted stock units (PSUs). Compensation expense is recognized in the Consolidated Statements of Income based on the estimated fair value of the awards at grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized to date associated with grants that are not expected to vest will be reversed.
The fair values of stock option grants are estimated as of the date of grant using a Black-Scholes option valuation model. The fair values of RSU and PSU grants are based on the market value of our Common Stock on the date of grant.
Earnings Per Share:    Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, assuming potentially dilutive common shares, resulting from option exercises, restricted stock units, warrants and other incentives had been issued and any proceeds thereof used to repurchase common stock at the average market price during the period. The assumed proceeds used to repurchase common stock is the sum of the amount to be paid to us upon exercise of options, the amount of compensation cost attributed to future services and not yet recognized and, if applicable, the amount of excess income tax benefit that would be credited to paid-in capital upon exercise.
New Accounting Pronouncements:   In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update “Comprehensive Income (Topic 220):  Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income” (ASU 2013-2).  ASU 2013-2 requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. generally accepted accounting principles (GAAP) to be reclassified in its entirety to net income.  The amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  An entity shall provide this information together, in one location, either on the face of the statement where net income is presented or as a separate disclosure in the notes to the financial statements.  The amendments are effective prospectively for reporting periods beginning after December 15, 2012.  The adoption of ASU 2013-2 did not have a material impact on our financial position or results of operations.

In July 2013, the FASB issued Accounting Standards Update "Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes" (ASU 2013-10). ASU 2013-10 permits the use of the Fed Funds Effective Swap Rate (also referred to as the Overnight Index Swap Rate), in addition to the U.S. government rate (UST) and London Interbank Offered Rate (LIBOR), as a U.S. benchmark interest rate for hedge accounting purposes. This update is effective prospectively for qualifying new or re-designated hedging relationships entered into on or after July 17, 2013. The adoption of ASU 2013-10 did not have a material impact on our financial position or results of operations.

In July 2013, the FASB issued Accounting Standards Update "Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists" (ASU 2013-11). ASU 2013-11 requires an entity to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (NOL) carryforward, or similar tax loss or tax credit carryforward, rather than as a liability when (1) the uncertain tax position would reduce the NOL or other carryforward under the tax law of the applicable jurisdiction and (2) the entity intends to use the deferred tax asset for that purpose. ASU 2013-11 is effective prospectively for fiscal years and interim periods within those years, beginning after December 15, 2013 for public entities. During the quarter ended December 31, 2013, we early adopted ASU 2013-11 on a prospective basis, and the change in presentation had no material impact on our financial position or results of operations.
XML 47 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details 2) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Estimated Fair Value  
Less than 12 months $ 1,015.4
12 months or longer 45.8
Total 1,061.2
Gross Unrealized Loss  
Less than 12 months 6.8
12 months or longer 1.5
Total (8.3)
U.S. Treasury securities
  
Estimated Fair Value  
Less than 12 months 316.9
12 months or longer 0
Total 316.9
Gross Unrealized Loss  
Less than 12 months 0.4
12 months or longer 0
Total (0.4)
U.S. government-sponsored agency securities
  
Estimated Fair Value  
Less than 12 months 78.2
12 months or longer 0
Total 78.2
Gross Unrealized Loss  
Less than 12 months 0.2
12 months or longer 0
Total (0.2)
U.S. government-sponsored agency MBS
  
Estimated Fair Value  
Less than 12 months 358.9
12 months or longer 45.8
Total 404.7
Gross Unrealized Loss  
Less than 12 months 5.4
12 months or longer 1.5
Total (6.9)
Corporate debt – global
  
Estimated Fair Value  
Less than 12 months 135.1
12 months or longer 0
Total 135.1
Gross Unrealized Loss  
Less than 12 months 0.6
12 months or longer 0
Total (0.6)
Asset backed securities
  
Estimated Fair Value  
Less than 12 months 126.3
Total 126.3
Gross Unrealized Loss  
Less than 12 months 0.2
Total $ (0.2)
EXCEL 48 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\T-S4U-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY M939F-C$Y8C$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E137T]&7T-! M4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYA='5R95]O9E]"=7-I;F5S#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C M<75I#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/D]T:&5R M7T9I;F%N8VEA;%]);F9O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=&%N9VEB;&5?07-S971S7V%N9%]';V]D=VEL M;#PO>#I.86UE/@T*("`@(#QX.E=O#I% M>&-E;%=O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O&5S/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYA='5R95]O9E]"=7-I;F5S#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9I;F%N8VEA;%]);G-T#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DEN=F5N=&]R>5]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K5]0;&%N=%]A;F1?17%U:7!M96YT7U0\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D%C8W5M=6QA=&5D7T]T:&5R7T-O;7!R96AE M;G-I=C$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E%U87)T97)L>5]297-U;'1S7V]F7T]P97)A M=&EO;C$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D%C<75I#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D-A#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DEN=F5N=&]R>5]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/D1E M8G1?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D1E8G1?1&5T86EL#I%>&-E;%=O5]$971A:6QS/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C8W5M=6QA=&5D7T]T:&5R7T-O;7!R96AE;G-I=C,\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K M#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-H87)E0F%S961?0V]M<&5N#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I%>&-E;%=O M&5S7T1E=&%I;'-?,CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;&QA8F]R871I;VY?06=R965M96YT#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O M#I%>&-E M;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT M:6YG96YC:65S7S,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=E;V=R87!H:6-?86YD7U!R;V1U8W1?26YF;W)M830\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U M-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA2!);F9O'0^)SQS<&%N/CPO2!296=I"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^1&5C M(#,Q+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)RTM M,3(M,S$\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!6 M;VQU;G1A'0^)SQS<&%N/CPO'0^)UEE'0^)SQS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U M-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XR-2XS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S6%B;&4\+W1D M/@T*("`@("`@("`\=&0@8VQA&5S('!A>6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO MF5D.R!N;VYE(&]U='-T86YD:6YG(&%T($1E M8V5M8F5R(#,Q+"`R,#$S(&%N9"`R,#$R+"!R97-P96-T:79E;'D\+W1D/@T* M("`@("`@("`\=&0@8VQA2P@870@8V]S=#L@,3`Q+C4@ M;6EL;&EO;B!A;F0@-S@N-R!M:6QL:6]N('-H87)E7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XU+#`P,"PP,#`\F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-S4L,#`P+#`P M,#QS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4&5R(%-H M87)E(&1A=&$L('5N;&5S'0^ M)SQS<&%N/CPO'!E M;G-E'0^)SQS<&%N/CPO&-L=61I;F<@86UOF%T M:6]N(&]F(&%C<75IF%T:6]N(&]F(&%C M<75I'0^ M)SQS<&%N/CPO"!P'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPOF5D(&AO;&1I;F<@9V%I;G,@*&QO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E M*2!B96YE9FET(&]F("0V+CDL("@D,2XY*2!A;F0@*"0R+CDI(&9O65A'0^)SQS<&%N/CPO M"!E>'!E;G-E("AB96YE M9FET*2!O9B`D-S65A"`H97AP96YS92D@8F5N969I M="!O9B`D,BXR+"`D,"XQ(&%N9"`D,"XS(&9O65A7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'!E;G-E*2!B96YE9FET/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XV+CD\'0^)SQS<&%N/CPOF5D(&AO;&1I;F<@9V%I;G,@*&QO M"!E>'!E;G-E("AB96YE9FET*3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S"`H97AP96YS92D@8F5N969I=#PO=&0^#0H@("`@("`@(#QT M9"!C;&%S3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U-V$W,U]E,6)D7S1D-#E? M8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-#'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO2!O<&5R871I;F<@86-T:79I=&EE'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-#8N-BD\F5D M(&QO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S"!P87EA M8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-RXT/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!O M<&5R871I;F<@86-T:79I=&EE'0^)SQS<&%N/CPO6UE;G1S(&9O M'0^)SQS<&%N/CPO2!S:&%R97,\+W1D/@T* M("`@("`@("`\=&0@8VQA&-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U-V$W,U]E,6)D7S1D-#E? M8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-#'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO65E(&)E;F5F:70@ M<&QA;G,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO&ES(&%C<75I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO&5R8VES93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES M92!O9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XU-2XX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O M9B!S=&]C:R!O<'1I;VYS(&%N9"!W87)R86YT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R M8VES92!O9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ-S`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@F4Z-W!T/B8C,36QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!42$%,3TU)1#PO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/CQS M=7`@F4Z-W!T/B8C,3F4Z-W!T/E1-/"]S=7`^/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*2P@25-4 M3T1!6#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$P<'0[/CQS=7`@F4Z-W!T/B8C,3F4Z-W!T/B8C,36%L=&EE3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XF M(S$W-#L\+W-U<#X\+V9O;G0^/&9O;G0@3II M;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`[,S$L(#(P,3,@=V%S(&=R96%T97(@=&AA M;B!O;F4@>65A6UE;G1S(&9R;VT@=&AE2!M;VYI=&]R('1H92!P;&%N6UE;G1S+B!792!A;'-O M(')E9W5L87)L>2!R97%U97-T(&%N9"!R96-E:79E('!O2!T:&4@175R;W!E86X@56YI;VXL($5U#MP861D:6YG+71O<#HQ,'!X M.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`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`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[4')O<&5R='DL('!L86YT(&%N9"!E<75I<&UE;G0@87)E('-T871E M9"!A="!C;W-T(&QE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z M,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I;F3I4:6UE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^0G5I;&1I M;F<@86YD(&]P97)A=&EN9R!E<75I<&UE;G0\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,3`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`[)B,Q-C`[)B,Q-C`[)B,Q-C`[3&]N9RUL:79E9"!A6EN9R!A;6]U;G0@;V8@ M86X@87-S970@;6%Y(&YO="!B92!R96-O=F5R86)L92X\+V9O;G0^/"]D:78^ M/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ M,3!P>#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!O9B!A2!A(&-O;7!A'!E8W1E9"!T;R!B92!G96YEF5D(&9O6EN9R!A;6]U;G0@;V8@=&AE(&%S&-E960@=&AE(&9A:7(@=F%L M=64@;V8@=&AE(&%S#MP861D:6YG+71O M<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[4W5B#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^1F]R96EG;B!#=7)R96YC M>2!43II;FAE2!O9B!E86-H(&5N=&ET M>2X@1F]R(&9I;F%N8VEA;"!R97!O2!I2!E M;G1I=&EE2!R871E(&1U&-L=61E9"!F M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,3`N M."!M:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG M+6)O='1O;3HQ,'!X.W!A9&1I;F2!A M<'!R;W9A;"!A#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S M=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`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`@52Y3+B!(96%L=&@@0V%R92!2969O6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#(P+C,@;6EL;&EO;CPO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[/B!F879O6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO3II;FAE MF4@9&%T82!F M;W(@96QI9VEB;&4@365D:6-AF5D('1H6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^4F5B871E2!P6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO3II;FAE6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO2!R979I97<@=&AE(&EN9F]R;6%T:6]N(')E;&%T960@=&\@=&AE2X\ M+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[=&5X M="UA;&EG;CIJ=7-T:69Y.V9O;G0M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^0VAA2!E;&EG:6)L92!C=7-T;VUE2!R971I#MT97AT+6%L:6=N.FIUF4Z,3!P=#L^5V4@#MT97AT+6%L:6=N.FIU M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5V4@F5D(&%S(&5A2!A2!A;6]U;G0@:7,@;F]T(')E M87-O;F%B;'D@87-S=7)E9"P@F5D(&%S M(')E=F5N=64@=VAE;B!T:&4@8V%S:"!I#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`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`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[0F%S:6,@96%R;FEN9W,@<&5R('-H87)E(&ES(&-O;7!U M=&5D(&)Y(&1I=FED:6YG(&YE="!I;F-O;64@8GD@=&AE('=E:6=H=&5D+6%V M97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,@;W5T&5R8VES97,L(')E65T(')E8V]G;FEZ960@86YD+"!I9B!A<'!L:6-A M8FQE+"!T:&4@86UO=6YT(&]F(&5X8V5S&5R8VES92X\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I M9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ,3!P>#MP861D:6YG+71O<#HQ,'!X M.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE28C,38P M.S(P,3,L('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A M2!C;VUP;VYE M;G0N)B,Q-C`[($%N(&5N=&ET>2!S:&%L;"!P2!F;W(@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^26X@2G5L M>2`R,#$S+"!T:&4@1D%30B!I"!3=V%P(%)A=&4I M+"!I;B!A9&1I=&EO;B!T;R!T:&4@52Y3+B!G;W9E2`Q-RP@,C`Q,RX@(%1H92!A9&]P=&EO;B!O9B!!4U4@ M,C`Q,RTQ,"!D:60@;F]T(&AA=F4@82!M871E'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE&5S("A4;W!I8R`W-#`I.B!0 MF5D(%1A>"!"96YE9FET(%=H M96X@82!.970@3W!E69O65A65A2!A9&]P=&5D($%352`R,#$S M+3$Q(&]N(&$@<')O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O M;3HQ,'!X.W!A9&1I;F#MP861D:6YG M+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MT97AT+6%L:6=N.FIUF4Z,3!P=#L^3VX@36%R8V@F(S$V,#LW+"`R,#$R M("AT:&4@06-Q=6ES:71I;VX@1&%T92DL('=E(&%C<75I2UO=VYE9"!S=6)S:61I87)Y+B!4:&4@#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF M>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE3II;FAE6UE;G1S(&]F('5P('1O(&%N M(&5S=&EM871E9"!M87AI;75M(&]F(#PO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`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`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`P,#`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`^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3DX+C0\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE3PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/CQS=7`@F4Z M-W!T/C,\+W-U<#X\+V9O;G0^/"]D:78^/"]T9#X\=&0@8V]L#LG(')O=W-P86X],T0Q/CQD:78@#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^5&]T86P@:61E;G1I9FEA8FQE M(&YE="!A#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3,U+C$\+V9O M;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#MP861D:6YG M+6QE9G0Z,C1P>#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XQ/"]S=7`^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ=&]P.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#MP861D:6YG M+6QE9G0Z,C1P>#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XR/"]S=7`^)B,Q M-C`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`[26YC+B`H06)R87AIF4Z-W!T/B8C,36QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U M<"!S='EL93TS1'9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+B`@26X@ M07!R:6P@,C`Q,2P@=V4@2!$&5C=71I=F4@8VAA:7)M86X@ M;V8@06)R87AI6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXQ,"4\+V9O;G0^/&9O;G0@3II;FAE6%L='D@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^(&)A2!!8W1I=F4@0FEO;6%T97)I86QS+"8C,38P.TQ, M0R!A;F0@=&AE(&9O6%L=&EE3II;FAE2!S=')E86T@86YD M('=E(')E8V]R9&5D(&%N(&EM<&%I3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&EN(#(P,3,N/"]F;VYT M/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIUF4Z,3!P=#L^26X@2F%N=6%R>2`R,#$T+"!W92!E M;G1E2!C;VYT3II;FAE3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U M<"!S='EL93TS1'9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^('!R;V1U M8W0@8V%N9&ED871E3II;FAE2!.86YT0FEO4V-I96YC92P@:6YC;'5D:6YG('1H92`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`E.V)O#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,CPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`P,#`P,#LG(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P M.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^.2XY/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-RXT/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^-#,P+C,\+V9O;G0^/"]D:78^/"]T M9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE M(",P,#`P,#`[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`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`P,#`P,#L^)#(N,#8X M(&)I;&QI;VX\+V9O;G0^/&9O;G0@3II;FAE M7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`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`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`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`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O;G0MF4Z,3!P=#L^261E;G1I8V%L($%S6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^*$QE=F5L)B,Q-C`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`[,BD\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^4VEG;FEF:6-A;G0\+V9O;G0^/"]D M:78^/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE M/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^26YP M=71S/"]F;VYT/CPO9&EV/CQD:78@F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,BPT-S(N-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#L@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#DN,CPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^26YT97)E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#4X M+C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9EF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^*#(R."XU/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+7)I9VAT.C)P>#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH M96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ8V5N=&5R.V9O;G0M'0M86QI9VXZ8V5N=&5R.V9O;G0M M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^475O=&5D(%!R:6-E(&EN/"]F;VYT M/CPO9&EV/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O;G0M'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0MF4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^/&9O;G0@3II;FAE M'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0MF4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O M;G0MF4Z,3!P=#L^ M*$QE=F5L)B,Q-C`[,RD\+V9O;G0^/"]D:78^/"]T9#X\+W1R/CQT#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZF4Z,3!P=#L^,2XW/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^,BXW/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE(",P,#`P,#`[)R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R M9&5R+71O<#HS<'@@9&]U8FQE(",P,#`P,#`[)R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE(",P,#`P M,#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#0X M,"XV/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP M861D:6YG+7)I9VAT.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+7)I9VAT.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#$Y M."XQ/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUR:6=H=#HR<'@[<&%D M9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^5&AE(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.C$P<'0[/B0S,"XT(&UI;&QI;VX\+V9O;G0^/&9O;G0@ M3II;FAE3II;FAE3II;FAEF4Z-W!T/B8C,32!O9F9S970@8GD@82`\+V9O;G0^/&9O;G0@3II;FAE'0O:F%V M87-C3X-"B`@("`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`R,#$R(&AA9"!S971T;&5M96YT(&1A=&5S('=I=&AI;B`\+V9O;G0^/&9O M;G0@'0M9&5C;W)A=&EO;CIN;VYE.R<^,S8@;6]N M=&AS/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+B!4:&5S92!F;W)E:6=N(&-U2!F;W)W87)D(&-O;G1R86-T'!E;G-E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"8C,38P.SPO9F]N=#X\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P M<'0[8V]L;W(Z(S`P,#`P,#L^,C`Q,CPO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/CH\+V9O;G0^/"]D M:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C$P M<'0[/CQD:78@'0M:6YD96YT M.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,C6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3,T M+C0\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0MF4Z,3!P=#L^175R;SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[,S$L(#PO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#L^,C`Q,SPO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!A;F0F M(S$V,#L\+V9O;G0^/&9O;G0@3II;FAE3II;FAE3II;FAE M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O M;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!R97-P96-T:79E;'DN/"]F;VYT M/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIUF4Z,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^1F]R M96EG;B!#=7)R96YC>2!/<'1I;VX@0V]N=')A8W1S.CPO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B`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`Q,CPO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MT97AT+61E8V]R M871I;VXZ=6YD97)L:6YE.SY&;W)E:6=N($-U#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M3H\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@8V]L#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`Q M-"P@=VET:"`\+V9O;G0^/&9O;G0@3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&UA='5R:6YG(&EN(#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z M(S`P,#`P,#L^9FEV92!Y96%R6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MC;VQO3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO65A3II;FAE2!A;F0@1F5B6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&%N9"`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`@:7,@2!T M97)M:6YA=&4@=&AE(&AE9&=I;F<@2!E;G1E6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^5V4@:&%V92!E;G1E3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^.CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X.W!A9&1I;F'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H M=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP861D:6YG M/3-$,"!C96QL'0M86QI9VXZ;&5F=#LG/CQT"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\+W1D/CQT9"!W:61T:#TS1#5P M>"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\+W1D/CQT9"!W:61T:#TS1#9P M>"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\+W1D/CQT9"!W:61T:#TS1#DU M<'@@6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,7!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C%P=#L^)B,Q-C`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`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXR,#$R/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$)W9E#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@ M3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE#MP861D M:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXS M,#`N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`E('-E;FEO#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CEP=#L^,BXS,#`E('-E;FEO#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CEP=#L^,C`P+C`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`N,#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z.7!T.SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^,RXR-3`E('-E M;FEO#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^.#4P M+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CEP=#L^,C`P+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXT+C`P,"4@6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R<@'0M86QI9VXZ M3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T M.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ3II;FAE"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M3II;FAE6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CEP=#L^,S`P+C`\+V9O;G0^/"]D:78^/"]T M9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M3II;FAE#MP861D:6YG+71O<#HQ,'!X.W1E M>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2`Q,BP@,C`Q-"!W87,@/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#$N.#4P(&)I;&QI;VX\+V9O;G0^/&9O;G0@3II;FAE#MT97AT+6%L:6=N.FIUF4Z,3!P=#L^5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM M87)I>F5S('1H92!F86ER('9A;'5E(&%N9"!P3II;FAE3II;FAE'0M:6YD96YT M.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A M8FQE(&-E;&QP861D:6YG/3-$,"!C96QL'0M86QI9VXZ M;&5F=#LG/CQT#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0Q,2!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY!F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0U('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^3&EA8FEL:71Y($1E6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^26YS=')U;65N=#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^3W1H M97(@;F]N+6-U6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^-C`N-CPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^3W1H97(@;F]N M+6-U#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXR-2XV/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.SY);G1E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY/=&AE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^,36QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG M"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIT;W`[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.SXR,#8N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U M8FQE(",P,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN M;W)M86P[<&%D9&EN9RUT;W`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0U M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^1F%I#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#L^1F]R96EG;B8C,38P.V5X8VAA;F=E)B,Q-C`[8V]N=')A8W1S/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.'!T.SX\6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M M:&5I9VAT.C$R,"4[9F]N="US:7IE.C5P=#XQ/"]S=7`^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY/=&AE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^ M3W1H97(@8W5R#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`N-3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.W!A9&1I;F#L@'0M86QI M9VXZ3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXS-BXS/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q M-C`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`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP M861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O M;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXD M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O M=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/"]T6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SX\6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C5P=#XQ M/"]S=7`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`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`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#L^26YS=')U;65N=#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M/CQD:78@F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#MF;VYT+7-T>6QE.FET86QI8SL^*$5F9F5C=&EV92!0;W)T:6]N*3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE.FET86QI8SL^ M*$5F9F5C=&EV92!0;W)T:6]N*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD M:78@F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#MF;VYT+7-T>6QE.FET86QI8SL^*$5F9F5C=&EV92!0;W)T:6]N*3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`N-SPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.'!T.SY/=&AE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P M,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,X M,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E3II;FAE#L@'0M86QI9VXZ M3II;FAE#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^*3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SX\6QE M/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US M:7IE.C5P=#XQ/"]S=7`^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@'0M86QI9VXZ8V5N=&5R M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.SY!;6]U;G0@;V8\+V9O;G0^/"]D:78^/&1I M=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T M.SY'86EN+RA,;W-S*3PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O;G0@3II;FAEF4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^;VX@1&5R:79A=&EV93PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`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`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z.'!T.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE"!S;VQI9"`C,#`P,#`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`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`Z,3!P>#L^ M/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL'0M86QI M9VXZ;&5F=#LG/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(')O=W-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIT M;W`[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXS,2XT/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O M;G0^/&9O;G0@3II;FAE3II;FAE6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN M9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#MW:61T:#HQ,#`E.V)O6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^3&]C871I;VX@;V8@1V%I;B`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`Q,CPO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.'!T.SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY/=&AE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O M;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXD M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ3II;FAE"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY42!R871E(&QO8VL@86=R965M96YT#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CAP=#L^3W1H97(@:6YC;VUE+"!N970\+V9O;G0^/"]D M:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@3II;FAE#L@'0M86QI9VXZ3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXD/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.SXS+C<\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^,2XR/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#LG/CQD:78@#MT97AT+6%L:6=N.FIUF4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SY#87-H+"!# M87-H($5Q=6EV86QE;G1S(&%N9"!-87)K971A8FQE(%-E8W5R:71I97,@079A M:6QA8FQE+69O#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M36]N97D@;6%R:V5T(&9U;F1S(&]F(#PO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P M,#MT97AT+61E8V]R871I;VXZ;F]N93L^)#$N-CDW(&)I;&QI;VX\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE2P@=V5R92!R96-O#MT97AT+6%L:6=N.FIUF4Z,3!P=#L^5&AE(&%M;W)T:7IE9"!C;W-T+"!G MF5D(&AO;&1I;F<@9V%I;G,L(&=R;W-S('5N6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^('=E'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^1&5C96UB97(@,S$L(#(P,3,\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^06UOF5D/"]F;VYT M/CPO9&EV/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0MF4Z,3!P=#L^/&9O;G0@3II;FAEF5D/"]F;VYT M/CPO9&EV/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0MF4Z,3!P=#L^/&9O;G0@3II;FAEF5D/"]F;VYT M/CPO9&EV/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$=&5X="UA M;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1F%I6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE M.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^5F%L=64\+V9O;G0^/"]D:78^/"]T9#X\+W1R/CQT#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$ M)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O M='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE"!S;VQI9"`C,#`P,#`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`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3F]N+54N4RX@9V]V M97)N;65N="P@86=E;F-Y(&%N9#PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZF4Z,3!P=#L^,3`N-#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`N-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^,3@Q+C0\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^36%R:V5T M86)L92!E<75I='D@#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C(Q M+CD\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#@N,SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUR:6=H=#HR M<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@6QE M/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG M:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP M861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"XU M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^52Y3+B!G;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,S`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S`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`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`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`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`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`Y+C(\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^36%R:V5T86)L92!E<75I='D@#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"XT/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,2PX,#@N-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,RXS/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP M861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O M;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O M=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P M<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^5&]T86P\+V9O;G0^/"]D:78^/"]T9#X\+W1R/CQT#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O;G0M M'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ8V5N=&5R.V9O;G0MF4Z M,3!P=#L^/&9O;G0@3II;FAEF5D/"]F;VYT/CPO9&EV/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI M9VXZ8V5N=&5R.V9O;G0MF4Z,3!P=#L^1F%I6QE/3-$ M=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5F%L=64\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1W)O'0M86QI9VXZ8V5N=&5R.V9O;G0M'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^17-T:6UA=&5D/"]F;VYT M/CPO9&EV/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S$V+CD\+V9O M;G0^/"]D:78^/"]T9#X\=&0@"!S M;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`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`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`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*#`N,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#4N.#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+7)I9VAT.C)P>#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#@N,SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R M9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUR:6=H=#HR M<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^5&AE($-O;7!A;GD@8F5L:65V97,@=&AA="!T:&4@9&5C;&EN M92!I;B!F86ER('9A;'5E(&]F('-E8W5R:71I97,@:&5L9"!A="!$96-E;6)E M3II M;FAE3II;FAE#MP861D:6YG+71O<#HQ,'!X M.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^('=E'0M M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P M>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL'0M M86QI9VXZ;&5F=#LG/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P M=#L^/&9O;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1F%I6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^5F%L=64\+V9O;G0^/"]D:78^/"]T9#X\+W1R/CQT#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE65A6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP M861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,SDQ M+C8\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/"]T7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3I4:6UE#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^02!S=6UM87)Y(&]F(&EN=F5N=&]R:65S(&)Y(&UA:F]R(&-A=&5G M;W)Y(&%T(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#L^1&5C96UB97(F(S$V M,#LS,2P@,C`Q,SPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$P<'0[/B!A;F0@/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&9O;&QO=W,Z/"]F;VYT/CPO9&EV M/CQD:78@6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP M<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T M:#HQ,#`E.V)O6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M4F%W(&UA=&5R:6%L#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,30W+C0\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S0P M+C0\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C4Y+C4\+V9O;G0^/"]D M:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M4F%W(&UA=&5R:6%L6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&EN(#PO9F]N=#X\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P M<'0[8V]L;W(Z(S`P,#`P,#L^,C`Q,SPO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!C;VUP87)E9"!T M;R`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US M:7IE.C=P=#XF(S$W-#L@/"]S=7`^/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!W:&EC:"!W87,@ M87!P3II;FAE M3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U<"!S='EL M93TS1'9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^("AA<')E;6EL87-T M*3PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[/CQS=7`@F4Z-W!T/B`\+W-U<#X\+V9O;G0^ M/&9O;G0@3II;FAE2!A<'!R;W9A;"!F;W(@=&AI'1087)T7S0W-34W83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2P@4&QA;G0@86YD M($5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD M:78@#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ M:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^4')O<&5R='DL('!L86YT(&%N9"!E<75I<&UE;G0@ M870@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE M6QE/3-$<&%D9&EN9RUL969T.C!P M>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD M:78@F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^3&%N9#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`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`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`C,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^3&5S#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3DS+C0\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M8F%C:V=R;W5N9"UC;VQO#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M5&AE(&)A;&%N8V4@;V8@8V]N2X\+V9O;G0^/"]D:78^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`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`\+V9O;G0^ M/&9O;G0@3II;FAE3II;FAE6QE/3-$ M<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z M;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^0V]M<&5N6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)A8VMG"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.#0N-SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z M,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PP,#$N M,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z M,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-S"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAEF4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MC;VQO6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^ M/&9O;G0@3II;FAE3II;FAE6QE/3-$ M<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z M;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-#,Q+C,\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE3II M;FAE#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S M=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE3II;FAE'0M86QI9VXZ;&5F=#LG/CQT#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O M='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,38S+C4\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@"!S;VQI M9"`C,#`P,#`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`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`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`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P M,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-3@R+C<\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,S4U+C4\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQD:78@#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X.W!A9&1I;F6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^('1O(#PO9F]N M=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^,3<\ M+V9O;G0^/&9O;G0@3II;FAE2!B96EN9R!A;6]R=&EZ960@86YD(&EN=&%N M9VEB;&5S(&YO="!Y970@6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN M9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#MW:61T:#HQ,#`E.V)O6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^079E6QE M/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3&EF M92`H665A6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^06UOF%B;&4@:6YT86YG:6)L92!A6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,38N M-3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BPX M,SDN-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CQD:78@6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT M+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M,3!P=#MW:61T:#HQ,#`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N M="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^079E6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M3&EF92`H665A6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^06UOF%B;&4@:6YT86YG:6)L92!A6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`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`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`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^5&]T86P@:6YT86YG:6)L92!A#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,RPQ,#`N-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CQD:78@#MT97AT+6%L:6=N M.FIU6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&AE(&=R;W-S(&-A2`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`\+V9O;G0^/&9O;G0@3II M;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\ M+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&9O65A6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^+"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&EN(#(P,3,@8V]M<&%R M960@=&\@,C`Q,B!P3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE M.C=P=#XF(S$W-#L\+W-U<#X\+V9O;G0^/&9O;G0@3II;FAE65A6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^('1H6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^(&ES(&5S=&EM871E9"!T;R!B92!I;B!T:&4@2`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^('1O M(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N M93L^)#(W,"XP(&UI;&QI;VX\+V9O;G0^/&9O;G0@3II;FAE#MT97AT+6%L:6=N.FIUF4Z,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^1V]O M9'=I;&PZ/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`P,#`[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-3(P+C$\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-3`P+C8\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BXS,#`E('-E;FEO#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,RXY M-3`E('-E;FEO#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-"PQ M.38N-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BPW M-S$N,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X M.W!A9&1I;F6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD-"XR M-CD@8FEL;&EO;CPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$P<'0[/B!A;F0@2X\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS M1&QI;F4M:&5I9VAT.C$R,"4[<&%D9&EN9RUB;W1T;VTZ,3!P>#MP861D:6YG M+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXD,2XU,#`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`R,#0S(&YO=&5S*2!A;F0L('1O9V5T M:&5R('=I=&@@=&AE(#(P,3@@;F]T97,@86YD(#(P,C,@;F]T97,L(')E9F5R M6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^(&%N9"`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`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^+"!R97-P96-T:79E;'DL(&EN('5N86UOF5D(&=A:6YS(')E M8V]R9&5D(&%S(&$@8V]M<&]N96YT(&]F(&]U3I4 M:6UE3II;FAE#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^0V]M;65R8VEA;"!087!E M3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M+"!R97-P96-T:79E;'DL(&%N9"!A<'!R;WAI;6%T960@:71S(&9A:7(@=F%L M=64N(%1H92!E9F9E8W1I=F4@:6YT97)E#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M2`H0W)E9&ET($9A8VEL:71Y M*2!T:&%T('!R;W9I9&5S(')E=F]L=FEN9R!C6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#$N-3`P(&)I;&QI;VX\+V9O M;G0^/&9O;G0@3II;FAE3II;FAE2!W87,@86QS;R!E>'1E;F1E9"!F2`H8G5T(&EN(&YO(&5V96YT(&UO3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^+B8C,38P.R!!;6]U;G1S(&UA>2!B92!B;W)R;W=E9"!I M;B!5+E,N(&1O;&QA'!E;F1I='5R97,@86YD(&]T:&5R(&-O3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&]U='-T86YD:6YG(&)O3MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE3II;FAE M7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA3QB2!.;W1E(%M!8G-T3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D M:6YG+6)O='1O;3HQ,'!X.W!A9&1I;F#MP861D:6YG M+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[3W5R($)O87)D(&]F($1I MF5D('1O(&ES3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^('-H87)E#MP861D:6YG M+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`[)B,Q-C`[)B,Q-C`[)B,Q-C`[1'5R:6YG M('1H92!P97)I;V0@;V8@07!R:6P@,C`P.2!T:')O=6=H($1E8V5M8F5R(#(P M,3,L(&]U3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^(&]F(&]U3II;FAE3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&]F('1R96%S=7)Y M('-T;V-K('5N9&5R('1H92!P6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE2P@97AC M;'5D:6YG('1R86YS86-T:6]N(&9E97,N($%S(&]F($1E8V5M8F5R)B,Q-C`[ M,S$L(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#L^,C`Q,SPO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[ M/B!A;B!A9V=R96=A=&4@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN M;VYE.SXD-S8N.#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^1&5C96UB97(@,S$L(#(P,3`\+V9O;G0^/"]D M:78^/"]T9#X\=&0@#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-2XR/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^4VAA#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*##MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^4VAA#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[<&%D9&EN9RUL969T.C)P>#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^*#$P,2XU/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUR:6=H=#HR M<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^ M)SQD:78@#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI M9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X.W!A9&1I;F2!T#MP861D:6YG+71O<#HQ M,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAEF5D(&%S(&9O;&QO=W,Z/"]F;VYT/CPO M9&EV/CQD:78@6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N M=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW M:61T:#HQ,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*#4N-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2XX/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$)W9E M#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZF4Z,3!P=#L^*#0N-SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M86QI9VXZF4Z,3!P=#L^-"XR/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#(W+C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,RXR/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D M9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D M9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^*#,V+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P M,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0Q M,2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([=F5R=&EC86PM86QI9VXZ=&]P M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.7!T.SY'86EN3II;FAE6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(&-O;'-P86X] M,T0Q/CQD:78@F4Z M.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CEP=#L^06-C=6UU;&%T960@3W1H97(@0V]M<')E:&5N#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(')O=W-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ8V5N M=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R M+71O<#HQ<'@@F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M/CQD:78@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,7!T.SXF(S$V,#L\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z.7!T.SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.7!T.SY);F-O;64@=&%X(&)E;F5F:70@*&5X<&5N M6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CEP=#L^-BXY/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CEP=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A M9&1I;F#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@3II;FAEF5D(&EN8V]M92`H;&]S6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.7!T.SY);G1E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZ#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CEP=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.7!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^ M*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZ'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,7!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C%P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@3II;FAE#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXY+C$\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.7!T.SXW-BXW/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXD/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`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`[,S$L(#(P,3,\+V9O;G0^/&9O;G0@ M3II;FAE#MT97AT+6%L:6=N M.FIU6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&AE(&9O;&QO=VEN9R!T M86)L92!S=6UM87)I>F5S('1H92!C;VUP;VYE;G1S(&]F('-H87)E+6)A'!E;G-E(&EN('1H92!#;VYS;VQI9&%T960@4W1A M=&5M96YT3II;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"`\+V9O M;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^.CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL93TS1'!A9&1I M;F#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`Q,3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS M1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)A8VMG"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3@N-3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3(N-#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,3`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`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`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`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE3II M;FAE#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S M=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE'!E;G-E(')E M;&%T960@=&\@;F]N+7%U86QI9FEE9"!S=&]C:R!O<'1I;VYS(&]F(#PO9F]N M=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^)#$Y M-RXV(&UI;&QI;VX\+V9O;G0^/&9O;G0@3II M;FAE3II;FAE2X@4VAA3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A M=&EO;CIN;VYE.SXD,2XR(&UI;&QI;VX\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE2X@5V4@9&\@;F]T(')E8V]G;FEZ M92!A(&1E9F5R"!A"!B96YE9FET M#MP861D:6YG+71O<#HQ,'!X M.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^+"`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`\+V9O;G0^/&9O;G0@3II M;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^(&]F('1O=&%L('5N6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO M;CIN;VYE.SXR+C(\+V9O;G0^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MC;VQO6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`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`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`Q,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP M861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^4FES:RUF#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"XR,24@+2`Q+C(S)3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG M+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^17AP96-T960@=&5R;2`H>65A M6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-2XP,R`M(#4N-3`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`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`Q,SPO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[ M/CH\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1&QI;F4M:&5I9VAT.C$R,"4[ M9F]N="US:7IE.C$P<'0[/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT M;W`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`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`C M,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#(N-CPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3@N,S$\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$;W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^.#8P+C,\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N M/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5F5S=&5D(&%T M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,@;W(@97AP96-T960@=&\@=F5S="!I M;B!T:&4@9G5T=7)E/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`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`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HS<'@@9&]U8FQE(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P M.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE M(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HS<'@@9&]U8FQE M(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X M.W!A9&1I;F3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M('=A3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"`\+V9O;G0^/&9O M;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^+"!R97-P96-T:79E;'DN(%1H92!T;W1A;"!I;G1R:6YS:6,@=F%L M=64@;V8@&5R8VES960@9'5R:6YG('1H92!Y96%R M3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"`\+V9O;G0^/&9O M;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`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`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^(&ES(&%S(&9O;&QO=W,Z/"]F;VYT/CPO9&EV/CQD:78@6QE M/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG M:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`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`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-"XU/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZF4Z,3!P=#L^-C`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`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^3F]N=F5S=&5D(&%T($1E8V5M8F5R M)B,Q-C`[,S$L(#(P,3,\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[)R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M3II;FAE3II;FAE M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&]F('1O=&%L M('5N'!E8W1E M9"!T;R!B92!R96-O9VYI>F5D(&]V97(@82!W96EG:'1E9"UA=F5R86=E('!E M3II;FAE M#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^4&5R9F]R;6%N8V4M M0F%S960@4F5S=')I8W1E9"!3=&]C:R!5;FET3II;FAE2=S('!EF5S('1H92!#;VUP86YY)W,@<&5R9F]R;6%N8V4M8F%S960@65A3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M("AS:&%R97,@:6X@=&AO=7-A;F1S*3H\+V9O;G0^/"]D:78^/&1I=B!S='EL M93TS1&QI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C$P<'0[/CQD:78@'0M:6YD96YT.C!P>#ML:6YE+6AE M:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`Z,3!P>#L^/'1A8FQE(&-E;&QP861D M:6YG/3-$,"!C96QL'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`[,S$L(#(P,3(\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$ M)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,3$Y+C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,3`V+C@W/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^07,@;V8@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1&5C96UB97(F(S$V,#LS,2P@,C`Q M,SPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[/BP@=&AE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^(&]F('1O=&%L('5N'!E8W1E9"!T;R!B92!R96-O9VYI>F5D M(&]V97(@82!W96EG:'1E9"UA=F5R86=E('!E3II;FAE'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA3I4:6UE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O M='1O;3HQ,'!X.W!A9&1I;F65E2!B965N(&UA9&4@:6X@=&AE(&9O65E(&-O M;G1R:6)U=&EO;G,@=7`@=&\@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXV)3PO9F]N=#X\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!O9B!E;&EG:6)L M92!C;VUP96YS871I;VX@;W(@82!M87AI;75M('!E2!L876QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN M;VYE.SXD,3DN,R!M:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O M;G0@3II;FAE3II;FAE#MP861D:6YG+71O<#HQ,'!X M.W1E>'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MT97AT M+6%L:6=N.FIU6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^26X@,C`P,"P@ M;W5R($)O87)D(&]F($1IF5N(&5F9F5C=&EV M92!A&5C=71I=F5S(&%S('-P96-I9FEE9"!B>2!T M:&4@<&QA;BP@8V%N(&5L96-T('1O(&1E9F5R('5P('1O(&%N(&%M96YD960@ M/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXY,"4\+V9O;G0^/&9O;G0@3II;FAE2!C;VUP96YS871I;VX@86QL;W=E9"!U;F1E2!C;VYT2!R86YG M97,@9G)O;2`\+V9O;G0^/&9O;G0@3II;FAE M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN M;VYE.SXD,"XW(&UI;&QI;VX\+V9O;G0^/&9O;G0@3II;FAE2X@5&AE($-O;7!A;GDG2!V97-T960@=7!O;B!C;VYT2!I;F-L=61E9"!I;B!O=&AE M&EM871E;'D@/"]F;VYT/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD-S,N-R!M:6QL M:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE2P@=VAI8V@@:6YC;'5D960@=&AE('!A6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X.W!A9&1I;F2!O9F9I M8V5R6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+7EE M87(@<&5R:6]D+B!792!C=7)R96YT;'D@:&%V92`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`\+V9O;G0^/&9O M;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^('1O(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT+61E8V]R M871I;VXZ;F]N93L^,C`P)3PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!O9B!T:&4@<&%R=&EC:7!A M;G0G'!E;G-E&EM=6T@<&]T96YT:6%L('!A>6]U="P@87-S=6UI;F<@;6%X:6UU;2!O M8FIE8W1I=F5S(&%R92!A8VAI979E9"!F;W(@=&AE(#(P,30L(#(P,34@86YD M(#(P,38@4&QA;G,@87)E(#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P,#`P,#MT97AT M+61E8V]R871I;VXZ;F]N93L^)#$Y+C8@;6EL;&EO;CPO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/BP@ M/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE M.SXD,C(N-B!M:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9#PO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L M;W(Z(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^)#(U+C(@;6EL;&EO M;CPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[/BP@'1U3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^('EE87)S+B!792!A8V-R=64@=&AE(&QO;F65A6-L92P@=&AE(&%C8W)U86P@ M:7,@8F%S960@;VX@86X@97-T:6UA=&4@;V8@;W5R(&QE=F5L(&]F(&%C:&EE M=F5M96YT(&1U6UE;G0@97%U86P@=&\@=&AE:7(@=&%R9V5T(&%W87)D(&]R M+"!I9B!H:6=H97(L(&%N(&%W87)D(&)AF5D(&5X<&5N3II;FAE3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,3(N,"!M:6QL M:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^+"!R97-P96-T:79E;'DN/"]F;VYT/CPO9&EV/CPO M9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`Q,3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL M93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O M=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P M,#`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3`W+C,\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!P#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+7)I9VAT M.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C$U M+C4\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`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`E.V)O#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXF(S$V,#L\+V9O;G0^/"]D M:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0W('-T>6QE/3-$)W9E#LG M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M;W9E#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^3&EA8FEL:71I97,\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF M;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^07-S971S/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^1F5D97)A;"!A;F0@#MP861D M:6YG+7)I9VAT.C)P>#L@#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X M,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3(N-CPO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1&5F97)R960@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^,BXS/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-"XR/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^*#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*#$L,#`U+C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ M#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAEF5D("AG86EN#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#$L M-#`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`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`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#$L-#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#@W-BXQ/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CQD:78@#MT97AT+6%L M:6=N.FIU6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^070@1&5C96UB97(F M(S$V,#LS,2P@,C`Q,R!A;F0@,C`Q,BP@9&5F97)R960@=&%X(&%S#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,CPO9F]N=#X\+V1I M=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^-38N-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^0W5R6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#@P-"XY M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN M9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`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`Q,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^52Y3+B!S=&%T=71O#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,S4N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S4N M,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S4N,#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^1F]R96EG;B!T M87@@#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#(X M+C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#(X+C`\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUL969T.C)P>#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUL969T.C)P>#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUR:6=H=#HR M<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`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`\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^(&EN(#(P,3(@86YD(#PO9F]N=#X\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z(S`P M,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^,C(N,"4\+V9O;G0^/&9O;G0@ M3II;FAE"!A9W)E96UE;G0@"!R871E3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"`\+V9O;G0^/&9O;G0@ M3II;FAE3II;FAE"!R871E(&1I9F9E#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^070@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@=V4@ M:&%D(&-O;6)I;F5D('-T871E($Y/3"!C87)R>69O&EM871E;'D@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A M=&EO;CIN;VYE.SXD-#@U+C8@;6EL;&EO;CPO9F]N=#X\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B!T:&%T('=I M;&P@97AP:7)E(&EN('1H92!Y96%R'!E2`\+V9O;G0^/&9O;G0@ M3II;FAE3II;FAE65AF5D(&EN('1H92!P97)I;V0@:6X@=VAI8V@@=&AE('1A>"!D961U8W1I M;VX@:7,@"!A69O2`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`\+V9O;G0^ M/&9O;G0@3II;FAE3II;FAE M2X@5V4@:&%V92!R M96-O"!L:6%B:6QI='D@870@ M1&5C96UB97(F(S$V,#LS,2P@,C`Q,R!O9B`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"!A(&1E9F5R6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO M'0M9&5C;W)A=&EO;CIN;VYE.SXD,36QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^+CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X.W!A9&1I;F&%M:6YA=&EO;B!I M;B!M86YY('1A>&EN9R!J=7)I&%B;&4@<')E65A65A'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE"!L87<@*&EN8VQU9&EN9R!R M96=U;&%T:6]N2!T:&%N(&YO="X@5V4@8F5L:65V92!T:&%T(&]U65A2!H96%V:6QY M(&]N(&5S=&EM871E2!O9B!M971H;V1O;&]G:65S(&EN(&UA:VEN9R!T:&5S92!E2!E>'!E M2!M86YA9V5M96YT+B!(;W=E=F5R+"!I9B!M86YA9V5M96YT M)W,@97-T:6UA=&5S(&%R92!N;W0@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^56YR96-O9VYI>F5D('1A>"!B96YE9FET'!E8W1E9"!T;R!B92!T86ME;B!I;B!A M('1A>"!R971U6QE/3-$ M<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z M;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^0F%L86YC92!A="!B96=I M;FYI;F<@;V8@>65A#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,3"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZF4Z,3!P=#L^,S`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^*#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D M9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^,C$Y+C(\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD M:78@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^5&AEF5D('1A>"!B96YE9FET M2`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`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`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^('5P;VX@86-H M:65V96UE;G0@;V8@8V5R=&%I;B!M:6QE6%L=&EE2!A M;'-O('!A6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5V4@:&%V M92!D971E6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@ M'0M86QI9VXZ:G5S=&EF>3MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6UE M($EN8RX@*$5P:7IY;64I.CPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/B8C,38P.R8C,38P.R8C,38P M.R8C,38P.TEN($%PGEM92!T M;R!D:7-C;W9E6UE(&-O=6QD(')E8V5I M=F4@=7`@=&\@/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQOGEM92!C;VUP;W5N9"!D979E;&]P960@=&\@ M:6YH:6)I="!E86-H(&1IF4@8V]M<&]U;F1S(&EN('1H92!5;FET960@4W1A M=&5S+CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P M)3MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE28C,38P.SDL(#(P,34@*&]R($IU;'DF(S$V,#LY+"`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`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`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`@=&\@1552(#PO9F]N M=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.C$P<'0[8V]L;W(Z(S`P,#`P,#L^-3$Q+C`@;6EL;&EO;CPO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[ M/B`H87!P2`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*2!I;B!D979E;&]P;65N="P@2!A;F0@6%L M=&EE7,@3II;FAE6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6EN9R!O;F4@=&AI7,@8VAO;W-E('1O(&]P="!O=70@;V8@:71S(&-O+7!R;VUO=&EO;B!R:6=H M=',L($UO2X@/"]F;VYT/CPO9&EV M/CQD:78@'0M86QI9VXZ8V5N M=&5R.V9O;G0M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&AE(&%G2!E:71H97(@<&%R='D@=7!O;B!M871E'!I'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE2`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`\+V9O;G0^/&9O;G0@ M3II;FAE2!B>2!/;F-O365D(&]F('1H92!A<'!L:6-A M8FQE(&1A=&$@<&%C:V%G92!F;W(@96%C:"!T:&5R87!E=71I8R!C86YD:61A M=&4L('-U8FIE8W0@=&\@8V5R=&%I;B!E>'1E;G-I;VYS+B8C,38P.R!792!W M:6QL(&%LF%T:6]N(')I9VAT6%L=&EE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIU M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!I;B!T:')E92!P:&%S92!)8B!C;&EN:6-A;"!S M='5D:65S(&EN(&-O;6)I;F%T:6]N('=I=&@@3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAEG5M86(L('1H92!C;VQL86)O3II;FAE3II;FAE2X@5V4@ M:&%V92!E>&-L=7-I=F4@;W!T:6]N2!/;F-O365D+"!W:&EC M:"!I9B!E>&5R8VES960L(&-O;G1A:6X@52Y3+B!P6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N M.FIU6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^5&AE(&-O;&QA8F]R871I M;VX@86=R965M96YT(&%L6UE;G1S(&%N9"!P87EM96YT2`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!A;F0@:6YC;'5D M92!A('!A>6UE;G0@9F]R(&%C:&EE=F5M96YT(&]F('!R961E=&5R;6EN960@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#MC;VQO&EM871E;'D@/"]F M;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#MC;VQO6UE;G1S+B!/;F-O365D(&-O=6QD(&%L M6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M86QI M9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE2!U2`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0X('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^07,@;V8@1&5C96UB M97(@,S$L/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z.'!T.SX\6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C5P=#XQ/"]S=7`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#L^,C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^,C`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`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`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`Q,SPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!C;VQS<&%N/3-$,B!S='EL93TS1'9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXU,BXX/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF M(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z.'!T.SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF(S@R,3([/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#L^,"XR/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF(S@R,3([/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF(S@R M,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#L^36]R<&AO4WES/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#L^,C`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`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`N,#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,X,C$R M.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CAP=#L^-"XS/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`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`N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`Q,SPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!C;VQS<&%N/3-$,B!S='EL93TS1'9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#L^,34U+C`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`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`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`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O M='1O;3HQ,'!X.W!A9&1I;FF4Z-W!T/C$\+W-U M<#X\+V9O;G0^/&9O;G0@3II;FAE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^0V]N=&EN9V5N="!686QU92!2:6=H M=',Z("`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`[)B,Q-C`[ M1F]R(&5A8V@@9G5L;"`\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U<"!S='EL93TS1'9E M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"!T:&4@06)R87AI3II;FAE6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&)U="!A6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CL@9F]N="US:7IE.C$P<'0[)SX\='(^ M/'1D('-T>6QE/3-$=VED=&@Z.39P>#L@F4Z,3!P=#L^)B,Y-S`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`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`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT M.C$R,"4[9F]N="US:7IE.C=P=#XF(S$W-#L\+W-U<#X\+V9O;G0^/&9O;G0@ M3II;FAE6UE;G0@(S$L(&%S(&1E3II;FAE&ES(&%C<75IF%T:6]N(&-O;6UE M;F-E9"!I;B!/8W1O8F5R(#(P,3(N/"]F;VYT/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^36EL97-T;VYE(%!A>6UE;G0@(S(@ M=7!D871E.CPO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.C$P<'0[/B`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`Q-SPO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!C;VQS<&%N/3-$,B!S='EL93TS1'9E#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,C`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIUF4Z,3!P=#L^5&]T86P@2`\+V9O M;G0^/&9O;G0@3II;FAE3II M;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD-#$N.2!M:6QL M:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&EN(#(P,3(@86YD(#PO9F]N=#X\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[8V]L;W(Z M(S`P,#`P,#MT97AT+61E8V]R871I;VXZ;F]N93L^)#0X+C$@;6EL;&EO;CPO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[/B!I;B`R,#$Q+CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X.W!A9&1I;F6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD-RXV,S4@8FEL;&EO;CPO M9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.C$P<'0[/BX@($QI;F5S(&]F(&-R961I="!F86-I;&ET871I;F<@=&AE M(&ES'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE3II;FAE2!C;VYT3II;FAE M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%T($1E8V5M M8F5R)B,Q-C`[,S$L(#(P,3,N(%=E(&%R92!A;'-O(&-O;6UI='1E9"!T;R!P M87D@=&AE(')E;6%I;FEN9R`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`P,#`P,#MT M97AT+61E8V]R871I;VXZ;F]N93L^)#(U+C`@;6EL;&EO;CPO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[ M/B!C;VYT:6YG96YT+"!M:6QE2`R,#$T(&5Q=6ET>2!I;G9E2!#4U,@26YS=&ET=71E('1H92`\+V9O;G0^ M/&9O;G0@3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&-O;G1I;F=E;G0L(&UA M=&-H:6YG(&-O;G1R:6)U=&EO;G,N/"]F;VYT/CPO9&EV/CQD:78@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#MF;VYT+7-T>6QE.FET86QI8SL^0V]L;&%B;W)A=&EO;B!!6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`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`P.2P@=V4@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&%N9"!42$%,3TU)1#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/CQS=7`@F4Z-W!T M/B8C,3F4Z M-W!T/B8C,36QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIUF4Z,3!P=#L^26X@,C`Q,2P@=&AE(%5N:71E9"!3=&%T97,@ M071T;W)N97DF(S@R,3<[6UE;G1S('1O('!H>7-I8VEA;G,@:6X@8V]N;F5C=&EO M;B!W:71H('1H92!S86QEF4Z-W!T/B8C,3F4Z-W!T/B8C,36QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&]T:&5R(%5N:71E9"!3=&%T97,@071T;W)N97ES)B,X,C$W.R!O9F9I M8V5S("AT:&4@3F]R=&AE2`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`X+"`R,#$T+B`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`[/"]F;VYT/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^($]N(%-E<'1E M;6)E"!,3$,@*&9O"8C.#(R,3LI(&EN('1H92!5;FET M960@4W1A=&5S($1I6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[8G)A;F0@9')U9R!I;B!T:&4@56YI=&5D(%-T871E2!#96QG96YE('1O($EV87@N/"]F M;VYT/CPO9&EV/CQD:78@'0M M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U<"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"!2159,24U)1#PO9F]N=#X\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[/CQS M=7`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`P,#`P,#L^,24\+V9O;G0^/&9O;G0@3II;FAE2!O;B!2 M159,24U)1#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.C$P<'0[/CQS=7`@F4Z-W!T/B8C,3F4Z-W!T/B8C M,36QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U M<"!S='EL93TS1'9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&YE="!S M86QE'1E;F1E9"!B M97EO;F0@1F5B6%L='D@<&%Y;65N=',@=&\@0TU#0R!S=6)S97%U M96YT('1O($9E8G)U87)Y(#(X+"`R,#$S)B,Q-C`[8G)E86-H960F(S$V,#MT M:&4@;&EC96YS92!A9W)E96UE;G0N)B,Q-C`[("!#34-#(&ES('-E96MI;F<@ M=6YS<&5C:69I960@9&%M86=E2`R,#$S+"!W92!R96UO=F5D('1H97-E M('!R;V-E961I;F=S('1O('1H92!5;FET960@4W1A=&5S($1I2!$96-E;6)E2!T:&4@8V]U2!D969E;F0@86=A:6YS="!#34-#)W,@8VQA:6US M+B`@07,@;V8@1&5C96UB97(@,S$L(#(P,3,L('=E(&-O;G-I9&5R('1H92!R M86YG92!O9B!R96%S;VYA8FQY('!O6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`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`@F4Z-W!T/B8C,36QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U<"!S M='EL93TS1'9E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^+"!42$%,3TU) M1#PO9F]N=#X\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C$P<'0[/CQS=7`@F4Z-W!T/B8C,3F4Z-W!T/B8C,36%L M=&EE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U<"!S='EL93TS1'9E M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"!T:&4@96YT:7)E(%)) M5$%,24X\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XF(S$W-#L\+W-U M<#X\+V9O;G0^/&9O;G0@3II;FAE2!A;F0@;W1H97(@;6ES8V5L;&%N96]U'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^4F5V96YU97,\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P M<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^-"PX-#(N,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N M=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW M:61T:#HQ,#`E.V)O6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M3&]N9RU,:79E9"!!3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P M=#XQ/"]S=7`^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9EF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^-3DS+C0\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-36QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@F4Z-W!T M/C$\+W-U<#XF(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$;&EN92UH96EG:'0Z,3(P)3MP861D:6YG M+6)O='1O;3HQ,'!X.W!A9&1I;F6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[5&]T86P@'1E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^(&%N9"`\+V9O;G0^/&9O;G0@3II;FAE M3II;FAE6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL M93TS1'!A9&1I;F#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`Q,3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$9F]N="US:7IE.C$P<'0[ M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^4D563$E-240\+V9O;G0^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XF M(S$W-#L\+W-U<#X\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-S`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,S@U+CD\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^ M/&9O;G0@3II;FAEF4Z-W!T/B8C M,36QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/'-U M<"!S='EL93TS1'9E6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z-W!T/B8C,36QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-3`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-2XP/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,CDN-SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-BPS-C(N,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-2PS.#4N-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZF4Z,3!P=#L^,3`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-"PX-#(N,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`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`\+V9O;G0^/&9O;G0@3II;FAE3II;FAE M2!!;65R:7-O=7)C92!"97)G M96X@86-C;W5N=&5D(&9O3II;FAE3II;FAE M'0M86QI9VXZ;&5F=#LG/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0X('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^4&5R8V5N="8C,38P.V]F)B,Q-C`[3F5T M)B,Q-C`[06-C;W5N=',F(S$V,#M296-E:79A8FQE/"]F;VYT/CPO9&EV/CPO M=&0^/"]T6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`Q M,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@ MF4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P M<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,C`Q,CPO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S M='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE M/3-$;W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,3`N-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3$N M-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3(N-CPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE M/3-$;W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-BXT/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\T-S4U-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY939F-C$Y M8C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!297-U;'1S(&]F($]P97)A=&EO;G,@*%5N875D:71E9"D\8G(^/"]S M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L2!297-U M;'1S(&]F($]P97)A=&EO;G,@*%5N875D:71E9"D\+W1D/@T*("`@("`@("`\ M=&0@8VQA6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MF;VYT+7=E:6=H=#IB;VQD.SY1=6%R=&5R;'D@4F5S=6QT6QE/3-$ M<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z M;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q/CQD:78@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@ M3II;FAEF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE M3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US M:7IE.C=P=#XS/"]S=7`^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-#6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-#,P+C,\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T M6QE/3-$<&%D9&EN9RUL M969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A M9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE M.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,C`Q,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q/CQD:78@F4Z M,3!P=#L^/&9O;G0@3II;FAE3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XT M/"]S=7`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O M;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z-W!T/C$\+W-U<#X\+V9O;G0^/"]D:78^/"]T M9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`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`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`Q M,B!W87,@;6]D97)A=&5L>2!L;W=E2!D=64@=&\@86X@:6YC7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQD:78@#MP861D:6YG+71O<#HQ,'!X.W1E>'0M86QI9VXZ:G5S=&EF>3MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA3I4:6UEF4Z,3!P=#L^4V-H961U;&4F(S$V,#M) M228C,38P.R8C.#(Q,3L@5F%L=6%T:6]N(&%N9"!1=6%L:69Y:6YG($%C8V]U M;G1S/"]F;VYT/CPO9&EV/CQD:78@6QE/3-$<&%D9&EN9RUL969T.C!P M>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z,3!P=#MW:61T:#HY-RXT-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z,3!P=#L^/&9O M;G0@3II;FAEF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,S,N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M.#8N-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-SDN-CPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#`N,#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#8N,SPO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^.38N,CPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I M;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.#6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)A8VMG"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-34N-3PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE M.SXR,#$R/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C-P>"!D M;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+7)I9VAT M.C)P>#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,3@N.#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-S6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-C,N,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S,N M,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^.2XP/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#MT97AT+61E8V]R871I;VXZ=6YD97)L:6YE.SXR,#$Q/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C-P M>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P M,#`P,#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^."XS M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-38N,3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0MF4Z-W!T/C$\+W-U<#XF M(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0@8V]L#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3,N,3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-C(N-3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-38N.#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M86QI9VXZF4Z,3!P=#L^,3@N.#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-"XX/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^,38N.#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0MF4Z-W!T/C$\+W-U<#XF(S$V,#L\+V9O M;G0^/"]D:78^/"]T9#X\=&0@8V]L#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,36QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z M,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-SDN,SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-CDN-#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF M;VYT+7-I>F4Z,3!P=#MP861D:6YG+6QE9G0Z,C1P>#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N M="US:7IE.C=P=#XQ/"]S=7`^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE'1087)T7S0W M-34W83'0O:F%V87-C3X-"B`@("`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`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`Z,3!P M>#L^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL'0M M86QI9VXZ;&5F=#LG/CQT#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-#`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`[ M)B,Q-C`[)B,Q-C`[)B,Q-C`[5V4@8V%P:71A;&EZ92!S;V9T=V%R92!C;W-T M2P@<&QA;G0@86YD(&5Q=6EP;65N M="P@;F5T(&%N9"!AF5D(&]V97(@=&AE:7(@97-T:6UA=&5D M('5S969U;"!L:69E(&]F('1H6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z,3!P=#LG/CQD:78@#MT97AT+6%L:6=N M.FIU6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FET86QI M8SL^26YV97-T;65N=',@:6X@3W1H97(@16YT:71I97,Z/"]F;VYT/CQF;VYT M('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`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`[)B,Q M-C`[)B,Q-C`[)B,Q-C`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`N M."!M:6QL:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`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`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`I('1O M(&)E(')E8VQA6QE/3-$;&EN92UH96EG:'0Z M,3(P)3MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@'0M86QI9VXZ:G5S=&EF>3MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;&EN92UH96EG:'0Z,3(P)3MT97AT+6%L:6=N.FIUF4Z,3!P=#L^26X@2G5L>2`R,#$S+"!T:&4@1D%30B!I M&ES=',B("A!4U4@,C`Q,RTQ,2DN("!!4U4@,C`Q M,RTQ,2!R97%U:7)E"!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D(&%S'0^)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#`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`@("`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`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD M:78@6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[ M;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ M,#`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`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`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQT86)L92!C M96QL<&%D9&EN9STS1#`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`^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;&EN92UH M96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC M;VQO'0M9&5C;W)A=&EO;CIN;VYE.SXD,30N-R!M:6QL M:6]N/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^(&%N9"!N;VXM8W5R7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^ M)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE M.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^3W!T:6]N6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-#0P+C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE(",P,#`P,#`[)R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+7)I9VAT M.C)P>#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#L@'0M86QI9VXZF4Z,3!P=#L^,RXS.#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA3I4 M:6UE6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MP861D:6YG+6)O='1O;3HQ,'!X.W!A9&1I;F'0M:6YD96YT.C!P>#ML M:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`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`V<'@@"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M+W1D/CQT9"!W:61T:#TS1#1P>"!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[,RD\+V9O;G0^/"]D:78^ M/"]T9#X\+W1R/CQT#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-#,S+C$\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BPP,SDN-3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P M,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#$Q."XQ/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL93TS M1'!A9&1I;F#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`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`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`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,BXW/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,2PX-3DN,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A M8VMG"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,"XS/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`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`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`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#4N M,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D M9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`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`E.V)O M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-3`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^*#(R."XU/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0Q M,2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.CAP=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.'!T.SY!#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0U('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q M/CQD:78@F4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#L^3&EA8FEL:71Y($1E6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^26YS M=')U;65N=#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`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`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`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`N-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF(S@R M,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ=&]P.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIT;W`[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXR,#8N,#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M:6YD M96YT.C!P>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD M:78@F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^1F%I#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$ M=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^1F]R96EG;B8C,38P.V5X8VAA M;F=E)B,Q-C`[8V]N=')A8W1S/"]F;VYT/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SX\6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C5P M=#XQ/"]S=7`^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY/ M=&AE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#L^,S4N,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXQ,BXW/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^3W1H97(@8W5RF4Z,3!P=#L^)B,Q-C`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`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`N-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#L^3W1H97(@;F]N+6-U#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE M.FET86QI8SL^1&5R:79A=&EV97,@;F]T(&1E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M/CQD:78@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.SY&;W)E:6=N(&5X8VAA;F=E(&-O;G1R86-T#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY/=&AE6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^-#4N.#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z.'!T.SXS-BXS/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXR M,2XT/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z.'!T.SY);G1EF4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P M.W!A9&1I;F#L@'0M86QI9VXZ M3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM M86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CAP=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T M.SX\6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT M.C$R,"4[9F]N="US:7IE.C5P=#XQ/"]S=7`^/"]F;VYT/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY$97)I=F%T M:79E(&EN6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$<&%D M9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R M;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[)R!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3&]C871I;VX@;V8@1V%I;B`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`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`C M,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z.'!T.SY42!R871E(&QO8VL@86=R965M96YT MF4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`C,#`P,#`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@ MF4Z.'!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF M;VYT+7-T>6QE.FET86QI8SL^*$5F9F5C=&EV92!0;W)T:6]N*3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE.FET86QI8SL^*$5F9F5C M=&EV92!0;W)T:6]N*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT M+7-T>6QE.FET86QI8SL^*$5F9F5C=&EV92!0;W)T:6]N*3PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`N-SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY/ M=&AE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`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`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL M93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^ M)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SX\6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C5P M=#XQ/"]S=7`^)B,Q-C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@'0M86QI9VXZ8V5N=&5R M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.SY!;6]U;G0@;V8\+V9O;G0^/"]D:78^/&1I M=B!S='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T M.SY'86EN+RA,;W-S*3PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O;G0@3II;FAEF4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CAP=#L^06-C=6UU;&%T960@3T-)/"]F;VYT/CPO M9&EV/CQD:78@F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#L^:6YT;R!);F-O;64\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9EF4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#L^3&]C871I;VX@;V8\+V9O;G0^/"]D:78^/&1I=B!S M='EL93TS1'1E>'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY' M86EN+RA,;W-S*3PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z.'!T.SY);F-O;64@;VX\+V9O;G0^/"]D:78^/&1I=B!S='EL M93TS1'1E>'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY$97)I M=F%T:79E/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O M;G0@3II;FAEF4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CAP=#L^4F5C;V=N:7IE9"!I;CPO9F]N=#X\+V1I=CX\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O;G0@ M3II;FAE6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.CAP=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7=E:6=H=#IB;VQD M.SXF(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\+W1R/CQT#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N M=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SY);G-T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O M;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z.'!T.V9O;G0M6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z.'!T.V9O;G0M6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O M;G0@3II;FAE'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.V9O;G0M'0M86QI9VXZ8V5N=&5R M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE.FET86QI M8SL^*$EN969F96-T:79E(%!O'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.V9O;G0M MF4Z.'!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CAP=#MF;VYT+7-T>6QE.FET86QI8SL^1G)O;2!%9F9E8W1I=F5N97-S/"]F M;VYT/CPO9&EV/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#MF;VYT+7-T>6QE.FET86QI8SL^5&5S=&EN9RD\+V9O M;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#MF;VYT+7=E:6=H M=#IB;VQD.SXF(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\+W1R/CQT#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[ M9F]N="US:7IE.CAP=#L^1F]R96EG;B8C,38P.V5X8VAA;F=E(&-O;G1R86-T M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP M861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.'!T.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE"!S;VQI9"`C,#`P,#`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`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`Z,3!P>#L^/'1A8FQE M(&-E;&QP861D:6YG/3-$,"!C96QL'0M86QI9VXZ;&5F M=#LG/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(')O=W-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE M/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^4F5C M;V=N:7IE9"!I;B!);F-O;64\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1'1E M>'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N M="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^06UO=6YT(&]F($=A:6X@*$QOF4Z,3!P=#L^/&9O;G0@3II;FAEF5D(&EN($EN8V]M93PO9F]N=#X\+V1I M=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P M<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^;VX@1&5R:79A=&EV93PO9F]N=#X\+V1I=CX\+W1D/CPO='(^ M/'1R/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HQ<'@@#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^26YS=')U M;65N=#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^)#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIT;W`[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXS,2XT/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z.'!T.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`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`Q,SPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9EF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,2PT,C(N.3PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T&-H86YG92!O<'1I;VX@8V]N M=')A8W1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M M9&5C;W)A=&EO;CIU;F1E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`^/"]F;VYT M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.7!T.SX@(%4N4RX@9&]L;&%R(&YO=&EO;F%L(&%M;W5N=',@87)E(&-A;&-U M;&%T960@87,@=&AE(&AE9&=E9"!L;V-A;"!C=7)R96YC>2!A;6]U;G0@;75L M=&EP;&EE9"!T:6UE2!F;W)W87)D(&-O;G1R86-T'0^)SQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MC;VQO6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^(&%N9"`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI M9VXZ8V5N=&5R.V9O;G0M6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXR,#$S/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.CEP=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CEP=#L^26YT97)E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,7!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C%P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,7!T.SX\9F]N="!S='EL93TS M1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C%P=#L^)B,Q-C`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`P+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.7!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CEP=#L^,3`P+C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXR,#`N,#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.7!T.SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O M;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^,RXY-3`E('-E;FEO M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ=&]P.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z.7!T.SXX-3`N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXR,#`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`\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.7!T.SXF(S@R,3([/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CEP=#L^5&]T86P\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^,BPS M,#`N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.CEP=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXS,#`N,#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M'1087)T7S0W-34W83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!M86IO M2!T>7!E(&%N9"!C;&%S'0^)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[ M8F%C:V=R;W5N9"UC;VQO6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S;VQI M9"`C,#`P,#`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`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^3F]N+54N4RX@9V]V97)N;65N="P@ M86=E;F-Y(&%N9#PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,3`N-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`N-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R M+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A M9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C(Q+CD\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9EF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^*#@N,SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O M;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQD:78@6QE/3-$<&%D9&EN M9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L M.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`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`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`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O M='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"XU/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0MF4Z,3!P=#L^52Y3+B!G;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^,S`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M2!A;F0\+V9O;G0^/"]D:78^ M/&1I=B!S='EL93TS1'1E>'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`Y+C(\+V9O M;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^36%R:V5T86)L92!E<75I='D@#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^,"XT/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PX,#@N-SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,RXS/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O M;&]R.B-C8V5E9F8[<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X M.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/"]T'0^)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0W('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP M861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^*#`N-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR M<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R M/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M52Y3+B!G;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZF4Z,3!P=#L^-S@N,CPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P M86X],T0Q/CQD:78@#L@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,X,C$R.SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D M/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+7)I9VAT.C)P>#L@#L@'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`N,CPO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAEF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,2PP,34N-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+7)I M9VAT.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN M9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#$N-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,SDQ+C8\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R M.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!O9B!I M;G9E;G1O2!M86IO3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)A8VMG"!S M;VQI9"`C,#`P,#`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2P@4&QA M;G0@86YD($5Q=6EP;65N="`H5&%B;&5S*3QB2P@4&QA;G0@ M86YD($5Q=6EP;65N="P@3F5T(%M!8G-T3I4:6UE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`Q,CPO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R M/CQT9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@ M'0M86QI9VXZF4Z,3!P=#L^,C4X+C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-#$N,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,2PP,C4N-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^.3$Y+C(\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M'1087)T7S0W-34W83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'!E;G-E'0^)SQD:78@'0M86QI9VXZ;&5F M=#LG/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q/CQD:78@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT M.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^3W1H97(\+V9O;G0^/"]D:78^/"]T M9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T M>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$<&%D9&EN9RUL M969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A M9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([ M9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`C,#`P,#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D M9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^-#,Q+C,\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE'0^)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR M<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,38S+C4\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@"!S;VQI9"`C,#`P M,#`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A M9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-3@R+C<\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[ M8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z M,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,S4U+C4\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M'1087)T7S0W-34W83'0O M:F%V87-C3X-"B`@("`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`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`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`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`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3,W+CD\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,RPY.#8N,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#$L,30V+C4\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ M<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZF4Z,3!P=#L^)B,Q-C`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`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`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#,Y+C@\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,RPX-#$N-#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#@W."XY/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O M='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/"]T6EN9R!V86QU92!O M9B!G;V]D=VEL;#PO=&0^#0H@("`@("`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\T-S4U-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY M939F-C$Y8C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R3I4:6UE6QE M/3-$;&EN92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&1I=B!S='EL M93TS1'!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^,2XY,#`E('-E;FEO#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#DY+CD\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`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`E('-E;FEO#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/"]T M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2`H5&%B;&5S*3QB2!.;W1E(%M!8G-T2!S=&]C M:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78@'0M86QI9VXZ M;&5F=#LG/CQT#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C M,#`P,#`P.R<@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-#DX+C0\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@ M'0M86QI M9VXZ6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3$Q+C(\+V9O;G0^/"]D M:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/"]T86)L93X\+V1I=CX\ M+V1I=CX\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M)W9E"!S;VQI M9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#L@'0M86QI9VXZF4Z,3!P=#L^,BXT/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`P M,#`[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB M86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T M;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1'9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^*#`N-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^.30N M,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`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`Q,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M"!S;VQI9"`C M,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S M='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^1V%I M;G,@*&QO#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N M="US:7IE.C%P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#L@'0M M86QI9VXZ3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R M:70[9F]N="US:7IE.CEP=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z.7!T.SX\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^ M,3`N-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M.7!T.SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXF(S@R,3([/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.7!T M.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE M.CEP=#L^5')E87-U#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP=#L^26YT97)E6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.C%P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z.7!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN M:&5R:70[9F]N="US:7IE.CEP=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z.7!T.SX\ M9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CEP M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.7!T.SXQ+C0\+V9O;G0^/"]D M:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO'0^)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O M=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C M:V=R;W5N9"UC;VQO#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P M,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,3`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,C,Q+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'!E;G-E/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P M,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^ M/"]T'0^)SQD:78@'0M86QI9VXZ;&5F=#LG/CQT#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`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`Q,3PO9F]N=#X\+V1I=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL M93TS1'9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIC M96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"XV."4@+2`Q+C#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E#MP861D:6YG M+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E6QE M/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T M>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,"4\ M+V9O;G0^/"]D:78^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/"]D:78^/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@ M6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN M92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E M.V)O#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S M('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+7)I9VAT.C)P>#L@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I M9VAT.C)P>#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HS<'@@ M9&]U8FQE(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV M('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#LG M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MB;W)D M97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#MB;W)D M97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE(",P,#`P,#`[)R!R;W=S M<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE M(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#LG(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^5F5S=&5D(&%T($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE M(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!D;W5B;&4@(S`P,#`P,#LG(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE M(",P,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HS<'@@9&]U8FQE(",P,#`P,#`[ M)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K M9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HS<'@@9&]U8FQE(",P M,#`P,#`[)R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M'0M86QI9VXZF4Z,3!P=#L^,2PY-#4N-CPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[,S$L(#(P,3(\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^-C8N,C`\+V9O;G0^/"]D:78^/"]T M9#X\=&0@"!S;VQI9"`C,#`P,#`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#L@'0M86QI9VXZ6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`N.#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#`N-#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-2XQ/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C8\+V9O;G0^/"]D:78^/"]T M9#X\=&0@"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`[/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-#8\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3@\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`E.V)O#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`Q,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,S8N.#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE M/3-$;W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,C"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#LG(')O=W-P86X],T0Q/CQD:78@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`P M,#`[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O M<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE(",P,#`P M,#`[8F%C:V=R;W5N9"UC;VQO#MP M861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$<&%D9&EN9RUL969T M.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I M;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`Q,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`C,#`P,#`P.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,34R+CD\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,3F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X M="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)O6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+7)I9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.V)A M8VMG#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE M/3-$;W9E6QE/3-$=&5X="UA M;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`P,#`[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@ M6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P M,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUT M;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3`R M+C$\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C M,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$ M<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z M;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB M;VQD.SXF(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT M97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ M:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0W('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,3(N-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,BXS/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^-"XR/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A M9&1I;F#L@'0M86QI9VXZF4Z,3!P=#L^*#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*#$L,#`U+C`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI9VXZF4Z,3!P=#L^*#$L-#`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M;W9E"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^*#$L-#`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`P,#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^*#@W-BXQ/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MP861D:6YG+7)I9VAT.C)P>#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE2=S M(&)A;&%N8V4@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF M;VYT+7-I>F4Z,3!P=#LG/CQD:78@6QE/3-$<&%D9&EN9RUL969T.C!P M>#MT97AT+6EN9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT M+7-I>F4Z,3!P=#MW:61T:#HQ,#`E.V)O6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[)R!R;W=S M<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N="US M:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD M+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R M;W5N9"UC;VQO#MP861D:6YG+6)O M='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`P,#`[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@#MP861D:6YG M+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^*3PO9F]N=#X\+V1I=CX\+W1D M/CPO='(^/"]T86)L93X\+V1I=CX\+V1I=CX\+V1I=CX\"!R871E(&9O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z M,3!P=#LG/CQD:78@6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN M9&5N=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#MW:61T:#HQ,#`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`Q,CPO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^52Y3+B!S=&%T M=71O#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,S4N,#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N M9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$;W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,S4N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[)3PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,S4N,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O M;3HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D M/CPO='(^/'1R/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^1F]R96EG;B!T87@@#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^*#(X+C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M*#(X+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`[)3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^0VAA;F=E(&EN('9A;'5A=&EO;B!A;&QO M=V%N8V4\+V9O;G0^/"]D:78^/"]T9#X\=&0@#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#L@'0M M86QI9VXZ6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2XR/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C M;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,"XT/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I M9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZF4Z,3!P=#L^)B,X,C$R.SPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP M861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O M;G0@3II;FAE#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$ M,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE M/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^*24\+V9O;G0^/"]D M:78^/"]T9#X\+W1R/CQT#MP861D:6YG M+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUL969T M.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[<&%D9&EN9RUR M:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D M:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q M(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M<&%D9&EN9RUL969T.C)P>#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E M9F8[<&%D9&EN9RUR:6=H=#HR<'@[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T M>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N M9"UC;VQO6QE/3-$=&5X="UA M;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$)W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^-3DV+C@\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T M.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE9G0Z,G!X.W!A9&1I M;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO M6QE/3-$=&5X="UA;&EG;CIL M969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[ M<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^,3"!S;VQI9"`C,#`P,#`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0Q-B!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HQ<'@@#MP861D:6YG M+6)O='1O;3HR<'@[)R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA M;&EG;CIC96YT97([9F]N="US:7IE.CAP=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.R<@'0M86QI9VXZ8V5N=&5R M.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.SY!3II;FAEF4Z-7!T/C$\+W-U<#X\+V9O;G0^/"]D:78^/"]T M9#X\+W1R/CQT#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.CAP=#L^,C`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`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E M#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ3II;FAE'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q M-C`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXQ+C`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CAP=#L^,C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXU M+C`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M)B,Q-C`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`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`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`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`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`Q,3PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!C;VQS<&%N/3-$,B!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z.'!T.SXQ,#,N M-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N M/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US M:7IE.CAP=#L^,2XP/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\ M9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH M97)I=#MF;VYT+7-I>F4Z.'!T.SXR+C0\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.W!A9&1I;F#L@'0M M86QI9VXZ3II;FAE6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N M92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIR M:6=H=#MF;VYT+7-I>F4Z.'!T.SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY M.FEN:&5R:70[9F]N="US:7IE.CAP=#L^,2XQ/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R;W=S<&%N/3-$ M,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/"]T#MT97AT+6%L:6=N.FIU6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^/'-U<"!S='EL93TS1'9E7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6UE;G1S('5N9&5R(&YO;BUC86YC96QA8FQE(&]P97)A=&EN9R!L96%S M97,\+W1D/@T*("`@("`@("`\=&0@8VQA6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P M=#LG/CQD:78@6QE/3-$<&%D9&EN9RUL969T.C!P>#MT97AT+6EN9&5N M=#HP<'@[;&EN92UH96EG:'0Z;F]R;6%L.W!A9&1I;F6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MW M:61T:#HQ,#`E.V)O6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IB;VQD.SXF(S$V,#L\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@8V]L#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ8V5N=&5R.V9O;G0M6QE/3-$=&5X="UA;&EG M;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^3&5A6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q M-#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CIB;W1T;VT[<&%D9&EN9RUL969T.C)P>#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E M#MB;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^-30N-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,C`Q-3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!C;VQS<&%N M/3-$,B!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[(')O M=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO M=&0^/"]T6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`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`P,#`P,#MP861D:6YG+6QE9G0Z M,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R M;W5N9"UC;VQO6QE/3-$=&5X M="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M'1087)T7S0W-34W83'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA3I4:6UE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T M;VTZ,G!X.W!A9&1I;F'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`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`Q,3PO9F]N=#X\+V1I M=CX\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1'9E6QE M/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C M8V5E9F8[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO M#MP861D:6YG+6)O='1O;3HR<'@[ M8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MB86-K9W)O=6YD+6-O;&]R.B-C8V5E9F8[8F]R9&5R+71O<#HQ M<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z M,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^-3`S M+C<\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0MF4Z,3!P=#L^5&]T86P@#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M#MP861D M:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O<#HQ<'@@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9EF4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@ M9&]U8FQE(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^-2PU,#8N-SPO9F]N=#X\+V1I=CX\+W1D M/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O M='1O;3HS<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L M96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@ MF4Z,3!P=#L^/&9O;G0@3II;FAE#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P M,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E"!D M;W5B;&4@(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@ M'0M86QI M9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M:6YD96YT.C!P M>#ML:6YE+6AE:6=H=#IN;W)M86P[<&%D9&EN9RUT;W`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`Q,SPO9F]N M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O M='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P M86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT M.C)P>#LG(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^56YI=&5D(%-T M871E#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$;W9E#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$)W9E#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^,S0X+C`\+V9O;G0^/"]D:78^/"]T9#X\=&0@"!S;VQI9"`C,#`P,#`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`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`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E"!D;W5B M;&4@(S`P,#`P,#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT M+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAEF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CQT86)L92!C96QL<&%D9&EN9STS1#`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`Q,SPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MP861D:6YG+6)O='1O;3HR<'@[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9EF4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR M:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV M/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^.#`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,S`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I M;F6QE/3-$9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^25-43T1!6#PO9F]N=#X\9F]N M="!S='EL93TS1&9O;G0M9F%M:6QY.FEN:&5R:70[9F]N="US:7IE.C$P<'0[ M/CQS=7`@F4Z-W!T/B8C,3#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`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`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`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z M,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R M+71O<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+6)O='1O;3HR<'@[8F]R9&5R+71O M<#HQ<'@@"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P86X],T0Q/CQD M:78@6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ M;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#L@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,3(R+CD\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^5&]T86P@#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP861D:6YG+6QE M9G0Z,G!X.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[8F]R M9&5R+71O<#HQ<'@@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS<'@@9&]U8FQE M(",P,#`P,#`[<&%D9&EN9RUT;W`Z,G!X.W!A9&1I;F#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^-BPT.3,N.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F]R9&5R+6)O='1O;3HS M<'@@9&]U8FQE(",P,#`P,#`[8F]R9&5R+71O<#HQ<'@@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R/3-$ M;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MB;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O M;G0@3II;FAE6QE/3-$)W9E"!D;W5B;&4@(S`P,#`P,#MP M861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)O6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E M"!D;W5B;&4@ M(S`P,#`P,#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`E M.V)O6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D M:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[)R!R M;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG;CIC96YT97([9F]N M="US:7IE.C$P<'0[/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ:6YH97)I M=#MF;VYT+7-I>F4Z,3!P=#L^4&5R8V5N="8C,38P.V]F)B,Q-C`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`Q,SPO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!S='EL93TS1'9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD M:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P M=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#MB;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ8V5N=&5R.V9O;G0M#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[<&%D M9&EN9RUR:6=H=#HR<'@[8F]R9&5R+71O<#HQ<'@@F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG M+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D M9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIC96YT97([9F]N="US:7IE.C$P<'0[/CQF;VYT('-T>6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,C`Q,SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I M9VAT.C)P>#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`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`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M.2XV/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)W9E#MB M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!&:6YA;F-I86P@1&%T82!;06)S=')A8W1= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE M/3-$)W9E"!S M;VQI9"`C,#`P,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P M86X],T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^5&]T86P@#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M,2PT-C0N-CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PU.3DN,#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PV-S0N-#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,2PW-34N.3PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^-BPT.3,N.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0MF4Z,3!P=#L^/&9O M;G0@3II;FAE3II;FAE6QE/3-$=F5R=&EC M86PM86QI9VXZ=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XQ M/"]S=7`^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II M;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0MF4Z,3!P=#L^)B,Q-C`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`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`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`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`^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X] M,T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P M86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[ M(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H M=#HR<'@[(')O=W-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO M=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O M=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ M8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN M9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF M86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+6)O='1O;3HR<'@[(')O=W-P M86X],T0Q(&-O;'-P86X],T0Q/CQD:78@F4Z,3!P=#L^/&)R(&-L96%R/3-$;F]N92\^/"]F;VYT M/CPO9&EV/CPO=&0^/"]T6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A M9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)A8VMG'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM M86QI9VXZ8F]T=&]M.V)A8VMG6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O M<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A M8VMG6QE/3-$=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@ M3II;FAE6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.V)A8VMG'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M#MP861D:6YG+7)I9VAT M.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.V)A8VMG'0M86QI9VXZ;&5F=#MF M;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE M6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG6QE/3-$=&5X="UA;&EG M;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG M'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB M;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR<'@[ M<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T M=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X M.W!A9&1I;F6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O M;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I M;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q/CQD:78@6QE M/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`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`[/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$)W9E"!S;VQI9"`C,#`P M,#`P.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#LG(')O=W-P86X],T0Q/CQD M:78@F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE M/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG M+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O M;'-P86X],T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^5&]T86P@#MP861D:6YG+71O<#HR M<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI M9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E'0M86QI9VXZ6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PR-S,N,SPO M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB M;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN M9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E"!S;VQI9"`C,#`P,#`P M.R<@'0M M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ M6QE/3-$9F]N="UF86UI M;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^,2PS-C8N.#PO9F]N=#X\+V1I M=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C M:V=R;W5N9"UC;VQO6QE/3-$ M=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ M,G!X.W!A9&1I;F6QE/3-$;W9E#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F M=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II M;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZF4Z,3!P=#L^,2PT,3DN,CPO9F]N=#X\+V1I=CX\+W1D/CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC M;VQO6QE/3-$=&5X="UA;&EG M;CIL969T.V9O;G0M6QE/3-$;W9E#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.V)A8VMG"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I M>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$ M)W9E#MB;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^,2PT-#6QE/3-$=&5X="UA;&EG;CIL969T.V9O M;G0M#MP861D M:6YG+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E M"!S;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^ M/&9O;G0@3II;FAE6QE/3-$)W9E#MB;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P.R<@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-2PU,#8N-SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CIB;W1T;VT[8F%C:V=R;W5N9"UC;VQO6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O M;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X] M,T0Q/CQD:78@F4Z,3!P=#L^/&9O;G0@3II;FAE3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ M=&]P.VQI;F4M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XQ/"]S=7`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`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT M+7-I>F4Z,3!P=#L^-#`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`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`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`[/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MB86-K M9W)O=6YD+6-O;&]R.B-C8V5E9F8[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1'9E#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF M;VYT+7-I>F4Z,3!P=#L^,"XY,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL M93TS1'9E6QE/3-$ M9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R(&-L96%R M/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC M86PM86QI9VXZ8F]T=&]M.V)A8VMG#MP861D:6YG+6)O='1O;3HR M<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q M/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z M,3!P=#L^)B,Q-C`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`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`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`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`[/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&-O;'-P86X],T0S('-T>6QE/3-$=F5R=&EC86PM86QI M9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P>#L@'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P M=#L^/&9O;G0@3II;FAE#MP861D:6YG M+71O<#HR<'@[<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$;W9E#MP M861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR<'@[(')O=W-P86X] M,T0Q/CQD:78@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I M>F4Z,3!P=#L^)B,Q-C`[/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.W!A9&1I;F6QE/3-$=&5X="UA;&EG;CIL969T.V9O;G0M#MP861D:6YG+6)O='1O;3HR<'@[<&%D9&EN9RUR:6=H=#HR M<'@[(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@6QE/3-$9F]N M="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^)B,Q-C`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`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`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`[ M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$=F5R M=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#L@'0M86QI9VXZ6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^ M-#,R+C,\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$9F]N="UF86UI;'DZ:6YH97)I=#MF;VYT+7-I>F4Z,3!P=#L^/&)R M(&-L96%R/3-$;F]N92\^/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$ M=F5R=&EC86PM86QI9VXZ8F]T=&]M.W!A9&1I;F#MP861D:6YG+7)I9VAT.C)P M>#L@F4Z,3!P=#L^/&9O;G0@3II;FAE#MP861D:6YG+71O<#HR<'@[ M<&%D9&EN9RUB;W1T;VTZ,G!X.R!R;W=S<&%N/3-$,3X\9&EV('-T>6QE/3-$ M=&5X="UA;&EG;CIR:6=H=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE'0M86QI9VXZ;&5F=#MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$;&EN M92UH96EG:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#MP861D:6YG+6QE9G0Z,C1P M>#L^/&9O;G0@3II;FAE6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.VQI;F4M M:&5I9VAT.C$R,"4[9F]N="US:7IE.C=P=#XQ/"]S=7`^)B,Q-C`[/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$=F5R=&EC86PM86QI9VXZ=&]P.R!R M;W=S<&%N/3-$,2!C;VQS<&%N/3-$,3X\9&EV('-T>6QE/3-$;&EN92UH96EG M:'0Z,3(P)3MF;VYT+7-I>F4Z,3!P=#L^/&9O;G0@3II;FAE6QE/3-$=F5R M=&EC86PM86QI9VXZ=&]P(')O=W-P86X],T0Q(&-O;'-P86X],T0Q/CQD:78@ MF4Z-W!T/C(\+W-U<#XF M(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0@65A2X\+V9O;G0^/"]D:78^/"]T M9#X\+W1R/CPO=&%B;&4^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\T-S4U-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY M939F-C$Y8C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!O M9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2`H M55-$("0I/&)R/DEN($UI;&QI;VYS+"!U;FQE2!A;F0@4&]R='5G M86P\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@ M,C`Q,CQB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`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`@("`@("`@/'1H(&-L87-S/3-$=&@^3V-T+B`S,2P@,C`Q M,CQB&ES($)I;R!38VEE;F-E+"!);F,N/&)R/CPO=&@^#0H@("`@ M("`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`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA&ES($)I;R!38VEE;F-E+"!);F,N/&)R/CPO=&@^#0H@("`@("`@(#QT M:"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO2!O=VYE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%L='D@4W1R96%M/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`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`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`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`@("`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`@("`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`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XT,2XY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S&-H86YG92!C;VYT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO2!$97)I=F%T:79E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XV."XS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S&-H86YG92!C;VYT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!$97)I=F%T:79E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C<\&-H86YG M92!C;VYT'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M&-H86YG92!C;VYT&-H86YG92!C;VYT2!R871E(&QO8VMS/&)R/CPO=&@^#0H@("`@("`@(#QT M:"!C;&%S'!E;G-E/&)R/CPO M=&@^#0H@("`@("`@(#QT:"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@ M>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&EN($]#22!O;B!$97)I=F%T:79E("A%9F9E8W1I M=F4@4&]R=&EO;BD\+W1D/@T*("`@("`@("`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`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA2!M87)K970@9G5N9',\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO2!S96-U'0^)SQS<&%N/CPO2!M86IO2!T>7!E(&%N9"!C;&%S3PO'0^)SQS<&%N/CPOF5D($QO'0^)SQS<&%N/CPOF5D($-OF5D($QO'0^)SQS<&%N/CPO2!M86IO2!T>7!E(&%N9"!C;&%S3PO M'0^)SQS<&%N M/CPO2!A M;F0@4W5P'0^)SQS<&%N/CPO2!M86IO2!T>7!E(&%N9"!C;&%S3PO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D($=A:6X\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO2!M86IO2!T>7!E(&%N9"!C;&%S3PO'0^)SQS<&%N/CPOF5D($=A:6X\+W1D/@T* M("`@("`@("`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U-V$W,U]E,6)D7S1D-#E? M8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-#'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XT,S(N,SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@4&QA;G0@86YD M($5Q=6EP;65N=#H\+W-T'0^)SQS<&%N/CPO M2P@4&QA;G0@86YD($5Q=6EP;65N=#H\+W-T'0^ M)SQS<&%N/CPO2P@4&QA;G0@86YD($5Q=6EP;65N=#H\+W-T M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U M-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N('!E'0^)S$R('EE87)S M(#8@;6]N=&AS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)S$R('EE87)S(#8@;6]N=&AS/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO6EN9R!V86QU92!O9B!T:&4@:6YT86YG:6)L92!A'0^)SQS<&%N/CPOF%T:6]N M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S`L,3`P+#`P,#QS M<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,RPY M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO2!O9B!C:&%N9V5S(&EN(&-A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A65A65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO2!#871E9V]R>3PO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO65A65A65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A7,\'0^)SQS<&%N/CPOF%T:6]N('!E'0^)S@@>65A'0^)S@@>65A6EN9R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPOF5D(&EN=&%N9VEB;&4@87-S971S M.CPO'0^)SQS M<&%N/CPO6EN9R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!#871E9V]R>3PO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPOF%T:6]N('!E'0^)S$W('EE M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPOF%T:6]N('!E'0^)S$W('EE87)S/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA65A6EN9R!V86QU97,@;V8@=&AE(&5N=&ET>2=S('-E;FEO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U M-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO&EM=6T@ M8F]R3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`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`@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\T-S4U-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA&EM=6T\8G(^/"]T:#X- M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`Q,"P@,C`Q,SQB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S0@>65A'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)S,@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO"!B96YE9FET(')E M;&%T960@=&\@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C@\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'!E;G-E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ."XU/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'!E;G-E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-#0N-SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$V,BXV/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'1087)T7S0W-34W83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO&-EF5D(&-O;7!E;G-A=&EO;B!C M;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0V,RXR/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPOF5D(&-O;7!E;G-A=&EO;B!C;W-T(&ES(&5X<&5C=&5D('1O(&)E(')E8V]G M;FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6EE;&0\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!V;VQA=&EL:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XR-RXP,"4\'0^)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`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`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U-V$W,U]E,6)D7S1D-#E? M8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-#'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'!E;G-E(&9O7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA65E($)E;F5F:70@4&QA;G,@*$1E=&%I;',@,BD@ M*%531"`D*3QB'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO2P@;F]N+6-U'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO65A6-L97,\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO6]U="!F;W(@ M=&AE('!L86XL(&-U'0^)SQS<&%N/CPO'0^)S,@>65A'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO6]U="P@87-S=6UI;F<@;6%X:6UU;2!O8FIE8W1I=F5S(&%R M92!A8VAI979E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO&5S(&-U2!P M87EA8FQE.CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO&5S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B M;&4\+W1D/@T*("`@("`@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPOF5D($=A M:6YS(&]N(%1R861I;F<@4V5C=7)I=&EE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XV.#`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!D:69F97)E;F-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`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`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`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`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XQ.3@N.3QS<&%N/CPO"!P;W-I=&EO;G,\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'!E'0^)SQS<&%N/CPO&5S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO69O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T-S4U M-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA2!3=&%G92!05]S=&%G95]P2!S=&%G92!P6UE;G1S($9/4DU!/&)R/E531"`H)"D\8G(^/"]T:#X- M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB7,@04<\8G(^55-$("@D*3QB6UE/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`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`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7,\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M2!O'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!) M;G9E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!);G9E M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!);G9E'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'1E;G-I;VX@;V8@06=R965M96YT'0^)SQS<&%N/CPOF%T:6]N(&]F(%!R97!A M:60@4F5S96%R8V@@86YD($1E=F5L;W!M96YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO2!);G9E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'1E;G-I;VX@;V8@06=R965M M96YT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!);G9E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\T-S4U-V$W,U]E,6)D7S1D-#E?8F1C8E]B93DY939F-C$Y8C$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#'0O:'1M;#L@8VAA2!O9B!T:&4@365R9V5R/&)R/CPO M=&@^#0H@("`@("`@(#QT:"!C;&%S&EM=6T\ M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q M,SQB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!C;VYT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!#;VYT:6YG96YC>2!;3&EN92!)=&5M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%L='D@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@ M;6%D93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G1S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,SDL,C`P+#`P,#QS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'!E;G-E('5N9&5R(&]P97)A=&EN9R!L96%S97,\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!C;VYT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%L='D@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO&EM=6T\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6UE;G0@3V)L:6=A=&EO;B`H1&5T86EL7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`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`@("`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`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`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`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BXS/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N M.G-C:&5M87,M;6EC'1087)T7S0W-34W C83 XML 49 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2013
Stockholders' Equity Note [Abstract]  
Summary of changes in common stock issued and treasury stock
 
 
Common Stock
 
Common Stock
in Treasury
December 31, 2010
 
482.2

 
(11.8
)
Exercise of stock options, warrants and conversion of restricted stock units
 
5.2

 
—

Issuance of common stock for employee benefit plans
 
—

 
0.2

Shares repurchased under share repurchase program
 
—

 
(38.3
)
December 31, 2011
 
487.4

 
(49.9
)
Exercise of stock options, warrants and conversion of restricted stock units
 
10.7

 
(0.2
)
Issuance of common stock for employee benefit plans
 
0.3

 
—

Shares repurchased under share repurchase program
 
—

 
(28.6
)
December 31, 2012
 
498.4

 
(78.7
)
Exercise of stock options and conversion of restricted stock units
 
12.5

 
(0.5
)
Issuance of common stock for employee benefit plans
 
0.3

 
—

Shares repurchased under share repurchase program
 
—

 
(22.3
)
December 31, 2013
 
511.2

 
(101.5
)
XML 50 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
 12 Months Ended
Dec. 31, 2013
Subsequent Events [Abstract]  
Subsequent Events
Subsequent Event
On February 12, 2014, our Board of Directors voted to recommend a two-for-one split of the Company’s common stock to be effected through an amendment to the Company’s Certificate of Incorporation. Implementation of the stock split is subject to stockholder approval of the amendment at the Annual Meeting of Stockholders, which is currently scheduled to take place on June 18, 2014. Per share information contained in this Annual Report on Form 10-K has not been restated to reflect this recommended stock split as it is subject to stockholder approval.
XML 51 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Results of Operations (Unaudited)
 12 Months Ended
Dec. 31, 2013
Quarterly Financial Data [Abstract]  
Quarterly Results of Operations (Unaudited)
Quarterly Results of Operations (Unaudited)
2013
 
1Q
 
2Q
 
3Q
 
4Q 3
 
Year
Total revenue
 
$
1,464.6

 
$
1,599.0

 
$
1,674.4

 
$
1,755.9

 
$
6,493.9

Gross profit1
 
1,348.8

 
1,483.2

 
1,557.8

 
1,632.1

 
6,021.9

Income tax provision
 
63.5

 
79.7

 
69.5

 
2.8

 
215.5

Net income attributable to Celgene
 
384.9

 
478.1

 
372.5

 
214.4

 
1,449.9

Net income per share:2
 
 
 
 
 
 
 
 
 
 
Basic
 
$
0.92

 
$
1.15

 
$
0.90

 
$
0.52

 
$
3.50

Diluted
 
$
0.89

 
$
1.11

 
$
0.87

 
$
0.50

 
$
3.37

Weighted average shares (in millions)
 
 
 
 
 
 
 
 
 
 
Basic
 
417.9

 
414.1

 
412.3

 
411.2

 
413.8

Diluted
 
432.2

 
429.3

 
428.8

 
428.6

 
430.3

2012
 
1Q
 
2Q
 
3Q
 
4Q 4
 
Year
Total revenue
 
$
1,273.3

 
$
1,366.8

 
$
1,419.2

 
$
1,447.4

 
$
5,506.7

Gross profit1
 
1,173.0

 
1,264.7

 
1,313.4

 
1,335.4

 
5,086.5

Income tax provision
 
72.5

 
73.3

 
52.3

 
27.2

 
225.3

Net income attributable to Celgene
 
401.5

 
367.4

 
424.2

 
263.1

 
1,456.2

Net income per share attributable to Celgene:2
 
 
 
 
 
 
 
 
 
 
Basic
 
$
0.92

 
$
0.84

 
$
0.99

 
$
0.62

 
$
3.38

Diluted
 
$
0.90

 
$
0.82

 
$
0.97

 
$
0.61

 
$
3.30

Weighted average shares (in millions)
 
 
 
 
 
 
 
 
 
 
Basic
 
438.3

 
436.7

 
427.2

 
421.6

 
430.9

Diluted
 
448.6

 
445.4

 
436.3

 
432.3

 
440.8

1 
Gross profit is computed by subtracting cost of goods sold (excluding amortization of acquired intangible assets) from net product sales.
2 
The sum of the quarters may not equal the full year due to rounding. In addition, quarterly and full year basic and diluted earnings per share are calculated separately.
3 
Net income attributable to Celgene for 2013 was moderately lower in the fourth quarter compared to each of the other three quarters. The decrease was primarily due to a higher level of expense related to research and development collaborations, an increase in fair value of our liability related to CVRs and an asset impairment charge related to a royalty receivable asset.
4 
Net income attributable to Celgene for 2012 was moderately lower in the fourth quarter compared to each of the other three quarters. The decrease was primarily due to an increase in fair value of our liability related to the CVRs.
ZIP 52 0001445305-14-000438-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001445305-14-000438-xbrl.zip M4$L#!!0````(`$J`342>Q]TC='T#`+I@/P`1`!P`8V5L9RTR,#$S,3(S,2YX M;6Q55`D``]LR_5+;,OU2=7@+``$$)0X```0Y`0``[)U;<]LXLL??3]5^!Y\\ M'R>6Y%QK9K8DR\YXUQ=%!-ONE"F8I'L>?!4 M2!!B__'K9@,D@%_^^61;)PL0DG+VZZO6Z[-7)\`,;E(V_?75U]%I=W1Q??WJ MG[_]XW]^^=_3T__VAC:3.[.0_,+ZBEKI,GIX&I>>? MWAL?WG\@;V%"WIOGYVUCW#([X['Y\<.[5N?M9-+ZOZ=/Y.-X\O[M>6MBCMOG MY^9(Y91>5W/:PG&ZRE?O`E.>A>=GK5.8Y>Y M0B@QUET7G-47MI,7FD#SKU$G19*?MUOO$QIX5W(Q5<7/ M.F^"$N$%JFV^;RBM3X^)A+"X*T^GA,RC*R9$CKW2P8F<6](5FBG+@_K?O?%/ MQHO23??.I$.8$=W-4^;N'SM>Z=;'CQ_?>&>CHI+F%535MM[\]_9F9,S`)J?1 M#RBZ3DY^T15\DMZI(4Q.O`H_S01,?GVEP3H-B7K]),U7P6EG.8=?7TEJSRUU MGV_\BGQ0#').J/GKJ[ZZMO6ETW6GWW15WRZX99$Q%\11+M>="@#M3')` MA$-!=I^H],MU#?4_$)P-9D38Y!;L,8B-53P(PB0Q],%X/1>7;SOO+HDQZYHF MU2>)U:?2X,KKER.'3&$@^%00V_\%7Y#($E4O=9;!L>@H-?7Q"05QXHD&"<5# M=B^N__WJMS/UWX?6N_:'\U_>I"].5RMAJ@V)#@/ZH[.I2X"9B8NZ;16/VS&+@B/QGXZ/!3XS'&[ MT145TD'O.1KOV=8>Z#1'X#3H(2_H(>@.Q^8.(U#W9.)#Y&A<9&N#H-LHMSG_ M\Z'_`F0^7\568155?_Z0*I80?#!$_#0GK#P^X"PMSIK!3=Q6!&8_8*:42]_Q M#'`=:A!+-@*>M78C2'N!=._,0*PIW`2@MMN/8"7`ZL,$A`#S@MMS);DOF5"9 M^]03[?+)L%S]8FJDG!1Z1((Y($M/SBXS!UPZ`APJO+(]8#"ACNPM'Y9SN)_D M5AV1>L/9]`&$?H"!A:I\@/S!80,F-^@),+^XK`'K^YR?WOS#PXS/X;N M4K#-*R:R>"\DQ0HA)#G9`FKKDE3]1V M*_J6\%!`%?GM2-+5[R8T17@/""]E"&_9\,8U17C3\%YP;QC*'WP=4OF]MU1= M:&-F$_%]E>`]<(=80U@`CK<9V`@B*7D[9JV2M>D]Z!90*!P M$R)5(240MC1L`\%-UW#NQ0C$@AJQHIO+L"].CA(&(1@$T?A`E M$#5IG>E(VXB`[`[(M>J,F.2IMG`D[$,P=@?#^VPM.%WQ[&0#'CE6(B2[0S+@ M-K&6TKFV&5]0L[:8Y-J)H.P.RA`6%K5K3$C20$1C=S0>9L3B=48C:2"BL3L: M?U"3_*CH5+<=P(B;AUBDL1B"81$I58/X@TGWKG,_Z1J&:[N67F\JF%=ASP7, MM.@+\$>A4L.Z^U52;>:>(UU\2/@YVB'01PCT:E0Z'*I-?2LJ$S\6J_<.G,^$ MLALNY97@=A\DG3+O!X7_M>"2LND%D;,KBS_^#N:TZD/:5?"A(O9L;/'5#9?1 MY.CZ=7/]KTR`:O$?8%Y["Q'JRT,VT,TK[^;;FQ==.NW2A=VHGJEF<=XP;3P( M:-':D0-"E1M?D#EUB-4,N#;9CD#M!U3EYTH6A`@G3I8$SAUGNA[!O:]]KE6- M0J44C6!HD^F(TWXX#8A0QQJ!3]Q4Q&4_7(;@J(X+F)=$,+T+02/`R3<:$=H/ MH1HL`U"0'UP3H`@\GT&O"3N?Z:7A8E]:6E;0L]7[B-"J#W^OM3;\Z#+?7,2F M`#;^CC/?OH[J"(EOW*>O(T1B=R2BB=6NX/.ZC`QFX8CF2\?,1$S2F/Q!+->? M1F-9_%'O4N0O`R9!+$`F5Z>)BEQQT>?NV)FX5M?PG%!?%,XY]18W=RN[\&;( MS6[*K)Y4>TB#..Z)8S0@O4'V9M`7#4]O50)A*Q&V@>`V]W9X:"YF:0T0L!(! M\^;:#\%Q19,1RZJ`D+7:7UJW>A;]N]/W$3H]5U(&4G:-OUTJ:7+)Z>Z"6N1! M]:/)W%ML7EXSH]I,K3$W3,;6VOLB]+1/SSJG9^^*T.-?\OZ0]"`ZE4&G4.#Q M+CE4X&G_RV50O8V9E";OBLOX[K1S=@@9.U]:5S"NGHJ*Q'9!%;U+VA\.HZ*& ML9(J%F6Q*=Y6.7JVV>Z M#_F26,ZRVGCL,-,]8>?+X5(L-_D]MAP0MJXK,UX9JZC:;&65"B+/#E)MXZ[(?>2I'5_:,"7W2R%? M=*OHSN&VBBZ._/GKLT0[MCN(_!KDUTF%R%<+^;>OVV\3#7F.S*]C?JU6"/T+ M0S^".2Y3>Q3+U*IV_E@I\)C MS;I4!;>6WJ)2F8'Q2#MYK>+O/?0E!QI2/+_CBRJ.U+>*?D/A77*8H''NO8-K MG>H_G56FXXXE_.TJ"R\7ZD\V$TJ>KZ;W1VE&OK&Q/"3/VA?QP//B;QZ]2UJ= M`[+CP]-&>*H`3[$W0OXE!PG?"IY_$>:S5FG69E)2[5\H>A#V/>%\\/[PFI`0]"%MUG+JJ^N=TI;.<(5%WIKQ)&^^]@2 M"$-U7Z-',K\ECBO4<FT#C]E3W#(=*K]]5OZT0P.A=_T<[WH(=Q%$YRK=N1YVW:$1?>ME?.LY MZ1NF;L52-TS;"L/?.L!8_)6F_\R?Y52(_JZA_@>",W\?G M[##SE_;G9TJY3(U!-P*BM78C2=YDIB\/_>H-AK>+RWB@>3V!C.VJRGA^'/-Z M`AD[597Q?7$9#_$^-Y#QO*(R>N&QF(R'C(WZ*5M%&?>(C8>6$9/=RB2[M>`' MG*7%63/`B=N*Q.Q)#':/CJ%[5`.2+N?TQ]*&RJ[S4(R?M+5(S7[4Z'<$U'$= MO6A/UUSHY7O,WX%8SJP)%&VS'JG:CZI@\=_V!PPFU)&] MI7XU=#_)K3I"54_I>`!AJR>)5G4!`XM4.7]_`2$#Z#440=N5.9BJLA[S4P5;Z,CU\Q1SP@ZMJ`K)>B@?TO^XN)"[^P;'P!6 M;:`"?!\68/&Y"N7^A-`AGN-OZ=)(X099D,.(PVA7 M!SWC([F1TAUG7UQBZ<8UO43Z?JZ[\-4D*]JW(6YG^`W_)D.1E2VL1!NUV7.+ M+P'JBDJT4]LZ.Y&4YY)2UZ5L#D54D=\^RD5K&D.O2F"0WI+IC6N*]&;H[1%+ M?^(QF@$X-]S(OAN[9GK"(*_^!LWK+%VQDC$5>G<.5C3)>61>37) MSX2R&RYE;QDLK3($RP-"SN@\Z?A$SJXL_AB42U6.:^SDK[$3EMK40F5ZW'Z- M'`L.>:UH.W0KH@QAB,,67&F"*W MLP'5S!O,%:L8Y3#*[13EO!WI,;YA?#OJ^!:C%"/;`2,;=L2.(XA@/Z?2?G+' MF1FU$'8]JN)5.(/8KEP%$E\:.OEDYX^V8B8D=^\ MQY3(YR-2L2RA]/B6BRK&N(/$.,SF7SJ&8!Y?4=_`#+YBGH2Y>XU\=^`ZN9]+ M_VRG7=T0ES0[=#[CHA'/R51SH%N7>`=QLF+CW2NT,(;L%T/"A3UNHG4]JO+^ MKM[!)-LNQ]1IK\/;-XP(=8L(.!B(,07'`3&R[1'9<)RC.H&FEIVA!OKL+HYS MP:5S/ZG!UW<[49.Q%JG9BYHA2"#"F'59N%J@+EJ+3&\GCG:P'\G:BZP16)9Z M]GP&!H)82M^N:5-&I3?#;P&!Q$V(58640-HRM`6KE]Z+$8@%-6++A'7'@CP1 M5O%`E6=?.#$U82"R482-'T0I1$U:9SS2-B(A!0BYE@XWR5-MZ4C8AV04(,/K MDP:G*YZA;.`CQTJDI``E`VX3:RF=:YOQ!35KRTFNG4A*`5*&L+"H76-$D@8B M&P78>)@1B]>9C:2!R$8!-OZ@)OE1T=W1=R`C;AYRD>%B"(9>6EZUB#^J=.\Z M]Y.N8;BV:^D7-L'FE_9&HU`#O?I54&[KG2!].F,3Q?VH[[> M3PG,8(M=O6^U[)I_N;[W89Y3-3[KFUO@L_AHN:OG MR$]QX'`4Y]"D/0B5VOB369J;[6T0`1G;ES'3].8Z$VM`J'I87)`Y=8C5#+0V MV8Y$[4F4.FQSYNTGUPB*,O8B.7N2,R"B*4^UN*G(RYZ\#,$A>OCGD@BF>M?- MZ.?E&XT,[K&NM M#6=)Y)N+W!3AQM-N^>WKJ(Z4^,9]^CI")@HP$9:X=`6?UV78,$M'6"1N)G*2 MX42O3.V/;ED6?]2;8LLN,_7\:K$`&6W<&CZ`_")77/2Y.W8FKA5N2*HN"K?H M[%/I'ZLV6[LILWI8[2$-\K@OC]%0X@;=FX%?-+"X50FDK4S:!H+;W%OHJ[F< MI35`PLHDS%LF9PB.*YK,6%8%I.RLU?G2^O+0?P$>GBECI[B,ZI+.X61L5U7& M\^(ROCOMG!U(QDY597Q?7,:/AY/QO*(RMLX*RWC(V*B?P%64<8_8>&@9_9[_ M!;R*IM(_`(]*9Y2+OU'F0&NH]^!-R/+76LW MDK0?23W+A3$5YICR:V:\;@)$N28C/R7R\\T$^NT&IL2Z](3)^?Y>?S=*V!)Y M>\935JG\*:5R^MO_A,S(^'Z,7\[ICZ6M9YLV`=>TM4A-.=1@7V,?NK"W\?(D M7]T/;[M-@#-F*+*R'RLWU-";Y,S)TCO?&'36VXTD[4?2+1?S&1\M9?=S$P#* MF(O\@KGI";83ZX3Q90AQ8>@.*XK4KP?Q??,X+=@IMZR-N7EX#;K MD:K#4+7/1XQ*S/[-S?D?EY^O,'$H#^'GWM&ZSQXSS84Y32/]M@^V07^X-AFC MUQZ]UZ8;"WVVD3[KKZB0_@L5^O M;S8<[4#D^XO"9Y;N!$,;[4?R3H461A% MRR$0X^C+TSZ$J=[@CHLEF<\%7Q#+IA9(AS-HS%?ZNVF`A.U+F`0BC!EAI@D+ ML/A35KB;/H`PE8=`ZWJ`O0>[Q5& M]06$#*=!K5<2:7]YVL/D-:_`YA\<9GX,_:.8?X3);'G:HT&Q;Q%:4CQKLT+B=D&/9E/&(&;FBC#IPHS(74T7>:V:J>!L=N6:. M>D;0L05=*4$'_5OR%Q<7%I&))095&Z@`W_>3?Q7*!3==PQG2Z:S2C\UG:1.M M-;A='&3R8$Q>,Z6W`5*&G51587_5284=!MLLI?%]0B#TIE M,O>^C)/57N"VL`IAKKE6!N2L%,ZB4UX/`7UIGH;T_RSZ:_VJJN9>@N^ZFN:1F"+6VR,Q0SR<1S[,!&".6,37 M8HH=I;>A!_P\#\"G4I4]!9]+1^R5CQR?2D5\+=3K*#T-Z?]9]./(176]!$Y++[N9[66DT7"3E( MV!EM9[/!4&1E%U8&("9S)'(^6]PU5+H+ M(KNY1IT)VFXWDI0AZ8)[RP'[2V6_;4DV-F$_$]MO8+=X@U!!7-W?1+ MV)P*,H_@"U7B"E4?#!YF^;A.C,9 MT*^'`T'&09WF2.'8`!=D+&%3OT3 MG#H:H5JC/GHW>O*&-1*;Y>H'A+<6E`V39:IN$-E[(V/YFXP&-G) ML-.'L7/-I"-<;?$J!H^`42[NN`.R[X*Z[GV7F>VS=CL5P_OJ+A9$;QJQJD4' MBM2(L$J]5?X]5%:,'LD\58?>?T(5L/6]9`=I5C=2;6JS2H>[V6Z6NLQ@NZFU MXJ/:>_\A>ZXT"^\1OJ^53S,-"IQ7*&.4_8G M$)&SRM/O8*J3TSY(.F5YNY'\/WMGUMVVK;7A?Y259OAZVCM)'NJS[%B5[)[5 MJRZ8W)+00(0"@$J47_\!I#A3E*@9Q+Z*[<`R][N?%Q,QQ#\'OR?71;,GL=VI M32Z)S\O;3]QC>J@^/_DK2[8F"'UU:E^]0'G9!]KJ6+9ZV75(@*ZZ:E%-0M=9CXIU10YTG1\FAH_2=X3&CQR*?NKM<%'P**:0,[HHCC1 M1>3LCO'OZW)8TY^-^D.?9GN2@`^-K% M>>L3NDU!K&.PCCEF'=/F<1I0K9PFG[&*M1S6*+"X2S5 M+_/H-D;[+6U!@O9:UW7E,PI(.LX)X'C#QIKACE#Q%V$A7,5D8Q+K[8^%)M") ML<8.^3=8:AJ M#RP\MVFS!^*Y@RS25_PS+IQH)TOI0%L?\0GR9.7>RV=H81VR7QWR(H#(4*QT M3LN[_G%6\(*5234OUS1HQQE!K!&NKT;`R4"L4W`>$&NV/6HV[(Y1R[D]F!N M\T(G=829)C(]Y"D$GB[O;)VYAS9(Y!&(3-X!.`S>)@F0KPI?0\']T%//8@QB M23W(3K:.+HDD@>53:'7QY6_!3`-$-MJP\9-HA:A/NXQ'.48DI`4A#U)QG_SH M+!V%^)",%F1$;^C7_VUYUZ2!CYHHD9(6E`SYG+"55`_S@"^IY>?^-W!2&R>2 MTH*4$2P9G7<8D6*`R$8+-EYFA/$NLU$,$-EHP<9?U"<_26?)R(>'7-1QH3]( MK8:,!,F44K1P)G>#<83)@,\7H0*1%M"%QWRBOA-1WID\,F<1%M]KD!]T'LZM MAVR;5&OFMFNUC<0VSY7*G7LQDM<;J;\4]31`ZL])?5YOI'XOZI.R_9!J\6Q? MU;X3O$GA8LC(ST'\I/_G$$"EF)&@@PBZ"T5`52A`E[NC/\Q7]D^3[@[3YO"1 MJX.X>B+>C`8@5OER#H'5$#^2=1!9T;L.U_':)@(R5F4L?--*O"K*XM6+P5*' MR;5X75N#TA`GKD4Y%BO/"GXRV^=SMY.2#Q,YJ7#2T3E8G.L\!@E=F)?$^;_V M)(#'B)0Z%?'>UN=0/4]ZGA?.0Z;_IA]UW_W(9;3 M=H!T^2WJAVB'1%\CT=GVY63K>+PJW_P"#_2WI9VJV>=^`94^_!@)TRG^";X8W4IE? M3^!`GUOO\^WI14]7/-W:1S_V\8RVVWB]I3MX,8R-SA MS#G7;\-^CFU\=K=O@6WQU7+7S9F?]L#A+,ZI27L1NFL3GT3K;F^O001D;%_& M?#^Z^8JP(:&ZL1B0!56$N8%64^Q(U)Y$Z1_/>3!6Z4'T':>H$B^2LR_(R`D7,],\M$8$>7;LQSJL/&AG:DZ'TP#!GVJN:B)&>S?3<`Y\* MLIA1C[#<\E3&UH/>,%#"^I/V-D:;+%*M#Q>Y:<--I-WJG]=Q%RF)@_O]=8Q, MM&`BW3L8F@T'G:U#TNV"N3"1DPHG?Q$6QK-;C/'O)/#`')EK;GD12Y#%;?II MD3LN;GCXIB8AZWF1#2(^ZBEJ:ANO62*.IIUD1X!>^%KBG/'9A> MW9[I"\ZHGC'7N&*Y8RN6;6`'5Q[;O_+8$LYP!?&5KB"V@1]<"7Q-*X%M(`97 M]%['BM[K9057YEYV9>[5DF']Y(DM*VROEH`O/#"?(CACNG/_8.[WU5TT)V!H M"MUY+G`%M9MYQY709U\)?;4L=&#*W9X5S1>@`%>).;!*['JYPM5>U[O:RRYJ M<-76Y59MV44*KKZZ[.JK,]'RP;Z%5!].*T=R)1]CY(V+&)RI@*A/+/4(V!P5 MG^OM>?H?$#P8SHB86WH@_OIBO6T1)[VXNI`O8(LKXP#4BO'`#0#RL3J?^2GE M,K:"!Z$R.[`L;3!;4K`Q;M>)N%W0GZNY>0OO`@?E:%W/_H/^ZU2%RG0?>_[2 M="3]/X`P-7.!AFW1NT['%_VG^Y2//0I:&A>(J(L8*:AJDKUR"-\D?`O-%+RY MD*HR2B_]/S)TA+/7ZR7/Y@1J-7>=XO7"P]K"+E"Y/?ZN$G(#$Q`"?/-V4&L7 MQRZ$N2PK>G7XPV.AN>1\K(<'T"<2_"%91;KT`G_(I1*@J(C*KG=ER/B6S^=) M[4?GJ[^Z`LU_<%3Y8Q;3>0'ILVKP>-IWU1FX`?/BRP8OGN<.K`:Q90/F67)] M1P.JX)$NP=`OT7I_2-04]*,)7I$_F7BX&Y52@_/:RU%&8K MXA(87^@J4G`_]-2(3F=6-T<':9/.)V\7!]G:RM9#H'7S0$KS:I,(;Z8_<"VI MD02)JQ+77C+D<".'+^#-`L[X=.4X764AD)DZ9I+>TB/U3`:":2-N2EG09?Z]\S)"EK#T"@PHO)KX5/NN``Z-=.A,S,9 MJ[\U:2A]DCD+1K?JR8$QU;GMY""9GEP7S?ZBW5!NRD*IE:I)PS%?]#5E,GN2 MIE0>\VGJ:O&1DC?*J$KO_<+!Z,5L6LF%NSU=;$UM:\^RN8=H(6]CZ3+CK5FQ?S^->G%SJAF\O/X9%Q]K@6/=ZPNA0 M[`'OXL@#AZG8D![+IE)O'FR#ZFVP;O+7G MRZ06J0\WV:.Q,5YG"5A21EYTI4$6T8%+LNL$;(S750+N&0\]74&#*!V\U7$2 MML?=82(&NHN@'S`^8<(TVOU57]>'LSD1Q;Y8<@#R"#S0K?T;*Y\L4_-)E171 M]\"GVG`SZE5*VTW8-AD+EV75ZGC,CE!#*K('V9J+;E.O=.]//Z/^2FHDXMAS MQ':T3=P:N,NMXT"`3]4=\9@6B\ M[,79]];?_--[O<$7>,RKG'6W_VN9<:WL(?7=ZWVF9T7?HN\QW]_TA^N[TOM,RH^_0=YGO_CO\&WUW>M]IF=%W M;OKN!MY4%FXVQ3J&@'+QA2N0O[S[[?T0A)F*O@E!__ZO)U@S\LB#J2XP-\]3 M/?P^>QB[_5=5>SVONX/<75P94I?UW/G[Y;2C#QM]B!XZIX>0W1;L?GCWL9B0 M_V`;@C9;<7NI\^%A'S&-N2D_-?+C6T(^K#9A^BA M;FQ#T(?-/D0/G=-#R&X+=C^]>U^87/SP$=N0$_*_26YL0]"'S3Y$#YW3 M0\AN"W8_ZX%A(2.?$-Y-\&[4"NF]&+V_%A."O??-\-9+A>R>AMV&GG=\(`NA M04_V1B!#IOAD2*0R73FSAU\03XU!*6;SG;:[]6CC,UI:2N$J-[@_`7<.(.\G MXST[YW(!P?/"?$12![0R.<=\CCQ\N?Y71A_6*%=;HPQ#M7N%8CK<6)]@?6(\7^3F]-5)QA[6 M)GCADK66=NN,]TORC*TA6@=;/ZPMKJ2VP,$X5A*7;%MQOP8[% M)-P1*OXB+(3^*OWR#RT]$=YL]0A+8`4F;J6B,.^1"_M+R><&2 M'H%.D=2_UYOJGJ8N[VQ=MHSFDO<20!V4U`77_Z6^C3`;N=8?XI:#9G^^+4-%B:(\HV\_9!J!8*I+O.\ MB"ZO#:9I8>LYV*;!&HL=1$!6IO\,^'P1ZIY:6D`7'O.)^DZ$_57&CJALU\!Q M4I*RB:<<`",I7`P9.5C/Y49K=#S3,7\(]&].!4C+^YFMJ&@2`!F)9^A"$5`5 M"M#E[N@/\Y5+A&P.'_F(-QF0P/+].:UXR,+%_,?YUV-TF''F/\P7@B^[<$1' M.R`VQX^$K.>^O!D-0*SRY1PBI"'^#A,R5D1%9HAG^IX7SD-F M=D#\$GV?; MTI_%GR%A=++20[\!D;,[QK^;?3FV]V';$[6W1,A90<370("6ZR?X#\$28D,F MPCK(U'8YD)],L&CK=1Y<+L\/Y-MN0XUD.QOAW$GA@MDN,0()8@BPN^$R+W'%QP\,W-0E9 MSXML87YI$$K%YR#,`3;1S^QF9#=ELD9@#VF0JW1*J4$_-S!*)YBV*H'4U%$S M%'S.H^U>[O)2U@!)J2-E3!A(/70/A),?'T\J1;-MA MC+RM]\;VI@+B]8-#(M(MH7%OS]/_@.#!<$;$G-CIE/4FG6T1)[VXNI`O8(LK MXP#4BB7G]'8=@'RLSF=^2KF,K>!!J,P8V=(&LR4%&^-VG8@^"^&-"O^-\H?` M>^<"#+4AN\[![8+^7,W-"BH7$"A'ZWKV[YY'3ST7$I\+U/6/P)_%*OR)5.P+;HG:6]@)/K;&WU5";F`"0H!O5L9H M[>+8A3"W'$7+9GYX+#2'8(RU=:!/I#81646Z]`)_R*42H&A\`O)ZYYF,-S2: M([MJ/CI%SMS^]0)BKDUHU%F"V;&FG^R3Q;Q=0,PUP%O41'K/2V^VK-(\2FEK M\P\Z#^=(^?DIWR7"=&EHDKC\INQF]!+W8'EPCY=@> M6.BH_XN%15]=P%<%[=%=77,7>N587D%JSTTMM@371C?6_]US$@W02?8Y*9\U M=-+QG)38HJY`\Q\<5?X8>JJ=IQ*XCZ<].N.:G8']._L=A#U"="OV(5UQJPN] MSM*I,MTZ2RU>.UV-\+J.3[MXGCMP6M+V3%_'`4EGR?6=KK@4/.H1NJ]KSX?` M-^>J)S]Y"/1?G-(W!CTIP53ER;26AC_Y4<^;43".R;:ZEDH_)Q?$/TQ>B)B"2GZE#Q,N8+P`SR3-?Z') M;2+Y.^LJ=\^ON^&%J^>M9*NUO,G>VH/U/>;48UV*DGY_(4?HDD:7O'SGY?SU M)@H$VN-`>[00%GUQ'%^DIP9^)\(OGH$[!*$KI;DY1"]Z43+2N1+44^!'4YNO M@;5K,=)#`O-!KS.^>]3.T)`>ASU?,+X"B(1X7ICW:9W*?WH>]J8XGG5E==)->J]N2Z:/87 M[89R4Q9*'^O)!/X+079:1%G7\G2RP);70H?5)Q#84O8JM)WH3V\V-7GRDY,V\ MX$OO(,3!Z,5L6LF%NSU=;$UM.CI;@.(ZE5[7:9N>]P=)F+`HR-M MXWOS3%>RO^KK5GHV)Z(X0NAYT9Y5.0(/=!_TC97WD]5\4F7U_CWPJ3;WC'J5 MTG83MDW&K*K9I.,Q:[B&5&0/LC47W:9>Z3&)?D;]E=1(Q+'GB.UH3VUKX"[W MV08"?*H*)Q"DW3%8.LO_M=RXSSW6[.F=7[;M!#WYW!=UIF]!WZ+O/=[>L(?7=ZWVF9 MT7?HN\QW]_TA^N[TOM,RH^_0=YGO_CO\&WUW>M]IF=%W;OKN!MY4%FXVQ3J& M@'+QA2N0O[S[[?T0A)F*O@E!__ZO)UC)9&[RTP7FYGDJKR=R#V.W_ZIJK^=U M=Y"[B^N5ZK*>_?U*VM&'C3Y$#YW30\AN"W8_O/M83,A_L`TY(?^;Y,8V!'W8 M[$/TT#D]A.RV8O?3YT)"/F,;^V9XZZ5"=L_$;KI(G<_G.@^4L"'1?ZE[Y*7KQ.L" M[73.&T9;4@>5P4U75[ MBGO,^@]W"9S1'R\0H#U.9(]46W2'->XH'PV,;MC?#2T*#GNR- M0(9,\*XCQMY/SKOV5T8"PB>%^8CTOKH?X(J M!4%E0G=`&(N+ECYCR'/G(:?3OS,NT%QVF:O-XVP')S=762+GF,^1AR\W&Y[1 MAS7*U=8HPU#M7J&8UQ]8GV!]8CQ?Y.;TU4G&'M8F>%6SM99VZS['2_*,K2%: M!UL_K"VNI+;`P3A6%SCV/G]]4;^5H-L6W&_[A,4DW!$J_B(LA/XJ_?(/+3T1 MWFSU"$M@!29NI:)SKX#$5Y;5KN;SP!,06,2G<"OH7ID;R5 MLKF2YLZL4)CW3'8CN)O6&8QMQ#YFS;A#OG*-U@X)0_]4BC\$BU#)J,`O:)>C MV*5!6W2'M>XH']R![CB>.TYPT@>ZXZSN*._(0W<6;.<=*]XQ[@?_(/<+^&PHJ?>IE,P6V@EL?=6Y^HCGL#O/P2!6= M1K-5`R)SE_4.9I3Y0NOX!+ZYOGL`9@P_X&+!XTMN[0:B&O9Z?>:.<7>8B"?R M+Q=FSE`^3\QN0VV+VV^A?MZQJ22U;B`+549/2E!]XGT%/RMA-QT[2I"[AGRS M!DA*;B-N["(PA9UEI5$%I"6;%"W]IV.8U(>/?)1?O-[S)8C`!.MTK;*3&DA/ M5IX+-253*#?:#U*&X/=7K^-,RO&"!U+KZ]^:ON!"CPZVB#9.7(^G_VKJ2[C1Q)_Y5Z=7<-]J7>S`%KC_M5>9-] MZ),?3:5L3E.D)DFJK/KU'2`SQ07)190HKC[8M)3,#'SX8@,"D9_+\=+6^<9. MRR$X89Y\*/O7H_;P?7E5E/>=]LQ:COE6MGZV>L5QLZ!I?-6BS?P`3WN.X2[# MAP]=N'VE!G=I$/;AL1IP/.5VU`$$>M_AFO?PC5;JN?!X\='S8!T&%2TV`.'" ME>^I/]K=""*UQPO@XJO^S?"O5GG\)F-#JJS'X,R94E];Z]09$*.^>'[(%QY4 M:[GC>L_Q)MG;'GSS>UD,CCS.?!(K5@%PXD9_U?!(?IL.]S/]D_B%'+W[TN]=O;^_*_OTI-!-[&B&6C__" MD&KMJ_VCTRO*A]GKSH@A*\9_P@P95V,EH2>K?"DWZ_>2;LS7G;3;H]O1N).: M+VX`I6M;].##,"$[,-?_-QH,CY\N*[&8*4!Y$A@7[DSA>E<,4T^^/_J#02S[ MM],6)^_+CZ-6MW/SD#KQM08_8K?_5SKC>>PQ[-,9M35$%Y[-@?BE5Q8`U]_% M]=O>?3%1R!K8,^34>C@N_)D"]G[X(]6A0J18_$CPIQ.WJ:CYW(BS&H<+8Z9( M?2[!]7V:D-PGU M>U?#?OO?9\&&;+QGSX`/K?)]FZ^Y$./,Z4#7:[5;(UZ@W+HZ\B73K:NHBP>;CG M.?]C#!Z^?KDZQ=F>#.[W+U=G.;>/Y^M&:2?J9'7Z\1S=S#!/>+X_MWZZLH"< MUK7*\N%FTN1R(;(;%*E1QW'/^-)QSD9SLP,]X3E/;4PF*UO=;O^O5J]=I",R M:?CE?3&8+_)]O"3V2]\??1O>C+JF/3:%Z4MN-!CV;XLR-<`;_^RX6;(9,E/' MOP4T%UX]+B.NP.\\:/2XJ+@6B0MKFECSH>S?]L='_,Z7+XL87)C2Q)2K5K<8 M?"J&H_*IO59:*"=HC&)X1;6KDYKQV8P)+M^H@]C%7;'4WTI!#JU0J##(LREMN-@:CL.BAA''R@<86G'01'@7;^7 M;E+VN]WQ^SLGKV8Y"RZL&OJYT^)2\'.6TWZI]]EGO<]!4>$$!S7VGV_K\HRA;=\5HV&D/WO;:QTV.)<.MHY6EX]T# M#<@;1-\@>=`TF";&Z67A"\UH?G9N1[<7NCSW?6V/T,XVNIG!]M2H2IU^^:X_//;C%DVCG'GAVN(P]S/G:F=>B;UO#V?F M?+4U2NVK.P/;Z5^U.P7X[5-W2DO'NQ<60'BR&Q;0C\3FRU M.]W.PJL7/Q7W_>Y]ZJ0S=\UQ$R$?[^PJ[(H![X$)X`#8&XIVQ(1_CGJ8'%M5 M&T`B(';?'21$'24D1.T&DH5((?G.M^,VPXGC4X^0O M_XWPN5EA%P(O(_!2K"X,WA6#SX-\9SWG["..Q3=,9ZQ6V;EO#<<%T;5"?NH, M_CU?[C4:OK^;OL]\RHG1MT'Q_Z-4.G$/?^6`W_9&T3>8+I#_K+-^#OVOW%R[/]JV"J',X6&H MA)]W>O\J6N7G8I'CJ44Q_+KN8UROQ4V?7_#MN75(KF MZ9GJQ`;SLS<-8;O3$'EL*R5C1':SIP*(_+/5@SBG,^X<_77:0'IJ)-[!P^:6 MF'\[1UCW>8`J55^&T+EZ.+R["&U3WS-K;ETZJM!J'RGQ-K7FRT>\-R/^ M(NO=HUYGPH#/@,E7R'J_FEYO=+LPC;?C`N1BHH_S5];WKB^9?5ZZ>>/#OESY MKQ_"IZ_]<<"Z\+#KSCW,\>+PTW??@>\L6\-^IN/3QW<&?4:P_!V>T"39+$#- M=YQYG"]Z_=M.;_4#QY!,QK')`_-[UK^=&?9:_%I#^'ZO>/CZO>B!_-U5T[5X M[583-CZ/U/DV:IBNN8?-7K?5@ZY30?)]43Y\!4Y_+[[>I3<6ME;R<_5ZP:RN-%6ST"M#&WP/4=*J,`'[>Z-UB3FWYY MF\KUOK8?VMV5P\@NWNZ1DS=I?VVW>M>=:["[*Q^Y>/%6CQS\:(&17XG@Y)*M M[CX:7*\AUQ*KMH5]_2<\=WVL\_YAQD8(:]-__M5J,[42EJT2E&H=(B6,21*32<:0G MHFJA"3>9J%R09XCZJ6@7D,;#9>^*9E!G7].;5MO+<>"5,GW[8"'8_W';*N?7 M`_-[+V1+#7?*,J9I%\[LZBJ(78J@-])P8H(@Q/(HK?!H@J#EUCF]B"`E;!F" M<^AL!2`]0@"9MU8)QJPQ*&`;&!)T`J`CD>E,6RA3[(4`W$J["?+:41DTYP+D M)(K@:L(-%HC;17DU_'`3>3=7G*TTG08E,!/,@=PT6D8I\Y6F*^$YSC0=P>4O M*WH#RS[&S)CF!\ M4CIF&5?((_`?G%10ZX!%S@Z$,&X6.A=E:XE7ZI\Q7I,@8DPSQ-\M;F3/#BGB"5:6DZ9#;(*+Z().A=\B;5[BN"?X!?;"2NC<%8X,'4* M*RF"D*X6%N),F@G;$%DL"/!T`5?1@`7BK)+86>\5DN`NJ)O0(`A#B>@DK1%'O;\#]/)'<,%*-(-(PC(,EC@"`JBPSI9QF_D^S!O?W M%/%>>&RK"$X9@PP58S"!@D=LG`]5K.JY=";S.F^8;O`Z>QP<7K6*08QE)`84 MO;2>.P/]]+G-TZ<#W,NK,-88W*)3-$H(>(2V*.#*A03-=.Y"Z(&I,#XL/"%! MB$1",H6UX@22%]#L"D_,AU15?-2?7Z2XX$$N4X)(;CIA/.S%5,,,@ M;L[QXKY;8Q;]H$@H0-R"+O`2+(LBOWJB7H:K:P]4;( MP^+:<\.59W'-"Z;`L$4P9L2#;:.LSFXATG.9>8.0^D6Q:VY*/].>_&G++"[& M2&!V*8D2>TN$E56V9(E$(3,[2BB4D6&M3,\?P\KU0JDQ)3Q$'(F.',P`KZ)O MPU**DBWBY_[XWODOJT%?,(^,DL_NNS?TX[[J4<0-%;%8SE*&*,=8#\I5J. M0LZQS&4#UEFXO6,X]@T^V0;\U2_/6!I\1@D1.K<&9L)%'I!W_G'C3^:;:(3F M)0TG/AL355A>"D`M8TXX@01BG&NG:C[;R*3(5H#.EL\KBBF\PP1)9[00`0*J ME#E6&[F*Y1;UO#CH)T';:QD$3XW7QJ8-=`PV&INH8D5G:HC*:IP(%ED%X^E. MQO;F>2/?J)3E5C/G=8B::@YAAWLMX(?YV0>%V9BB%S)P(:12DV#'"?^I-2T.E05G6>%Y>=:H)RPO1HD8Z M1L%9#%13&V*HG2KD+2%;U3X*.D."&FYNBO8P+56/'VT7'_V:J0Q@;&3D%#)7 M)Q4DMMK6]91.:I-7^T]6NI^*\0:CWCV4NS6^QF#$)-+@[5+XX4RLC:\Q0J$\ M#>'97N"Q`+GC$$)[&CEF:7U7(,.1Y[Y:,M+!:I=QDO-\<>*8D'Q%GY06[+:Z:`8,@G]^*]4,8B&EV]D$-QR`.F<]39+9.P MR`)V$/$#L9RQ/C!+Z\+W`+'I:2KQ:=]AMFG8C$3T;A:80X<5@T"%*YB,-P2.5#OC*R.K" M#4MM?@!%RRS%>D48R(Y@\)Y2I-.()0W,&^?KV-UQ'D26:6+.LRWQ_<%@6]W4 MF>#J1U$,_T@W[&3=;5*+GW[965OXY(U@U'/-L%>6Z>`C>2SD<;SAN-H^8:`[ M@T$KBZR*P4&LC+SU"*G:.I`8"%M?D[,_-DPVQ!\]3",25\7X3M0XEH\#3B&B8%!3,9L3"U5HC`L$Y2C@_?K\_NFR"4WK7 M5WJ]$2#DB_NBVQ\?ZJB>L(Y#@C-KI`;W*HWCC&+!-00]UCNK@4?Y82.651$> M-HN>@XZ"0%A*$=/Y1TX-=E3$FCO8QMS_(K)/_[LFFK6"1;`8DBHIP':")BA1 M]\R(/J]_)!1GT?WKC*8AIGH]@R$(1X9#TFTC3VT3+,:QADEQG>6$,.G[5(DU M*9V%P=#@E#+$!@,3:LDCA5G(8R=*\ASFL!7<]0?#]S?C5QFN"Z>%U382)[DV MUD+>[U%]`A'T&N?JO"]MWI+_FR,!-HTRIT4`:FL$P8-PMJY&43;O29,75AVV M2WP92\`EX3%$#Q$W9!_4*:-MY1R-\";GBR#[S#NVP&ESQE!"C<;,6T-!>$R9XQSB84B\I#D8`-T2]F`$AIJ9Y]2C:5Q"UP6JS M#LCQ:#TWU$C'D--,UJ9!6IY%A`3+UXN7FXN'-W"#!%PWZ#`&7^Z#^CVX"0 MP6%J!!;I_*(2R`$=ZXTVK*/*-W_%BT_=LC>Q3WL*;=>*@@H"$1FW##&B%'B4 M>EO;=%PK#_F#HR0D&NNB8EHC8*6J2]L@OL@Z/;!\%^$9 MXYKI>/#^YFUOV.I][\#%9C`HAH.GDH]2%A47C$4DJ6.ID+K2+$]-P&)3+;,OD/IUUBUB"$-0T)* M"5I.40#D*\7WU#F>K]SH?.7F*=+WAIWK3G>4`L2KHCTJQUU_PL]V=W1=7*<= MA&0S1L/J9J%5]B#$'-0=0.%1HT5%:1[DVW=QKNN/EHIH`[/$=838&X*J>H\) M#/JL[:[[I.(JX?QM=J0O(?VK`))S=AX0CD/0)##EK*7",Z=DO2>+P4SZ!D"J M".3H\&@V0/-PL`AVQRKN/-9,*:U<-'4'/&$L:X"#"0E>GM[U^J4*59V M<-WWXNE&*H)+URAU`((1^1!<"/71TH"LSSNYH?R,9*,D3Y9V`W\`:DH5"19D MU#&U,<*QKI\*QN7[EG5GOY<7=A,+R@1%8!0%@_0>$GXK.*I/W!,N<+YCQ'8J M[>)6R':OO7[F*SJ6SJR0%(*5(+A0R`JAL(DQ2`BLM7',9\=+5!ZT;`K5X&GA M5%38\^`M-59[JFF0NNZ9%!G/6Y]@2F7>[+#)XRT19E7,ZBP7$/IP(4V@P8.I M,56N:Q'F+!<&`ZQ92+14F*WB:(J8MB)&XV6(6&FG:YIKR\!7YF4:@%"C2,T1 MY6K)5DZ=YLEHI\HBR#BYC:JV;0IRMKPSGN0\/VBP3K((A!O7^?K.H-WMI[;= MJP_7/G[!/CQ^_-].4:;UCX<_TNK'G!X]7O.V!PYB,+X`+^CBS"W_G'0.3RH0 MR['^M1^:[S=S98KJ883@W'!8AM3(F*0#=$1&!]I!(/,E'@,I\[9I-`MI MEZ%V*."2?8$;P/XI)8TE$7$*.1P"MH[!9=0+G*_]()JW1SPD=,-@".,<%N]O M'J]N>.2^X(Z10\YB$#98$QR9Q)Y.X$X&'.='P)C,%YA?'&YR(F2V8$P5@10" M&>(]DY#`5V[3>(P:W*;B*MOF.'1T]V:'$4`*D8@``J<&M1P+5:>MR*)\F;@Y M!#@09`_;3/B`/`I$Z@!66`FOTHI!E7.`#\P70!77V_J\^U:GFY;68K],NT+3 M3/&,S#)D38):!/FV(D)#)$GYHUEF4N8GNAC/S?)2(/<"^$&9#LBH',:I*8F2 M2F+NF?%5"&_!YXN4BD(ZE;.PM<1>Q)15^N3,Q;S".X!%2(,D0`M:Y*U4 M$@'+LO/T=,_3/3W=/+H86/`6UCM&C3>2E4N=A:5O14JKWH?I?;'YIP*>?5@&LH=CBZ' MLYY%XY1,=@9*"->OC5HZ3L>=<`Z+H(3S,@2SJ'H?8YZ$B>CZ*W+=@"O!*M+% M:T/$@@4H0-^88+9OB!Y8QASSL':E779*4UJ'+$N< MQ"CC*JN:%^<]&(%_@#N?M<\*V^[\4W1O+GH_'E\577N]K$F?+T&%AJ.B&U)G MY\M1[_$L3&DQ88"CI@APU&!Q6)E=%Q&UV98;57E"VL%@";]5],X&-X!MI$0V M\)2<&0UA%EDW/1LT7\V=43;?;EC?K]H%4+2^DXY@`Y@1*01QX#@IBCQVW'+P M]#EF-#-'C.?-:@X&RRJ7.B&MP@$84336&!8E`+ES(`3+7#)CJV4F1TGA.KGI8)/FP8;4V6"J92<(F4).!'&:Q?M M7-J"")7YPE+G1U(/!I]I#/6NO7F,^4G"@S8AE6/V$7G&M$D`!4L8):O:%.+U M_=FZ`;2A+V&XERB&X#$!_Q-+)C6=VUC/+,V+\,%U!XO-TQ9VIC"`Q7%J!,>T MC]RK.(-*,8M7)'CGU9P/!JGM_`>AA=`QR*`H(T89:9R<6R)N!5GRC9/E@@-ML9X'[E(I8:=DV5G6S50QYM&JXSS-IYYC7R^9+XH0 M6&H#@,QJ^=R"8[*+/KX`\CE?G;EP4W%G*7CB)X9 M20629=4X@O)\UF.\?CSML"&K:\S!4!O!X*3":U($&J3G8DIAX#TB0^8Z-Q+; M$9=TSB"F@%)H+(322"/,YF8FM5C+-H`.20*[1GP;)SE$CKS7FB+*`K!XX2V? M3_S(<'Y,X7A]YKXA'(>"0%SE(=0@%&H2U4#X&9DBDRGCB2K6&UWES%TPW M"9&MBT3-H:V2043B"=8XE4RC@;((A(+,`#<8:$6V6;KB=.*+QWO'G"$Z*IQ$ M7%%ND#"!BEAR!C`O>9($6U&"Z%!D<#\(%'LBB&'!:D.1M)0NCCMCKE;LDHB\ M-.RAH+#/!2L=@+#,(TN0H"(P*_U\=AFME7H0R#LD+QMQ;(`V2,PS4S`G+Y6S_ M4.AH8&7;H1?\"&R'*IUM]`%CA[3S-++T7X^E`>]WMHQ1X77.C!LI5&_M$4_] MBX`2,TZ043QXJN=&B5B%J-"1]@=M2N66QGNKP7,N4U2EX9G' M<2S63Q8\;,CJRI>%()A(HYVQ$7O,4Q;2?(Y[8F(>Z,AK#C42J\99)TPY'"RG M6%)A00[S==<%;G2>TE%=#&[/-G!V M$1.2UW-*)7DJQVOE0)X/K5K01^JTU]ZE4@C*@.?)B$=ES-[9/#FGRA#(2Y/+ M-L31J$`)%40&+Z4Q3@4S)XY>$+'B'&.5CM1+$\".UUXG.*:6X"@0X3(@BJV? MFWQCX-TLFL`W."+PH\EJ"WXO0E0:%`.G6`.C2"HZYSXN\K@B5;;*:,Y+PW_+ M#!-#F74TE2Y3-B4\2$;G(G#4Y^7(*]VBV(L(EF]>IK1LR7HL$\JF@Q/,P,S% MA$D=RZZ4!.ELOK*\@\ENAO%\6.W37'`#6$83&:+:$N-#=--L*&-8,!QGSFV# M>V5F(K4?0LRG2*2RRD3!HIE!+VC$*IOY#?3[9S.:1*U5("%@20Q#H!&AW&WV MSF5'X!KKM!^/S!GA%.>&L"@,5SRF[D\SW0&5RIL]U4@@V]3`!4YM:*J!JC4, M%5GLC2N+EGA&&B9UR9JRKGRGD:)IAO4\R(9UO(5M7(W M*[M6U0CJ4E*$P!QFTEOD(^<)+D)I28HBL]E!,(KH!G:G%F!MODVMB"4D!DZT M1=PA'W19*I]@'+,9I,'_/"A,GG:(U)AH*4DI9X&!I4`>_.ZYB3`2].T)U2'J M`,YV%(L$A+P7*=>9!*Z4ES<-7CC-^YJ!P[%!Y*X&L.R8_M"@*>5"6L;!3:,V M92Z4DXH"@BNJLZ"#PF_#0^U.XB"QYB$=N++I"$_9T\D@A]2*4D_/L`;O"PQL MK0'FQ;!@SD1ET$U"%E@?DQ4)WJC29QWPJ)2P8AUC($88PPFH"=@C418;<20_ MA[%1Y90Z@+5EJ(QRP(50KB1ER`B12M3/85$*YTW29-[;KM:P[+J2D01%\X*: M2,$T@Z5V2"RJ1UN5D2+&V/X-]/-5UD`\"&&)XSXR)2(GT2]*_!"Z:DMU@PW5 M&J"S!8U.YXY@.7=81AVPQSJTW"4[7`).M,M.XML(+G0XD@F$& MYTM-DZ(B#%WCD/=X57AG$R6-\4-[4@YM^_I6B@;*0R3<&:LM!TFG!FO3?`*6 M>G[D2PX1ZXOZ@W1$X8M4/34&8X"3=5B!*>E(V0C MS.5LLYAJO+[OO.XC5P#!EOLI&GN")6=4(0QKJ!5:N;)=,78\,WDP_/7C+.L\ M[B9#?V)0";-HN57`%!2ETA`'T[=LL4IDWEQNLV+H*Q]PW=']-AJ.QW_.@XAE MD94_BK4Z)MZVUP@)1&#A0L$1!O^$LB:OBZ"P>;ZF7-_IN.\A*QWD.DV`.=62 MWQ>L-LNS(YX877WJ#69/TF^9\?Q;]U$,Y&:_-JQ=AC260T,`TCEH9&F!@ M9>$J%O(2R&7.P=+HUG^ZZD;UB.I1%K17U,5`;821P'AX295PR-.^L,QDMN=1 MK:%KSFB)26HM:*1&$2A@V4[/$6?ST#(867+7HE0X*@\UZ MN'X\O>V^!I],Z4 M#1T8./S9%CT8-'F7!/XP>&[>J7=S(RJP,HZF'!81=>KC:7S)6+F-+(OI95LN MC33ND\9O_>%5IQA/BM&G\_;HHMV9R@1$\+A4#$XIB\57XONDY2' M&W!='>&4@3M$*9?($N":TA(5*149`TGMD0]73'^FOSZ>?KR:=(87Q7C>;>GL M_.&(X)8&:_']Z:_>CM*WO_+>''`Q'!<&Z99AX'$$B9A8.(SX@0GP<; MGBR;^V#:FPC>+_'O)[/O)\N!*B6XQ\#(J44JNL!)Z6TR2?-*$"]'#E6IPOW= M2+$A5%&)@@1J;YP(N$S38JF!;@/MDQ=B'BTCC%)*L,%!RV#*V>L$0KF/.2]B M\HP0_UETAF>#%%MZWTW+X&DO1:%F36>GZ(`O:P;=R M>3_H%J<]&&OQ>^]K>CF!Z=%;?/<91,-$1)0:&1$WPG!87,F0G88WLYB\33KC;0C,)X+U\N?2ZF/O`5*I=SNUU=FBVOOFG MT?"R&$VN/_7;@S)GXO+B>1;=0)AD3DOK*#-"*LY<:=F]Q7GYI2SS?R_`5"*+ MWX;#[K=>OU^C6:\9)D!S$&)1FW1BQBTR`CPB>;>[]38UJ@#C-N*N/3Z'*]/_ MDDR^MON)M9J):X]&U\!MMRFIX9@//`:"E-"&Z*A]N75A/5Z1"T(HN\LIUGJL M2D;RT`D@R4"`RA&)L8LXE8%497H_88CD[;20S@)#>QE)&@AZ*"LI&!0=PLY: MJ;0'^94]J74(P,!7'8Z^.QWW)Q+\8'X5C$,!_>'@+J<43%.V+O48B%.VFF#% ML^R3RD:RHNOXP^[MBVIT3IU)I5F8P$Y[ZQCH$O.<1`?^!"5Y9>O9MB3J"RM)?;DA6`?.!9*`YL* M)`;E)!&\3)^W(;(LF8-DQW,."OMZ&R&9]M>DM8)IC8!':*YN^C-;E+/<*H5Q M=P49=(%5_E-,$BF[210[`4G8_K#SS_U)(#?E=@"_]1_&M]>?PHCUX._UL M#&SQ#4:7D[='/Y]-WM[Y>A\8YO%YT3L[G[S!!/WT]K+=31WJCK\,)Y/A1?KB M]\5[D^'E[(TTB.-VOW//W%4R/T^M[?RN]O^I9>P.@T[W)W>]-7WZ;/<^7 M8;\[NU'"^54K_;>U!'>K/>BV;@!OW2#>6F3M'9\.1\7;_\% MO_"6XE<5#VKZ8\E.U!7U\@%))0_XJC4JQI=%9]*#1>CZ5>M;`6O9*,FT6W03 MYIWA>`)OG_5H^'VZ-(U;IV"N6U^G[D0:9!N^UQMT^E?I>[U!JY-, M1_I@^D=Q8T->'[1=.#F'X98G(.;@G*6T9%CTREH:K?-9S]'66;LW&#_P>7]6 MPS2A5,R7_.XRKF!QVK?,ZA@@;(UOC.Z79*+^'H[*]ZY;D^O+F3PZ_?9X:K,6 M'S4*M`L%FFE,&_1AV.\/OXW?;#V]U^`.Y6SO%Z>3-XO9WANDR-3T]?)-!\,1 ML+=<0Q8WGJWAG:+?GU_S[@@=35^/+]N=\O7FK.=;KSLYAS]A3%^2'1D=@P#Z M[N?182S9[+N6KDHV4J[G MK;2,KUQSEQ>?VS)Y$,;]PY0.OI_"`OKFO->%Y:Q2F&[HS@;X+!Z7'M5NRCT\ MS3I%JJM0*8*+0[_KLIO=/DXZ<]5,]6:J[V)N30^9UF.:WY1GK,?SI".WC=HU M:M>HW5Z?Y_?'D&G4KE&[+1$LMQIK,M73'F`]GF2Z$[GNK-K.56UW_CD;#:\& MW>-Y@++3*8K3TQ?FH_[U^O/K5EF^:REX795%JQ&,M3-UE2\%]X(]MY73('-F M*.LR%?^]MSGW$(0[0&HZ72N%2FK^.M\@J1JN@Y@UZ7M?1JU.OVB/WAVE3>ZC M7Q<@-`:L,6"-`:NA`4.O*PN&'_:<:V4;;!:H--D>JM$T'JM:YJIM1%27;M!C8:\8(U`E47"V[TH=&' M@]>'7RI4B*V<\+IH465^=J,N+UA=&D)5E>-6HW#4LWIT'^SG)L)7(Y-4*8C/ M:JL81Z_5SN=6711MURRX4:Y&N6[YD;N/^C:JU:C6#ZA:OXCJ*':U&\9U4HV99VZ7;^[*\VS^&@^,['NZKTK%M#[8YB5/Y(WZ^NARU9P60 MV_UF_[0)]VT"!ZXP=ZTN.KMK-M\HQ`M6B!DK]C;U&HV31O-:S1OB3'* M9EG;I?/[LGS<:H=G%J"3IJ"X#4U12\G MT@0<=P\G8^JB8+MFOXUR-C7(UR[31(TZA8HV*-BBV=W:2T MR:[9K6?[LAS8D^&DW6^UO[9[_>3%'I\.1\?C-KBS%S>>;;,[N>]BX[<[]='+ M[ZWN\"J)XBFM^@ZB?'1U1O62<5'BL MJ*%GMR./OTZ#;"NO7_I[:5S]WJ`X/B^F=@H3]-/S#VR;AUOZSBUK@T`QII+K M#<"0SEXOWW0P'%VT^[?4"Z=K%C>>Q2P[1;\_O^;=$3J:OH:YTBE?KX#EI'=1 MC/^?O3=M3ZP4P>;@Y*'Q3`1XC>70M5*/_7B_.$"P2,(" M`1I'M^A?_V9F%2Y>?8$4V%W>M<4F<61EY7V5\I'=*E_"E;,CPV^]6;*$C[`F M0:)`?KZSCMG;[,,OVR17`%4.+Q=DV]V;++A'A)J`^?65:?YT)T=4>5/ZJQ>>5DQHQEZVF+%(,K:7HJE9[!?L+]@MR<(V[ MWABV^]WQ`LEVDNTDVYT5GO=W84:RG62[1V)P'"?>RDF:0NH3QXN: M`P`O@C:D6), MBK&&D*(48P]R(Z4=5G[<2+R1?2+Z0?"'M)YDL MK1FWPS!:AY&3,&7&IDF)ES+QJOVB+/QPZO@R`-8@L?1\`F"ZVCM#V7Y3V.W4 MJETREV2N2HVM/)1:LI9DK5.D3,]Q)K5,F4K.DYRW8S'V99'=:9W?Y^7C?BA. MS67_3KU$-F_*F-H#S6A3QM0D/TA^D+D7R1>2+X[YA+4E7Z3K)]GEF;.+G`!0 MC[?6H/C(*7%['2:.KS@WCN>C+W0\VXN> MRW6^@VZ?_[@WK=53>^WNC\?H15#>J=T:*26EE)12LGE2TJC/Q)824DI(*2$; M0:M20M88L]/KB]D]'9T/BO9=!*W**A`I0!M'E%*`UNN(]VNL,Y5FYCT#Q#]3 MR'/?]6<#K(0TWPO8U9*1/-5T]:`J]3O#A.X9>9%S$W\3?*=*.$D;)(G<@) M$@:_P!?T\M_SERM?\Y>/\>C2=>3%+&X7>D:YS\#$',Q5&"4+^/X*^1`N*:^$ M`P<@`*S*A,UH/1^S01`?Q)V*'<>AZ]'7K`NZ MO+2VHP\OK_&.L1G*H9D5("J"V(L3)9P+K%>V!;Y=`E7!3F`/U:ST=/HMR"ZC MS4N6L#)">F%Z_]!6*E^#O'5AEJ(`B6*+O46MK8)/+6/KNR!9I*%]T" MVRFN$R\5M/?P)M^':X!8@>$)&A=VR4O@FFBF`'DP[P:E,H?,29-0\8&>X[:B M'*M"+`-3(`QEPYYKR\AQ$6EKT(^>"[N<(()G;:58_37L)Z`8C\3%#TH`J$CS M,\>5A>,%]);5,>#@]QU!^T"I*#1UIHSQ*;JJ[<:F'B-L`7FKM8/,`M@^#:"[ MY<:/`A1$+R#:0WYD5PY.\"!X=.HN M[!QTP+PKR)8O8@:?@$$`2.(F8(1$&0%?K*8@8PRMU6A2:C_:H-@RW^&153>* MOCBQU8',/G>`"#CUP*8X_MZ$>;&M+>5VZ;G+DJSU4,]N$X>R#F./=#"2)(BW MF*L+%')^&"PR]0&,DHN>%4"XK&Q_\5O3Z0#0X@#H,2S71[G_MG8KN'1/Q?W. MR<0+9L#8]'?YH4$8K1Q_E[3R!W/&=9GOBVM^?:6^HK_!XW&SO_?@X]I;`;=^ M9+?*EW#E[`0U;KU9LH2/L";A:)$N7,?L;?;AEVW'J0"J7,M2%#19>\N/[E$. M0\#`/=9/=_IU5=^[(8R^O.6 MZ^)IZ,].%;2728T"W.Y=K:V5D/%N[/?$A=$N0X>G5GR]SRWL78M:4IBDL!JR M-KN>&GIVY,M)"I,45E.Y_GU1];B^AQ/@K)%&!]U7":+MC71(-GTRFQH_@$WO MP.79&7<<)]X*$R'W#7J=%IR)XQW72&>#Y&\85I5<)[GN%,3U>Q3&QVW[LX'R M1Q[\;P8\[^_"C&0[R792V4EE)[GN0KA.*CNI["3;264GE9WDNF?/=5+9U:+L MY&B<._H-KK'^,HU.,=VT06ALG*RK71=<=H-3?:UUS[YSSM`Z9SB?X2*H!N^3 MTQ>D`&L`*4H!]I!YI[4-QI:C$:1TD])-2K?F2+<33#F_;-J11IH48PTA12G& MI!B38DR*L0LG12G&9+!,"C`IP"Z6%*4`D\&RA@7+7G9_S5KBP2S#K/VB M\/-:ZZ(Y*;6><;Y),ZRV5A>E-(5'3JW@)4<\8XYXK;8[=1/*\];*DEU>,+O( MRC;)%Y(O)%](OI!\(1T.R1&2(Z3#T<@P8(.B\J=$HAW'+%%PL6PFYX,W4T0] MG]R&IG?:M1U/*A.'DKDD:Z;.:2SIFLZJP/5]=A(@LV:Q1(Q]FM"R] M%&Y2N$GA=HGS.*1M)L67%%]2?%WHR!-IFTGA)H6;%&Y-$6Y:2^UH-69)I'DF M)9B48%*"G=$\Z]580"'-LX=D@G].'$#.ONO/)G5+V/&]@%TM&>V,IJL_;6\% MO*FZ7?1%":?_2N/$FV_J31HOF3(,5["G&V7*?(_=L%A)EDX"_X/C@5R$6O$" M9>YXD7+C^"E3PGFI*4A9,G^FP/4CYK+5E$6%N#6TEK*#G`<"*6H9,F+$I^BJ MMLM0CUD[+CB\Q87"TMPP3A0/ULY6.!LIVBA.,(.%)RR8P;>A$K'$`3QX20S? M`I82G(:/F('[8U;&R#R,%$>)T_G<&'$7%1^ M&_$D9>5$WUA28)H_O7ACW+YH>ANED9-X82!P$N,2G1O'\Y%3KP`A5['C\[E4 M991>)GW=LH@I#A($;G?\]M$[=V@'2O=43(Y\([T`K"G^=_FA01BM'']W\_,' MD^!47.;[XII?7ZFOZ&\0_V[V]QY\7`.!Q\I'=JM\"5?.CB%WZ\V2)7R$-0FM M`QO@.^N8O,,1\@U MA=%D[$,RUSF92^_+([VE7_Y(OQP6?`+]+R71,_8]#*N^(&%3>$(ZXY(A'L\0 M9GU=%L^%(:0G?J9A>0W"6>-$S@/*P^IJI+OHI-?Y.NR>?RY5;ZEZI[Z3XAZ/ MT8N@/!DSD5+R4FA52LE:I:36/^,(FJ-.EU='XST05][]=O6]I11?4>_X+[=;5I? M*_UYR^&9AOXLZSC)<1P&BKV(&*'X>'COV"I/W)C[=Z8LG1NF4%<"H\[G4'&4 M&R?R6+*A-EW?]YS`97'6J@SLZ@78*>V&:113MS)\4*9I#+#'<5NQ_61)V@[0!BX\%5X\QPY8 MVIJ(^?"R&;X8H2^M,E;6$8L1(3-:LC--?2=2^*V*,P<019<\OGB=Q7/S)SR^ MW_?$>_TH&?9CX.5_XN5O/?#8/9<_Z6,(A)G`#GU>.K`;BOW[+K*?:+P=_03< M`K"P($;"`1*X#2-_=@N$K9!^CI77[+OKIRB"E*$3.#/G#1#:PHGHFXRFW:47 M`;5LE#6(7*(KZH=?L62Y\==+%G@S($T:$S#Y-+3?O_M8SR+AOCA='U#C(#%_ M.=*`WETG94QU34XH\+R]%/08^&CR@EBP\O^^O(PU@_C)B+JM_!UE6QR6:*SX ME>A-4%E)=ODA:#M0QTA?2$D@JE`@[24HQ.^,?;_:_GX=A;/4A>?>+CUW24(U MC;GP>VG;@2CZ\NZ:UOS>?A%K)K*+F>^_+&%39BW<]8BY#).Q4;AQ?!H^`APT M9PIX+-J@@^LHPS1_Z/@E!?"K!0LSW[-PA)W"D=3N?62 M9<%VMQX('70TO2`%E0/_^J3E4+E%2"2OO3>%[86_)/`04%!!`)P:Q>B#"/]@ M[D4Q>AFK%8O(U/>=-`!=!L3GH)\2)-'F:KJY$A^5J1,#`&!@O?;*[[@%G2A` M@,0$(24K2!XNG&_P*WEN M*V<&'T%AMQ0/9U@E1&LDT'/%CJ[90C@MN_H?KS]@1P#&W64`TF&QR;8SL9<4'@Q9U/4:6R.`5$,7!;^ M"E$VQ0^RR\$4V;_7^3=OSA[^)I>C M"'O'"7@X;`'RQ:TDOG)]*WRE8@T8U491_Z\06!(X[8;YX9HT,_)AX<%Y_\DK MY>,P01/?9>L$UCX<7VG:&[H:/UM&!SP3_BT:#&X:1?`TGR;KKI?(Q>_>`9SI M+)O1FP!O\RF^9,$&F(8*V,IS6LK,0X<#3`W?<;_-G2#_8K@DV+`(@;9@[T7X34` MTH;/$/8"(J>9)(VZK-2=N`W+=A3<$'`A5JV2J`)V9@`*T0I-`N<18J03T,3P MS0G"KG\R.MVVJL!=/DB_>NP?D$0E4FN5O79G#>N^(0DXX[;+U=3!W`\\E<4) M;"AWTOAZ42#.9A[*9;CE)*LW>W6O'KD\"Q:=`&3JYZX'4B1+;PZZ=.;%8CI\ MG#@+EM%F*4-(^I4$DAM>P<^K,&$B@$4;S0J_&K?_8QBA$EZA)^"T2R1./D-& MV&#E8@E(*0,2E%1]P!)AW5)H3SCRN]K:V1*@W->7(NS$(@PU42[#;H6A!@Q; M"B;G>UG$E:>P:@SYEF(Z9;4V3Q,L42CH)2>J3'=6C"EN+=V#2LNTB7__$7BH M7[^BG1>W1.D$-XS8=\\-T<*[2RP_1<2=5*+K6K=MU2_3ROMT+O&L==5VK_ZE M%!F<`Y+O)`<^_$D#97.BU<1@"J*%MW\YI\K9_DG3K;9Y(O59(JU#RZ+(%!7( M21USR3KFNC"+[TCW80["22@0&8=X@`M01L1PF^A[K/:DLV]V$WS[B80A-U!YE&RL?45- MI88+HMY#$;2%%V8UHRY+*7(:MXJXUKO`;2NOZ:HS1]1&*9E?NJJI/.M1+<,N M!.UVO&`KW(89?&'"E5-=:/33VJE`81ZZ:U$"Y;$ M68:A>'7K?D$Z)XY#^"KAE;&1LR8\@\NB_'V/,:J$O&XZ"0NX05:L0RRS\)Q2 MZ0)!SL/S12::+VIW$7EX90W&'Y8QE"9?(G+I,"[!T5L,_80#MB3_'?502-YE MQ02TG4#H[C(,N;\A]K^5;6J8^D4UGC!LT83_[J$,]3&,`?_&4;4)2]E@)F;U+LNG)K-#QVOL/ M2'B%6YOBKS/;F^^$?*;*AWT6Y[WMRFPUQ)#<5,PMQ1VU@X(&?BE;AJ4JL"DF M2Y?>U*/J4R!'U(RB>R4!V1//X2ZDXM=_^7#]!M6@J'3%`C6V]K#$!9_(35@@ M$0>[$/_(!0+*R3CSZZI"!HMG\7GI&N03/"U+!<*JL@7B6DC59M<*]JR>!EN^ M.J\2NGR$")9:=DJLKTI6_6TZW$*5^7M2<46 MSK@?0RZM6"<@'>P'4=,GOL30K1"7LU;I;;LFWTF,O(YU@M1:;LL5!MPVUO;C MMDC5P'K%'O-+@:%@CV&O,Q7;^/K+0[Y2,E48':( M<8L]WFLA-E#\7IJZR$-N)<[).PW@;Q%C^FOJ;PI!WN=6M?(ZW/]+1_'FW#K! MDZRW&5.<53T':P/(DXXYHU)<]"J"[$*ZE6H&YXR]:2L3O!BEO(>9GC)MHH64 MA0\B:B8#`PTY?(\Y5BW$YTZWNPJ71]NSL#B^`R`_071U,$1I'.P7\%(:^5UKZDH M\:3NC:JLW5G18;TAF?)D-MS43]G4BV;*U`MW`HC9C[7;=&`R*A\HKH753/

Y2;T,I"'H@])D%8GBLD_JP#KC,^02*:M;"V8UL8MWA!NWKG`3R M=%[FE3:0]RY-5F1AF4/.!%*=R$L)EYW;?*AN3UAVH-=N[8+R*A12YD]@Q?QB M@5,NDC*S""H'TX''.'.:Y!Y2T3>V8SZW"VHEORMCQ()O'AOT1#[;AO\>#)?E M$)Q3[).EUK(W/S<7-"S^V=X>0/X M98^5P.L=BE('[F3U55CP)MYNP"YQ1QF`=_-2J@?#Q+3VS+,C,9PUGI%!FIFC MZXA=!6P!SR9=MR?^C@R0Z0I_0Q9LE4/R2^,E,7/.93EG85;AB3IA?TBC6#_2 MSI[L!#`])4Z*(I,X!+3@1A&L3_!J][>L[I9\\N728#*Q/ZT\=7\(E?<&/!^# M4-KZ@,\:8MC`@O*JB%Z%4=5_F-V)U@.NN%->U?ZDT".]\9+DK\D=E^;SJ5WM MR::<'`Y^_(Y6CLB M\CZ^]RQ*%T6(/N;I5#*6B1L3X#UE&:Y8&"X"?T;1JH32<+?Y%#-L&CS-HR^46F- MDRQO4;W@5)<($)8E!:9>B.\@F.9\%T&'8&XGGU@"4$3.+!<&8K&PL@:2[*6Q M6&X(58D8&Z/YH)PL4[$O%8;%!2Q`786#9,CPN7'\%"DRB_16JL?@%?*K\^31'G/P>FKFW2U[NHFD#=-Z M9C=\I"M5(="()PQ39>;NCH03WO5G'KQJ908W;?QTIV.S,"/0CIIS"UE9^.$4 MR":GGS+&\Y!7D;?,WEXQMK/U[&LN.5O_FW:*%&6IK#*C/MX"0Q;JP<:9K%\& MF.U?#"MM6+S5KL&^7_W1_MK.,%NF"G*^]Z%R#S#X4#"O7!976#E37RR&+XZ0&E"%BB\!X`UY*5SS><^K],HW:ZP8QR"8:*MK5%$"VEI;` M;(L18L,/6$8^@ M,"I`N*$:*[[A7)4(.2Y*(;9E][WD]C;H]PLG[>)#VO(UP?O'H5*\@BKV!!"` M[JEB.VN\.-@JSZ.!E,:&W<<<-C]!D:I-6IE)0>Y:_@R\NH4%]15:458,C91\ M+C,L")LTQ%BM&D(0FX11N[+8.^)95??HU7US)K^35&=YL>Z7;QGH)Q$PG-U5*7)!4 M.Q"A^!!&ZV7X%=P8^W?E=?[7F[='@OB/C4W\-0U803XQ+!+K"ZO"I55**,^R M,L5U"O+/V:W?+(`'"J1A/(6CHGSX]$57=6%5^]P4K'9QBRNP\C%%UMHR5>QT M`5L@`.9]XN#K.SQ](T:QL/FQ)N<VI M!'(X,GKDX6$/>E8X((R(W+!9;6!%*]Y,G@EZGZ7?L%.]')0L0"A&^/!(9^;M MBN%@(LG^\[MWCF@%1`N[\G*<%[,&^_KGB,TC6#3E.;<`DGQ9$[P%(>^K(QW_ M\>4D65M-J]ON?WWZ.$"G8]8\B>#-T>$RN0.YU>^TKPF\:/W&7!QGQG*%6RY[ M1`UCA`71F[92J6T_?&&K)/`BAE(@EOG\QWJH>S+7N(6%3JBX6F";X&4AU7YA M$D:82N+RG7%;8#5]Y3F_$FOG[8+AFFPN?`@F`"N[S;W(\E;?5D3"?>DNTWOU MQ)Y=,O9>M(RNYN!W>_0/)*MC[[LBQH;OYJOS36X=&A^^TW0O"*\R1N!(6?"] M4X\>&`PW(5GDK>UA[F*5:*SO<5KV^RAYH)(*DBJ66N;1YCFDEI@%7TDC;;DS MG*REQ7'"$9T,OLLG=!8S!D2S5_9[7G`#9[UO_$"EXR#\'*H,/A(N0%GBI"*?R7D3TL]S15$I)+!DPK M/GNK52HJA'$%E*N$O_B`-#&?=P9XI@[(ME(-D68E,T579*8%,B_@8(`I9M&- MAT?!$?OE>TOQF'+**4]&.2[X6C0G*[LT@3W@QUCP$Q;P[]P36T-&K M":MA:P;_(V;:8+DB]SWX`AO(#Y?&OP<2H:5B=6Y"\OAP[M3-H'^4D3R]:T;KQP$),@.##NN#EXG4%_3MY M=7Z&'&-YZ<$BZP`GE@+%)7XSC-.]^$[$7&MC>I`JHR)% MG<6N,0\8/-5=IX>YE*VV8N7G-%X_HH;^$6MS#L>V,9%EEW3 MB&4#.T2%8U'8[JSP=)_\.-+=E7!/`U!Q"L==:VNJJDSK3.`W53A?HC+9*B\. MMH]^0K(9`5>L,`U@:*)U<[NP..?Y(W7%>2\HD)ZAB@IE(/OMIW?V5AH[6TV= MF*]_4(EQ*;NUWV/;==-R2=K4#;P@@CO@?7P"Z_D#2+D#SH?XN3;?XU-0D)M^ M**=UN"5Q3[IAMPSR9&U1L?>]'C1@/B*SF>*$K:B14'D]_#I\LSMJ05@58B$:]TA;HL7BKOFYO:^+."<<8O&C\YO`.5MHBV)#JV)%B M3XCDP-"FXJ%BW&BII9(%6,2:B<\\R5/.`XD(.?H(% MR'E\_;U7?0WF6:Q\9+?*EW#E!,=Q6A(7`1Y>[O-OQ)GUXBN25C/F"D9]BP*0 M8[%34[B8^DUXT^H,")S&&8+IEI%M9FP626W8'6P%<+\Y(H),P;N]FPCN3$JE M2.73R'(=5VDZR&A=]!32>0U;L;0C=48%]<[DA2 MA1R^U33K*>.S2Q9EA_9B>H5'4-EC4/Q8^K0%.6UNR>CT&Q; MV-@KGMG)")O\\-N0?QLK0^93ZW\,+$YST`X,KF@54^4HJG(W6[(YR`=63Y#]XK/ M22_9>B+Z\U;9:Q0ZF7WW\]_&OT_@OOQHD+P,IAC[?PJ4@-"HR4PNPCF[JR_5 M\@C'%O?_R]?/GZ[>__Y%0=--*$Z*#`GE6OJZF*NQ/6DI664H/FK/ MT.]\(NK^\<`B5B9L:AY]$EN7ASCGY>EF:(GC\Z@0>RMESH79U:X\H[K*%A_J M=6^Q>D`Z7Y7?5A)T)?G&PL^@J.[Z!#D7'F)"(N)=,@?P<#LY2 M/$&RJ/0S\>JK)$S@7>=J;.KVZVZ_X.U'8E.H(WE3%)U7\0[2OC2#-W;F+-GD M->25X_^V)XWG&+Z'G,\Q?S^VL/:IG=76SG\MTMQI;D9FM(CH,3G":O4'MCH")27]N4FA^,4_6> MLT8GJ6_.H&\.G(TB%`'?B:OIIJH/>&@,4UW+-)BASY396IRS57,]S/4`MQ.IG:+Z6IG[BDU],W M:*CBAB*@8518S$X)+2(!6AZ4@X&XG1HY?!O/6=';#@\M(23F3Q?OE"[UZ9)" MW%>JD)%=-.!1R`I3-V>?/[Y=O'"P1Q!3_3'84U/T?*8AG6"XDV4*4LI#D6;- MGX/)C,IS\E-V#*5TG@SOZ#B)Q:2WM=I-!S%2`>5+,7N<=[:*`P,B(6'$E>)@ M^Z,'#LF(>DQ8IJ.S%F)INI+R(4/'@#`/XL;$@\ MG#T;Y^C,``9\_@T/FU,@AMO1KI-565,#L(2I1MOEE*7'';EH?/F\/H(.E@#ZZD>K^762.O!XFH:)DFXPBW^GG^7 MA&O^Q8E5X==TM7(B&NXQ]Z@PD5(5V*LM4F,%M:$;=\!RH:U?HS@*R/($RKO= MU3WUMU>4GI)ASF?SY&V..8^JX^CO\FM$>G0'V_F#$\I58G9/7//K*_45'R>\ M=MSL[X?G<`'9"R_@0#II$F9?4/*&?W/KS9+E6XQ]&'VUHUL__3*E24U7A/MU MS-YF'\J(PB>6P(_R3^AX(M#!KZ_T[BLE"F_Y'UI^\<_)K/@8[7T$P03W&#]5 MGE`\>N_3BAL[C[Q/>^1]O3._[['W=2\$SDO!9_]"X)3KNVQ^.#>74<6<+2R2SB]7<\TLB;*9E3]1AD[K5Y2N@Z9FWV M'H>O_+9_X.$[V*$QJQ1Q2]JJG[9Z+XRT['B[\>`)X84*,'&Z/H!*0,4O.]Y: M\11KG?!`/T$"C[DSJ"J5CU0^9U,^^@N3$%_*T>%1*1PXYM%A263U$YEQ!XV= M`%>7@!])/Y)^)'[.@)^[=-Q+Q(^T+*70?@%"Z92FY!]B!,@376V'GV7"Y%7LC5JL0%E:,]O\< M,6I5J/BII]VBDA.CZ5X%$<-(`QM1QORTB'%YR)0J379>Q^?P'B/[M,L4:U3&LR6?1GM+J M1^K%9F*M=KK'ROD?:4H<1',SR.I/9R.G^Z8.[X\*(K8:<9&/KM!KBQV>>/=_ M4(.89!G),J+1M=O>[725O")Y1?**5"^2923+2)9I&LLTR.]K7*!4RIJ7*VLT M59JR4LA((2.%C#1H+DK62)9YUBRCZ=VV+IFEB8JY*12BG0T[A0ER.O34+$M^ MNB]R9/%X0^RY1B=3'R**3UI>\8!BB@NPXIZ1_I&[+G==[KK<=;GKSW77&V;Q M-,XBE%PAN4)RA>0*R17/=]<-M6W)[3Z]$&Q*C+&V$+0,)$Z7$CFOB-(M688$(JM3))U(.GD&A1G/ MS/I]<0PF3;D?''5XK@S4C*$C$C^7BI]FS$EI%GYDW9RLF[L[=*72S#\ZR;DI MC/<##1RS1@/G&=DQSW6[-4-N]PO:;ID1E[LN=[W1UD[CK,'GRA66+!.1W"`# M$A(_ST>:7CI^+KTZZ81#9A=>^)`C'2X08S]ZP.R+RV7)9+$L*I!T(NFD/GDK M<^.20*0@D=5)3?`E7B*#:7J[)SE+>B&EFEYFX:?N1,O$LT79Z1_I&[+G==[KK<=;GKSW77&V;Q M-,XBE%PAN4)RA>0*R17/=]>-KBQV/H<0;$J,L5LW$F0H468'&QC3;W3P4<[$ MDPE5F5"5="+I1!:?2@+YT00B!4G#ZS.>F1'\XAA,[[5K&%77M?K..W]&ALQSW6^9*I6[+G==[KK<]899/8VS M"I\K5_3J:R>6W/#RN$$&)B1^FB9-+QT_EUZL=+IZK_':^\]FQ>H2Y,W$F1R2 M=_F.P4M(;KTX.I$'@TD"D8)$THFDDP8ZY0VRY9KE3;Q$!M.DHI:,)1E+:JZ& M,-B+HY-.OVU*`FFB!&Y*^VIM539R1-Y#0\52<3<-/W)$WNDUDCST]B5MMRSV MD;LN=UWNNMSUAIDZC3,%GRM7U)FME.P@V>'"V4$JB9>XZU((GD<(-B6J6-L$ M1!D\;'XZ\'0HG/HIFWK1K"YJ:B;29*'IF<53UY3C4TYBE3P7`I'I=4DGDDXD MG4@Z::Y[U"!;[G*#1Y+!)(-)!I,,=B>#J?6-8WH)C/7BZ$,*X(8+X(9$AL]) M)S)VW)CTZNDP-?GTY8-=%RG),/`SS#U:NARM](*V6Q88R%V7NRYW7>YZPTR= MRPWB2*Z07"&YXL*YHL8(YC/BAN>ZVU(&OL2ZTQ/LN@PB-C\]>#H4?@BC]3+\ MNHGK(J=F8NUB0H_/)5W6-]L/P<^+SY.].`*1^51))Y).))U(.FFNH]0@6^YR MHTC/A<$ZFK3H)&=)SI*JJR$,]N+H!"2PG'7:2`G8?[14.?#F!6VW3#?+79>[_C)VO<;4W3/:[8:9.)<;MKDP M;M"DH2/90;)#'F.PZALM]HS8X;ENMYQK>A[IUY`(HE;;9LM(H4S]U7M:4H,0 M=XG'*#V7+)C,ELILJ:0322>23B2=2#II/)UZZ MW'6YZW+77^*N-\SB:9Q%^%RY0M:<2G9X"CL8)V"'.W`E\?.,\',*<7KI^+GT M8K_3!;X^!6ZX8O(,\P>'>.0$R:/9")F..(V+^%PH1.8U)9U(.I%T(NFDN5YY M@XRY9KD3+Y'!=%T>LBPY2W*65%T-8;`71R>F(4=(-E,"-Z3$SSH;2[/"" MMMN0)ZW^W*[ M9:SKY>ZVC'7)D6["$E1EK.M%[;=,\[R@W=9E9/,%[;:,;$KG7CKWNQKO(7:> MY`;)#7(VF<1/HZ7II>.G%'[X.7&F/MM[?>ES:26^%["K):.5:[KZTS9^`*XJ M#NF+DC3^5QHGWGQ3NT".T_6!G<8FPAVPB\=TUPE75+1J>,Q>4?X8L!3E'Z`A MKE@P4Z:.[P0N4QSXO&81AE.*F403?\$=$'GR[@:>WCV^Z^/SGG]/X:N$XZ[>E/L0;5FI#''FQ MZX=Q&K%KV*N!'[K??OOO_U*4/QJ-.5]>' MHXFAPZ5IX/%GI?'LU6^6:?94_$\9\,K['PBQMX/I@_4*3\_`1"C`LBDVU?'0VVB&G9/ M&W?5B6H/."`#M6\;=FV`[*'#*FPC#ML_KD1LYW+U:\0`$J55O*\&]?8N66@3SWXC@%89X&,Q!/CG(` M7,5>1(SD<4L!`0^WE[^A&#P\Q`N24)FRY):Q0!DR'Q[#-8L-0@@47Z!\39!O MKD&ZQW,6E2P$_(3_A=]@6P",%1@MFU9QQ?OWPY;BQ$J"OS/65JYAF;0,U$H1 M6W@Q!X+44N20WH+5(S8^VE]']O\JO_LAJ#OE@Q-]8XE8,?X<;U9`F\JKX?C] M[__7?D5/GCM>I-P0!@!_>)7O.5//1S4HOA`PPKM]!_4AK'WM;#A5%P^OH(I@ MC=/IOV"_\/JYG[I)REOOITX,#T&(!?"@2UW@_TS-KM,I$)6_H=_A2EQ[6_F: M3F/0SOAL>!Y>E^VU72*!$0#8@OU65LQ!$3;CBKO8:_@8>P`R!R5BA9:?;K)E M`*:3,EZ(V-PE*FJBK-)/$7/#10"4BC2AA&MZ,-H13A3`OP#W'B2':51"<@FK M^?MO8?]KX9H_:5JOK2EPG0_KK<>F`N0@H&A4P6)0&0!6@4(BOHAZX`9KI6V> M&&[]N.G68!%,]XT==ZDL0=<``\*"'.)`X`<@9R_Q^68`?3(P,^''I^+P@-1? M1_`2)W'JV:)U&"%?MDHR`G8L2%=3OD9B#O@J*!OM+?R%(3*$O)J#A1W>(AN6 M&=^)E[G8>GMTX\DC4USF^V)+?WVEOJ*_P<%TL[_O8<6XOJ.MP*)EP)$`5@]'@HQ$..K?-/A#Y!N'KL! MD1B$"IH+:"DY?$%S;PY0.$$`>/P/U?'=#0F7:.3Z>;)R"ZR/.?I\!:)U!F8&34 M`OP59@I14GKA#"-0&)P8,9=A8*-8CJ$ILS3"WT@0@US-0[#5./3MTH-%WV+\ M<8Y:/L2`L:,$@/J84,_#GQ1]\G4?,YUX4)\U MK$9:]L@J^%5OCD=9FB[<^IV7(=RZ>CW"K=]5:RB[;(IPVR,+]+:U.W#Y4>:" M8.J"!U^9&]8;7Z%X'>`-GW7!NTE+6?WGM"MA3D4I`W3)#3 M?<"*B"G,+0$S.JLPA6>C M*DXO99\>,&YZ6=/'4G7A+6!2F3)EEK*#E884V(I8O!:EAI(!CC``SYT=BMGI MUH'08E6PB.VA`*47\$K*&15>I@%9-,6E64WGD7"CB"-B\>9!L,A8RJ4P/'.! M2:DLOWD9X8$6)M@X=ETG9O?$:]*NF4=(V< M]K:V/H5/;A)BP2J6&+>(?HK4,##PRV*A3`.0<+HBYJE4&/@A@.MOP.J^P0*# M&4KW%4M`M%'5`57HD>ATP]4TDXR\(M^)IN':QX)[NF`-G[C5L`R)+X,0RWY! MO>#V\):+2CH?"_*+FN1TA;>!R1$& M(,@C>CJ*"G@3O11^2OTD*ZC`V@JJS^:E$2A8?6?*'E`LF-4(XCL/."Q`D6'L81G#@&[15.$P<(;Z;,HW!5$>CE]J$IPZV)&"`; M]F#N\?67F9G?CRXBWH;]#N\^?\D[>D;E%Z/=5+IN!FCVPS6;99I#B7B[T0ZL MM,RAU"5@CC#/E%^3=P06:'E@SXS&&`2T\2R:B_B!/)!945 M;UF*M\29T=[3*'K9`NT]^%]L3Z_1HWAB7V7RGD]_1W?$(8MC3EV52#K8X^A$ M6";EN-ATB.WF/)QRXX!C")Q<="[RNYTLO!)GY/E'X"&Q?DUR:\?#9EAND`$Y M9">'JXN$ MY`[`5"+9Y%/:@+\1?>@B]+"UM!@\Z37H9&P'S%;/[<.LGQ>>;A*DX`H;8J7$ MW8#'@-UBB?`:%PT@@C[!UM\(^SG*G;+(YXB!B`G]3ZUXWFJ:1L+S1Y\QC#B4 M(&-]A:'!"[\YWUF,YBQ(#UQ72TD3L64M0`WB/,CG6(1TL'6Q0#>,T26%)[L> M&6QYT1=?^L5:#'3?)$U2V+>5%WBK="7V>JL1>8L>=O;>H2#&8:I"O^%XV=IC M$A&E>RIYF!QI'@`?\+_+#PW":.7XNX@N4EEU)YM]^&5[OM?^_%J>RC'W3NBY1WJ,8/GU5:_[TP,S<^)&[;'W/?K&!]UW M>9.(ZYSF1G_NC,TXTGQ3PT`N0=&9*%M_5^+0!\\],X#.,Y#JV&CGI\O*3YG@ MNZ\L.RTXW!)Z1.KJ_BPQ==QOBR@$-7`E[%G796P^?SZ\PHM0P3AY`%/4+D4. MHEEP%>FH'99J"O;^5!?J[J2V8R@\`::V9X8^'5666=]8],LF&KSO99TU<`JI M]1!B:NHDWJC%,K^GXH1QG]^DYR.XB5 MII"#5$5U<-1#)/#S546&)L_&D*KH08S3DZKH*(9JY"BIBIZ_*KJ&GQA5Y$J% MA+Z1*<_DE0KI`>P3)IAWWIL.K$T,5W(%QOJ[,@M3S+D])5EPV>&P^F*H=^'V M^0=9=?!>]1^/SXN@NQI%Z>$S5\X&6-.++;APQ>-.L#;E^YIAI3.OL=@IJL#B M:"IK^^ZMG(3YFYHKTFBI,^:&?&K[6T2QD$66VN[76Z7&3PXP6N=;@ZF=9@V\ M;/!\RZA]T#Q?QIY)QQ?"2/S/W;)``)/*D(81FWG)V>L#J8H,*_#\#!"7`.'5 M8C&C\E5EZ@3?J,(W3M2L>$$?'N_`ZPJI@&W)C]J@ M(C5X-CX'!$628,EG\2Z\<9$ZD1,D#('`\ONEX\_Q$GP35KIZ,\^)/!:WE?=; MD`J8J&\PC?:`=6>9%TZ(QV8Z6B(5//!#/4#`>3>\102'QT>.2VVHA)@D\7EY M+J\73):@2Q=+?&"GK=AWO)).I5@Z-ZQZB,CA]V';71!6&M$16"0D6.K9V+K; M[AA6K?T9;65G/W/ZR6;?/9R"'KCEM!-W/E2<&5.A3B2X,G7^@#WI==J=6D7M M->@IH?C>?)OHZ9DSY&(+QH+]!+5FAC97SC>7/F?,2\-*Q+N!P MN$M/'/42>=.43]-%>\C[-Z)E1^:WX,T]>ORKL`$)6D"0.-]4<^ M?8)W%XB%.J69K(R?,R88OP3]N5@ZN0UKXN,";56TUMYL=$0^Z5;=#4AY`Z_O MP:YD)A6J=%(7R=*+9E=(QINM9>>=H7B64G%26)E$.,5=,G;V,4C.%25NH8GY M>]9/[6N()YS$PMMG>8M;O'W$&;80B'/\T&3[:*-![7#;BP7ARG,5WN66]2^1 M11@`23K937E'$[5=\^9:?NX<8,2A&^F$ON+4`'$HP$']9+6I/106^J\T*!TR MZ&QUC&9'Q'K!#:"+LSZ=6N=$7);P#B`\7`:,R+\PQX>'O'\_1-&7KMA,='&C MW,AU'WX3P]KB^4:YQ=.M0*&T2)D45D1V;17K^.8+IKF"K%I'Z0_VYNO>V26* MP?O-A@E@\U0&.K>)W6S:9#B'Y! MT(/$4>3=EMJ;^2"/5`QL*LR[$A2M+7.7.C[SLYFSF09L#L(X"W00]P%``!\8 M'-@0.<\Z_;(6:&IB#3<@2S>ECK],$6UU3J\C=H7=E,!Z\9)5<(1]FA%;I*". MPHCX]F<<"I+#IR1.M*#FTT\[S(OK%GVJ&?A>O*,8^=\IH?DF]`54HH>V'#;[ M6;2G^H[[C?R$@&:@,&P0!8#Y'!,:%A6F/N#0247GZ,R+Q4NR`$GYT6UEE+), MT08.X9%?@JVX)8INB'IIA_D[MW:-0RCP3X>IDB\EY#&2TA`D#F:FR)08"-?KZY+A]4<] M3]',^_PF9E2.DSZ[B)HR'S>03MO-0LIYWS*0+<:1%[#/,QS>/M@X-9<.-%8<"9%YCE-NMH)R;&.[*1==YJ'<9X>O&*`HGD MK@0YQRR1L$@Z@)1,$X=WM@L^P=-Y\:FW-%..#K?(Y(="IXPZT:QH*,]G9+3@ MQY"OD8;_Q```/T"*9U#QVZ7S'[@9F\QOG3C!6/;?,"=\3M^M;$-["MXM<>M.$$/ZN.44#26UZ MD9NN<)^$.\-G+*)!7@A,,,PPA(T3`P#3WBRE85IAE$\568`=L*`;<>]G:!/, M!'"8K(T\,5,1P)I[.%J`TT3`(P`7N[>[$I.^V6DU?@_(\97/48@S80&V.XX& M/K;B$Q/J>PQ:K-!,X#K18[F:A+V'%T:;(L?$!UUY*VX*X+]Y],(+<"9%1MH@ M"=8A"YRX-%`BV:QY=L8+YCB!0!R5#LX7CI>@1R]0N@?@X+F::QI@=BNGW&WINN]`[RM^7GL\-H=1/J-X`SX(&E#`. M,?IY>>`=7^;3#J^+'>:,X.%\%)S21D%Y^,4%>9X98&!CAWX6\XI*J3\1^`L+ MSH-_-\7`MQ::0F@<9Q$E>%^+2VJ0IUGTHK+,-<;_<51+JY@-QG`F'GPA!GK@ M/@%9T3.*T3^YYD,(".5.P=*Y*4GZ)1,\64`&8XR0819FD$1)I*S,+=EF52'W' M%[Q%"V*.SAVQH5<`02:?R,/O?:7M`^M@RORV8I00[99-DAF;8[U1AHZX@B)2 MC00@N3"8#G`P/TM^2)R9GTZ.RY)TJ*C,(D?`.67&7`]'+Z)0%1$@?GUYR[@S M5LQW?.V]P4%@81SS@6G9'B<\OMFJ^'`^7\,SOR1@: M)V1R5A;NTP%6?NT!1%PG9*2"&RJ\4FY1+]!D)6.=MI'<]%S62/DYV(&V(=!'S36$.G+GR+H4IT2.EI_?!WA=4! MDJP^8_($*SA-Q>J)*>(=%@*J_18?2R_L6$<9@LCRE2KR1VR%\NOU\-WH33'N M]8_VU[8R83.J;+N.G!GCQ2$T:U=Y/;D>@JQC[!LRRBP$KXN'P')3M6H(%ZHV M-XJG&SX(#D=EYM8Y6I9I!*H+Q_'ERAI`_S+^V_MW']Z-ZHG8^`V?EHEHO/Z+ M_?[32UEQ(<"F$46&HG3!?34LL\_C2$!UI(_!RJ/XV.V2":\!C1HTZJ=([D[, MX\^9P90982)#@,J<8OII,,$LYX31M0(DL\2;62:A]+M67/FZ2PIO+$ M`Q@-^1V,RNR4/@@7/K^ MQ55""]):?9HVU[36GK&R=I*$4<#$B=,]7>O^$BN?:))M+C:'#$LF?67DQ0E( M+O(\A@`M_!YXCE#5HLX7127AKRN, MHK.H2(FA9%QN8L_U'!X#=@5Y9+4B6>D;2=\7*CP0=2]*4^R*2)V$%AK7>.8` M$6&]-3KU5OMQ$W<_(\8E3LQ'2K]&.O\84O@HJ/"A#8SDK)R\:&N,.:^M:Z[9 M=R=^0Y=D.10^^CA_I_([GZG,ZRE1WF.`A"KP>*1X6Q17-F#"IE%>_X-"!D_2 M<,E5^'?J*8FSVA=YYC'=K?#QE!H\$JZA\#$D6B(003[:30I;K?UPL]._0FZV M<#9VEUF$SN/2F683QX?W#WG@S7:3RJAL?B/FWEJEM1)VTB!F5#?.3_;:%:DC MAM&5+$3S5Y3G($Q?CS[]]0V&O'PZ%R,)^33O&UQ5/HY;H(D?AP(WY&E>?B`8 MM<-6;W42"NU@PH'FW3.!MPSA5/X=BQA$_);"9U5PD8A6:)$Z"ON.&]16_NK@ MK.+/#E+0-V6,*:2XI7SV$1AO/O_Y"Z-R#N6FG6_,,(S6HA`&3S>:LV#F8+YV M"S4950[!SDUR!7.4LHGV,Z;0U5^.LP$M.[]:^^6-"-"-G!L/P'"7*V\&8$UY M"=D.$1U$39FJ^*^M'%VG0\Q!;N8Q0QXR?!S0`^PZ\S?*(`IO@Q,NX;CQP"E] MG;T]RZ'>8X^5F]!/@3GX>W$;#?>(@39$N/%M`+% M62!?);S`X#8LM4)PT97Q8IU&W<7'F,X,GD#']T$C=4/B^= M"`33>RR$PIJ3.5A%,_",7M//;ZBI=$X5=6G,ZYSAZXK'94^G6*)$;\(S`D91 MNE!L7A-$TNZU_7%DORFR6\(J^.Q$SB)RUDOEW=_(>,FSWG$NX$K922'1*Z_. MEP19"YQ2$Y>%+34W%_@+OM[``H6NWG+(7Y=W3LKNE@.);B44ACL")O MP.3"+..8Q^YP@?78XMOFQ2\BWRDG<3HY%&>ZVRXZ]YG//%P7-3J`@9>>Y`#KNBB<)BF@3_%X/FP MHTRVOJ8?WXB<^=^=!&/U[WD1?AA1IOQ=X+:5U_PGN`X/I_3]S168N6Q6])%3 MN0&X?>`7Y/=P9Q-,1"P7#-!O$B_@`MXE<>3XXOI<&GLQ!WE+K&+)[1NA`[)% M(=3BF4Y4]&7=X`@7'KGEOB$F)+R`>Y@`1MG]*2,/)5/)&8>]]BB+%M^*JEJJ ME621.,V2:ROL"(TR@5\N:1$A.V1U/%@ZKW_Q6595@.=89D1"8>3=K<007HB6 M>,:E66E*<^.W%V:QD<P6I;6;2F= MEFK"1U7#CX9FM;JZBA\M"[ZU3/K8T5K];J?X2+=UX8)N#R[HMC2MW]+4#GXT M.U:KI](3])[6TM%,@@MZ_5;7I(\]N$W'%W=;_4X/'MAO*3VXMM7P$6'H M]3KXT53-5A=;9("`X2]#:UG]'CB)&%\&1PU;FTM:.K-7!$JVW=+R^KNT",/* M'JWU#0"J+RFS)G@_%2?**UKEU#B7U`2>MLJ+KT-^0B^67O/VFAL\&AC5B.A2 MYW>;;85'Z-"*`-4BRK:P"XBW-(#8Q%%9;I*76,]3K-R:@BJ8%5;]=E+P'66D$BHL'.WP+RY!-/X5%2I.8+TSZX"R4L1M_475U!I@+WD M_B;;#8"1GS0L*J'WAGRXRBLI.W$8<#F0G9=*WJ?$<5\E-"5!B])%LJNVR50T M]^'D)]\G=7J_,N(]%<)*>*"Z&&C\+^$MAO?HS'FN]#T<\.1B72@P")GEHKZ3 M:-WW14=NDAU`F2D5[&N8EU@X2HMRR6K5ZS>VR9!;VBYA3RC;QD.+5R.*OCM> M>?EX5(@C-_?@HJE\<&FB_44=-_SDQC[Z\R&'[#TJ=%%1MV9+Y/B';`VLC:X/ M.37(&K:;QFN4:N([[NTYO!$-0^^YAY8^WM_[`'+2<9UT$78FP'_Q,SWZ4,(/)]5L>"768$`GT%78!*=N)=$FOMJAG*I&I?Z M"`Y8P6WERQ@L7B'%X^F^,&PZ:@MN?M"M49NS9>5I&4 MU=X)XXKR*EGS.M7$U^!&G7E+)_LHS8Q53)5?OMUO6U&OG#1H77EPRDS).*Q[%63ROV.*VR#IB-X['^>SU M],U^*^>45DM3-=^E:>J_O1O9_V>_"&%X.7JZ--&(>Z)Z,;XL<+!X#OM!A5QR M>.#&(()"^SQ+PI8ZU6;G=^IA>ZK:Z5K]E]K2=E$RN`#J_X,_W)907Q!`'K(/=+>>CMW(]3C,[Q$PFTDT1`U..;,2B,1 MA:]8U9H9O6+6=']Y1D;#I-]!Y?PKG7F9N@_"HO`3KLNJ3T`SXBU2/]05/GY) M5;+*BRN./9%.K&=F&FC"3VX2DLC)7`<[`"GE@S6ZE60K*S7E=7;5F]QYS81- M#:[KB,'#*!^':@IU1D6LH=;"!&5)675:&GA1AMFI:-NRW@)EA3_O*JM*S#%; M.]>>1;\WK\.@U-N<1HM4P:&!))&R"B-6:1T_\/J\:@2-=&[9\_C[RY(%KT$8 MT&@V'@X6Z0&Q!:V7)2;>\-*,U51,V!&3B,#J]+]M1&./0T/67K/VHMU25LS' MN)(#!B;&P'$B$\;(P:>/]U(TNL8BH.!@JUPQHY2/+JNTKSO[BM^I=?U`$.+O M-&.*)NYQR+/WEA]`3%6:2_*$4`#:\!^!?;BU9)4.&,C$T2K,QM8):V/Q(3E0(V:C01' MU#T,YIUWXI.SD9_BP29_<#G)<31-DEN*,J!0D\%XOJ))'_^UQ14 M>S>3+\.EY\\B%OQ/K'S`@4E`^$-^=$K%.!I^&`[O8QA]38$[O#`2II`P&;`O M/PQN^=SD[4!^'L.VJU['#=A1?NI'O6?C3,%<%^4JJ=S;7B39(3Y MUO0TH]/I77K;JG^W/G_Z8+__Q]?K%[%;/[_[\/'3WUXN:5*#7JFY-4^+Y..5 MJT.:O4H82]5+MB@(:VZY3-D&6]B+/L5>:4QM7@8Y=SP_C4I3FK/3)';F(,,/ M*'*IF+28D+[S^'(TCL?32L_&0<3;*RL;TOP-)2NZ;$*74W0.-14Z0A?DIM]?&Z0T&-%DH[/ M_/B^]B*<*5H"4N_D2AHW:@^<-'FW!`J:_$J,9)#Z8K#['(<]8_S3P9/>?&I( MS,E(5-"9>6^O,.LQK(?&SH8>CSUDG__\B_+E\;QA\3>"'ST[T*2(- M//N;XZ?L,XN^+AUQ?!?<_87-?WTU>8?IY_\U7]'\S97CQ[^^>O=Q\DKQ9O`C M*)6KL=8=6V-+G?3USG`R''9M5>N-.EU='TS&H][P%2#6XP]+XUGVDE>_J6U5 MJZ[I#KAJ6(AQ;"&]X;@W4;O=<6=DJ;8QL;5.1RQD:/3[9U@(_1K;?&#S?\09 M._=?0$?O#F`-IJ&/!R-K:-M==2(68(STGEY:0$QO>O6;U;6XAFBK>Y>P#=$3 M0#]*1*JNJ]9@;$RTGMKI]VUK--$YZ/V).3P'Z.]X)=I=8%]9):@GP^Y8,\>& M:7>'MFH/1^9H+!"NC>U19P_49K]G$M1'8.:@/!)>XPB\@%FSK]I]4]4F`[LW M'`ST$8=WJ$_&5F\?EC40R2>&]Y\N\Q?_'--)4'#?.@Q`M-G?O?B?XFG_+#WM M`\G.@TOL#D'F&`.M`_]GZ"-M`'LRM(:J;D_LH66-?\02M7J7.)YTM;$^F8QU M=6+KH\'(-HV^8=F386?]=H=Z`3;Q&MR2--O=9Y&C4UX8=L]>;=,;:V+)[\`[:1M!" MFMX?[!4>_9.N4:]]C9W>L#,9FUUCH-MZQU+UC@IK'`R'O4G?&.[;R&ZO^^/7 M>']2-3L=6]>,R<08=6$CQVK?1%(=C'HF:&'=.K,*N#AW8O%X?UC@$ M*V.H]?8*54W5K"J.1G9GH`]ZMFEWNE;?U'L".-TP^MH.<-I#@0-/;`F.LG?# MW@68(_[(DD_S:^=[!- M8$ST]^SV(7`>!_=DQ#?_&."3H:9:^F`\[/:[F@WR5>L+&\XV^Y-!=P=P8-X] MO'@"P(WC@.NVK8VT/MAB8VNB=_O#GBIHP[8'EF[N``XRIG,"P.V$'Y")Y5+7 MX<OC@0_*K>Z^NP%$TUK;XVRLE)[>GJ]N+NMZ;[@'KB M==]!C?V1;70&FC:Q>_WAV`97;:3E;*0-QI>X[GM(#Z3=R:#7`V_#&H[`'C<' MPXP)P0;88<*K/3;-61;_+CL'Y#.VPH7!28A`!/>$T728]9P9@3=(1VZ6F\`6E'O#/N=X0CUBYV)OL$8?+8GBKYF(^@>[-0= M#8<6>+2=06?2U0VPCSL#@9]QIZ_MXL?0?SP!A4D18SU,$87!H6H=VQP9W7Y' MLWH30S.'0D,,C=ZX;[_Z;:NLETW M7:5\%85UZ_#^/XS:-+LIIPHN7UDF=>R6'A98BT7K>R7D^L%Y.: M;W@2E(\:=)<.->]Z`9X=1"/-LJ.?-JWRKU@MD0;@`_D4D*74*W\>@R?";7Q$ M&I6-Q\Q-Q1F!KN_$L:B]C14'\QYXR=4\C*XP1=2ZX\&EH0;!DJ?39/WN:H%!6M^'?YH0&>"^3O MHC]_,*=_E_F^N.;75V"MX]_QVG&SOQ\NDV^]6;*$C["F*15A7-'Y[^N8O4#QZ M[]-*-Y[YOOZ%P/G8^X#2+P/01]]G7@J@C[WO8@!M]@X>DEC[RT6X1OVEH@'T M+>U:_EMHX/)7-"^#OKD3S)+.P:HY-&3>+KT9Z)EZ^P[N-X:MBFR)G^/XR<$U M7AW'E5#.F:VV_J[$(8X@RRKG3H#+/?@K60(N%2S7BL'/W$^XKU%V6F#>9\Z* MI'9)[:<@L(_@H?R1NZ?-(/K?N8_\7OC(DRA<-0.P#T4,X&L>`Y"<*3GS97)F M,V!"\:#\A4)FDA4E*YZ$Q'CHM1GT/A21VF9`AM=%W&YO,? M(,RV\S9U(G3`$W5YEU@AW$2[F%:7$F@00ANG'6K7G@>1+=0+)29W=$M3B/)/ M9Z.Y8R@\`::(7&M%U6NK;9X-6P6W_2#\U4YI]]8A4KI)Z2:EV[FEF];NG1Q9 M%T$S>-^#A\5)\27%EQ1?/U!\]=I=*;ZD^)+BJT&D*,77_7W+3EF.M/IC$9\\-K7>H/J3\DO]P7 M'4:_W9$*1#*$9(@L]:Y+AJ@ED-&@X.T/+235SQ9JD_+H;GE4*Q+O'ZX\NQFL MJ>WS53"_X!BO9%K)M'4AT6R?7E==VH"73"F9\OZ:M--6I2:5FE0R[04Q MK=X]0P6]9%K)M))I:\S\]\]0-RZ95M8ER;JD'R_33C#NX\_"[4OH96[WFX/.%YQ3D`)4"E`I0"]/@&I&M\9A$(_&YT70W:F=6RDC MI8R4,K)Y,O*U46<)J+0RI94I)6CSB5)*T!HEJ'JJ5(@4H%*`2@':2**4`K0^ M7/;-)EB@%T%V3_722PFWG^G$WGW7GPVP$M)\+V!72T;"5-/5GWX\UB1PIP#N M_B?)E9Y242\JR#5ZBA>`YN1_EU\3A-'*\2O24<-K\@?SDZI=YOOBFE]?J:_H M;V!J-_M[#Z*NO16+E8_L5OD2KIP=I;URHH47<""=-`FS+[B%0-_<>K-D^=;J MJX5L!EGB.^N8O^L:[I%E)VC@GA[(NSL%7%4&BUNM MQ]ZHF9VSO_/1;^ST'WNG*1=Y$E@;O\@+Z4*Z+#=$XD?B1^*GGOI*36MVQ;(P M#K=@@V>7<-%_'`KSVWYWO"#FQPZS^(WRA;F^$\?>W&,SY5.:*.%4DZ9,N M@HZ65BJG.BO\0.5'^(05797OU8\H;M_'=_=VNW<\BZ9 M`B!!$CFN3+"#9&JK\3_=BK>- MPJ+$"H*?6-W-("@`I`*0`N#`!P+>_IVMZ;?O_7.3`PYWQ M^\4R+MU+OXZ8$Z?11HF`F:C*W]2`^^05@['?V]PY0QBQ/E M-?N^9D',Y,2`1F1+3H'$)R1,GDIFKXT:YWS4.L:C&6PHN:X17->D'.6364ZK M87[CO1`B^4WRF^2W$SA_S[XHX$):&HZ@L'&%)%+N-`T_IW3>J'4R<;XK4Q:P MN7<"-T[24V,/UGDJ^=1X1,)S44B2&UXL-X"_5!L[2,](LLIS9A5=LLI#6$5V M1MV[,\JY<3P?APQ>SYLF.*5EWWF3$-099DN(D MQ4F*DQ0G>VMJM5R^,'CL?]A,\7@$CFR8-TH8\/8('!VUUVJ1OM6)!=YSZ[S) MRW.<`(GM!CYB99B@NY82L$32E/37[_+7:SS*\27XZY)57BZK:.U[#[R1K")9 MY06S2HTG#SV7].&CZED:Y)U?4J%+@]#6.)%S*8@[9VG,,T1?X^CNQ?4UZ.W: MYG(^^V)/R5B2L>[-6&I];IAD+,E8DK$*QJHM%/CL&>N)6:X+-Z&OP\3QE2@_ MV`"2XPK660Z(6ELYH7!9"D,/LGQ\Z<_[KLQTV?NC<`??)3\ M4Q'6K]'@OO,<^9=P7+R47%)R20E^HH'[<-<7-O_UU62$AP?^K_F/Z]$KQ9O!%XZ; M7*E&?S`>=(>C?M?4[,G8''<[O5&GJ^M#=3#N::]^V\)]&8_7WHK%RD=VJWP) M5\YAF5BZW?<"=K5D)((U7?UIFV_@QJHLHB]*&_ZO-$Z\^::N/>=_XN5OO03> MX/(G59"*L2:.5`6QNMOX]429?_33T(F7+3JN2V'_3KT;QZ>C@;$:=V^!M^)$ M3)E[@1.XGN,K7A`G4+;RM^9*`-6PC3"LQU8''/XUI$'(,'"\5SC%7#.1H"HS--@%K>4 M/]I?VTH^;[*`6?RR0!T;(*Q7\1J/1(;7*LZ"!>X#+_XP^-I2@'6OMJYL91<@ M]KZFZ\@):(V`I_+S%WXXA:_<,%J'-!1SQJ9)!<5PNQ/'L#`,0,-[2[^]_LJ8 M@NQ:;&'G35M!M"V=&Z8`XF#'O'@)MRU2;\:0(V(E8CZ``K\#_H%=6%3$.\5> M)]D;X(J5XP4)_%>)G3E+^'I\#\@#MFD#*%ZRF)6?CC01L1N/W<);UT"3X0SE MM[\1S]XH4P8[-H-WP@7P@L3YQA1G=N/`:Q:,@JT1@SW$G=UXS)_%HAY<%(X!4LG6CDN["9M5L3F0+ZM8X_QG0CV0=P' MSUI2YZKCNF$*2X7;%2>[)HPROL6E$`O`>V=(`2X#`3+U!0D'I4,U@#I8D.ZG M7ZT/!$Q]``6[4),)DE6!C!6^8^;!6Q*?Y,@RC-;Y8 M0@MN`ZD#P-XN/7>)"!^G4;AF]/""=97P-D`&A_LY&WT',8;G6,/V>+!ASH:N M`AA7M&NX5OA[0R=>+X"A^$8RV(1PY;D`-HBM%%Z1$*\0&J-L#QL'ZLU@F@7UOY24Q`092`@/#!,0&!SX@0T.I* MYJF?44>98*=.##@+@](2E*-K6`(AAA$*BQS':R=!B'$-"P02;BHH"][@(R1\ MJT':L@ANS=$._\(K@88JZ%F#F>BY*(VRWFOX$9:R$AKH"+C%QL$E*V#@&_%J M(.P;CP!!WD"=H]QZ>"-H/:"SXKY;Y#^\>T-[CV]*?8';'!$7+]H$'9-^R%R.IT^%/I#M=,!T\XDL7 M7`P1%L-C]PJ3A-@6_'JEUFL9$#FWE$]%N%"&59M^B M6F.^$.0QR^\&<)+-6FA!0,JN["^+,N`@>/F:+MX12H!*DNVA[\-?):F7BS30 MW4'Q/-3*-\34'KE18#U%M#'`61Y*![Z2'!#\-8V%8@9*1CDP9U>@?.`S"W"O M0%\`A0LDW@(7PBL86A/`O]NH8`%7`4#CK("&FP(@PO^=(N7'Z7KMDUS.P&@K M'X2DQNT(TP0,F8`(92_WD\7ATTX"V"5K#6W!,IIV068'GY@QIH_:%+#M)AY< MTU:^@EP$[>=O6M4G.6AZ)BCFN<)"!')YGS$VT++O5[ACRBK/OFC&OR[$)F)Y M#\-G0O'K&KBRI;R#'0$D?@89FRZ`,O&NWR,&VP'2'BY&)G&0D5V4J+CY'+$^ MX-L7YE)8T:>DXT#9PM91MVHK-SG+2.<7B)^SQ[/,_()'1&B&@NNS`,F#)`BT MJ\"JT$Z-N<]"6U;HO(*$.#XZ]",'31 M=XH8YPQGM?TJ/D&D1.Q'!02]#=?']1]Z$2B6B0_IT9QWGNINBLJ8+,Y"83+# M[+5-!>[R@0AJ\6<5X+41(&(U!@YC\GLFFLRVTUZE[%X5X/]]6U4^()78\MFN&<@N2 M;$$Z%$UZ!PU-1AX#*&)@]5DJ1`?[#B(@Y2KZJ''#)26:%F2HLYD0FF"2*T&8 M<%GHH"\/T*.`(2ZO&M"E!Y&=G[OZ0EVC=."6!/+6*@VR*`$999EL*2FXHR*N M<#5`32VYF2T,*#*B!1[V*>2R>R1D.%[#,C\AYL)PR[_BXM_U0:9N.51K>&Q, M#DSF:#B),`86W,8L&5ZD;]K*Y\JK*FO>Y]?A'@@HR0F")Z=@-G!3]B:3R#&[ M(:<%@$N6,3["!]7I.^L838ODEH$O&T'FCS@H9\$8)\?W#J\7OSU(^60HP@;$WHR1>EH*:A/D39;O+O63WU"R M:[GU0Y&/JI6;*WXTI.&=\$?A3"*A%#22,<$,:3I<PP6(2(6C:'V^"MTPU] MG3MG?P14;YG__0$D9.*`KT`_T+.J<:'\@DD:<`3QY9?];913(E3%[1X`W7.] MW*,K'`L2KQ5Y0^Q5EAH9Y(`!#VZZ\68IA6[SJ$`!`H\4<9YY(A@DR%&:X*QC M>`_\,*O(!#Y1#O?_%JB;787SN7@E6+IKBKES79*Y&D7`;H\%NU>>P?]G9C,7 M!U[)HY]YP5T[(*%ZLM!O:EOM=XYL0@FW3]D% MXP7M@@4[,#+MOCJ::(->1S4-.^W^MK`QW$2&]H=K6>:IN&+G!O MZKWQ9#_N]RM!7=[*A3_CHL;OI0/3I#.\?H(;#"`EK(0?*5D M!&W^.?Q+>5U75FEAO:&NCU5+-X"@!H..W>EW;;4W&1I:U^YH0[.TL#2>O?I- M,SL4JJ@L;!?<[17%R:?Y[V$XB[^&_NP0]QX$TC`F/7L$2._IZLBR.T---3GV M;;L+/VX#J??[V@Z4%1`>")]Q'+YNMS>TP2X8CDP0=MV)#7S)X>L/^[U.?QL^ MPU3-NN`K&/`@>)..T5.-4@.34;MYC`&XQU0QML@V?J5O^AX,5V,!OS M\TSB!^-O,AS:(-2T7L_H6MW1>#CN3@3^[-&@8^T`V.E9ZAX(RT`\`,1[H+#? M[YN#CFZB!=@?P?^/55M`:*A];8=-#`-NJ`_"^S")JHW-D=&=F)8Z5OOJT!BI M@@@'D\E@L$N$W8YJ/`Q$'O":L!F&?:Z=[^*R@3C0YL%L;0V'@ZYE]4&`]GO# MSH@8A]AZH!D3=4?VJ)JU#?!QD!X/_SUHHM?KF0#_:&*,!R/-'FJZD='$0-=& MQB[X:N]0-,&0VNH:UI_:`RM79JV]!W9_QCX M0PH)/QW^R6@\LKKC06>H]GL#:S#HFK:`'[1"W]Z&OV/N*(7C$#T1_#NH7Q^/ M-+#@QJ8&,D_7NEW=R)2:J8.6VP;?LG8$RJG`OP?Q=X%&C'YGW+=&EMK3=:O3 M%3JEWYD,+'T'>N,0[3\$>JHK`_GT/G1K8.`)6#A@U`'Y]_O&`#R;H2V,NCXP MMC':%>KZ_C4EW.]T=/79E:`=(ZR%K&;%I,O)BS+>D M45%!?H_"\/X$G(*!-M8GYJAK6B/8`J$&!OJ@;W1?1&'X+8=G"K8A?Q#B\U)S M*@=*W;^RP`LC*OG<93YH>W>?V=ZT31!B/O-XZ?LKPL M,>:08O8B/IS:/4&Y!/)'364$P>Q$`.Y.`7L,@,PY7Z>Z?MW&/,"\'RZZNN_M.=[5'51BUQHW;N M^\[^PN>YP`LYE?BR>F(E?AYPU$REEW.W6_,$N#S>YXDQ91;5BL&]6EW2EJ2M M>FCKWF-9G_'([J?CL6U:ZD]5RQ\KL@"_5EV\VR!4-HZI:Q=Z!Y%]$<,!ZALO M<1?-_>"Q$D]'E:49]1W1>]E4@_?)Z;I2@#6`%*4`N[\`T\\Q`?PBJ.:I`NQ" MPAFG1*'6[JL'#-G:1L=)<=_8DZZ>C@ZSWZ_/GFH*5YS:,I(<\8PYPE+5=D=R MA`PFW3^89!S2P3WIBS5(%#7EI).GX\D`K5W;&97/_K03R5R2N1Z,IYZNZ:>G ML.?"8M(5_\5H]P_DE/3:1+442,_8\3![IG0\)$=(CJ@$I^11[-(5?X`.U@_I MX-,?9RQ%T4OT%OI6ISZM_>S]!,EDMYLJ:HN#\R6;O@#;,:V>B`:K\NR M;.ETW(V.3K]3WTGB3>$*Z89+CG@B.FH-B#\7OI#.^)%"BG;W@"8V3Y^[E`+I M)?H+NMF7SKATQB5SG8JY3M\=]UR82[KB8``$UM='?!=NGW^CL=G2P'RJSV%[-$8O@O)D+$5*R4NA52DE:PQJM;I= MK;Y\KY22][71?Z9!J_NN/QM@):0U;:@RW6=?XBSB%HU:GCM>Q,(AFL6.ZLF(.SDFG M(V;%P>A;2"I?L?18Y$3N+([LOL43C..4S@I5$!9QMN?9]EYK M6ZI:[]ZO(R]PO77ES.5*N)N.@@7<`M'#3^]0:5*RY/MA6YD>P&?^%Z<8,[] M2V0BS,N=;M_,?-_,\KZ!71`N^$'3=&!QES6!#@=Q1ZULJ.S/3#:-BU:#I+9S(OI0$@\F7W*4($#HX++A\>*X"'9 MA0'CX9AG%O,CL(,8+-X;<9HZ'N(=SI1Y%*Z(#.D$^&0)[M]BB:=;IP#;IJU\ MF@.MXQM`"VOSFCA:2WK7H%'IWD/64LP*.^T<,EY-')YSE" MQ*KYH=Y#,)C0]770E![PP]&5KTO&Q`'J>);+`[KXL(THPD"D.1$M=L*F4>I$ MF\)/T"Q:(3>:*U\SQUTJ&[@3EK[P@@#7L^_^%LI`,R?A0L?`^^@9""$"B)(: MP)FGOH^",3O"/N.#?(T*[L,=IZ@S/6S%'P#H!C*9L3E@ M84:[#6_\QJ[X4US?28$8V;^!&(A\73?BSM!,28.UX\T*HES[*==U8"W`!D3G M-`ZTVFPZ@=!]ED[!+:#>RUL2<@:,TU5Q.SG6I3.;\%MPE1V/^"!VEVR6^G`O M(+6! M2V;A;;"(G!G+7D\"C$#'\Z6\X`9>1;X[746^[BV(4;ZT?Z>>,&1"%/3X(6+K M%#Q\)V8E5!`]Y=]S:B)RP3O.M_U:K=L/M`8R6"#JPC5&9Q&G,0AAE\NR-)@! M]J=A%(6WQ(%1A#O/:0;!V/],%LW#:*7$#C`Q7<5@>S",JR1P?^RXB,$8B2#T M;\C13Z,,A`L/X8SHD&Q4*CK1-!UH0;(-$)-$%+/:M=*\<--+;BF(3.V=A4`6CGSR8C^_.ET"[(!BMBEMT9#UH77`Y_DIS=6%P/Z M.F9)XFSPGM00`G%<$\">F%LUJ]VK=D8LUO_B? M>'GE4%UP3E[#N]'(JJB0Q[FL,& M]I#PO5T.Y5Q`J;S>`OL-=SF!QF^\&?E<6W>*THPB45=?>NY450@M$1*Y)=>/ MFY%T7R&K=A1/HYZ\CSR>.;V<&3/$5KR*B7H4L+EO=2%JMX\N;V`U].4R"V`)=R@!0B&(M[G!/5L&\BX>O:*W#-2[$&0KMXH MZ1I7BL%MT!/IZJ2\TK7J);S23BLV09NG!7A@D'O+?[2_MI49'LL>Q>3(W8;1 M-Y(2SAJE9"O[P/TTV%>00SR.$E**&U3-.B2]N$[A4XS>V?4>(A`NH(]>:W3# M_7:,+0*.?>_?J3?#BQ``GAO;UJ=9+#.NK&O+AS]!`KFV:L$3F%`9@+L#/Q\G M7'$_62U&"3TP"&L*KY<,K5),F_RT9)_`J26D=ZH$W0Y?A*3L@1_FSSGW].XZN%XZS?CM@T&7FQZX=8CWH-.S_`DKV M8^E!_+97"AC^X,_X,8#TZ?<.VM(DV-CIZO]NU M5=/N6ZK=?046IL?7DL:S5[]U5?&?MEK%USY4G!%A6!-91IC6.Q'"!H9IZI.1 M,>ZI0[,[GE@3>]0;=;JZ;@\[0U/;1IC94(317(HRQLQ3D9@YT31L7ICK:^I>G=DF(8U-O0A7^P0%F^/MQ>K6<5J MU2>N-RO%^0(FU]<$@Q=B?YT%NRPF&_4&NMKO:/I0TP>:UK,U2V"QWQUTNF4F M`VL<'_4;X$\W#F/P&&Y^*$[/)NE[ZL#H3BS+&/1U6QV,Q]:@#Y*^W[4[MCGL M6_MQ:EX<0L\GV#2@24WM:N-QQ^Z"D=B9Z+;@]=%0[8_W8]32K1^&TPDB5?]? M\V%,;UH5IK=.A,[NJ#,QQK:J3ZSQR!JI71"9@NDUV[:'!YC>_,'H-!Z&SO.1 MISKN3:Q1KVL:)AATMC:P)X-^%YA]TC,Z:K?W/,CSC.P.XG,\Z-E@**N#4;^O M#WH6XK.G6B98SI.&XO.!]'DV=M>M81^$I]8SK)%I=*V!JG4$NW=,S6PJNS^0 M//%L\@HZNZ=RY$9=0-P`R%$;=BUU,IF8$T&=D]YD>$`9:?V+PN;Y#-!AU[:& M6F^H=2:J/K2-D=WK=_N#[M#HC75C=-``O2ATGLWV'*C#@38R[$G?Z'5,=0@F MO,Z)LZ.I=J?;--OS<8J]6]5#ZHF0.=3&0Q6\:%4U35,#66D;%M?KW9&MF^H! M/=2]*-+$@R0KI'DJ;/9-D(ZZVNL##L$WZG7!AL^LSAX8HONQ:?2M'\SJ#Z3. M\^%3U3M@$$U`L]M#RS;-KJUQ?/9L>SSL/QM\ZE5\ZB?"YV34&PV`#KOV2!M9 M0WMLF7U!GR:H^@-6O*%?&#[/IHJ&@,_AV!AUC'Y''0ZMB:4/A5>DZ597?PZJ MZ&Q&YVBBJ<9XT.WUQN.Q/AP/34T$P_NZ-NDR0-K>E>GM%5Y60^$L/8%ZD<6.)D,^V/=''1`WHQ']G`$NY8E MYGJ6W=]>8+_?O/6AWB+^W_H=ZS!_UAQY[8IFH/ M>F"GB1S[9&*IG9VB!*/;N+W27\A>33I@^/5Z>G\PF8R'FCX99GPUT,;F>(>O MK'[OG'O52%:B%Z,NN@9=]"Y`>>_=L,^^$]R![+ZA@1=H=#J6-AAHAC4<#C)[ MNS_IC$;;R-9[_045E?6;ACH93'0+ MQ`"HIZYI#4:J(#8#!+FUJZ6L`^L_LIH#RP\CYBT"V*UPQ:Z=[V/>FRCVO((! M-#PT,CP.+J0[[`]'5G>D:=UQ5]74\:`CN,8>=&Q-WU[(E=;K'%K)4<">O)B2 M&75P-59W:`RZNJ9U>CUK8@^&X!<.K2%\T0EY[TA^,=\J5KKI:C8OYW?&"]T"$GP(L0`30O2`E)OTTGSA> M]#?L0?H+#7BXPZN-O!NJ$2T9FE[\K1`_^*(OO+D^";_FG93A_.NMLQZ&H@&2 M]R0(N3`!B!S_'\R)[F!3NS_25-L>#ZQN?V0,;5OM`RIM"_S>)>'L@3V>F(8VQ(BH.C1''5"I(]L`\6#T MM5T)9^B'J._'H4[_,:@#CNV-S*$]M'1MH*FZ;7='NFY-1L.QI9KCR8YRM`Y) MH2>BKB8=,=$T,'9'/?"VU8YN:G9_8`A!--1U8V<]5[V#;/0@$527()T8EF7J MU@`\Q>'0`'?+LH4@'9C&8-S;D0*J>LCE.@W\=VBUWF`$)I5N#H<]>Z)K1A]4 ML*A;U0:3[DZE[Y5N=@XIZ0[0#M-X]Y#I5H7@\`)IVW',P&*H4/S#H!X-.ITQ:$#;ULS) MV.[8_;&-=J0ZGDRZ0]7>A?H`T`>@>2+HQPADW#$[(WW<,VAF;M^@,[",G1A#USS$?@\"]5WP&8??Q#$8)PRGT8/+ M/\*Y]N%Z]7!Y!Y::.;'LOFI8IJ79@T$O"T!VL(QXQ[([Z%?<%[ZZ5W>4=2=# M=3P"@W\\&-J3/FA,HR=8=PC_NT/_G9,O#MN)PVCSL$U21VJWWP=9:7<&XVZO MUQ\;XVR3-'-7YW?N9.,61?`6=3(8_%']D!JL=3^`*Q5\'-4D/&F#II5,/00J,?:D3U777`<[P*\ M"M`3H3]*)&"V6/V^-AX.^W9_`@Z&(0K5PA>4['B0T?58MW;:DBSC8.2L#,1CP#Q&%P.[;UGV8`*+`;P:H)E& M$Z&3U$%GN&.V='JB>>JI8#[*@C4'7=M0_W_VKKRY<=S*?Q66D\PF56X/;A+= M-:DB0'!W4LGT[$Q/3>5/6J)M);+HI2B[G4^_#R"IP]!M29;KS6+*=CBDI36=@*0=(XCQ2&-( M>#$/FP08"O^8^#4=653=[V!,#6#&!A*16$':CD44VYEX$@LB:1/Y"1&,^9W" M127>+!7;4;J\>#:Q,6&*#**2Q6JRQ#9!D8X]1A.QJ(^U.:5VGJO,[_+!L/>8 M_WWS(BD.#8ZD$#)&BC`=05VO5!(:F40&2:_R"/%*OS.?K!V-96D5!=2;.#$8 M*:V`1LH,;OM9-/4G-A8W7%XW%OA0(UV\PAU!X*5`>)A$#&N:I&"ZJ'%'5!GD M[RE?&7GG4[6CH2P3"VA7:)(4*PAJBI`()ZS='H\,2;ULDJV,#]L.I?VMZ5'. M3%L/NNWL]F0B?/H".Y&ZH?\B49C$(>(1YR)D3#`]KEPX2CS_A2.Z4A]W,(BW M8-,R];"+/R,<&?`VB-'$"!ZV@`)"8>VI!P;7?XQLLE6\!7>"I\<6]1Y&ND4H M05JGD'*3F,:$0=J!5"3:IA5+?;O'>'7EM3ZM>QSTTMPKLGO0TE@(.U&:IB3B MI+&4,#'*:XO"F+>PE"T'_=N@S+.^Q?;]NT-P_SSX4F9NP4Q]Y$`OW]`?)N#. M0TTXP:%.I2(*CZLJ%D)!N$686H/&?8QRF4Q-G+(D5#@DH,"8I4)%N)$I`PYX M?9O]#L_.:-:VW^\73\V!1!OU<[1)./PWYA#(TCB-29N+4KLNS,M%5[>2?9)V M,(:EZ9%*N$5MB4T(Q69L-(_"UM&&6'IC8'AE/KW!&!HCM)#POU9%Y]^?W8K@ MH?EJL>XLE.6FLY<)4[:O%H8*V<48Q,1VGPL(@PAJ9I=K-VMREE0WJZA;.*RI MKM:&W7+;'XP4%XA2B4T=LLG_V^:3,.J215*C)0L",%J8INYSNE`9G,62'!E_0[MR-Y[QQ8IH<< M,C@1(H44Y3J-0"41&D]"@DWY'!`+U^7OE0-;-RZ-@6@>@;8BS#&)P!.WC7>E M3.+YL0BQ14MV%Q'T6O*7R2=.5$BA0%,QXI!J,PUQO@7I@.+#FZC!""^;8=J: M_BU*!:T$\>9;Y9(T\B4EKR!Y:1I%(+(SE8H$2#EUV(7H'=F/\;];:9Z$9VO134J<)HA2!EEYBV M?::("&\4F*X7N!>2M^.Q+4]T(YD8+B,L11ISB4S,FT0W,CKQIWP.,+3?!MW> ML"I[UZ-JO.;89*4]&'##>(04I`")1BR*I39&*,5I.XG/5>AY8XK%DCQ^31)W M/\2E#BV$M)[%"I0R#9F(H92.;>*CE83$F/F5RN&&V!9Q=O7IZPM,J:5,F,8) M3])(A3A,F>V00DQ-$=;4!W9=UKG>B,Z5HWW^J8`7MX>UU;B6GV_L@]O?YMTT MP^"6LY]O&E;_.KH>]KJ]K%R+46(ZL[13XRFX*'!23*A81M%X=@*QV)L1%9C( M-9*P?0_2X[(]-<\MFK8WV]VDX$MLIVY"Q*8+D&'\FL#_:`BN`.HN+!5KUY)R M([STE*`Y`6DU6:\=R3K5<*K`APG#H!Z&LIV"!3#<#H5P?\D&G3?7=Z"AK%A6 MG2@E!9$DQI0J`F.@N)DO4(@IXT];SDML-A_*`RANKS[09B"T6,MI(Q;RY2_[WH^/M.7N&)/240-9`DX3KE.&$,<,CX!J5!D4L@`B5]$ M@(_T)+$.O]]>1E,A_A0%I:,DLML/=<@32,_!$>H0!)5`XLID)+U"E7#?P1^S MH/0Q6!)HR^1TV)7[PD/E"J4(*V&GKG1,&LLAX2S.TH):]BR./=H+XHF6"E,4 M:\VI(").3",>R@3UUP'."3&'$Q#Y]@0$`M$10Z$Q("HE1"*X/5D@2K4U)^QW M4>8L[SIF`;V'[`!)B#<))`72S1;&##(">_H#HH8:3OV)'^HO;#MF&1V%$6T2 M=`Q7.B(\23%+P&ID&$'%"@()521C[:_(IG/V;QRS0'9A-#.H6T_9PP'-Q6#% M$L:U-)"J@R->O]:967E^/*"T>Z%`V"9A5!(X4%[8/V$V1&)-#!9 M,:V`U0@\3T)"P>SR,4PUO?CKS_R?GQ5(<1>"G.3=:T01QJ9&D-4NQP5!HOT>6 M[MO\TQ!QFC",8B8)CD*BL6AXB@UC8G?FK[/AW2]Y)X>/W<^#.9`@DX;7J00J MG@AD(I-P',8F(BB)M4H330A+9*Q2K^LS9U'&$NZ\BI&;:.7;,S(F7$*\$2&+ M[99/9%<^:<&$5B84,O829$(65YD;<'*<&5@,MIF&@X>8L\!H`?<7L_1MA/!N&I<0]:2DD62A9D8(0IF=IU6) ME9!.4V^!$%MQ"N,]=/.PQ$HB05,M*3$AIUPV,Q:0.:?^3FV!%D\A'9M\ MCL)87I5)"A(Q;2`C9U@*@Y!0[7Q%PF/JK7H0>4_OJYPPCB1/O=K^JPDC`B7"=2ZICJ&!O(_.VD4:RB MT.C("_B4+^ZQOCOA',Y$"$>*&25%RD/%-&.4NGDAQBFF%'NH`6_EJDYQ`F(3 M.2@=2X*13DQJ&$O3F*+(R4%2G];HO1TPN![2.:! MU6FBW8DV4&TA);G=9@=*ADU,((/Q(B$Z'?D<19JR4>5K<6@1(BJB(D0LHDJX M>$@3GDBF?(B3.4#6QRJ,MX^(KS&31$MBSVU)+(AD&&FB4.S,)#(RC?W-#WOW MQ?M8I7?B'6(A(P@J..$B"2.)F$["L.D;B7A.Z1NQ#=.8E4LGMI#4XA75R.XG MD1$E)(;/AD84MT=&IE+X/4G!-G0&^QC.R2K>)FXZ88C81G:(38(,U"\X;IK> MD4[8'$"\Z`@4[:WFC=[.9Z<"*DJ(H$0J,'7%M1"\$1.S\ZH^2.J&?>2=BVGK M%.?$#(@+"_9NM#V[%6I.S91V]69HC,$<>94-F;/G\BR9@]2@F+`X"15"6E(: MZR1&]5)$V_]'H0^>>8*2>@>N+D$A3R/JCC\G',6I8O?Y,/@I?PI^*>ZSP2?WMV'O/_E'C!ZJ M3Q??W5:?7MS>[PWR#W?@/>ZJCYB@/WUZR+IV`_J'ZZ*JBGM[X]?Q;U7Q4/]@ M!_$AZX,F?OS7:%CU;IX7OLO^/H_6W@",JE>]O,]]?:KIN2[ZW?I!$Z8'4UP/ MLD$W:/@>3!AOW_J]?4Y+PO\O-FU?AETLN%=<-,O MGNIQWX#.!H]6:8=!<1-D-5R0_4M_&GDK&P37>="[?P#ERKO!]3,\8M2I:B"U M8=`;!#=U\`CR)GH$)7B7^DF]QE75/UT%OP--ELUY_SD`_;)G1(-K;)YNJ9C[ M+/]1P7WQ6!]"!O>7Q>CV+BAJK.=BD/6#^SP;U`2T?[5O&0US^XK'K.P5HV%P MXXZ<[,'EO8E&7,*7YH11=Z7,[(L]LRSR<*.COR(7C\R?U7IZJK]5=[^<=>!6_H+##< M)C,)=,M"&PZ#?SC=L2PZU?&[^\`<[++>"OX?9+[NYU\?G/MO3,7!XSR4Q6V9 MW0=5$=R#A=Y:E9@UH<>B#TKK`N)BXP0]O1E5]MF>CD[^KP[2HAEG?>O$O!7CQNQX,#![2@]== M_RMW7MT-ZLZME,Z`]K+5&T<,/!C>;A^S^AT3XL`&6I!Y35%PY`UC8.Y'GP#(I;1Z$F^%C"LD'5Z_0>W,N= MOML(50PFUO=00DR`"]KGKN'6G<(#N=G0!:3^LW_/PZBJS0?^W(2.T]5ZWYO/ M=]Y-81F,#[3]Z(UX&WO[+KM_^/0'+-#4I]_K@+^&K$"S:IT=@JKU;GJ=:5V= MTH@UW-9EJUBS^5F'E&_2^4ZL MN_9!-T6_5TPS>;DJ@'^NP.-`$F;QM*II;SOM*9:$31":/3O7.GOG4N?XZ_%= MLX[[TOJ:>\A/P6&`\`J+&`/OL[FUA3BSRO08*'TT,? M3B%6@1^_6V(?;;R:,*<85<,*GFQ_!>^:\:=HE^4'_]0+W>N MY6B+VYUX!\<-VPT([C*(+^,#C(.N"Y9-J%C[52MJY-F13#G&05'>9_V9-+?Y MR1E$-^\4=0$#/P_RFG0JH-(95'=^2;H-(YS$U_.)=5[0=HILN3/6[]I9.AV[ MM`9CW1D,P#(TO[EI$X%L\`Q)2XM-%SAC"B#3Z3M(=)NAP'WW[CUE;LVT=D9% M@](Y=82)KIVF'H3LJ^P_VQ_=D%XX^\P-9NJI5T$\L`Y\/,I!/FQ'LAY7 M>\,Y@VV'U]CK7RXA8ZFN@G3UXW)7&+H"L9A$L:G@-=,':-W!$]Q3UZ_]NA

5)]#P%FYZ*^GNAE.R$4C_#63>8KM%\:V-K/[^I/HYC:P\4>U!_GWYHXVV\ M>#Q^<%67%WF_WUSSPP6Z<-^'4)"TWS=WB4^];G4''V%,UT4)1O>A8ZN1AV'^ ML?TPG138P4P158X_6=VWI`Q^N)`700G*ZS[C\;7?5]W)QW+N$QPM/UR$Y$\S M3Y@\>>[3)C?B0]]W\!>^SP$NTH=&FQ\A9;:E8Z."=?[Z:<:\R(M<=OI[D^]. M_U0ZF[._K"1SRJ!?FL%>F^)+'.BTCYKE_I$QK`!";%;R\:[7!:^WTTIB*_Z, MR0TOEO.J<85MJ?3P-1A"I=(-VC"T#2_G>L7YZM5QV<-.^?53T10G-;SNNDS[ MMDWS9?)?9Z6]M@)XV4)9GDZ<374K4Z5O8*H^+YNWN+S,>\7;6O;&?% M.X#B^678+N/(==;Y]VT)X:K[H:D".YT<*OSW$V#=UT& MG7Z>E3]!L46$X94\&\2Y:[0N M;W4VR+KGGM%1.I^=,O%-O=(AFQW'8EGG?L;9Q`YH8IBRW:7"[]ZXSM7V)S,J MBW-)<2XI5K*#7E(<7:T]1_NM5!5GF_B&;4(*>;6SY3+OQ2+.=?9BWOXM@_?: M/23_S`?G"N"(7,_[J0`XEP>8C#L6@SJ7UV?C.J!Q$2IVEP*_>^,ZE]>?OA15 MUC_7$COS.1LLHJ8/7X-N,;(['5^SBOHDEIWL;JG2NBP\^25+[!)S<14>C'$G MH4?G;LC9@YT]V(EX,'S)"-G=.H^S!WN1LW[O8!+F77\PPDX`@JE3#(8]T(L7 M@'86<*UX&C38G/:RD=TS]F#/:,^'_Q5TRKS;JX+2@CP6\P`%ZYO&,#46SJ3? MM__:/[1`P'!=GG7N`OO89XN,DG_-.Z,*"+$P1M=]"YOH,%[<9MN99]JW9@/X M[VT!'`NNLV'/`K\X%*73@TFYG&%H%PQS4%3!?08L[SE8N@9]RN=S"]FW'(+F MY)'"LOZP6!*6X'#AAI6XRV&G[)X8M5O?O<`3'!OPVL9.5P MA>:1-#.(,5A=@W18YOVLP5I<`5"W`9347?:8.[6[SO/!"U"I:2BIK-.!2`(/ M[S_7\%&SP**@G%,:6N-&C;G8N`H-?+;AQSW^UPK^J5%T80`_UBA+RU&76MRH M!J>]@8ZJ@=*RV]LR=W"K@Q;F(',P!ZU76L@*B]PV->RU@=5.Q\V<#AI3C7ZU M6PH7P[?],0JC*Q[`H\"G^#,[V[+Z^_?@Y&%J/T/\X+!7:[>)7?/M=( MO+W!8]%_!%\,[+ZS#Q^5X)V'X,WZ16<:C=*BVC8XZ%91L^`)QE"!WW]QW13J M[03KUT8`FPXZ=,VI\&#C3TU^#0[\(CCFH[*`@`0NWOK405[#]SK03`=/W`YE MS"(7](0X(R@LKVUJ5=S[;=&M#OX"]_G M`+_MB4+W=3>8?6=,NH68=-OV[(:CAP6L!%9\6N+DPX>J;M,Z4N`Q6[8AC]DB MCFYVY0RXM2Y[STAO9\5[GTAO[R8QV!`QM.E!;`(? ML_Z))!K.M8'<&X$<7S6M+.G>D>>:J]+8`[CJ=9;U8]/WH?]/)X" M^7FT-M3]0=$4CX531P&8>#3+\\YH)^?M6">=`1R]MIW]S4Q?A417T=G3'*PX M._W,YO=FR8;.^F^Z1^U8^+$S?W)*;F,/:-V/^`T)VY5XYHT7@_ MY+$C0#QVM>&Q-9(\CODT@2:KNS$&`0X`JM7[ZV]6%4""S6>3`+I`YNR&W"3Q MJ,HZ>3(KJRI3("@*)SA$7&_AX@N;.PD3%19%(%?I,.'D"2=/.'E"+J#WP>"/ M#&2!WB9/P_=];53%' M[T[PAW:GEWII:H1M:1">==$YK8=KMYU\$LX\ZB3<":V2I-]>?2E!4M>YZN MI6"'^J&1DT521Z?K,_F;^0RJ%"^S15+&\R2FN7'8(6AZ1U'F\1]D/3751GX% M?HB?IY!Y]NR-AE6I&E;)%6@^`GKPO4ZBP+(F+!,3[(VPLQ1!0%-@ MT818+/?-8)-NG&[SL5/]=HI_I)?7Z5'8-QNGF3^PC!9%*7VBB94^T21E?V4Y MJ6C>II,[W_%@?:"Y38#GXODR/59<%`NJ?'?Q-S)]1].-@';>ELN,(PN>*HNE M@RI*FNP.+H[KSK/KB\=H7DAO-ZYBWW]'TXJ4.8F*1?[$KP.86*@>@OXS1(PP,S:M5LMQAJ^PNR^84S11D2R'#1_H4SF=W M=SQY$,\1!GU.8I8!+)<6Z?(3ZP3]+LD*F@.ER@^V140L7\M6F5'9YG MYE?O`T]JLYY[C$F()1.C/CI[3Q+?+2U"LQ<->`#YDS/2YPV-CUXC$Q,;T\_U MF*Y3S61E2PV6IHQ/0']^`B@R7=43D^@A45[`]"%9%5Y6'*EWG2+8CW+?$;IFI&HK>?*>-8$\S]1NHC` M>M%!#,EMSCY4*O.,=:BK5W'$#NO&E.R0+G)[]PK48W1"/1Q4;&[40L.7"BJT M:K:+],'.'7>X"5]JCY!Y!3]3G]I=^M3M^@>K*"M-=;&ILMN]Y9&2X\/\>2!9O!<))537#O8;?/` MGJ2DFC'2VN6&E>BH7Y]/^?P#_'W@WE^R9;[L9:!F_=+5!(#+3.Q$BC#?Z:9] M+27H!1%)H% M5666$;[YA-&F$(9-9)O3F[:3SC96B?;^M9&:EC(='ZW--/-U1G0VOV]FYB\? M\FQQ_\!NH=$3RGP;\9)F`E5*:ONN>!X%644?GK5J/>UX1:Y16>;Q[8*GSH1^ M[?3O1M+GF#IO+$`\)Y/X+IY(<,&,YWC?D3N<-94VD#XLK?@':&="!9`5RV`" M$],MH23#X]4W4EP"WU.H+V;\MEN:_?1)V[M9O\"&SJID]5HO5*://HB<>O9M&4 M)<^%VP@TF+WUX'BN)=)?75[EOH7W_<[C;W0`6,+@M?2[+-9$T?80SYM@?/:B MVR=N%.DMZ^4GH+GP([/B54`OJ]+^,D>[429AJ1V2RU,",\6(MC<%9+]L,$^, MOYA5BQ7/`ULP[MDD9C]5"8^?R8F):<9L/152.EV-2\6TT\6D]BWJO/?TLCJ6 M]TRF6]\XS\G7.%L4R5.]C")V>`M0P:H2K/E?ST9]5WQFQ1LLK3;UPJ2&%S9= ML"(#8`^-&_JOQ?ZUZ;^JS/Y5F7CA#ZU2QR)K#/=N@#9A6".5:2SEAV>-GRXC M4O7;%*T)0DJ6W-&KK>.S!S1=/-HBII5S=B55WWF>30B9=N#W<1?/:'OVQX=$ M[2[^H8Z<+EJL52XWI?CG.P>,S(>#W`J85A;]L%4V8$@!>LA:G M7[:B.+(9P,M?V%HI34C.6)695;!@LR@',12UX=VZ/-JLEO'<)'!N!0NZ3'$N M86;S,QMX>F;SEWK*![)*#BXA.J`9:)PW,EJ46?T%W\O"ON$YTTW+FG]K+5^Z M>J-SLFOU+&31R-C]_X>H0ZNGN@7BK4/\L+VB1[. M/4]A)%KB^7,WQAU*.]_*N0C4/]2_X_7OPC.0GZNQF/@>8?O._8A5!'NB'_>;ELL`4*=>8$/]C09&.@9..%`?4!^Z-,*7HA4X M#=]CA-5=1OCHG:LX5^@Z%G@I$P7;P#DXSL%1KS"V-3AWX**LOCZ2=P3?53PF MU3L)O>[IV-87`ENU\0=D[,_U?LC)*<`;R MRGN1UY50`R6<9@N:I^@3N9#DCUGJW,7@FQ]+GC3[GF+D^5Y M%4?ND"&1(9$AA\60R(^OXH7OKGW96\,:0A,M\SN[;U5K2J=YU6F2DSA=5`73 M6*KOY$F:L1IZ+%OJMB)S-.,HRW]\1-KA8D]B;%;-J9E;)26/U2MV94_>FGJ% MMK,9:*SRPV[)E?X\_^MZ[]82P2X+Y-!:&UQ<\/Z-L3]E#/ZDC&Q#EFY;3/<[ MV+HJ?,9X.)MO8^`I;.8P:@`=7M4D/IQ?GF8A!BJ,OT8LFSVML90O>.+XB&&H MSO>[^9#3P]\>\N;#7N6?/-A,W@R]/S*C+TJ:WLO(IV9GI>3?[S:;E@ ME1/O4_M^X$FJ4U1-5,T.5=.X>LUTBX*4,'VIYS:;=3H19@BSLV'V=FQ@IE-"R28L>H=P;]]FT5SK=Y?(OA>KT=FKJ+%&V%PWBG^C5:X77 M&].I+96"^2+U*+-A5YT[FQNSG,!C5V(CWR8/47I/ M5M\L-Y9L2/24\8';BL5\CW3WK*<;\Y(]1&$M@<->H2ZBAB*5W#@7.+HR:JUVY:58 M(=0%9%5D5635TX%CZZ/6*K]="JNB;X^^/5JADZT0*-P[C*>A$7K!`H6,"Q2H M"TBJ2*I(JFW&2S!J?Y9GCPJ"\D%+M,\28:`)S=&QYFC46JV%2[%&J`I(K$BL M2*QG[LXQ,'C2BI\OT#FD[JCFPT8.52FZSPEA1[K:@I%`DA2.@W;SCD!2&^9V M6X$$*!SLAE4A\%R4*=9(Z1Q5EV(L4:V0S9'-!P6[ZV+S_]M!6;A+)_4+K0L))$GA\(=F$LTD:A>R.[+[)>+ONMC=M-M;0+]X6C\O MXU\'NM47,_%/].J=B?W2K.PQN1_RU)$Y_`8,NA-%@R&*K;=5.?RD.G6?="49 M^P0:7.$HY,I5`I<9T,/N8=%800\;V1S9'-G\,F%W76PNMY?7XN+)'&=BN%C\ MZO1TY6#K/(.30%(4#GO791K-D8RF$;4*&1T9_6*Q=UV,KM@XV^EHMO-JZY@# M/P.('-3O8J\@9@YS4^&9]6."X1TX0L&7YE.1UU[7Y-VF:+6X3(OT?F?WO).GM'(KJ;?16!5Y59$D\ M7;Y)#&"V4Z3[H%@/HG6?>#N08NO9A>4V=XN=+,T>`/?ZK@PR(YIA-,/#!AN: M833#79AA4Q_9:(;[CBA\7T8@EZW7-_YN]&LC>4*CHQ-"]]WM;'+C*6LD(0-$ MV5/B%,B/?VZ^)LWR692L`5VAURP?S/H@34B25-?\^$9^PS[#`$WJSUN$_"6> MD4+ZA3Q*G[)9M,&[LRB_CU/>R&A19O47G.39-X_QM'QX;]K*2LT`%TDT+\C[ M^H\?GF-AU?"MJ7L4;6L@[HB0$&O-CV]4Q9Y_.PC6=7VJ;C5.O5'1M-[?>?*- MEG/JG?UW$@7[$@T0;/%@2/XPNKV-YBJ[UE:V>AB;KD('PMP/KPW;>R[`?#(A MLUN22YIR(ZFRHI[@7:!JHFJVK9K&U6NF2U?4I4;&0X09PJQ]F/U=\.@5J MI]6GZU^FQQN)UN7[89F,%/6WX\#E5>)K'"51.B'2YP="]D.L+T+))D`B68IP M;]]<[S7F*HSB7/I[E"P(X@OI%.D4X8YTVBN=GE>2H,_5^+ZB0?P3O7IG MK8+^ZA3@=H=S"QA<(D1/E-EUGSFM"ABLQ%97,EA]29N)!*>*D6%3N>IN1%)EYF(P\'$I:@*2*I(JDBJ+8:&E)&.K(JN/;KV:(4P MQ9[X0+I,(R1CWE+4!215)%4DU?:"]EI[64LNA51/._LESO;$@=KIRL&U:Q@ZV)@LD2>'P=UWF$2."..]!=D=VOQ;\71>[RR,3 M6?W,R<]Q&0\[4*V^B(E_HE?O3&R89F6/R0V1IH[,83A@T)TH&HQ0;+VMRF$H MU:D+I2O)6"C0X`I'(5>N$KBA"AWL[AULW6BQSNVE>]BH5LCFR.:#@MUUL;EF MCC1D0XK@:0H'/:NRS8J-J):(:4CI0\/>]=% MZ6J+B0POGM)/RH-R2<342[H3Y*!^EWL%,7.8G@O3<_6ZF^E2K!*J`O(I\BGR MJ2A[_R^%5S&?.>8S1SMTLAW"U+MHBUZXO(#E\E`5D%.14Y%3T;\7T;\7:-FL M.Z;YDI51TA96!)*8<'QSY3C#37*"@"W+IR2ONZ[-OTG3;'&;$.G_R.Q_)TEO MYU!4;Z.W*O"J(DOBZ?)-8@"SG3+E!\5Z$*W[Q-N!%-LOI**U5Y[J=&GV`+C7 M=V60&=$,HQD>-MC0#*,9[L(,*V:+._S0#!\94?B^C$`N6Z]O_-WHUT;ZA";^ MH(G??NC0!B2=)W_YC0;!K\W2J?L\GE."OB"3*4LE2)ZK70;%7'U<")Y6S*)]#00B+I%"[TR83, M;DF^&@)-N9'.0""30T5?-4/1IZBRLGDT]!3Q,AQVT\#-1,>G-'!_&J=]Z-V% MPL8]:X[,$LPQC&7*/SX'J)2'<]%V)ZO^E)+=YLZR14H#&\?.@;MLS']%9!K^<"%XBZ M6+,54LH59=0[$8>+0N&T]&C_X!6PUK,6LZO7ZFJ^#=CN6;IE]F.6TWG-?F.. MT&O-0%P-M2'TD/60]:X'>J+!32S6^Y"2Y^![Y0GBCI;2HR%5P"'X-DD64S(5 MLZ%AGLVDI4:GI-B?B^K5VOF%%/0@&%(-6CFD&J0:I)I!48U@\KFH8-_5Y#@) MLQQDFZ[D2;Y-'NBI<&A16N;1!`L)#U*7KSN]R;&(&W@"D[=.>VFA#\IJI6FO M)+V64=::*X*\-GS!=0>S7T@IS?-LNIC`G5&"A2I?'79H3M&<;KU-D7LPIU>1 M[0NY"TWFZ7K("SK$;+?:#:NU5\GAI`5/ M,48>MU=U30Z7-FT1@S%\"R3T#25W6 M=1W1Y]_.\WV3UFLXM;L>T*+DSI$3/;F99$5!6)7UC9Z][(F3S9+D?U*TD2K! M/]E",SN8TI(DI-NH_BM*`:UR@$6"E6 M3N8Y*>A6\"Z(Q!QIK?((]*?N"^<)8`C*"W$C?=>M*L1-0D%W==/;Z0=!]9M9N`:;?;YI439 M#X1/`_0FT3S@KRO__CA>81ON^5:L9JS M=0)]A.5AK8%[%+![+S1[U:U&[S?:^JEW:KVW=5B"508D6'E`@G4&)%CUA6W% M`NI80+W/2+5BO$+.W-?,D+N!+U565$16/Q'I5R6JX6=(%4&*2/<#5,JC%R;[ M67_$ZHBOTYRUZHBBU&+.4@GK$J(A/@="6(T9B\*?WR0L"H^N![H>2$)(0A=' M0H+)!WTA(69`(C0(Z\-?.O>@`X3,@\R#S(->SP4NQ5Q-(>.*,HHR7]!=>,-% MH7!:>ORAL6NL7HLUVE_+0%P-M2'TD/60]:X'>J+!32S6PW+Q;3<4R\5?+=6@ ME4.J0:I!JGEMK^:RO);>@WW7E``89)NNY$F^31ZB])Y`B](RCR;ME=422)Z7 MK\M8%_0*ZH):>@^I@[$N*'+710BN.\*B.8SF>39=3.#.*"%H,E\;=F@RT61N MO&G*F_7#5`QT`REH+>".OO51P,VA=0D027(<%\9+7SS;\\@C[)8W`EYQ$Q2)_XH7S MDFSRAQ3=YX30O;.MQ0-0U]N7CQCPN0WUUA,Y!^2R;JW:0%N`%&WV[J?+9)EBN98D,E0+Y M%`O6846J78`<7D6J*RA8MUF1JBI?]PHEJ9R1W&J))FCWLC-"UJ121[K0-:G. MIO=]&'YF\%A%IJ915)9EG;C2_&M1E/'=4ZOT3]%_ER7@0M`QY[Q>+&:S*(?K M"B8E+A$JH>DRQP\`J$XD4L#7!32/B3LJI+LHSJ6O4;)80:EY<<:+)7H`++J\ MR^[Z7,)_JI_OJMR)T*J<7?D$A@D&+Z4CYY,)F=V2?,5$FG)S#BZ9(+8`4Y65 MS4C#*?(]5W'V-'"SYL4I#7R_%^*G>"&->]8LFK!%RKA?HX4X5SWX8 M#`%9"UD+6:LU*5DC&TFK#=(Z:H]A;PV[AITO:58^V_V"6UYPRPMN><$M+T/< M$7+Q'<0M+[CE!;>\X):7BUEJQRTO!^6#6UY0#W'+"VYYN5#7`W<>'"M>W/*" MP+NP+2_B+49U7MA(PGI&PD4`!!(<)CB_'MCA:C(F.-^^#48?*9W+ZBI6E)&[ MD+N0N_KD+E7#W3"M[X89YF(?9K"_4J(7%5"=38$01.W+1PS(7&&2:C[\MJJH MK8W_I9ADY`'D@:OA`6UDH?ZWX)(+%&/HX70E\]6+QVC>@:\ND"2'Q;L""6Z` MWKU`TAL6[%H-$HH!,B'B@((X"')[#D+'H_[ZG@-R#'(,+YYBK M7S#XN"BE;,YR_M,UH2F&=<3E8%$QA&L$`P*1&)"YPMB@,CIZ1_"UQ`91_U'_ MKT;_<8WP&"]<\"0VKRZU?8W;GSQ':2-Y3CR;1SP[#B^Y1=.^5-7&LI3FLMEQ M7N/(K#F-"E[\"04]*DK3XS0J3,'+:1&OLGI['-W&25S&A!:E2K-9S-\0KYHS M6>0Y22?TBB@GTCU)21XER1,\Z0Z>(]T^L1)P&ZU_WL4;Z?$AGCRPAT1)D5&7 MEU<7@Y=E#2=8>ELES/SNIGXRW)!(4CV9K3UXR6>P/A/=5BAM>D1;(\R[]L292G\!*0 MP,:P/\;0L95(;TE#JG?)8E(N>$6Y^@V_C3Z/I"G--Y,OWT9[4A5LHVV,0,95 M=J1ERB0IFDS8R>:X'L^2MN)[D.S=HES`B%3"/5"^K?K[+]\OBG?W431_OSKX MNSJK6KCI]+^Y7%U:%XZARX^+"?097O4%]&Q,]];]])__(4E_V?LD>@J;GL'^ M1"8)H#:^B\DTS+.9.YDL9@O6]U^]#Q]@V'F/@[H4W4=>H>\7D"0=?GCE)W+W MXYO0IT?+_J;_XXO_S^K%_]SVXD]Q\8?[+2Z6%]4[`W^&=O^599?:>_^RX>.G M2A*?&K4!UY[L1<5#"#Y3==VSAU??^A5HX0%K-_M+,+M%=>FJ$<\>Q26TA$2= M=&+M>?6B:L`5D#_A#>C,))Z!SO[XYIWQ1HJG($C0B'=Z:'B^$VB69MB*KP26 M-@[L0'%]PPA\WU;?2(LTYH)?%-,W/[U3-+9A]@!\6ACT(4&K.J875-P"'Q^C M?'K!(/L<):0X!"W+<'77,GW#-&1E[/MC4Z/0\BS5,SS;>PXM6W8N'%H:LE8[ MK*49FN4'AN>9AN5;KJ./;D(+62M8UC+54(G=#1'44-% M==50'8]K:-F![%C/H:7(EI#0JA+-?$CY\SZL2A]73P0/CZ?*":H*P;0Y0;,. M\!?01Q`Y6LE3\<:6!?B%!U!G:9H9JKKGN[ZKF&Z@VK;";*476*ZJ;J#NG6F^ M$'6MXD$H*"+UM0I%=ZSXEN$%B@V3`EMQQF/5L7W34E7'4!1+WB!`%:%X#BO6 MG@^M:T/+VK0+PC"*\[_3H)$0*'R9E^=:MJDIJA;(MFKHCF>KILF1"+1HV]IS M)%HV`O$,3D0@[@*BHH>NJBENZ&FA*8-A#@*9^83VV(2)Q?@Y$#7EI=,-$9#( M3(27S>8Y>0"AL!LP(+<5:[LIRU!UW0\!'S+,&FS=,T*3A=-D7]-M7=F=,EY#0<0EN&6[L:':BAEJKF;+8]50QZH;C)F/#_"P;,78,&>Z<:'0$,\Z MO1HHC'%@!KIN^(XAZYJF^*[I>J:JNEI@C@/;>0X*1,/%F@XG-!3=="QSK(1@ M/TS'-JO`4^@HGHY(N#Z3X82:K]I&$'JV99JF8:E*4&'",L'!V'`GG)<&(SN" MQJE/[YP=.APL7P_TP`JMP-`UR]<5&#";3U?'H>.[[L8LX3C7[U11'C%*OV3E MW@XO@=)7L./`Z/R2I:NM'YT&P4+7&MLP;(X)H:JHXMRXX]5GS0R8VQ M/&8D7R+NSD?O%+WZN"A_92 M37]**0=J8!NV"SJI!KJE>(YB5TJI.=:F4@YJT%J.;PHS:('B>V9@:^#ON)H> M:+;N.,S1T3W3,,T-3=.&1Z6=S2K%&419=W3%#6"R8?B!X0:NZE>:!U^;F]ZJ MK@QN%#L+)PLSBJ'BCK4@#$/-]%7']6E@N%KNA.^L#?Y4M:/6.]L8Q9]71PR\ M:NOYV@!]X&JV>RMH("N6.U9LF",;2@@P#>2QJLIJZ#E.J&],C0UC]U;0S;:< MTVIU3ZL#U[9-CRXVCVU%T6Q5-ZH)/2B7;FY$Y#1M]S3PY:U^6JZ8_E<.H^/2 M`Q];I;Z$VCA*HG1"/C\0L@>+U>L;#3HB6-:7:NT.K@"SA9H:!*8?&K)N*IZM ML$A8:(66XVY,V/B>E+U#L4W`."CG1,#"T`@]R[%46]-M;ZS;BN%6@V3XMK,1 MKM25W2MJ6CY`&KZ;IE*S!(H1G:LC'V[$"QW244?F8QQ-"I<`C")_+ M//Z#?[DV)G1(]+\I(;E5M':"$Y\7MP7Y]P)N";["/U^>YF0]7+#^^Z88/_P2 M-N0X]L?F6)95!PC'!62K)OB_X&8$,CA+IA$VY/C;9_^?'X-/_^3)7T"DNCJR ME6T"W2V<7>(L/F9)/'E:GI/;-2MI3I_![P.JM&R;NO/@`+I:[6UH@6V%;WYZ M=OJU>6KU0.'[;<>A-P[//CLX#C>N'Z=G7^P_87O.B6#^D5[^/B[A#1/^I)5, MI8;/RLY?4O4CQ?N-XXYGIB;8^Y>;)("]99.:9T[IH=A\5>$UXZ<];SEI205E M+2DJZ9=QWCC-.Y*\?0=]#[PLIX=OV7E1?OJS>3JT/K,J97EU.'?27#9:'M6E MYUB_NX$WS4E*1YLV_?&!L#NB[0V0XN+9*=QYE+/SM='R/"X[VPK(ILMZ,%PW M4GPGQ?3.&W[0%C2=WK#E\I$49L]>76;2OQ>`BKLG^C+^$D+%"9T@\_H=\.`\ M6]P_9`LF9W[5M!+-#3UD?)?E,W9,=YI->$_H==`+>H"6/B%O+`(7TBTI'PE) MEP][?LZ8WE&])(9)X$CZG;"CV05T$O3H8;.%[#_P[[O[C#[L-BIB=JR:BYN^ M9\>(EP_P+#KLBX*?MYY$Q8-$4W5L$R%'R`-H-_1UN9F0'=-FAY-+=CV\K7'* M?/G`HAZ7JEM%HU^5Y./5#D6Z^9!UBXY07I*<'H*FW:KD24'*7D5/3E,L4KPU M#[JS`]JKYTGS:BUX)_H9E*+TZ88=DW^&]I'TX8Z.])1`4V;PW$IR["@W=)&] MM`'-F)XIAS:!%')IGF>W-/T"?7FPJ2=A3: ML^S4(LT)@)72P%JG*T[8J5+Y6H'HS9[]SD9_MU38:7P^LAE=/8&W3>D)J8)):]F,Y5TYF&)Z[A[TBV.G9(J<@?RFBPEO/+V& MRGV2%>5(.OE(_'-#_LS@+T_$_WI'E^2!6!EY?.(X\.#=Q><'T,1Q!$K[,7IB MW7N)5S#V0O`)`UUU_<`,K?'8]JK3&)[J.*9[%5[!(V_/;99,^8.83-\QH4I- MN7>4..3L1">@MP\18#SB&O(`'2'YNV@.=/.53"NUH78BY00(+@,WDJHLV])G M]O.'Y<\?X6?IK0M8HL:?ZMDGT+%:Q4%+)!=4,)$4ZT:BF/I.>DMO^:Y*WD%? M&@,ML*0!`AB-4=+CF1!OI$^??X-_>W]-97^9P$# MI*@Q3)E20>0CTR>._F7&&N9J9PFX.W24 M_R!/E=7A<87BO11-N3+P@9>B^_N@1]HT^G:*JFG3+/H6SQ;S,"] M>9I5K@",&`&`QM29JQFHTM>(>;H55\'<@,T)Z!R-J;9TEV>S=F3R)[UMH4#' MVFF9V7++?F"Z![1`YY9<9QB]`IO6?U.K5D_0UBR4JIW.G*_LGG#K3AU1P.D< MS`\S>E4V8697V6R@:25N*J>6Y),8$,R=96J8J+=^2Z2$3J=@RE(C._^#QD7! MRZ0TQ:^N!#KA.L%M=#VUH`1%DY/1=\-4**TS4]T<:!:S[@MRUN_U6A$:Y+8I+SCG*/B,_U.8Z8+Q35 M=HXS)>/015HAD;!98SR)Y_!H:49(R;_-20F28]"40Z\H@))34=U8VG$!)S=$F:0TG21U]&B:C@I:D;2?V>/X)CG-^S* MRE07F31?Y-!`:ELY#-BH4W*CLEG.49J@7;X='I(DE`0;$@$1WI&8QN=JQX4E MW$NB.;?_-`R33YG]7D8$J`MXF\3%`[QN25>T*WQ8AFUN/B^=HC4#$'V-XH3% MKNY6*0&;LS*&OZ+V@6@R1L!$(3V2'NE/,4=6NQX1`+65!_EDPI:65M-23>&S MCU8>/VS(?5F;*[$$M:"B,W!.X+JB=D;F,,Q5!LLF[B;-R7B5%K0F*0^XAM;A M9L&+Y48J]H@J_V4=I.!0QCPFW9:29?`6U*4M"7!09.45AZTN7)W;A+B MQCUKF<&7*A(#?E+^N?G0E*T*;:K5\L$<\F"2D^J:']_(;]CG8AY-ZL\O#\$^ MQM/R`?Z$/E7EZ2B,KAVT64E1(`$*I\K]E;FMN(#-C3>(0!00"E$%MPM)/:_%=;ZH M%'MD="ZM08"&WH=ENI&_!(`B\M?Q_*6.=.0OY"_D+X&@B/SU@@V3-M)7&_0U MD.A^ER+\1`H0'BW,F4ZEZ6JW/,;,VH^9J0=B9F>7I.[=D=+UD=464D31B*Y] M(M2(2]8(N<6Y!6H$:L0%:`3:B'8<3X$FTUW*]C-)$G9JLCI^PH_(3V=Q&A=E MSHY68WA"($8ZM-+;JI!?E\I,=62VAKU3Q2:*GF+L<`C*>3G*IYBCUG;RH'*A ML!,_\T%DM#!`,(T!P_&)/W\2DJ4:+BUW7L*:% MNH2ZM&.[LJ:,9-0EU"74I?-U2;%:G(U>@RYAR'N/-QU]DVY)2N[BLIG=MB_W M6B`I#Y??+B<8X.@];.\71?4PT(:ZU:-NF\T6]`\6>>D!QC$-+J]8R['BG#P MQUUHW+(]I^F0V`:!(@QL(G\A?PV$OQ33:7%S!?(7\A?R%_)7G_R%_E=WL^_O M68+@;=?WUK"&T(3,(?ZA+KP$\_2#Z<&[R/J]GJ.>M4GX'.!;VBQ61O#M#6PG M/[CT&!7;X=%87@7M>,"XS\27&LD=EJ:8.VT;.O\88Q4ENN MR]`ZN/:V7Q_I+0N_*N@4?R7)TTCZO(NQ:'W155$Y%H.D=5DYFM;59Q2A:B+&JV$CO3J)':4;*AXS7$EKD MS5+,:<=^]?'JT\#A`B,2WIR8J:-2WYLD!4@8XA M.H:58]B;;3(,9;B>G6Z9P_;L3'-D=.C9W?"BSZPBYP;E+XW:M&=?SG1:=V?[ M0YPST@8,.$T9*9W.)-P.YJ7]V"SJ')%^-4$WM;;IB[J`[-SC(FWH]^:RVJL%G'DQ52I/4_P9EE][(*E;>D22"LLF[$0Q@3>GM.9E&<4J?TD;F&9/H. MG-T\NJ^K5/89OE"WG(,XS^%C#MI@762^H1^&=F-LV.CSRJ5W49Q+7Z-DL:S( MO!THC?JIZ+:BV]H7=?)0Y;02L+SJLIT3"M92K-L M2I)5+>55W=>H*!:S7>$!+-UY?NE.Z]S*G4;?]1MU?.$0-V0/:Y\+RNESMX+K8D]I!UHNCTS[S]([21E9\I\'(EK$Y*5C4E4X)E4-,8F8%`F3ZD@] MGB<'$E_ITOL)Z@7$KUD2E7$2ET\X8;G40%3'$Q*+*J!FM&82$$"BR:=S`*V$ M]*ZQZMR>YXN0$DT^KP2IXQU7C)WL%N_OU7X6J=[/0KIS)P02Z;!T6B#!=:OL MFH*S401;7Y;%1K`AV/H"FX,QC1-B&O0HGO26[9+];K@>\K!T\M)4SQC)FO1. M,D9&:W4R$$*BR:=;""DC3=XZ"S5&2FM)P!!4HLFG:U#9NT"E'LU4&-LXPHN` M]\6`[ZGT%)-D>H&^Z[`462#!=;RDB1-,Q!IB#;%VM5C#E(@OZ10]8)QOW\PJ MQ87$LXUE*3N&]]OH\TCZDI.H6.1/TO^2/`/0+>;TM/HB_TI&TI9](?0(X%H> MG>@QRJ<%??;JU.#:6^+9/(DWGD%3+,T7MTD\29ZD,H_HZ>7Z:"$[)UB0LDS( MC%0GHWO-O%?$W\Y]%7N.-(,O']@Q?B(M"G9^+C(F?"JTZ&L4)]'M M4EQ1=3SSN:C@GSZGQS@)O!K\7Y9?*Y4>8O@EI_S5>!SO)UD+O-&VIQ*!5V=/ M`$A^9K:"3ESP5`?+U`2`'YZG\_$AGO"CHJM+5\_-:!Z$;%$6)705E(N=69V! M7%BB,)YZBV==@&>N-^?V"9H3)4__"[Y5+*N;C4;4:@!O1@647S>#%]QS0M:8`,L(LOR,QDW7.8$[E MLT63&@VD3QU^%H35&6!^FK98S&91#M>!")+D&<=0]%.\-E-UM93R@#6HXR0' M>+2YBZ/-BG[FV6;5[/OD;^^'J?N^KW>)GGJ?/92&]B/1@2P8#FLRA_)Y0;7! M(P]NME-CL(,);97D%+'3/G:TEK#3HBQ[AU>]R?)83[+;UKC53L^@FOB(T:J/ M;)KZD>15QF'4Q9Z"EE=VZ%Y,7?Q4)W\4HUD>?)?#Q'T1)6(TZ`O;!_8/W`>& M5KH[7;R_IU4"#B2.Z*TY'T`%X[2()]+?:?H^,1KU]D,J_95GWSU>$7&/RIZ9 MQRH23FN4[(QEMI:$2""Y"D>'_0EN"=75D=BZ^JR@-B%HI4)ANV%!LK];I M(Z0=G6$-"0P);.ANQ:;@AJ&HYF@S,;J8\KQ<(*(E14NZ4U2V*;=8 M+7S0J#G7DIZ_6J\,/NKA/43I/2F:E7!H;'?_5BL,[9X4VCVT>-][Z+9]C13" M%EXJ?@XM#2!^$#_BRP?Q,S#\(/^T[4,>-S,>OG/Y7[RX&084+BFR)X*";U' M@%T*J>/J`,W;Q0^FM#:%0_9I7S["6+&WBC(RVI;$:M2[$T7K>H,G(P:R?/:J M1MG01VIK2_FB0+_KN11JA&CR&9CCB@"Z8$IM'RZ7PJNX4+5'N%7Z,%RJ>G5U MN\REJK?*J/O3#SAC0LW#P.>S^RP-%[+:FWRA<@U?<`/SOP62G'"0NT(^QX4L M7,@Z:2%K'N>XC-6;3G60I$@P&V>KBMJ;O$11HZ[]2]2K"X[-&N;(TC$LBQHQ M[-6<@;FW"*`+IE1<[L),A]UE.NP^S0224X^"&T9^$ZV/8UU7D=X$M5(@ETKX M**,0*9B$82'+'#FMS56%'WMD&D&91B#!=:MN/6Z/0:RA5;M2JZ;=F+HV0KO6 M:1#ALF(%?R<%+:"[-TP@9?E:6>&OM%1VS"LP\P+(&,P4F,-7%8R]4I@M1)G&]HLNA%YCPZ^W%'0>!`N27X?'+IGR&HE\C M62RY(:[0;EV`W=)N#,=HL2#`('#P*O-Z@0*+KSWAQUCM:Z\+K.T7WJ*I76T< M$)D*E19]C-,%?!T,BIK]6IK=ZC+-,,#:WB+.V;0Y?)8T])'=WF(KTB32I)`T MV5\Q1Z&5O8=2<0A5M.AHT5]SWG/CZ$:+FZ;1IA\;//J^C*"'VZ[OK6$-H25Q M2MX]$$:IBBK_^3FDX4WKW,*^:(CZ7XNBC.^>6I7VEP3R+@T?&$/^D3N`]YS/:=?F;]_"V-RV*S>/69,\&]?\$@L<&0/GW^ M[48"KYCD4K;()?+O15P^P0!F]WDTH_MAF7M,QPJ^^QI/"38'$*;E2`KX*]CUA32+GF[HNAU% M`!]O.OYD-D^R)P)(BJBW'X/3718WTBV18+ACRFVWI'PD)'U&B525H$<%Y]'E M4^`ETN0ARP!<]7U14I(\C4HB>="T*'V2IN0.\#,%W?@&X-Q@V_K1-[R/M+WI M@K(KO;2^",0$;;SG%22A^]/%A+;UJ3?]OH-!;(>5[NC^:)AL/4GP<-KS]WL-HUC:HDNC_*YC`V)/:=I+[<(M;(>:6?>$8@$@EFB0P+=U? M[WX?,>XBN,8]:P&>)4_&,'HI_]Q\:$J1D&QRZ_+!;,XI34B25-?\^$9^PS[# MA'I2?]XBC2_Q#+3Q%_(H?E@_P)_2IFLB#IB31O"#OZS]^>#XO M7S6JN8UB.;>WMR;'.&(C!FO+CV\L]<\'HP;KD8WJ1N74^WI_8=_W]?/"TS;8 M=)`TKK5]-M0VD[S5T,@O65J%/RBWMQ6^PW#\"]*B]H^X+?)C_7[D['^;)=,? MNH7=9SIE.-;<]=PVZM#"%!T>C.K0OCIHJ`Z;]_W.WG0@->SK-<^%H8KN1=77 M_Z(S&,F'N9^@#0SIHL/?:=#O6(7!O<''>"S[M@=OSL]PR\&`TX8,(VV8WE[E M4JSB4P3-KR@_<0I?>D:"YFS^'B M;+H_S(W3ZDZB3/U,FSM522&,X:7BYU!8YAKQ@]5J#T5=L%;MJY/89=:J549V MYP(219-PLBR`_;N>XH6*JF,UVCYG*59;2!$%^J]B;]^G;Z,F?>8,"[S\V/ MEATU#R?FSWT!K8_E5U&TZ/7GY8-W!8[;"==:\AUDI9?L7&XKQ\X@=HX8+9;. M.ICYY1KVCZ`N"JB+HH"KO\150YJXV/9(:6_[[2')B(*%%MTH3"1U^"`,2R2P MT853'M5Y#J@2?B3]9H)1=;/M9"H@;IX^9Y'F\,[[%'Z?LO03)"VB*A=%44HY M2:*J\ALTZ%WM%_.D%/"0.HL$>,KL^KA8JQ9W2Z3&XZFMDR+IL3J5]2[BYY^J M_8MM0.!8D2I;3A2<9V%9U@:>3Z/.E+&1WJ4X)K\+%3'=V%D+=ZB*S3_2R]>R MNGP$=X=F04@GY-TXHEF91,CS\F4M'<>\T<9;UL9\U4:>[F1!V\B+(4[@O2!3 M`JU;S#->&3&:/,3D*YG1+V$@YSD!')8DG['4*9O/AX[`HP">`(>G.;6;`).& M[LWS;+J8E-(4'IID\QG+$$,;S5-QE]IXIEF M.I(A92-Y6ZD5JU&9+8HHG1;?80H0$5.`F'K?&3+,H:3R./4^`U.`B)<"9(O- MPZ0@5YP4I(<<(!)FV\!L&_TDUY"J-!;2*F&$A*D9^E^0PM0,KQX=O[[4#&KW M.]YQ80IULE^O9=A0Q,P,+]DF;&-F!MPWA)D9!D/VF)D!\8.9&3`S`V9FN&`E MO<+S(3H>'1<2(!>F65=X_D-1G)'?DP_>$?BEYJCRJ8>NIH[=EUYK-F^::GJ6)>#L?N& MG>)G3UL4T_I5;W[21H:\ZM?6IIS46G5O:W4YM'35M"W?4`/?F:RJ&[K@5$,9&X"F[6BN/G(Y:J^QIK6F,0TW7_;$>JK:B MC=7`"VK8^EHH[VFMVA%L][36=\<``]^SQY[IZZ'G6X;)6^LJENK8NUMK=M1: M=4]K#=748?@#63&"P+-5S9?'56O'CJ&&NUMKZUVT5MN+6UG3#'7L`U6-8>AU M!V1=M=:AS+8/"9T0F+87">.QZYBN$1CC0`]-,]0MVEC%4,:A'AK>'B08G2!! MVZME,."^*]NRYWJRH:B&8UI&)5LY#)5QWUJF[<6M,W8`GKX9.KJJ!X'C!)I2 MM=95_6`G;I618IS56C].%B7SK%YB'E19]FQ'"3UM;(2NK2M6*%=JYKI`$'O, MPY[F5FUY>8./\!7,L1G:AAW88'L=-5`TWPYYBWW="E1MC_6UNFKQ?G]!T\"I M,8RQ*UM&8&J.[X_5VDQXJFKM:?$>T5<-R:O+5 M#7^?J=A'9^>V>!\!VR9(=PSLX%,39YF.:_B\Q5Y@@2^QI\4=HF(?4>BV:FHV M<$1H6^`V**'N5[0&ECFT=WJ18.#VT-K9.-YGDDW'<&5-"8-@;)EC5PTLO9:Q M`H[P'@="Z8XK]J%"]TQPPP);=U774T/7T&N7QU'`_=FI>2#CSE"QWS0#'\BZ M-U9T-81_;-U20>&X:1Z#,[R3W>2],Z%S6[R/*WS7\0,W\#Q+-A5-UD$1*QG[ MREC1U#TRWN.RG]OB?9JG*$H(&)95`P!LNF/#U+V*W3S#=8(])OI<''_,DGCR MM)Q*[[9]R\:&JJ8!F[FAIS(_PK3\BMC&@>+8SIN?G@7=FD&$`\G3M@4Z18O9 M\8_T\K6$B[5@:18JB8FVW]2*W#N,I/0BGKDTFQ`R+7A8 M%7JV*'B\,"?S13YYB(I5"]G;HI*GO:Q$,HOR/T!P5;5/17;`7AFYIIJ5I51!MK"C@%ET%"7.*>'^;)=-=''SRPM`1 M,EE;[KVF?*2*=F9"4L,>2I[/P20DQ0Z^:@<'LG-P6!MN4#Z8"7,M"1[N.T5L M=8>MULZN([806\^P=71].2>YAJM^6!@LD4.%4 MNW7J$_Y8D1"9/L79$WVCZ\[(Z5PFHHP^O0_3*"'7(->\"M<8Y@B32B'7(-<@ MUW3--9IBMU@(7/31/Y=K!A+R[E*$OS_?H\#W$6`>\E<()+4CJ\9!\$/G,_M6 M5R%L&J(+T87H0G1U+3U,UK='G&RK)TX)>U3@ZTD8IBO:J/M=+$]P1P9.+M!W4+= M:E^W<#LSJA:J5B>J98UT5"V,R1V?P9SG#L+);_^D<](>YZ,+I_1-/'2MK;WE M`*P/@[KT(@/^NF6;>E%(*Q$[9W9]OUO36L(331"I"R^VA]W3*C56-7 MQ8F798:7]8E7!8O9P6'R;9(LIF3*2PS3`K;3W?62>;%D7CGWEDRB14'H+3$K M+YPL"OH]+VO[$'TEO,AP!*]_M\QH\A@5TH:07]C9"NO5PC03ZI1,LIRUZST= MS/JPSV:J_E/D*L$5">U:G.ZA_+,ZP:EA6T&Y4QI\TYN(E6U;.P67<4N@H"?L M^Q*S:FPY$BJXF#=3UY_2X/TEK__==JHBS&G6U%Y#9?1/E34VD!@(]$8H47X?8XY4KG@F^= M$*!F^(X5,:.K]#_WD@%21()YF-2QM-"2:"-SQ63,Q%-%O5'!<\"V@?H?:33 MLR0F7]EK`=*TJ920RC*/)FRNQM&\3EGT^5P%0.4_\+["#VQ+!FQ^W>@4>RR7]H2&.Z'95?_6'[K_U="5RJ6M#6"1P7LBJ8#O MDK5&WE'L+L75%=NU3=P,]5R0U`J1;R2?Q&"1H.-N>787^)R@=[&EIUI(WL"B+$B;##/TK,J*JD;;3TMI'HY+<3-]RLB0K?#>` MG;74X#^I[3M=:5;->%:DM8KH-:@^VM#S=KJDZ.K(;F=.ST(GLZCD=!.W)/2_ M1L"'[4&D?9;C2^*/0%JS**9A>>`LDKXCZ70M M3O0LW4?1_'U0K4U\)#F;BW\!F(X3&(:? M_O,_).DOR\M82O5?[X)O()WTGGR"B?:OJ1<5#VXZI?\)_KV(OX)KEY:%!R^/ MTP4\]=&GJ%XH6S;OFFIJJL;FB6_87E:V=,6Q?3-3^]436>" M;?3LS"9W*("02D#=+P'H,#"P)FMCUW=#=ZQI8X5+8*S:IF8\EX"B6P,3@+9? M`/Y85VPY=$)7-T/?##33=[D`?,7Q_`T(]#'^,)7YP#(B?(F^T>>=VE&MT4\G M4.U0-61;EQ7+U753-BQ'#73'=SQY[+N-?O)XT)N?Y)&B.L][>DS;VNO3)GJ; M?3)UPU.#L6%ZNJ8%CF:%OE:!-PPL5=G>)TU_M3YMIZ1FERS;"0Q?<]2QY\JF M%;BFH]==DEUW>Y=D2^VJ2Y_HQ'T2)S&[Q2U#`E8S2CZ7X`Z66?ZT=O$QF/SP M2]A$)8S3.+14-Q@#XFYMF8I@>Y:H>M[FF5:?JTS1ACL M8,I-TSU`X1QA&MW`#G3?<)RQ8ZNN86JZ:P-T3-NS75L-MA.K+!\TC3U*)\QR MF/VF:U?X,=R85SND7BH275<5P[/EP+;&\/^AX:@58`(S".TM(GDGCU3[A8@Y MU.R.!7%8<3S+5!W9U1W3`*,#IA?`42N.[^G;6(7*05$&)8 MOA7`;-%W/6/L.H'B`*[5BK\L+52VSQI>[`&]F@0.`W_L!IYM!Z$+_\"T*5!] M3ZD@H!N6O1T"KRT`.N\@;CK].9M$R?(Z\M*^&]K8.KKJNX'ON6/5J;TX>6SM`/U+G9?7 MZ/=^9==4S8.YL0L^FJ6!&0LLIYH+.J$FJ\:.\7ZAS6ZOW_#E9U*6"3G)0S%\ M)5!\S80K=2,8N[[I+GUU/PST[29-<;27=7>]D>UW\H#_Z0>>HN%]B!IRJFIMF* M`3Z7IEM>H-?K!7*@JQL+)I:L/5\R.-2BLSN@[>N`X^JF:XX=R],-SP*GT1B/ M5556'>`4V=&?=T`UE8TEG],Z\)GD7^,)80N`8[I^[&6S.4D+'DJ(BH=/U3:N M,,]F0;7?Y]>[SW2YMJJDN(M'_EF]ZY_N8Y1/OSS-B?LM+I;?+ENP>M1?V9+M M3BF-;TS79'6\L"\&D>H>46NAVC_+4NI&GJ:AJ:(UE M)P3.LS3XPZN(P%-M98T(F#P-0S&'+L\5/;8N3KJ4IQBF[CN^J=E:H*F>68D3 M<&MX&RQDFH90XOPE8SOMR91)I/A"-Z*OO3@KRE^R\A^DI$Q_G[)=M]MX;H=H M)R2Y_^='DM]E^8R&'UD#/BVKL++6_T9KL!X0=!`H\M@.S2!T9%UV?=?5ZS4) M51NK&\O#C#5>+.93I"&@T,^@!_!Y')FZ>U9H.;HKA\X2SZ%J;A@EW=1.HML+ M$_0V0'_Z_-LA8?N*8X']USQ;44/=L77769*'8=H;'H!^&GD(+.R/[`@@S.6K MK^AURHG&\,`@K.8TA@RFSG<,PP\L-U0<555K*C''BOWFIX_*/\R_]B#DK;T? MD.1?3.XK.C<];VS;=$+BT+F7;AFU&V+HH2NS,;#_JJ@^#D,;WF`C?*';LN\I M0:"9FJ/)H5TO.7@Z3(,#$+SZ#W5(X( M"-,Q=6R:GN%:,/,(9;.B97NLR::VZ2*?Y&L<;'?GLCAF6QY8?\>0/4U7%;I2 M:2J.;_GFV)+'NAS`_.&Y,!S])!,EB#`.;-)40MTW/=D%1*ANH!N&:5634<=Q M'5-Y+@Q3V15R>$5A?")10O5/@,F]Y]+]99Y+U\?L_\_>M?6VC2SI]P7V/Q#& M#$X&L#6\7Y*3`7@]")!,,DGFS.XC3;5LGJ%)A1<[WE^_54U*(B79EAQ*)NUZ MTX67[NJJKZNKOZJ6%5USG(6WJ3J:M.$`J=8/RO/AOA]3M`=DV0/&4%Q9$LT03T50$95-@S?EI<1%,57-B(H MDFYM<)4/+-MO55S>(NT9IMT/K+S,IN^6^?3%IRR)H]N[)X)56%RQ;%^S15UU M13`\G/RVEBG33EKX&E^Q0OB=W0B?,_`-[TQ^&7"B3?T5+W\= M@S\31_636J+$'"R^&R_X:3W\QX;))QLOR<@8#FV'J M2MQM(>/J(!0LJG+>2)Y'%K&\#.-.I859E4Z;+&=^]E\48<8<9O-F>9.FPV+> M7J,.*P\46QM?;%('NHT^[3._5OE M/(/TEN6[X+8D*XJZ#@/(E]>T$#(N@.:@Q%>LGI!_.1525O+4S0=$7V<_-;+@ MHCYG]9F+U3FH6'++,Z*Q-,)&'[#"S748)UC/[0Q^...YU5=A_C>KSV=LO6:> M9\6\WJZ!1ZY*E#4%,XH*1+QLQS^@J3$G;M6-@"MF#-.KQITC]['JZ"37^J[2 MM@T%Y5VGF;7'.>0L2DQP1?&Y`+5X+BJO9>*$"2>$?KED<,FX164GR88P+*@ESX3PLXH*KXQQL(T:UBT&-XAQOG&!6?Z=ZRS_@6OA3N`[! M55>8VQUAM0><2[%" M%2!5$4^;TCC++F`_;RY9K6SIUHZL>IXV(L%B5UD4X1[?=*&TKQLD:"Z!`6+? MX[);M:!35:>HA[9!]/KFLV]5AKK=%+R`A\RJLD)ER&J`G@FS.(6.8;.;8@GU M0QE[`T.97B":SA9U&)H""IV&8;V:NJQ#S'>QB[+6J3>+)]?\T;I0%9?G.8(W M:LD"U(IN?_#5B.`(_[P6!Y@ZWP>]K6MP\+EFK?MUDG)1S6#H8OQA58ML42LD M1,8TOS!GO#[$+0Y`5\CK8GT#ZE)4"V3/P[A>9,*$!PYJ>)Y59:?=_RC:+8WJ MU"#&@5ZXR%#&S7$9SS^!^XJF=,&V;O?7(447)G205IT>92]*'16?PAPG MMU7HT9_'_W=[A82$39]=;J\S`]5475,U#%AJ*HYH6K8H^8KORYZ%#OQVBJ*V M+H8=.M6;+)1]9?$AR^>7V9?;PO[7_<)P+$_2#-L(?-?V1%62;-?FPE`TSS/$ M;500<2(J3RF,O17#CAA,@-N6[548L8I70R[`8B;WRT9VO0",P]$5W;9QQU71W5HV2'&T M[J"Y/:G)/$)+>&6Z+*VE<[]``L5T="T0+=TP)<5Q+5&2:@QQ`E-QMC'A,&]W M7`*YB+-B357NEXIDJ[YA:0[N'EBNY(J&JM=2\1W;E[>#B62,RH3VEXHMR;H; MF*8L&Z;MB)8B:V8C%=NQ]#ND,J[Y)OCX^8/]@,E8CB1;IJZ"8KB6JYJ>;-48 M8IJ!;FPW&7%<^+H7AHABX-FN;EJB"M;A@'08IBBI+M&*[A6J8B26KCD]E&E]`S%#S=6Q8.+!+.XWQZ'F_8ZH] ME"2*(WMA9QTW3`<$U255]T7=\535#=S-,R]WI^)[F!HXJ.J;::+XER]X6$F6]Q7RP?O:HUET.HP&NM!1(JNKY MIA*(@6\W>JWZEFQN[!S)P^OG`Y-=M[N2KRK@$4H>],Z7`M&6U69875%6_(UA ME8T-+N'3]I?O[=QQ\8.\=9C:=$?6=,-6--\U-%-KT%P.%'6#2%EO;`_*=O<9 M:TD4;4."F1IA_K!J;K37&P*+OX.!W4%U'?"[ M15&T[N= MS=2!;FE6H$M!8&JR(]N.UJ"PX_F>ON$<;R'B/+$_M;_NBFH`*JJ9NJ^JHF*Z MMKI8$.BVITD;PRHU%,2]._T]8D7192)NYRD%BPU!&^D&-?U@[^J7!LX@LJ5X M6A!XMJ<84D,U@D6.N,DRW4($_)'V'K3K#Q!L#3=0`LLW82D@:IX4Z)HC+O)8 M35#N7>AD0^S[#D1K7Y9\W71TVS)-U]=5<"G\Q:A;VA8950R])IP+*6^`"%SZP$,6-_XV:1<-/\N%,K)K@T)P.4G2V M[&L60,,K0D$DJZSM%??NJA;)%,^@:!%H&BH.,C\X`X.3<<+MQ:^7Q)D5EZ5D MT64:?T."P@T38,+AM%)D"2P9-34UK,6)6;$-ZR'COW8H.$LJR7MVS1)!@N[. M*^A<\WRARREY5:4AKUW$IK\@H:(Y,Z7F5=3,HAC)-3@9+NE7>5M*[28AQVOQ MVN9BSK.ISS)I<>,VF'C[=TQ>[UAV7K#\FC^^VT?L1!&#OH3Y72.]V7.\XMXG MKL2R^?@E,Z6E0TB0Y+25^D7;Q2:OBPU>"$\"54$TL14[7 MJ;"JL[]Q]>($(6S?DG[*FU#8<#K9: M#E>CFE^+80#.I8-_RH2="C$R]VY/%P2GL)XF;]L-_PL$FW&UXM1$!--Q_?RY^F0C"%\:$W\$P M!,EL.%Q35D1YW)Q#4O.Q\.*[M+TMC;HQG`=XS]!Q(2^THBC1AV]SC1\8[-6[ MEW%&K!N:M\^+LJ\!UMH=:$[(NPJ_QU?55>MW'8UOC1B'+ M=W'(%T_!P^!?+Y\2P/K M[9]J9,-?'FQF"\UQ"3*#1?SKRW@*"-[O$:UWGR#?8>-WI$WRN5\^R^8J)_?+ MJIG2%@[`_+O`<[J$A5MS`%END=_N+L9C)+C(30MW#J@=MCU['/!)%D`6T(,$ M_ZC#9Y]X^EN\N09Y$C.PZXC?AU6LK>,+-:GA@RC5:]XW&1E"M(O!!8$ M%H?0M"^K(@/#4/VZJ,3'9;QW&*UZQX/.PVC+.CC(!`X$#B\#'/YL;00-HT5# M!@9E9V!X5&0"MQ0O>'6$LR8Z'D6,S69/`"/K(=E>/5?N%VY6-WHDQ@Y(:B,& MWR,*\SYN**0$A!A^-` MVV/D,Q0%^JEO(?3?9ZY"O79:/E4U>:+WU?6AC"7>=YX+4<+"_.T),MY.?EUV MAW"`<(!PH'N?JB@3B5"`4(!0X`6C@'PJ2M9$(QP@'"`<>,$X4*N`*4MR;SHP ME/'\42PXX.[C^&,P>/PM3^&]#A/,^:*(Z1$CIO(Q(Z9[Q$6V$&("D:/1(4' M!3<*/3JT_5XH^HM&G^J$$$0011XIN M#F4\?S0^25A`6/"BL(#V1[9'MD>T]N>Y3'3*4"R,3(Q`9F8G30 M`)ZB5K*<%:60AR43BIMP3K2%)P"BT>'-*]7J+W^=G&:REV=N+Q2@)KL@NZ!Y MA.81LA>:1X:SG'LI&YT?2_A/"*-O55S$99RE0LX26/)-.5V]V0*%CT4\9;`4 MA`LH4#4@G'H^@:I7LFSV6'>#]F'(]LCV*$A,^S!D8F1B9&)D8L_>Q,B#[-&# MI'+IBW+IR:JT$47B>L.G^VV/ZMU1O;O==PI$;:(>76Y[P?\H=(\V&@C>"-X& M!V_]\M,)W@C>"-X(W@8#;YHY,0G="-T(W8:N8H1N3QV2)'C;)V[Y:QF"<+9> MW_K_NA:99?A4E' M8R2\9OE@+DXA8DG27//V1#SAWT$IHL7W+6+Y&E^Q0OB=W0B?LZMP`^!OXFEY M"1^A3XTN@IXEX;Q@KQ#T2C^-K3L1.\2W>6/>GLCJSP^J?M=R MFQNE8]^GCZ6AU$'JX"%?.)(RQ./R=DD^>Q0%[[AGF[[4`61YOQ<6,4SB[%6" M3IB$:<2$L-S5;SEL>SP6L:MSEJ]&5I%.!5F4>B\,2!9`%H#W_5%ER([_E,=@ M!O'];/BC-XTD`]$>R'#YT_6JM>O6?7+%F9 M@D3!,P*+@VC:%WAN/(.^IP.9+^MTGX_G!71D$*UZE\ZKH8*#3.!`X/`R MP.'/-"-@V!D8E,-R:0=$;C]D8+_V"^G,T$&!+YUN1AI'&D<:1QI'&D<:1QHW MQ#-#QU]ZQ;X.XP376F>S+#\KPH0)!8NJG%+-!K[!.10%>I$G^DBGIFA-K+ZZ M/I2QQ/NH6"+A`.'`CIT6)PIA`&$`8<`+QH#:%^BM3.Q0QI)P@'"`<&!O%:#B MMWT%6EY*\5LW+"X%]JV*K\.$I72\YU'CI2^G,)EL3,2#J]90;.K0S@O9%MG6 M8:=^,C$R,3(QFK[(MLBV:/H:GHD1=X".YQP($(T.;Z2)01$RL@>R!XH1C17N.@\.CY!)0DH\=R MRL\]DD2V1;9%P5HR,3*QH9@835]D6V1;-'T-Q<1HK[%\\ZG*H\NP8*U5;#8O MXRRE+4<*G>U`'Z)0,MD#V0.%DLDNR"YHGB![('N@>6*P6XZR.?;EVM>L#!,A M?+C>/D62AIE*?J>P1W%27W^G1#ZD#M MJ'7U>"?A/G\0[+&.U^.E.0JM(X0DA!R+KA)"]NLFFCW2(@@E"24))8>@JX22 M@PZ7$E+V'X4]/DH>4H3OX_`\3GC!_MZ.L*)Y9/G";]`R!G=>ATG%!-Y$X@^,$?(&GY0Q"(K`8`(7 MKV3#F*A'$\G*:@XGI-XU9N>CM@F("(@(B`B("(@(B`B(1@I$E*A,V]:$-X0W MA#?#Q1LJC%"^^0O^*%E*91$HO>\1JRVMO\P/6E*1N3QSD+,D++$F7K9D3L#'(IZR/,0+*'`W M()QZ/D4\7TF6>822`>0*D.V1[5&<^."+4S(Q,C$R,3(Q,C'R($?H0?:0`_M, M"@XFJU18BL3UAD_WV]Y!*BJ,(77]>(43GDAB!X!]U10G^M'EMA?\CT+W:*.! MX(W@;7#PUF_R`L$;P1O!&\';8."M1YH'@1N!&X$;@=MPP*W?B"3!VSYARU_+ M$(2S[?JC[66TI)/$*3N[9'QD)%G\^>DW6H[5N*^73)AE"2`\:)[`!T7(V3QG M!4O+0@A!Q9+D;);E-V$^%;*94.(-89PW!5O@E_?LFB6"T@[%"J\*T+1X!F8" M3:K2[+Q@^35_>)S.J[+XY?ZZA<]N:%KW=*8@$6R;MB7C"OP,81(OO6\3R-;Z"+..*:M&M?Y6@+$J] MG81"ND6ZM:9;\B/6!KT?KCAVJL,AZGT/2'0C-N(C"O'(.G>`X!QI'&G%D@8^L0BC-@'(RB=_QXIVE?01]Q5PX3^G$V%+!?BHJA8;WX: MK;$HZ8KR&BFOD4SL>`L)0YH81U,N\AZ>>T#G=U8*T6687B!7ID6UH57:\6%J M?&BDB/VEH[P,S"%[><'VHHD3K2]%&8KF_Z@#3$OX>X3[A95EPJZ0'$L+B@$A MS_-94-":G=;L9&)D8@,S,5J:EV^^YF%:S%A>X,H\3*>_9KF05>4R"69E?T2I MI=4'E06GTR7(+L@NGGX:?BF+\Q87DJ73_EF0M(P85%V&NT9C%$GSQRO8\".' M98ZDDH,LF_W%<7]@((?2XQ7`(0G=R\0=>)6=M*'AEDO9P M2\T0A3J.7X4YO$28P@UE!C]DY_6EMT(X16'R?4AAEN7]B*"\R?KI MN'T=)R'*DA4EJ%DQ$38"I-UNR-'C5H`O7[BF+LKH=K]&J&GU";D&_^I2R4H!W[:U3 M:Q)%Y6I4*CRB.*R)T:\XTE'&O&P[D89:@S(\;RM:/TIVB!F?OKKO471^E6=S M=BK,P[P$M,EFLP(4[?SVF-IA3>3#8F\8P?<%'NRO+%F5;P>5^V?UYO,_?ZV* MLXLPG+\.P%S_C=;JQ4649$65L^(KB,5)LNCOW_[[OP3AGQN7MLH_?(`NP2W3 MC^EG%E4YPJ43`CS^V2JQ]@XKK,'?61K!7;Q/RS?P7L.7SVSV]B3P<*[Y0_W? MK]Z)$$_AAS`JSS1/EDQ#,V0]D(+`\CS)4TQ/-V39U1U;E4]^6W,+VD/R0%6Q M;3X7U5"C&FI;[AM-+;1A=Y!JJ`TDD?>9R8?J7+7NHQIJI%M40VW8>\-40VVH M1DP5K4CC2..>2G#$ZZ4::L/`MA^F*3Z'K>C#]7GH>\:/VOD=ROA3MC&!!('$ M5I"@&FI40ZU'*5(-M4&LL2A9]!`:-A0CP_LH'YM,C&JH#<8DJ8;:'L*B&FK# M@:GQH1'54*.H!MD+U5"C-&VJH?:2D.?Y+"AHS4YK=C(Q,K&!F1@MS:F&VL`! MBG#H^2Q"R"[(+L@N:''^6"XDU5#[?_:NMK=Q6UE_O\#]#\("Q=T#)"G?)%+M M:0%2$L]98+>[W4WO03\56IM.=&I;64G.-N?7GY%L)TZ4%SLK.W(RZ`ML1Z+( MAS,/9X:D>LN;N\*@ZS2>66@`A+K<\UCZRU/`Q]&2XKMU`_HENOW')# MK.A#]>`>2)?>NX(OD[0XR:;S3J:S*E_^,%?$YI=Y39A`RBN5^^:B,%1^8U48 MJD#E'U>-Q'_LC>%C;Z0D>.RM`D>)HWS.H\1J/SU).7MF^&!%EELCI/U'C_I,#+P/-2WV_LC-W"[$ MJI2](E^L$8@2AQ*'$H<2AQ*'$H<2AY5WMV+ZGJ?9N/:U#D=Y<5BF8^>5]N"\SB2R`+(`LL)$U0&B();B0!Y`'7C0/8,;_4^P^[G\,)DK+4\]]F67G MZ1AK\O6L[LCS*1C&R!'9NFCU1:>V;;R@;J%N;7?I1Q5#%4,5P^4+=0MU"Y>O M_JE8!ZF^:M\]U^.\2L=>^G!:%88%NU.LK=10VH?B,[LKE?1$B&WEH(+L\*#" MPR61]D&.MFU<(8,A@R&#]?&(!?(7\A?R%_+73BTPPCL\'((,A@R&#(8,MN?! M062QQT80>Q2YWR:V*S5_,2]_EYL>F$&(.:LH<2AQ*'$H<2AQ*'%[F9>_]^;O M"FB7GVQ>?$T+$*I94;CIX*)Y(461#G#K'3-R,"/GUOM>AT>LZW%O]%*?OLP^ MU@]%BD"*V%%TLR_S^:WQ2>0"Y((7Q05H+J"Y@!2!%('F0L^V,Y]!CC_\!CUS M<.=Y_<91K^DBIOKO,@C[ZA[KW?'0/ M\YBQ5`"J&*I8SU0,7S10OT6M57],S/+;P!$2T=WSS6H3=Y:^C MT8SZ\LSU!0/4J!>H%[B.X#J"^H+K2'_RT?F^@K]YZ>#++"NS*LNG7N'& MX/(-F^/JBRU0^%AF0P>N(%R`@:H>\=3S"52]9DQU6'<#]V%0]U#W,$B,^S"H M8JABJ&*H8L]>Q=""[-""Q'+IRW+IXZO21AB)ZXR?[M<]K'>']>[6WRD@_I'8 M.6X;T?]>R!YN-""](;WUCMZZ/9^.](;TAO2&]-8;>O/5D4)V0W9#=NN[B"&[ M/75($NEMD[CE]U4*X-QZ_)21[YY^,^0QG5NYYQH5$9CK M9HJR*;#L_/MJH].\F*3C:Q)#ZVLN&V[@]`9N/%Y<\],K\JKY#D(Q6'Z_!9;C M;.)*[Q?WU?N83](6P7_-AM4I?(0Q+601Y&R@Z%_7W,6-=-?W!?O241P@#G";#]R3,L3[9>TB/AL4 M!;]FGK5MJ2U@>;\5-G!U$F>G")ITG$X'SDNK=>V6[?8G=@,W^>R*JYGE],!C MA'9>&!`U`#6@ON_765Z?CO]09*`&V?VGX7?6*3VHLG/GO4N+/UU5>J.\Z$>_ MWM2>1BTGGG[XI?,[Z]7KM^[700Z_37,DAK6)@6_W+&V/#K=O,[`_MPOQ MG:&](E]\NQE*'$H<2AQ*'$H<2AQ*7!_?&;K_I5?T>9J-:U_K<)07AV4Z=E[I M!K,"4\UZOL'9%P%ZD6_TH0>*A$=A5T/ORUS6]V&Q1.0!Y($U!TV..'(`<@!R MP`OF@+DMT%F9V+[,)?(`\@#RP,8B@,5ONPJTO)3BMU%:GGKNRRP[3\=NBJ_W MW&F\].44)F/RB&Q=M/JB4]LV7E"W4+>VN_2CBJ&*H8KA\H6ZA;J%RU?_5`S/ M#N#K.7M"1'O'-_1(8H0,]0'U`2/'J!>H%[A.H#Z@/N`Z@3N,6P+7YL77M`#- MF!6%FPXNFK=J%ND`]QI[Q4?/)Z!$98?EE)][)`EU"W4+@[6H8JAB?5$Q7+Y0 MMU"W9G599/<J#\L,-W>^^UW&S;5D(*Z]4+;_=:5G?W)MSG3X(=UO%Z/)I[(77( MD,B0^R*KR)#=FHFJPV,1R)+(DLB2?9!59,E>ATN1*;N/PNZ>);<)X=LL_9R- MFX+]G;W""M>1]=^IT0U6*]IZBY+OUXLU4+I0NE"Z4+I0NE"Z4+HP3WE-."/X M#7KFX,[S=#QS7M-%/#^PCY37^Z2,7AP1Z$W@XC63\DCL#)(KK=D>2)U+S-JO MVD8B0B)"(D(B0B)"(D(BVE,BPD1EW+9&OD&^0;[I+]]@883JQW_!'RHWQ;(( MF-[W"&_+[R[S`UTJ5)=GKBZ8#8MZ@7J!RP@N(Z@NN(STQJ-[*>5[AQFE5U\3++T].P,.KY%/%\34.U@Y(!:`J@ M[J'N89QXZ\XIJABJ&*H8JABJ&%J0>VA!=I`#^TP*#HZO4F$Q$M<9/]VO>UNI MJ+`/J>N[*YSP1(AM@?:%(D?!SG';B/[W0O9PHP'I#>FM=_36;?("TAO2&](; MTEMOZ*W#8QY(;DAN2&Y(;OTAMVXCDDAOFX0MOZ]2`.>VZW>VE[&"SCB;NL-3 MU\P,9>2['FRT+#[__?M9>7B2IF<_V#0K_K\NDO+.I>6LB_\K(A_#D=5(;-SGR#;*;BZ42\$\2RUB((#0F$#0B"PB3*&;A M30BW!]WE&)X*J0>$S5HEK*^D5HFR$?PO($FH>!R:0!I-@IM(44GE=H5M-XA] M!IJ01"I:8Q;)V%H=LMU)U\HHG@ZM!W21:$*)"&,- M?.;[U&@>L@5:B07DGA]:QT4Z+4>N*']QU<9P18J12!D;"Q-Q9B)B50-7'`6B M%K;=P;4ZC"?$ZP%E#!E-PEA:HT@HE(Q,$$4+JH^DH3L4K^[Q*N]X4M/6=:3> MS"7K3I@",-"D4#&)N#*^-3JD2T/-Q#+2+:.",=6557'O,)X$*78/4I$FB0@D MYXK9F*C0)+Y=")0B@6TI(%`_?;9`T?M$2A)J2:",4$Q&G(K$J`50-O##ENTO M@_`)<7H_LMDTA3;2\9MI616S9AWX``[YX.)NDKY:\XG/%9!,K`*FM#'45\%\ ML!$S(6&O?K[ADJYZE\?9!$RS7]Q7[V,^2>\.PMWGT:X$`/X]*ZML=-&5DSO_ M6E_^0U;!$P;SEB[A\E;P:I>K_\;`X;V?(E=4X'IXH\NN9%==\0HW&KM!G4P# MEU2GSHM`,NH`2Y-@8](QW..\3Z?.5>6!]]H=G1P=7+4]2,O3`Z_^O^>^S++S M=%PW>N"E@T$^FS<_<%DC@G#9HB/Y/)^G>4GJRJ5GZ<7\NO(T+ZK#RA43[W-> M%/G7Q@%,I\,;+:R<>OJ;EQ:N?E@=*1IZ:;T"EM6!]_4T&YQZZ=E9D?\%VE>! M`(U`EA=U5H?P7Y77HX:?5IXZ32O0HR/O&."XNKST\M$=(,[[4YVF4V^2%G^Z M)JSCE;5^-=UK>C=T=>,@D4.XLLAG)]`QZ.;D,S399#5!\R#7Z4FCP9X#\9SW MN!YY-AWEQ61QW><:!&AF5.03:"LKA@!>T3QH5@)8S3S6&5)EM>B/!].9WAQ0 M_<#T/,W&=6\/H?W#$N;OCA%DY>H`9A4`_Y_EH^K6YEVKW.!TFGVIP6I`/RN` M:Y8@>]7%6?/01;,7WNM/SGF_Y)6[DBCQMZ/'AH3N(Z<;?)8!I[JWV7GMA5?I M]"2#T>I:('\KW6@V?IN-W!ITED1:2&*-'^HX,D:%E.E0`G_["JZWZM7/'RC[ M/7BWTMDD:+:5P2`,9*PV#=D@0>1)/)K/((]QZ-I MXK@6\WR06K"X%[2,\QET3O7?0B\ELTL)4@?(1QJ0)"(^-I3&U MQBPRVM:8(J2W0YK^=2ND(;B\)(@2[@=$)X'BDL5+2"7XO#6D3\%G;&>$ M+DVD`LH2/Q::Z8@J7]`Y`K#&L8@_$:%W#,"&["4B)H6FL0^K6VQ,(D6X\%J5 M#B*IGXJ]ND-ELV5.P.#!C]AF%,[-/9K-W/W3HVJ\^%(+Z))"<)X\::)*9+@K."R[G-&FX) MCU(/!K/)K*EFH2?@@&;_F3M2MX4E=R;6=\7T?&8M2S3WJ:SM-TF3QI8+8J%$ M=$M,#V3_1JAJ8R!Z"^0&K'D'G&"0^)'A7,8QU]H&D0G%`LY(&.ZWX"0L:&W[ M/Q]`UU#:.X"4BB=4!1K6)`V*;'GB)W,@?4IEV-JGIKP50GT^,-YASMP!G<\C M1G5,(Y^#BQ820Y-H(8/2QD%KXUK)GDK@/:3EQ\H:YON&!C;V@;X6*[/AS,JV MEE$1M+9L>C!&UA?:LA%8?%9I*0P3W$I&`[U8,$E(J6J)#!7/&,_'LY:2OB`Z MU#H$^U#7,`J[Q)$:VSJ@--\>ZR&,=Y_P2(SPI2(4!IDP'U:U6"^=A!"6N#:Y MJ#X2<\>2\AC+2X8V8+&-M$UX%$MC`RX6LL*-4+PE*R)XOD!NML(9<%43X7/- MK04S/Q$Q7WBJ,0V#N&4<\'"'1NL_BKPL>V(*<$85>(,13X0EH9(A2-S"BN(B M2EKGL3A8KNLCU8RT`USNWD=G!'0A"4)8Z[5OA8VB1:!*4VJ2UCK/%>C-[OO_ MM&L.,:3>DPD"8FD21BR,`K8P]V(I6(N1`T!UKR%Z#-F2T$0^K%3@Z;+8CQ/P M( M'[_R!."!)Y%D$@S_T,:P5B]/?H$G":306GG$$TSQ4Z\\0G,>4:;"V%>QCFA` MN%G:JCI6HK7R\*W)4>L0<:_6G2ADS+`0"%3Z$0FHG_C)TMB3@6WY0XS+<(-% MNGWT^&F`>KRZQ8"+";2ED65Q9'VAS")U1Q,A_5:HWF<;J%O?X'F,JH&'H+6Q M22S!FS;&\H@L/&K-3-*.OK!-G)TN`+H[JL(30R57/DUH(D*J#:'+@*9,2,N, M8!+^OG^3NZ'SFM2Y"TG$.%7@K%(KV*7W!ZM-:WEA]4F1W6'R)&:5U34I@EB# M5>ZSB"L:+7<26%@-E?GLA]-4F#EA?@/H6IKL=_6JSLVW>\? M?+_@ZN#,!_&U3@(91`%7A"9@:NH%:"!S?BO;R[]]5=L(M+QPVH!YJ-,AC;K$X+^P5@I.P=X'FZ83`^B3B)?-\& MP"DA`_N::Q4%8(G"4@466CM/DO)6H+F3;M\/!5Q20'<;^"ZS2*[JB-S.UDN= MN;S!7%Q^_&<&'`.T=/&V%HYK*G9YS3P5K[F`W3B6N]+D2BZ?+=R76=W?V]M; MN?(JH^]!]U"IT`+#\3A0M6'(V=+[21@+6H$&*EMKXF90]F<>DD5:U?O1Y=6W M//*I)B9A";AQ8:PC;K6)@]B:Y<1$24):_+";B;G*#5UK=O@ST1)?^!:41">`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`18O5G&EHU+TWQ9.+'97%*\Z73=8Y0;(P6S M-LN4/"5"1!P:[2+$$#D9^/*0=+$<$L>"N:8#)LU3"CP/(<'SP3,YCO5'-KHU MI4R`T^.5PF33A-Y'!?/6HV0&ZF7)`A[H8[.)2^"/LMXL7?)-R3"=JCH`+H^C M-WN/U"V^Z`$PMHKC7M/P1,\S7,44'=LBMN1XBEQU*%D*<[T;S3=2HWV\!TB^ MX'Z[NF^9*J"F^9)"')=%@/5*^HK6<+\WM/^^$LG:1_?!,#FUAKV0TO?O[4M18#>.8`7Z*Z-F^:2G$U%11EDW5UT5'DVS-]ER9;6-M M%,#7D&\1^!-2Y07&]V0(FBW98!R@^L`8Q+*`*H9MV89-G$:O1*,IH'.J?$U6 M;KH!5GLESJ)EF$16'-,`%E`<7W(4C^&L*$133:TQRG$KSB^"UAI&+_"V)TFR MQ&:=.J;C^+9FBB9;15L6/4(,K5%INBXK32V@E*:C1S"RAQ4_6/<3^+\T(R%HW,0@I+>P+EYE/,(>%27LH5I M6*EC> M!%FF25AJI,RN%"G/3JTBWUR_<8C8HQ?`2"#\'L>,0;1Z@E)U(SGU?2=_ M(2+X7A&4#[IQFX0=<-18\URPTY\2V.7I8BX->4`DR&3`\^9MG=B&ARDNP)6O M>L=RN]D,7%/PC%NE(-\FN*^GT2TH3I!EST";?D##NX!0ZE#JNF"NI4$R_>#V MY:T+R/3(]%WPV"(MUA.>YQ']H!_`?*$%REUK6)JR MKG.3JH!U`/H!Y8O>\#&8B2-E3:QGW![&?$`7LG*5%-H)IX M5VI"&LBZ.53174`]\-9ZH+5HM'TI(?)0[#1Z?R>YD,50Y@M,(O5.0N?@2J?, M]QZ0W>T@^I7E87.S2]N\U1=QZMK*H7"A<"V'E(;>7CSY(EG>=Z")HH>BMQRF M*=JPM;TL:-=0N,Z><)V*F]YQN'=94=WG:N__^28/>B>%>YNXL[-DFC:4,-N( M`H$",2_4R>V5ZS%X0GFY<'E1I?8BH;YP/AH0+%>U6:[2]J_H8KEJ.QWY>6\7 M&#OW3CCWS^B]L`?U5\;15.N+(&)"$&6S1[+Y@1A#X\V%$V,]%%T4 MW4,+:6WVAZ!91=GL)![M$>$ZE49CJ'4:IR*?(7W>,E%:60@^^;EA'MZV47)@ M*$:++25[(WK!Y@ZEZ;U*TP_66-5TDK>=?^BTV M:+K>FZ/<;8'P@.("%@AW3)]-D^O%034XN?%-K2!.-;O,#!1R''(<I-A'B4H4E2@JT3-2HM+`D,VN]BJBJXE:\D1:LC^$ZV]Z[>>"G?R]\?JE MSTNHQ%%"K\?\?/J/1!)_?'M9.@:XI7M6N$&$A>6+%27`X.7WY8R:^8,Y.860QG%US:O=$3GN##-KV7W0B6#L3=^?WV.'#G M*G(<>RNZPO3-1:FU]W M.'>Q]4,1Q:'2%NI]64MV'^XR13V`>F!/I#\81'GC0<]]67^]\P3>2AV&KN_DTS(+0W'">#W\'R!*:3>2>C>8Y0NY]`\ M699;/"H(3\5#X4+A6@24LMGB829X6"R*'HK>OF&:*;RV:F-!#V4+9 M6@ZIE*%V,MYZW[$6BAZ*WG*ARCA!B;@O0H1FK:?Q7(\(UZFT&?L7A<^D3G5> M?(;TZ3;1N/]$]U-+GCPP%-)B!(>CZU&:WJ\T?3!TH[U-*$<%9F//[-TY`]J^+DP_/,@GTIGD>(NLX MU@Q',O)/0\#8M@KB9\+_``/N\ MA';U?#=Y^B2,TAE;G]<<\+9U-:6+GCE3-UL[_Q-IK07/A"'X5OZ21H6(D-"/V@#M76.20$HQ#`_[<=@"H$R:C$$R2V M1K)3+.6VY8`O5KW*#!=:)`GZ9LTK/P&.2GT[Z2+@Y)JXLT.!WP MQ-2&4KLI79M M9%?0M608VV>2&D#2$OG`8$]I6$1@W)Z'PD8UTZ&W5W*WWKI%`WO-6&S%@V*K MNN2IC,"YA5^9"'P-BQ2XOKPBF()]!]^7&3O+_F;]G_7%:P4H=E\^FVX)-L&0 M_+(C;-&GQ7*0IBNE!8/G;0P]CB4:H\:_DZ@`BOU9!`5X)K6:*(`%"FY/@2Y? M_G0^.\+C.`K'E7()ES''MF MX_[YX77SQU3+^#]!!O#H@VH=5]U.ZWL4!_SY$?AL[%LZB<*\ZD94#`F\6'@: MH#L!,8U>FM!$D`W*_%L1$F#TBM<`[\93#$*ETJX&TW1 M3,`=Q1W%.$MG#^..@&Q.*SN.A<&2@?,UJ=GBCM;KEK%5Y/S(Y/N)7Q*?,'B5 M5'4HMJOD6H\*7_#^6@8_2))9$(/5.5?'O/S*+O\8%?"&L'S2;VDZ>@1"-3=. M'V4U%EFYG9^LH@O)W.P0MNB]I;-,>*@(MJ[/MZKQ0?UG?]#L'AA'VNHWBX2&E<1)-$N!4^1Q-F&<^67^>)OM*D M\>1&(]DW7PP@(AA!YBRQL0`!LU-QG#Z^,`_@F"3LTCTK*?4Y-2((3I+R^_)# M$[#50=RDX/S!/"JEH`=1R&^H\W:]L[#W?HY&5P_+IRM!_?+&0L%KSJ&XDQ]YW](T' MW8?]N]M%V0[B`!QM(2BV!.X;X]@3=I+W?G)L>]7^5Q3S>U,`E`:B(N''8'H%;S.*SA=\S]V$&('X>L\$C)LS8?%#L)] MM>KV=JY-G__U\RR_?@B"Z<6XWRL,XS6<9O04:V#%X`;_^ M]W\)PK_VN+?^T^]`]_"9.1.,CM_H_:RK]N: M*2J&9_F2;1J*`_]Q-5V2',E55>GJU[5U.2#ZW[2L?4OU]"HU^=LBOS?-:,[: M22I',:0YS]I-9UDX9O6>:1:!Z6+]H<)]$&6+M!3K/JGJ)4$]G(<5AX2[60ZT M9R69='(7)66=)0A#5I:!:UAQY>ZYT8._CF#(("]"+#T!$N(Q^ MYT6Q,)QEC`1P%[P\9IB,0%L5`*,P30NX)F(;<^>O&0I_4?ZJU73I_%T,R26@ M:!".A2]`Q#7;+^[.7!XDS:L2N;<@KW_?6Z!%PU840]$TT30]7Y9RGY?*8/VBU40,?%[Z< M">9223>,LG`VR0OF,N<+.>2RR:O9S4)OD%3%ZDGPS)7%'2MHAPQ.9C2'P@9Z M\$HY0WU%N;`Z=SP;T665=CW-4JX6F:;D!6V&7M5\R%$2/JQ,)?NI+)HOGK#^ M\C&-2[+D`8-NI<4C8CB#2@QJ7;DZ\*SY,*[3RM5868-Q\)T"(2CKDRPHQ/P) M'0WW>%I-E\5=C"?XT\8!H"6,LG1:U7"C%:/`&6G$Q`SN&:6/R6.0C>H&@KIU MA:W+0U+1FB\HD#R=4!`%0+G4K;=CH/2+H++7,17,:B'=*OOVE/1F;;NFK%D_ MP^]9RA(X#34L_2']P=3PB(8@>''^Z>I:75+*KJ$JEB4IEJDYANG+BB7*I5*V M9=UVK2MA!LS%'S?+1U>_$DE3=.XS+X&_>/]!@,F[`#-MHID*<1S+(*)D6)*M MJQ5@CBY[4@,PF4Q4+1/"'**YGF<[FN/JNEO\Y31X^@[,R6C:&\US$'C&(8BM$DA1)]V6BN**D>G+%OXZBFI[X M3F.0!;69=\RH?,W)_":Q"']]S%]?=V'F,^9CYFS;SA1"@>Z[`)NBS.8^T=9I'*J*..LFY"^U8A$<50\964#>E`U=4?YHI]X%_U@)>%X^%M@.Y9Q'$N&BF_0!ECGC]]59I0TO@W*>_Z*C1FQ; MP;`"%TM_+8`:\![I]1U.C%!+\4[=N%V]&L`MHZU#X%I+PBVN.31(.48CK^ET M$)V$;5/PLW3R&0)D)F'+*ONF]"6W&B39@0A%=21-]\"QT'7)U15;DD3)$56P M3O:Z00(=OVZ1FB`<`:.\`T9%)A[X%B;\8YF^8MG@F%0PNIHI:@VC::R'4_O` M"/'O9_`)V!5.RE*?,V"%KU-:=OWF-@76H>5UM\$3S5WX`-P9'NP#R*[D*9(K MV^!A>J*G*8X#7CMW316B^0T?0-;6_=!70-LAVB^$++9E0)3IJJY';)^XFN?: M2I6K)*+N*(U5U$VM[W@SM,D+'I]C&[:M>*IB@IR)EN3+E&_*0KP$NVI3N&8HF>:LFF5L>Q$C'4!C\1 MA9B-(.+2Z+:/_C&(*>N^I/@66#G;]#1)-BK"B;(C;8@:#7).A//A*WBFA_*3 M:-JR(VJ6+0.!-%<"/Z"*\DW?5L1&^@$":6F#>3T2VDZPWD?]6)JE&H[BB;8# MD3B!H-70*B.L`C'T)C=(1@OFJ'.T7Q`"W3$=B-%%U3-=SS!$7Q7UVAIYBMK, M32MB(]G4+MKP]PT]$'OD'2"NM1U/MVU?57W=A_\953.#86NVYKV+O,-C"<]= M&H^JM$-9R.%4/^M@^'91E2J")Y:F^![E57'NCF^[3I/Z@CO.;TN7L_(G;LWI M=&L.J\J\:F^.:IQZ;TZ_]_0@@N>.X)D<$7=>V`EKN; M>5G6C6;M-C^WV*>/O(6\M<9;;[HS%'GKHGFK.9P*-W(=3,=_#_]\HR>\I]OV?A:[B'JQ)_X\MJ?)V@EVRY\%T[#[<'@]ZJ\>L"+JK_T]-=UL;_+` M>7,-*C!48#UA151@>Y-*(>B!]6:8T=D'W%_2Y+K-H!M5^_Y#F[I(C+WI4"_J!?KT18:Z]J-0IBYX$!H9*")I[]!5E`F4B0N0"5&4ACK*1`ON:H^" M\"YI>[.U5Q"S&6^^&6H)5%+HI;LI98TR%!]>XJ> M!>>AED0M>2Z\BEJRU60<,5%+GCZ?L7WV]LD`Z_N627_OLXO9)HKR(*0!GRC$ MFI,'`JOR[=I2F='[F(9%7DW6R9=/ILOA)WI=;LQDDXAHDO.]P`-A-KV^SQ@V M?*?A_[/WK<]M&\N>W[=J_P>4-]GK5,D\>#_BFUN%Y[FN2NPT4!\IEZ=:FA=U%4Z1GV7)W?5-6;-B.4VGZVFHCJ2ECV@YXSF!.*=:1+8$) MR14`$NO\U%693-B:)_+7Y&5#TM.N+H4':I>G:-\V[6E^$A61.'^7!VH3.C^[ M,G(Z/WO\IR]I@J<^P1/9;'-:\1#1A\ZAT?E9DJT#R1:=GR79HO.S1[P-8B7` M?3BTHW3U@6%\0"(>.A$X?)Z?)(XDCB2.).Z$)>Y$$AY[[I3.2FE<%P6XC.D= M+@M@#G=I/AXN\"1=?,:E2/0!CY8?"P[V M[;40(,X8$&\U93BSV^?Z_CR0P6'T$^&%\+(]]::-!MLU>RR2_R+.Z!'%POND M;<"N6%'P0Y!4P^HH5="V_=B#$OEE;;T*[N_.^[*?6\YU*]U>MY=`V!T"NV># M346V1H,=]3K[]!>!B\#U&,-G6@/:O==MUV@;]/NO>16GH@#+2K=[2B"<1@)A M]VI,!_<"#'6XVO&OHN@48>EPD?"98"!LAL$B">3PZ!]XP0(`D0'$-IPV\;/!1!4'H0V MPIZP#GI%&V'WUCJ/ML$2>#3-JH1\@CY+V(3;0/4%/J=4"/]L@V>V23 M[E([;99]:6UU9IN&ABR"]QHV!1&4"$KK[]/M`0^?$90(2J\72IHQ7(&(5P$E MVJJZS8L>W&<^(NH=G=IZ1+)7`TQ.\AJ[6#]K6_XF;IP$_(>K8KF-ML\I<[D/ M4@YO.U3%V-?"Q&/H>1)RMV\/CG0DZ4C2D4>H(U5C\%B5="3I2-*1I"//14G+_Y6\0,6:ZX_V,`Z1$N3C+V[85R;*JK\XWUQAC>MJA7^APZI M_ZS+*KFZ&Y3:[A3DI"JEN&!2P:Y2-J[XED"INF'2K&!CAL.1."%+Z3(NX==< M_(I%WG$A44Y97(F4R8=)47HE+/E6A/ M)L'WDA>.[^Y#Q'?46<&F287C`8IG\.P27Y77Q;UES+*^+)-)$A?P2AA)7/'9 M)-F$7278KSV]@R^WK,0GY755XC!PP"O-W$>2Y/+G!S#GZ24KED9&4RXD55:T M"VG.I)OXEO$)36-X3+RFZA".O2<3C^1-@]L&FEP&)FR<%WS*/Z/L-4K:'"FJ M(UTF:;HN'?44B4`:/(GT(R0@T+5DRYN0$>S[3$A5E4N7*&5+9H""*UE6#`F;P-0NV3BNX5_@S22Y@@L8/+@J6%Q-\=,EJ^:,91*0-L[&"?(+ M99W_%H_'B'R.V$S0;OFG"^E;EL\S"5@#E\]`[HJ[Q1O&#;`+%,A)"WT)#`RP M>4GVM3?B$U?X%9.%@D&B35KT"5]/D7PN-NX:*%YR3!8Y7/&0<%\4=YS#7\LV3@#?K6'!Y M!Q,60\!7P)#R.4@-!QX'W/<*Y6:.4IIBEL.\+X3)2.,,!P>P!,W.KE$VD84Y MO`'GDH)(P&P:LHVD+Z!.4'MS-$H\++F)6KW)5_F2;E6:9VV/?F0-?R>R-!W8E4'A!!P"];.E+IC&=TMUU6`'P8JV-$%=H/SG,U8T MZ@!%!6^#6Y8P[]RSQJ'\VO>%.(C0/@N+!H\'Q2B.@R_](B&7/51U+9C0>NQP MS-$4+Y0CT*L2^YZI\O;143M&^4?PF?T7'AYB";<`]FSL#O^4B]P>HBDFTC3N6?6B6@X))^UQ9/)@']F`GT[2YYI=*WPPO[S1]1^W)KE6\W#-CP"/GA*)$DD28-( MTLY;K4FSDV8_+!ZW5G/<`QZWT/+@"'5Y_$K21=*U#^GZ=9D2(1$C$2,%1M)U M6M+U!`5&I^4VDS/J+>5\_/3KRM(Y%9Q[Z9W/M+%Y?S)W\ON6ASS9<=(R@_?1 MP0U27T<@BJ2^'BENMJJH^P?J2<@.J3%28TARO8+ M]F"8"1>$BY/'!=D)P@/A@>S$OD*Q(THS[9.V?CQ+*E$,8G%0E==8R$KJ-'A4 M&NE\NB:9!VA7=BSXVK=-)V@1M%XHC4L0(XB]0HAIA^BV2=@B;+U";)'YHH7& M)Y#P:_R]K3*YEX,+I(S..'&F#]=Z[%CPL&^K37@X8SQ0(IEP0;A89R<&"_L( M#X2'D\<#V0E:<'P";3_FV;N_:GCX58)%@:M\_$W*9[Q^,R65CD@?G4]22;&U M`QR1/A9\[=NF$[@(7)2Q)8@1Q`YFOTQ]I!.X"%P$+K)?QP`Q6G%\_WN*_;UX MZY>_ZF2&K:HNL%'6-"[@UI5N)4DF31AVZ4QXPQ[*K5%NC7)KE',F7#R!'&^= MX:JL])G^V-F_((I^(K@07,B,D!DA7#S%C"@:V9''V1%:TGRH3>\MQ']Y<43H[(I_4OI7X+6B7C(!#&"&$&L>]J?-M\0M`A:9+V.`F*T>/G^4P6_ M23%U::-\V6[DT-21-92@'`L(]FVJ"1!G#(BW\G"`>!WY8X++*X:+:HYLLA\$ M"`+$E5HZGT23IB@CAU),!"X"USYV M(UW(LC&2#R9>Y^TI$/H(?8^@DV);PQ6`(]-&X")PK9HVTSD`OEZ'::.UR_?N M>%S4;,*/7N9\'7/H9B6DJF3<5X42S:`4.`($"0 M8[6G$.Z(IS--D(OTOF?_W MLBK+4HP#I*EVG_\)JSB")<%RP.,NNJP=ZW&7DX`S+9X2;@^.6\/2#P#:D\`? MF5."Y;'`DIM3>[A.+61.!X[TSRN@_Z\XK7F+3BE.02W$V9A1_I#RASML&ADP M&*<%*,++F>.%\NV$"\+%&CNB*U15FNP(X87LR'/M"*W;;J;M5URTE2;LBA4% MFTA5_)W*YAY"$0VN?$X[T?K#P63NP#FL/720L^4#5$<]":G9=X!!"HP4&"DP MVA=P=-)&^P)(PY&&.UH-9V@J;4@D%XT4V%&)(BDPVFMRA"X:[35Y_Y%5*RE( MT8U9>ILF\662)M4=+8'0$LA+&,EC`*+LHY"".F2.:E?2T`Z%5ZZ'R#R3>298D'DF\_RP>;:M`3M2 MD'F^GXKX6Q7#_-==?S`%V:%.FF3LW0WCQ%=4^K;3L$O>+!])=% M]D#+A[V8,=@(5@Q*0;2K)%LD6WN2K9V3?72>8#,=_1I=`NCR?J/&.XVK>G+33[3N"2_B+]1?IK:/WE'.(0P4D(S7/UUXFD+_9) MPD\5_-:F9]\""=^-A2M+B]NTN+W#EG]SN+8;QP*)?7M%!(@S!H3N#+<\>RZ` MH,31]L119U64HJ\C4D#GT]9R#Y5RJ',L08P@1A"C&'R`&+P3>^_#&R"-=,91 MQUM;UD?.T*)RWKL^"3"O&3#*A:S8U#+VR1NE*9!_LH?E5_P[YU*,B/_/8HV$?^G3?R9RSI($.D$`Y_#FD%S10O[,"SSG%U[3T\2*+ ML:_CT!L=J"39>O$#E21;)%N/E*V=8V-:JME,QWMA&<99E%A\Z<3BRW2S?\ED MEV8@F]A%[:YUV]C_*"P8.7BSN3Y.J* M%2P;4Z[S4+KNV3M57W1Y7+5']M"4.,TMJX-Y#028,P?,8':>`$.`.7_`*,/M MOWHE@*%4^P.I]JQ@TZ2JV$1B<9'!(*F\P4LKJ/V=MWY)S77(L]SW7RI^@"'^SLH+*6,5GGBX8A-6Q*ETR3)V ME524;Z!\PU9RR".3L@W[<0@(-V>,&\K2$6X(-T^Q-Q;AYH!>[Q%%I7NMXGL3 M9]=,2C+I-DYK<08XQB.[V+ST*`/5UZ2QSC/"5P[0!>2UZ3B"($'P4=[$8`4$ M"8($08(@Y;F/"8J4YW[OCO^JDS+A#GW!TA@WLM"N;8LJ3L01QEDN'&/:T?W2ZNH\ M0WN9=I%2=HT@^**NA.*,!BN5>)X@'.Y@)6'O&`AW/-A3AW/C7SOT*),MFDQ2 M_H#R!X=GX_MO,K1*JHP_5MIWYWE",G_)\8_K4!]Y`3_@G_A/^3PK]%'<./#/[4 M^/8QD_J027E=2,43^]_BO?VNMQ?2'(NCE^,T+YDTWKH!29K?).,;?'Y:3QA_ MM7@H#J1D596R*/3IJ#?S#I)@;BYS/64@;F.HVS.^FJ4[#^S[I(RDDR;@C44'PZ M0PXM&0N$BJO%"8F*<[,$AL29$(@LP1,4O'I0.9*^PI_@$;%@%%P`S[I?&!\[ M(#>,G>#`\#%7#Q32QY=5*_*3[$-$Q>";4D>+HR%P^8-C`PF:Q@5P!.XHZ[0J MI:LBG_)7P'NGK!@G<7J/$U_F2?4O5J0@DA?W!+V$%R578`F0TD"\N(`?470G M[):E^0R%GG\';M970&;@87:-0Y3F>9%.Y@D\!`;TC57`C3]:&6"`,U#M<&>7 M'O%UP3B,[@T*R`@VY?I&4F7%$-2?%?DM/!ID`:BW?S.=7530[`2%BK0PIVE0*K2W[A#-Z08>G:[V"]RD9J<#CB"9U!(1WF M"8Q7\!4'6=:7(%=9!1R%N92@7=)&<3124RXHQQ46:IPKF(JJKP%&=\Q+/I3M M<`4T'I+4I13"ZZLY8P))T_A[,JVG'03<9XP0XK?Q#)@*U\(7F$U/X3TI]'%& M5M\J/^5).'DA`\\>6>,8-6X,5[T34!R"SS^CT1:O5)61/.C@52Y#!QN^.O#P ME9^$S5R`X[X$"96",K\J"+P_'27+/P^"16'E0"Y361SY-&/5MT#`>7+.%N'@C53(A(>M=HTVQ< ML%AX`PO]NZ(]MSH6W&YQ`03C@G*Y:L0ALII7-ZT>_IAG[[AO<<](")NZ&`JW M,D4^RXO6*0$GA8=2L1@6!]$EPX&M6DO^SC5O.6UGU*VD@(W9])(5R]!-4RZ6 M)OXFQJ[`T\L$#7/)RU!^_/2K-(Z+X@ZH-(^+"=<&PQJL7:7Z!]TV1J8$CTKA MAV'D6SBTZ%SPZ&4A-QB(E$@8O>.":1IWY.*TS(5;O^(7P@/@/:AWA1,,@C@! M]_58B*?((_G`M+,[M%.MD11^!ZB7JVY:Q[LOJWS\#=#&J3=IC16W=G6!GF=\ M!1[H1AF6#2DND"=_U4DAGGC)>&0"COR_EGH(N93S;\(K;<5B`0[RI MG4'7?`(35]3%++[#7,9(\5$4&&1-&*@\/CHTU"7$SR4/ M&=K0^P$:+*(T5(&;P(F"^&BIA($_K!K6C7HQMTOT=Q<3S+,C5!R:HHRT884? M:8N,VX'8+SES8V0-.F]N\,&\KLCI"J"Y0FB`QR4B+N\;9K1[>".$X[,XF;R# M/XWC65+!]_D-%R8!OM,VMW^PI199#^LET18QUJHSC@+6\?5G=8$I(8%RCK^6 MJI.':-KHO7B:UUGU#%G\"I)=2A\A[O^<3^/>@LBJ3(H?\2$@CL4T3L5?YH)) MS9\>,E?6T/;J<$'##X8QLH=7-P<;/L9I`Y-^-6AHTZ)]L[B:[6R37#"T1G+' MXWI:"X^A22'#SP4#K5%V=B4)$XSI.![XKGFZE";Q99(FU1WF5#?;OL%BWQ\L M9:0/+Q/K)\=-='=B4C,?=8CY[.YR6@-;W=,V")]JD:(L6%47&+(6;>8&7$R0 M5LSCQIB@;7,T?)T`[D!!7EDB$&%W.8;(=)G<[]R\\!3(3/36^"L,] MXPMN$0IVFX`V;_*N\"+T8C%/7/)<)L=.][T7_+I)UP]N_59X[K04OX_3.)F6 M?>>HFS=O'*.+-CL_`SCB*T4:N8BS$H0:,_ICG'M1IZQU;:\1_8N(OQ+9A[06 M">0"B+#X])"DZ&%(C,/<*#>^UB48NG$[H,6:2X>5+@`V;# MT=I^AFEE-9.^L.(V@2F\_?#YRT]\]LM8B&6HY#8&+B;_O]78?=D>22@J_#5M MWX=NQJ^90..`SX4#'M<3SMO+._Y>&,1*!IPOK&T9!KSW:^?YCYJ"P]6+?+'T M75"Z>=S&EQN$G'?)N1RH"*J+)K`NZ\L_<741%QEJ[CW#E;_= M9I.0>9W%AHM&^.'/0OKOB_XT+ZOEVE0C6=/X3YAO6!>`*6`\_LDM02A!.D&& M"K&(P6"0\]Z2WFEK)>ZF(JH*OG+&1)%EML#+&@YP)S--QJA1+CKVF$.QX>NRKYFV?I/N(4O#8+B&\-XQ%IV-1[] MU&0X\CJ=B.A?+']7;'R3X181:8I4+=MEI)92(O.0`C*GF%E,DV_H9O-U6A!% M+NWP<\(PQXXO0$J#8U/4(/\"=1W_!`6/8V/"_N)\P0OXXAV06V!S)/W&%Y3C M<947XFI,=":39KD.9/L;$J4Q$XLJVEVD0-``7+P!*N7%'3)L+!8C@;U`EFJY MJM\2NQ4&=.MPF93_R&+0]1!6P%TCR6/CN"Y;G=71VS"^#LA7WR&>R^=?)==Q MFX[A`MQJDL;F7/0G!"$/"LYMG@)M8U#D'+<\\8LKI;C0/KGF;)?B2["YTE4- MN@X?(?X&[\8G%,BO&Q;?XF(R#``$G`=+39:Y+&NQVBK6=5'0P8OD.HJ!/PFO MFS+01A-PDZX35O8YL.EQO27H"GB#^256`->G0KLGH$EGJ(V!/[CJGD^!:5S* MN?GA`(-K0%,4=_P%+:UYVW,1-<%4+D1B7$.>BJP+#!!\I MON90'DG_F<^!DP57/\N__UO9?471)N2$FU,)G4R3KEO5]XP)@P%JJ^.!L#W=)U7D"KP.9G(!?'E^X9]D\Z>D"9P;->6 M<%L#5^+?>XDPL48E\[^`O//$RKU>WH M_2WB>Z#E&OIUU.R8[PXAN)?1(GDGXXF,R=_-DXQ=*':YUPVE*#]SWZ[!@I,%)@ MI,!>4($9CGF`&M8G(37/56`GDL[8)PD_-!OI5C8D;SJ32E'I\%&INB4J?785 MMD/K)]48KL3PL:!DWYX2`>*,`?&_A^\F>2ZXH!339MH&[`4L\Q'1]G0UU/Y: M!YR!ZMI(G&/!'65%"&($L:.&&,7MZ^/V9MLY1>Y'H:-.3A5IZZIGO/((A0#Q MF@%AKZG;\\H!02'[9MI^65:%I&CAB!3/^40+;Q69>F=N:7A"T"/H[0-ZNB$/ MUXSKE6./(OCWO^*)G4Z]:(I(*"+9KH3DX3K[O`Y-0W!YS7!QJ'WF`0SS$7G* M!SKTT116I^,>1[!;>FN+&MI.O3_:GO]^:U5QCJ&=TDG(W7.3RZ0C24>2CCP] M'3GLH3K2D3MZZ-1*;NND1`VNS56&Q.Z93@\MK,Q6EC4K>?,L+,P&_[N6IKR. M7]Q4FA[GQ2QOJR!*'ZXZU?8O'GC9"S9!<.R1,VP57E$>D%Z(HK=#4V;6O/%V'N@J-H*KKPU&"]^NEHX'-O!N5A@ M<*5BXX-ECYLRGBHO/S5\>ZH?5&VDGG"%;,4>O#CY2H7L)^N:`_4S7-1?ZY;A MO&&=JMHH@9LU`&]YT>S2XU*_83]_%P2@?O*$E_1>UKD6A43AY6V!V/75DC>6 M^%VIF)76$+?LA(';!D)?EPSKS M8-+-5_@&%N^F,+.HM=@JH8NFAOFRM0HO"+K@+];GR\3JT,$FKP&VAYU\TR2P MP_#-;&[+JFZC2--=2Q3`7FEFV!6YIC?'HJ(SUKO>AI;[=9\Y0D0;CT7MW<88 MQ1/4,>)5W$H]!'?Q.&SB-<]IE]#\^@@UF)0K)2CO-R_+ M8*22HB[-,[A@U4VCB)!QJ!6794GS,:I4H2*;7J&"GI*;W:W*Q=4:S;=&X^5% MNRI[KXGO2J]?X0$U98Z7/3K[.FXC(43!\V65UJ;.\`HJ9GG%>,//U9^F\5W3 MA6B7FJ[X(!3^>-DLM:S'-YU7B]JNG<*N<=/L&`:XMLKH:E>IE9[(2+]%$=,- M[9";WED/RWS[^=__5I?OKN-X]O,'KA*^QM\#T8FW+MA7D!8OSE:%0'5Y30G4,[X([/K.K7]X$6+']'_K__1J\0:8!*=+RES?OC#=2,OGE M301D?!=96N3Y>F1YIJF8D6$IMF4'IJ6JKA[:@?P&N)N(I]7EY,U_*+*J<%V[ M9LRK(WG\<",H%P?WQJJJA[76\VL/C MU0W#40V@9JC[FNNHNF$:#7TA:`F4WG@5PS@`??^[N>^_/[-Q&IF;X5 MVL`OVVEX%02NIO6@1;S:G5=8,5PT.?N0W3+A#;;\V\(77=$M5PTL4'VRXQNF M:CD1\$6WC$C5PZAG4MX=0D$38ZIW?A#INFR$?NA%@2/[FAR$#6,4W;:]'F-4 ME4S103ACAH`,3;$4W;`M`W!C*%K#&4W65;O'F?WZ8&<&F8'MCFH%AAH&NA&Y ML@)^L^W(46-W_,A5PQZSS+T9G@9&VC\>\$`=73=DW;)#3[?"R#1=V=`;CUD' M7[0G6X:Z7WVL_D-Y:+BVJNJR#8K'5[4H@G&8LMT,UU`4KZ>D+'7O_O)#PY6= M2#8BV]`=R[4PZA:^]:IZD/#56S-5W3'M*U(]V0U\`+5 M:88;.D'H]JBK[=TX/S19J,[Q;9E\V1_S(W$3J^I5F>'H6^;/J1X@=-K.^KC@:Q_G_<2W1V30]:7+K%7&E_F?6?O,]A=9.4S1WKFZ=WG]UV>)NPBA4BU[[HC86C M$6V,>$?.2U;-&=O8\DCT6T\6C87*13>U2UXB`P>__OUUB7>Q+!:IZ&:EFB;XTX2U+UW7/$WGM$BD.[ZV:KI^\']Y5MQGNL@LN[T>^R!`WC<6E/]AR MKT+3GTEH&WQ,MF'!O>D'V*R!WNLB)98%OS$I7^E=V*Z]S!E??L'69#SCO/+< MC9/E;:E*0%^,$YPM%ZQ.CX&DQ;1N]#Y@K]!=?> MX;8I-YLT>T-^[2B$QPJ!X]G@%'B.;&N*;GHA<+A='G!MPXOZ#M@Z__8)(QU\ MMCNPS`0[#=&VH?B:96B!J@=F(_&^[UM63^(51SG2R>Z"'R.T%,W2(L=S%-N/ M5-F.FMEZJNT&O=F:]F$G^YF-67(KNLT]=M$E"C5?UPS#"`&%LA:&=M@P,H*` MIA?R*K*B[SRWY;B&F,D6)FF>'6H035BF[=J>'"J6K#;X\Q19[N4:-'E-9FC? M$]D!6CH$;*JM&:;L*Z:M>T'0&A-']5RM'R:;VIXF@M*XHEGOGC(?Q9-EW7"L M0-$B0_4]3?7;8$1S9:VWK.>L6X7<=7##S&H7<;,`![9OZ+(G1UH4!)IF-D8+ M[)C1M_FXO+DF*'R!B6VS8TZH>[+E!0"02+$5PS*\9F*F[^@]^8/@,S%XH_VZ=9[F_&>PB4&9D.:83.JYAN6IH>*JA-VG*0%/M M?JY',==D(YXW!5QER*J\>(KQMS0K<,#>.YIC@Z[U=55K])>GV,X:X[\NF;)Y M/,\:^A;*1Z8&5B1RG"CTM-"S==VUVHRK#-.Z/W3[,$/?9:^-#O`$I\MW90,4 M$`P^:A-N86!ZO80;J.,U,<'3A\Z76#Z)C679M2M2!H\UY)$5R1;XQ:!K-`NL MNJPWT'4CS57Z.S5*0UQVTP&)%[W?>SOZ?51-$M+?>\66_,4NO__M3Q?Z5 MQMN6P!7/E-U`T5U74\&YEAU/"PR@&83HNJ;U_6EMNQ_PE/D>*0W=RR+^'F=L MVW*U#D9#L4";^>!5&9KCV9$#`9>KJKJE>CW[O4OH.`05)^PJ@1>S7Y-;],NJ M.+M.,`SE8AOB3G5,A?\]SR<\>[A"KP^"7H(.T?(Q\.8M#_;N?HO_S`L?E[<[ MI!S_52<%7OU[D8]9"5%*R>)B?`,/#,#`I_D,<[OP(^X(_XQ)_*T;GDS3="U? M=1P[#",-!-9PV[V$D6+T?0[-ZNNKQ]%H:`JKQTUA0PU#3_$\4*5&8%N>;K:[ M2P,YM,Q>TFX/%%Z]_.]X?&0WR7T@]C&U(+)M50,_296M2-466U!MR^BA%3Q! MLX_77<8US%S4!^;BJ:H"L6BH@/O0R@D MF[KB^(;5[M=0/$/KS0/S.GV;>K!Y"-7AYVD:7S:GA-SK@HE-_[_'!1K&I8H) M9\F_[J:X$VF+XI!!71BXB]X#<7--2W'!R0BU$!RO,%R3.GZ!R6N/G7RS(VOM MQ=NV2`6:)1N6KD:6ZZJ@<'PSY.303"LT]-XF'M7H+\TRH>J&KGBZZYF*J@2Z+9AO MR1"<]*(JS7@IO?8$"L`_K,BSWV_B8KHMV)#!B[`"3_=)WDIA&#,:E[G9(># M`:`+`S/2``>^)2M18R0U(W2UH.>(GH(T[.PAF($517J@F*JFA1[PWH=(0QB$ M$#<-GN+DGR`#%B@"WW*M"#6#!X(0*'IC')S0#WO&X13($'WZ_)N[S2-RS!#, MG*9%5A"9AN%:CM7(ON%"6'^R>N`97J)L!YZJ*Y$9*886.J:L*H:`A*>H@;MF M[_2V4.YH1.*WO)C=Y%_N2O?OVTX<0K3G^YZC.G+@R%:@.:XC!,,Q%$OM"<8I MS/Y3-LY_8Y-[FF&#M=2Z%B*T<VR0\'PT,+:NN%J MLJ5JCJ^W*]X0C$6]/3"ZNL8+?]KH=EFM,$U;]=W(D$T-HB$]L`.@HUC%D^TU M&UM,;8U&?,;PZ(C30THIA,C=,X#DONV;$,MI(9`L--304N"'OF9>LTKR;,DF MWFS8$F8ZCFNHGF5&A@`I#JLI@VEU%D7M)!=WI[R-9-XJGC?2AU8'0B5S7,F7?!++K>'1/\]I# M6Q`%]P\1F)M@LVJI\\C?6(S%?%!'106OE#6^6_^\ MSI6XLU64?MH61/BZH7L!F@7;PJ.^OMV>/(QLV>U%U6MV?NQ$P9]A4=/IT MM;AZ\6%9,^FE^!"".39=Q<=DKVE"-./8K>)P#4_N&X$]\J&SY?Y!9FAG@@$E M<+%D@J9'BF\K.FAO/PH,-?(U70_-_A*&9V+R0\DL\?HE?VD>,I.X4[ST8/\'#TWHB'CXKL$9C M=7X`,32,=JB:LN7C`IEK>6[C&-JN%;T2B,W%>"[S M=-(>E6^(>M*E4EVIK*=3/#S.:P(O-ZA>WDE3W,@'\*W8-4P3JY4/6P&8#V!S M`?1CK4DN6O&`9SS,`*]R/(2_1BWO*D8[(&JEI,<1%C5K*?VP]= M./!V&,M!=5O$+5IJ.&M[_NW09(Z/Y9>YP1/ MI!OP:;5\(OHLAZMMZU*^TG*HWSMH#[1\N.O0F*&3.6P?NW76G62+9&L8V=JY M12)UF-U,Q\_Q?%&"OQP*K$=$NZ-#\>!:[K1[TPW7$_'\6Q[JUDC?.[E.0FKP M/NKZ2@KL"$21%-C.I+*&;&M]TD+S7/UU(NF+?9+PC[SXUJSYX$%SBC.'CS/5 M+7'F4VCUB*AQ>`7D."-S*$$Y%ASLVQ4B0)PQ(&QS9!`@*%NT*VVQ1$QYPR;2 M=9Y/*%UT3+IG4"*^K)76#I#F.!9$42;C%+"U94'EK+!G#R9Z3Z7:N6"3HO3W M7_,J3BD4.4SR=15P&@!NDM>XA^LY"[\GD4\;+@F[*PE//AFKZ?*`;M8VLIV$ M%%$JA?07Z:\3T5^JX0R7NR+]=<]?_1O?_+WN^H,-["E[X<]N<"O;L_"L$R_- M/<%C&[WQ/?+Y:TX[_&#:(U6"F](DSY[[?/Y$7*';PT"'.SSN!"]$_-Y';#T]X+J\,"UF'O*`"^:IIGSN)3B&;:[ M%(!!RD2!*\[D`;UX-WBDS\<\>_=EBITM?0;_^[4&TOK8+K.0WG[\XO_J_X2$ M_32N\DOX$[*4'S<")8]DA]E+8W$U7/6%S2I^T(F?;1I)TH=,0A.+)QXO]H)9 M31OIPV(62/+I:_C_?G6/45X&%Q?I;3PK&%P6E]5/QS/CX7'1'ON[DVX`&9?8 MW7;<.5L+PHLBBXH&`8*M9*^Q,@\_$\AA%*<7>%6EYCY=8?.!XO9^%XZMM?E5.\22J(JO>KYF MZ:8I*XZO*Z[I6/K_9^]:>QO'L>Q?,?;+S@!)P(>>.\``>G&G@.ZN0G7M[L>% M8BN)MFS)(\E)>7[]WDM2LFPY=IS(CIVH@>JJ*))X>7AY'Q1YKM^EA72W,&WM M%:F'/NSB>#&MR'&XB66\HI!1WS`-2S/-1PX0-+2\B M88C%$/S0P)*QIJ:K=SW/LCI,*1#Y=ZNGK1H_1*Q=>A"%A@7#'UK"\$P[=`TL MN:I+Q_N,=#FSC2TD^GO%.KRD.;6X&01.Y%//<5WDN#*C6B[!@N!3'-.6MV^4 M-->(GI;XH%WL1QW['V.J.,%CU!AP3/,GB`7`2B)C`5(<0!#W,ZFN%/N!O-BJ M1HZUND=W:5'BJ=TK_:]\46%5\;24M;3G('(^07\B0\''%,82&\)`MBYRW3KC MO42++9-7-.DIG@2&L1CEMY#"0KM7HQ(DO)[ECS4#`[*[/:402T(F=(V!I#P% MG"*OPD8%22ZTG^E*'02-N@RHG+-A\E8XN.=!4:JEJXI&)(QJBO^&M]7ZE0 M7-4@GT`W6IP1*Z#D\*WE6XM2W2-;4HY,PPL1`S:$PR![W/R@;ROK(%2253S$ MQ7U=GEW5PY$/3585<61E)]/8N[*R8(B*#VF9`30O^3\!%AEY3 MB]1P^687;+?+Q_?*'N`^UJ99^[80 M^^P5J8<^[(P$&.?,(@$!>3T641XVE0RYS;OUXQWKV4#@D#Z4,A-4+)8UNQ$6 MK$H?T5X>3J+((]]#XG2(&D08D$!85NVAPY":G>B+*67:Z,8>J=[6C1=P5+J4 MPTSED2<"QX08B+&H+J=J^)1VF*(@+#MU+UY"'(EEH9'!QJ.@3C;G=D1(S6KC M.WZ'F)%N*0O]QFYT0L\/2-WZ7YERT5A>K>Y]3>>ZCX??\3@3`1+,NX)`<,U] MBT:F12R81,SNC-`U[=8A[P#^BA'Y8/S3;QB1R`AMXONVS2PF7!JX#M:*DB,2 MFH;?F?K76ZH`O'%$/B#I]!L&1%#+]#TAF&#,%Y;K&0;1`^*9A';99?RJ@`)%O$4HIH%Q.7+$+KS`R/Q0Y)6B/@B*R0!LY%U$!F&W;I" M-`<+;1T]:7W!,P-[TL">="Z"GG<'+V1CXV7M?AGP&1ANUB@;:X;2EVY$.*XX M2"H[J/J@ZL?0+>2+/@\MEZS5K]@O-9P4W'@N7!3-!V+(C"1E,GY?F/9X5O^, MH#P[^]*[_;ULPHV!I>7E!P-;EL MK7FK`;N0A9Y3!K+5`VC#_8,N"2(K@0QICVJ%7W#+Z"ZS.97H<.T0: MYL0'GQ,]$DY\E#DQK"N]S!WKJES:(=^ECSW[XS."]'*-TL?AQF&=&:UV-0_CQ-Y7ZBC->>=EP_-_E;4E5) M47Z]"XIDDE9?%U59Q1FJL3>#`3J0Z$6VQTV+,26H3P+"S$U!+<+=38JI M5N,'2+4+/MOS>&#X$;.LR+"X$X2`H)(J8+;1D):M!(6,PW/(^%`&3`3)?5#%TB()TCUI1SV]DD'=DGTEL[L$L# MJ"4B-S(#API#A,SFIN0?P0X8H1=$G0Y0FQL[P#ZL`\&B*))#9Q<)`E>((&*A MRZ/`=SV/U)BST*-61V37,#<)1KHR'"[C+E@YY[X!BNM3@T>,"3=P0JW"G%L& M[R#,O*YZ]K9@V1]J;!_QE\\]_I$F!I$;+WY#0:.T$?'// MEVP.IDC>P#?.TK=>^7L2HPAHF$61_'.19./E]O>U[BR_)V/H)IBX/:?H?9CM MAF$*&'H_M!CAU/9A\HF`@ZG@AMOE97%V#/\6Z,X*9OI>,',2NJ"M5F!:EB3T.."8&;O!3.$!PX-(K`--C,M(Z*^)Q3,C`?"[\!L.CL< M\#FA')55BAQL7^^:N[EP5!G$W&0[ M.R;N[*/BSGE(B&<)BQ*P*D80>9ZF:/,B+^KR.!D.Z<3&YXG[6?E(0Y@RK;0WHV' MUPG)'O,ILN^NW].%X,L?HJW9W&>NPQW+$2XS`S_P?(=9$?<,TPM-H\-8NM;W M%_2G%PC842&P?>8+W_==B&R%<.S(Y(%K>T$01LPP62S1;R57\G-X08NW%XIE/[T?@]_I7.%C,_+XK\"4$$+++^$GT?S<;-N+E?>P)'04. M\^9%.N7DB!B9GNT;'A',HR)B'F'<,1`C)GS.S>Y**26]8Y1G]S^28H;3X;`E MLL`);=]F`16"(_=TB*2">I77)EW3!^:?=A8>6ZT?(M>NY<6`0-8-JD8-ESD6 M#3UP37KQGA#+["3D$/-U^(O?(-+:IAV&001I5R?PYZYB53X](N:- MO8:(08Z#B#"

`W`,':,+QPJ[T]GH,)>?"!$#;-_:K-G,TGM" MQ'*9")D3^-!]1GS/A9!&ZPBDBZRS3FVY5E_VC9VG';%,!J[*(HZP`T_8+C6Y M0B1"#R#(%G?%.NG-:2`YE2$1S+=<2'WL"(-?'TQ)Z"M(2&@[0<>0G!X)>N.N M(V$?!PD:V-3VW8!;S&%@.FS#<=1TB2`V[G[6`Y_;EP$Y$)%3F53NA\0(P(X* MR(L%C5R#U!\1J0#7N\6D]A6('#Q;C#4#0LTCS1:3"M\R(?X/;=OEH0?AKD;$ MB,#(=G0$1'FOT,Q=-ZE'TA&3.YX?,!)"_ZE%?)/9M=N-C%!T,@##,=[)[9[* MC@@1"=/WB>4'`:4^6.[0K?>T1)QTXW?7W:QX<;+0C)GKAN1(D0@S78>Z=N2# MP_4$XT$(%E4Z&>:[8=11$NZ^7_Q^&D,2FCZHA6#""@B$\KB))ZHS&C/L*HE) M>5]*/MXI\?3B M#AZ,2YJ=%)?UY=$PLKGM6[YC4`>@L6SN$`#&]0W#8%[048_#$%%=6T=$P_0] MF<7PZ^R^WG_\]4[D19+>9VHGWW@9)D7Z")UXA,!H;PVCU3#7OPCV1R#V*%20FW2@S7WE%?3R9>J6]=M5BCO;(*`0LM M;M*(XL*/H+Y+=:058-D?^]_^_HU;OZ\P?14X1\&7702^+')=#AFQ:7B@OXYA M6%Z]0DY-)Q+'P#L*"2-*/D6YVRCB$"V<92W1$,>D2BN$=^=!BLOKZF,Z MC4>M#E]J]^1S7[/1[[AS9G7&S;["NNML]!>L,MOJY@B/GOQ55L>-\6J!Q76G M4T5\EHSRM0_OLQD\4.+^>?R]@NP'2!'/DT65CLNK=L7B\JX2Y34!(E#5?%*.GAWPZ75[G3UCS&"5))VE<+-5[U+.EY'69)\I? MJ[+!ZDU843=M%?#%%V+!7#SKA`9R=)=F<88?T0$07:4-GB_RV6@;PG7!8NA- MF51J,DU;!U`:.!_BQP2ZD62;-9[3`F6>)V.TBZ,[B`15[>$2RSD_V^2:R+(8 M-'9$EE]^1I0;)6)1_4U6;`>?D M"JL8(^*SN`5FFLDK\KUI.[ZE;?.Y3%(MLQ^EDU.G$ M@2_31_/TZ3LI]`0U1T+X'WCN39_$Y":[82-XU72;=7M-%W!>C.,2IBT6S\;J MX_!#8T:NI&;-XB7\^0G:"/"B2%B].EZJZ0*/+.9RCF>C1.\+QD=4L@*_/1DX MIFO>D/[!J2/TJEV%6Q?S+I)[+-J(-<'A9=!]Y'VNH;ELW5:F#*9OW)0LOP8K M>0^6+85T?OR0P;C<+V4U^3A;@A$8RR+HVI)-9!C:*5Z.+@E+G*..C',P?A+7 M8G$OC5(\?D@3:3ME6?MK68`3_1<6HFQ9-5TZ?31/YXDLXOX`#D8:W'&12/U; ME.A!TDK>.R_2!%I=MKS5'$8-C93T%EI`?.)9X639>'SY:)*"H\/Z]#6=*+10 MH<,K00,RK->X$G26EQ7,FDC(+AF+KN2)C0IP,%Z__V; MNA*/YO!:T#TTN]BPQ`_%'>/;"@EMO*AR,,\+@*`6ZPK';*P.<\'[0*XYH).T MO/JJ!'V%$Q;E_9]6Y*`&'D8CR1ZP)>EM(!T&O&!BR9+V*\%DX(#.#P6;PY24 M-D$ZJ6EZEUPC\2IT-).C,9UF28G(/>7%=/*43I++GB)?)3`U%BU#@1X;>J=I MYQI3B?'(N#E$C$%1RV=#^/:0CA^4#YZI'*N:A#O&,%OP#3J:PI1S?7B[-@V52P9(65Y?&Z5W([3"M6C- M0ZK#>DY//JR+N).Q]C.]5M!N0;142E)*D[C3L>A72?BO=#R+TZGU*CG$#QCL M@D8T7(>;\_Z+TH#-JU^@R_!&:3GD87>]4`:29)`.H_V[PGI<7_X(P4Z!ZF3W MI8H+5`C:$A7$O'B_!Z9PI:,(:FO^K4V.9^>[\CUQ>Z[I7%6F(>C+1O$!F80.VC$BD&X9]09X_K/A3+;M^AY4NNI^FCO"8[@%V4$0KXQ?$8`H^[Q51&J]-$64@( MH6Y!C#QK(E.5V^>0Q"*6A5[1Z`2QR1W`?.EV[D<'\W4K5D$\4.H5'#V?V^K4 M+':`;2D?\J>LODE5,[]-D/'IU0"]8/5UC8?I,]5@-]Y8@]TQ3EUJ_#0-?FZF MZ^TKXD/!X3X*#H_4M@'EXEYJTXY<\GO#G[Z"$6N@J=VL6PY19U_$;+VR!)X+ M0&=16?)LJ/RP()5Q=$3.9>Q[I.+[A-Y9V9=G%@Q>XYH_'*<\M>F-W==L.I<1 M?Y=)\TF\M225?VD&VYN9'MB!!W;@XQE!DYL#@_KI;>OSW,`G$^P25@OGBV*, M'X]&\R(=)_C5*Q_'G4U<O$6[N,*\[WU M)1`_^IV'5)]UE;37_1!Y\5/N'(_GZ;8R7J\-DX:;A3.V(PHTKR80/5>^]:I@32KXNP>SSFK-8#S"2O8*\.*%T_O7D?Y?>L`\QAWXK;2O^/MPS0N_GYZ^"V M#]QJD>+WJ_0NE=^C\+"X^G@W>&@T;K;37R1\+L/^V3WT,;']SSR?/*73[G+Z MD&"V`U_3NN%#@CEXJD,"X8T])<<)D_K:^G<).ZU.M\-OV,CWNHU\EZ!%/5JW MY_?KO747U\DZUMNNKM%S(FUS`6K/E^&\Q&*O*^BQ-CN!SAZBH/L&;[Y/[-ZXLBMI]DI-'Y9I#@?\3JIXE)`R1/$.X-KO.$DE MV<25YA#1?$7:=[=NG<=+.5-6="/UK6VZNS?;D&$Z?IKIR#[#=-SVR;5(INVM MURLN-$FE`KU9KEC1%"](VNS;GN705]S-XM&B3)!-`RF^3LG?5"+!T&@) MCK:[[/0:F%:\,8C(BO9GHWN2DT=#,]B:P=:\\IO'![4U*]>O/7/S)4IS7>$' M*>G83TKU1HT;NU^F-XQ!H('K3C_7OKB=MI.VVW,OWV[?+N$HTQKU\ETG_-P2 M8];LB<]O!=S&GBQIWGY)KZ(/*-WF^4_=\D?CCVJ[R5U[O49/<'JKM MC&,HZTK*)EYX5E9L09&Z=N5=A57;6%D;,E9$MB%06PGX8GCKCJYW1$._H:.W MRSKL235GW#@O*PFL1K7N#;[U^8$`(7))+J^*D@-4C^I#H;X7)M5&.RL*P`*C M.AB-!K\6O6'SM-PFI#G_ZE?@1\@6_B"!IBA4\-54@^KMBDF]E!N,_@^/""(1 MNF0LEIC`R"^0HW5$V(YC%$F]I9FJ%6Y%!H@SU4`#^ZE_8Z";' MX@9.$N=R`9K8!5J2ES88(/-O'14K0YDKPM(2-/ M:F'D&Q858/DOI/VD5361]E$3#DN)/,E.O4ZDV-DD- MAX)U@=S)50QXI5)M5>0/HX36HM59J1EIUAE/"'3&17J+YYQN(1FZ46=2M]@- M\,EHF]:I&6,4HLM8V)G"BKNP30*+CN11;9U;5'TK)1]IP3+:.I8$SF"+G.#(V5Q5HUD+EAR`VI*#3$5:^*,J' M=*XW1';3]R8S11;O22[I7)6U&"$O.S)W:X6HD"*VD:[VG=)J8).211A"64!Y MGI?US%TAL"'>9D\:-M)VM^.UB%DI]_^S=ZV_;2-)_E\A@EN<#<@^OA\SN`7X MW/'"B7.Q,S-[7Q:T1%OHU?S@N)9R&0([K8PT2#P:G=Y.8:MR/2`,J]!"V(E)?+ M%4@![?N\@ET`VOC;%OWW38D+,IKH286%;*2_AN;"&A=ZT/,\8L=W9R%II;TXM7]WDOX/JBLKZX'T/\#E[3>H^U("`8Z9LW]7V^P,5`S)AE[\JAAT5>&YD* M[`+UIQJNRU.$=BO&QAU)P,XQVV@.K1H'W673F(RAZXP3'K4>>.$T4#NX@S.KN9>088C M5V(`W$";G!=8=-AO\CNM6]L.,Z23`1(XV/Q/"D(?20,]`Z1RKWP1?.#`A)0U MU50G(6&@&QBU:$A]S$A4JGQQWW)8+`&-0(<>(GQ*AVD<9]PI>3!9FH:@/`4^ MV_G!"GK$:+:5H(/:Q"K?&O(@@O,?P<%%42[B`QNQPN"6XH]5JIVZMZ!,Z#8C1J; MB\.?'D\(6PD/^/MGGN4XR7P"24Q/>A\]_>*/(QNR9'C.0>6"S8]A/&3W#@`K M64;J1,1GRGXFO'404M9W]6%$_;NQW<>7!VS2-@4L(%A]4@H[T_`@PQKC^MF7 M45\T4U*>.TR][8V*]NZ*.]'64O)PLPOCJW?N=MRG]&$&V,+;'^XQP%#R_Y3C M5R+';'))^<7`+JTYK5.]0SK8B%KE#7<$9QA-#(@,GI21:6'GX]G`$:F,FG\701#P'F51U/R+#EVO0](R:+($J?RI` MB8I13.[QK`;Q;P7F_D48]5LX M]^"$W+\E8SS;5+,V7,=YT]P#;0PG,@"T/V-`^S>P\:=@H2[:_WYSXBK8]F%L M^;:A)WH8^(EM)4ZF>P+;WK)2%U[<5"5_:]/.WOS5<`./G2.%J<<)^H/4FX]0 MG^F^&5B9'YMVXL2N;81>(*AW;"_11]2#K?*'J']7K!'-XWU3?RK!\HWN/X(/ M=59Q!_X-O'/1@V$/.$F8DW]<)0-F'(49PTL")TAM/7)"(PK=V$_$4@1A&/G9 M-C.FI0=;O#R#O`/R93W.5^(X3I`%1FI;69("8WJ2,5\AK)MIC1?)MK<7Z8LS MAGP9C_,59WKH)T;L)KX;VE9@FHXA^;+B8+1>CN[;GYFMC*'2JUORM2DH=Q#1 M3&T_SOQ,CVPK\M+4B=-0BJ9C`5/;K)Z8MN_OQ^N>)'\V]O=8Z,`VK"1P8S,R M#&:YIX2_+79WV<#ZZ!-(]=V$CP'=L1&S@V MTM"-1OP[CN5]>?;/&&3VX,(?!VF2I;H5Z7X<15D:&ZX0_BA-TB08+S_P[^[' M_YXT?S;^]Y!^$.8D-(,LL6+'\BW#BI-$[/W4]&-OFWW+\_9<_*_-_#ZR[QBA MF66^FX5V&H:N;X:F+95\$,6CP^O$,?VOL/87,F'JT(H_BYTLRGS#CH,PT2TG MM.3B!Z$>IB.;1#?V97]/DC\O^T^LOA$YP+KGNX$/UIB9@A`X8O5!(QAC]L$& MV-,F^]KL[V/@)%&D9X9A9,"XY\2Z[@N]'[A^X(ZM:\]SC<_+_1DE`)[7+9CI M?=;05?VNKF1T$CYP1E'0=OUL<0]3/XD#PW0M*\F".-!])Q4<9TG@C73=D-'G M$7=PWIXRPST=EBW.$MW5K4!/HRRPY5:VG.S5\K:'H":AG=C@)/F^[?BID\!) M+4]H)_2-$6LG.PZHPS'X*2\7_&Y<+Y=U=;D&%YZOK]LH;\OILY?.#G&U0D>/ M+3?QPM!"ME@-F7ILCRP0<*""'6KH.30>CL%]%$ULZF9J1^#,.V`])(ECQ7+] M=%!"(_XLP]^A:+X.?_OIE2@*,\\'QQ!6TK>26`HH./9!-HZRV(YKOC8&_^>Q M'9B&O@=>ONDDGIO9L0=>OEA!P_:#T0J"AGUM"V@]QE\(P_!Q9-#X-8-T$6'L.QD=[.#,@AN?.,*0BU,_,/V1$^-Z.V(U7Y$_Z_']YQA&$-B&GQEZ MXCD9,*6;B6LX!OJKCC&.'DJK%>AS*DW]>+%AIQ!)P%+EC1D17@O@JLR+,2]\U?MY)(U&NG)S#4]JJU?G7I MV*)3VIW63[4VG.LQ/-Z+KG#[@O<=_SJKM*RX;C`OIO\A+B!G=XB(8[Y0J;Q< MY]4L;V:M%M7PEW:4A9?1L5:V[::8[7[PXXHJ+WD(WS3U'T$05TTQQYO93X7& MLJH=7=4KV"_P^^,?>G*T#P65SW"]G0#<@A].%YC32"58%YLU9T].-TN1ZG=! M?6IV#=-18?RH'867'RF[Z<0\5C)TM/['6E-0L5*KY/90+0;2Q'5K-S>878<% M>7WA`&9."/JF(J!0,Y&Y0J1HIC,@4I3MB>)'!4H195HKU\624O0JJN&A1TM1 MT,3%4=PLI%&GIVPE%[)@XN/IY:F&-^0-E8D"3<6*DG3ZU5LU\/ERA0F$1W\+ MP_?'HCIB^&7.O\1Y:0J>F9XP=4*OB,"BFG&AA2!G.*O;:X?C/F]/K>_IY7158V:&L=D=%.X?YZ`BA4BV5FG5]6^#G)U0^!GI/XF=,-\;V#PL]^@?3(S8)R(Z7J!Z6^CTY_D\!'/^4H M2%P6]E,QN\4GA3+W#>?X!XW:D[1=!21\'CY+&01:VLGDY5V^TC[@1X]@P2\^ M%4V%$P`OSXK?^]\>\S:)BFHZQS1KK8N$T;LHRTA#,3A9137E&T7C&_KQJ:8I M_T7!7Y:BYG33%GO2"@8R#4DML\P?9H#41RXJUN5V9I6,U;05*0M2`4%?CZF,?V]`(F_N92D^[=*368''(*GBN1`%*N'#_3HO M5^TP[98W-^L7DD##FW"ZL?:P)H&E^E.5O%9Z_X`J$6;@%78LD/K#L\$8!,N8 M3LFNF@#LAH]5T\.=PBNH$(J;&0@VU,DPP:FO\ MS0,3QF4XK..V%NP)%7<#-ABH#^IV)[IJH*99=D825@>0=0:?YLZYG&DF8Q(Z5A;KA1R(0%1AN$HQNA$&QCQ*A7D+GYV/UG^*C_[R4 M)G=*.>BQ="O:$)1$]]3NH=^2,#Q\/9"X:>88GI-D3F1;7I;&E@C?.5&LNU]F MUCK5V<>1GG^3D^B>GNFIY86&`7_;H>.*0+(9)UDROA.WW>U(ZPXZGD?H'G)J M.W`PII%K.0'&[]W`DS?9L6D8^OA*S;;-[5O1/TSG/G>;<6HF9ABZ:6@!`9;K M1*XO4RRRQ!Y/J*_[VZ'!_0D]1V%I,ZKI>5M6Y7*S?"_:3"3[I$X/8NZ.Z[@P MF::>689KVT8D8])A%,?^B'+3"K;OA/:DZT7,Q*(WRK-X,B(=])H.#`2F'=BP M"4V9TVJEOF..8-OBI^`>=7\_B3K<3/;!,/TU=5S>#6$\3 M>8\.NS0Y466GV5&'/J63/:PC&B MU2_@,'$"T-*N$YJ!&]AXK9")31AEII>.+V-'"9?/)O!%_%UA[(_-P6?Q%YF9 MZSL@G9D?1*%N6YG=)0OX5CCFSW[A"O8$/LK?![1YN&@9/:SG)J^8<,+JGN&# M46B%L66'MKR:M$(C'&TY>W0S^2@Y+Z5\'V/&M[($D_L"T.R>YZ6!&8E;Q\0. M76=DS-K&@R?OP4E_PFSP(]W.8M\+TA!/*]!W;BQ)3Z)D9%$ZHUJ9%Y$.EH7J M/^_>V)VMS.8(^-[A!IPI[&4R,*7)X`ZKV7D-_MC?%<_P*6LZBXS(T7W3UL&L M,]-([Y?-<:-X+''.PQMHFZ,MSIO;'/QZ,J9CM2D$WK&V%S=J$$/:WPEU,J00 M%S"G.'3HO)5*6=L>EZQA%GBI#VHB!@V1V6F@2\N%0N\-3HL5B,UQIRD]6N<=VL:MFX1]Y5+^CI?:-=EO9KGS3*?%ANJ1>YJ=OO^P$5UF]_V MC4,[9(7)H-L=MZ*5O7+%MD4A**NJY@L-?+W)5R65@BN=+.&BQ5"Z7 M&UCQLKI9Y"!+U"M4MJV#T4EEJE=DOW#GOUDQP\MA_J@RZH,-^@947#H3)DN#C_5"VY7TW\7VY?"9QN\.L3Z9@04G>+CN2B?QOY]LP+;HC;4 ML@\D9HU;I$(YYFMCOKJ0(X.X8?],VBW\'6KAEU-/XB9'7(4-1B'I:F!!-P[Y M>GZ7W]-=]F@J&8AAPO^KE_5LL^BZZR@/YYMU+5Z0TRPKNH$L$A`93Y2+BQ_N MR7Z]0?_]8`J^(H78X8>WW+VRC40+X*Z=D6BCIWU(?SX_>WN6?!=="2;:SV=) M^+_A=\+L=]7Y;Z*]OW@;GO_C\NJ[8/>_SMZ^N_CYN]FW5S^%YQ??BYKJSYBC MDM,S/I&9?#4'"F?U$C.@I,WV:N;CZNW!Y^%XHIU=7ETDX:^OA\W/V3.'+*?_ MRZ?E&IR!BA-"RDKTUM>.R+P#PPD(EPD[W]%Q1O?Y'9:$UH+/,^5VG1+"0IHT M72M%;D+_#JQWX*75WI-[HH5_TX[DSXY%6F#9]-T_LXLX/#][I_WZX;N8UU[9 MR)9+G#.J?3B[PGGXSB:!'Z:^F(A?PGDRK>C%C0U&2^X7VM2;VSDWZI<^OG2E MKGHG1W'M[Q60SK[S5=]2_D^/Y\447E&3>04N85<";J<>&"]``*@B#L@X1L,. M[U9@YE3C5@<=:L"B7)8XFFRN3SET729*@3A!G%=\5XALN$HVQNL2_V!\1_\+ MAEL6,OXE>N.3I-R!\RPSZ92\`87![DL84QBBJ2!X42G2AHJN)5_#*#7+8CVO M9Z=]SV(U^_D(\Y&.1Y`6W#R[IT*./<%$][RZG^S$KKCLEP"X%9ED!68H=K!- MW#500-2H30-E>F2!*4U]X$C)O>_S!)%?3L4>4HG+0\L7=VV=$3D",X*ZU'6: M8HG.T2>Q$VA3Q8A23*J$ZL"W_[/+$2<"7N\&_L;R%*^X$33EVBN)R4_O\"[% M;YE7.2-'<.#MMT*!+A(]MS=+"6^!<;6<2T4XU1[++21.CL#5$KWL!K4)#)PA M;&."Q&')C=C:(.-P M3,E^BTI4(,`(J4.0W(J.3'JJ`(\9S1/R0PQ,_ M79[CG]OKLQ6[]<5DV,VRV7RQ(K?^7U(WJP=;1PKF\"\8WDT<`(^`(TVTH^+T M]E3IR8Y-S"?[`J[+?Y>Q*EOH`MR"J`CO6V M@"--8'QMX7,*&QA5E4+LNIK<60+55@V,WD2:YM6-N=%G=9V M:'^PG/DV0Y1N+=4_Z;`"17K.8(@)1/ M^/7]2MCZ]-E[[>BR*,")7"MHE/;Q-]MS_0$5T-<*J3J@*QLJOK`Z"!<+6,F. M)%6,Y1X2B?JBK.]:Z(`6=0!N+=XOO1R=4G??VQ[4<"AB3PQ&&[;($1.2LLOI MNDN8@J#V*]K\?3[]KA)'MJGQIG-55-2=&O/RYWP3G.\F@`6ZJ]I115FW>I^&2+E_CF9"#..QX_U;)Z:VC8`Z)TB*L,1#D2.0;%JG.-A&J0!:#T MU$Q,#37P)SV`]:NS>LJ<;.%U#@N/KHOU'1K?\F/L7`S%4`R"9;;DM:!JQL(0 MV$?S,87T%_QY8C'3X-%Q3HF"TX>^4[ZG(A[OGHG?KT#[=DG;PAF]PI3M]*V9.13U119/@ M"H$FF(5&`,=R3*6>XJ=+1.JY*Q26>]7?X&/%3LZ(J0.FA4YX<$LI MZF/'/J95P+*5!V=%Z2]?MXPU]HQ=.F&?I")W%]%8?E]Q*3'^&,SG+KZ`,PD? M18!/DIZ)+)YKL4N$`/E4XPT,(\LG:%\E^2`G,-H,_5PNBNS(Z-YB5Z3#D*6B M'@$K275$2`H^(V,*I^,.Z-_VH1B3X8A_:FEO.-*4O^WMC\O>_NCZ>5#\!1'\ MONRQ^0NEE5!MMJLEV M^>M)NT+CFT!B;XMJ^LR'$:X4DX!.KO/I;_!CQ7H[>AM=P@&)\9NMSTSDVYP5 MMH+-E,M[`&5PD8DT%8$\E/OK]<#"9=$4I0*6]'O@@3ME@\-?`MYC=)(WY` M!8V^Q\@/6/X#N44#FU$Z%=U>#&SE80<-4N.;9D!].?`R:"$(](ZCD.K8;!N` M'S&@G5%/9"DVHS9TP=/!,!1!I(H]D&[0LVBJ3:F;CE"4!/Z*J6@X',WJW1QF M2T9E!U7/#Z+$4G@5Z\F'FG[O^?Q652.]]W9/+EG@P)G(0+`?*- MI;8]2+&^A65"P^33V)545(GQQ\H2+IE:F)#_^/_L M?>MSVTB2Y_>+N/^!X;N)L2,D#=Z/]O5$X-GKB>ZVU_;JQMD7B&3+`Q_1J8F%JI*Y0X1\>*\Q2+`TG8& M_M.:+=@$+L!8W7[@P'[/T:_`1-.8#^O@WR5;NAW-8`>Q=R]$=S<&HMEX/K8E M^!WIG;*25=9G*N@5A/RY0\"DO"/\"Z1MD=^A=U.C`BC`P9ZTW&HL<"^K6@P5 M9)0V-P>Y$*W=K_L6098)'2DZ.RQ3IZ(VT1,+H9B!?KDP/BN11;)%<)FZ`B[X M94\N+:0,T>5''FTF1!DZ@^L!Z>K'ST./J5V M1,/G)>`&?+?&0MKK'+T'\G2PP)JJIRE)4:^8U_A>^!XLKMJ=]RCM&7%(WO.Q M\_5:S'*JLH*F=F.B`M6&1(1B;/@S_HEA%+!$&G/K2&K9:8)O?@,O" MZFJADSEFQ6=PEDX<5N\-?=-&;H\!]X>/&5*#&'"/$WA%\HKB\:S4G^US>_%* MOH>LRI?NH8`7\J."'B0:!B`[<8J+DJ.:4)F,DWLI(J&C'0U;[,I>*BG(E5_\=!C9F0- M\._=T[QQU-M_C-.]Z:ZLEZA4,>T,6XZU5"S0"4=WQI>`R6PV%)!= MP"90F6K-=VA#9+S?IQQJ+(HQ[=8/"5A MP]$$V[C:B#*20,K5U!?-2@K&6(318IUPF///*OJ>>)C0P%2OQ,*;(F]'XZ5G M<-]3\@0/PJ1<7Z^FZYF2\I1[)"=[-TL8/;B&6SB(946I?<'C9;9"BG$--QPX MM#E9(HW#MEJ87)+MTNAJL4?Z_HT_VDI$/D!NLW'PD3D(L(#*(YQ)(@1E@]JF M.)P0=4\UWV,%7O#M>]I[@F":<=Y*1IR]:I.V&X6HV3'>L2N4\"Z'EL*@3\K%^66>-0I]$UWYQA,!S;]7*36FUJ21O+8K2I>PM#F9"J@ M,6F83<$=VW7C$%S19'21"Y!N`EQK^8PK\CJ7WP9R5O=+?@L*F[NE^U55Q@%; MZ<,=I516ZD1J1>M)E8:#?YOGB>Z_,5[H5#23L=P!2%9!A:2CCRHA,I?,7:&-6O< M7"I;]RG=<2RP07&!"VERJDR7D8\+%FMH!SDR[*<%TP9 M\:@ONC(]%4%,FE8EUK.AR:.:01LK)]J:Q5<\((BRE\WFZ'FSRGHF&0IJLCBM MY'(KA_U!!=%,2&9H=>!%K$K>?3OG5Q>Y>C_=5AW_("KB^-"NF:,[T&2M?!RBCE-1^3(#49^LN>I0 MT_L/&C=,4[+!Z-18P)6F:`C8!-3EJ/(M`UIY$-GYTM7GUS4K9T9+@E)DZX6( M$I!1)G2+#*B.1_Z+F35/>(Z'#^3"S^AB3^J]P%3_UB, MG6\X5$MX;,W`.[FCP?.*0".S,17#B^Z;J]&GUJM::^[SZW`/.)7D!+'B:A;> MK;X)C2S@&WA>EE6%@RFSK'-9YJ3&M<5Z6>T/`ZRFY\[NJ9Y=Y$\D?PC2]1LQ M;UI()V;II"V?P5'&,GR=A,+P$Z^7#0F8AA#^B9K!W M>;U4P+'MY).AB/T(Q812QV0KJF6(5$K?.?TU*SZ2=BVS?BCRT;9RY<6/AC3+ M-#;.)&O9$6=$"(%2]U\K<1`"/:>",K7VC02`-`>5[V#Z<9JA"<7RL_>*,-PV M!AN/H."H`V;%\Q1L/H6OK63_C73._KZ@/*/\'4?44SL!_0,]JQT7DA]`3'=B M$%N^ZF^CGN*A*F;W`.G%N)`>7>-8D'IMZ1L2+U5K",H)6P8.=#%94^A61@4: M$EBDB,G,$\D@18[:!+,O\![XATE+)XAL=36Z@].=7V(MH4C44M)*=B-Q5Z,) MV/58L+WZC$%:D]G,U$&A>/38Q%*,US,9KFXN(98PHO@.;M!R#%O\P\$O8;+K![Y[1)(_':0GKB3<<":8_R#G.<4UZ\ M4/&HR`4[HO1')6]-):MP4]6K2U2F["=,%%(:D@2BE5-@F09^O.?-GD\I<43L MH/K:BF#*RQ&H8(1)@COONBYG\-Z+40T47LXQ@G^[@0YQ[+AE,?B6.?I2MAXK<8\-5I&\P$8^H-X`_LGMG<(+:;L'28< M9K)^*5^H#3K"2*DQWL'KU&7UM3QBL/67DHY"$7\ZP]"28L+R"5%6XTU!>U:D9V]J=4>2])V-H$P.MFL"EBO6(5]RO9I8Z- MH[?E';`(LWW*KBB&W+15`Z`V80A5HK\8II2]%%(<`2X_O-)P9TBYB:BM4`#SOBH-*R0 M07W*RI26>&6P'%MS#B=<)A5S&T_Y+%LO**K>G/'ULN0E4POJN&`IGG^N)SWN6L3B>X,CUO7I>K^%"(X>5?Q*S%UU,0]$QU'!GRLJI M7ETM_2=T`BHL@?PTRWB``(OJZ:HXK7W3D+*4I.2"%-:7O6+UO:Q#DT,S*)/L M)CE>E@5K^Q_%RF^DQ7N>RKM.R(QJVA_A_&>X<9=TP0M(AG!=S,AU`$FH9$,( MJTGE;T+U^HT[HR6O^K*L1X0-3`=I^C\5%,S.OE?KN M>0UJB)#/6G>^(T5P:LR MSOIS67$VVF'HU/>T*NXK.MM$0/F.D*19/EW])"4)O$<\QOB[^M`%M<%UI4\^ MF-5?(?0E_\S/;[0W#&-S264$]/OC08'OBLGJ%GZ$-5V3I7Q)A>W+.O])_*"J M`%R,0E0E?T(MBJ0L?GYCO!E5P%SZ69>?_?^J?6$YLF] M3VN^J)N/^N(V,OJAAYB2?(^56#<5>*N32QY\'H]SN,7>M[;;V-"DZN]`%%93!X^E,D4@F3#NJ6^:/N!JI2]QX,(,Q:-*RRX?BS@P:0*`?\$Y] M)1Z+]1G=D*@(PB(2"+4A8*L2:UMJXY%0M/F^EKGM*L\F]R)Q750-W`(\^K6= MP@W89F:-)WRX]\D/(H7@,VJTFY:SHA25#0J%/2`I"JZDTDM/G;$-9%D;_ID- MH-+#6(*?G#;J^ET\IH>7MBD%C+AW*TUUC=10A*SD6T8ZP?` MJYLD28ML7F1"*%BW&4.K4@'X>.F4!.B0.)P"A8\7);QC\!.CS65W6=]"CR%6 M7^?TJ$W,F>X:LGI_Z,J-`?>;8$*\[8S3\6<@M:!T(:\^*Q%U&-,\YRJZS$]> MM\ZD"AC$_Z(*RJ9Z51%;1?'!`SBQY\VJ8`,LJM6C3?EL49[,R@.H,AIDHZ!" M`HG=0N5/+7R./[?`9_L@2"@;2A7O#!QDM8D=(AI39.'2GC@F%[*(JH$*P30_ MW$PM/!(5?>0+#;-K(6C`MT3RGEJ`68=CHH`#5*`@B36EF`X>"_'P` M9$6^6@%&(:.G`0IA8/^;RV=-ZO4:*TL*:B1NXT9A>09F?^F#$O9$HI`UF#SM MY[[?$]"$T[TWI,E[JHL15T_3C2Q06SAJ0G;'[[`.3J<@\&S5U!9CC%E?'T`V M%S>DC`)2V*>N<)6OY_<%M_:G>*_F[9*#MCTNH;@;:QPL&%8X+A"X'S3918NY MU-;<;11H6L54FEMHS:^8`:;`Q[9*Y[!L?V`ZZML/GSX3]_&_\3M>BR>?L/ER M"17'D`@#%?N,>J70]A%&5NO1/0^CBDBV&ZT]:$9^-)?3U1Y/:_#AU"N-GG:; MH64_`3>/5]BV$*C901*@;GBAX:1J"0'%BV7;V+1,%Y"Y*>=<"(267:126WA> M\T(FK,!!5;M84Y4U]A8@8S*P7HN;&S(>V7EC]Q17B*ST3AZR3"E44XR(5Z:B M?BG+"1:^GE8GB;>B[\*FR@AF!5$Q%WZ/U]P+3W&Z"<+,2TNE6I`%I\I`$T6EX2FDKS[O,<1:T96`EKH1 M[)3OVM"SA.;^.\;JVOV=VFL[SA^:-<-._EH",;]2#^./N'GI]3-ZO9BM(>91 M/Q@>ZYNL@8^B(D-%X6V[5?&486?FR>[4P48 M:7P$.B.E59RJO(2\WBUTR>_4I'DE1E1#$*>A11?S@@51#(9B$R!U`WE>-`WQ M5P.Y3>O!OG1MJ/_F,V=[_+8E$LC3ND%F1MPK9W<8!UV8KWV97U= M8[?V0O9FJAY,@C-+:!,X'>!&`A./3HFC)?`7-Y6O?&>BZT<8&25B]E]WZ.1&ZJ+\^V[11@@<6U25*28`5_*1:[TQG!(@H+Z`ZHUZAT1I\D6"C!S/;[- M)^LSOA>V"&;*9U1$A/LPOA]]Q4$7;+;+:27P8Y.HQ18Y@=^9\SQ/NY-5S`!: M+\:\]WPL%D`)!4S;XA?OV8R<)M#%$@L%P MZ$EO<6?&M MR_G0KNX7")D<8?*5YZKCO`34DGP^`T!E]9?$58+%Z!UYME(6PZ)DHNU+CA)C M+\K8W,76.YJ9+^R75C^_.J_GBEN]'/14SF;;9`![U<8[N#6(V7S1A4BJ&!ZJ M=+ZS1>#7619'"`3G4>_D2MZ]+R>^B&TA9N.WU(U$4L$&8(F/)E/4:E?DSJ!0 M_3RMW'1RU]Q.DW#U.R=773'1YN-\ND#Q&^+U0-9-2-_.*;$<+0&#*OBUS7DX M?.C/]'1X0X9Q;&0H6`"A":E#"DZX(%V[\HX,=04+.1GYYI7^'-MAT"K@!_U" M&34\NV?=O74NL=O4D=("M6+:.W:B>?!#6I\-1)9`#FI/U^PI8]H:F6^-N]F^NE'CF"_+0H".=7KSKT:_ M[4MDW?*7^OK\-TKC!+#A1EG4P]VO@LM-=[[@J"2O=6]1++*I\=O"]NY7R'X3 M>>7F&[>4.<7P)G,F7EU]'Q_F_C7[_@,*J=AXUUR)\J@VW7U_])J!:A#5*Z0: MYP5-V!CM6I883?)I3L<>/J*ZJ)OVHFK0JY`7;`@XJWM2)EOV6'Z;D1[N"L-K MKS-N"VQY/S-0\P73%_@-9J-BVI#-,I_R(??TMR:VI%0I2#(;R1>A-$1TKW`* M5Z`,SFTPTXJ:060W0K-C4$E-%5,"7+XB_4@#$KN\;B::4$B55\8RU#,>UF"M M[?DBGQ8BF"BGI=.#)&R0R+>SX2C9'_F"%5I(%"T<55`NE#.!]0=KS/[C&%.L M\2UX]57KN5L7RR`[0/K(97EM`O^9`?V//K.=.)67+U[;S*3)V/#09M1"*[;* ME'*QFO'2;HYRQX:#MO%C$,D;_1IQ"CFPFH#.%Y$I!M7'$F^$O_2=7TG2[:)$ M^B<4BEJZX'(6UP46*2*T"[]#T*Z\1GF]X$\6AXX!=,KQ#3PJASTV-2_H9$,* M&($9*W%A6>()_(E#/DG99.J.KV"N8$LU=V,SC$'<:5+6X+Y6JQPXR$XM],." M!R6_E3,P4B^9"FS&C[%`XK7J.8LA?XQ@5L'(%5=[6R1S" M&YG7FDO08/"QO<9!)?!3-KM'=+)S%5\!5H4L8,6R[5,F%3G6DTFVEXO+VV;& MQE\D'*R"EG/1Y'IR[/@2B^M[-8:G8'SAIJL/_LR_`/]$R,`3^L3%B,_0NV"GI!D^G8/`%6)J M)7L;A[FOV71'DGY>Z]4,LE,V4)#8G,8M],"^+7JI84=T)R44'E,::Z//,"%0OJA5+X2X/%S2[L+;O07$W2^>90 M;&W,ZAN>FZ`J=UXEQ567N(5DY(%940CC5Z[K]G,HJYJ8=D:JG\(]4ZEB1S?2W?#[S9,`SA*N)>;7\7L(+I3%*Y>?7BT(R M#C.A<'NT)L/QTH.6KBY7E!N>%%B0N>N@P*M MBH3\XF\$/#D91?CTC]5-MN!+H5OC-PQ!-8?3T'1-U1<$G,A8W,1ON#6W`:RY MUPOKYF:=]!VIUG;1Z!RV74IH;H_WJ"L0V,Z$,RUO$7ZO71?4\R30D-743<5C^??Z*#P\37-G#A"?)3C_VB_ MERO12(80Q6B*EA3S9:,'6FQ0*8[7!ZMN!1NBF?6\12XNPD*&;I:)20*8[9W+]EBS7<,`UE;!=U&J+( M<9(0*!C#*LR[R=>K%@`TCQ+0Q%1IMQXWV<>@-K0_'6?[1*R'*4&VU M'+Q^765TC6'-];@JEJQ>JUK?M'(TS?5;H4ZM5@T7XU%4\K*'7[)ER_-34,KE MH2$;&M\-?USS:!2A`/-GW&3+AL44R"87B=\F3,JI$DSX#EO)$O/@P#Q"%W5U MT'=I8IRX=EL#[I2!7AL.A5!N[@BE8K&J&3U>T>>I9C:_.V M:4I69TCP"7T7_2-^A84GH(2E8F=QVR598]('8!]N,CO5&CR'A@@X.!==2.D^ M8U%)%#33-%O&B-P2\JL&U^()I7DR-PK_@8U1K"+^AET;[GH`O,H0ZGD M?`[51FE?EJTP)AL-*BV>AGY%=PX:[W"8+9DBVA)%45/2*QH"(K+2(FBNUH7S M3G)V%=XK1TJ4-.'P%V68VN;!D=^45UHS3(JL'-;3@8&)?,)5VK^`:#8]7H9@ M5"=(R8?Q8AG4BUM6*^A!@YBTIW*U;A+_(4@>7@\G;T2N%1\ M0Q][(=[!$]W,>9N+)X"-7V.9S^RB^1L6FU=Y+@OJBZK!/JC[EM)GK*B8&N.^ ML\6+27M"*OV+;MLVHSDZ3,P7Y(&J#6IX2.OLDV^/2*%.$<`)6Q89>[U0.Z"VR:>^6XLA0711%%"1`(]L:H6Z3R68J]9# MJ>R(??]>--CQAN;NRRZ4-W4Y([9&%@%2=T;1Q'C/]AANJ?_Y@IA;ER$=/83W MA&W]`:T^2O$?`P%CLC!6")(=/B4;0@)J"NXP/F'D0HX>POH7^A=,J=2CMY^_ M_+UF\!2@S,BXA;/.=>*V[WS"[URUV+$ETK%OWT-;X2J=I]UN3]:PEF%C:\82 M&/D64A0Z>-BPIDZCC6CF8DTA7A02]FRU*O`;8;5-:>1Q]@='<"LW6QC;#Z7' MX#Y,SF?C8%4\+R)%VXQ4/`&S$!S!:JQSGKI&[F@.:B[7J.XQ]I<.R.HX=DD\6YP0O^)@EEN/D..GEB&ATO3CU? M[4K?^]KJWZXWM51K(YM+4A8PBD`%$WS>&C<*9V"K7WX9DXG*HRXV>S2YG.3?<3Q? MG6\U$.!*H09],>99]#CB^[ZIZ6$"E1/83O=L6&+..LNK'%8F5'B52U`?02&] MC7MZ@B5<\%CY<<]&?&4M$#A?M7G7KG<4+'$#WY+6!#.&VP&3-9^0*)C#.HVY M':5\BZ>WI?(G9R];L?`*HX37O<@@"Y\F/KK/5RW#&O,JQ52II]Q\$<=$4HKV M13-`NW.8%=.QE^-Z+C&DP7J*VHMZ;4H*!\,%3=?+IZIGWWXMEZ`TX=_?_=2JU!3-_'"F`MZ`\SD?ST"66#CRXYK.6Z#,?F0` MAGVOD53H[T=O`[A'<;V7QKM6,:;\L[`[:P4D@$FK*/SA?3QH%RB8RI6D;\SM MT)(1J0ZH?*";NQ15*:*O=<2@2@D:G(8+2PU=M-2"**A6V%/4C?7,8KH4^VS, M;:`I7Y+=TNP>:#'8^B7:)V]_"8)/[[C":3^9HV4P20BG_%BQH>4,6_`6U MSB]PQOJ8XYMPN%>^;=.L`8=MNLA8";RZ<_6(@\BQ$`@5ZM08G25`AJ+&2NEU M):O!00NS2/DVA(('6$X&JJPRV<"QID29A,R@ZPK3#S?%@BJ*F2\I"HN4TA2; M51AU7COA5S4*92-*DX)=)*SZ3E:BRY[L!4-7D.MJILI7_0`:+S<=-3OR*(YG MIA?N@;^MX2`HJA^4^CXZ_4T,#_W&.S#04O@/WA7/E;FGV^]^8F/O:Z7@,87' MI@1]W%0^?;G+EJ//^-"WL.$?,76%#(`O3_+OS;^^8V(2YHOQ+5I<"(O*X.D_ M\[0$T9"W;E:.`O-&T?BZ]NYJ-%)^Q8,_+SB>X[K.]Z25RDBKO.E,XZ4VVQ=` MZ@.-#S&77::CE(0=J8"W?__RE06Z?BT7$_@PK?4Z6_PQ^LC+(Q@1OWX(/WY^ MQ_I;V*.N)7\D?'\E^'-+_%&5/>%DNZ+'C7`D9R6)LIZ1^?RE@-5E%W\8/T!#YC'Z-R"5I?6.4?"_J55N%Z&T5HF^Q%ODE MSQJ@U3";XA+Q(EW1/K6MZYH!K*,-T0QKI8;9M[]__/4=:U272\0<(E\C/H$U MUK*?F<^U\7EX'IM"0K"/\)ZF39]R)V_U=TPY]G=Q,X>.U2C3YX`D&LC#3#*5 ME[Q)]I:YA;-,XFLUWN3HG^!!UY.B*8=_:[#7"ZPN&H93,^\WYR7=O0QCB7NF MXS8V;(>*FX(-!NJ#->A3V!NU5S&71A*&1SCUUL-9Q&W%XR>0<,S001 M(%)`5]R$#$"U5C23C:I>-TNZ32HV9;W*I"%1LI1%431>60R+Q5_(WH&F2GJI M"A;&11;ELRM3\?/_^X*"(8@[W_,]O+NTWHV("_P:,N73C.`ACS8Q"W?/#Q(G,-/9B MQS6,6'O/FK9[E4(ZG9D6E; MCJ6'X'<;OAU:B69U*/><)U-.&?^#J+6")(B]U`JCV$\U5PNT1&=\]A/#BSO4 M6J9C]9*KDO!X$A\Z"KZ;>"DPTTM\(["T)(AA9_EQI!N6 ME6IFK*>!DS)"`RLU?;_#3MM\8,)'WFQJ=NN;2:V[5L^7VOD6&[GZ%SZ M7M]2C[Z.D_,JC=FI>(A9CF.$B>WY1JR!3K)-5T\\SJS0\0QODUF&VWLN7@FS MC(>996E1$AEZJ$=QY+@@-G8:"699<>ATF&7[9\JLSQO1UN:=:57.@X_1A\\< MH>CORW*!K>4?JU\+,-69F7$PAX-(TQTO]8&EGF9%D9T$-N=PX!IAW)'=WFOT M92S^/'9E#X4:VW#/^;IO>[8>:G%@@I80FQ+&1N?8Z\.>'$%2=BANPP]-UTX# MW7*"Q(P\UPS%C1ZZNMZ1E'/?CX-5BFW98)A[4>B8L1.%O@.6&F>4&42)W3F] MQF-TRI$6LH<4FKII&K891Y9II;#YX&7$PH0#?ZGC'.GZ8V[J8V[(CI,;6+`C MMAGYMI,Z>JR##6V(A42Q&W068IF];M[15_*)X?0%/'F/,9.OY:>L:VTWB_P' M?_X_9#UC0H,[(Y$6JX/O12T_I214>R_TWR@JL95S6IPXKA-8X&H:X&;ZX,79 ML9W$=NHEL1>X3S/6]F##,_/4>")/X:6_9,6"]!AHH5A&SC]6_RE#ZU%6WZ:S M\HYR&O4.CKL)L-69\?:I*@)>BD%Y=HTV`YO% M$=_!W2B-=2MR/3M-X,*+C#0.`Z$L/*?GWC/-QQANKX*]1]86CF."I1Q%@>D; MMN9IKI$X@N5NH'6B+)+8M4*P'7S!W"AU.I>? MV1L/?+&L?:HB/L2>\%/+##7'2/74=$W7,LPD%.%+-_;U#DO]0TSC'\W3[9Y! MF"2AY<#!LBPW-5P;ELT-4<-+["-Y!C]Z^3_J_G&<,/1,S=4]SP%!M9-4W.Z^ M%6I:QU\QSLM6W>'D^!&L40NM(`29"D+-]=.$KSX.]#0\DI-SE/5_PC^0@T^? M^E36*]91C;O=KZL/]L;#*$SB4$O3U#9,.[$C+Y&Q),\W.EK\42;?$Q;R@[BU MXQ1%H9]8093Z1I#H<,_!G6>*($\8FYU$W>6C+KVS8M<>$9+0L7S-F+: MIITZ$?B//D]=AVD*)L53,BV'+N)'L&G'H8KUT$XU9(MI6JFE.;$?"39I/5E" MXS&WXIGP:9_[T$A@U;IFIIYK6'H2:"E/ID9::'L=_^;9E=61N?1QH=3*'ZRA MP`CU$A=44Z!IAN-Y@2?S*J&G:QV=KEO'/4V]J_@!;-IE+%AA`E*7I'KH@^SI MAAY:HJK&T)T.FUSW,9;[6;!I#Y$SPB"PDCC5,#&>I)IMQB*W%;N1WC6IC,=4 MB+PT+AU2G)7&FFN$D:DY9FJ!I$5^*'22'UO&21ET2M[L%S3P(M-SDRAQG#"Q M?<>,N7,PSDFC*+%=+%\$KFA6($HM(RV)]&ZR2'\)S&GB M9R)JUGI.4!4(8,'JU#]1!?SA13H6^&_H_-H@8X%C!I8TM.'J[_#'T/>][@]? MPTEYM,\A,B-7MXW$]9THBGT=OA*+TE#X)ZM3R62;^WJ\Y\2DG95%7NK$CFX% MIA.X:1"%K@@+!'$0=N\P>]_ZV9?'I(/X$Z>A%X8IJ*(H37PW=NU0>!_@WG:K M,/;-&AQ$_DDYLT.\#!.8XGK@PP;@NSJIDYA=XV^RL^'8'O(7&(YIQ4X"=QGX^I;EF[KL-W[.UVO&QV'<`I MQTE2._11?3M.:FNF;XC.*UU+O)[RS&?FU,F9M(_"2AW-!`\C2B(GT!P]MG3+ ME$9`[/>X(\\M?S^&3;LBM8[M&Z[A:K;E&%:D>;9G"#:%J=D)0;KNOB'M([.) MM;,IC9=?*9EZW+UPN5??"V-9\Q[==/]2Q]RSD&?_0,MT@??/7#2`!%0#@ M:X&#"1"^ZG,YSQ9;`00>PB'8XSL"H6N63U<_282N@H#2Z7?UH0N$Z9EU4;WD M@U=L0E0^F_'/_/Q&>T._U\ML+'Y__&KOBLGJ%GZ$-5W3)*%+A#+.EG7^D_A! M!5W`Q2A$5?(GPE4&4A8_O_'?C*KRCOVLR\_^935I?JQZGT"T_/S&-?[4>D+S MY-ZG-5_43_V]D[_P=2YPVWG@I_E;7M%8&WX$&0K>^Y9X&1N(>.KO'#5/_5-% M,H=_V4FF(M`(;S.=E7<_W183$.(?,0*DS>R!/P_S1Y)KOGF85USS"7S%Y?<1 MH3B,Q%B@9^!E#_\4-3LFG*&C%L#6?KF"E']G^?[,P]Q,)GX!0=UV']?@.J['#83V$5X]P/X^OD&SMRC_607DI8O':OUX(F](#UT5";^6`5E'T]!;>7*2Y&N(`USNNICP&41;"CZ^%;-L*/=XH&J8&WV/P/7:7Y9A7>]=@_[OX'H-`_#L+A'^\0/AK$8C!&=_. MVZ_E*IL-9O\/+CUNMTN9R^^C2;G&UN>G]$N==Y7I\6J3=_'V]1%1/AMM&W-O/##FW@D"([12+4H22XO]V(_,0,P!'ME!F'B:G1BI+R`!4_C?#M"6[_=":C^6V-_+Q?@0YFI:Z'A. MF$:Q[X1A&+A!F@I@,-?3.\PU;;MWP$HO*8>3_!"+M=",?#_0M,#2@U2SK%BS MQ?A.."H=U$7;,W:Q^&&2R\7-U[R:_UZN\OI3=L\`DA[#Y-`T-,,P4S,T0C\U M#=N3X**V;<:=>1FZU0N_UD?(P?0^Q.'0\M/`-$PW%W,&? MNBR^M'J/<1\MAY"\#WBA"0+G6+X;FK$7V'$0FQR1%\A/_.X8*-WNY?*Q2-X' M(,]*PRC4K-0V+,V`@QNY$@Y-,]WNX!>]%PGV$10_'<'-21,XM:;E>X'FP6&` MN\01!R.,;&U` M?P>Y/[I>/.\(YH!\M'_RT'*O[&=GUUFH M8A\D8I`(^3W?'P1B"$`]>83`Z'*8%_#"5=,K:G+5O2O]V<_62Y&X(10R"-<) MA>N44R1>BX@-SOH),%X'=?2*W1#/OW(&-V00B$$@^/>T01X&M_R`6#DPM\Z; ML/C@)+P@)?1ZG`3#&R# M!&(0B&<,?[\6N1C\[V/U9?PR*]?CO%[EU9`M?Z&*Z_7X$[HW#&P:?/5!MIX) M;GV0K<%7WYN%OV6+]30;K]85T#>"GQ#>Y'ZT7%?CVZP^6K1^4$:OV$/1S6'Z M\B`0@T`H;;/'"YB_%H$8?/43S3QY03P[7Y7SBAR"(7DW.-N#;#U/KLH?NCX& M9_L'#5P95,X.@7J6F0'G@/1PNM$`/XACQ]?DMG?,$;`[)P"Z#']V/.ETLJV5C4D2>![ MAN>9.L>=M\-(CSOP_F[_$(6M%!U,_1ZS"<)4MXS`,8TX2IPPWK<3S'3YV)4R2T#0Z=/N]HYF> M0O>ADX]T74M-+712U[9,,W'@!(C!(%9DNATU8?CZ7J0_.$OH4=0_.*(G-,,X MT,/$M!/?BOTPC2,Z,&'J.([5G3.E]VKHO:G_E-UC,T&=EM6GJASG^:1.JW). M#_FP^);7J"6#\:KX1H]YM`),C-@(M"C0`LU.]=2Q;3WBNY'&NM>=++.Y&8\D M\,BKVZ$U8S>PK#"VS,",--NU0COBLWZ"Q$B2[NHVE>8/6]T^JC;R4DMW8M.R M#=?Q0?,:?.M@XPR[(TB=,4;'6MSG7-3/?)Q&Y7Q>+KZL>H<$[3(@?-=.C,@Q M@L!*0UL.U!WW'6=@^^Y2F5A*81J*!&>/K%FAPKN)\-!*[AJ$#-N^/7M<^VL!T M;=WT+-V+HLC$<8YIPC+O*[S^I>JK+N[9/RG M_EL&!]RY=/_!'_(/\9V@:3$(OA?U/\;Y[.8?-!KB*VC:;)FO5\6X!E?GMWQ^ MG5=;.9)&EN:GGN7Y8.]IJ:.%(*1\JX/8[,Z,=';O],:Z]N8"&.4@R%E]R_]E M\OC]!7L[%X'O M`[Z$HX-/+XR.5-?CCO[_L0O:1W?&@1!'3M;H,1XHQ7%L>WKBNU9B!R;8`8'NAT*MZF`,=B<@ M&SN7L$G34Y:PST$*-^,4W_L&O)%C9?R8D)'[E-9KZI\!5_# MAX3Y(I\6JP.S*DGHAJ!O#/`H@ACTD><%OA`+5XL[=K/1B9T_@KCCK&JOE?6Z>M0X;`/<'3,Q_014@J$%H",T.<$[==ST MV<=A;^3Z=6VC@D*7\Z]9@OJ?ZWI53.^/E:.F7^\8/=?E;,(>E,R7L_(^ST>< MN:-/LVSQ,&#M"UXC?>^_\E&]+!=U68VRQ2@7"ZRS;T!%3=-SFC,U6L)Z+T9W MM\7X=O2O-5`UQ5#)>C')J]&7?-Q&,+`T_>T?[T;E=`2G<_0!9X0NLMF(I\E& M43G)+T89O`,>/0&GZ"U^#/_Z;C0% M31`$D1X%[YXCT26]"T-_P%.4FK=?@#&_EZN\6:)NO+L:?5D#-]I4X@N8`1DU&R[Q"G,7L!I@&;Y#<;G]YO<15=4[5(W>7ERGSL@\Z1:#!..S3 M3UAPP0Z`\Z>GOHD>0^N!4UK04'EU`!.>+&#P]V*^GB,'YL5J!;RXOA_-LKNK M$57=CG*N?7'C]]O@>G27`Y=/Q:;_;1I7S@B>-.M#WCB$8Q>GHUWWK\RCTDZR M=#+R#>W*/2[Y(.IXZUW@_S5H,6B678"J0V%%FV]V?_4P(MH9*'8P5DJIW2=P M82UXZ$E(%Q M7_\3F"8D%;\Z0]D&V;W-5J0+X4OY=(H?0@'/,U*8:R"$:>5Y=H\0M+,U:.%Z ME:W6J)Y!-Q?S98E*=%XL2'NT-,/52"QQ#I03]6*-U_QZWKT\HH?=9TA[>0W[ MP?\%"<._+?(5JJVBG!3CT9*97$!)O>(::)+C9#EZ+W#@&A8[GV?PIP*X`,N/ M\S&%YII+P]3IW)E79WV^/J`(:=H%W9-AF543O`)BL!3&L'O`ON6R*K\!4S+< MEI[!?+@YH/YOV4D:W8$E,*W*_\[%40$A1.L`'[J%A9IU0;NT*$>X>+KG9QO7 M!SOY\'HX*:,QO`X`1Q8@$)40O*-""8=M] M@X7+"W:CX>?Q-*C?7V7?F30T0K"$TU0)>KF1*Y;,;6`Z85-52P#WBET<2_#E2]^,3V7:;O/];ML"W M*B;/!:<`.2],MY78Q:)-J(<;7'"+C%7)@>F#3P;RR\5-B;`6VX\'O:-`SJWX M>TKZ$*B&NV+%1#:8YVC*+49_*Z_K453E[.O!F/C)#LD6KB;"7ED*#0?^OS!O MA3X2J@/DZG(&IBO:*OEX33,D<26-=BZ7*SKG*G]_%]KA%EISQ&= MS0O6D_EG1 M;/QL]?H:XD3S@BT0G@HGKI"ZG9]PQXZT82?TC8PCT7P!.P6[C/X^3&>G:^;I'QR;]M-[1T9VC M*I]E*W;9/JRJZCW]J*^D$TD;PK$EG9:S&,ETC2$8S-:@9EV28=UH2S#+P-PJ M,;;YL#8EO3DIP1!W4IBG=G30FMD/`(_;-9,2&>AR#.BW$^^G*;8QX$ M!)CLZ.\%NA3`JI.=*M<\]K$ZJ5#8_I5W9'6DGND-(W'2HYW)^(-_$7>%&T''6R2K)J0>&O.K)\68&9R"[CQ<K'@6JQ9,S>!MUZX%OU?6UR[SM7HD_)DKJ+J)H8HS.+N MZUN:AF5UT']C%,WA7*(&^.ED_#?=*_M8_NJ"#(I?@N!3HZ6!`Z/Z%A?]-JME M&)0;&"3V[\]TK2M*#\D55SQYN'V9IS0SC",NE*QN5*=LQ;2;M^4,[U9V4TJ; M`R^VC>L:PVDL2;FL0(FW)&+"+F)D$0DKGO\,30=2[%ES-S)KE?YYH=BGUT6Y M!&+FV9B*38&V8C&!&PV\SK.^03]E]^5Z55/RX5IF?RDTE?^D=T-*>RJ0YGQ M-(6,\#R88+J0.2R9?B]7:+2!##,&8OU%O9ZC?A`?44POO$^X^3:1K.ZYIED9 M#'W\E"GMLXTW&<9M6,@Q[_K!.)4<)HRQ>,:>'$UWP M[1EZED!LBF]GM*ITMMY,6>0URB@%`?!FI\2Y0@.V4K`[&MR"*L-YZ+.2_L8N M="%])S/BNE.^#KN5JHQ,_DEV7[?3GM?Y3<%!`M[M@)O:LDSGKWE M5;NR@JMU,O#T`*]7P$*\-"C?(2B:TK%AKMGQ[_MC>UUHN?&*![H">*4%FDOH MZ3?.>!.(1+^9N4F*I\:9_*F=@)ZP(,SFY]C)I1>BU5(*:YJ-6/!"KS3Y_-\4E"T@&T\ MINJ`-K:2`I:453?YBDMI65V,BNGH%NS.O+J@S"O]O5G&>(7?5JUEX$&YOF&I MY0E?'I&_23`3?6%5UR.6TGWH,MZ(D=^QC,W-`K9:WNB;P7L=>-*>\Z+]4%OK0N/=6AU^4:->L4CU=0__RFK/E9?5GC"_V\V M6^>?\NH+A2UV@9I\^#U5V[>,)#9T-]3"(-23-+5<+Q6@6;[G..V:>_&2-W_5 MKC1=6>!>I!UG.<9#RT'H+\M(/2.VG-",K4`/>!=1Y&B^:9]J.?2!.EBO;LN* ME-+CEA'IB6L;CADY1IK89J09MD`#BP+'5YOJF`WTYJ^LD0C6L6T9FR0]C?P' M#Y7G65H<.%;DQ[J;!KX6&;P/.C)#)S9.0_[']:I>92Q.^DCZ#2=RX3]AX)J: MC?+AB)8-.P@BKX?^'70KM#R1\`?/3>+;FJ_%MF$8@1VY<1J:AD!8TB,M>C;" M23`>AZ?DVGIB8,NKY461$VE!)`#8O-!WG`Y"SU9"Z=T'$/<05%7L.U%LA%X2 M>2"(D0L_"4;&D1-T&L<>1UR#N/.AKM=H+'V<8JX)4TUQ?OUHZ+4H3M(XL1+3 M]VTO:)Q*@&UWNG9:U&[BY@G$;]/VY>N:T9B.X%MV[H)&B/5W4@T2)EN M#XZ)Y?J=QJ\3+&-'4UX2@HZ.'%B)&R6FX5NQ::[ MEI5J7&C\($F\#@=@O_?;QR,MZ$?Q;A_X3]U.(RV.]-BSG,!#0`-7('K9OM5! M(]0=I],Y_!I9MQ^&0AP841HFCNWH1J);OA;()E^X!KN][TX'D./'\`YQB."! MOV4XE7!U_W%Z1!`EW3'``C,06V-+`O4U\STTC8;'X8)GX/:AE<["]UO7O!FKFQHYNID_B!EOBP MW8XGX(X14:3;+0VGH=,&_AP+_CB%ORSS:G6/,K&"9R;_6A?+>0=Q#\#I;N<58% MKN'J4!LZU*P@]J+8=%T_U)TD3&Q/HH?K;@<$1O?<+NC<-F(.H7FOJ\]/P$]) M0]?V+."\GEB&U`%@3W0P:2W+MYZ?Z%TP#UH":MKS8RVV;/!1-5=@U01I!%9- MEVA^7Q]$]+18_;H)V[?7_0F'P7%](W4#P[?-V`XM[E-Y001_Z)KS=I]9P5^_ M%UE[G-(@U2T=M$;LA.`\N)87Z)J(;WD@=%V4'+C7GT;57C!Q<:C%J1W&X/E8 M-G`G]`0F&OP<=V#B=#B('2"K0YDED=XH1HF_@4XBVSO,., M8.97.>:U=H"^69%I.KZG!^"QQ+;E>4D@P9+A\NWP_;+'E'HTTXU#EO89CAU%FBG!!TTSZ(;9CK`T19T]QV:%IAZ& MKN?;<0RG+M"<-!+03';L:L^A"0]?T2-W*]!3PW5UQ[?_V+6>C1#96?MA# M=ND>UXRUQ(C!&D[BQ$B")+3`_K6U)(W=P.ZBSA_C;C;.AS^NX2>NFX"Y8!/6 MHF&E&N=/Y*9VQUYU^R*D3Y6-%\T@S3%!DBS;3)+43VS#"Q/.H,3U@XZ=T9F0 M\0!_^MVIPT#-(L>*-2-P0"6DEILFH6Z+2S:V?=?[]P0U$TR^H#+.%=4\2$:? M=X6W7-E2KBR7X8)L]1PU7]L+@%YJ10HOZ=:-XQ`(8E@7U,_+*Z=DY\U/!Q^F M/62M-6Y1GJUB,8&MIM_5ARZPVFO6/8_RP311;C3.9S/^F9_?@(>/O]?+;"Q^ M?[R6N"LFJ]N?$+Q"3.F#O9AERSK_2?R@"@5-W6N(4N"W\X6\/9.L[9ZMIJN\?D[J_LK[/Q']@5NIA<_/1=9^[\YZ:[ M5_ZS<^LL#@U^[RGCT@?]->BO07^=7'\Y5^Z@OXZAO\XD:/&<+`S7Q0Q)>WC> MR.!7'N17&CO\RD-X]0@O\?BJQ["]JVX/_X$GY:6(P'-;08-$O&:),+PK:Y"( M(3[TV`N7`'^EN^5&Q]\K].JHZ,R\8?J*5.[\I[]:+T4&1OB&H-LG5:V MCF84OWK9&GSN][_F64THK#B*#,=9$=C8X&X,[L9.=NC@;NR=IOUW<3<&B?@W ME@C7N]('@1C\[WUY^QLB22YR/B-T<+M?HA)Z/:Z![IN#WSWXW8-P/8MPN?;Q MC.%7+UR#X_T^75>+@@#=\>Z?,G#WP?$>W(S=[+"O'[VU_>7]36-$1_D=H[* MQ/V[/D^MK/0+S;"'OM?!SQ\$\V4)IJ_[)TC"_UN(Y1`A>/]K7M`AO^F_XPN#F#F[,[+F`:0^I^D(A!(II^->N(S:"O12*& MW/UVWGX=O/X7``K6#DJ;8`9/RC4BBC\E9'_>%O?Q4,-V\?;UPXK9OGD\))/# M^7D6YVX(P`PZ\ES.ZJ`CCZ@CW2.B/0TZ..V[X;W7^^7[=EN`JULQZPV/?4='#3J15J:1JEKF'8H9O$Z M1M(9]F<87L^XOP=6]+35FP>N7O:*JY_;-:(TB#S?2&Q?=^TXCJTHB-/`<"S- M\`W+U*/.W$/?[!E#_>)8L>]!T#7==RW3U&)'UU-8F1VQU;N)YFN=U1M\J/L+ M7[U:N/AA\8DKTUT##-/("9PTMGT[T1/3=P//9[SPDBCP^H9[GY`5AVH$"5[T M0<$NVCDR6H]U5S-CST\\PPW-Q#+%0'DS#3N<D]XYB?DQ';A_E&4>"ZFA;ZAF.&29BZ M<2(H=P.G,_#6U_U3DGZH8!^RAZ[G>V$8^49HNK;EZWK"%;SG!$GPD7JJ[P@I*DJ###W8N7C0[1->>_`!\^`MOV=ME"#D! MW'Z:Y<)_01V1:6AQW#$%3-]^P>QXBDT8ZH%KAE;@@TF@^;[KZM(\ M!CLQM#N"XMHO67D^]60XCNU:H0$W?QR'8>C$OJ9SO6$F@=4]&9YS#O;`049B M8"2FD82.%NBF%7B6;1CB7K7CU#$[]ZIV2E:8#U@$7A`91NQ[OF;$4:J93F1$ MPB+0`M/J'&K-L'M&F+^X;<0!;CLV+=%#PS5-/88]\L(HULTP$*H-3+:."6#V MS6Y_6>+\E'L///S_S]ZU]K:-H]WO"^Q_(+)88`HD'E%WM=,"ODB#`O.VTS;S M+OIIH,A,(JPL>20Y3>;7+RG9CAT[B2^4+IIAVNYTRDNIJJ[I]YHPX]T`!YIG\DH;!D>#JXG1C:Y-9[NV.O`T;Z7B MEE-%Q3^Q?+O!O.OHMC>@CL=QZ[D]E7]42OPZ75*/N>W+.T7%0Y?G5,YNJ'W=-4]:JB\+YD*:J_O>M:*@X!J&[M*]L=C M595V^X[EV!IU=$K[U#7Y_)K_QW"]/N4#YUYOI=+&QM.%@[3T[`IW(A[^VFS` M,!S%=/C8QN!#!6H8;G>&ZYYB]>U5#S'=>#9PD";>JK:6$%2M:W,N.WI7MVRC MYTZ;UE%[BKDZ]U$.*+!RE&I@6%;7&?2\KJ[JACDPNN8,OI:A."N=B*9O[NK= MO(Z_)U$8/,Q729;K.RCK^_URL#A+]_3N0#'XM*NGJXICN)8^[?RZ;I\:]MF' M)^M]BZM4E^&(9<6*S]=DY#^_&Z+&RX7E5W'YVS#G;PC*)\TL?$X*&Q=[[>=6 M?BME&6]AN\>+GQZ+,IX792%J4,KXBXO#`;[`=Y:3Z*53`QTR6#Q#D%RO?6J8 M$7Z-6%3S.5\TW(5H1#)B^6TR[)!Y"I_%\/U%N>;OY4\1&V>* MAZ1LY(>QN'Z2L>M)1*+PNEBD%7^\FCZK0]9G!7C^L:+2_./T.;SL<3(*@W7O M\/F%.4F>EH9/WD>S2R+Q\G,2QD$T*:K&+10&X;AX9JR$GY&KI,H2GYDJVC:=*5]`[HM;?"9 M,RF,AP+&XOOB0^,DYSCXL2D"Q.>.Q4(O[DQ>WJ:_94[[!#N>B+._/;.O? MKVX=6=[=,KV1:EO=B(W6!\S&64^[57#(1R$/S$\WMAN.VATL$5W+D$:-`R"M MGK2M(!=#/+GF8_))*I`W.IG,#-4"%%*XK"!#(IP(M](S4CKS2Q:W9P0SD!=%H M?8P,S>HXE5NK$:#9R2T#_8)^0;^.J5\FPLPCGG5=-W1!VEL$VC,UH(Z&>3?FW2!7)>2RC`-D=FX+N3#QKO@<*T2HQ=,,W42.9A`" MA'@D!(4C"O/NVIWEKY$UFRM&[9DBJ+8ISSW8^BD"R`5R;4,NS>D8(!?FWYN/ M`=8G?<6$XP@R5,&9YN-.2/2.*4V,7C%.70B%&7Q]"-4XPC@*5LX/.(.GC>^^ MOTVN\B3W(TPG:B0[4HVX^:G/0XL5/5=4`^=>,<\',>M%3(7$B45"P;^*.%F^+OX`=,<3'->]PMH*I;NP0@PXO&\FB[Q,&A;&(&U^^=M M>XE9?PV"@BT[I34^#!XF$Q%1?!^7?;-'W/*BAKUFV_:'%3,<35XDD]WMV0C< MP0$#C6P*5J&1$C72DACM"1JYZ8#\^61$.V:WV3:OS1]%!NG?1/*=9Q+;S%/6 M/_N,WL/EPY@5R>MGU\YB0?T?&UVQ="$WCF?U+;5O&R8UK('7\VS+U!SJ]0VE MKSF:ZIY]^%U7OF]0T<>"'[>F\[^M5-7I*K9J.::J4U-5!F[7M/1I58V>/;!Y M5:G1I*K.#Q@O7K=2;TQRUJYIF5Z-=U9E66[%ZBB:JW:@6GI^MXM=Y MTY-5*[4V3-OI#XR^08VNX7J.3HW!K+$5F_9XK1O5UD5>SLT:7'D`SX6R?E5W2#@(Y`\>SZCVY`%XK:G-V\#0>N5A:V.U"HXYR1"1>,XG&3;'CV@:N_^+=4 M_&=+LT^YU9?+[9F>JI@VYZMG#OJJHU*M/RUWC_>]VM-R4]6HON"BW/3EC!"T7ZP]"//L;7(ON= M6)3;)@=@W[8LVM6=GJ*HGCW@!N:E+FWM:E:O^AR`3V8B],!Y)(NO/\KR7"71 ML'S0W+SD*\LF$8="PKPH"G_, M-NN30#P0OXT%OS,_W=1VV(SZRF94DK([%D\0-NK8&ZZPGZHZS#5^NQ0]UTV9 M43D:C1MQ'_:,0L)J`$5(V!829CC.`=)[-0(WD#!(6$V@"`G;0L),2Y>X;;W1 MN(&$0<)J`D5(V!829AE&QX&$0<(@836"(B1L8U.9Y[JC0<).*E*63)/]FB99 M)B)F7X>KR2J/MG):!I#%RBF"#VT^E--T&^&'P`EP8G&=S-:03@N<`"<6%UX, M"_T$.`%.+'KR-15)&\`)<&+!KZ*H5)Y?I2V(SO8ME8J`0CP(C'/L)2Y8U-P0@PHO&,4*G$8ZE@!!C1 M>$;0LK MAJ_&6#R@$0^M+_+SB`)Q0!P0!\0!<4!<78P(Q`%Q0)SD)6S:^#7LGI^%`=Q+ MAY&PO5U*;8C64UV=Y;O4E(Z#@_40`8C`*8L`[5`LO4($(`*G+`)\)"`MCGM= M&A(B`!&`"&PE`@:F`Q`!B,`IBX#6,3`2>%+/"O?8--_%.@BC2FK'KE!:"`T$)IG?<+2#JC5ONDA-!`:",W1 M1C2(4P:A@=!`:"KW;5>?J+@N30^A@=!`:([E/]X_Q9%1-B0^ MKZU_P\I3JQGY*8P)OSD*DSA[O&&0"^0"N1;)I78T MD`OD`KFJ(!?M2#N2!G*!7"#7(KDT9%NKUC74,@^0Y*->D)T6AVO7-55>UUT7 M`E3=0X,1;6:$ZLB;*8(18$0+&&'+&X&"$6!$*QAA@A%@!!@QGT,.?;+[XL/C9-TY$=+P*+BFOF# MRS32`8NBZ37OSY2SXCMOCF#V?8U)+\,1R\@G]H-\34;^"NU^A,/\EG_D=;I* MTB%+A2LJ\L<9>SO[\.YIJSX6*EU+)[H6_!OXA8K"O#_3E'^_"KIE`$]OI(>^ M[^`O1`51053P"!7<;9=CJ:C380$=WY,LB<(A^9=2_#ONJ:R`]T,LE=I%JPJ5 MYK[$`'6+%"Z'Q]G!L46_`%E`5B6J!60!694@2P.R@*Q*D*5_(2NFV]6ILG>. M9KTHBN0"$1C5Y4WYP`IQH M`R>W2MM^C(-DQ$CNWPM_REV8A4E\,$`P=9$KJX; M)GH)*8Z*&KD&*_)8C%E*LEL_?=9W\7;%P+NVWMXGA4I,2SXI5*,FKJ](OAI\ M\8!&/+3N2#_C"\0!<4`<$`?$`7&U,2(0!\0!<9*7MFGCU[9[?A8&<#L=1L+V M=C6U(8Q/=766[VI3.@[\;!`!B,!IBX"-30H0`8C`:8N`XT`$(`(0@9,6`1/3 M`8@`1."414#K:-)2O=2E(?<5@0KWWC3?Q3H(HTG.AK(P@W60.H1>KPNX:A%= MO3;:S&=ITJ(&U[[IJQZY06@@-!":9WW"B,\`H8'00&@J']%4GP^F+DT/H8'0 M0&B.YMN6=LRR]DT/H8'00&B.YC^'CV93`R#ZUKO_%$=&V9#XO+;^#2M/LV;D MIS`F_.8H3.+LS3'UIV7ZO/%9@E,\,@#\`#_`#_`#_``_P`_PD)T6AW'7=5M>UUT7`E3=0X,1K6:$@7108`08 ML>28E.;U!R/`B!8P0F+6>3`"C&@^(W2E@X`TSSLC?BX2'JV]?N%SF14I8%$T M;=_W9\I9\9U;()A]7U.+RW#$,O*)_2!?DY$?OR//56>=4^1'.,QOW^KV)NQ: M;L7-+][.+\-1O@T&7DCJ5-1^F4VZJ.>^L-@[RU1YS&V694K>%CKQ>IFVV\M2 MOZ9)EI%QFER'.0DS7I316+BFR-4#R297>>H'.6\8_GN6D^2:W"3),"-9$@W) M3^P^B":BV8@_2G@5__;S,(G%57[PUR1,^5/"./?CFU!PQL\REF=OR'6:C$C, M3+,5$^!F9>WC#-P).B4\X]_3?PT9VE&1OX#B9.< M,/Y+5/SI>A)%Y('W@&0X*3+V%+MQU)?8C M%K\-2[\TX;_&_/YL,2L@_Q^W5#")?'%%QL9^RC]%#V`NF+LQ<[538.Y"5LUG M'_E_)/*7M4B0XA0C^&+$B9G['B->,T'/DI+_Q,)GQRRPW`[XW8'8O$X]C] MF,7\\I25+!=:PC*N!OQMA3Z("Y/QB'&C<`-'_E62%IU^=L[_+BI=OHY7X-H/ M4W+G1_Q5_,&\)B0*_:LP"O.'Q^?.1!60(,K2Q#.F0H4494H\K0SL)AWBE$(_]>3^[_I>?)]G% MC>^/WWZ9#92\,/;C(/2CCS$WU:B0NDMVG_>B)/COAW_^@Y!?9O=\94'$A2B\ MYG`0EWV>Y)^ONT$P&94CIL_"/'UNNY3=CQI=ZNJNIQJZWM.< MLP]/0/:25#V'MY%]"=Y,ONA=&X6OY1Z;3BB/+SWXY2Y*'K"<<;>SCZ\ M>^KR6M\#/&J#L=8SN(&"%Z7A]]AT?+]E]S&]U=CU1JJ;!W_GSF\TG5WOU%') M2LI:^THV)*1*[5908!_8!_8YP`HEI:_ML"Z')U-3\!&"\-N'0_(OI?A7]1+F M='"X9HKT:`MG-Q/.;_O5#^.,_/1;DF4L>T,>!^%\DL!'X&(&L3`&?]'*QZM$ M,34@2W,#4DX.=IC;+/55\[9Z=3-^!5!9Q[N-5XI79A;[&GD!!N1Y@Q<_)C%_ M>0;)DB99@.$C#*^O62`P^!N?[Y*/.1O-W"S])"XJ6R#T6\[_(WR@F9"P[<0` M@&Q='RK38-^9GV;$C8<<9@,6L-$5UT*-GN_;UP!SX.1!XBD=II.8OJ7P/:Z\ MXK@,%EYA``_`.P;PI$5H`/``O&V`MW'2@>?&)Z];6\SJ#WFT_V4S/MDK+/.XBJE^&VWGRY;*5C![O9=]SI)2GCCR7L/KCUXQM6['`3 MIXJPP%*U;W$%2PV'TJ>GA\:`H/IZI^L!&6DIU:JK\=-!X;Y5IHJ\&,6G,NJ# M`$``6B,`ML1HE!``"``$H&$"4#:_K5)56ONW10>VGXPW(RG1OI"Y%,?O)ND# M$0<`27$2S;])6;D%#;ZU8\[@:V2UZO#W42P9LRP7066*(^C2,O76R'RU`UWC M8K7O"[.?-'F!8U^UR2-(&C-8`NMJP;HZK5'N33DJ(0[G1@8!W\`W\*V"R5_K M-P4TY$C#"R:LW482Z$[=[%/EY*TX.IG[]^2*Q4Q$$I4^C0.>:AN:>E_XF%BN M`!O`AL?YDC0Z8&8$JK29*BJHL@U5<#)JXY-1_IT?1B+(X,5UDEZ(S89DY*?_ M967@P8P%$_ZP$">FL.^\SH:KC;&`."`.B`/B<+9&ZLCE*^./_;M(LU-XX(HQ MS!N2Q.7Q"!$Z:NVH!7.KB@6O;2=OYMMS1*:&,+[C'XL$#27NSD4Z)V`*\_77 MYNN6O)2A0@9+C(H$Y5KVV/Q<;+Y=>_V:S[_\/,DN;GQ_ M_/;K$X?'YTG^^7HAB7&1PW@IA7&YUG@I7G?);=,34?P^_/,?A/SR^,RQ_U"$ M]/M\_>TV2?-+EHX&["HO@O+S>[ZRZ_=GWD`D&/RB?[\5S,\>V!:JMJCMN,Y9V02A^7C)MGP[(.N MJI93M/%B#9\ISET!95U2H+ M+X92`']SZ()D+;NL%?DS!EPX_Q[VD2L"SK)]GV^.GW-:7?=;I&W]0L MQU3ZEMV;5HO?W:5/JZ6JJKG:%#N7MYJ*;]"U;I=6U<'`\UVJ6+SBI45M[NZ8R@K%;=4O?8-OH#T M/P,6W?S93Z+(YSU0#5W_W_L7>US8W;2/JOL%*7NMLJCQ<@"0+C\-4*K$D$F@TNI_N MIP$2)3YVX7W)*G6=!N^#%_\H3V2^WW.L(`3P\AW'M7P_$#RPK`!`+8@<-X[\ M'O)26^'NL^OQ/43VR>9^9&A'Y!$OHKY'>60*B!*"F+&E8TD`PCO?_>]>Y.]& M\4_9,JV,?Z9WQH=BF=R?D7=N7V1Y^F:>2@)`3?+]?M8&-^YFPO*+3KKQ[W55 M9[/-N3(.]1$O_TM60P^3YN$>I5SYS$5'O0;.PX$'CY_(.1[\:T>6:4>6"%P1??]X8Z^K:^'DU*W&LV`",,*UJR,^,)L09RP1Z@A;J M>59.X6OI>M`MMI2G$W0VXRZKY]#;O8/J..;]HS/6*]4/=%[`L'`UJDQO,#TK MRHV1K%9E<9LLKHT?API9K3]7Z6]KE`%^.]"6E&62K*2=X(-?*'JRA)`N/R$] ME?*4Z3+)/P7QH#*'MQ@ZQ[`!242MT'1&[:@Q!Z!%?[(_!(I``/7D,MVF^3H%8 M%#?0.-BVFJV6+`S`:AH+6PB;$?B5<,&$X^D4VK=IS.D?%JNE:HV.;I\#H)MN MY2LKT+7EBRK`S;5K`U8AJ$J9$!_N@"D:=5;#10@<95;]!Z_&IT8;<&C.UX(; M`7;S:I9*J-,X-P%M`LU-AQ7&Y!!W&:5 M1--941K3K)H4:\#!*P.@9+%I9/BSH\*/&6*L`?=55K`!"`3`!\%S/(I?(406LK!W693D!"%T!=4R1)^ M@`DHICOHJ/K'NU"!Y12CV2_-!P/P'-P:KP/MK"]7N1=R90*N_* MF(.&BQ*+.C+@E5F:3Y2IU&6*D09"]:;*JH=#Q@MV7WG?+TH%1K$N]ZULL2CN M$APS:&>K]B)_,U=*!,!=_'E>5#(`RP=AX#ZGQDRD$XEQF M#66Z@C"MLA@9]=]@U-\8%8@QP08`7M=RHXN21<-7$QG-\+IJZP:5,2V,O)!'`<*H`3W*=+:`Q,Z8K6%0 M::/!*[P/!F'HUOV_G^*Y8+T#T5"5C^F>-!/#I;IZ!FI6NMW"FE*`3.&44 MT@LKU0`XM&YALFT=;@6/!D&3V2Q%?77U\+-"KSFVF=;S8EHLBIO-%2H"\][_ M[-O%9X0V<+%LBM_JZ46A<-*[#7_0-\!/$T!XF"6\XDH)F<$?TDKR`OX/ZBF- M%!PNPTHM6I#JS9B`06=X$^*&]/[?53!H]+$S@8V(6VN\1QZ8M_R@-,I$CTJR M+,`*BU*'FDFQ!%?"\(99?4\>[2)XL,F.?KQ\HTVCV@;0SMV=VU3:#;`+P:.4 MKUMH%8#.I"(CQ,F\W@&4K:UU^WTT=EX8%C]*R9NP`68W*<'"]D*&#M0ZVB)] MRZ?*(AK(>T)PN/``!RZP?44)WR*!RZ6"5<"^9Q:VH:DEE-.U!,V;M@4DBS?@ M@\@KT8]6$&;FT("&KB8*M=Q395&W"8#7NMIM!T#FIDR62+VO/P*=!4^<)-GT MH(S095I*L&NE[?A48SX2ZF4!H`5U2'\T?K?MJR>F)AFFGJ3!J.L2[8T_`G3>P'9/D>B@R:OR(;'IKG$"[2!G.#.@G^X((.&:)[<8 M>JMB&T5T7/L,B(_L%3/K%-**:8?-U'*4T.%L7J M*-ERM9"%564[6H/O]K'.L%RVSNL88)-T8M'%\:J3&=Q3V$R3" MK1.C6ZB$:T!3C2'.$_16S+9JB-[IK324!5:'`$I@["JWFH(%;:HFTY+SO9*J MP@B^@("*J6@AJW[2!G;5T)4X7*>-]W>:618R3.NV)HLD@QBEH*9"M5L*R=(* M;/ZJ:T-JU'M:OTME+@FSW+7)_='!@$.0`$OVAD6OL!M3)KU87EPOI%Q`=N8J MN=PI_ZE,?`_,&JN6K*&?*SPFJOR72:XMK)0N8,K.TB)0D=NBE&ZR3:X;!&E< M#`:O/P/^WDA[N3:V\ MJ^W+.I6O%BTAT!"C+:&3EAI&)%-Q,$WC'TF^A@BSE4S-(OP7J-L:21<$I5(& M*,UNTG6MX+&ILJ@J0;7"#+')6Y^J:/TH2[,Q`EMAY/OS3%]3ZU$@V)X8PO]: MR4*\M-DRD6%L!>.:E.!@J/!IN;[9J=)OPV^)F%K66RV&1H`Y!$;)M\EJA_D! M"I>2]!1;HY$Y-/8-7ZYU-0I#5=/&3;+:JAB@ME8424<3Y>6H]I8[W"N6'C7, MV@U2U/I1]P(YV(9=+"1L;0&1`^Q:\_-.-&W`;3>X9U6SN+!7K*OG9;&^F1=K MY1";-"FQT>V*2[O*LJO;!L;T0HNB[_H]<,"?MIG=&ZE-2:.:#`_ZEXM^+;## M;'Q&0\DZJ8*^V*A6Z02WIQCE&IC#5@@P'*QF8)T,`*X)>X>2Q99%H@1@!R58 M[FXRTDZ)Y%4CM7BTA!_TA(*9)U/DK55=RC*.,4LUP2T`$G6MM[&ANWD!:L>B M.XVJ?2 M[X]I7:OD3:VMZ:P7.I!"+Y--AV\4$W`'%:@O@+U%GIX'>T&[%Q"/LC,O-RSA MUWFG,#+5D5V5I7]I:^F0I*R:XKZNUQPL;4LC:B&DLZA;MG.Z4[F9IDL54\M<95Z5"XZ9B4FLA%`7RA$UQ[ MAM/>V8:T%AM5EH,;"F0-9@;&KR#M-Q`:(FPG0.^0H,YZF-XN@;AXSV@;>3`A MENC9">TZD]NB?7>I;;9MOFI7T'9RF`_O`N]#A.E+8LP5IYWHY3:9*.AT4W+> M,$6FVD!ZF,YDYO,C9G18YM&4^.,&`L52U]-5EZ"E[!8Y=M[TH5^HH\C;LFD! M3.40\F*1A59_9TDYJW;L+=!7O)4_?BP64SQA36_4:S8`M06N1._<0PH`[%S:6%)5 MD/[_Z548CR1(VXG#%*4L-H`)6,=N)V4!@`5NEE;_O7T;-J)%R]2*#FM;RT06 M?Z[3R3S'-;@,TXX/;;O-3@#-SH")`2'+U?2H@*T6%3-=ZVGQ7RV5R*T76RFE MT*V$`)=8S3"PCES@EHE-QUS5$I>L(B:*^2JBV%X*4[N6F^W>S3H]0).X2'I? MJUCOVFT4#4??OT&3PD6@K)(KK?W.KCH]]3733(W:;X+*2"!)R[8UWM/WG!W9 MNG1PIU-U\K;TT&.4!#9WJ!=1YI.(,T=OS[8<&O:VI3NV:_4?:U"=#Q!IP(;Q M@#H^H2+TO-@S4:HXCO1FMXB8C/4VNPG;[.__'RS1D*W=0TJ_ZNE\_8H46P^G;%#.,U1R15NZN;JZ(UK@YX,A6 M:B>@%G5F%X>$A;;0F_%]F-7^1D)J<][?2/@8W9Y[)"*,G8@'0B0F(:+W9`MU*'_"E)PV$KGCW5LL]*9WP!5D7T=&%$;X'(CC.(*)V';C M**3:R((H]/M&QJE[%D<<,AXYA,VO/W^\5_K(,0,:",L)0,B15P<.;($3P@9M3L5XT\JP=#C%C/9U_'YT.(B$.; MI@@((*G/PE`TCQA8`>D_^86P\%04M2XZ(2)T&0M]QV4^AW'9)&*1[\%`D,&<_$MP)3->WK(`12)8:+;FL#_S@#';_085317K0 MO.$",!H[@ER81$+0F%*FDW3;C`\E.]Q^JBU9#YMW0'G`(3WW04N^'6"PMT.' M,AH0RS,CL_]T(V-/B/=:I(?-&V)=`%CC4\DYAYX4/"@ M2(HC-@\?G$AH3.X"D0$\@G^%Z='0B[1<@14#"O5MW.QI:D>`P<(-(8!NQ#R+ M![X7A*X-DG+;BQOI;-?MVQ8D"F>4[@CSH;_@'1R!ZB73Z,ODZQ*/R5?WB<;W%81Z+VM)SWA1$SNV\*$))@15^#D MQ@V\FJ%%>K*RGB*/B/-$V1]ZPLPC#A$NA2C%P:MC&D/&ZYN0/\8!=1VOA\.L ME[R?+KN>$5GA^V=Z^@/6(0EH[('/FT`[@M".B*>#OD\=S0`[W&O'D&WH^#7L9D.ZZ[GS&=0=)!]2!`J,@*W2AR M7`^0RO&XIXW8)I3T'M-S+,?<#\AG56J;F[Y7E*'CA[U`;)NB]WZ%9Q_;^V*)RP'UNV6.2UW'AF@ZD1OY MH>/$+H^=F#!NP:QA)9)'%NM3)\+V@\"Y1F@.MLG/9?(E.6J0)A46)/Z0;P)- ML#Q;@'4V58:0]0W2-GN%Q6>?O(%#(SXU@8)3(>+`-5D06E[8&"90X1[H.;8X M&%.><];^+YLFOR='!F8SS$0@,D8$V`&03?A'HSGDOK0W,&%:^USSN1'R7547 MT^3+L0J+Y2$%\]P@HB9R&D$;,@;)-.M5(*W#2.;.:*@`L2N,!'VA(LB7MK4Y;5*V$^NT$.\S3? M\803680'-K!0`8[D:VSTN>EZO7=A M+7B_>F*17I7SV8]X$^QR8U+=&N/=FNV2M10$`3%XAIITW;,%>CC$-*Q5@,<.H!QHJ4]"`3,8FQR)-BX+[R(!A[\`YF7%P96`$-S&&-V(/Q>NO4U#?(4=[,A`PF9H-2DEF_;CADR MJX$3)^C'@-[;F9Z][#.,A[H`BBZ'""TL%_<4Q9Y#FMA&2-B;+TOT%BJ>>V2# M6`WQN&T+*S*=(*202CJB65;P0TJ]GHMQPBY5]QGL9:>!"(%ILVV8)U=0SX]P MZ=Q#3R,P$M^W>C-'S:=%@`%S]MAW%.^LLC^V$:6N_G)^]-LZJS=X0Y'C_NZ= MSCKMPOC>)EG^0U%5<5DLP[3*;G+98?DON>]^D^4W05+-XT5Q]_=T>G-\DPQ5 M94=J!3X5@!-6Y-*(F3`['H^]7L7@GJDY:58.6=PX+7L%4V+;D1]1^$\\D\7"WW-W[Z#U`<_ M5ZMDTGP^?;1WV;2>PY\P)GT@@'SIZJI*_]+\T7V80+[@?RM4]Q#$]I``]^!I ME@..492R_.T[;GY_]/B!W8,0](WTN>][]@Y?YP!/.U9S/'-FU,\P_;3B6L?. M\MTY*Z5_&LH%=/GP.2H3^6:LLVH0P^AH6Z-M7Q38OZ`3RR]YVA&F M_4`2))$XEZ^^(-6]."<^.\C=J^QOXK"M\QW7=LSFOO(Q;6=`/(>>\9#);]IJ M\+Y+'BXY`M@(8".`G1O`*"?79^,#W[;5/!7`OI'RQ255^*$Y+.2^HT'VCPUI MWF,T,M+S,U+S""-]C*Y.X)<72+8H/Q]6O127N73:-'K$*_8(*O@U&3UBK"P- MKBPMLEP?II*UISQB4+XID[P^6QA^0=K\=M'HK$K\NC#EFM?.Q6WKI?C86`@9 MG>M9\5(<8J3@ MHT,\WB'HR,!'!CY$&H\WK8@.V>#XY>/1D8?6OTK9,V^XQ$ M>R3:)ZR&-R(9I[?R*>21/;P@*'H][,%VQC7PD9F/ MOG419FY>B]&W1F8^5(7R#25X"NVZS$?*/3*,`0R#7?=/=/^#,XS1(?[(#G'& M76>OQ2%&ROW0HV'YN.;]DA#G]63_U!ZS_Y%9C[YU"=]RSY?VOGK7&HGU7]^7 MQ2RMJJS(D\7X\7-SXE7\;U MZQ>%.Z^'"?!Q^7HDV:-K7<*UQ+BO?"39)\;ZD42,).(XL(CS!>V78OTCJQX= MXO$.88^O+QAI]7#=?BKJ9#%F_9>'G(<5MW-VAK7Z8DR+-9Z#]93#,[[MEQ6? M[Q77QW3[!W@']A4A])I^?8U^$Y8WUD9&E/Q6;'5$R3/6?_D97_TU8N30E/S/ M\L3/@]&7\_^Q=;6_:2-?^OM+^AQ'/$RDK!>HW M,"1-I0"A=Z4VZ29TI?UT:V(/R3PU-FN;)MU?_XP-22`%`F1LQN;:3]"UG?'A M7-=YFSDG"),#$]?,&8?I_5?,"7Q'/"SM7K#QU-:>:?2:EMG0[;:1C,ON&49W M.K75.+<[F-JZ]MMF,+55M]\XMM6R,-54D?L*LU"\X$Y?<+L,4/X#+7=HT;O, M2<>F$U,_(IBABAFJZ;HRF*%Z-@S$J__+W)4"S&TYG4!>JTJH.E1]]KZ/81"M MWJV6VU*^^2$3#U<&=A\IES;Y%[`#[`"[M=;S^37)`':`W982/(]B/DQ:C:FA MZCW*5^\ARVTE?U%OS-;5*FQ66,&FM>L:Z0M&C<;A3Q(]I6ME,9I"8E2.ZJ2; M@F(70#"!>_VZ6JM>,S(75R&T)KD/6PM`8`JH(@AL;5%I.9Q>*83.@+Y`7XJH M(NAK;5$=:O)ZQ[\JK6>T[4A^TC7M#[`;V`WLIBJ[)=&EO)WMA=::M[IG.'D\ MR3#>)O3H)].JJM$H\*,@3,9GW#+?R2+I"/8O\7%,0VO66K(T11609!T&`A$E M1H0F+Q<,/``/A6*;B\"O_HBPCUZ#&RIO\U)'/FCB,>CD/II(YUT9!+JITCW MK=^Y4.+>-54PF[4W#T"4&!`3<30-W9"F+\`%<`%<`!?`10EQ`0=*4MRH4*8F M2]EV@G`4A#1FQ&4W\0R8'OE5/R&W7G"#H0%*\5)Y4F"FWL-X"B*:`%:&6TCS?[\;$HF@)Y0-X"CU'>W(ZRFS4434_.HHC%)/FEF8N" M)/)I&WG031T39X$((`*5%^`"N,#!3ASL!%QD.5:H5,H(UA1*CV0IVR\T_,XF MHR&XHE14GDR3\'%S.!FC"L"R]GX!+H!K%ER&1(<9X`*X`*Y,DS2` M&"`&B,V/(,%L23^R_)KA"Z%'6?A<8 M#`P&!I.6==$EIC3!7^`O\!?X*\==%DV)P_G6E1J&7('<0&X@M^S#2ZMN2#Q6 M!/=L/O/X+DVR+;Q^YO/,>WG<9]4[EO*4;F@'NW^Q;18W<\\Y"P=YGG3:TXK6B7]+G3%>?R^0"Q]/F01N6#W MY"H8TE\X_)Z[\9WX*-YIJJ)"_3PZBMCQXX>3ERKWO*C9]/*SVMH+BP5K9*C3 MQ9Q6+.O@543,8W-ZHY[W?;G_0;P@7E#%%]QN-^6L)"8 M^A$Q-%WZ#O8]C@N>EFN^5A//7^56JYDCO`$62I7@V3`0K_XOVZ9%;0;+Z011 M#%6'JF>A6Q_#(%I=OL]M*=_\D(F'*P.[CY3[@!U@!]CENI[/KTD&L`/LMI3@ M>13S(8U54?4>Y:$:*_F+>F.VKE;AX-\K$QW[@E&C<8A#?_E2G713L%38A:A% MR*MIO:9SA:]EM30CA]%&A=":Y#X<3`&!*:"*(+`-!H[605^@+]"70JH(^E+R M!'`A=`!'0``>"H\'=$L'+H"+Q9Y3$XB0$*$IE'?: M:>CVI7V-5)Y"E%2>3G]FTT:G6N3)`:YL1M1F/T83T`*T]A!:A[H\%QLC:H$\ M(&\3CS'[S:^JH&@G86^YHMN+P*^^B'"/'@-;ZF]SMD;Z$J_'HY#Z-.:!3ST4 M2I'NVT0,^^5Y:B[[9\QC'-Y$3FU#-]I" M3@UX`!Y0>P$N@(M5,:&TX@M"/\"EY'!!!P`YT9I"^9$L9=L/8NH1^H-R+XGE MJH,@K$94!'7#Y_@./;_SI*;5@LMDGFVA^W+E-^BV_.W>]*.FUJS9NY=H(30O MZ[`&+`F6!$NJQY*F/!<;#`F&!$,JH:M@2(DY.T->SN[MXMPHVU<(7<4N$!"H M/V"S^_?C:/J+:6CXVOGCKECCUT.SAYS MJ;T@O*8>NW[*GEXQ)_`=[O'T%'\_N:8OI-+V`N?[A]]_(^3]KT]KCR/NLR@Z M<_X9\X@G-T;MGS/?GIX@Y.\G0KYB@]-*KVMHNOFG]7>_6R'<%?]`G;AJ-3K& MV;EFZXU.T]3:C?9YN]GL-FS#:)\WS'JS\N'%CS;[`_3YD$7D@MV3JV!(E_/S MS.V>6'KUCJ7F0#>T@W7NF>--30`V51SN"Y,P^3[[4#\(A]2;@[V>7//TX$D" MVV&>-[WFM*)5TN]"59W'[YN_[3UWXSOQ4;S3%"%"^STZBMCQXX>3EQK_O*C9 M(L03:JR%9:,URACI6DXK3>O@53S.4\;T1GW;^_+Y@_N]UR[]>C_1]IO`3*HF*0S@@F-27RW>E1P;LN:(7;2I3$&&,LXC4FC.UF.E%2O7A4!*3$/ M21G7VVR8\G:F*O_;2W2=]]`Z3_A%_)M8F3`&B0L><6$[4P=_&]-K\HOO!#1[8JTG&Y(&B7OV(W7/@L$\K$@<4C\:L#!DJQOS(9NGAE.`;%[= MK*M0#RF$WBF5RUL_^[8L?]<)AB/Q#GX<70X^^4XP9'WZMGF'6S]IZO=.TSZVNK4_2>%WCO&UVD,;;81I/-]^8QZLW\\[C M;7M?[G\0+UC(%RQ(C%BL`C3D@X3V?`,'7=JN1.@6=.N%;DGK#0+=@FZ]T*VU M0V/DS58,:/1YS%QR'=.81.@<="X`FM< M01(>F9;QZ`.+B#,.0^$R>C_)B/Y,>.>@QY+-/!A^4D024WY'*W8SS^UFKANU1N824>6W3^Y#OPDP#9AF!SN] M-1TSI\`T8!HP3>9,H]6:8)K(*+2WQRS:IC0`D` M`4`\-W4S=7EF]]=?/3L/1-WV:\!+B?%BFO(FZJFB^3MQ1A6*A;.4;9=-#C43 MGIX3)'&RA0+Y!(4HZ+7]V.49!WIH6)D=6=Y";OOM)0"[&-4[E_ZR)3:@+WOZ M"^`"N#8Q?`U;HMW;;[N&;=#3;D;?:M>UQ)TGHS#XP:/->H,I)JWBDM16E<&U M6^;D[@74#>G]PFBKDR7H[/G`LBP`5.(H$=80Z0AVACE!';(]=DJ5?425?"`[`8`L;4XZM@W#D``$#.`,.5M&R\+(-`>!!MA"\Q! M>[015N:A=FR#!7)WC=SR(!,;]8`\(&\G-K&90T^I_8`>]LA.]\CRV5([-LON MFJU*MFE(9A.\?=@4!"@!2HOOLYH2#Y\!2H#2_D+)K,MK$+$74,)6U=>\:.D^ MLT+24XZV-DCV+AC3OA67%7JTN[PNEJ_)]BUM+K,0I7S;8>CUK`H3F\BS$'J7 MM0<'C@1'@B,5Y$BC+CU6!4>"(\&1X,BR<*2N&5GU>0-'+D]?O(O3`Q:+KE_P M^?V[<52]I71T?.W<,7?LLT5&YQ6>EU# MT\T_K;_[W0KAKO@'ZL35;D<[-]IZZUQOM72SU;2,\U:SV[`-HV.UK895^?#B MIYH5>Y\/640NV#VY"H9T.2?/W.YQGU7O6&H"=$,[6.>>.:[4!$A3=>&^,`.3 M[[,/]8-P2+TYJ.O)-4\/3G]#XC#/FUYS6M$JZ7>AH,[C]\W?]IZ[\9WX*-YI MB@NA\QX=1>SX\A>$\4SS>F/-] MK8*L<]O[A*878Z%;WV<59:';WE>8A:K]"Q9DZTRQP@W(9X-#UADTWGE%EJL] M7H^4D[*;3&?.;WA'H]_0MNA[5DHV`6+R3<_9.(/_,M<-93^ M(^5^1`Z3F(Q%?Y!>&`S56-@7&GYGDQCHFCEC<1F7=TP+R`0RBX5,-=:4T`/Y M#W-O`45`,2,5"T(F'JV&OG?2IC7.:H\PM]7T0^I'7GJ(08T%G;G_-X[BH7@P MV`!LD(G*)_L.%5%VQQD/QP)^JC@(E['X?VHL9:[*H\:2)K6FB?^4[7DYA38? M9%F?;%./^@XC7>:PX8W0O"=R,_4C8FAZ?N>E]]@ZR#_`4.BBN1*CZXNQ%^-0 M8NJ"Z%I:'<`=@.[*'%UMGDONPU1;TI8`J@K[6%E6S9H.^0%^@ M+X54$?2UT5Q;!)<(+D%OH+=2TILA\:@GZ$UN_:5<99:OXO\$+G'NJ'^+&3D9 ME-5+-P'AT)(7/&[%0:I`1YH7!;B4&"X&!N@`#\##L_DP8#]@/X"7=<5AMN1U M>U9%\V%``(BMQ:%+;']>%D!@(^D;-I+*:UNLCD"+RT=2A:ANN^Q#75-UXE.Y MW``Y0`Y?J6M%'38$EA20':`H'6L'/800_0`K0` MK<3*?RN'?>,`+?8E85_2[CDM@W8?NRVD29]/MU0VJH`HZS`=>-IC/.FFF=6P M!2`*B-I#1!T:FL1,UIK2P=8IX&U/\6;(/$4(`P9`;0BHP@%&MTQY":"R(`)[ MK]ZP]RJ_8XY[3$@;&"Z,9+S%2$:I,4VCUE)'G'M<4P"!@D!!H,4C4-VT,?=; MD>`6'`F.!$>JQY&'ILPMH/`RX66"0=572C"H1`;5LBJ%@$!!H"!0)942!"I/ MEBU+!0^T$&KWUBA]IN#V+IW8N_#Z!9_?OQM'U5M*1\?7SAUSQQZ[',R-$IL, M\4I&>/63Y_:%$-I>X'S_\/MOA+S_]>8NNXD_^5$;ECZF6[H9W6MV6XUNPW;,+I:KZUW M*A]>_"*STNWS(8O(!;LG5\&0+F?>F=L][K/J'4N)7C>T@W7NF6-$34`QU0KN M"[*??)]]J!^$0^K-`5I/KGEZ\&2XLL,\;WK-:46KI-^%'CJ/WS=_VWONQG?B MHWBGJ?H+U?;H*&+'CQ].7JKS\Z)F*[9/D&@MK+*O4?--UW):L8V#5\$VSP?3 M&_6\[\O]#Y;S!0MR8*-8'AOD@^&L<]OU)&X7@6Y!MU[HUMJG@[#A:V6WV[IV M0"+F\R`D?A`+S\T=LV2K5QTID`(:U&*'FA@ZL;:HZKHI<:=6H;7FK0D*$!@( M#`26.X$9>714+(362,RPJIS.R%*$>JVE+7%DI7>OWV.Z+^]9*:O5DN=/J8** MK#TC(*+$B*AK&CJW(YFT23+)7&:#\^L=""K*N?_=CJ>MM')H)JL*P)#H`+AR M!-=$3DU#-[+7L+)`#*'XB5EK+:DI&=*H&H14XL##:EH(/(`((&(N.26-.\N" M"(3B*YOG+K/!&)^F$A65)UIHU1ORK';IXP2`"^#:I+QYI&E&#N7RLL`+8?B) M5=.69.,-;,M&T/&Z.!JMAKQ.1JJ@`F$X$/%&<4A-B)<%%PC&5VRDJ-E+++&5 MWR!,$-(^Q0N&U4(PCF`0BB.P&.=;6X2<^NJ MH`*A.!"!4%P1@ZN0BYNE;/M!3#WB!.\U3AOVXKS$+Q@FAOO#,#G7Z]GS#Y3>"Y*G4W*UG` M\K1<>P<]:7?>@1:U.VB2'$W*MI2^["7!/2E@"J"OI1L^UD(W0&-@<844470 MV/HMDXP<3D`70FG`7^`O1501_`4W;%:5Q`#!#;0XB9-LP7L`5LP7RI M`3$4&D_Z]($X(7-YG,W!!9!1B1-G5DW:C%)5\)"UU08>2HP'))*!"^!BD9V0 M%O8!#\!#X?$`.X&"XQ:RO0C\ZC]C\?`!9XE$DJ:OP2CF@8]RHTI\5)ZDDMXT M/+5H^*FI&<: M^V?,1\DDE",R"OF0AN)6XO+!@(7,=UA$N$]<-@J9PVD2Y2*WAMP:( M_X+P)W)4"K%2>7)43:1_D?X%M`KB(0-B@!@@-GO:'YMO`"U`"]9+"8BA>'ER M&8O_1RBFM"%?MIXX3*-FRU(454"0M:D&($H,B$--'B#V(W\,N.PQ7(Q&K0G[ M`4``$,_[6*0E1?;#?J#^N*K^&%/_EM]XZ-BJ%"V5)]%DZGJMA103P`5P9;$; MZ4C3ZC4M-_4JMZ<`]`%]&\A);]KR&L#!M`%<`->\:6NT`%]B1M]H1U&V7R[:?%&V)RP8L#)E+8OJ`MKEY$)%T\BEVHO5_ M<].YG'-8&4R0:VHY=$JF@0V) M<-%`8$JI(@@,>TT4=-&PU^3D@L5S*_T0)!"6071A)50"2 MM1<%6+QBOR869_KVIC`Z;C"^\=B3U7DS5DKA%ZTK)?E"R:*1@B$S1[6N:+!# M8<]Y".89YAFP@'F&>5YMGINVQ(D4,,\O4Q'O8BK>?^'U"SZ_?S>.JK>4CHZO MG3OFCCUV.>A.`_H^?3A+POGHS'<_3P-ZSJ)^\OR^>.NV%SC?/_S^&R'O%STD MY#]HS'^P3WX4A^,A\^/H(^7^YR"*/OG7,8U9\F^7@Q[WJ>]PZGT5S!6$P^3` MRM/CA?#]1,)7;'!:Z74-33?_M/[N=_\[_8O_7?EWVC__P]Q;\>->,2\]$A/= M\='9`X^>;N_0Z*XGZ')ZW12"W9.K0+S64M68N=WC/JO>L519=4,[ M6.>>.8[4A/JF*LE]0?^3[[,/]1,)>W,@T)-KGAZ]YVY\)SZ*=YJ"5N#*HZ.('3]^.'F)I>=%S>;7GO'86N@6K9&B2Q3)ZO#'O^XRB+-0NRD)S_X/;WE<8'34+LM#-UEGX+']S.R\DN2W] M=C\Q'#>!YZI4TBQ9F/2\W/IKI^;G7-Y?ZV@9IQ<2TF"0S\.XPR0VL MSJWDM)PKY@2W/D\&*W"?7'8^J;"HP"?/695?%K3%`Y/;HO%HB:(+13Y9D?:H MC^+T(9.4H7C,DV3`1'`/-M+#SX$S:8P#+EK,11Z-(C[@@HT&83!485%GCC,> MCCV:C%U5A!ZY'P?DD^\$0_15@D,$AP@D!!(J"0DI)A_X0DK$92HL:`)U$BBQ MF!7186&PI1SWP`$"\X!YP#SP>DI8(,JB9JNDE*>4\;@3K[A:J!Q*U_8/=J!K M.:,XO?J8Q^+QSG13\?E@P)S$+I"O09C$-3C9DI.!V!MJ@^J!]*2E5+?)=.$P_F#XXU=YJJYT%X8_#][W]K;N)%M^WV`^0\% MS\U!`K@5OD1)W>D`LF7G^"+I[KA])B?WRZ!,E6R>4*2&I-KV^?6WBI1EV;)D M/:JH*G(U$$2218K[#ZXI?$-*\IU4QKD&$5@(I8/ MV29R7YUL3)/(?07U?4_>>";CVD/N*SST[SXTKVDD.'5J)OIJ3M)D.`WXD33" M9)^#JQW,*(X=(S7D+LT$IPZPOJ<\S^1L,A6.R8QDY9[ MHI'TS%([F$R8S-=-IE/!@`*83'#7#H(;\ZN+F$Z"4T=8XK"]Z_++3MN/=?D5 M1-CK]`2N4D:S:?I`4IHS4C2\I#.LMRPNXG+,Y0+J6Q#NFA,0VT)=^[+4_V71^@S[PV>YH@ MAX8L6_3@S9JICJ[S@_13%CCLC0$%^!2)J=LEIM[15(B!IB)SG(2/ZZ`BP);= MT0E2:4Q<(ZT4MAYZI\76GR:K*K_55BZ-IG@`X!CS!6=>D$\CX9FE=;!LM;9L M"O:>8.'`-1`)X#9O1%"A$$T0G#;",DWC(+@]PW^;S7M>N).-1PQ7YBY( M&SE,5EW2:S'2)-[O?S?2/I,YSD M[@=(E-P^D]6(]9KLMA_!CHM?:X.QPP82F MK`@@!&*\19Z0:T;2EU,XR(L1&*28/U$6VXC)9?DM(S%?A1#;>7JL8_YCMUEK M;TX#/32$'O9,)3>!'JXX4.AC^WM1I49N:!AG`G$+@P!GP$K9)&692`57021^ MRY7*(_Q^'N^EY`G.$((7PH7V79.R?9?XKOC3+1O>B%VZX@C^>78;3C(BVF@9 M>K_EH\TXGY;MOTKR%+=*A4G(1%Z_.%#<.&?=Q0Y5[WI8HJU'AG5R\=9>V MK@?4.,LS^K(X>Q5G"6/NFY?O%W\F3M(QC9XM$FQKD?&DF9@75SZF*5?P M\B+I-$\>/RC7(,4GI9WQN_93\1[7WHA.,O;^\<6'EQ&^URW7$ZOU7EU`;V!Y MBJOAQ]C<[FUI]F:'MBL_L.OM>J1;^;6:)5C;(,%:!@FV9Y!@G2VO%0/4,4"] MRDBUW3Y`S]Q#=LA=TB_'LAUH5C41Z8,2E?D=4G60(NC>0%!NO#%9S?XCIB,> MYG*>34?4919S$A/,)80AWD>%,(T90^'WOR0,A8?K`=<#)`02JAT):28?^$): MK(!TN"#,AZ\[]\`!`O.`><`\\'IJN!73F$'&,\K(\G0JLO#,U4+M4+IYT5@3 MI]=B1ONA#$1CJ`VJ!]8#ZS5']713-[U8#^/B95\HQL4WEFI@Y4`UH!I0S:&] MFGIY+94'^YK4`)C+-GZ2)[L/;FE\P_@5Q7E*`WECM3229_VQC+F@#9@+VO$J M:!V,N:#@KEH(3AUAB1Y&DS093@-^)(T83.:AU0XF$R;SU<.Z5JL'DPF3J3%W M:20X=83U.>=_FO7M.A9]O6HH/;/4#B83)O/5P[[W6WYELMIJ'*@!6B8MX`U> MVU9P8WYU$=-)<`H'XD6'[S:\?82]3D_@*F4TFZ8/Y>"\*`G^(O0F94SDSDJ+ M!P#K\N6CA_HT\GDW'8YKR[V6%E$J)"`D-YSU^N`(] M-A+)^,<9O[Q"W#0C(QJFY!N-ID^JM/CEI!R6>,H52VSO%D=]S?G_9G\>S7HG M\JM*BV\^<,/$'UXLGMR`!6Q\S=(G)G+MXWWTLA#$*XKI6/9RI&$7^>X+G#47 MN#SS8I<+?+]6Q7?Q0A:.>6;1M!U25OH5ML7O2=H`,GO/`62>\]V.*<=B`-IS[ M2Q:-..O?K&?S=/;*U>_5^`84#XI7@>)M/*L5+5[6IPI>BLSTKW=T@OKT@^YL M:R2U"K2.R4U0U4AX!JG<+L)I=G'G1D`UO++3M5N>?04]WL*564B="H"IQ?Q/&7C M\^@\C&DE7G#;)0K&'"(A$/^`0WR=Y[M=\[\4]=NG[B.YSN. M,^AT!W['<4X&;>>\<_3SBP>\1=[`1HEJAB3Y+&3MB(R569);N7<5OI*RTS>8R8-#[ M"6JF0,U^#>EU&(7YPRZJUH",*PP^UA"_T*_Y8<_B89L&9I02RBSS'.HNWUSI MD>5U2',E8O&D",9#OT"GH%.H.^BT4CI=Y?+/A=I;)=2J,Q:KB@:5[\2WGPTJ M75A.O6A4\$IW@O5;:L@/J@CW=571'676[$;L*R>:/GVR>K3I+L\GDMXW"3Z# M6A>Y;BI?#E,*IFDJ6A.)+D48.:"M$NFA,G)23=7=KNRD4=^5-\2H+OF?@#[L M!^R':4JDA\HTS7XXGKRYL76Q'\U>9R*12'NJU%5UGMO;:);*$2)72$74<&5K M+RD&N%HKY-FM-JP0L`!6!:N"564I3M=K=<"J\.WAV\,*2;)"''#O$$^#$=IB M@\+"!@6P`%(%J8)49<9+$+7?R[,'0"`?6*)UE@B!)IBC3-X(D4/U^C.J0*6M.G8B!"=DV=@O3O(*F_N!IS;LX6>PTNTH&H0H7CULUL./ M/+;N(PWIV*?1P]6.0AH."6PSP,.N8-/8AH<--@>;@\WKJ7;-8G-+7E^+VI,Y M5F+8+#XX/35[6.TH6NT< M;!_3\!I`<%"UF[V:F#GTID+-^B;!.6GE>76Q2H`"^!1\"C[5)?6_+KR*9M[H M]@<[M+,=0M]9V*(M8U$8TP,H@%/!J>!4^/1+%W12&+: M\4W#]0PYG=A2V9V6([2[,"A3N\*P-FA!F&&39;V6"& M8895F&'?:W5AAJN.*/R84RZ75[^_\'KAOI::)RS<:,!$WMW*2UXXRS.2L+B* M%F<)8TY^Y?O%GXF3=$RC9XINB^_,3US<`PE8%,V^\_'(.BK>\P<4/+Y_1&E+CQ=^*NM>VSWU4#KUY+MW5?! M!BQ@XVN6$M<^)HYE.SMX%X`FH"D;FNW&([,O=M3)0L=#J!G43+Z:_3JKYWS8 M1=5VFT]7O4PW-Q+2Y7LQ;T8*_"H.7#92OTYH1..`D:^WC*U7L:H()0DXB20Q MU%V^N5K9>; M.:N@NCD%2'?8=X!!'55T1YDUN^9T-L#@26R/DPR>/FG(2`-P1T-4'CT;#%(B M/51&3F*6@D-NUHJN'*ICJ@IY$0M5.]9EE(+'>PW`&A@]!KK'I-(W1I=7RU)W0L=;#4 M.3@]-5S9EBVC@M1DC22IG?XURSPB(HAU#]@=[-X4_6L6NULM'ZR^Y^)GLXZ' M"J!5%3&5[\2W5S8VC).\PN:&H*D->Q@:K'0[B@81BE]B`%=@<;&Z4VC6+S5V_Y8+-L13#9K$I M_-1P95/>PTHC*6JG>\VRC;8EK^M5[6TC8`5*!Z6;IWO-HG1'8B/#VE/Z3GU0 MZD1,E;0[`0=5N]VKB9E#>RZTYZHTFZDN5@E0`)^"3\&GNN3^UX57T<\<__?["ZX7[6FJ?L*A__!+O/RBT`9'RY@X[7-53 M\YG%#C/\-N??IQF[VXHG;S_&MRRX31BGT=/)[UX.N=%_#6G>9'% M^'ET'L8T#D(:?4FR,`^3^)R&Z3]I-&57_`&<1$GPU\]__QLA/RV?_(RF,7]D MV1>6?KVE*3NA61CTX^$@C*8Y&UX)E9B?I.C/P=]T[;;?>\LW/GK-MOM_WS7G?@=QRG/^!_Z!S]_$*)%B5[%8Y9 M1CZQ.W*9C.EJV[=.!SKJH5UM!V>ZK M8=T-`HS%Q7P\:G>_>Y/XGG/S[$"[ZN,J_T'C6"]W:>*Q2?0>.[R_' M3RSG:^`@&3-"\SP-KZ?EHBE/R"F+;EC,$,@UT&73OGAV_WCLIFJU:2;5[D'5 M_:5A'WM>K]53+A-=GOZ^H5%P#;@&7+,SU[1]C#`#UX!KP#7*N<:UNYA_NS%D M#`EYJQ3A'\7>'AN^H_QNZ0TCF=C[Q"B00P22Y,AJ(5GCE1R/W6>%U,6F0;N@ M7=`N:)=JZ2D,@]O&NQU%&5=K`HA[E$SN[^!R M+6R<`%P`EQ)PM=N87U-A],Y\/_IL-&)!3I(1&8HR!5%ND;%@FA8-YQ'$,W8A M;-92%_H#_8'^0']J&&ISNJ:[")\GH@XR.R9B]D,:!CD3@A$UC-,XS/GG=S1- MJ2C.I/&0)*)5'98W6-ZH2$_P)?:4J?OJ!M@"MK:0$]*9`2U`2PFT.ABRAIC< M%C*<-0S!XK=ZTMDIQWGCYD95$X_8:Y.W'="$'D[`DD0#KJ2GG;Y@\RR)62-O MMEH#&H%&H'$U&GU'WCP9H'%GUURCI7!%;1DF+"UK8%8U:)"VJZZ1;/7EQ3>; MKZ@58IT2TJ&/T$?H(_01^HC8925U.<"I?/GHHBC2&B^HNV?YJU*WU;9DW;9`@`9``2&"+FW9:76GY5KH\2(T#S.8OK"0GA2`V M@BYX"BBX%EWPN(,F;^M0]T>OVG,#T8!H0#0KB49:.$C[1P^B`=&`:`ZVVD3A MW`[+T,WFN*Z;.+K54-"5DT6+)AW%U%*18G1%[R]ISBY9D,1!&(54U.=N/5[T MM'?>[G;=T\'):<_S?&]@.=W9>%';[_1/,%[TD.-%+>/&BSJF3,/$A4J(NE4_ MLNR`%H63MQB)1F]8=DBGJV9.Z8ZIZ[6=CX>YGM`MS/6$;IFF6YCK*4&._]7Z MVN+'T'R:)^D#2?GZ#H&Q.N6/JR@14Q"1;K?41Z27=>A`\E.8,_Z=EDH(]`*] M0"_0"_0"O4`OQC?F'\Z3E/$3DYS>%XL.,@Q'(Y:R.$"L4^<->&U8ZWNG*Z_M MS4[LI`N4?I#F-0`P-0>,-#L/P``P]0>,+6\D>4,`@U#[FE![G+)QF(LQ!FR6 MG:7EJK5)!*6NV?,AF:N44]>QG>H$922Q(?(&*"H>'2)QE0H,`H/`(,RA3E!$ M*/O#UUS$KW-ZS[)C$K-BJ.F(#5E*(W+-8C8*<\0;$&]X4QQ6RT>T08U#`-S4 M&#>(T@$WP,TN]D9:MY&FX09A[M7B/+VE\0TC84R^T6A:U`@3&G%(TSA`;OFA M&:N>*WR[):W0""M[0!`0W,6;4#]L%!`$!/43G#801)Q;,X^_7HY]/_CW-,S" MPJ%/641%(@NRMA%SV$8<+F(.B-4!-SO@!K4.P`UPLW4.M]N2UH#2:.`@A5M> M;#L3P>TI]WG3G(9E">,D*1UC9'0?FJ[JN;2WD$6*Z!H@>%!7PNZUI+5*K"<( MY156`GLZ"$X?[#GRW/BF0P^1[`^?<_XWQ`\0/ZAR5]MH>D'<#;C9+B$+M0S` M#7"S_2(3!@?Q:FE2G`]P(F$QP6G>;D_+Y6:36.IYCWYW*?U=B#CGP#_P#_T;AOR.QB@OPEYSU+F$D[=;3 M9%?.I1U/HN2!L:\L_18&[''`+1N>)N,)B[/B5/V(GZ)X]7DD?N0FYN(8?N'B M2?CWLCS;9FAMOW_NMYU._^3<=IQ3K^\.!EXYM/;4/N]VSS"T]I!#:UWCAM;N M>ESE/X@;-/(&#=GD-+M?%#$K,SH5NJ=0MS,Z%;F%VKL:[:V(5*9I] MWB3),!-Z,D18S4`7;:6PC8CJ_)_*=,[X^*+=K2"+V`BE$<==IR2(&$T_'L5) MS(Y^G`L!_`7^`G_IR%].!3VVC%`:\!?X2Q-5!']M+*I>!47,1NC,OO1E2'1? MI0@O6<:%%]P2&@_)D'UC43(9LQB3-A3$S)PW8F9[9]Q7[DAYGKP^9+H@0K5/ M!$34&1&6Q+4%$`%$U``1L!%R'$^-%M-*Q\"Q*.)7=DQN6%S,?A.>*1V.PSC, M\I2*Q$>$)S1BI+=V>M5U4JF('9H`SOJ`S_8K&$X#<`%< M30077[9*<])K#RZ$C3]<)3GWS#-1,/3N6E0,\6MY*ADB[%Z\EN:G@Y34!@@V MW^RIFIAUK`$K"T(EW9M5L6L`0L`4O[8\F67V1?;RPAY+W&FZ;W MY)K%;!3F\XEP>5*9>ZV1E,WEM_H$`WI>!>G]ND`/@39@JT)L^78%LR^`+6"K M@=AJMR6VO:P[MA##_G#)AM.@\*?#>-;7%X$!:02T1?+#*VWEU$8+:E'FLJD( MC2]W$7%+>4[3FPT-3=`B!#;!7^`O0_C+]GL2DRO`7^`O\!?XJTK^@O^E;O4M MH1^TW"[.*YM%QWF8/_P1#ME%/!)=C\7)+MDW%D_9>9J,S^YSEL8T.IUF_-&R M-#MY^)(F8HF=]>/A[.*V:A;=;?MG9_W>R4F[ZW8[W1/_U'9FS:+;5M\:H%DT MFD77I]4P;M#T&S0DIFJ6JPKYH.GJLV@@FD5#M]`L&KIEGFXUIEFTU%W:LW_^ M>O';Q6!)=KNNV[/I9(4@N3P^K%D#=B;Y(A8Z7OFL^/EDABXU>HS:$8K\!'.C MV]^A9>+&HO*.G:Y50>J=$7JS;_02%`8*`X5536'N<"+CY&Z,V^%&;(;H-,D?WS8M#_?_VF1`)@:FK<%K5KN?*6HW6A M-""BR8AP7'FN`1`!1!B/B([5AHV0XO9JM)R7*%Q7?`!?`I63'U/'1$AC@`KB4!,*[Z%6BV.4WV[/_\OFW_J]_?KTR MSK/?Y?I^O/CMT^=_-B?%#YQ?XZ"-:[4Q`1"(`"*>ZL<=>6W'`0@`PGA`6/*R M^.J"!T3UGXZ[^L_^KY]1\8+82#-C(XZ'_N,`%\"E:'7JM#8N0P6X`"Z`:PMP MN3V`2ZW+;[9G?_'UZO.@_]]-<>S!@C4.8K0]1/4`"`#B"1`6``%``!`+:TUY M.2YU`83I<6Z5LNW_+PW"/.17Q\@H24D8_P\KYO-@N:X1#=5GN>Y(K,"L_6H= MV`*VMI93U[$=]1H&B`%B@!@@5I^8LTH1?L[YW[!^/P#S*&AR?%C_66(SNC=D MHPMX$`_3!T_&X:6-^##P`#P\V0^)8S'K`@C$A]?D12L[:">/N!>`J1BM0*:I`.8`*96P/2._9Y$ M?[_9P$08^\.I&%O,'S;-PV^,T)N4L3&+\XS0>$@2$>,F:3F;&K$(Q"+>[E'@ M(18!0``03X"P``@``H!X`D1/7E5Z70"!:/6:N;7)`XWR!]E>J$;2,Y=\ZI,$ M9ML^&HDBH`5PJ0&7):^5(\`%<`%<"^!R'%@N1'RW3?]`4+?2<;[/$W/=R3T9 M)M/KB.V5M6S$'HV\L;Z;BM#X\;[^L==S)9+Z6X(S0H\0=`2#@<$,8;#V<=N2 M.?8(#`8&`X.!P:K,L^IZ,EN\@L&>K[Y_S"F__5>__\KKGWZ<9N]N*)V\_QK< MLN$T8I]'9W$>Y@]_A$-V$8^2=$Q%BYO+7G^)K3O$B5XE\)8QH'(8V^)%DHKN)*W-O\S/R!Q>*I7++1QZ/S@6/9[N_> MGU>#?\U^[%\#+O!O10+619SEZ52<]3+,_NK?A]G\2R^NX_-$_-!O;'S-TB,2 M#OF9^56]LUW?T:S%&:%0V3#F%J1\OWC26#S9Z!FOV.([\Q,7 M>D0"%D6S[WP\LHZ*]QPDP>/[[>_V+ASFM^][?LOJN9WV=X\`#42^W"1C[Q]? M?'@)N*`Y,. MTI9]CPU!A':KG/GEN@<`P+(L915+*,"+\+6PO(;B'4+QG)K1H"+'H#CMD`5% M"4H2OY_R=4`J+$YYQMFRAYQ.TY3%P0,I%S[O56BM`IF:@&K-]$P[^4!_0%[K MA#9@&3\OS=F0T(SP[Y, MT^"69IS"ODR7PPH5(E+[#$1Y>VEOJ=:F4:A#;I.A>2X2O(WV`+37-O#-L[B* MTVUUP325+<[,]VS^X'_(64Q.:10=DFATD8")P.<$&M MN,!QVYBG5V%PQ'@/XE.2DV'U,=XJI6L\"VNDBMH)#AI76;BX9FLG;:+"N@BD MD0X3%D]8/&'Q!"X0Q_&'C_9]%2Z>S/]8_ORQDJ^*9(GU!CD\/ZP@S^T69GWNH+B10'9\VKA5V^QM]L=/CMLYTHX M?Z-*N!VNBI#_:GUMD:&H-TY)_%@!2(L*P(S0E!%^D<$T>HQ.Y[>LB%#S=U'" M_T2"Q]J)\A@RGD9Y.(E"_H6\*((61V1Y&O[%R#<:31E)1L5GHUGQQ?P$25%\ MT2)7_(\OSKUT8?P\9^A>7$/:R/L(2MOE/U[ MRG\A3PBCP6TYGJ2U7BO7-!#8O[)_9<^`:3Y-V6]A'(ZGXTM^)GX"^E#,5>$_ M^GG"1*U+?/,KXW+)-FL6L%#CWS]Q.N>],W?0Z;?]7O?\U._URAK_@3WH>PYJ M_+>K\;7^W4W7U>S7E]LVN$RG>2JY^UZ,&\[!EEG,J72O`RBZG M)'0-PD8F8Z5,TK!L:1W#I2[?C.C3I,7:SHP^7VU/7CS;;*4Y2!2\=JRUC3)M MW*U^[VVRJE'E=3#U#.9^*^!L,VNZ@6,>W%X%T[AU40>8(AF(VH:!ZVN*7%O> M["%='BY,D5+@;%-@V$!3Y$A$%$Q1_4W1%?\3HZ.G-.3[BDR M'I#Q4(^,AX;X-"4Y M:`Q5853"_,*D*WI/KEG,1F%.DKC(=V7W+`W"K,A__7)+TW'(_\#=$R$/)J0C MW)4R!W:;I5=]8QG?V_)B&8W+C8=7L(-7(&V"'DH]DAL!#U,#'HL12A6 MA3(NXB`9LQ,FRF3*U]RG&/#_9?P)]N/AK,!DZP*/KG76[0[.ST^]@>O;Y_[9 MJ6O-PAVNZUL>PAT'#'?8[I[QCG;7E+F(Q@QPQ`V:%^E"T3GDL^FZ&:5.&&4( MW5*J6P>-MD.W:JU;-H)C^\M1-(&0%DW01V3:@;>ZK40C(C-:[#.:$?)S_0IV M((U0FGW#>>`O\!?XJVK^BM)<5=U6@1KE*V968BN2[2%$E8OLOI_>:-2@T2I'94A!QTY*`? M<-'AMR7VZD$..E@2+*F#KH(EI;)DUY;8!!HL"98$2^J@JV!)J<$XNP>6K#Z> ML7\]XTYEBJMK'K^Q.$_2A]-B\%>^=7%CQQF.) M[;NNC^+&`Q8W]O:L;>PXJ(S3Y#B4_AGKRD$^**%!Z1]TJR+=VKCT#[MLJ^5X M2>_(F/*G$]((&VLF6E"S5YQ($]X\E.%U*AA@8836()H+`M-$%4%@&XNJ([.; MOM%*(S'.JG/X0J4(_TC2OT@8DTF:!"R3YKJ"X&N:UF^"%DGT5V5D[Z]+N%^5IO\I$4,*:=0?\W5!GGT>?9[F64YC MH:,#?N/?:!Y^8U^2+"R&&6Z6Q?^OV>_\Z^D,%W&6IU,Q$/HRS/[JWX?9_$L7 M(E>-9?DES=G7.SKYK1CHME@)T#L][;BG?>_L[-0^._%:]G M*:\$6-"A_YEF>3AZD.NSWS(R2B)N-KC025D%D$W'8YKR[V7%P,EX]I@(+9^3 M&#R93%/^W_QID8S+KG@B*1=:)H;C%:,JX^%\2!X1L_&6E'/+2YXM'1^A6%## M:WFGNTB"\%M1=('+&^&[7.#[M=!>IT,O>+^H_%@J!=D\A=.X(A2NS3=A7%XD MG>;)XP>EGU5\4M:I^)W.DTT\>*&*U^;&:;<"B?:N!_J['MC;^2<]W.2>T22. M)+U"23M:);U2U6JV&IM?;F=5`%RHT8&;6BY9GMYNLIH?]NACDM+)5!/-!?Z` MO\WQIT=%S^:+W(H1BT(RJ-UAU$Y1C9D\ZU!!8&I?,3X&5$A*<_8R+%`\,S8D M89PGA&9D1,.4?*/1E)%;-KQA16@A?Q:1&(7W;/BN/!F+PR05X0B6K5\+@R%V M8HB5F1&[:K`LL"\%E+7S;QH1,@:6@"5@2?O$8_O`J\^]/;&6U[:^>V;NR9"[ M"-Q#D[<'B$Q)#6H^]=`W+8HZ)6VU[RL+U[):EG)YU(7$P3)@&;#,]K(H%:;K MV(YZJ-6%:_;/+S?=+[1;/6N%7RAMU@R(6>$2=H]5JE9^35TH!6!H)AAL@`$! MF:T",NXJPZM^DC%(R+RR\/WW8A&%0!0"T,+26PN`8>GMMGHKMF0<:3P--M*V M]]2^ZM/&@@-X`!Y4&N&ZH`++\#5&V%EEA-5WV@4;;1@+K,M"H=O&&AQK<.`* ML2WCW(%:67VO9:T(OCLHDZJW-+YA_.T=38=+;6,] M]]1U7>ODM.N?V/USZZ1S=MX=^!W'Z0].;*NGO&WL!L<\8V5M>W>6C3EMB]^3 M+GTY.\YWNS6!M*L^KO(?K.<--GNV2_'VKJ2!ZR0:ZE3T6S,W^^T>G0J;M>W3 M?6U_>572J+-NT"Q..V1!DE(AO??<(I:>NH7,5096.A/^7*8GYO&9""67"DBK@>.N)H64-5I:);F M$5-9ZE9-B9\1NK-O8!0T!AH#C55-8^V6#?J205_-#I$4QYWP/X39+?DB=`!K M4?EK41.3=8&!:D<(B*@Q(CJ=5@^`0-1H4]F>TI@.$3/2DGQT M*:8T*]BA"[(0SP#$*H28[7KR7.':@PNK[0]GTS3!D@)+BC?%X1Z[=KGZO)2U=IBZ(P#I[M6S_+^6_RS)&_F0Q5@`:44]]5@#M=J^" MS3A=`(7E-7%A>RVT+`L[9)HE:5FV["6DGU16QUR9ER3NV MVWY+VC"ZM^O53=`C1$/`8&`P0QC,/O8<1UZ>!QCLA<^J:6.-SSF_^Z>C,_XC M`Y9Q8=*<#?O9?[+A#3_]4UN,[&O._U*\^CPZ#V,:!R&-OG!:%&TBXH#UX^'3 MQ[-K^34)BBK5S=IR+#33Z)V=GKFG9^>#SEG7._7YJ_Z@;*9Q_*[5.A> M-;JE'38;W$FG7!D`A^IQN%M:0D7&8"?'0X%DGU:-<#WDTQN:P*#[$!1/4\5# M]Z'WW=W$.#_LL84=FS7<+<*%*0WR3!:H-1*C=F@W17#J]*^(C'-G57BJQR1F MTIP8C:1GEMKMM%UYP`8@^VI@8UK&["LHUT/'&&2P@KO`7>9QE^.VNN`N&=QE M_&;?OJITE3*:3=,'DM*:`P/N/+J/^J"?^QNK%*6"['KQ+*\]-6S.SI1X*MK M)$FS>%8QJ_8?!EFI-D4E2+BCTAS,?0F(-UU2'L$1BD1'JH3`-C@S9ZW0+_P']C M\8\]PDV\\/U[I!RPG7$I_#3;!+R@\=#X;23X)]M\AG9]$ZXE34\A*?O&XNDV#1=- MD9UV**XN#\V(^F8MTM2,&4;@>RU?N<",T!MQ'%)I06$:J"(H;`L*:_=Z+0L4 M!@H#A6FDBJ"P+2C,[W@M#Q0&"@.%::2*H+`M**S3;DN<:F>TWH#"0&&:J"(H M;&-1^<=>SP6%-:KD4Z;(?DF3+".3-!F%R[5Y!]LY+?LU8^=4VAR1')Z+^(IW\(L3.+*`ID@H;=)2*H0#\M. M;JNM7+5TP95J.PYL`5L+QW5Z:,0+;`%;2NQ6#W8+V`*V5&#+J6!2)*`%:#41 M6G8;=DMMC*A>H:!/+)\UO28TS]/P>EKV*+C4H@`HAXLA$=1YYO"D0`$<8CPK$EEJ4"$4"$\8BPCSVOAY6$ ME$"%1J%!11&+"4M)=DM3]GY)D+L^I;T+@LHD=LD%01H]2GW)\,T>BQ4*L6I^ MJ?/D<&@<-`X:!XV#QD'CH''0.&BJJ;Y*NRZ-7[;F!:$`T()J5,6%I!6K:/WH0#8@&1',PCP9]RD`T(!H0C?+8 MMOI!Q;H\>A`-B`9$79'7FNOVH=-`"Z`:RMP>?+Z#0-<`!?`M0@NI^4"7``7P*4"7'9+6DD: MP`5P`5R+X'(Q;4UM:*AF$2#)I5Z@G1JW:_=<1Y[IU@4`JBTT$%%G1#@]>2M% M(`*(J`$BNO(\4"`"B*@%(GP@`H@`(N;K"`M>TYI@Q(_%4.97O[_P>N&^U@PJ M>GZ!"\<\TQJ+JT0AG##FNE^^7SQIG*1C&CU3+%M\9W[BX MP=VR'$M&G;D%]N2>9$D4#LD_K.+?8:NR`FZ'6"K51#N6+2U\"0=UBQ$NU>M9 MY;IE_P[-@F8I82UH%C1+B6:YT"QHEA+-\GXG2Z+;-:BR]XQFK[@4R3.:H?'0 M^,7C_F0TW2'49^1\=Y5AU*LDIQ%)V3<63YDLL&HD.^U0+)WE5@I[1@-%\'B) M`W31/RTZ'ZF0E(*.LL=.QZV@4,((O1''(=$;%*:!*H+"MJ`PU_!B.`T0`$4^K-=^5-Z,8B``BC$>$?>RU?5@)*8$*C4*#BB(6 M$Y:2[):F*V,7[Y<$O.O3V[M2J-1IR95"&CUB?4GRS>:+%0JQ:MZ17N,+C8/& M0>.@<=`X:)PV0H3&0>.@<9*WMFWC][9/:!8&"#M50V%[AYKJT,9'W3W+#[59 MK1[B;"`!D$"S2:"+)`60`$B@V230ZX$$0`(@@4:3@(_E`$@`)-!D$G!;KK11 M+[H\R'U)0&'NC?DAUD$837,VE*4SV`?1H?6Z+LJE17=U;;B9K]*D=0W6_M&K M]MQ`-"`:$,W*F##Z,X!H0#0@&N4>C?IY,+H\>A`-B`9$<[#8MK0R2^T?/8@& M1`.B.5C\'#&:306`[EL?_BA*1MF04'ZW](:5U:P9^3Z,"3\X"I,X^^&0_%,S M?MZXEJ"))0/0'^@/]`?Z`_V!_D!_H#]-TQ\D^E152XD0$IJ6+QSGN5TT+4=\ M%N!2`RY?WF1M@`O@`K@6P(59-@`7P*4*7';+![@`+H!+A5MHM:05?=<>7.BF M);W4"[13XS;NGM>59[IU`8!J"PU$U!H1;8R#`B*`B&>!26E1?R`"B*@!(B1. MG0%9+32D61V,^+$8>/3J]Q=>EU.1`A9%L^?[\<@Z*MYS"02/[U^Y MBZMPS#+RB=V1RV1,XP]DU>V\%A2Y"X?Y[7NONPFZGC_%S;^\75R&:_DV.K!F MJ%-Q]\_1Y(G[W%TB#G#X9_GN4D&9&;)!EF)$NB(?F>W0?15#PV0L<)O\7_ MI7F8Q.);-/CW-$SY6<(XI_%-*#!#LXSEV0]DE"9C$K-<_.AP&O`KIA'+6GLC M%LAL##*=)B#SZI9Q!(X%G'+^\M]3FN8LSW5`Z>?\UN&7#:<0^CWY_O.;S M,*9Q$-+H(AXEZ;B@FBMQEBON7IQ$2?#7SW__&R$_+9_BD@7)3 MCD(V[!=DU)_15#\>_AK2ZS#B@F(9_]MTS(;/3\XU(1:.S"4;?3PZ'SB6[?[N M_7DU."+AD'_`6?)=Y_1\T'?M?L?VVMT3W[,\R^T._([C],].SCWGZ.<7ZK.. MA%9ITB[:MW#,,S1;',R%94CZLJ;$]66&8RX(9T!RO:^/'%?R3I7\7BA$[" MG$9+(M1DZ7C`Z)SVV23H>;%XG.VTT/-"*1/6QG4ICON2)GR%EC\%B M#%DS`W6+LY+[:+>#G)GX$&L`5!$$JR6E$PMG&7K$?)7(+RF0#6&A!;ITN M\K[J9J%5RO:7)!G>A=%R.!T+S$7'MRTQY1X+S/I;JD]SLS1/CU/C)KG<31HF M4V$*]]E3GIVTR/I87A+?E-<_68S./I?!"ABQ(TB(!_;TPJ>5M9>P;BXM\^N6P MTRYB$EGYXJ;B0B(LR\-Q(:(7MR?^^"B:_\_>M?8VCBO9[P/,?R"";:`72-QZ M6)*==#?@V,YL@$RG)\GTG=YOBLTXVI$E7SV2R?WU2\E)[+QEAZ1(^7P9.#V6 M3)7..4466570&FC-FGL>#=6:A>N_]-H^\R+LG::CW\D21D;:7[173"&`+V!*$+6[5_8$M8.L1MBKO:.+DS\MV M_#,*BA#C:>9G_"89"ME..19S5[D7C:W%/KP2R')9F$R>C]I@9OW2AAR!/:&>5'0 M!6$R_F&RQJ7UF4QZ''[=B%5A@.AY$#C1:$ZXI@=.@!/@Q!(GVI[7#9M.(J49I1B`+3G8JER*`>>DD"ZO M#(NYJYS>"3=(U*J>:]KN2.BLK05J1`=&(6`0,`@8?P&S);2;T@(U'..BFWHL M"7FFR!^JNEBT#31X!B/`B`4C+!/Y=(@3(9].;]UI3E:"R;/C>M.3$L`M<&L5 M;MDM%]S"RKJJ"><)/V$<34A8GE[PGS^]@(6%D!@J3IWBU&GU<_-=FU]H`V=. MH5_0+^B73/WR.M"O&L[,2QL8VO'>'\QM>CO>AX>*&]J.MSS4O;PL*MJ8ID%: M=M^-:$9FQ;9DDMUL%SVMV?V+MK;TWWDPF](H$]W^E6^'UI^@G=+WI[ M]^/IC$9IV3CWA*99$HPR.C[-V,7%R<*T=^TGX]XH"ZZ"[&;E]J_>L&L:]L&P M[PW:/=?J.E[?O6W_:@_=OH'VKS5F#'6TRQC2)D4)F3]R(V@"SJ=_BZ,KIH?, M2YR<_HG061WQ>R6R(,KGOIZK_WD>U7^1%6^_I84RY>!GZDZP`,_2,@//\PKGP+%"9\J M,Q:?O74ZHM-SFBPTR3:W"<_^QPI953E1EV$_4L_FM"4C/.$#9!DEY3,V)?C\2Z6U?*C3'*6S4(I MJ80S;"I^W@K+;")^!*["3>WEO8RZO!&QPHQ>LV6V,E-1L]41;B!5F(3%L@+^ M;X.R;*QVJXL\&WDK.?U]_8\RWHYIM[K+$F4<]T>#G^=^^M+%68([9_X;=-$C MRE&K,W:-EHD>ZEAWKW"8($XN:("5=_U^NIDK[X\<2U"]::'-]NQ@'A;FRW,! M6\;VJRHLJG]=KOU4H-I).+0VD#4?T"6?7$!V-/J)H;9#X[FH"KB4*M^@C`9U M.BV3W_';MRRC"A8X3J.J-2Y\+:^;2[[U:LG! MRK&H)HMFO>::L`__9'<^,3H!N9RW4PU@AS]V],@,5RL17$K>-QG^0Y-1D%;. MKQ8[JN]L,4')=YJ0.1G!Q3IB*LTOC:,F%T_HU`\B9C,UAM5G_Y:P-73NAVH, MZ(PF4_+Q)_63%$>PX*7%<'$R2>ADA8(C8H=SR"@81&DPJE!D1-J@/AY&Y/<@ M#(O9-*7CV&Y1HO;D6.] M4?->3XK4\V>KB!6Q7=00JV'S7GKH5H$:4,!/=?R@AACPH[]]@!_-\`/]X3V' MW)1:"JAAJ(:(-;.20E?"EI@J3$+06`'_MSFE$DS;1`U#L*M9CHO;/(D_WQIM M.>4@MX&"+A%@31%U[`YD>W>)*:A-JW"X21DO]M$T^35H>_K6Q9E"W1)VX$N# MB],Z[9;%;2M?%>B+7DN!$:K91[.)*P#48$GE#Y>FZ"HVJE#T6PWUV<"MJH\F MQP*>*/H-YB'P6=%.GHV-+'Z++Y!+?\-I-O]6R'+*06X#]1P;6=C(6FLC:Q8D MV,:2QBD!18H4\W$=R[2DV4L5&HF>7X)7#8[-.F[+X];Z#(S8&$8H9A_-IK<` M4(,E%=M=J'0HKM*A^#(3$">)AM.COHDM(ZUK(\J;@)4*3:F4CS(J48))&17R MW%97?)MN5=X]E$91I5'(<&+I)O%X#+`&K[:A7LW>=MMV"WY-:!"A6;&"'S3- MZ/CU,`&)$T+_F=&B!2W)8G+%KB%!5!83O,BS/'F]90:"F?5J^&(MS*\/LP#M MZG"L3"SBD953+Y"I(612=U;4''EA"_XVO[BC%BB`ONBG+T_MHPN_6H9:=@.N MX+<:X+?L;:?K<&P(H`4.:EG7*Q18K'O!CUAMW?L"#\X+/\-440<'5)9"D^,< M8WT#;X:"@MEU,9OK-HT>8.6WB?-NV=1?)9UVJ\-OLQ4R"9E44B;E-7-4FNP2 M6L4!JO#H\.AUKGNVNVV'XZ%I^/2JP:-/F<^>\-GO/_/Y\Z<\W9GX_FSW='1) MQWE(CR].+_V$[OLI'??CZ8Q&J9\%<72:Q:._CV?%Q[0WRH*K(+LY*W[JC-EE M/V3_\^NOOQ#R^;7[??=OIC3*>M=^,EZ^WP\_S,L?Z:5I/IW_V\-[LW<3%2_@ MA%Y\V3H8%`&?/]H_SP9;)!BS?_!'V8[=[AS8]H%MF=Z@/QQ:IFFYG8'K65;? MWN_VAEM?'[W0Y9=S%DQI2K[1:W(23_V7Y7OI\C"(Z,XE+;V%:1D?JESS0%8- M1N<25$'$/,;\[^6;1G$R]<,'HF`6W[F_UWOFP96^7?#,:CN[]7 M?]KK8)Q=LH_LF6[IPY@1^K.4[MY]V'O,AL6@EH.7]XSRGDU)JQ#^+,?R9YU;?R@CN?.])J'P3ZK^'T^-3NX;7.,F&C3A*L%>6YD`%O` MUB-L6<`6L"4(6Y7CM]CH?MF.)T'Z]\Y%0BD)BG=4G%E/_(S;476%K*@9GZ5% M;KFE?@M@N=%R.Q_(#C%;GO%!$],"DTW'I&7.,6G9P"0PJ1(FK99572[BD,_"\(@N\&"I:F!*,$+$J\@H.UPG%;(<&+);IM8 MC0)LLCQ+!V`#V&2!K8N8QAHQ#?8:IN3C#?63%)W8L8)8\^B\89,=XK0<%"X` MA-8[F-VRC6=7H4[+]/0U&D!5+Z@Z+X'*JJQ4B&U4F$6PWPL8OL?D)J`A.H/7 M362%#"=X2Q,+3&`-6`/6-A9K@E+LUD^)>RG=[L\HH_Z'CHSA-CZ/#J*A] M7/S(ZCEU^T;?[N]W/=NU#HRVZ7;-`^]3IN!KGN=H89L'4S^CK MNW/2AG/@!Z][)&DC*4*:Z+H&U@D!UV])G+X^MY7%J@IKD-/ M,`B8`E"$@%4VU4>CU99FK07;:K(?=Z1Q*Z,`=8.Z0=UXJ]L<;AW+M,1/0[3` M#B9ID#%%H`@9@XQ!QB!CFD,1,H9@&00,`J8M%"%@")8I%BS;[/SDQ7;PI-#. MJ"B;LI/.XBB-DZ*T_(1&(Q$[Q'`-2W5-WCCT(CB7C[]T>9T6M\ZKJG!$]"0* MA&@P(9@OY]Z*>"67K0J+4`D<=*DE!*D*`>!&P`OP`KP`+[#>`"%`"*PWU%AO M(%OD'>'!W_=/>:%-(9/JJU=#4P3[I7,]HM;BU5X=9`+I!KR:W) M.,Z^&6X-)S[W^G$RBQ,_HV1,S[,E#M[M,)M[9!+&Y]4K\JMG/WU52SMQ,FVG M9?)"BBH<$>W@P8@&,^*CT7)Y`Z797AETV6"ZX&0;>`%>@!?@!7B!!0<8`49@ MP:%D&%"AJ+Q((_;2E&:D>%@Z1GUP-26J.7L;IN6VN+4GQ<8AR`5RB`/G!HJ!8J`8*`:*87$&I,+BS. MM**U9_^0<9R?A_1=O6BU**W+KXAS51-J7\S9W#9,GMG6;QE."QR)GFM!P:!@ M4#!^^4?\4M:K6FV#R])#W"!N$#<=ZW%@;@;Y@GQ!OC0M>8*Y&<0-X@9Q4T7< MS&W#-3GNDF!Z!@6#@D'!)$[/.AP/4&!ZMLI.\*?,9\9Y]OO/?/[\*4]W)KX_ MVST=7=)Q'M+CBS^CA+('^@\='\5I>AP=1E\S]L3[83SZ^^NO MOQ#R^>D-?OAA[F=!'/6B\1\YN]7%#;-^;S2*1A$=.>2EI`R+>/#8PRQ"Q_B MK/R')3",F+UHPA4.=Q9>B/OAX?.%C.[?`/&C,5F\`W+W$EX%UFMFJ&"Z!X[@ MWBI!Q'S<_._EFT9Q,O7#IY:\OW$)9S*B87C[G2];QE;Y-R/EZ.[OU5_Z=3#. M+G>[7JOM&EW;^C/4KI[]V'O,<478UL^=;&0">_9`S85#FZ48_JR M95L?WE2@AP)Z>Z$I^SI'EX'J\H"V[`?4!FIJ/^!ZF;4/9C9/IR'-.JKUDRW< M"&5>8$P&=$2GYS19."_;W,9"CMM"[GZX]EO'2N4C\'74"9@U[?NA'XTH\;.J MDQ[!XZ&3((J*R5A\H<:("F:"?6"?"&SUV'"*A4A*^I=^,J%C-2"?Q63XSXQ& M*27QZ]B7-J13/^17;@(T!`V7KQO0<3XJ>0B$`6&;,,T:1F,VP2*KS&V03R-@ MWP@ZL31%:D+A6R6[E;<=T5'0C8&;;S2/F'(J8^/R. MQ>X'R"??24MWPA!OX`?X`7Z`'^`'^%G+/@(+VIHZ3S'GH=>0X;AAZS8TO$!H(#83FA901 M"Q7K(#00&@B-8*%Q)53O4^7-0V>@,]"9FE9.GH3F[ZJ\^O<*S?OW4YL6[1KE M*1LR3<@X2/F&NZ#-#6XI9W),NU>%&*)G,2!$@PGAM?G%%4`('?UJ<5V:SUYX M9/9(>Z_D"'NS;*ZKI0G9;4"QIQ2S^55)5@DTS:(8?([,6#8:7?-8X56,+SVN M9*&=BSK-SS.>?2`0EU.M8TWU:CVRQL M!"O!2I58Z77!2K`2K%2+E6T#,UALPXK9ADV+FB8DH5F>H/($@G]5@G\V-IQ` M"!#B_CJ./6ER'#5B1RU+LOZK/,'@<>5,PAU]OK:80`ONOKQCW#)NO M34N*T")>HT3&A!X->=JNA/Q0+4`C>FH$_8)^0;^X1T%DY)UJ`1KHEZ+Z):9! MHM98E=)A$3J@E5()#];.AP#EY!(_O'0QNS+O5W! MG=MB!2Y%=@7<)?X^0WN]ZN,"74`7T`5T`5U`%]"%RO$5S8G*\;536]Y6F2J@ M4V(W3)E8AFGP*X*A_*M'P!9"`Z&IK=H.OZ"IZJ\>0@.A@=#4(S0&6N%`9Z`S MT!GTW%)':%"R`)7CD33'XWA>R^.%$U5X(7H2`SXTF`]NFU__%A!"1[=:7(>Z M!2(I9J%P@?H4@\]!]Q[=%GB;4K@`A>,5E)T-*;MI=B2$J38B%P&L!"MY&='C M6`P,K`0KP4HN*UT;U1_`2K!2+5:B]1%V847MPJ)P/()_JYFCRT^,5*&$:&!52(E"43V!" M!8KR61['?6X4Y8-$0B)5P"HDDI\M.QS/RD,B(9&02"6P"HGD>`+$Y7@N"Q() MB81$JH!52"0_6W)M\0:)Y![5K75WD2OCF`YV!SD!GT#9,':%!V044OT?F'X\#S$C\`Q_`A_OK')>? M%P8A='2KQ74HOB"28@X:KJA/,?@<-"#2;'VW*<474/M>0=79D,JAIBTA2K41 MF0A@)5C);2]<1B=XL!*L!"M7BR6A3PQ8"58JQ4IT;\(FK*A-6-2^1^ROMM/R MJE!"M+,''QK,!Y/CG!F$T-&C%M=A_U4DQ:R6"XJI3C'X'/0?TFQIMRG[KRA^ MKT)*!&KR"4RH0$T^TT-E9T4F7Y!(2"0D4CV)]+HH6PJ)A$1"(B&1+QW,ZJ+X M/202$@F)A$2BRUS=$KD4U?V4^;7H.\/L*@!]ZT4^5/-V\9SO?;4*;.>^_/,\;?>^HV33LFP'\1-*?)+0<3XJ M>C20BR2>$B9::3H_7];B1O?/G_)T9^+[L]W3T27[O9`>7_SPP[SL#=&+QG_D MS$P7-PP-O=L"NH,@'85QFB?TC.GM@X%EF/8?[9]G@RT2C-D_L"_O M6)XWL/O=X4&[WS,&'6O?Z`XZ`]>SK'[?.C![6U\?O:C7Z/[2.UOG/2]=\X`W MQ1Y7Z0F"B$WPYG\OWS2*DZD?/G#BIK%,-6[B]FCD<_DR#?9,MRZ/(3[T9RG= MO?NP]]B%/:^'"Z:XS^[>5M"SGOAVM?9LG\0`U5EH`X&JG<_ M)`5*\*MG'^4B"O?#[;R5=?)@R?9T[27X-%$Q0Z$)5WM]ITEQUX79XHO%Y_G9 MD?L_3^@5C7(*X/$'G@/@+0/O&UWZ'W?3^64@CFAP52X25E]=K'!$3(#1U?4L M_=N:C*`W?WJ_F`!>'G1?J/78(BU(XYRMG\D^328T(OTXF57>:=/(C,JQ79[A]#@/8QK\ MRL&^:;X%AFJR'WN!LLSEK2JB_",Z"L^"LDF4PP%E%H`?.-IJS,GK^ M@K*@+"C+L;@.O*P$RJZSU19-G#HM7..L] M&%H]8V@9SM"TO;[1_9SG"SWH_PHKYN%Z1>7^X>_[2_R]/L^#B MAM=[+_^\GH_G/`['\QO]1N-)XL\N@Q'QHS'YGL1%>@`YC"Z*D^3%:WH5*:H_ M;_GUW2!COS":W^EX1N?P2\GY#5EZ_%Y"_=TG#_M.?7_UT^TAO93,DF#J)^RV M!8S3(,WHF,07MU5_V8>3X8^CP]\/!WQ&%W)(G+E]"*\]1\1=!@V/\6V3'X># MWO_V-N1A>_LGO;]ZWX8;\KC?CW_O'?T\/=N(Q_UT^/NWXQ\;P]NS_^D='6^* M3)7N\O#T['C0^VLC'KA%>LQW%Y[3#\E\3[-T3LG$_8\@*YQ.#K^1OTXVPKPEGK)+6MHDH>3D\*QX_,UX]OEW"C2-DWS"X%$8HIC^ ME-,@FEP%!=BR2[9(FUP2ACW2IV&8AWY"SMAM_1G-V1.E),W/TV`<^,E-:>;!9F<.Q9I35NWBMA*(NX-\R3>(;*=`+"9(UK MH&HRZ7'X92VKP@#1\R!PHM&<<$T/G``GP(DE3K0]CU^F?%,X@6V@5RKSA.'\ M>"""#PHI#U0RNQ("4B`7R+6!Y'(,6T*AN*:0 M"P'=>>N1NS0PG-N6M&0I6'N[T^9YFAT*]G#Y7:T\'8HYK%?,H?O. M6@Z>A4H`BER'4@>*B-]1S(9U%%S1,>FE*QL[6E=1W%_N9NZF7:OQ@.KGN M=!(IS2C%`&S)P18ZF"%=7C\6TW6D9PLVE!6I$!T8A8!`P M"!A_`;-;W!8$>J.&8UQT4X\E(<\4^4-5%XNVP:\!F"KX%ST'`B.:S`B+8^?9 M_V?OVIK;N)7T^U;M?YA25:IVJVP%]P&<$U?AFJ.M^+*RXYSL2VI,C:1)2(X. MA[2C_/H%AJ1$B:1,22!%4GBQ26HNP-?]-1J-1F-?&)'B1&D_W6[9G?W9E0#I M!F(;VT*F%+Y(W-HDM_`&SM+<%VZEF?5DPT^W[I]EW39[H5BO,`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`SMSW0=;>)4\VTA5PJ%)6YMD%MCG#B":/T:EBB6*)8HEBBV M/S'G=4+X+N9AX,GRW,/RK*'(\=/ZSQ&+T7T#FVTA3XJ';0^?=HXO-,6'$Q\2 M'Z['#Q%O@_&^$"+%A[]UO/WDJ,;VN+^FZ);1CK??(A1WUPA%!7'U,IZ;-EWL M!68HE9-/<:]$S.TB)GT12BND(NF)F(F86T5,\H*)B/[^\R9F"F/_H,.QQ5[8 MQ;#Z4F;%V:`LPSGM37LZ=1UBW-.#PU,L(L4BOEVC@*181")$(L0U(4`B1")$ M(L0U(42\7>G[0H@4K;[CW-KZLN@.+V-[H5N$WNX:G_U)`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`ZNC06& MZ]*G.-J^1GV*H_"'#QZZE@U!,_?<<'2O1K*J[WWX\??9A_9K;ZJ[\Z/?U8/; MD3SK^+%A[=E,[T^X+^?ZQZWCJ_+;]FQ[4WK[=;_K4Z&9[[C[Y/ M$^^H$Y*5+YKRU?3##[>]G>M&S4;WKSTFMG"M9H4%@K8Q/QX@^-TWG;&;;N'D MQ@??AS?]PM30;6DH30U-:W=K#HJDH-%U<_EV5QX*CETYB(K7^[&[>`U;?7K] MN5THOOYZG%:,UZ5X-"G>K.*]+6?^("?3D5E%G,Y+'A!WND=^]1I`W]Z191I4 M2O2.3^^GJ&@WCV6L/%NO>"L/M6D_[!VG^\RO,.IZ<''W>E':7K2!]+*G*4#UE$E2,8M;?!.^ M:QW:E[2\[[92]1)G]YNS,%[]C<39+5&]Q-G]YFS,(T(29[=#]1)G]YJS;`,E M+Q)E$V439:.!*-(HNPG*KK0+:-'G?WP_:EZ>%<7%JP_E6=AW<5RVNT'Z9Z9J M.MVZ&0W*C[Z'JEMW_GS]G_^19?^XOJ';]=?]5/;+0=&5_1-YTJOZ88-*6_C8 M_G51]IO2H].!-"EO]+?OMH#K*3LE/UBF[SX\%+>I!5)_[/16?X M4N9`N5SF$&!!F?CY44I_ZJ:JU]M[Z);7Y;E MAZ$WB>\NPOO?M%MU9M!@S`/A"0^$)9(H)#U-)CR!#')[\/H]^>U;/7]8KR+A M9?\]JH:71WU/RU%;O;X]G/7C>=$?=[EQ]>"T#!L,C_KC-S\0SN,R;&GL^`>U M@(9-B\WQAU^FD"Y1-Z>PT1Y>3JWU>J>(SG.A$63(($8`FE&W)O2O.7A-5E*W MM4"S*S+IE-VSW_V=IV%_4K\S;L$B`2V0#IN1CG(LMXHRXKS-8EC[`9UYZ7C+ MRQ5W@"^0#E_-&NR#>+Q+U?S:;@0K3Z3W=8NS\B?_\*$IAJ4KJL&GHCM:.C3' M8A.:$9=!WEJIG%H,#04&:NL]$\2HA4Y2H_*;MMMCUO;_X#7#AVB3$EL)N#T0 MYB-H."M6*Q1`P#(C'50*8>R8\&)EP!DI+`=+Q4H.$7NN8FW?W#S)F(8%=,)X M?\E@QI$$&F@X'M.T`_+&7&%J->%J'E]\8'9"'+&&,^]Z.T*-M-ZA4]1H(I%W MRA&FACA.!5OD;+#-C6?;()FM&L\`TYHP18@GDM"YY(;HR7BF%--+#1]$Y%!L MQ/+=$[S]D&FD88U[WY\XC3G'S`J)*<+*LY%@B_V$'OÐ7B$*!G+-VW=?^+ M1[L\>3L*^-Z4WM%8>FL9V*SDFBDEC>,6:*2I!6P:=Q%*J`7VD\*-F<];L&R- M--":I,&=MX8Y`(;DWM&W!AMC)](`G*"%4^>Y&%Z21G0O@X'<(8U,SG(_#W/2 M$3.)&0DF^$+W#VW0R]A6P2PW6K$$@YCW'BAE&@-GL?+>!+T2#,H)762^-AC. M>&K!W---B&S:9CT#[YL[AZBG#?&NN@;>LO&I9:-`V*437K:A.,;JF.V"%".Z M"[-2Q+ES.?;B@](Q":%S5DWHY@##;ID4.3^$-$DQGA0C^>N0808PY%83HS3# MF$-CF.)<.(P`7RI/"-@ASY-`XQG72`(5,/@I4'"K$+"8&(2F!,TU='*IF06' M_)F:V4]M_C8(IBV6M-C0C:6$_F?4A_!E^!== MLR2TX@9OWA1_5;U1;UX>1V_=;.(1`\1R#F%NJ3,0&2P58M82XGDCV*W'R*-Y`P22PQ!G#B@%/-4 MM$RWT7CB70M@[G0&<[Z_PKUZGFR:46_W@. MVC(+"K6#6!,IJ730,.29**>9J$3+V2!\OPTD';R.83Q7!>+)<7]L[M\RW$GN M)T=`2(2,]#Z?9L*B*>Y<$?V,<;].V8T/NT5Y6,[0``)'H\_ M[)_JKG],UUO'=2C\XUTZF&MHL"+(004LITP(,Y&0!4`NE-`ACA'A6QVUO193 MU5]%3,[YN6F>6\DD%(3EAK/)?@R#*19DH9A0#+]M5\3T>#/V>"E99ZCWQ!2G M>>ZT\5,D-MEG8F!.*4A26J^45C-YS%((D`6$0^\T.\IU",RU4B(,*+C8Y.%G M)*4(+O#CR82%TWL;$=%PU?[I!6;;'<_E)[G9Z>5H[+EB.I0`6,I5CDL,K MD^>'K(5"`C!?EY@6H;;'0EK-X'%+I9.:,4LPX@J$--FI]P`QP8N%!%B,`,[. M".G)S9W%80^']<)1#%LCK9JZ>`@[LMC%\\U>E_NP;4+:!@>/>M[X6:W56&"B M``4,\*FUR_-E,D)1LH]V049;X=Y!*!261@HO*(.HIU$.IM8.4RB66#L$GXF0 MMF$^ZXE#M$-&20FAS9$P[(I(F-G%,Z7]D=&M98JU3FN7[@IU5!GOM&&HK<#. M>7O&KQ8,@&2+9T%B30*X$Y&MD$3D580;&YH,XA)H[Q4KK"1PPH)<:"B`%*'2 MPN()*5X7%W9$%/$6TF9%H1WAT+MAF$N,_:P38'!5T`4QLW`9[1"MRU'>A"C& M:>7O3MN_-G(T/*_'Q]7.(GYTG9"#EA=M\',)2!CB(=/)B-QJ$C)L-)(*#1DIZ6=60].'TIJFZHQ.3J0;O*O##S]@Y/4CHEB2.::J4@)T9/8U": M>K]_47H89"PGE,=8(?E&7R(A]FX:.2D'G:HIFQL9-'ZD'53]INHL26Z(1^^; MF["Q`<2[A""'.0L;"*Z<0VT@$NYVHA$2\]6G-H#'$TL@KM=Q0P`FA\(`"K5@ MN:**T*L8N<9.P;E,+TAR\?P$$-G9N"D!1!UWWBHKI@G6&"`U79A%++?VM@2X M%\$>2."B&K3W?+/:P/)4:\XYE#!D0Q&$@1_IJ`MNFJ)84`@6C6]1,9OK05R( M9LIU/!@B:IT`1FFKF?"S-9422LMF=:?Q$8+ MNE0T(LXR^EZ(9CTQ"JNX$I@#)_V$#B!CG)T4@%3^)RJ6B8:`0T+V1#3O1L-F M6/1#K>&[?+?)+KWE?@3B4E)-#=**8:_6U)IIY4^*#)ESP!B8JQF[KIX\&6#X M#L!R2X#4V'*#,6"",(K:P=)P")'19JY4*B,X6CG()T/LCE(5RU4+8RTIQHJZ MG'OSJ45NIWLWC5GH?Q$4VZ^8Z\/&(;I+F01B`A('-=%:P!P([Z-.(*(H7[AA M$D=WO38'T2T3.9UYO1]4G6^;K=D!0`KJH8*,2,OR7(3:R5.K11ED:MD`0'F< M4/7]NK8E>.+E>'+I&*82.P@01<1[/*'.56O4.,WMTJJ<.3L4$0?4)\%SO&E' M]D^F654?Z_#3Y(TA%/D09C/O,%(M,*)&CN7#`30=C"G.UU!&DY)!'M`./Z_%&T)^AECP[&Y1G MWC-]C!M$$&Y#4&&EEE!A;%M`M$5>6"'F*\9306,[C@_NZJ81?X@!`8183:'" M$&%KO*NIKE2;^/'.+G(->.SH]*I=VS2@T0R(9")7-%>Y=0YQZZP5TX$/D=PM M=23\P$=B5.^,TN-(Z(\7X(Z:9K2D8,5\)80[MA\PFA.*=0Z1HA82IBD/%0ZT ML=!QNB@^+2+NHU_4EWO"U-QWW6!UI5P)S0#1,*VZ-X$8B4L6EHKBK+#_#X^ M;^1N1@9YP0)%3)"I`%P1Q?PXACF3!AG+)R!;1^W2\L@YOE]UY,C=C`SRG8'" M1^%K%9`ZY"Q*@&![@H_2$WR-5'9YP3,,XP*\>A=7P7;\4#\>'O4[_D75E_)] MM^@W[^MNU;E9)<>T/,\>Y_3%JAM7I M9:P3W<9?P^6OJJ%_0V?\I!;LERW:V2SU%-K@J'3+Y2U#R)ONOXP^_ M-/^=>8@",K)T>658V_K5.?]=LF_:G'E_O7>MZ&:T^+:I!]::=:_MKPMR(0J,F*87;6 MIFV%9RYIRDP[!N5IUSN)_K[^U=.G3QSG`89ODV>7$XM?6VC63I]P7V/Q#>74P6 ML-UUO_1,&J@+"^B'=/=T!UCTTT"6:5L867134IS\^SU%BK)L2K:D4(JD,`@2 M74BJSE?G7J?J@*!->\/R%XI!!DB7R#_'+%Z6Q'9K430NHIC$^^&:V$VS''&1 M_34=C`?P:^.L^!15X$.I0LZ3Q[M!_RX^[[9JWS;\4MX0J8ACKRZK[B\J`O.K M20]FZ68Z'-:7728?>J->I<-F8%2V%FX<]F;`E'/1OQMDGZKK@.X%!DIN<]"[ M26\\SON#\I;'P>0N`<:IIFT]S&JI[E$CU]JJ6<3.53/LS373?*_X-+##70/FTB+KF M'K[^HQKYJ#FTUR=I26O/S>WY$H?@ZNV0[^JE(_+D1W_5R9?KM-PC7J.@K)(B M15:E!*6F/F<'4V_'ZFW2>,C.4A:`X M=YP';BC'+M1-'K'6)&+,_T0?,/(MX/PF(-\.^'UM!7W*J2M+A<'!&$6(M$IH M-0?>6,E+X,D'?.*X[VLS^U/*AULM-0DZ2&6-0E1+7W8O4C:_9[= M0S`-<8D#[(HJV'_55B[FUD%N$7?84B+2H'F@4LTJRKDR7)72W996W9Z2=J%< MO5JW:@!D=>OSA8:0A%`L!,N.W1]A+SO)C$SVU>%/DC7#_>K/15IY+I%%L2XJY:3;26 MLYW;6AGO1:,Z!JGFSL[&&+88Y*O%IZER@GF*0+-X4"TR6KJ99M'8F)>#Y(PU MNW6\-97WB-+!A2AHFF]/&/L*MA_J"Y.BE594'?@J&^[9*W505 M"KK$[^MH@,<5@:^`<%*T#+&)I*/4,F'ER\M( M\TT\$FQ9:?B!<?+2,$FLQS08QE6*B8X&BNE8,AC,LF-(^"'R3/OF M"0E.A>0HA4#0$E#&F-*9,%F:AF5-K6-B[?"@>6O'/B<0*DBL.,Q\B&="@(M2 MA0^"HJ7;H3#>DVQ4>:Q^5:Q0%A`LEXC58A\<#T)AS%"JB!56^UG&4U-/<&/C M8.,H@C7'U2HU3=YJT6Z!AXFCTB"DI`^&FWJA`RO$ M[2D`8:ZOR\?UAK_U!M<_CUSO(19BO>51(.L5X1`ZI]8;3''0LW5EPXAV;O_( M;!2OO++-D;O448()TPH<)1Y0F+$^1,I4-^BBC73JQF/<$8V[$`@2VY$()3B2 M`1,+QJ]>^7/P1S6#UT.#9]F"Z2[E!%FD?6""($Z`E*A/24/<@,D:FO&T=VMF,*XU),F1>8>,,)8V"] MZC/T')C]QAEZS1,>#H`GMA*BM50Q#A#5"ZJPI1X"&1($JUT?3"UIVO:#E!GR M1MS&P)4/W).8VH#PG5E:KR0XA>2W5@P;Y#-6JP7L///28RB6P2Y8'WE8K@K0J,AM3:N"-Y9KBIXX2^ MA.@"HXT\U,-%:3O++:QFVII4<@A^@A:8&56;IA3AQHG,3-$3,4UK66Z((X(T*GN87'?)]]`=FTV$#J64@.HUW,5,OU/:RCJUDE)0 MQ`VA$_I$W+\MA8XHJ;EAL9*`<.PQ$;.S9I4%;FM$B8)LE@+>H]"MKC]*!6(R M:!I`))Q@&.2F3K<9;AN)E4.3G-VN`03C4TFI]_$\K1!G7[DZMV8@U#ST^'*= MU!H2\51!"4J!8ID*"8Z]K;6"T"]/:]M9U/-[]C`M^G>]>!Y%?EOT[I_:LU2% M?2L./7KEL"-O-4(V1=X2XI#5@:0&K`%5!H%7UEC1G%E,%`\[:E#WYO!:(@F' M[&HU25IBPQ$6*28XE8$0D6H@"3NB$`FH$:&*FJ*]4[."\YZ38P*7X!DC21Q# MTF`M)8WDI/`1E\U.'YI_\QDB)=-EJVF2P1JPLB)NK6!IK)*H=\AJ#]IC29'Q MKFF:U\D^W?QTS?I3=R&>=5YVH"V(3YT!G:7:K+H]]4:G3"EG4^VM4Q!TU^E>HU%S.9\+S9::\F=CV'R,KQ6$>V$L M#MZEBF'#"#A1MHZ,&=:^$?9QKG3C],2-Q_CSJ#^O^5%N95A,BD&5]-) MW(KP,?\E'T4:BGPXK$[N+ML[-ND"+V-#%^/W+!Y\DEVGO2(R]/@M]YQ)Q!FX M')+%W0A6<#PSQ"X`US57/KD0C3/,6R%^YX!&/-%KQ[E+$I# MRATP=2/+R+7F;_/R04*Q)6^9?G]Z/RT/EODU'E,3+RNRNVPT'GS*JA./WMIY M`!K-!0_\YI@GF*C4S??Z,HH:T0V$0TM5W)%`3'H-%NEZ^#H+YQKI>LT7D$0&Y MN?`O?_);\FXI911<@>B@<@3.<%T? M.0IW-@W)D6.QN5'>T,OA*G!I/-<<^X!X(('5>Z@]5FDC@@-'JC@2++2SM5CR&9;#>D"`1=B8H)U-L\AJ]1I.PQM>+UMVN%ALSF,;U(0%JJQ#E@$WI4PB MIX6HW6((XYK9FJ4%+XY_D$@@0WE*'?SEW,X=84X;^?45&RX/ M']-MTU];*4!MJ;"Q'8^4TFLN0!W.T@J>P#<-PR(D!!W'B>MVO+JI,ZACI0W' M,FZ0M]Y)5*?S#17!-"K,25V6])W`^?4!L4:Q?12.7&N0TH&ENG:WG7[>K;-* MTLKF"3K'@?"65FJCHD/MD#:&&K!2FGNI:5V[#*X`X@UVO9!"D._*5JV57Y#" M.^_!D^0(RY0'IT-=,N1\BAJK]K$IZ)&F:;9#<7W/R5*K>$J0%!!6*V=2L/,S M!1JL6U;6>9PX;FGE-Q%N$_=N4`3^II;8@O'A:);U,JETS>67"P+Q]I'JRNW8 MQ]$D( MP3D$X?71(X$;UT&=,?>0YN":.$49L8XXC5%TJ3U)ET5 MG.7?19>\QVH\5P#IK$G>`L)_2RJ,C[53U8H^@+\5V4U6%&7_.B!VO^W_?IT6 MB+G_AH<@_]8;GR?0AWO^U1/7S85[\^%]5/%F1R"]1;+=5][C%+G&Q-==#;*!YGA21P<;G\>VGP3"[S<;5]=5#8BN^ MJA_9M'\W^XFC[;6V@H/=0M^R_;*OF20^ZY?6X^E#BL]WP6]1:;="'$A.!G^+ M;)F,[5!>Y`XEIE^Q0"DN\7W5+G+%]R6AD63@(?A_%[1B?$E:I?749+;VO[Z% MU%9;(BH=6G4'!`XQH#^'"7AM&KXH\NGMW5RTDRAZYV6+Q"6VZJXWGIF;LN%G MO?&B9+M*F'JCI'=[6V2WL9=BN]Q6SANXK7G5&/#'$;BZ%1C_K2_!HT^NVI2W M69_(16$Z3P:U&UL"&G,3;G9W*$=HC`1!PM\Y>DUI35L9K.KJ>-4M^ MJ':NQ5;4A^UN[&9TI!V$V^>0>H"X)?C`A8D-;0:?LN&7\R3[/%>W16\TAM`] MJM>;#-SZQ)1&Y_@\TEU:R/('M+A4[;J>M<*O/,S2FU[4^$TI+4/7I%>U'JIB MMSA9>U-.$B!`[=`.3M,S^F?A*7AW\/%XLE^R+ADEK>K<4_.TRV6B=AQL<&SN MLE&2S5I0)KW8?JMN.3ZN&KM'7H@\,Q]_M] MU3T)AM";3,&1_I),>I_+G$Y,X43]5F1_3<'+CJG<\7DI2[6TQ8NR8?4[178S MK%K+@Q_^W%8>[4R6]YED/+V_[P$Q,7Z]BUW0QA')9:%L*8#/_83!.&:`Q@`> M?'^5#?/')@^L"\3'^?H#$`-CJKWBP\=Y<5];]A$=/[@,@>> M]+/A<';-^S-T5KX?/_3Z]?O-$]&/@^O)';P$FJY*CKP`13/L/8RS'^L7B],: MB5D85#%_%8\[B4,9O3^39TF1/U:O\?S:'R;73R^+I4\HQ_+^3(C_>?:$IRB6ZJ`%!;S[QT#'2X#M8CEX?+8WD8$ MKEB=Q%YW4K]_K]OBQPBRHM95-3O9]G-S3<0D9>N49MPSI/M,5D1"[?: MTB0'A-_!J9C]`3?34:6KWU!06_)@.0FM@L@4N6SF%=O&;Q=8M"Z/\;ZK(ND/ MLU[Q_BQF7,Y^F(-P:-S5B>5)B^4[C"_5WO![8J)O!&#KLOR_.W503LL/J0^+ M+6NFJG*2ZA39\^2Q5Q2]T61`Y\;U0MJC]; M(KO)BZ<5RZMLE-T,)LG#L#=JS3P?$,+'I:=:!>Z4%=A*H`Y%^KIL02=B>Q0Q MM(5KRT4IL^J];I`I0M4ND"E"^`[N=@F6T_59;,N M_"N1V"@I?RABM-N\^P'YQ/LL#&ANJS@$U_A[TD[?X0HD4_*2[1R_HUA,[$+] M3BP/12S?,7VI]X9?5QCP/2<1NL*`XU.)1QU'870IN\1")Q"=0-36OL6T?Y=7 M.`8'O"L8Z-37][":V5JZ].17,SO1ZD2KJ\7I"@:Z@H'O4DMURJB+ZSNY.#&Y M>$?4I>@"^RZPWTW!P.Y+13OMU*U,OBP8T*HK&.A"_DXL#TLLWTG5WJ):5S#0 M)1&V*1CHR@0.3!$>=?2$R27OT@F=0'0"\50FT)I`=-F$8W"[NS*!3GV=_EIF M5R;0Y0PZT3J6E;F3%[$NPN_*!`Y52W7*J(OK.[DX,;EX1TAWKD`7V.^J3&#W MP56GG=X`[ED?$_KP.;G.I[$16+T*]ATN6):=Q+\]P$>Q.-DE#3K!/AK!?H<1 M;F^=XNL1[FH5JI>Q\^32ZY>\_LD__R-)_O'Z;>6G?SP,!Q,W+Q+X/7:^Q;%J($+V M>W;S_LR#T\+^B4-VA?%%_)?\:_;$T548-01 M)+U`9V6Y0CFHT;1\U$_D+6Q6$_D"HN=#'<^1?(9%B�?[(_/_J%<:="LQ0^ MERA0;"DCE@I"L3$V"$5U>O;3"W9<9*TW6HDNX^9#ZR-;OGVLQG,%$S#+6LT1 M34I(7Q63UZC;<0/<7T<)<'4QC2UP,2E]=':>Y-,BL7FON"Y;G0^*K#_)BW'R M*8^U,Y,\@0_R^_LL=B'^ZB[4Y3`FCWDKS[FXR8L+\$F2<63Z./K_9^_:FMLX MEO-[JO(?4*H\Y,%2YGXY/N=4S67G1(E])$M*7'ERK<"E"!\08'87LI1?GUY< M*!(+$@"YN*K++EM%8<&9WOZ^Z:^GIZ>YTCB,KX$=O][F?/2/U?UM1IC2QZ(' M3#V[Y+B^`A+_=#6]2[R997,[M7DX^_PVYM?4WW#&7WM5_ZJXF`QGK[+. M_U$T.ZK-YNNH]Q\3L!TU,S^`H;^]S;,.1I?-A<+3&32DD(.C7C17)==7\.7S M4;PK8-IU\T4)/MRCY.5_]J[RJC<:UV#@8C0MP'@C^SQ^#?6*M>0AQELFQNGMT&\NFW=Z77S(OP"1-H8N1OU!L15/>A(XI2DX MEZ056EC+F8E*,Q:)I#[LG".9>)/@]73!MGWG!M&:G4[P1#;F M3DO"HGV^#9?C?<0_=IDP1M]"WUKRK8U3OKC#\[`=?3Z<5F[F383_:3`:S57( MUR(O,2=\@@OJ:6]/_,O>?.[DD^-4BSTPTTM)+`C<$4DL,VW[:W: MPXWE)^$USR6P$TEG[/0,TJA?%GDU+34>+G+4-^5@7$YCV5Z=?^G=C*O!]'0Q MJM+N52E;HTJ?75>Y;WYB$@\-(R`0$%ATCRFFY]@V%@=8F8_(MJ?+4+L[R'@& MU'7VAQ<18@@QA-CQA0WG%1VLU.WS8C=4[D?!42='1;S#2Y".!2>HW!$03P>$ M>=79E=#G`@B4[(\T[2CJ>E;SCH+\F(CG?-3"O])]M.IZTL&]8P'AQF?S$'H( MO6V@)R3I[BZ1[QQ[J.!__*DYL3-KX)W7D[I`18**9),&Q+9K1SEOID&X?,]P ML7C[UQX6YB.*E/=TZ*-I`H#'/?;&4(\;;EV#&BRGWIUMS[_>FE&+;=*.9+<% M.1(Y$CGR^#BRVT-UR)$;1NA/;BFW87^?Y:Y`-XN.3L-Y*/S^JBCJ;ZWHMNH, MI))-6H;`-$O?BH:WZBF2>*[?U<5Y>=!O\!#N%BRN$FYB>Z.JXX% M,KL.FQ`19XP(:O0K@HC`S-+&F:7A8-1,O@8$!`HPK=+@1?E]!3YXHZ(O%\//@^: MU1K5PQ%1T?FH!Z%P#QR5.6)K)\J<[>'>YW/!%BKS']_GP^GU4/6DQ`N@4&%L MHC#PZF8$!`+B#B`ZK#H[%T"@Y'[L:-@(][R/B7'.)_JG`J-_5-:(K5U@RW87 M]IX]M%!8__BV'%\65348C_(A'NY&/;$-T:"<0#P@'K[AH;.8]ESP@/+Z8=O. MFJ-_R+_@_O51\<[Y*`&-V] MCZH:`?%T0'1X&=NY``)E]<.V_3"N\R%&_;NGG,<-AU=T+C^'5W1V6#_P`R'T M%3V\14_"\S`W@BQY*KZ*+-EA_E=WV/H+.7+3D/SABXSW-K`[1MOX`M2S&]QL M@ZT_*JWCO9C-?UHF_MSK?PNMX.[!C@9S"R1A=\SH>3HC<=8G7'0:=_,HS2'WON M8YE_&8!JZ/_O9%`-\(K?$UUT3SM!@3=D;NEN`%ZV^Q3W2?C.2V`GDOC8>0.E'WJ3JI@FDF=A+XRVN.C5^1<4K-T+UK,K MQ9/DE>W*48X%%KL.C1`0YPP(A8#`M-/FMDWCLH`O[A5?^E?YZ%/1[)C69=[' M:WR/BH?.YYB:E-T1U-F?4T-L(;:VL!/'2WQ1@&^UY[3R_B`4&B@T-NCD@#>6 M(AX0#[?G?Q`0*+R?5N\Q+5*^*&;+\`,%'Y\'PQS+/8Z4K,Y'02C6X?&<P1[C^ST?G>+O4>.)/I"CD2.1(X\/HX4G'980H(=J=YJ[+T]L6-S-3_SZIZL'EU^ZS83V8S$MLGX3MD[!]$K9/.N[GL'W2R<;8 M:!]L<8/MD]"W]N1;V#X)R^F^!]QWSHNGG3[`MB.;9^Z%WL,-\B?A-<]-.B&! M(8$A@>V=P!1'`L/"T(Y,&(O+HBR+1DE=WQ2C:GY\H(:O"T%M3IB M:T>]CA%;J-4W-N'/^6ARF??K20GCZ\&?FL8N7WLWD[)_E5>=9>N1C,Y8H5". M5Y\B(!`0=X[-=I

R6/=,+DV7]R^N;;]]"EZ$&1#D+^2O$^$O M+F6'?8Z0O^['JP_?$K#JSW_^MTGU\E.>W_SI_>3F9CBM?X@"_-^_5+[92(U$7%"9.<)JD--U%IQB+5FL07O_WDV^P?F4-KLD7U-O_:&#G,[QAH39+](AXADR1AQ35*>,<:']_8$O?@GX`Q6O^-WQ;SB\1R8U_?MJ M.[MK#H--0H(O9]%[`;-8N`:QR;,[PZ^F7]]X,I7+QF\/XPGC?,R%'6#,:>:H MI=Y(Z@)-=#Y.Q101*\:IC>Y@F(M7L8%;W!NP$LHI2ZVCR7&16>]5`E.S:'ST MSLH5`Y9L_7@7PWG:N%.$=[[TC5L M:*((7K`H8*'E+BDGN+=<>F&=M8RM>CW,M"#<]72;V=(=S#8X3;4CS(>&AJ0) MA'&8K;`Q$X0GOF*VO,VI.WFY?`?3%9I&8IES)`CF"5$AI"`#B2++`(EIUR+(;EE408QA\%WG0,VX_Q,=:E MD8LHA799)(0:H2,L?=,Q>D:2T>W53C'Z[#$N[-TL)S\7]=7X07)X&.=,6J.4 M#C0HF7%&)=AZ;EQZGX:G`V=$DD=9^(&!/7,J=X"_+:SD'J89%*RB,UM8F8GD6[9@C*YWM,YM<9<6=F>,`*QO9;"6>.NB)29R MNC`&K-2M$)-I90]KC(=#46N`.%1@@1%%HU16V_E40O2$'=]4MGRO;_,F.E[W M0F&NGC++8780W,)K36&!=&99.A(K?$/Z@S/)>$9"\%EH_N\!J-:K^?L$1>3D M,>&4[1RG(24FF.`!:%QY"B2VP&F$1;NU.AZ(P)]NC(V<6W@C*+'X=C38:"$9H\/-):*UD"]RBE3A8,Z"G MCWZ3>,K#2IF(4-I8&+GE-#-S;HI2@G1:'OY+$!Y['?^:M5)Q(R`$)-(9G6SB MSK/Y6NF%S"1I9<%$UZ-_W=Q\5%3U.\!%R*NK-!S_\>_%Q:>B>EL6=?[%]?N3 MZ\D0_O9B6D;6(*8LKHI1!=__>M0?7Q?-%ZU=6F/QL7X]JNIRL)):*D/3C;!3$1BB1=\(%I#K26:.:)L,ZW7@[58A4C=#?8QW1L M,/`/L!:+.CH%\:'/;BT+Q)RUEA#:BA&?,]A8])OUIZC>%=5DV!SG3.7X^FT) M.'@++FH)-H.8.0*TFSLPGLU3;K@H`D;;QQU`!VKM&K2X9GR7!/CA6!Q M9A.:G'4KUM@-B7'+@>_'&&O`0R-100%Y@),P$HG-W#Q3YH,PH:4TN%E.=A[< M&%U1JI<\Z$"=#EGP,A/,A2E6%-!*C)RV5DRYO-?6Q;#W88AUJZLQG')8642S M8R0R`1ZR6%VM,RV?.(P%9B%M$]PV\>ETCQGBV'*RO/6R-N$?HH]"LRQI323H M;.`#>.U2LA@XO.'6:V]M23QAB#N8XZ-5!DD:;HAN(D"8$F<0,E/7_L]U_@IOZF*-Y?NYF8XZ#=U`TUR95+#CWX:7`_J_&D( M!W0;ZR%`HHH'DF6<@#*>K8:49;'UJNUF1GC.'`Y@I#7HEX(SGWE'`F=_CB?#B]?7-S"1[/*RZ#>B'C[2"-_M6,$2%R/( M;X@MJ=64T(S>UA"!0&]Q(+5F0V]9,\S[4VWR=E,3N"%H]J8*JW*CBZ8.JOQ< M5//"K)5<<)M\>/PK6KF*VT\EX&9X/^/I"UB3MN#,4,U6LQ%[F4/7/BIJ2XIZR$%Q*4C&7<9=NS(),D$&#/RP"8"*&5U&T5%)^<:;:,8$"PIJA,4R(>=<@,%V1> M(N"CA!6IG=D]G/-T!*PM+22(#MP0+R,'-6*T32Y;6(@XTMK`9X>)@N?!_`$, M9+RRQ'LF0:X%,(SD?K%%F`456W5DXJ"K\L/G#TRTW'@O/:4JB$`M%;?1!2BT MUAYR*V][U+'\3J(+(%5&>9*!>&M3XF%1'^L3K$+MK#\_2'31(32VB.\-B9Q+ MW=274I$9K?RB;LE''F(K6CTL+/9L'"*(;THTDG,Q$AZ-EOXVM9"UR^/I8<#6 MH>=L'++X#(1R3,%Y("-!8<&Y31Z!`4(KR=XZ=G+,EMD%"P'0,I=YI9H=6!"" MUF>W+&1(UDY3\9V',/$V2;VVYG4_>,M\TDE`[$N,#UPX%1;[LX%IF;76Z-;F MU*;S/3XK;0P\".L29R"2B9(A,E"0MP<0:0BAI:-`51S.2"L*AP\(01H=T!73 MQ*6,>JZ%X/.M7D>]$ZU`0+;*[P[C7P_[0DPZ>"U;7;.Y*#W*&*94T828E M$S*VV(/*2,9:;WZ>,3CXA`Z1.]!6^M"4N`@7N&#"CZ!O)$D M\S1E2E#E$UO$I=&F-H780Z^S3^.0701=,5.4)`5+E`\:;&CAOPMJT4:UBG)U MJ\3F-&SW3,CPH)QUF=5.RA2-;`Z0+>(3%FQ+3^NS(>"-%ZFH(.IQ&I!G@7IE MH-3<[A):E;6/S\CMMDF.)=K=20Y4*$>L8<%G0J3`I%-JL3,9G6_93G4DK7\M MFA9JMPV$_CYI1AD'PPG\;-9\X\VDKNI\U+1S_P[2N6SV;-BEG%II$HU2( MOBG.@JB8S+<_+(_"W4V+W[8/4LO)NB<.=D0>0`(IT91U4((:-LO@9'+AE?U>NFQ9&[F^^; MRX>^9ON25&\\4PP@RCE7PE%W.U&F8T973%0(LJQ7MQQEQU-<@U9.A7>JV=GF M-!+GL[2(#RV\V4!639&W#NL<;(H;>"NX*+'6,FL-25FFG=+?CH/3X%;-4+'E M]>JP+Q'\])='IBC^G[QK[VWC2/)?A[Z=74]NJNK&#>>NV2D(T3+ MG*WM;N^*3%E8.XF]=$PO32+=1***/H!-%GS42AI&DQ5=V`$SW,>U2[&73NRE M262;2,PV`5U1@J0!4:,DC[DSSZ6B;EU.+2'D5H)UCR3RC;,HJ$N$NN`DD81Z M$#;762BHA+F,W+MUF7V$_W4?B]-XD9&%6"SVN:B9I!2 M81XKVUWTSMJZM9J?]:)'7YK$C>+&6A^LEL1B:)L%.Y7:+M@Z&&[6,BJ8\'L@ ML?>6+V;5\+%ZWVURI%*;>D;_T0OQ9UV]BFW(#3 M)&0"7PN@4"Z$W+J1QG)V*\GLBN&VE=NQ%_(>RKC&DP%.Q.5'J;,RN^Z`,#*E MTEIE".+H8,A[0!%ZI21UCC`0HRI;YVY"X"+>"5F[^/266F(_S+F1O.!#="2X MK!+QV5@3KB.,=;Z5)>*&/+JEAM@+>1M%IP$/*%JBE4XF65#SY/I>08P@6]:; M,5NZ%'LA;Z,)HZW5*#L3<8)0D3WKCJ!"E$:NM])Z444O*5HVDL>29$QQS',D M"!#HN-.=Y/3V'M'2B]%]4;U[ MD2])WD;)J:D)UF-R7)K1A8?)[`+T@_?K'4&ZK:^[%_(VBA9-P9\5)H.W0()2 M,=DN-BW$D-?NK0DJ[IYL[D`>;G6_:V_0_UQ?%6/,F_)#-2PGLS*7S0[SQVI< MSN;UI)SM5'*`.(S^4<)8 MUQ3$^/!C7HW:SK6/OQ07F@CG4Q<.B.<4@Y\$F/`?TZ)"U@- MHG\*S]4M!ME,WKZ!^%A/+\[JSU&>=2)F`[R5!H*%2`KI9C"2+ MWI)7E!\PW6Y8SJ_&]>2AT%D1N"#**JH)Z%UPL#EMB9;1]9/$W92!>4:B[]8] MV)KFTZJ>?0*]<5X,RT53^>C!6]S>!F^RPF((CG"P(UU<,CM\UJHWZ>SZ#MTA MTK_=G.N(-72:VY361A$=+.KEG"?C??_:X%[F?&=&]^-%>5Q-1\=5_6$R?/L0 MOVL.%K1FBBCA=73!DN5\LTR$8+T#[0,E>@=.=]H;)8T1X+2K)KF?6(HW[J06 MKG?3CS)SP+,.9D@Y+J?U9`G"0U$R4DL09])8(BQ,M1 MN4B"6V&#C9P3:EN]II.W_?3_\H#UVA.,.25)4CH8H%_C907E*&OUFR12]0*^ MK^-.#W'V'\?X6+G#8$I/'U5HKKR"4]>*>D-ECP4.E.@G3#[6BOQ(A5V3HN:0+?FMUS[&"H.+:ZP-+A.?HU5A2;9TB?:3TM-#-F]^F@SK MC^7HCJZ_Q])9+>Q'/6[7RTA)UHHD(H7+K97'LN:]X&.&Y[H'JO`>;^TPG9MT M.F#=!C!TM7:L=6(EXU'T>,#LP=C9W:Q_C-C+PF/QL*!U3@1X/P394FX)"6M2 M=>Y#\^TN\G>8>D8P8SX0[BAG4C`L<;D$@"DI7HOP@A/ ML0S$VF%_*JZ:MWIK6_P/_>]B0H]R>4S%XPC_L9C,?55_'E;E9%C>2/>;ZAB+ MXUGYSP46SKF$?_K5,V[_O@9#=8MII.:P2)(%%S@*<($U(3$#;\ADB.OI!GV' M:[8#:!72\QHH_E?S7/KC`G>,'QT::;G5-!B!V5APK\K[KN81]5'W+7I+;V_5 M](?PB`%N$P:0DDG>&S`W.?."@;79I2,+PGJ[IH;<]2'YUQKA0\'?1`:A-&6Y<#[.>:L4;N-L#[Y,)D7D]/J>%RZV:R@#O3ST)I[+VHWC^JIY&Q5:DDI0R+S`J=@^#!)=*%&;B8;+]F M%[5"O@@=#W`YU4YDS@RQ$4A1U/'4K4,AO.ZG?U5W-I*>1L>G:7E15,T%$JQR M7DQ&L;PLQ_7%^ML0S[^_8IGS8%<%*G5@!`0`!L0V^LA@'$4OL])Z'#:2]17` MV..6>K8L6,6CI,HG*Z+).K4;3A[^OE]![Q60/>TW4^&"34DGY;3E5`43R-(\ MPR+$_7PWKPR,K7UR096@47G.;+12*DX9:?TQKY/O61RO#(='>>E\-720!.MD MY&#+I.2\RYS;UIJE(:EU)8I>"I=GW:^564K'4B!@CR9O!+!$=R8E*$`'A,B>]G3`NG!4FX2Y"[57V4C?;F=J MB9@<$")[.M,SQL5L)97@^4N%!7`%;:4'WO_N[>Z_LE7SA*WO0)U7#DPP:VBD M`$>F;3`'_*'7G/_<;Z(>+,-LLUM"J+!9IF"YB(Y@>(=L3WUUIDX?DGYYQB@7 M)YV@&:P/RQ.6]8'%H=LM0:/`5NUEJ^0OS`[/?SI&52*9I$2PV'W"B("@N[,A MMB:OX"MS6[:,?L(DXB9'[HS/@;BL?;=7+K3K[]B\-A`>PQ#@G"2MP4[G7%J6 MP%9/'18Z)'](NN3Y`T8"$YQ%;RG>?,$,--ZT84*1>!$/R?AZWJ#(*&1FSDHM M@`>E(>"KN%:/&1!/L#".I-S;]^'D5>J4 MK>1H5LDH:86C7'%O8Z:A/9/Q6@ER(%SR`N$W@N>F;&+24B0GK/>L#4-*UNH- MX8:[`7-95&,L#]?FD/I<#A?+FK)87JLOQ?:'>6 MBVJ*V7H>F5D^1IA\8/H,P?_*9:,M^.4HU+-'7JXP(`YTRECT7`=,F.1TEU]3"+NN*)029F3*/-$VUS5YSWA.8)#.F M%*A4*[EB2D@CB>RN"V?->BN&<6YW1N3AP7]56';D$N4Q5`73$!-)%5C>*G;7 MK<`.R_V@%69W9Y+-`]\!CIY8>@)S4"M9#M((8!&\'4^&)Z&H-+ MM0L0FX>\#H.3>CJ[U2!8U(OSQ;B8EZ/OI_5LAJ4\BS$V\7U138[Q!:S7N;F^ MQ\?B_^HI1C/,?CK!$;K):!F>L=+/:IS#W1\?9;<>C+M2?;@(_OKY^_JRG$[0=@C@!W27]>`]=UI.AO#\UO!:8[/CB3O- M-1J^WK(N?TQ4CJVI$K^.5?]\&'>XEOCPUF@:1PUX55$S&L&[P.RG+;-Z2D,_ M*F>]4OCSH0FR:GY:G):^&/Y>CFX>^C";+KUF\(JY)VQF#5QIT2>RBI1+GO+J))X"XR,]'))IH,Q*9S67 MF8+3Z`@@J(QP#K[N>3B8Z>,;8HW M`OO7=#!5]M($IZDS2N:,+I%L]9;0NE^IZEMA[:>9YD)39?"`;C"`P(+.-,>DK)&<\=AEG0Z`Q9H]5T8/RKW^`3X=CE<""IJ& M1%A0A!M*>-0WJ9),-/?'O#^5\D-&\>M)/6%$,(;#?U11"Y8F)B]N=R12_KI6 MT2N!]YEU>8K)4U`HT4>?=`B6F%8B&I]%ZE?L77_Z\.?#_8E[0((*SX57`"]W M2H$:#R:!!9HM%F:]/^K_SPOH;OX[HUEK#Z+`.&\4)SHFUE44X#[T^//)=M`K M0?.1SE+63H(ER7PP1%NE1688_$@()D%SOI_5\77!N"$;`KA]7$JMC=0L"69- M5_Q7).EZ6Q;L-1&^,1[#QB25L&#N8B&@Z(+IXC%(Y*)?[_3)FS7[)7Q?"T=Z M@##QP(/VCB8,6NE*(&<#;N\K%>0'O+N@LQ1.2>-9`F:U-@C*VMV%J%7_5$H] MV5UY);COX*Y@G:%(&8@_2>$O3;SJ8I`H)_TBSN*;@?+K^2P<(T"C4LE9/+M6 M3C+2[HHKQ5S/)7Q-%LK^SVL$IX(D*S0GUD7P!S$_0X.F$32P'II//I)^)6CN M-0)O,JE'9!FQ/IP5\VX1L M+Q-RURC[Z=G-S%Z`VG-'"EE9%9-46MA)>> M4N[-*MSG7<\WF-?JF^G$]J!RLT8_5P.Z],)LON'$7+5257TLJ(4 MD]$/U1)\7#!@:9Z7HUB>E%/X$=;&\NEU90'V`ZI2-!`B!+<*_$IMDNG"+2V+ M.O2/Q,1#F'YU5/8U"3^6+S$!6:@D5,Z,4V?`B5=)=_6:HU7]*BVI>C-,?P_$"2X9@CK?)O)Y>O6NK$BB%/>*B(SIPDXE+/:G[WO>5'?/P=3DTU7+:$\+\9X+^#E5D8P.0. M;N9A<#,1@^N9&("5-,"Y>(>C^1NVO^/0EB05YQ?O_XTJ\L!?OY6#JLFG.*@7 MTT'YQQ`X=S#$\5],87%,H1]X8'`.1L35X+PA87"RF(QF;P:_OOW\=M"Y](/9 M-4WM+Z?7YNG1K-M%&13HG3[RX?-VO^;HN'$?5EX>_,='__D_WPPF]>3H3C-O MNK<1^L^+"S".BF42R5N=GX[!)AH#O[>^'LB$X_EJ#_AZ@0MUT.O][<"-QX-Q M!?,\:D%X:G+A9X M27!6#HHI6%9CZ!=$!0+13DEYAZ4*Z/^!CD]A?N;E%+HI)K='T?2^1<_G-WR[ MBLLMOD5_X.W@-X0/.CN'M=K055Q<3&O@(^RD:W383`/VB0RW.GIDLYN^FHE` M(LO&%;K5][QI?0Y29'7L;P>##Y-!T68+?;-DZ.7+=[K!MR\6Q[!J@;OGTV+4 M9-,[!V!@F:'\@U;A\T4QP>X:5+^<`5I?RL%9<5D.2MP,+''2YS4\N'*_%+BN MNV#:0`G:I0929B"!T#UZ%)X].?`WD(>O0#0V[WWG):X]_+%8ML,2G+$2SC&W]U<%I4D^7:&H/KBDMH5XOS5G(,A].R^V54S8;U`ED6AMZ*CZME9ZN-`"%CP'"Y'NY'#/^L\>+U M$'0Z,21=6*H5:D-Q^-<%).K#0QW!9PUKK\,*MS@@$5SA?R\?!?`GB.S@8E?F[$XKQ>T1P5HG!K]F?KB&@L MDX:E&MYIF&B`@K91,O!:TV+5"688_S5A($``V7,L,?=F`/2!,!C@8Y/3-ZVR M_^>BP'T25-7'K3T/"ZA&&31O%3H,%`^,IN]AV8'5\?_L75EO&TF2_BM&O^PN MT&WD?6"`!O+T>N!#*WMW,4\-FBK9Q%"D05+MUOSZB:B#5Q4/D91$R^Y!8UH2 MJYCQ161D1,:%37V_X`W,_(0!^P/5M6NW?48%<>.>6^_?:E0(P`?L0+MFT!BNZ?!1YP>/2/QK-* M1.`,^S8`NP%_41YF\.RT@%]4]W0@$WTTHNZ0R%+,4-U\ZDT']=**OQ`#Y.@M MK*BH#)-K$,HE>Z81DK]5^Q@IG%;?/ND-JN['?;#30,(^C6]G2S#\!_ZJO*%Z M49ZL>"T#HE7JS$IYUX]NUP+-?]<>V2E=HV6/"_8Q]GK["`;.$(MO\96OP-#L MOLC9&>OWR41"";8<)8SQ9)QM_,XL>$>IAUFMG=F]GB,7ORU>[S0CB6MJC>:6 M"!5B4M5PRBBXDAUC-YDZ?/'CJT4;#1PW"I(QOGY5VO)+#3;*USQ^FU"Q''[G MPOG@138V"V.9YRE&J16/`INW+U_KC,I+VU]^)R\Y_-/`<@]*SQJ@/ZZ*P1]O MBL^]88)-/;M;"6C`V\K5H,5]MQU0)9WV-B6C13*4`["9U(`J;@3K!%0II4\( M*"BUB\GX>M`\?XG@Q-MB-KXLKF[[5>N7Q=W[(W1^6@TY*$.%,-1[8[54U$9K M1922N1B$`DW2B9$D70C=D]2S0JRSW_,Q(Y2&,^< M,GYEK,$/A_(6U)**5'D=4L[:LBRS##5JPJJ5O*[GC%IK-Y].+D$]4DVS"HGF M$(CSVN=Z]^MDN'\DA+MP.,BR`&JXBH$RIX5U)!,76&E9Y!"CH:T,-KUR&[]U M(8)L=IP./)#DO12#$9LJ]:W(V51`=8YA/N>)W8!\?@G*$!5)G/W"9=K]M9XC?V:;O7 M@F]NBDD?[-++HDQR<"#Y?Y;.PD'R$831C%)EM0TA&Z$SL5%&!=9,\JLV85W1 M9%:AWK6<(]>^=3/&'%BBS&8IM5<>J[)@[3)(0:-O3YT62AVU]O$(54]Q6327 MO(=!;A,!*U'"8:,!]Q"D;;J[A<05;67A"TK6E[UQ)8>O>!O03`N6=6#1&FSL MFQ6)IO*G3*"A71TLI#YLQ=W))-,F%GDW3X*(@VE_.)Z6/O^V;*;Y`W[Q['\/ MX,6PB+LW>+BLYC-/9T#_K'A_/?]TQU>N#=5:^HZW9?RIW+UY4@[2ZJ\>GO// M+GUR>HG^/AYIN\J+P`>W0G(B0-*9-SI$D'<VJXO-D!WNNVX6'D%SP M&DXVX0(_#FK[<*)S-E&;ZCP.<#9K9HN;\"-T!ZH M^4CLV'8@+J5?=S[K[^83%`_-[Z$B4#A<'7CN5@7GG;>F=B@4TZPU819^N0Y^MVPR81Z#>9R(D)50DJK@6SBL)EFAD6A/P3MKS-:@6IZ0^3\8W'1E2T_MG M('E."1+@:<8 MXRG31!:)>V5"RJ\8I+JI]%T=!/I<[Y@E>GI+"<^KF0-E^+OH];\TF0)EQ'HI M.K?TTW/8Q.(?10PQ0 MOPA=WS2%CUX/B_X,@Z/PIS(`61%2!L&:+WE]<5EBA?_&13"]BDM6WUFFK\#/ MO<]%DP3Q$E-?2BP!W%&__/W:]_RZ$8%J6>-1&2MLO1K16+H3>O%M//DG<.Y; M;W(UK=E7YLG?U%D,951[<5WV=3(&[QHS`WZMHX%E\L$MD/H)?)*K,L-BM)20 M,.U_*:YN=^6_K(?XCM(VN]76NSU/K:VYJ*^&X]L^X%),VF&271U&0<$Y'CF7 M23F5P+(J^VP1YC/-3+?.++I:#[N3JD="X(#S*K'(O!7@!E,B0HJ6>%93;KT@ MK8(J*O0^)O_CD_YITH,?5F9%[TK*E\%G0:1*B@.?@ MYMNI2&!&$UEJJ'*D$*R5*IP,!]Z_=VI4_)M?W)_W^7->>`[^# M-\Y:&H73%'@-I%O"/9@U&\?YG`O)1V@YJK$O&_&*I[JJ05]MZ7B5&?,A9(,S#E MP1"VH#N8;C?LY7IUI,T>6#P)OZJ*7FQ'6'I\\T;\7WJ5 M#P=_-=[F*0'L7>*9!O"KJ:2!1&DHS_"3\BTM+8G\0='_`/`-WX[!V@3S[@+M MPM[-;BX,1GML`04N.@.T'8LI9JW`KV[Q+O.PZ,<])R.]Q&9@(G-N!;,R9@S#[FZ&(S@3XF-W36/6>A3A&_H MD]U'"[!K50@I)Q1EL'`S2#(GVFC.0;KW=VBV(_C4H)]WD";CB"8J."4Q^A!8 M2-J67%#H@^F"4M)L&A89&"P$&9B$Q`C0;53;QZ("^L'\7;M`W8"9MN]GWPH)G\. M^L7:]4)O5.PRT3*FDU#ELF(B@YFF!`#06O2>#S82=Q_* M]_$4WA4SK)J:+FGGBRH(M\DINS\&"XX;8RE8,\X(HRGU,NL$',]4&V]`"G[Y M_8+^8QN%&U>[B\Q+$.H1G$%[IH4?N[U`C1VX78YW[WG0*1-AC#*)17#Q<_91 M)@$.J<@NM=S/N6C!OMHN7RT0SPQU'+'Y`+!ONM!:NU5A1C,)IHIPU"DBN6<\ MRLRX,<8[E3;>:'W_L(]O)T\&.Q$RNY`T M9[)&W1#;ON_ZB?HI9#V`8B=2&4*)C('E'&B#.G>$/V<-@^V'G@QW)CUH&&ZI MXPGT2U`AT!IWIW+[VNLA[9CQ76\XN[NL.L"@@OP MZ/>&W>'J=0MR(&_&\!"4D4%G[:/1M=@QK5QW43MA!\G==/:VF'T97[U>M`U[ M_VU43*9?!E_!/^S#+S!!,+0=".I4@'ZN7QUO"T;8>KW%F_'H,S87PG>U\5R\:)<(&L4L'"(N,K!3 M=63">6FU#@I':XC4+8(6#*FFF_.]T7EB9.5+)E>@%0\%K79241-M]"6AG8`=2_0*FE4OMM>CUV6=PL?>7^FOK\5H MNMEPWQP$-DE8"E:'530F!6J-UF(!IZSUK2[JG)J52NXM:UE9<=5(&EM7P-_6 M&]4O_[I^>KMALN-]\P;)9>&SQ_*"QG!QHZL+.,ZPQJ"ZY_7%J+@>H$6#DH*# M%SI>/=^Y*%D?0;*`6+2,_BPNAKW1SCB[\F#E@:NA!9'4,^^:T4N1^=BZP1/$ MK")\7^Q.##S[7H%GE-*,P4XNO(A)$L+JWM2>:M_N&$()_0G\$O"+8ZS]@>U? M>-GZLEVY;0+,4J=D9-ER!]I66=J,1P3%V\KS5V?%J*=638_(*&RO`LXK,=HY MK62(R=MFCAP!?^)L&85\HC\.GZQ.%D,6B5,J0`\R.-J;N8F4N]8ME_[)IQ.< M.!B!=BP1(7RR8%,QJ4V#NM-FU\B(A\2]^G-OZ._*#&>T+!&C%9,3X?O0&_;6 MQFVLIH@\CXUS?-1$."M)#L:2D+GTDBN5FR,KN-#=P<[NQ^G[,>NT0H#ME:\5Y[9K`^>R75?92X_\_^HC"+[_S_7BT$<;].0$8 MC6]GK3O3.4_/T@+;Q983Y$-D1TR66NG`2:*2*#>_^GRK&DS-PL7E+=!=P-`'OZAN_&Q;"RN2) MF@B$)*BC,GN5E5>)26-#S442P/)MMU:\SQ7/OLC_V+Q4%8].UA9"\Z"D$)09 M11@78NZHTL`[!KM+]I.C)^:H.!$OP2/-Q',;:20Y@V]B2&QX&74[ED3MV>S. M'>4?9\BW5IU)<,*&&`C&3+,F$JM+:O0E=2K^\OL%_\>]H6Y5FNQX]/\'LR^O M1U>#/P=7M\"1Y3-Q\=*ZDN6J!.D]]KYYY=S%NV)6A6F_P[VS)1-182=L![Y8 MQE(OQUQ@\TTA=.CTR;B6^W'J%'#_9.X.LV5+LA61F4F7G:/4F`2,=:%QN$EV MW:EKSX^Y=6[Q]\3:G?LV&^6T%=H'QX6-UL,!MNC<*I]NW]9@_V3L@7LVV8A' M(F<$-JLCUG">&D_0A)7^'L^0L>5("T"KY$8>63=/&8/R.*-L/_D]O$[.H*!%1QU:&49)64,N;G;85:J[G%[ MY\CM\O/8E@OQO<2FS8.R.]V!'(%Y:(D(S=,$3%B+=Y9ULAZ8# MUUQ@:\WAAUEO5@"%;\;]WG`]"[0F]-YYJ5I;CYV(,G-42R)`S3B0049QLFCF MK5Z6OS'L9M_AZMYCD:S.5>,&,$,3QR89\IN:DWZM*/J5J9;VW!,_]:=SO[,IZL#^A;6>+?;R>#Z56UAW8.Z#"` MB;,66:]$LMK5HA"I4[J55<]*Z+UKPRS#!Z=C+3V\'JO.1%:Q`PQ38 M/&I7+V`7,TO)Q&Y>PB1DHHPA MNM3&H+4H$-%B`LBG/6+I.+6^K(D8?+HM3R`X[IK@^/+OWPQN!K.5O)FEXVR? M(V?-I"5>Q$PEIQX'HG#-TSP)F47=E?-#7A*UH/$DZUZ"(EU?%S@8KYBK'2Q1 M1`$>]0?#064E+'IOU[/TX@`>FV!984DX4!20CJAZU*% M@%DPW1XYX::&X.CU/BSM;?[SE<`7#0:K-#Q5B9FD018L2\)&DT#@NTU1OTQ M]@56#H--,)Z@15P/\GA_/6^Y^UASWI=*N1.7403">2*1"`56>)0@/]ESF2,& M!2@C<1VJ`\E;1@H>FMVU"G/!_"C["R_]:HLK>KKV]9M[DGF;C*>:4L-1'3SQ. M<`Y)V1(!KC@-:N,PBX=!8+W&8%\`W.?!>+JF$W8%;&G(V!TM8_:$4.#OD5BQ M/MCH4ZLA7]-;Y^$EX!")=WWXOV("EDT)PJ["QV`8U4Q:GB732?LH:,5T#]Z@ M;]7?G:G8NWXQNQON].$LN+56.**43>#0IP"\KJ@U7B?>:O9YIB*^'[':P':V M.A#,]4I>ZZ!CO9\%$^TF.F?*VGMH<&4T%81:<-9\D(X(4=$KJ0GDD9E[A"C? M9_\R`8XI#BG/4:GLHZ6LWK\"1^ZV.E2=JT3?AV9L^T^TAUTL#-5!)F9KFJ76 M*3PRS0]HOR[1O^P*4*J3M,8QQ3-X@`8<`UZ=5U%Q%5N7%&=*?WY_^=;MFH!* MC&1<&&;`Z24I$G#W:O$.E*OOA50_O"T^#297GP;C#?Q=&:C&>;#94IDD3&D"1LX]D+)M29W0L//+8-,G+$]=@P..)Y* M.6VL4(0S1;VL+7('INKF\7)G)OUOQY.O7\8?[J;NU2XWU"F9B'521\&B!R+_ MS=Z5+;>1'-M?4VAL8Q%F5)\ZR`@";5-@CP8J&&_GIG`MT@ M&@T0#1!>`S2R4,E8,4S9FN"8XJ5)`K"K4J[2W!>GT.['X7V\.G6&JO] M>:0>YCMRD1A+5>`SN.;STHY`? MY+'"GO8Y26R."I/+`DRXJBRZ%?H4>FW5V&1\D>>S^:2H^!(_SB9%[^II>^$F M3;RQ/@%6G@51!)#G9(A5W'/"6GD!&SWF[H>RCKG[G?.24G)>CBZKF];QJ,L! M?#/L`'_3)T:=\)P)QUB,U=63\YZ2U@FA4HW[M0>.]I%P=TF"X-%!C.%($C)0 M"#>=8+E.+$HD;VGUJLEW@GQ/A@M$ELI;8ZP+PIHL0_;5G3^8Y*#;[%22/=:< MCR=%>8DEU0L^NL5-)8QP^FX\ZA_3/R]F9D+P>.HIO%'1&*]01T%,S9`D:!.9 M:1:I[!_.`\=^WR6]$1+\P4`9U[`9HT9^SVKLUD32NJQXP,@7^L>-1O,%Q1_8 M@/^L,[OL)3D\NL`OI@#V$:9$"NRDGIPR-:FAS&I+![(-%7K_N!\78:4`R=!G4OB`_%%U`JTUA.ERD+XTGXBFVPO*K=_-Z#<0<7/#4Z96,IITIJ:EV]_1AX;"T%LS&WQPUS#>FO MX(^=7RP3GV!$Y1!O5Y>:PX\GD_$W>%+H7<-?P"V:?_E7T9]]&H=B,NN52%0Z M*+>8NTVOK_GTC;2OF_'P!K^C.8(]"<@D@9D,5'D:C<"^3J"UF$J:9^.%3JT8 M%I-&6ZS]IX&^)LM_]%!3#*K,V6($%AFK)N&]HV*1]X>IS1]GX_Z_SZ^7FZ^8 M],M-9J4._J&SAH%RSL1&YL#I%:+.MG?H99:>? MTL7:KSE-L!O?%%/1>J/;GWO3!3?^IW&M2IK;9J_Q?@P5@!7.0>#=&ZSZA-G2 MH`*D#<%`E+1NUA')9]"$G]&(7]U15K]S(&#LT98]D;8P)3EK&66+:4ZXM`Y>)"!8S7_#?(R.Q&L1AP8F M$G#-B1645*>H$L+(5LQU.I!/=$S,L"6L8TFJR(4(@J7Z/L2#";6M@].JP.3$ M.)\TET%:357@&>82RVDDXZ':J\8%$ELQPPO`>L3*A3A2"T\\$0M*&$]SJ#(, M$P24[=N]$Z-\XFMK'QSA#'22-N`C4XYDN\LY#=3DW**GDN*%K.*N680$9E+# M#L53?\&3RKZ^E@?H8>>UY3,BZY)KPSVU&?[SP8+QESK:6.4+:AITW)D!_8PV MY"#MFI252FM!M6>)2"N]3]6T@;_0-A]4R$=8EX^:Q$ZX(:??S\51*=8!:[%H%G M`ZZX*/=%[(0*C$+EI!)N="I3H]L"R^U#29K2<''J;*6=$BR MW9GJ)9B,3B:>0JCALXX:U*<5C@EPORM%ZB"6WIEB_)R*](A<'&-C4CY3SXDS M5%IG*N?;RBQ\*]YX"0'5$:EU5"GIJ7,L$M\+4>A4]GI9>?0&[\$"C"$X- M5\018<`SC0("JDK->/!163M+03_,<'PH^D5Y4PRV;$CNYIJ-I M;W%^OOX<4#A7B96;T*4*:0, MH4K@SGDK@Y(\2R^TVM+RF^T)7VII?:<2S>5D.CM&D-9XCW5&!A0)J-$@L;)N M*4B=0CL+#%:E>1Q!GG8;'B=)F,JM0MSK0O@4&4TQ&Z8=*LKXA#3#RHC]'PH**&"SV;G?>Z'\7-&G.<6\SUJO73WEXUAL^7(,5);WC7;N&X MP6Y!6UT$A]YH4`XP^RI/QE?OR^MB6([:,97X)_U[;W38IGO7@U6PR@_?8%'_ M./\R+?YOCHOJ!OYIMWIN_GTOC[3`4FV*+;]2TM$I&EA.(>!!@J5JW9F_7@+_ MW*^1MX5[KVRVRW)AM)_FTN3A[3Z4(!#?J9@P>SMCEDZ($:)UK[/BLD',-:BU MW.(UVGC& M);&4\4!X]M:S:O%*V.R=9"^ZRGY\X<`A&`XK[3"]4P\7]ZE. MF*)8].D9_,->G"(@$(!Y217U@4LLN4)%H"@%]>"\M_>K3=60XN&B6I-V=9IZ M=3TIOF)I4\U'5265A$4*?O\V+)+S\WS47T;R]>O5V]!HE(.RU<&I0TJ?H")9 M<"ZBSX$**0RW=>(BO-0N?*"\P71TZO$_E6@ZY*]J*K(V()&4>;9.*MAZ=7V3 M('HG7\CW*I(N::Y616&84-1$FL`3U3)5A1A@"L"E?T$R0>;0=\7L_.)3[_?M M">;P^]*KOSLA>]\K,2&U=UW.>L/#BR"HTSYD$X2..4<-'IBLRZ,4HZTR%2JX M[K*9'@[EF>3%FOFUB[JO13RUX$?#04!(AT'4N@H'<[#5\6UN3N5!;R<*`:0G MQJI`@J[I_T1N4R*!"U$%8D1QT65-$H:^7BF5.LG1']`XMZ[;;S M$20MK<7UK(+DF2I!/3:*6*IQCXVT6I*F\L<7].[L-AFRDI%IS[DU)&>9ZYI@ M"%3:-(G_+Z3UY(K8$FTL>/#)9^43!.QH.>JF@`GJEOJXHS^N(KY`;)_\!:0,2;O(@\I.DND(8K5 M?28%V5(D3IM=8'^D:3A>$1VU`ZR2/G!8_DY$KKD#C4-K@VG#EBX!/ZKJ- M^O@P9`8O\?SN8$D$ZJS2A&F0A"$0+VCJ5W586S@/:A$<-;J3HNO@%F'BN+/4 M.B^="(%2B)'J?G+HNK>I4E3#*CP_R$Z$,%(:X1)WC'%.8PHLB/H\**1V_BK; M2-)]?)2K3C(/0"E\L-1E+6"MZLR2X-357:H4XZT\`'THR"V#/"G(+FX\MF[Q M(0-$P1-VSE#53%KF?;N`'>;[96'LQ-RD/<'23X'\S\[D$&I*`@O>VFZFW`>C M6_5-65K?7V#8DV(ZJ[,8W+2YYB?CJU@N[K&Q8/[\XMUX%,:3K6UPMAPZG("_ MC*VOC)@C-T%;@5F5%,G_JVZV+F7)UOVJM8KEE>A."7VK2,\O/A33:WS(ET75 M.TS2>W@6SE<83\$B^DEO-"@&[^%K^Y-RP2QP>*,=ISTE0BCMN`@F!!D3F'$2 M=#`L^+"MWPCY']D2PCJ==-S5?\OW<-9+8RACUDM(6-@[*8[!<("L>F`F2 M%"PG8CFXB\*0$%KI:#4O2BW.75)X(DG],EHLSQE>7[C!#=[\#7XN>L/9OL9@ MG,6LLC?4SX]ZV0G8SJAF:!;..8Z&]!F_(J$C` MC`JI&8$==\HYOF-OJ#3U:1(&?BW[R#MU76O_#D6#(5FIT.53V05#J-/.12FP M/Y/+A+0<(L%WP&Y!>D+4 M#6;<8@X^AJ3T.Q#.[O@1(@YL'TH5A)!1<\EE6L)EQ('=:'/(-HN03P[WF$JS M![@#-@=B0C8I"*L4C][4K0L):><+['('C@-_1XKT.(6]#V;]E,1GE3B&9A"" M<@YQMP6#(5+TUE#:OM-07>5S!_U9)'5@46G,(2Z:<)0^Q`A[1&@G$_C* M^\]8#A0#1![PMP4QX_GSDV<;)B,A7%F>0"=8#0M"U?EI4I*6AJ`;U*][X32@ MC_M%,5AD/7_L#8LQ-CF]&H^6D>O[^6Q)2W?XN8-*UG`9HTK91>8#Z/60X5>- M!1'PZLYSAXX#.@F&/8=@T24O$]&!TFBYHT0G"A@8IB5`<-R>"-:\Y4J"1X:3X2$^`3@[JWR/@3!';W%:#&JGH'K+BM(=L["'XRFL MR>WA6;VK5A_PMZL??RZ+"7JCM[^B+]IT-\`@7?5FN.#K=V_YR@TUO?8=_RAZ M^`;4$7FR".LW_)G5>]?>B34Y`+,<7>XK0$Z)$P/6'G9%Y"1GL^)/3PK4_`XV MYWH:NLOT!RY!&^#R%0+FZS+UB83F*B;VP>D1GD[=VN2R7@-_B%%9H;_\$P[&:8 MACZZW$N)WPS;M='<$7`Y`BAZ+KC`+D0,@K8@2(P-_VNZH'1=TY7;OGYM>!_0 M11I?K'&]@F,"X?5L4O9GQ6#Q^F_P<'@U%K-%5^%BVY\OQI.J6?GN:YV[R^UO MO%%X\!?%VN]Q&* MNZV$XN&8=@F<.L5\MMXJ4"A2,TJ49XPP:UTP[4YT/>]-I>5'VE^'%X%_SY8$H7DKU MIE_S<3])K40@A+JF<'"W)PS6=6`9./;"8]GFY/9>6@G`-3%P\O. M.F:DL3$K+DQ(>=4;'E[\2ML+3?62G`-2!T#D1)\%<*PY1.<%J4K#@EJ6H2$B!Z>T7 M@TS2YT1T/S]RT-9':GGF2;#$2-*AGB,>1-@Q1TH]$-$R*+^/4_O`VZKQ#;XT M/=4M!A4>-'^D00BOA0K@%T7PV3*(1=MFI=R=6'A]!;P&[V6`WM66I@E:QL05 MS9[CU;\$+]6#Y[,$[6)2V[FR^5&8EY#9W^49U7EM'>_0OA_# MF&^GL^J1>ZL^@W.`AG`PW0RFS(%-QX7N(K<48M"M8`@[;@J/@/.AN!F65^6@ M(QR:(C'>8:6:*HA2,"6 MK-XP3Z.NG242MO0SI+)QH+_E^P\=W;VMLH(&918M.@SMH+QY-9W=#HN?7E_`(\\N>E?E M\/;-HH/$JW?%MUH8A>@9B'U7M^>@T*%W^?8N^;ZO?#T7XK![.O\"-@`NT*MNFLCYKV>EJ\ MJ7]8#KPW+"]';Q#,VJ`FJY^0K@>',OKIM7W]:C+^MOR9KM[[O[/!W8^3K4]8 MC.6GUYK]N?&$NR=O?=K=!^E3?^[)O_#'!+AK/52K^::8+`@0JB7X93R;C:_> M-K87@ZVROG?6?U^^O_'29+'G\)6]PUS;T$@H<0'APINOY0`V\4X=@*]OVXGE MZ&LQ*6?;/]>[NG[[)ZK(4B#XEI5T8`C;A?V'?.Z7SVJX_/7]LJHT7R4)>OW[ MJRFZYZ_^M#S&>`Q9;I'?FIK%9,EB:6VQKK([2MGC2>'E M9#P?_9>]*^UM&TFBWQ?8_T!X-X`7L!7>1S()0%V#`)/$ZW@RR*<%3;9L[E*D MAD<2S:_?)B7;\JFKFVJ2;X%9R(HHD57O5=?5U4'IGB3IFW_X/B&3R0&0^-`9 M8BG'&Y?>JWQD5FP52'C"T9BYF7M6V$L[4'GVCXR`*`#\9VV8>TF$'"15P96M MS3-ZS-;39H.FO.XRE?R(>.F[HSB)R='K6R'`?L%^P7X):+\QSP;[Q=RC M;9?C6FW*7[JMTC$5X:F_<&7_A9"3?UMDF#V=%5!$H01O MKPB$:#$A=*>G@!!('&V;.(KN:JJ(O@0R0$R%>%#+M)"3K2HJ__A>%'8AP0&* M@6)"4PPQ^#(&7XF]>7@#L$@MCCJ.;5GO.:RA12L&R6EG+OYR*G+AW?+.5S9H9)(($*9[&V:.C29C^E M("G*YNQ].KJ:74%C5W9=)]OVUV6/+95E979O@6ZU%C4"K3"A,*'"@1(FE&4< M:YGLZF*TK/KDU^ MR*2)'@OSE-7H)TG],"-2,J&7E@FZ9#%!^$3ZX:6I%^>9Y,6E=QY3<63E,7?T MD^GM].#E1>6$,S3$"9QM$,:X&>P\#E$XQ-MW`!]:S`<.G>EMX07R!\_+]D.6 M%>6A8.5J["^218N5>)*D$EE.\9L]E-K<1NM2;XQ'4V!K#KN19'?LVR3AVL0.JVQ6X'+AH# M0$O0DHFKH3OL9DF@,0!)!#0&M,HD-CJ.4N2>A<0""`%"W*SV#-/^R"LTP0%' MPP#,5Q>JF?P/^1&%=<@>@%HU4@N].&@8V$&$:!@0U$K!&"&N!R]:QHMCU>Z9 M".P1V/-I&.#?*@KKA,KDPX8!A^'(;C0,@):@)1-7P[+9%=70,(`DPBX-`V@3 M$,P0-CIZ4M2>@70""`%"W+4),",$L@E-<+O1)@#SU?Y:)MH$D#,`M9I2F6L] MQ1#AHTU`5"L%8X2X'KQH&2^.515S!1#8\VH3X!]A^"UKV!I*(H( M![4VHCB)I`&(W1AB'RNRPJY.@?-#V7A)^YX?NNZTSR?/"/T0YUY\%=+/+0X9 MW?J`4+4O]PW'Z(^L_F#0URRU/[`7!X0.%=T:ZC@@](`'A"K&GB>$ZGI3#NRL M_0?Q@%U]0(W_&:\'.%:QC>$PG..[V]5PDN?;7],D>[E%HK9;&7AI.J>R$>-N MOGI10<`ZL(X'N%S?+Z9%Y.4D$`/M[C2ANOC+*SNB`7J`G@?&[@)K03!?A?8E88JQ;L2Q`3\%DZ(=/R->&F&*BY#-Z), M!X:WYE[R*DO[AAF!Q1&F<)9OUHVM)C`3,!.=,A/JB68Y&+T$ M.W!X.\`L&N4PG4SKR5RC]X[D0BZ(?QW3Y[N:MS"))!Q#;V]7K3/?NT5VET/T MJVDU3$85A4Z\5SF0"^1:#2EK.3X<@2:H!^H]#--T$W/SL*X=.JP32'!H2M'8E>L1/($O+>>+ MP7!^HBC(QP*"447Y:KGY?@YI__6PMA9.')NGM%;LP>U/1D_G>&! M6#M+310B(B$(;@K$S6/%[MD')R=B/5`7U-VVD,:R/P3+*KC))1X52'!=V+K-L*6D":/4D64%F[AMME/T+9*N7,IXC>`@ M:GP@V]Y;UBQ989Y_$9LV6+JZYBCS+1!N45Q`@?"%Z;-)?.HM9C>2`),;#[L* M8JI9.S-00!P0!\0!<4`[\E5YO]E(*D*/6SSR%USVJC$:5C9F-MU\IV+6IK;E[AT37GV`SG5^PNT48@ MC[<'`RL)*PDK*9Z59-T-N;](T4<)(PHC"B/:(".JGMB:PVNO(EQ-6,F:K*0X M@A,WO?8Z+T_^?O+S*Z]7'B4*8W)Z79U/_T91Y5>'Y](N-[=RS3TTR%2QE;+" MF`)\\??JE\9).O6B>X!1RL_O'UHY>YN:C6'>H=4X\G* MR09IV.IFWAWI^JNU)+C/U^6%2MW7U?Z#>,"N/J"VU86[%3K6#']H5[UC2'PR MO22II"DGDBHKS%*@\)^V:.ZM'W(OP\RGJS-)F4KPUS3)7BZCU78K`R]-YU0V M8MS-5R\J"%@'UO$`E^O[Q;2(O)P$8J#=76RJ\_(PB0%Z@)X'QC[<=F\(@OFJ MA>1$C)OY1'+P[A"%!,$B"0[0^J/*X@BSTE"E>%>"F(#?P@F1CK\1+\TV+O"A M36^]&U&F`[$[7VR/`SM7@3@@#H@#XH`X(*X=@A,+<=B=?[<[/R#?293,Z"OL MS&_*[C)10,2LS8_?,_/8^J'+BBZ+*\#KM,80=@!S9\Z&-;T0\\Z%D4 M_6.6,XP$C,13UZDGAFU@)`7LP.'M@,`]\XK6D[G&[AW)A%P0_SJFSW8P/,P$A\6">J#>IF&:HS&<4H%U M#>1JNN"XTLWB'.ZU*ZK[+?1)G!%49`^PQ#5N)3-U=@&:*`1`MA&$V#VJ4N3- M5QM4Z<"7CO/%P`("0J!<]6*YRMP\3X=RU?-R_)S3?VMA["P<.3N8T=,U=BV: M2.B!6^#6:DBE]\S:L-7M6`O4`_56"U5V#25B44B$94W0>$X@P7%EF[UY4;@A M=:IFX0SRX9MHW'RB>]W,TTYL76$8P6%T/=C4738=VY;-;A/*3H%9(QB("AFH MMO>&+\=4F9]X)39ML'!US4WF6U[;@C\HK[TPN36)3[W%W$,28.KA85=!3`1K M9_X)B`/B@#@@#HB#X`1'7$-*%+5,/?QP=EX)L/QOB,F'C4P"'33/HV@6QOJ` M$6#$`W'8JJ(RPPMX`5XTGA=8*<`(I/R%"&8Z$AI>)+D7/4[XMS#`;A9I[Y_O MILU^2D%2E/K9YX"W9[71B-(QLZ&P:V6[%K4U-Z_PZ)ES+(?A>+Z=)=H(Y/'V M8&`E825A)<6SDFQ[(?<7*+HH84)A0F%"&V1"M1.%Y0E(<#1A)=$H(&AR[75> MGIG]Y.>?>/W+:Y]$5V^^^-?+A-@GE5CFHB_+;+NC3]J/$_]_[O_]- MDGYY<,E9FLRHON9GD1?G;AR,_BS"V93$^2C+PZF7D^#WC$R*Z+?P.WGP?53* M<2G*JK*B_5O_=C$\DL*`ON'Y^:FLZ?+`U.W16!WV-5TU3*UO#TU+ M55V5_O_HZ/T#U:Q*^2*Q[?*Y='84Q.KZN#[M\HJOQJDVON MX4^F4*K@$<:44HN_5[\T3M*I%]V#J%)^YO:+*P5*5,C1\C/OCN2CZF\*2/_F M[^V?]D<8Y-?T)7VFI1VF&(^\64;>W+QX^]"NWMW4:LYVM?;S1*%F@ZQO=2_O MCFSKU5K6W3<0RPL5;:L+D7Q^WMKTBS`J;ZV-Z6:^$XMD:4Y=A(WEAG:N6ZQ) M7AQ(Y:KAY>5?Y&;%8`7!EB%-,6I`FIBT90[!CUY<3*AC4:0E\J:>?TW7YG1> M(9(Y#L64*0>`PA1N*[)JEB)O_+4,9C"#S$0Y+M(XI$:05,";A#_+UW`!!01D MNW`W2*:S(J>6[];650#,DDG^PTL)#-_3"=Q3ZRXIM"OD]LP,[9'F>3)M].6: MZKOO920H,4'BC,8"27Q&TDF9((G]Q;^=DRQ/0Y]^^Y>5Y0.N@KXE*LD9;H,?$IB:ENI+916S.1I92>E M\R^_8R/<`;8W'`"#M>.N6JJE!= M$>G7E/J:TI`ZE]+8"U/IJQ<5&\<("/\W64D\*E_BD^DE2>\`K"DG$O6=U1;F M`X2S`/4)KAG-2BK_DPK0A@1.UNNU-!N*['HQ6]]J:X58`LR@`G[8A?!=Q`_'(%QI MO'FOTALD@$??IBA;&%=4YQ](BT(DQ,H"+'_=.=1/49R>S#\YVA9V[1_(-7^I M_UIEV^%UBQN5"+-N'S-;MQ^KG)\%BC*?-=1V\0U#^T!/0>S6TCHC"HL/'Y(UW!,KC]C9H M@F,VGQ-F:9L.5U9#T!K1-6*P\QG6SN;J0NL(J"@@%44!5WV3!9L4MBBRV;.M MVD0C"A@8^E%[[J_ELA_VB9VWR610;LZD&JI^P+U*"2FW\6X_FLW4Q^Y@-%;, MX7`P^D?<"G:M?K*N>4VZVS"_3\M\CR<#)G"J`O MQ73JI6%Y8O,DC*F>PNHHATIII7REE$3EYF@I3Z2D2"5_5?B2=RM]*=U>]HW&91*A/FAPFZ&5-.4$V&*/+;MC MT'(S*9F\C*H=OK6\+"MFSXB2BN+M"P.AC%F^2,94=T*_9L=4!!8?&`@.B\\A M9N$=;#7# MO1OR7R.SCV%$LCR)(;FGD3OZF=-8IRQ6)Q/.\+WK18`JGLQ831/Z8'\M6@>H M-LY2,O-H?'TO3N6KHI4H&`LA%L(=,$QOI@26%U4#A?.Y]*$:1;IH@N$+WH]> M@)P-4+L#:N^.196JF,8 MYPV*^XI'B(G!C/96["N+A6]EJXK*+'?8^NVIH$RG*:-8/?Y#M,$5<*4%7,'R M`LJ`,J`,1N0*FRB%K>FNK5%DN+(P,C`R,#)P:!IE:T"95E-&4:T>1O@+N3"+ M@A"E-ND<8)#KOM)YM:EPT#PNB#\G=#%U&U/,M;UBCQFV`GIQ+5I_H'5H'5J' MUJ'UMFI=,(]'.(\0K``KP`JP`JQHK]8UN6=`W?R-H"@Y1F8I:*0243,6^'@V MH9./VR3Z-UYX1#E9:V_Y&&A@X>*9M`4@BL[.90%`6@@0=*<`)\!)"QHS6N;] M=HY@<.4.G'5H*X'$&#H"^315/F+,21%+/NB;0]_<^M257,W\FZ5ADHI"O`,Z M.#I#!Z=%?DQ;U:UH4'>'U(V*.+0.K0OM[0CG#;:5%0;:1,`&)"0@G_98TZ;+ MI^G=21R'S%Z%R39'.C108H<>,-NY6A:*Q6@J`$Z`$W;V%K5Q``2&!-U)(L02 M7228HO9L,`O,`K.P=`E!L,[A1&%94.\"0@Z$B@/N5^6_T^?Q8L-//(W:R(J5 M6S3Y8"9>$UV7%JT_T#JT#JU#Z]!Z6[4NF,L["S\\P"@;"3&/(1-X/?=/F@?0[M(D>FK?I& MJ11:A]:A=6A=,*]'.*^PK:RPV6TG!ANZQP8D)B`?T:QIT^73]&8E?OU>HUGX MUWQ*6!ER,66&(7G-#PRZ4-SJ'$YP,!@``D,"G``G`@;E`OER8D437228@H4: MQ`*QL'()0K#.X<1T>CH`(J(%%F7[*K,N&XS(VS95C(5;-/E@1![_%0F'WG9) MW6CV@=:A=6@=6A?,U1'.%6PK*UA6*T$'T*'A=,`BT46MPPC68P1%R2HRFX"( MY*'XY4!^(KR,"G(9I@$K-(DI-#2:UFR>+!WC4[AX)6T!",KKP`EP`IP`)^*& M1P+Y)$^2.A2FO\I/4 M^//Y1Y<5E)`&;F'MT5`Q6JE#ZD:#`;0.K4/KT+I@KDYSDSA@!5@!5C2<%0PS MF"UB0UNU#1O8Q;Y3#EI'$E'\\B`_$7Y,TMEU\F6>L8*3F%)K3.JQ+>4R1^]M M(Y_.U\DZ!Q#44X$3X`0X`4[$#90$\N6:FT5J"\%,!1X=F`5F8>D2A&"=PPFU MP)AU*J0%%B0[S']]1K)8F+HJ/TFY/J&?3V)6:$+FMX7U1T/&P)L.J1OE9F@= M6N^&UAF6[EJD;<%VJAMS3>NQ?H)D M$!5FRD:F$*4_MJ#A;)?]@@06UP*W+#J/!=-NT,19NT>3#.0FL\%BJ&K8B MH?\,6H?6H75H'5KOHM8%\WB$\PC;R@KTG((.^]!!XT"'-;*"?%HD'Q[FM.GR M:7JS'[_$U^?83Z8$9YAOG>+!!,D7JQ$H1_`)$=N"$-0U@1/@!#@!3L2-R@5R MYL0*)[I(,%7%((K,B5QSNRH(>2#VUCZUAW4OCND M;S0`0>O0>C>TKL&RB^_C-#>9TS`V*%K/!!U`!]!A$?\8H$.'U*VAQ;D6ZR=( M7O'3:Q?:OO^<#=D&W,19APVSA0IU!9DEWMM"CQ;KVV!7A(.VA=Z[)PQ%:7U.WT'*@;N:[N:ANY+HQT6WJ",G)= MG=(WRCP=TK:*S&:'M(W,)H)[!/>/5[QM_#RP`6S`;#+(1VAKVG3YK*0?7N?> M942>_/S*ZY4GB<*8G%Z3ZLD557[U4#[TON[+L'ICQ1K_M\CR<#)G;I"S8O:, MILM-A(]N^^YKK%F^6*BJIZ9?\Z0IW^6V).D;72%.21Q(EU[DQ3Z1//IZ1M(R MG>)=$2F92$F19SE]F\I+(G\683Z7O)1(LY1D9F[<_KMO9>5OGS]RVN?1%=OOOC7)"@BDDSN;4=TKU*RV(MX4:+A@BJK'R7^ M_][__6^2],OB2I+G4?69,_JX23!.TG-RZ>4D<^-@3$A&&1>76CXGDW='XV&Y M?>_?^K>+X7^*[/3*\V;_.2\W/+H_P^SVG8]A'$Z+Z4"HLCLT'7WD:H.1XYHC^L9@J(^&@_[`.'I_IGR\>:)U]\7[&;R?3SZ#[O9' MRF`\MAW#&&NFIQ:Y3,8.SW$-45'W\M(,$BF,Q)G"PW>[2?M MS^\^]J/KS*Z$TC*\6/[A\BK7/7UUY,9_=E\%H.HN2 M.2%?_QZ"PDO_RJ4K$D^!`O?N\BR;WH M]L;82S@@?CCUHNS=T:FQ(F]M8`_[LF$-%'-DJ"-9-ESC1MZV:PZ/I"(.%[=1 M9,'1>\5P-+G\W[XZV$`(AY!U*6J%CZ@-JV\-=%-7746E0E<'ECM8BEHV57GT M2-2F:K=9U!6L53ZR=G33DDRUG7E$+(N'^B< MS(K4OZ;?=)8F5ZDW=:^H)W-%%\[J)QY8VP\+6_`\H2USI`],S3"-X5ASY*%B M6>.A,S!TNZ]:KK'RY%GU]4?O'?,^SC:YJ?4/0=U7ZAN>I:%/J!2JJ]8^B;KR M(++K]ONRZ_0U:G/ZBC$<#LV%"NT^599R7X4W/W'TWC)[]II'>>+6UC[/(,GR MSY/%P]_]8[!>.>:J/V6;`]T=V;IC#!55E0WSQG]P%=,9/[*V%EWRY/6Z>>;> M5I[I(B5>5J3SZOJ/7EZDI,+B!?7J24J"]U%(!\,`46!];FDLA6;(*FCP\R.[L57=#C$2G$:N83+*6).F8 M:(.P$39PNXH8(T\(LN7&-T30F%A@*4$B48O(A6(P`TH'SHOYR`][/JXU-`CB MI,-,/7',S35U@;5QQB@G>2H,/>A)M-9,2-XQ[T)DC@*`#U'/QM,#"T7H>6+\ MNHOK>X].()43P01,\8D-FK9066.C**&B3PFJ[<(U9]Q'"I8HY1*1VB?58.2\ MD`8>==8TN?P%&C7,@GTTCM\N^I.\%GG[>M@MC+"HTAB&@D3`2NXU413%)YM% M54*!%HR`.HZL#Q,_[MQ]F<1^;))(#"P35`AF<5['8+6>F:0Y+7)/JJ39HTEK M^&S1(E!<42>$4,`8-TH&TRX4&2,EN,(B2N]CD/X8='NC\;!W/D'_C)WA`!\9 MO?^4ZF'5NQQ\G)R/>MU>9]BK1N_JO))TU:,50E36"^)2(UI M@3.M"E77CM3=KJW<`MIN"6_X5]KUN&12<;8RI1= MIL_9"_RGPL_^@+G*56<#QTBFDB,D$"VMM<`@B0B1Q8CJEE"M5W'@8AF&THI= M;:1WL?&R5X\:^RZJR70'9[3!4$6922J2E)!VM'-(/VYJ*),A.2E7#;T?"Q=D MY$X&3F^"7//P!D,=\>`II.A112J%9*1Y8Z@.A.MRM9$P<<]#RNY@L4-R..\- MN^>]^O7@XL4F(VE"A6RIM`9)E'-G`VU'DP:,F662KP[`QCNX+692EAL6<6*" MH,Y`5+8QU%,!Z8'<]N[DL[N%&$H\#AO2#@5#?8R:I-9"X=CJ&A3Z*UV6@GL: MR_3^[*W=8!IPHRUR"U=64)T2-;2=BCBL)A3D*I87H_?EI3L%$,<8LU9[S[0) M(CKAO&[I1C*A"M6S9^-^@EB9(2H$D)$QS8`$A3*AL50DHTPA&8";^XZ5=[)X M<%&_K;HKDW(-QRXM#E,?ZX_?A_97S=1C<4DA"CM%%/,4*:,:26?_$SD2@W"9CD0U#.!\N%P(`/($P;`6.$,DO>\V#MKM"D M(]9QI']/I,_'K(05S<"AGX(H-GKW3)-;#QRGTS*&-W4_(,\$#H"XS@N+\TRJA((56 MKN!/7]`+P"YY;UZ\:OK3[]=?\P'-?.+NK!I5PR_5R.-07.:UU(^=_O0/\5L^ MT+!YM?C''ULKAM*FS:CP9#C8J5^FU"LP;X%;Y9-5\0\X%3ED!C5H" MYFZF'PQVS:19`"[4D_/QITD?)U(]R0OS@ZZ?C,;U534,O5'SVB9`;1*(J!=) MYI2<6JG:,P8N.16*'4Z%)'.(B+)]>*,U46`<@$I:>)`2L\@T=FV$$@H-"+0@YO.M^RN/QY^G/@(Z%.< M4Z]8HIC*MIO13FB36!'V#V[NWAV^AR!#H:3U0*3@S!*NN7-*S_"4G!<20QZR M/ZYG+8H2$=4]YT(R1F1>]IK-NFAEH?+5\AG>0[#RGBG_P["^JJ"J2' MP*R=FYFLE,6&@%X^\'4P9MX?B>P:NZ-7SA@J,8$E#@602 MK4G8LJB2QA@F0O>DR,$$ZP+^T,1$&;2< MY3$I07%Z4\NGGLAL[8Q&MCO?NUU MJS>]"_Q3;W!YENM]1Y_JH1V,>_ZC__US->Q<3Q=(?2ZY[>8:R]^KX54QE]$A M0W4!S_$'O=^=N3L4DR8:$%3,J35+DB4=4O`019`F$C`.UN<,Z_$R;.I7X\FMU6FH.?-+9J_P7V?__>O/6Q^>/'Y^YOJ M2]5?`F#^S.O!]60\FCY`5V!;^,BWTW-HTW%(P^H_D]S3VS]OX4F4:+F2&G'9 M*'`9"9Z#P\0@<1XY1J.VY"3BKT5&+I:H=6L`]PYZ'(W1_''U_M/\Z5N:W-VFQ>]VI,?W.Y7K)>[,6SU'[@7=2 MH8`!XE70KCU.*0T)\N35)[2J^N6T^/";-IO^C1-VI]//=P;$03?@D&S1?#+, M*1()DJGD5"8,4C-\'$"*)Z^>/P?ZG$'3@74MW?0EU!>3J_DCLX+TB\D/CL[> M="98JH*22?":$J6, M=[0=$AN8@Y`/'@.[K2/S5LIN-'WXWP2H6(*8(+L[/P@1K6=&)Q M;&YMJ>Q(#M9;M!\P!.O`/%#GF26YUJD="P<&>Y3/"#[_;;GE_-$W#48,%^/O M'E\?=OJO!]WJVV_5]RU:MI"D8"%&PI)2F.9R$F=>0"5))Z_R#-6Y2I^\7;LY8[%7F0_YW2-6Y6J25U^_2(J^@6R30%',-E@QX M["J?%Q1"6#SW,ZOVY$023%"56>KT#WI56-!,OK/JNA[FFPER5<%V\PHL9M$F M..VMT$B$SLTXQC-GD&/^K$9+O;JUI=7^I%Z_&GITLLMZN,W`1I*4U8)9$:5P M*.J\);.!)>C>)Z_>9)'VK-W,S(4(SZ9M+'9MJ='5'C4W!Z1^W1D70\K^3O\V M&5"].*9D47Y:Z20PR2,83602>K8@94/`G+PX](SR7B)I*B46^[?0A=7>G567 M^7AX9S!^U[G::@X:PRFA'JD06,29().;*>)HDS]YY>.;7^.[^,R_/_OP[#3$ MT\6N++>WVIM_U'W,9SK#!M%MW$AYX[TR^38512B3RD.[IFN]H0''[UV]V/Y* M"ZL=^&?5[_\VJ+\./F)I9K>!R,!8 MX<]KFFIZU!M@?C!^&9`VOZ`Z_U*]J]M;0*YRQK>&&X#-!+NZ9C!<+Z&]*@R;GHZGJ&<"$%@8'2(FM"&H3S@;+9H M8A(KA#TJB`>%F#T]B%&24JTESN]$C$+^8>B+BRKI@S?,\;VCW!< M&*,:,"A9.(%`O5$4G!(-QBXBG1?++7NDB*/#UG'"DT7B18F(8H)Q1V=+651I M6OCO/.O<%\+>'AG"201IJ??@.!*$S&=OTAQA1HN\'AA_6(98Q/@H$`S:4JYS MLJ)%0LG`_2R#<52@LBLK%S!=V#/)QC_.C@MD:74T(A%!,,/AB#=-K@UDVHOR MV#UCF%/NF0O^]N'/XP)9*\0V7Z?&,"T@(JH09TL5U,:2;3%UV3?&1^?()E=2 M$FL9"9I0;@BDV:),-#H6!7F8&K-'(XNC0)"H"$+ZP#$0N2RR'(>9E^*+1:48 MQZ?5GOGVZ*C`)6UBHI09+1D(!M&DEF\M<%N+6TJV#P!A>F"6,01TNQHPE MY4$AH(I&;D*0(DXQ5H#_*34I')@_LQ=FF2S)`6.=3YE[S4,`C]H4J430QI^= MQG2@6)!])$WZI#"VD*LC`J?HS:CYC1"\Q1A11SFPKCC^4/R9ON!+6(,X7*R1 MF)WA7#.E.6=$H?BS\>$,<&X!T8%18QG7`.1"1I^QM"MRACX MX'IC1ZR/2F\$'HD3QB02D3B,9$:V>L."+TNJ01P6UL>D.Y2F*1^JX"HD1R3E M03=^+9/@A!0)\*'Y]3$E:8XRIZFD$KC*Q[B3D[SE:1M3+`LW'MJO=XZ);-FO M]>%B3:EDE'F%V`9/))>`KBT8EZC]!'4''!./!V,IM#1*ZQ@3,G.0F(2W,9$: M8GVYCOZXW''_BP[)*@^OZX&S;DE7^?CE1?C47LHNG"T=2>>Q7.D`BYK*K8SGM: MD>,(H(0_,WDOU_ M5/80<)C6'`6VQG^,BHJQ:-5T4!AW`67WTPXXQZ(*G.&.)8#(N6(A$I3@;?Q1 MB<4R'Z):/SW%?+R#ZC]$K+FO MO,'GX[@S+?-:39]'CW>HA$.^DQC[3Q`?3@7R@P^"*1]SH9@K0NDCKUO^))#3 M;]K!UWN#7"'Z>[4Z8>\9V,6O:T%W1%F9\M*[L3(9FL"TP.9K/Q_U)$E;/;6M MV8LHSKAP@[5""K0V6HPQ#*,+9<0G8I0UC'E/97&-&SSXFNRAB(#U.V'2>P76 M$A,L.*:]YO-[0#$S+';"M-(/MLRR4%YWO+-OZ4(0FP8'*%)03-K!$\^S# MZ6@UU45\8`?CCKL#F_"#'K$*SP<&5D:>4O#3;PSCL>4U5"NJO/#R$0+&6EKR M"2)V,V'T#TI2X7KZ]>O7%]_.A_T7]?#R%'F>G>8_G^8'3]KGQR@Q_W*"=N7O M@^N>/#O%C__E-+^I]S+_Q%__!U!+`P04````"`!*@$U$[$AS@:\H``#M:P(` M%0`<`&-E;&`L``00E M#@``!#D!``#L75MSX[:2?M^J_0_>.<^,>;^DDCUE>\835WDBK^W9G'UB@0`H M<4.3#B^^[*_?!B7;LBV1$`F`E" M_?K)^$G_=$`SG),DF__ZZ?N5=G1U__]LM_:-J_CB_/#S[GN+ZA M675P4E!447)PGU2+@S]H=)JD4*S4M-77!\O_@A__C%!)#Q[*Y.<2+^@-.L\Q MJIH:%U5U^_/AX?W]_4\/49'^E!?S0U/7K_I,8S]IAJE9QD\/ M)?ET`.W*2@[YJR]_?F`_O/K^WFJ^-H(@.&S^]?G3,MGT(8@U#O_U[?RJ::*6 M9&6%,DP_`08'![\4>4HO:7S`_OY^>?9*`*;IG&;T)YS?'+)_/SS"`'&=,G1G MU8(6)_G-;4$7-"N3.WH&_7-#S_.R!(687C\O"AK_^HE)`1@,RS"7(/QC1S'5 MXRW]]5.9W-RF`,NA/+T_TPHEJ2CUWTA3UHI+BE-4EDF<+,D\JZM9/`H"`C51 MAMXUBE(J"H#7PD2TX:\Z*1.&97F4D<]065DE55WP:-Q95*I^W,SBE:!"6W.X MNJ82?7E9RRE@N*XGJ%RP_WV!&N]0"LLRJ_$;*OX$6*"J*XKK`C2AY=$=P,1^ M.LV+*\3J:V_$<,ECMHYS&`BK8`)M[1Q$XFJ80&LMZ:VUIM!:O@E'E'P!+:X"HM6\ON`G&3E*2Q"QYN;I+I9 MC863/*O`.07?-N'1L+.H5/VX6KQ`C^SC690F\X:8P_N@5SU26\X[/CD%B-`U*_,T(U#9\*K;_36-CTK1@-^!;!]U^*J+T`[ZQJ!F]9%?73$OL;)7-88H\P M_%/CI'4KMZ,@A;IS$ZR?//4MX:!J3X'JV](9-.DM4&%;>`=P+W$"VK':'H6Z MOH#I7#V>97%>W#3&?J?2'&6':_@%%1G;J+V@Q=4"#(@NK;9]+UX3SLFCHYAX MO?@HUUY*@%90-'^D]!A^C9/J`KR);IU:RLC1B+M9ZA0EQ7^CM*;?*"KKHK%'NQ3N(4JI_IS$Z"]QC-9TTFB`2*7MX9OB M>@L8;C3L)&:[S,GYSC1ZZ-=OPJ=#Z.4?1]A(RM.D<'2U%9.AS@E+<0Z=7 MQ83JQ@-2=:L^H(X[QNMB$O\C3AV<$75L$$VLK)&M'U3*?E MG6N8\(HFT'9E3)\@X_EF)\'5#&]W66"P"=C_52>W/'&ZSH(2=>/L;=[R$C7EZVW.XL/U_*\:%14M MTL=+6M8I.QLP@XH;8I7?,U23I**D2]N=A"C2F9,1?60I:@$?4WJ(&JX_NPI( MZI2>)2PZNCSPFA%0)4WBQV87LEF3.I7?58XZS3GITU.<@':PC3@P"RAAIZ=H M5G(MR.VE9&G%BR5/8Y"6MB(MG4%:.K*UY%L$ M>,H*T'#G\X9;\'R5G!,8S,`B][)NP5A3T M>?,$6G(._\PN'+$KGV59WU#R.WT.,*0HHNFOGT#W4'*-H6%%+K4B7PMY_?*8Q M+0JV"?NP_'JS5ZVDWC!&4>38""Q6"F:K2#_#^6%X/]6>4K%2O#T;OF$:?_HD M=+!C!('N_F`6NM1XS@!PU^CQR^&;P++L:/,;IJJ(R4X#%SB.:YOBF>9FG5_DB0;"K$*XW`[<"=U4;0'C3O+ACJ)763B M05/XF.$MF;22B:(\NU%TXN[1K99E4M$ZK]\,W(M\::,>S><%G&XSEX9=<+E!GF-_AR4:K`M:-.P!GY>FQ*F)[4[.".Q#C^ M"4QY_XR\9':T]ZF=L^(\S^:T4#$&.NID/8^(:^G[&O'9]S$@OG^F/0:>\S-) M8?NS=,"->$;D#SIK,#7LGN;+ZWN:WM$E;^3BV5HC8!Q@D]H2=N2FOG[VY)GP ME5-4OTQ[SEAOY=,\*9?WK36R.9GJL27AU.O4U\RQ>2^Z7R;L*%L3U>=MSQ])M4BR64;_AZ)"-%C;A3=#`!-3P@;NV$NR M,+YP3T8201^V?]"%35S1`A2]7A1Y/5_`7[11NG/02J@EC'%`'<]S-,>W`!O= MT37+,I'F$]YKNV2?MP<>WMB?&Y*@5\J.;^QC3KPJ>1PLEUZZ)BF:UF6 MH]FVZVBZ8\`0ST\_#8/U]3'M[($-$6-I#H!['RFYCG>`:0LNQ<.`20[,] M8FFF$6/-I[';3&"6&1LDT/'^6M=BZ#<^YB/9U&*)V%Y%:!K8M&*PWAP'PQ"U M/*+9&/Y@J'B^YU+D]V3B%&SIL9@H''3Y5'QG*[^O[:T&-14"C@4XRWR[UUL/F%>;6UR4W7U%ZIK&LD6VJ5 MW)E;GR-77Z/L3NVJ>)R#G*M,N=G\G**2EJ.4 M$/J&'=F6,<%#F)PMZ`X/["8H]'53]Z@KX:B8&E]72L_GBB%5$8#B;,19=GV? M-R;!<(Z]R`+X+>H:]MZ>KI@0S0:A.BVF/3OB0KCV+`U&((""#0D;YFK\UFFQ M;0BND^+;:5X7PNCV+`Q0T8EC^.:^YC"9%-N&P#HMLCVYUD+(]B2,#4'==!T) M"ZF:Q"'3(ML`6"=$MNL%+2AB<9WA7'N1Q0:@X_N1A&TP]T>CVB!4)<;7M@<$ MOJ&LCA%F4<-L?HHP2Y_RN&K1+$J3>5/;:/$*R2&AK,S3A+#KW\:KX'0%B>@6)=@AJF)9(CM MK%PD4"K6NC4-NX-<[S]FZ'AQY'Z$[M^MA[;W=']H5'3XU2(OJFM:W!SG19'? MP]3>-M(W?!TB;'LDCO?V7/S0KLIE0*3D,-SJ.3:P)]@ZSG'F;6.!4'=<2X_V M-_>T8`((0TD1!XJ:DIVF_:UE0MW5/31P8V?,B)]X)@@#2B$9EN\`7:.''FPN$)@H"(S8D;&VJ"94) MIH$PE)1$OM@;83NM#5M*A+YCZW8@(Y^!FBB68!:(@VF$J>#W/,.[S@8O98#J M4:R[MH344,K-Q4$NHDB$QK$.N(C05HS900$./H3!.(@+@D%2.2F`MFLH[#0W M;"L:FI'MZKX,6B@W'85,$0*!&L-LX"+%]D*P*EJ!;KD2C`?E)N0@.@B%2$DT M.<_F+!3&SKZWQ9'7/@L]QXZQ%4GP%Y1;BL,BR,-`41([WF47;,-6"B+8,DG\ M$0*'XO>*A."E@@47Q6J5:C3NNA2\X>O0CU'DX7AOD\4.[:IP-BC$'O^!.%X"/BAZ_+B@JZ^*1J\_??QQ&IAEXL2UA?WC- MX9/YYH;@;A<"D1+OGY`F32!*+U`"CNKJ&>`UVK;%`#H+@Y/K@IN+]M;E$\P+ M*8BIX,DE.XN64?(%%1G;^UY[PP.\V00G;8Y`=^$061;RI&PQJO$%!?-$"F** MHHE/BC9N+3#[MJ`+FI7)'5W&P5AVTM]I-8LWO\_34Q*,&S,F!M[;K0C1,XUT M^%19HAWWA[<8I5M*@?UEF-2./D)H6KQS*A8X)?--UWO+JR=U=4P-BPY[M$%F M"SA.9*Q_%^K$-%P4[.WIO#[=\G:&&PB(DOD+E0LVDMZDV:A.4%$\PMCJ=*]Y MRH>&;YFZ*2J6Q/'Y93E/=,&$2,-[5A%G$=;]8E)0=O^#U%MY_ M'/I6Y!FZ)<$"4!,@$=?W0L!1LP>;W]*B>KQ(45:!7KH1^X8$VT"E,3B(&9)P4L$0#A8\M\#!CA$$NH3HD4HK<%!/#\!"\6+/?\SR M[?>PJGG$-8*]O:0CH)]%`2,S3\B6A!@7B.FZH%4"HE]K(R4;QU4%?S;!_UG, M(FBG:7X_3E8.9HN#`K!.WR50V_'C]Y*=HE^]=0AS\2HS#"C?,B9VD!)Z$?*H M@08Y1DJQ>,Z-LUB^`=;4^>7AEF;E]J$/P9W)6X]7=I1,C21$?A4Q@// M:IS@4=<:T=`J.Q-V=G.+DH)YLR<+5,Q;SPMN+A#JV(\"5\:1"34;)B,21QBB M*OAR7)=)1DM`X29*LJ;USTMCN2/:2$ M?D0LPX\DG&P)/CJSY,+<*^!P27&*RC*)$[SL#O*_==E<3`"/YFEOXC=*-MMU MNXH(L6X%MDL\3<=QK(&'S1YH-(+5JZ"1'D3$Z1F>U#\J>Q2`K&*F^IX5%*7L M??NO*,E8F'66?:9%<@?MN6OU&CI*AI$9(]V1L?EJ&&HN18\X)XD'=]PC_%\+ M:,+EFR:UG^+:75BH4Y/$NHQ%T#`_/.64X*WL[`@[[`!`+B,WW:;6UC*A;_FF M8Y@2PK"&HMP.(W)*)*QJCAEBEKF"?J;+O\%S?7Q?4<&FYP?D$W#H!V'1LTD^P)7UXUP/@'0 M>N2XT*$2B.7^@,02A'&O:,+36W',)]T<@-V`R;:X0B]A8>1BU_)C6_.@O1HV MS$CS;,-8.K\Z15Z,O)YL\CXLFY3B/9IY]29#].I]F5VMK,U2&E.`FC(N_!D? M/N(N%^=Q^/8F._U.+'M3%F9OV[$C&?F;C0\?![K@.XFHD'&7D_?M(O5S& M-H&`CF$$D2<55V/ MD`>SHN.PF%)2G@*L+)0,`^H;8J\]5X^S>'N M#M#19<[1)E/;\E_(+H1K$<.0P"S']MYF(9\2X\0"/0KEWF9SV(5G;\N&?N12 MK,M(LCCNKM4HY!*`[AAVW"S>FCIF!]NM10H8#U9,B+NW&1LF9*^)A7F4"0P: M0&J&6(\)[&U9F+0C[$:>!'MLW/VL428P`>B.PJAF&VZ)6/,/NS#J;5DV::/` MDW%!:MP]K5$8)0!=E8P"/V1]PEW3OFL7M:U@5>H)*RFWX\+VAU%P[] MP#*1@>4F]Q]AVI/2Z]NG/7'P*G<\%WE1<3RWN[4,BTA;L8\_VEZ4$@8)!%4% M<8#F*\[/8E[B;"T3(D/W#=WZ<`%5%SVVUV MT4[EP\#&L>[I2/-)1(2F=QHU48],DL@&6-(QV0V0]#\FNT%82&A,B>O$FJ_; M\(=I1IJKZTYS;-,-",*(7:@=&/[\8!..4KA5&S]G95FSC+BS^#S/YCM:09L+ MAX%),$'V1\OKH]H<$H;N>)QJG`\K]Y2*H2*C(`. MNU.MO*W/"_$%2YH,@ZNJBB2J*W9H\CIG.1B`:-"AH-/\+*LHK/-M?H3@FABF MKFW8$D)I:@YB"^/+^R?'1\99D?OQ0[V7,&JO[ML#"LTN_`;$5EF&NF9RGN*A M;R`KL&002LT6T)0()0GPL:EVFA?0C]GR14S\>%V`=XMP@VA&FO^WZOOG''\# MR=F_PM`W`\\B6,;58R5T%D^A'3BJ%/>Q6D+L M8\LECJ/9KAMHGA_8&C%]N]DJ<@*,HP"C*9]QDT;,J<`]]D3+NZJTI`R&3CN: MG9P]9=K\?IMGS46.XCSYJV8!&/A[;<1XP^[(0^_=X:<]1U MY$@^*I(27)[/=<%\(_@])P,&3__*0M_&NDUDO#:MYD[;:$-`*>9CKQ_=8_A5 MXP>N`SUK8PX0)D3&47]%E^A&G<_5H3Z->?FW/&6!J9?1^Y*V0=;LW*]*F"\B MEW@R-N'5G"29P!RM#/GIS]2K)"6S^`4"Z?-U2YTP?U@T=CVY1TQ^X%E;+/8J M^-VRGR!OXYAS9T+'V*$2N*HH!#C"3K$D8"=QIN0"@>\+H[."T9=N.6#RI*1H M=48\U0)=^S(#/6>_NL[7[NXM8,&E17F,R@2W#,@=);\AQABT6?Y\B$'1< M35[/[=LI@;6H&`"UZ=3<,8WS@JXEI_[R4!4(>BS)4/%X]O_E76F/W#82_47" M2J).8+],YO`:<#+><;+Y*%`D-1:B:4VD;CN=7[^D6CW3ITY627(``QZ/Q>O5 M(ZM(%JLDU&5O;0;8:N29MJ"V6*Q+U%#*G(?CG1'$*)N+?9#C]Z$W;0O.OXX" MTPYXX@/-BGKTT\CFX2>'P00&3Z0SFPU:VT-"&')_#&IU,T7N3EO$?G! MEY%M$P6)U]C@!79#V.'!PK/!2R';4L[X[N1)E>15>MP;@_J_:,7\?-_SC MJGIU799J<(V&^^!:(VH%3(06;-:!I9`(%TB4O8&H-KL?Q$HNKIE*5,1?TE5: MKHO*9:`]T76W"B)*F3!YL-B0CEII!(;9(!?JFQ?USN?O"H4\.8TDWY!3HD?I MB%M68"66M)CM.%Q@3"LM\H<%#&.YV">QN,U?XG2U$X7J<9GNW$8S=>-58=6P M9'2O)+*(F0C?6ZRKH]9E`Q0WG"N7?33NG0F_/V)5ZC15$1163>9MA]*11XF= MR/5MJ=;*7,^Q8;#'X=RNI^V6S,F7D9RG"0UL@+4'*5CG?,DT%FBT$U0Y^OSX MV*&=1\T%H\"U$V$FL"]8_H<@X[GA."!*GN9OVHLM6!X*Q$Y%DFHZ$#&Y`` MONO`Q\,^1][Y(QSE.Q=5^0SQDS?7'1&232')@QX\1TD#S':Q4D&&_3N@CZMR76PJ`DC[_3^"/U\,3#E5^]"B M[-<-.'GWZP>9NA^PY,Q9U;(Z*I$&Y7K[<25MR)T.`&KRGA8K.<#RLRBJ$)]( MS32S&];:^+U2R8+??),F\K/X9?,2B^(QN4NSC5(+5:S>Q\VZ7-.5NL=HL#5Z MUA3%(>&VST==/J-B;A`C0\`*5?XZ++(:=?W$,U]!Z M?P_6EV_M-49QP&QN)0`7<3@GI),S#P1C.,/_5/^`JO'[E][R]*U7=VG)LEQU MK&$%O5HF,KGMF*$Y0VOE[8RC?B'\_CZX::!7"\F1I94^3Z5I($-H`*P[E/ MA6$3/(J#?`T_USF#^;YC=8*G;A3I6T5D4AJ'?N@;B1N'AN-0TR"F(%743T*Y M[X<>&\8-'/%)$ZC,'NI:/8J4I/"$,1SBAX5F^:]B^:582]&,2!L(9F/\3Q[[7*;(,>FZ$B<238+E<^[)T MIQC7#T)MC3+E7+R1O=H>?=P;HEZU1XYI,I\(`$=VG&,.*)I<3".-#36&:=EE M9+4E??3%72H+JGC`Z7LLX($<;:M>(F?'L3`7FS)T1B0%P'HN+'T2KW1=['Y^ M3.J![IVX1E*TL6Z)&9$[B7$*:,H#GAGQ4S?0 MJU;*2;C4\A;[5G9&E-2(\5S8N,O^^%'NMN3"7PBN$A=4%Z9J[[T3>);EW^4. M?:S]V:,EB6<2>,);[(G3C#@+"_N@"Y=.)O194):];<(N+I5Z*HY(&`2>1YD1 MN!97*4Y](_ '=;[Q+3"L-@&/&\'X%XDZ$\E^52_O*+6*^SW=/?D2OB<67* MI'$M!^)5"4ZZLQDM>J.1G0O?JH`<[Z]BQC+NM#JUXKMAX@$X_@7_-,YIP!:# M=6=VP,%E57-\\Y:2D4U=;EG^J(T&TIAE=W>7P;W&^UY*CC7QN4L6^_94JRQS M2-PFF1.RQRH>R2"*O!>,[-A*;"]8;"0];):,@@Z9*`=0]%I*SLO)L7K<<2W8 MN+Z0(820>*(%NNEHTG=%N5A4CMCQS,`"N`%Q?E2RC$)O*OW34^LHS1JS*M;Q M[*VO#T5S0(6-L9HA6\2&NU_<9P6N`MUCDM*7*D9.S%L;I^% MTV4T9)-0Y"V'R.74(WTXTU*51(1SX4*+<_V.02#^&D[!*_G`K_YVN!^NN MRS6HA9=Z3@+@B(=S88_!(6W0346=_>_J",NW^8OZ>R>P%:_#(Y55M*F?JI?& M!Q^T9*J":$Y-2I_Z(8!VQ+F11R+E!#A/I%*_R:4Z+[;]E&==2.UZ0CD<`#;A M7+/CJ,GA:$VSH5,78+WV;JJ`')WP34X`_--PKKU1MFD#D1KDGG.!B7G4XM#)*T*E\:L:>"?M!=G&SMF%"',UBG`-0+/.WW M&%I0PXG&,*?44QWMNX.WB>>/&8Z[U?&EKHYJH\!U?1*&H>%XL80AE/L=RY3F M3F7IF#1PPZ&QDW"N:[1(-I\44(PI4WMNU(/K,W5:2D:V0[PP)HN+PXPO[-.H MN]J!1232$6(#Z-1<7HW=L2A$G%W86\&YD$H[O*..-'H`TG;(T:.JR(J92/R0 M&;YIND8S6!U./-HKB"RJ1QG MW#$?\0S7(&0R@:&*=RP"DMZ\]6AE!DG54;VK!XSZ3OY0KALS,8ZH56+%$K)@ MO]O9\.AB5G8LFQR`RBF+:R3\$+9+H'7MTNA@X* MJ.=KEF61418VY@@_%[D4V7JK\C96>:;_W*0]?*B[U*2>:"4LM@%:KH9[K_6J4CE>">XYBPVNB,@S`"P/V*8YI<=YS'^H MS`WG+=W*FJZUMM1X5@_6[>U/#_(7,XSUUH\\GS32@)KEI=KQ]VO MGDJ,&?_E"BH$B.$`&=82"].P.F%`NK$5&NVQIH+JM&&C,SQHJJA MXVUQYMJ*RE''KL7LY3K`:11J]QDS%+OC^3'I@C,-<"!+C78#_*J9"FR0GP0< M@:I_6F.[[D3S6GWX6>2%KIW,U#.M[N83_?ZS)'61TDQ-G\=D_^R\RQBO%I8C M#V*+F`!F#9;1/%2,9\8Q`%8X_E]UQW_/BS_>PL+UILCUTG+<0G`"$18"RZ-+ M-T>T@H5*$J4YRZ^BTC?]27*]M)H/73Q*M8$$:(W5_04V/7^AZ M4XC'Y*=-F:[DI%&!W&B9JK^_*`D5V\?D2_J\2I.4*4\LQO*-\G!\_IQG*4OG MVR_8Y/*ZN@=UB3FZ?W,7+^BDJ#S*Y#)!5RQ5SS&3O'@Y.KK":F]*>[V*F21X MKU0@5\M$IF?ZE(S+[``SSON7URS?"E&G\NLUWM:RD6/Z\@^$^L6QXS5)]#3E M&`!N@][./XE8=J"\V[M;UI"O^@-J8JRFUU:E1( MI=7&E/:2D1\0TV,Q,\+0]PSJTM`(DB2I7_S3F(6FF+/Q#L`($-2&23Y_>;UP[^6M6!`55&(IVT8C M%7!BBP,I"^VH#9+\%YJ)\DFL-T7K,G#ATXA:-.86B0TJ0LM@Q#9E5Z6&J_2: M'X;"3;QALL6))0X@6STP8:C__8(D>]CYR.3@8PF1Y<;<`U#[..&^8=2^%J`0 MQ?^YR!-1EA(NFBE=U)D*5PJJT7JASR'>CN,$YP;EA3[4,#A2.7EWWAY<^#J2 M2HO0$")5KK7DDT4]4&%0H#KT'W+(WEPP"KQ$^+8'X3FRQ&-$,-1T[QYO5OSG M5)HXZWS5NCOH64W$O<2UK=@W/&D5&`SA M?`.N7AB"7HNV!LC!:F_*:]&KG6IV:VPJ%H6.&1-U53&[R]&KW6YS/V\NJ$;L MR:W;XL+9ZQ=G#HP;THYG[]M])UX+(1>EG??":R8J\:R.?+Z'!-K2U83:#S`G M$`#/'I#<]\&H-R'$<)KR:B]!->5_-[18BR+;/HER(R?08_(>#?"W%=UP*6(^ M9=NPWG&=N@`J@"_LJ^";3'Q,W],MK;CL5Y8FVW3U7#N43=T\K!@N9^)%;6R* M`;:X5@*KPJQ2%X)?[EL=X;KR.OZ5_M6D\'I5%)EQR&Q_7*+9*1$9C81"(`E\ MLM@7,Y`"/]7T4(AB&)M[W\':W^OR$"1"=13Y75#>/GS3TT#DF($3.PLV-!$) M.1GD<(9GHVXB4RA$9XI&7=1&86W*=<[^^)IG<@Z6:ANQAGJN>]X0L!EUUAXL MCINX%']NY![L7KUPPFJF`X;__I?ZKUBR2O[C_U!+`P04````"`!*@$U$66&D MN#^H``!O4`@`%0`<`&-E;&`L``00E#@``!#D!``#L75MSVSB:?=^J_0_>S+-C@!<0Z.KL%*X95R6Q M-T[OS!N+EF";TY3H)JDDGE\_('6)DT@B1)$P[9Z'Q+8$?#@XWR'PX+GYZ_^^K___5^__L_IZ3_8 MQWG?!")Y6>GGQ)J[N3O^MKE68F6WEZNDI]LOS-?/C[=5+JDZ]E M^DLYN=.SY%T^2:JFQ+NJNO_E[.S+ER^OOUX7V>N\N#WS`/#/-KEVIJC_.ETG M.ZT_.H7>J0]??RVGKTY,O>:EA?U5RE_J;Z?5)L/CQ.'9\LM-TCKO=Z:_^$U: M2`@Y:[[=)"W3;0F-47CVC_?OKAHV3M-Y627SB7YEZ#HY^;7(,_U1WYS4/W_[ M>/Z=@8G.;O5:J1[N]9M793J[SPR#9\/A%KI*TJPO M^#]8Z+P*^-]9''?Y8I&5: M+6K(/BLU:6K047:+WCX7I.\-JJUM+`\5AY4M[5_Z0I M\7.2F1Z\+O%]4OQN:#%%7>G)HC!(=$D_&YKJCU1>7"5U>?LK<;SEIZR=Y6/0 M6P$CJ&OK0]1?"2.HK3]X;?TQU-:NP>G+?@\US3-C/B^:.(3>%EK7HXKV"NS/ M-A@NVV;"*O?0*-L?<+OL@^&T%*M-YCXPSF9I-5L]"SR?5V8<:X;!J0W"UJR# MXK-6I:T%%V@MU&EM8E"\[Y/YXB:9F'#,?*2229JEU<-E\E`GOKC.TMM&F,?[ MH%,Y@];<]OFT--`'UGF99^FT'M^Q)*NG2Z[NM+;I+UHR#HCM,BD,-W>Z,J/M MK#/0K5;Z17U5F?\;/U[Y'=&O=N44_R=-=/%[G`U M.\X9KOB_JO+)[W=Y-M5%64?$U4-7Q+LM'8]>Z.NJ#=?C-/V4:-FM;4G::_FM MP<*VM/T@L.L$?T[91^F%&9U5S<-;5L5BW<7^34]O31=+)^:K9I#6#NY`0PZQ M6PNLFSWW-;&0:D>#[NO2.FG2V:##NM@^P)W,]5"/U4JJ*4N:T+EZ.)_?Y,6L M"?9;05OD/1ZA3(IYO:9[J8NK.Q-`M*':E;Y_)):-1TNV_G'926Y_KAY0F:SY M@];,?'J35I=F--&.:4^>81#9^K`]ZZ#X6IMUF[S'(U3IW(P)TR3[OI5225K\ M?Y(M]'N=E(NBB4?;`'^M@!'4U5(U?9MLV_X!([;QMF?UXG/^W2(I*%]G#1UTNLGH-_L(4W`BK M_&V>+*9II:=M:`\RX@BSI2*ZV')4`SNE=#!U//[ZR-UTD>GSM)Z%7&XLG4\- ME"R]>6A6^YH^J17\H7;<(;>43T=S/=2C7O`R88&>UKN4]+RTZI#WYQH*E2V7 M-ID'QM@:DMOE'AAEZ_2J7>Z!409'H0P74V36=GJS1GR8^SYSON05A?;5!?GQ`V().6R?..@,SO]6;D M?'XZU3>)B?8ZPMMI9R"P^2Q)Y\=C_NOE9Y/Z]&BD\*WMAX; M#`T"@R'+)]N8;EB^27J;)/=G=6MUILU(;/U)TWZ=`KBZ5>4OJX]C M2XBFVOJ\TK,-R"RYUMF;5P94W-54C`4+?`Z5%T:0A#"0`H=0AA!S+F%(?PAK MLOJFF;Q8^^2I&6GZQ./9:,S$!$9^Q`,2$4RE!!+X@J^8X,@CHHV);_JDQ>0D M+TS7_>857.=:/;P']34W13YSY=[<&7.FHN:#IB7Z99+E)E1]\ZHJ%OK;A_F\ M,D^>S)K=3*81TK?+R<.!1;YKZSC([T/OY<+0UFAI8'C_`%-\%(5MDL35]+'"@ M(/0BP!6@@%`A`%G7BR$JXJV!V&"RV!D`_BR*GOR5#\?2RU&!>^]_5X]Q.]^] MTQ^UAZ)F7D\?[TVGTW\NRN;8]OOO8O[]`8F%H=B32$*/<4`1DP&(D"!JS00% M"+B2R;81S<\:.=*;NR.0_JER+)H/NOIM7N@D2_^EI_6>HR7TMX:?NA\]1#96 MIF**H#"$1-`C7'$?06J>RA4;@5)^)^%XSTXX0Y#E7CIKN,H0)W29WLZ;P*SX MMKBTOB*@/F*G#Y53-_.Q(B("1/B(0(6\@*`(RXU[L.K6-OG/46)."'0LNT^% M:62SY3)FI^YMCX'8P\BGH6011E'D5:6(O;CXE7X^?Z%M;B@/?]PD6*,`>]P@*?(DV7$0A MZM8"#2:IP3S=;=*O(XLN%&4#^S(O&L=559%>+YI;&C_ER^M\]BCL2,LQ5[X' M50A-6RXCX!%&V69\`@,QLHC+?;^0F`$LI@Q+%9F8(/0C$H6AIUS% M/D=-1%I[?H@Y[,,(?.FK;AY'4:BD+P#A,D0,"N4;-@*(`A))@L8UQA]23KV3 MY4(Z74.ZEMCW&+.Q'PH%S6"%$LBHQR!BG*_=016@CB3U#$)CAS2/68RMP=5Q MAF./^A&`IK'GGD!!2",9>.OAE+E46S_1Y^[&1O=*.$ERO+Y MR+$U"#S.<"P@1$*INB>CW$=$0:5JI@0VD;(*1K9V[4H6/:FQ$\0"4:E;XB`"G%"&*9U7222@0H[[GP9;$`Y M!C4[FO?OE]J6(U8A9B8`@!'U1,A8$(:"U9,O7B`H"5`W M=0RV`W,)N MZAALD^4XU'$LBRZ4<5GD1K*/STMO$<2W1+$4"OF<,C]2)C13).#"=(MA"*20 M/N+=(HKP)>N@,WE/O+]HVPTA_9VBW_EB=><%/N5>J,U5G-_@V6QNVI&'DA#A7U M3&`7!(($@OMB75\>(3K>18RC/6BAB#ZX>OD:&=U"POBD<8@D?K[?K?XDII_3 M+/ED8M[D7B^J=%*:<'?GG'U+CK@Y3A4A1!7A?N2%E-0#@A43@JIQ3:[VR'\^ M!#_=_'E=)$:4+,VO)JF>3W2[/W?FB(&Q'RA"$660F(Y0R6`=92%*).SDS\&F M1X?R9U_\=/+GVRQ?3,S(3!>7=TDQ2R:-II*L_3EMSQG+D*`P(%[H(8*E###V M\1I_$/%NV_,&F^`9GOV_EOEBUE( M@>T[8RS+G+$R95T1?SU9Z*\YM/27&K*SJY2_7G M^NJEF[S05_=ZDMZD>OHIW;-SIB?+IK>,D.?Y)$!8^2%E6(!PPZL?C&0K1._> MW*H25RSVHJ)/7_(?\=$;$[\<(9\#3,:""4:`XL3'BDF(:1B@=8V1H-U.$_8^ M*G"JF^'H1X5 MYFI\0>L`OK13R=&LO7RUC";4?0XB<2^.CXD!W':\:YTF1HI($U%%PA,J%&$8 M@&"#'[..J]:'[[@:9T_2E29G;FX_"?`M54PI$Z8*1JH>5=C'A*AU'2(!Y(AO M\>[@AVV>/(J'Y^G3T;75;EWIWH7ODZ_I;#%K=>)WZ6(AL!!4!%&DHM"/$`^` M6M>#!SP:Q[3!41[(^ZN_$S\:/JW\^#A=[(&(0N0'O@*>!$+XS-O4H[XJ$3].TW76KIOT+"D>: MC:$7<.@1*"(,*:=`2N"O:TZ)&&&HYM+=O2CL**;_3%H;30CY4B7F/KA93]=_ MRE>;/=9]@%Y>8%M?F[3Z9M^=Z(>8B7TF!./4QQ!)1`+%./[&0H"<+:!VWA?S M[NB-\@/RY7+K*L]GU^F\F0C;,3]&BZ(.+9O*-D'FQ4_*Z-A:-'I=5D4RV7I(9"4XQ#97"2)"`D_5.N0@CUFWSM< MS(W/'P[H:P?#$%-.!8-8P0`0$DCC;?G-QR$6Y-]6>3W MNJ@>ZE<+5R9%?37V_6S_"\&FS?X1-!+ MU']WKSP_Q>]=EG+V%.Q%$4,4>$HHP'DDB/`D)9N1&@E@Z(TST'^93T:?GGKR M<8/0RW'ZI^3K,O7VNR>=E!M3ZGD^)X)BGPM&(_/7>IJ2(-"Q_1_L]L*QJ'R, MOGENO<#^&U=[+BFN+Y4T(RSL>;CN2GT)([SI427K=E`$O72=C\,;+I3]-L^G M7])O]Q%ND>0Z21P0@#PS\J`*A6$81-+;[`8G*L3=IJFC/XN6.M(XXN9M72-W MS5Q;B3&1D5(2>CBLM^2@^M17M`F)>,=#M_C/(M%Q>,6%XM7NL/JCKGV7SF_I MK'Y!_+\:&BYUD>9[%_PZ6HP1CP!GBIJ@AR/?9Y")]20/B3CH-MPB?Q;%NF%] M?$,GOC!_;IU&=E9V+#TJ1?,RO2"LU^V!4.$FF!&TXZ9D\-*E.U8'C3C0V.J# M1]5^].6'?#[9^6P\!8S8$XPC$^!!2KB0BB%%-EX(I>JV<`Y?_%+D,_"5BR>F M90YPLZ)J,8X[U%3,?<&0QX"0O@]#B02@8!.V>6.=(^MUR\?`G#U24,\O]FA[ MR<4/$_2T7UBX]]BT7AS&5]/^6BQUC!YYG1@CYZKC';:&7 MASTNDZ+IS?:W#WAV1>?7?)_NO]5YCN2A_CD/N1!)C#0`E,"*)JPP(6:"1OH1B` M^[Q_=GKPY"%>7&$T`Y'(#SW*?8,/^!YFT:;&@GC=SIT-<\.L*P]V8L;E5-;Q M;Q8#6`$?!F$DI$<8"ZA8O1VE9BDDKNX5'E<\UB]I3R6(_MX:!4+3K0%&(0RY M%PC3S45TPQ_#9'PQ6V\>//CU4=VX>OD:&4U<-UYI]!`%]/HF*N)YQKBG,""8 M,(`E1NN9$`,7=KNV[`G?+&;-O^6;J`[CQ\V$?7T1QU655$U$Q)(L,8BO[K2N M#W?0Z;2A):AW8RY1-`M:AG;]?9=HY91^L"%^@^JPX=D MUM[M=;08PXA%1$42R4!R0B2J5WI6W"`)1O@2J+&*)W]*A_Q'M(\Y&ET$]R?5 M:E>-EGKR^C;_;`BO%V27"EW^_J,VEY_&Y\V/FMH=O?[6=#$+0LPYA"R0GL\Q M"/W5%N-0A::@;A-)8WMCP*&=T?[8/[Y1'75*IR<=F9^O/Z!MTAJ- M)5$02%&9>9B:1`%(8/5BHQO=:&B#L=+(&VTIA\U,)?=D?"OBB1(K!X#G5R;$ M:%:;4?%@3"$?*YVO*[^'$?/ZGEY)D&LA@&YD=Q*D`KY3O._Q*-0B3+FZLMUO]]^J^M2 M5LTAA-UE&@]UR<(P"0=""4BH58P[XE$S8BKD^",^7Z+3>!-C$R7-JV#1!/KD M=\6KM?IYL2JJ8*E>%Y/BY7:)Y9\KV09$-K+KMP:^2_Y)7Y)YX3T*=A*!F`OI MN::JU9&:L;@SS_WD?241;CD2)./X%487!OQ2_?C[K5_7P[@NG_/YZOEF517Y MPT[.'.H8=!T"(*A-B+%S`JMZ][(9/8%H3/>3I^=!8G2B9-N6M2Z/$>S^7AGV M6#!M#;804`F4!L"^C9M)Q./6@_/;'`X$H/DG,+?OE2C-W"'(-C+^OWYX3$H MZGJ$YCZO[O;6=/VX0X:(\4QH9<,J31QRP,AFPX]1*^)6NO-4F(]51$F0B_(NJF:XG*Y,OIK-I&-F+%KJ:/1;A$3OOS>G4.:O3-:`2&M0[ M+X!)0E"KJT@@=92T>R\^F$[:?:`4>:1PN=J,N[V0[/OOBZ):WL\>WYWH7>+N MVC\CSEN)G/,4P^"\!=2(:>:",0=1$N^]1&`ZB?<$5-Q60[FJJZ/D\U>_Z7U` M.[<8=G7(3*!H4$A>"T*`XT0S19O1*LWCU';O9?72B345,AMR'*K>QTLP=?GG M8;35/IJQ1+ZVONFI_J^V3I^"W1JX'M[^-:_^7:SJU]X4DW7U6H#G*9_-ZY]\ M6=46[MC&\U859<>PABH5LCVJ]_&V_-T7%SKF.9EBDAI&J-5AZ;%80^.]H=(& M'P)PCP]:V^?#HGN]E`//R#B"P&O%E$'`*62$)_85`Z`L'NQ:[;V%4GJ2ZL[* M*6DQR].73$E#M)<;P.NPX_+[K2U^-C[VZGE#1^Q/SNGXA(Q2JR@B"DC&N##0 M$^@;P)`'0V7912;K)*-#.01Z0VQW=!CYP.K\=O.C*O+ENMH8[,'4H=V=P@PE MQ-0@[91W!E#E"6]F:.%P18&ZN7@]2*[L":IAR/"I?"JJQD$$"*-3`4D:M M5$Y($TS1-^2"-S2R"[3[9]]98!V"D,$+*69WB_?1U_@=H=HZ]<^D]HM$]D^G/E`;@BV-XBV.9,G>?IE1W`#.H4(:**8IP<8V M\R0*QT6U>HMA]L^.E&@-EJ^PK1D/U<+)!"U@;QX+>8I_] MLR`)3(,HA)U[G&]7!Q73.JZ[3SET>T+FO-8R6%5>8>B4I$(8W5KX!,6%Q_L[ MI#-(Z*$?[.*2H)JAW);5\L]#F4S6#^MY6.2FGZIRN?QM417YO![;IX#DS[I# M\2/_8V=ZU*D/SEA](@$+Y)225F-!J<=OLX=:L3CF].9?]\NS.-3ZRA@Z.57F/!<(G2=7QE""O.<4 MU!7,!6+.:`0=$5))!8D\:-G_"KDR6`.'M8".A_G7U[=A+-XPD""VI-A9?*Z,E476% M6$6IA%QQP.I+8U\M!VGQ4+90\IW>SI+KGBMS'%1_CUP9+SR&U`B*E:4<82!( MBPF#?B2%.H:D3]\8_I,K\Y[4@7#X)DE0]3Y\C@@R(EQCA2K!;=S*-H)R-17W<3&W+O-4_=BKHFOQ=&?'(0H*MQ1H;C[@-+DR#)T=>K>4=[\RH-L!):Y5BGDDHD6'M!AJ&=+`; M,?O6Q2?S*[G5G$8BXV9\,\?&;AJ"\0?>F1$+@:9A\1/:>^>($4')-?A*'F=] MC-!V'@_CTTIDW(P?@N';^!E`Z\H&$E'-/'40&-3N>7+O\:]B3X^'T:=)8+0Y MYUOC/'_9R%Z+:WY8(7K8EYVS+.;&D)X*555Y4,T/;[+Y5BXF._[Y1_C3,GQU M=0+)EPXG`5*^)G,6.4.]-PAIPBRCW+Q6]44Z_!$=+*+4]T&!!)/M?J(@UOAJ\GS@ MG,)FLTQ"P00#]2Y#,/P("KX->YNZQH*-_##"\`S83HR)Q[*[";TL)O^Z*Y_^ M9_+VLIH1J/U;S0:TP8;F]TS-YV_#VY($4_:&R:\@[=$=!SB?D,^0PK2NRFFMSZK#R4M;33-`ZNO_K&#*B;H4 MB6<0-+/A3L?YINDOSTPBD.T,I=.P&$*RU_6R=&#-;MMD6D-I#076BT#J,'<$ M=#-^"5S<1WK\SMFE+MBQ0`Y&A(-?]T:K#%E.O9&86,><$QPS;]NO0AL_WO4Y M0@X?2?(D'"Y3IJ-;A8<5Y1G.O`0X']8/AX^N;+;+)"6NOLQ=$TJ55MA:)%LL M#!I,C-WV@Z,DL'W&Y(3Y#W.V]H]NW?+'2L_(F./^+2?%Y,?G7SA5[;_NZ*#,4]?U,7@*-N!>`MBN7 M9#`N/SO]KD=Z[,OTZ,1)LGRJ)[#[M-T'K3+IM4**2,`LYT#7.=VMW4B41^.P MM_J6VBF81,E*3<+_BJI<7-WGU4.^7V0?-LYL\/U>SOLZ#PEQ5M3[GYNO@YJZ8_9^5AJ^7#QAE%7!&H-7,8N/`'51]2>1NE M!2"NYE+R\^4]RRX%-%$"O"Z61>AXGR^FT^*IF)>/]90>\^>7F?GOUU_5?J%V M?D!0((A@C;`ASA@+)*+M3JGE.O*$;/)K%'H6=%]P10K_KJY^75;/^>-C%>RO M^<-L7BQ7Y:+H)/DNO3,1/#'BO93`:^.950"9=AX$Q7W?R:^8[UWL/6`5)?,O MLTGPN(LCOO#=/3+$23`+@#3UV3[EJ9`0-N.EDL4%V>6%R389/E'R_%I6C_?E MS?-2?=HOQK\TS(Q43$//.0606`\AAZX9G4&1%9_>S8H+$=^IN$2ZGL7J>5XN M#OFS0'B161X[=)V=TX")4I8WQ>3\FLQW7*+#MN[ MA_IEQEGMG0:8$ND$MM[[5CTH:B*OYKVTC9_$,,6)>'5?5#NF>$#(!WMF7##D M/+7(:P:DY)C8EJ)*1UZA"R]MER@Y4"D#*YO!PXC@ZW;WC#JM8;#>+60H>.&0 M8L];UYN3N(RUXS>3?J4([(D8]\66J%C<7Q^085:;_@Z"X.ZI^OO";;*G)8*I MRPK(Q@OK2":[)D7G!/G9V7)2%X!^OEGE=\7;(`[%CP[VS"P5"&J. M!)`$:L:$1Z09O[`P;IMS4)L^K703@A4K;(I9UX]UNVFFK8;<2&P=Y,Q`8A%I MMV$-L!<0X4THSA/1.4%^?E8M5Q]2J8M(#_7."&;"$(:==9)91Y&BC4?C,`1Q M&1B#!G_32CDQ8"<(_J:8E(MIM.0/=L\XIL%)04I:J)%G@M=&R>M,/,7/U__YYWH-&JQ.Q83>0(LB@2T>)K/_KA_RG_M%O=TN(Y)" M1K2C`C`MH#6(O1,4N;A@UZ!AZ%0"/1&:.'V^6,WLER_D?]TG?T!E_Z5E%K2) M,\$A5$1KPV50,,'$>!L?=I%:>=`H_ME!E' MO%$&:VN"_V!5\")D,^J@0B)+L`P:>DXETY1`18GWYB&?S[\&-";K>3>S:G>/ MC#/-"9$82,Y(H*92RC7CI1S''3T;-D:=2K#)4.I^4+2IHS(M9J]G1,,?MH^& MAI^R+\5=/G=!F:QV%4[ZH%4&$;/(`X"U(@ZHX/IYUHR:$Q%W9NAX3^G2@EJG M0YF>`*]#V1FGV&Z2>08P%TP::(R0D%##>;O*2"?&%YTZ"?4R*0SC%]]H`DEG MD5JLM.*/Y5_EUKY^M\]5%ES.TFF:#`0N"=%DO5O2XF19C<=)=L=W;(`$>!-8$<>^&H=@`U,@5P MX^Q>OIB&5]_.5C?W>35;W%W7VTEV7:S*ZZ(>4)AW>7M8ZYSRS,P"12SQ]?UJ M1AI//8#MG&G`8!QQR_$0:4"P$VN>X_5-)@55D&K/'/7!@086.-HBI&&<\Y\\ ME#D>ZF0:<&LIT-R29J[!,XO3* MSZK62FYV=[]:WI;5RW!OS(_[HLH?7PY?O0_S1U$][.+5"8_,)%&(T5IM2HN\ M%4`RUOKZB(TDH#L>:@V']>GFT-LB6MY^FI<_\[E]_Q=3+E?=S)\#S\@H,0DF04LC7AT65`AIXUUIH)+(L0?H@])CXD1K4*%JXV]MB4L_R6QD46;T? M,"NGU\5_UK.JF/XH=7%35$_%U)=5K=IFBY?`_??;-G2_BS.G/C?S5%GEM+(2 M:.N!-H"!=HFV/*Z^5/J#VN,AU,"(Q[$MC&;U_+58W9?3SXNG0/L&HY>4G(V? M=O*J\Q,RS.K*$;`^U@(%P`HPW,['.AE9F/,7WDON#=LAXKM-E:*<7],YNMI4+=J\OH]?%X$#V%2+)?U^KLG#GS"4S,I`0#"`Z>)UQ)89F4; M9@'>1]YS]&MN30^/]P8GTU[,NO?VSRU+[I_K/_%*5V>E MU!4PK#T<".P'R8N__E,Z*RW1.%B/7#M@+&Y0U9I$AE?'??UG1QH-*"OV* M`JF,`!H10P@"0L)FE#4FX\C)[`'U#A7ZCX(F3H`I*_1C2KD@RB""*00*$D11 M,UZ/(R\W.6.UQ#A1IL(G;L\LMD)_X)IGF@<+F/X_>5?6W3:NI/]1'^S+(]:Y M.2<=YSB9><51;#K6C"UYM"3M^^L'E$1ZDT@:!"DZTP_IV"%(U/<5@*I"H0"8 MBD)[0&I94PMLG+$$8A)W/5%)8BQ#A7X+G`(>11^%0LH=HYBKJI<$^;3ME#/> MC)'$70YHD@CL4*'[>?_ M?(@"+S95=DE3IL^11T.Y=8>@)S*N!MA:YI7A=02=)%[2]E$2>]ZW>9`)PSPG M+9MX/OIP0,Y'.4FT`)!DS&$6EYE#+RW3*LUA_"@9-PE,YT`Q+210;ANO=X596:1PFF'\4?)E$OC/BV>:17V_C*O4 MOV?[$S-?5\7#;'[][,*S9TD4)\WM[J\(DB!(RSM>I"9`S_G/^X*M5X7F_678E,G8_W'_Z4T'$DD:5+\X"9 M0)3*.$-BYH1$.LZ=E=0B6*UOYP]?B]55>93X9U,* M7>=W!.^`@&5M.:@!@)0S"2L'/_KHB>5E/LK9RYRJU!_''U7@&'#LJ63` M(R$T$8*A"A&56I,B40H(UA,QWKZ?ZP3'$R4[-SVV`$,91;I!0SQBC! MN365O)0(/KU,W6P,=M"('%C]^3HROFZ_K@Z18!.L&]\XH2!;GP3D0GL4;")E8S&FP',"/^RR'P&6.(7\15=%9:_I^+ MV;I87SZ=H?Q2-!UW;6P7C++0$D0XD9A+QJ%0'#J.N;)`"918`V1$/>AO:.8$ M:,RY/KJ%/PY'_B^+J^7/Q?S?Q?6GZ]C]^ISL=D4J_7%C8GJ.M]<;#?KLD1D M>=+_%/]=FP:-E1-4E*!Y!!A62JJ]M)((3":223_HO)$9HS$TXML\SFHW\ZO9 M8O-M^_!P]_@4U[PL2B1CY_^.?]YO[_V45$0LR%E!@Y M9.4>(4\0EQ.YL738&-M8Z(VA7X?ZD-6Z^/@4*'_L$I?NTCP(P@1R1`.JF-76 M$FH.Y;*)(1"VFLNC2]X6CVYK&H1RBF+!K11,:J105*?:$:*)IP4SQY_S4O?Z MSI2\"$TV[GR0\V)5UA2;7Q4M0>=CCX?2-8*<&"ZA42CZS%K57C@4H]W<\JZ( M6BDH]S**<;3NY' MUW'NLP'TYRG"Y&+&$^$_5Z!XMB@Z!(?KIP*/\@@A?70;--'<6@=DU2\OP40* M/&3$]TT@.!6+)([>5L>O#ASHQ_I7A[M;KIOJ-;W[1:$L`JJUT;CT#("RW+-# MH72BRT-I(T7=SKM(CX)==LWX,KLO+F[>=*VY8$_R"P,T7&%%'*662>,A5*J6 M5AGCIK>8#TUK5^T9`M<_79LF8Q'\&4J407E>]^FB6B$_W7R?K7X6FZI+NKA9 MKHIO#\75_&9>7'^/$+=4<.C]YL`)8UQS+:5!"%F%(AJ5/^\C^-,P6,8BN>D, MX^#@9E&N[[^7K_NG;C;%JH=6O>.5`5K%C0!O,ZC0< MJOWTZ*+-XWG[9``1!RHD1L9K$A'!"L.J?QI,Y7CL65E/!:L?F5').I)9/QDL MT4Y#@J5Q@AL&,$"TZI]C*"VG:9@"6^2J4%Y(Y&*US3+`@'@M`:W\/<82F%^GKP<,Q)GOA\#$YG4R\[3Q4CD_A(9.J ME<07SP6JE)(6`6>%X56V"A0;9T[,;%D]RP\]I!_E!3EIPQZ/YNO_FMVMRWL?%UF96U7 M34ESS0T#\<`S1R!T'%A&M14*UUO05J:5G1AZ*WV8Y+FL2"5Y.$]WLNX^OK_Q M^;4/<,KGZ=0X&(B-EYYI@H2&"*FGC9_RKKRT&7JPD3T(WX.AE8_S+\7FVRSV MY>]B5NK>KK#?[C[5=Y%_\BV!:T:!CC.9U51@BHYJ.'6NRZM@Z/:&06]$R!VFT&`3>676.=)6KQKL",C8Q/>$Z[A MEO>F0IB=7Q`H%%H:3A13F'+HF6"5(V*E<6E%LP6Q MCCU?ZI$#)'J-1.)H(0J!2K=S)QO2+/$RGLQGD#(P\_IP7@8L!CAM='(B'O#& M66L]%MX!!8R,D%D('*T@)):/%'0`+I;#H93$ M\)?98O-4^ZJ9U6//!AL7,0$]SHU, MOW,Z?KO9KHJGTMNGJ#S9((BHO<\&2 MZ;#5NF6#Z72+(!#3#F#`/">48LBXKBG!^T\(PS MR&.FHM$H`8/:(_:$H@2X-?@XNN2]"\\H33Q'D#B&5728"8"P7D(E)FGY$N(9IPC%GT9HT)/+WB4AZ[.A4?2`/KS%&$R4:2) M\9_!_KTL?MW-[^?7AZW_YHC"T8>#*(L**L\Y=$HB;B!3L.JE@7RT(@%]R]!T M1GN9&9)$Q^5^=O>XWG0B[NC#P1AL.(2:\6B>:R:TA.1)864:<4,GP>4B+@1Z.D]HX&?O#/"DO--8,/YFB:KP(>\84AO=:USTQ&24O>5G6`W^6 MIM#%BSS=*!#@J8.<,PD@\T!QH\Q!0H(L.%-JP)L.MWF,QQL$1@63QG#ML372 M046QJ?F3=JR:DXU^8@YR7F=6YT!CLC[AYTC(SUVLWLS6;1[AVX<#D5XJ3+U0 M1GJH`.!:5*A::R:9,-"7T3>I]SU1&><(QO-.?H_?;;7\3S4)T@,BH`0:`1%M M)6Q)-)<.TL5!Y:?K`?:AJI'UWNC\:3HP.>=O"M3GR`VYG=]=KZ+,?Q?7\ZO9 MG8F+1+$RR]7#86_'DY\=C;^&MX1N"!`$H^H!]9JQQ5!E==%.+(3 MV\8>W#+,!]5$5&5_J+2?JNS?$1STJDQ']P2ZZ)M;K8"KY/<@L4;U8#&+\ZA* M$E1G2.7_>[;8WLRN-MM5_)6?7>TB!E4!Q!]WAXDX[;[L4\5SCGWRLGAX_=$F M]SWM14%B3)%"1#`;I_EH)B`#@/`:4PDX;S^+DEG"4Z[[^U\2K+"::><0+_,T MK-?`N$HRC^Q8=>./NO-#D[4<";7Q3@41;G*4J+,1X2FSFQ6ZRLG5&?P@W;6Q"D' MI^I+\F<7Z^7=_'JV*:[U[*X\M/+MMB@V8W_NZVP51;\M-F4<;/AO?]O$/W=@ M7]R8V?K6WRU_CR#RB\\N[Q]6Q6VY>OTJ;ZE?WA=G[\`963@'`M\VRZO_N5W> MQ==T81,IVHK[K4%%4X_7!@5'G@J1<6>4HL5$SLLXDPX,3SUB*N M`TO56B#@Q8.!8B2U109*`0`W2@(-#M(PBZ>Q^=^'A-V->_[-[8+,IIH7GD.N2C_9IT3L@('1+-]2O&"OOR>4I,,P(QAQ;[J M9NOV[]'G@P*26RVHP`AIY;1A5E=R08\G>%M99KZ6PZ'TYVC!9$(-4R1_?-+W M1F1K*=WGCP6JL6'"*"445)1BPJ"I,:&)=>@'V^'MR<3K_/YT(,:)1]S?+Q<[ M4[F5TS?/!B6I%EI((@B`@",&A:KD042.=F=PQ_3D)"K>1!GZ@3`&J=]7NZJ= MC]UH/?)TP!HZX86@E$M!'95.5>APJ41:.N9PAP-R$-L?AC&H?2I[\'4VO_ZT M,+.'^69VUTIR8[N`)=>$RNC(8*FQ]XBK:G+C1B?>,#Q<*=P<=.<$9`SB+\M$ MB$5Q[6:KQ7SQ<]U^L\31!N6EIP@`(#!W')2."J*^DHS#Q**8PY7`S4%U%B1& M&=Q75]O[[5T9R+K8W):Y@F]B>.T#O>L[`I-68VZ)8Q9P*Q%FE%;R:PE(DB8, M5QLWRZ`?")PQE./+R)F\=4_/Y6YI,6ZW1!O:A8<1\;%-8T:33!194'9 M.JP%N4FKASW8,I_7,,\(S!CT1^TL#93"%OO_?UJ\C6]?1EG\%_[I< M[2C9[&MGE>'+[\OC8Z(QHIOC`P$`""V1+DZS##M%H?6L0LY&CJ:E8H/IQ9NH M\!G`':E^Q,U\4V8K-T60ZH<"4DB@N`9#(A'5GE-F:@`A8Q-+^QY+/9(!2DHP M.V4OE=__4FPN;K[/_MG?$/)6_H/2GG"Y3N6G#??%@(6'7C@EJ;%6.L:@X+5[ M!V#:!4"#^;M#*]2TT$[2SI?!FUE927!WU\'WK1^UW-U%0&*8\,L2X=T%_*V!./WORS$!=P`)P5CE`KJD66, MU`X%]6D'=K-?(C^IJ2@'D.=6K=W86.]X:T[RZO:*``5PRN&XM$.-@$<`X2I9 MBF,GTXQP\2>K40_XQMF;_._MOG;W^OORA#.P&PD_7H^$RV(O6'&H[;:7^;*X M6O[<,[P3OW%[<]A/!ZT1=(X:J2@&4C*#GYFC1J>=N)`?75DG!OM4E#RZRN[F MIKC:^,C,NU?D3%\(5$!'X@1!%8#>(B.4KC;)!&4@\1YZ\/]!9_/#>[X=P@K7 M4A2]7<\715E"XO['?-&FB$GO"YYJ#A!GB&JFH"74NRK:(PA)O&,&?OA@_AA@ M#G5ZS18_7J47YSJ[4[XYK<1'GB%3?K^\V6FU[7I"YT2+P+TA/OZ'$0-&*[Y+ M_><\:H@F0J'6T-\8\K6=U3GR=.`&RNCS:J]LG.JB/`2P2BY@U"1N=>C-R3(W M#I,]NO-2M);S.F\?#HA9RRT'!F'#G194H1H&9DE:QLC`AW1ZT=FH&@F0C&$( MO.SDE]E]>X'&4TT")<(0+J@#90JLM,I:40,EE9GN(9T^5#6RWAN=/TT'QN>^ MY8C.%*C/L*OYK5C,EZLORTVQ1G\1&GWDJS+O;5O$1VES@4. MNDH"A1.KZPZ6.#,8PYGPZ3^&\,X>--`^7*>"N!)!I!#*3'NI[6)()I M2=R#9;(,.(:SX-.78?R7?#&5(-"9X5--`S!0:4!)7+:PAY(A&:>D@P20X[3D MM\%R2@9C.!,^_1E&+[N!WL'P\:8!*1Y[ZC'E1EIG'02JAL9BFS9+#Y;:,2## M6?#IRS#Y"[R82A#NS/"IIH$:!5CT-Z4TDGAL$8[6Q/^1=V7-;>/8^A^EL"^/ M6'MF*C=..>D[-4\HM4T[NF-+*4E.=^;77]`6Z54B"8(0XYF'*7=,T#C?=XAS M`)QE+P%A+&V5GBS\8C*&,^$SEF'Z@3^;!NF_2A\:&@R!1E-*C%+*`>KZUVUN:UQJ+MT=+6;>N/Q`#FX[^I!L3)(UEG^JMWZ26?2/N;A M6^.3'61G`.445'=W&GIS0.`":E.CQ&CT+"2$$+7V!YHYUYH:1U0'ZZ/0>4_\ MS^X(>PZTGR#^]-$6=6:VOWHVR.A\>,"BD?)4`H.I$:VE8E*4NJONW1YF'"DO M`T='PE'F4FJS_+'8W2>7-6;L?+G]=^<]].%A00%((U3`:V:1MHYRT.)%HP]4 MZ`3TA#?2V<`IJP)-O>Y>R_JQ8<$9S3"ECC@GC4/$(0D;*3UR;+[&/0]Y!S4B M&U;O53-F9_;GIQ#E%:$)CJR[?7_Y<_&]TQ-X>T#@A/):+HDL5TPB4&?7-.?& M`)6*5>J]J<]!TJL2)AF023JHV;:,'LK[ZO-CN MZADU"^*7:K=[")@]O#M,>D_`/`KDO?)"VVBZO'W)P.LXFWAX0,)"60*PX MC184`F&9:EUU9DW:J<3PJ)V3G4ID@>4TA'?N.`\-"4K7C3^IL,[5($D0C64C MG8O+Y7S/(<;2UFQ[,[M1A+O2?XM#I88[5I=KNI_VX!'8>//08'2Q0 M6B(/!!$`*JB$8VU\HG8VK5K*9#O0\=2].GO*#5&I:\>O^[L9]GAULU&6A+_=1:XOK_EG0QUX2H#*80JXH M]U(PX##F[0TK`33MPGFR8X.LFC`92J6_>K]8;KK*"[WY?/`.19LHD-,,*6*T MA8^';PS(F37)F7*!3\6D_)K@%Q>5NJT[A/=>`1Z'!.@TA-Y`YIB`!@OD5?NQ M")[8%JE0MM5XQC/!DG08^&*YV6[OZN[2GS?+.(GMXUIS=O5YU:A_*T M.@Z-L*9.DH/MU0RS,JUU:J&\LJS&IS"2)=:@WU>;:G&S_$]U6=^EU8T6SE9/ M-U)FL?WF;]9_UL=FU?;SIMHM_NK1P:RCK\J$?S6`Z/99;"4!S`F,M%"FC4]W MBJ?MAPMER(U?Z^:#;'_MW587'Z[7/R*$/^(L'W3WX>>76OOPKT\NDC^M'RIG M'EP/.T8$Y)QGQD,<743K;?P<62L3%B!M;2N4=)>N+7E1*1R8&S7XO+JHXH^7 M9ZM[/>X7F?MZ7-!2QITBXU@X"I4U#O-'GU#CQ+9RDY6GS>\8Y0.GY#;J<6FS MRVU=Q7"YNKN_)SJ[:D^!NA5CX+N"H!`#$[\,QXFPE`C]F(.JF$T\;0[4EZ?] M^7Q`7F!/@!2>*F6,0]ZZ1Z.9>*)8ONIK;WK6^4$I0G9T]Y?U)>OR9KG[V6'( M7S\*QJ3GW)!%52\-'^;W^Z MJV$XN_H:O::ZT=_WQ>KGWQ;;\^7UM]W7==,-\/FT#T4:C7AED!XPJZP"Q%K@ MO258FD9B8M$O$M,Z5#D*PY:D*$,4]\O='_]77<3IFFJSBT":]>KR8'_NC&\/ M7GGOE6-"<^F)U=#"]H/QTJ==QQ:/>$U2GY,@>"H;]1"2JKZX'& MZ=7X(+7$VC,B:?3;HL@.ZM9'I_&K^C6B87-:I;$837EW?W\$=Z@SZ^C6KZ\K MW6W5ZG*?)*PNXJ_B6T_^YT_;GK:9Y,=>H0NOG@Y1.Z.E(IH!ZSW$6,4-%!(^ M;I&ATJJ[Q]O44.U-W8%9):(]'`H:DJ=7,Y\)8CD=)^)7:&0?++E5:A M+!I&";QA)+K>VG!N]]()$N6>[VW'6+IZUUA)0NB]Z<'L;C_F0O\I(E6F+K&# ML2%*`$VT!='_AE%RVLC,/)I9D=?QU"64V!D&40FU^!0WP^W$.]7@C:>#X()Z M`@3D"B&DJ3.6-#(II6=6?R$[[>,A*4'SLP2H?57(006]GP\*`C!E#;%8>@J= MM775@49")Q+CE2<[ULY.>C9DRB8.Y6OW02,XB#+!J:JOCZ$#II52(3[3N*8\ M'G]&8`KGC65KZ``UTAZ9^/5P@ZS%PNOVNW'$J/GZ_WG(&]+9(0VK]ZH9L]L1 MS$\ARBN"7V^J:!G=7Q?WJ?S[RO2=_L&Q84$JK(4`AD7@H(TKJS.JD5)26JSZ M:H;"W+T)6T^&3](E9D>'@8[J_?U&!\A972A4.L=4W-4XIQ%HY(@XI?%\FIK] M0WF>#J8IZ"[5ZX5KRK535COL"<6((>(;2:W5,_GP)^$N1^.78?!-KRA3-7ZA M1A!KXTKG.%*>6L)@"RJA*"U^-ONZ,2\U246OA`_QM8[4N=O\_+B^^'>GY_#Z MX:"1(0!Q!+3ETC!LJ&./]I#-+E!N`G]A-"JE3Y+&M(6S#$.NM8Y>D)3.4F94 M*QD6/.T$:<+8MPGXSH),D0#Z^RJ"%YWY;T\>"P93Q9R#WC`)C24"ZM:."54L M\/4D)T0C@.A/9U,SZF+_QVHZ4?M?-97H"97-OP=U<[.?7AU5C),W@/;LSO1.1W)ISV37NQY0'_%X&#Y)V?L-_WY&&/QU\$J;JWU3E"@"8"4 M2MIX]I)JG)90FG]?-`ECP^6?G#&CCGYC\==!(0:4QS)NNZ"&$FI)FI,\61?? MGL?.91K&ALL_.6/N]_-CC,5?!\B\P$I*0(D%W&D-'V=,-4]+Z\R^]YB&L>'R M3\[8/S[_ZQAC\==!$TL),`XXQI1'FJHV<%=R*&=2W'T:QH;+7^;R<%R),PP0 M1=#%+14"Q#MK-7&M9:8@[?QO\M:I'"2P MD0Y@">:[8QQ#5=\:5VGHO#<=F-T^<@[49[CM^5*MENO-I_6NVJ(/A.Z+\]N[ M*CY*CU_M]!@:ZD1M[[@&)GI^U%$(H6TMDX9IX9_E"YGU)F(]*3YC&<8?T+-I M(-2;X4-#0Y1>4ZJ%(M(3X3PE@C<22(#26J<4*GF1D>%,^(QE&'Z0X)FB\=X, M'QH:`*$6"L$,Q00RYIQM#\FDAB#-NRY4I"(CPYGP&;]*X^?3$`-6Z;>'!J^A M=81&$T6AUE8!P%L)#/5I9Q2%*DUD7:6SX#-^E9;/EQ(P8)5^>VB(.WGEB&'& M<\4,X5(JU$A09Z[/8X=<8)7.@L]8ALD'\$S1$.[-\*&A`4%+N9:,*0<=U9I: MTTH@46+WA4)%&S(RG`F?$MNGL^_5ZNR^T5H3-;#]YV:YVU6K.GJ@X\RD>W!@ M=:UE29R-\CD(%*6HE3BN8J4*P)SD#"4[/*=7B,Z]=9_AP3&@M+(NBFDE-MR` M-@Q-,J[=?,]:S.Y^9N[J45Y//=[N'67<&Y;UX,A@"?80$ M**^U,EQ0`TQK.YDKU7^FIV^1EYYU3FB*A.,M;FYZ\OSRT>@D>4,))M)93Z.S MA*AKO2^K9*G$S3D0/1*;$DQ_7*^N=]7F]KX*6+?+^-;C`;B(CJ%"2@N0Q,`J MWX23*LP2>PD-WS:#0H0QRAG04%-=WS6`MM8D=I+-UQBG$7*`U5%H_,K\ MSL[8GH+6T_A2G5;U\:&@G48$,!7-#O`882!I$PNK&&0S251M/7\C&2182PJP:F7@4J59S\D.-3)QF`Y`$1+O;F\7FY]G M5V]7^/YC>W^:_3<%[5D"WC0G1?XV`7)=D7S&D2^!X%V\(CFI+TON`(%W6#(D`8B=ZJ M=$:VGTP=YS,OQ?5=P91D86-P_M M'-Y0FHX101&&C8PVD0M&E7!.`=&:0\K2U&(R4S*16N0%J4R@>C-5]:/:+*ZK M5ZI\;`7I,3H8IQS`QA,//!32&N%:A]DPDY8&7:#.U7A#DQ^=LAKQY(OXN-YN MSZN+]?5J^9_J\N^KL]VW:E.WG=I4W^I=5/WPQ?JV#)]C.OJT;+AV]\B M#34(GZICOO+H=P=/I:@[KV./C#3(06::JT\E$2R5C3<7O9L0N_)I6WYQ41WT MA[J&!!NWDPYPI>/ZSBF/_H-IS]>92FQX.F%<<4[-R`))><*?U97:U2J\CY>- MMKNW"AQ[25!U\U_F*'`<00J$$$:WD(K$Y6+"4.2IE"(C2&5MD%ELOT7#6L4? M+\]6]?K6K_W7&^.",XQYAY%7\KYLAX>@";+3T2=,BQT;?G=U4MLQ'I<2_#?J MZO[Z'KVG8XR_>#)@X$44@BG!`#=.UHD/C2Q>^[1+9_$K<#P.B2>L9FX+.:QO MXHOTEN*-$[=^L=S\[^+F;F`+Q3?&!8"XYI8+!`U2)D(/`3/48*81T,QV'M%, M(VL[T>V3V>O%S6)U47WY5E6[C_5$(L_ZR2':TV*2^N?K-B5=?1FG^Z/!:XX% M]P@`ZBVQ3F"!'U"&/JY?:8&BD[5X'*4G+\NVSP74Q7OO&PFXY)`3*!301"GG M$?8M'-%;*J1C@Z)>YJ`=_5I0#D.WA/^1L_6@@]`29@S`Q-,(&4&&/8+%?KT6 ME+WIZMN#,`VA]Z8'LPO#F0O]I]A^3MV"$CH`.'9*6>,58HHI"AN9M07%:M6. M;$O7F[J$%I3#("JA%N-;4"I@HW]'-)#*.""Y=APT,MG4N/?)[N:RTSX>DE-= M@(QM0^BC\L8-.+*.6^FI!Y;:1DJ!2:G;^E_=@%CS&Q]ZYA%%`@F/>:, M<(AY7"8;*8T7>K[N9![RAC2P2\/JO6K&[!S,^2E$>468HJ-AM,W6=IL=A*O-9D"G!^=@^9!PHC)75(OI+<6D4!+AV?R118B;>:?J0I7(]&I42 M/+_E,7=L)0X-"5I2PG7]_]:#N#/V$;A&.H42SZ$G[E4UPVU$)GQ/I3V=;N+A M0<%%V92"5GF#G.:*6R6;NR:BL)SO]F$\:3VT8!1*[U$?9K=IF),:E*?_(:[X M/L=EI[;;:M==F.'0D""Q9M0@4K?YP)B+:#/;:V>NX,RV"3EH>ED\+0\RI7G_ MN%S\L;RY#YH91/ZK<8%8#5&=#86IYBQNB@1OY12*SJ2U<2$-&`M/,37XM%Y= M#%\!WAX5N#9.<TE5PJ"33QM)$1,)]V,#W9+F(J%<@"S@D48/!2<&1HT!A( M!*(W+04G!%O$4:ON2,^M]/KTJC`6H<+IA/>*^V3.:M?NO#Y5._WS*6#F9K'= M+J^6>_>I.\D]Z]\)6&'FC)+<40.8Q$8;T@:\173GY7E,$[QW2D3+:F8KS-/L MWWNA>RG%!B;H5@N'*>*XAX(A[W'Z/+K%U=P$]*LKX0;W+!FQ9=6I@^]G. M_[?->KOMKU#'7A`L0W5RL$:BCCDQJB[)W$CNG)A=#Z%YJ51&:&>P1K72I*]3 M[2N"A909:26,&PI`ZXLG@]K-A&-I5%I6:\%\J'GH589H9U+`M6+N,CB"51OY)Y_')1)=>P% M@4@+=/P?8O;_R;O2YK9Q+?N/IK`O'[&^EZIT[$I2-36?6'HR':N>+>5IR;3G MUP\@B;3L6!L$@I335=UQW"2!>^XA>"_N`FC"9X10MVV7`"CUQ\_F[$'Z-GSU MM7Y<\W?Q,/FIGS?](-:UN/'R]X)@K[-BCI58E9M$Q6,K.*D=(0)9+3TT8MOX M&&#,4*D34D\LN@`?B\IQFH7=< MBS5$MIQ6FW4>VM=6DP-%,!2%XY8ZPQ`);W[3DQL0QH49;C3\4G6=6IR3AM!' MX\'@HN!#47\?CE77M5G&>QB63![^!<9()8*UW\AL+1Y87/QRU2749IT'T774 M9D'H8'AE*`E_8((\`HXV,CDCTAKTEJ_-2E7[Y9"43I1N<@3/2I9^?5-%I=;" M!^,_!O*DU$@A_+)@RK289V>[\@T M&JZ+TK5"W[=ALT'X\:@R."_F:AA2GAFQ3Y]_G/WO=LXGG)_ZSO659L$B8%1X MH(PT6F-D6Z0L(Z5Z8YUGWERBG]].3KTT&ORP8]7WGGM!A(P^JC,N,J3,Y^"7$. M$6)VR%J]L9GO6KGQ-]6VO4%8$N?+]7;MFQ+X]>DGT["2_D\]FOLPS;WVQ26/ MJS2@&E'GHAD%PZI*V$^:B2WUQ9 M8>`81,HJS@TBUDG1'*8(*+0NK6*TP#D[&35\&21EENYW?>0CVPL'[JJ8T!`[ M9ZS@1&('PXK5N,]4`YFVM73^B_W1=A?R0=XCK8[ZD`?OB_OYQB@L&2)0Q9I: MZYOM.1K[M`UW>R&+]DYCQ$58?5QN#&Z#87B4*$^%;Z/'$QH2[%Q5*1^^P);C M8!=1X"UE#+?(4`('U@\]DS[>GI.>C$>QSA,;P4]K-;%[;44%QY(&(+P37@LM M(-&-/`ZIM'W"SIS_;O1[*2HE7?[M(6(G>_ROKJ^H)\$8QI0JX!2G5B!O7MS: MQ-,-.G/XN]%V#F2*.(*SQ>0$UV#WLDHH:34$E@J+M2+&ZA?>FN`%%7(!/YHO M<`'&)9ERU*)[?6$EB3?62BR0-@2&_U(D&TF()WZXYGV:0O9H]2(TKEF_@S/1 M^U!K#T;XPVQ^/#=^YZHJR"T(P(@#SUSL741E*X,F*&V?OC,C/%4!;ZWN9``* MMY'X5<]'/^JO=90VIC:MHXG+9WA`N2?<707_PH1_O-%880RQI["U;X0=6HI@ ML:KN7(#U7ACQM1[/?DPG_U???9INVEW.GG[.ZX>X5L8;HH7C[N_KV$>BO@WO M0M#DEQ,[*>4;KD(>&2>5@RYF_EEOE&^WT`.\:2Y#@>AP^>8"91`>`F^W75_J M.Q\4H,;CU=/J,5:GW9A/P;N:=<'=U"$KC@E0VOMXL@220".JVD@N5#@MNZ%` MC+L7_A9">0@<;E_5C5"?IO4;L=3T3CW-5M.E^WO\N+K;8-+*/JT7B^_U(J83 M95J4<\RC(L)P0;F70@'*@X^+9)-!SP0@@XWR][M:]P!]P62Q31OM\?-NS47= MP/!]INO=%]^N,^&^U'\O(?IK-ET^'-I[RC-`A:RAUF.I).,X?/TP?$%.4YW6 MY*%`XD(GI.T%TQ)L;"9_,WTET\Y;%U^HPXOIR<^H$(I)/<8R[PD#0K#@?S;R M&PC34E[9E7*J*]A*TB8NO=&@GDTC-KL+;!52XMND.FL#N\7CE$93[`T MP$CLO)!">PB:XCT&L$BK0Q-72LR^8+T*6G9)QPH%*QEJ[T#`2EH%F6*NP]^V%/E'0VWRVD5=N]-<(*8Q1]@!+K!Q`5P)N->&"&U+Q9<3LTW.5.\Y MQ>?G`7.M)<9$&H:,"U@)'*QO9&*$=B.ELM*ZX::/Y%'>.;7&:5A]5&8,+O%D M>(3H;;N*NBP@D@N74*FN"=4X^!"3)*ZRD@&@^L?6L)#EP`SS55EP<2>\0I14PP MH:@&U(AH6FD>O&#GTLS#?JK+4Q6?!9G>H^4%6[AZ1+7`!'+)$'=A"?0^`LT4 M(5@CDQ:V*=;"-;]+D1VR$F3*VSS38:Z85:["[Q@D0\HS(T^?5:6=QQQZR0C0WE)$B8]R&4`A4GY@L88, M^CFIS^IYJ!2IB1@_U'>KQ_KF_LLLBCYZW"1>+6[N;U;+Q7(TO5OWUV]>EZ;& M8!,K^%[_O=1A8O\^P(],(U1:>.,,0=H`@2T4A*MMQQCHG-`#*XC.N3/>#X)E MV??&4VM<@45;:A@NF4Q'T_%D]-C(ET#!RX>IL`/.4`<$=))YS"0W+8H`VK25 MK8!;G9.'Q6$L2\9WK8-/TT/2M7V6S^-CEI$J);2BE@@I'6(FO-Z$N`9+J'!: M'F&YR!E^>/505M.L>@ME@XS(2VC)H& M3R1,6D"B0%I\Y\SL',NRW%R77;T(>CQ+II5Z\;[8:GKWV_OZ>=MM(.&[W^/\ M*FRILIQX(Y3"T+#@-X)&;P([/=0L^YSOP/7@WUD2UFR\EBQ,W$V7D^7SI^E: MEN7.%N>;C*MF&HDCNM$\UNDN`FK?'D;SNLPHVT/7>TDB4P'8N\GC*E+L6SV. MY<(0\Q!$A)$#PS%*OLO7*. M'OTR=KVB7RCHL6RWO`-5U!B'E2#`$@2YEA8XN$634@L&>KL78Y[P'RP M"7K?5O]:U/]9A:'%P87!!M.!3H7?7'NTJ]=WV%E8':"^(PEH!H!1S'42ZNK'=>%6L4 M=IIKF$$_AS6>A$I?63J7)O$3;:`W+MAR`B#*"+5""`DDD9K'-50"CC`%OIC5F"'9]V2U'#E\YCQ(#JMWS_F"%W[^ MU/1NLR,^6<2]D-6\7AQH2-#QB)4G3C"/@JUF/18>(,SBV5N6(0LE\6Q8%.IM M&VU8:BBQ*ETJ[#I+J;O-],WS*P*E5\H3PL.70EH%!+0M;CCQ,+WL]!T,>V;] MZZ"(@[Z>.DO.T!U0,>"R)\\'- MM0)9"3T`6\F1IB+M\+?LZ6!#95\G()>@5W.DX5J`-3P+-?[/:C*/$=6]G#IP M5Z6,IDH$O]="#QU30FO1R"CU4)*XADJD?,@69T\SSVV#;3-;+-^&[(]1Z<`C MJH@?!MX+2Z%@1@L&?2N]0&FAT>PI6%?!JWPP)SD=K9]S.Z^?)JNG?:["V^LJ M8Q&U0F,M9'"$L&*0NV9N'JNT2N#L&4A#HT`.+"_3\V(GO?^HLG\,&Q M<88`!+RQ)'C"P;?1P;=QB/BT=L39NW`.6^,7`'KZ-V11C__KQ^Q70.Y7O5AN MOB";G]]^.S:_W=E!>5T,\@X_CMQ104X<9$`1#,*JQ1V(IX0@+X2SD@*9]F7( MWB]S:"3)BVK97>;;^61>3?V]^>=)N\_[;*P=`,*J@@Q(8'=Q` MJL/K@KQQ@!E&15HD,WN+RZ%QJ4.(>_"QM^VP`U"3V=W&!C_=OW[GY@I@K$&L MO`R?6J^L?LXFA8(M ME3Q1:>6)'54M7!6-9U>EV")AC[T3/IKR=NS6BE/%O.9&4FN9=QQ+V4JKA"?# M2X@QD*ZT<%'9]Y@$B[_/,+UL=?Z^V0/8_KU-SR/YH#F&Z323F`,.+5* M",>#1:D9:Q!$#`PD>2H_(7[;@.T)T:0`X>?9],?W>O[T:3H.X\==X^!2[V7- ML5L":!!9)A@'$@.!H0$Q@6LS8ZQ(6@IQ9QVMLG,@,S[Y-!HNHPE:?;FMHA98 MZ0"FG#F)*&%`1R@(,H($1S$M#-Q-:F06!1S5:#(V6;5*TK1*FBZ2@ADJ5&Q> M3AF7$BJM&S@$IFD>6S6%,A3S5H9@IT\%L'_2CRO(J_&OT]^1I]714B:^NJRQB2'E-A*<(66N\]*!=H+PK5G9[ MFA.5I(%9/OF+Z#'@>9(>=Z^K,'(:!`0P($QQ&$]DAXT0P\59!0Q%]\=3GF[ZTA,8NO^;LHH![@B78IG%USY MLHH8A@_KR]S,\_@QV8;?^[Q*8134`N9,+ MURXX]-^3Y<.GZ=WDU^1NM3Z4HC7==F;[U[IO0'VW#H#<3,."^0^E;K_4RT_3 M\>PIU6S*,71%E-?.`F=U@I9HZ3BK5DK0)JCT$U=Z,KN;O9?\6GT-%J<=*("@=XMI[:[5MO7O*<&(WCEM1:*$,X0MDY;Y*&C&Q1B8]74QJ!_3-BC$Y3[ MWZ2Y<%]FNVU@9;1[*!5`0XX)9(:I1FKE:>+1!Q\BFM$ACAUOOZS7U9?$O=DR M_A!6X_6+]V[5'+ZKH@0B&3[>82CG,0@K*\+-O!T@:=UDX,>) M+V2%+]M"L^E4LYW(USK(/1G'WY^_TWOX29563CFHJ2%6Q963BO#UW$[MSO&P\/K8Y_7OK%#SMY^Y^<,8$^3T]MYZ,6BWH] MP\;8F-2+QG.*3E.,_,3V/=,8!IHW?PT?CTP M=,P(:F5LQ'KLM1TNEL>.4,TV1N6$A%!BS[CE&%"NC&-;#`5'B8T@,Y^>VA-K M9L/`O(-N*'F(KE>+`.IBTVQ[Z##K`LT2FPKOS7333_OX@5='[ZT0PYXXBXA#BA%(`+&@D1=* M.\#V']DT>`(CCU^9Z6U(=2K(`-Q7AE.%&Z9#A!/JZKJK!JG(_UFQZG$ M4MZ:1OIYQ[_U\_5QO^/G(T;B"7=7`E,*XW+G!#0<0>&D:&3V6@_R`-W^#<;\ MR!9ETWMS/FH:G'!WY2D60`F+!'6"`F\,:#Q"(;0WPS4@LVIT'UNR(_=GL&9P M)N70R3(,DBS:!?AH]?`IMU>$6<0$%M$2\\0ZCZ%^6:Q5J0VV$\V8K'H\@2,7 MPE78FFE__.WT5(^E3M?4ZEB)04>N$%!YHX+;Q2S>8W=T!=A:F31=&G+$Z9 M8?QS:35D6VCX;"K/(K=83IY&R_KFOIUT^\/+*3%'#:1S'E,AAZ3"0F!/!3`! M!N)MBP*0`SN*_O_9N[;NMFUL_8_.P?WRB&M79K5-5MJ9><129<;6C"QF)#F- M^^L/J(BTXTBB!($@[3DO39L2$/:W/V!?`&P,I.&Z&(!%%Z-WJ\\/V\UN7L'S MW>H?6P6,!)<66B.QXU%.J'V;[)*0HHG5JRU#DGQXC<4)E,2)?:O@+7*@69T% MD,00%F-7U\JH()K(Z]GC;^OZ/Q6IWY-#4JVV,&G<%+Z*;%W7R\O3C9E<4[?VG]P_; MYJ[E9H_?[=T9F\=Y?BCHYOX044A1J)"V$ADF6R2MF%HQP&D(KK+.QAC)&2T4U`JC M=AM14L8GEA,8CBW#X%7$9:[7U>)V]>VN\_RQB0<:)'9#OVR-N;"GX!O#+2VP MG"EJ-014=_.&V<0=,@),Y&:D<,Q86#`1HUO4N*:`(&D1B,&#&7>64:8:0%4QMLT M/S5[4<@"?FHFA$HPX%D,EQ;FGM=!$(0*C*71E@"#*#(.MLN?!AQ.I$3[N+'N M(%".Z(ULNIHL65R2D]T%AS"@A#`!*86"82-5F[+2<>%-+)LS%,%RJ_H\YR0G M@DD>RE/>>O?C'Q>W=^>:GXO:!^T<=(8YR(@A4`MF>'N]1R,LTN[,#K;<#,2& M(2$;+R!^!M8U4?'A;@)6QE@5S30AW&#CO[TNY/#A;F#KF`#(79 ME0;D^XW/2UV-],Z"$!HH2"!"1%J.+'*\335K87#:2;S!PMXRIF4X_,:/@9)C MGP`$!PI;JA&74A`)&.LLJH<\+4$R6#P\L"W)BM4S5HQ5$6M?D.J%6_3_%:E. MG"H0'')`F(&:62^8=1;NC]9%;T'SWC(3T\6R7$4J0@")$P0RP*61U$EH3(NA M(Z34F8&"%:G.9LU@%:DNPWR6OR+5L7Q_6W_TE\4R>NGUJFK?$]>/W5^I^=VB M^E+='+F&E]91B#H0GC&`'&54:ZP)A2TDELM2;S./=!WO;$+4!4%.VS(Z,:A? M9_?5^T\_#.WHY:CK.@S("]B$"48T)\\4CG.[`Y5[":9W^6YHM9[+GB%P?>ML M*L^B(W?NW@:),I`G:_DKI0S@"BC!*"62626T;XM0*ZZ(<\8;A2R57O$NQ22\3]/K MB,4TD_2:#9_IWG\U=\V_OENI^_IAM=T]Z'*H2;=]!<\P"`./(`#-!><8*(HM MBUH$B+>'R0"@,/'UE:DEPNQ4,?5RSIK7NCLOM:>ID`ANQ MNPCWV,-`5SY0]%-5WT9[>+>8QQ^/@-T\S+?O5KO7X+;/0O>B/SKF2TC[9XXW M/DX.%W]RO9HM3:1.?5^M=Q.B7MW^O&ARE+LIBW^5UU\["LWG^Z4+"^+>3K.@[66HCB=&9:2.@15%#: M%BU:KG[8R7WCX:E0CXCI`/O"F2B[G6UW/_FT\,SZJK8>;1,D)]A#S(#@)CI$ MNHD86E",-9/<&2[%@Y?TRP1BB8#KMV]D?#[2WIS9T3;!4H:X!88@SJ5W&!K% MGA!#<+KYU`PZ>\F"S"B]/39,+G,Z)1*D*G]3S?_GMO[RO_,FV%T_?M/]_C]> MJGW_U^'OOQT*%KO_&8`CS@B)M17"<@B`$[X=:Y,RFE:N(@/F]940E)BK[F%= M?SZC&NVSSZ)#91EGC&@:)8?(,<5)1V-/TF[!#!:8YU-D!C#2LMG+Y?OM7;4V M.R+MT@DG4]F'/P]*20PP8`9'\@%J.;>\'2G`B8=#![N\E''^Y0.EQ(QLGB==<5V%<]3:?$(+A&G$EK^T"PAZ^WCA^5LM8VR M-_6(/C>$_[4Z=9_^5+.@-"%0`FNH<9QA1RSLI`3.3.P6?7$V9,1NJ,3F>C:BO1(/Z?"<]%YRGT$*9)2)(P4\.E&(;)=S+]WZ]EZXG07CH\X`\X0@P*0B0U$-$).\48ZPO M5:,C,3+F=&+B^Z\"`)A9Q3#RWD`%&8UR M=ZL<+^9FG!FN9,"WSH5%DH[^L;B9_34[K:'GWP2$I`2.MH)Q:I`EOQ]34 M/)U6.)E9/U<@D9;C^V,]^SI;'<_$'O@J.&& MI-FHP0H'9=98#DB2%/?[W6Q9]YJG[[\*0E)JJ/)"2:Z)(DJ+CE`8X+1=CL$J M^616U558).GH70R+;F9?3ZOHNX]"[,1H$7^?0&RYMI1ZVQE-RM.6O\$JZ&36 MT#50I%FHOV;S"-;-HM=(O?PPV,9L,L&98H1Q(KP0+$YQ;)@"3HFT4^K\E2CJ M6CB2E+7;ZVH%.:VN`Y\&Z(#UD#AHFGKDFCIE92NHLCYM7TF\$H5=#TB10S:S M9;79YY=^JNN;S>F-HT.?!\TUT$S39NL:6`4PEJ252DHVL0ALA)3O]:"5H,*. ML,_'>IH*ASX/SD/O4)0`*\PDL,CJ+@`UR$_L/;/R5,@`6I'#`_7C;+E]W(_Q MU!&"[SX,1`$B@(S$)M$PD1C5`BE6>C!(LGRZK\*KJF=&L'8PTA=AQFG M'C+&-7I*9SQ_F7T20>@(RDX#:MQ#`2\&4_Q0P!ZT7V;_JM=I1P!.]A"HUXA) M+C'2<S:NF?/Z.E(O-O_MV[`\W"(13++&A MUIH86\?0@!#92:=DJ;W/,[?<,VGJY>ML.:"9[`[Y=V!M>O;'?_PXQ%A1`&51 M7'@8$A1Y)T0+@REW>OJBW?%K-5IG1J6$(=X7Y7H^U-X]S:-M@L?15(D8W`-M MXM1!4=9./LS]!,L>YE!6/2P\;X\&D]O:GH3VE[I:AW]LI[4 MY^'/@U=06R6-1T93)206PG6R"S6Q<]H9$*^S@U)BTOY@K_2CKE;SN_O9^M\] M%KNO:3`(_SQRYW`ME5S MIA]1IZ`WGF!NE.%>MS)*Y-.JF5V^PS(Q_R\1GE$HT(SU;[KT6J;?)BM?@W(U*AA%(L,^*_##J7A>AIV4@ MT#2[)4)K#XT2PFK1X0<<+56(+=532-':2R9D16B4)>%#M+#Q+V:WU:D2P:>: M!80EX-[)YA0)D(03`&PGI463/9E5:&;0$2$5 MT,S8D9Z@/#[ROL,&/2T#+3=9B^OLJYO%]KF(/:'LT39!.N:9,=@!AK7WW%)I6U`8YZ5 M-C\F%^%.CQ;EZ?"QVE3Q=^YZ0]KO/PP&FZ8\7XS2K')$-XEBVDJBA"JV5W5> MY))-+S\<(;X"E!+J[7QZ];"]J]?-,P^G'8+##0(2S$#5O'("O;%<8\D[RVE5 MH@LY\+&&H;R!+!"-H_S>-?Y8D^!E7`6--]Y:J[%JLC&Z];WC9#'3-?[7JJM7 M^UVU]3\L@XLIIHWL$ M,`;44@T,@:VL0+"T$L.#&?_K57;HR89L\!2Y.GK4%":EE8)&V&-EF"`&$\(T ME5BT$D*OTW:Y!R/`.+FE"T%*.J-DJT_5.CJV#;F;\KF_UMN/U;R^72W^JFXN M4OHUW07E!'40`L<5,)I9"Z%O)75*3*R$U!!T*`C?4%L;/Z;_QRE`?#!6.R?U M?[IA\-YIJ0&3&`I*,?+0,A/C>F<`,U+^!]O%%QT9"P'E$M$FS/\ M\9]X+V5S&R/M_'GF7'\N19V3?$E!Y;\EP\\=L%)SBA02T4>1E,`6%`+,)#/\ M.71\?G+_(H!>=_)62("A:%.[&7%2E$]W?@^@_XNS.*F8?6V^3&Y MN']ZM'@]R7TAM*>^>1L#(<^%8`K0U@)3*B?VA%*0))<8H:UH92QY2O4+Q`_F120#EC^D/CBTIG#_84_`6<(:\ M`0X;B3CSROE6/J%(FD\X6"2?F0!E0"L0OP][#'$[6]TNX@]\>[!)K6Z:FGE_ M+IXBOF(_F'9,\.W,[W+V>;HL<,,O0:@.8RSD4>32H`#3GI$]K+C MZ)65VD$XF*884)/U6`A.-J7Q,8K9=]^N^R9H:J)P3$'$D=3(<>%<*[1FJ%2! ME+-2%D65_-)U342L2%#2C*T_(GGZ*C2EKBDD-(Z;L+B\0011.[VX\1.NH)"@ MAT.:O`J'UZG3R>43RJJRO`I_B7#>/]SW*O&[[P+V&A%F48R*,$.*8FXZ.;Q) MC!>&>YDV10,OJ]-=(7\1/*0UR6 M6$B M/]]6QE7SF][8)'CD/+(Q_*&(L$I:* M+B\;\2I5C&N*A,@-7I%3[,WC/"^QZ*7'B5;!0`<4M@QZX.+*1I67G8P`\+0L M5/8G4D8E2#[XKO(*WJVB-9I7FTU[*B."L#=4#6D3?(7+>PR"2QZ72^.QH5XK M)IGAG;R*IYUSS_Y6Z/@>Q.#0EEAM_%&\_KZI/CTL?UY\.G5&^YSF(8H,`39\ M=]><<26$ZE!6%!2[37+O[:U1%+(\R1SH)#PFLN M)1`"(4@)E<9V:SGQ:8`2%R#+Y7"5N>U_TM=S7^?+AYL8\+6'Z-0?F^UZ-C]%F=0N@_;` M<&2,1]&[4PQ+0TR+CN(JC4PC.,RYR%0(R"G2+".]@@!6>2L%;^K)1S@4LK!% M@S,U$;>YG-*O9-F%>)9AUP]+;=K"=7XW`1@('+)2.J.]1]%OI.VDIE:QM,K`8#;PP*[:*#RY:E.00DU$QU23`*K9O8G9EAE-K#G"S( M3679N7*Y"9`(X00WVE*%,-$.L6Y5;VZG32.@'Y4O&7!+2C8?Y.WNJD\U''!G:^KV::RU;<_CZ6:4_L+"D`F#/=(2\]C?*F)[@RR88D[F?SU MF:*2*)8+VI>',P_?GWA(XIWG@T7=C4"NA-/(6`LE@FZJ@DNJT0WWB]7%G M0-"*F*+[S[/%NMDN>?_IJN#JDGZ"U,V#&T!RZAPA0B%&B=86*>HQ\S;-.,G7 M2YXAT2O!HN=)S!\E.$&;TPV#Y\9[`+3E$5,I.C\E]_5RM3GDJ9S0.5C=E,ZU1@'FF,-?*1X]3@` M6B76_M8L?:R72_]_[%U;<]LXLOY+N%\><9U*53;Q2;+[RF)DVF:-+/KHDHGW MUQ]0%F4GMD0*`B%ZYKQLS3J$B/[Z(]#=:'0?K!1QY.E"8\8ED=P[AB'4&&BV M7[4$XY%IU>_XY/!\D'(J?H"VVUJU!!A)O5*<4>\E(WR_,3$WL3K^9^%_0)*TF"S6I16Q+; MH#;6TF$`6&3AG]&"4BEI,!Y*Y6B%7@X61!FW\,N/X`8UR\>1?_Z2O>?VD_@X MH-[LZX<+Z2P3RAC`/?;*HF#F,??(4IE-8/IBW5=>]LWG"V\I M%UPP(3773&Z;?NYD`][$&@,G+Q%'*\N>HY)7,>GS02BG6G7E:O-]7L_^O:[G M02'5:B]K3R&68\,*U;9VQP(*QXCBA"*#P0X:B*7,U67PI'*R9RJY&0V>'%;& MH>D^=_>-H,*+UL#<4,:T,-A!X*TEQ,A.8JZD4=.[`)Q6D0/9<39B_P2NY.=( M3SF8J5(D03A)?5^6/\O%X7H^;SQ54.Z`#I,@P0[FG%),,&SG11%@`8R)7*X= M`^@F%2A1ROJ\KOX[+X^KZN4S!5,6W^+\$%_+IY>)B_@*BN MCOLN*5Y02*Y%,*,YAUP9R`5P6^00HL%'MC1;W86AN2P)O8,+X#=>0*'[JD8, M'WPJV_CYYQN]607T5RTBNES53\CK+3NF2XPC2+6=#<_3DD;'%X4-$F5KDV-89AJ`'D83T%T#$C M&-1"BM[SO4Q2]L4OWAY0.,FAT1Y(UU[C808PVDFG=-A"IA#`2*&<9@0T)AO) M>"6=?M358G87OMP_>Z(9?4,+!80V1F+-0%OMT3*#6`>1%VR2$8USM=U'GO,P MRF$[O9YR-^%>1[5O:,&P$M`B1CRWB'B'==BZ=](Z@_%T0QKI%-G+D"28_=V9 M,KF`QG0)EP>3D:A<5QP M;*0ZJ_D,B4AX+D*!07'N(Z,*;)6Q'&KK*:1`4(S,_KOA!KXOR^%TS?7Z).VDY=Z M/'5K(49SOZ?E)<8H42[]E^I[N:Y6MEZME_7W34#=W)7+V_#7V9^KS-\'NZ'V]#Q]0[IQ&G`#AO"&$".K[M(^Z8G3I3XN-:%\/P,I['\6(^ M;SY?*`6P8)P1$[X1(R2&%'60*AZ9N3_:&=\(,<\4L%Q,W9\"'D_I2*DMU_/1;ZG&F\Z>K91,\RO7C MU;R=V^+:_>^FWE;X''(.U3^X,`PKB*C@$CH=W$U)26=#4#J@SL\X4G^=W577 MFWG0VD$1^DZHAOY$$63U1`6>6X`\98))`'<($.]8Y(V[M&=6*1799,%ILJ=9 M!Z4<%((:,+IP2"O+$#5*AFU0$2&@Z(`2@.5J[7U2*"H]"W[/NTL.7):X]X9;'XQH[4!GK!.$3:ZVSD.32U/JIDD(3`X5 M[X7MU?%O3Q:.:J\YUD0K8TE;VX#03A:*Y<1Z18ZIY/.0R:'E?Y6SNV"%+Q]? M2CZ@-^C!484&GGM$/&`66.,4=<[LL5)\(L7$-` MFT#WX-01PPU2'NUY;PT249Q(7C,\!R<20Y6#&'ZS#-AO:YM<^_IG^U_]394. M#RJ$:(L]>D>#:V^()Y;J+J&#.,CC0A;):W[G($,RD*+.L$QS_[!95\N]1&U, ML;E9_U4N>ZYV]8\L/`#62JO#E`TU0E%/?1?0(03&V0#):R6/J>1QD,KQP>\[ MV1_YOI^[W4.#A3`*(F805M8P)SO+E3K&<_6?F5;`*!:>;.KM7_+!]-DH#OWM59\B?QZ/^.4R/+Y\K%+3! MAD#*"0N!QQH0L9=#:1UG%(\6,TFBQS/DOV@XZ<'*XAXDQQW%!D_QAU//ID1RK2[$CS#1,^H\`Y\=FM=+537CF M6_GS1)H<^)6VD###4A)BD,-4:(!P=P)%$4/9++IA?$FIU`%\20-:%E.^^E$M M-M67:M;<[M31OYP<'E009P&6C&$#O1+0$^+W$A+*XBIWYH_'G[^,),,H*MIV M52W;#,;RMOI\\Z5:/33!Z_G>5JUY#'2]"L0/_[@RS6K]^48'PEY7UU?+:C5; MU@\'^KTF^-6"`8$Q%!!ZB"TW%%K8Q;1H^-O$BONF4&!S*?"B2/.U6J^?4LR> M.MB$>>W2V-N(<77X"D'OP`)[;+%P>-O\&$.I)31[LYU'WC\>S^%(K/K4^$PV M_7?BQ7'&+"BT/6KS]:)G!].M1D)IL&K9IMJM8>)5IC8:@ MK^V7/K0.P/&Q!2?8AST&:JXM=@A1354'DN4BSO'/EH*=F@FO+P,GA2_3O?"W MYCST=OCQL85PQ@`;Q&-6`FZ`$LAT\@HBR71/YQ+JE]^"Z5@^5)MU/5M]6,QZ"BL?'%%PR[03R$ING864JK"4=O-ER.?: M.89?ZDR%?S,&/GD2Z5_MECWVPX$1A20`0,XT8=@";3S4`NRQPCY7AYYI6@UI M0+L4(9ZZT/:O_KUC"X$-:BN-.T\A1I8`*^1^J81$3]=6.%N#`QB1`JN_/TOF MZZRN%K.J7Y\'1P1F(X\QP@Y#:`747C"]E]]%MG`?+7@_ECY3X1.ESS_FS696 MK=;5\NJN7-Z7LRVGRGG_=]H_LC#4VH`&4%K!=@DS$N%N_L#CB9W9CJ3?Y#AE MNT7UL2Z_[QJ2[/JC"[QE94`\Q-9`X8!#G"+5YKWO?A406[,FYAI\?;DX+ M4>2EF/0Q_\L3&%DR),DW'/D+56:<,DVWLT&O66L,FK MUF0::,;!)\NW\N=5^=@ZIX=9,'!D^"Z$HEH8'4P0Y:@S M1+/G0!:=6!)P:BZ,@U(.1MAJ6?\HU_6/ZC4<1^AP;%B!&/8*26\IA%YXC@78 M;VT"J+@Z/*.9`&-Q(2%$D0I,JMM@T;3GB[WK_9%!A4*XS4Q1&&H' MJ70$B'T,4IC(BS>CW84>:<%/!]"9N_@OD>?!^_A;HPH:]J8`!D$262J\Y01T MZQ*16,3%34:[USSR3IX`H6SF^M?-XKKM^7;"TGUT7$$9UL08#1Q1VDM.M>OL M6P*0CEN[1[O\/-;:G1*C"[INI[MLA7.0,!8PTRW%*>,(VTXVJ(2-TC]_E_H_ M&YU+:/ZY"FR$W_YZ<(&IIUHK@L,VQ%"@=POC3F(.(TMQYPS7I7?=ST8IY;[_ M*7;K?QY8<"D8%&VQ>69]\$(4WG\EQ'(^L=LW*=4QP`"(QBF/]W93A;E=M[4Z MJL6J?"+\$S2/9EZN5O5-75T/JKI]\F\5S*E@Y1*D-%%2>(F4A'L\B)O8+;\1 M>),+NJ@%8W>5S/V.!`6)!!DP&J_*KG^'LF7#0.D,P22 MPI3/"V@6M]^JY?VG9EVM=H'G7N/_C3&%A9!H&Y8L!YU@P@OFNDPU(C").\+- M%@-(^'VG@NARX:!!EE_?T$(:P@C%`F$`@?8N^+]=M)I@@.(N7&8+"J0F1#JD M+AL@B`H,%$`YP2$1W#BG#?:`D[WE*KV/JYDGWBL74F`TU@7<@[K`( M0N;77?+FZMBM@X`P#`:;`R`+/`]D(]9+;BWBE!C@T5=A9 M;#J@!(CU2YN^[N^#!U:,.:8%T9[I!P"W@,G.LL<0VTF=KXUAFI' M@BK+,MUV3;]KYMKBM3BV3LUH9U]C?O0)8;IH=.>/9;.*BAUO!Q9,:P`X\%`0'Z0- MOHWM:$^()G%VX27;8,2>2"3%*0":="97R0L]7&'6I=LGY!\=3H=I;&2-8X? MX8V4K/$_FW(9[+KYXY=JM0DD_7RSB_*$W?W?BW)S7:_;EUSLU<>3.'+,8$ST MN_/;#W5;.Z+<+6!A6O/ZYK$-NCV5G+_PVR^92-,SLWK59BD$?_/C@+R:DW^K M0-1231R$#&J-.:78`^B(D%)1H?K#^Y?%I"_7YJ3?*3!#B"MO)0G;II:(64H[ M+*2-O"">..%F1`TW^;";;!+.L]#S>?-7N9AM*YV$Q;-:_JA6`_)PAOU`88TU MPF.&D6?$$6(M51U<;16N*:;BC$2(@[1+"&`.X_;XQ'NS*X8,+R1U7'*'L!&8 M4$^,T_MOV2FOIIN4DUJM)['F+/3^*=R97&K.>Z#,!6(ZW6Q]L[3-YOOZ9C/O MUN#>P&__X`)JZ(/`-#B(WC'CD*2^DU@C/+%[\FF5^'LD)C5:N?D1_.W[9NOK MG<2,WX<5T'%NL>;!B+3*6LX8TIV4EL.XK+[18G/9.'$F3E%'@<6'!$(`E.ID942*&ED=CLG0"DXYK9C)92E&WA.!NI+&E%N\2G M#XOCN'QIYO,@TU_E\OH(42)^K<`$4.`1,HY!R#3S$MO]=Z)9W)%0!E-D[,C, M^%A>WN?1Y;S]4[33LQM?,&@A06Q;K7HF>.:ERL`9!7J`G>S[ZI16WYPAT_TQA M,.6(,>:0HA198##<"TU=9`V];`4'LJF\28-?#C-J.[?>J-"+IPHCVLKQ828%87?FSOM_<#[CT]^*Y M0AL;G'E#//-MIUX"`'6='"3VIL=HL9$H#;RZSA%R>)5M[C;43'?SCV3'[_[#=$#]?\JF07=RMLT[9FI^ MAKK[AWGS6%5?U\WLS\\/K8R]1M/!,07WB"+)+,*&6@`8AFH?5H#2Y,KB'6A` M75;%S3B@3F)9.X3;ITTKT<[$6:G-^JY9UO^MCIV3)W]7T?9@%!919@UACCEA M\5Y#D&)I[UG] MIVUDOQ?]6[,NY[ZLE]N&UV/P_*P)%=H+AMM#4:$U:ZL.:2X[S6`+X@)PHYTP MO\W#[)"L?X'MYX3>$50&U3`0O;W@70!/WOMT\?,)U6 M]NA[9/GYJ&?C[O=^\;Z_^HA_/M1/E]V'&2PIWE$([YVV3#A'*=),Z@!9=F[04@CTI2C/_$KJ^WRBSGKS^VW7'$H53&,=]9H/]C[\J:W+:Q M]7^9]YG!OMRZ\X`UY:K$3CG.3.4)U6[1;M65I8RD[L3WUP\@B>Q5&T6"8$_[ M(9%E4@"^L^#@;$`$06@(]%)A%\5=`]T$/XQM9T+TUMMO`#8MC01%6PE/CL!W M5]-9"L[XQ?*'^.ZAYCY]#1DPB"=N9(AD2&.E-,+$WBL%TZ[VI+>^AD/KX>$I MD#>)TU2!FL5JO M?CPAS;+CD4*T":%&6G$'-$U7KD`N+9,6.^0@AX/G7':SWM/S+SL<+V)+/,56 M0VF!HA00).T.6T)A&?<]#<9/>Q,SAZ-`L4F:[^91^56_K*_6FX%_W"W]2$[) M@;>"<@!Z)YBS'$H$'0)6UGFCN+2+\E@B/RLDO1C- M_U3\=T+/\2?/!H(PBFH4;YHF,QL_*]^LA[>,ZO46F.Z(-L]:C%^&2I;\\&I5 MQ7%NU'QBJ[MJMMBT;-V5>A[/&S_^=I"00$JYXKO] M<$+W.&5Q&%6S^)M??X@G[N75++6FGGR+I$BW3J^G=]5N^L>UPUF_$[B#J9%_ M2J_`GB)JG6/-J2'^*2O\V0^_](E8N:GNWF@.C040*HD\UM!H5Z]#2Y.K2_R( M#R*7X%F$"WH$.<0>4R"%A!%1HQ%W0@O22!LV!=^=VY([X M\]>(.;6#]CBN9 M_63"+7I"-8>VVG5V^N6FJDYU#>][):26=32U+Y-20Z6`EL0T8F=H+D-\Q.98 M1]`.Q3A'-ZO]+P5GH()0,DJ915(#G3H'[58H(<3E6DF7$^T$+K@(I=?(#\69 M("6QP1!Q@+NXI2Z6TQ/<.\^>#8@8@3A(N#A$XTJBW5:O1SA26.^!+@CSS-=_ M&219?#3;O:^:O+PU[N_$>-X/1+M+00TMH&GI";51=0"W62#AGI%?1 M1.#1_F1TBZ&F$-O7T@7T9%;IK0OH>4`7FV#:+G8+C`#"IZ@V@5YP(PB5]>(- M1[E2O`9J4W8RZ0_&:\_#\"WX=9K?GSA!B1=,2I5L3LRM\S6JC`I:KB>R)7?D MB(*U`_6-9;M!MSAGZ8@Y=4`/22=MR@SPT#E%C8Q_E%98>U:O3QG5KA)R7)'= MDTE\ZFPP.AR[9X6=#C0T+L=#N.D:7&&05Y2YB?A3Q'. MDWJS/WPN:(*]@'&O$LYJZ9`F7#0&DH6%96.UHL#3WNP7K#\+'5OUV,<:0^V4 MH-2H='L50@@VA@.%TT8)7$&,+*"40D`EM``8L_-;"H]58;D2`SIJAP.]&,:]#ZQ^K*YF M*:K6'_N>,U9`SAKHF'3,0Z6B)I"2UG@RH7)=4O%*F+A'Z(MAY?>+^=VFR>8& MV-6FQ>8C05ZLUN\7Z]^J]7T(^5*6;C-FD#Z=(CGBB'&IL=1(PAK?M%>6%:`O MG;4SD++[-DO"+Y>ZK]-RAEJQY)Q*,5REK1SAIF==.\`8EH*9'Q-"ZM:WI]7B#$Z`?@X7?V?7U;5N_FZ6L9]]6.4_ESL_]+8P6B#&!#$`QO_`Z5!1M1X MJ#4Z"7EB/PXC*`Y1+]9.[Z:3:CX9PKIZ.';@TJ=:-\RP,%AX MZCFO64`JB]NE)I3GA1K;7M$!K5JUE.IT$;]4Z_6V*FGK>OOPY>?;S[/I]>S[ MI^75I)KLCT`/-I<`D@/&$::A%0Y3H21J,$:P91?:DB^,.=<1-1;2#%*=^R3A M^ZTZ=\-B&A*&"6&60>JA6SVA#%%4'8.8Z$ M,S6&E-(B[H7)R2J]5>>>!_1KJ\ZUQ"KJXSX0#1VH2%2NHEX\(R!7PO%`]2`G MD_YP=>Y9&!9Q@AE!J:-Q/&5\IXO(+8E[/TF?=Z@2KEFY52HMN2-'S6,[4-]8 MMAMTBRO"&3&G#IC:UTEU+F1Q*1@`J#TQD&C"I&[`5C8;KPQ8G7LRB4^NSCT/ MU"R5?-5JO9PFQ\YFMK]&DJT^_O+K*??G['\OEIX.J M7=OVX>*C.9FG2V!;.=Q^KI9?%LMOJ;'H9KTO3>AP0_?3?R$`HW74Y4PPX'$\ M:,4S5B,0B(MVYOUP@<$5QNXQH`^J@7J;`MLD=?2`GXCXRSM[>8YV'J[5B! M2665BO8)<\0281UTC7V-1E1_+XP6N*":0\`XA((+Z`P1L,94NVS79Q7` MCX.#.P:&=7_^/EUNWLG!L"^,%DCRHD8DX]82T8V&EM>DQC3!748>[0@8]G)P MQ\"P_]R6KL\G3:+O(GV5\_!]ZA2"Y%)$^\@@3S75PABH&W4A-6C7#[.\%/$R MS^0]46G$,K(SO%)RRE`R\FP*P0HHO!+.0Z&EIZDSGZS19ZSE%;'E98R/2D8N MI=(89.0!)9Y44M7GDY^7T^LJ4>E+SAC%B9,)&$3;PE-&L861,$HQI.Y/XJI= M55YY+0[*E)O>Z?6*)&AXL0E<4@2`-<9IIY'#"'G76,&,O][82.?,.8P*(R`];F9L6V;KC2%RTA?+=8QX$0IV;\;) M*:VF.E.RW/VLJ`3)+O9;IMB\GD;!`0M]X MC@%NUTDL0^BJ%.[O%^\BN/_B(,5`KI7+)A:,0Q`XAI'W%E&L=.2CFE)4P7;> MR3%$ODKWN&2EZX@E\$$(I"P)/'%B00-EL61.,R@1\X1B5"MUQMSQ.^Q'&U<; MJ03V0]I&LX3X;B9\R;C#446F\9$@*!I61V-0N9V:! M:2<_Y75N*C.^UB5IBNYM>51]?:P2_>/W9C'?K/[V:I9:&Z)C@I%W-@'SQ"J( M1E0[XNA&18Z-?2=+Q;_NRJ#V8VNHU!EL[>7_>!TTM?V>V9BY:\P<@Y!H$L2_+:T`1[#[BE`*5@`P#8F*9. MA3FC7LO]8T6+6/]TR]OA]OF>K;Y^759?K];IAI#E=+Z:7F];FQ[)0LDW@\`I M=1%!!Z066'O-B*UC;PQ`VTX.1*ERT&4Y<+%$&H.#X,'B'Z\Y3VKAXS%#5'E. M8J:EEYP11IRE=4D-$Q05AY/(3"3 M[DX$F$3D*?.N&5G>YH;5'8>3R&PQ!C4.^R1X)!* MCN^M=>9M.Z]9>5'*UR([%U%OW+*S*\D86'R>S2((R"@0'EE,';4>`^YD$WA3 MMI`^66\2U!$!.XQ&_CI?5M>+K_/I_S_^WBQ6ZP;-S:J.M@WN;("@N,+&1()Q MXRDP)MJU-1KFVG?)SL!D M;[>5N,_LODK/'8I0Y)U(4(!Z:0W36%E$M+"6U`T*.%9%-49^Q0+1!6TR M)T8],:2>9'MM3O7V:EW=W_W<6X)4VYD$AS7%SEFCA>31YB/"U&5RG`+:+OR0 M,[:=@_?'09QQ'V8;6AV%9]CPQ-'I!8J9X-83IX2!D&@',6XV=J?;U6.5EG;5 M/T_G#UUT3=IQ"^3!#D^%2.69SK?Y#,/?<N&1IN[@[=1_3]XX\__I9H5;EU>-N+HF>38#E;&F_=,#`%7?`:60%XJD+ MJR-&0<>,P():SH[NJSVA>WU336YGU8*L"2*;!1<@G6R_I]455Q-_O&7 MJ&>K^R\7\W740&ZVT='_^,NJ^IH^]"XP&]6_N=[]S^DA+?+HN:`)9RR:6DA[ MJ)EGG*8+X;8TT9KG:GAR$W]^>7W[N?IK_#;2-?[>`?8LA!\6W0%;A#6[M\_E M_^ZMOE=T86Y?8IBV&"R!:'4!1!8'G-![@4RIDC:K$@H?(CU>WLW4F MMFV8]:]/QGW.M"VYH[->I9V#^L:RW:";GU4?P?"J.'7`M(C[[>6GZDB=S-YW M@I.&I$X,%FH!@4**^\9"(@ZV"[@.5]?2*XGWI1Y<"&H.IODT72?KY=U\,KV; M3FZO9D=,MA>?#])B0)!.36R`VF6Q<`#\(X_YJN;SY6 MLVWS\9OI[Y\6;KZ>KK\?W>K._*4053V"$5@$%".$<4&@K[&@F!1L>%U(VV.< MT@MN_]V\5)Q%5#8+%6B6C[)5LC328^,CZ0QA6#ILQ#W.;AQ%Q+V/&1!QE$3%H5FTB(12-AF[6\R8IBTK4\JKD>^6?[IL=MY@RX3F\DK?>Y&)@@G5 M2N%_3/->?'FP.:[6BX]19N.N&.5V\_VOD=CQ6UNMJ^6WN$>^],]?%LO:]_#2 M&;ZWL0)5"B>[D$$#';=6&(!JC`A#[>R5\DH/^U/P!5`E;[K$QDFR>CR#)EFB MGD;;$1,<-XM9Y*+5-@$EUSB[))`ST]?=#J1E' MWPE2.4$T`<)C1!C@!,E=C9)B#HFC6<6GFJ^-8^W!;/:E.AQY(P`O@0&&",,P MQ!IZ[G9EZ(IR"W,5*;R8H]`AXHL^T.@A/V`/R;?)9'G7$O/A\T@1H2J)B$ MGF"G(%"^7I>!V)7GOKV<1$\#1!T"\WH(7XROM1!ZYZ?S`V5V-'+\[-E@/0'( M.@XA0,89;+5NT*%6%%)/V!%-%MVBD27*LJRNXE'E^VGT?>'I0+T!3FL&;5R0 MXDQ0K&ISAFC?CL*]^2RZI?#E>+1R#;R;7Z>!*UMM_S^=/V"UPXV"SWH_"($, MI!(KJJEC6A"(:[N%:2`+R??HR>3N":7,.GL;<7FW6MT>[-BSYXU@M#$.$&FI M84Q;(".`]=J\YX7H[Y[HM5^?7X!1%E]YFN-V=@^OHM_.^J$_J79V'NR^=_:/ M!1#/.(;JB+,E1"J)/+*-O"G=KDM3/Z7*O7--[_`-SU`O.O-:<]2+OQ:4B8+% ME7/:&6$00\S56S13CK>K?N^GNG9@ENH"O^RFYRXQX#J:9\N#VNC`6P$*+YFR M3#)C/`>40])L\P8?KQ3+6.?9.X]TAU-O,8!GGO)>_?^WGU?5OV^CS>_N4NIO MGE':^?X[TMF/YW(H3'#LE8!,/+!B;@R7U-JD.$RZQN951R#8:,)71'EJ<;R.5(%%MG^'1MQRL.][P1 M..3:,,Z<5@!29:&SN`:$VFP)=^KZ;:]T[`R*3, M5>N!EB+NAUY@5XN5I@J6%XWHC&+'.>`BC%X?+Q03H"B/!08G_5%_]HO/!PJ% M5)0H[RDDD,6_X:0NT]<>(E6(U[-#^ARF>"M4LCDE'AT@WB_6VP*[7WZ?3=TQ2I$;=-ZTS'HO/_Z'XXYW\^1_?-VMP MGY955N2_O#'?&F]`FB^+59;?_/+FM\_G\#.ZO'SSC[__YW_\_%_GY_^./KT# M<;'<;M*\!JA,DSI=@6]9?0O^E5Z1;$W_K#H_[[X-VI_HAW_\Q/YSE50I^%YE M/U7+VW23O"N62=TD>UO7=S]=7'S[]NWM]ZMR_;8H;RXLP[`OAK]Z\1OL7^?] MU\[91^>F=6Z;;[]7JS>`!I=73=H]E5![S]?"!J@5_H24W52OYZ2-5BVY? M-IRO=+S#AX]5+5ZM9KTO1U$G:\4OQY-'OBQZS;[VCO[4?9,]_@B&F]0[N.X] M.?U>I_DJ7;7P?/1LD*U^>4-_6FRK\YLDN5MT7BK*ASBKENNBVI8IO*KJ M,EG6"\>P3<>R#1P9Q#%]#QJ^'\1>Z$1!%/L>632/7*3Y^6^?>P7-1^J2>"-B MQ%./R[0JMN6RK:>H-E9#MW+_/J@".UG@:R_L?WZ^V(7SV,9B^=R;T>BY3JJK M1E07.A5GVA?INJ[Z3\[9)^>&V56W?^/PZ-#98JG4V=:H-6M8%&7_-CYZ9V"Y M!$6Y2DO:V.G_*BF7KV1)]XV+94&K\;OZ_%'N7)?%1D,HA?H7K[6'!O.L-4^* M$VN^K+;K],/UD#C:EB7]Z4MRM4Z_T*(9T;#_6`0$(H)B`P6V8R-$+`<-Z3O$ M-A;U4*>\6L"4)2I2VNH7ZKPC1>[S=K-):($KKD'6"U$"^@JF M-U3\RV5/L^=\/#N)W6)PZR4RJP>19Z"3";XV0@%3"AJI4^..U\(C[%.>"S,! MH?JX"LVOKR`BX_2J?@;(],E!@#")HRA"`?T?<@++PW9,/"/T#-["*?ET?461 M"9I%$^-Y9XZ4L)%6SJ0\C8VB4/I^2925RYRFT8P>->5S$6"$@\@V'-MV;8*] M,,:P3\K`82C2/3BOE M&P!C7-1&H@.K7L&0K+$S8I!T",\`:)P=DO2!W[-JX46!$[NV96."XQ#%H6FX M74K0-`PB#Q^NQVMFST'YH'4U%36.,7RNR2!&N6$2[1H!KR8@"5/`#1(A^V;) M$;$(CF)$P@Q)BKQ/-FE<;)(LI_V+$$=1X'FNY48(^K;OAWUZ%K)->98()#(M M4DLR2,3QU'^2!O#32%4 M;#9IN?C3``S,HA"Y:LEBI8R764U M29;9.JL?FJ:4'3DH\H/`M;!)^16;)NR'@R!&GBO$%?''ZX9*HPCTDN2Z23*N M<7)%KV&"4!'T2@]1GCAR#"?R]LV%)2,B.`3)6#,D*=(WABS;"^S`AX8;NG%( MPA#[?5HV"@)YCG`F,#5)Y#I&1.;0W\*1V$*4<2EI9LT@ M#AR4(4'8C+23CSK3.2F&GQ=-/%5GZ:A11XBDQN"9H$E1,(6.=W#4:/&[+$\O MZW13+2@!B6\'!,=6:-@&L3W;V_7=/"0_6,R?Q@1CQ:-&A`7'C$&_.JS-1,%;HHM+23%MF:[J=@&M7'COZ][)37RJ]2F<6.^IQWJY1_D MY;9L)LR0EG]\8%?0!FY&,`A]N'[<[KG,:0E,J_I34J>P'G9.+;!K1!&,0R.V M'"."1HCBJ)?@D]@3X8?*=#6S!5]?I\LZNT]!U@D$)54(?D@JD`":-TL*\Q\% M>:/4=SX6GF%@V2E30$QYM^61.8G1BIC9FS^(!>A5\R=#YDM&"C)S M='[,&)KC8^.@IB(#7\7F,EW?++K$WF_9T-J'ZR_9)JUH4_W M]9?B,E^6:5*ECW4N0F)X,8RAX<2Q04CLV"'J]3BQQ;4D6[N(B7":-]I9H5^V MA?ZZ'Y[..MT5)U_U9\MQULXJ1\2XVV?&^R$S&N&@4PYN:0^AT0[J`O3J)2=E M]&?3JCNZISEWYZ^178\D"TSMW-'?-MN"ZML4;)X4J;K)1?:[_9QD_R[[W.Q+ M6?-ITHT^7;=_3:NK M7,=FQ3,5[62Y>^)*=[HXBXF+C4AE+-(:^-R^Q5\*U+[#:'B%%P020B#V@L@/ MB1-'9FP.[002$JX9JRGUG*S'?P.==1G:A`#3K MC!2HW6>8H7(5?8_2U5#'"Y?),[#-:1W45.P'+>W15;<:GU^JQ2?.Q3E4Z%.' M7)RNT"@8JFSG3#_LIDP7813:$?&=6T(SZE:W9L)2JJNOI\FY0I.^AW]3%Y M:(X,&4Z\(4$8T'K;(QAZ!!J69<*H/1T*$V01[F-3]*K0N!)M=Z03*\Y[TD&G M'33BST`C_[S1#_H`3G@,U"C#CZUNFR8G9P*&J:(]7"LWICL)<5(2BT!T&W%LUMKQ86C;9'4!%=&*P[1Q33?8+,F!;O MISM;T$&0T55A5:5T] M<]ZS84$_M$CDN"9T8\MRV`;]IHV%3.@AWLT':A/5QX%>9U/4=TI!*W46QYL+ M67FDM.O)DIF4<4W!%5.\U2)+>/;O.'@LX``FH>4ZQ$1QC&T7(V@:-/4^<=^* MN$:>U*8X87LJVQ7DI"W(5P^BE[`HMIMC8C2`URQ42F]MO=5K2F?_,6P/U_@JP"RV)S5[#!P&=+6'V;U%1)#JY2<%,6VSOZQ;JX M2:G`DGZV3+;MZMD'P$8;JFR3T6"HK*S]P@/[75:"/*F;R/8^8G_(E-)("]I! M:ERKAMC;]92C%^?PO@@O+;]1_B+-88&-^J`*G65/>O"BK]?WVN(!))$=^@[R MPYA@&Q(2=$E:/G&%CO`>D\Z$E>;REOXFK5A1>PJ4GAG2XQ(2%HN./>AU5[ZB M'/H8,QI">.(5US"!O,,SZ28H">7%[OY8>[C)]3ZM+]GRM?1=457P/J%5*0-F MP0Z1*/+/-4WZMEA3+ZMFQ&&!L!>%GLWF3;!%NR2F!9%EX=BS8M,W#5^$9JK3 MUDPX*I=MWJ%Z05+797:UK9M"V"SD7M^DN>A0JW+O^3!W2MO%T,<<;Z6"'YC8 M'\$@MW&]$0SV%7?#K1/#4-#1(X#4E3'<9X81BYV`^A&D>>$),2!%?0Z/.(*G9.C/''->.WU@J05 MW,Y>53\)0E6]YWQ4/:G=8E@=G.ZT[NU";N7NK[`^VTU;G6K86M3:(WS5EDLS M`:R^^(J)7G=-B&TY[[AN%`;8MWP/6G&`7(@&SGL>%FJ]JDU9,US;2>@?:(>\ MI:KHH6.*;5:+5/4.:^7I*5JH0E8JX*=8EOS%X"D8G"0Y92P46(U.Z_3L/OV< M+K=E5F?I;OV[[WB!:1@Q#HEMD]"`F*;>MX5M4^SZ4OED-`.Q/9J1%=%5IQ%4 M@TC1-N<8-_E0.)&18MSK18&=JC/0&YMW"Y_FM#[T91>/KN@>;?U,^*8BDB?K ML!69,Z[!UW51GK8^5[]OJYI-D"X0A`XT$6U[FLB('2<*0MS+P3`26B>J2X-F MYGVXZPXF8"==EMF2-5DJ-A8"MGG&)G:_)669L*T9;!*W:&93%3<95634B,;C MQ'FDIAG9][^?MB7!3O<5J;RFT=VUU_2=""(,\B M=AR8CA_"V+'LT/1Z&9'!+I]EBTY&==BETQ:B]2!3K'5%B[WR3KN\V:.Z[9/X M/,5`Z!Q0^[*=XIWWT1DS9[2J"(^O`Z_(1NF]A@<[`H9V>!"8Q(ULTXG""&*( MXL!QA^1-2^CN%E5I3C=3/VR#>FG.7K2OK\QV/IB>PG$QB'+N>9K+GM`7##R" M3=59,!-<*@_KE0VD:FP;A\>%92/#B^W(LEW/"`B*K7AHU@9.('2*AEP*DTWT MK(KU.BGW-H**-A\E'1S!-:7F*:+8''`E"B=N'^>,(OX@>,`C:(DT9CJZ+<(@ M1B%V(Q(8<0QCY$8(#J.?D2]T:8ML&II1L]]!50X;;A_E<*/#PO'`.4T'\P5O M!*`CZN9,L2,U8M7`Q--W(<$A&,2&P$",8T.=\F MIN%9KM``I6P:NFN0019H=`$F#'QETH2K`%D7.5D^@8&"4);R3@]5GS?G&!Y' MVCD7SHT-XQ!82FP90YZXV"19OK"(XR'7P5%,$_!-['A^GZ`7V&+;&>53.0U] M6G$*^,/KI32!--BHA$&O.C@5A5HA8AP2-'6^)!(-Y'4625DC2Z-?4S9_O+`A M,B,2.-BV0\.)H(%]FR7FPYA@`H667&Y7J.&_L133/`L>L9'G2%-G:,24CWO,2@#>S$R76VQOG)QY[)K!1#D)R+ M>K9M'''H"(R4&#L3)JF)Y7#SACJ#)`B%BKQ9`++7X$*.3?S0#CS#1$$0XAB' M5I=F%'MBM\B-2F@Z0O7B9+MCX_P4)91F*Z4))>"B9D(]=8B+4".,G1VAQL3R M(J%&&\1-J(_;NMTHU375`MLAON?Y=N`$H1$Z8>2ST?#0\"W;-8C0$)'HLS5S MB,H1Q(VP.7R$T>F+&%2H$M!*.56?Z\"+(_B0=6TFQ)"67ZAY>02Y,')J[5V6 MIY=UNJD6/FU3$>1[%C%MT[!@:""GFUZ#&(O-=TTF2C.)E,VVLXA`$Y)H2VJZ M_.5CXBRS5@RFT^:J%AJKRH4C&)\\HV?"_^GC+DY(2*]6)B!\2P;&]8CQ@ZA.N4P5-KG*`^.G_F9!B16PA.F8/'JYA3 MRYM_C<.VKC7A[=W;PW`X'[*_XB[X/4C1>'N.6[R$&?(\^T!N:2!W.X M+&(.-A3S*AK3=E;AIMCF]<(Q0P(A<1S?)"B,H1&8\2#.-N&$/55.15-V4W>M M@NY&G+YZ63ZN7IY>R3GB3(^),G:2+JJ&/#U):^$,M)'\M;JFK69]_5+!W/W_ MT2D5#5IMCU3*0816R_EP?@*OQ7C="`0[A:"32`$\B#P-B_FL.[9R3JWW,Z&IZJ@. MU];I,(V;AU_*-*&-^8=&17OL$US^NS"(HOZT>RN, M;"32=736G4Y'L==)FYAV1TPZ@C@5ULZ$:TI"*=2_>6,(UB?6'6N'BJKN MVY4+-B9A&X0$L6L&'HH"SR1#^H$E=#:`LD0UL^W)?41W9;9,U9QVHLYX":I- MY?D8Q`UD.QO.YF0Z=WWN4Q+OB(&\^%.1!W-DH9*XCH%1G7%\T[##XJ*/9;K) MMIL%BBTW#B(["D*3)@<]T^_/D;*(#;FN\Y5[LO[%@*!H5[[=M8I$)KG$?>*8 MHM1JD1B>]M8%?IS"'8&).ZTNR5TP+^(6WUS<89`OS:!)FS&'>2]Y\86*]T&* MBX^..H8H()Y%,'(,RR`H=IP@M"P2X8A@RR%/QDA*Q`L9,E!0(QVT18 MJ9.L*,5\&:Y?=I M5>]M>GE?L"23=3>.:?H.-CT#.K9!F[@^-APS8!M>`AR'KA%R]<+'IJ$9L;T: ML>F2T<8=Y^N4GHE!=B?I#`S6C9@`J=+EVYOB_J*-N.T>MS\?=HQ?\>09J*AR M\<1D419&H?;EDMZ'^Y$-:[%MORW@/M=E]D?[X0(;1A18)C9#`T6.X[L1Q9U% M$#8\Y+F!V%60*A+43)]6BLJ!/C4V\PWR3>ZP/*L:+8`I[+N)G?7-+TZV>?=E MWXZ,ZRFU?29C>FIC>G%3KS+#9->PK.)M21MR'ZFBHKNY9V'8=F0$Q&*=90)C MB$UD][UEC_XD=!#3^.0T(P_QS]NN&O'M1TT$(V9R5>0#'Q4GS@(Q)AXN:%F! M5AYH]?43O:==S/*,9?P+6<;X/1,8JHSH^`*6\6:-7,SW*64G*[";((`')OA'R4MHU&8$'YE.E@=BW%)LOYYM8P)6'B&?EAR9"1?UQ':X MUTN?@0*]0)H\FYYN$CW(0Q0Z8CV] M,2EIIF;7W-B)DKR:99R;O)VSJ8R4:K()>*BI8W7$GJ.=)Q6VSH1?BH)YT@E2 M9Y%@1V=(JSOZDW:CB&E:OH&(`8T0QK$1#DU,#PHU[^12F)A(LL<#_Q]WU[8< M-XYD?P5O.QUA;Q#@_9%7CR-\T=CNV(=]4%!5<(DS)5)#4K(U7[\`;T7)JC(2 M!$CV3L=TRY94.'F2/)D`$@E)^B#319W,S9.@M;H!O\K+;R>1LCQN1'-F&O'J ME'(>)3(SRYA^SPNZ#VG!OFBNV.-5!_M_/M3-W>GN!I(X"29A9`1.F%B&Z\1^ M.J`(#`=T&$KQT+H+8'ER6A;H0Y[=Y$?F(/F9HQ*BP7/'I3F6GSWV2%$/%;58 MT0GL6MV)862*S1]5>F4C:JC+NO-S2/4DRNCG)]K\650T._+%\/=M:1L?_QU3 M;SZ9[7$$#HX9%!<3/THCT\$!2QA['%::FI(*JF9PW16NM$$GE(B#J[L%(5K_ M@7B+%_0QJ_Y%&S[OGS0EDI=:13X!B^WR[I"7VQ=>.:%M'30NV*VNN4*>740*:F]PYA<1F):YX>B75ZL_O'`T'U_RHM#E-6WZ;'\\7>Z M/]`!6^K'KN''IN/CU"&6[[A>,N;57BJ;T>H#M+Y&=W!GB;(N9\D(]0;\-$^\ MIS+==NT[6<%4!YWL0-P0Q"WI?;@-59=S@+#2:_;O)M5?M\T7(\(BA,M$B6\5 MFQD'T6T6OB3CP)PA-2M]6E:4^09%#U5% MB]T3FF"=S+;E=7X6W6`E7XII>:U^G=\-:/`%ZL145@7WV]-1)5:=5TIUI*FN M(_HPWN[AQ:%E1C@EMHM]&UM)[-G]WGN";=B]N4>T5I89$> MAV@M+A+RQ9H51A]$[D;2Y9[M*:UB^^2JC62)%%9?-A1OYT5CVOWW?='65M^6 M1\9TW6W[?2F/1Y:8_3U+]O7?_?L]<_[U__(7_\WJ&"38O9;3?83J,3*/20F MQ&NZ!J;#`U+TMP'K'XQ\-(7[7VBH8.>048]Y:1T&4GI!AG4Y9R,JK,V\6Z9I^E[L6!Z)B.]89N*,,%S;2:Z[X\!?FZQJE*;!P@@@ M+_M+L,+O?9BQ/^XHRIKV#/0-/>1%=P3P^^10M)Z\5]P72M->+0[0F/6^:=>" MF3^^70I[:R:]`Z/S%9'` M,/@1]]CQK2"*3=L67?&:-8:^0#_`0E-??4V%)J>/J` M;]5'6AU8VM_>X5'GW9#%/L[K^[+_X^2*Y&_T9Q,R&OYUS=YP-XT-3%++]GW' M=PTW&M!83BATY89F"-JW84]PV[OIXYR7F>;-P\7N<(LZ04ST-L`_3`Y[P/U= M:\]]<`*-)JC1_W+]+R+,PEH)U=3K'UEWM!<1?Z*X\%+Q(NEN;X=TU:;5D9Y^5G@2QR+']AP`66-;UOY[F&SI< M="$XK?M(;"1VK4S"RR8A&W`)I!BIO*-C7Y,//92VGTF0&#A-/">)7>P3G!`C M#H8AV?`N)'[-&4=S%.J7\$=L:``GUP)I%J/"A4*+D`DN"I+D45?ISSF2+I?Y MS*9V(ZJHQ)1?RW<4T3-7H?I^*`9?E,'8L$S/M!+'3=S0'P8U/0]T7F?>2.NI ME%Q?I)F\SE(J#90JTZIU&B9=)`JN5T""MZU84&/$-$N*(F'5XIG;Y^]?L^-X MKM$B)F')FVD8KI$Z,?LZ2,>!7`(Z0P/_=,WJU-Y,SB9CA[+#O%T(NJ(L\>1M1E!D&E*J>(Z!R?*$U93]\RY=#Z2,] MEO=MP\F??,)(^Z%];&';=H/$=2TC27S3BL94*S'L"*(E*L;3K"X#Q';/87\" M"=08)`5>]X^]U-V1_MELM2T M#;^]@-.,0N(FO"QRU"\S`NT%K@)0LT+UA]V[=U%R17X=QPDF<5OW&4PS@>[2 MD\MIH/12RK>F!S>BXNMR\#*!7-\AOXTI.WH\7'\JBZYG8T[W;;>&[J[ZH5^C M%P>>$\6NY8:AQW)`KK\KOFSQB1:?JZ#R MLE8OS"),<1DN-`+K.L6@#IK`7%HYD?MR]\!?I_:5VPJAST`!%G/OV7?;Z\;X M&<+B_(.*#DQ:>!.)FZ?^Y&'#@N!_"X<]3D<;S##I0]GO"7HE("ED=>6PHM*2 M4ODC!SWOUQU+_7I+Z?.Z'FQY@8T='/I^B(/`"'TK&J1+.\#V=R M6V`S"P#EB11+Q1?A$";NDO3I.2UYAIX+J?%L1C>2WLZWX^4)237$S-*@/K%- M(AQ@[#NV[<3$#XW0"L<%5!]C4!.8&<.LI$-R"PISZ)37(@U,JE&C=:;YYRD" M*A*0UPUK$M02`562(@=0@_S(DN6RRL?]'&)%'G$-KGH)L=D0@4^&@;S$(K"Z M8^BG:U:A`1#T@@\=+8=-?(\.GQV_"74Z+0 M2Z*7]IB8[FW96<`-%^7'>S^LUMQ?L5` M[E\'V%!991^*)YFD@S2U M"?BW[&=_53B_H?`U=#$F1FP9V+,\,PD*0U[T]V]IR:/%J5:93VMA65=>O>;-+R`V9^?:8+=L1')U62>5>TN2"#CD M>>#%;%_H/;^5H#B,G953SS0LAUC$#TUBQJD;I'';PS-RS2`2;NP@_?GZWM4> M$AHQK=T/%39_6V^RQC9-.N:!Y[ZY\9A%+`7 M.\0.,:W`(&YLC8@]PP%M6Z\(4_>FTJ0O:=7;UIX&/C)#WAZY)2AK3>&EM(?1 M&,3D-I-N.+N\LP6%]J_A9Z!43US`>[T&A8ZWENVMO6-M09]X:[?FH? M:@WLV\ZB]?J?ZW/7I=BQ_C.RE>BS`2;.-J1=V3DR_=C;,PK_D^_I^^)[6=VU M&6QOQJM6A$]75?G%ATD#>]G!HASB.K"!DZ6[$_C@"]L-4,@`NC7+! M^->N"9RB8*N1=-#(W:B13`SO.XOD&ZXO[6IH^-NREV'1[W<1CWES0-Y&OP'[ MEJ*;8F\(!;>UGH#-Q;;5B#C?:WU5UX`C6_WY>\1)+]IV,6W-2%[_*WSB_T[9 MW+*L3E"(9UDV<0T68B/V3^Q;[@C%3D)8[P4-XR\8C8:`@W93\*ABJ%&W,LK^ M]")D<0$K:(.RW:Y\X,.;09LQA2$,>Z0D,!S[4"TE;'ZD?5) M``?Z!O%_HPG>-UTZR2&_9:'@#DU`K[=8#B?VPINOT4L;>?%U6OBRZ[)N,B66 M)(+'+#_R8)66%>\'_97N'JJ\R6G-RWZ+77[,^^*%9TLEGI]XV'&-(/3&["=#$^6=*$E`LW^W$@(6,[>LQ/^ M18B6"`]_%A7-COSL![^E_7,QB5$O%\^C.&4A"3N&EX:>Z>(P2`8H/@Y!7?QU MC+^9()`73/#1PV@8.C++T'!3+&*_@H[\NO;F-BO&?5I:=7_&!-V517,K'RH4 M>A0:'=9QIGQ`..%%'#!?C7F6X6\G!`@S*Z3ZZOVT.:'78.)9;==%)ZCA0S]@ MQ-/,MA57^!2513O)>,B.'[.FS4?CK*$O,*5^%)JA08CK^D84QJ'?7C+58G)2 MTX+VAM`&9$&!WS_TZW_W[8'(^HSH[^E-,U%^B?X3^KPFIMV;<1A,Q*Q]95&'`L1+*SX,=.EQ_;FAO=%W50/ M=_U:T]_I_L!K/G?L6ZTFQ7F]8_GG0T7')27>&3Q?4(TEO+<1T5C$U'+YET._ M9)QDS/6(2WS#C?FB0^J2*"2XQQ0;AA="DD2M0#0GB2#Y`.:#>AVD3=3U^&8I M55\O'9Q#M5IAAWOPKZOL$K;.EW99@@'W-T\Z^Q3[+[3)J_92AE?"BQ,G1FRD M%K;2)$D<'V/2A9?0M2+/%TW_5`ZI<5]_>O*4R\$)YR:2.P"+ES;Q-?AB(Z^X M%M-^N2Q9%WW"+_`5&[\;_7-S2ZNKD@TWPNB;"KPJ*+9K$TQ""SN$1"2V/=MR M>CQV'(8!)#'3!D)S4C9V#!EZ@?!;9J#9ESX/B.GI)LB'B6L/N=75%C1ZCGKP MQU8R+EF*+RBO=J]M1(;UVUDN_#I`KI2*RB/[NNSV!()#1;L+KUX)#VRR'IC8 M-&,S3!+;M)S("8@3DRA-0Y+XO^L6H'@TG7G5!",Z@81NP*W59 MTLL'4^R"(V$#7Y$U30QMX>(C#5:56A\KZ9*>"91'.KV@CXGI)\;4F6]_8U_5 M6=L=J=NVOC;])/9C*V0833=,C(@W6>F1AI8K=%?>BO`6W"]^9A.:&M4F1_PZ MOMVY'T%3R_I=2O!=K"LX'UH2B[77%NDRC%"I4>+/P4;2:#79.!L MX=)*SIB5=%]E%5]<;>_ULCP28M],L!Z9`[*3`WB9](_; M?'>+\M,)>937Z(;R[;Q]7F<']M,'WCEP]J6POR<1.%F2H7_#LR0I`G(8F\%&,K9%$,F_$PL.D8L:(H(CC:ZG$$=GFC0IIGQQ(-#*N. M)JN1JRRB:"!9+J9\X]>'9W==UX9I5/F1-[=]Z#C=&XYNLYI_22NZ9Q'E0N31 M'$S.7J:IGOOM!Q2H0>(A18HJL:`2[-A_:%465[<9RTOZR_GBP#;\(/*,D%B1 M91'#\_$P$@]IPE%$[N,UAXT1%$2Y)(D2B`/Z.8()_X@'=8`$KMI41A=`V?73 M)B?E+^F;+<&O&GI.<^>QL@61G6E!J>P1`1684:I]@"`:G-SG_WFZH^P1 M.`E]ZH1N$MNVX00L<4X-:\R7L2'4<%CNDW77"'9X()H!)T=`9[7R`E/7'@H7 M`"E-A?,#4%*M/,U>Q)XN24\N%NQ!J]'4EPR<4U)IIK:@G_+@2Q4/"T0KP^,# MO,VJ.8""R((D3P+: MJ9\BF(`.>!`#U+WS4CHJ21A`3/43)Z>H4@2*J>>K)I^3T'G\;$%'9UI0*GM8 M((J:?O[R,>@_W["&;V'9.[F3,WX+(2>$N9_H=(F@?R^K^ MMOSZ5`?O^E'2-,&I'WD&L;W4L5,_B.U^E"A,`>DA_*,UB]L("/)"2Q`D('-Z MN8&)W8@%!>^D-$^"(H#RZ:5*3O^`E(G)X"^&GA-#>4:V((DST)=*'@O8QCEM MGHYET0\1DB3T[<`(;-/T'2LE_,!>/X1G)`9@QQSTN=JWRCLTL*U?&#,B&SKZ M2`%NXO1`)/?$8<2`-L.U$22["RY,E.@N^-3"\]O?4CQL0?UDH9?S'P.([GTN M=N5'NG^QK3.97..0!+;GX]`)^;5=41+'0^EKY,1>*JR$LT?2K(T]/H@"S"=/ M0"P7Y0TFGSVTU_=MI31U/J,`E5V463G=G5N*,S6HPYJICZ/43KP8ARE.(A(EKC,,:X2N>$FH@K%T"WO;_N5%_?OD M0"%(GQ0P*Z+YRY(*5/W7^#R=)Y"2?06T0H1_67J5;NG?TZK)\H*?,VM*5+:^ M.'M0K2@;?AJ-MWE@080>:_J#_3SEUX#PXP=-]K,LRKNGV?4`OR?T;`A1YXI- M!!&%YI1ZGEAP^\;9Y[`_Y`5]W]"[^CJ);6QATR;8Q08)?-_PA[/841S#NG8L M"DQSB%+8L(';A%JCH(TZEO7TY2BX>2?#0N;2_M74#U2=+UX)!ZNZ?".=.-:Q M_9>6HZLY0&QZ\^<]8ZYHKK*G+OYE>WIMNU%$<&KY-G',.';2('+'<2Q+Z`8X MZ0_7'!UZ2"BEPGW;Y7D2F)WHI@BFK0,[`QS$\6BG"3#;T$V7W/1BH.U^H.V. MX4(/!5,XE)V;4*+S"Q;F9P1S:MC`5F(6_5/3\@"I$\B.MF[*@ST8B2.3E59(L M2.&(=M(DBT=&\I85V5?Y.%MC,HN\+0CM3`M*94\2Z'3;SZ;K(EU^'U=R^D'; M,0W3]$SB!,1U6?IL!7X<#S7-,0E,\>*\N0-I%N`17GL)NE2OYME4"NCRDBS" M%/IU`@>Y!JOU;#(AY^@6)%5.P6>1*WB4[C()YV1;%7=;$'!EMI0:'BY0$>%= M637Y?]IGK/Q^5='[+-]_H35EOWZ;%?N8/M)C><\Q7/L6P79LI9X?6H;OABR- M)^/X$2"O5CFH[O+#"53^1O5@T8"V70R=X`55XZGD7B`BK$4[+#K\91B'%$>N MQ+QDY:0R#P@65HJS<[;J4@/!6X@S6NPJ-3^9H/BSW^=\[.R8_/LA;YXFMT.W M,2]*S=`W^:)1&B9>P`8\3622$(O7<&>&A#A^:7LH.38EGLRH2318D M%!A!ML4E)$XLR*ED;)C!K6`TN,S!V0B@B+I-J+XJ6TH-SQ:P&.<]>\**0WYS MI$%=TZ;^1)ODY^[XL,^+P[NRW/_(C\=KT_&(;?ML-F,ZB>>3D,USAK%=@X37 MC[2Z*47+;)0,"7F5INB$WZ032M3"1&'&OK\3U2:U_%[6^]6(A>G^2T;K-X@A M1'\;,:(!Y!\+UZ&($'>AOD0I[QNI&U%K4ZGQ004*7J>N'VES6^XG&GOM$S,B MQ(^2)$IBECHG?C#J:YB:H$)"V3%TKXR_S`@D-4V:0C$96X(]X(IX1UP':9I1 M+:Q39YBY($USN=R(<VHU3[B"G1G,\_"O8.W^;W5Y0]=DP2#_0Z38S_H^YJ M>^/&M?-?$5"@W06<6U(2*:G]1$K4-A=.LHV3?ND'0_;(CGK'(W0[Y'+X>AC#!(8$4`(@"',&N@GL209^.5R$=JY9U MZ8!$+&=]V>\JGA[J`4'C@A%YTF)[C )MJ,A%TX/4[G`'01NG:$0&6E&Q.$ M16O?*,>DU'`\==+ZF&;%]K^R]3X_/"!;]2_(>@GV4\\-J>M'%)&`)3[@WP)! M'%./H+?J?1NQ8:]?"EA.C6OP;+QXB*V%-O61_',TG>E]1MA=2(28,BE[]4!TY?#"&4!U&JP7`XUT_EO@=6K`LXFD#)LRJFDT*DN34;/.G=)5"Q2J"^WE M03]:/*LOFZ^=7%"A%M\WY4V5;W^*EX1KH/S'G%#^5_5.SP$KB2`$7A0G40B# M%..0!E&'U0]"I:G@+``MR_;7*:?VZL(9^M6D$^>Y9^W+],X"THK!,,EDGSE:Q=*2U"PE?AB1%`(;TV1AVKFF^$I-G-,1.1!8B#I:<>W4YWAZ%9KOS0512Z+DH M0L3U?`1"GW$\28Q2SI!D74#M^V5'2^(9L:F6.% M5#TJ[TE)-;S3D5)=$J6U].KV1[[:K_,O=U_Y)'2SSZN4$R)N#VTWV3K>5[OR M@0L/1WA9;NXOBY_YJEF"K.12Q&R\(R]URA`U\A*4W[\TEY0/6;&Y3A!V@P3$OAL$ M4"4)4B?2TD)FH3&,1+T)G%V1.@4+^=$ M:#272Q&A\8Z\%"%#U+Q]C;C<;W;;I^OO5]>`^2P.(X\F89@$$``6IMTGDX#) MO7HJ_W&69>7[IA`/H==J+EU=2(&,\W)AB0,WECA7W\@W=J6E!U5^ M^[?[\N>_MNXT2E#Y8,L]N,&B>KM`B1FYG&^-%+7NW,!0?P/(T"6` M`0EGMT^#B%4ICZ#4-LB)/*`!W#L<:D!*`F" M).AL`<]'\K4^-`W8/@>\7C>OGRB5G]`EZXWT/A5/:@HA*.H>ZVDQZ3UTJ8[C7A\;,9D@:>XQE!$?2H.M1G&F]$E^]G.7&'T%3J:YA"2`,/,>(BSPL9 MB4+2?3Y+&%,KAB3]L2K]6*O@T;=RQWOOML6C*9]OLZ,FAT9IT9.WF31*0G.D MR5F8ALCC/J$)BHY+]_$_Q$'=<8<3&^KJWY.=]=$^K[,`))C,0[ MB![S$]C;!"R.U?K]*%,3:<&:2ZRSKG-W5HNLHBB,HU-.*";C44T\.E@73@VL M'@KUT.JZ9Q/+RCF>SDB-$7H7(C]F?"DMM#]%F4KR;?&S?BRO.;D$DS@"*$B# M.$BC@)$X8,CEW_$\R+PHD5J8T_ULRU.\`QS-HYS*7,G)CDV:U)1&A2$KRO*" MBC-BHDO:0O1#&WYIINVH7DHOMWEQOV&_1*'P^SQM;DJWRUDPA$$"XP1XL<_' M4"YA$'*;81R#@+HI4+IE0JY>>\U>V^9KO\ZJ_LL;7&A2]U`X1< M'.*0(`I0'(K1&PVB&#"F5#9-TX1E8>I0.5L.RZDX+FU-TN503HXFH$]-B7KF M!")'0)I+A(Y3K&B=YJD%$(E@6K MA>4,<>E=.+,5`M5%IMG85],[+>(M+TJI4">U=F4E%@O12]M>GEP)LTBJM-X> M,==>B6%>0#!C<9BZ84"IYWD4-@91("X-JTBJOI595%/OEMP(*N6D<1H63:C? M/+?E3O)S1N+&<[H0%3/@2&FZN:G6X\JJ'^FZ_*LUW!U"I2SU`IA&V`Z;ZHN'R[-`:A ME\#0#PARPQ0&`#(64B4-F@J39=T:5E+;M(XX6>U)7?+>].F&R4(IIXI+C**: MD@X#V/G@M$Z\?.QNH+J](_,7I3<4@S/*/764%Z+VD[M]LES>E+1K9)47>[UQ MIVU]'2W^*\4FV]P6V;H#^0*CQP"+D7B\CD4X]7`4Q#U&`!.EB?.DP*8^'O?R MS(F3UUM>*Z?8[$J'_U?/R^O$V&H/N&>_WK,-Y7RM'W:4*NFGH5% M63__O#H7T[MRX?3.U+_8N=/GH26EH?'QD,I%$X9]<0EI2M]/9J7)`Z"1FHYN M8'W*(EI`0E?AA%S,4QSZ.^SSJ8D'BQ7G::!MN$$Z#!`U\BV=PT M;]<[U8\\WSEU[Q%*Q7]Q=1A(#Y[_TDY*$P59-2\M+[[ZJ6DP]1DXPZ/W5F*Z M<`8/Z"XH21D)CE2>FK89+"Y53>S^R6PU1QA,):SNQ,4)N/F6#_7W^Y.9R7^;?$J9;:K+UG7TRNQ M%C3\#9[4^."G*M?%*NLKCK8_NN-Z>5L^J!8QG*%!&$EO,[<%[5V4@0L7CG#" M^4VX\?OB4Y8ZX?I)RV)PWT?:LDF`6N*R'@J-U%6793N@K3Z7NZ373E*U6^<# M)PXZ>1P[V:Q>Y>3+=AKQ=;&NE-5SW+W\T8UF(\>R*@7)X[- M5#M&EI3T9VP*4@.%]]!4%S>X>!>DG1R0O`OT:H.8_]QG6YXDUT\]CB3;9?V; MOEY(/2I*$R;$:K.*),A MCA<"E M`8D1B&,4)2P!Q`T")2$<:6J*6T5B5G8KOL@/`#6N%XTA5$[F)N123=YZ&NLO M!MCF&\>=Y^J-.T@&2%Z(C)GRYLBM)&,D2HG/0`O42K1 M8\[JA%L^/=0/?#C\H>)@G0-:S4K/!NE7W5"9DGG]38^1I%O>B7B#0ZG=`E-Q M6(@^6G#LY*J[6>KD!WO9_Y3;;_QO*G$2X::KH+][.MBO2_X@E!#D^@1$&`=A M#%,?IOU8,P6^TJ#/D,VEZ.6%4WODU"XUIVEO#B].[)Z>]7*=*FC&@B0YFIPA M/HJC2F-\VQE@RA%X;J!I.`0+$53C;KT<>%JAS:28ME6+4A0&"0QQ&L=NR@B- M(@@:`!"@1.T^I#FKMF?3\KU6K^J90?Z-*:4%ZJUIY3RETJ1)'*>7BH%X/XJI MZIBZ9FI1)ZV:WZ^^;?.LVF\'%ML"3"F*H(=BES*2LA@@DOI!9S&!&*O(Y`@S MEG7Q^]^N_N9TX)RJ1Z>H?F-XE).[B2A4T[?O5P?NAF(V3RVVTQ2=42\#O"Y$ MKDQX4AIO=,J"]$?Y,]]NQ)&VN-P^ENU!#:Z,Y#[?W'(`KZ`0&`,_)#A,(YAX MT'/=..Z@A'&BM)EKP_X4$G;?H_Y0/8J3X*)N179?U[48H6H6@B$K=_/&05D' M#W"=(=YZN-Z>ZP?-;O^1KPY6 M/U;5/E_1IR'4JTYPF*B7\[@MJAX=]`&"%"0(HR0B+(QBXG;HL(_4YMK30)I; MK3_1*^6-[FEB);L?OK@PJ6Z;-PY\N*D]>+;8W#CAW#PYSR6_=\09>#*7QIN) MP-FM^$E#O)!,,+77KS;V9R!=]0W#`P2QG/$J645)2E*,891$R/=3$"*&>^,0 M*QU?,F/1LMI_+OG_GRO^12?T8F1XM7_<9INLK8VI/5`WQ+Z M!O)<+[S./_B68NZ,[IIE?B&R:MBIXV\E&J5,_A!Z.X;/CQJ-21"#((#$I8!@ MBGPO3CJCOF+ELW&6;!]![\`Y*]$/__F?0A?"?W?NU^5-ME8]ACZ.4CF%FXY- M-64[$+D003M+U+D3Z$8(7HB`&7+FY?ES@Q1)"Q:IJGSW6O/\)$T!<7V/>6G((`U9U,D@2!(E M3=(T8?W(#F\O(ZZRJC\1U/[)PWT4A/G(2-U]HU)1/X=[+Y6P/G"F1 M>48L[01E(1IJR3F-BS"Z%,I//4^:)@_E=E?\7[Z*RVIWS5)*(^B#E'B0D0B% M84S[_6[?!=>[M):>AAFPJJ6P/3UYE.S".0*,Z$S7%J^2L=`9*%6>HYZ\3 M/2?;H5E5G!EHVYFTRG%X;@)K.`H+D4/C;KVT$8>:'+"(D2ZH4(I5Z+ M"E*"@E-3;G`*ZN.BZIFU,%X[R<+C`.9E7VX(!S-%H73N.%P]U8 M6.16Y6U=>[/>M7]/$7P&?&&1?)%(!7MU>H1NFQS-\'DD9TXEK/T M!MN)5SP/<$"5H@`QB/P`PB!U71X.OSL]``GTT/4FOQSGCV\D/@(DP@&F@*4XC``@S;L`A-"8(]7; M0C:)P/*:W7#3\G_[6O+;0]'^LB_:K[U7;#0@CQIBPUZL;5&(2Z!QPS5>Y_@Q)9WJG"6H7T@>-N%*: M;WE:_4G,$E/N8EQN=L5F7VSN#^_KT'KVV$/+JT_%IA3GO3Z*BZEY)2I>/?^4 MYIS?IWSWH^0_^%9X7W@>B@FR*,01]B-*"-^TKF"`58J'[U$_):'6:T2 MM*M"1?.OG?#LWQ2'54LD3TFDEP7=NOBWCVX+,7(.+@_?PFH;17MPNG'%&?AR MX1SRB)@_LU_<-:Z5/)]OGYI3A!?.9ZZ`_-,YSG7S@&C#U]S)9M)@OYG$EMGT M%I4<%TK1T:2[4*S6DWG"OZAVQ>TU$UZ;6IU M6PCCF@8P1##FR0-Y0>IZ'@IABRB(,55::+8(P[)2=W5Y[*NU-._6Q-H&Y5-J M=8M_^5+=`C6KU*K1>[]"K>SI>)W6(]>F3#^;4]=3ZN<3ZF[6<$T)\7!,<4(1 M2FGL$@R"#G*:N%CE'M2<.)6$7OWNU.GU+OO2;RZ6UG+#+&&<,GFHK%$M/\/( MALML"C+>2-YOCC)/Q?@D9BD\ZKNJ[-=COJERFF_RNV)W%/O3W_?;HEH5M^*? M_8I6%)&(>-1CP`M=C@E%%'3`/*I6)=H^&LM3DS^WY<^B$N]Q<;##7I;SUH`E'7 M,*J=<(ZDA-:1$],4&?F?,9@*%ZR6&%2M:U8OU4WN/I0A]T_=BIJ:W27MPC#0\9D_BU+'J1,IF'.1F4`L)@5K^;$$?RY=O3:'FFS'I,WUFJC1!^!8R1YK" MTY=ETZK,,B]0.M`\UI9E!6YQZ0FN M/H%*JCH)=WK2V4U!CFKG/,IXBJVWY6\TS\O2N/'N'!9SP*,-'0K)$6+2O78=8O&IRF@HTE54G')N133\U>+J0L M2-7.<_>VMAGB?ED*9\JIXSIGE#*Y%>LDO\NY[97"O/\:(,P"1A(:X@@0+\8X M93T._CWIU6D;QBUK8`=9YQ2-/<(E%I_GYEI-'WN:U5><9P^&PN+QW$'1J\?U M[4?N<&R/Y4:DL/+.J8^D#7J$D[691KNH_$L^PKNH_^E$?1=OF MF[W;:XV3>/Q^Q*Y_:PMG*HI<'_F'\85X.'8M,\;)P]/JZ?Q"_5Z+O# M"%6'6_RXN&T>I-GP:7.+89W]59TY32VWHJ[1)DZMGMML7DM8*;?J7SE1/YUP M?_D:)RFA"*=1'$8X#AB+XWZ^E`0!D3DO.PD0RP=BO]6"5;])+/IMW\$GW(Q\ M.Q;V=Y2-AF&>G>1%16RZ;6.CD=,?!53[!Y$23Z?H=J.I_L[J]="Y'RCP<4)[ MSD\N8X_.LB/YM[1?+1W6)63?R7PUN#^M2+#TBF%[AT9GQX7YONL%KA\EE#"0 M1FD4]3OE'O_!_U-W)LV-&TL>_RJXC5^$[,"^'&N#QQ.]17=[+CXP(!)J81X% MR"#8;;U//U782&HA:P6K3Y;5%"OSG\`O:\FJ$IE&-&B&X7%U7Y]=]S856]'5 M:)/J\\TW6B*\8`X>C/ZY5J/EE3XS9;E`^"R9QUS"TV;Q=T-R-7HP[.70+?(0 MCC!(0(1HTSXD@3]/M,8`'/K>O+\AC3VA M_62:FK1X;4:WN'Q`NX*NLNLP''W%A?G&)]X9S&E6WQ+:Z?:J,?K(&A]G4PJ[ M*`=AB'+?RW,W#>CX?[($9FXD87F>FNCD?74E/>)@-@:HBM5?O%AM;6 MCZ>UCJ.Y8V0)74UZJ#QN%A13]7"#%2(`8A)$J8LQ\7T/)WX^#\]1!L6/WQ%O M8Q%^RM)26C@^)"ZAF1CW+.H>BO<'5>6T!%'*;O!MM1>417AX2QM\-Q;R/'UH MNL_ENOE6LPO9P$.SK[N/=^R*MNEWK_W1G_6FV@UKB>6&%&U-6;G[>#=B]Z"[(^,E!^@VR2LXVK?)]`6F#E@RF$UWJ,/.P>,;9_"9 M/2+'7CNO__6-<^*Z0XZ>L*G+_87KV3(Z([%@@#FF-VQ\W"Q)E59+],;$BY6V M"M0P\C=/O9LSRPHD!'@$Y1A'*/*R($H`GB?3$>'?=&"H?<,I]D]#:=5H2,ZG M15NB(9;6Q!+039_O9KMM"(I`D:(%P9&\,7SN5.Q/PG7\ZMR-X3I^:9R:1HN] M4_6&E?0WSFV_=V'NW-*_Z.\B83L8]AW]L[+?#G!R/)5R::*)A;XA8I\U M3[/LE%G)Q6@L-:R[H*G8J$Q7@.P=5&GS\/*82*^8_"6%TWY(F@R.K`+]KD16 MJ'XP;ZYNA`@&,09)D.4@P=!W"9J.HDXSZ"&A,D,#[2]5KO/V]DWA8\E,1($/ MO-<.@!AY#]:RKO`)A\$A$D'\]M^@F47.`1;\@P4P>#Y'NK$LH)]TO-BJ;0 M`QT,NW&H:=?#W3FA^+J5\OI:`C`]OKS=55052!Y)8ZE._8W=;8**MGVB`\T? M1;O9K7P?>JX7NC!)8C;K'GC>3,4(!8$2H13:-0RL:1\XZVX,FX<_?'SGK(]- M5*69BNB2<%M(;PVLFRUUF*D.XA-^&?*]K:(("#7$PE8NZG#M$B:UR2=/S>D7 M0R'2*@A`YKH`18BV32)*;3#5':64XT+#9M6VEAHBM^7WLMZ+;LM35E(2?P9% MU("\^9>#>=>FW*E8(F23E-E6FLFZJZ[8]I5> M[6CA=!:,]\".3KXW&"XJ*L%)7<&R%IS;_ M+M%4KY#R>*4_(/K_57?:)XT2D.8$9GD0@X"D&28$SWU2`M6H*MFF89BREWK= MFZ5WW"RKL"0^%Q!7`S79SX.9=HV57U=/A)"*^ML*1E6W+O%0BVQ*&)Q^-V[/ M84LR]+]]P1QE\[A;9_?EOFA+6.S*S?$'4+/K5K$?IVZ,W3!S4^"%88@"--D* MHEAV]\MR!AH&[(>F_O7O/>VNWE4EFZ5LUO]VFD>1XR>O&SYY(%L5.4WTGO]A M=(IMPSY8W7>!)\=NG-ZU7V^9;Z!XNSR7(:<*2>A0.B M,AORG8X.FO9IE7DPC$/@>W%$LZ.?(NC/`P2:*X6NS5%HQG#.F`U1G\W@%DYZ MWL*$9AIHS:'A4O,0HR%B,PZBLMH*/0E/+L\BR(FCL/3>W9?M"I``^`%(79#" MD!"0Q]%A\A>'4H>B"39A&#R]$6,YI?+*.9]FLHODVN72L1[.C+HV;WHCA-:X MA:2TE3."7EQS2K".<=?3)JFZWY?#_*QC0<7^.LL!'V(-Y[GEL_\\T M"^IR73:MJ2GC'9W)'JEKL!0D/(^=*ZBGI<(E7+JTE3B[JIEM)7;!_JY M?&3+BZS,G>W39!L-RKN[S.8QJ-YV,2G_Z1L>&;>].54\>#==T[9CU93WX M<5\>?!PWQ';%O\M:VS57;SX^K^0_S<^=#7M7-7KSVH55ND32.4'-%@[;[R7; M'@#6ZY8^X&.JCEU"V#%2:9XG2>3GH1?.5;@(1;KGH:7M,)Q1>V/&5[SI>_.Z M*B-TQD+;I/(B83`V=SQ9WT=KLM^2802_UFK3P,H1M'5`8L)5\4E=3?+*(YR= M/3/T*U@-<+G[6']MBTU5?_M2TMY(O[EK17`"$4IR#R9!@`'T?'^>1X99IL9N M'088AO;!1.>7;T55[_[E;'M;V6D"N]E,58)K"84DNI>.@@9F'T7EW1R-T6KG M"T=4E@$UA[(BA-89*%O1K-7'2TS6+ZCR"2^30;\SUKQF3YBZ"8E@GN`@R#/B M9L"?SSGP4!!K/.=%V18N*N@[[>7KR]-&9DST/HA28N'("?/["M'2?AZ,6H06 M/1?FDL)\+#<3-/MX;LA/SI-B-`LKW\G^O:6I917@/,8@RE$./-EH%7ASXF4=;(T&:9[&/P70:09;!6*WKQ-.`X8[3(GCR"0M4V'\$JI,>!E13]>T M5C\,L.*L.;%3-#5);1^:E+SAFG*2%$D15Y_:YK%LNZ=/],'L0+TA?^^K8;\^ M!CD==.8(IQ')(I\$7N)-9L19"*4'@EI:-SXH[$WJBS?*R:@;Y[&M'HJVVCXY MF^J..E32QXC5SM'>UV-;KJN^\Z"%@0IQ48&BX8!HIN1D+?UICM9LL17(?%-/ M88:J1\9JJ&IPCXNRNF14Q.Y0I^-E,/%!G'HN)!3UT$V2Z5;>#(+4U8%8OI:, MXU3/[B-Q!55@J%$ZS>"[FV?RHMEN* MQ.<5X2\JQ,,P\3WD>C"(H!N&+LZC;.Z@NC[0@2V=]AB'F_A6IP6#H4+`Q:.@ MF9,"NZ869*:`JL)D-1$QJ_EKQ&$N2IN3VN0U;S25Q$$4`I#@W,TAH@;-DZ&> MCU,=\%8RP#BM7[DQU0HL+'=O&&\(K'[Q]7BH?F^8F)B*K_;*"Y,8IBAQHQCA M*'+ST`VFUL(X(W/UKM2:IDA+,K6YUU[<%%)2I>.D1SW-O:$/I1V38L(PXU;3 M:F#Q>\$%)4%1Y&LHCMIDJZG0Q[$?@,!#.",XQP2ZTWZ&+`\P5BJG$&S+<&4% M*PLX1L\P?^7\,M\(^R_5.@M1;25++@S*JJ?ZXMIE%J<"B51<2$IK'ZG4W+E4 MAZ$DDRYVS4NL8>[!E/;3($Z2((->1.`\M9;!S%/:E"K9IN$B#?R"8R\N5776 M6_H/PV&V[%"/^])9-P^/1?WT7[O3TU!$KU_5%A)NB:%34C:E$EK$CA:JNU429V&&,S<`,(^P%^:)B^):2KO!Y&NS M[2">8+&MJ.2V,DS&%8[26SEYE%CUH1E.0F,WSL#$#W'N!U[J9L1S4>K-K9(0 M^ZIW.PLT9;AS=UQ=X?Q2-_6OHV'*`U1!1>7A94A,P_PZ6&T!P@[&"%),0GN+ M02;C#0?+I$52G/*?&)K".$F2U"+J"),`N@#Z M)$I1C%$2Q10)<]%#A$(M=6("S2U4XWK4^]*.+Q%Q50BF6U43$+.AZ_6J9,(H MDU#;:IK)^,,%-&FAN)E&^D/`J^_E<"A>W.WF MNF^1ED3PS(8N+VF4BNV7KNCV[-*JDP^O:"<;^S#':9R3%*4Y2((I1P'B8Z$3 M`):PQW`"^/.W+[\YN\DTA]TQH241:`Z*2A*X7CQ,)8"B?P.,9`5U5;%=IZ@$/IC[*X]P/ MB!B:X>?/]X]WT"44J-"C(.0 MG3.1A4F4QO$A:XG=>VW>&M.#!)'->=<*B+Y4L%PL3.6!8P]8F<24%R8G;,X! M9]573`!Z(OL3T5^3PQ+HURFU5NZS84H)ZLT[&K_M_+F2VA3D?I3F@8<2G,20 M0!]-DU:`YB4-RP.:##%,^]ZN85/GC5,/=59WXW3#;5F7=]49;%PA+/K`OTA$ M3#%_"!O;/=*;?_3YTFK>OR6Z(NJ58_D345[=5PG`:Q)8*]O1/7UWZ`=X3CO' M."-A#H!/``Y2A`CVT)R"$B)T!^+2MAG.`(.I[`C-[\JW,"P>-GWIX%H1,Y4A M#F%]I:3Z]5)J>].&0'`4,XF)Q^`G2BY&W)?(-^;"<#$%]9>T5[MJ M&/]L6;$B/DR@KTB*@1O#&'LACA!VPQS/@Y[,)X@GXRQDBN$$5_O8X'%#?[/KJO4\Y#\4A[SX>#<7]K:YRDMF8&!)?_FE M[+IMR5[,W>=OP*&V`8P!=N&EA0:'V4 M-:JQ*:9]#8T0?'X9OK?%_]4#_N'>3_#:U6LJS1')/2C$.`P`G$:^O%A,@(F M*.:>S-?2FN$.YVCCT5S@EQ_5;O=B1O"78N<4SN/PVO(> MFJS6JJT-\]%Z'6I,/88B&>1SN=FOV:/X1_TRE_U94S7I?_^[V5:;XFD5XM#' M28;3/,\3XA(0!/,>"(^:Q9U)M+9J.*/,MK)9Y,.*U/2&[9S-OE]3>F4-Z^5K M^GHR8JM9I\=EO_ZY/5.F_R3[U?V@CT(JTQM\CI1VM;B+I;:3D+\Z"!@BP7X: MK;V>[`+)[FKRRR\4M^??ONGE.[.(S)TK7WD-W_KDZR]B2P>%-/]LJ%$M[?OW M_TY?RZK9**=ADMO[YK=#A5M^T2?SA]% MN]E]964-JYBX/DEQA$F:NQE(?#\Z5)+E02"RU*#:ENE5A.:@(3/J\DU[+2FL6,Y3T]3(]-8%L<[,:>F2V9*)+&WN-&:>1D&2458BFM>K M[KA)\$^U6V4DSF.V;.O&`:3TQ%$V+]W&2<(U5:7>BF%ZL5[C8-G)6^;\Q8P3 MY9:"EGS$6D9&,5;)*FB$4F\*=(9/ZJ):0B8-CC2ZGS<=-/I0/)2X>2BJ>H6\ MU(61#]E2)HK],,+S/8F`FB)TV9=J6]`E^-7&IV4':P1I)*H/'WP,2B,Z0(+[+O[IJVZI[Z;Y:')Z]*2%EN6-`0QWD MN<[0Z2UYA.@CJ*BU_!'UXR*!I(3A9M#)44#_LV^KW:;J%_;&KE9*7!\C%+A! MX$8X@BX*O:E9-XV%SMQ7;Q22I*`71SJ)B!+LR!(IJ9CA(7F M=W2TMU@O2OB4=RUJJB[RFQ%2YT(_L]#I3;1GM7]636K%7UQS2W"FU27NE7]9 MN31@;07](`\`BM,0!6$8PR@+TJE%+X="1YDK-&,88A\^OG/6QP9I(]EE`54! MIE4[?=RR!E52A.(6U7HP\7O"S2-!]#T[$=G=_JZC_EYHPM@*01 M\3R7),!%,,;8\_+)%@)2_@T0I@Q8&EVL0MKY<5^M[YW-=%(G*XDNAI,Z[XOO MI5,WG7/+JK&G^FB16GECD3I/0FN"),;(EZ>E.M1HYV"U(T?1!>,BL)W!AOAH MVWFVQ9:>#.KO[DH9PP^8 MW;$)TGOZC>SM>VR;[U6_,>'H'=5PS)UD`%Y)DHO$TX:]"L9];!9\001[_F"] M9L\Y;?)3LZW65;F;KV$-HB3*TR0!0>""((JR,(P\$J,T]D*79+PKI@HMF(/R MP2AGLNIZ%R*_K="9KJL&62WINNKPI-'^S(DN8JSOR\U^6WZ\^]2RG-`]?:(/ M7`?J#?E[7SVR=#36[Z,T#T&:I=CU\RA.X\SUIO9S$F="JQFZ&C6]K#':R1+F M9.F-T]O:S]O/UDIN%-(G/N=:R#5T%P.4L8J-^OY^LE M9H3CYN.;K<*GK_2;^AH7XD.`8S]"(`M1",(T]=*IZ52PJE]'>X:I>/X5O7UR MF*%R-7!:U.9CX=)":\3@#9_"1EC((=L9#.H4W1(":G6I,?>,ZN(>:WBLJXF0 MZ^801;X?(HQPGB!65S,T':-$Z.I`'>U=DWO3.RE7A:=%;47N&1+:`/>N4ZK' M(9P,^21DMYU\,B[QDD]:+F[RP7VUW=`1^%B0$\<`$93D.4IP3@(`B>M.K?@! M$JKB$_QJPSR;K!%=,Q85B(]+!K410]!DR+5*\$Z%.(,42<4LH8>L]8V6QT;T M\.@)/V,S)((Y3`(80H`PA0U&A\FX*,AP2E1.5HJ>!BVJ M'!\M3(HFAHNCR:GK\.*9%&>`(2N:)<20-O_Y.X&VV655_^PGW;3YJHT MC3#(2>1%$0KS$$MO9';6/:O\-MD M`&M>^XA>2X?EY>2RJ7#HIAF342@G%J]YFZ$-9=,?4[1"8$RP.M"I,F$)Y7Q M3B=S-X!4]P][-H0/TL?,_E;=M'\6-1W,YHZ3IG&:,$LD(`@'>9`/9@/?=X6V MDDS9LBQ,(\*7Z50WRIH!I$S*N`EB3\O4')S*:=4([N)H/L7Y'`$*J)8=8B72 M[B`:CI M\+H;/[IJZ:Y+R>>MM6_+;?E_Q?B"?;F[J>K[_H_-<\,O3W:_MBX>RK;8=O5IV@A4U0%X&_K,RJZ+C?2QSFN&SLACKPHSZ'#YKJX M>\Y\,.'+/2$N\]UI1KM:[I44/Q(CW@(U2F-^GFRI(PK.C7M)HI8T\F6A?S3V ME=P7/X4L=_S%JL&(ZT99Y`09C!,W3&)$PB@[&(&15%$,N2];5H`!C.PYHAPY M@B>'UGB1/"OL<6(0&*8C=+'(3BP(]&RT&(I8HH&S!G63). MWCGXAZF;'!+LBLG+Q,3*:)ZU$Q)ED/*%Z)9)CT2O<*B2I:]P M_VKHS7[[M;RA*S]PTMS)XI!I;.#!,'4@'DVCS,F,2)R$/5^T=,-/ M)1@FP,\ONC.$XX.%X03CIW('GFE1-Z(/@!LE7E/]+'%N4/XN0(\1<)!+D;\7 MVE3T3X'TI0N@BDNB"JA,EW@25/_8.-G7_!'SY^]UL6NVW:G@H:!,''HY6V1F MQ,,PR3,_0>[!LA=Y4CF=!LS93HH:7E\?(8(CC+)S/!/DBJGLE.Y4^;X7HB^F?3H;2Z5:;*TU*WHJNC_4I0[7H,NH3?L=[X73ZLT@:$7 MQ[Y/8.8%*'&@-]9'"&`(\]6.WO*)D;K0J5H6&IEQ/S*/00H/T%]IRVNJ=H.4 M/JWONO,@7NY1/AO4).'JTF>5:8,:V.,$'"CXB4/]^P6X[M#R8JH+$,1/B)14 M1MWF6+!$:KLFH)5FZ)-XS?61[O9T*-KY2J;]+'6\.`P]XN88N;GOYP>+?A!" MN9==E_PM\5TG_H/?A;TZ4+\U^Z[KT`#T=N@+;X@^YXT;[[PSUM!D8F8]QV>YX6 MSJ4UI>0^X:M6O'K?BB-X0(9&'/"#8P>6U%H2N?\+:C4C]P(>3`])_M%7PU([ MH5^/\@\"[)0-N82+`%.Y6DT_3F1B^&^T;;>4CQ@&KJPV#,@5O2Y:VO![=90V M*R_W4@]E7HB\)/'<.(G=L5)!D$5B+[\;,F4_$C-8W0!O#EA[!>A@]K=PJ?"> MBRF"!>+FM-S*A<87;."(X:LC3O/I.96(;M-R:RJ`B?5D[3ATEIS/0HTY5I<0 M30QZ4UGI>LJ/2?QV5]0TX5<3^14WNFOZVW"-BK+D>;X.8H.YL_7W>7/ M8V?`L3=\$GG\BX-'H'-)^\T*ZVTLMF6VS.:5#'83MZSE9S(T&^+$1M[TC;V0 M?;\9'/_T)8YIJ1*?VMK=9_?'LX>E2=.+F;93@@,?L/3K"7Y.%H M$!,L];*YNA7+T:''(GNRJT&:F#Q/PY>61;Y$`MMEDP( MQ_8TMYO7).\F0+(3U0G:17"&NJPFD9R:"DQ'S\Q&O\YVVT.?^5-ST>F:=2%J M/:7';V>?4Y,M/^VD]6.YIA\#)45S=T77E%>-RAFOV1.MUV7#)],O<:I91=CU M8.H$0>`Z0>RFCD/(`!'E'I9*Q)D2E^6(P%'R%]\[F(#W2T`'H'S%7,B\.#Y+ MLTE.E1?68JJ3Z]Z-3SOVC4[:M?CV?F)YK4[*]=O"Y%Y_(0MOI!8 M,HOKGZT5)J??;'3Y7CPE=$=ORO:*]E?Y3@"%6K7:O=(FY9NNF59\[UJB^VK.%LU M[:]5^]^TO3HH[BK.^1E!!",81G'BQ0F,W1%P$J1R#ZW-AM)RT/K7[BA&K8_W M:'B>H8WH9*-;OKC47KW?ENCQAYAEXIBUX\6V)`4NEC70# ME]5^\2,%,+M$J`2R"9IF_H!VE)!UN&WCKDB.?<=%*(O3,$^R.,I@/'J!8!RL M'JJ&_>KCW(%.#;V,;+YR5%@^_T/+VSOFRL_%(ZUY_OV0R5BQ/X(_[\KU'=B? MC)&@;-BZ[H&NN:ZV%5O['2W[EA)`%?O.S%'5?I]96*B]>)VO+'#7],<*P1\V MZ!QQ6:]G_=6#M28[4T5P$XUH/U5C6#__PGZQ;;[L>M!CU,%]T.G^95JT-"_* M^M_%=D]7D9@-YK_F93[_<%&#T'@^O]KP#N/.#>@\[]'R6K1:UQ;:3`6.YF M"PGNBZ7'5'+-),UH/[P?D&$6.>Y[G_!N\T_:WE4L@E2WSX>*&$D8YKF/L@S% MGH^)!U,O.FPX8"*5H;,$O);#^!'`5^_AT;X>;=D_>ORXF/!YZR8NS/WQ\_+C]IHJ0 MFKWGKQ@C=2FQ&26---<\`$#JY3[(@'3W`>3;?6E(/ M]D0'KF`\<*7+"J.:;3Y#-)VNN1<35-\=E_Z%@NO)YIPJQIKI4W_%4&N(&9L1 MUV3CR07>Z_,>7,O,&;[3^MY=Q;'CD)1`F'M1%*0(A8YS6%([B=1-TAEA3K4< M97_W'ORD]+#FG(TH$3F7WWZ+B92'7L%]G",L6FFK,HSG$49%[H(>*A/,BC:#Q+C7$J5L%^.6BG"G*;`11X M+NEVUMP=M4:=<=?56GLN+^B-KO[PB\*/VF[J_5:E?K.D6+@,0J;8:]5H*L&' M64RB?ON.P+>;R_WUMEQO^?N5&SIF_ZX<7D$O\\/$31%_L1+'\.`(=`,B_M;+ M$M%;CIS#9<'JYLV;&P\#6-!V:,>L6*D'3Y9(I]"[-$L$;CGB@D0LX@Z_)Y8I M^_X1'=:S1O=![__YFD8_2L^2>9UGB0[(]#`C#_X<*<[#H7MT+P&]$9]7]^O^ M"WRY?]B6KTZ&.OW:K^\^DRU^P7[,_W^=^__!,5/WL5ELU^YI^IT]MPEKGCQ5)/1@G)`S#*"!LUINA&*(TC'V2X=SWD=1^B@%[ MEN=UO]"*"=##7;GN[JMV-B>F5G"[UZ,`! M'GC!!W[G"$$']G5+3IZ.3UUXSQ&KN\G*$I(BK$7!YUMC$,_\84W&DW8LC@41WA\WG4` M"$:$,][,$^#MU&`T2?M21J-1G]X.1_.$"8]'O-U6?S*3-*_JM-I?MS?[+5ZO MJSU;YO2%N_FK8V1?UPS?*@DRU\.^3Z"?(9)[',$``OG0D[K`;=:R[:O8`[#A M(06.[`(4HP?-<;D4V?0$PRT@)HWSD2^GD0><74&P$2DX-,?547,,:"<62RDF M3ZBFG199B'Q:G[IEMUL@5FMRY=8<)L M8`11&(=)&"`WR)+1.@ZP5&UF0R9M[]6/*/OMJ0OP4(S[3D:*39DB7DQ`9^!< M3CE?Z/ZMIYMA9`,=]"B'[6Z&L]\8GU@TQ=@[H9:&Z5^(3)KVJK+:9[6$L3/5 MX'U[5]5=,6($<>K[<0!SY#@DQBD9UIO,JIMF0N>@ADQ-+82=W#6@."#44CYY M9E44SRJIFDK78P-8@,\)U.TM4\*JIDSQ(M5,W9N3*J9)DI9Z?=NW35OL-N7N M=A5D,(0P2[S8PQET"$Y39S1+B"]US5S7UDSZ5;U`-"!@4N2J*Y@M7LU(V#<1 M2B?3L",TDB*FPO*"54S)'0$94Z=)6,=(=7]?[4Y/`)/0"3"$.$0X"6"2Y&YP MF`"&62R5O&W"GF4]ZR%:6I4:X5M,WJ:F6D[B!I87N!@5X.V$W)ED?2&29]2E MREXG59>^=[-&-T@Q7IE;HKG^N4)CWJ^O2E>XIA1>(DQA'$GI?ET/5QZ,*# M'.9Q+'537-7&'+K4OT2AJTFB)"KJD07^]+7H`GPYP]TT0M2CD!$A23J7*D"R M;IP3'R5:A(7G>TV+9E\_'QE>E:,*ZIARAZBM( M_]X!.Y&_:91!T2F,=?)D9S#RO%F:OWS$S,GIBQ:5"]$972_>35X,D"*L-O\L M_J>JR9X%\GLV8O%3V:QPZ",'IS!`3@A1`/,,H=$2B3*I]9+"YRVK3(<('""! MWSDH685184U,72P3)JDL`XZS)%F1D_=4G)`2#=X6(B,Z'E3&.I&D?/Q:W--O M-Z_LI=5]4>Y6N1<&`?)2$V.CSN!#-,>!(9;J+R52

SS9=^U$EK? MTMT_Z?TUK5ER`5/7#B6H# M!KD[K363T28G,Q\P]GL/2E2E]4B3*`\R!7G:%3S>\WD!"G#?Q<'U*.E#00_V M%\KV6;L4QB>\?*#31FA<0D$);1\J@_U*=Q\K>4[H;GUW7]1_=%-2`KT(1IZ/ MP@B%:9!%;GQ8T?)ZG5H[6K+&IM_;NGX&!XAJJU!]AA5WO&R2J[WW)4[J-)M@ M;\B2V0Y3Y7DALTMS_IS;(M,C2D/21JO#'-0YS&S_X+K0ZPI=^R/ZU?1 MB`VD=;%=[[?=S[17]>_;\K,%O4:K+V$MKP._,M/Y96L;O:O],=A#;D!\ M)XZ2)$()\E'@.>'!GN-(37.5C4P7+'ZE[4<5?$U%6;T(5,6?7]>%LGR`PQ.CN)W]D7NI5^DD$89-C-2>Y[$<$D MRI/19`QSK+F)*&QGEOU#CL[8UJ$XI"[$XU5[A2)'<-J$TL0N1 M)B.NG-\<5*1'(V67_?UAV>[[;L:/MR,8H2@EF12-R/5[4PO4/VX M,K01*,.HHCY9(M.0/BUDY^^%)!F%4J!VJ0JEXLK9#%]5>L05:CB2?V=ZF+GY M+LF@DR)^69Q@A-($'831R8)02J4T;=E6JC$O\F]O=C?XUH:L3.G2*BA5$S(J M*5=CJL='EQ#F6>F=(>N4;!FB>2G29>'WYX=@5FD>_% M;IA#-PFB`.8A=T<,MY>_;&TLOD$"/:<8'ASYAY\0HTB9T(2-( MWX^WCPF9(49YY+R\((:C$`9LD")"`A=')''#C!O$208CY,J]6:ALQ7)L?S>* M9!\F5*=/37GL,*N:9I412&(? M)5Z0>CAS'.1FI)\:!(2D2*KN@_!'+5Q M5YK]0[)3_U)737-95S=ENTI\-F9BY*>)AR(>O%."1A,^1%(I(C+?M=RU.R@\ MFY-AD0R:4NR(A4E;Q,@%QIZ3RS.<6!GM1P2<&/`J-"UDS"M!K_1[B>3(_[); M5_?T>_&4/?%WS6E"=Y2;"[,LBIS<]QT?^A@E"?;A:"Y-4ZGZ::HV+"M"#PNT MQ1.7A<>R.?G.MY51\`DS)T:$+I<+&1W:;E1FNYCLX5I_.:`9:\@?5KT!)FE$ MO"SV8]?';AQEXV%>0-Q4[I*VLA'+XX;G=Y?]V#F\4P&*MJW+ZWW;)2VW%2!T M>\O:X!]3'_Q\PMFIDQY=FA'N68X88X4'U'UK>WK5T@Q]I7=S27_?\ M>/S;35IN]^RG[Y^LR?VD6]XE490Y$">!&QPB8I[&B.[V2>FX4$ MA2[&S/Z*X;ZNM*]!G3,C,S"/$4E%QY=7VZ>N6FWRWHXHE0L9:/I^B-[;D2-& M?!.&5K=U\7!7KC]+%2-9Y&+DI+Z#,T@2+\5Q.AH.GB7LU,Z0,;(7(E\& M'7J[BV28*O5LK*\O^5\8>AF;;>2AYR:.RY;HJ3-83%",8JU<+'$SEB7L]5"K M;@"IZ:9LNT%W8F5LG$PQ_9J(1SGA^DBMOLZ65_HY13(96/*\+D2C3'AR+OM* ME1RQ"CY?=FO^-`E-:?_/5( M,D`")-4]_="Q+9LXYSO@68"S]#[XTG0:6;NV9T9AZ&FVJ2AAY!N&Y:BA':JJ M$H96P.2'34B._'-T2CQI@5+4Y(/MD4RP.3)`_;C^9VWS%IYN.1/)\+K27*CX M^)1K)[EW+0?OB1`;)D"/6."_$F+_LR_+%2)'EZ3E"7-88Z7)A,K6L$@(K&>L MZPPR6T);I(DYSF=[04:?.WY"U1I"176!<2`0Q MDHDW3VCY(1FG83YAM@]%@8WT6H6VXQN1YNF1KIN!$P2^WX4KH?\ M8?]LD^;EH4#'M'G+M`U/L^S`MVU/L75?=1TZIA5_H9E&,"CQ;\A"TV3_8>*8 M`UYAA-+&N48>!>BG<3PS7S:/ M:'M(T>==@'8(Z[^MG^])+B<]_8!%@;B`I+#2GQ<.!Z/8N?MG3 MXL-L>Y?CD!-524%_MTD#+>N>=N M0CM@NI"Z!3YD7]HWW)/+KI9(T*<2]!``'03UB'=`00`M"LVE?Q\'T`+1M?.\ MN`[?+.Q;$!W+B?3"69!GF/Z[\21N/(Y3](6S(O_XO05@!>I<^+P`%?&.L,^3 MHDU%]EQ\1*&904#V8)97`/WKD%0O'Q[H=GQJX*"S"PB?9'>1K5G/,7@ZW:`/ M#49_`U\?T>D2[W;X`>A'O'\B9-4E<#1M&!.S`MMV%S_DV:%$)5EM@XHJ)KG% M3VE2?=CF:1H7($UVJ#=:H;_$>\H!2?@OXC1]`34#F%R$U\PI&Z01#4T?QZ\0 MJKXCE/6&'=9L912M?8X?52("%GG&;I=LR.!Q_,D?Z*5Y($(8%?(WWQ^3S2-] M=$P',&#F]DF)R%M*GU[_=D$J$C"<'5_QOHZU,?1;5";?LIBLM3M4Q)O=DC/M M%2BQ_U,E>PQ(DK7:(F['4<0[;!S!$?X5.#QA=K'/A!&C\'Q/JD=05LD3F?R` M'UX0V=:_3&648-$W>J2')$CJNU.\V"$I']MY%P]%'F,OLL&UQ:"5.7C".Y`. MI$CH`P[E@4H!LYKF1+*8^QX:Z&]]WSU.RYQ0DFSHW]2\TMD8J(&)SK%`-1>; MOJ9#=:W-A<$=!7K*"[K?6\RPO,@'&\SO"T6S?CRFNYE\^1"G%#O,.*JH'-I/ MVO4QN`])*F(\YKR*ZM*%UHVHSR7>N&UB1FA?\M#S/==R%-^' MMAN&D:[90YYAG^L)B1<02B2V1;GGAUW]WE8!=Q1%F M+9%^^;'5?1U#UN9^WKMKYU%]V<>*[OR@,.&[#C>2'@ M8HZVZBCD0D"'DGK@7'9V&7)96M"(HEZK&U!W?JGW9P*[VPRZ"-??XV+[EPV_ MQH8N,[S\E^*5)>NA)00IB\8GOQ&#PGF]?7G59FB(;4(K\FS?-8/`BD);=]UN M7>A$7/,81R\FV=U_PW$:-FYH/,)LE^"3@LOG\%[%=05@FE*?M9QK$M%;T%VY M&Q>&^D+NQ\7QDTO:GIP*[MR*UQ7T_4_*N:G\]$)'UQ7;#*#CA'80.9YEM11J MEL*5M#@A65.=D9P$#<3-XU244TJ*3:4N5$@"3AM6KX\8FG#KY(CA_LSQPDS5 M[^(D<467SR#NA6C].3C/9W_7>$[N?\NS;U]1L?](*W"39W2'7[)F/=M4M#@VF/G:C%Y&LY0EI'PAMH",.W+'K^/$8,IPB3P4?G_XE M5($SR#&H4L$0 M^DSS,(0L-($:/ZN,"(GB-!(/LD,5NR10!2GW^?`J)=L#+AY83$&PP`:9PRL>LVVG2UT(L5S_!#:#K0LP_$MC:YL M!)9O0*8[`('+R3<,IE3#P`GN"/,@#U=Q1L+JC(10:\$)L@";(0_L89:##719 MUN`$#5Z;,`S*)5N&@1RQV(W-(,'[*G:+4D:.2:,KM9F3,?9 M"R#-8[J,-P0X,$U7U+98@HF>BE6.Y%FQ\`HQZO7'<>J]W,5%E6R2 MIYAD()!97\3]B+^ASSN2G/`E3N/B9>U;:J1!:"E*8'B!"K4@,%H*355C#Q&G M)4NRR3]212+5+GQM2_W&Z(0A'H&9IP=(5YUS,*&4AAZ]/;[S.])W] M^6T^\S*#0T;*A?]:NX9+L,?&(9Z$%(DOT-.!2R..?P+Z2"/YF[XWH%D'T`PUQ<3_P-#7--,T[*@ET5,B?TI_@X>N21V.#2:L:]JS>(^#2[S3 MN!RR)#NCST%8`@U/2Q;PM%Z'+$%+<#O.O-1_8K^C)QB)CL<0\?])/(]!K`MV M/8;#+Z8#4=..X.]QM7F\Y!1]WO7I7VN.$BJ^[BB.8_E.X*BNV9&)WP.FN2%S MT2;9!VE)!GM",[%`\2L5UM-1OY3].$ID@Q890AWO=1R?MO[?2OGC& M0;[M,[9T:0OLMC.SU(6X(6W7%OS*TC>;))C1[C%D?A/9%\TUQWG'@B:IH1_D MB>3"Y;I6*'_I:P7I[5#XI3/0%Y&Y#V[`'Y'*/D^O$NEB$.*7G%:%TDZJZ]!6 M--5278>`*\SN&K"W[;(-HD+;-:]-95J`)&83V>(=`-M#" M#?[))^$RQ"#.4LL6QS!+3/JZ<316;GJ@T7>EU_'NS8A?MJ$]`^Y`0SI&3#=@ M*$>QQV$(Q\,XJB7-;VVO;C^-RS+9)6C;FVUE0=W5HLA5-,^U`\M4-;\CQ'%4 MI@X#\E:?)5FP:VY.Y^A] (3X(DKIO!90A!A"'\[8C_D=X9Y^]Q(WI&W'U7(A5AX3-$7P-T"!"`PGUJJ($1=+Y)H(7]& M12])X*DGDJ0$>Q2383`T4QI'#*26**Y>_V+33ZVK3*69SP^(M']^3K8_]SDN M>:XCI2=.OY;4T%3IP1*_@*LZC4"$6]>CN/IVUE^0:,39VVE$),3N9IU8?GYC0''(LN:" MK8D14NGW8!>Q&V@)Q\OB!BRB`"8Y+*,H2(58R/]+JL>/V3;!OMTA3ONW:#WR M_MXXCK21Z><,Q[R_0GCW"57U_.BU`2,O#)0P\'33\%S5TF#7U4+S/4N4,9V$ MV$FS>\D)("$/9*@B/C<9NQZ7U'_.,U1/9>QKEL:%[V8ITJ$D`O7_--MAO!5? MW$X0;O!I?>J1Q=6KE)R^%]#RN3H.!_K4[BO,+:C9O;E=(LZA6-QND9!2W-<2 M]0E`/^+/LV;T:IF4E_1.4O].&I<5H$%`HV-Z80%U;)84\(N0[$#/:-)-=0-. MU+1XAY4`M\Z$*[NP=V%&&91A.0.JE; M5N55G!Z59%'3>*N>&?-NF-4OD[$1EN>5`;JA&EYO;'LLPB&3L4V6XXZUFN8O MYHLU0IW>$^/=37]N/XP;C6F\L&%"FLT'NZG/NV8B-,H^G M-LT>D>VT,?EL7NNSM3R#'M.@YOIVM\^\GMPTVVAVI^Z:JOJK^'<713VAJS=^ MN_U)O3X!P$AV`$6)3DRR;?R2'ZK34L-^>6'3>"GR/`<:AFUI>A!Z@1:IH5E3 M9CBN$@F[#!5$CFSOC5))>]B:>7E?C\7LK#S\T! M3EH5"6^$*$J&`K.!IY>E&%>F>1.'U>\OR1%AD\#0U%^QXKT!UT$TQSQ)PC+` M%E3.V%3U!"ZY[C--1_%46S=4R[=@NS:,S$AZMIAH+2T&9[)/CM^*H)D!SHM.8W> M7)%A$X<]R?_>QS^2_6$/\H=_HDU=4T6&5L2;QP0](TEE MWI%??2;<&\35B;SF9)&"E%(&.9U`Q80^K][-GU_-_LGNA==T41$0HRC&ES^* MD?0M1$'">1Y6+"D2<#:/H*U'\?.L1)L#6?9K$9/9LT'\4JY-0]5[2;?[:)T\TAK6MYL>5Z1@4YUR,CT'-EP>^3:\N_!]M0?W<=;FM[9?P=7W=M<'.D>&TV,E<7`"'!",8@(]FIR M5YVAZE$LJ(O-6#F,#.`FE, M6]&;4!C9+.YGO/V*J)V2^_$XUQ8^X.7C3;6&GN?CR!"JMJ;;CANX3FBZMN?[ MI@U-Q6'*&QV_BCP=3FD#'7&@1QV/FA8`)(=6GA;004KX]=YCTU-O,G9)+8E# M9`E:2"`WN91MPWDM_F7SB+:'%'W>PR^58'U'QE]_13\J#[/_QUK# M_SFV9T:&K6J6[UA:`%L*`MT/>2['!2XKV9=O*26A=%S3VC;S9CWDD($UV_7X M3##SZ?D^P@V9H$E%!!2`:7U_R>^+F='\H%1D`?$LQBI3!DG2C4+[.J4?QP+%KR.);G"7_IH$[N9S+TV1+O_%( MF>CGW5U]]EW_Z%`F&2K+`)6;(GFBL7ZVQ>YM?LC(#*@[_,<;0GE'=&![D6;8 MIJ9HMNVK/@Q-SPDLUW`#1PM]E4NMSDJI9%W\*:X.13W+M"$=Q-D64-;H5U\. M^WTSWO1+\BU+=LF&3-\^L@1:GGBU];P;@%'%WXSL.>U"CZ\5..%LU0B?5+#U MN%L=-TB/0;I%SNP%;%OFLRHR97;-%"UBKRS%?BT#C-=&;QE4<1X[8WKH_6D] M2SY*\^]E=]1M^9JK02]4#-\.3-LS%'*H$P;85D/H&&_5Z`I90^)Q9TL639_# MA`%*&?A'2]ODQYM7<+IVH"D"WH6\V6)X>7UH*0X@YO?J$ZK(6G?-_![OY7>: M8/SY"14Q><$AR76G'C%6%?@'!_RSYD.L.CKJR-Q(&(1FH+J^%?JV;1MN0YWG M1Q[7),>)2)*=,4Q>U!U]4SW@ZCWH&`%'3JB;V/`"CLS,IXO%".&*UIY8R@O1[U-SG<_Z:G': M#$S6+JE^R\MR[=G0LK%14#7]IY30?,@ MPZ9D)8'"KRCK3N?@'2'E_8I\FQZV=;1;U(61554D#X>*'J=6.3UOQ9L3+Y>2 M7_N884&@&4)Z/WF&<^@)N_WDH*YK@_C6_1X2U)$5= M]WRR]-><4=]UNLV'IJT;6N@9AH=5FQ=ZFMG0&ABF'?!HGED(E*S#>CR1M[%H MN>K/],`_)]]MB`_TU/.!1/BJ\PB=3:DN7MY\ZOF5J#N&P$]ZFWS,Z?'.Y]K* MD-(5(S#KIEB(.9D7@WQ!;REWLZ@GK&&3.M_;M`Q;#:)(@3HVHHZMAJK3KJ'8 M(5./QT$/EFQ2^K1PMWCBP8=-BTN#AD_[LJ$BJ2W3<>DKFFT04`O12,-H_ZF= MTF``V&IOX)X$0?652ECG>J]#.X)0MWW+"%3?.&:B1[UNZZ>E0MT)# MT9563[MVX'$>+0Y?2+(N[6BCO33CABH2L*/DF1ZFQ6F:?R?%S;S91>/P93Z@ MG`9:/AU\BFI+6)NE0%T&Z?BXY'MN%.')B>/GY[%(40-Q]@>LH]&O\ MHU&2'LK0+JG6MNJY@6X%MFJKBF];$(;ZT;\,.*._<6M)#PB;9@?M>6+\@UM' MC8:3-5B<#DG>^+$!L3FIP[2U[@]XUY#W?J9^OQ?0NAIKBL%Y(5I+&#L7&OR* M@8G])J8L4?5Q_Q0G!7'0_<>X^(;*=:"J5J1K/C0L4PW\R#*]SAB('..%A'S0.$-80A#HH>:_A9J<*X"SN%P[Q!\'Y$*T MSE@N7A^DBP"%6<>T*<-^OG](LC;+F!S'D[7SK$RV3:)*K\5IB8G"7W[,FV6-+,^T?V1'-J1Z7`B"COET*N?(4>%>GTF.Q35ZDTCXAN=_5G.0X=OND M9K7IVWKV3U?'Z103&X>)A'C%VBQM&RW$?"T.EGS9;S]O*0SI+4<;@?<[SJUM M7W>5P+-537-=Q3,]!8;M:DYH*ES=EH8M(=E\4:J.#1Z/[141UQW+6!S93,P$ M$/)9A#YZ?9*F+AXZB\L5)3L2R(7HQ+%WC];KAN`;7M8W`=2?435U;V(>:1#H< M;:"2$@H]XXW.3*AS7O#45-+:Z[K!QRFAH*&4^RI9T(T/.XC7+H`DB&(A"E$* M:Z^OAZ3!QY86=(\V:5R6M%T$=2>[C,8H+]H2S_]%6W(:$T';]#RHJ'@MS[N[ZF:DQGL,(7E:PT7Y,*XHY6>FV[:6LHP2.EE]PSI8"Z*K.04WJ;(AS9#G-A?RP[*>OCTD)4%J;KN+8]#[> MX*?1H2U;\"U.LKH?39J7)6H*B[&>3IYC.O4%?UP5=''\TS+YEM$_(W_PKT.< M)KL76M)1=])'NUT]QPP\-050.M*I"`*YX5$!\+8R>5L1]Z\B^61$@7HN*8!_6,\X@>6SJ?Q M)!`@70FV1+7>SCOJ_]`W=!\7?Z"ZTKSL.`%QRR3U64O,)F^2AP0Q,2:`S"2? M8HUS)+Y$EH(3I7)H>O,U)D@\G? MHQJ[N74RWK'F0=4CWX@45=%".W)4%[8+AHH5J'P*>/@ZTO4L)6U%PKNAK:;Y ML6/3BI)!&]E,FL3*;75]0]?4&NXB0%<4V7A0%Z*O!#!RJ1WT2&B8M0]>!/NC M)0I0_6^O=MV/_\/>U30WCB/9O\+;5$6X)TB"7SB2(#%3$=WM"E?W[F$/"EJB M;4;+HIJD7.7Y]0N`'Z)EF0)(@$)M[!RF7:6R\/(E^0`D,A/[O$ZWQ\)UWW%# MV\:6A5UH12`RXZZ:(;'M0.@R)8G#+I:QUO5N3VDR8QL%.[;KOC&R'UU#HF-T MJ[F"Z>]#7N6L,99H#Q.9[N%3O"MY1DP".Y#&IP[F9^JA8_>0%NKU6H?PTS@B ME`I\H8ERJK"L4/X@S];6KC+LKB^M7`$?1E$86M#VK0`[@>6Y75?5Q(U`++;( MDS*D\O5>^+[$=+8N3J%VJB*JXE2F%O8O`18AU9I"L+9R-QK*W?SK+J\(9U/FH3-Z-?TE2X-FUMU3FXJ7D$4 MQ1"9B.R(`S\*4`0=OT/CN)%0DV-%$!0'`/N-U+X!R0)_Q8EB3K\M4Y5?YNYM M%W.)W-WNUX&3SMS,?G6AY:%WTJ98BK^T%6*Y5G)OG"62RI>O3P9DJ70T[?%\ M=>>9UL*KV`Y"LDR.H6TEE@=B%SI=T55BVK'+MVI5"$#Y"K:%+:&?@$HWC&OR MM?F?5@35XFV2]#\J[C_7UET#?PCD\E_?+U.S^LE2QE[++ILZ)NL9=V28A4$3NSZEN,#$P`G M,2,WZ"%X(!+J>"9S7,6[J2]]G\9N/R5COS25XQF;I`7HE11"[WHZ9OWN2(== MT'G^1+<^,[V@\WYGKFD\FQPI],V0QZX)Y5WVDNT.V"9+83";$Z5/Y5$2A&]GMJ[2]0N)'@GC`G) MW%2VM16WR09=E+1Y5"UT9?4J#J,@=H(8>E82N]AT?"OL4%F)9Z[JHDZW?"JG M&(J0!/:HN5_?WWGO_EOTFNK+#N(33HU\(Z:J\JZE_JGNHAY1Y85*_8T9Z42N@G;L5V0N(%KF9Z;)!;TN[8%28`LKLNX%H:D>/V+NE8? M;1N1O(,_X\[7I9PU:P*XII^D3@2](9L\1RJSFFRO4 MDBYRK=@ZRS85)K31ZN)PM_DMK6F!\>OMP\>EQZN(;$N\($QB'R0>^"Y[UOW$-AL52;#C5U MU6ASAN6O/9M"\(C:JW:9)O*NW,SW]Z@M0"N_@+?'BG\4(:W>+;,1"*9IDGV& M:>(86F;D^2#$_1P"8U.P38/,D=6GW9"_?THKM1(MTQ6+4 M2WOY61S36P6^T$5C59AVJJO*Z)NNI=WM%QEMJW/[0-?Q[2>;E1]`#,BH#HJ< MV+'(_YMQGU3I>,%,,9TS]%))C%5[#6_?-8**:Y=%Q;KD]*E<:8M]KJ3.\LA$ M357N"FFB>D1Z8_S>L,^"(N%%]I?1U1$F1815AD-T558IMEV25GD$3M?6+[N: M/,XY35IORHDLFQY^.BZ`T+%\8/F)T]=3NL!",P55>+QEUZ3YKLZVVVQ='](M M/63<9R79I!XK>"95.DH@?:)FJF%;FE`>X5VGKO$B7R)R.)EK735PND&7A&\F M59/#JK'QE"\4NQZ![%JT35X?2N$\,PFL3EP)JJ%3VDKP"$^3E>`I7R(K MP$OO>SMD@[.8N>(FSO%$<5-#KC1Q:WKX#/!=6]Q.^1(1M\E"Y[=*+@2>-=3/X6)7Q^LX=/;W:_G]^H(F^G!Z7RR,DGAUC*]HQFTBG=O`^$ M5`V-"R7RKR`,`X#B`-D!<&(K])"%.U211Z\5GUVU)0N*4(QQ1M76IT.7"3ZL MWY*@Q*I=Q2?,&GE)3*?EI>W_5+GZRG+TN5VIB;`O9:W4G'Q!DN?*/LYWZ6[- M7RD08HRM&-L)"#Q`2P;"N*LNPU9B61+JMV1#4GS4=%J_]=#!EU^_)=U9LR:` M:_I)ZD30&_(3UF\).D%\;E#E9;WG"&56\\T5:DF?$H&YR_9M8/7V`17/S\7N M6UVL_UHE8>!9@0TA@+&%$\_S[2[%`4//3B8'7:8.N%1Z*MO\U[3AQJ%\-:JG M=/JQV1QZA6,K2GF='TXYPF/YI0R@P1!>+WSR`65\$9.Y?&NBDS(M^C@N(H>L M:8E43T59_Y&5SW%V7Z\2`'P/8FA&<8(LUP)1?#ROLUQOC?NB+(OO9*J9DR$EQN>$?"AE5,[*?CJR2'%=,\UIR`]O4M,D3G61J/F& MC"4LS:"&6Y"(_K5B>/OP=D"$$0!6',=FXEIF"*TPZ!+GL1TZ0&R=-7T<]A.QE.LC>+=H5&,*=CV^)RZV\##5O-TF-C@- M`M2XO2;5(O^?/F:CH M*K$CUX66Y[IV@J*$3G-=L3Z.0\!YIZY"`(O%(Q>[\V>2&WBFG^OQK_#.GW.' M2QKX0^J=/ZK]\O]W_G#=^7/NY'F!.W_.>/_#.5GIHZ3%!*W60K$[?^:3.2F4 M_J6J#F3<[/;AUV+WV&]*O<@C*P:<`(1#9(,$.JB/F06QS[4OE#CWNS(Q#.S``1@[IF]:,+!@?]IIX@C.%\JED"K66)K7M7^C`MF/ MK%SGU3`T45'`752"-2'XGI9E.EJOIJ/3YRBVCOZ6)?:-;<:!&F?TUC%'LX]^ MN:<&&D,+64>*ZL;HC6PR3"Y'#1><,"2Y3'BN6?I1T7J:6IP,KAGN.B[BGAR3 M'VNRY_TC_1%EN^PAKYO3\W/8SNY/'&PB!WM^B-P(!,`)0MB?K+N>4,,BM4@4 M3VX->'9%Z'T#O\O3.8K:>BAJ;%9[S"Z48E_#97Q3ES[>$IN:6D<1X$8T=-1' ML\^-8$Q0R:0SB^R12649)VHR:2QD;'&-]V31\J(5\&R(4.AZV,%.$CG(]_H$ M]A@ZB82J4EE0A&1_1E5I6U1Z-JJ[:#G19>?PZ;M&?A$3>'GE0S]5S="(RB_D M2DUD?BEKI=8&"9+,O[I_>,C6]>T#F86>Z'+S+JVSVQUK\KS;T/_09(&7=$M7 MH6=Q81]'-@Z@A[#MXB@$=G(\@``>%EK@JP:C>HW/\+-@U:$LL]WZU2#(,J.Q MAN6]-@WN=YOFA^QHC^@27[G?.%?Y.KE,<*'?>ZL#;U#TU$NH\Q+[86""'A/! M7-+'%OQ+^5.3R6`Y>T^7_]Y$(0@!JCO;>`&,I;Y MD\9=8$V?M[>TLTP129HNE?I9BWCEK$M=L>L@R0)$BB_$9[E#$Z%58AK?$EL" M?=SR>5[`0X*K+%\)@O]*MX=L%<>.$R)@>9&+DCC"L0>"9O#$M!,_7#7Y:]_J MM*SYY%/.N"*O\"E$[K<9?2271EH;]]ECOMO15YFLRYHA!%54D@?X]'-YVL64 M$Y64;%2A\FE5HHP@\!!$(8(0>L`.+-]+ MDFYPU[&B5AF3'6=IK)Q1Q76Q`RA'%3-ZM=-E/?R)WU->#_Q4[RFW49/>4S'* MA-Y3O"V^_TZ8(#\>^]SM-F=BE7%>K;=%=2BSOGN1YZ/`]^W0@HGK0PA`Z/L= MKL!SA!*#E8-1'!'\=MCOFS*`=&M4ZZ=LV$J#O*TI>\G>G0Z^B MO>;4NX]_9:2-YR8LFBCV&Z-%/V@N2KUT[HC(.)IPO:YRB#I5'MN`BLX)B*(KGA`8C#1S22X\//4SCD0"DIP^*KIQ7 M[4"^>4$CWXG-"J.7T-\81Z_2:.71`*.UP*`F&)^H$9^-^XQ\1T9SS!;/%)O' M_\@$L9!C-9D>EK*VN,K;(U+H_UM*[YAKTI6K/S*:QMP&7=ORV?_.ZZ=!HG+2 MUG14J\AWD!OYT(]"RW-C,[("V$]4$'/E!BN&H'@J:(&W_4:-NH5^KOQX6/?2 MU\4(E9XK=-2X]&OD(S')_[_B'H'N`'JX:5J'@+OLF0@=G6O[7@ZLJL*@]8.T M7I^X+GPLLZ8L__M3OGXR[K+JL&TK\(FF/F3LQDR6%,)J^2OC:YF]Y,6A,N[R MQZ=Z?@7^9(;/S+T+N4R'2OP%K"P6?0\$MU_#2%*W1?RR(\O(9_:2]+L_A''L MTSQPWTG?$-X7VTS!B`O%X(C).]D8V,;/XUV;%(-ZM0^]@*ZN,7VCHGJ^JO:;Y9 MX3`T(] MEJ^CM"C1FR$%(Z(RB2E-E&,:]D+"HR*L`>OB.6-1-39,A)P(Q%&$L1>'%L)A M'/>1)\-\)Q!P:N#4"IWG)\B=N']KCM'3[94?6)BS@4'TMMOGZ=>4X%@P= M+[$3@)(H]K`)0DA`.*%C(1,)G5;)&5&QGO3(C`$T04V11"V?TBS/JIC^4'Q- M7B7=AYZE]\9H4!K_T_[WC^Q';43DY?IKZ5T3%YLC&B;7&YHHFV2C"I4/L*`* MQEF9OZ2TTTP[$'WTV).W,C$*31N'O@.M")EV;,9)-R*`D2LB?3.&4:QW1V3# M-Y)E]_P[VSP*U^3/(91/\!;B4DSE!J`T4K./J1J1,`G\:J);,BPII#]\(F?* M'R3`[C:_]:DQQY/OTS/Q4X"1;=K0LUW?C&/HNY$'8"^A,+!M[F/F15&I3D(B M1MR\JPIA^G>T9I#@8H1OTH^^\:=H!=_SF;"M=KVDW?-;NOG$?:W?_41W)#:U9;OMCTO[5@]_99#4[(:9T]DV>(#$3OQ*7GXVGU[AO_:=R2+RJ'1VODF]/:>$Y?C?NL.XICA^MT M9/+L?;(^L\%W:7?,GNY>#1H7+/-UT]*UZ%OAY_7K/RK:.(G^N[RNQFS[9'\F MT#.&Y\VO?_@[S+I\5[$,#T)"]F-/L`Y^V:@+8TT^S&NCS*N_R!B@`;_>IE65 M/^3K_@8`:@2[[8.N)^_3+6MFVOJ'&%V\9.6F3!_JZO,-P_+):;^I*\"[3ZN\ MZ@\LAR@_/3!LZ?-^F[&BO751U9^;QK<#>_MO.KDBX8W!^WU9_,B)IX@G'NC^ M](7M3^EW-64(S2(XW[$VYNSOVYN`!GFHS,.4NXZ&YN%(WZ5'MM<@M,]9NJT* M]F"0QV!=YO?96S<-'F;VQ`WN9$YWU0.9X,@357_/LMT`*C&QSAZ+DB5@/A7? MA\[KGFF"N.,I?]X3H_O+\]XC?I-N2Q_/EMZ4/)+9\[XHT_*U<6`WV)%%]I75 M@;P[)U_2`]G,3AV1*6JP@K6H;:KH[X@L(J:0 M]*<5ND\A,;NJVLF"8I-M%AK#IM\ M88.EB!1@"_1 M<^,6DD8:]!%-HX?*,YG51'WFV_'NF%D*,2)WR^RSLGZEC?MKLI:C*[L]W8.< MCI_$;A@CWT\"RT_L$-A>T,=1?1,*-=*4-JAB7>IPWK`K/)H=9X]5_#X7243S M:==5.!;3LE%Z-=(W7BI']$ZZ-S31/_EVO;^31`5Q8GF[NW3[9Y5]*Q[J[VG9 M;F57MI\@AVQ<4>AY<0C-@%YBT@YHVIY@]M[4492?P^SSNJT4[I`9J*B$DV]F M\,B[5EN"0M'%6H/)(*!Z^C02M@\YNY0I/(MG3:1+@B'GF MTV[A\@GC%L%_%<7F>[[=DM&)`)-'-K_?9F%5975U^N<^:='#?@1BX-I>#"SD M.EY_]N#$9BRBB/)'5RR/C1X>L1D-.$%A5$`ZGTI>EV\QR>RP,M%\Q_C-N;_2 M1D&%>1Z14W4^TT1;%1I8+/7XRU/=[J,6`/8"$X4H0$GH6F&",01.!\!UH5#" MMKQ1%:MLAT:>K(JR.EM.%1(J5T:[SW\.]7Q+ZS35G.@:_=5RJF'\*CF+.OZH M89_*=5O&>;4OJG1[^_!KL7O\-7_)-D.!'D0P(0"F!5WLN2CV'=="\?&$QS>% M3EB4`%"]<>\QTZP5BO47!G;:"E6-"SACD==F7S!,.2"^-#K`9YV@D<9.(7DL MKJG29YHHKUH;3Z.AZ@GEK-9A]^L\$B#DIRK?M'?LT(N,HT-%4W`K5#S?TPYL M-,/[%%*0X,AU`8+0#X`;F:[OX;Z`*,9!?D!^BU8"I.N_#WF5TT_GY_G/8OS,'+RD'[7(Y5_(U&+Y MUT2TW4E19OGC#K7W$?]!JVG2IM**;-[8'[?G`0$7>2:,[!`@,X3(0DX(6D`V MBFU'J`6*,A2*)^46N-$A-P981;NCJ/,$WZ9)#R>(S;SG^6]1LWC5$+<^>Z?) M7(]LH-3[3Y-=U`*&GO9B68A:;MF^RZJ,_&-:#A9G+]FV8"EYR8]]MJNZG!W!8,5!V!T\V*$)A$Y998RG6(H[B.RM'X"7'=L6SFUI:,P+KK)=L=LKML73SN6##G=&`O2FP3!="T[`2['L`)[!=\,4Z$1&C^ M:,K77`R@,4`HO-":32CO,FM)+D476>]HU$BO+C(WNJJ2Q;HF"B;1H'FW0Q@6SXOG_']XW1 M(&XSTUK,K)I5HV#?!*Y')%6EYS016:4FGEY+HYQ._FJRM*0M]JJO6Y&3:TL=")R]RQ%`ML!\\@^`P&4+1P;"Z7?#*Z)(UB MDOF>08V6E!=H&U$_681KHG32S#FM!Y-*$[>"_9Y]#_OTB:]EL2,_KK-!#=HI M#CMQ$7!='[I^XN((AKX-H&TY3H!M%P!+1-*D#ZY8XPA>XPC8>(M84.[D$\^G M?U?E7$P01^G62!M%*1T12V7>T40]U=E7+/283SKZ^%:G-1N\OS,QB,CV/S0C M)[1BX%@Q^9]O)1X*?+(PQ1'_=7W3OEYY`+^'=+U[0S_@YF+0?CJ;FKQDL\TX M&[*?2XMHQ+[JQTF"_V7OZGH;QY7L7]'3HAO(7.C[8_>)%,5!`STSO=V]"RSF MP5!L):T9Q\J5Y.[._?5+ZLM.8LLLBI25Q3X%26S5X2GQL%@DBQYVW#C`&+D> M<9(P\DAOA_HV*.0`/WR>?#ST`F,X1Z";4(T M1\3='I3/*7;^JDSM#()LD/?[YAC]8]M6G12,H'E";!^8T^AH"SFXZ4;#V+Q&CJ^%:(0L M^I=SFBDD@-,>*QI&@1<0C-GCG<"-*$5#6L5R`Z8(19UN8>F.BP\%:<%@7_AU M_\J_[)DR8V",["%VPX;""UMQETH*Z7]CM' MSXA^3&9T(7HRO1VOKH520@Q(;_ZX:Q(%7XKM9I4X7HBM"$=^8A,O3-A0/<3P MIF6!*BE"GZU]XEXU%2WN.2"C8HB,=]G/_C[8]*$HZ_Q?A_M,>3&+LKFX=:@& MF#;UA-Y+J!.(8G%1TL4N7(LX90T6@X.Y@@`=47%!=V1(6Y#<2,$_H3+R-*@Y MPIWT70]U/>W#[E-9K)L:(56]HJ9O8]LQ`QRXF-#(PX[50TH0`54JU(E#^W+G MT>'DS0&\RL/>4STANE*Z#"=`%U7'#X<;[P;H!CH,&4:'OCF9/S)@S']*?)SI MT2F??O\M1&9G:2KDM+E2>L67C+,M^^_]K]DN*U->Z!9M'O)=7M7MVD>';85B MBJF%;.KB.,!AXD91G][QXCA*0(O(:DQJ%N4.Y8UQW^)LQ"%]AA2ZT*R(:L&E MY_E9!BY&]P3_>D3PV&SF.'V!S]3TK;PNA&JZ*+$)ZYS$X MX4Z*A&?,D*J?JO@>5\)K$0V3P9<,G[B8H$=Y#8H!!52O0+5%HB"V7.PZMFO95DP1 MCN-^#+,I;.^V0K.:(^HC6$,MXG?W:;ZKWAOK;VEYG[6+'>P1=;E?U_NR"0]W M8QN'M'M"+-B^DA-@(\VI`MZ=TG5>Z8!>*C6H)>@6IW`D\-;@AX4$WSI:5FA_ MB2^X\4NPDD0NZ%/L-_;"9$90W9]@!\^R^Z/];#&FW6X)JZ+7^9, M;CU<*5U3U\&OO/@-6/06IFTA.B./_\(B-Y`(\?WICTT%^MU]>R#O8U%5JY"0 MF'@>0L3!H1^$"?+LWA1UW1`B&S+/UZP<`R0V"^>8H'O091@3$PW=9,%TX\!3 M=_[V'0+D'?3(=XD4_V*3QN;5.NH;M.10ER(UM MZA'B8TQ7V];WT7*1J1*'=T+$2Z%#7I9>$,Q58!*&]^SJN8ITM;LAQV3 M`O87O@*=?\\WV6[#]-3QF9Y&L1DZH>U92431H*>>!Y(U%?8T"UL/J1&U?,#; M29U,ODD)R6(2-S>_,)$[H.LDKKF;_L!V#W'VFB<721N1.964+T3HE#;I55T4 MU70!Q*XUU2\5)Z:%L!_CV&>Q8N01/PGZXQL>0<1;[;)[GM,2E3;8TX6Z6=1V MLV,@<"$;(C.P;@'Y$M4H#41)ZE''T'7VD;P@8E1CY"A;C)Y(PG^E'5-H@)4T M.!N2K=BS>6%R-K&,"+&=Q$3#3CO/PP[H>,1$4W/.\085D0F!IE(JF%Z:CTU@ MIJDAI&DM`J>%X(-SDP'+@6"2DF MV":Q;YHT=/H"4IYO(]#"&."QFA/;O)33I92VEMYRH&"D9TCPM)!>((.\F/R2 M@(LNUXZV;4H@29=FQC?J+) M'+J9'9@Q++Y7;U_[#(#WERU#:Z1'LW"6"F=SK M^$*R('/]?'W)0"^\\1SRD!*9O2`SD-.QU*\V_RQ$,34V\%5-9KU42NKO]S3? MMBCBXN&AV'VIB_7?WXHMX[W":96O5PGRF$V;."8FB1T[U/2'8:6\<;;E!X:NVKZ$T&,B(L"0A%)7,=.`LB+CMJ*K.D;J@>` MS6K$`6)_H<(5ZZN(<3?2<163OY#^JKI5A=8W5FGO)'FU9L']OLR^.3RA0BYU.D&U M:D+XOX)ZOJ!26D1E7?(FM%2Z<2!)G4:AA+)NM\6/E-'#MR+S\@OE]ZSZRAZ& M?N;5BL0D#JGC.S;UW<1U"?%0;]U+*&BE1Y')V;3T`+/IUCU0@R-E81##*B^B MTTB'JN=L?,O*YB2J->OE&'E"0JF$_<4II)I6G95&A:0ITD12/*3Y;A5Y21`% MB>W$H>-ZU(T3W$>Z7H(H4J>(@@:OKH=_MD#5BJ$HVRJD4`/1JH7P,L=74,$6 MD[0&`FE_$PH(;1-(_Z0($U:_P20M2E+L;^N[_;8/2G_+'FZS[2UCVP%5(U1@3K/R#0B-NZ(T-AU&(^U``N5.!;UB8CTYJ M#^\HO=@BG%OH+G,V(G,*"5^(R*EL4:'M[9P@<)]8DPLNM(/-)`B(@X/$L@@B M)/!]&_N95CJG*-D!V!(D["5- M@N(ES>X"94N^+2."-9$@P5I[(PK)HL&XZ[.D[[(=%,3FP;Z96&QJ',06]BS; M"7LHKFWY(@JFT[YF8?O"@/)]"J`2<)J8'M>UI9"L-G#CT]4>M3'`%A##^=P" MJ=1W???(5>[[G#VR_S8W,=;?,B,=O)95?`=.7GW+-HT'TX?609M]QCZ9UD9: M9L9^M\W_SK9/?)_.;6:4V3K+O[,O<.8E3,T:SC>7.[->VP"<$,G+4`J/Y36S.65XZZ^!;K`M(:!_S95@2#^!Y`4& M]5-:,Q+63R9)^8:FC_DN^U!G#]7*]HB'73:_\"V,G<#S'#ID>QF^2,>F)G'K MB]K8Q&$;#6Y=NYL`;H$N3%W#([*K5,J<<=6M3@.G"K8[P?VS$'75V$#);4^R M5`IK\&_%]ZRMOC&^W/:YV&[9X/`C+3NPKUF'>\C\3B>!Q6J.W.B@0Z58BW?$Q/C:CH')L1Z?:%%D"6)'-%FGFQ:B MREJ;6,SWUBO=@(73+?_3RK>(Y=H^<4(3V3CP?9/ZO7&*$[1ZS,J\V'RIT[*& MQL53[$*Z^DN(PKV^`V.DM8&S^WRWXP%8<6?\3Y:62C=@";,-#73GHE@VN#VC MH#=&!W)16[`Z3-)[L*#$+T0?%3<*M`M+CC*QI;]QRW%S!>;MN/'%K(#V^FA^$GD""_]:;*O.PFZV>3MTGN'D*]+]#>3]MD\R`*4 M+C<(K`LNP`.*A?/8*6U>]>B>@B5X!;`LN`#OR"T+ME=I\.OIGCNI'$8WOEKX M_5F&YY^'#$^_Y_&P4ICE34&O75;SZW#2YI*BNGG(NKL'/=VU]]X9[]@$I1D1 M^!O`361&7O,`)F=]?&!AM!M]F:? M!R1JSX\`6%4Q@]%$J/))C`C=USA*,L"2GLI(>.!-S&9DV@4[5B)+G.*\#IM' MF1ZFU/7\T'$=EU_AWANWP\3O\CK)3K!SF;\X;S#*)L MOXF>"6Z45)X!1IEPGZ3Y+J^SCWQ[WXM[8/^KRN[VVX_Y7;8B,0T]QW)C)S$= MA*+8<2G&&"$G=&P2)Y"`1(E!W9F$XWN/V]X\7,3:%8W\\.GSOZ4/C_]!7E_P M?6/PZ]@?]@_-E.>)]>&QJ[0T>D4LH)G=(;!@IH7W2X/OU074-T:+T>`@9U9* M$=Y&A%(I[0O12;5M*C2^IY!L[)%AILL?=IOL[BR4"C_]EOY5E/&6:4%;N<7$ M@641/\#4<\W$3")JNSTD9(="M5/FP*%94UOTQL=A(_FA`<;ISET9MT]&TPJC M:0:P9-4LOA-(Y2[(;3+*^W_-8X`T[X(\)Y?N/=J(QV8335;V69ZUR<]VL4X3 MOS`GL^#F^$^'Z*8:PIN>;QA\;C:][R?QCH^%*;7;@G) MX+F:6LS?JV>),)HR2*'I6(&-O839-P/*0B`?=XA<*TJ$9F-Z5]J(18N\E0T4B MWV]^D![/AOFV";]L![_F0[NZ/[ZM/!`[2M2L('*8(%:S^M M_[G/RVQ#LN_9EKVPFT]EP7=G?,[OOPU%-6+D$1)9'@K<@'@1<1T7]8:],!&J M5:?.FNXEV0XCFV5T((W'%J51-C!!E864T"LPBL_.+&RH'D@=\!D=0*-%*%>W M20F[D"I-<[,\N293>NEM/GRB'<(,]K6\GCY(B5!U;B122O,2AANU#2ITO9&0 M@>-KMOZV*[;%_5-GQ$:):84TL>TP0FQZ2Z+`&Z:W"16Z#$GNR9H'A`,>B#;! M^1%0>:W4P!3]`$5*NN'T`&1:*TW3R^0=F.NW>KV:H$R6WY<4G)-:::J6(*OR MX`L5;PMP`^3'?)WM*EZ"Y+[,FA/PO3Y3.Z$FL=@/Y,;$#HD7.KU!%N*#KOB0 MMZ)91EM@PNL& ME)T_>,KJ97:A#PRMQ$0.\2UJ)BQ(]!"-!I.F&8#J5DZQHUEZ&FA`W9E$FYCR MS,483'L:5"2GQ&21@1(!;4+D2`E32G4OWDR6<8/.S8]76=5Q<^&N3*2AZ,@TS.2.EP! MR%->V0N2V0)-_/:8^>U\MAKFR.O M=1VJFBDK"J?T4JY4HY.6,-6?HYFG\JK::56PSZ<=OC\.94P]8MK(3N($^S0, M_("$P3"".PY@N4ZI5T9>M%%J@X@L3TL87/0T3'CKQS3J%!S`KWXMBZI: M^;[MNJZ%G3!V0^S0Q#\DH'P?"5WHIZT4Q&3;-N=1;[;)[_J7)LB8+0*AW1FWO/,8*R%X, MP(QC9.KD3IK[R0*HE70MD@CWQMPJ>893.=V?0FQ. MUDK51*K5Q5%"YY9`!D9.[B`<+U_:0*T1ES$X2<*2=>%01?)SO=UOV(3OUZ+8 M_,BW6W1;U66ZKE>8FG%@QS&UHR!$OA/%;MSC00$";<'2!D+SG/CW8O=+5Y'E MU)[$?P<*GCY?B$GA(MP`$\D#Y'-":;P;A21`E41AXL6LR(,@F5H\C\!&H6KERXYJU>5*F4CW3>A18 M*)@=;(VMB0O(K(4(0\@AA/97Z@,3FW5!0%40IK2B'%EN6&8A$&,B8=L MQ\6)[0^3?]<*8\@JCQ*#"UOKN5J`,C$P$>9YH3UQ6ILD`A$@86+[ND\*0#_F M-D/NI^92F`^[=9FE54:R]N<*F98?Q@&U<40#VZ78Q<,D,O8!U3:T(="^W[O% MT1=;NV]&TM=5Y_G_9.=[FETT'M8LQSN*HISGH>2-T2(W!D>^Z\&+WF&DV3V` M'>2+<)-\_<7U-_:7S-CL2^Z>MJKR(U\'9+]UEU)=Z&6O"Y@81P]>%_OMAI=: M;!]=[;?-A;V[[,>)THS]R:N;$__+'Q[3O&P.;!V!;2&>^OR/,J_K;,>,W1U? MJ\6_Q"_H;=T\]>^JMNR"^SSZLNSR+XPY[;F:W\! ME[!-7W\CBSG[M-1NK.WI?6%ME[%6`6&S`PNC$&&;$LN,?*O?">9%'I:X/V^B M0)I0T M4B@LHL=G!%[#6-$@IM0T,0F2.(FB('#L0;I1@(6N"U5D2K-,3CCU-)5#,1&< MD3Z8ZCV[G_J4[LTL<>-$C6B:(H87(F*J6E-H>0UA"?#GL^=\=PPB^?G(:X:N M"+9#/R8Q,GWJ(R?`*&&:24R'WU3OF1$@VZW"W(RI[?2X`V8M/EAZ5`F_0JGJ MN:F%YJ5?Y9DYP<\4+KD:P:!D\]Q$RV66E1`NFDX5H.1\[E0EG\M(E"IM4:'M MY0.5P-KSNY;0;K=/MZ=L4M>,?)]0Q\'8=1W+\2-[R$2XGB->]6JBH>4%LVKX M$Q@#YJ0.F-)LD!DMM,FB/YE+2'6J&3F=<$5K2VQ6U?E#L\QV*G`Q[HK2J/;K M=98UB9*[O%JS+SUE:5DU_WN]@E?M;__*UC5?A3M^XO0[U,99/3=6J'+&$D8) M96TI-+RMP%1'GTKY7&RWM"A_I.5FA1T_B-PHH(GO6!9V3.P/TY70#X3N-IWR M?,WCP)?]PT-:/O%9>;O,WA0Z?;TT?]]!!R8^I!@5RW;H)A,V,O1HC#\Y'J,# M-/>1A!.3["XKRVSS-?W9!3.4->)+7:S_ M_N.QN>4W^9F5Z[S*-BN*4>0FKDOLP#%1;/.=PST$TR>@TT(J[6H.21A$XS;; M97=Y;13MAL&LP\8CD4_?TO*!3P?8*_$]*_DLH>+-,(JV'4!94>H0,>6YEB]@ MXM2C-+@_DG[JQ8`:#5*C@VH,6&=6,0"+(T*GPQ<+T4(M32OTO\JRL50_"XP(T([.=J`/FAW\VE<,[Y M2B?W%XO/I'H,,N91CL:S!U[F-!DQXKC/S1[$#!>X:_>4YI2BYSBKUKNB.I3I M;^F/.J)&_'L5AW8(I MY/%)^VR\B9Y:=K",$R[C=X;,:*#-_W3">9HNI93)8%>36"/'EC:P2Z^W47<%ILGKK;)&_J/GP7^=L$`3^M!#(')CSW5#U_0!"OTXMBDR MDV"AAQ*5`%"][=IA9@N:;9*5IXU6VGVJC/:]]LBC+I.\:J=8@M%.C5OXHN#B M'A&+CD-G]("-(>(K5K]K\`$-G0D[75HN@(YA^$)@5>HP30*N6AN+&4?`Z`#] M/5T7]SE[E_7+AI6BVV9]V9C^*@:D"Y,LNQ)S8YLQK)\,,DX6O;[\U)3`&EAE=&:-#O8SN5A4 M!_3S[GB)F.18G:1#BE.X5&5>]VLG.#.;?U:+EG"#DG4$`[2*(]_%)`@B@$-" M+`H#!!8&*/"(ZSHQ5X%*98W/*#0B4U;>4HKJG")_!2'='_.L'G1>,C!\DI8+ M0M[1+G++MF_",F$$D7PIT=^2O(ZRXG:=I92=+_GZ[WT)8@\Y/C8#9+DD#L(0 M0.+VC04QW_.^TUI0'$5?XKIBCPA=2`F5R=SE*#@?:6*A[CV^1I6F'T^<0,KS M+`2.RW4>221?4O(YN\]E(T_F28FSO!'5JW,@)B.Y7I^C.TPBEP8VV'?G.^%7(^; M3FU#<2!];[UI_,Z0B2[T1Y/(MYZ?@S^Q"#N*.B4+\S/<7%A_3V53DV7V9#,* MN9U,0MQIMU'3N'A,LGQE>L1"9@0MRT.V&X,X\.%QM1X%7`].R&MM@5ATU9^' MT"E,BU)&7!(D>7R$4L?O]%@E1.UL<>L%8X(1;!S;&L>RD09Q1+4I5/$M2N%= MF=#8^6(1W$WC0MNF4V2;!&88A)$9X``X?7-18'&]^#6U#<6QK$-F4&C&Z-W! M*11RK%AG8D\L4ITE;M02=@J#`@O9F9@%]4R>Z7LCCL*_H5[0.3[&^*O,[R0[JYWG>9J54SLXY, M"]BF'X4FBA!9H MU0G?&+\JNEHQ!],7IO::N5J3]8%NK+RY.*(7/,%+]2)`V-#L%DZ6'_DA\3'` M+D9AB`$P_1X.P*8E=,%>$899]:AJ)H[=`^1#Z,8)^U47W,;MYRAS%9\.Z>"E M*<(BU4%JKN6/8_B"H*CVF28*H=S,UU?W9Z'UPQB>Y4]I53XT9=(Q[M>%SI#^.^67&\/:$1F_:/I.ER5%3/D%BL$R#G0NRJ MTO7?[XNG?[36M9&K_?EUS'K7_G%HXO$\$7,KJ*X'P._W'(ZN=?T_J! M%49C+:;I(`*9Q">V$R''8>6"6"55W^I;#7WBBDS;)C8U6[28-NN:2BC?Y&I& M+L?&E67G1I<)NC`%DL2L)C,=6=842KK?]"R`K_2#+W0A7:UBS\)6'#G(I__# M!-.Y4[^[ZYD8""TP)S6D^KQL<&MA^@&_`'^CS_;54#?]6-_XG2$S&F@:'.@? M:1([RQ=G5Y/0),>6CT_PQQ+$=WA_F[`K1=^*'!5E7VOQKJK+9%VO0KIN\\T` M!I;KQ1#XV"5VWYX7A/RG]U,:41R.;KNJS!3A$'%V-==B$CN\G<2AP?C\7EZ,.\%^/5KZC]PLFG3M[E\&"#H?O4NPH M)'A[D]*.0'O)?=K.2+_D-(31V>CW=)VR,KBP0L,WGMB#F7'&IJL9*WKP M"NF*!(3801"YEN,'(?$C#_;)75X$`-=K*PO`4ASA6Q.,XL^<_MN';,]J?C36 M-+6AUC4%SO)A6!&1,DMVU97Q]2LRRLY4(ZE>O;/5O&M;==$O[V6CJQ[R$_WS MQ-BW_%THQ[IX5^#0'7U[@9A2G>RX,KK.T)MB?!^X&;UU\\">=[1.8_<*2**^ M;IZ`]\?S7LO!!R'^=US^WIX7K/^07O#/BGK]T8^^ZM^]*_3LDYH%'D5 M!29GTTEUR;E)P#)^UV':L)#EQ>*#3FAJT@ZB?['')J^W;96E[\5SLJN?;^LR M31Y7?D"91Y9M.0[&@0/9,5_?JFO97!E]DII2/(4@+Y[=W+:5W MF2=/5\B/''!6]:1Y3@LEDV=-H:1["]5;I5&V:;)XMTF'.`&(8N3$ENF%)HQ, M,^Z:!*'M\^]&3FQG#JV1%Q>GDLHA-#/R*:8RFE$I4H)U/DK'B0O'C,A(MK3[ M-W_4R@']PPW+&*-B1%7C5+BU^]>-@&QWQ9_3U>$R?>>D01+I.NB"+%,*^7UR M2K[VYEZFV?]5*^A"$L>A MB6.`301HZW&?IPXBQ^92!JD-JL[!ZF'2!?L`IY'T0(U]AU3H"KXLMCG6'$L0 M+1;!3QR_@&@<,1HW2W(L\N;!`ER/6Y6<.#_L:;QDFU[YQGC,=G2Q4>3IL5<; MC\DF->A\A^IEUL3:;GUR9CA,?QZ!C\)S*Q/9'M!AB2+=ID)AEQ5ZH_7`7FNX MWMZ4Q>:PKA'M@AG;8ZW8([_+D: MJ1"SY;*89I#;N8G64QLM.97Y)W8V7D>^7!L MRS=5C'W']_K$=Y,FL._`3I8.+DK."8=3.+0Q)IYCQ1#$GN6BOG''\4UNU9#6HF+A.$(:Y/&(A#!YS'*H MQ"*DB@D%@VBT&(T!R"OC1/3-PD0+R,4BA(\\C9=#/)]F\/)R3C:D\ZJ#S$#@NM%_H@>T64O/T MYB&GP:W)IU*UR726H[.Y4)-)U2&N2["BD-K3!$^XOZ?K75)5V39;-SWB^E!? M;^&:]L1#\V[K->TS)2H>]V7ZD.95]I2V+["U5=Y"/W1,0L'XOHW\R/>PB2WL MF3X)8AM@H0K+:I$HUH'7X(WB4+,%^@"_T1A@O+#`:$T86?-2L>_X#KSU<9N8 M`*GVF)(S[4ED7SC&GL>)FIQ&5@%D@B866(GCNZ,-R5\=..0D^KO[6;LBS%\&>68F@\-%C_ M:^;@(8/9"S%D5L=I$DKFM;E8<*1,"BS_S,N4HF#EW(\3VAYOA\-&P/<(=F(S M1-@#D143A^)P+>"&/@[!E"`BH?E%`D;RE&0[%OY_WA;ES\UEEL>D_'=:L\^, M*ET?RJS.E@XD'[/+'30D.DK+`"'3OHO!0#J1RM>3S2N-CA<3*S`!#*T(VI$% M(H3Z60XD)M=CJK,`T7PU.:9,@UK'J5U+2O?9O$O)):HO3*%:P4)2R(.:Q/9Y M;)6TC!Q!L/*8W[UW:4/'-RTZ^T1V#%P/^MBU.U38#X#0*[F*H6@>]\>]N:O: M?6ICOP+/S1O]EWGA=QK="A1`T(^?7`-$K96D`J-(5JX#W8HDMBP0$\+V-R%R M0$@L0ABJ."`^(*[0#4G%4+36@9G"/Z_7U(9_!0Z;-_Q_6&U4J_#_X8;.3'[\ MY.%?U%I)X7\4R:/#/]S\WZ'=>N+%]_7XV+2%7((!7:K8-K"PXWC0#GN%^\KS>OKR?QZF'+BZ>*"6*O3N+LDQPA8#,S.%P335G%M,_ M$*#YZ.=6(_:R2/4]?4KS0_HMK5<1$2^('"^V?&C'7A2YGA='+$/(=F,8NN`X,G@' MQ;A61@P.T7'1S)SKY(=QUV):<(2\R]'%D3*-56U&S$0SWBT6/Y46@1'4Y]JT M#3/YBB,2(X_*56!&A,#8A9@U!:B:0?JAT$;&F.]7//4\J@E[ZF9P\RAK`%X9 M^:4)ESP2^2:DJOD3FY0.:@A_Z=B:?WKZ#B47P\QX`K4),1-,>!->IM+!'5IN MRH(&+I:^M\(Q`0Z"D>,3"P4D=%%,Y\6>9^(8.P`)9LH*?+'R'-C?BCK9L:(H M+_86FB#2O`:?_)AY=)S(N3`H1C"HR5@8@[R8W'T$>_[QX=^VVLBO:<)>;MQ< MY]]9_G.9Y?=14F75/_/BKDK+)Y8:_27?'U@M$\I"MLN:3H22W9IM2-$?OQ>[ M'2G*/Y-RLT)!Z`8$AC&)33>,;&#C[@4NA'%L.2+JO"A0Q3+?FG0ASUQ#U_'- M"3Z-U\0F%Z?'YZ_ZTIB]:4:1&T?CC,:Z*V-HG]$8:+RT\,H8V&C\SJPT.C/G M/F%0Z;(+<5Z+GJ*).`!F.$KB%D.K6.<&=HT6N^4\*:AXG\*)XV5O8-Y?4/M4.8]'`!?O.+JI MX/*$G)/"Y9&-U,,.+=M<^=^L?G@#LGJ)LGII4V_V<_-=*]<,`P]"V\*FXUI^ MB%'_:B;"GA,?CS!NTC(K-K=U4M:"@C@KW!%G(:\MXXZH?6&/I#;NTOLLSUG@ M9"_/-E\X5B/G]:Z@+NKGR\E:.##)^)/:]([F5:]$CPKC&Z4\VM9^[U+:)]-! M/'JW2(?03>.6(>&LF?V71E95AW0NW9KN2;72-8\+EU"O2^)U M91P-_"0*]I&?%(B8M*[QR75,'@^2I$RR8Y92L_XUFB]='>\O.4Y*MKBH5I9+ M;.Q[*(P)BN/`-1&&O0$>\I>5MPFXE>L=RP.GG2"_9X\`&]MCD=QEU6Z*IQ>1 M/]4NUD\/F<7&3\SFOQF]U:P+]79_;ID\[\_Y=%-"G_IK"JD,8M0JJS37+26U MMVE=[]*VY)P;([JTQ9$58!SJ<`O9\B!9=*4HA%3YVO"(ALWKDWSSCZ+LWQ3XFCY1OSG+ M*IV87Q>1.OD.U4_KCC8N<1E%H;_FT[M1O>2O*7CCJ%"K>!/M MGSR>22)AEN0%,9>,O78%Z;"[F$I(_^!;D9N9_#;E!_G+/,_FIH4CN'&UE`;D8G"\[8M?+OV/GY M<'K^(IWNC1.7J28GC6W^6U,S>%0W[9G/\,OWH6:C7K!J]*_9+JWJ(D]ODN=F MI$3/QX_@^B%+G])-4[T@MG!``#!M[`$OBIS(]:P>1>R'@7@U:6E-*U:+4XW? M(SRCAVSG_TW^/14_O>?U0NTONB9#6SF"_9WR>MG>W[ MJUMCDVVW:TA+9-]>JBS-4ONZXIC0(A,'YHP`)[GAB"& M010?T^\L9HXRCA(Y<^ M`=V9B4;%Z[;F_EZ5M=65MH9X]^43DO-DG5,*"?3J(`4RS"CD]CJ18/[+KCBL MJ72DY97G[CEZ1U[1Q.K^A/U49=51;.:\LV87] M9B?LVX%)8'':":M83O]-6=QU&7^G,GO5"D';\DP$+&1BZ`$<8J?+^XLMXD&N MFYRZ8%6L2BU6IDB#;>KFNL3^A-=(3H!%IO(:T,>SQM(`ICH9ZXTS!M9=&2?[ MC!<&&D,+KXQ3[_CU5>\8V#DHQ?KI>H?`0E$#N.H7FKKT%KY%J7J7G%O4:M09 M=%@4ZT1'H>>8%2]JQ#;[GV_H\*SI)`W_<PZ"Y*,\":EM*["@DDJ\YJL@^3:]+:FDFS"N(?D5]KQNITXUPN0#6QDPL`*`,$$A%[?0FRY M2&232^!K%:\%&!+!'2@13OB"D2(ZQ$(.`\%Q>*$DI)P(N!`X1K"D27@8@[R8 MW$7$-BBRW:;=&KG>-].#_/X89[IV`<"`!"@B-L2V28B)`]*W:T6(/Q-&1F.* MPT(/L1'>H@=II#U*L36?!&ZYEO3STBJZ)A\P>L1WFM2,.C>50JW0>GA>BB>? MG.Z*_/[G7?:4;JZ,#?MXG35/@=Q]T+\GGYUR,'5^G2F/9#T6BA+M*13U1M%Y M89I4Z4.QVWQYW)=%>R>FZIIT$#`#S\*N21#`CDL\V^^;#")'J(CFE'94SQQ[ M:$8VP"8ZEYS"(^?D;1_:&L!:;?Y[GZ-*$5`*SNLQ099CR>LHJC1[N ML/0KNV:0I^7S<)G<-8F`X]EN[-+V7!H$<>@Y3M\D=!VA=R>FM*,X+!VA-=+. M,6%5,J`N$'1A0,F@59,!)<640GZO$QQ0;+^X+@]K-O_\DM^4Q3WM>OT@#CT_ MQ&9@A<#W[1!X)(:P:]-U'&*+C*A)#2D>4D-L[+G$?8=.4.NG<[NJB3G:"86DJ?Q//V^13)_6DK8&GRP%;`V;,T9H8 MR9I$*%G6\!ZGC2&).TK!]?KP>&BN+L3=/AP+DO3G7=J<;^%B4=?:?YO.S M(%>.[T>QXR/H(1#;`"&,<8_/H[\2B6>S@5*^%5.QJGY'8XY;G.UH1W_S]ZU]K:M'.V_PF_-`7+.2R[) M)=D/!;@7%@':GL!Q6A3Y(,@R[1"515>4W+B__MWE39(MRUQR;U(*%&B.+)O/ M7#C/S.[L[$?G1:3^>!BJ-<=H658X$HE M60A!%L00N5TC2$`S"&=UCC@QWQWR(*&8WV,:'$.N3Z>ZVCN?1G8\#5:C)2^G M'%D$.IP$%33X);K*6:5:+-@[_F53+O[U=55LJJLO7[OE-!`A%(74)0$D?+!( ME``09Q[,V$.]-!+)LJ8]27'J]+=R]<1/8-XZ#)+HBM9$'0[+=_2I3RR)V>%R M:F!.C-=C!`&'HRAF_D!]#T4H>[Q((J'#[20^$QMD6L/\Z\U:)%8)EW3IZ.:224+ M+HSM0#HU2CZQ_&C(&].Y)5/C(H/WS&A^;!]7K^ZJ5O>V5O><_>\_\_5M,YAV M[BS*A\?YZIE/Q.`_SA\>E^5SGC=?Y//V'OCQI(*)O-H43WG]_7Q5U5BF3]L; MK-"WVKT4F,2&KB\58I5J/5DP@_[R?;YNGHWW/&KO4!%ZWGVEG>Z7\@^VJ7"ZSE.G(_LB[9\?Y?%[_WNM7$XMV$>G%8W]8R>< M\XV+Y[3RZ2XOU%CI1%UBV"TL*6A,:Z&TZETU1U/-(=D93%*2IIGO0AJ0(";4 MHW$'U(^3<-;<*/=E,U]OM//40(PB@>^E.,.):B]NS3<.R1=U0N+XWD>'11C@ M?"A63L4%JWXQQV9#K:J=R!28T@H.ZZ8FG"]Y-?CU\):@%UP>98DJ0!U;C3+% ML+4^_)W#J!RSJZ5>I6##OM-D`K#79KN*U&`=-E%"F M88%%//V:'K5^]_*E'[:@-DBXM];2Y&K&AF4TR1*5RMQ(^E'$@\\@$, MBE-)$Z?VL0X.5SV4_[O*EWD=C2:0C`(+#.000ZHW3A&=/'LLH9L>A%5_*OJK MLZ,MP5VAA"]CMVIE:BL9LG)]EQ>;+2Z,/"^.8H_B(/8ZJ(B& MGF#L-H!0>7!O01DM'$:93D_AH,QFQEEA3S)SO"#?.@K+ABF^8`NSF%2!Y+)A MNCFT<1/]\5@T0ZEW4(,$@9@!9)4.`PUBE*&@@\JET,M-8Q!J*#P8**/,-,IP M>IA)F<6,,].>9&?+3$>LHY"9IOC"A3#3)!5(9J;IYC#8_I5&OHMHZN*4D#`E M&5]ZZX"FA';M7W2EB9G$$8HW?W7"R&K]\H=1EI61RVP?T%#;7DC4FJ``Y7U` M8J;0%K'^7I^*X\>H?SSF_$#(=HT_B9(X<@$&68A"%&/LH;X62)";Z@YD MTH!KB&\-UN.AK5P[>2L!/Y3%3RGR-(WW+]UM>3EF,%^7YQQZDG@C/F$NL^_< MBD^VV7,A_O$EM-`.M:9"1I7N4!="M/+U(IE_%1G.-"VWVT;\5H86/XF].$MC MFGDQ2K*0$I0D'7X(P\026A8';IB6K2/=$:8W2KIJ+6XIZ>X)?5FD^\J:^DEW MO$-=-NE.T(L>TIUJ.!.K=__(B_OO7)BG?#V_S[MVC<_K8I'S8ZAW[3%4WX5, MC!#RR]280&D*0=^]D24I-31_0!9\Q4W6'4RGQ=GW5CDU4KY7T09>/F@WGW/L8Q=AZO?O'K6FV7[VH50MDH-J5NQ5F-,VVA\%B4A\PF" M,444`>H#D-%^#Q%&9B,&1&B&AP[&4*A)DW- M@S@4Z0C32-."=;,?QLKQYL2'28J15_E40F=_3_('S!(24NI#MV[QQR0,^R/! M@))!\=Q&W(HI8G\NA/KB1J>])14XEII:?I%3C9\I<6:ECCR33BEW##C6N90\ M)E0C6O88,Y\^]NTG`PR2(@G3&&*?I&X&/$`0"H*^(3C#6.C6(,N@*^;@_O"\ M)2PLV>Z:B-B(0LW!H.J0Z:C2/" MW/]KE]3B$N<24G6KQ5"[I)C93)_S'RH5IL!S*?1!EA$0^BF*27=9BG2"`&&E]_`B';*R\[@9"N+>T#D"0:65L"D=[>%OP? M\R4IJL6RK/@&9]T#?"FPY]3-\+Z3RB@YD?)1X"`((LHX!Z M"049Z43Q8T1'3ANR3`KQ#5$%DX?&T*9E>A0A4\N@GP?%GEY$?SLU,\&\>@W\ M'A];ZFXVL;2M*CK&W;9BM9_1,8!^&$5NA-V88!+SF2"=*#BAXT;O6R:#!0U. M_XNXEOK$3QQQ!ZO(@H@K9DYM$5=XK?0M";V9EP91D,#8C4(OQGY*HR#L)`1A M2G4'8HVB:8C/DSJC-)=B.IU*3X5FJ2^=Y<[FQ51U\IQ"8>IAP',O)",QH3G) MB8HQXVO+7\:(XF>9&Y'0!7PL!G,LC&DW,!]2G(;">Z66X3?70*4YSU!B?#T) MA6F[F\L=Z!/0T,0^"SEFT(^1$F61#"``25A MOU\4AP`8O19/$.O9MJ.9L:R>#FX]YK2DM>Q%!G-FC=MOFDIAT_9T][!I7<"L M(M0-6YED&@M8+O`0]CPH[XI`?FAP(I4@TI^T1>MBHMI0^UY\ M5!NL"&U13]=1)JA.``RW#BM1`5]S2T_1P M<.A/\R4#K:M^561GQ46K>1-K9\A&9&=/9J<6VMDPJ7?\V0O._KFM4 M`$B2`'8"1#!`&IM.I&/7TH32@SK:@E+/%Z[J**MMJ*!\'["&M!48_FSX^O)H MN9'++",+>M3/0\:BBM'/PZ-,9P$%_YG]B4U_^]P,8AJGF>L'#'L(LR@D_U#X39KPNR_AX"C+)]>Q M>M%&KI,,9P&Y9N7Z+B_V18@]&+IQ!H@?TI!DOAOQ^]';&P)2$MG"K^+(E5-L M#\E*BAUA:M,LJ\C&EA/MSHTNCVM?6=0(W8[WJXMGW`FJT4:Z4\UG`>^^7.P. M`I(&.$LP]:,XI%$W:OUA9'QF<=3&O;:AGG#Q M,72T8HSMM8F9;LI$N:^K=;XH[U?%?P\_QV6UZ5'50NPN+4NCU,>8E581SD(7 M8XC]+KI'&(=XXL`X%9`4[Y,=)*`+AK,^Q]8?D/Q/.TGPUWD[B[,)K,XZ7\[; MO<6_^F6^N>KF:+'7#+"$8(C\E($`Q(8';9Q]I MD(ATRE@&77$>0-]C?%;Z//.;K_FA@,6KI('E`3>YLW,[S>617EN=J)$L=1I+ M"B5;M5.>Q9NO9PCWB_KNQ2CQN@6$L-0_FQ?KPVF:U$>A3RG!*$XB-\Z"&'<3 M>:+0#0<=X+,5N^+@^^K&@QJJP[$Z'.Q[9YC/P_ZC*["S,;V<4FWPC.YVS^=Z M;\_G]>491UU)^[1N=5ZE96JW%=YEO%I4J2FQLM(*F]E;?]JA'CE3O369T::= MO'=EG(4^C".2!32-L><%B'J^W\D&*/*M/),Y72Q;CFO>ELLE+X79,YK]0'MZ MFF'4.>8VLWS]YYSZD%P[GN4;_K"&:WK^7YJ24+-N>E,_V;WK(-;D$6 M`0D.'*3(.WN@(V"-(4V'DZ=+I7&TZL6)QO2?<5TQF'2 M36Q-.UX>A?WIL@]!I[#@3*T\Q[WX/$29X@R=RI5M>@LRDL.34>\+B+,84.H1 MUV595Y0A$`9IO_"#@5`3P/E(I3@C:<]L6IZ02'<5TPF)22^Q-2%Y>7SXITM( M!)W"@G/(\ASWXA,298HS=))9MNDM2$C:4V-;%@W?E\ZC)`!!D")$8AB[7H:R MK),N`2"V(QN1*I+B5.3P<+3%V8AY51C=@K1#8-?)2^,,H2RA6>JEK@L2$M!.M@P28.$A\.E"V7$^ M7"0?.;.@?SG;\$-=Z>(#O@J=V;@-+V;PP<'^\[ID[_GF^3.+$AM^02&#_,BQ M7N<_-HB9\%\SXB8QHID7HR@+<)`1XJ(PF/4UR;?5E\SV^W MRYR?$GMLT7YT'CG>YF!YAUBP2).AZ&$%E&8=BQ4WGWN5?NY5V@-TOEWSZ\$< M#M2ID>J^J.=]W9T@!HF*MR1LRY2H5.:EHOEM^X;_?O=IM2@?N\^??U M_`=A_U=MB@7#Q+)Q%I=7M5/N8"$W8QB`[V,W]A,&A02XAH4"!)#G"JV'*<:B M,5@6-6CGP[*LJE^J/53V;LF>UH2P;6)^S)GUJKF$;&?I_+EJD[*[WI8?(;` MJF)@5_E=L7D!R4/`AZZ;>I"P!)RF-`I@!XE@`,;%??DX]";(3T7%UZ8_W#18 M?W&8G9MX[["/F_@_.O(K,))HU#=KG_$1?X=[+_XSZ$Z+W?F`.HM9%.V%M3TH MTJNSH7517J&H;T9XU>H=$=U)?I>OU_DM`Y)65;ZI&-'\I9C?%,MB4^35"S@Q MQ3X%A'@@"$.*(@@RT,'Q:#`RLLO%H#&JL^CMY'=W^:*)'9NUQ'52N=S)/)H()-M3E`3,F7(\ M`728ZZ"?[LRQA]NFR"^DXD%17XW1K(OXBL1\,]JK5.O`T4`[YEFR.%/<%8MZ M15X4&PKC&,+(C4$Q;R039\WH\F0!HY8$`P=Q:ML.Q;+-7??,_K ML6KSU?,?*N=FSO[T(G>J[WD^=*E:-VB>9D9G&+#W^6*P6JZSMC? MNBM6[,4NYDOGL:SJ^6^_#3H?;<@\G+T<'/0+3-@-(^(E-$C=R`N!YP9NUF%"D8_&E8H*@"C. M%0ZQ\<#P];,B:N0])]SI`P?MI14P2#Q*,I(1'RDA2")(F[YU/? M#X5H0-9#M8?\F_R^6*UXN*X[HU:W]3\?RFV3*F[W[VO@@;[=(Q(.Z=*L,C!\ MFS"(8*AN(+[8VCF`:4%D'JC'4U%8MBELB;C2Y7H97=4H;D22?;Q[MOZT2K>; M[^6:QX>O*Z;Q+QN&J&F-Y6UA%7KN;NK^O"X6^17OMZV=>D91!D($`I"Y;AAD M?DA\ZE&(8S\.0(('78-D"52-BWIOG2S[V/RD#%T>LD3[PAF]]3XR/N%$0H& M[69->X)B)JM!-1EO!\OYQH&)4LY(_0UC"O6J$POP8[2F)!(?5Q^7[%;\WDJ[+?B\?KDM8[1*1\F!>K&4(1\%BL`VX*@P!& M<>!E'8S0#Z))\6?BLY6OC.R0\87N!IOSK4$W.3Q-5?S(P*51YV(A;;2Z]<2U MTWH3B7B2+&!K+)0EWGM14JH:)XY1&)11OLXG_U*L\D^;_*&:16E$78H`B4'D MHLBC`4X[M"2"$F9#*H>H>L6#0VW+V,6>7%*F*JFWW\`%"?M-)[@0(67QX?C* M`Y?/J074OOR@Q$RGEAW,^H4E5&-:"X,&2&@VBOKY/^U0B_3VMNX+FR])WY>V MNZ8YP4GFXXP5)IAW]%`?QSNVI0&:-6UE3ZH'"DH!*Q(.#^02(S.G[":VS7NX M3K&Z*][EG?-W+'*:88C MZ;G@588Y3^?NY@$J3M^G7`7\\=1X],9%=%\D+<,CM%SNJ]DS1AY6>.\U=VZW M:]Y`QL\>--,-IY\L4*C2-X\;V&!&*\X@6*$(.7?X2C>-MFJL*R"K`]B?5AOV MKE7%HL&>43]&,2$HP2'R4TS#V&^Q1]0+A4;\60%82\I2=)CV`MI^N>;DK2A' M0INN$>]2O6#*TJ3%#B!GH5)@/'N?Z?2B[B<[O:3G-7%=P'H*:WRISG,AI;Y< MG4BN^!48;%CA?\6!EG=["ZXL>%\QAE\7"\;R]>=?5\6&?4IRQA$/Q2H_]N.[ MD"C1C[0'K`=8;6K`WH[/Q M_NY<8^,>=/NS&C;_22_76]_A5J?G8W6!FM]ZZX^L]=FKN^X\8<5RHW]OY\MF M4LBK=W^]LWGSLVUM\RW/F_BAX38BY"_BP1N_-G^:%\OZW!/[W3Y2\%^8LT]X MUGY?7VOSX1`'/[]V_"_^,GD10H6-WUI\,.I/-BPZF%5`:47^";EC92H#"Q M.1_Z,'+[M8`'S"W.EP"]28/11*B5YB"(CM7<=G">0S%M*3)N?9".%J?VQ2J< MY)'X8L?+Y;HXV9^WY:5_]=,5^>M5X"2NE[.04"<(LS3QHD06 MZ2PB@>\)55!B:/6OL\S%EW__X\=_LXO/^"M5I0T`%.\PK!T48%RJ!,")M=ZF M7/S[+7_\2Q],M]3;_^7E*N\^X+>>=3@:YWZJ-3SFVJFWL2+[>?>R8>K[HKSS M@B2B24;3W/6(,TR]XYBIO\IBWO2<5F8_J[QJ/$D^#"[1VDF%Q67:^63!PGJM MG6QHUH4'2)^J#>>PB/OYQ.OSEA-P;AVR')W.@JXNB,IG&N1]M_*MT6VQVEN] M"IW4(8&3^ZX?X#PD891C88SX;A3EH@J&G&C0LV!9K0Z<.GC6@"<<-+%3.]]@ M'S:8LD`1LW*NX4U03IQJ&`?B3,XTC`R"FQQ7X$X!UTWYCZV@-/8H_M-M3_G, M=\(\CE(?^SC"A.2,>DD>>#@+TSA36IL<9<#V7'CG$VJ=TKWR60L[-7*Q#AMP M\@Q&S-)-_*]1.4$NHT"<";>,B^'5;?JC`=%EEGV=),HBC_@Q(7$:4IH+4X3T M]B(6^K"7-'6-3,XP\*G<>""UJ,8.AF/I1@F^*3CGU.S+&*+SY!Z-.$[SCRXP MZAPD3Y_?\97`J6'_V(H9W%>^*=N?7CZ("9THM1[%KT1]U9YR=Z\P#4+?R4C` M,L8"+Z>$!-(/G[A!3#(7Q$VFC=OFK/9ED4:Z)CO8];YU[[]`*U=1A>G,V&'_8"(GF)%6\F9"UM:B^\EB]H% M4GUEJFCNY+_2A\=B)0A=]D']4M1_EAM965Z6BVW=-43=''@/\.,-KS]> MBL]#E\!L)$EQ@>S,^0$NG[V9F@\GQFS8,=-_%@5;27=1O$S7]%=]KOOZX M*,1`;:E\:`J]ONT^K=\:VFI2%4ONV>436(\!"*?J M61VL9L(\>KZ_K$#U`7C_W&7_W5=XM>KMB$JV/XWMD90RGZ5N$.18D(T3^H,M MDB2ATO1^E`'+O"!<0GN?P"]BC(+N-$],AAJ,+\"`J9S`[D.5O.'M_B8YPSL\ M@WT"D+=.SIG`[]SGXXS$P`T.*&!MP;8U7_+5JJB_E/*"K"LGR,/`I4F$6>)F M"'_0_G4?0.@,.EUJM814I&'^`0+)2<[P$XT3= MH8W;3&H/??^YH0$$>??C*W\LZDW5]";2/,,>#E(GHG'L9"S*\G0P$>!<:9%* MYWLML\3@#>3\/Q29=RH+RZ#`"&%P!,J96L``WGJP")#>*PT[H+[?%?5]@?"G MT3=`/H_QK2)J!!+GKIW&N,['#P0(\^&%^)^RYNLNM;TEFE*"0]^C+!=E&:.) M+,0Z2S1.LO3JL:RON1(%ZAF`C.E#7]0G$X-;PYC^8[T8.Z;?#/78T!Z'RQQ& M^,@(N+%!`AKOMQ5O.BN++PP(TQ4$&+2$651E`H+.!O,I5E`((-> MWXK]D2]]0R^5>LE\OR ML5SQ!UDC#!N/^;>++WAGW0O\S/-)P`BA3NJ%SLYZG'FA^F7^QDQ:+IKKWM'V M\,:!J_M]V=99T!7LYN!6*+?/@S2L$E<$6:M0-X@VY!;[LZ"N5]Z;0U_Q]G=5 M;(ZIAGEPYR`B%J+B5DL[JM5V6SXNCPTG1`G#/(\ M39T\(WE$L>.1G>G`PP!],6+/NK@,7J+!3;3S4T=8S("LI"J3XPN5E'>AU903 M,QB#M&1RK'6%Q`3FJB*B`LIQ!3$*Z3SDPVQ(W-X(A`C'YVI1KIOR+9WRXD#, MAIR4^(F7XCQ,4M<=S(5II+2C-]:&98%8=9Z-F&R,P4]!!R:"#L;];Z.F1?=C MX`-0_$0PZM&Z-IQJ3'X\]F/L;0"M.3"VB3"XV4$$NC"/UP]W_/*IP9]Z*R3% M4>;F<1PZ;D!SUXU=-E@AGD^<+IS">%/HR_H>AG>L:&NC\,<1O@( M[[F1P0`9ST2>,KCF==>M];8NVUZMS8^Z6#?%HNU6UAZ"#%F6N6)^3-W(RXGK MAGX>[U9@XT#M8*))@Y9KD&=NHKV?Z-!1C5O^C>&M4*:<`VI8S3)[E`'5S#G0 MUBMM#B\Z*_8-FANTN2LVJ%H_\M5CB38_N2!*=,]K6035[1N;[0>N^>;N/]!O MU>](AO58KIZZWR^J!]F>LUJC`OTOK]:;@_>TVD_*-_3E:NMOE?S_BJ\M__G` M^_:>376[KFZJA>S)65?-GT,K3MDANK>[+!]*\3,Q4&0'T`6_OY<=HT4,S7:Q M*)NVN:?\S3';HW?Z%#-\3-5,#Y`Y:)WQF+C%)\JP+O9'>?U(SO^9ZP2,X,3S M(W]WE)<&2:2^>FO.Y#RT4:/)@D'4S>BC!<"M*.1YL3:KDA8PU^]>O1#^EJW, MM7_L71=_.Q3.#^CG726W$FOYJ2/B^K/:B$^T4ODDA=6"IE8-^DWX\/O_0V$] MW?G#_*CZ1<05&A507K5`4SR31ICCNM]K?EL7]\."#0T\DI/(2WS"6!B)@3*< M4_-S10X"PJ^W?SQ[)^ MNMP4MV5O=3@[2*1_#"]Z<"/$A)$/J,LC2@+/1SBWC3S74?]E7E#]B;BVM;/ M8Z4)G%?&PZQ,RI,BK,?3';A'ZNT1[#T>93"A3XJV$8Z_:<$?4G%DA!MB_O?0 M.2T&QK"=CSZ8"^FU9!B&"Z(BEZ6`8'G*=NR'3N1Z.*5NYN51$LM=[,YV'ON) M^I%N4P8GTI'.47-"8@!I9269%F0]*>GQ-:\E!H`&B\FT@!M1DZ;#?QHY>1>? MTWIB#M[Y"(K!F%XKBFG`()+"BL4=7BXK.3B+U2D?G(PYC."8,B>.HY!%8=S[ MD`4D8]`9BCG#$TF,=!@5.X_-:8W!%"AKSGG0U].>%OB]LQ9$R&`&P&)TGDR, M%J7RQ=/PCC*A&[Y:\9_RJ,^!G-F5,65D3\N9^03-1]8LQ/9:WFP!J'AQPN7W M;Y\_79!+\KW8W/TLGGA=K+D8A/7^1[WY/`]P@#/L$^)Y#F-9$.2#>3>)`9\C<(NH*FG0EOF)P!H-:[6,$@YI#+ M%V.3(CPT/)^4?UK>U]<#^N":>A& M0<;"Q(FRQ*7$B_;JYC&J+"_@;[8L(GM_('P%QT=!":Q"`^/[O2M:=`Z'!T#: M5F'2HV807&K,^S+*8_RJC<8<6%3?>6YB0(!6G-:;BG[^'/PG^Y3W9D2-SPB) M/!QD&8E34?8S?S#C,\BB$OR[;:\;"8\^2I?^(GT"+4IHX*2R\F,7(N#BSC-T M]-9N-&""+,_8A4N/)<&P*2Z8O(KUZ)J(/BIS8,LQ[G,S@P/"F-]DM9I5?,5O MY1W&+PY]$A;D!!,_H\2-"<69&Z>#15'.*G7\,V#&,H^VSJ%<_!KM7=0ZA3\2 M306*G0Y(&-MV&+X!GQ;QCL01P,'3X:E'QV-P56/FDP@<(VDSL,V!KPU%PHV/ M*0B+7]X7J]47$?)BNWJYL1ME<1"DOI/&42`$!&/,!G-A[&?*%#["AF7^;CU# M@VLZI^O'X*=`VA-!!V/LMU'3HNLQ\`&X>B(8]8A:&TXUECX>^S&*-H#6'/C9 M1!C<["!29.9E65U]+F^+%1.E_*9KS^MZ$?5R@4&&`^9@1F5SO-Y$'"2!"AOK M?*]E!F[=09T_L!O0M$`Z3;FV\8'1+`@:A7ZX(KJNG:7XP\LNEF]$_@8[C,'G MS(PPRG4^?G@`GOSNV_L[2?+(\>,D2HE+2)*Z04CB>#=S3YG272'@+[7\S`]# M&G:;$QR:]Q]V:ZC`GG1E0`P\Y85M+V,=]O^7DGHGHJUR6P:[464*H=^=<_:O?P.0->C"!X$RZ6(\*@9L;4*`#@_RI6&V>+HI->96$ M#G6=G-$D8@Q[29#[7O_]8>JGZDZ80T-R.DZ2ZCHK:)\[\:)/*K-;U`]#*1R45:/Y1+) MYQ\UQ:K][4/-E]O%9OSU,@<0'%M,T4%I#JLG6G[SD<,#U*)BZ%+TO>^)<='G M^LJ)/<&X!(NY6!KG8>A&N\HM9$&@OG"M;\(R3_[M061+U`SRCM-]$ZY=#Y=A MU$-88@2<"@PZ#9(P/MWYA`:GT,6TP`'(=AH`]:CW<#0>MHE;W%7E8_F\V^B. MD+=KP5[M"S=#"Z)BN)MU-"T?!>L828]'=PZ4;2`*;G3(0>C\ZU96S=]NACW/ M*YH0$@5N[.<)"RF+J+SYOC>"XUC].B_P-ULF[\Z?O@X!'Q2!XZ1`SU8A@K'R M'AV=8S1P=``<;!4E(Z_BKU\-K=%<^C+H8Q2J#6YB?(#*WN*?U?WV M7G!R<;TJQ:SG>S>9^=L#7^.]XGZ[(66]*:KUCL6;*QQFL8^I3_+4\5/A@.=E M@SMN3&+UNMB>#Y:YM_>\+T.D]^CZ">';BC=H*[Q_5K2(QVC1!;`OLD%L9#-7 M*D7W/-($K,K[#/5>(^$VZOWN,H2?9ZCW'7V9788@U?T\,J6G04/&'OJ,/8B, M/1QF;,0SI5CO:\-W=$)@/R%ST+TIPN33CG.(EG[G&V&M*E9[._U<9^_:E9,F M?D18*`RZ013&;I:X@^&`4O5U=B/6+.OCSL>#IW.8O!\^V!".-8.R@MY-#C!P MGV^'[=Z_8>GI4.:FQQ:@5)-CK+D;,!IK->51@>.8QAB%<@YJ8C8@;FO4P?HC M+H4FK?A#.P372V'KIMIVF0 MDY3D8>ZX.X="X2"@9:)%+VP?_N`?#YQOUX@?6O=1T_F/VLY<:+DM91^W>HA! M5HIZLRZ[.5/0H=FD"Z9/S]QN$]4YCGK/4>LZHEVB+@X3I3?YLILH4+?&F21, MM]&QU<2I-C?4Q_"80DZ2ESDHYS2!\JF'O)FYV%6:A-@-LSQB81XPQZ$."P=S M<>:J]TL<86/Z>==NS]3,?.!]%$?-L(P":&Y>-15V1F901C$TLI_TL(-V6`-H M.^G*7Y7=F?6J0>6JNJWDPI\0%_$Q=,/KUVM\OS6_#^V#[\5GJO5BM5V6Z("$ M/CP[._`@BL1'85=\ESRUU7R\+F2GWX-5B?T!`G,'!X[G!CZ)4\[F'`3(1!AJ M$S8@+)##`_Q&7GU!"A%N?;DI[TFY6O63PT;\=%DMBTW9R,B_5P]BU*[+JR`+ M?-]SHBAS8DI#)XMI,#CCN4Q]BF;-@\D.([37MW2N(^D[DLX/ZR0-VKO?G:4< M`H#OSMM(D_(9AS-G2/^K;N\VC:C?6O\NR8^[LBX>RNVF6NS] M^E'6]U=I@+THE-.^E'HY39PT&EY[#5,O4K\;SZ83EJ5SYWI_@K5=RVR=;TO@ MC@4NB2Q1AP#08A?!!R1,@JX:L9HO!0&=2ZI@&KK/TLYM=/%&E@Y\/V#H#^C' MG+($4-*Y9$M/3.UF34U/1R!X3%*G2,H<5'62./G$HUU[W[!?5>4WGU;\NEC1 M_6\(;S;-51BQ(`U2-V6)F`NSP,6[^VS#W,W5Q=2HU6GW!8?-0%$^W[;^'BX- MH87T6'MK:33^T#V_*:$?L\=WN0>]\Q0=N(K(>4'7W;^;$GP3^W6CDJ"Q-_<. M/DI[<:8PGH-6V0GLZ%Z;6>A4U4AHX/I6V'CU3M>&7Y=?BF5Y%;IIX&'LY8E/ MP87]UM&^Y=`-QQ=ETCZ"2,_`Q@K"O^++B_(?VZHNES]X5EZ6]6.YS'DM)TK5NAVAWV[PL-]ZE8>88I9AFCH9 MS9V,.)&S6Y:DL:,L&M8]L:PH.__1N@U`GI47$:"Z#Z%_()LVBG8)8[./0Y9^ MNSUL"#/:SY^"(,TJ=3"UVF>M\QUUSJ.+YUF[W&?MQ_.LX7EF#2!VL\J>F7>@ M%1[`ZU(DLVP__N(Y-'N>9"RZQY1ULJS-07:G"Y:?X\$`";8POWGZ4F[N^/*/ M]:,H%=HB`:^7;>>`@Q]=^1'Q/.IZF"9NXOC8B?R=>3RX'G7=.3@I^>"&R*! MYX'=B-A5.^?DB%_P^WLA8V+2L/BS/Q_9/P3W7;IDBL3G#I^'\1JG#-]1-3.? M@%GHEH6PN-UQ"[S+^*_E\E;,6VG95+>=`+9WHE.<^0&-F1,F+L->FF5>XB6Y M&SMNG(78A5QGK&G"LM+T7J$#MV#-"\8B>%I-)@0/)AXZN%FY[?AM9-X@*$-0 MSN3.X[%1<*/C:S3;]#>UXS"*@C1UTMY<$PI-Q?*-HY!R,`VN@ M,!Y'7=:Q`*$!WAG3;<$D\QSMQ6`,T-FR#S2.=_E'"QAE!AH,E4O<]+;_6#>; MNJWC^VO??9\$.'&R(*,.=CU7.!`.IJ/<`_5R,&'/,B_M713S"737/V?5SDO5 M":!1B-5X:FIT893U'-B!P/8.GJM/A`)J)ZC,).8S836C(7%[0Q3(=5_Y>KFS MWIM*XB3,`R=Q8^QY\JY?0H/!%,:9TD'%,=]OF0.H$1XW!=2:<-"H$;FZ8`3GGC[5X:LMF(WM&R#,1=;$86"YQ(DQ) M0/TT#UU&*7$C-EAD2:IT&[@!,]9W,#K/VAXO:/`-VEG7!)QJ%#01DC`FT@;1 M"O<T5QYO]60/N]12R]V<*985MUC,` M#",P%6RUNJV;`AFPN7H&L/4V5@V!KK9GJH;*L?U2PYC.8:_4=$CBR'?O+R*AR&:<;\/`A]+_*"?/"%TLR8F&@[<'YU^8`& MY^6)!ND^DO[;X$7]-(U7HTDR9%R>?HGDF%.Q29(T^KQ0-:2I[:[:"+_1HB^? MFP_H_B!A3S)A-R*,T8>#-('35+[1>?@%I'!\C`!M-`2H!;'\4:Y[5T*2!)2F M8Z:ZYD$E6XRMBBQZ M1"F7_?1+4"(MRQ:-`P(4]Z4[%P?GX$>>_P$.0.#+P1+'(D8XQ8C+E`H2B421 MUA)-B-'MU@.:]YS.6H_VX5B_`5^@*ZXVR,Q6.SS3@B6;#I3VYE*+&\^)]"QJ M#,`WD<6,(3THG;U+IF/JW693K&]^S-CO+>?K0):KU7QC.G("07EED.J+!TP(.A17!Q3FQP4=BT!5 MW+RY+;_^W/9*BP#N?J<%`!\)P''?7QJ8V*"Y]$C#RN=RP+L`#>2_\@\SR5(I M9:ZR!/$8A4E"DW:<01,>F=V%`6G0 MT7IN$/*0AEP?0WEH.ZWG$*!`-FG0/LY#D6<0H14DL4:HX#Q_;3GBJ0#%LTJ#G M&%:[30D-7",.AH'K&@$L<'7O@_U<+!!U_MUNEOHHZ7XH[H.XAM`7Q!!&4PEB MD,^G00SOL'D0_^W#'S,>RR1&0B%%",LQ3U@:=0(14K/[O2$->@[BO\T?YNNB M*H(_BC4TF(UX&`:S:Q2P8&XH7/4S"9"JQ"_+Y-';A'39;*OY4 MK)?EYEVY+2K\)DX^%/5+L-[*75$_F*2MR',L6A^:GJ M+HQYCGGM%_J/H&H\U2>@%55SH;+V$+*FZ(3K*_IP":0P[=A[%S3N!=J_X.!@ M,8 MO")K@.K<\JM+RI?6?.?]*3V]CI:Y(GJ#G]C%N/V&EB*>)#QC,6+(;WYTRR<`0*G"S"-Q0]25+IP2Z*$QEF M&1%)%(>$*"5YM[S'0V16,'!ES'.RT'Z=F5BDEG)FSQ66+$9!.B!9-&A/9Q;I MT&1A3]:1DL7_9CV<6J@+*I0T5.[ MV<%NSD.IXB1!*`DYEPRAM+,KDMQLF=>5,>]5J.AEE($:UIH$L)Y81AO?G;*W)"2B+6A-] M.FU!![NQ1$S%@H@\943$*:4,MW9#3JW6):R->:\UT7.U)F1=#;'E"JTUC8!T M4*V)GJY+8#2\U&0+U[;4-`+DT4I-]*34A-R6FEY&951J&DAY8KEB>'_.EIJ< M@`+GBO@->I*C<'2PBT.9I)P2PE2H$LX3*3J[%$MADRNLC7G.%=JO,[D"],6R M$ZZP7#$*T@&Y0OMWFBNBH;G"'JY=KA@%LH/9@RUL<$8X!\0@(PQF.;&,,+P_ M9S*"(U#&W_N^?RC6[Q_TR]>>;%C]<[/<;HOU;W5#S>T:))9)1&,E:SLJ1"Q) M<&>YGL<8Y02'YCQG!>UAL'>Q.\JS"@Y.!MI+NXMW7(#N3Q(78@Q+$P[P>OFP M^'5H+ZB@=W;7_KC![4+S/)!VKWJ7N1W(!)RU\@&Y_[_0/FB?0.IG!@(EU,:/>IB#6XB2F+O?^GH#0(JQ*_E^E;?3R^+ZVTW&D.J%B.19)1*A&F$ M),O;8V)81)#1V<"##'A6"NW33]JI0'MU-6".9X?/3$2\DX,)B14T+WKR$I@> M31G$<2*Z,JP/I<,7:Z"^',8[,<()H31+22YBEB`BNK/L&$L3HS-F!IJXB,;8 MS:ML(=KIC`=^+I3F,K.EE^$`U`9(&@(*BP4I,TWQ"VG`.N6%ID#/>/0HB#V[ MB8C'@`Z4KEXCH&1\**ME=[D\RQ7.0ZJ2B%`-&&8P@]LF#%:B**8.=[Z>!EL=2!]I)W'!.2I`3Q MD"=<[^Q%43&-DJPF6F'4]!&*@"D-C$=`'J M_1EEL((`*F6TYV@KCF-$6#U+07F$(T23]K`P1D("+I`:-NM;$^H_OYM7Q2+X ML-M:E"A,X9B7)3QP@9`3P2KD!2&DBL6_C^0ME!:O.FY<2[LI->_,O MSJ5N7E`2QA&G"8I89R*E##0M@+3K.>K;/0D6RZ<@.H:%`T]@@"4#[<7%:@6/ M"/JJ!!:@)A+Y5JZ?5@:LNV\>^[O[^_GFQ_O/LM@LO\ZWRZ_%VW6UW32[MRMV M736;.681KV<>*E."9Y@P)$+)VC-"6);G(4@6W)CT77#<>ZF_2'KT,SAR%"HC MCD`;*LSXC('B\QK>X%^MEZ-+DQ&[/M5R"W\J@N:X5Z=:YP.:L0S^??Y]>;^[ M_UCHN=6R'G`UUY-M:W?R[FU`MNCOGX? MU$3$V',GRS'??:!4/]I@7XO-_+9XYE8X$XHI%(D\SE$>9E2*3'6%RJCX6-^7M>OF_Q>+M^OWVKMB(\OYA4]P5ZZKYX9OROE"?/Q^7\6PT!3T>R:[JWH"W&XW\ MQ*`*.[6'9:O%Q[6"JT!W)7CLBSXXINE-\*0[P;X_P9_UC__E*N@Z%AQZ=C$1 M=_!4C.1^S*<_N<0P:N?/II#Q'\&P9/.NW,JBJ@?Y];1^P:K_*1:WS7WNW0_\ MM4Z%NB?OBNTL3VB6QXA&.1948!42T7[`PR@.T:S.G]?EH!3CU!^(4AV[;BQ8 M[%[?@*:GW-JMG_?*S'0_F%?! MH0-/4Y#N0Y=9ZHY,(9=`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`M@V%=6$F&^U\Z>FO`.B$*/3E?O5TO MBN^_%#]F(E51SK'`0N2IBD.5A6EK*!+17&^;S]&]=C%Z`,`<*.>%:*;LVAG`+(``_.Z&GAC8CF%Z\?A(/*/.WPF MX*V83"#.[?PN![X,%E&]_])0K1=ROJT-Y1D7L:XU(H(I3BE/46M(261TLJY] MZV/%^>'KRMJM0/ME$?)`:N:Q[P^8I0@8LW*H!T\@O"(,=L`FI!"6'7A!*H:@ M,-(,5EM9-)M35O/;&<8J5;FB2<@43X7,F>"M@8PFQK,&6*N>-:)S)M#>`)0! MR.9U1?"'!:8$ID0SLL$XAW2\?+H6\$(+[W7QMO\V5U,U_]4%E@;\!SU![^"O6.!]LQF=&#/[W4Y&`4= M3!GLJ#G0B7,LSDC&8'034(_A?2@=ODO@BN,_B]7JEW7Y;?VIF%?ENEB\K:I= ML9F)B"6YY$I?WTCU]OJT+5?$**>IT5VQPZV,4X'4WOWT1;L7M/X%>P?!I4AK MG*8ER3%(6I4F;2`ZJU&>H=);JQQ*<@+:XZ@CSVJ7;M``5.@?Y6JWWLXW/_+E MJ@[C69+'(F$DH7E8SXARD2D2M8:PY$:;-^U;'T=U.J^"O5M@K0%#,]48G[RL MM,4*8=[ZI9RB4F M,I.2A&F<(Y(+%;;V8FIV(]!@(R.MFQX&^9UWP=X]^/*I)4KC553_%.T64\$` MW:VIOHBD?VEU&,7):,W0?CQ?:'4!!J`\C;*)>E)V6VY^S$).$*^G9$2$4J4H M83*5K9E0*:-C@FW;'D=G&I^"UBFPN@!QF8J*/U)66F(*R9F"/.E_KW#8D9J, M7EBZ_TPFAF``J,.'W?5J>9.OROEVQJ4(XXPRG":"4*1P*.-N<5@JX"P&TO(X MRK#W*&A<`NL"")2I*OAB9*4)9GB<*<)1WWOUP(;19-3`ROEG6F"/`#)#*>_O MR_6G;7GSY=/=O'Y=WN^VU7:^7M1CE)D*.4JS*$8L)DPJEB.%'N=%TGBWE@-3 M(\U6&A>#QL>K8.]E<.0F?-8R"*_QW&4LLG8S&&NH[F8R/8#ZYS,NR$Y&E]ST MYOGU@VW5&)T=MHP"R-KR6&;YC`U`1&$ZHDO>,,4Q8R; M9*J%&>2T)CG)(KD:YL\'5GQ%RO'COUGL'=-']I:7/`*L5Y6+X22 M8\@3.1G#56].KPIS"/6OLC-5EV=&_6/-WT`.VW#Z'/IU[Z*/`*B`!R\U_N,J2-!Z&ORK M\370S@:-MSV*Z)DZX*232]&W.O#DOVN'=JMZXK>H\_ZJK/013/7SV-[IDYBZ MTS7TR9S;P]5!V[(+EL5NT_Q)_I@KPQ3FYG#ET!8'XA=7E[4E,X M@L5+OTK/KSAP^,BJJCBZ83-1(R-,RBB*N#L9R3!'2XMIT%S_+0[H";-\[]EY5.@*%!Y,(G+QO5 MN.HV#5Y8/D[`O*HBMB`G)2;6G7A14X8A,986?8@L6R_T__3,_>M\5>C;O;=B MOMG\J$?`_YBO=L6,"D:%(B0)1:0$BY7@M#6>D1!TWJL;B[ZE1Y^BK(?V-_H7 MQ:.?(X>3$:R>\'(+>R+AYKA3I<_W$YKIO\Z7*SW)R,O-I]KRI^)&7V>Z+%H] MF(4JES15(8ES+C(E,ARA3@13N3_6N]J>K:P_>%=O6IA2A/FY5 M8D$EERS%+(E;FPE6!':CXB!3D.BSNRSQX%VPZ=R["M9%QOT%Q!KT$? M]G`,A_=C/17@*+]]'!^/'D?M63?N'UL'>S#U2:`+NE-1/R=].14^=X``5SQ\ MK5LO-S_TE864,D*B>KHA2)1GC"?[LYLHK`$`[JOZ7-0*L_AM_GU?@3C2'!3G ML6*(A2R55*EZ@L-(:S(*HQAV6Y6]'=^;XPZN!"'$! M=2(!XZ0KSRY-V2SMV3`S2[:><<%2[I[42Q5&K+L M-V,LIY2G(D,RPR07*6XKCB&J]4O-MN5VOK)8[GNU99!P=$Z8;]/1_V28<`!) M6:SQ.84T:&WOD@MZI@MYQK0F(@^6SO M+1_TWC@]-4CJ"0!3),5YQ!,2*TYYV-KDJ>20$<8@0Y['&JUO5\&#]JXI+!:M M?TV%7UJNCF"NK[S6JGOVK]:UDN MOBU7JYG(8DR0/I.6M]/&3H2T29":C>,I)# MSA.).K=]>GX!JFM@QE'8M4_BE,LX3ICD*:8XSS%';?L)IRDDTHP;]1Q-K1\C MQX]!C(`)320.X'Z7`U\-^WK0N[I+[0)V0F,N24Z4$EC%H"1IE,NM;CC,-K0Z\V.4I1:$`QZ'4FD"J04QPVY9^+5'U>+?<8 M8YE(I$.]?K'``^RT<2S_NIQ?+U?-_K9ZIOO\F^IN*SC+!2=,DDQP%J>*TBC) M6OM,<=#<)'3-,,92V,9IJJUF/,41FLF7+=7I"9=V3\](T#([YB4YWY6;[ M6[&YY^5F4WY;KF^K62@P2TF693A2-%5I%*%N&$@5!WV7;].^9_EI7/JI_H?W MP77G%%!_K+"9"8]O8C#%.8(EB^NQJS8OL.B1EB'D)J(I@[IP>GC58!S@[XH^ MS'_H3?WM3H&(Y5)QSD-$2(PC%I&8=YH5$M@G?78F/&M)]^'*P]XMRT]^H-P, M*SS^D0$K/BVM@T>7_KSG*9B^HM`PDA,1EZ&]./,QSR`H$(G9[(K%\Q'2#$X/LK?@7&NU84'Q_*-95W^9]U_2,M68$<&"Y:9B] M-&L:7W%>QM,O.@.13D=WAG;DN?0X00-5G_]C[]J6W,:1[*_@81_LB&H'>`%( M[CR1!#CC"$^7QW9';ZP?%+3$ANK`$/>7G90E2X-0N"5(QY'D)4J9&^!CCA^); ML=N/TRW?10C[`9MHQ21SV5BQ3X;18"AV]DIRB(72Q=T]D]6.-V78#.<9ZQZI MH!;)4CE/B!9@44R%QM.?!T274J#GB3DC/XI,6J(]JE:<./*I1(I8==\S\RS' MB1%%7@"3`*:^[Z,L&>993N223+B^3V*,12K\AN-;D\TJF7(_&0KGR'@ MF-)8I!!0XNL7*0I4EQH9XF2WP[5RIKX-?O&];Z$][]GD62(H*A:\N,>.8U!=@H<2/\F!+S:#L:)OW+$D<)Q\N)$CU!Q`89A% M4JR[:O>+_C2K")ERF59#/"HG6R][R%I4I32P:HD^Z;#DA<2K-#GSRJS)462(9`!./#JUZHM@!.^%M0,)6+G:L>(=E90(7&>("W$GY@>/4<=B-NV+K_L^WL:VPJ\ MSR_;<$&J3XP&NBV1*1V6/#XCK8L<@3;GAV1S-W1_YZJ79-A+/1R'3A`[;HHS M;^BAAZ,L$;QY468$D1=+ZL+%$11H.*HK\!]OH`/N\QI\XP#!?5&#YI:]7U<` MO8'@KMQN>:U_]Q&;(>S;VZHN_RPV?^/9X@)4^[9IV;R!Q12#-S)*^6J>")IV MDICZ';WSL?=.!^@*O&V:?;%9O.7\$VK.R)L*D9;HFI()3_K*J](AM"BL=I-Q MLHQD7@2C$#L)B?@B%`V+SP##R!.3,>&O-ZYA/:(9`A:\(&%E]UH!Y#AOW/'W MN&+Y4?C&?_*7QO1-W(/SEYS&7">^SF146B!KCTEY86DIQ9\E@B:/_YE%I`(1 MLZ7L4UWDS;[^.1G)H2CP8QAG3I8FJ>/1"`_;:T&,DG2U*[[F;;&9)V82`\QZ M)Z+^G9ABD9(S4.Y`>\!XQ15G737MWX`#G3?H@4(%X9M@.8&2\DI(6<$2H$]2R1*Q8)*VZ,D6CJ\V92\8C_?OL_+S=M=FM^7;;Z= MJ.2*(L3K`5T,TY1-^OPP&(N6`X\@3ZB`6'TXPPFO(T(V$RLWOS`56_<@18N) M-3`[3W@6)E5,B"9\U#T>;EKMC0O-[Q5H7Q>KV_VV_YM(84-^6Z;%?80PD.L1MT9S&P&WGTJ*H4 M"IW:TC"<86T;$(+B`%%0TG00.D_2%N923-)&&@=TX-4$'S@`/+-O:T317J;L MC*)IY-L21=-I467LX10_Z#6,U)5Q,A&]KXO;8M>PI5!_J.-=U?"[YZYO/N4_ M5@G-$`["V$LC1"F&(8+I`,,/4J';+W2/;7H>-WDCJ[[MQA3P8F-F??T6)1!&A6J#59NZ-.$N@EA_PG2`'EN,'17#ES/$VI2 M(?'UB]1'-@\VR@N9^VEDF),M+=!*FK&2@HO7$0C5#\SFU!)A4K'@Q7H!03*T M79JU2N,,HR3"3A2%$$&"'0>/LY84.Y)5V'*#+2(]D]+L+KVL08K469XG3(L2 M+"93SU^-9=E]6&?T21NUEJB5/GL$[[T2)&K^YEK^(ZV+3=FF>5W_O*GJ[WF] M^<0#X(IZ44`"B(+(10B%'ONOEZ*(T!2Z(7*%3KDJ#&-X=<.0@1X:F&(#GSMT M9XH(M=,YW<[T*PR1#F4^+L3S2R3JDM?F MYUU'Y75'_.(IT"E#9].=4E1:\JK(HG^2QE0@02U4ORMWQ=NVN&M664:3*($X M\IR0O8-NYA`\C)K&5&AS67$HPR%[VEE)1WP6X%`A1INA3U.:=F[-W@S:OX!U]R]NOK`C2W!?/9)F^+[B?,6>NG[QI@ M*__^3>-_RKZ4[T_>LB_C[]=]77TKV:OUX"TLFC>S(R,GN8MWCGN(=I*T/Q,! M33OPPE'1N'G5,N^!<'7[O_=-WS'B4W6B$)4!HC*')N=+^8[8+)+U7`5&%$4P#?TP(C`[#A]1 ML8"C:U3C`>79[NCCFHS/2O.NC+?:\:8Y+)#D\ZI\V9#[+>\6U46JXP1T$F.Z MU:#DO37*WIP70"[A1M557G,%^G;2#V`"CO-R7>_/L7=&TG7S;XED:S?K="M\ MC;0)[,ES'LIMV0G[]5_4_)0'^^!317_D M=_S`!_OU#T6[KW?-AVJ[S0YKER2+&58D,!4[0W9AL(8W M&*;V=+([3/E%>\I=G*C9!]G^0@X5$_N'IO%H_,"[DZD_"P*C@8?MD`8<3>1K MB<'([L\.9H+/W%!PL'3I+5[3GCM;GF+)0V-)A+*'CR2U8#R29G1>&%F"1C'U/ZGU"\OT"6;.J*LJEY:(HK(9E=Y'3(\$ M#2GEYL.P9.=)FO?L!:_?=Z\Y^]WW5=.E=9I5`(,PPX1B@GSD>!&DWEBS&,?0 M%YEZ+P+(?(UA#Q;419\485.K>XZUT[0^F3Z`U:-PFAVF)(>7\Y4F[>SRYOV6 MRFA"GS?OC`"]%=V?O'_9C4OJK1#UXN)LQK-V*[DAF^?)ODG"56,$*42P$1_Q M#H^.XP:0X8N"P(_&^.4$KEC7Q44@S5(>E3Z-(]SEXH1FIRG%B0MX2W><&$SX MJ\4)(>K%XX09S]H=)PS9/"].F"3Q/%W3P M],09LUY3BC:7=Y?NF#-:]#CHC+X]6@4.9O%/)X;9$7M47",>@19Y$.R.0\M0 M,"\:+>@.Y8J?#"=NX&:IDT'/RV(8I]&PNX\"Q_<.%3]TIQ997AQ'O-YG@"13 M[5/L-B_7^5A>KC*74;O?V_EFS"Q7$:-%]?WY=)NWOU?[[>;MW7V^;OMC1>6W M@E?SL1G,*LB0Z\1)Z.&8.*&?(1H-QXA0E,2QAI2R*H1+57R#E@&_`N4-./[" M%?C.+>E[,N1@5[2@[*SB9TB[(^6#==U7U;FN69ZR'Y4FZ$"# M'C488?T]20XH+9#F\_Q*K.7I\%+=JNR'A/G M[M)IHW-NO[,^C?OV."#]P<_D%\TJ=CR2$)>DQ(%9%-/("X;2$>10/*L#H_(@ MAI7UF/YB4CHYFU[T^,1:82E0>5XJ%V513`_'/:MR*GI@0+88@4)-PY8A4DMW ML,V$WZ?/)]CL^05$5Z#I-EYX4W!^MJU/;/5[A=_RNJSV#?\KGMO-CYLQTUG$ M@[D#^]94.I%PW"F M0T?^'=P-R`2GVSK(G#>[7IA'L>`Q@KL"G,T1WQ5@"'FZ>,"X\-3Y9=+.S)0U M,F[)Q%BG196QQU-6SWZOZC_>[M[7U;IH'@T=9P%R$J:C:9`Y;D8BD@3#T#!- MA`X[ZAC/L*)Q9'W4[[#):IH*H8*BMA"7TJHV,'I`:(VNG>9MCK!I8-TV9=-A MTBEITT:7N+9EY:YL;HO-WZMJ\VAHG$0XP)[K9%[FN6%$(72&H4.?(BEM4QC/ ML+8-R,!7#DU6VE3X%)2VA:B4EK:1T`Z@-Z@5B]L]Y4T1H MLNV5$,)^ZMD7)T#\(3\_M8?;I,>QXQ\E6YCX,`J\T`DI]N/`1V[JP<.8CA=%0I=$*@VT ME.:`SQR.J-*H<3A/!ITZ1$G]C7 MD.HN+W>K($48)V'J40=FA/A^&@TC!W&4"FTM:1AN.57J`>G2)1%&U=3)$)G2 M&O4BCXNJU)$=":V2H-9RQ9*Q:*9N29,UKWXJ_E+G/_)=<;C1&P44)NS[?(A) M$"#D^1[/>A#D0LRD,YA=,B7XO:;K3Y,/\7_%OU*1:AY19L[+C6E2Q'1E``(^ M]U#FRK,4,0*5308)4BYF&K!=@9QO,/*RN^'"P_[60N4"HX?6GZHIDN3(AC(B M6>B5^B,BHHG7;?'G-C\,P,\.!)A&#G8CZ)$`AU[$!Z!AD#H^F56Y+_ZMAO7P M^A/][W>QR$LOQLD,+31&AY@2]C"D=%",$@$5-$:-G`;.IFB>RDVM.Z5Q4@S8 MH'!RP"M5Y\OFY]^5N^)M6]PUJX@2',9I"H/,RV+B$NCAP]PR9)-,N=+'^5^_ MW'J48P(=*.FLO`!K@BEY,X1)KSEG<64V%S\R,B<1+TZ?)>M*%0M.I>!ER1!0 MD;Z&^UC+/:V!?)^O_\B_EKNOXR?Q;O-QSSM9'%>WO*-2%"0APQ$$3A"G3A!" MVFDQ]7-\6F_VVN+YY7U=L%M7^?,\>M9:)(/V??7G/#&C!OH,+MAPO_\DZOR_;?-MUG>CN31USF9B83KTU M6,"FJ=R&;F(Z6@%&,T!O!^@,.=3F@5D"?#%'"B1;[7.H7):6`=IO\QILRF:] MK9I]78R[4R=?2O[3^_$AN!\?@F)\"&ZJ&A3Y^A;P\;N_.?O[REM@6KQQ*JN\ MK*MM2$W@>6-[?@9EM]![>=>?\IF`>YJ*_G:?U? MQQO&D+6^S=;$H8M`]9R*.#0^% M)=')"BHJ^]Y935'OMU&&_\[$E[^:U[N)&7%=-LP&TNTGCK>GK6(GC/T4,JQ9 MECH$IJX3#R##*!;*PB^+S'!D.X(&M]5VPP6M#VI#C+MZT-7NU:%C^6M-<4=J3UV3=S,;3I\SOOA3J/:P3+0FW:X"?.*QS-+@IB49R3"EMDGP/)` M9=CXF:%I"1B#$^^[NMUO MNO[K_049G>E]R'IUB%FOAULV-(4L4SY7BUD6N%M[T'KR,,23AX'?A,9->A3# M;(I6&G6]YO#)M__U&TW1YT,UH) M\H&`+OPUC`)=*<4EGP2UV&;I0Z`]WHUV_L)\_0OW-3B:.@E^=B<:]7E+(A)> MX%&Q/#I>@I&9$?-BSM*8A/Q'GS0[KE$G1CR_1`TS!SF(9*D/,4K"+,R\$6J8 MH5F=""Z)[_]*0M*`9W6E)2_K5)/)R8-ECY.4TS#XU\E1"KM)*5-I[J&P/,(M M0H%PUM*T.Q;*71Y"\_7-$3['&D7(=7R7H`C"-,$1;[,Z8(5N+'2V\2(`_S^/ M:=;_2V0S%W#]A7*:_!'AIO%%WM$XFZ*,93@5'PC+X]PR'&C-=FIQR.Q( MEU9;]L^J[I*K<5VS5[,KWR3CR8%C_34)J4="B#$F#@HBG`4N[NJO4YHD$2$B M`4SGN(;CT@0JUYZO==$A%;UV0RO3\T+%I4@6BP`/4(()3'#$>.KKR'`8816Z$[K MP(;%\NPQ0M&^OUH)GR>9%^-:3#//G]:T0S=%J#PCG$8\8HERFK'M<3-AZJVF.&T>R?P6W[8.ZEP"_P+T!!#FA"-ORV)[9V.B# M@JJB)$:72'61)5OSZY?@MZ2J$D`")-6';K55+F2^!%XF$HF$06W#-%R3&`R% M9H"0AR@S;`,9R`OD8LN)@VGF2++9'!X.]?V7=[>_TE'F5*!%0\L9,9:-)T^" M";B,R\:2YV$[&T`J0GPEW*=.GS>AHE*@A#FN+U*Z3/-B7UW;S]M<-GWF%T22 M].X;O_C&WZ6_3Q[I=VGR4U9G!>CSL2_[EN1_U8_HN`19CD<#R\*(42^$ M/G80#J%;VL%TD%0J>45B:^;=7C@P4/7BQ<'9S3-H-`9#E2_X+QHJZ:]#MWI7 MOSWZ[8`K/_+AKQ491M`IK$AB?>Y%9!8M\V;9?/"?<5,KG`,K<7AK1"9;_0*6 M=,)AE.S_'>T.<2-KVSO;M*#E0M^D-#"P;6*#ALUHEF-`J0*BD4-H=FY<*O#$ MQ6JNT4MZF['`B7F&&3"38_$*KDJBSM]+][17P]K'H3G#L!.Q7`D;3M4B4SK! M9%DFV\?)71K\VMSS1'3YOS^C_;89,X0X0,RG'O0]#'W#M5R['=-BKG']%.]O M,F&VF3*4S/H92B6^C&KI0-R(!TKK5]6E5^H` MDGA!L;AZY#%$,XQI!`Y$A!'7]9'%`@][I!G&ABRPY!:4[+=K7T.E0""K),I! MGNW.M'+7]*K?"SS.9>)'(K>2]3%:_#>/\TV!0;PM7;2+\V8($CH>8:[I!K9M MA,QV'+,-EFW;@E(/&,M\K^:8E5_):5]/XU=W9&-6*8C$`E5=Z,A%IY442P6D M`PC.D,$8H%9"!*-$?]WG;K3ZZZ?=\.NZ;'#^;"`(<44PPMV@X4(&)+ M5Q!+?;MF,JA/PMHJWC0>5;,K!Y<8)>A%2HX8:I#:KIO+\,,;/-ZK31V%W4JX M8H("QZI")T`A\113N?KBO`CJ&OAVL-`J0Q33MHD1$-=F&(5^.QA_!$KN9:4Q M(VCFCU:H]IJ;](M(HU`3HQ#]@,G12(=5(]!25'(4ES-T,@W'E5#*1"7>O/$S M'1+Q/8Q7#;VR%@+P!5L)I MJK62.9D?"YH:)OP6;[*[E-_?ODQ/77T+;F_C#?_[7TO6+OWJE[BX1B'R`X\$ M,`@1,ECHD[#+FX8(2^U(%A%0=YGP0W:HW]S@BOQWL_)[9?C%YS?-_,!OG2:@ M446VA'@98RL@[S7863W5OS+X^]>EWTR`JO?5FKS$2$.-]2FZY\5'\$#:,9#Q M5_,81)EW:RYLQ]OJBG9_>:,DWW+WG9V6US4M@]`P-*%O(<^@R"9F=S)(3'4[ M`YU"+N7E.H6:'@_#2S.EUTM*I3KFT^[S]$T!-7YO%=;7XOO$I\$'\7QC337! M^VF?'1_$`^K'0=(+SF08]?N\6K++-'XE&TFW-:$'O^KN3%RQ3H$TSO,?_`72 M](XK86'?Q;8;>I@8MLNHASRK4<+!AH7E,LCKDEU[CEID=]BXQU<;Q('F+4]6 M]\>;;VRU!UQ]\$)_T`"@;4V_WCY7`$O M2]DT3Y[>Q&#_9FL3'=O:\-8=]64[SKS\C?:4-R^`"#Q42LK>\IK)V&(N=H5V MEO.=[?675@/`50!?U'(.WLI-!R/W8A-SE%O"^N<*Z']S,EG4-"FTBQO[+F$..X%_UU']- M[Z]D76([(XSB&896;XF5D+`&Q3+=DW@DE?*=`S]&RU*^"1GN)PAGD9SO3:YN M7P@9O!;1\JF#,0[=P$.!00UF$*?;81`LU25A3KD6H^.HVKSE_/KS(-41=8JU MW!R#%]-A)#//8F(Y[EZ;=<>S>V6Y7I57V2ORPJ2OW4"P%B>@P!P";F).HZ_, MD8/`I%<JPYX4AF<3.J M.&[AC4D!>V&_MBW1J4.9^D7+Q9ZR5&8+V2,2K?9>B;M90'&1HXT9H!>_BK8I M">[`WTEA\4TQD&'0YQ5C#R**#8,YMHI_+C@CQ.DVS/_8-\>PT%$(L1^\SHRC%V*QQ']%.6WOU>&N>1%U_^>?DH>D^!J7$SHMHKM24+YAB-.\R@Y?0\OQ M;=OD[TGY@6T[Q`WM2CAF&*$'A>J2YY5(,W>V`M?MZQJ)P8Z+S-,\__KC^Q\@ MCYY*=LW!8_DWP2/_;+2+TVVT!\]Q^:_?RI`MXG^^:9($FX%^H@53,YOY/#FO MU\*R$7>E`AC*6CV;<@$ZN[_X7:4(Z#6I4CX#7=9IS&VVJ4BH_OC',^H+^86- M^Z,,<>IU6AHI2M-#M`/QL=6<\X7,`Z(3ZW>X?!N;#U?P'\+.G"-M M%/,C/GP9FR[LYA=2.EMR&4EGXX[*YV=YT1>G74/HVPY"C-J$^LQA'BTW:,W@ MQ"=2NR0U(VIV]C^R@I-$T_F&/QO[AB=*A__"WTLGSI0`+YH4FQMS9>Z7RSBH M+9X]@R4`W-GLE$K@5[)K4JS4FZR2>LCDGP:@SY_CB#][5C^[&_]]X"52Y%>2 M7V/3MB%E!`48^BZ"."CW;H'C8YOAD%*I#HLJQM-,A0.Y0"<8^).+)OM:C1)T MQ1AO;F#E^&X?KV`\S M4X&P7M8[#9L(ZRD`?6VLIT*E4ZRG#*Y)K,=O71WV^_X!&,MAR,$F#IE#0HL% MH0EI.[:+B%0+#B4#:N:]3AQP$^7)Z$>@)D$ZGMVTHJF$WO(+T$.\](M19Y"3 M9+C1P*^8XL;K),!Q$P$;LVGMG[A*XGWY!??/G^*G$E\>6-IF&4_:F-F&Z;G8 M@L1SC79T:#"I7GJ*AIPQP.NDF[QUG82Q].YU+GC',Y\XLKHWL&>P$MO#J@![ M;6RG2*O3.UEUH$T+Z][*T<26Q/(\&X8XQ*Y!K8#BD)!&",\-##(YOAL]\FS\ M-URDZO:T$R"?$/_-@O98.I0">K[([Q1FLB'@9.S7QHYJE1,)"A5!*,R505XD M#U$17]UV(W<_L"3?[#(N6A.AH@!YQ,38#&UL^*405L@Z&0S/D:%*I0//QI22 MM*@673%67`Q8.5)LQ>1E,@."'.8!%]HPF\W`;2$+5#0AN->Q%^Q#B:R>^?AXS?)_JZ3S;\ MPA@@=>^(S]'^K[C(J^J7RVVY7)--M*MNN99_^%NE`("R;?XFP2T9-&I&>OR. MN1;L`C08+IXC?`N42%PX`=Z5D)P254[%?)/AF41AJ'U^FZ'`X#MO;'B6;SDH MP$$[)(%HW)'NB'$T4]CWY"Y-;DN"*H.*^OF#JYL\WC]5UVUJ<5O*0BHH2QC> M\92E`UE5E(761%EH%&7)PKMBRI)618"RQL$SB;+,]EU"YIC0M@,K<)P0FF9H M&7XW)++I5,H2'6=&ROI7FIVB*U,%70E#.YZN=*"JBJ[,-=&5.8JN9.%=,5U) MJR)`5^/@$:8K>L@3WA;%SQYNDK2ZD,'KDY/TKMP6E3_ER;9IP4KV^W).-L>_ M_*>KVZM#P3O[YDW2[^[^FMIV:%H$$1L21)F'?,=KI60XD&I8.+-HFDFQS0AL MP4/T*WDX/(#'+Z[GYG0U9KDC`]8R/8K<1M+:9^M M8@&.C:7KU!Q)MY^2Z";9)442YTVV?7N5=L5(E!?]=:U7/,,D#/DFA32`V,>\ M<7R?5I5[?TRO))I=3Y/8Y(]3['JIP4,C-H@*<,LCS*IU"F_TNE=31JG':I*! M_.(&&Q_JUZ*7H?[`:-R(WXML\]=]MBN7:/Y?(/C[D!3/[>'3EMNOK]&LU%JN M3=8D*XCL([1:=R4N8R9E3^U%9H!8V"'4LAPY2>L&QLP-3<=!+B0!\ET/NJ0; MV"=$Z@KC]-%F(?;_D>1G!2"*2><+)%-`%.0P>;!49*ZWD+X70!"/7QU$J!S M1#4=U;4PE`)-7E.3*G"$.8GWRB[#._X?OI=XXHVACI+CM>.YD!%L4,MV?1>% MS/>Z;3Y$*)2A*'6C:F:LJMU]W(LH25(*T17CK&6`E:.P"E.^E:U^&(AY(B"; MF=6$(3Q#>O1LQY4J05(UIF8V;,4$>U[_G/^,I%_:4@:N&!TN@:L<&7:0 M]2H&+#BS%0H"-\9(E1M@)70H'*U,KWS=N*[N+QG6;DOKL8_QL0A M3_!YS&"N0VQ&H6'3CHD=)EE0KGALS918BOLSVF_!IGT&==,(//5YVLF8"QZ5 M+`BWY.'(FP=G&UF;LY)U1(^2>)X[YM!DF950J#;UWGD-5BV,8MWKOY93^C[* MXVTKQ=5CU6_UZ/B!8S`3A\@((&(DI#`TNMPC]H6X5/F@FDFT$[6GT:P65J;? MN%*4S[/GH@#+T6:/;4>Y*#I(@?P#Y^+#]75?L] MGISS[?,UO#ZP>)[2!O<:^BAKD6O3/,\575J?@T-S_8I<@S?=L*` M.;P3>S,@\4/&K@O>+7SB:?F[HTBYEDX@\;57=3R/*O%4'96_C]S$(W*EH"D\ M&E_+>?B8H9U`R=/6VW;&R:GD^99?C(1GX`VXB; M&BZ42J0J&E)SO#N04K9^1Q6F8@RU`)QR=#40<'7E/&+@G>$RQ>BOA-A4:Y5I MG;)J,J=Y*]7S,?H-D&G8EN5@:-L0.Z;OD;9),"VCPO`ZC>_XS:`?D[.HT^00 M6L9>O8S?B+R:C.I$6TQ*J\Z`O]K$89.6SK&H,M1+&U:NC6+Y5 M):!B2=?^2E,UVK?D[OYX]$N#``:^$T#'\BU(L>.[L!T',QO$OY*<_X(_=]ED6&^B\GLV,8;;?X^)'FBY$U,47A/I625FV<-^5CU2F4Z9[22PK+!?F58V6$2 MWV?$\$JOZ/JF'X:!V79\H+8)J9A3TC*T=M^DJ\QL+-1B(?_\&*LM.'N12EE? MU=EQ(*5+SR;:8R41O1[=A(K0E``H%L'_[SXIBC@5.#NC3FA0B+"+30LZ?N"9 ME@$#%R'B>J%A0(D07MV@VGFR$752T81"C`6B^)G!'460+:H:RB44@BT1R2\# MNL)2B9\GYKGB0@EAG$[%Y.J!7D-0KD&K3.OL')MGWYGRZ"F-J$&A!A"R/ MN8BAP&WOXE'LF\ZHC)%*`;2[GKH9[6!#W'4OF]BZ3*=5I-),LYMC:L[I5;.Q M?$+B?C:+C,I'+669<1Y-CX5DDTP2F+V?<=)A@#5X.LT:'L]%Z0-349W.M8%= M@YC,ILCU/&QYAN-TZ;`0NFYW/"U>+CAQQ#$'T6-+!P=-TY26ZKP/JXH2'350 MCCM33M(HW?`.I_RN]YW^X/VJG565ZHPNT1%&?R5I)57:2)7D2((DWS^R M'RK_$?\J:*GQ7];$_U+V&^9(<++S!XU5C^SV.0UFPFF8V@"4I[AAUY>!/+ANHA%NLY^(QI,Z5 MP2A!>"4TIDB94ST1%4`D3&+?-_?Q]K"+KV[YT'6,F&[_>8AVR>US&4"2S28[ ME`NZEVD@$O6P2TV&"67,=1WFE?R*(#9"CY522;T/JU,.S038B@XN+\'OH!._ MHL!>`=!J(,E_6@TDQHYKL8T<=W9FR6[?-\J+>N[EV'4"TF>X=P[[K8299U$U MFW]YR++Z?;2/:74O,'MXC-/\=;-U^MQ_Y&O]/@3A1=%?#OPYD*O;ZK=9%IL$:_$WRP'PV@LM;`K]OJD6\#+/ M#_'V,OT:[Y.L%)*4LC%$2O$@-0-J!,1MA?1")-61?5[)9O-):?SSM5^J))W+ M$XVSFV8OI-UDLWN@QN_4*O'0HU;JHWB?8P;1X7DF&?ZC>YUIRJOR.`I,H-_; MU`_?#%+:547*C_LH;2J(_AWG12]_=9;75ZO2$#MFX'L>IM0Q3<^EKM=J8S)# MJI?U2E70[+]JV3B//5;278"J.:;=1_?',Z&DRG'/:53]'K[Z%Y]J M@2%OSHE<"R(&;4H)]%'(NCUO6$H\B]\>(YAF;UR)!)YJF3J/W+XU_%O)G<]Q MM,]EWUR?UW::/:UNL\WN/VNC-QI]L.WD$6/H<'-3;/[1G=//&;?YZ3.KRVV:OB\,PH,S!06#;B#H>+25K!72I)U9-Y%3_F2A:`7NP^X'A' MM]U6]^"BW5N7][F.PZ\1LA"$O@5#CYB\R3,U:"NPY3.AK./R4NKV,YV((#JZ MJ]G'15*7*H/'??:4Y.6'N[V.S)VV96U]WBPJ%:T;`3P\[K+G.`8/<=S\ M]6-L,;E3@$X+'(E:UF/U-=S27`<0V=H6Y$(EJ(,'B_]1_MWBVC0")T"^Y3F( MFH109%JLC\I\:XE*5&DA=5])J&M!!@6I1;;Y"T2MG.`VVX/;0\'+W?/!3NV. M"Y^#0[KES1=V._!8?JWTC87%+#]OY:I6HZ^@@/7%9*DT_"C)WW<,-4-!Z^BY ML:9M_*(X:"IOG6@8T:8_N_+GK&FY<+>/*PGS[FT`/X"&87L(>M0*<&A2&EK( MXYV'O"`(L2?62&;:&/K(Z(5DH!=-Z*$,#6!*]8"9#]2QW5XF@"O:U.4L"*?V M#ZJP6\,60)DNF8;))95N;.ZF9;6[._ MZL0%M;R2*1KE2(ME7I8$6\I=)OHEVX/_B:`\^ M1^4'>=WY8N\"2L)\)AVBRV`KR7)H4R^;9][KX=>Z4W)QC6SL8!/[CD4L:KL> M"HR@E0);H53+!\5#:V;7AA5&%NEA*H#5JU\^H7'F#]^QKNG\A-96MR? M<7!+4F@#['0&E;70QR)0:>W&\>% M)/3L5A!D,5<#@TJ,KI]$;3TD*H.P4A[5!*XF*KW@7,K+5TJAJ]!TI23:HSJ= M1T=8Z&-1Z1@%Q['I:"@U$&HY*^-:%.)!CP0>81[R;.?_V;NVY;AQ)/LK>)GH M[@C9RRM([AMXP8PCW&V'U;T;&_M009<@B;LE4DNR9&N^?@%>2[*JA"N+ZNDG M6[?"R9/@R40B"<0IA-:8&CM^A&PSDLH_OGE1A<9$58!EW;)JAF#CPLI@KUQ: M)V:UB*NXG]Z29!A*\R\*/:S*`KBV//]>$1B.1@: M45C^X)5A[B*.^FM::N$A;+2*DNF`64M M'@:-3S/7@A`G&4[//*&AI35GZ.=2NK$7J-*RN[ MCWG=RCKRJD59A9WTYI15W$)I994D4[>R_GY+:I)?4R7:1&[6M1]$CILJS,2,^HJPK-6<35$L5%MY7'&.85UQJ>NJQ+^>5NR*F.@ MG*I*4ZE;5#>^[Z'8C](88XN.'UDN2L;A`P^&FY;_$D9=8PH)J.PUC'?#\[QC M6,']`,^,I+[.LE8AU4JPP7W_=4JFNE!R\_^VY)'?+#E1%*1-5@J_T.&R[^R5 M,O(;:3>>9_O(V,D>:YB@_Y`>UO#F;S4] MM3L-W:6B!$MIGT%N516/00,#-M;:M/1KM">9XE!.6A8-Q^?VT[YMVKR\8M>(]N.B MS(]@&OI9P&[%R9"/$SR.F\:Q4`.<\F"F@WR/KSO'J(]6[/K>FWW.3NX@TT5F MH"K!5W*;[Z[9;S;[KTUQ5>1U(;QP42>?,S-8DG?![&"F?$@0#M!=`"2O80H) MPBMTG4H2=#&]ED1!FSW/DP6]1/$78]@-(DEU=U>T3T_#L#!.HBR!F8=P%F/L MQZXUCA>E4.SE7ME!#.M;?QO1`3#198P\>YQ%EB6($ZRO/.?LC._9'F'G5$U% ME="5Z)"Z'<\K*7J(X3^>LK@IB^MB2Q.)R_W]_>YQ'OL+N4NN-M!%J9VF#DH0*TZ'EFM/#651@%RA`RC-P3"L79_KZFI/ES=-!WM>[E1? M=\5-=WR$Z+&1!CW"IW8K<8:8'O9(#P21%9P'L-,N6P\73'B7/LA1FM@34KJ` MMU8BMDM8^ORXQ:7(Y1?L9S"Z(VDVOAUFEA?Y@1>Y3NR'H>,$4[<$M(16PW(C M&);9'Q[OX1@FWL.P%.GC%$[CS"EJXNNDF=&]EW@Y)6E*/*Y%K=2,>"Y$&BCA M.RJ176M9M/N6'0V+KAYR:NS5/TB^:V]_)>P(V4V21'3$,,T)!/_=XQ,ZZU"=48'##1=E5NXT0S9_3[*L?#_':R2\H/%ZR5O#T83Z MC*E,S"_%_)+MGGYHR5VSL1SD6(Z#0AB%@6]#!]MC!8*FMI'8G<#2HRQ=BE3, M+P7HD\LQS3"GG&YD$(:\DGK+4\"6?\T4]"2ND M%5_W[*O^[H)-:GEV9L/4\1,+NE'J(LL;![0LATN`U$: M6@A>0]ZIQY!*]]P3S#>'_9./1?ZUZ\QC(Q?E M#2FWCWV-`\4>#AS;RZ"+O,CW+-L>-]S=R/6$+@E7'FRAS:0)(#A`*%GQ5">8 M+S%=E%NQ,*!(JY$T]36Z3F2KVIA>2=*JSY[*T)24T[1/]26I'XHM0=^+9@-C M+W`#B+'C>R[R'1?!L5;K(ML6.D]*:H!EM*OI>A,'7*PIA4*3E"Q!_H1DRAQU M4M(DR)I)17K"S.LJ)$?DNI1'TH:7U4:%$%&%:5!Y-4Z:M&+[T1L;812%J1VY M888"9/N9-:W*,S\4JM+)CW(>K>G!2:J-#)="DF.81BVZ\RJ#)I7G1X)>EQ\% M4M>E02J&O"Q$RM3PE>R^D(==<5=\UW[..Q.A$GJ>`@'@9VAR`D2&Z+Q MO2HWL0.NU\<5/MZP_HR@P(!*I)(DR1='$]'@8^4R-7;64"=3M*#2-E5$5/4S%>S=8],^'2E)W"2P[1@&,,YB M&,:1[=]_A(T\SAT&VE3<@S!"M=1."B^.E=R(^H,!*\&;F1)D7F3F1["E2N9+T3M6*YV?& MZ"!%X-C+=CA8(,F;?I/9BW"$7!^'*(FPC2PKB,=+T[PT3;C>R%/X>-,J,R$" M#))<2XD,:YSJ8I8P0641Y,K009;/&3FE*/+TK45-%"SXX:A*13(D5>1W^L?# M%G&$+2^T(RMVK#"P,S?U4#2.EZ`$RVN)P"!+*XI;MCV80*XK`K4.:%B11I@_-6``"GJDX`"J2.U% M&]$<):QS<"PF6UST2FVD:N-9H.1U#K[E-EMU\M:RBL:;>I M,C@/5V/\?L`&=NP1'.X= M5!(M):YE-&PIFI4D[?$"3)R/0`'[G8OQ7-2SBMP)#KDU3XG46VE\;(&F_6]K!E"UUHK6_4,PEDCTZ_0/)RK4T@ M#=!L3"!?(_U<`MGC4A-(03^\'8$4-4Q<(*6HXRN1]L>M?+KN3J+[XQ*UE.V2 M/'ZZOF8O\E%3'F)W$@A,[2D.8.&$$IWTBC+FDTN3X MAD5S/C:KZD[P^^/]Y7LP8J??[L"SDXD&]*!X`E^DY&?*01R5UA7X1DQI9[?T M!RO^<3D[94`-9MC@P^J<(E"678%SY,^)+=6>'^63O.3(.U;*->R*-51V39M8 M+3>S!9%&R/TCZXX;B8[H=-EGM2%]55=Z%=/MKP[KJJWS74"G!% MP8-FLD5PD:'?(WQKC;,Z0RP0HA\YG]%>`(87S(#/=Y>7**4G5B#&O+.2A8@Y M^ZJ%IKDIX;VKZK;X)[E*JJ:=0,$,94[LXS!VL.W;$;0".()"@2UT79A9)(8E M>0(%&"I34BOG`\VZ:YQ^DR+!;,'-1&$=1"FGR M'PS(V$Z"T$F7"\!9*@-G:^N2@$>F&U4-=J0QE6>K^$9O!%C(+6;#P&_D>PM^ M_T9V#P3\6I7M[9'0L%+E/^X##?*OP<%O+`;HL%@R$&@CF_,R#M[X=$UED:+Z M_;:N]C>W]!_2(7P:N#:69XV1\O^ M)7VT$+OJ8V&G<>Q:K-A?DH&CNTSM\M7`D3.#`+4(#":!SJ9NZ?!##%FSDT7N M+UFOLV5W1XH&%"VY`_5\]\FS>BEU=0NV%.\%*$G;7X?R/_NFOT$,%.5VMV+#S,S[K[;5;D>VHPQL\^;V`M#!'HIJW_0[,N_:V[Q\1V&P MYNKZ$11W]WE1]P/49%O=E-U,*DI`22R[4SM^9BDFR,M'0.W>[^A0#^0=N;ZF M`QWBHUB80==%2:Y^N>@.!+ZF'PT>\MV>@%MR=4,8<';I4&?#X5\6U^SS+\"W MVV)["_*:`/+]GGX^1=)6X(YYFPR/P93[L@%>$#G`0G)W/\S7?,>NNP/-+:%D M7N4MZ?YF'H-F"N2FJCN#2U)T&U;4AENRNWK75N_NQD5Y29]2NECJJ)^=I7[K MC-8I?FP/ZTP/TAKVMLYE>G5^'3.6GW7`!I"8"L$+&#TGCC/? M&3$B9%EF$C0-P!;,T'K!&N7KFN(UG*+I\)ON'&UAEYE,TH;@U.=E8Y;&;%HX M2=/A9E-9VL+N_BM-.V>:-F=D3Q*U6>G^I'G:ZY-<2Z*F\5EZG>N>&V$;^QBZ([3,@5RM3$OB6;)V]D#5Q6Q" MINHC2OU*L:[TYF1601" MN=`$EE^=V9\LT4WX.M6G\YSUL"R9V2AT#ZZT141W5XBKQ[-WWFH/]P_L:Y!J>8^^,;E6,%12LE6I-=NS/:';!"ARO30. M48KL,,X"VTGC$15$H?E^;7XH?_)>;0&?Z-7U!=QA5MQ?ZM'F"6-?= ME2WNSC>F[*K6ZNC&EB5YH4[L&9[O^8F5QEF4P#!T$L]&,!GAN3[D/R=F04S_ M8AW8`L[2N*.TL)^,[BJ]TG@MO$Y;W*]+-ER;\:_&+2:V/W*P#T.?TF>;3G^U M'\LYW%CKL?B4>DM;,CK-UMIR+$O[4NW&,S[/R5PK3C%=#,<6\K&;I=Z(ST]< M;\%68WY0_W)MQ@+^TIV(+.BJ!3*1X^W%"Z0BJJY=M*W8C(O7EHS\U63[DLO- M-=B*SZHWEX_HLEMO8ZTL\08RDA^:60Y*-A#%,(1N&EANYD8>2MUL:O@-H\1, M-J(`Z,_55JOL'MW)QT*>62#Q>+F]=H&D0\6=IA*.A=RZMF2#,ZMXFQG%<9]J MR28T3)DWETGHL%DZB]!&N*;-\_FK9%_7]*'<9#!PH.-F*,B@%T'+">()!O1L M7U^CJ?C8;Z[%5(+>T\%^#PY3WS)C:M%\A)PBP%\5>Z"8^]]I*QV"&UTT,E_4WF@LQI#0]HE#!%A"I)_K%]W\+LK.'OB4BPQ%*N$*#*IVKBPW*!AT-#GJH M$HX.W6!V@,HKQW*<8H6$`P3J9"+$B?\Z@:!N0(E8L`QHE57B^P_80G28S]/K+` MW[HOYN7!0#_[99=*R_,?4Z>TMWG;[3^TU0WI-AUH1"!UW6]IY/U`/]%/%R5JT!?2['=M=?TY M;]K+;_D]N\Z7O8%W2=IV1[HC6P80;F#%%L8(AU'@P"A)8Q2.(+PPYG\?0OO( MAD,-PPM0`Q#H(7>W7U/0@*$&(VQP@%M$+?7[@2,>G=4%8@%*G'VIH*7?#0)1 M[*SND`MKG5MHJ,EI[!G=W-#/T]]K6.*)T'8M+QFA?0Z`R9URU MQ,P5#65?R"YOR55;S4-6UX=0:&2MB_)FV.7ICS5@^^8#+B]U7`NFOIWAP,U< MW_&=:,25I`$6BFZFP2P1\`8;6$8Y6\&>\B>ZR]8,S))QL_7)>1&R.FS;)QY]$G19/:3SZ';PZ'7O4=;9IKP$U,#F MJ7"\E*/6$J$7L_=YT%Z6:.X>LX]5>?,[J>]8:\9T&$R<(1PD=A![<9QE?A(G ML3_E#'84BQR[(C6`X7B;Y'7]R![8KGFUZ5]K(X#27K2//SW=9Q9L*I/C\W1\ M7(Q*L9C'X+RC[-]UG6`7X(]RN\N;IK@NJ&*>[<2JET@ZT?.EQ.E*&KO4;*@T M3C(%\=E$#H:IY:0P\Z$;NY[KA.DX!L)9LGD@]==*1G9>_6B19^00A<2CPKKD MS_A$<#X)W(RM\`G@QWYBY@L2(#7CY_YQG#G824,GBZ&#O"1.;<\9!X-6Q'5W M@MH(RVP>=@'UXN"]$87@*L">>'0U0YQ:>#W;F6$O$L,I).)$KE!1)(PX(2VR ME/"5YM@('TH:MKLE[X>FV;.WJ3[7Q9:@9FB:R&_(I^O/^8`BM1WLQ]B&'EM/ M.,B*\:1T;FKS%^+T#VU8E;H7&(H!)[AG0,'/78G]OD?[BT@9Q@#S'&6S\Y(N MIF@=WS/8"S#"!1U>MKLQ(^ZWG21>!C7@!X'BUWG]H:5CHGN1LYAL>/:$7+#7 M.>FO-W21=_BL#"Z[SX?0KESX$F;R6)G+G$O64-0R:%VUR+P6S*#3H?,&%R5# MP,Z<;WZC//5EL[_75=-L(+;C.`SC./6MQ/)CR[.G/D`79ZE(/JUCO$7C&+OB M2+1JI854OC1[:3Y%0]30US7`ZR[(8(?X3@@O0(=QX1R<@[43&;E.SE>2GVLU MJ3(W1875[5!FOY`K3T?&,L,+V0G[*?WCYC=2 M*;]VA_&JY_*^4DSR#_SVN??;C'-Q%>5B[Z22ZN5_-6JJV:P?%-4$;3(5$;K6 MH1/W-F_ZW#7=D]^KY)9.8/*A['9BJ]VS?':4"]2IQ08&*<38S@(["=/$@I%K MVU/1)HU@&UG9G>G9F^HMB*,>6<+5VA6Y6=E99]\ MWA=PV.LL;05Z>]C;$X-%+U1VIEG0F[5F'TM7?U;E:RVEH;Y&FK?#D5QSTP2X MRQ_!5P)J\G_[8G@OIIZGQUA6$E"%XK`G`^Q+&@%O*G9ZW*@7='H->J&YU*3J M-KXZU&*38WU%JN5,/U[!6IA^[@7@'V5-\AT[X(XUC7VD2\U/Y8?AA(LO>4N2 MO+G%N^K;/]B5S\WGFK3Y=[0=[HXF5Y_8VVE)=4>?VEM2-L4#-6=;W1'V01O+ M=X+432//@EGH.G&(DFR$G*$`B2P:SXG3<"K#,)#FL/>SI;8V^_JQ/V*$SNK_ M%2VPG=6M?$O+M^)1L:1EM@IT';T_,SR_`+H8'6T#S#C`K`/,/-#;1U>IG847 MX,!&T!D)GE@)>C.'#UYX06O09R<6P6N8*2M9.*^"BFI]#[+DILX,."T:EMT5 MY;Y+6#]=3VT3'>Q-Z-NNE609S@(O3'TOC.Z\0V?89?B9P;Y M%\!`,TE[!ILEUW/74"]LDAM#&ATCMDUT'I](;AKI=(?1;21N5CDVE?1[:"7: M;M#`(QM.IJCDUN'+EN:VATNCZJ;.[]"^O>T/W1[6/G:`'3M*/(Q8JZ]-KD7N3=%/CQ4 M^(%.%(?SSHDF/I%!73]F%4U+#(#I@N$.`V;0KLM==,^-=CDZ6M=.?FSWS_28_!3C>F/:=A@; ML8$@3%/?3GT8^JQ]TTP#[MJ&S$95C^RN"$S?Z:1@1R-T^LA5[`6.HL-2#A"; M.#&4H(5YTTV,Z(J[3R)3K#=@0`LHW,58%R@#+,7^M!Q_0J`UKR!_.M`#1/J$ M/-U%-E(Y>D#683CTJALI[:E8W_')V-BQ5Z';I#ZN\G)W\MR61G(RL&KV3-O. M$R:!10U`4@GTO=8PF4>`DXZE]%7X>MG=-M[,"*?,/QH&>1AFWHA&B08S>-^$O]>JU541,!F:+ M9WJ*0CO-ZQ9LO\[SLE]F@.!`OG&\M+M[/3TH("JS:D>_-":Q:TL"]GQ9XJ+W MG"#)]N;7^3FK9KH<@RG#1QX]#Q46"RYF/' MY%^226Q3]8JLP]1O-KDT8L^MS,`_\H+,(/=[>K/<@3THM)%,IHNFBY=J[TA3 ML-YEW38P`K53LJ4(GZ]FJHF7LALK.QDH0S]G2[BSPZ;]\!>IZX?.R5DX=+M6 M_X-?[V54)75O<"^H=W.\MV+1FV46A_+-IVV._-&5W^?[3G6/'^XVH>4XB9LD M9I@X"#J^ES@Q0T#^X[\"66ZSBD40]?D78>V;'W,G.V*RSNGP@2RI8X[IT(X> MV2W(_&S!T^$!*9K'\I)7+'!GN!;3N+D.6Z_,S;;L?:630QZGV&T?\>YYCS_? MHS:5WB*ZI==C;HPT-)"!G`!YMFE'9NHG`6O.CTV!_.+T-E0G%7MD=)!UV+I: M#_BKA2=VSF%ZL%X MUW="[!R" MUA!;9^$O)?44P0VIHZC=GX,>IXYAQ0G='F>A!-EQ%!WK,7'`-6F>_NW*LS[' M*9[@3OT)3%V.HGI($@NCIU-@T=N-Y.R@_86/"YMEIW.WDGVQ,PPH974CP9!Q MLK>H;\I-D9%$D6?&I!WH>X%KP[XISXE2H:`QY?L5AXW3?92"@6,27WRA0S55 M8L'CE*6EPL<;G%P((',87$D(F65"*:]#B:SC1L$*]IF!/_,"?VSP4[T)81(X MD6,$J6TYGN$[5FBP!DD`\[@7=+-:T;$;\+'-S4FKP)\'+-_2[I)-Y]9X4GA8PV)/CB&E M["XB$H0_%EL:[G&,N[_S8@3A:[G?IV7U/:MVFR"PD.F&-G0C-_&BP#%MELGS M(B-TN`.RM!95+Q/;@VKJ[@BD48*ZOWR\O0;5:KLDM,3C=V^@(]M+-V@ M"*'$<,+819X7Q49(](TU1U]'VA3M9O'=E[;P]ZW)JD8X]RC4(->0"[LA=P8; M]^"+^BTQ6=/MD,$/>5'0,B<[M:][P8_NMN[VXN@^_^@,B7P9N4FTKV11/=N, M\]FY&;2(G3/1-='=>MIWT;;I]L//[?G`=?(#5]N<[LTQ[,A$;D1&?^PX(0SI MU4G##!-&,1N(MX)'3\A%,6%TWDXHN_9XCF^MEQW0&T!B9)71$AF=!)+.]$*^ MO3][AI[_5.7;9GB!][G(+]T4H>[\"2'.+PQFA0Y%;9U2H)%-2=*!_ M1G2['BU`XJ+NYKL0D>#DPR2)$A0@R[.\)&508.)[TL/#-!AZXL-PK];HF)IV MQ-/),GXZ[,M73.6\P/=YT[[D*'J>I1(7\145%G/+C(WD'5S0X04=X)M^"WG_ M]X>[=@/S&/8-^(3;S'*_GN>XJ`O9,$X4BM@PZ MIQ5=.P#L1(>-&:2A!V,O]!!*?UM' M??'QE#S>(N1$REV=D*)S5<:**(3,5L,O]R0^BPM_4\SS&< MTVQ%4G".N:G-3NEXS!ERS?TYWB M9/;U+=OC;WA+1+;)<8VZDSG+Y_IXU#(]MO-+6>=49(>S.N$=67%GVV83V9%K M!*'M!Z8;1&:0)+YK)DY`UDR0+J!$]A_IQ*6XCI743?[4OF[!<[GY\E[B6Z"L MU4%B"Y?!B@]DT?BA)G:`HR$WX&@*&!VQWYY\S*P97UD/_F(FZ=YO)=$;%T+V M$CY?29A?Q/1R^2&G34[^Q'5]^Y@5M]_Q_@7_FSS]6`^P-XD=)`9T+"=TC"@- MK!!%%H,;^):K1UKF850L,Q0"J-B[1H4B]YTO6^Q:=.NFNBGY1HEYR>F[=_$(:=(`G3O`W=)?T9^G>]\-VO)S4CVP9%[N:D1$K6"( M._;JQ6&"R?*3;H)T:PCZP_'?W2W`0U;02:W8=.PXMB,;I98?>X;-@/J6E>A9 MJDQ%IWB1\J^*QI>?XHTV@9CL,M5RH<-;^L7C>%M%^\$5%G;.^$6)LLSM`U>O M,[,)D*8Z!C6MU:Z2?@&S="1A+&,81>ZH5F:"'/8X!MTS7%-M0MAU/Y M=KPU%'XF.U%7Z4>I]U90_"&N9X6?4^FZ&KUZQU-*RS]S>\?5ZY,:`LY_N9 M%N\MIF>#BHV+05>J9^]X2HF>R>H=5Z]GTHB0IF=R7:,_1[A!AFLBPPDM-_)2 M-S$-9/G#`C*EITOJ*`^)HOJMBD3"+M&<^Y/JC:5S?EKLO:_I6]BW^T42$UK\W'G2:I?>=8 M]&@!J73SQ?G%F!8+Y6.8@+WRV`(%(Z3@+XH5M&!U%V5$B+P0CI7X8R415XUM M/Q\-H(Y`OL,[_YWO<=V4!8;%[A-N:&"OOV2O%%'=7A@1N="PK,CP$'(39'IN MG)!V/11XAF=`R^0^M'-V2XHCXX"O/9*)GNC10@0,XX2K8.:3>SDLZN=5+`ZN MDE*!\S>U4COMW,TOF%YH1F\JRH]*/KX=[>G$!P7Q0=WZ(-L^YOBE#3W@T-LT M^Y:>]PA[0TKD$KV&`SCE&5.JZ(NRU"$NG[*\V*2D%<^(4>`DB0&#&*5FQ)I- M()*C#YQM+:X0'4YI`8V7XIDJH8!=V3JQ$+&2M$(!P;-O:7O)JIPFD^COM!>U MK48H.K:F2(4@SVL7"U%S>.5B$DV"@M&W];G`W?4O'^]OL^H!-[#K3;L(D]D* M_G;`V_P^Q[O;_*E_<.-9OF=9=NAX06J[,`IBPQUTS';XKVW1@$6;X/0F`&+# M#BSXI6BITG(A,K<-G4V5LY"[0P:).ZRP`\">G M#48`:@7'?5?+>&^*%J[#B[.UDIY/=I]7=3,2R5X*^W,#MVT*_('^@/QOG9.? M=2NQ[*'"G7:>'[793^-6GKI.YO]=]57OV56ILP9SWU1O731/4_?;[^7/@.`] MT;FW\,11'(5&BD([2*/$#*#K>`R/%\-HLJS+!*%=SPGXL9[G]3$X9-0(B8HN MU5D3I'PI/\W5<.:BG]6[\X\"\9;JJ!FJO93#I,CUKT+=?"]GB77G;^5:+<`Z MKTBK<.0:U5F)G9=D61VQ`B<,L[Z,QETY>KTEW]/FA=,0!<@G;9FF:2`4^B%9 MV[.&DQ2)7<0^MS7%"GL$"$X0@KM70#&*59PDDLRWOT$OOV+*.)M:1:R98%B0;]%=X4T2LIO'$RJS.Z'0D3CVX3R%YW=)MB$%]TFTP5 M=W1C%9G;LK^)(GJN\P+37;*?XM%36%!@]QA\ M2":3FQ=Q1T@-@<:HFQ3@AX6."(> MKKFCJ-GGN^4.%II"KJ20*^RK*PR]XC;.",$3"941BMM#T38H#!([-0TO-#P# M.0BZ$63MAJXO*^SR-:9Z$4F(EQ=$.?F;'3#E4RQ*43Q5=I9&ZA\NLN+=C5Z9I%Z/*/32`S#B"W/CDTWH!-8)V49.-^P M$=?E9="XKR5 M1+8?&X[G>E&2!($_Y%R0*W3K\5(8%<=F^%0^T[7_T1:0M6_-S4Q.+^;2R2%\ M==Z4$>U';AU;!3JSCKEN^F;DR#+0F]9EQA=+A"ORDIB<:.T7ZU4>O32\+U(+ MN&5RAHL':_86UO\MJ[_)L@9EAYQ,H9,?V_WSCOS[8_%"OJ:L7C<0P3@R@]1T MC#!TDB"*AK,1?-,U^=\I715JQ9K7XP/;#N#,],V"SIV6@[L.OZY"_5A/Z4T& M@\U@,/IZ>\^\K.%U]"*9Z<9E>]/D=*4R1PGD.9?O+"M-D*Z`F'1+852MD_NLH>>=@@9O'XMR7SZ\@GR`!S)JS()R*>1-_0*IRI&K MD,0T+_(&?_@SIZ)YT9O:!%5.G_HM1582-4J%5Z;[])?(8]QM3KO-?G1/?\+-!D++LE$8P\!& M<01]\B_VYDKH&7SKS'4@52RX='O/KL<%FNP'V/>P%ZMK3O.GYDJXN0CR9 ME8"8R7[K$W?V81VD+U7E5MY#5E79%NXI^JO9;SE$1P5[5D?XW:K6\\A05:F6 MX**EMKIOS,1U81P%EA70)(F=F'XPY$J2*!6Y^EDW-J&YS<0+H(D#1@&-GJ.4 MO;/L6X?;%MG&+M5CJYC"B(C0^A;X;TO4TL[_#1?J0N:KW9LNZ`;5PO.OLMQ] MS_?[LW##Q$_3Q+0"EYXQYM&S!/TA/X#H*#',62[!9NY4K/9Z>_8GJ(;5X\ MP*>R:O+_:VWY@JN\W)D;#_D&BE)(5G+(L^W(C&*V-RKTD2%4@U6%0?W;O0,D M<&@QT7=[#[_N,1(4)&4^X1.<-;A#3%#.[-WII8-*2P\;G/BL`ZY9*":R>T$( M5/MK)8%>N9FEWF&PFIH>>B;_+)I-8L$D]GT+^8Y+3_`QXM0=UD8QC-=1U^-% MJSCX]S".];V\V)9/N"WS90+;2-=#V.)E/A6>746>[(T"S@WHK;V^;K*6FI^* M[K+VNA]'MUE!\:_'N$@!4+17_/9%0&%"M!4"I[EJD6+@"/OHPT_$M[T-5APA M+S(3$X8H3M+(2\/!!C=)%SL,:S;PM6^16B5I"Q08M3IZ?;.J\1-'HZ\C!SS) MGYI*E]*ZU4J2".OD1F'14[(#N=7WG9W/PXD5+.^]078<>59DQ(EMFV[BQ08T MAORV%=EB]Y1);UXD/$ZZJRP].<&7E3+!QR]?_R-[.OQWK#F6B1)X(1XI\\5* M8HHZ^TI-G5IP;,/MMGK&XV#33^6'H_]0&/J&"Q-D>'Z2P#3P;,L*4M-+8RL( M/*Y4HKS65->!.H``_SC@HK[TQK`J-OFFFWJ)%)LC,@Y'X(9";?H,:L>R$^W?]=D.3CZX!NN M7O+M$8X%71,YB15:9I"Z41`[KL/@F([-=5V*:@R*PUV/_`;LCA#!]@B^.QQA M]%G=XQ>IV:ET$4?!=B7>$8NC/6@P`@?03WX9?\:03ZFIJO2/0*5T)7Z:5O]$ M656]TMU57?JBN^*"WL%\EY'GMAC4CYCF^8F%[),^^P0.=/],=R%[>;?/']J& M:[J9XKDK"3Q6Y?/#(_D[Z[^`.O^0O;:Y8GJM>W5^%(/+P_B/N474Z4X[5QK5 MT`W64/#486:I=W2)R#8B'^3;;'];Y=D>E75#,?RKRHIC332PD958:6"X(;1\ MSW6(6@H1+"E&-LQ^]"B%`GF,HCE$%7-G(J)YT!G MBPZ@@ M\NFI++X1[2,+U0/IV8]9?92Z-$6>81L."CT;V7[L>N8@=4GJ('[-F=6,^B07 M`4>&)T%')H\#/*&`.(]''HG11J&@NG3LM<#`"-FD_:PS:121%&UT2E&3BU*R M'VUU$5HG,;N[&V*[4="4V[^[L5#_`?ZGIM]4DD?O]WC;G!,M^N,QB'_L".3O M>?.8DX\+#%YQ5I&XS'Y$'R_*ZHD(%3UH.VO:VZ%>MP173JPIBP=<_7.^9%WR M\%FUDM(M5B%4 M%'/=Q#:S"<6RQ%`)UEVF\L57;-%`E9C\,$"@1[145>5M8B[N@9G%Y$KJ)W.M M^&4_BP12^&:^?8GY:_F:[:EH_9EOZ5Z-%..:""4J]^3)LKN3^;@O/8UB)TX, MQS!#:-N.8;O1,`.'+G\.1D7CJFLC#.L-D?H6+;@G<-M9Q78,&&0/%<9TQB,T M@U;B#XYY]=*NF+8K9H`+>KP@9^)WI)%VH#!"V+#@!!%/@H" M.[7C.![23&9J<[VXI*3AWU?@IOEAGK@I=X%T83O"E2QJT^B7(VC*W7"%Q8Q+ M"OHTD*52--_RR@3!G.7#VR9_.=FN%Z6F M&\(402]P4P^E2>@/BU#'=5.A8LC,MC141#J$@&U M(.G)[-&!([RI19*YI`I62C22.U&O+O58\%],G&34%"YS<:FP((G%-0B#3'-^ M+C%(I8DO_'_+B,A\Q3G54*%H))@E.M@W7*TP:5MM;6CLWV`/P(6;760L7J%Q+_\;0IE1[W_@S$S%( MRB#`"0HI\OW$+P#*4E@,DDA"$H47C&6^WG9Q2IR`=#`2.P2V#(]BX8BI<:[# MWY>`'#GXU4#/D4-?'0OVO^BK#H8L97Q:-K?E:L6\R_R>5Q@&J90F.7]R M!;U6PZE'`QY#Z\BS901D1QXO,[8G@A-E8#:K7&F)]`Z%50;P-D1 MYC)FSKZPVAA,HKV,-7^CFHGYRL_A/U=WW[>N5D$IDP%@`4+>-TDH0&`0&)-0 M9J2#AA3K_8N#;GTKPK+5SOOW?TO#(/A/#W];SG]5_?70G4N1:\#3`?@XCTV+ MK1R#;<':ZN5UBBE.>M#!4*I]<2(LU7IF/I<_V&_YNR3'ABO<[-_0!F8D'`;G M<">C`4!=:'PQ8TAC>J])AJIMUPVN%_FOFVI57L]_/2LM1WZ*61)*"0PHSI.< MQF04F\%$:*RK*5E3=#5>>(^KKCNL[T);++J+I"3C56U+5*2&58_NN"9(# MV>G6WJITYH.G$V@=B5=-X>Q(O&K,G,;.=I0DL:Q<5C^9X_Q9[JL]@ZC`(2JR M)`B*M(!1ZD>#S-3'@0R#:0FR3%]%LRRKN]HK?]U\9S_OO#[/$F13;3TTQ7AK M,B#E2&NCUIAI/YV+K(Y!=(2IC"#K"$V9L:6QL/7D$NJMM[_Q\/+W(!&'$0B2 M&$+F43PM&H;QY*@1E$^=M\$;%%!-G M+12E,N>IT'1V1.*AN0^O?3+BD84]G/:;V`UNY/U&+&F,/RIJ15[VMU6U*#O9 M@\B$4!!$21RB,$O2(H.Q/\3I,8I2HE#F59(S7:'W9EN]3:7W9W4_UZ_SJF$L M5>FU#J]RK7=',[U:KQJ.2M5>ZWA.5._=W=?;SJGU=D,3Q-86-U@5W@?BZ;JP M%O1N>`@SINRO#1N`1ZZ1X!S$`"0T(9\`$P#`:7H2(`YQFL[I<2_"1@@2A9PIUS]2@C/!C=8Z& MWP-`R/?V"$/GTN.B8X98+X\D+,J/R,>FOGG6/10E14((CB,6P(&0/8^\A:B7 M#(-,*,LS*&Z23L2ZJ7\SWXVH`JZ$AY\.5Q4WO^/?-_JYTY;X$C,)]M(`W%$B MT['H!*=I@Z55O?JXR8<@2D&0DBC#("M@@G`T-D;&&80RIRJZHLY4PS)089'! M4[U890E*0_6JCT9K5C*(ZI>M+"%KI'*U[8=?0_7JHVH!2V$1'*YAJ5@C4,92 M!DFB1>BVY*=VM'GX4=:K>?<>4-_B0>_GJU5U6Y6+C0.;@1SG01*'F,08I?S- M512,BL1Y*O8Y M(D50D&0\B`!(K,U2Y_LM<_P8J]V7_$+>,2R3OOU3`3FQ0J9MT.28?-3&XT^# MU^DS^9V?+Q`Y$J3JX.=(&*IEPHNK/G7AT&G>WN*P*"VBP`\+FOLL=/69\`B/ M\6N>"KT@9T:2]4*CI19N&3"%RHP3XBA;93S0R*T6/.K#J=W.;0E6$QW=*Z$; M!+:[JX^U;(_%QV_E4U,O-MW7;_IBY+.&ZPO['=>G(U5C:^9"G&K.F-.MU\H0 M21[/L_UQ72X?/C;K<:;G+`N"F&0L)LZ#/`5ID8(\'02F41S*G\JK2+'L3#[, MZ\=;E@T\+OD3P_[6%HB\'^SCWUD`JW0!RPA1.A!>\VMP.*/D1Z`+CU` MFI8(]\])@B,^[^GF>[EXO"^O;O-ZS4+N_ZH6Y65]RU\:YAG0Y_)G63^V1;7\ M%_.<]?R>/J[6S0-SHN3IT[)9/-ZL^827+_W-/]=M4$+R,$[B'.(DI)AMZC#U MHP*Q&"4!2_;DS>HWG98#,I[?[;J'^F@ M=6F5Q2(8]Q=8+NRQM[9VAF#9@/^(`SCO"PA#A/P&$@_*02+!@M:@T>;`3C-[#+AM M^2'^4T+'!?934[S1W1@RS/>I>9C?/ZW6EP]U\W/DV#`A*4X`HBC-TRC'241) M@2(_`!1&-!;OP%'[>LM<^.GJ`W[_/U^N_W[YX>/55[D841$O`7JT#Y4<3P[Z M_+U72(DQ%>&2H$[[L&ESZ',D[;'I7C`.T:H>7^Y:?X@H%3%R@2%556_TMX@,)UZNULUB_FM@ M73^@)&7?%0=1!DF6)$4V9OB)Q*0)N:^US(B77ZZO,OS?,L^])"P"?&@/$3DZ M[/508D-)5"3(T!XZVES8JV:/"G=L/\2$:@"Y0(2*FC?:NT.&!O%?\YMJ72VJ MNNRE9#S3!RD$&,0`QFF1IH`%H!$%V,]Q*M0BJ/C5ENEP2R&9AU\!(@%:M(N. M'#5NZ:)$CPH(25"D7:2T:7)+/7M4^0*#0W2I#I8+E*FA?6-DQ\A09]OV-9RC M]W*"W,^*(,X#RD0E),EQA@:*QEF1"Y.GRI=;ID^9?FIU@`2HTS8V4IQNA1SI\)S`T&;JS:]REW2OP.]- MLUA]+-T]SKUO3?<@+<7 M'K.!)VS\8OCSWA6@A?$1BIUP`1TAY"DMWOM/^Z[T;3+/Z/A7'M;)K>EEF>^`'-,Q]'%,,L1QD(Z:"MGQ*AOLN-\UKK+MQW:!HKI>C1IM@;K\"E30*#A$^;;EDD&C'VZ/K,]])V M@GWQ6+?NEU?4NY_W'_OR^&U5+:KY\FD&8()Q&F?0QSFEA!0@208E@QQBN2Z. M*36SG(IUBGI5[=V.RF[R,L98/UJ;RS:9&;#A[^\DE66;99Q=;55.VUN^DN;;IY73<9K^&[&1YO_2^+QOFB/ MS'C+SOR7F5X=@^`?;?0YQR([TR5T%N-?M!B=;PDFK?L^?P`W@1$_XL=7]/)S M.;^O_BH7__C1U/P(\VKYOOKG8[7H+E8PB'V(LC#$"*40P]`GP6!BE%(Z MY-C3E8NGLDPA)9<+;7C*Q0QA?[;EY5OF)EO"8X`\,,9L;UMK[M7#F]<(^H2U M:J?VD1,%[A=.&V\Y;=YUQD&Y\`98O$>&B\>!8=[#VX+&T6K"Q!O#!HR7U:JJ[[+V>H_N MT'W4-(;4Y^U3D`9QC,*<1C`=-$WR&,DU!)Y!0>OMA!O=O>_-_8+?D'+'C%AY M;^Z9'27W!YO$R2M_\9MVF:OXUM7/WO)?_"U\!RZ\-W\+HG?IV]9!O/F;_W9, MV?C-12NOK!=,!&?@"_YGV'Z._26X\)AV/\H;#M6]J3#%YI;1BS8_99W7F^=U]GF=@0ZZ?O554O#@$VP)QQWQ%`@(^M/)%L-(9G_: MH^]H/ZJ*`$H0I#%$`,`P@B1)QR*$G^?87(9N2T/KF?:I:N2;UDV^]3HWR?M_ M[Q^YBV/H=9[OT.`[0_[732@>UB,\7LS7N>:FZ,?(69IMJ2:>6;EG>)XZYS.ARD M<\])%F:B#+1HEFTI^79CPU;S>`R++,%I7F"?I.%QC]LY7/]=]`HR4:T=-D4^:GUKG3P\K\!IW!$Y2N28K2R/_"@A6 MWB:%R0:2@`G3WAZQ@\C+-J#E&4^S;&EZO5Y6WQ[7_#+0ZX9?9=UU/K)OO[NL MUR7;[>M9$D19C'"!_`*1F((XI6,ZE!&8R3#DU+I9)E.J3Z"3KY88U[J\4'*T M+$C(%]YHE]<;YFU;YJT;;]D\"Z?M*.GSF7J^JN;C][S;?FK"`P2F'! M%$^*+,[R-$HCFM`(D*`(B)_(3(4\HYI25*HP&9)9YG6F[79O]M9YK7G>8-\% MOR-A\SEOL-'C1GI_MB:)WMOB`+B"C/U*EE^.\*==>2M>P-ZZ''$B#FP&1WR0 M"T@TSCVIDAYP2!<^S]?EEW_-?_0W!14P0$6<@*"($`VB@,:(#M+\+,)R+;R* M0JPWX`YZ>4NFF+=BFGGSNV59GAA&;(5,]F-TA`@T077D(=:UHC&ZTY1Z$=I7 MR]>83QX9+MI"$0$)#>,`Q3#BO0\I`9V\T(WL#M(%1HI[W M_?CAJAR$QAD)0I2S;#DA$("L2.$H-,6)K\H_\I(F):'[C7H:3*0`ISP=V452 MAY.V-'.!F%X`)DE(Y+(1Z%?A#Y*81Q'60C#D1%#4@@-$C7T8D\XV MRZJYYU,#.X=[ MFU._#VJ\;%8=L^K?E_S5H?879Z/AP[`)L:L!U)TC31,V'>1"8X`I4-S` MP$^C$NT.[*3S:XV+N"!ABD.`*8[S#`W2\SR%:B2G)?*UT)P>KK)$-QFDRE0W M:N@>W1T#3XCPC*#O'.69L>H@Z1D$S51D-ZHTRX($4)2A`.743U!19#0%INR2BP!5 M@5.MKNX2\49Z0BAF4A&((PQBB'&&QS0[H!!HE$U51;XF*M3#5JFP.06LYI/> M\U/@,?#$"XNZZ#M'?V:L.EX*-`.:,/61QU55EZL5;1Z^5=W;6)_+F^:NYH.H M+Q=EO:YN*_YZ5E>GQ#?_?*R6Y0+7B^V2Y6KU^,`^7J_95J_8AU6,CR@^GY6KTS7+3GQ$V\)UR,4<>Z5=(13 MS@Y#X]8#)LA:[:7L'RKVS>NF+C_-G_B)[%5==FU'E[?7\^5=N<8WWZOR9[D@ M);\)^\N/\H8I7RZNJX=RZ+6,`8`$$H1H&(9\@F4TJ$6+#!9B[#25-O99Z-8; MM/3JQKN?LU#16W^?UQ[^L:SNO:"=]AX)DQ,'IJ6<(.P)QQ!4>XAEZD4X,X%, M;FYSGKVN0PC7_VJ>*X1OV9;>IT^084A3'Y(,)!"D++8*R*`/C0*HP00FU9B4 M`N9%O=KK^S']8L;%VN^F9$_HL/);-W:9HI)*`4I0@; MJ^,B-UBQ\Q@IV`-6D@U&=IKY&4!)BJ*0%B1&M(AP%`QBB!]%(H4;U>^V7*$9 M-?*NA$>Q*<-TO`8S!4)RQ98=<`1>2#"#TJ*Y:3L%VRCZK&CM:&(--4E*'TT] MR=3RH#A%P`KJ[^5551@DZ9+Q=B\FBTE.@CA"-$\A!7[DA\D@)@>AT&P/U>^> MC"Z92DI$(`&3#%W:04B5+IDV>G0I@9(*7=I!2YNE2%098NV?(-O)RR/#9D\>K_EW=MRVWC2/17\+!5.U/E3/%^>20(.=E'E2T!-O_+J#`5G$*:DB=CR&]#!_FT>2U*41*&;AQZ MX7YQT#<$YNDB*X']74@`SJIM3CY3HKX<7'.IKQJ:A=67GFB;IKX<1`FIKQK")JLO&W&\ MZKLW]K+Z\O.BE_H*X']??46)8#YL-SHKLS_FA_)ZO2WK78573FJD7N*89N(; MR',A"B)[."SC([ZKM!.'4JS,G\KBGBASL?%`Y+@=[29_>&SJMQO4J]BTXS1,/>A8`30M*TH]9WB[ M+0LR-:Z1.)SB=RW^XP8\[*)T)+(I4AN9F?3[YTYX"OK_#4(;P"AW#^ M93%^.7*B^7D6RY)D\,V6.#$QY.#P"3=?Z93O&FTD0-`-[-#R8C,9(#@>8KKSKV)8B6%$(*/-.Y MUC8"23#M8BB21=^$F'13_LBVS0_:X6EEIR9$/DS=./7<.'+-R!M6(A!"-OM9 MK,DC*8X[/92V4=EDJ>-B4#2RJ")/4BP9"+V9G="IT4(5L9+C`QO!$^+!B`>N M""#"G[::+V3,1947IVB*KN,77.SP?K)3KQ(7)G%DIDE@D)$\T[!C-`R=I`[[ M[IND\51K?`?HL!S%6DQ7*J?">J^43EFJWU-\O2C%DR.`4JIEQP$.RJ=$@[>< M\,4$84;UC0SB)EV.#Q/IDKA=<9UM\,HU`QC&OA-YD>WZ9NH%=/;1C1[&22QW MRX)I2,6QXOKME@5X(JBDKZNSL2MK[T(ZL:KV+\#UGLAEMN]_B M[PTD;/RU"E%,A@^8 M5Q;7CWBSV^+/]W'Y]%SA1US4^0O^6*S+)_Q[6=>WM+C5`88%C21&GDE2>]=W M#0,24383)P@C\H5C6]552F-S-IZ@]>O MVA)]WC6?[Z,UF2/M:"6Y3=>0_1CA&W3(@RB*`BN.D)5`/T(.Q>0DJ65#*[68 MECAFAJ1\N?RU%:#<-5261X:`K@7O>[K!J9%-LC5T()^23_/=\F(OQP%G M8L#,'M8D-,QM=;GH:R6WOMJT[ MJ1GWAV*UW6&=N*R;^@`X1:YAIK:-4C\V?`33R#5""R+#2<,XM+A:0R^'4G&X MH:C+`A=-386JIM9\N*/FM#.`P1Z`O].O>)NK/P2K0 MFP6^CAP\MNP*'&RC/WBPKC_["%K[E@]1RCS&-'-9ZBG1))!I0,3)V="RKA$( M=P>$_0Y!]"VK-NVBV>=G"K&FNPD=;%ICO?OL35".;3=.W31,(P>F2>B$O@L' ME-"`3$6H%H*F>D5K)(/9`2384>G+B[9N,:Z;_&FO>?>O^H"7_?<_5%E!DB3A MR#>/FWG#G78>%H]QXY`V[*6VUER!UA[0&W0%]B:!D4TZA3097F&*8[.Z7[O@ M-:_U)R/6`DZ8%*;&@72,,EHW^4O>_'B##/HF(F$3I8;AA%Z`8C<,!F21![D: MI\T`9\9P5+>RU`48D/5P)008V0X2#RH+^D9.('D]-WH31P8K]`P=?-QSA@M% MCM4X1*BRF"$L*"5;6BBX(5ETE:])CMQB_&^1-W4;R4[`1)[1=F\W`S."5H)2 M._4'F&[D,!7B6`K;C$&BVD/OX\6.@I<<):3[3D[(6-)M*N+'P9X^E+06=;.4 MGRB:<+IE0FA1]0#\)'%&F?F<04>M&]BN2US"^`57]V7UE!'BVW_CQ9Q$$"%Z M)#<.TBA.@B`VG0%SZ*0I\R6+I8'.&)N>#Z;T>C#XW+*TEC57VDA@';;K`*;PQGOO@U@L6N+[-*N@=\P MO02!-Q^R%UQE#[A;1N\*\H[6V0D5S&)"2_,VY!?3\79-W9!A\N(!D,_HV'?X M(2^*]@,R/"9_>E`_<%9=M1^.()[,KT>#]`O_5^"%?"?Y+@*5X+S'.?W+9E?1 ML88!?IMZ<4?Q8W/JNH\N3ZL.EX2TX:+44$XXUPS^4Y:;;_EV&Q6CQM!=%^EW MS_^;R`M,RTELWTT2SXLM(VS/_T>TVDX0\BP)2!Y:<58U:@7?86R5:K"!<[8O MFW6VR?R"A//E.`/0EN)CXO6XL\3'YIDIMB*W:#*#5F5=.OM M^^,[5=$=4?QLW:Q0Z"$S<&T?^="%=A"8+K+()-RS#<\.XDMM7N0.IO+288^O MG:J\=P/QSP'E_/<-&:@[>]=0)O6:O*F2C3JZ8RB?,O[WLDVJ5JYMA1!9L1D& MAN''46A`8Q@%V0CQW:WF^M6JUW[V[UPWD6>=O8L2Q:E4\CD2E:2+]*C5G79T M%H'A8TPW)>%$?THR1$A@UH8O9+96-'UG$:(YL1?$411$9N2ZMN.9\3"&X;*U MHA?ZQGR)24G.6J3/:(X=A3<1(DC&E MBH>0^VY_D^4%WB1917=4ZGXT&!N$&".P_<0W:+YDN>DPFF^RE2.<.(1B@1I0 M@0$6^`7A^WR=-[Q%3T0I9).F&=CCTZ1CXA:2HO>9.:-!$ZG41'RF6G%T8UP" M*>S9T>6KZ#T`+T30]I&3>,CP46C9GNL.`&!H<-WHEC>JZJR)K7A$5S"(-Y&2 M1SUC4K4(ZYP)%@_AB^5R[^D.T,3.51@V-N\3!%US*+YB3!1%@UAA7S3 MP\>""`NNAVELXEMQDD2Q&T/'=N@6OV,.8YI^S-0_1LI`BJ618/LP`@<&=)PJ M.(U+-N&;C48^K7L-:T_@4JIVCJ4S0B:%7$VT2XXMI8*G3W1W['>22GXD7]8K MSXU2(W73`%FIZR`SHKOE_4@.F<4*[9"Q__KY=LDH)M""$MXJXV"-<[M,#6'" M6V9,7*G=-]LSPK)WQD^?)LHRQ8)3>VBB9#"K",FE*IS5&.'N_Q^+XWW^&R)K M:5G18XZK-##=D"18$+H(ID[HQ,ZPU>\'26#P2(SLL96?)>Q@@E\V/>!?::&3 M^M4F';ZP2:?D1>,D\LQ;J,HEFKRBRLPKYWFR)_VJY?#^-61F&:2(G3,C$UO2AQN272WN-@[#,_M,M:<1CL_\>9!QR"-!;`<9F M@*8$)^9MBS=8$*'_;-(UJW\UB0)S6WVQ;\,,I+-=!CZUUD:78C_AYO/];?:] MJ^9W'.%Z$T[LJ*[L(#73((E"-T8H3#S/#/S]7JIA,I6E6!JCX@3S\\G.$#RW M.9?TX?FHLC0\=6'F\C8&[7M/<@)BW%#P]3"=0*/IQ!"8CD^A?.`[R[,TV3R7 M>G^29T+P/N]C7@.\[59C*DQLK-MRT&>>F;("U/2KT5-SU=[EI?=AN[3R:O2L MT$_SI^=L3;ZY`-GAR7GNSR^M.S(FWZ)5YZ=WMN=QMNR*P"6?,?5.J_Q*O1<`X9V$#JA M%<9V&H;!_D"&E=@^<\ZB"H#BA*1#VE6MKT'3@R4BUFW>DWE27V01]X!Y8I,R MIS`D(3KX@R_#&!#W94!ZSW0]3P?4X.;@F`XX2'1R#$=&H(.#Q,+]'T.!ZZ?. M16,#[?(*O''NM[A#6K+KG21NX4T M+HLYX-BL#!L:J1M[B6.3D&QZ(4KV2P^!G_`UR$#]/7OY52%]F#RS M6J]N@9>'U$MKN4HX;:;RC5N'LO- MRD4F,FS?"&$0V+%EVX9]&#LQTE6!'V@\8=-C*4,RO=IA]VJ/T;&_X=V4Y)G\ M\V-;TVQ'0V9\9&$@:>Y[J!FUK(\YS]_IB; M0FE)JMCPJ@\K$;!M(5&2>*[+IZ>R/ZC4+B/CH6W='2[P?=Z`9_*S4C-109=( M2$75>T-^+GJRL'F__I]V=3')//&,D^9/4-^E6C1#G>8W3?17I84\.:H,,J5H M M@^R`6Z(6\[E@N@(K8U^Z[HZ1:J2K8UB":BKD@Y]`0\7LXE#."<1Q5*OYWZYN MZ,Y"?5N>V`9M%?SNN%]$AVYHPMH![QNMTF]H;5A!:)E)XL9AY-I&&'JQ/5HG MCODZPRT.5OEJ;MMX>RS'IYIT;IT63:*4/'T>5C70!)C\ZWF;?D_M[O&Y2 MXH\3DQTW,!.'!&\W,LP467$0P:'47.!Z!M=D8RY,JNG")ON^7_C9/8\. M'ASM:&HH:PPT3U0OF8[\B41*JMD"6B2?]HFU/H:3BQ0/W-5Y@>N:H+G+BPY, MZD+?L'S/0R*X5, M]@1;(KR\$_BRVQ-WU*X.-PNH$H`!-!BAUJ+LR`5FS\BX6D]I(MJ*C62J8"*7 MTKGO+0>&!8W$IZ6&41`ET$3)D*$&7AA[_;WEI&`\&C$3+![%>&T!LW2,[RSW MO=PNW5;^O[[@RNHR3:1C;JO57'#E(WTD+N.'^'?R%?EP^(C\A\YWR2?_`%!+ M`P04````"`!*@$U$NPKAI^[]```DY0P`%0`<`&-E;&`L``00E#@``!#D!``#L75USVSB6?=^J_0_> MS+/;``B"0-=DIT!\9%*5#V_LGIDW%BW!-J=ITDU2B3V_?D%94AQ;%B&*I&AU M'KIC2<#%N?<>`/<"(/C7O]W=I$=?35$F>?;V#?P%O#DRV22?)MG5VS>_G1WS M,_'^_9N__>]__]=?_^?X^%_AEP]',I_,;DQ6'8G"Q)69'GU+JNNC?YH+G:2V M6GE\O"A]]/"7_?+WB[@T1W=E\FLYN38W\8=\$E?S%J^KZO;7DY-OW[[]I;5U/U?7IA#YS6UAKDU6)E_- M>^N?&_,A+TL+J,;UZW5A+M^^J:58,T`/H@>7R1FJX,\*.P M+G3X8Y:426W+DF=3:1LKJZ2:%2Z(&ZOVBL^96:X2AD"+=H>+!L'KREI'`;MC M%7%Y7?^G;(M?X]1.RW6+'^/B=VL6V]29F@:9Y:\7DQCT/X56%, MG2HT*["Y6F^X7(<)I]I]HVSNX&[5>\/I2%:7REU@O+E)JIM%7Q!Y5MGDU.:V MB0O"QJJ]XG-FI:N$(=`ZL--91*]X/\;9[#*>V'#,?J7C29(FU?UI?%\7_GR1 M)E=S8N[N@U;M]*JY:_]T%-`%UJS,TV1:YW=AG-;+)6?7QKC,%PT5>\1V&A?6 M-M>FLMEVVAKH6BG=HCZK[/_G?OQ\64<'.LV_;679C0)ZQ/H\R6^-^F51@^)O MS9DV%Z7*:;%AVG MM35%.VV_,5A85[8;!&Z3X/.27;1>V.RLFG?>LBIFRRGV[V9Z9:=8/K$_S9.T M9G!;"AH0NS/!VLD;7A,'JK84.+PNC8LFK04.J(MK!VXEK@,]%MNCMBUE0^?J M_GUVF1#14ZQZ7&^4V MU^H`E:V:WQL3VF\OD^K49A/-F#;4Z0>1JP^;J_:*KW%8=ZF[.T*=9#8G3.+T MQU%*QTGQCSB=F8\F+F?%/!YM`MQ"U*#X'8G17N(^M&FDT0XB!]7';8AK+7!W M7=Z9_*J(;Z^3B6WPM,BGLTFUQ=3J6+UWG(Z]8#LI0Z%N9/N68H;"W1CW;BFF M=]QNO7$K(;MC?EB_.8_OFI&M*=II^XZ]Z.4:?:!I[!T;JG2*QXT]+U;H`DL5 M9U>)%\7GS"Q7";VB=?6THX`NL'ZU-"ZY M/BO88=O./EQ?OD,DKOY96WQW')_B^M#9Y\MP5B:9*6O'AW&9U/^>S6YNXN+^ M\^59.']UWM`(=!^, MZ2-DO-OHU'$SN^L]/PG^*!-US@$;*_:(S7%T<:W?(U(W5CA6WQVGS6MN35'= MUPMP\X7Q/V;)KMNU?H](W;SM6'UWG/\WBXO*%.G]%U/.TGH/ M_K-M>$ZL\K#I=G40DF3R_OY;M]\3FH$OZVEN`[TJ#>\;%A@IO4I)9.53A/R MYEI]H7*UI4OEGC$VAN1NM7M&V;B\ZE:[9Y1X)Y1X()3^3BC]OE&Z30(N=3M` MN/4YOS[/\SV7[3K.-%7L`YNC'QOJ=8!L=E&:/V8VDE1?71X4>JE\]TAY MVM:X'M]2P!Z09>:J/ICZ(;XP3Y;/U]5+B^*':O7-"*R^&0&2.>!UTCI$^F2/*IRCHV[7JQG>,^JVRDW0?RYX([Q'YNAQ+3+>KG(KO$FU=Q MVC'>9R*[P=N"#-5SB`Z>ORU,:<>Z^:3^P99:E*UE=GJOR4/CYJXRV=0F[//& M;?-I/EFGXUR_R[B\F"LY*X^OXOCVI!ZL3XQ-1)??S(?O8P`7-\7\9?%U]#"_ M\8NR*N+):HTHK8WQ]HUM,EI?,-($:0X]C2$,.**!!IPQ%$K@`R0]_B0B2^N; M;_)B:M%ECV4]Y9#$YR@L;7[Q]`]\7"?I:B7HLLAONG%UWJM%K0ZKKGCRM"\.TT/71CDC[ZA`2NQ13;7P@]#' M1&)*H<*4<1R&C`?[Z:C;W'"S0==MQ$0,!EX@,`L8Y4H!!3PIH/(A%4(0Q.3! M=F!G"N2#6?=19^Z-8ZM'VA[,4://L_G1S;NDW$"JC?4BQB$&@GG$HX$?AE!H M1I;&9(+APV%1/^[/^S/V$*1Z`E/F-W&2-8[&3\I'DF(-(0J`L),I8%Q*P%8] MDO`#&HHZ\F_>O56'8,NC+B3-99*9Z>/G*OCTW[-R?N7`1W-S80JWB6H(#`@Z'7SLRX>49KWLS#TRX3Z;Z+2M,G";_,=/ZK-T# M]'?6/O6PO0WEG$1%G$!I#1)`Q(06'H'<]NB%-;#67DO2H3\1Z?HP]/"T6\+5 MUG#2E,E5-H\ABN\;LLMK->K'4LVV5&PG/M),!H!)CS!H,UK,2$#5RCU4MQT3 MO3\7/057V M]4S!@R2G/=M_"#9:E#:>*(TT#_^^SY[O;G_)TU3GQ;>XF&X@XY:2(D`]Z"'! M?&,$V>N(E37#M(<8:4)#?>S!=_6"TU[\CO)C6R.Y@$=V$@@0"*P\8!- MUVQ@#`)-)2*J[9`RVIV+[4F2[\_&*,#.A+8D7^=MO&WL^K/ M[:V'A7!"N:8B@,QFU92'5.F`6*MY`0M\'^G!)LXAEMMVY$T?&US;F?_0CP(@ M00)?VU0$,*%\$D*I/6L-#`EF@6)DJ&6+UT[&SDT]!/':1B`-`=XN8B.;&VM( M`>$,AAR%D(1"+-W!->"'LXZVG_AO0.>,F<*-<>1N@B/$O0!`.\$()`GV>:`P M6EA*!906?,/&Z,"'83'$D(B=2Z'F*X\`C34.O:4I+:L$GC M`SK_/!2E.F)R*__L@\G?#P(YKQX['+CIL)4("JP5L:,00C83\#R?([9T'?90 M6XZ/\+SA.$*.X7PUR#)HG)KRB_EJLIFQB<"FA<\?2T:AP#($C"E`!+7*("YK M>Z)0,:%QT#;W>@5CZR`,>+KPN9/UASD!9CUAH+B(M'9#8?'5Q7 M(](^#>M=ZX`CZ85RU^+B@(U3 MX)K2D0RU%+X=>"D(M>82J!(5AU6N26[H_O M6EE#IN^%(B4U\00/O4#;'$PS+*2=TWT?**D\(MJ&4OX8E[''P*+6IA_!H:9U M5\2-_%P2]P024$"N/0*)!E+"Y0$UJ0/:^$1<3YG/XC+7M6]^7EG:Y4J?+25% M*`1*R/KA2NT'/@`AELM'E23#\("V\]L2X6GRTZN!Q[Q`ZLS!;AJ()`DEYQ0) M+I$*`SN9UO;"2B,O1!JUW=T?X?Y51]35[,:P-+Y+LX:9SAREH4[4((>6%@=8TI%@@#D!]59$D#',A/9N4[&=" M^FB**TO[9PXH;_/%1_OW),WK5T"6+F-".X$1`2K0$D"DL<\880$(Q-(ZF(3P M<*:G;DB2[\'J>QH!]GDJOH^!``=8X3`$Q*<`^&&"]&JKW8 M>XA0=0WPAA-3+]2(*-4X#.RX9B,I0'`0:K+2S7[9]C#4"+G4G]OS/DR]+QK5 M?Q:F^?128]V(()_ZFB/?1[C.Z:3PY%)?$9`#HM;.'G=@T"ZVW'S866 MOLO[L&T[+EP4L25TF.1GD\1D$]/,A1=K1,#*QYIQPD/([,BJ%08+O(0SU39W M&>'Z15])H\OO+\[BX,A6WEC%?Z_MY+_/"G-V: M27*9F.EYLN'P>D>2[2`=$(0\A@G5GL]#*H&_LJN'#^"$9>=,6,NPH3S0"0// MO^5/\?%+ZX$=J+>%R$B&,F1`"^91'2I(N8_)4F,B>=L+#$8T"0[*N?Y,/\0: MCLCG;YJW>MB_RF2Z>--P>']N(30L"C;6C6Q*247]]#*$$`C!`F:MNM17M7Z2 M?(3Q^&#+@UT;?8\DJQ$W+A0VUHV08AAKB:GG^2)4$D&^ZL6:B@-:'.K0]VZL M:FWE00[RS(1T4S9Z3R02&I?^CX&>(6?AJUWO49XB'>PH:BM<0Z5^7];[ST]`K.#[0;A0)*Y<>!Q MN0B!@$/B84\#I("4]B/KNY:=%X)Z&1LD;S-9K?XJLXEQ35 MISH?M-90M'U-PM;/=1Q`6#&X-X;EX.:UZ!W%1A!A`1&#,J"0"PZ4`MY2<\[D M`40O0]*C$T:V\LR>SNU\<+C18E.UB"$5"!J&C%$L/2H8U,L-@@`*2%ORCXR' M?V,X"-;6WH,\$;E86SW/%QO12_SFX7[Q^J[#Q2^;W@VSC9C("Z4,!?-8O MB'WP,-PZ'EPO)N(!L1;&(`PY)[Z/"*Y?+/M@!=]7['!FTD''N1Y]L"KX/^S[SX??Y*C-NDBE-U M-TEG4_NYO@XLLWRYWR(^Z`U#Q`67(:0:8L`85M;;ZKN/?7@`YW5'P\J&V&,L M/GYM4\5ID=^:HKH_3>.LLB7J2W)NZTE[H(GCQ?8CGP1,^*&-"PF0*H08PN4R M#!72:WL`8X1!^UCZUIC]^]KZU?>=0)<]M(Y;C("$4O@`L,"F6Y!IBNDRAF:2 MA6U?[CS"%..0^TY[C[Z^WK)Q&WVP'K01100)1EIJ($0@F42*LU5FRC#TT>$E M-H?9J[KT\M[S)+E@SGE\]U!Z_876@[0;<8Z0)YCDU!,RY(']M%Q*9@2TGG=& M>/QM+#UDC'Y];;//YBO@.VXIJN^:MADE18C64[BG8$!7,[D*VSZ?M/W1J-SF MNW^*/C(.3P[1*][E^?1;DJ8;Z+PL$F$&"+*9%M?$]WT<*+1ZV(-IG[;=A@A^ MCM5-/&SI@A$/JTN-AAM>FUJ,F`JT5A!1OSZ>1NIG%8-5&"=:/VM,?PZS/0VS M'7MTB-ZB7TXCOICZM'>27?&;O*B2_\S-<&J*)-^XD=Q28D1$`$2HN0W4!/&\ M$(9RN9C&`@':IJ;LYV#>Q/9A/#:^-%/,BF+]-L%@;4<*<27G+W?$?GV6!$CM MKP(PR5L_Y0)^TGY_^68[YXXX.%KK@T=J/_KQ4YY-7NQ7^X`1(1D*8H-2R)F0 M2H=$LY47?*7;'N:`/[>X!TU7._;S$+VM89UVM5/OD/-N*RH2G@P)"H%4G@=] M123@8!5JHN'6,5_M@T0]6_P1__;P,HPGL=DK?AL&!8H*V]E]B##UB.)*/02A MOL8J4(75H$>_*`KOWHAAB[O@UC.WNW M2H-$GEIFY(LGP*X*\_#\UVE,;*8&@H`'/B%$4FW'1`\O\4/L M'=";_?IS;=ZGR7N@S.:K&USJ1C;UYX`2Z%,FE.`4P)`L=0@D.8"#HYU[TYTE MK6S?XJSZX>+\_V?OVIK;QI'U/YK%_?*(QF5JJB:35)*MK7U"*3)CZXPB M^NCB79]??T#9E!6/)5$025'R/*3B."0(?/T!W0TTNG_9GZ=UU_-1<4NE1\IB M%IS26IBP04$Y<05)"SN06]D^LBVPX!@&//A>J9,*YF%MI`*B&+&I?-$`S#CGJNT5"AQ?05)FWLS.]J%^EPT M:J_0%N))"2,P&'-+F$M*69H-?I`=%S`@5=2:Q(\NM'4JV<+C4YG;T?37>;FZK^H"/6WL5<^LKX.OBIN/]\]7<'I]AYR1+$WXC<.6H,?XQ^'-;0 MF2U&+$'J(+WPS%NMO:BVZ)^Q$1Y=06VBH9*M/(<`FY-[48Q_N2T?_C&952<9 M3]1^^ODUJ9]^&W];_U5!NV.]?O.Y"(PK:S$&Y@FU"G'Z',W(`T\?RO5B!W@] MIO-EM0V`^UC]JMNFJV^+XG]7"2A?I2YH4+!IQQLQ2!J4 M1H)K3Z2WW#-1>SH<@\M=R`=XBZLW^[@=J,]$HX.K^QN8 MYB^3SJ@KR$/>FH0/,R8+TS-PYF"5C3>?CU(AXCDQW(,6WB$,=J/\L($K.!-M M4;;[V9*%Z)FVKC?!9L?M6K_$J#F./79`K4Q_?/#)CZHWTCCRV5F_KR'7?(MG M(;EX9VUB5]4Y/W[_H\K@-Z_#6W>'NAUZ)2;R,XF449AQ9X3T+)"ZQUSIZ][& MSA!U])%*S+ACH!,&6:&NTL+Y&D&&4Z^8/\$2U57*>71)][O9T7MZ-E\79P_3Y+Y(3>RL M7-/HY5A%FV"C`%7[M4AHQLAFC61I0ES/;F;[3.D"XG[D?G@-/$^<(J3DYQ08[8>"Z429;)EP$G#'H:/T;3NZ+6`T_K.X>>GP;XO%JKB!Q^U1?KE/PRN3C'UU<^9^/EDTH&D[ M'X@XN5H8D..".VV\TC;9.\_("<9S5?$`(\"[9^Y91-('F9.97$QN9R^]K_`[ M8DEM]'[4+I@@!-9.<\8"4MR+S;BQR-UE&6`L;O=4[`+Q/IA6+_C%D0S;^UZT M1EHD)38$D!'`&;6N'B*MWMFM8ET;S<%7J_(!_FTYZVH3+)RM2=< M.91<,VL\&,NK*C@`0O+<'9,!1OIVSZ;V<.XO;=H1-'K[A4B9"R$Y]HQZ&I3' MH+RNT4+.Y3)H@-&_W3.H%8B'X.<*D>U$XW0W":KT8%1X"A@&T*-@PST MBJX?=[^]VR7RO:C"G;U^+G1;W%2Q]?O48K,6H@\`.ODQP5#LC>9*6=CXXXSD M7F\X?BNN\R+>'7'BM9KL!/>\BW=U5[Z7\\7/71F/5S]6TV0:WOPZ+Q>+?\[F MQ6A:]>W7M,!_JUXHOH[^N^MFQ,D-1U%E#*&*>&.T`ZHX#_1Y]#A-]US67>A: ME\^ZLXBC-S+^GO[5"1E_:CC9,Y)[S)G$6`9"DI!9[5MC@[,5;_.--?U$QMGZ M"N;->Z3C*0(YKS[>7:2]\;L12VTD)IXF/0!!&,<$K\?K'.VX6""B9M%5UI=CJH(3Q@#U3VFA-$#][8=T^@M$H($]! M82^)\%79([&"TXS"_Q&`TT,Q4=8$,YQI+(Y$0M9Y(WC"](B7:@=2;!Z,=!_/["$8+ M*E#,K>+4."X)18IM,!$X7$$.VCZIUS7^?P>CO40^$9KF,TLJ)J2I3+!@RM>F MCE'2Y:KBBPY&RV7N641RN2%"25=0BZB54E`I+/FTB M?9DA0DAXY0.J;!'!&7/,>KE1`2+[PNA%!YSELJD]G"\I1$@@2ZQ1`BOKK%+: M&[09&:!P1<5QNF=0*Q!?;XB0Y8R$(#E2"(,BPEL@-0Z8Z=QHM`'Z"]UONG6) M_)F/))\RDY>K5P>LG\JGA&N;6@T-#F9:_$H$"@D_3:7"7`%6WDM>8V@Y7%'N MCXZXU?R0LV/9#)O?OQ>+Q=>[T>SK?XKI0_$A/7VWV(RX$Z[O_6+T5'ED&*DR M&D)01&_)5TER1;71SL+(UF9%FU(<]@S9'N''^>_E[+:8=SM#]GXQ"BFU,L@+ M"""2>T"TLC6V1KI<)VR`=LUESY`VI3CL&=+M;'C!3&JM,=:8I@6%!6#*@=_H M?F/ZN]3;>?CU93,_5V+#9OFF[D?URT85S5K_5F2!.,RH$I" M<@-)!KCV#]TK:$="PV9\;>-A\J3%7HVY4^]@QS,$4%HK(D5FVUV MBGGWJ71[C#\_(SM;]Q/:D>>PYTL]QMK:ZV.^'/AF9`XCX$GM*@C!>V956B)K M?+7,M9F::XR_Y\L9Y3GL^=+'_'B-GT6\2JJD"0<1N,?(DLWIB`R!_NU##&DV MG":]05]$>=77=W(114OBH3IU\H"2V))3:,BZM(<43%EU4!WUO815)[%= M'/UU0=WSRZI[#J_[^=SG,'GHBL2'/Q,9T91A@X47R`06P//:J./&H"NZ#C%T M%K'(WFG7#WOVM1Z725#8L]3XIIX!#56N[QL$3D>NF#?`BQ8!) MVZJ,AF0+MVW^_HP+"(=!@,6*<<+``)>JQ@4"RK5XC[^V<<8]SR%8O*=(94AL M;25JD6I.& MHS3)8'*@C#-8@9>8.*B1$D:]P^V%$]C4QM9"KFC.LZVPCZ$M?R%RQBURX+45 M2A&;S'QA:SQH6EW>WPI[.E7/*Z,S;2.T2]K]GT@>J:<(7$A2`61XH-ZQ&A%N M:>Z]O@O>/C@':UL54O>T_8OGV"YE=SG<(BT7 MO'%P#KJV)J#SF[;MI--]LZ7HA22"4&^D%RSYOT3"!@O!<.[MNPO>*>C+>#U5 M%L.,=5K?.E_\W--W$ND$B0P8.^Z3G6;`&@,.*R@T8^S+>`R:-NXM>BL"PEU+)`*H*C$8'R-B<:0:],-T'$^ M"U.[$D0?Y-SJJYV.%HO)]TF5EJX*=*[068VFS[;%HQLMB\8L/:79&+0%"H@0 M*36RX$`C5J,DPC5YS#W2M4>)=&K;E=-$M^?\G^8V.?7K(1UILNUPT77-ZM]P)(QRA3()#=+$=?8"ZO2,DD<.I@%JVL#=!=)*JWS1[*I=_SWU_33 M(HVO2KG]$^!UQHK7P+->;0H MQK_"16.T^]QHPEG\\) MQ&D](JM4#YD?^O-BL@19MHYA+XF%5_/RIIH:\\,IA5\]&A$+G&%7%:M2527L M(#"J1R,]7,%EM':$^3IO\&DX]L&*S]7J>$#A;)Z)R8K7SG+D@DH3(HV=(*C[ MKY&_HDC!`6F;7/A[H\_!]63KJ4B>*\D%<%MYA+8TOR M6;CU(?L/D]GDQ^K'X=HNV\]%S9D/7!M@G!LPU#FB-UA8`PB;>_8V(,72NC2;LR0+XRR>_#&:+6%2?DGNUVQ< M_#8;_[)3N>Q]/EHCL3*.NJ`1$!D4XIN%4@N<>X7_LOAPK-S*]I'-8T'Y4`U@ M=_6C-YZ*.H`AAFDDG)0(JHS?&_.(F9![>NFD@MYRE3\4\V_E9F/*[WXC&6V]EY5X+$$*G+IK:RW8:6&_Q_Y=,A+;0S6*# MOY_\W^./2M/LY\#KYV)RJ[`T'B,CJ!*&"VS-IF\$Y^8Y&5"UQ([E?B*B6=*& MZ:KX-IG??)N4AZV\-Q^.G$C#,(#P%/GT@ZE*+SSWTB&46R-]0#4..Y9[&[!F M"?]S`CZ]>#>:W=P4#\6TO*^&=#]Z7(\L?/S\P>PG1.,&TL)%&`5"+?/6.J0) MWVR^.@G9=:[DNR%)5U!G$N=V-:TD]#BZOY\G>W7Z8S(M%LMR5C1B39.WHTH> M,PM!:Q3`!N$,(G8S#D9RUQ7UCBC3`&5+OQKDX%=7,#89B^3@M9X=V%K:?BB",,@HK#H$'XP0E M+P80"RK[C/+][!V>!&B6H#_.QN6'XN:5\WK8LSCT7K3>0?"`*&?:*^I"")N% MR7";G6;H_6PKM@QQ'CV6=\5\QQ`/$.3@FU$J07S@C@002&M)F=O0VX#++B$] MH$/-KBG2-LAMGE%NG\-FG'Z_?CUR#X"3G^2P(,%BS&F0F\T5R7*CZ`:8J&3@ M1^`G2J8KCF4=AO^U@4A%Y5YYC)([;JI923=AJXXID>O&7H@5DR_<(YF3A7:> M,6L]POC3O+R=CW;'7.UZ-!+'B`U6$$6M]URD]NOH8X<\9*NIR^/#L2(K6T7V M!-E75ZK*Y`,^?EF.;HOG3APZ,COX9G1<$0R2**09!B%4(*SNOW+_S]ZU-;>- M*^F_A/OE$=?95#EQRLXY6_N$4BS:4:TL>G5)QO/K%[1%VL>Q)`H$*5HS+ZE$ M`2#@ZT^-1J/1G9R-Z(.8N'F9D1'H5*)0S-HJB;=-@[8:\P!&>0 MH'\XAF0&NP-IKJO41--DUASL'CBFT7)'2EJHD6>"5T;8\TH\QR+5>?Y!+NGS MTB8WVAUXXR8W/]1T^E1$=#)/YD_K80+0#D3`N'6`5^4F&.7;E6EBM$M5/Q_D MTC\OC_I"/>UJ]_KKY<4?5^;:?)VL?_R:/,;%+\HGQU#ST8'KW=8C!.^)(M4; M&F,0`LYI0GR]'BAXZMGX@T0%Y&)1;X`G$<@6]S>SOS;WD^_[:?*V72"20D:T MHP(P+:`UB+V0&[G4V[T/@[_H_-AYP@)U'C^GXRGW^.8-QLYNU,T-T] M`F>:$R(QD)R12&NEE*OG2SE.?:[X44(!SY/7/\R]MG MS/&C<%'<3>8N*K'UKL1+[[0*$#&+?`19*^*`BL=SS^I9R\JGO;)'@&,!=,&FB,D)!0PWFS)TIW!I6;WI59,@*+`0>&<%0$OFT@BRSX)X6.U^_ MW_BZC=V_*FZ*N+CI+E[L[!``1U%O&Q5M`J0:4;#!>%B2 M2PII21PVU7Y]>5N[`'91Y6V[8(4QC$".O7#4.F:KH*WMW!3G9Q"#,!Z&=`0_ M39D\9[2*G*QVTZ_%,G[Y='.S_M=#E%=$K/CYM,JX81?+=30?&Q;OI%#ZB$%1 MS;&RV'@)L(PKC.C5ZX77M8VW49,UB@B"4>2>*--)YZ`)LUTXC! M^1S\3D_"`0656>,=K^>"%%1!JCUSU!,'@`6.-@AIF.KA'%%(Q7B(E4T,'0S[ M\K:Z^C63Q4VQO(Y+,<5\OE6LJ_CI=#:-9]-5A=[7V4,11]WI0T@=+Q!-<.6+ M81IP:RG0W))ZK?$$G*K+1A2X,1[*#22D)$+^=[F<3W_-IL5S@H%*N<[N?JQ7 MM^7R:;K7YMN/8CEY>'I[^C+-JE+=+DYV&#)(HA"CE;J6%GDK@&2L\<<@=@:! M)>.AY7!RZF[^;3?^\O:/>?E],K7E&`\9!Y96&E/C;-:/GXOUCW+ZNO[P8OH4DOCJHYV<;#U"P*Q*4`2K M9YM0`*P`P\UZK)/)V<7_N:-XCWU]R66(X)`Z?6*<[2N3P/WY4&5"S#?3 MJ.;5S?-OZ=,BGJ9NBM6JLAGVQ()T("0`0'CA-O);`,BN;JS_@?7)]OW^N M/-Z/^AA.5J_X/'#!XS?6ZP>H>.RCY80AQA9KYR@FS#!512L:[S5R\F#.@WZT MQ8>O>"R=E9;HB"?FV@%CL:M1U23YZGY$)X2^:#9`Q>.C9),SNU&>TE$D*CTH ML8/",$05QSA"6,]?FG]J'6<1_I&EHXX32@^DRE`ZRALEG49&>`B)CB!!;.LU M8`;.(&XQNS2/+AUU',9ICT$S%)-1%$AE!-"(&$(0$!+6LZPP^5LPX5B)M2@E M64L!47+0'I%EK>FJC$3EU>I9[1T23I)VAD(P%3@&/O+$44NX8Q;PQT@GR MJ1<;(W*(]"SW'+`F";]%08?7508`87%UB@"#G''>8>1!LS@*4EU?(XK`[%G0 MZ6"F18JGEVSPWD$OH\V!J/",>JDLW<[.:)_\FQY1G&//HNX*::(-GU*O`3DM MJ0**8BP9\0@A4\]+`)=Z%3BBR,/>K?8.>*;E;^FK7`/42%7%8S33V@IKG+7U M"=8PFUR[8T0A@3US(3/"Z=E]^JK68"4TGCIAH?;0&60<9_7\@>:I9_P11>?U MS9#<&/_S1G_7A2.%!&**((]')24ED+7/UEB;?)DR(C?$B!S>(Y!@DJ[\UT.$ M<[&N8\/VQ?B]TS14E]@(>B*C)8>M95X9WLR0)%=-'I''\[2"+;/BG^?M_CZ. MO-LX(.?C.DFT_)%DS&$63<3M+"W3*M4Q-D)-='J6Y)!`FMNT"MI8/3U#:S;T M[1SV,>9`MP`P%A@QA3B/6!`EK:V]0!8IG'H0'Y%3=3S@6C,=:XFI#]MH)%:?]HFF=AJD>A!'YB$?$ MJ*RR&.(<^:EZR'TWBR<,M5H5Z]678MV$8=TSU@)A"E,FIF MS)R02$>=7:^:`Y2:(>EHUW6?Q89'P<$>I3($%W?$Q>^AWXX>02)LHF%IG#/. M1E7MI&I^9]KC5$_#B#SHH^);'C& M`0&KA(I0`P`I9Q+6[D@K87)JN!$Y[S\`#;L+Y@3/$)Y\?JO_G$;F1PB)3P^: M2'#C(`!4(A@M8B>B8:,]01(BP:5ST4X^1.Z6LZ]=J>7M/JB^17!T'/%_=ZWF MR&$"`=99+BQF!D3E13"VH%J=490)05)+2([(CYA7R.5@6/?[:[R_GS6O\9HG MRS>SHW^+N6YY=LZGU1NBI'&"\T1(Y1DW3''%A`5."LLDT4(A@@_&CY\0BWUZ M(&V@X"%&5%*%,*%`$!=QL34:7JGDDAGCT00]L^2W"ZD>X3^1@0$(X@D%":(5T0Y&.\S6:S/Q#',^Y.I/[&4?4)^*1L^OZXN=KP5;]PU& M$$.Y14HQ8XP2G-OZ]\DH$6>DMSI+O`6#NF";=FOT?3F)B]"S\CHJX,7-X6=" MNWL$Z`3WSBM*%.3".V&<:Y"PR3E//P@7$F57]H'MB?3*18N8P'W=`O>0<(89 M598H(CRK8C&WJR20I3YJ/SJR9HB[GE-N5:F(#\&KRX>B\O@L[BZ*R:I8715- M=I@OQ;X3R-Y^P2@++4&$$XFY9!P*Q:'CF"L+E$#)F2`_A&Y*$'?9'[A#*J=X MV/B^3#2@[T",(#3R0&FA(JS!QIQFU M3S]D33FB*O5%Z`BC$[-2+2^L0^C'BV)=87QY:Z)(9NO+S7I5E62H,J_MXD[; MKD%CY005%6@>`8:5DNIYM9((3,[@_7BO^BHSOD.PZ7H6M>GM[&:R6%]O'A[F MCR\^OJNB.@[%R7^.?]YO[I_7\/S_ZW<+YG4?-.#J@0LB$F(NI,3((2N?$?($ M<9G*P!$&+?;"P,&0'X*;VWH,]5[^^.)P?CSDQ#_4-0CE%,6"6RF8U$BA"&IS M**?GD!EG6*=]9L`'I-?ELLKY/+LI#GCHWVL>JL,2Y,1P"8U"PCBM&E\1%.=4 M*3:?@-]G3A= M\;[/ES;R""(9^?3E\E]<7G[V]3VYX!-'C!`PQ56Q%%JF30>0J6:U2IS#AF'^Z9! M6[;EE$.61_*7M0K]=/MMLKPKUO64='%;+HOKA^(F'AB+Z;?9_8&=K?O(@1/& MN.9:2H,0L@I%-+;K-SZ"/Q0/^_2(#T61?4_M>Q=-%FI^^U6^G9^ZC2JB`R>/ M&#)`J[@1@.NJ`@836#&HZQ6;`9/CGCL9^Y-)-Q9>'C+E?V\90,2!"HF1\9I$ M1+#"L)Z?!N>0`^*DC$D%NAL1(D%;$J%I&2S13D."I7&"&P8P0+2>GV,H-6!J M1#TFKU\]Q08VQZ\1@`<0?A`,=L#MQ.--% MB]07_-C0X)\I)1]EF.>NG M+[^:W?U8K]X>V'8=;EMU#@9BXZ5GFB"A(4+JY3:UJC6>:K.,<+_JA2N](9V/ M+U^*]?4DSN5S,:EX^Y26N5C.RO>BP1-&"5PS"G362=^0\9Z9IDA%#OC"-=Q&T#(608)M)*?*#GDF^P&?K..<]YZ M`^M+*+MI@\:1(P4+,`(.4*NY5%1JSJI\"<]X<*_.JN!4+SS9GZJP`L8CH0H&)K]*V0N4EK?&(N_@9/:X=&2&393`N3E;Q7OE8 MV8P6E(12.:FL1)(R;1D#-?J(RG/*D3(^7J9*853,K(+/LA&S&2QPYX%P1&KJ MI.1:$TIUC0A`/O61Z`C=6*/C9:H0QD7+V<]\^K(9+%B'`6/>.&^PP-P9X&NS M!FF,4[?Q$3K,QD?+1"&,B);??A3+8E(]].G.RI>Q@L3NJ42(C$8,\B:"PFR# M!U*IF1-&Z(P;&2F393`B3G9G8J"4*$VEU=Z#N'@)L#+UVCEAJ5=.QX=TE^O) M_._$OR.1/P'K,N6[)012!3#V#`"FHG5,^YA(KD51 MIQ#TDYNGBY@6_NM]W4)UT$*$88,AY!)921ALC%L(4J.X1GCR'893&<%N3ZE3 MIIQQP`ZB?WI,,*LYM64G4$[Z#V$CK>&YXK91;W,3NZ!*`]T8ZPQQ1 MWD4SD&I<:VLDHQ8_'S_90)91'J"'H-'8\A0S7!5.L$@951U)!,"P\19*KE+? M:X[QSK4S2?+E*#X.]4%X^68%!ZL+OM>^BGER@$A:5>%`FHIX;N:-0X6!,]H6 M\[,I`Z")`8COECC^.ED^59W8DQ_R<,]@KV=C[\E M>P:ZHPBDFN)\1[[4--FI.`3UR7GFM"%?$UR=!3#U)U1(C M,BEZ9D$&5$]A@%ZT>$J^LT\`2*%H=BG!I.`4,N1A;85%4SOYM>^(6)/7[LB- M:)*N4-/I[-FG6#D*EK/OF^I?7S9[T]3OZ1,L(-!!9A$U@&%IL0*DGC,`Z(S> M?&>06]D/JDE,:!)Q/5^B?GKR/>][U[VS0Q!15P)#"8*,8$Z,I:#^)6"I06J< MQ0?0!!TYD`O2;@1X>8QWX&7_[AY!(*8=P(!Y3BC%D''=;)M8H]1LW2.\-.R+ M`ETQ/7%:FLY5MI0FGB-(',,J[JH$0-B82Q*3U%O#$480#N.PSPSX@/3J5&6+ M:<(Q9]'4I@0KBK!BC>)4$)Z!QR._@-M4V3H.UP'9DJG*%E1>26'_G[PKZV[; M1MM_"?MRB;63<[[6.8GG&D>UZ5@SBI31XM;SZS]`$FG'EBD*(B&.,A=MQR9H MX'D?`N\.&&TVI[B"U(%F\W947)$>>YYX.]^R=1J@61K,E^II-OT^O=]WH&CW M?!Q\.(ATCZ7RG$.G).(&,E5'U[&!_`INN^E14HN>XA'WPX M&(,-AU`S'A4LS826D+R075Y1UF3/0N\#S@OKJ5U\7IU:6SB#/&;*><`B(9OAE1NH:@FK# M"&C1"YY9$OZ_ZMMD%E=S5U4I`ZXMLZSU^0"%]]A*:SP6`BM$&&T.."Y=KI4Z MPI*B8:W4/E$NDNBZ6*U^PN"8O^/P@,"H8-(8KN/ZC'1046P:KDM[!9=`]R39 MM]FL?D`$E$`C(**]A2V))M=^=4:98A=DELB/SQ=M M*TNRT,#8060%`@P%,'.6<20.:!XJ:IGB7(9E<` MCM"T[?L,Z@O3\JQYWEZKS7;O"`YZE1K`>@*=A,1JU;37(Q[` M*TI%N0S-LF#.RVK=9D+=/&RK0/[Y5:VCH.;5\\W#0_)BQVDFSU2V(*GV*>7*&RBM8`8)R1HUT_LKH%._YGHYK%]QJF0SY]\G\\U#1&:S MC#^J:W7W"3LW?\[VB]FW?/YYQM?=\9EQ3J'7B"I!A5&4<0V$UY@(I*$YZA?M MN"D.M`#[RSIW^DF"%U4P[AWA*Q;->`^.V*Z,2>&1SMX`1*BX#27Q1 M"/JL4^;@A-H*\CX<$)3P+$X,(.\M1BVMW(!$>94D&QOTQ MHKT4KV5(D%CBB`"15"@OXI$6S[?=C-.%Y/P*&F[W);*C#,A"M+N)4[?,N4MU MY,OGW8F[_S]O#]O]CX/YQR%.-+^,FKB`R#MJ+"!42X&82/2/JC/!*`)PS=(_ M55R+,]'K[VL_L)NU>=3R7A2!P?%[0$0P*[25'B(#ZJV1\^RK8L9F6USJO.@1 M^Q)NDFT14%K#9/8RX5;U_,#S@0()3#3_,<1$>6HH\RJNRV#(F(_?WC7O-_T( M?-$_S!J_O- MK+IY^*E;:6HM.9G5/4O]8OFF]>16>K=17CI.Z]\M&/7R_F"$%JF&-1*8,6B= M0);6V$DNKRCM8"!.O2WRO8!4AMUGYJO%;'H_65?W>C)+?0Z^/E;5^C+[R]>X M@FWQ?H1W.H^3F490%ZMM/6V';:7+\"`]E@0SCJ5@6#LL4R8;1292P$9)'`VC M#[-RM5I5G1KC_?Q@H`Y*+RA'$$BA%'<(J?UJXF]`[G7+(_R^^Q7NHD=42ZB1 MNPGN+YOJ3),WSP>I*`1>:N(!$QP*'#':K\NG*X"OARVY`CW(B_-@+&)E3%:/ MZ=2+_W+_V4R?)K/M.;@VD^7R.9Y"VPLWVQ2R+N.#-$H:QQB%!CNCB#-:UNL6 M\1R[-OIDR_VML3$`ND4VG:?)=)8TEZC0I)O#OU9WT3)+376.WU]X=&R`SEO) M'63$:R.<$0B#!DTLK\!/,@R;^D:V")/NMNZ_U9?JKHK\CY/_HUIW(%'+L&`- MQ#Z>Z\A(JZWB2%%2KY(BE^L3.;DU18EVY#TSJ#]82Y`GY1/,H^R>VV_4>/U8 MD*G`"$=P#,->*)W2&^I5&)J=;C_"-M']4N,,$$M0P>ZQOYW\O5MWIVVD950` MQ!.G@(**6^E8W("91!EA>Y)^B=(?IB5XLTU9^@F`%KJ\?S@PBZD4 MUEN"+7#4``D;W8PQEZOYCK`\L%^6G`UE<=NZJTT=E/)2:FX$L`(Q;SBJU74( M(OES0\`CO`2L9^7C#!0+]1CX42W7SY]GD[C:^7VRV'XDOU.[]M$V+-!X7"K' M./)84T:S34JZ_6VQ MN/]K.INU:J['APM46V-S]9H2=^'KBT`"HEN!2![XT MLV>$:TL(559S))'W2(-Z]E3+W)+`T5HY9W,B$[G"*NH?B_G=*5KJR_,!4DFT M99XY9Y`CT`K&ZG6=<6G$:,V9LQG1!XSEE-2CVFE`#AEB4^Z*%X@8B86ES$W$KTU-@UYTGW70QO_^Z7MS]^W$QB])8)6VHXWV@W5X1 ME#>:*O-L)88?]"_YA5YZ%<@D=?'Q?+]6VU_*X7R^7BKU1UV):Q\_[I M``U2G`D1-7$GN>,8@V8GEDY?44I+'X)]FY]V-J`EPX&?)\\I^M0]$/CS@("5 MMTYK#0%C!&&%6=3::I1@]F6@(SRV!J!*+Y@68LMR$R7Q#H)VPAP>$Q!.?2PA M4CZUL[2.8,?K]<%\7]P(_2C#<*876`O2YM/\;O&]NIW\?0)MWH\)1B-H#(@' M-4#:Q#5)TC@=#6*YI]((72W#T>9L6$N&F+]43]5\T^%L.CP@$$0I(SSNH,IZ M%->EB*U7!D1VR'"$GI@!"-,+IL6\=B>=3!^,"!`JZBCF0'-@""'4ZWH#A1+9 MW+9_(PPQ#\"7?D"]C)U]DGT=1-39.9762JV9$\*Y.B<',N6R&Q6/,.P\`$W. MQO,"!U"G8,"'8P)T9)MI`9@%%BLF8!/H8)!2<94FTC!^F+Y`OHSRVXE';<," M4DSQJ*A13;WP3C$J<;-*1W)C2^.VG(:A4H\X%TZ[?`7-23O31T.#E]AA;QR! M%!@@"2.Z]CH3,*6Z$U0%1K@S"/MF6] M0B1A;D;$N*VN8=C4&\I%U.K%_%MR>]OJSU:%^M5C@5D=%3XL##20X4-4^;@6-KJZ65L!>&8%-HQ;QP'Q$FCL&X;[[+X)XS:S!@]?G@AK MF?X\'[:-:*%*RZA@'(6"&:D51YX[PKE0#?U9]C52XA?<5OJ#N4CH.R=%IP4U MF&X@4)1"&;\,C1!AK/9V,L=-;H=2^0L2J3>4RU0@[*6SG?6QTOT#3P>L/<,& M,R4@5Q`9YG&=OLBDU\7:A94HC>U#M.^J#\Z%M-3)M9AWXLC;1X/WUF,)I&!0 M6YG.8UJ?PYP!B4MY!?]'"7(FGB78<;NL)JO-\KD3/]X_'*"CG"B@/(Q;KH'8 M25:;>%&EU[FI-=V=?7+'D'GU+?6F^E]CR-F(%G$2W]]O\UY3Y[+I_:>YF?R8 M1G/C%;O;7,5'!P=':?)@(@:,B9LG$;QQBW-L:>XN,T+7W@`,ZAW?$HSZDBY( MF%?W;K*<;R^"!^.C3TD'=!]@OZ)6N7:\G[=0/E;K=(/IS_.YHMZ\-NT3`A*BHRIKK%)8 M[OHB*\6()D<-AH%4D-EL\5<2A5\L[6+SY_IA,WO?0JU#;6>Y4IOUXV(Y_6]U MWYE?;P<&@90E1%+D!0!&*FLDJE<*;?9M."-,&BS(JS-1OA2?;C;KU7HR3PUX M3B34JY&!.I3N#]588N40,,I:4*_5F.S[^$;I52S,J'R8"P>\,L[!#J.#9H`J MA!1+S4Z1UA[29EMF+CLL-DKWXH#4ZA_JPO0ZX?AK&14@M4H`S:`"7`N/-4:F M7J/,3Y@?I0>Q#)W.A/@B-/JT6FU.H]!N1#!2R]1_&V/G$22*0=1\(E[*7!_0 MZ1[$*Z-/%KS%8_:[N78-VN^>#M1BJ+"FGB-G'"'*<%FO"2.4:\6-,/=P4,J< M#VTI)V$#P^KF(=TOXF>+ORY^=UIV'>9EDL7]M M5KM<_-O%E^IN$8_<[<4Q+]'\VT5']+I<8#?`GPM&48X)#005&O`O#L M:ZM&N)M>E@3O:J.S9=#.I*2>;_D!T9X=VZO,U??%?D M1X\&QWVT5KAAQ$+#!/(8\#A#KU/2,.'%$O1_$9;T)(="VMO3=!6G>""@W:[/ M?3@LB+C!^Y1#3'5J^.@(P*"&2UY53\11L&T`F93L`M)T+=E_)+J:5P^MF=U' M1@8.M;2860Y3VS_.E'+X93^VN6?B"$-ZH^)?OV(I8H2D9OV?OO^83)<)0_,X M67YK=9(>'A`LA,QC9!1A%%KC#46F7IGQ/#?KY'^-2"WWTE].XD^W`,?UQ/_\-(^*Q&;KBSH\I,Y'?88M MQ"TT@X"5B(<)A)BFWD#02.IK"\]:@7*=A".,48[J2QBG>(O45:1PBIY$9%-- M2#QNCEG/AP<$;K`$5G.(D)1`4PV4JU&><9;`N?`&HZ`%EP9)FAJO`A$R]\J3$09? M1\7(X424Y?B)<,PFJ]7T87JWDV2#5;3RZNC4/ZK[PWKKJ:\(7G&JM0(PSEX; M[I5ENEX1@BA7DQUADYA1D&Y@^938&/\Y7U:36^FTRG2?8;N:V6DZ?XEJ> M6HVI(R,#,,Q@K.*2O<34("9%HVQ$F'/=2"<4K15L&C$*.@XCF2*6_--D.DNE M-_&3^3J955^KN\UR"\9ORSC]+V^6TW[Y\NDO"]Y&))A.[G\E)"7*O)P$QK)< M!SOL'H?Y5;DZN+!*T'>K:J2.J!&T'8C'=``!8 MS:[V[1[N^57)V)=,2G`NSB_E)5:VVOW[%2+[YC`=\BJZOR083E**OH?04PDU MUL#6$8AHVXDKNG'\PMD2@\GD,JQ\7UY[$A_?#P^8RZA#*RA1M-<\$9#1.H7/ M48US\W9&>58/08:C?#L;\\LP[=/\*2*Z6+8WZVT=%[P!W!F7EJH-0QY#2AL0 M"1N^\/G:N94/]H4.U:02O&S]Q^Y=[_:"8"%QF'F-E)+0L'A`F$:=X-CFQEE& MV4_Q(C3K`?7+'I?[>UC5_/[]+9M9!VC;"X,TJ5$I,!%OP;4P6A)>(T.HOJ(J MZHL>J#W*(,L;'?_^UM)*CLG#P<(#2NY'?NFLEP6+A(K;O)4(.LBPI9*XQI!" M-O?FU.ZY%M>Q\Q63P,5VP3:%=M1S0$AC-U%?[N:8ZR3: M>7"7H-=YSJ06[IWWXF"5%I8(*QETEGI`.%0U4M!E&[JG:WR#=Y2\L#NOJ)PN MR.ADV*^&+'@^\0]$@1%$L:."0L"H.``X*V$0#..E6\P MEQ;D1J-'Z1&_-$T'$\M%J%EGM5>[QOX)V?UO6CN(GO":P(7T.'62-YI8`N,_ M@6U\9H3EW@`R2C_ZV,C9GUPNPLY/4>SS;]/DCCT6U#DZ-D"4+$Y"L90$<@RY M(TTDBV*8ZT_J;DW]PCP\4QB74#EO'N)/(B3KY\^SR7P=U9%T]\"/M*X3U,R6 MMP1FA4>(>@<%<\4QD7(MPW:[Q#;_N(4\KT=&Z`QVA)L M")6$LJ@D6UN[@CV0V?\_\+D.U,8)^*4BL)30$ M$@5U?L7ACXZQ%S&-&,W]D^F),]2*D$-E88)#"Q4#$#?8V4 M9MG5K:<7&EXJ?%2*PD7E=$%&[]LV#Q<^.O$/!.6]A]8CAP7#27+*UH$W#QW, M]7N.L-ZA9/AH6"D45AR^5#\VR[O'R:I*S3>Z7)-]?'!P2C`HD)186N@=8[RI M7?*2H>�I=7#P8CREPLU[?5\KNM_NSL.7H])CB,.9->`FV= M@11B;5^L0DAS>ZV-,$A^::[U)((2%(L?P_[+N'GH2K$/QP3C#<;06@MK&]^?&24G#0^>"B$ ME%0YZ#CP7D;MN7$FH/B[ZRE6N!"=AA3'0'4+!R#)KULX\++@D*940D8IS_V;NR)K=U8_U?[@_PQ;Y4Y05KXJJ3,XX]21Y1\@S' M5F5&\M'BV/?77X`2.9M6B(0X\GGP-B9(]-W+>7SL?IDN`*U70]LG\"+?#=188KBX'S?5?'X]^K$N$+A:I&T2ZS`_HY/W!D<\,,0S MK@S56&`BE&P7AC0[16.`%23/3/>2:AI^B+VWT'K`#$EC%&6>>.(T247D6R]- MDMS0YMO9-"I%Z*)Z*F*@[^ZJF\7571RI=='KCW$-=#6ICYQ.;M,?:57Z/:Y2 M4UGLXSA]ZJN#YUXC+R0S'E&O%4;N<>V!6>Z%>`,,1_2R4508_S/:WVZ,[48, MH(U".\^TXHQ)K+#%S9T)/J58%SONV;ME+;E9V0'4)>BV>:RH*-)L]C-V_E^C M^YU9[`>U#]:F6XXQ9)H:9[6W#*^+Y[A4$E&5"CA$38RGZ:;CV>+M$:T/J"^' M8M'+,=(H(Z5D&`G(F7.-W)3`W(K11Z_O5Q1SDWZCK&>!3GUU8-P(SI&"TE$N)<:*\P8MP4ANJ'6`Z_#> M*%D0_Q)LW9Z7V=S)$SV*QRKL?YO>IR!84\-Z!U=/>W'P!G$F(&%QW>@4$)89 MW2#%HKO2^]FA8DPM1ZJ#ZY7WH*&LS=(ZL[U:A67GUU4*UZZ=V4E<:$7-_GN\ M^/HD(.M^5+.;\7S[AFGV"X/FQ%#-)=<*,FJ!ALU%`Q%DZ?NOIGJY?"RJF1(V M]=/RV[?[>O(9W3=HOI_<36XK2<.*J9Q@[X1G;G0>Y* M9H"7Y/0RG_<#7U6/+[S:[IT[GNUZO[S3E4_%FE>OOV?GF?/1TN_ZD4*`KSNVR&SZ'%O"L9: M$ET&222`B"ECI5+0$2&C7VN=VKOFZ.T`S-UXL6>U]?A0\!Q!Z[SB4&@??V$) M32.%C_2](#/?EWY?GR')`[>$L:\S0#=(O;YBZNHNVJ`/=13P9CR7Q4+PHCPO6_[D?/KZML8,BD=OX'@Z,`&F>!PD;Q5+^,H=9``)%]L&^` MUKO/Y5ATL\1FF##2XN0DE)PQ1'0L-$A%N:B MJE4.=$89MLK/.6R?7%3^CV44[>YG?8';WZK;+U5_:_,.OAJ$ME8!RJC%R`G" MK`6LP3C5WBMV"/,29[/A*?"<@^3Q@$%SLN!J\@0!-1O/H_AV.8N_KX0^88K* M_U@@W`#I*.,&$B*1,YB+!E'J2+&%_?=J]GEZID%1E)D'CI9B*CVW`[A__GPF M^(F.7.;7@F222FX(EZG`$.8ZE8EKUHC.E5[G_SE,BNOTG.-D^Y&VU^&,SAVO M[CX>J#!.2V>1IA@1B37BO$&<.YM;DW*`)1$&Z'^=38_#<,->G/.\FCR1OR=G M+.^3`2#GX^R=+G[5T!`?%2\;=)&WN>6XWI1+=@ZR'NV9%='O\/VSM8JN[A[% M[]U+V_'-X"CAWE(EG%<@^KZ:H5;AD--?PE<;\/@IK>!S#Z`3QT(KM6%8`R$< MCBRQR%B%5+NL@][EGG,]OK9.[QG$`W2>3M!$D>2\USUN>MM6^/DPG=6J7RQF MX\_+13(.U].4#3&=+*)R8I^^-`>`=^7J=?NE0"&V1"HO@9>:&$:$:2?#J#U; M;(.Q9%Y\K^>HSJNA,[.]/W8?A!407DD.F(76&>`)UZ0-;QB2G8@ZR'V[`?"Y M!YVC)#>P,NSJ(N=BW9%H#R3IX4,-[]=J M$5WN^^<]O/@,"$\%5["^$(!$I3'%H%\I##K'\%ZS_.?^^F%>MXXC(?K<`B/L M4VD]Z(EK<28V]SK!`9X2[HV!!3?3C]/6,**XAVZ&EMI'3].!@D(1`R*$@AC;:/`$:U\,+C%E/A:6ZB[1ORKLY!T)[WPH]7 M[/!=K0T[EH5WP.M#;9(B2)"E$@"CF134V`95@-0%%?1Z@\.EH&;/$75\?[[J M*JM/MYTYP(?;TB*(Z'(S%34?G5U,TH5\-KJZS`C.B/1Z[S9[/_)]K+Y7DV5U MR.W*+Q\-3E"-B>%:*T(MCNM8:AN)/$.YKN0`9]"3=?KJML:3H"Q2E"]:BOFZ MGW^=3F_3PG)7Y'S#XT$[+;FBE$=K9XFE7@K52$4)NR""Y"OT98F]TW$LYM$\ M[>MN=FQZ/'"CN?#&^3AD/,*(J?BQM528H@OR*#IC1P2"1??=XT823ERY,SMOAQ$G(5B$"VM)#W`L@A>24VZU MCIW'/,Z@J7#8NO>09)_9.OX^G=Y/&W2G_SSLRIQ&F2_F:G+K?J1+U`YR,;KD4ZIW-2%`1M,-&XR< MLKGE'@9HC3JG6SG8BRR2J_I(Z%^K234;W4>9U.W#>#).&*4MSK58NY;-![T@ M*..UAPIYHJ.+(!R1LG'KJ#$R-T5C@(YQYX3K!>&L6FWJ(1V._[]:"=.[]U$= MDR_CS_>5FL^K*/.:\AO(FV8W<%0Q^_700UAI+J5(6:\&X M<(JB1B:?G]\TP&R]KM?WIZ-9@B&_QSGU>4?7=#X@*+2W;?#**6*0I]8RK2UA MGNI&7HIE_U4MWVQTJ&ML2W!I=<-:$G_5XR8A+RTIQ^D6Y\GN*WSVMH[C!T=; M3:4!`HOHX3GI53M^*,WETP##21WJ_]6%/EWC7(9;JU[N7[F_>#(X`)5F1AL6 MS:ZDECG>C$!JEDD=GH9^[UVZJ:3N:[NIK/U*;_Z M=C3W(V(4E1N7C[.?[Z,;,#^Z&$&/7PUQK%+'25(@1=AZQF$;1_,XN^SK`!/& MNW;%AJ.58Y^5Z#1??#06P6003KMC(/6?4`\.X8IANCA=QYGZ!GM\NQKDD&NIV;Z M\#"=U'>M?YW>1YW.]6@^OCF8>WO?%)RB47!D,=#6(8-]*CJTQH)@N_>BU2W, M._[:\C=GSOI%N@3KW&@VB>-B_J&:??H:,3P@8+JM27`2`V&,4P(23I'@QK=Q M86M)=LHCN'Q?J2-,S\&8?=9HX_.!`,^<](0*R:V@3C,@&[F4S<[W&V`,]'35 M[N%*#J#G((H=WR\7&T^@[&D1#*00"48LE1)3`QFR32"7&0#ZKXQ\.63)@[0$ M7?Y=C;]\C5U3WZO9Z$OU^_+AOIGNJ/<$XQQ(JP^E@"14$L=( M.P(9P[FU+P=(N?XHDLG%'`6>0 MB_0WZYR0C9S`P@M:K>!M/.H"SR%K]>3?M]&$TGNQ:J6]Z/DZ5DELMJ,`( M:>6T858W`:I%]DMKC/Y>)8]FUX[ID\="M+*&B>AL M"P45I9@P:%I,*"YV.UR!&,YI6GRY8YH/8IFLC7:G8R\?7CT;E*1::"&)(``" MCA@4JI$'$5GL%N?^29&GQM>7.YP$8`E"7*=2=,O9S\,HL>'I@.M"BD)0RJ6@ MCDJG&G2X5-DG;@:X%NV$%*=#6((6ZO:V3D(;W7\8C6_?3\SHVW@QNM]+D)WM M`I9<$RH]QREETGO$56-4N=&75-&G$ZIT"6:9T@R+.'56M\TFQEZV;&X0M`$1 MSX#@R+L[#U&B"B=+6 M$MA(";G)S4$=H%O3[0*H0U"+!N!^BR:T/C1_2-2M?3@PJCSPU`N+/"46*B9: MB4BCCDK1\UM=43]2:+;H^_A-/\QZ917/H)XAYNH@A02*/B4D$E'M.66F M!1`REAMB'.!\6HI:V>#NIL>6LF:'W&R_^3J,EO!;PAX;^-/S%P,6'GKAE*3& M6ND8@X*W(1:074AT@/&JOLDX+$UE,?MYX':T6,ZJ?XWNE]5U.D03-;FNUW4] MO?J6>NA^5+.;\<8:`*>\+DA&@998R#B&I<%>2M&&=9##N5D;`PR.%>%D&344 MNV&.X#C>()/6M9Z'X"[W M+,$`HVU%7<(>=5!\=['N>5,Y,]6Q^WNU^#K=1<-#F@=JH068`ZF%P`9AG&X. M;?$%N4N2PS/^RR;B%N%>#\"?W02N`+T94YQ-)<^SJ^G6Y9.]2CZ_'(4?:Q6@E6?JMGW M\4VUDOEC=3/],JG?4HN_\R!(OY\.6B/H'#5240RD9`8_<<"-+E<%X6*(/C"5 M#66`I(I(=W?537UQZM%>1$=?"%1`1Z)QH0I`;Y$12C?;^H(RD'VGS3"+-0R& M[]VKYGSG(1IFN(Z8Z?N@_!XO7M@C>"\(QX8X"RPQ1P%+=R,>YR8W,#'`J.E7!TSX` M[7OLV70$^G[^IH<@=H+0N#R2'@ODN";`:L1Y-*N:2,?V)D?T)]W[2>SB\I`T M]@U/!VZ@C)337MGH(D=Y"&"-7,"HW&I0;V?H':S8#4/O-#!+N'+/>[DG;?WU MPP$Q:[GEP"!LN-."*M1*Q&SV73\#I4>V/G=R(P/(\M3X??10[4U4W]8D4"(, MX8(ZD%+DI%76BA8HF5W#>?`T.4ZU.UF2C6;6<9E/U60\G?T^751S]([0#]7L M)B47+*OX*-V:FG%HTZ`X9H(2)*B@D&`4U[:\D2#VXX)J%YRNQ&FOV)[*#OA. M@F?=X`>S8UO3P*T2$FG*;;K;P%CNH&LD4-A3?$$;9C M<]-`N3+>2B")1A"#Z)?IUIQ*!',S`P=XK+-'V]$)MJ>R`[^3STP8`@>S8UO3 M``Q4&E`2IUKLH61(1E.XE@!RG'L"?8`'+'MC1T?8GLX.]+P;Z`AV;&X:D.*Q MIQY3;J1UUD&@6F@L?GGK_%L^Y]@C.SK!]E1VD'?@F0E#^&!V;&L:J%&`Q06= ME$82CRW"T7M:2T`8RYU9!GC[4&_LZ`C;4]E!W_%GW2"'SRS;F@9#H-&4DKBN M5PXXQRE1C00"F]P]_`$>#^R-'1UA>SH[$'W>C\.-Q]:V@1O.$#+`:B`D!H1J MA1L9>+[U&.#9O1[YT0VXIQ)DO612D]NCW(Y-S8)&`&,H".<&`X4@\LPW/:

!:(F#ZVW3R):+\D'"XCE_=$TW?]'B`/"ZZ`!$4*X-D*BNF MVN6Y=.:"2H-W&4_O`,IS$&1O/'US@\`%U":AQ&CTH22$$+6S)3275/GU-,7N M84D6FD7.5SV:OKU5D%X]&V2<)SU@T29Z*H'!U(C6,#(I+FC']E2%OCS7="*4 M93;E9N/O434I^;JQG1_'\__LW;G=WBPH`&F$"GC-+-+640Y:O&B/;,5#9..>G9FD\H MMGE`8$3RFNY M)+)<,8E`G>#7G!,"-*N0D1P*?E8M*P.J21ODN[CA?=FF!X&\[8?4Y1?BWR]7 M_ZH6&Q^E/KUQ3GQ=L"XN\,#;**+'P#.KK6DD-=;.J)774%6OBZ,]/J\^5:N, MM&K?%K@U4#OO,'7``0V$DNT!$R4Z-4)I@AOO5V-5*MA)I/HUVEBU59?5]O9F MM_[R8;'=U5_4&.*/U6YW:^\D!PQ::R^OP8C0L^H!%K6 MY:T$V,E$NBLCM%O??\'ZR\,OVQYRR\WMI@;.+[=7BYN:\MW<&OCJ0"RJ2[92 MZ#S'<4(ABN2]?>:I-]J3W+R-0;>R^)?PT_]6?8X&]ZNMMLNOAQ3"CL.!EP<$ M#*0E$"M.XZH/@;!,M=L:9DWJL<#D(VF&'0MD`?-U:-)Y&'!L2%#:(RNIL,[5 M($D0E_9&.J>3BSA-T"4?JMY.MB0A6N8`Z?"-U6>UO?OL^SG3>19PQNA@@=(2 M>2"(`%!!)1QKP\NTLS/*\ANN]F='2;GA+9]A\NZ,$OY'1@3N#?'Q?Q@Q8+3B M^W+V3?Q(G(ESC>O+F8:4BF:IF]-/=S<]9^1HOO1XT$[YB!2/;-=U'1MM-&WW M"E#.R+P,UNL+%Z<#X2Q-DC/)$:)!9!8@RQQE6&."D;!M.H1/;E;5FQ0_JLWO MZP+7I>EJ/,&)GBB67UH>G4O5C2L^WP69+;Z>GP]]ZB4!*H,IY(IR+P4##F/> MWA030%,OW2=XZI.51:,A7-K>^,5RTU54[\7G@W'_NRH"< M40/.,9>E5#S+VR*_N*K4M_7MJJO(Q$M#`G0:0F\@W:YWD M<5]>MF2"-.D,^8F9VVYO%ZNKZL-F&3]B>V_C+KY\6!RU(FDO"A8B3[6'C-3' MDDC%74*[-&,+4X]F)G^*ETZ8(D"7L3L'_?CEJO[XNO;WMJ[%=3C)_G5SNJO/ M&:,#\U!K(;2V%!A`-2"P/:[`/KDC\.2WW3FL46YTRZ]DE]7GZMN^B\%^7B2X MU$??$)S51D)K!452>T`AI.V1AO`F]4!G\JEXN=>Y7`AG6/8NJ^^WFZOKQ?9@ M1NUM]6EMKA>KK]7?5^90'_"):=TL5U?+[XN;H^[2"+\E,&Z9]]!Q:(0U=,/?_L@WN+]^E!;^Z@=[A@1 MD'.>&0]Q=(FMMW$JLU8F+$"J39U\#F0ZT_(B6CC!(++_LKJJXA\_7ZSV<^"\ M#(/GXX*6,N[(&U>?Q=?VE.^;E+U?%<0%&)@XJQRG`A+B=#WZ<2*V>2+H+_`]>#88#\@WYCE MAY\<]+VQ^L/",B&,\U9K;43\ER%Q>CML/0.2@4Y#6>+`(*7^L'#&B6B/",84 M>U=W152-7,#)U'#JB4[+(8H]H_YP/S#+GRCUKS_,M""68H2C+;'26`FC_WR0 M2$$PI\C#0?KLKC_<#\CRU!A6?UAXZ;2NFPHBJHWBF'/92(<,AG.E23_5GEM_ MN!^:);@2-]/?ZCZZ=?^G[]7QM(N3SP?D!?8$2.&I4B9NN[UU+5`H^>AO\BQ) M4>TZ/Z!%B!)UL*QO?Y.MFM58.<-2B\!- M/EICV'HS&,CRU.A<:UYZ/`B$F<""*T`EM=)+Z7@C%39B1KGM0U1ZDAU)2);@ MQV7U8WWSHTX%>_2]G6O-R7$AFELKJ>&0`V^L8T^-#TF3T4@G_^6 MX"C06ED)+")`*U`GUS<8<&]3BSM-WM,=SJ;Q4'XMIOWWXL_EM]MO>KW9K/^H M%]W%]_B3W<^>5#OVFA!WF5X[1I3GFE"-#),M"AHDIV9-?DT;AVN98$X*^;K[ MW>]O:S_LXLNGY;>J;F;\?;'Z^;?%]G+Y]7KW:=TTJGW\V4(0WWG:BUM?71T.O$+7R\NJX^W]Y$0CRFV?:<+N;=@X./ M>TJ(M`#`,BH%U!Z81FK"P8QJ6`Y5^],:W;FQ'7>*/J\:O%6KSW<56M15_%%< MKUYM!I_Y=3VG>?);`[&<<26\0J[.2_$$";+7G*(&:-IY>S(9G,ZQ$D->&[A` M/"YO/!+:0\^1T0C>(64!$+.J95*`3V>4=A])-9,P/W02:551+ M`:T?M14I:)?8>.:J!VJ5QM&B.D`%=`I)K5&+D*9J5C%TB3H]KQ9H/R!?AR(# M:H%2%K?'$GC#B$%,&\[MG72"1+GG0Y.AZCV[%F@O1,M$,XQ="Q1C0Y0`.F[: M@(((1LEI(S/S:$8;Y.%J3Z@%V@_>$I1ZOX[.9O/AG11ZX>D@>.WB`P&Y0@AI MZHPEC4Q*Z1D5TLI.F>%PEJ#(HPSKN^KLO9H0/1X4!&#*&F*Q]!3&'6)=`JJ1 MT(GDU*()WCIG)TPV5,MF)N?KF4A`Z:54B$^JSCP/,YP1C@+ MI[-GZY<'X\[2(Q/G'#?(6BR\;F>;(V9&G3GS*+M/O[Q^V)9@D%]OJFANW9]7 M^\(W=ZV2.A>L4\."5%@+`0R+P$$;)YXSJI%24CJK=,<C>.Z<1:.2(.*5R9-)+4P:.C`?Q&%0IU6R1:\JU4U8[ M[`G%B"'B&TFMU3,P.*/H/4?GQ7[0CT^RL3HO4B.(M='".HZ4IY8PV()**$K- M@)J0O9H6Q5*1+^$S?:HC2F\W/]^MK_ZWTU-Z_G#0R!"`.`+:2L>$C<"4+JD42 MZO8UE:\ZD_T?/!8,IHHY![UA$AI+ZBBR1@JAYI60DN=X9P!\YY.@J6%Y=??+ M:A*@]K]J`J`'!&C^/JB;F[O/J^_^CQWAG'H\8.&BTU67I)6$:T\!4:)=EIF= M41!%FB+7V3$8&5 ME(`2"[C3&MY_,=4\M3;"A)S]<;3='[O1M?V/#_\ZI>WXXZ")I008!QQCRB-- M%<&N(&6SEBF/%<,4.XE`HU$M251M[^QK7`RI(%VZ'L(+^`1R1%^&QV M'!L:$+24:QGWY0XZJC6UII5`HN0>19,O[I.1'9FP+;&_O?A>K2[VK5N;6_OM M_VR6NUVUJF_O.XY!N@<'5C>%D,39*)^#0%&*6HFC]9Q5@;(\QR+907U]&G4> MF9PS/#@&E%;613&MQ(8;T`:M2<;UC"H/YZ1`+W8E(5V"7Q]N=X>O[HS#>O)D M,`3Z"`E07FMEN*`&F-;D,C>CUEYY5;O."6N1"*S%S4;UJX>/!>4=BLZ4HYA)1""U%C=%,)1C.C4.G$^/ M$+G6DP'PE21!Y_KQ^,&@$&&,<@8TU%379\X`MX;3R=1N*!.T#&D*/,*")/1* M^1.="\3]0T$[C0A@*EI!X#'"0-(F!DXQR&:0!SM4=2]X#$G8%?$2KM>;[M)! M#YX*R-OZ^XUDD&`M*<"JE8%+E;H03'`;FDG_Z>"5B1UK5KMW9[7B>_9T`-%Y M!IYH!JSW$&-EVC#)Z&+#U"-/,3U"Y"\`E(IB$=-P^^W;8O.SKB__4C'9[M+# MY[T@8!U74B>GUJ5,<`M0:N[%C:756U4EW%I MW*?D[Z(D=S5IFK2[>\&V\`3+DMX7'.&B[C<'""-QZDIG9&N(ZY":^9`N-U'6 MY>'OGTBQ7,5?LSN0\O#GIW0\_.V#*1FW[%&7BYM#IYL7"-5(_JLWB:_5L&IRR7&>,#L8I![#QQ`,/ MA;1&N';;:9A)S;:>(*ER+H[YD2W+I@>SZ=UZN[VLKM9?5\O_5)__OKK875>; MN@/AIKJN5MO]PU?K;Y7[\J6JJ_I7'^)N(RK[+-YE^#U!`,F<5QI0QXF.VQIH M;3LK/4]-&)EDD.\8#"VO@U?C27WI4D\!$THIHY><&J$X:2O;W.N=\,Q+<&=ANKNS^_17SS%EB=/!@R\ MB$(P)1C@QLDZFZ.1Q6N?&N\QZ4/\X?P8AN(#1KQZQ\,G.3]_V9:'`CHNK'/, M6QF=#&*8)H8:S#3T<89W)B6.@Y-?+#?_7-SN;' M!.\4LU-F.)RO=?DRM,V?C\2/VUED7=T$G'I@J6VD%)C,*+IA@OY11LT4/L+, MUC&0642!8-)CS@B'F$?#W$AIO)B1?YY'V7TZ!O;#M@2#QN@8&`V^]5QA&X'S M5C`;[7]KIR4JEO!8]M)WB+K[]`SLAV[)P_"AW7$\A](3RJ#'TD`,#9&M9,#B MU#IEO5>^-\N;++B68,S0GEL<*(R5U2(NY=$L"P)7E4X-HX M:3335'*I)-#$TT9&P'SJX>,$':6QZ),%V%<@3V\3=&)HT!A(!**K*`4G!%O$ M43M5D)Y3Q?'Q:304W;+GT-MV`_*N5Y6#%\8%@+CFE@L$#5)&>`A!*Z=F-M48 M39!%$]RUY51-X0S1O=U],&W4KI7@?;73/Q\":VX6V^WRR_)NQ](GYC'#[PE8 M8>:,DMQ1`YC$1AO2XA@G^'R<_4Q\.IY_6EP;95G="O,P&7PO]%ED/3X\*%$W ML#!<&<\U!!QQC]OEQ"4W'I\T!XNRY2AGLRFE=/VB`VP_V^__=;/>;L\GXZD7 M!,M0G2NND:C#@(RJJYHWDCLG9M7I:EITS*B6"=C&5IIT^]B^(EA(F9%6PKC_ M![2^>#6HW?L[EEIZ:X+[XJF1,JMB7L$1?3R7^I'RU`L"U49%B24C6#'"E;*J MA18:GIH"/<'=T=0HF5$M4\I,>Q)B^Y?-3'-:*"FP12YN/:1$AI"[>C4`QRUS M9Z!W09R:@@_M]O^RNMD397N]_*Y_'HJ8[%.QZ\=?.D1X'/G6E:E6[B,"KZN` M2NT($F2[G9;8UT]&M9;9!$`,"YR[],;(`,O5>^YF6W-$!U'9IOQ'L8QQN-_P!BI1#14*YFM MQ2.*.+E<[1F9;<*.6!`(`"K3T7E6-$A!4CBH.[`=N\%QWV:+OO]_1SFBO:3J5B<.YU+E_0:!80()AP9K M[8"@6`!=^\P,P!$=L+?/E58@O=7*%,H2!JF"%@&O(.:*Z]I+`9;F!JL-T(:_ M49LJ4U.W6JE",6=`Q$QB)I5C'$!6>S_8BQ$M>NTHNTFEBF;8'F=0.IG>\")5 M:=VP(OT2=F4-XHA9K#;[9J^2US<7B,SC0/N_8K+PL9L'%[Q+7A]H[YK=9!\5`X9(V6T$@!#8C>3#TPBX/#O"@HQMN7(IHGS[W M[F*HLUWN%\\'ZDFTZS"E"CC%J17(FV??,+NV_P`][FZ8T@:JO7A3Y7)ZAH6\ M_U@02EH-@:7"8JV(L?J9\R8Z`WWY4?\QB2_33)_\.FGTOGPP2.*-M1(+I`V! M\?\4R4H2XHD?CQ63I\`#+,A"KQ<[]D>Y.!TNN_=4B'(+`C#BP#.7*IY06 M7#S8Y:D3G?5K!UB"ZEB7^\T5AA#+&G ML#8MA1U3A&+;)#AX@#W$WJC M\-6T,P3.[^J3%`\^*D#=WZ^?UK.4%/;9?(@.==D%[W,_&3@F0&GOT^TA2`*- MJ*I/SZ'"N6;&`'=(KLS]GC0T!/[7PWPKU(=Y\4HL-7]03^5ZOG)_W<_6#UM, M:MGGQ7+YK5BFP+.6%H,V^A&(,%Q0[J50@/)H/2)9)0XP`4AO41G]GKM?=YVX M@N)Z#$K<5J2__[F?J%)4,'PK=;$_;=A-Q.6GXJ\51/]3SE<_COF8[7P@(&NH M]5@JR3B.ZRZ&S\AIJG/+4-S:%NGEA+^*/OI@M[8EN(.^3P((ZRH,)E5WYEO^RM.U?*54F2-TE MF0.*?@'4WH&(E;0*,L53LK=K&JY&XFY9UC;/&^IKC]_7*\*[.7A:ONS8 M+UN"5SD'A"0"@X#2J<^?`0*L1/[F'TC5.Y]?)W9XG0FLDH-QSP[WD3IF4 M5Q)_P1@Z+.W8#[_:UOK!^2('[5NMQN`T%XAIS!%V@`ML',912NZU(4+;$<4, M9>NW2:LD$(@U#QD6L!([."S(I:&8KI;+2YMYC,6C27*+L)B43FF%[ MJTGM4$`>W18+L"$*4:0`1YQ2Q`03BFI`C4@K MON;1OW0NU]89=/1!BZ1I!=6K1PST6#W6(ZH%)I!+AKB+4Z_W"6BF",$:F=P# MI$%/4NW;UJT#W0<%VRWQZC!7S#DC/!)<:XQQND,^R4?C2H_&[OBW2("S2[PV M@[P/2K53XE5IYS&'7C("M+<44>*37`90B)0?T57!+>CVK!*OS1#M=_W[V"A# MY/EL"1&#HJ=@A%4**08HT6`[?R,&H!]1)FO[*U,\E-C2*`-G>M';3]WR:'>U=!OT1^U];] M,#\F75TXO!F76_E24$(K:HF0TB%FXM1`B*NPA`KGQN<.VBAHD\[7T,(`&%UY M;P;Q((GP4]'4542[U\7VPU?W@SUC_NLLHS;)4K]B]@2Y7EQ!NA%(:&.8U` MI3>!G1YCUD:;X^=V=-=I@%MYOY$N=M[-5]/5SP_SC3SI10VCV0[<$W#L"T?B MT,YN&RA`6@(E.90VW:=G>;KR!R)NL8^`GMRD/3:)+8O[_WHL__SOAV*ZG;_B M/UY/6_&GL.W=E^)QFCHU7WV:/+T78';HT0"\LTI+*[T`E`FH/+"5#$SC$40# M=:#/LE50SU_9FI'"%,E[FGV(8^>OOQ4_C[+BU;/!<(>]1@89X[DC<7*`O)(` M&SV"$HA]T.(R5-OG125N.AH^0(?]1P(T`'#H&=;,>>XUQL1O^TM`E'P$F\+= MLN`",+M3?C0>=I%`YS8WURNBJQT+2W,5A0`Y`MSRX M!,WV];]-&E_YZ?)^,DOW+1V?&@X]'A1'#F!'+$]^/*!62%'S^(S+])X-HB M9H6U#'+B`?/&P4H>(E5NL*7\M5C2"KA=D67#7!,7P<=R<7P#X\63`6H&=%PL MF8'6<9#V/&W5>^A<;K(`!+\6-RX!M2M*W*U_FTWO_:RW:W?/SED!URX.G@K(F6 ME%=^*,6BN'F@3O M&322"`4@5I& M[G(W+`=D%+:GYK(;4/L>_ZPS-3\5J6TPY!0&J/R/2F\"CG]$\(9O"L8Q+1EV M0"N')/(0*5/AP2'(K7YY2\/X;$J4?4+=1\3FWXOIXX\4-K>]TN33.B7H??[^ MQM\X8\`U?56P2E-'4P*\9D1ZZ002%1K,9UMV`_(2.R->QU@/B7FGIKM&[PF$ M4BV%XX@SA:PP5)EZ!#+F1C39=4>13"[F**"7W-_I;)WBB+\6]^D6IVFQ/*?( MXL%&@1,F(`#628^QC]Z:B])6DSR&N1&A`YS6>J-8:VA?;6+;2%`\O(7FX1_K MY2JYYTVGN--O#$8ILBE))*$!EA`MI*NP<4J/R$%K@R#G3&NM@W[%E?:0+,W7 MVD-O"MXPY+$5D'"I+$%80E9AH8'L+_ZU7$UFXY@*NU5!'W1\;0QO[`(U?]B) MD.':'WA#$`)ZJC$D6D:'2QDK2&U=:XAR$Q4'=+C0F8/1#<17HU=3,@6$#6`6 M:X33_ILW%MEZ%A=$C*C:9NN:/H=)#?&]!F]V\C=@SJY%D,(:Z:CV`EBKK*': MJ-KBT#PWOW.`#D#?W,E#N-_,9S5?31_>F*/[=^"DFW'66_5^_O[F).!$A?MV M/Q2H,0XK0:*EBB)TT@('$4IWN7M*+!%H$Z!:DFQ&OOC+=`&&6C;!Q["!BB(ZI^?BU2O.9F*XJX$LE. MEOT\V"8@3YBAQ&D;Y>'0$<8K^9C`8SK+NEC#IQF3A>D5.'.RKN>[SP>L#(P6 M!'$82T"T`H[C)!=7UCNO1I"YWZ)NC[,E"]%>]O8[N/^%:`.]<1Q:`1!EA%JN MHY3"V>C*,#6"U/Z!+68M:J-?SK5W?8PAV'.)!0/0""&==1+MI-26V=Q4G0'. M5>THN\GU,R#&A=.Q!_/J&[=UB<"C^/4&\Z0AQ@"I"0P9#??*^>RO;X!;K\/9*&\ MDN:.\_Y`<;$+^ZKF#]LRB-CK^8O#$">8C6LQZ+#Q`F-7[D9+X[!R% MX3&]?XJ50U3A#4SUVS+FWSNI+#I+\4?Z\7]C\FRN%N4CXO)DUJO?I2+Z;^+AY/$/N\%@0&/ M)7%>8&`%LA)Z`':2(TT%Z5J^[_N9XN MCIX4'VD5E-%4B6C76>BA8TIH704"(:G'4"-^J"1L3RN],Z_JYRX*S)3+U>O4 MR5,T//**D/##P'MA*13,:,&@KZ47:`2GPC?!R?94E.6BU;LA=XOB:;I^.N18 MO7XN&(NH%1IK(:/?BA6#O`KN01ZKW.HQ0ZMO."#ZM*&'RSAR(H+X\,-QJA4^ MNH$NU?`$WEA"A(R>H(Z>H$/$CZ7NX6#9-F,[_+):K[:JW_??K]6[[ MZ][^[LM[N=[AUHD6`7+B(`.*8!!G2^X`@2+M!@MG)04R=S4;6K7$`1&L78WT M>VAWMYC>%^G$:3LZOJX6T]^W/YYU>'>X>7``1",2.BB!T='AICH.->2-`\PP M*G(##H96E7%`/.Q0/5?8"7FP$&1QW,D)D M0/+/K;2"*%@;M\YE;SP/K43E\-G;F=+ZK&ZS.7F]_>(V3A$%&$WF%/71;'L\$!4^"+(1I41? M3I&#^0Y=0M[IF'_Z8U;^+`H=?_T^7=W-)O/KC/@T8Q?SY99%\SA-KJ:+S05U MS[/T&9-`@[<$9AVPP!-(XC3KF(00D8T2-"=&R).\[RC0+79_V_G-&G57QM[6 M4NRTM'R6YIR)(?>5@7**(-(DI4<;9*F@A.T0HE;K$1QD=\J;UY%T_:BA[]GB MFC7P^I\TI/*0:^$PE5Y#9P7D?EN+$,0_O'$1RT/W3$9XY\7#)HYS^MMZLX,= MP=[AO]C__>/T:9K.0.Z31A_C4K0OSJ%MY[;>'V!*EJ`808*,HY0I[FF%AY=P M1$GAG;"DO+Y.^ME*?%>T='KWI;@O'^?),SJZEWA&^P"AH7&*M)HJ;6STI30$ ME=S*J-ZB5VZ;BUUB?J6U"?TBBY-&A!NOI9%.1V>&$J,X$`@[B)V/YD)+B]/^ MM>W;8?&BDXO%9/ZXZ>)V1R9=`+-SB8J'N\G/S:W3493W#2#],R4MO/_J0X4` M!M"K8+#F4&"@B):(.>H1$!7VBMOL^T!N>_(YFY'EK6HR*T2@9[D.I'9>JRO! M::,E$\!$-DCG/$;U9O.'L?TRQL\3Z;2MO>1H)W` M&'!JE1".6R\T8Q6"B($1;26V1Z:W#MEUM)%EXGPLYX_?BL73AWG:I$AA)M$A M.\BX4TTB:!!9)A@'$@.!4QU95?48*Y*;Q3U`W[YU_K2,;7MLB(_1#$8\-PO4 M`BL=P)0S)Q$E#.@$!4%&$.S,"(XNVU/>239DX]HJ(T@>(W;-@A+,4*&`Y)8R M+B546E=P"$Q'4&BR7T;DX=HJ(]BV"WF\>-$XL#@_`BU,]'^$8HP(P]!&"F*9 M(2K7"AE:8EEO[+@$W3ZLY"_)W3A1V*I^)EB%@-66"RB$!:$,Q?_/WI5MMXUCVS^Z%_/PB#$W M:Z7*64FZZQ&+D9F87;*8UN`N]]=?4#;I(99$09RDU%,*13L./'\N8.0TB`A@0)CBT$1O#M;C($!<4-7$3CAP`G9] M;-*\K?\^[*DFUD&KPF9L&>F8TRO&3[8/3# MG[.YOO^8+=?%K/B153"NGB<:50A_SN;9\CZ1X,=]))CJ#+]2#`!+M(4JKO>D M1B5Z,A<0-QZ4.T?PM5=!C45?DZUN=+G8K-X\)]C#5Z+12QT"-/ZCG$&(4L)] M8_0"GUK+9D)*_IP)G"ZI7O(^'E,]?\O6LYM=,^WJV_/AI*9U'/^E@`1PP.`H M*,&,L`)*VN`31SK;.%Z6SR/8I3J\+HVQ$B0^%-G78EZL[\T\6ZV*;T5^_7NYF&V6E1B. MS(/8VU9@"DODO01(2VY9-(!,@X<0,'6[>FKEG@9FYU#RZ"5*LAH]%2K><%I9'1JW?JI5:2:(*M'$-_$)L"G_"Y?;$:@_^.'@\7< M6,"==UHK9(V23\=UG`"I3M74JE]=%OG3A#<5ZG_*Y]LJ=-O]FYMR'@GS*5]O MEON.K@_6AT"IQTH@*!WBVGMKM6VB*)3AY#2-J574NI`9T94@>W$`L_MRLWX9 MO7L>L3MI5ZU=X\%K+10AG"%LG;;(0T,;*RE:C5``-.2:0&:;J42M/D^^=_<5WR7J40<\ALNUZ_I1M7*ZK'Z(6V$ZB MTR-G>YN//@1"SD/`(:9&0\FC0U$C031-OC'R[YVNL624Q-8ZRF+*Q2J?;8N- M?EEF5:Z1S>YWAM/VOQ4H@4A&@R-^RGD,XHJ.<-UO!TAJ?6'X][Y5Q]!WML`] MU"Y^[,BG/(Z[F&V+Z1R]"["_I:"54PYJ:HA5U8I-1;08'L>G5?+^//S%-YV& M$4>?E9%\L8@+:EP[GZZ/KI(C?58L_YG--[43=?O,D!NT4%+3D78WE[9Y+<@J M"$(0(%Y*PKVTRC]46-5&,":/+H74WTC;5/#<^UY`KLJY8TH0JJ622BONZK%& M-_>"SA)T(_*R/W`G,HW'K,G9QVSVF#AL#)(,1R$0'OUB!ATS@EIAJ3I89;+G MD:K5*M_*HG:JBGQ51Z:JH%25A5`5@5]4*0G+^K]5B>C5KI)FG7\C."$AE-@S M;CD&E"OC&@PY2K[RY]Q6B=94VK5*#"R((4(\>K.*YM'JX:K'5;&G9-B!-X*` MBA*)J(BFC_+6'L@\9C,6OAWL<\X/UM`Z^&Q##GCB+ MB$.*$4@`L:`>+Y3V`@IJ=2;Q%@PZ!=LDGUG=%?/LRTV^S'[DT6>?K=XO9OMK M/>Q^(R`BO?:6*8"]H!K&M1[6_24:IEZS>29<2)1=V0>V25QX-R\WL^A)Y\N/ MT;F^S6;;/F3SPYPX_&;0VA#J51P#<5X93A1N9@E`ATNW3_\D3L_S^@)W3XNT@,*6P6F:=@(8C*)P4]9B]UA=TC'M\FZ=[ M>0S*P;?Z?-`":O%V\!0+H(1%@CI!@3<&X'K,0B>?,IR@WNN4`;O8U1G28[%K MU"+.("2PJ]>^)=1Y#_31?#P=@SI!?77"@!;].A'I@%=K\^']% M-!&7LYO[#_E=/F^O1?%0>UKKUU"BBZHN/8P!.L.Z['XA)+X M]/A6\!8Y4&D%`20QA$4_S-5C5!"E>J-3-N0&YU,:UF/Q"2?Q"3?ER!F&E#KB M&/,08T^`:<:(DHMZ3RAG820 M=KA9YP5+70.GS-GQG=D1)#?D_KDI;[\6BRTEJFLY8]?SJAS/8E5$;KS.@UUM MBZY>?;O:K*N3T:O'%>3[38O-]FX^%'1UZHXHI"A42%N)(JXUDE9<4I'CD1BX M8S]_%/%-415L<3TF^3"EW2`!5A89K*%V4!@A%*!/+B).#8Y/V7T:E>9#2FL( M5C\,XXT01`OF'GPW",L]9@QQJ!PR7$*NFO$:I5*WIR]@$4[D1=FO!`9AW%U6 MS"N3RY?+S]D\_UQ!LH5I']5VOA0$@-``QJJ8AM:,."QJPTUJ0"](T7(0A4UA&4/GUJW$:*2@%:)Z.-2;CCRULC&$($( MI1X/GZ""[8]>?:$]!-O>+R+R^6K]*5OG-E_&SE=G.Q]7^74SACU<:]E"1%=9 M9[WPSFBAH%88U9OODC)^09'+_IC6#]:#N!?E,B^^+QXJ(LSN*]^I0F+;]>/6 MMB-;"KXR-J0%EC-%K8:`ZF;.,9N\`S/!:%%_O.L7\Z1\YH^;Y>RFJF-0=^KJ M1R6AEHKRV":"=PQ8+#P"#B*KO(8>-,@)I-OWQ987+=38_,S)UC>X0['GF*Z>%(MHU$`2A`F-IM"7` M((J,@_6RJP&'%W`ARKCQB%[$,*+UM6HJ575B@NUM+CB$`26$"4@I%`P;J>J0 MI(X+?G(ALM;DE`_D7.3?H_5\_:5WCG;-EG8V69="2#+,GK9%MA__5'R_::LY MCWH_:.>@,\Q!1@R!6C##ZT-S&F&1>B"Z_6KWDE#GR*4^`1\O>O$,K%-"&&\W M$[`RQJIH8Q#"#3;>.UQG<6B*86K&3/LXQOG3;@#ITOTCW*U@T$ MS3S0$`DNMO4@G<0DNC@<(<6K*W=33U.WCTJR2YG`((#A2W5B$LIB`2, M-;:`ASPU'M8^A/'*FN\]DM&S*NP4[F?$FD"IM%=VX1G72A/.>&0-Q<)80;7A MFI`'*1C'J#Q(^D$RMW9%/_ZQ*+^N\N5=M0^^34Z.?RZC).?%0S9;-I]MYML? M/Y7S>?0N_Y,MWZJA.L1G@Q&2"*^D]180J1&+*VF-M+,PN>#JA"-9)Q%N?QK7 MF+(9-'>Q11"PMVG0U[>#ICK:K0I"YAVP-F+MGTC`@+S`J&XO9LL-6+\ M4'SZ\SI;KH>9!>,3ML4)\Z'%/.7ILV.8]=9WJQ-2'7\R`*R5TXQ1I9TRC&C) M:UE[1DEJ0&"24?++FSD=B_<,)\^[K%A\*%=5(;SYYKJZML1ERT5\;,#9M+L/ M`1(?S5]JHC5LK!71Z7>JQI\:GCJ])KD;\,M,K\[D?8;S[7.^7L\?3J\--\&> M?300:Z+Z=QH*1Q1V4"CG:X2=X:GU@":8K_G+S*=T\9[A!/JRS!:KR+/5[WFK M0&/W7PT`"@X!!H1BKC`V$"%98PRI2DVUF>0FT"\SB4Z0\)1GT;1"#MA9Y(V6 M4@L)(`$*:%;C:A!V`V]K/80D*=X^'[&$I!Y[GN!)KB$V9P831-HQF_IRT-^*>;Y:EXO\8W:_M>3T??,K%6',[_+K M';5JTQH*%CKAX^J`'&5Q_<":4%B/SG*9?$'\A&DV'"/*`473.?%^SV[SJV\_ M=6UG8=K3&@S("UBEB!E1E=10V&O>@,K])5SOU3<-VK*M2SDDL:[3&W.4,H`K MH`2CE$AFE="VB[/3KWR0@#%57+FBIK&62<=YX M?-2K7_AL5W?:L%L9C,6O[JY_$)+6"=2?SH MZ]^.PS9)F?5ZY9=4@"I+*=:.04QA5:>^T?V`I68EG0DW$F5YY)5?QV'\DB/G ML][WA.]9V0GG68A7<,CC`FF@9M8+9EU$L<8QVG*IUX-..1`TFDTRIN2&M&2. M*[!J;JH?WR_4;;E9K*^^[7BE"0##%O90SST(0'/!.0:*8LOB.@80KZL/`$`O M,K=]6,YV4KJW;[DF671I0_E]4VF]\LD-7_VG6-]\7)9?'_NNKO^U6:UWY7P, M].5@%((4&`8-<(HR)QVN#\]!'S7^WQYN-_-BFO*O>S:&9]8BRL1 M\1@)C8C45'%G"8B_`MP8C14=^\3:,^`?MG&?QO`EHJ[CY_\\,@=@9SL!2.8U M5,9X#8"Q@D';8.$4[[\`S32V+5M3HL5>?%=@G]DAL:.XV>'G0G3_(<#2V.A` M\.BJ"LUEC2KA(K7VR)159"\4'D\F?:JY=WGY?9G]N"EF4;E%I7R]F<49^JU< MWF[;&D6I?MR>D`O81^Q.]&7?\(XX@1_K*9S] M/"8":@$,Q`X;:;P57%F)HA/#B54&'BS7WW[E-_EBTV^\I&? M+L*[7&1S$]V:\C9.@,I9*Q??/Q15$L36?3N4>'=:P\%:"U%TGY@6$GH$%90- M6O2BKJ@]G3"O9_^0R`]APWZ.8MP:WD\K17;HAOB=[P3)"?80,R"X<0#IZ+`W MXS/67))>&8@(K_G7$?2#4.MA\CWOZ<$,@IWO!$L9XA88@CB7WF%H%'M"#*66 MMYLBM4Z7\=LVR\FHMF?-*I_]S_?R[G]G5:A[>?]`FL?_O.;+XZ_#/SZ_%2IN M_AB`(\X(B;45PG(8+3?AFS6;NTMBP.GR*D^$;X@%PFV6Y8_\X&7#SQ\+L?N, MLVBQTSARB!Q3G#13P),+BE=T1X(.@$Q+?9W/K]8W^=)L2;B-C.S->WW[\:"4 MQ``#%OTS80&UG%M>]Q3@2SH557@B'2'1< M9'5"#$4W>.S8KENLB_7]'\5U_@S]1]*^R5E]_RBMBKV?\^5=, MD"<<`28%`9)ZB(CDJAZ5L?Z"\F1&9L7/FNQ480Q(L>?C/A@HWOE.`(Y%A8^L M5Q$EBH'BJ!D?D_B"CA&=)MZWN7(RH$F1HC@OYL5M<;T_0/3RJ1`!8U8QC+PW MT?ED-(Z[F17\DI17![(IN\(Q2;[_+*ZS_V;[I?O\F8"0E,!%G:RMH)Q:I`FO M^U1=17TY09B.97L"BFDQWJ_+[*]LL3N*_\93P3G#F;."6"D)8(I[YNM^<95< M36Z"$=V.I7L2CHE%4VZS^?UJ_?YV4=X=6J#??#@@JH6*8S)2.(&=HMAH+S&` MS'!L2*I"GF#YS8ZEW06<24+_E))<$T64%@T9,<"I M.W,3O,^\8S&?A&.2?-]'E^,Z^VN_>%\\%&(C1@M-D4"3CSH< M?\'XN4GW%!C3-/)_LUFQ+JZ+@TKY]8/!5F8"$YPI1A@GP@O!XM*"#5/`*9%Z MCI1?O)!/A3))T-N]W7H@^T7]QJ,!.F`])`Y&&T)139VRLAZHLCYU/TI6 M,8:QA]55)IAQZB%C7*.G\"VPJ40Y/G#6^U78(Q`E#>3Q$WI>=>@<$WJ8]H83 MY(!&`DE,@666&B8M8Q;;@PFV_8S0E(M9[.Y#A9I/Q>K/0QDY;[\0"*=88D.M M-4H+P1DALAX=5?*25O(+:*FD\,IHJ M(;$0KAF[4!=4*KL#:96=`SK$2O'3ZJCO=;Z8W=QFRS\/:)5#KP:#,$?1&A:, MBZA]'8>R66(]Y@?KM)U/@*)C'=,QLN/PJ.[P0<5SZ-4`##;62V"H=ZJZG4HP M5(]6>)E:D7F"RU!W@C_(J),P3DOIJ'SX1Z?W0%K'3T\&"@B*71*"&B2EJ4H9 M-2LGA.+_V;O2);=Q)/TN^P"SN(^(_8.SQQ/NML-VS_Q$T!++YHQ*JI54;GN? M?L&2R#JLDDB(E]0='=&N4@D@\>6'S$0BD;BBLA[=B6K5):1#*!$U>R@64%YT MF!I.GLQ_K4D0D!H")->:"RV(H!C4*T`(0*K2N`3CP^F:E5N=R+J%/3&$\R-,MSK:HP2^=0SV!,,D??OO"2".@IQRG=M[[(\M@KE M?9GEPB#::<&M<9CJ6JUR;Z_H3$`GDCX9@$M%=A#V[->*/[WU2;MUHF4@T#@$ MK-#:0Z.$L%K4^`%'KZA`7B<2?\FB3M$=-E>JQB+:948=[2%0KQ&37&*D MF>!4XQ*)2J]+E%K+9H*Y\!T;MGX`'L7(O<_7Y0?9E_S8W3''F@6$)>#>R3+Q M`4C""0"VGD(679&9ZUSNITQ>.LPC[@V/>,=$ESO#7N#R=D2"I,8(6\^5M[NZ MR1PKS"H[K/-MEC`!"$4<1#5@(G_V>AW MU)A0IU,W[B88^^J-J/W!W:>/]V89?\P_9=]'\N3JYS]>:='`F3O2*H#HC#O@ M-?;`8LJ$-&7^1HDME)2/=5?8@3=N,I>/-0N, MQ01]JD[DO>H-VH$FZ)@7IW0_3Q'7C#/DO020:\@EC4;9$2$58%#(4>?IV]7F MPW25Y'\W$N[O]/9(;G4]E%^B\OFV#+*.[[?ETH@WG]_..53YJ>)#[%-L#P[[QS_NU\5F M7LP>"-=B29;:=Y!2284U=@`+%*&B4H,*+ZSIU9F5/A8(P^&?E+CM\RB2;/%P M*=S#OM(L6[1X\2,T[++[`)2$&D3D*:$>*Z@(E142EJ`K.O8Z(&M6HPMJF#R^ M=8E[-Z0^O]-@(/*$`*@\D$PIHY!@%4(07!4"*$9U5(S)X$@@--JK`[S*XH!#D&(PQSL"/P!B?9LUB;0[7C[``F1 M@)&()`2$&B`TP-6X)6=7=`?>>*3K5`1)KJ7=BZ*%)7C-C4SH*@#*''?*:L$D M4-@PYET]POC9Y9-L5#L[D%S&6-3TM)@)S'JE*?/2"%G6EW#&U.K> M`D[C,W)8&0UADO5"=2*N5`UYZ*6NQX/B'R]>KXRW%!Q?/ MD(N7W9A2%B^OM`P4&DNMXHJ:.%ZD'4:U$\.4O:*HT!"$>&7QT@WX0Q"M]D:. M@G6$;\TZ"`@IQQ'4#@DI`&0$P7I61Q_]"CS+$6G7BPRF::<[M<]Q/@+C%2'& M(^@]$#CZ,14B6H+4LY\3\BY'9&7O\AAQL[']%F(P3FGK<%G!UCJ$H.7(US`: MF7H9TP2Y-IX/V`WV0]K=^*YOB^QSL2BV/WY;;3_DL]679?%_^5S=EK5FWMW\ MOES7GQUJ]/MR7D34BL_WVWSNLO4RXKMY=[.??!_O/V^*>9&MBZ/UK4=XFT"5 MP-Q+H2@6"I;W:IE:QA[9U"CZ!`_5]+%1/GV))46AFK]-'.S[?'V;+:,`7@L^ MI?46%'<*.N/+@^442DRYLK67;MP5W8[8)3.'0WPD_1Q?^MGP]H.J1ME.O9[H M+`!%HY6B@%BF"!">"%OE[PKK66J-X>97-\H=!Y?YERR^WJ>+HN)@N`]3K.3V M;E7.DCB/G@QH=XB]#-<^CJQ)$D;[WH(VNKR.FF/I%;<:`6>J%$`A-32)7)S@ M19-]D+!_Q`?6A[LW_RW?-J#;L6:AW)\%B"!MB>"&0`01JT<9X;Z>4&2O''A= MZ9T+^2C$VB\.EU_*?&:3K=<_;E;K/[+UO*&%/=5+0$A#``G0G+/2H\40UL!2 M@U/O\)D@[;JAPBE^=0;U*'2K/MBI_C84>]XR8*PD`,I0$P?L:`1653$&$:%. MM9(3C'`/0ZNSX!V%2F^6[]>K6;[9?(B2C&_P-6IVFW_+%ZN[V\.KU-2N`J0" M&(N$(]HYX;P%O$H($9JI*ZI(,@S9NL5[%/;%'TS\O=@FV\S#/82X&!?>:>DQ M4]@):9VSM1)/KWXSP7#(,%SK!.:Q*%9]M@^PEXYM_']\H2*@)(PI!1N-\1L)H5)N+.+M3LQ8G&#$9RCRG(3O.`K:\*[G5 M6K5L$)3#"F$E@!*:.*<\HX\.KB6INP[\S\J9%%3/RME_PM9MMOQ2?%[DN]]/ M9>B_VC!H')T!;R1&QD+M/83E/DGE=H+4`P/.E?D2PGO.*?($DAIZ8VBJ_R2OG('#0S\*/Y-H9[J#G&5FF(4.T\:BF3#U^" M/RLCNP=]S/WY:BR_9,4RG8ZMN@Q$`.ZH]MQB[*4#4M6UM@0T./ENFN8["D-O MUO?-S#[Q'T51_K*./1K$3M[V2I`J3E23$"@7013`UZ7(I):B=0<[>9Z[5IIE0+O M>!3Z9;6:_U$L%@_E7I^'F!OL!'36=R"$(V@`U)AJ0`BPOJ[](0U`_9=*N58Z M]B>$/\-)ECAW&:9$1>?&`Z]-!*;VMN18@X4P+ MPP%EQE(*/*FKL$G"I.L]H^=%L'7()6G_I&H)[R@1C">OVS*8\;QET,@RA!6& MQDIGO74:5-L:TN/D(\CMTW2N@$,=`#P!,J4<:3K<0R`>:A&UKK:\O#D34E?7 MLI!22YA(K@GF\_1\=+-#E,<*N.[K0K6,N^Y;!1X7S-)*@)7VU$+B.;#U&#%+ M/5G2^L#2MWS]>37TSN*Y2PNE?=T)-'IL6&`<65-K$<8"B`=!$;` M>J2.V"NJ1S@&GY*!'L\-;Z6@?FX71-3RG`OD@"*H]JJJ8--@])`:>2H,,P:3ED4=!U.H8:DQK2F'CP8D%?)8#^G5F?G M9(;?X>W;(DQ^3>1N;O+9MOCV>#_8ATCV0^7:]G\JJTPM9W%,6<-KM3IZ0F": M.N4$\H@"IJ,JA*Z6"=:G;T6^G'SX/M94XTAA/`:_>/WMDSKG]^5AHF=?;LW> M5KV'*""+M+>">2>,\.5^_QXSY9!-3K^:'G,'9UDCEO),BI_J/@@!5;29R'@65SP.4F-0A9J)'US/JO(2.-ZQN*9"\@_Y7;9= M[WZN"PLVV+D\N^^X\A)Q+6\Q*3-8).%4,/:H%)(/]4ZPYL8ET+M+64V%VX=O M8#FZ27I.MT'@*!GAXU*$6\ZTTZB^N$5%;7!%E3TN@=$=B6DJ9#9?L^67^(7S MCC9T_*1@XZ*;>*604Q8+8YR%IE8,W%U1/9!+H'Q_DDLZR=]HZ3#[W_MB4^Q, MT*(,"E9.U>R@HNZFX^"$C:M[S2PDEAH+B+>U09/(75$-UK%X.XJ@IJ*LXX)J_N_[S;8+PK[L+H`(!"7<4UMNAZAH)DP=_[$*9UA9* M)[LD@1,-D3:B_9M^+V_O; M.FQ]*,CWFA/:I&T0WCB"*%&64,4$0>S1?='WY=1'O'?OZ\6Q3P[5-ZP=1^!6((LEU9X[[D#3F%@1["[KU>^_U3]GEQ++!SHF5@#J"XEJ+6"0^DX@C1Q^6^3Z_2 M/\$=TS[V^KN%=P@J?3I4%EE]+XYY3*^V"=(QS\HU#6!8Q]EBJ:S7-8SSY)I, MTV-/9Y)>]8/M:-SY+;O-[>HV*Y9M&?38,A@H@*9(ERL+PQ"AMCX.I>+X4T]Q M3)!'':Q*\C'K7^/**3*NQTD+;R@_4<8H-=@9L0&\X4;PG MV9*$Z!!\>98`\/1>[)/FZ$3+(.)4L]&"`XP!M50#0ZIJ/!H(=D79I^>+>]4G MM..NR=\6R_S--K\]9K8:M`X,1"@=+L^P`:ZDD!A7Q24T,S;5W9E@)EQ?-JQ[ ME,=E5A*A@D;88V68(`83PC25N"K!Q`GSU]")K)N$VU*`O2Y$$P!NA\)H32YJ-)Z".NAV_Q/J*_.GI"X!P#$E?"@@I'D&!`QSFYQPY0,-B=,4/0M8]@ MP#AR&(+#AR]Z+E]ZG7^-[UU\R]^VO&SO<`]!$`845,!1"8P@0EK@'\>>7&F\ M]3;7I7*P'YR'61X^.W]T4UY"^437ZWR9WQ3;C?L^6]R7EU'N?(C-^WR]C2NC M^,&GE?N>W4:+4W[]0[Z]7R\W'U:+A7_5K@_UZ*"]B@@SB2#3&B!>&K_:^AF0 MFDDRP:(/?7!Z8N(98C*\,L0C''ZE1;#1TW):<`VMB-?^XS=;;7@DX';*L^A#0B.2+4WN=1V=E\R'?W"_*?Y-$+W*<<1V6_S M7MG?JOM@"?768P@1!Q$YR3F1M<@@OZK2WY?&_SXE.3GMOZ^0WI_^?_4!@1DO M"+5"*V2T@(!B"/;(4:M`_W><_64!1I'DY&S`D](N_RJV7^/W2QGL4Z&/7[?6 MZ7,"M!`J*[E"$GMGL.&D$B/50*3.B-1;VOZ:$T.+=,2I49^I?S[`M]G=)G]W MH^[N%L6LW(O<56J('[TM;HOMR?(L/3PM&,4D(((B80T7RE%C7(5I_$MJH:'F M9=W^FB93$.QEA7$\TX@C;Z`'&/NR6K2LH@240Y*:Q]"ZH-LNC..6?]'V#/&, M2+U/7[/MOU;WB_F;V[MLMJWKG[Q>Q^B\#@/W%$&E!6;*0D$\=;+:S*)2J]3S M)A,L_MI'Z'L0T$==54:YY)OMN^63M;#_C_#C[&OWY1733=^^N\YO5^K'4FHW_;+;%3"WG^[I]#S+Y M%*6@XPO]YP@69_8<-/`1'(2Q`0)+0[0EIL(+Z;(*WK6D=7;"FI?G\P=%?Y`R M$/6(RE29U;*,R%2C>]1D>ZN7P-+6O0:H$68`*,BL`L`IQPFK,+(&7=%UP?TR MM&_DAV7G3^E=996,Q[LN$YC9JL<@G,$.60L1H=3I,M465=A`1_K?>+P25O:) M>I(C_63"+++-IK@I9OO8R[F4Z[+[H*D0C/'HA`I1IG-CZ4$]-S%*C=U.<-.O M2_Z-*()AU6.SRQA:Z\CVW88R[F>A=$0!#BF"@`!?H:0Y3CW:>F%AK_,59>_0 M#T+0^]O;;/WCB0.RJV4?UZ:SYH MU4_0CE,ERJ/1B!+I/#,(/LA#&2@!.GG4;D0LFDS_=AT%"2T3T5MTF%/G6`0# MR/\G[]J:V\:1]5_"_?*(Z]94)6-7,K/G$<7(M,.-+'EU\23[ZP\@BXSC6"(% MD90LO\PD#@&CO_[0Z`8:C1H-!T7N4R5GN+TQ$$OF(\)_(N.PK=;TCFR$L%QJ MIJ%2F"M#H.<`:*WC7P5&6+26.AH&"U_-JE7Y(;HX+V7X>UG>KJ=&;$?'#0LZ+V9^/8"'Q3WNX MGVTI.M9\$S0U<9Q,0<21U,AQX5P]?LW0!9S3C*KEEQC2?MI:)^?A5P M#,4H)#2.FS"8KE1`M)6!<.,OZ$&(#+V]IODLW,;0_<=(_OOU?:OV?_DN8*\1 M819A;3%#BF)N&CF\R:ZVGG>E::BA= M;FAT1HPYA8/.RJ=]=!N\5'&H478K&8O(>VP2AJK814<;)Y M58Y@TIAY*MP%%/P>5]7S81601:*_RLG7V7PZO_NQGS`OOPM(.0"%=P@)J>*L MLI+39E8YGWML?3&KX3'D.!+L,9SN#]4DU0B;W:F[1?ET+[75`=_9)GCD/+`P M_D\18Y&P-`:E6_DB7KE7?\XH6>PD9.H;^#&(M:E"]Q*+5FKM:14,=$!ARZ`' M+EI4JKQL9`2`Y^[VG%$FV$G)U1_T1WE!?\SB"CHIE\NZ@'D$8;NX)L)G^$:' M]Q@$ESR::>.QH5XK)IGAC;R*YY90.Z-.VIH$Q1`B!&@M#A,;>L9_.&6-JM*+PETVO++!/3"TUF:SOU]-4%$;=SQ>K MZG]ME=\/[RPX)+SF4@(A$(*44&ELLTH3GYN=<5:E`\^"@/THX,24_+/133`6D9\TC5#B%EU.3&_X>':/-5,;U5T&[8'AR!B/8L2@6+IR;&IT%+^$&C3C$7$D)9PC17ND9A#`*F^EX-00 M$.%0R,(:#8(QEZH"[&8>9O)C[/8';O)@`#@4-62F>T]RAZ MRK0V"-0J-GQ9Q(LRDH,!?PKZ;6*IP\QAEPZ"T)`H#(AW#@$)-5/-1C*%UEW0 MXWK#$**%=;V@?B[F[D@S%R`1P@ENM*4*8:(=8LUJDAY2'6W;9;!@Y*11$P#N3?Q71=/A4UB1*@R^/Y+UBG6FL_;KDEW-GH]I6Y1OMV?6H7&P&@EFK%&`>:8PU\K%Z6(! M5H!J"K(K7YQ13#F:']8_WGE)..M5ND8]FZV+Z0%\:6D6/(E+-[,>1R@(P1`S MB9IUG-#<%Q7@NSJ('P#I,=:K>BG]U.EYX%>^#AHS+HGDWC$,H<9`L\9:"L:S M[^B\J4RMOE:FXP$>DS0=F!*$`P082;U2G%'O)2.\64R9&^TN^EBO[AZEP1UL M.!#$,2CPK%+FUKAM7O%:S2??KAXVCQ"Y[^5B4BWWOEYQ0"_!:R5)]/(MXA@H M@]*.6HT!8/:"RD#W2:'A$#XW0V.XL!`:%]WU5.<0::]JA)CAA1K$ MS!P&X3,"C%FM[82O59RF6%OT)+A$7A,*%;4($86W;P08J)@YN*!C:]WKEV,Z MM+#U_O9!(DH\--8Z3)U1$$2!:GDXTA=PJ7M@/;]>R[I7U,E M@"!Z&\"R6E+EZ045X^Q%W[\E'O0&[2C3\Y1E=ON?I0!;!87'0EE$XW]LM(:6 M`12762.E;NPQ$M(!`&N9!7'#7^^[#%;UAO"HK-I_6^_Y9P%Z"BRR1`MJ+";1.4K>UY,4 MB&1O1YS1W;Q1>'(XE*,2PJP7":)=U=[W?A^\I5SPZ$U+S363F'N0S*<%'@%O MLH\XS^C6W"@4.0+3,;ARO?XRK29_K[:/O37#;BG1OJ]94`1(C@44CA'%"44& M@ZV4$$N9G5IQQLS)T_)\,%!/29V_X@AV5DCMWCAP0QG3PF`'@;>6Q`E72\R5 MS+X_?H8TZD?Q'=F4C7!>):\OB^)[,=M=RO^5KP+E#N@X"`*8Y9Q23'#RL6R, M$5D$XP)JE`ZAI'E?@&8I^FI5_F]:[%?S\V\"4Q9RYB1D2,95EC.!91I3NC$$ MB;V@H5YR(G\9Y'N*ES=ZO4R6KEELCRZ6%9/%FC[]O/GZFY6W5:3 M8K92D\E\O7D`^GH>7;CJ1%/_]V%TF/F[&X7T8AB/O@0D$%`DJ*.(;O0AK4`0 MM=Z2&D;*J\5=,=O>'3'SV3*.^F;SEXV&KFZOGRF]UI\MEY-%M0N MUF+0WQLLUY'O/$9:B$=/W"A'=8.U,[EASAF:F#X(][(,^1FIYJS-TBG33/JV M3EP;&D,>+###&A#'%170,2,85!2ZUD5Y&"DC_291MXN-_K3,(%9+ZP6[H..58]7=QI[CD#T-C^H!MYZPM#4-#"L! M+6+$++?'0.Y:KZ95V.?M`]T:J6SC`.7]#J M5D%Y[PE%V#`*M4,<465J&87&N2=]9[C'/_Q:E@GJ28C3*4=@3ZN`K3*60VT] MA10(BI%I9EN,Y2Y[\3I?4$NK_.TPDH]"^A5.I%S64WNBQ M%*:<>L&YPA@H3*DDA&[U0H!KO]4P=+;,]6+^4"Y6/ZZG21>S&_??=;5Y/+?M MH*IK%R'*ZHF*W+8`>D5YE(L>NP;<:?NO M0^O@D%:6(6J4C.NG(D+`^CR0",`N*$FB?QJ\O/;1.]PGI5BWRT3MK0,U`'AM M*$+$6&,]-U;7,C-S47=*^F1`5W9E(ST&N_0Z`I82CMMV"W_],#"FC#/<>\,W MU9YTNNR]E01ADUU__@UQ)D>O\QY!'8,>C;"M_'CQ97!4>\VQ)EH92U(A])_. M`,4R-W_X#./H(0ER'*IC,.1C$>&9E8L?SR5O95D$#SSTB'C`+K'&*.F<: MK!0?K5#'&$?G0W*G/XS'X-'5ZFNYR"-36]/`.-`F3A;"(3'<(.51,VNL02*3 M48>7]'C3MJAGF,<@E5\O9M73$PPWOOJ>_K1LI=/N1D&(]/:?=Q12:H@GENHZ M[X0XR'/#_#,L_#$DD7H#..MLR\SO']81P$:BM&[O67P`-A4 M32L.V5`C%/74;\=/"8&Y7L\9/14\)$&&07D,0_.IF-VU[?8TWP1HL!!&0<0, MPLH:YF3MYU/'>&L%[[?C&P^^IY,+ZFBD:%UNGGT5!)0@NE\XAH`(1#.H.+"- M#`3FOC1^AE%UAMY>TWP6;J.$1=6LNE_?MP="S[\+$'+'`75(:LBT%(9QU\B! M^`75]RD7[ MI/SZ>UG>KJC0%QZDX4Q;*!7`GI"?",AH2SW#KJUL=R7Y3WJ3**G49E5U;QC+MA18&\F^+:O'O8KJ.:O+5K)A-JF+ZQRP. M>9TX]J2!'_L\VR[M`R%0*L)<=*^,TY9Y@%4MNP'M+\&^G66B#P*\]&0'@'@, M']9&`_485?:XG<@_NA3RV]TH`&\40%YQ(J$V`%E@72TAECHWW>H,%XT!2-0; MKGFI#,7R:[3ZZ7_)'W\LIHFY\288;?`+3I"=63GIMUYU#7+H*S5*5S:2<@=TAA MQ$3C"7`@<[>>SS`I<`!.#83R.'8I(CXKIG\ORSJ!L37PV]DF(.X,B6NU48Q9 M)4&TO[J6#R"6>]+/WP6+^H)UK#M7JY1?G[8I/Y:KK_.;9%B7JVY;!UV:!T>P M-9`P*QUB3FF,$*NE=CS[1H1X%V0:`.$Q>)5>[/VGFD[CP.-T*&9W58P0U')9 MKI8O_]Y*LH/["H0PSS6VF")F,324L";F(#$VSF2,&QKN$].O_J=C:/=K M'\$S`8PR(MUM@\IY+S%ID*8R^WXR>.]\.PKG4;RN^X>B6B13?+6PU?)AOBRF M5[?-\EG2*%#.Z"TYB#*"DGE%C.:'0V)_Q#@?9R2;O8V=^!,@S M;XYMY(SC2@^N5%$E&P7YB$E]%F?F]U^JV>;''3C60Z]!.*]IA%A*+C#5@'+F MFVUFZ[//@"Y[_WY\Y$^;59=VBI^E@1U@_[+[#)@:!J2.H;@!2AIHB,);?)"Q M*#N)Y;)W^\?&?9RTNV49?T\ZP+#E8SF=;S9PW/>')@.X.WM:VP:F'0)&2`"1\S2E6,O&]%KOLFGT/K;Z M^\9W##Y]_AK1TL6RO$EU"Z*]W.CNJGYC\8_-.6J,6M+Q1?NV6D9O`3N27HI5 M'BF#`%84LSH"1_B(ZGWOXV!@>,1'.3(H%K.(RO*Z7&P$ZF[36EH&AS%WRDHF M.&"<>&U0'58CB7RV$_].3@IZ17<,)OU9_O,,A\5\%O\X*9\=;'2GUJ%=!>2H MP91R2;FC7DO%$98($B(\HAAGE[I]'V<$`\-]UAGMFXO?EY'/KN'FFKH'0&N% M<*2`<-N7ESVSLC62[;B7V>$VO5NNJOMT5[&^H_RX!;IU2[.7SH-SB,$X:NE0 MLH8VU7BJD8C<9U* M54Z23;*[CRC&9AQ5R6)6ETQ\?OV"LD@[MB52$&_BG'E(968(BOWA0Z.[T>@& M%1+R:$B\]E?[0'F7M'CJ@3'X)0PH8T`83XZ`79;88H4AXR+Q%GKK& M5*G>S([U+E)^D>UOM\8MX_&D8-O.^C@]-I1G6H`J9Z)7XMR^SS.J9!:")8?3 MKVZQMI[\UYV,.H5XD"#"_<]E\9#GG_/EOD+%JV\_%49H&AL`A2HZ&XQQ;*$U MSBL)*WF1DC,J;=?AW+\,)W2,K-9H''^7/A&P-2%!KBHGD*A:=: M6$)))2\D>$;%\KIGU;#8IV7BR[_\NH[ZN6<'!2\-PQ@0(QDV&!N:=E_Y?#5SI/4JQ;33";HA1D=PCO839U\L_V4/90Q MD&9[Y^T!@6-FM8K.%M+[(*HCP%22,6U3SW^GF470DY'3";1)FN0@T^?B(5N6 M$KV/N]UJDY?E7[+RLLK!JWK#-?$YBP`"AE-#="E-6+K*VW7NB3BVM. M,RU@8#IU`'BRK9.ORV#%P054-]O%KP8?O>7(H#V,5IHWB@GJF?%.\EK#$MH< MJ[ZJ.X%]63V=8IQ67RZ+Q/R<;W?KQEWJC4<#E%R4Q\$<.(X%B436O(X@6#&O M>WI]L.!R4(>P>"OE5EY^:-/T_L7#P7*FJ$1&`D"!9](*[BN)-$VN&C71^W4] MF;H7XSH@4SZMB^_Y9A.G*UN66V!KUAP9&(RACCGN%!4,(*LA$;7EA1E(9M`_ M*B+<*<9#L.EK]CO?M':SWW@Z$">E4\`AKHE2#E#&;"63A2"UQ=I$+[SUQ)O+ M@1V"+/OSN:,@G.#-Z8$!"0T4M\I+I+BTG!(`*DDY]\D4^D>$?GO!>,"-["PB M'9>/(Q8->*J%QXC1Z.TQ6EORQM/DQ.CS@\3%-EM>*8>Z@G>0FQYU4EV=IGKS M?[O%9G]19:,?GOW;/I'N5.+4F:^*^!(J.#06>P*9`5(@<4`#$P)F<,S94;L/F=61$D-&C@)QIPK`M;Y9#+4"-%?:IQ<0G9!0-OF5U M`_58-"K_NLZ;-ZK&L?NT):1P5!K(QI`:05+ M-60DPM7W`X]GU">D)VYTCO%(>_K[%EW23PT+&&C--`1`:F\90U"2ZCP5ER7[ MAF+2KWS]K9BQF9B*^&#'2$DWY1I&!NHAI@82!PSB'"%KF*OW7()G=*FIFRE_ MZPBI,W@3,^HJEWS?"^[SXNY'\]V2$V."DR)^)N.>H3(!4!LF6;VF-$J].S!! M2G0V>V_79+T8VT$.A]8/P$&QZZB9XUB'UJ6$!,>P5DMY2"+WP'`M0FWD"J-2B2A,T MI?OB48?P)FY1SRXNJ+OH&=R?S-IL'A04PF4W9(6A=I!*1X"H8P7"P-14[PE> M<.MID^H.W`NMEC\.$EK;+6^-"C3NIQ&,QUH_PEM.0*4/B<1B1JWO>K9<.D!W M,+?HRVYUNWXX/[GNV+A`&=;$&`T<4=J7W45=Y0L0@'3J?C/!6VQ][3==XCNB M>WV^6QV<@X2QB)DNEP=E'.$J`Y5`E7SWI/V5-?G(G56^O5[F7(SK&)SY4*QN MDJ,RKP<'3#W56A$<-TZ&XL(H83Q(S*%-W@K7*XQ8SI,;-$V/'UU.90MS)QGC8?SKQZEY7NJ[@N;!++/- M9O%]D=\^0732Z3[S78$Y%?T!@I0F2HHR+[ZNS40L:2XDUY5.&N(HH@?6#05\ MDJHZ=.MQOV]^9'%1E(NC%')SDDHM1P9#(?;<&"2-EF55@F>N`_3)S5JO((33 ME;+J'.1ABM(<>@^4#QRV^>.M(_<33P6G%D-Z',UVT`*#7M/85F)QSF*=# M?7,YL!U&_9KU2=.X@(7'$"!O'(B*$$09L*JUH1.I!PM7$.;ISO3I%.+A_*UB M=?$EGJW,'7=[(;F[Z<_Y*`XC^"1[,Y$A(Q M(QBRJD+!8I.:_3VA`%S7=#AZH[ECK`?3_8MJ\DAG6XA5!N+C]6<4H)\A*:Q60.DH/ M(:0$8I(:8YE0<&X(DG6/=)\FR-&N6F<:']VP_>C7?,C;G*:V&1Y,]#R]U(1@ M+SW$T>"SZK&?4-Q8F&HLUC:PY$\]D=JL]7->$X"42&E.';7>$P$DDKY"(G)_ M1K?5NR5&,1CFHZS\M&Y6UZ,`+"9"$4.(T`I0CPQG+"I?BSC%1C673.O;:SDJ M1/M:3*=?$30Q$FE/'")6,$UQ]*4K!+1PR47CKG3AMR;$4;^E4[R',"N/?G"K M&DPM1@<@'*;&24>@TU1A%]VS2F8!DF-8$^18]S1HN\$DPSTJQ5I58&HQ.E!. M&8968$4LY,XS*G0E,XE^VWPHUBD#VK(K&>DAV/4^6]T>O9O_^J%`J#"(H;(, M$13,1Q$DK22P,+D/TC5Q)64^BXX`'>;.?<1EL;IKI,6?#P:)B2X+?EJ"*1,4 M1&_\22VS.52D'((:%X&:E%92_6(4Y.//?<[FZJZ6Z'3=CA9#`V..>6&T1\HA MX#UPT3L\2`"UF5&J6A^TZ`GF0;:6/-OD/XKE[;O[G^OBUSXC9M.\UQP?%;!A M0%#H"/"&.4P\1?5B$!JGY@5,,'FMU\VG,X2'8-&_L@C5*E\_/$>AD44G1@7# M,(V>`XD"DKA(G*085S*JJ&;GD^W6)XNZ0W@(%OG=>K78[M9Y_%J_^%W^K5D5 M'1\4C!':&$X8=X)399TB=:@#,)MZ+6V"Z6Y]]_[B*`M43Q*[X4 MW[=_1UQ.FSW-(X..#F3,<24:]5>H@)<'I56TGV(6O3V73(<2C MAOW>MZA_USPX`&$8M%@!9('G0#EB*W^!F+B.YN.MCQ=73D5[5'[]M2XV2=S: M#PQ,:P`X\%`0'U>39L!6*ID035)]M&L*$"9,>UM&I6`\!)O4S+OZ]_^^-V3)O\*ZKGPB8E_T5N%'4,(N8,>P,PT[CQV'\H:9_?_6JQOMN]('#FI.`46"T$E\`+B&4E?=G: M%3GDTOY5P,%IHWB+*B+#1-)?Q#XA<8ZW&?J3] MG/_*5[O\5%BB>B0X@XPDY?X3]P<'@(#.5!(8*U*K35[A8FT[E44G2`[AFNW# M'V5G^\4IBC][*F@2K08IB-58<`0UM:8&@2"1VHYA@LY^3VQ(!W.@@DC%?5G( MW?TN*W_E.FKQT^0X,B(PYS@'GA!`$%&BO"N/*MFLM3.XM-^*4C"%,)*&:T@ MM1!ZB&B%A:3-9O3U)##U1+)^`1^"?"Y;KQ:KN\VG?/WE1X2RAA:-:4.4P(G`15Y(5443!/09*"J1J^Y^[ M&:4(]$Z6-$B'H,O_YF4_K?Q6_V9HPXXHX4U%`.#%:M-0Y]<_GB"690][5\](SXE_C7M=V>])W!`J?>* M:>0TI-IHYVJ[$$(ZHRZ-_5$DD8LI$S`B$0^:^Y48YU/QV)N")QH`67:=XV5U M6$TAK5>_MW)&G2G&)F-'4S#ZR<.(F01]'3Q8H(B,LRRQXG&FN2%6/Y[N*BU, M<_RM'VF?1H MA9'^8.]3*53?_VY1ML#-#@EV49;EXOM#J2]O;HK=:CN.1CC]22TT0[L7A#@1 M6`B$*#'$"6-@W!PD@@)X&/^/'JG@V!.U3HMQ7OVQ"]X:D):":VR%TC:ZJ,Q* M+A]QDE:;Y".O"6J+KHES5&OT/0E3T!UC9C,,I4*X498H;KVRCF#D.*8`.B*D M5$0(-E(:4VMV-=0M.^L]`3.$N(K&+;&8:XFB74T/6%!IDWN[7J^::$V.8CC8 MAW!\G[Y_N2S^CD;1OD5Z=#_R]:]\TZ*,6;L7!&NL$1XSC#PCCA!KJ:HDI\ZG MWKN_.L(E,^(H[SJ$?7S"-98T:S,\2.JXY`YA(S"AGABGJ\5,G?*S-(*ZH<%9 M+$M">Y`+:=77^F)MB]VW[??=LEJ`C;>QFP<'J*&/`E,-F'?,."2IKR36",^H M6VBW!'AYC:QKI(?FUJ>(5[$/SIW%JI?#`G2<6ZQY>0*DHL?`&-*5E);#&9VU M#L:G"S%.JBERBL]12K/;;(O[?%V:`*=5T05O"RIJ=P87QD\4E9P$ MP>$N&UXGEX:#?FAE]25;YIO/^7:W/E-=O1X8."*0"`4THD(*+8W$IK9:D4Z] M]S;!5,;!%-;%*`]KO)_V;=ZW*%-R]KM"F;VI253@#&J-.:78US!'F&948W1H M'[*?&1BD0N"AAN&[U>F5^KE8+N,J^SM;GTJ&2WA;P`10X!$RCD5<-/,2VUKK M:Y9:46+2SD#G?'E97[#W>1@_U*&S9?F?DF,=A_&!00M)7/-8`(5TM&N!9Y7< M7KO!@AT_\_6BN/VRS=;]]KOLE1MGQ3_29B#)M3C](>9'MK[+;[\6>R.BO$#_ M>`OGF&N1]K8`E7>**,H`PLQ`A7C\QH.LRH.5X#RV[),;=3(^U>, MDCSQ9'5__/[\8S[G^_)LIMAL-_O/_59^[J?L85_PO452Q64O#EY($?RI8(3$0D>7%$-$.22&`5:C8.;$G(1Y>VOFDW`;Y#PG^[VXW]VW MZ/'T[+F@C?4,&N*9-T`*`@!UE1PDO4G&5.?_W-E[U;TI';M!LA;VZJTY]?B/ MYX)A.HK`#`(8>(*9U4Q5?Q(&J?!S_W-9/.3Y MOMS9QY^EC(V;Y=$Q@7M$D60684,M``Q#A6NG19H97 M;3:[_/;=ZM/^=+J/)?#6[P2L(GP6J8@@U-AIX!2O<)1Q+YV1UW>%].]@RB9- M_;)1S?;AW;ZWZ'[;_;C]D:^__LA6CT;=YG_RS?9)]*]E`RZ?+=9EPL/)XYM1 M/BAH+Q@N\WF$UJSLVJVYK&8&6S"C,NC7N)B&G-M)K[K]'Z6PB]7=HZRPC[7T MQL^$,N.`$X@LI%HK:.+\U]NVCYC.Y^+3-:Z0RV=L,-Y_:Q;OVRL%\/OGXK$8 M8#LCJXO?",)[IRT3SE&*-),Z`E?AQ[5,O5XPP3+S8S-^A.E*NHN0OCQO;Q?E MH]GR]4(]G$D=N['0YV\&A`B"T!#HI<(NJ@H-='T"UJ+ZY/54HAZ!XE.;ODE; M-B_"!56+$U^L_XIC3V7*]?63`0/''#)$,J2Q4AIA8I\4BDF]ZLW_LSBF-WNC M9:V^2#+XAZ>MRO]G[TIW&\>U]+O,`]SAO@#SA^M%`WVK&JGJ>]&_!'>L)$8[ M5HWM!%WS]$/:EK+'EJR%4E)`-PS'$LESSD>>G582B22`@@&CJ622&\NDQ2[L M=(X,U*CP(?I01:_R]?WB,G]#>)>[B85/7Z\N\LOB>A7]GON=>T>`TU-86QPO M@Y1XBJV&T@)%*2!(VI*V%$[)7=Z7$+Z9SCHB=8,YR*!%T"%A5KC&LMVD7J`1%?7NPC9X,J#<'O>Y M#!!A&82`8(&)8]P%6[%<)Q;"34?V6N'V:1+4B+9]R%`$3=`98U'YT=RA%[_- M",(H8`P#P(%G-GQ6OEH/;QQR&X^LU.5KT2Y%>TG!#RP*X]RHU=SF]_FR^!$) M<&@_<#PU__C3F80$4LJ5XYP`YR0FIL*:`XW3&Q,,W'8C1>W3N!?/2+X,[[S^ M9S`-U[-EF+N:WRY6BZAS;A?W^6'ZQW>E6N_)N(,6:VBT*]>AI6G:V"O!'2HM??P<+B3AW1U! M<8''%$@A8:"HT2A>;"I(A5%L)F1K-I2F/HH+ZC&A4:SN2[':=^I;Y/-3*@:. M/Y1Y895@QG+"M8ZYBIR4AX@CED[H/K)AF5YTQ)$^MLA#RYYO-WE^JF?LK4>R MV`*7Q@:24FJH%-"2F`JRADY(>4OK&&Z)(4.)V]%S]>V',F>@@E`R2H,Q+C70 ML7G58842PJ:-#A/59N_"O)Y3!M3Q2V/,UU$@K[H"FFA@) M>:410`Z;1CE33%--ZLPS"7_+MUZNPO+-WX_)%&17(B%U+`L6I M`X0"],`(XOJSQ6-MTX<0X4X9-%B^YS-;[Z/G>PHEB#&`04@ET\A2:"72%A!- M+<)'G?%=YWN>V6WBI!S/GHBWT)6V=M M2NNQ*MWX,#`""!\CYP1ZP8T@5);K,!Q-*&=N`-Z_&Q.N1_G/F/!ID2GB!"5> M,"E55'/(;WDGM9K&HZX,\HC*;AT6(M8IE+.7WO5M#X]0:_*\*=P M4ZKW)C6UFH8+SZTPE#).%(40$OR`)0O,A$R&!GQ[IVEX/;KUP?M_+5:G-0U_ M_+M,$^P%#-NH<%9+AS3AHCKW+9Q0(E,C[CUO&GX&[7J1@4:-X['&4#LE*#4J M7B2&$(+5>0JG=*5E*S)P!NV2L,(&;E4+&.;(>H4,@]$[ZSA3>XHY3I!J*FU) MI[(-I:OTSJYD0IUFMKFYR"_SQ7T^CR$M]W>^OEQL(B\>M/^SLU%.&R7C"F)D M`:44`BJA!<"8`PV%QVI"25)]"ER3.&,2XVE1A*6](U*Z(14H<1AT0/[1@V/?3J' M+]:'K^+OWNLWV^]$,N-53$T23EKFM9/<(5ER0B#9-&I3_U;R8K.(Q<"?6!J` MK4D;UX0;E-VI_Y/OKB^B82ZS]>SZWSW1SO;YIUV1V\VDXQCK6-G/^0= M0$Q+@8PO>6%5X]LEI]D"MRF^TF9JT@"K%J4VF[O;/3G4:OZO?'M3S(ME$^&G(,II9JE)+U=(JL%/H\. M5S%;_3*GWT#+K`?T<,$A`C%3Y`6"D"`(@IM?GY*-AJ MA=.C0]7SQ?];9:+[GZ]NC=U!U,F@F)0#&&H0\YIQ:(1@`E+>;Z:#Z$1/AX[X]+'VDG,L#!8>.HY+T5`*HN;)NE,R=LWMC.J M!3XWZK[7ZB*^Y=OMJWNS^7B\OES^_KV3R?OYW<,-A<,A"=58XP M#:UPF`HE445C!!LW>9[FY4%U'7YC8>M@5>;/:E<^>)4Y#+NP8I8AC)E4&C@= MC%_A(?.4`(38,2Q^5IGG&0P$U(8HK@C"SG$DG"EI2"G]O#VHMK!U5F5>CU4) M5YE;8A7UX4`(VA)4).RRHEP'(V!"52H#\/[]*O-:E$_"\!I!E;EQ/!8(611X M1(+J0.+G`U4)UT>/H?'(0=)/3&@>MB-0QD(@&<+-`*22\( MHR7%M!1B0KOFX#9.[^Q*6L`/'LVO=]O-=K::+U;7%\5RZ8MU_&.'*>BO#YAI M"<-6$>AK$11":AZ66U$6Z*9`&*/>VJ(8MIQIW@KO1H:*+W?'+F1L>ZR,2665 M"D8#<\0281UTE<&,1>/"IMI8^+$+A7S;SM;;-!'1DEAVAY)&#&VDAIN;.+N- MO5N'8?_(9^O'-;WOA%A.?SACUA'&M.7`>"8<#79%94P03SZ2A=>/0';&FS%L MP4^KFOZY+C:=J.)OCY912BRT.-A%$IJ8*,$Y.-"4>LF;AO`34DFZ$+!.B]N: M,*8788\D^V6SNSKNI[M;V>8Q/"^]JV+5?EEF*O;%>&;.[1@IQXE1) M$0=)4[_(Z5NSW(OJ*K^.,=+1"FO7E!_#QAM.JZM\L;T+2RYAU^'&^\IH&1=4 MR\G(LV#LV8,XN[^_K%8[Y[I0]Q?&2TC,2`4*!F. MM4#=H"!Z34J:1G)WGL?^*>[ML&8,XCZL9T-Q#+13P"AKJ;(^JFXE/95M?+== M[?C-WK/A5MT(>V)F9"KL'`,\_KWO8;.:5Y4H1?RJ3]2<.H5,5W MFO:)5&?&$N'RV/`V"-./"M3+ET7OZT7EWGDTE6?(=\3)Y-A$%1_ M3QG%%@;&*,60>G#QJ:;E\E/JEY0FYCKG]830-SSD,BYID%EKC--.(X<1\JXR M((2(^K&=O&A133 M#D1W):XM6FI6$JKB"ER4Z@*:4\, M6ZM"ZII-HX!*N<#!T5)K(IFD2C"#K0(>062U)J3R;'IC)I#KE"Y@NN34*##S M2N!U*-34G$J&L6)88P)`O$.$>.5T)33>\>Y#]Q\8-]WR:A3(>26&.]QY4VLJ M&626>BWC7<9.(F&!A+[R\P/ M[>N=GRH>_?*2TI.QTW,]11:;QD2`H&E9'8E#$Y M9H%IBKTI=8]-,_VA3;8F?2?`T:WO(H\M9\+WIECM5G\W6\:V[N@8J/J=389Y M%!7$@D+BD(/2(5_VQ&%8Z-XNF!I+!D1+$M[6+0*]>`!PO? M&ANO>2@+;IB1KOM"UE%Y=Z:#Q7I\'P,6:VO:;Q&GD]MU6I]D!A7A1#(!.(7" M8.4X*7L2,40;9^Q.U"^;)G('$X<$L!BCD20>:-J7H5,&=4 MTV3?"?ICTX1G]SQOE-W;H@FOKJ_7NRKT7\(R%JO-XG)_4#9H!AP0EEK$E8*021-T"U/)!`&D+P?&)]*28G32 M1Y[[W[O%]NW807'W=`H9BX)!O<,>"0ZIY/C!SF#>-O7\)]76 M_1-Y;?!^W,@[U.$/#+X7L\@$9!0(CRRFCEJ/`7>R2EM0=A)]YC_QUQ+[QPW! M%*T^0JPBQDOC,!?4<2%,F6[.,7IT;>G';B4\%0">Q_X6$[%^7ZWSR^)ZM?B_ MI]^;8K.M)KE;T]%[`EL;(%-<86,"N[CQ%!@3S.%R,^+&T*9WJR74)VA`M^*@ MO.KCX'"W/Y;%SSS_EJ_O%Y?YZTM]MISOQ7:V?+GD[1_Y]J(BR3L'16=C9HQ@ MK"3@U`-G1.`GXA5]$71-._^DUIQQ`($LTF3AJ"&RUR;#N7OX*O[NO7!POQ/) M%*!>6L,T5A81+:PEH#IF50\W(7Z"*0&^]IS'_DSU>Y:].99`YKBIVS1@O)@YE(A"F3S#@%M&F<-R&%;&#EE M%#/!K2=."0,AT0YB7"D43C=M`))[IR>"ZYISS)1A MP!"C);1(&@XD4:4]SXE2$[B_XA/6_-UKQY.ZR)9)IRQ8$0A[:%FGG'* MQ6$=5&O>6^?>'G*($A&(HCUV)*$*OWDOU,/*5O-(O"^SV]P6L9M!@0I&/O3.>D5-@C7:Z+:^+''_E*_,AN@RV#B-M_%MN; MG=H=[?F;Q8_OA5MM@]5_]%2N^:8L'"X(!L(BH!@AC`L"?4D+BLF$#MPS9>&8 M9+5*Y^'4Q9.`^A*F5?9^;87QW`$SKK@#3B,K$(\7R3MBJL/#\ M1$J8 MR8T.FHLX[^+JT:&\V187`>_A-`Z8WWW_^VJQ#=_:/##[-IS-K_WYJEB7?JC7 M;)7.QLJH4C@:@`P:Z+BUP@!4TH@PU%3-2M%,20H(J7"T_]R)G56W>3J+#YXY M00FW$EI``4*.&\BU!!)I"XB7AD`U=.;$256F:KF;6/CT]>IY'>F.`-\#EW7X MS5\G)4VT/&;F+0708VP]-X!;[15]H+%$$XJN]"6,;^9+#,NZ7E3D5UQ>CX^, MQSMZU$7V*]YL[F[WW^WVP'IX:&.@S&!J//72*Z*]DT1RJDM*:J#A=-3>P4$P M`+^&DOPG/JM'"U27V\7]8OOS+&FO]_),92"5+^F=._S$=H6\9HC998!!)"34$"ED;,>>U[2DBHRH=M$$Y7W M;AG6S/M]9,I!R0H6X^UL=;G_V_G2W<>PF5/:6L.)"J:U,DX(`TE).4E\T[25 MVO4BDQ/U!+G7J5LBSO>F6`;N;_9%*X,X(UY.XTNQ?:\IT6D/9A020IR6FCCF M'%4(VG#&,DDL\"H(QD#.A%`2D#O]!HTH:"(:/ M.E3&8^RW)0S/3[V.2-TOK@]E6I."M_8(*8ZA8A0:&7OMDD.MJPIJM#UJPG>S MVM]*6.QF_SQQX9W5OO]@IH#QGDIO//)&(*DA@N5JO8-3JBYIB>U%A_3MPQ0+ M.L?MP8JL(4;O/)5)R:0EE!/#/8=!US`"E&L,WT[IIIEN9*@]XO9BR\=Y7N0_ M[M:7-[.8%U5W#U-6M\7=ZN@&?/0%&>0>P:!/(XKX_Y=W+;UMW$#X)Y7O M!]`+.1P"`7K((7>B-83"0&"G4A6D_[ZD5JM(SDHK4=R5+9T,V^2",_,-.2\. M-:5$\J<3@.K2?A(TG@'?4PF0L[$G*X+M@RCN'_MM=LP MCX9,SIF$Z&<8IF(TF<7=AH@8W4;RG<8^)@"+U/PN"52NB88F_+=SXOE M9CD7PF7@"RE2+AED?TQ$E,$*#69GV`5!:_<8]="8N9[1#8%3=KMML&[U\Y]# M1O+E'TF6"8$2D=I2,RZT0A%V?H&KKC?6CPR?-KR^,B.P9\L?:V`R,B.1:`D0 M$`84I]S3J-'TZ]6!UAY'YD&PT8JQ54#HJ"AQ_=>74I,P?'WXV-!$72PO`$B# MBE'PP1F[.R6I]7=P+;.9C%Z;LG*6;@:'JQR]TSLX/GE!/159)RR-@J.CQ.V4 M`BB_@XC=]2)]VX&@`2-G#LV-MKGX96P*41`6L+CP#!!X\/ZGA1W,;,WTIS\V MKI3G\>A;%2=G:12P[Y./8F-@=)(1"'JO:,@$.:V,Y-NNO$X)'VO1\0Z#M&W1 M<3TOJ^R(/5#V^?X_3MRU'YV3K$,CO"`F@P3Y\Y/QC"@TG(GO43EC:"\YX[RQ-Y!^7Y# M>;Y.S^&;I`(_K5;KR]*`W8P$'@")L$&"4CX0FQG8TU8"PY.CY_#1[<]SO.?3 M7O!C:<$J9L^6$NQ6%];+YY>_MP+8K'J_8+F_5GKRL?B+/Y9(WLY!^LSG((1U MED46=HKK?.W;HNR>W+;:8YM>/=>C.YR5J(E6N:"L`HB:2$W%SFH! M7MT(Z_QL]R',/C#"VG'Y8UEO(A+I*/B\;?.\5TOK1)]B4TJ06MO__/SWD/4V MZ7L1-[/=+F/UO-6\-VP<,%4Q+T!`S$<`$LNL]E*C9IOB:1\5YV'T]M8UZ;_: MRSVCGT@L&!]CH#*HD@WG#ICHJ8+H:LW==^2KMQ;O:(*P":SS9IGCS^T`#.CI1B#XY.DQCHILC$DJ:`J_\:+;I4_1\K<'21;&\KV-%JJ.'H#I)RJ MWAB;DA@0!EP#:"M#*!%L@)Y7F)GX\8LWYCB*:ODY6[;JET!'%S_\]O7Y7RAO MNRY7I4=)D2(]A:(+/Y5<$)(3#P(]HF`Q`)1\LN!`17&O[G8WJ@#$66T'-D550)``/;,OU2VS+]4G5X"P`!!"4.```$.0$``.Q= M6W/C-K)^/U7G/_#X97.JUF/+ETEF*I,M699F7,>VO)*3[#YM020D(4,!"@#: M5G[]`4!2X@4D`$D3TZ&J-CLRB6Z@^P.Z&XT+?_S'RR+TGB!EB.!/1YUWIT<> MQ#X)$)Y].OIY?-P=]VYNCO[QTW__UX__H*`TQ.^6L(34>A8E((4^6LZ,U&>0!8(^)HFVZK+D_AEMBBJD0%AQ@'VUS*\ ME&1^/E>E.Q\^?#A1;]=%6:`K*-AV3OYU=SM64!\)Y#U/88\62T*YATN830&; M*-*('<\`6"H,/JG6C#D7?BV!Y* M0LCVU"#%:^<6R0ZQKQ8I7ENUJ*XG5;2G3"+_.D[ICN6CX\[9CLW8#$JW9J1T M>VG&AQ-`?0FW0,[GQ_!E&0(,.*&K@?C;KFDAI3DN_0T3V<8/LHV=][NT4;'& M<":-MWV;LE3[;8B#8E**W1N@-\PV[$^VS.=DW9H1UZ-V(YBE("6?.E M8YT,^N]FY.G$)Q'F=&5MVW1TZ1];&;4\UXA2$0(IMF=.SA)1(_:IK!,"8<,5)/4N?+I<(3TGR2#R4 M/OQCZLA'<.JI>/5CXD7KH]J3)25+2#D2P54FL%<,YA1./QW)F<)Q.D7XCP_" M=R(.3HN4*LB'&,I?"1(_"I48MYM&IARD_?YTQ(2^0Y@*_Z=+%<"IJU2"!&'4 M9*%",'$52I#`L*GR+"ETE4>0,#&;WJ[O20Z/HH2'Q(2OZXM9O^S%,!CR.:0] MLA#,YQ`S]`1OL)A&PUO"V)$GJ7X>W51.ME6[;+FM6Y2V:=/K?CKK"+V4+R&'*!PSV"F3&LQO>B<7YR>[82I]UU2TP%=/1`C MZ(>`,31%L9<>1GPX?L8\&F7O5^6Z]JMA(3[32(]-#W]QKWWP$DQ#NN7LE M/&M[R'GG_/RTLZ/=B2MJ(;2_1X@I?JR+@VLD9UF("Q7:`UG-H3X$.#W3A@`; M=A[`@9=E>$!GK0I78VYD5&^$3\^TKKT&JS:;2Y.RS_8&VYD%;AKG:8.;=W9` M;J,61^=FXE/OT$[/M`ZM%K66.K`>8'/Y7U\HYPF$0ABI\3M`OXI>+#0RAGY$ MD9RG=Y]$KY:/!H2.@9PT6V&Y0P4&]_=>X_YD37]7_^]E*E1P;ZKT-G5ZZTJ/ MIX0>RVH//<`6(#L>Y1>^X^*:]X_S0.ZQ!^D9;0TW22@T0:AJ M27=&H=KQ:(UV!;5AJ>1[7:"89>5M>!T`46IP#.WJF1CRT]_KXK8*>%HM4UJS4^%$CN$!G;4J7+V3D9'![/V@]5`U6+7939F4;>^J MS)S,N&G*K!["2A8>3$,U4Z_!\MR^M@_DJO?2^KVD`=ZF!8=1K@'/,<8Q\3'$.3]HXYS:$=[:8`0^@P]ZZBKX-(!#GB?S+0&0OEJ7A3(C2\'P]O;ZZ[C_UK[ZI[ MV[WO];WQEW[_<7R`)5'K`Z!"LCGD2#1U5XSRS$R`7:HQ90F8]UV.>:O'U5IE M;#B5^<%!2)ZW&5]Z/@;8+@SC;/PH_KGKWPO(A@.OUQU_\0:WPU];/>)RBB[O MH-L5.@U'`XCG;B`.[QY&_2_]^_'-+WWOYE[\W3_`6:G\74VJ$WL3T`8C:P;Z M8'CUR.QEZ-J-UC.GT7H8GUD-CSGQO\Y)&$#*Y#(:7^T(F8:A`;Y+)_C&C\/> M_WT9WE[W1^._>?U__GSS^.^V@7D-)]P2)E74D`/M:'*@DJZ-:G7+GF0I#`F0 MCB9Y*1#-D7,HXC=+TVA<8S!">=7WQ2FU,L8;"EE^]N3^]U)K[E+F7X:[R=@E_ M;U/!`V]0;O]%+K81QP;;,KE92')YAXBDO;E>\6D%91&[R5[KJ4,A3M#2Z+:G7R.Q7$!O>BNTE" M!TE+?4A_L0S)"L(KH>HIX@\AP-9XZ$@-^57=A#OEXR6,/,7I``1VG$37<3`D M"$6471XD6EA:;+NJU6L[!ZYE88:H[%KJ(6KAO':`,,`^`F%^:C(`B/X"P@C> M02!U)Y];8N;"T1"H76B,WYI]::(C:_!4%5ZFC@.@E>IWLY9;,#8$?Q>:$>H* M;WO-JSL>ME9W&\YFJ$NYQZVA/ICI.DB^P."!DB#RN7N*RL3%,./XH'&Z&Y8*MH1IFU-5!B6[N59+9H:`]X/&G9J! M:Z\#M=.ZK=.TY68&L>0H'4!LH6NT4[SM>IPM-S.,I54X%QC;M_1F4+Q35&/' MR[`IZ8,FDK&!L*6Q2[S=^A&\6*.4I3#$)+I[`I/;BQ5]BY7M%FEH"`V63'R6AZ"UOI@#/$-"]BYC4&5T/A,2/*/0]LQ<'0>#KS[5^NJ4G1?S4^%3RO$` MSUJYKM[HNI%P3MU;+KN:K0&981-+=,KGFT6:[E*C`T0KEJ0SK.KK;"#.Z;ZEY MN0?RTQ/#Z57$$(9,FO(KP)#\=QPM%H"NAM,QFF'UV2W,N[[ZSB_"LP<2(H=+ M"G>OQV#.=,=XXTKE1\+2:I5/416K7TG5LD2FTUX?L"T#;GL;_ZS#VFM`[R+7I,"[->.V/X9_L@.U\D/SA?#C7V MVF?27X$(OJ-B#% MGR_-;B1K[V.[2D4[&5,3%X.1U&UFJ$6KI4;O M@9(EI'PESX6H,[Z_1VCIT8V M!K.G^XY`+4[M-7R5JG8R?"8N!L.GNUW<@%=+3=\_(T`YI.%J!%D4RNL8AT)+ MJEWL9PRB`'$86()FQZO>))[I%I+7C+V$LXS@-[R][];<#_CI=.YF+)U8UAO. M,]U*LP.:[36C5B`XF507CO7F]4RW%.V$:DN-[=B?PR`*X0V2IY]4>X1O$YH+ MT72E[@12B0A;1*W9&4SNF<;DIKR]FQOQUYJ_\IJ;&M+42>N6>FQ5[V9Y7;D: MC.^9YKH"1US;:X#5?2=70-#+&^,A9BY9L`KB^G'8T1U\5YR.%2LOR^L`AWOR MJYY'_6#JZ(ZM5X%S:%=NN4QJ8F($J+5<;@6KA2F*MEFT/SAF8F*$JK1.; MH6K?*;E:+5_L`ZH+"Z@NW:&Z.$"5U?+E/J"ZM(#JO3M4EP>HW-=G:EG43Z([ MNCLSJF%JZXQYVX_-.'Y41D3?VEEPALO?O)C/`0+'J+N2WF#'SG01MP:0%D?; M)=6Z6:\J'@QD[;K MWM%855`;,FT=7::MB$0K[-2/)R\L^`B62X2G1#U+GF!,8A'BA_(9#..+O\"$ M<0I\_NF(TP@>*1@E,O_I]OJGG8[4*GF"=#7F8`8?J+R,8\'NX&("Z9&'P0)^ M.K(JB<)0VJ.T&B8`XHA'LE&?*8F6GXY>)C1$'Q&'BR./"Z$^'6&"<;3X&)`% M0/A&O)"R'GEQP26DB`2/JF`0T21#>.(L8=)2G4C%5\V4X?+\?1_X\VX0J$X# M0BT2)?DO+;#\<$>9P!ND^I8C3*O(`/N/J.N4[ M$,"R(%7%OJ%I">!$;UDL19S-*)P!#G-6L2L>JH(/8+6(\RB)J-;%&R=R]6B= M(<+B$,"'HH%B[EX9:X#PB])M&$ M3Z,PW2,EC&$O$A'-`E(U2Y#/2J)N1]U$38B&(D8BZL,K2&>PZ/XK7S?!'RP( MY>@/5;+_(E?7-M93^ZIQYD,K"IF6+I=*'+=.NMK2;T7@!PJ7``5I/`)R\8A> M:A-)XT2O'H*8H^O;VXM?^I\'A=&G>]-$(R+:&:`PDI\N'4,_HDA.D/HO?A@% M,!A0LI"KWU&<,!Y.BY^T$S93N8Y-OIUUDZJRFOAF-6S?500+4+-D30*H- MPJ.,09@1\1I.^)T\"*_^ZDXYI'>$PD?1X0="%_\6G9^M/_2QUM;>V+W&*+*; MR+N(.,1"0M'[6]8PLW[SF2A9]IRYGY-9\?4T)93D)Q6PM6LBE=!B()C+V,Z80 MA%*FSR)`FD@">8=U254[,&I<(G@G-=V*O_:BIB*CIG6FZICW2UJHKT<0H_@_@(QEFEU89-2\:V/XK8;XGB`831(2FW^5EJ'K91#DB%`;R M>*"8M,0';O%L?;-!02JKH@U(U:0W>(E9V@1A12#S\Z*YHICXQ5"0'"WN4@K$ M4Y7QC=/V9+I98WQ&?/Y`R01,4(CXJAO\%B5)\8U*_H2:&K",8"]G*5S:CK1I MEKE.$R/HDQF6_N4F$&71%(%2>@S@X!;%Z$H/Q5BTD,N"4TBI/#C_$I^R*LE8>U$DC-?=2ABN%0[?&J%JRG<1#%%#"G\ M#KL3LT@?A#U16B[CTF6R$)\/.>V+-R#L[(4(RT8^4B0WA+#X.RTB["LY=JN2 MS9W#]TBP6?V22QZBJY#IYU#$KV%F74P)MA;9C68K.`660A9?L-D#F-GV`O5- MT"E*&SZ2#*XCR,D(RMU+:HUP$\UK97;GT0`=Z';(%/NRH5"3N[&NY?<$^S82 MYLHU3LAJ`ZP5INQAC,4:Z%OT;=XLPUH*J25X,^(^`*I"NQ?$#'+F2]H)&/"/ M`1+43#R^:8BHU\I_VPF[+MO`5%Q%RQ]%7,"`'\=V9E0UQ=\@M%DIK/#5$C0A M*"2+A?#'(LX;0;4DT15M?%*SKY(CM2C9.$>3$Y1@M0%F!)>1W"7%M#+6%6J< M>#7]5DDBYUT)3JM;A*&LGA6DK2K31))9FDE;KK//&[6^$W(ZX<;W8I([2*#64>G,"RCU[FJPCJTJB[-@+H1ZR9X*V-VWO(Y:H+NX-`=E-U_$QQKA6^CFI[ M#:1B[-/K9!H]@D\01U"7([4L_=;`C8]NKT9B)EI5L0>N M#="3&/Y"@AM\@WVRD#M#DS-\;"-T79$&&Z9T,TKV.M#,1K3LX\*1QJTH&W<* MSE81\6L07JU4FECV4+G8D>NZ\F)5X7?!9AO+OIF^OGW<61ZY[>2*X"@W>/;, MM>%JZB^6(5E!>@>X/Z]"6[F*M;26JMJ.\RNIJS+':!(RW<&UN1XYG:%WGLK M/[0>S'7TWW07\SX&KL":1+P4T*W'DI/QMV;6<&N605(-"!$`B:?H"3X0+G^` M,);45BWV[)J;L;&7,3^;WX+N%>?SVQIPO9TLK8WMS.7US]$;1/@5\?D-#M`3 M"B+1K[.&8(-TDL0)U&@8RHS[YV[WX1[R>*9AJ:T]5=5P6[2#E$E"Z=NKTCR".*OZ%>Z^ILHHI5.^5N%!E(CJ"T-6I3BMD5&"F; MD-Q-&SZ`&;4RSK`Y+R MR'$/4+H2_?L9T*#D`-W)&[NX4RN2>-A3<5=6'"ME5%&^&3VPXJ5956+K"C99 M2A&.!=F;+^7'T=,L1?;Y+5H@GLOHY#Z+N5;&OOB]5E*Y)F9>^.B/:`$F^6U4 MFN<-W)AZ3?PHV>/5%Y,T>3VH\M;*O1?V5%N6??WHO3^=0KDI#ZY]CUR"DU8' M^RA$<8/ER4.F;D9-]F1>(T%&Y;7AZT&\#T:OO@JR%D)87I1.0$

3Q/GO/TE^F.U*%\FKWG>P/$;W^DK;:3P M"&)H9E*B^E=-2EG&+2PM,:>7[&4>Y66RI&BL>^V_\%BU9%J\G#B[/\9[`;X3V0L!RQ[UV9=(`G[Y_!>6/ANW.IH'!V]9" MJ>]G[JR:E(MU]YFOY*0DFL!O%Q**V0-$,]Q_\=5>,Y49$*ICY:/;5B4;M])8 MW1?BW)?P#)2K2VZXF$(R+N>;XV>PC*_1%$AB>2>(O$*S$$MM3=[$<>$BS&/Q M4P-;4[\]33`GR9OP_8B-9"IT[@J>:L=HU?<7S,7>3BPI;W+MLNX(LBCD9/H` M&)>PI)9K##F/611@W8*N@5U92I$DR#C9M)E,L[(D]QXE)YH&B(GX6`[3LD)V M9]5$'84D\L6(A;3P/9]2=LJJ9`.&N6B.VE^=[K,6/;EZL-L6?CM#OBQ1YN#X MB(3A(+]8YE#^]=/LY<:.X$0,2GG+2KR>(P)-T3MGXJG_57[<,/-")HM1)M6^ M+V9O*"4F#UO(ILDK^KK!DZPD^`)!R.?YL6Y1KA$C/3_34/=SJV5=T=E4OBQ> M,2@"O9%R:_HW9`\8)P%X*>!;>-A`QW0+9R!4'WN$<@M+*:]5\[YY.9OD@ZO+ M9`.X)C-=6Z(!8TWFQ(;3>.?$`/CJOHH[\((6T>**4$J>XVM3Y6WKJW$T^0WZ M_)'T(.5`.A0W,]N^)7@F5RDWFY1%/6>GG8M"/S`6:^)8K6CT MI9ULEV]1MO=QH^TD+!9^*W):2-=DF>X`CJ;BA9J6I78FFP:O*]#D%+>VW?GT M=7V1MP+6*/6(PTF(9B#>KE58T=F&L'DA@JT4N42\*U&3\NXJ*PJ#9*,RQ`%4 MW_<6[AU#M559;O#.7$7=?Y'WV67.@N["H'ESMHQ>5!R4GGY[%-9%W@^U!'CU M!3!US<,C2:4PL('R+:['8 M8QN#]=N>DI.L($1()1.V(X%,:@&M.85&!8_YH(3(]8M4PU;0X$`?+3KKUG(D M9E%01*HCW-%]XR0?0HGQ0"_ZW7X[["Y"C8%GB0U#O0@SAH69 M':VS!#,"/>W+[GX--Z"?3?6.'MS+='SKF/@TI"2`@\^">$I+OP"'-B_<1"0S MB)[!FO.:0*"B:@5AK%NVV@HQ"X)FEU?$)V!A8\54(\"'JW_NRO2VEDG9+,.\ M`L6ZL6&HE6!$P)-XS]?Y@MM5>X0]>7EZF M>JDPN(L7G92.-]OU+!77VHCDBS"$EWAX%X+,1RI=G^C=KNE#,+HV`GU(&0I) M*3'F7A30`$P5((CXDL:$T8B80/N(<>':)=ZA-5:U[VAZR\-9E-(YR$+)6K0Y M)XQI5A\K7H?6@1E5_WKHK5O@(O*%.!.TC<&,8W<`'<(-?I&2'\PSD#2_H>RU MV-N$9,#X#KA<+!\3AIL(*RY+KIX.<'V4"(YEW<]#G)`]J!X+AV^MI54VI'ZN MXM\^9I%\T/!8\5V3K47/:4!KD>1>H5U\5\E>+D*@DR>2+L*-][W;ADO\K\(S MS@)E30+!XB@\'ZGP4^TDBT3L&!T!JR80@AOM=7V>OB%.[8 M45I%"+:00NLCUJPMQ8P:!C$%R^1?!:JQE?%-V3/X409"&L./[LJ8^5&&M%$Q M#$KG'*TEG!U;^8@>J+S[P+OZ(H2$/>(X:`89NG2C5X]54@_\LR+'&'JOTW'Q M9"D:@%D!>0D6X7TBQ',AR0J\?D)CU;;)EI&MH'N&71K!58L8 M50.AD+D4[;+\F'X]1/Q$`P.;^[QZZ2\>W&KV#F,J8C:`<.%Y$H@780M5TRYB2@.8IGME>F3D MYW)28!8\K/VN[+#Z,39H,:,5!SG129@6KB@^0PBQ;6,UE-+31NJ0P0*)A\I- M4$F!RRQ5;S;5;C6<'ITO505:YR,*"O6([K0CB^!Y5?`.=S%`8M(>:%;-X?9W MS,-7S+)%E@)HT,:TD!B%$W03TA#9=3",$AA6Z^7BS\^K^7HN[A'[%R_GX@+! MI5JJ_-24\`D7`$-#VM/O^(@Z+H]I/R!I#+2(^DJ%K_4MOC M9TD,DNMTEKD\E6>=GLI&7M=)+:!SNZLQQH=`0S2DOM(Z!O]FZI(`FAWON']D M_.4+"7:U*7)6%;S;W8K(%VPAPT?M*+);<(\0?[]P1@,OK["?50>=EF)%=AGS MP+S=B^.$GSQV*,URVTZV@ZD1WNK%ID0\D"VB(!!7&<9CH'=X%)]3`27>$Z,' M4PW3^HJXYYWZ%ULAAF.XG6-V>CK9"QQZ5D;#O<+0*)NO46Z2ZP4!W%^$]>=?^7APFP.YYXSBMTMF5B0D@#BGUI'Z<$A44<$.^I_=,2%LE_(LU M-V%II44S%QCI"D\57T<_)>6]+!A0Y:HP[6NT"T/#A]5)@)]$OPX0J&Y[)&'& M("9K+_IIC6%C337!Z_-UR//D#"*=#=V47^MG<+$3%+>=UG1N]@ROAO3<(A'E MR1-/R?'-S<=;_;[_D)&[VSJKBNBL;+D?>:+? M1T1G'VO/24,(,;C*=]S=^ M:3:6S_WB-ID=U+NC.7?$M2O[AU&?Y>!J"6E:&Q845_IMC`GS1K.B_<(_VXF; MR$XLV*^0`#0Z4E^QRM0;_\Q?1*"&G@@7EC#$7E.3:\-3CY6S\%(L[?D-=.^R MKS";P81CL_(S]Q1GQ,T:TMZ@AX[DH,(AW,I,N:H_458\]!T%B1$XDR M(PI/9PF"W6X#[L=9DLNEH(+DRC.Y")&K\QAM>#,L;@EK='7$1OH-4$I"\54: M<=@:RJ?1^E7_O"KHQ,\2^E;<0K0I)PD^>4D$V3(6H>GI3\GQB9_&IT;7P+W;I]?Z.!]\.(XV)\0[!E/_.$!2\T("H-C%AC,D@W6)W+8$'K M^49'#SQ M[_]02P$"'@,4````"`!*@$U$GL?=(W1]`P"Z8#\`$0`8```````!````I($` M````8V5L9RTR,#$S,3(S,2YX;6Q55`4``]LR_5)U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`!*@$U$[$AS@:\H``#M:P(`%0`8```````!````I(&_?0,` M8V5L9RTR,#$S,3(S,5]C86PN>&UL550%``/;,OU2=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`2H!-1%EAI+@_J```;U`(`!4`&````````0```*2!O:8# M`&-E;&`Q0````(`$J`341#]/8:6+8!`#.@%@`5`!@```````$```"D@4M/ M!`!C96QG+3(P,3,Q,C,Q7VQA8BYX;6Q55`4``]LR_5)U>`L``00E#@``!#D! M``!02P$"'@,4````"`!*@$U$NPKAI^[]```DY0P`%0`8```````!````I('R M!08`8V5L9RTR,#$S,3(S,5]P&UL550%``/;,OU2=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`2H!-1-8QX-P0(0``/)@!`!$`&````````0```*2! M+P0'`&-E;&'-D550%``/;,OU2=7@+``$$)0X```0Y`0`` 64$L%!@`````&``8`&@(``(HE!P`````` ` end XML 53 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Fair Value Measurement (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Recurring basis | Fair Value
    
Assets:    
Available-for-sale securities $ 2,452.6 $ 1,809.9
Cash equivalents 20.0 27.0
Interest rate swaps   1.7
Forward currency contracts   17.8
Purchased currency options   2.7
Total assets 2,472.6 1,859.1
Liabilities:    
Forward currency contracts (9.2)  
Contingent value rights (118.1) (277.4)
Interest rate swaps (49.6)  
Written currency options   (5.1)
Other acquisition related contingent consideration (228.5) (198.1)
Total liabilities (405.4) (480.6)
Recurring basis | Quoted Price in Active Markets for Identical Assets (Level 1)
    
Assets:    
Available-for-sale securities 433.1 0.3
Total assets 433.1 0.3
Liabilities:    
Contingent value rights (118.1) (277.4)
Total liabilities (118.1) (277.4)
Recurring basis | Significant Other Observable Inputs (Level 2)
    
Assets:    
Available-for-sale securities 2,019.5 1,809.6
Cash equivalents 20.0 27.0
Interest rate swaps   1.7
Forward currency contracts   17.8
Purchased currency options   2.7
Total assets 2,039.5 1,858.8
Liabilities:    
Forward currency contracts (9.2)  
Interest rate swaps (49.6)  
Written currency options   (5.1)
Total liabilities (58.8) (5.1)
Recurring basis | Significant Unobservable Inputs (Level 3)
    
Liabilities:    
Other acquisition related contingent consideration (228.5) (198.1)
Total liabilities (228.5) (198.1)
Avila Therapeutics, Inc.
    
Fair Value of assets and liabilities    
Estimated maximum potential payments related to contingent consideration 595.0  
Gloucester Pharmaceuticals, Inc.
    
Fair Value of assets and liabilities    
Estimated maximum potential payments related to contingent consideration $ 120.0  

XML 54 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accumulated Other Comprehensive Income (Loss) (Tables)
 12 Months Ended
Dec. 31, 2013
Equity [Abstract]  
Summary of other comprehensive income (loss)
 
 
Pension
Liability
 
Net Unrealized
Gains (Losses) From
Marketable Securities
 
Net Unrealized
Gains (Losses)
From Hedges
 
Foreign
Currency
Translation
Adjustment
 
Total
Accumulated
Other
Comprehensive
Income (Loss)
Balance December 31, 2011
 
$
(5.4
)
 
$
1.8

 
$
8.7

 
$
(67.4
)
 
$
(62.3
)
Period change
 
(4.7
)
 
2.4

 
(24.7
)
 
39.6

 
12.6

Balance December 31, 2012
 
(10.1
)
 
4.2

 
(16.0
)
 
(27.8
)
 
(49.7
)
Period change
 
3.2

 
133.1

 
(20.0
)
 
27.4

 
143.7

Balance December 31, 2013
 
$
(6.9
)
 
$
137.3

 
$
(36.0
)
 
$
(0.4
)
 
$
94.0
Reclassification out of Accumulated Other Comprehensive Income
 
 
 
 
Gains (Losses) Reclassified Out of Accumulated
Other Comprehensive Income
Accumulated Other Comprehensive Income Components
 
Affected Line Item in the Consolidated Statements of Income
 
Years Ended December 31,
 
 
2013
 
2012
 
2011
Gains (losses) from cash-flow hedges:
 
 

 
 

 
 
Foreign exchange contracts
 
Net product sales
 
$
10.7

 
$
80.9

 
$
—

Treasury rate lock agreements
 
Interest (expense)
 
(3.4
)
 
(1.3
)
 
—

 
 
Income tax benefit (expense)
 
6.9

 
(1.9
)
 
(2.9
)
Gains (losses) from available-for-sale marketable securities:
 
 
 
 
 
 
Realized income (loss) on sales of marketable securities
 
Interest and investment income, net
 
(7.3
)
 
(1.1
)
 
4.0

 
 
Income tax benefit
 
2.2

 
0.1

 
0.3

Total reclassification, net of tax
 
 
 
$
9.1

 
$
76.7

 
$
1.4
XML 55 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2013
Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
Schedule II – Valuation and Qualifying Accounts
Year ended December 31,
 
Balance at
Beginning of
Year
 
Additions Charged
to Expense or
Sales
 
Deductions
 
Balance at
End of Year
 
 
(In millions)
2013
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
21.8

 
$
12.3

 
$
6.2

 
$
27.9

Allowance for customer discounts
 
11.2

 
74.3

1 
73.4

 
12.1

Subtotal
 
33.0

 
86.6

 
79.6

 
40.0

Allowance for sales returns
 
13.3

 
9.6

1 
7.4

 
15.5

Total
 
$
46.3

 
$
96.2

 
$
87.0

 
$
55.5

2012
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
10.1

 
$
12.5

 
$
0.8

 
$
21.8

Allowance for customer discounts
 
8.7

 
64.9

1 
62.4

 
11.2

Subtotal
 
18.8

 
77.4

 
63.2

 
33.0

Allowance for sales returns
 
9.0

 
7.5

1 
3.2

 
13.3

Total
 
$
27.8

 
$
84.9

 
$
66.4

 
$
46.3

2011
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
4.8

 
$
6.4

 
$
1.1

 
$
10.1

Allowance for customer discounts
 
8.3

 
56.1

1 
55.7

 
8.7

Subtotal
 
13.1

 
62.5

 
56.8

 
18.8

Allowance for sales returns
 
4.8

 
16.8

1 
12.6

 
9.0

Total
 
$
17.9

 
$
79.3

 
$
69.4

 
$
27.8


1 
Amounts are a reduction from gross sales.
XML 56 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of Business and Basis and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2013
Accounting Policies [Abstract]  
Financial Instruments
Financial Instruments:    Certain financial instruments reflected in the Consolidated Balance Sheets, (e.g., cash, cash equivalents, accounts receivable, certain other assets, accounts payable, short-term borrowings and certain other liabilities) are recorded at cost, which approximates fair value due to their short-term nature. The fair values of financial instruments other than marketable securities are determined through a combination of management estimates and information obtained from third parties using the latest market data. The fair value of available-for-sale marketable securities is determined utilizing the valuation techniques appropriate to the type of security (See Note 4).
Derivative Instruments and Hedges
Derivative Instruments and Hedges:    All derivative instruments are recognized on the balance sheet at their fair value. Changes in the fair value of derivative instruments are recorded each period in current earnings or other comprehensive income (loss), depending on whether a derivative instrument is designated as part of a hedging transaction and, if it is, the type of hedging transaction. For a derivative to qualify as a hedge at inception and throughout the hedged period, we formally document the nature and relationships between the hedging instruments and hedged item. We assess, both at inception and on an on-going basis, whether the derivative instruments that are used in cash flow hedging transactions are highly effective in offsetting the changes in cash flows of hedged items. We assess hedge ineffectiveness on a quarterly basis and record the gain or loss related to the ineffective portion of derivative instruments, if any, to current earnings. If we determine that a forecasted transaction is no longer probable of occurring, we discontinue hedge accounting and any related unrealized gain or loss on the derivative instrument is recognized in current earnings. We use derivative instruments, including those not designated as part of a hedging transaction, to manage our exposure to movements in foreign exchange, on our stock price and interest rates. The use of these derivative instruments modifies the exposure of these risks with the intent to reduce our risk or cost.
Cash, Cash Equivalents and Marketable Securities Available for Sale
Cash, Cash Equivalents and Marketable Securities Available for Sale:    We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency mortgage-backed securities (MBS), non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities. All liquid investments with maturities of three months or less from the date of purchase are classified as cash equivalents and all investments with maturities of greater than three months from date of purchase are classified as marketable securities available for sale. We determine the appropriate classification of our investments in marketable debt and equity securities at the time of purchase. In addition, our equity investments in the publicly traded common stock of companies with whom we have entered into collaboration agreements are also designated as marketable securities available for sale.
Marketable securities available for sale are carried at fair value, held for an unspecified period of time and are intended for use in meeting our ongoing liquidity needs. Unrealized gains and losses on available-for-sale securities, which are deemed to be temporary, are reported as a separate component of stockholders' equity, net of tax. The cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. The amortization, along with realized gains and losses and other-than-temporary impairment charges, is included in interest and investment income, net.
A decline in the market value of any available-for-sale security below its carrying value that is determined to be other-than-temporary would result in a charge to earnings and decrease in the security's carrying value down to its newly established fair value. Factors evaluated to determine if an investment is other-than-temporarily impaired include significant deterioration in earnings performance, credit rating, asset quality or business prospects of the issuer; adverse changes in the general market condition in which the issuer operates; our intent to hold to maturity and an evaluation as to whether it is more likely than not that we will not have to sell before recovery of its cost basis; our expected future cash flows from the security; and issues that raise concerns about the issuer's ability to continue as a going concern.
Concentration of Credit Risk
Concentration of Credit Risk:    Cash, cash equivalents and marketable securities are financial instruments that potentially subject the Company to concentration of credit risk. We invest our excess cash primarily in money market funds, U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency MBS, non-U.S. government, agency and Supranational securities, global corporate debt securities and asset backed securities (See Note 6). We have established guidelines relative to diversification and maturities to maintain safety and liquidity. These guidelines are reviewed periodically and may be modified to take advantage of trends in yields and interest rates.
We sell our products in the United States primarily through wholesale distributors and specialty contracted pharmacies. Therefore, wholesale distributors and large pharmacy chains account for a large portion of our U.S. trade receivables and net product revenues (See Note 19). International sales are primarily made directly to hospitals, clinics and retail chains, many of which in Europe are government owned and have extended their payment terms in recent years given the economic pressure these countries are facing. We continuously monitor the creditworthiness of our customers, including these governments, and have internal policies regarding customer credit limits. We estimate an allowance for doubtful accounts primarily based on the credit worthiness of our customers, historical payment patterns, aging of receivable balances and general economic conditions, including publicly available information on the credit worthiness of countries themselves and provinces or areas within such countries where they are the ultimate customers.
We continue to monitor economic conditions, including the volatility associated with international economies, the sovereign debt crisis in certain European countries and associated impacts on the financial markets and our business. Our current business model in these markets is typically to sell our products directly to principally government owned or controlled hospitals, which in turn directly deliver critical care to patients. Our products are used to treat life-threatening diseases and we believe this business model enables timely delivery and adequate supply of products. Many of the outstanding receivable balances are related to government-funded hospitals and we believe the receivable balances are ultimately collectible. Similarly, we believe that future sales to these customers will continue to be collectible.
The credit and economic conditions within Spain, Italy, Portugal and Greece, as well as increasing sales levels in those countries have resulted in, and may continue to result in, an increase in the average length of time it takes to collect accounts receivable. Our total net receivables in Spain, Italy and Portugal are composed almost entirely of amounts receivable from government-owned or controlled hospitals and the public sector and amounted to $348.4 million at December 31, 2013, compared to $324.2 million at December 31, 2012. Approximately $86.4 million of the $348.4 million receivable at December 31, 2013 was greater than one year past due. Our exposure to the sovereign debt crisis in Greece is limited, as we do not have a material amount of receivables in Greece. We maintain timely and direct communication with hospital customers in Spain, Italy and Portugal regarding both the current and past due receivable balances. We continue to receive payments from these countries, and closely monitor the plans for payment at the regional government level. Payments from customers in these countries are not received on regular intervals and several months could elapse between significant payments. We also regularly request and receive positive confirmation of the validity of our receivables from most of the regional governmental authorities.
In determining the appropriate allowance for doubtful accounts for Spain, Italy and Portugal, we considered that the balance of past due receivables is related to sales made to government-owned or supported customers. We regularly monitor developments in Europe to assess whether the level of risk of default for any customers has increased and note the ongoing efforts by the European Union, European Monetary Union and International Monetary Fund to support countries with large public deficits and outstanding debt balances. We also monitor the efforts of individual countries to support their regions with large public deficits and outstanding debt balances. We have not experienced significant losses or write-offs with respect to the collection of our accounts receivable in these countries as a result of their economic difficulties and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse impact on our financial position or results of operations.
Inventory
Inventory:    Inventories are recorded at the lower of cost or market, with cost determined on a first-in, first-out basis. We periodically review the composition of inventory in order to identify obsolete, slow-moving or otherwise non-saleable items. If non-saleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized. Included in inventory are raw materials used in the production of preclinical and clinical products, which are charged to research and development expense when consumed.
Property, Plant and Equipment
Property, Plant and Equipment:    Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation of plant and equipment is recorded using the straight-line method. Building improvements are depreciated over the remaining useful life of the building. Leasehold improvements are depreciated over the lesser of the economic useful life of the asset or the remaining term of the lease, including anticipated renewal options. The estimated useful lives of capitalized assets are as follows:
Buildings
40 years
Building and operating equipment
15 years
Manufacturing machinery and equipment
10 years
Other machinery and equipment
5 years
Furniture and fixtures
5 years
Computer equipment and software
3-7 years

Maintenance and repairs are charged to operations as incurred, while expenditures for improvements which extend the life of an asset are capitalized.
Capitalized Software Costs
Capitalized Software Costs:    We capitalize software costs incurred in connection with developing or obtaining software. Capitalized software costs are included in property, plant and equipment, net and are amortized over their estimated useful life of three to seven years from the date the systems are ready for their intended use.
Investments in Other Entities
Investments in Other Entities:    We hold a portfolio of investments in equity securities and certain investment funds that are accounted for under either the equity method or cost method. Investments in companies or certain investment funds over which we have significant influence but not a controlling interest are accounted for using the equity method, with our share of earnings or losses reported in other income (expense), net. Investments in equity securities of companies that become publicly traded are accounted for as available-for-sale marketable securities prospectively from the date of such companies' initial public offering.
Our cost method and equity method investments are included in other assets on the Consolidated Balance Sheets.
All investments are reviewed on a regular basis for possible impairment. If an investment's fair value is determined to be less than its net carrying value and the decline is determined to be other-than-temporary, the investment is written down to its fair value. Such an evaluation is judgmental and dependent on specific facts and circumstances. Factors considered in determining whether an other-than-temporary decline in value has occurred include: market value or exit price of the investment based on either market-quoted prices or future rounds of financing by the investee; length of time that the market value was below its cost basis; financial condition and business prospects of the investee; our intent and ability to retain the investment for a sufficient period of time to allow for recovery in market value of the investment; issues that raise concerns about the investee's ability to continue as a going concern; any other information that we may be aware of related to the investment.
Other Intangible Assets
Other Intangible Assets:    Intangible assets with definite useful lives are amortized to their estimated residual values over their estimated useful lives and reviewed for impairment if certain events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Intangible assets which are not amortized include acquired in-process research and development (IPR&D) and acquired intangible assets held for sale. Amortization is initiated for IPR&D intangible assets when their useful lives have been determined. IPR&D intangible assets which are determined to have had a drop in their fair value are adjusted downward and an expense recognized in the income statement. These IPR&D intangible assets are tested at least annually or when a triggering event occurs that could indicate a potential impairment.
Goodwill
Goodwill:    Goodwill represents the excess of purchase price over fair value of net assets acquired in a business combination accounted for by the acquisition method of accounting and is not amortized, but is subject to impairment testing at least annually or when a triggering event occurs that could indicate a potential impairment. We test our goodwill annually for impairment each November 30.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets:    Long-lived assets, such as property, plant and equipment and certain other long-term assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to the estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of the assets exceed their estimated future undiscounted net cash flows, an impairment charge is recognized for the amount by which the carrying amount of the assets exceed the fair value of the assets.
Contingent Consideration from Business Combinations
Contingent Consideration from Business Combinations:    Subsequent to the acquisition date, we measure contingent consideration arrangements at fair value for each period with changes in fair value recognized in income as acquisition related (gains) charges and restructuring, net. Changes in fair values reflect new information about related IPR&D and other assets and the passage of time. In the absence of new information, changes in fair value reflect only the passage of time as development work towards the achievement of the milestones progresses, and is accrued based on an accretion schedule.
Foreign Currency Translation
Foreign Currency Translation:    Operations in non-U.S. entities are recorded in the functional currency of each entity. For financial reporting purposes, the functional currency of an entity is determined by a review of the source of an entity's most predominant cash flows. The results of operations for non-U.S. dollar functional currency entities are translated from functional currencies into U.S. dollars using the average currency rate during each month, which approximates the results that would be obtained using actual currency rates on the dates of individual transactions. Assets and liabilities are translated using currency rates at the end of the period. Adjustments resulting from translating the financial statements of our foreign entities into the U.S. dollar are excluded from the determination of net income and are recorded as a component of other comprehensive income (loss). Transaction gains and losses are recorded in other income (expense), net in the Consolidated Statements of Income. We had a net foreign exchange gain of $22.2 million in 2013 and losses of $10.8 million and $3.1 million in 2012 and 2011, respectively.
Research and Development Costs
Research and Development Costs:    Research and development costs are expensed as incurred. These include all internal and external costs related to services contracted by us. Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval. Milestone payments made to third parties subsequent to regulatory approval are capitalized and amortized over the remaining useful life of the related product.
Income Taxes
Income Taxes:    We utilize the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for years in which the temporary differences are expected to reverse. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. We recognize the benefit of an uncertain tax position that we have taken or expect to take on income tax returns we file if such tax position is more likely than not to be sustained.
Revenue Recognition
Revenue Recognition:   Revenue from the sale of products is recognized when title and risk of loss of the product is transferred to the customer and the sales price is fixed and determinable. Provisions for discounts, early payments, rebates, sales returns and distributor chargebacks under terms customary in the industry are provided for in the same period the related sales are recorded. We record estimated reductions to revenue for volume-based discounts and rebates at the time of the initial sale. The estimated reductions to revenue for such volume-based discounts and rebates are based on the sales terms, historical experience and trend analysis.
We base our sales returns allowance on estimated on-hand retail/hospital inventories, measured end-customer demand as reported by third-party sources, actual returns history and other factors, such as the trend experience for lots where product is still being returned or inventory centralization and rationalization initiatives conducted by major pharmacy chains, as applicable.  If the historical data we use to calculate these estimates do not properly reflect future returns, then a change in the allowance would be made in the period in which such a determination is made and revenues in that period could be materially affected.  Under this methodology, we track actual returns by individual production lots.  Returns on closed lots, that is, lots no longer eligible for return credits, are analyzed to determine historical returns experience.  Returns on open lots, that is, lots still eligible for return credits, are monitored and compared with historical return trend rates.  Any changes from the historical trend rates are considered in determining the current sales return allowance. 
Sales discount accruals are based on payment terms extended to customers.
 
Government rebate accruals are based on estimated payments due to governmental agencies for purchases made by third parties under various governmental programs. U.S. Medicaid rebate accruals are generally based on historical payment data and estimates of future Medicaid beneficiary utilization applied to the Medicaid unit rebate formula established by the Center for Medicaid and Medicare Services. The Medicaid rebate percentage was increased and extended to Medicaid Managed Care Organizations in March 2010.  The accrual of the rebates associated with Medicaid Managed Care Organizations is calculated based on estimated historical patient data related to Medicaid Managed Care Organizations.  We have also analyzed actual billings received from the states to further support the accrual rates.  Subsequent to implementation of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the 2010 U.S. Health Care Reform Law), certain states have only recently begun submitting partial Medicaid Managed Care Organization bills.  Our accruals for these Medicaid Managed Care Organization rebates had been at elevated levels given the delays in the receipt of complete invoices from certain states.  Due to the receipt of more complete claims data as 2013 progressed, the accruals for certain states were reduced from the elevated levels at December 31, 2012 as a result of both the payments made being applied to the accrual and a $20.3 million favorable change in estimate of the ultimate obligation.  We will continue to adjust the rebate accruals as more information becomes available and to reflect actual claims experience. Effective January 1, 2011, manufacturers of pharmaceutical products are responsible for 50% of the patient’s cost of branded prescription drugs related to the Medicare Part D Coverage Gap.  In order to estimate the cost to us of this coverage gap responsibility, we analyze data for eligible Medicare Part D patients against data for eligible Medicare Part D patients treated with our products as well as the historical invoices.  This expense is recognized throughout the year as costs are incurred.  In certain international markets, government-sponsored programs require rebates to be paid based on program specific rules and, accordingly, the rebate accruals are determined primarily on estimated eligible sales.
 
Rebates or administrative fees are offered to certain wholesale customers, group purchasing organizations and end-user customers, consistent with pharmaceutical industry practices. Settlement of rebates and fees may generally occur from one to 15 months from the date of sale. We provide a provision for rebates at the time of sale based on contracted rates and historical redemption rates. Assumptions used to establish the provision include level of wholesaler inventories, contract sales volumes and average contract pricing.  We regularly review the information related to these estimates and adjust the provision accordingly.
 
Chargeback accruals are based on the differentials between product acquisition prices paid by wholesalers and lower government contract pricing paid by eligible customers covered under federally qualified programs.  Distributor service fee accruals are based on contractual fees to be paid to the wholesale distributor for services provided.  TRICARE is a health care program of the U.S. Department of Defense Military Health System that provides civilian health benefits for military personnel, military retirees and their dependents.  TRICARE rebate accruals are included in chargeback accruals and are based on estimated Department of Defense eligible sales multiplied by the TRICARE rebate formula.
We record estimated reductions to revenue for free goods and volume-based discounts at the time of the initial sale. The estimated reductions to revenue for such free goods and volume-based discounts are based on the sales terms, historical experience and trend analysis. The cost of free goods is included in Cost of Goods Sold (excluding amortization of acquired intangible assets).
We recognize revenue from royalties based on licensees' sales of its products or products using its technologies. Royalties are recognized as earned in accordance with the contract terms when royalties from licensees can be reasonably estimated and collectability is reasonably assured. If royalties cannot be reasonably estimated or collectability of a royalty amount is not reasonably assured, royalties are recognized as revenue when the cash is received.
Share-Based Compensation
Share-Based Compensation:    We utilize share based compensation in the form of stock options, restricted stock units (RSUs) and performance-based restricted stock units (PSUs). Compensation expense is recognized in the Consolidated Statements of Income based on the estimated fair value of the awards at grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the vesting period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized to date associated with grants that are not expected to vest will be reversed.
The fair values of stock option grants are estimated as of the date of grant using a Black-Scholes option valuation model. The fair values of RSU and PSU grants are based on the market value of our Common Stock on the date of grant.
Earnings Per Share
Earnings Per Share:    Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, assuming potentially dilutive common shares, resulting from option exercises, restricted stock units, warrants and other incentives had been issued and any proceeds thereof used to repurchase common stock at the average market price during the period. The assumed proceeds used to repurchase common stock is the sum of the amount to be paid to us upon exercise of options, the amount of compensation cost attributed to future services and not yet recognized and, if applicable, the amount of excess income tax benefit that would be credited to paid-in capital upon exercise.
New Accounting Pronouncements
New Accounting Pronouncements:   In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update “Comprehensive Income (Topic 220):  Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income” (ASU 2013-2).  ASU 2013-2 requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. generally accepted accounting principles (GAAP) to be reclassified in its entirety to net income.  The amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component.  An entity shall provide this information together, in one location, either on the face of the statement where net income is presented or as a separate disclosure in the notes to the financial statements.  The amendments are effective prospectively for reporting periods beginning after December 15, 2012.  The adoption of ASU 2013-2 did not have a material impact on our financial position or results of operations.

In July 2013, the FASB issued Accounting Standards Update "Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes" (ASU 2013-10). ASU 2013-10 permits the use of the Fed Funds Effective Swap Rate (also referred to as the Overnight Index Swap Rate), in addition to the U.S. government rate (UST) and London Interbank Offered Rate (LIBOR), as a U.S. benchmark interest rate for hedge accounting purposes. This update is effective prospectively for qualifying new or re-designated hedging relationships entered into on or after July 17, 2013. The adoption of ASU 2013-10 did not have a material impact on our financial position or results of operations.

In July 2013, the FASB issued Accounting Standards Update "Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists" (ASU 2013-11). ASU 2013-11 requires an entity to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (NOL) carryforward, or similar tax loss or tax credit carryforward, rather than as a liability when (1) the uncertain tax position would reduce the NOL or other carryforward under the tax law of the applicable jurisdiction and (2) the entity intends to use the deferred tax asset for that purpose. ASU 2013-11 is effective prospectively for fiscal years and interim periods within those years, beginning after December 15, 2013 for public entities.
XML 57 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)
In Millions, unless otherwise specified
Total
Stockholders' Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Balances at beginning of period at Dec. 31, 2010 $ 5,995.5 $ 5,984.0 $ 4.8 $ (545.6) $ 6,350.2 $ 248.3 $ (73.7) $ 11.5
Increase (decrease) in stockholders' equity                
Net income 1,317.4 1,318.1       1,318.1   (0.7)
Other comprehensive income 11.5 11.5     0.1   11.4  
Mature shares tendered related to option exercise (1.9) (1.9)   (4.9) 3.0      
Exercise of stock options and warrants and conversion of restricted stock units 166.8 166.8 0.1    166.7      
Shares purchased under share repurchase program (2,221.2) (2,221.2)   (2,221.2)        
Issuance of common stock for employee benefit plans 13.6 13.6   11.0 2.6      
Issuance of common stock related to Abraxis acquisition 0.1 0.1     0.1      
Expense related to share-based compensation 216.6 216.6     216.6      
Income tax benefit upon exercise of stock options 25.1 25.1     25.1      
Disposal of non-controlling interest (10.8)             (10.8)
Balances at end of period at Dec. 31, 2011 5,512.7 5,512.7 4.9 (2,760.7) 6,764.4 1,566.4 (62.3) 0
Increase (decrease) in stockholders' equity                
Net income 1,456.2 1,456.2       1,456.2    
Other comprehensive income (1.1) (1.1)     (13.7)   12.6  
Mature shares tendered related to option exercise (0.6) (0.6)   (1.2) 0.6      
Exercise of stock options and warrants and conversion of restricted stock units 472.5 472.5 0.1 (10.6) 483.0      
Shares purchased under share repurchase program (2,050.7) (2,050.7)   (2,050.7)        
Issuance of common stock for employee benefit plans 19.2 19.2     19.2      
Expense related to share-based compensation 230.5 230.5     230.5      
Income tax benefit upon exercise of stock options 55.8 55.8     55.8      
Balances at end of period at Dec. 31, 2012 5,694.5 5,694.5 5.0 (4,823.2) 7,539.8 3,022.6 (49.7)  
Increase (decrease) in stockholders' equity                
Net income 1,449.9 1,449.9       1,449.9    
Other comprehensive income 143.7 143.7         143.7  
Exercise of stock options and warrants and conversion of restricted stock units 554.0 554.0 0.1 (69.7) 623.6      
Shares purchased under share repurchase program (2,769.2) (2,769.2)   (2,769.2)        
Issuance of common stock for employee benefit plans 22.0 22.0     22.0      
Expense related to share-based compensation 325.0 325.0     325.0      
Income tax benefit upon exercise of stock options 170.0 170.0     170.0      
Balances at end of period at Dec. 31, 2013 $ 5,589.9 $ 5,589.9 $ 5.1 $ (7,662.1) $ 8,680.4 $ 4,472.5 $ 94.0  
XML 58 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of Business and Basis and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2013
Accounting Policies [Abstract]  
Schedule of estimated useful lives of capitalized assets
Buildings
40 years
Building and operating equipment
15 years
Manufacturing machinery and equipment
10 years
Other machinery and equipment
5 years
Furniture and fixtures
5 years
Computer equipment and software
3-7 years
XML 59 R83.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaboration Agreements (Details 2) (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Intangible Asset Balance $ 2,839,700,000 $ 3,100,400,000    
Acceleron
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 0 0 25,000,000 45,000,000
Milestones 17,000,000 0 14,500,000 13,000,000
Extension of Agreements 0 0 0 0
Amortization of Prepaid Research and Development 0 0 0 0
Additional Equity Investments Made 10,000,000 0 25,000,000 5,500,000
Intangible Asset Balance 0 0    
Equity Investment Balance 127,200,000 30,500,000    
Percentage of Outstanding Equity 11.00% 12.00%    
Agios
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 0 0 0 121,200,000
Milestones 0 0 0 0
Extension of Agreements 20,000,000 0 20,000,000 0
Amortization of Prepaid Research and Development 0 0 0 0
Additional Equity Investments Made 12,800,000 0 28,700,000 8,800,000
Intangible Asset Balance 0 0    
Equity Investment Balance 113,000,000 37,500,000    
Percentage of Outstanding Equity 15.00% 17.00%    
Epizyme
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 0 65,000,000    
Milestones 25,000,000 0    
Extension of Agreements 0 0    
Amortization of Prepaid Research and Development 0 0    
Additional Equity Investments Made 1,000,000 25,000,000    
Intangible Asset Balance 0 0    
Equity Investment Balance 69,400,000 25,000,000    
Percentage of Outstanding Equity 12.00% 15.00%    
Bluebird
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 74,700,000      
Milestones 0      
Extension of Agreements 0      
Amortization of Prepaid Research and Development 0      
Additional Equity Investments Made 0      
Intangible Asset Balance 200,000      
Equity Investment Balance 0      
Percentage of Outstanding Equity 0.00%      
FORMA
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 52,800,000      
Milestones 0      
Extension of Agreements 0      
Amortization of Prepaid Research and Development 0      
Additional Equity Investments Made 0      
Intangible Asset Balance 200,000      
Equity Investment Balance 0      
Percentage of Outstanding Equity 0.00%      
MorphoSys
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 94,300,000      
Milestones 0      
Extension of Agreements 0      
Amortization of Prepaid Research and Development 0      
Additional Equity Investments Made 61,300,000      
Intangible Asset Balance 0      
Equity Investment Balance 61,400,000      
Percentage of Outstanding Equity 3.00%      
Acetylon
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 50,000,000 0 0  
Milestones 0 0 0  
Extension of Agreements 0 0 0  
Amortization of Prepaid Research and Development 4,300,000 0 0  
Additional Equity Investments Made 10,000,000 5,000,000 10,000,000  
Intangible Asset Balance 35,700,000 0    
Equity Investment Balance 25,000,000 15,000,000    
Percentage of Outstanding Equity 10.00% 10.00%    
OncoMed
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 155,000      
Milestones 0      
Extension of Agreements 0      
Amortization of Prepaid Research and Development 0      
Additional Equity Investments Made 22,200      
Intangible Asset Balance 0      
Equity Investment Balance 43,400      
Percentage of Outstanding Equity 5.00%      
Other Collaboration Arrangements
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Upfront Fees 149,000,000 113,500,000 103,500,000  
Milestones 0 5,400,000 1,000,000  
Extension of Agreements 0 0 2,400,000  
Amortization of Prepaid Research and Development 3,000,000 200,000 0  
Additional Equity Investments Made 13,600,000 13,600,000 1,100,000  
Intangible Asset Balance 25,600,000 27,300,000    
Equity Investment Balance $ 30,000,000 $ 29,900,000    
XML 60 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Financial Information (Tables)
 12 Months Ended
Dec. 31, 2013
Other Financial Information  
Schedule of accrued expenses
 
 
2013
 
2012
Compensation
 
$
261.7

 
$
170.3

Rebates, distributor chargebacks and distributor services
 
217.3

 
187.0

Clinical trial costs and grants
 
192.6

 
183.3

Common share repurchases
 
45.7

 
41.0

Interest
 
49.0

 
26.3

Royalties, license fees and collaboration agreements
 
52.4

 
19.4

Commercial related activities
 
46.6

 
22.8

Sales returns
 
15.5

 
13.3

Rent
 
14.8

 
9.5

Professional services
 
9.3

 
9.8

Other Taxes
 
7.6

 
8.3

Other
 
88.6

 
84.7

Total
 
$
1,001.1

 
$
775.7
Schedule of other current liabilities
 
 
2013
 
2012
Contingent value rights – Abraxis acquisition
 
$
—

 
$
277.4

Sales, use and value added tax
 
50.9

 
56.9

Foreign exchange contracts
 
55.9

 
33.3

Collaboration agreement
 
7.0

 
17.0

Contingent consideration – Avila acquisition
 
62.7

 
17.4

Other
 
23.2

 
29.3

Total
 
$
199.7

 
$
431.3
Schedule of other non-current liabilities
 
 
2013
 
2012
Contingent consideration – Avila acquisition
 
$
147.5

 
$
163.5

Deferred compensation and long-term incentives
 
127.2

 
99.2

Contingent value rights - Abraxis acquisition
 
118.1

 
—

Foreign exchange contracts
 
89.6

 
0.6

Deferred lease incentive
 
28.7

 
31.4

Collaboration agreement
 
28.0

 
—

Contingent consideration – Gloucester acquisition
 
18.3

 
17.3

Manufacturing facility purchase
 
13.9

 
14.4

Other
 
11.4

 
29.1

Total
 
$
582.7

 
$
355.5
XML 61 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Divestitures (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended 0 Months Ended 1 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Mar. 07, 2012
Avila Therapeutics, Inc.
Mar. 31, 2012
Avila Therapeutics, Inc.
Dec. 31, 2013
Avila Therapeutics, Inc.
Dec. 31, 2013
Avila Therapeutics, Inc.
Maximum
Mar. 07, 2012
Avila Therapeutics, Inc.
Maximum
Oct. 31, 2012
Abraxis Bio Science, Inc.
Dec. 31, 2013
Gloucester Pharmaceuticals, Inc.
Acquisitions                    
Payments for acquisition of business, net of cash acquired $ 0 $ 352.2 $ 0   $ 352.2          
Estimated maximum potential payments related to contingent consideration           595.0 595.0 595.0   120.0
Fair Value at the Acquisition Date                    
Cash       363.4            
Contingent consideration       171.7            
Total fair value of consideration transferred       535.1            
Amounts Recognized as of Acquisition Date                    
Working capital       12.0            
Property, plant and equipment       2.6            
Platform technology intangible asset       330.8         1,172.0  
In-process research and development product rights       198.4            
Net deferred tax liability       (165.0)            
Total identifiable net assets       378.8            
Goodwill 2,041.2 2,042.8   156.3            
Net assets acquired       535.1            
Amortization period of platform technology         7 years          
Current deferred income tax asset       14.7            
Net deferred tax liability       $ 179.7            
XML 62 R72.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accumulated Other Comprehensive Income (Loss) Reclassification Out of Accumulated Other Comprehensive Income (Loss) (Details) (USD $)
In Millions, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]                      
Interest (expense)                 $ (91.6) $ (63.2) $ (42.7)
Income tax benefit (expense) (2.8) (69.5) (79.7) (63.5) (27.2) (52.3) (73.3) (72.5) (215.5) (225.3) (102.1)
Total reclassification, net of tax                 1,449.9 1,456.2 1,317.4
Reclassification out of Accumulated Other Comprehensive Income
                      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]                      
Total reclassification, net of tax                 9.1 76.7 1.4
Gains (losses) from cash-flow hedges: | Reclassification out of Accumulated Other Comprehensive Income
                      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]                      
Net product sales                 10.7 80.9 0
Interest (expense)                 (3.4) (1.3) 0
Income tax benefit (expense)                 6.9 (1.9) (2.9)
Gains (losses) from available-for-sale marketable securities: | Reclassification out of Accumulated Other Comprehensive Income
                      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]                      
Income tax benefit (expense)                 2.2 0.1 0.3
Interest and investment income, net                 $ (7.3) $ (1.1) $ 4.0
XML 63 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 3,234.4 $ 2,090.4
Marketable securities available for sale 2,452.6 1,809.9
Accounts receivable, net of allowances of $40.0 and $33.0 at December 31, 2013 and 2012, respectively 1,061.4 960.5
Inventory 340.4 259.5
Deferred income taxes 25.3 93.2
Other current assets 436.4 320.2
Total current assets 7,550.5 5,533.7
Property, plant and equipment, net 593.4 578.4
Intangible assets, net 2,839.7 3,100.4
Goodwill 2,041.2 2,042.8
Other assets 353.4 479.0
Total assets 13,378.2 11,734.3
Current liabilities:    
Short-term borrowings 544.8 308.5
Accounts payable 156.2 145.6
Accrued expenses 1,001.1 775.7
Income taxes payable 16.0 11.8
Current portion of deferred revenue 27.7 17.3
Other current liabilities 199.7 431.3
Total current liabilities 1,945.5 1,690.2
Deferred revenue, net of current portion 23.7 16.2
Income taxes payable 235.0 188.2
Deferred income taxes 804.9 1,018.4
Other non-current liabilities 582.7 355.5
Long-term debt, net of discount 4,196.5 2,771.3
Total liabilities 7,788.3 6,039.8
Commitments and Contingencies (Note 18)      
Stockholders' Equity:    
Preferred stock, $.01 par value per share, 5.0 million shares authorized; none outstanding at December 31, 2013 and 2012, respectively 0 0
Common stock, $.01 par value per share, 575.0 million shares authorized; issued 511.2 million and 498.4 million shares at December 31, 2013 and 2012, respectively 5.1 5.0
Common stock in treasury, at cost; 101.5 million and 78.7 million shares at December 31, 2013 and 2012, respectively (7,662.1) (4,823.2)
Additional paid-in capital 8,680.4 7,539.8
Retained earnings 4,472.5 3,022.6
Accumulated other comprehensive income (loss) 94.0 (49.7)
Total stockholders' equity 5,589.9 5,694.5
Total liabilities and stockholders' equity $ 13,378.2 $ 11,734.3
XML 64 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Components of share-based compensation expense
 
 
2013
 
2012
 
2011
Cost of goods sold
 
$
18.5

 
$
12.4

 
$
9.8

Research and development
 
144.7

 
102.4

 
104.7

Selling, general and administrative
 
162.6

 
116.2

 
102.7

Total share-based compensation expense
 
325.8

 
231.0

 
217.2

Tax benefit related to share-based compensation expense
 
94.5

 
61.3

 
55.9

Reduction in income
 
$
231.3

 
$
169.7

 
$
161.3
Schedule of assumptions used in the estimation of fair value of options granted
 
 
2013
 
2012
 
2011
Risk-free interest rate
 
0.68% - 1.70%
 
0.21% - 1.23%
 
0.21% - 2.20%
Expected volatility
 
27% - 35%
 
27% - 30%
 
27% - 33%
Weighted average expected volatility
 
31%
 
28%
 
29%
Expected term (years)
 
5.03 - 5.50
 
1.30 - 5.17
 
1.80 - 5.20
Expected dividend yield
 
0%
 
0%
 
0%
Schedule of stock option activity
 
 
Options
 
Weighted
Average Exercise
Price Per Option
 
Weighted
Average Remaining
Contractual
Term (Years)
 
Aggregate
Intrinsic Value
(In Millions)
Outstanding at December 31, 2012
 
42.6

 
$
58.31

 
6.9
 
$
860.3

Changes during the Year:
 
 
 
 
 
 
 
 
Granted
 
9.6

 
131.96

 
 
 
 

Exercised
 
(11.5
)
 
54.23

 
 
 
 

Forfeited
 
(1.1
)
 
73.96

 
 
 
 

Expired
 
—

 
56.74

 
 
 
 

Outstanding at December 31, 2013
 
39.6

 
$
76.94

 
7.1
 
$
3,643.4

Vested at December 31, 2013 or expected to vest in the future
 
38.9

 
$
76.46

 
7.0
 
$
3,595.3

Vested at December 31, 2013
 
17.0

 
$
54.81

 
5.3
 
$
1,945.6
Schedule of restricted stock units
Nonvested RSUs
 
Share
Equivalent
 
Weighted
Average
Grant Date
Fair Value
Nonvested at December 31, 2012
 
4.5

 
$
66.20

Changes during the period:
 
 
 
 
Granted
 
1.8

 
124.96

Vested
 
(0.8
)
 
60.17

Forfeited
 
(0.4
)
 
63.20

Nonvested at December 31, 2013
 
5.1

 
$
88.15
Schedule of performance-based restricted stock units
Nonvested Performance-Based RSUs
 
Share Equivalent
 
Weighted Average Grant Date Fair Value
Nonvested at December 31, 2012
 
26

 
$
60.80

Changes during the period:
 
 
 
 
Granted
 
46

 
119.02

Vested
 
(6
)
 
60.78

Forfeited
 
(8
)
 
64.26

Non-vested at December 31, 2013
 
58

 
$
106.87
XML 65 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Net unrealized (losses) gains related to cash flow hedges:      
Unrealized holding gains (losses), tax expense (benefit) $ 2.6 $ (13.8) $ 0
Reclassification adjustment for (gains) losses included in net income, tax (expense) benefit 6.9 (1.9) (2.9)
Net unrealized gains (losses) on marketable securities available for sale:      
Unrealized holding gains (losses), tax expense (benefit) 77.1 (1.0) 1.4
Reclassification adjustment for (gains) losses included in net income, tax (expense) benefit $ 2.2 $ 0.1 $ 0.3
XML 66 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments and Hedging Activities (Details 2) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Fair value of derivative instruments    
Asset Derivative $ 206.0 $ 133.5
Liability Derivative 264.8 116.4
Designated as hedging instruments | Foreign exchange contracts | Other current assets
    
Fair value of derivative instruments    
Asset Derivative 63.6 35.2
Liability Derivative 24.9 12.7
Designated as hedging instruments | Foreign exchange contracts | Other current liabilities
    
Fair value of derivative instruments    
Asset Derivative 41.5 9.1
Liability Derivative 84.7 31.4
Designated as hedging instruments | Foreign exchange contracts | Other non-current assets
    
Fair value of derivative instruments    
Asset Derivative 60.6 30.5
Liability Derivative 41.9 13.8
Designated as hedging instruments | Foreign exchange contracts | Other non-current liabilities
    
Fair value of derivative instruments    
Asset Derivative 4.3  
Liability Derivative 25.6  
Designated as hedging instruments | Interest rate swap agreements | Other current assets
    
Fair value of derivative instruments    
Asset Derivative 17.1 0.1
Designated as hedging instruments | Interest rate swap agreements | Other non-current assets
    
Fair value of derivative instruments    
Asset Derivative   0.1
Liability Derivative   0.2
Designated as hedging instruments | Interest rate swap agreements | Other non-current liabilities
    
Fair value of derivative instruments    
Liability Derivative 68.3 0.6
Not designated as hedging instruments | Foreign exchange contracts | Other current assets
    
Fair value of derivative instruments    
Asset Derivative 11.3 45.8
Liability Derivative 0.7 36.3
Not designated as hedging instruments | Foreign exchange contracts | Other current liabilities
    
Fair value of derivative instruments    
Asset Derivative 6.0 10.4
Liability Derivative 18.7 21.4
Not designated as hedging instruments | Interest rate swap agreements | Other current assets
    
Fair value of derivative instruments    
Asset Derivative 0.1 0.6
Not designated as hedging instruments | Interest rate swap agreements | Other non-current assets
    
Fair value of derivative instruments    
Asset Derivative $ 1.5 $ 1.7
XML 67 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Fair Value Measurement (Tables)
 12 Months Ended
Dec. 31, 2013
Fair Value Disclosures [Abstract]  
Assets and liabilities measured at fair value on recurring basis
 
 
Balance at
December 31, 2013
 
Quoted Price in
Active Markets for
Identical Assets
(Level 1)
 
Significant
Other Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Available-for-sale securities
 
$
2,452.6

 
$
433.1

 
$
2,019.5

 
$
—

Cash equivalents
 
20.0

 
—

 
20.0

 
—

Total assets
 
$
2,472.6

 
$
433.1

 
$
2,039.5

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
  Forward currency contracts
 
$
(9.2
)
 
$
—

 
$
(9.2
)
 
$
—

Contingent value rights
 
(118.1
)
 
(118.1
)
 
—

 
—

Interest rate swaps
 
(49.6
)
 
—

 
(49.6
)
 
—

Other acquisition related contingent consideration
 
(228.5
)
 
—

 
—

 
(228.5
)
Total liabilities
 
$
(405.4
)
 
$
(118.1
)
 
$
(58.8
)
 
$
(228.5
)

 
 
Balance at
December 31, 2012
 
Quoted Price in
Active Markets for
Identical Assets
(Level 1)
 
Significant
Other Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Available-for-sale securities
 
$
1,809.9

 
$
0.3

 
$
1,809.6

 
$
—

Cash equivalents
 
27.0

 
—

 
27.0

 
—

Interest rate swaps
 
1.7

 
—

 
1.7

 
—

Forward currency contracts
 
17.8

 
—

 
17.8

 
—

Purchased currency options
 
2.7

 
—

 
2.7

 
—

Total assets
 
$
1,859.1

 
$
0.3

 
$
1,858.8

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
Contingent value rights
 
$
(277.4
)
 
$
(277.4
)
 
$
—

 
$
—

Written currency options
 
(5.1
)
 
—

 
(5.1
)
 
—

Other acquisition related contingent consideration
 
(198.1
)
 
—

 
—

 
(198.1
)
Total liabilities
 
$
(480.6
)
 
$
(277.4
)
 
$
(5.1
)
 
$
(198.1
)
Roll-forward of fair value of Level 3 instruments (significant unobservable inputs), liabilities
 
 
2013
 
2012
Liabilities:
 
 
 
 
Balance at beginning of period
 
$
(198.1
)
 
$
(76.9
)
Amounts acquired or issued
 
—

 
(171.7
)
Net change in fair value
 
(30.4
)
 
50.5

Settlements
 
—

 
—

Transfers in and/or out of Level 3
 
—

 
—

Balance at end of period
 
$
(228.5
)
 
$
(198.1
)
XML 68 R65.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property, Plant and Equipment (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Property, Plant and Equipment:    
Subtotal $ 1,025.7 $ 919.2
Less accumulated depreciation and amortization 432.3 340.8
Total 593.4 578.4
Land
    
Property, Plant and Equipment:    
Subtotal 37.9 36.7
Buildings
    
Property, Plant and Equipment:    
Subtotal 258.0 228.4
Building and operating equipment
    
Property, Plant and Equipment:    
Subtotal 30.8 30.0
Leasehold improvements
    
Property, Plant and Equipment:    
Subtotal 128.2 78.1
Machinery and equipment
    
Property, Plant and Equipment:    
Subtotal 193.8 175.2
Furniture and fixtures
    
Property, Plant and Equipment:    
Subtotal 46.3 41.2
Computer equipment and software
    
Property, Plant and Equipment:    
Subtotal 286.1 239.5
Construction in progress
    
Property, Plant and Equipment:    
Subtotal $ 44.6 $ 90.1
XML 69 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation
 12 Months Ended
Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Share-Based Compensation
We have a stockholder-approved stock incentive plan, the 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013) (Plan) which provides for the granting of options, RSUs, stock appreciation rights, PSUs and other share-based awards to our employees and officers.  The Management Compensation and Development Committee of the Board of Directors (Compensation Committee) may determine the type, amount and terms, including vesting, of any awards made under the Plan.

On June 12, 2013, our stockholders approved an amendment and restatement of the Plan, which included the following key modifications: adoption of an aggregate share reserve of 105.0 million shares of Common Stock, which includes 9.0 million new shares of Common Stock; increase in the maximum payment to an eligible employee under a cash-based performance award from $4.0 million to $6.0 million; and extension of the term of the plan through April 17, 2023.
With respect to options granted under the Plan, the exercise price may not be less than the market closing price of the common stock on the date of grant. In general, options granted under the Plan vest over periods ranging from immediate vesting to four-year vesting and expire ten years from the date of grant, subject to earlier expiration in case of termination of employment unless the participant meets the retirement provision under which the option would have a maximum of three additional years to vest. The vesting period for options granted under the Plan is subject to certain acceleration provisions if a change in control, as defined in the Plan, occurs. Plan participants may elect to exercise options at any time during the option term. However, any shares so purchased which have not vested as of the date of exercise shall be subject to forfeiture, which will lapse in accordance with the established vesting time period.
Shares of common stock available for future share-based grants under all plans were 16.7 million at December 31, 2013.
The following table summarizes the components of share-based compensation expense in the Consolidated Statements of Income for the years ended December 31, 2013, 2012 and 2011:
 
 
2013
 
2012
 
2011
Cost of goods sold
 
$
18.5

 
$
12.4

 
$
9.8

Research and development
 
144.7

 
102.4

 
104.7

Selling, general and administrative
 
162.6

 
116.2

 
102.7

Total share-based compensation expense
 
325.8

 
231.0

 
217.2

Tax benefit related to share-based compensation expense
 
94.5

 
61.3

 
55.9

Reduction in income
 
$
231.3

 
$
169.7

 
$
161.3


Included in share-based compensation expense for the years ended December 31, 2013, 2012 and 2011 was compensation expense related to non-qualified stock options of $197.6 million, $155.2 million and $154.4 million, respectively. Share-based compensation cost included in inventory was $1.8 million and $1.2 million at December 31, 2013 and 2012, respectively. We do not recognize a deferred tax asset for excess tax benefits that have not been realized and have adopted the tax law method as our accounting policy regarding the ordering of tax benefits to determine whether an excess tax benefit has been realized.
Stock Options:    Cash received from stock option exercises for the years ended December 31, 2013, 2012 and 2011 was $551.6 million, $476.2 million and $166.5 million, respectively, and the excess tax benefit recognized was $169.4 million, $49.3 million and $31.1 million, respectively. As of December 31, 2013, there was $463.2 million of total unrecognized compensation cost related to stock options granted under the plans. That cost will be recognized over an expected remaining weighted-average period of 2.2 years.
The weighted-average grant date fair value of the stock options granted during the years ended December 31, 2013, 2012 and 2011 was $40.44 per share, $19.33 per share and $17.09 per share, respectively. We estimated the fair value of options granted using a Black-Scholes option pricing model with the following assumptions:
 
 
2013
 
2012
 
2011
Risk-free interest rate
 
0.68% - 1.70%
 
0.21% - 1.23%
 
0.21% - 2.20%
Expected volatility
 
27% - 35%
 
27% - 30%
 
27% - 33%
Weighted average expected volatility
 
31%
 
28%
 
29%
Expected term (years)
 
5.03 - 5.50
 
1.30 - 5.17
 
1.80 - 5.20
Expected dividend yield
 
0%
 
0%
 
0%

The risk-free interest rate is based on the U.S. Treasury zero-coupon curve. Expected volatility of stock option awards is estimated based on the implied volatility of our publicly traded options with settlement dates of six months. The use of implied volatility was based upon the availability of actively traded options on our common stock and the assessment that implied volatility is more representative of future stock price trends than historical volatility. The expected term of an employee share option is the period of time for which the option is expected to be outstanding. We made a determination of expected term by analyzing employees' historical exercise experience from its history of grants and exercises in our option database and management estimates. Forfeiture rates are estimated based on historical data.
The following table summarizes all stock option activity for the year ended December 31, 2013:
 
 
Options
 
Weighted
Average Exercise
Price Per Option
 
Weighted
Average Remaining
Contractual
Term (Years)
 
Aggregate
Intrinsic Value
(In Millions)
Outstanding at December 31, 2012
 
42.6

 
$
58.31

 
6.9
 
$
860.3

Changes during the Year:
 
 
 
 
 
 
 
 
Granted
 
9.6

 
131.96

 
 
 
 

Exercised
 
(11.5
)
 
54.23

 
 
 
 

Forfeited
 
(1.1
)
 
73.96

 
 
 
 

Expired
 
—

 
56.74

 
 
 
 

Outstanding at December 31, 2013
 
39.6

 
$
76.94

 
7.1
 
$
3,643.4

Vested at December 31, 2013 or expected to vest in the future
 
38.9

 
$
76.46

 
7.0
 
$
3,595.3

Vested at December 31, 2013
 
17.0

 
$
54.81

 
5.3
 
$
1,945.6


The total fair value of shares vested during the years ended December 31, 2013, 2012 and 2011 was $159.3 million, $144.1 million and $162.8 million, respectively. The total intrinsic value of stock options exercised during the years ended December 31, 2013, 2012 and 2011 was $814.7 million, $293.5 million and $147.9 million, respectively. We primarily utilize newly issued shares to satisfy the exercise of stock options.
Restricted Stock Units:    We issue RSU, under our equity program in order to provide an effective incentive award with a strong retention component. Equity awards may, at the option of employee participants, be divided between stock options and RSUs. The employee may choose between alternate Company defined mixes of stock options and RSUs, with the number of options to be granted reduced by four for every one RSU to be granted. Information regarding the Company's RSUs for the years ended December 31, 2013 and 2012 is as follows:
Nonvested RSUs
 
Share
Equivalent
 
Weighted
Average
Grant Date
Fair Value
Nonvested at December 31, 2012
 
4.5

 
$
66.20

Changes during the period:
 
 
 
 
Granted
 
1.8

 
124.96

Vested
 
(0.8
)
 
60.17

Forfeited
 
(0.4
)
 
63.20

Nonvested at December 31, 2013
 
5.1

 
$
88.15


As of December 31, 2013, there was $246.5 million of total unrecognized compensation cost related to non-vested awards of RSUs. That cost is expected to be recognized over a weighted-average period of 1.5 years. The Company primarily utilizes newly issued shares to satisfy the vesting of RSUs.
Performance-Based Restricted Stock Units:    The Company's performance-based restricted stock units vest contingent upon the achievement of pre-determined performance-based milestones typically related to product development. The following table summarizes the Company's performance-based restricted stock unit activity for the year ended December 31, 2013 (shares in thousands):
Nonvested Performance-Based RSUs
 
Share Equivalent
 
Weighted Average Grant Date Fair Value
Nonvested at December 31, 2012
 
26

 
$
60.80

Changes during the period:
 
 
 
 
Granted
 
46

 
119.02

Vested
 
(6
)
 
60.78

Forfeited
 
(8
)
 
64.26

Non-vested at December 31, 2013
 
58

 
$
106.87


As of December 31, 2013, there was $3.9 million of total unrecognized compensation cost related to non-vested awards of performance-based RSUs that is expected to be recognized over a weighted-average period of 1.7 years.
XML 70 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments and Hedging Activities (Tables)
 12 Months Ended
Dec. 31, 2013
Derivative [Line Items]  
Schedule of fair value and balance sheet location of derivative instruments
The following table summarizes the fair value and presentation in the Consolidated Balance Sheets for derivative instruments as of December 31, 2013 and 2012:
 
 
December 31, 2013
 
 
Asset Derivatives
 
Liability Derivatives
Instrument
 
Balance Sheet
Location
 
Fair Value
 
Balance Sheet
Location
 
Fair Value
Derivatives designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
$
63.6

 
Other current assets
 
$
24.9

 
 
Other current liabilities
 
41.5

 
Other current liabilities
 
84.7

 
 
Other non-current assets
 
60.6

 
Other non-current assets
 
41.9

 
 
Other non-current liabilities
 
4.3

 
Other non-current liabilities
 
25.6

Interest rate swap agreements
 
Other current assets
 
17.1

 
Other current assets
 
—

 
 
Other non-current liabilities
 
—

 
Other non-current liabilities
 
68.3

Derivatives not designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
11.3

 
Other current assets
 
0.7

 
 
Other current liabilities
 
6.0

 
Other current liabilities
 
18.7

Interest rate swap agreements
 
Other current assets
 
0.1

 
Other current assets
 
—

 
 
Other non-current assets
 
1.5

 
Other non-current assets
 
—

Total
 
 
 
$
206.0

 
 
 
$
264.8

 
 
December 31, 2012
 
 
Asset Derivatives
 
Liability Derivatives
Instrument
 
Balance Sheet
Location
 
Fair Value
 
Balance Sheet
Location
 
Fair Value
Derivatives designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
$
35.2

 
Other current assets
 
$
12.7

 
 
Other current liabilities
 
9.1

 
Other current liabilities
 
31.4

 
 
Other non-current assets
 
30.5

 
Other non-current assets
 
13.8

Interest rate swap agreements
 
Other current assets
 
0.1

 
Other current assets
 
—

 
 
Other non-current assets
 
0.1

 
Other non-current assets
 
0.2

 
 
Other non-current liabilities
 
—

 
Other non-current liabilities
 
0.6

Derivatives not designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
45.8

 
Other current assets
 
36.3

 
 
Other current liabilities
 
10.4

 
Other current liabilities
 
21.4

Interest rate swap agreements
 
Other current assets
 
0.6

 
Other current assets
 
—

 
 
Other non-current assets
 
1.7

 
Other non-current assets
 
—

Total
 
 
 
$
133.5

 
 
 
$
116.4

1Derivative instruments in th
Schedule of effect of derivative instruments not designated as hedging instruments on Consolidated Statements of Income
 
 
Location of Gain (Loss)
Recognized in Income
on Derivative
 
Amount of Gain (Loss)
Recognized in Income
on Derivative
Instrument
 
2013
 
2012
Foreign exchange contracts
 
Other income, net
 
$
34.1

 
$
23.8

Treasury rate lock agreements
 
Other income, net
 
$
—

 
$
3.7

Interest rate swap agreements
 
Other income, net
 
$
0.7

 
$
0.3

Put options sold
 
Other income, net
 
$
1.2

 
$
—
Cash flow hedges
  
Derivative [Line Items]  
Schedule of effect of derivative instruments designated as hedging instruments on Consolidated Statements of Income
 
 
2013
 
 
 
 
Amount of
Gain/(Loss)
Recognized in OCI
on Derivative1
 
Location of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Amount of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Location of
Gain/(Loss)
Recognized in
Income on
Derivative
 
Amount of
Gain/(Loss)
Recognized in
Income on
Derivative
 
 
Instrument
 
(Effective Portion)
 
(Effective Portion)
 
(Effective Portion)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
 
Foreign exchange contracts
 
$
(9.7
)
 
Net product sales
 
$
10.7

 
Other income, net
 
$
12.6

 
2 
Treasury rate lock agreements
 
$
—

 
Interest expense
 
$
(3.4
)
 
 
 
 

 
 
Forward starting interest rate swaps
 
$
6.5

 
Interest expense
 
$
—

 
 
 
 
 
 

1 
Net losses of $13.2 million are expected to be reclassified from Accumulated OCI into income in the next 12 months.
2 
The amount of net gains recognized in income represents $6.3 million of gains related to the ineffective portion of the hedging relationships and $6.3 million of gains related to amounts excluded from the assessment of hedge effectiveness.

 
 
2012
 
 
 
 
Amount of
Gain/(Loss)
Recognized in OCI
on Derivative
 
Location of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Amount of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Location of
Gain/(Loss)
Recognized in
Income on
Derivative
 
Amount of
Gain/(Loss)
Recognized in
Income on
Derivative
 
 
Instrument
 
(Effective Portion)
 
(Effective Portion)
 
(Effective Portion)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
 
Foreign exchange contracts
 
$
74.5

 
Net product sales
 
$
80.9

 
Other income, net
 
$
(6.6
)
 
1 
Treasury rate lock agreements
 
$
(35.3
)
 
Interest Expense
 
$
(1.3
)
 
 
 
 

 
 

1 
The amount of net losses recognized in income represents $9.0 million in losses related to the ineffective portion of the hedging relationships and $2.4 million of gains related to amounts excluded from the assessment of hedge effectiveness.
The following table summarizes the effect of derivative instruments designated as fair value hedging instruments on the Consolidated Statements of Income for the years ended December 31, 2013 and 2012:
 
 
Location of Gain (Loss)
Recognized in Income
on Derivative
 
Amount of Gain (Loss)
Recognized in Income
on Derivative
Instrument
 
2013
 
2012
Interest Rate Swaps
 
Interest expense
 
$
31.4

 
$
7.8
Foreign currency forward contracts
  
Derivative [Line Items]  
Schedule of notional amount of foreign currency forward contracts
 
 
Notional Amount
Foreign Currency:
 
2013
 
2012
Australian Dollar
 
$
—

 
$
5.1

British Pound
 
279.4

 
77.9

Canadian Dollar
 
—

 
134.4

Euro
 
3,318.2

 
969.3

Japanese Yen
 
559.1

 
236.2

Total
 
$
4,156.7

 
$
1,422.9
Foreign exchange option contracts
  
Derivative [Line Items]  
Foreign currency option contracts entered into to hedge forecasted revenue and expenses
 
Notional Amount1
 
2013
 
2012
Foreign Currency Option:
 
 
 
Designated as hedging activity:
 
 
 
Purchased Put
$
—

 
$
228.8

Written Call
$
—

 
$
235.9

Not designated as hedging activity:
 
 
 
Purchased Put
$
—

 
$
160.5

Written Put
$
—

 
$
(216.0
)
1 U.S. dollar notional amounts are calculated as the hedged local currency amount multiplied times the strike value of the foreign currency option. The local currency notional amounts of our purchased put and written call that are designated as hedging activities are equal to each other.
Interest rate swap contracts
  
Derivative [Line Items]  
Schedule of notional amount of foreign currency forward contracts
The following table summarizes the notional amounts of our outstanding swap contracts at the end December 31, 2013 and 2012:
 
 
Notional Amount
 
 
2013
 
2012
Interest rate swap contracts entered into as fair value hedges of the following fixed-rate senior notes:
 
 

 
 

2.450% senior notes due 2015
 
$
300.0

 
$
—

1.900% senior notes due 2017
 
300.0

 
100.0

2.300% senior notes due 2018
 
200.0

 
—

3.950% senior notes due 2020
 
500.0

 
—

3.250% senior notes due 2022
 
850.0

 
200.0

4.000% senior notes due 2023
 
150.0

 
—

Total
 
$
2,300.0

 
$
300.0
XML 71 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
 12 Months Ended
Dec. 31, 2013
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
The income tax provision is based on income before income taxes as follows:
 
 
2013
 
2012
 
2011
U.S.
 
$
36.8

 
$
279.6

 
$
416.8

Non-U.S.
 
1,628.6

 
1,401.9

 
1,002.7

Income before income taxes
 
$
1,665.4

 
$
1,681.5

 
$
1,419.5


For the years ended December 31, 2013, 2012, and 2011, U.S. income before income taxes reflects charges related to share-based compensation, up-front collaboration payments, asset impairments and acquisitions, which increased in the United States from 2011 to 2013. These charges were less significant outside the United States in those years.
The provision (benefit) for taxes on income is as follows:
 
 
2013
 
2012
 
2011
United States:
 
 
 
 
 
 
Taxes currently payable:
 
 
 
 
 
 
Federal
 
$
352.6

 
$
101.5

 
$
100.8

State and local
 
45.4

 
(31.8
)
 
33.2

Deferred income taxes
 
(245.1
)
 
107.3

 
(67.1
)
Total U.S. tax provision
 
152.9

 
177.0

 
66.9

International:
 
 
 
 
 
 
Taxes currently payable
 
64.1

 
55.4

 
53.8

Deferred income taxes
 
(1.5
)
 
(7.1
)
 
(18.6
)
Total international tax provision
 
62.6

 
48.3

 
35.2

Total provision
 
$
215.5

 
$
225.3

 
$
102.1


Amounts are reflected in the preceding tables based on the location of the taxing authorities. We do not provide for U.S. federal or state income taxes on unremitted earnings of our international subsidiaries that are indefinitely invested outside the United States. As of December 31, 2013, we have not made a U.S. tax provision on $6.129 billion of unremitted earnings of our international subsidiaries. As these earnings are expected to be reinvested overseas indefinitely, it is not practicable to compute the estimated deferred tax liability on these earnings.
Deferred taxes arise because of different treatment between financial statement accounting and tax accounting, known as temporary differences. We record the tax effect on these temporary differences as deferred tax assets (generally items that can be used as a tax deduction or credit in future periods) or deferred tax liabilities (generally items for which we received a tax deduction but that have not yet been recorded in the Consolidated Statements of Income). We periodically evaluate the likelihood of the realization of deferred tax assets, and reduce the carrying amount of these deferred tax assets by a valuation allowance to the extent we believe a portion will not be realized. We consider many factors when assessing the likelihood of future realization of deferred tax assets, including our recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income, the carryforward periods available to us for tax reporting purposes, tax planning strategies and other relevant factors. Significant judgment is required in making this assessment. At December 31, 2013 and 2012, it was more likely than not that we would realize our deferred tax assets, net of valuation allowances. The principal valuation allowance at December 31, 2013 relates to deferred tax assets generated by certain fair value adjustments, and at December 31, 2012 relates to Swiss deferred tax assets.
In 2012, we concluded that approximately $900.0 million of our foreign earnings may not be required for use in offshore operations and may be available for use in the United States. These earnings are not treated as permanently reinvested, and our deferred tax liabilities include $316.5 million for the estimated U.S. federal and state income taxes that may be incurred should these earnings be repatriated. In drawing this conclusion, we considered our future sources of funds as well as our global operating and strategic liquidity needs, including common share repurchase activities and expansion of our commercial, research, manufacturing and administrative infrastructure worldwide.
At December 31, 2013 and 2012 the tax effects of temporary differences that give rise to deferred tax assets and liabilities were as follows:
 
 
2013
 
2012
 
 
Assets
 
Liabilities
 
Assets
 
Liabilities
Federal and state NOL carryforwards
 
$
5.3

 
$
—

 
$
12.6

 
$
—

Deferred revenue
 
2.3

 
—

 
2.3

 
—

Capitalized research expenses
 
6.1

 
—

 
37.1

 
—

Tax credit carryforwards
 
4.2

 
—

 
4.1

 
—

Non-qualified stock options
 
183.3

 
—

 
164.4

 
—

Plant and equipment, primarily differences in depreciation
 
—

 
(9.6
)
 
—

 
(13.6
)
Inventory
 
8.4

 
—

 
6.3

 
—

Other assets
 
32.7

 
(0.7
)
 
26.8

 
(9.3
)
Intangibles
 
311.9

 
(1,005.0
)
 
187.2

 
(1,069.2
)
Accrued and other expenses
 
161.3

 
—

 
116.1

 
—

Unremitted earnings
 
—

 
(316.5
)
 
—

 
(316.5
)
Unrealized (gains) losses on securities
 
—

 
(71.4
)
 
17.3

 
—

Subtotal
 
715.5

 
(1,403.2
)
 
574.2

 
(1,408.6
)
Valuation allowance
 
(35.5
)
 
—

 
(41.7
)
 
—

Total deferred taxes
 
$
680.0

 
$
(1,403.2
)
 
$
532.5

 
$
(1,408.6
)
Net deferred tax asset (liability)
 
 

 
$
(723.2
)
 
 

 
$
(876.1
)

At December 31, 2013 and 2012, deferred tax assets and liabilities were classified on the Company's balance sheet as follows:
 
 
2013
 
2012
Current assets
 
$
25.3

 
$
93.2

Other assets (non-current)
 
56.4

 
49.1

Current liabilities
 
—

 
—

Other non-current liabilities
 
(804.9
)
 
(1,018.4
)
Net deferred tax asset (liability)
 
$
(723.2
)
 
$
(876.1
)

Reconciliation of the U.S. statutory income tax rate to the Company's effective tax rate is as follows:
Percentages
 
2013
 
2012
 
2011
U.S. statutory rate
 
35.0
 %
 
35.0
 %
 
35.0
 %
Foreign tax rate differences
 
(28.8
)%
 
(28.0
)%
 
(21.1
)%
Unremitted earnings
 
—
 %
 
18.8
 %
 
—
 %
State taxes, net of federal benefit
 
0.6
 %
 
1.1
 %
 
0.7
 %
Change in valuation allowance
 
1.2
 %
 
0.4
 %
 
—
 %
Acquisition related differences
 
3.7
 %
 
3.8
 %
 
(3.5
)%
Changes in uncertain tax positions
 
0.8
 %
 
(19.3
)%
 
(2.5
)%
Other
 
0.4
 %
 
1.6
 %
 
(1.4
)%
Effective income tax rate
 
12.9
 %
 
13.4
 %
 
7.2
 %

In our reconciliation of the U.S. statutory income tax rate to our effective tax rate, we disclose changes in uncertain tax positions which include the effect of settlements, expirations of statutes of limitations, and other changes in prior year tax positions.
We have operations in many foreign tax jurisdictions, which impose income taxes at different rates than the United States. The impact of these rate differences is included in the foreign tax rate differences that we disclose in our reconciliation of the U.S. statutory income tax rate to our effective tax rate. The benefit related to foreign tax rate differences primarily results from our commercial operations in Switzerland, which include significant research and development and manufacturing for worldwide markets. We operate under an income tax agreement in Switzerland through 2015 that provides a complete exemption from Swiss income taxes on predominantly all of our operations in Switzerland. In 2013, we entered into a new agreement with the Swiss tax authorities which reflects the planned expansion of our Swiss operations and will result in substantially similar tax benefits through the end of 2024. The impact of the Swiss tax agreement is reflected in our effective tax rate. The difference between the maximum statutory Swiss income tax rate (approximately 19.7% in 2013, 21.0% in 2012 and 22.0% in 2011) and our Swiss income tax rate under the tax agreement resulted in a reduction in the 2013, 2012 and 2011 effective tax rates of 25.1, 26.6 and 20.2 percentage points, respectively. The increase in benefits reflected in the foreign tax rate differences from 2011 to 2013 results from growth in our Non-U.S. operations and an increase in the proportion of consolidated income before income taxes from Non-U.S. operations.
At December 31, 2013, we had combined state NOL carryforwards of approximately $485.6 million that will expire in the years 2014 through 2033. We also have research and experimentation credit carryforwards of approximately $10.0 million that will expire in the years 2018 through 2027. Excess tax benefits related to stock option deductions incurred after December 31, 2005 are required to be recognized in the period in which the tax deduction is realized through a reduction of income taxes payable. As a result, we have not recorded deferred tax assets for certain stock option deductions included in our state NOL carryforwards and research and experimentation credit carryforwards. At December 31, 2013, deferred tax assets have not been recorded on state NOL carryforwards of approximately $311.3 million and for research and experimentation credits of approximately $5.7 million. These stock option tax benefits will be recorded as an increase in additional paid-in capital when realized.
We realized stock option deduction benefits in 2013, 2012 and 2011 for income tax purposes and have increased additional paid-in capital in the amount of approximately $170.0 million, $55.8 million and $25.1 million, respectively. We have recorded deferred income taxes as a component of accumulated other comprehensive income resulting in a deferred income tax liability at December 31, 2013 of $71.4 million and a deferred income tax asset at December 31, 2012 of $17.3 million.
Our tax returns are under routine examination in many taxing jurisdictions. The scope of these examinations includes, but is not limited to, the review of our taxable presence in a jurisdiction, our deduction of certain items, our claims for research and development credits, our compliance with transfer pricing rules and regulations and the inclusion or exclusion of amounts from our tax returns as filed. During 2012, we settled an examination with the U.S. Internal Revenue Service (IRS) for the years ended December 31, 2006, 2007 and 2008. Our U.S. federal income tax returns have now been audited by the IRS through the year ended December 31, 2008. Tax returns for the years ended December 31, 2009, 2010, and 2011 are currently under examination by the IRS. We are also subject to audits by various state and foreign taxing authorities, including, but not limited to, most U.S. states and major European and Asian countries where we have operations.
We regularly reevaluate our tax positions and the associated interest and penalties, if applicable, resulting from audits of federal, state and foreign income tax filings, as well as changes in tax law (including regulations, administrative pronouncements, judicial precedents, etc.) that would reduce the technical merits of the position to below more likely than not. We believe that our accruals for tax liabilities are adequate for all open years. Many factors are considered in making these evaluations, including past history, recent interpretations of tax law and the specifics of each matter. Because tax regulations are subject to interpretation and tax litigation is inherently uncertain, these evaluations can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. We apply a variety of methodologies in making these estimates and assumptions, which include studies performed by independent economists, advice from industry and subject experts, evaluation of public actions taken by the IRS and other taxing authorities, as well as our industry experience. These evaluations are based on estimates and assumptions that have been deemed reasonable by management. However, if management's estimates are not representative of actual outcomes, our results of operations could be materially impacted.
Unrecognized tax benefits, generally represented by liabilities on the consolidated balance sheet and all subject to tax examinations, arise when the estimated benefit recorded in the financial statements differs from the amounts taken or expected to be taken in a tax return because of the uncertainties described above. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
 
 
2013
 
2012
Balance at beginning of year
 
$
174.7

 
$
596.8

Increases related to prior year tax positions
 
25.5

 
—

Decreases related to prior year tax positions
 
—

 
—

Increases related to current year tax positions
 
30.2

 
38.1

Settlements
 
(10.3
)
 
(450.6
)
Lapse of statute
 
(0.9
)
 
(9.6
)
Balance at end of year
 
$
219.2

 
$
174.7


These unrecognized tax benefits relate primarily to issues common among multinational corporations. If recognized, unrecognized tax benefits of approximately $198.9 million would have a net impact on the effective tax rate. We account for interest and penalties related to uncertain tax positions as part of our provision for income taxes. Accrued interest at December 31, 2013 and 2012 is approximately $23.2 million and $18.0 million, respectively.
We have recorded changes in the liability for unrecognized tax benefits for current and prior year tax positions related to ongoing income tax audits in various taxing jurisdictions. During 2012, we settled examinations with various taxing authorities related to tax positions taken in prior years. The settlements resulted in a decrease in our gross unrecognized tax benefits of $450.6 million, exclusive of interest, and a reduction to income tax expense of $318.6 million. The decrease in unrecognized tax benefits and the reduction to income tax expense reflect the impact of the settlements on tax returns filed in various taxing jurisdictions for the years examined as well as certain adjustments to unrecognized tax benefits for years subsequent to the examination period.
The liability for unrecognized tax benefits is expected to increase in the next 12 months relating to operations occurring in that period. Any settlements of examinations with taxing authorities or statute of limitations expirations would likely result in a decrease in our unrecognized tax benefits. Our estimates of tax benefits and potential tax benefits may not be representative of actual outcomes, and variation from such estimates could materially affect our financial statements in the period of settlement or when the statutes of limitations expire.
XML 72 R68.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Details) (USD $)
 12 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Interest rate swap contracts
Dec. 31, 2012
Interest rate swap contracts
Dec. 31, 2013
Interest rate swap contracts
Designated as hedging instruments
Dec. 31, 2012
Interest rate swap contracts
Designated as hedging instruments
Dec. 31, 2013
Forward Starting Interest Rate Swap, Maturing in Year Five [Member]
Designated as hedging instruments
Feb. 14, 2014
Interest rate swap contracts, maturing in year 2023
Designated as hedging instruments
Dec. 31, 2013
Interest rate swap contracts, maturing in year 2023
Designated as hedging instruments
Dec. 31, 2013
Gain As A Result of Past Swap Contract Settlements
Dec. 31, 2012
Gain As A Result of Past Swap Contract Settlements
Dec. 31, 2013
Gain Related to Settlement of Swap Contracts During Current Fiscal Year [Member]
Dec. 31, 2013
Senior Notes
Aug. 31, 2013
Senior Notes
Aug. 31, 2012
Senior Notes
Dec. 31, 2013
2.450% senior notes due 2015
Senior Notes
Dec. 31, 2012
2.450% senior notes due 2015
Senior Notes
Dec. 31, 2013
2.450% senior notes due 2015
Senior Notes
Interest rate swap contracts
Dec. 31, 2012
2.450% senior notes due 2015
Senior Notes
Interest rate swap contracts
Dec. 31, 2013
1.900% senior notes due 2017
Senior Notes
Dec. 31, 2012
1.900% senior notes due 2017
Senior Notes
Dec. 31, 2013
1.900% senior notes due 2017
Senior Notes
Interest rate swap contracts
Dec. 31, 2012
1.900% senior notes due 2017
Senior Notes
Interest rate swap contracts
Aug. 31, 2013
2.300% senior notes due 2018
Senior Notes
Dec. 31, 2013
2.300% senior notes due 2018
Senior Notes
Dec. 31, 2012
2.300% senior notes due 2018
Senior Notes
Dec. 31, 2013
2.300% senior notes due 2018
Senior Notes
Interest rate swap contracts
Dec. 31, 2012
2.300% senior notes due 2018
Senior Notes
Interest rate swap contracts
Dec. 31, 2013
3.950% senior notes due 2020
Senior Notes
Dec. 31, 2012
3.950% senior notes due 2020
Senior Notes
Dec. 31, 2013
3.950% senior notes due 2020
Senior Notes
Interest rate swap contracts
Dec. 31, 2012
3.950% senior notes due 2020
Senior Notes
Interest rate swap contracts
Dec. 31, 2013
3.250% senior notes due 2022
Senior Notes
Dec. 31, 2012
3.250% senior notes due 2022
Senior Notes
Dec. 31, 2013
3.250% senior notes due 2022
Senior Notes
Interest rate swap contracts
Dec. 31, 2012
3.250% senior notes due 2022
Senior Notes
Interest rate swap contracts
Aug. 31, 2013
4.000% senior notes due 2023
Senior Notes
Dec. 31, 2013
4.000% senior notes due 2023
Senior Notes
Dec. 31, 2012
4.000% senior notes due 2023
Senior Notes
Dec. 31, 2013
4.000% senior notes due 2023
Senior Notes
Interest rate swap contracts
Dec. 31, 2012
4.000% senior notes due 2023
Senior Notes
Interest rate swap contracts
Dec. 31, 2013
5.700% senior notes due 2040
Senior Notes
Dec. 31, 2012
5.700% senior notes due 2040
Senior Notes
Aug. 31, 2013
5.250% senior notes due 2043
Senior Notes
Dec. 31, 2013
5.250% senior notes due 2043
Senior Notes
Dec. 31, 2012
5.250% senior notes due 2043
Senior Notes
Dec. 31, 2013
Senior Notes due 2017 and 2022
Senior Notes
Interest rate swap contracts
Carrying values of the entity's senior notes                                                                                              
Long-term debt $ 4,196,500,000 $ 2,771,300,000                           $ 513,900,000 $ 520,100,000     $ 499,900,000 $ 500,600,000       $ 399,000,000 $ 0     $ 484,600,000 $ 499,000,000     $ 956,600,000 $ 1,002,100,000       $ 696,300,000 $ 0     $ 249,600,000 $ 249,500,000   $ 396,600,000 $ 0  
Interest rate (as a percent)                               2.45% 2.45%     1.90% 1.90%     2.30% 2.30% 2.30%     3.95% 3.95%     3.25% 3.25%     4.00% 4.00% 4.00%     5.70% 5.70% 5.25% 5.25% 5.25%  
Senior notes, fair value 4,269,000,000                                                                                            
Face amount of debt                           1,500,000,000.000                   400,000,000.0                         700,000,000.0             400,000,000.0      
Debt issuance price (as a percent)                                               99.792%                         99.452%             99.147%      
Debt issuance costs                             12,500,000                                                                
Redemption price, all or a portion of the notes, as a percentage of the principal amount (as a percent)                         100.00%                                                                    
Repurchase price, as a percentage of the principal amount, change of control (as a percent)                         101.00%                                                                    
Losses related to treasury rate locks                                                                                             30,600,000
Notional amount 7,635,000,000   2,300,000,000 300,000,000     100,000,000 350,000,000 200,000,000                 300,000,000 0     300,000,000 100,000,000       200,000,000 0     500,000,000 0     850,000,000 200,000,000       150,000,000 0            
Proceeds from settlement of interest rate swap contracts         22,900,000 5,000,000                                                                                  
Deferred (Gain) Loss on Discontinuation of Fair Value Hedge                   $ 32,100,000 $ 25,500,000 $ 15,800,000                                                                      
XML 73 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 74 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net income $ 1,449.9 $ 1,456.2 $ 1,317.4
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 96.9 84.9 71.2
Amortization 277.2 198.6 291.7
Provision for accounts receivable allowances 6.2 12.5 6.4
Deferred income taxes (246.6) 100.2 (85.8)
Impairment charges 105.4 148.0 118.0
Change in value of contingent consideration 171.1 166.4 (147.5)
Share-based compensation expense 325.8 231.0 217.2
Share-based employee benefit plan expense 32.6 19.3 20.7
Reclassification adjustment for cash flow hedges included in net income (7.3) (79.6) 0
Unrealized change in value of derivative instruments (1.4) 71.7 (47.6)
Realized losses (gains) on marketable securities available for sale 7.3 1.1 (3.8)
Other, net 4.5 (1.8) 15.9
Change in current assets and liabilities, excluding the effect of acquisitions:      
Accounts receivable (101.4) (30.1) (263.1)
Inventory (89.7) (69.7) 71.0
Other operating assets (90.9) 91.7 (66.9)
Accounts payable and other operating liabilities 287.2 68.2 191.2
Payment of contingent consideration (75.0) 0 (23.3)
Income tax payable 57.4 (455.5) 95.3
Deferred revenue 16.7 5.5 (1.9)
Net cash provided by operating activities 2,225.9 2,018.6 1,776.1
Cash flows from investing activities:      
Proceeds from sales of marketable securities available for sale 3,642.3 1,743.7 2,175.2
Purchases of marketable securities available for sale (3,983.6) (2,768.8) (1,693.4)
Payments for acquisition of business, net of cash acquired 0 (352.2) 0
Purchases of intellectual property and other assets (19.4) (48.9) 0
Proceeds from the sale of assets, net 0 15.8 93.2
Capital expenditures (119.7) (111.5) (132.1)
Purchases of investment securities (47.1) (30.0) (59.3)
Other investing activities (1.1) (1.7) (5.9)
Net cash (used in) provided by investing activities (528.6) (1,553.6) 377.7
Cash flows from financing activities:      
Payment for treasury shares (2,764.6) (2,043.6) (2,188.6)
Proceeds from short-term borrowing 4,462.0 4,494.8 1,878.8
Principal repayments on short-term borrowing (4,227.9) (4,712.2) (1,353.1)
Proceeds from sale of common equity put options 1.2 0 0
Payment of contingent consideration (225.0) 0 (156.7)
Proceeds from the issuance of long-term debt 1,479.6 1,486.7 0
Net proceeds from exercise of common stock options and warrants 551.6 476.2 166.5
Excess tax benefit from share-based compensation arrangements 169.4 49.3 31.1
Net cash used in financing activities (553.7) (248.8) (1,622.0)
Effect of currency rate changes on cash and cash equivalents 0.4 14.7 (23.4)
Net increase in cash and cash equivalents 1,144.0 230.9 508.4
Cash and cash equivalents at beginning of period 2,090.4 1,859.5 1,351.1
Cash and cash equivalents at end of period 3,234.4 2,090.4 1,859.5
Supplemental schedule of non-cash investing and financing activity:      
Change in net unrealized gain on marketable securities available for sale (205.1) (1.3) (3.7)
Matured shares tendered in connection with stock option exercises 0 (1.2) (4.9)
Supplemental disclosure of cash flow information:      
Interest paid 90.8 48.4 50.2
Income taxes paid $ 291.9 $ 469.6 $ 93.0
XML 75 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
In Millions, except Share data, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Statement of Financial Position [Abstract]    
Accounts receivable, allowances (in dollars) $ 40.0 $ 33.0
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 575,000,000 575,000,000
Common stock, shares issued 511,200,000 498,400,000
Common stock, treasury 101,500,000 78,700,000
XML 76 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Financial Information
 12 Months Ended
Dec. 31, 2013
Other Financial Information  
Other Financial Information
Other Financial Information
Accrued expenses at December 31, 2013 and 2012 consisted of the following:
 
 
2013
 
2012
Compensation
 
$
261.7

 
$
170.3

Rebates, distributor chargebacks and distributor services
 
217.3

 
187.0

Clinical trial costs and grants
 
192.6

 
183.3

Common share repurchases
 
45.7

 
41.0

Interest
 
49.0

 
26.3

Royalties, license fees and collaboration agreements
 
52.4

 
19.4

Commercial related activities
 
46.6

 
22.8

Sales returns
 
15.5

 
13.3

Rent
 
14.8

 
9.5

Professional services
 
9.3

 
9.8

Other Taxes
 
7.6

 
8.3

Other
 
88.6

 
84.7

Total
 
$
1,001.1

 
$
775.7



Other current liabilities at December 31, 2013 and 2012 consisted of the following:
 
 
2013
 
2012
Contingent value rights – Abraxis acquisition
 
$
—

 
$
277.4

Sales, use and value added tax
 
50.9

 
56.9

Foreign exchange contracts
 
55.9

 
33.3

Collaboration agreement
 
7.0

 
17.0

Contingent consideration – Avila acquisition
 
62.7

 
17.4

Other
 
23.2

 
29.3

Total
 
$
199.7

 
$
431.3


Other non-current liabilities at December 31, 2013 and 2012 consisted of the following:
 
 
2013
 
2012
Contingent consideration – Avila acquisition
 
$
147.5

 
$
163.5

Deferred compensation and long-term incentives
 
127.2

 
99.2

Contingent value rights - Abraxis acquisition
 
118.1

 
—

Foreign exchange contracts
 
89.6

 
0.6

Deferred lease incentive
 
28.7

 
31.4

Collaboration agreement
 
28.0

 
—

Contingent consideration – Gloucester acquisition
 
18.3

 
17.3

Manufacturing facility purchase
 
13.9

 
14.4

Other
 
11.4

 
29.1

Total
 
$
582.7

 
$
355.5
XML 77 R91.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Details) (Subsequent Event)
 0 Months Ended
Feb. 12, 2014
Subsequent Event
  
Subsequent Event [Line Items]  
Stock split conversion ratio 2
XML 78 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2013
Feb. 07, 2014
Jun. 28, 2013
Document and Entity Information      
Entity Registrant Name CELGENE CORP /DE/    
Entity Central Index Key 0000816284    
Document Type 10-K    
Document Period End Date Dec. 31, 2013    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Large Accelerated Filer    
Entity Public Float     $ 48,096,964,775
Entity Common Stock, Shares Outstanding   406,020,079  
Document Fiscal Year Focus 2013    
Document Fiscal Period Focus FY    
XML 79 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets and Goodwill
 12 Months Ended
Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill
Intangible Assets and Goodwill
Intangible Assets:    Our intangible assets consist of developed product rights obtained primarily from the Pharmion Corp. (Pharmion), Gloucester and Abraxis acquisitions, IPR&D product rights from the Gloucester and Avila acquisitions and technology obtained primarily from the Avila acquisition. Also included are contract-based licenses and other miscellaneous intangibles. The amortization periods related to non-IPR&D intangible assets range from one to 17 years. The following summary of intangible assets by category includes intangibles currently being amortized and intangibles not yet subject to amortization:
December 31, 2013
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Intangible
Assets,
Net
 
Weighted
Average
Life (Years)
Amortizable intangible assets:
 
 
 
 
 
 
 
 
Acquired developed product rights
 
$
3,405.9

 
$
(1,026.4
)
 
$
2,379.5

 
13.0
Technology
 
333.7

 
(87.4
)
 
246.3

 
7.0
Licenses
 
66.2

 
(13.9
)
 
52.3

 
16.5
Other
 
42.5

 
(18.8
)
 
23.7

 
8.6
 
 
3,848.3

 
(1,146.5
)
 
2,701.8

 
12.5
Non-amortized intangible assets:
 
 
 
 
 
 
 
 
Acquired IPR&D product rights
 
137.9

 
—

 
137.9

 
 
Total intangible assets
 
$
3,986.2

 
$
(1,146.5
)
 
$
2,839.7

 
 

December 31, 2012
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Intangible
Assets,
Net
 
Weighted
Average
Life (Years)
Amortizable intangible assets:
 
 
 
 
 
 
 
 
Acquired developed product rights
 
$
3,400.4

 
$
(814.5
)
 
$
2,585.9

 
13.0
Technology
 
333.3

 
(39.8
)
 
293.5

 
7.0
Licenses
 
64.3

 
(10.0
)
 
54.3

 
16.8
Other
 
43.4

 
(14.6
)
 
28.8

 
8.5
 
 
3,841.4

 
(878.9
)
 
2,962.5

 
12.5
Non-amortized intangible assets:
 
 
 
 
 
 
 
 
Acquired IPR&D product rights
 
137.9

 
—

 
137.9

 
 
Total intangible assets
 
$
3,979.3

 
$
(878.9
)
 
$
3,100.4

 
 


The gross carrying value of intangible assets increased by $6.9 million in 2013 compared to 2012 primarily resulting from the acquisition of $5.5 million in certain developed product rights and the addition of $3.9 million from other miscellaneous agreements, net of a $2.5 million impairment charge.
Amortization expense was $270.1 million, $196.2 million and $290.3 million for the years ended December 31, 2013, 2012 and 2011, respectively. Amortization expense increased by $73.9 million in 2013 compared to 2012 primarily due to the October 2012 approval of ABRAXANE® in the United States for the treatment of NSCLC which resulted in the commencement of amortization of the related intangible asset and an increase in amortization of technology related to the March 7, 2012 acquisition of Avila and its Avilomics™ platform. Assuming no changes in the gross carrying amount of intangible assets, the amortization of intangible assets for years 2014 through 2018 is estimated to be in the range of approximately $255.0 million to $270.0 million annually.
Goodwill:    At December 31, 2013, our goodwill related to the 2012 acquisition of Avila, the 2010 acquisitions of Abraxis and Gloucester, the 2008 acquisition of Pharmion and the 2004 acquisition of Penn T Limited.
The change in carrying value of goodwill is summarized as follows:
Balance at December 31, 2012
$
2,042.8

Tax benefit on the exercise of Pharmion converted stock options
(1.6
)
Balance at December 31, 2013
$
2,041.2
XML 80 R80.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details) (USD $)
In Millions, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Income before income taxes:                      
U.S.                 $ 36.8 $ 279.6 $ 416.8
Non-U.S.                 1,628.6 1,401.9 1,002.7
Income before income taxes                 1,665.4 1,681.5 1,419.5
Taxes currently payable:                      
Federal                 352.6 101.5 100.8
State and local                 45.4 (31.8) 33.2
Deferred income taxes                 (245.1) 107.3 (67.1)
Total U.S. tax provision                 152.9 177.0 66.9
International:                      
Taxes currently payable                 64.1 55.4 53.8
Deferred income taxes                 (1.5) (7.1) (18.6)
Total international tax provision                 62.6 48.3 35.2
Total provision 2.8 69.5 79.7 63.5 27.2 52.3 73.3 72.5 215.5 225.3 102.1
Permanently unremitted earnings of international subsidiaries 6,129               6,129    
Unremitted earnings of international subsidiaries 900.0               900.0    
Deferred tax liability on foreign earnings (316.5)       (316.5)       (316.5) (316.5)  
Assets                      
Federal and state NOL carryforwards 5.3       12.6       5.3 12.6  
Deferred revenue 2.3       2.3       2.3 2.3  
Capitalized research expenses 6.1       37.1       6.1 37.1  
Tax credit carryforwards 4.2       4.1       4.2 4.1  
Non-qualified stock options 183.3       164.4       183.3 164.4  
Inventory 8.4       6.3       8.4 6.3  
Other assets 32.7       26.8       32.7 26.8  
Intangibles 311.9       187.2       311.9 187.2  
Accrued and other expenses 161.3       116.1       161.3 116.1  
Unrealized (gains) losses on securities 0       17.3       0 17.3  
Deferred Tax Liabilities, Unrealized Gains on Trading Securities (71.4)               (71.4)    
Subtotal 715.5       574.2       715.5 574.2  
Valuation allowance (35.5)       (41.7)       (35.5) (41.7)  
Total deferred taxes 680.0       532.5       680.0 532.5  
Liabilities                      
Plant and equipment, primarily differences in depreciation (9.6)       (13.6)       (9.6) (13.6)  
Other assets (0.7)       (9.3)       (0.7) (9.3)  
Intangibles (1,005.0)       (1,069.2)       (1,005.0) (1,069.2)  
Unremitted earnings (316.5)       (316.5)       (316.5) (316.5)  
Total deferred taxes (1,403.2)       (1,408.6)       (1,403.2) (1,408.6)  
Net deferred tax asset (liability) (723.2)       (876.1)       (723.2) (876.1)  
Deferred tax assets and liabilities classified on the company's balance sheet:                      
Current assets 25.3       93.2       25.3 93.2  
Other assets (non-current) 56.4       49.1       56.4 49.1  
Current liabilities 0       0       0 0  
Other non-current liabilities (804.9)       (1,018.4)       (804.9) (1,018.4)  
Net deferred tax asset (liability) (723.2)       (876.1)       (723.2) (876.1)  
Percentages                      
U.S. statutory rate                 35.00% 35.00% 35.00%
Foreign tax rate differences                 (28.80%) (28.00%) (21.10%)
Unremitted earnings                 0.00% 18.80% 0.00%
State taxes, net of federal benefit                 0.60% 1.10% 0.70%
Change in valuation allowance                 1.20% 0.40% 0.00%
Acquisition related differences                 3.70% 3.80% (3.50%)
Changes in uncertain tax positions                 0.80% (19.30%) (2.50%)
Other                 0.40% 1.60% (1.40%)
Effective income tax rate                 12.90% 13.40% 7.20%
Maximum statutory Swiss income tax rate (as a percent)                 19.70% 21.00% 22.00%
Reduction in effective tax rates due to difference between maximum statutory Swiss income tax rate and the company's Swiss income tax rate under the tax holiday (as a percent)                 25.10% 26.60% 20.20%
State
                      
Income Taxes                      
NOL carryforwards 485.6               485.6    
NOL carryforwards for which deferred tax assets have not been recorded $ 311.3               $ 311.3    
XML 81 R90.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Results of Operations (Unaudited) (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Quarterly Financial Data [Abstract]                      
Total revenue $ 1,755.9 $ 1,674.4 $ 1,599.0 $ 1,464.6 $ 1,447.4 $ 1,419.2 $ 1,366.8 $ 1,273.3 $ 6,493.9 $ 5,506.7 $ 4,842.1
Gross profit 1,632.1 1,557.8 1,483.2 1,348.8 1,335.4 1,313.4 1,264.7 1,173.0 6,021.9 5,086.5  
Income tax provision 2.8 69.5 79.7 63.5 27.2 52.3 73.3 72.5 215.5 225.3 102.1
Net income attributable to Celgene $ 214.4 $ 372.5 $ 478.1 $ 384.9 $ 263.1 $ 424.2 $ 367.4 $ 401.5 $ 1,449.9 $ 1,456.2 $ 1,318.1
Net income per share attributable to Celgene:                      
Basic (in dollars per share) $ 0.52 $ 0.90 $ 1.15 $ 0.92 $ 0.62 $ 0.99 $ 0.84 $ 0.92 $ 3.50 $ 3.38 $ 2.89
Diluted (in dollars per share) $ 0.50 $ 0.87 $ 1.11 $ 0.89 $ 0.61 $ 0.97 $ 0.82 $ 0.90 $ 3.37 $ 3.30 $ 2.85
Weighted average shares:                      
Basic (in shares) 411.2 412.3 414.1 417.9 421.6 427.2 436.7 438.3 413.8 430.9 455.3
Diluted (in shares) 428.6 428.8 429.3 432.2 432.3 436.3 445.4 448.6 430.3 440.8 462.7
XML 82 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF INCOME (USD $)
In Millions, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Revenue:      
Net product sales $ 6,362.3 $ 5,385.6 $ 4,699.7
Collaborative agreements and other revenue 14.7 10.7 19.5
Royalty revenue 116.9 110.4 122.9
Total revenue 6,493.9 5,506.7 4,842.1
Expenses:      
Cost of goods sold (excluding amortization of acquired intangible assets) 340.4 299.1 425.9
Research and development 2,226.2 1,724.2 1,600.3
Selling, general and administrative 1,684.5 1,373.5 1,226.3
Amortization of acquired intangible assets 262.8 194.5 289.2
Acquisition related (gains) charges and restructuring, net 171.1 169.0 (142.3)
Total costs and expenses 4,685.0 3,760.3 3,399.4
Operating income 1,808.9 1,746.4 1,442.7
Other income and (expense):      
Interest and investment income, net 22.0 15.3 25.9
Interest (expense) (91.6) (63.2) (42.7)
Other income (expense), net (73.9) (17.0) (6.4)
Income before income taxes 1,665.4 1,681.5 1,419.5
Income tax provision 215.5 225.3 102.1
Net income 1,449.9 1,456.2 1,317.4
Net loss attributable to non-controlling interest 0 0 0.7
Net income attributable to Celgene $ 1,449.9 $ 1,456.2 $ 1,318.1
Net income per share attributable to Celgene:      
Basic (in dollars per share) $ 3.50 $ 3.38 $ 2.89
Diluted (in dollars per share) $ 3.37 $ 3.30 $ 2.85
Weighted average shares:      
Basic (in shares) 413.8 430.9 455.3
Diluted (in shares) 430.3 440.8 462.7
XML 83 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Fair Value Measurement
 12 Months Ended
Dec. 31, 2013
Fair Value Disclosures [Abstract]  
Financial Instruments and Fair Value Measurement
Financial Instruments and Fair Value Measurement
The table below presents information about assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2013 and the valuation techniques we utilized to determine such fair value.  Fair values determined based on Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities.  Our Level 1 assets consist of marketable equity securities.  Fair values determined based on Level 2 inputs utilize observable quoted prices for similar assets and liabilities in active markets and observable quoted prices for identical or similar assets in markets that are not very active.  Our Level 2 assets consist primarily of U.S. Treasury securities, U.S. government-sponsored agency securities, U.S. government-sponsored agency MBS, non-U.S. government, agency and Supranational securities, global corporate debt securities, asset backed securities, foreign currency forward contracts, purchased foreign currency options and interest rate swap contracts.  Fair values determined based on Level 3 inputs utilize unobservable inputs and include valuations of assets or liabilities for which there is little, if any, market activity.  We do not have any Level 3 assets.  Our Level 1 liability relates to our publicly traded Contingent Value Rights (CVRs). See Note 18 for a description of the CVRs.  Our Level 2 liabilities relate to interest rate swap contracts and forward starting interest rate swap contracts.  Our Level 3 liabilities consist of contingent consideration related to undeveloped product rights resulting from the acquisition of Gloucester Pharmaceuticals, Inc. (Gloucester) and contingent consideration related to the undeveloped product rights and the technology platform acquired from the Avila acquisition. The maximum potential payments related to the contingent consideration from the acquisitions of Gloucester and Avila are estimated to be $120.0 million and $595.0 million, respectively.
 
 
Balance at
December 31, 2013
 
Quoted Price in
Active Markets for
Identical Assets
(Level 1)
 
Significant
Other Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Available-for-sale securities
 
$
2,452.6

 
$
433.1

 
$
2,019.5

 
$
—

Cash equivalents
 
20.0

 
—

 
20.0

 
—

Total assets
 
$
2,472.6

 
$
433.1

 
$
2,039.5

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
  Forward currency contracts
 
$
(9.2
)
 
$
—

 
$
(9.2
)
 
$
—

Contingent value rights
 
(118.1
)
 
(118.1
)
 
—

 
—

Interest rate swaps
 
(49.6
)
 
—

 
(49.6
)
 
—

Other acquisition related contingent consideration
 
(228.5
)
 
—

 
—

 
(228.5
)
Total liabilities
 
$
(405.4
)
 
$
(118.1
)
 
$
(58.8
)
 
$
(228.5
)

 
 
Balance at
December 31, 2012
 
Quoted Price in
Active Markets for
Identical Assets
(Level 1)
 
Significant
Other Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Available-for-sale securities
 
$
1,809.9

 
$
0.3

 
$
1,809.6

 
$
—

Cash equivalents
 
27.0

 
—

 
27.0

 
—

Interest rate swaps
 
1.7

 
—

 
1.7

 
—

Forward currency contracts
 
17.8

 
—

 
17.8

 
—

Purchased currency options
 
2.7

 
—

 
2.7

 
—

Total assets
 
$
1,859.1

 
$
0.3

 
$
1,858.8

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
Contingent value rights
 
$
(277.4
)
 
$
(277.4
)
 
$
—

 
$
—

Written currency options
 
(5.1
)
 
—

 
(5.1
)
 
—

Other acquisition related contingent consideration
 
(198.1
)
 
—

 
—

 
(198.1
)
Total liabilities
 
$
(480.6
)
 
$
(277.4
)
 
$
(5.1
)
 
$
(198.1
)


The following table represents a roll-forward of the fair value of Level 3 liabilities (significant unobservable inputs):

 
 
2013
 
2012
Liabilities:
 
 
 
 
Balance at beginning of period
 
$
(198.1
)
 
$
(76.9
)
Amounts acquired or issued
 
—

 
(171.7
)
Net change in fair value
 
(30.4
)
 
50.5

Settlements
 
—

 
—

Transfers in and/or out of Level 3
 
—

 
—

Balance at end of period
 
$
(228.5
)
 
$
(198.1
)

The $30.4 million increase in the fair value of Level 3 liabilities in 2013 was primarily due to probability adjustments for two Avila milestones. Level 3 liabilities issued during 2012 consisted of contingent consideration related to the acquisition of Avila. The $50.5 million net decrease in the fair value of Level 3 liabilities in 2012 was due to a $59.7 million reduction in the contingent consideration liability related to the approval of ISTODAX® for PTCL in Europe, partly offset by a $9.2 million increase in the accretion of the contingent consideration liability related to our acquisition of Avila.
XML 84 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share
 12 Months Ended
Dec. 31, 2013
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share
 
 
2013
 
2012
 
2011
Net income attributable to Celgene
 
$
1,449.9

 
$
1,456.2

 
$
1,318.1

Weighted-average shares:
 
 
 
 
 
 
Basic
 
413.8

 
430.9

 
455.3

Effect of dilutive securities:
 
 
 
 
 
 
Options, restricted stock units, warrants and other
 
16.5

 
9.9

 
7.4

Diluted
 
430.3

 
440.8

 
462.7

Net income per share attributable to Celgene:
 
 
 
 
 
 
Basic
 
$
3.50

 
$
3.38

 
$
2.89

Diluted
 
$
3.37

 
$
3.30

 
$
2.85


The total number of potential shares of common stock excluded from the diluted earnings per share computation because their inclusion would have been anti-dilutive was 7.2 million in 2013, 12.7 million in 2012 and 25.9 million in 2011.
During the period of April 2009 through December 2013, our Board of Directors has approved repurchases of up to an aggregate of $9.500 billion of our common stock, including the June 2013 authorization to repurchase an additional $3.000 billion of our common stock.

As part of the Board authorized share repurchase program, in February 2013 we entered into an Accelerated Share Repurchase (ASR) agreement with an investment bank to repurchase an aggregate of $600.0 million of our common stock. The total number of shares repurchased under the ASR agreement was 5.2 million shares at a weighted average price of $114.30 per share.

As part of the management of our Board of Director authorized share repurchase program, we may, from time to time, sell put options on our common stock with strike prices that we believe represent an attractive price to repurchase our shares. If the trading price of our shares exceeds the strike price of the put option at the time the option expires, we will have economically reduced the cost of our share repurchase program by the amount of the premium we received from the sale of the put option. If the trading price of our stock is below the strike price of the put option at the time the option expires, we would repurchase the shares covered by the option at the strike price of the put option. During 2013 we sold a single put option for a premium of $1.2 million that expired unexercised. At December 31, 2013, we had no outstanding put options. In February 2014, we sold a put option on $200.0 million notional amount of shares of stock with a strike price of $142.81 and maturing in March 2014 for a premium of $4.8 million.
We repurchased 22.3 million shares of common stock under the program from all sources, including the ASR during 2013. As of December 31, 2013, we had a remaining open-ended repurchase authorization of $2.068 billion.
XML 85 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Employee Benefit Plans
 12 Months Ended
Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]  
Employee Benefit Plans
Employee Benefit Plans
We sponsor an employee savings and retirement plan, which qualifies under Section 401(k) of the Internal Revenue Code, as amended (the Code) for our U.S. employees. Our contributions to the U.S. savings plan are discretionary and have historically been made in the form of our common stock (See Note 12). Such contributions are based on specified percentages of employee contributions up to 6% of eligible compensation or a maximum permitted by law. Total expense for contributions to the U.S. savings plans were $32.6 million, $19.3 million and $20.7 million in 2013, 2012 and 2011, respectively.
We also sponsor defined contribution plans in certain foreign locations. Participation in these plans is subject to the local laws that are in effect for each country and may include statutorily imposed minimum contributions. We also maintain defined benefit plans in certain foreign locations for which the obligations and the net periodic pension costs were determined to be immaterial at December 31, 2013.
In 2000, our Board of Directors approved a deferred compensation plan. The plan was frozen effective as of December 31, 2004, and no additional contributions or deferrals can be made to that plan. Accrued benefits under the frozen plan will continue to be governed by the terms under the tax laws in effect prior to the enactment of Section 409A. In February 2005, our Board of Directors adopted the Celgene Corporation 2005 Deferred Compensation Plan, effective as of January 1, 2005, and amended the plan in February 2008. This plan operates as our ongoing deferred compensation plan and is intended to comply with the American Jobs Creation Act of 2004, Section 409A. Eligible participants, which include certain top-level executives as specified by the plan, can elect to defer up to an amended 90% of the participant's base salary, 100% of cash bonuses and equity compensation allowed under Section 409A of the Code. Company contributions to the deferred compensation plan represent a match to certain participants' deferrals up to a specified percentage, which currently ranges from 10% to 20%, depending on the employee's position as specified in the plan, of the participant's base salary. We recorded expenses of $0.6 million, $0.6 million and $0.7 million related to the deferred compensation plans in 2013, 2012 and 2011, respectively. The Company's matches are fully vested upon contribution. All other Company contributions to the plan do not vest until the specified requirements are met. At December 31, 2013 and 2012, we had a deferred compensation liability included in other non-current liabilities in the Consolidated Balance Sheets of approximately $73.7 million and $59.8 million, respectively, which included the participant's elected deferral of salaries and bonuses, the Company's matching contribution and earnings on deferred amounts as of that date. The plan provides various alternatives for the measurement of earnings on the amounts participants defer under the plan. The measuring alternatives are based on returns of a variety of funds that offer plan participants the option to spread their risk across a diverse group of investments.
In 2003, we established a Long-Term Incentive Plan (LTIP) designed to provide key officers and executives with performance-based incentive opportunities contingent upon achievement of pre-established corporate performance objectives covering a three-year period. We currently have three separate three-year performance cycles running concurrently ending December 31, 2014, 2015 and 2016. Performance measures for each of the performance cycles are based on the following components: 37.5% on non-GAAP earnings per share (as defined in the LTIP); 37.5% on total non-GAAP revenue (as defined in the LTIP); and 25% on relative total shareholder return, which is a measurement of our stock price performance during the year compared with a group of other companies in the biopharmaceutical industry.
Payouts may be in the range of 0% to 200% of the participant's salary for the LTIPs. The estimated payout for the concluded 2013 Plan is $28.9 million, which is included in accrued expenses at December 31, 2013, and the maximum potential payout, assuming maximum objectives are achieved for the 2014, 2015 and 2016 Plans are $19.6 million, $22.6 million and$25.2 million, respectively. Such awards are payable in cash or common stock or a mixture of cash and common stock, which will be determined by the Compensation Committee at the time of award delivery. For awards payable in common stock, the number of shares is determined using the average closing price for the 30 trading days prior to the beginning of the cycle. The Compensation Committee may determine that payments made in common stock are restricted from trading for a period of three years. We accrue the long-term incentive liability over each three-year cycle. Prior to the end of a three-year cycle, the accrual is based on an estimate of our level of achievement during the cycle. Upon a change in control, participants will be entitled to an immediate payment equal to their target award or, if higher, an award based on actual performance through the date of the change in control. For the years ended December 31, 2013, 2012 and 2011, we recognized expense related to the LTIP of $40.8 million, $10.1 million and $12.0 million, respectively.
XML 86 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt
 12 Months Ended
Dec. 31, 2013
Debt Disclosure [Abstract]  
Debt
Debt
Senior Notes:    Summarized below are the carrying values of our senior notes at December 31, 2013 and 2012:
 
 
2013
 
2012
2.450% senior notes due 2015
 
$
513.9

 
$
520.1

1.900% senior notes due 2017
 
499.9

 
500.6

2.300% senior notes due 2018
 
399.0

 
—

3.950% senior notes due 2020
 
484.6

 
499.0

3.250% senior notes due 2022
 
956.6

 
1,002.1

4.000% senior notes due 2023
 
696.3

 
—

5.700% senior notes due 2040
 
249.6

 
249.5

5.250% senior notes due 2043
 
396.6

 
—

Total long-term debt
 
$
4,196.5

 
$
2,771.3


At December 31, 2013, the fair value of our outstanding Senior Notes was $4.269 billion and represented a Level 2 measurement within the fair value measurement hierarchy.
In August 2013, we issued an additional $1.500 billion principal amount of senior notes consisting of $400.0 million aggregate principal amount of 2.300% Senior Notes due 2018 (the 2018 notes), $700.0 million aggregate principal amount of 4.000% Senior Notes due 2023 (the 2023 notes) and $400.0 million aggregate principal amount of 5.25% Senior Notes due 2043 (the 2043 notes) and, together with the 2018 notes and 2023 notes, referred to herein as the "2013 issued notes". The 2013 issued notes were issued at 99.792%, 99.452% and 99.147% of par, respectively, and the discount is being amortized as additional interest expense over the period from issuance through maturity. Offering costs of approximately $12.5 million have been recorded as debt issuance costs on our Consolidated Balance Sheets and are being amortized as additional interest expense using the effective interest rate method over the period from issuance through maturity. Interest on the notes is payable semi-annually in arrears on February 15 and August 15 each year beginning February 15, 2014 and the principal on each note is due in full at their respective maturity dates.
The notes may be redeemed at the option of the Company, in whole or in part, at any time at a redemption price defined in a make-whole clause equaling accrued and unpaid interest plus the greater of 100% of the principal amount of the notes to be redeemed or the sum of the present values of the remaining scheduled payments of interest and principal. If we experience a change of control accompanied by a downgrade of the debt to below investment grade, we will be required to offer to repurchase the notes at a purchase price equal to 101% of their principal amount plus accrued and unpaid interest. We are subject to covenants which limit our ability to pledge properties as security under borrowing arrangements and limit our ability to perform sale and leaseback transactions involving our property.
During 2012, we entered into treasury rate locks in anticipation of issuing the fixed-rate notes that were issued in August 2012. As of December 31, 2013, a balance of $30.6 million in losses remained in OCI related to treasury rate locks and will be recognized as interest expense over the life of the 2017 notes and the 2022 notes.
At December 31, 2013, we were party to pay-floating, receive-fixed interest rate swap contracts designated as fair value hedges
of fixed-rate notes as described in Note 5. Our swap contracts outstanding at December 31, 2013 effectively convert the hedged portion of our fixed-rate notes to floating rates. From time to time we terminate the hedging relationship on certain of our swap contracts by settling the contracts or by entering into offsetting contracts. Any net proceeds received or paid in these settlements are accounted for as a reduction or increase of current and future interest expense associated with the previously hedged notes. As of December 31, 2013 and 2012, we had balances of $32.1 million and $25.5 million, respectively, in unamortized gains recorded as a component of our debt as a result of past swap contract settlements. During 2013, we terminated the hedging relationship on certain of our swap contracts, resulting in gains of $15.8 million.
Commercial Paper:    The carrying value of Commercial Paper as of December 31, 2013 and 2012 was $544.8 million and $308.5 million, respectively, and approximated its fair value. The effective interest rate on the outstanding Commercial Paper balance at December 31, 2013 was 0.4%.
Senior Unsecured Credit Facility:    We maintain a senior unsecured revolving credit facility (Credit Facility) that provides revolving credit in the aggregate amount of $1.500 billion, which was increased from $1.000 billion in April 2013. During April 2013, the term of the Credit Facility was also extended from September 2, 2016 to April 18, 2018.   Subject to certain conditions, we have the right to increase the amount of the Credit Facility (but in no event more than one time per annum) up to a maximum aggregate amount of $1.750 billion.  Amounts may be borrowed in U.S. dollars for working capital, capital expenditures and other corporate purposes. The Credit Facility currently serves as backup liquidity for our Commercial Paper borrowings.  At December 31, 2013 and 2012, there was no outstanding borrowing against the Credit Facility.
The Credit Facility contains affirmative and negative covenants including certain customary financial covenants.  We were in compliance with all financial covenants as of December 31, 2013.
XML 87 R84.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details) (USD $)
 12 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Sep. 30, 2013
ABRAXANE
Dec. 31, 2013
ABRAXANE
Dec. 31, 2012
ABRAXANE
Dec. 31, 2013
ABRAXANE
If Achieved no later than April 1, 2013
Dec. 31, 2013
ABRAXANE
If Achieved after April 1, 2013 and before the fifth anniversary of the Merger
Dec. 31, 2013
ABRAXANE
Milestone One
Dec. 31, 2013
ABRAXANE
Milestone One
Minimum
Dec. 31, 2013
ABRAXANE
Milestone One
Maximum
Dec. 31, 2013
ABRAXANE
Milestone Two
Dec. 31, 2013
ABRAXANE
Milestone Two
Minimum
Dec. 31, 2013
ABRAXANE
Milestone Two
Maximum
Dec. 31, 2013
ABRAXANE
Milestone Three
Dec. 31, 2013
ABRAXANE
Milestone Three
Minimum
Dec. 31, 2013
ABRAXANE
Termination date of December 31, 2025 if sales less than $1.0 billion
Minimum
Dec. 31, 2013
ABRAXANE
Termination date of December 31, 2030 or earlier if sales less than $1.0 billion
Minimum
Oct. 31, 2012
Abraxis Bio Science, Inc.
Business Acquisition [Line Items]                                      
Total rental expense under operating leases $ 50,900,000 $ 41,900,000 $ 48,100,000                                
Intangible asset                                     1,172,000,000
Notional amount 7,635,000,000                                    
Letters of credit and guarantees issued on behalf of subsidiaries 86,600,000                                    
Product supply contract obligation 153,700,000                                    
Product Liability Contingency [Line Items]                                      
Nonfinancial liabilities         118,100,000 277,400,000                          
CVR milestone payment         250,000,000.0   400,000,000.0 300,000,000.0                      
Net sales measurement period         1 year                            
Royalty rate                 2.50%     5.00%     10.00%        
Revenue milestones                   1,000,000,000.000 2,000,000,000.000   2,000,000,000.000 3,000,000,000.000   3,000,000,000.000 1,000,000,000.000 1,000,000,000.000  
Milestone payment made       $ 300,000,000                              
XML 88 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventory
 12 Months Ended
Dec. 31, 2013
Inventory Disclosure [Abstract]  
Inventory
Inventory
A summary of inventories by major category at December 31, 2013 and 2012 follows:
 
 
2013
 
2012
Raw materials
 
$
147.4

 
$
79.2

Work in process
 
99.6

 
86.5

Finished goods
 
93.4

 
93.8

Total
 
$
340.4

 
$
259.5



Raw materials increased by $68.2 million in 2013 compared to 2012 primarily resulting from an increase in the sales level of ABRAXANE® , which was approved by the FDA for treatment of Non-Small Cell Lung Cancer (NSCLC) in October 2012 and pancreatic cancer in September 2013. In addition, $33.4 million of OTEZLA® (apremilast) inventory has been capitalized in 2013 prior to regulatory approval, in anticipation of regulatory approval for this product.
XML 89 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments and Hedging Activities (Details 3) (USD $)
In Millions, unless otherwise specified
 12 Months Ended 1 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Feb. 14, 2014
Designated as hedging instruments
Forward Starting Interest Rate Swap, Maturing in Year Five [Member]
Dec. 31, 2013
Designated as hedging instruments
Forward Starting Interest Rate Swap, Maturing in Year Five [Member]
Dec. 31, 2013
Designated as hedging instruments
Cash flow hedges
Foreign exchange contracts
Dec. 31, 2012
Designated as hedging instruments
Cash flow hedges
Foreign exchange contracts
Dec. 31, 2013
Designated as hedging instruments
Cash flow hedges
Foreign exchange contracts
Net product sales
Dec. 31, 2012
Designated as hedging instruments
Cash flow hedges
Foreign exchange contracts
Net product sales
Dec. 31, 2013
Designated as hedging instruments
Cash flow hedges
Foreign exchange contracts
Other income, net
Dec. 31, 2012
Designated as hedging instruments
Cash flow hedges
Foreign exchange contracts
Other income, net
Dec. 31, 2013
Designated as hedging instruments
Cash flow hedges
Interest rate swap contracts
Dec. 31, 2013
Designated as hedging instruments
Cash flow hedges
Treasury rate locks
Dec. 31, 2012
Designated as hedging instruments
Cash flow hedges
Treasury rate locks
Dec. 31, 2013
Designated as hedging instruments
Cash flow hedges
Treasury rate locks
Interest expense
Dec. 31, 2012
Designated as hedging instruments
Cash flow hedges
Treasury rate locks
Interest expense
Dec. 31, 2013
Designated as hedging instruments
Fair value hedges
Interest rate swap contracts
Interest expense
Dec. 31, 2012
Designated as hedging instruments
Fair value hedges
Interest rate swap contracts
Interest expense
Dec. 31, 2013
Not designated as hedging instruments
Foreign exchange contracts
Other income, net
Dec. 31, 2012
Not designated as hedging instruments
Foreign exchange contracts
Other income, net
Dec. 31, 2013
Not designated as hedging instruments
Interest rate swap contracts
Other income, net
Dec. 31, 2012
Not designated as hedging instruments
Interest rate swap contracts
Other income, net
Dec. 31, 2013
Not designated as hedging instruments
Treasury rate locks
Other income, net
Dec. 31, 2012
Not designated as hedging instruments
Treasury rate locks
Other income, net
Dec. 31, 2013
Not designated as hedging instruments
Put options sold
Other income, net
Dec. 31, 2012
Not designated as hedging instruments
Put options sold
Other income, net
Derivative instruments gain loss                                                  
Derivative, Average Remaining Maturity     5 years 5 years                                          
Amount of Gain/(Loss) Recognized in OCI on Derivative (Effective Portion)         $ (9.7) $ 74.5         $ 0 $ 0 $ (35.3)                        
Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion)             10.7 80.9           (3.4) (1.3)                    
Amount of Gain/(Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded From Effectiveness Testing)                 12.6 (6.6)           31.4 7.8                
Gains (losses) expected to be reclassified from accumulated OCI into operations in the next 12 months (13.2)                                                
Gains (losses) related to ineffective portion of hedging relationships 6.3 (9.0)                                              
Gains (losses) related to amounts excluded from assessment of hedge effectiveness 6.3 2.4                                              
Derivative instruments not designated as hedging instruments                                                  
Amount of Gain/(Loss) Recognized in Income on Derivative                                   $ 34.1 $ 23.8 $ 0.7 $ 0.3 $ 0 $ 3.7 $ 1.2 $ 0
XML 90 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments and Hedging Activities
 12 Months Ended
Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Activities
Our revenue and earnings, cash flows and fair values of assets and liabilities can be impacted by fluctuations in foreign exchange rates and interest rates. We actively manage the impact of foreign exchange rate and interest rate movements through operational means and through the use of various financial instruments, including derivative instruments such as foreign currency option contracts, foreign currency forward contracts, treasury rate lock agreements and interest rate swap contracts.
Foreign Currency Risk Management
We maintain a foreign exchange exposure management program to mitigate the impact of volatility in foreign exchange rates on future foreign currency cash flows, translation of foreign earnings and changes in the fair value of assets and liabilities denominated in foreign currencies.
Through our revenue hedging program, we endeavor to reduce the impact of possible unfavorable changes in foreign exchange rates on our future U.S. dollar cash flows that are derived from foreign currency denominated sales. To achieve this objective, we hedge a portion of our forecasted foreign currency denominated sales that are expected to occur in the foreseeable future, typically within the next three years. We manage our anticipated transaction exposure principally with foreign currency forward contracts and occasionally foreign currency put and call options.
Foreign Currency Forward Contracts:  We use foreign currency forward contracts to hedge specific forecasted transactions denominated in foreign currencies, manage exchange rate volatility in the translation of foreign earnings, and to reduce exposures to foreign currency fluctuations of certain assets and liabilities denominated in foreign currencies.
We manage a portfolio of foreign currency forward contracts to protect against changes in anticipated foreign currency cash flows resulting from changes in foreign currency exchange rates, primarily associated with non-functional currency denominated revenues and expenses of foreign subsidiaries. The foreign currency forward hedging contracts outstanding at December 31, 2013 and 2012 had settlement dates within 36 months. These foreign currency forward contracts are designated as cash flow hedges and, to the extent effective, any unrealized gains or losses on them are reported in other comprehensive income (loss) (OCI) and reclassified to operations in the same periods during which the underlying hedged transactions affect operations. Any ineffectiveness on these foreign currency forward contracts is reported in other income (expense), net. Foreign currency forward contracts entered into to hedge forecasted revenue and expenses were as follows at December 31, 2013 and 2012:
 
 
Notional Amount
Foreign Currency:
 
2013
 
2012
Australian Dollar
 
$
—

 
$
5.1

British Pound
 
279.4

 
77.9

Canadian Dollar
 
—

 
134.4

Euro
 
3,318.2

 
969.3

Japanese Yen
 
559.1

 
236.2

Total
 
$
4,156.7

 
$
1,422.9


We consider the impact of our own and the counterparties' credit risk on the fair value of the contracts as well as the ability of each party to execute its obligations under the contract on an ongoing basis. As of December 31, 2013, credit risk did not materially change the fair value of our foreign currency forward contracts.
We also manage a portfolio of foreign currency contracts to reduce exposures to foreign currency fluctuations of certain recognized assets and liabilities denominated in foreign currencies and, from time to time, we enter into foreign currency contracts to manage exposure related to translation of foreign earnings. These foreign currency forward contracts have not been designated as hedges and, accordingly, any changes in their fair value are recognized on the Consolidated Statements of Income in other income (expense), net in the current period. The aggregate notional amount of the foreign currency forward non-designated hedging contracts outstanding at December 31, 2013 and 2012 were $878.5 million and $795.4 million, respectively.
Foreign Currency Option Contracts: From time to time, we may hedge a portion of our future foreign currency exposure by utilizing a strategy that involves both a purchased local currency put option and a written local currency call option that are accounted for as hedges of future sales denominated in euros. In connection with this strategy, we may also sell local currency put options that are not accounted for as hedges in order to reduce or fully offset the net cost of the hedging contracts. Foreign currency option contracts entered into to hedge forecasted revenue and expenses were as follows at December 31, 2013 and 2012:
 
Notional Amount1
 
2013
 
2012
Foreign Currency Option:
 
 
 
Designated as hedging activity:
 
 
 
Purchased Put
$
—

 
$
228.8

Written Call
$
—

 
$
235.9

Not designated as hedging activity:
 
 
 
Purchased Put
$
—

 
$
160.5

Written Put
$
—

 
$
(216.0
)
1 U.S. dollar notional amounts are calculated as the hedged local currency amount multiplied times the strike value of the foreign currency option. The local currency notional amounts of our purchased put and written call that are designated as hedging activities are equal to each other.


Interest Rate Risk Management
In anticipation of issuing fixed-rate debt, we may use forward starting interest rate swaps (forward starting swaps) or treasury rate lock agreements (treasury rate locks) that are designated as cash flow hedges to hedge against changes in interest rates that could impact expected future issuances of debt. To the extent these hedges of cash flows related to anticipated debt are effective, any realized or unrealized gains or losses on the treasury rate locks or forward starting swaps are reported in OCI and are recognized in income over the life of the anticipated fixed-rate notes.

Forward Starting Interest Rate Swaps: During 2013, we entered into forward starting swaps, that were designated as cash flow hedges, with an aggregate notional value of $300.0 million and effective dates in November 2014, with $100.0 million maturing in five years and $200 million maturing in ten years to hedge against changes in interest rates that could impact an anticipated issuance of debt. During January and February 2014, we entered into additional forward starting swaps with effective dates in November 2014 and an aggregate notional value of $350.0 million and maturities of five and ten years.
Treasury Rate Lock Agreements: During 2012, we entered into treasury rate locks in anticipation of issuing fixed-rate notes that were issued in August 2012. The treasury rate locks were settled during 2012 which resulted in losses of $35.3 million that were recorded to OCI. No material amounts were recorded in income during 2013 or 2012 as a result of hedge ineffectiveness or hedge components excluded from the assessment of effectiveness.
Interest Rate Swap Contracts:    From time to time we hedge the fair value of certain debt obligations through the use of interest rate swap contracts. The interest rate swap contracts are designated hedges of the fair value changes in the notes attributable to changes in interest rates. Since the specific terms and notional amount of the swap are intended to match those of the debt being hedged, it is assumed to be a highly effective hedge and all changes in fair value of the swap is recorded on the Consolidated Balance Sheets with no net impact recorded in income. Any net interest payments made or received on interest rate swap contracts are recognized as interest expense. We may terminate the hedging relationship of certain swap contracts by settling the contracts or by entering into offsetting contracts.  At the time a hedging relationship is terminated, accumulated gains or losses associated with the swap contract are measured and recorded as a reduction of current and future interest expense associated with the previously hedged notes.
We have entered into swap contracts that were designated as hedges of our fixed rate notes due in 2015, 2017, 2018, 2020, 2022 and 2023 and also terminated the hedging relationship by settling certain of those swap contracts during 2012 and 2013.  The settlement of swap contracts resulted in the receipt of net proceeds of $5.0 million in 2012 and $22.9 million in 2013 which is accounted for as a reduction of current and future interest expense associated with these notes.  See Note 11 for additional details related to reductions of current and future interest expense. The following table summarizes the notional amounts of our outstanding swap contracts at the end December 31, 2013 and 2012:
 
 
Notional Amount
 
 
2013
 
2012
Interest rate swap contracts entered into as fair value hedges of the following fixed-rate senior notes:
 
 

 
 

2.450% senior notes due 2015
 
$
300.0

 
$
—

1.900% senior notes due 2017
 
300.0

 
100.0

2.300% senior notes due 2018
 
200.0

 
—

3.950% senior notes due 2020
 
500.0

 
—

3.250% senior notes due 2022
 
850.0

 
200.0

4.000% senior notes due 2023
 
150.0

 
—

Total
 
$
2,300.0

 
$
300.0


During 2014 we continued to actively manage our interest rate swaps and have terminated the hedging relationships of certain swap contracts and entered into new swaps that were designated as fair value hedges of our senior notes. The notional amount of our outstanding interest rate contracts at February 12, 2014 was $1.850 billion.
The following table summarizes the fair value and presentation in the Consolidated Balance Sheets for derivative instruments as of December 31, 2013 and 2012:
 
 
December 31, 2013
 
 
Asset Derivatives
 
Liability Derivatives
Instrument
 
Balance Sheet
Location
 
Fair Value
 
Balance Sheet
Location
 
Fair Value
Derivatives designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
$
63.6

 
Other current assets
 
$
24.9

 
 
Other current liabilities
 
41.5

 
Other current liabilities
 
84.7

 
 
Other non-current assets
 
60.6

 
Other non-current assets
 
41.9

 
 
Other non-current liabilities
 
4.3

 
Other non-current liabilities
 
25.6

Interest rate swap agreements
 
Other current assets
 
17.1

 
Other current assets
 
—

 
 
Other non-current liabilities
 
—

 
Other non-current liabilities
 
68.3

Derivatives not designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
11.3

 
Other current assets
 
0.7

 
 
Other current liabilities
 
6.0

 
Other current liabilities
 
18.7

Interest rate swap agreements
 
Other current assets
 
0.1

 
Other current assets
 
—

 
 
Other non-current assets
 
1.5

 
Other non-current assets
 
—

Total
 
 
 
$
206.0

 
 
 
$
264.8

 
 
December 31, 2012
 
 
Asset Derivatives
 
Liability Derivatives
Instrument
 
Balance Sheet
Location
 
Fair Value
 
Balance Sheet
Location
 
Fair Value
Derivatives designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
$
35.2

 
Other current assets
 
$
12.7

 
 
Other current liabilities
 
9.1

 
Other current liabilities
 
31.4

 
 
Other non-current assets
 
30.5

 
Other non-current assets
 
13.8

Interest rate swap agreements
 
Other current assets
 
0.1

 
Other current assets
 
—

 
 
Other non-current assets
 
0.1

 
Other non-current assets
 
0.2

 
 
Other non-current liabilities
 
—

 
Other non-current liabilities
 
0.6

Derivatives not designated as hedging instruments:
 
 
Foreign exchange contracts1
 
Other current assets
 
45.8

 
Other current assets
 
36.3

 
 
Other current liabilities
 
10.4

 
Other current liabilities
 
21.4

Interest rate swap agreements
 
Other current assets
 
0.6

 
Other current assets
 
—

 
 
Other non-current assets
 
1.7

 
Other non-current assets
 
—

Total
 
 
 
$
133.5

 
 
 
$
116.4

1Derivative instruments in this category are subject to master netting arrangements and are presented on a net basis in the Consolidated Balance Sheets in accordance with ASC 210-20.
The following table summarizes the effect of derivative instruments designated as cash-flow hedging instruments on the Consolidated Statements of Income for the years ended December 31, 2013 and 2012:
 
 
2013
 
 
 
 
Amount of
Gain/(Loss)
Recognized in OCI
on Derivative1
 
Location of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Amount of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Location of
Gain/(Loss)
Recognized in
Income on
Derivative
 
Amount of
Gain/(Loss)
Recognized in
Income on
Derivative
 
 
Instrument
 
(Effective Portion)
 
(Effective Portion)
 
(Effective Portion)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
 
Foreign exchange contracts
 
$
(9.7
)
 
Net product sales
 
$
10.7

 
Other income, net
 
$
12.6

 
2 
Treasury rate lock agreements
 
$
—

 
Interest expense
 
$
(3.4
)
 
 
 
 

 
 
Forward starting interest rate swaps
 
$
6.5

 
Interest expense
 
$
—

 
 
 
 
 
 

1 
Net losses of $13.2 million are expected to be reclassified from Accumulated OCI into income in the next 12 months.
2 
The amount of net gains recognized in income represents $6.3 million of gains related to the ineffective portion of the hedging relationships and $6.3 million of gains related to amounts excluded from the assessment of hedge effectiveness.

 
 
2012
 
 
 
 
Amount of
Gain/(Loss)
Recognized in OCI
on Derivative
 
Location of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Amount of
Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
 
Location of
Gain/(Loss)
Recognized in
Income on
Derivative
 
Amount of
Gain/(Loss)
Recognized in
Income on
Derivative
 
 
Instrument
 
(Effective Portion)
 
(Effective Portion)
 
(Effective Portion)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
(Ineffective Portion
and Amount Excluded
From Effectiveness
Testing)
 
 
Foreign exchange contracts
 
$
74.5

 
Net product sales
 
$
80.9

 
Other income, net
 
$
(6.6
)
 
1 
Treasury rate lock agreements
 
$
(35.3
)
 
Interest Expense
 
$
(1.3
)
 
 
 
 

 
 

1 
The amount of net losses recognized in income represents $9.0 million in losses related to the ineffective portion of the hedging relationships and $2.4 million of gains related to amounts excluded from the assessment of hedge effectiveness.
The following table summarizes the effect of derivative instruments designated as fair value hedging instruments on the Consolidated Statements of Income for the years ended December 31, 2013 and 2012:
 
 
Location of Gain (Loss)
Recognized in Income
on Derivative
 
Amount of Gain (Loss)
Recognized in Income
on Derivative
Instrument
 
2013
 
2012
Interest Rate Swaps
 
Interest expense
 
$
31.4

 
$
7.8


The following table summarizes the effect of derivative instruments not designated as hedging instruments on the Consolidated Statements of Income for the years ended December 31, 2013 and 2012:
 
 
Location of Gain (Loss)
Recognized in Income
on Derivative
 
Amount of Gain (Loss)
Recognized in Income
on Derivative
Instrument
 
2013
 
2012
Foreign exchange contracts
 
Other income, net
 
$
34.1

 
$
23.8

Treasury rate lock agreements
 
Other income, net
 
$
—

 
$
3.7

Interest rate swap agreements
 
Other income, net
 
$
0.7

 
$
0.3

Put options sold
 
Other income, net
 
$
1.2

 
$
—



The impact of gains and losses on foreign exchange contracts not designated as hedging instruments related to changes in the fair value of assets and liabilities denominated in foreign currencies are generally offset by net foreign exchange gains and losses, which are also included in other income (expense), net for all periods presented. When we enter into foreign exchange contracts not designated as hedging instruments to mitigate the impact of exchange rate volatility in the translation of foreign earnings, gains and losses will generally be offset by fluctuations in the U.S. dollar translated amounts of each Income Statement account in current and/or future periods.
XML 91 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents and Marketable Securities Available-for-Sale
 12 Months Ended
Dec. 31, 2013
Cash, Cash Equivalents, and Short-term Investments [Abstract]  
Cash, Cash Equivalents and Marketable Securities Available-for-Sale
Cash, Cash Equivalents and Marketable Securities Available-for-Sale
Money market funds of $1.697 billion and $1.160 billion at December 31, 2013 and 2012, respectively, were recorded at cost, which approximates fair value and are included in cash and cash equivalents.
The amortized cost, gross unrealized holding gains, gross unrealized holding losses and estimated fair value of available-for-sale securities by major security type and class of security at December 31, 2013 and 2012 were as follows:
December 31, 2013
 
Amortized
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
U.S. Treasury securities
 
$
795.2

 
$
0.3

 
$
(0.4
)
 
$
795.1

U.S. government-sponsored agency securities
 
208.9

 
0.2

 
(0.2
)
 
208.9

U.S. government-sponsored agency MBS
 
450.8

 
0.1

 
(6.9
)
 
444.0

Non-U.S. government, agency and
Supranational securities
 
10.4

 
—

 
—

 
10.4

Corporate debt – global
 
379.2

 
1.1

 
(0.6
)
 
379.7

Asset backed securities
 
181.6

 
—

 
(0.2
)
 
181.4

Marketable equity securities
 
212.9

 
220.2

 
—

 
433.1

Total available-for-sale marketable securities
 
$
2,239.0

 
$
221.9

 
$
(8.3
)
 
$
2,452.6


December 31, 2012
 
Amortized
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
U.S. Treasury securities
 
$
902.0

 
$
0.5

 
$
—

 
$
902.5

U.S. government-sponsored agency securities
 
303.5

 
0.3

 
—

 
303.8

U.S. government-sponsored agency MBS
 
387.2

 
1.6

 
(1.8
)
 
387.0

Non-U.S. government, agency and
Supranational securities
 
7.1

 
—

 
—

 
7.1

Corporate debt – global
 
208.5

 
0.9

 
(0.2
)
 
209.2

Marketable equity securities
 
0.4

 
—

 
(0.1
)
 
0.3

Total available-for-sale marketable securities
 
$
1,808.7

 
$
3.3

 
$
(2.1
)
 
$
1,809.9



U.S. government-sponsored agency securities include general unsecured obligations either issued directly by or guaranteed by U.S. Government Sponsored Enterprises.  U.S. government-sponsored agency MBS include mortgage-backed securities issued by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Government National Mortgage Association.  Non-U.S. government, agency and Supranational securities consist of direct obligations of highly rated governments of nations other than the United States and obligations of sponsored agencies and other entities that are guaranteed or supported by highly rated governments of nations other than the United States.  Corporate debt-global includes obligations issued by investment-grade corporations, including some issues that have been guaranteed by governments and government agencies.  Asset backed securities consist of triple-A rated securities with cash flows collateralized by credit card receivables and auto loans. Marketable equity securities consist of investments in equity securities that have become publicly traded.  The increase in net unrealized gains in marketable equity securities in 2013 compared to 2012 primarily reflects the increase in market value for certain equity investments subsequent to their respective initial public offerings. Net unrealized losses in the marketable securities primarily reflect the impact of increased interest rates at December 31, 2013.
The fair value of all available-for-sale securities, which have been in an unrealized loss position for less than and longer than 12 months at December 31, 2013, was as follows:
 
 
Less than 12 months
 
12 months or longer
 
Total
December 31, 2013
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
 
Estimated
Fair
Value
 
Gross
Unrealized
Loss
U.S. Treasury securities
 
$
316.9

 
$
(0.4
)
 
$
—

 
$
—

 
$
316.9

 
$
(0.4
)
U.S. government-sponsored agency securities
 
78.2

 
(0.2
)
 
—

 
—

 
78.2

 
(0.2
)
U.S. government-sponsored agency MBS
 
358.9

 
(5.4
)
 
45.8

 
(1.5
)
 
404.7

 
(6.9
)
Corporate debt – global
 
135.1

 
(0.6
)
 
—

 
—

 
135.1

 
(0.6
)
Asset backed securities
 
126.3

 
(0.2
)
 
—

 
—

 
126.3

 
(0.2
)
Total
 
$
1,015.4

 
$
(6.8
)
 
$
45.8

 
$
(1.5
)
 
$
1,061.2

 
$
(8.3
)

The Company believes that the decline in fair value of securities held at December 31, 2013 below their cost is temporary and intends to retain its investment in these securities for a sufficient period of time to allow for recovery in the market value of these investments.
Duration periods of available-for-sale debt securities at December 31, 2013 were as follows:
 
 
Amortized
Cost
 
Fair
Value
Duration of one year or less
 
$
391.8

 
$
391.6

Duration of one through three years
 
1,364.8

 
1,363.8

Duration of three through five years
 
233.9

 
229.8

Duration of over five years
 
35.6

 
34.3

Total
 
$
2,026.1

 
$
2,019.5
XML 92 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property, Plant and Equipment
 12 Months Ended
Dec. 31, 2013
Property, Plant and Equipment, Net [Abstract]  
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment at December 31, 2013 and 2012 consisted of the following:
 
 
2013
 
2012
Land
 
$
37.9

 
$
36.7

Buildings
 
258.0

 
228.4

Building and operating equipment
 
30.8

 
30.0

Leasehold improvements
 
128.2

 
78.1

Machinery and equipment
 
193.8

 
175.2

Furniture and fixtures
 
46.3

 
41.2

Computer equipment and software
 
286.1

 
239.5

Construction in progress
 
44.6

 
90.1

Subtotal
 
1,025.7

 
919.2

Less accumulated depreciation and amortization
 
432.3

 
340.8

Total
 
$
593.4

 
$
578.4


The balance of construction in progress at December 31, 2013 relates primarily to an expansion of our international headquarters in Boudry, Switzerland as well as the expansion of our corporate headquarters in Summit, New Jersey.
XML 93 R64.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventory (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
ABRAXANE
Dec. 31, 2013
OTEZLA
Inventory Disclosure [Abstract]        
Raw materials $ 147.4 $ 79.2    
Work in process 99.6 86.5    
Finished goods 93.4 93.8    
Total 340.4 259.5    
Inventory [Line Items]        
Increase in raw materials during period     $ 68.2 $ 33.4
XML 94 R85.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details 2) (USD $)
 12 Months Ended 0 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
attorney_general
Dec. 31, 2011
Dec. 31, 2013
Children's Medical Center Corporation
Jun. 07, 2013
Revlimid Royalty
Jun. 07, 2013
Pomalyst Royalty
Dec. 31, 2012
The Chan Soon-Shiong Institute for Advanced Health
contribution
Dec. 31, 2012
NantBioScience
Operating Leases                
2014 $ 54,500,000              
2015 47,700,000              
2016 39,600,000              
2017 31,400,000              
2018 21,400,000              
Thereafter 44,600,000              
Total minimum lease payments 239,200,000              
Total rental expense under operating leases 50,900,000 41,900,000 48,100,000          
Lines of Credit:                
Derivative contract notional amount 7,635,000,000              
Letters of credit and guarantees issued on behalf of subsidiaries 86,600,000              
Other Commitments:                
Product supply contract obligation 153,700,000              
Other Commitments                
Number of additional contribution amounts             2  
Potential future investment             25,000,000 50,000,000
Potential milestone payments             25,000,000  
Product Liability Contingency [Line Items]                
Royalty rate (as a percent)         0.01 0.025    
Loss Contingencies [Line Items]                
Range of possible loss minimum       0        
Range of possible loss maximum       $ 35,900,000        
Number of other U.S. Attorney offices conducting investigations   2            
XML 95 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Financial Information (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Accrued expenses    
Compensation $ 261.7 $ 170.3
Rebates, distributor chargebacks and distributor services 217.3 187.0
Clinical trial costs and grants 192.6 183.3
Common share repurchases 45.7 41.0
Interest 49.0 26.3
Royalties, license fees and collaboration agreements 52.4  
Royalties, license fees and collaboration agreements   19.4
Commercial related activities 46.6 22.8
Sales returns 15.5 13.3
Rent 14.8 9.5
Professional services 9.3 9.8
Other Taxes 7.6 8.3
Other 88.6 84.7
Total 1,001.1 775.7
Other current liabilities    
Contingent value rights – Abraxis acquisition 0 277.4
Sales, use and value added tax 50.9 56.9
Foreign exchange contracts 55.9 33.3
Collaboration agreement 7.0 17.0
Other 23.2 29.3
Total 199.7 431.3
Other non-current liabilities    
Deferred compensation and long-term incentives 127.2 99.2
Foreign exchange contracts 89.6 0.6
Deferred lease incentive 28.7 31.4
Collaboration agreement 28.0 0
Manufacturing facility purchase 13.9 14.4
Other 11.4 29.1
Total 582.7 355.5
Avila Therapeutics, Inc.
    
Other non-current liabilities    
Contingent consideration 147.5 163.5
Abraxis Bio Science, Inc.
    
Other non-current liabilities    
Contingent consideration 118.1 0
Gloucester Pharmaceuticals, Inc.
    
Other non-current liabilities    
Contingent consideration 18.3 17.3
Avila Therapeutics, Inc.
    
Other current liabilities    
Contingent consideration – Avila acquisition $ 62.7 $ 17.4
XML 96 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details 3) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Amortized Cost  
Duration of one year or less $ 391.8
Duration of one through three years 1,364.8
Duration of three through five years 233.9
Duration of over five years 35.6
Total 2,026.1
Fair Value  
Duration of one year or less 391.6
Duration of one through three years 1,363.8
Duration of three through five years 229.8
Duration of over five years 34.3
Total $ 2,019.5
XML 97 R92.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule II - Valuation and Qualifying Accounts (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year $ 46.3 $ 27.8 $ 17.9
Additions Charged to Expense or Sales 96.2 84.9 79.3
Deductions 87.0 66.4 69.4
Balance at End of Year 55.5 46.3 27.8
Allowance for doubtful accounts
      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year 21.8 10.1 4.8
Additions Charged to Expense or Sales 12.3 12.5 6.4
Deductions 6.2 0.8 1.1
Balance at End of Year 27.9 21.8 10.1
Allowance for customer discounts
      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year 11.2 8.7 8.3
Additions Charged to Expense or Sales 74.3 64.9 56.1
Deductions 73.4 62.4 55.7
Balance at End of Year 12.1 11.2 8.7
Subtotal
      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year 33.0 18.8 13.1
Additions Charged to Expense or Sales 86.6 77.4 62.5
Deductions 79.6 63.2 56.8
Balance at End of Year 40.0 33.0 18.8
Allowance for sales returns
      
Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year 13.3 9.0 4.8
Additions Charged to Expense or Sales 9.6 7.5 16.8
Deductions 7.4 3.2 12.6
Balance at End of Year $ 15.5 $ 13.3 $ 9.0
XML 98 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2013
Earnings Per Share [Abstract]  
Schedule of earnings per share
 
 
2013
 
2012
 
2011
Net income attributable to Celgene
 
$
1,449.9

 
$
1,456.2

 
$
1,318.1

Weighted-average shares:
 
 
 
 
 
 
Basic
 
413.8

 
430.9

 
455.3

Effect of dilutive securities:
 
 
 
 
 
 
Options, restricted stock units, warrants and other
 
16.5

 
9.9

 
7.4

Diluted
 
430.3

 
440.8

 
462.7

Net income per share attributable to Celgene:
 
 
 
 
 
 
Basic
 
$
3.50

 
$
3.38

 
$
2.89

Diluted
 
$
3.37

 
$
3.30

 
$
2.85
XML 99 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of Business and Basis and Summary of Significant Accounting Policies (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2013
Net receivables
Spain, Italy and Portugal
Dec. 31, 2012
Net receivables
Spain, Italy and Portugal
Concentration of Credit Risk:      
Increase in rebates distributor chargebacks and distributor services $ 20.3    
Accounts receivable, net   348.4 324.2
Accounts receivable, net, noncurrent   $ 86.4  
XML 100 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accumulated Other Comprehensive Income (Loss)
 12 Months Ended
Dec. 31, 2013
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss)
 Accumulated Other Comprehensive Income (Loss)
The components of other comprehensive income (loss) consist of changes in pension liability, changes in net unrealized gains (losses) on marketable securities classified as available-for-sale, net unrealized gains (losses) related to cash flow hedges and changes in foreign currency translation adjustments, which includes changes in a subsidiary's functional currency and net asset transfers of common control subsidiaries.
The accumulated balances related to each component of other comprehensive income (loss), net of tax, are summarized as follows:
 
 
Pension
Liability
 
Net Unrealized
Gains (Losses) From
Marketable Securities
 
Net Unrealized
Gains (Losses)
From Hedges
 
Foreign
Currency
Translation
Adjustment
 
Total
Accumulated
Other
Comprehensive
Income (Loss)
Balance December 31, 2011
 
$
(5.4
)
 
$
1.8

 
$
8.7

 
$
(67.4
)
 
$
(62.3
)
Period change
 
(4.7
)
 
2.4

 
(24.7
)
 
39.6

 
12.6

Balance December 31, 2012
 
(10.1
)
 
4.2

 
(16.0
)
 
(27.8
)
 
(49.7
)
Period change
 
3.2

 
133.1

 
(20.0
)
 
27.4

 
143.7

Balance December 31, 2013
 
$
(6.9
)
 
$
137.3

 
$
(36.0
)
 
$
(0.4
)
 
$
94.0





 
 
 
 
Gains (Losses) Reclassified Out of Accumulated
Other Comprehensive Income
Accumulated Other Comprehensive Income Components
 
Affected Line Item in the Consolidated Statements of Income
 
Years Ended December 31,
 
 
2013
 
2012
 
2011
Gains (losses) from cash-flow hedges:
 
 

 
 

 
 
Foreign exchange contracts
 
Net product sales
 
$
10.7

 
$
80.9

 
$
—

Treasury rate lock agreements
 
Interest (expense)
 
(3.4
)
 
(1.3
)
 
—

 
 
Income tax benefit (expense)
 
6.9

 
(1.9
)
 
(2.9
)
Gains (losses) from available-for-sale marketable securities:
 
 
 
 
 
 
Realized income (loss) on sales of marketable securities
 
Interest and investment income, net
 
(7.3
)
 
(1.1
)
 
4.0

 
 
Income tax benefit
 
2.2

 
0.1

 
0.3

Total reclassification, net of tax
 
 
 
$
9.1

 
$
76.7

 
$
1.4
XML 101 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies
Contingent Value Rights: In connection with the acquisition of Abraxis in 2010, CVRs were issued under a Contingent Value Rights Agreement, or CVR Agreement, entered into between Celgene and American Stock Transfer & Trust Company, LLC, as trustee. The CVRs are registered for trading on the NASDAQ Global Market under the symbol "CELGZ." The fair value of the liability of the Company related to payments under the CVR Agreement are subject to fluctuation based on trading prices for the publicly traded CVRs. Subsequent to the Abraxis Acquisition Date, we measured the contingent consideration represented by the CVRs at fair value with changes in fair value recognized in operating earnings. The fair value of our liability related to the CVRs was $118.1 million at the end of 2013 compared to $277.4 million at the end of 2012.
Each holder of a CVR is entitled to receive a pro rata portion, based on the number of CVRs then outstanding, of each of the following contingent cash payments:
•
Milestone Payment #1.  $250.0 million upon FDA approval of ABRAXANE® for use in the treatment of NSCLC if such approval permits us to market ABRAXANE® with FDA approval that includes a progression-free survival, or PFS, claim, but only if this milestone is achieved no later than the fifth anniversary of the Merger.
•
Milestone Payment #2.  $400.0 million (if achieved no later than April 1, 2013) or $300.0 million (if achieved after April 1, 2013 and before the fifth anniversary of the Merger) upon FDA approval of ABRAXANE® for use in the treatment of pancreatic cancer, if such approval permits us to market ABRAXANE® with FDA approval that includes an overall survival claim.
•
Net Sales Payments.  For each full one-year period ending December 31 during the term of the CVR Agreement, which we refer to as a net sales measuring period (with the first net sales measuring period beginning January 1, 2011 and ending December 31, 2011):
◦
2.5% of the net sales of ABRAXANE® and the Abraxis pipeline products that exceed $1.000 billion but are less than or equal to $2.000 billion for such period, plus
◦
an additional amount equal to 5% of the net sales of ABRAXANE® and the Abraxis pipeline products that exceed $2.000 billion but are less than or equal to $3.000 billion for such period, plus
◦
an additional amount equal to 10% of the net sales of ABRAXANE® and the Abraxis pipeline products that exceed $3.000 billion for such period.
No payments will be due under the CVR Agreement with respect to net sales of ABRAXANE® and the Abraxis pipeline products after December 31, 2025, which we refer to as the net sales payment termination date, unless net sales for the net sales measuring period ending on December 31, 2025 are equal to or greater than $1.000 billion, in which case the net sales payment termination date will be extended until the last day of the first net sales measuring period subsequent to December 31, 2025 during which net sales of ABRAXANE® and the Abraxis pipeline products are less than $1.000 billion or, if earlier, December 31, 2030.
Milestone Payment #1 update: In October 2012, the FDA approved ABRAXANE® for the first-line treatment of locally advanced or metastatic NSCLC, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. The FDA approval was based on tumor response rates and did not result in the use of a marketing label that includes a progression-free survival claim, and accordingly, the CVR Milestone Payment #1, as described above, has not been achieved. This approval resulted in the related $1.172 billion intangible asset obtained from the Abraxis acquisition being reclassified in October 2012 from an acquired IPR&D intangible to an acquired developed product rights intangible asset and amortization commenced in October 2012.
Milestone Payment #2 update: In September 2013, the FDA approved ABRAXANE® for use in the treatment of pancreatic cancer, permitting us to market ABRAXANE® with a label that includes an overall survival claim. This approval resulted in the achievement of milestone #2 and the subsequent payment of $300.0 million to CVR holders in October 2013.
Leases:    We lease offices and research facilities under various operating lease agreements in the United States and international markets. We also lease automobiles and certain equipment in these same markets. At December 31, 2013, the non-cancelable lease terms for the operating leases expire at various dates between 2014 and 2023 and include renewal options. In general, the Company is also required to reimburse the lessors for real estate taxes, insurance, utilities, maintenance and other operating costs associated with the leases.
Future minimum lease payments under non-cancelable operating leases as of December 31, 2013 are:
 
Operating
Leases
2014
$
54.5

2015
47.7

2016
39.6

2017
31.4

2018
21.4

Thereafter
44.6

Total minimum lease payments
$
239.2


Total rental expense under operating leases was approximately $50.9 million in 2013, $41.9 million in 2012 and $48.1 million in 2011.
Lines of Credit:    We maintain lines of credit with several banks to support its hedging programs and to facilitate the issuance of bank letters of credit and guarantees on behalf of its subsidiaries. Lines of credit supporting our hedging programs as of December 31, 2013 allowed us to enter into derivative contracts with settlement dates through 2016. As of December 31, 2013, we have entered into derivative contracts with net notional amounts totaling $7.635 billion. Lines of credit facilitating the issuance of bank letters of credit and guarantees as of December 31, 2013 allowed us to have letters of credit and guarantees issued on behalf of our subsidiaries totaling $86.6 million.
Other Commitments:    Our obligations related to product supply contracts totaled $153.7 million at December 31, 2013. We are also committed to pay the remaining $14.6 million balance due from our acquisition of a manufacturing facility in Switzerland.
As part of the sale of certain non-core assets in April 2011 (see Note 2) we committed to make certain future contingent matching contributions and an additional milestone-based contingent contribution to the CSS Institute. Under the terms of the agreement, we were obligated to make two additional contributions of $25.0 million based on like amounts of other third-party contributions being received by the CSS Institute and a $25.0 million milestone-based contribution contingent upon the CSS Institute achieving specified results related to the collection of DNA data and genomic sequences and the initiation of research and development alliances to be achieved before December 31, 2015. In conjunction with a September 2013 equity investment, the parent company of NantHealth LLC assumed, and agreed to pay and satisfy when due, our obligation to pay CSS Institute the $25.0 million contingent, milestone-based contribution. Subsequent to December 31, as part of the January 2014 equity investment in NantBioScience, the parent company of NantBioScience assumed, and agreed to pay and satisfy when due, our obligation to pay CSS Institute the $50.0 million contingent, matching contributions.
Collaboration Arrangements:    We have entered into certain research and development collaboration agreements, as identified in Note 17 above, with third parties that include the funding of certain development, manufacturing and commercialization efforts with the potential for future milestone and royalty payments upon the achievement of pre-established developmental, regulatory and/or commercial targets. Our obligation to fund these efforts is contingent upon continued involvement in the programs and/or the lack of any adverse events which could cause the discontinuance of the programs. Due to the nature of these arrangements, the future potential payments are inherently uncertain, and accordingly no amounts have been recorded for the potential future achievement of these targets in our accompanying Consolidated Balance Sheets at December 31, 2013 and 2012.
Contingencies:    We believe we maintain insurance coverage adequate for our current needs. Our operations are subject to environmental laws and regulations, which impose limitations on the discharge of pollutants into the air and water and establish standards for the treatment, storage and disposal of solid and hazardous wastes. We review the effects of such laws and regulations on our operations and modify our operations as appropriate. We believe we are in substantial compliance with all applicable environmental laws and regulations.
We have ongoing customs, duties and VAT examinations in various countries that have yet to be settled. Based on our knowledge of the claims and facts and circumstances to date, none of these matters, individually or in the aggregate, are deemed to be material to our financial condition.
Legal Proceedings:
Like many companies in our industry, we have from time to time received inquiries and subpoenas and other types of information requests from government authorities and we have been subject to claims and other actions related to our business activities.  While the ultimate outcome of investigations and legal proceedings are difficult to predict, adverse resolutions or settlements of those matters may result in, among other things, modification of our business practices, product recalls, costs and significant payments, which may have a material adverse effect on our results of operations, cash flows or financial condition.
 
Pending patent proceedings include challenges to the scope, validity or enforceability of our patents relating to certain of our products or processes. Further, we are subject to claims of third parties that we infringe their patents covering products or processes. Although we believe we have substantial defenses to these challenges and claims, there can be no assurance as to the outcome of these matters and an adverse decision in any of these proceedings could result in (i) a loss of patent protection, which could lead to a significant reduction of sales that could materially affect future results of operations, (ii) our inability to continue to engage in infringing activities, and (iii) significant liabilities, including payment of damages, royalties and/or license fees to any such third party.
 
Among the principal matters pending are the following:
 
Investigative Proceedings:

In 2009, we received a Civil Investigative Demand (CID) from the U.S. Federal Trade Commission (FTC) seeking documents and other information relating to requests by generic companies to purchase our patented REVLIMID® and THALOMID® brand drugs in order for the FTC to evaluate whether there may be reason to believe that we have engaged in unfair methods of competition relating to requests by generic companies to purchase our patented REVLIMID® and THALOMID® brand drugs.  In 2010, the State of Connecticut issued a subpoena referring to the same issues raised by the 2009 CID. Also in 2010, we received a second CID from the FTC relating to this matter.  We continue to cooperate with the FTC and State of Connecticut investigations.
 
In 2011, the United States Attorney’s Office for the Central District of California informed us that they are investigating possible off-label marketing and improper payments to physicians in connection with the sales of THALOMID® and REVLIMID®.  In 2012, we learned that two other United States Attorneys’ offices (the Northern District of Alabama and the Eastern District of Texas) and various state Attorneys General were conducting related investigations.  In February 2014, three civil qui tam actions related to those investigations brought by three former Celgene employees on behalf of the federal and various state governments under the False Claims Act and certain state laws,  were unsealed after the United States Department of Justice (DOJ) declined to intervene in these actions. The DOJ maintains the right to intervene at any time. The three actions are as follows: (i) United States of America ex rel. James Patrick Eddins, Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Northern District of Alabama (the “Northern District of Alabama action”), (ii) David Schmidt, by and on behalf of the United States of America and various States, ex rel. Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Eastern District of Texas, and (iii) United States of America and various States, ex rel. Beverly Brown Plaintiff/Relator v. Celgene Corporation, Defendant, United States District Court for the Central District of California. The plaintiff in the Northern District of Alabama action voluntarily dismissed that case. We intend to vigorously defend against the two remaining civil actions.

Patent Related Proceedings:

REVLIMID®: We received Notice Letters, the first of which was dated August 30, 2010, from Natco Pharma Limited of India (Natco) notifying us of Natco’s Abbreviated New Drug Application (ANDA), which contains Paragraph IV certifications against certain of Celgene’s patents that are listed in the FDA Approved Drug Products With Therapeutic Equivalence Evaluations (the “Orange Book”) for REVLIMID® (lenalidomide). Natco’s Notice Letters were sent in connection with its filing of an ANDA seeking permission from the FDA to market a generic version of 25mg, 15mg, 10mg and 5mg REVLIMID® capsules. In response to the Notice Letters, we filed infringement actions in the United States District Court for the District of New Jersey against Natco, Natco’s U.S. partner, Arrow International Limited (Arrow), and Watson Laboratories, Inc. (Watson, a wholly-owned subsidiary of Actavis, Inc. (formerly known as Watson Pharmaceuticals, Inc.), which is Arrow’s parent) (Natco, Arrow and Watson are collectively referred to hereinafter as “Natco”). In its answer and counterclaim, Natco asserts that our patents are invalid, unenforceable and/or not infringed by Natco’s proposed generic products.

The patents in dispute include United States Patent Nos. 5,635,517, 6,045,501, 6,315,720, 6,555,554, 6,561,976, 6,561,977, 6,755,784, 7,119,106, 7,465,800, 6,281,230, 7,189,740, 7,855,217, 7,968,569, 8,288,415, 8,315,886, 8,404,717 and 8,431,598 plus two non-Orange Book listed patents, United States Patent Nos. 7,977,357 and 8,193,219.

On December 11, 2013, the court set the close of fact discovery for April 21, 2014. Claim construction is currently expected to be fully briefed by April 8, 2014. Dates for a claim construction hearing and trial have yet to be set.
 
We believe that Natco’s defenses and counterclaims are unlikely to be sustained and we intend to vigorously assert our patent rights.  Although there can be no assurance as to the ultimate outcome of this proceeding, we currently expect that it will not have a material adverse effect on our financial condition or results of operations. However, if Natco is successful in challenging all the patents in dispute or if the court rules that certain of our key patent claims are invalid or not infringed, such events could have a material adverse effect on our financial condition and results of operations.

ABRAXANE®:  On December 14, 2011, Cephalon, Inc. and Acusphere, Inc. filed a complaint against us in the United States District Court for the District of Massachusetts, alleging, among other things, that the making, using, selling, offering to sell and importing of ABRAXANE® brand drug infringes claims of United States Patent No. RE40,493. Plaintiffs are seeking damages and injunctive relief. On December 3, 2013, the court issued an order construing certain disputed claim terms in accordance with Celgene’s proposed construction for several key terms. We intend to vigorously defend against this infringement suit.  If the suit against us is successful, we may have to pay damages, ongoing royalties and may have to license rights from plaintiffs.  However, we believe that (a) it is unlikely that the plaintiffs in this matter will prevail and (b) the ultimate outcome will not have a material adverse effect on our financial condition or results of operations.

VIDAZA®:  On September 28, 2012, we were named as a defendant in a lawsuit filed by Ivax LLC (formerly Ivax Corporation) (“Ivax”) in the United States District Court for the Southern District of Florida.  Ivax alleged that we infringed the claims of United States Patent No. 7,759,481 (the “‘481 patent”) by making, using and selling VIDAZA® brand drug in the United States. In December 2013 the parties reached a resolution in which the patent infringement lawsuit was voluntarily dismissed by Ivax with prejudice with no payments by Celgene to Ivax.

THALOMID® and REVLIMID®: On October 2, 2013, Andrulis Pharmaceuticals Corporation (Andrulis) filed a lawsuit against us in the United States District Court for the District of Delaware claiming infringement of U.S. Patent No. 6,140,346 (“the ‘346 patent”).  Andrulis alleges that we are liable for infringement of one or more claims of the ‘346 patent which covers the use of THALOMID® (and, as asserted by Andrulis, REVLIMID®) in combination with an alkylating agent (e.g., melphalan) to treat cancers.  Andrulis is seeking an unspecified amount of damages, attorneys’ fees and injunctive relief. We disagree with Andrulis’ allegations and intend to vigorously defend against this infringement suit. On November 25, 2013, we filed a motion to dismiss Andrulis’ complaint. Andrulis’ motion seeking leave to file an amended complaint, was granted by the court on December 30, 2013. We filed a motion to dismiss Andrulis’ amended complaint on January 30, 2014. We expect that the ultimate outcome of this lawsuit will not have a material adverse effect on our financial condition or results of operations.

Other Proceedings:

On June 7, 2013, Children's Medical Center Corporation (CMCC) filed a lawsuit against us in the Superior Court of the Commonwealth of Massachusetts alleging that our obligation to pay a 1% royalty on REVLIMID® net sales revenue and a 2.5% royalty on POMALYST®/IMNOVID® net sales revenue under a license agreement entered into in December 2002  extended beyond February 28, 2013 and that our failure to make royalty payments to CMCC subsequent to February 28, 2013 breached the license agreement.  CMCC is seeking unspecified damages and a declaration that the license agreement remains in full force and effect.  In July 2013, we removed these proceedings to the United States District Court for the District of Massachusetts. On August 5, 2013, we filed an answer to CMCC’s complaint and a counterclaim for declaratory judgment that our obligations to pay royalties have expired. On August 26, 2013, CMCC filed an answer to our counterclaim. A scheduling conference was held on February 11, 2014 and the court ordered fact discovery to be completed by December 15, 2014. No trial date has as yet been set by the court. We intend to vigorously defend against CMCC's claims. As of December 31, 2013, we consider the range of reasonably possible loss relating to this lawsuit to be between zero and $35.9 million, with the high end of the range being the royalty payments on REVLIMID® we would have made under the license agreement through December 31, 2013, if it had remained in effect. CMCC contends that our royalty obligation continues on sales of REVLIMID® at least until May 2016 and if CMCC prevails, we may be obligated to continue to pay royalties for periods after December 31, 2013.
XML 102 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic and Product Information (Tables)
 12 Months Ended
Dec. 31, 2013
Segment Reporting [Abstract]  
Schedule of revenues and long-lived assets by geographic area
Revenues
 
2013
 
2012
 
2011
United States
 
$
3,862.1

 
$
3,169.1

 
$
2,860.9

Europe
 
1,865.7

 
1,617.7

 
1,477.5

All other
 
766.1

 
719.9

 
503.7

Total revenues
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1

Long-Lived Assets1
 
2013
 
2012
United States
 
$
348.0

 
$
343.3

Europe
 
230.4

 
221.5

All other
 
15.0

 
13.6

Total long lived assets
 
$
593.4

 
$
578.4


1 
Long-lived assets consist of net property, plant and equipment.
Schedule of total revenues from external customers by product
 
 
2013
 
2012
 
2011
REVLIMID®
 
$
4,280.3

 
$
3,766.6

 
$
3,208.2

VIDAZA®
 
803.3

 
823.2

 
705.3

ABRAXANE®
 
648.9

 
426.7

 
385.9

POMALYST®/IMNOVID®
 
305.4

 
12.0

 
0.6

THALOMID®
 
244.5

 
302.1

 
339.1

ISTODAX®
 
54.0

 
50.0

 
30.9

Azacitidine for injection
 
23.3

 
—

 
—

Other
 
2.6

 
5.0

 
29.7

Total net product sales
 
6,362.3

 
5,385.6

 
4,699.7

Collaborative agreements and other revenue
 
14.7

 
10.7

 
19.5

Royalty revenue
 
116.9

 
110.4

 
122.9

Total revenue
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1
Schedule of customer concentration risk based on total revenues and net accounts receivable
 
 
Percent of Total Revenue
 
Percent of Net Accounts Receivable
Customer
 
2013
 
2012
 
2011
 
2013
 
2012
Amerisource Bergen Corp.
 
10.7
%
 
11.5
%
 
12.6
%
 
6.4
%
 
9.6
%
XML 103 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets and Goodwill (Tables)
 12 Months Ended
Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets by category
December 31, 2013
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Intangible
Assets,
Net
 
Weighted
Average
Life (Years)
Amortizable intangible assets:
 
 
 
 
 
 
 
 
Acquired developed product rights
 
$
3,405.9

 
$
(1,026.4
)
 
$
2,379.5

 
13.0
Technology
 
333.7

 
(87.4
)
 
246.3

 
7.0
Licenses
 
66.2

 
(13.9
)
 
52.3

 
16.5
Other
 
42.5

 
(18.8
)
 
23.7

 
8.6
 
 
3,848.3

 
(1,146.5
)
 
2,701.8

 
12.5
Non-amortized intangible assets:
 
 
 
 
 
 
 
 
Acquired IPR&D product rights
 
137.9

 
—

 
137.9

 
 
Total intangible assets
 
$
3,986.2

 
$
(1,146.5
)
 
$
2,839.7

 
 

December 31, 2012
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Intangible
Assets,
Net
 
Weighted
Average
Life (Years)
Amortizable intangible assets:
 
 
 
 
 
 
 
 
Acquired developed product rights
 
$
3,400.4

 
$
(814.5
)
 
$
2,585.9

 
13.0
Technology
 
333.3

 
(39.8
)
 
293.5

 
7.0
Licenses
 
64.3

 
(10.0
)
 
54.3

 
16.8
Other
 
43.4

 
(14.6
)
 
28.8

 
8.5
 
 
3,841.4

 
(878.9
)
 
2,962.5

 
12.5
Non-amortized intangible assets:
 
 
 
 
 
 
 
 
Acquired IPR&D product rights
 
137.9

 
—

 
137.9

 
 
Total intangible assets
 
$
3,979.3

 
$
(878.9
)
 
$
3,100.4

 
 
Schedule of changes in carrying value of goodwill
Balance at December 31, 2012
$
2,042.8

Tax benefit on the exercise of Pharmion converted stock options
(1.6
)
Balance at December 31, 2013
$
2,041.2
XML 104 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Statement of Comprehensive Income [Abstract]      
Net income $ 1,449.9 $ 1,456.2 $ 1,317.4
Other comprehensive income:      
Foreign currency translation adjustments 27.4 25.9 (9.8)
Pension liability adjustment 3.2 (4.7) (1.5)
Change in functional currency of a foreign subsidiary 0 13.1 0
Net asset transfer of a common control foreign subsidiary 0 0.6 (0.1)
Net unrealized (losses) gains related to cash flow hedges:      
Unrealized holding gains (losses), net of tax expense (benefit) of $2.6, ($13.8) and ($0) for the years ended 2013, 2012 and 2011, respectively (5.8) 53.0 21.3
Reclassification adjustment for (gains) losses included in net income, net of tax (expense) benefit of $6.9, ($1.9) and ($2.9) for the years ended 2013, 2012 and 2011, respectively (14.2) (77.7) 2.9
Net unrealized gains (losses) on marketable securities available for sale:      
Unrealized holding gains, net of tax expense (benefit) of $77.1, ($0.1) and $1.4 for the years ended 2013, 2012 and 2011, respectively 128.0 1.4 2.9
Reclassification adjustment for losses (gains) included in net income, net of tax (expense) benefit of $2.2, $0.1 and $0.3 for the years ended 2013, 2012 and 2011, respectively 5.1 1.0 (4.3)
Total other comprehensive income 143.7 12.6 11.4
Comprehensive income 1,593.6 1,468.8 1,328.8
Comprehensive loss attributable to non-controlling interest 0 0 0.7
Comprehensive income attributable to Celgene $ 1,593.6 $ 1,468.8 $ 1,329.5
XML 105 R88.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic and Product Information (Details 2) (USD $)
In Millions, unless otherwise specified
 3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Revenues by Product                      
Total net product sales                 $ 6,362.3 $ 5,385.6 $ 4,699.7
Collaborative agreements and other revenue                 14.7 10.7 19.5
Royalty revenue                 116.9 110.4 122.9
Total revenue 1,755.9 1,674.4 1,599.0 1,464.6 1,447.4 1,419.2 1,366.8 1,273.3 6,493.9 5,506.7 4,842.1
REVLIMID
                      
Revenues by Product                      
Total net product sales                 4,280.3 3,766.6 3,208.2
VIDAZA
                      
Revenues by Product                      
Total net product sales                 803.3 823.2 705.3
ABRAXANE
                      
Revenues by Product                      
Total net product sales                 648.9 426.7 385.9
POMALYST/IMNOVID
                      
Revenues by Product                      
Total net product sales                 305.4 12.0 0.6
THALOMID
                      
Revenues by Product                      
Total net product sales                 244.5 302.1 339.1
ISTODAX
                      
Revenues by Product                      
Total net product sales                 54.0 50.0 30.9
Azacitidine
                      
Revenues by Product                      
Total net product sales                 23.3 0 0
Other
                      
Revenues by Product                      
Total net product sales                 $ 2.6 $ 5.0 $ 29.7
XML 106 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Divestitures
 12 Months Ended
Dec. 31, 2013
Business Combinations [Abstract]  
Acquisitions and Divestitures
Acquisitions and Divestitures
Avila Acquisition
On March 7, 2012 (the Acquisition Date), we acquired all of the outstanding common stock of Avila Therapeutics, Inc., subsequently renamed Celgene Avilomics Research, herein referred to as Avila. The acquisition resulted in Avila becoming our wholly-owned subsidiary. The results of operations for Avila are included in our consolidated financial statements from the Acquisition Date and the assets and liabilities of Avila have been recorded at their respective fair values on the Acquisition Date and consolidated with our other assets and liabilities. Avila's results of operations to the Acquisition Date were determined to be immaterial to us; therefore, pro forma financial information is not required to be presented.
We paid $352.2 million in cash, net of cash acquired, and may make additional payments of up to an estimated maximum of $595.0 million in contingent developmental and regulatory milestone payments.
Avila is a clinical-stage biotechnology company focused on the design and development of targeted covalent drugs to achieve best-in-class outcomes. Avila's product pipeline has been created using its proprietary Avilomics platform for developing targeted covalent drugs that treat diseases through protein silencing. Avila's most advanced product candidate, CC-292, formerly AVL-292, a potential treatment for cancer and autoimmune diseases, is currently in phase I clinical testing. We acquired Avila to enhance our portfolio of potential therapies for patients with life-threatening illnesses worldwide.
Our potential contingent consideration payments are classified as liabilities, which were measured at fair value as of the Acquisition Date and subsequently adjusted for time and probability accretion. The range of potential milestone payments is from no payment if none of the milestones are achieved to an estimated maximum of $595.0 million if all milestones are achieved. The potential milestones consist of developmental and regulatory achievements, including milestones for the initiation of phase II and phase III studies, investigational new drug, or IND, filings, and other regulatory events.
We estimated the fair value of potential contingent consideration using a probability-weighted income approach, which reflects the probability and timing of future potential payments. This fair value measurement is based on significant input not observable in the market and thus represents a Level 3 liability within the fair value hierarchy. The resulting probability-weighted cash flows were discounted using a discount rate based on a market participant assumption.
The acquisition has been accounted for using the acquisition method of accounting which requires that assets acquired and liabilities assumed be recognized at their fair values as of the Acquisition Date and requires the fair value of acquired IPR&D to be classified as indefinite-lived assets until the successful completion or abandonment of the associated research and development efforts.
The fair value of consideration transferred in the acquisition of Avila is shown in the table below:
 
Fair Value at the
Acquisition Date
Cash
$
363.4

Contingent consideration
171.7

Total fair value of consideration transferred
$
535.1


The purchase price allocation resulted in the following amounts being allocated to the assets acquired and liabilities assumed at the Acquisition Date based upon their respective fair values summarized below:
 
Amounts
Recognized as of
Acquisition Date
Working capital1
$
12.0

Property, plant and equipment
2.6

Platform technology intangible asset2
330.8

In-process research and development product rights
198.4

Net deferred tax liability3
(165.0
)
Total identifiable net assets
378.8

Goodwill
156.3

Net assets acquired
$
535.1


1 
Includes cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities.
2 
Platform technology related to the Avilomics discovery platform which is being amortized over a useful life of seven years based on the estimated useful life of the platform.
3 
Includes current deferred income tax asset of $14.7 million and non-current deferred tax liability of $179.7 million.
The fair values of current assets, current liabilities and property, plant and equipment were determined to approximate their book values.
The fair value of the platform technology intangible asset was based primarily on expected cash flows from future product candidates to be developed from the Avilomics platform and the fair value assigned to acquired IPR&D was primarily based on expected cash flows from the CC-292 product candidate which is in phase I testing. The values assigned to the platform technology intangible asset and the IPR&D asset were determined by estimating the costs to develop CC-292 and future product candidates into commercially viable products, estimating the resulting revenue from the potential products, and discounting the net cash flows to present value. The revenue and cost projections used were reduced based on the probability of developing new drugs. Additionally, the projections considered the relevant market sizes, growth factors and the nature and expected timing of new product introductions. The resulting net cash flows from such potential products are based on our estimates of cost of sales, operating expenses, and income taxes. The rates utilized to discount the net cash flows to their present value were commensurate with the stage of development of the projects and uncertainties in the economic estimates used in the projections described above. Acquired IPR&D will be accounted for as an indefinite-lived intangible asset until regulatory approval in specified markets or discontinuation of CC-292.
The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition. The goodwill recorded as part of the acquisition is largely attributable to full ownership rights to the Avilomics platform. We do not expect any portion of this goodwill to be deductible for tax purposes. The goodwill attributable to the acquisition has been recorded as a non-current asset in our Consolidated Balance Sheets and is not amortized, but is subject to review for impairment annually.
Prior to the acquisition, Avila had a number of collaboration agreements in place to which we are now party. These agreements entitle us to receive potential milestone payments and reimbursement of expenses for research and development expenses incurred under the collaborations and our collaboration partners may receive intellectual property rights or options to purchase such rights related to products developed under the collaborations. We do not consider these collaboration arrangements to be significant.
Sale of Non-core Assets
The 2010 acquisition of Abraxis BioScience, Inc. (Abraxis) included a number of assets that were not associated with nab® technology or ABRAXANE®. In April 2011, we sold these non-core assets to various entities that were owned or controlled by Dr. Patrick Soon-Shiong, the former majority shareholder and executive chairman of Abraxis. We received cash consideration, 10% equity ownership in Active Biomaterials, LLC, which we subsequently sold to Dr. Patrick Soon-Shiong, and a future royalty stream based on net sales of certain products of Active Biomaterials, LLC. We recorded the future royalty stream as an asset and assigned a value of $170.0 million based on its April 2011 fair market value calculated as the present value of estimated future net cash flows. Based on observed industry consolidation in the market that produces the raw materials for the products sold by Active Biomaterials, LLC and the forecasted reduction of net sales subject to royalties, we performed an analysis in December 2013 of the fair value of the future royalty stream. Our evaluation of discounted estimated future cash flows resulted in a fair value of $90.0 million for the future royalty stream and we recorded an impairment expense of $80.0 million in 2013.
In January 2014, we entered into a collaboration agreement with NantBioScience, Inc. (NantBioScience), an entity controlled by Dr. Patrick Soon-Shiong in which Celgene contributed $75 million, the rights to the future royalty stream noted above and licenses to two nab® product candidates. In return, Celgene received 14 percent equity ownership in NantBioScience, an option to license a certain number of product candidates developed by NantBioScience, including the two nab® product candidates that Celgene is licensing to NantBioScience, and the parent company of NantBioScience assumed, and agreed to pay and satisfy when due, our obligation to pay The Chan Soon-Shiong Institute for Advanced Health (CSS Institute) $50.0 million contingent, matching contributions.
XML 107 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments and Hedging Activities (Details) (USD $)
 12 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Aug. 31, 2013
Senior Notes
Dec. 31, 2013
2.450% senior notes due 2015
Senior Notes
Dec. 31, 2012
2.450% senior notes due 2015
Senior Notes
Dec. 31, 2013
3.250% senior notes due 2022
Senior Notes
Dec. 31, 2012
3.250% senior notes due 2022
Senior Notes
Dec. 31, 2013
1.900% senior notes due 2017
Senior Notes
Dec. 31, 2012
1.900% senior notes due 2017
Senior Notes
Dec. 31, 2013
2.300% senior notes due 2018
Senior Notes
Aug. 31, 2013
2.300% senior notes due 2018
Senior Notes
Dec. 31, 2012
2.300% senior notes due 2018
Senior Notes
Dec. 31, 2013
3.950% senior notes due 2020
Senior Notes
Dec. 31, 2012
3.950% senior notes due 2020
Senior Notes
Dec. 31, 2013
4.000% senior notes due 2023
Senior Notes
Aug. 31, 2013
4.000% senior notes due 2023
Senior Notes
Dec. 31, 2012
4.000% senior notes due 2023
Senior Notes
Dec. 31, 2013
Interest rate swap contracts
Dec. 31, 2012
Interest rate swap contracts
Dec. 31, 2013
Interest rate swap contracts
2.450% senior notes due 2015
Senior Notes
Dec. 31, 2012
Interest rate swap contracts
2.450% senior notes due 2015
Senior Notes
Dec. 31, 2013
Interest rate swap contracts
3.250% senior notes due 2022
Senior Notes
Dec. 31, 2012
Interest rate swap contracts
3.250% senior notes due 2022
Senior Notes
Dec. 31, 2013
Interest rate swap contracts
1.900% senior notes due 2017
Senior Notes
Dec. 31, 2012
Interest rate swap contracts
1.900% senior notes due 2017
Senior Notes
Dec. 31, 2013
Interest rate swap contracts
2.300% senior notes due 2018
Senior Notes
Dec. 31, 2012
Interest rate swap contracts
2.300% senior notes due 2018
Senior Notes
Dec. 31, 2013
Interest rate swap contracts
3.950% senior notes due 2020
Senior Notes
Dec. 31, 2012
Interest rate swap contracts
3.950% senior notes due 2020
Senior Notes
Dec. 31, 2013
Interest rate swap contracts
4.000% senior notes due 2023
Senior Notes
Dec. 31, 2012
Interest rate swap contracts
4.000% senior notes due 2023
Senior Notes
Dec. 31, 2013
Designated as hedging instruments
Foreign currency forward contracts
Dec. 31, 2012
Designated as hedging instruments
Foreign currency forward contracts
Dec. 31, 2013
Designated as hedging instruments
Foreign currency forward contracts
Put
Purchased Put
Dec. 31, 2012
Designated as hedging instruments
Foreign currency forward contracts
Put
Purchased Put
Dec. 31, 2013
Designated as hedging instruments
Foreign currency forward contracts
Call
Written Call
Dec. 31, 2012
Designated as hedging instruments
Foreign currency forward contracts
Call
Written Call
Dec. 31, 2013
Designated as hedging instruments
Foreign currency forward contracts
Australian Dollar
Dec. 31, 2012
Designated as hedging instruments
Foreign currency forward contracts
Australian Dollar
Dec. 31, 2013
Designated as hedging instruments
Foreign currency forward contracts
British Pound
Dec. 31, 2012
Designated as hedging instruments
Foreign currency forward contracts
British Pound
Dec. 31, 2013
Designated as hedging instruments
Foreign currency forward contracts
Canadian Dollar
Dec. 31, 2012
Designated as hedging instruments
Foreign currency forward contracts
Canadian Dollar
Dec. 31, 2013
Designated as hedging instruments
Foreign currency forward contracts
Euro
Dec. 31, 2012
Designated as hedging instruments
Foreign currency forward contracts
Euro
Dec. 31, 2013
Designated as hedging instruments
Foreign currency forward contracts
Japanese Yen
Dec. 31, 2012
Designated as hedging instruments
Foreign currency forward contracts
Japanese Yen
Dec. 31, 2013
Designated as hedging instruments
Forward Starting Interest Rate Swaps
Feb. 14, 2014
Designated as hedging instruments
Forward Starting Interest Rate Swap, Maturing in Year Five [Member]
Dec. 31, 2013
Designated as hedging instruments
Forward Starting Interest Rate Swap, Maturing in Year Five [Member]
Feb. 14, 2014
Designated as hedging instruments
Interest rate swap contracts, maturing in year 2023
Dec. 31, 2013
Designated as hedging instruments
Interest rate swap contracts, maturing in year 2023
Dec. 31, 2013
Designated as hedging instruments
Treasury rate locks
Dec. 31, 2013
Designated as hedging instruments
Interest rate swap contracts
Dec. 31, 2012
Designated as hedging instruments
Interest rate swap contracts
Dec. 31, 2013
Not designated as hedging instruments
Foreign currency forward contracts
Dec. 31, 2012
Not designated as hedging instruments
Foreign currency forward contracts
Dec. 31, 2013
Not designated as hedging instruments
Foreign currency forward contracts
Put
Purchased Put
Dec. 31, 2012
Not designated as hedging instruments
Foreign currency forward contracts
Put
Purchased Put
Dec. 31, 2013
Not designated as hedging instruments
Foreign currency forward contracts
Put
Written Call
Dec. 31, 2012
Not designated as hedging instruments
Foreign currency forward contracts
Put
Written Call
Feb. 12, 2014
Interest Rate Contract [Member]
Summary of Derivative Instruments                                                                                                                              
Period to settlement dates of derivatives is within this period                                                                 36 months 36 months                                                          
Notional amount $ 7,635,000,000                                   $ 2,300,000,000 $ 300,000,000 $ 300,000,000 $ 0 $ 850,000,000 $ 200,000,000 $ 300,000,000 $ 100,000,000 $ 200,000,000 $ 0 $ 500,000,000 $ 0 $ 150,000,000 $ 0 $ 4,156,700,000 $ 1,422,900,000 $ 0 $ 228,800,000 $ 0 $ 235,900,000 $ 0 $ 5,100,000 $ 279,400,000 $ 77,900,000 $ 0 $ 134,400,000 $ 3,318,200,000 $ 969,300,000 $ 559,100,000 $ 236,200,000 $ 300,000,000   $ 100,000,000 $ 350,000,000 $ 200,000,000       $ 878,500,000 $ 795,400,000 $ 0 $ 160,500,000 $ 0 $ (216,000,000) $ 1,850,000,000
Derivative, Average Remaining Maturity                                                                                                   5 years 5 years 10 years 10 years                    
Derivative settlement losses                                                                                                           35,300,000                  
Face amount of debt       1,500,000,000.000               400,000,000.0         700,000,000.0                                                                                            
Interest rate (as a percent)         2.45% 2.45% 3.25% 3.25% 1.90% 1.90% 2.30% 2.30% 2.30% 3.95% 3.95% 4.00% 4.00% 4.00%                                                                                          
Proceeds from settlement of interest rate swap contracts                                                                                                             22,900,000 5,000,000              
Gains on termination of hedging relationship, accounted as reduction of current and future interest expense $ 91,600,000 $ 63,200,000 $ 42,700,000                                                                                                                        
XML 108 R82.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaboration Agreements (Details)
 12 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Dec. 31, 2013
USD ($)
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2013
Acceleron Pharma Inc
ACE-011 Program
USD ($)
Dec. 31, 2013
Acceleron Pharma Inc
ACE-011 - Discovery Stage Programs
USD ($)
discovery_stage_program
Aug. 31, 2011
Acceleron Pharma Inc
ACE-536 Program
USD ($)
Aug. 31, 2011
Acceleron Pharma Inc
ACE-536 First discovery stage program
USD ($)
Aug. 31, 2011
Acceleron Pharma Inc
ACE-536 Second discovery stage program
USD ($)
Aug. 31, 2011
Acceleron Pharma Inc
ACE-536 Each additional discovery stage program
USD ($)
Dec. 31, 2013
Agios Pharmaceuticals, Inc.
USD ($)
Dec. 31, 2013
Bluebird
USD ($)
Dec. 31, 2013
Bluebird
Celgene
Dec. 31, 2013
research and development payments FORMA
USD ($)
Dec. 31, 2013
regulatory approval milestone FORMA
USD ($)
Dec. 31, 2013
license payments FORMA
USD ($)
Dec. 31, 2013
MorphoSys AG
USD ($)
Dec. 31, 2013
MorphoSys AG
Celgene
Dec. 31, 2013
OncoMed
Dec. 31, 2013
OncoMed
Celgene
Dec. 31, 2013
OncoMed
Other Four Biological Programs
USD ($)
Dec. 31, 2013
Other Collaboration Arrangements
USD ($)
Dec. 31, 2013
Minimum
Novartis
Dec. 31, 2013
Minimum
OncoMed
Small Molecule Program
USD ($)
Dec. 31, 2013
Maximum
Novartis
Dec. 31, 2013
Maximum
Epizyme
USD ($)
Dec. 31, 2013
Maximum
Acetylon
USD ($)
Dec. 02, 2013
Maximum
OncoMed
product_candidate
Dec. 31, 2013
Maximum
OncoMed
discovery_stage_program
Dec. 31, 2013
Maximum
OncoMed
RSPO-LGR CSC Pathway or another CSC Pathway
discovery_stage_program
Dec. 31, 2013
Maximum
OncoMed
Demcizumab
USD ($)
Dec. 31, 2013
Maximum
OncoMed
Anti-DLL4/VEGF
USD ($)
Dec. 31, 2013
Maximum
Other Collaboration Arrangements
USD ($)
Dec. 31, 2013
Eurodollar [Member]
MorphoSys AG
EUR (€)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                                                                  
Royalty rate (as a percent)                                           0.3   0.35                  
Upfront and milestone payments received       $ 367,000,000 $ 348,000,000 $ 217,500,000 $ 170,800,000 $ 148,800,000 $ 125,400,000                                                
Number of programs         3                                             5 4        
Maximum receivable by Agios upon achievement of certain milestones                   120,000,000                                              
Potential milestones payment per product                     225,000,000                           165,000,000                
Co-development and profit sharing ratio due to reduction of milestones                     50.00% 50.00%       50.00% 50.00%                                
Potential milestone payments                         200,000,000 315,000,000 430,000,000 664,500,000                   1,100,000,000.0             511,000,000
Number of Anti-Cancer Stem Cell Products Candidates from Pipeline                                                     6            
Worldwide licensing rights for Anti-CSC therapeutic candidates, term                                                     60 days            
Co-development sharing of global development costs                                   33.33% 66.67%                            
Contingent Milestone Payments to be Made                                       440,000,000     100,000,000             790,000,000 505,000,000 373,000,000  
Effective notice period required to be served for termination of agreement                                   120 days                              
Investments in equity or other assets                                         52,100,000                        
Research and development $ 2,226,200,000 $ 1,724,200,000 $ 1,600,300,000                                   $ 149,000,000                        
XML 109 R69.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Details 2) (USD $)
 12 Months Ended
Dec. 31, 2013
Time_Per_Annum
Apr. 30, 2013
Dec. 31, 2012
Debt      
Amount outstanding $ 544,800,000   $ 308,500,000
Revolving Credit Facility
      
Debt      
Maximum borrowing capacity 1,500,000,000.000 1,000,000,000.000  
Maximum number of credit facility increases 1    
Maximum borrowing capacity, subject to certain conditions 1,750,000,000.000    
Outstanding uncommitted facility $ 0   $ 0
Commercial Paper
      
Debt      
Effective interest rate (as a percent) 0.40%    
XML 110 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic and Product Information
 12 Months Ended
Dec. 31, 2013
Segment Reporting [Abstract]  
Geographic and Product Information
Geographic and Product Information
Operations by Geographic Area:    Revenues primarily consisted of sales of REVLIMID®, VIDAZA®, ABRAXANE®, POMALYST®/IMNOVID®, THALOMID® and ISTODAX®. Additional sources of revenue included a licensing agreement with Novartis, which entitles us to royalties on FOCALIN XR® and the entire RITALIN® family of drugs, the sale of services through our Cellular Therapeutics subsidiary and other miscellaneous licensing agreements.
Revenues
 
2013
 
2012
 
2011
United States
 
$
3,862.1

 
$
3,169.1

 
$
2,860.9

Europe
 
1,865.7

 
1,617.7

 
1,477.5

All other
 
766.1

 
719.9

 
503.7

Total revenues
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1

Long-Lived Assets1
 
2013
 
2012
United States
 
$
348.0

 
$
343.3

Europe
 
230.4

 
221.5

All other
 
15.0

 
13.6

Total long lived assets
 
$
593.4

 
$
578.4


1 
Long-lived assets consist of net property, plant and equipment.
Revenues by Product:    Total revenues from external customers by product for the years ended December 31, 2013, 2012 and 2011 were as follows:
 
 
2013
 
2012
 
2011
REVLIMID®
 
$
4,280.3

 
$
3,766.6

 
$
3,208.2

VIDAZA®
 
803.3

 
823.2

 
705.3

ABRAXANE®
 
648.9

 
426.7

 
385.9

POMALYST®/IMNOVID®
 
305.4

 
12.0

 
0.6

THALOMID®
 
244.5

 
302.1

 
339.1

ISTODAX®
 
54.0

 
50.0

 
30.9

Azacitidine for injection
 
23.3

 
—

 
—

Other
 
2.6

 
5.0

 
29.7

Total net product sales
 
6,362.3

 
5,385.6

 
4,699.7

Collaborative agreements and other revenue
 
14.7

 
10.7

 
19.5

Royalty revenue
 
116.9

 
110.4

 
122.9

Total revenue
 
$
6,493.9

 
$
5,506.7

 
$
4,842.1


Major Customers:    We sell our products primarily through wholesale distributors and specialty pharmacies in the United States, which account for a large portion of our total revenues. International sales are primarily made directly to hospitals, clinics and retail chains, many of which are government owned. During the three-year period of 2013, 2012 and 2011, only Amerisource Bergen accounted for more than 10% of our total revenue in at least one of those years and is summarized below. The percentage of amounts due from this customer compared to total net accounts receivable is also summarized below as of December 31, 2013 and 2012.
 
 
Percent of Total Revenue
 
Percent of Net Accounts Receivable
Customer
 
2013
 
2012
 
2011
 
2013
 
2012
Amerisource Bergen Corp.
 
10.7
%
 
11.5
%
 
12.6
%
 
6.4
%
 
9.6
%
XML 111 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 546 564 1 false 170 0 false 13 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.celgene.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 1001000 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.celgene.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.celgene.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 1002000 - Statement - CONSOLIDATED STATEMENTS OF INCOME Sheet http://www.celgene.com/role/ConsolidatedStatementsOfIncome CONSOLIDATED STATEMENTS OF INCOME false false R5.htm 1003000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.celgene.com/role/ConsolidatedStatementsOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME false false R6.htm 1003501 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Sheet http://www.celgene.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) false false R7.htm 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.celgene.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 1005000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.celgene.com/role/ConsolidatedStatementsOfStockholdersEquity CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY false false R9.htm 2101100 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies Sheet http://www.celgene.com/role/NatureOfBusinessAndBasisAndSummaryOfSignificantAccountingPolicies Nature of Business and Basis and Summary of Significant Accounting Policies false false R10.htm 2102100 - Disclosure - Acquisitions and Divestitures Sheet http://www.celgene.com/role/AcquisitionsAndDivestitures Acquisitions and Divestitures false false R11.htm 2103100 - Disclosure - Earnings Per Share Sheet http://www.celgene.com/role/EarningsPerShare Earnings Per Share false false R12.htm 2104100 - Disclosure - Financial Instruments and Fair Value Measurement Sheet http://www.celgene.com/role/FinancialInstrumentsAndFairValueMeasurement Financial Instruments and Fair Value Measurement false false R13.htm 2105100 - Disclosure - Derivative Instruments and Hedging Activities Sheet http://www.celgene.com/role/DerivativeInstrumentsAndHedgingActivities Derivative Instruments and Hedging Activities false false R14.htm 2106100 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale Sheet http://www.celgene.com/role/CashCashEquivalentsAndMarketableSecuritiesAvailableForSale Cash, Cash Equivalents and Marketable Securities Available-for-Sale false false R15.htm 2107100 - Disclosure - Inventory Sheet http://www.celgene.com/role/Inventory Inventory false false R16.htm 2108100 - Disclosure - Property, Plant and Equipment Sheet http://www.celgene.com/role/PropertyPlantAndEquipment Property, Plant and Equipment false false R17.htm 2109100 - Disclosure - Other Financial Information Sheet http://www.celgene.com/role/OtherFinancialInformation Other Financial Information false false R18.htm 2110100 - Disclosure - Intangible Assets and Goodwill Sheet http://www.celgene.com/role/IntangibleAssetsAndGoodwill Intangible Assets and Goodwill false false R19.htm 2111100 - Disclosure - Debt Sheet http://www.celgene.com/role/Debt Debt false false R20.htm 2112100 - Disclosure - Stockholders' Equity Sheet http://www.celgene.com/role/StockholdersEquity Stockholders' Equity false false R21.htm 2113100 - Disclosure - Accumulated Other Comprehensive Income (Loss) Sheet http://www.celgene.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) false false R22.htm 2114100 - Disclosure - Share-Based Compensation Sheet http://www.celgene.com/role/ShareBasedCompensation Share-Based Compensation false false R23.htm 2115100 - Disclosure - Employee Benefit Plans Sheet http://www.celgene.com/role/EmployeeBenefitPlans Employee Benefit Plans false false R24.htm 2116100 - Disclosure - Income Taxes Sheet http://www.celgene.com/role/IncomeTaxes Income Taxes false false R25.htm 2117100 - Disclosure - Collaboration Agreements Sheet http://www.celgene.com/role/CollaborationAgreements Collaboration Agreements false false R26.htm 2118100 - Disclosure - Commitments and Contingencies Sheet http://www.celgene.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R27.htm 2119100 - Disclosure - Geographic and Product Information Sheet http://www.celgene.com/role/GeographicAndProductInformation Geographic and Product Information false false R28.htm 2120100 - Disclosure - Quarterly Results of Operations (Unaudited) Sheet http://www.celgene.com/role/QuarterlyResultsOfOperationsUnaudited Quarterly Results of Operations (Unaudited) false false R29.htm 2121100 - Disclosure - Subsequent Events Sheet http://www.celgene.com/role/SubsequentEvents Subsequent Events false false R30.htm 2122100 - Disclosure - Schedule II - Valuation and Qualifying Accounts Sheet http://www.celgene.com/role/ScheduleIiValuationAndQualifyingAccounts Schedule II - Valuation and Qualifying Accounts false false R31.htm 2201201 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies (Policies) Sheet http://www.celgene.com/role/NatureOfBusinessAndBasisAndSummaryOfSignificantAccountingPoliciesPolicies Nature of Business and Basis and Summary of Significant Accounting Policies (Policies) false false R32.htm 2301302 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies (Tables) Sheet http://www.celgene.com/role/NatureOfBusinessAndBasisAndSummaryOfSignificantAccountingPoliciesTables Nature of Business and Basis and Summary of Significant Accounting Policies (Tables) false false R33.htm 2302301 - Disclosure - Acquisitions and Divestitures (Tables) Sheet http://www.celgene.com/role/AcquisitionsAndDivestituresTables Acquisitions and Divestitures (Tables) false false R34.htm 2303301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.celgene.com/role/EarningsPerShareTables Earnings Per Share (Tables) false false R35.htm 2304301 - Disclosure - Financial Instruments and Fair Value Measurement (Tables) Sheet http://www.celgene.com/role/FinancialInstrumentsAndFairValueMeasurementTables Financial Instruments and Fair Value Measurement (Tables) false false R36.htm 2305301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.celgene.com/role/DerivativeInstrumentsAndHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) false false R37.htm 2306301 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Tables) Sheet http://www.celgene.com/role/CashCashEquivalentsAndMarketableSecuritiesAvailableForSaleTables Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Tables) false false R38.htm 2307301 - Disclosure - Inventory (Tables) Sheet http://www.celgene.com/role/InventoryTables Inventory (Tables) false false R39.htm 2308301 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.celgene.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) false false R40.htm 2309301 - Disclosure - Other Financial Information (Tables) Sheet http://www.celgene.com/role/OtherFinancialInformationTables Other Financial Information (Tables) false false R41.htm 2310301 - Disclosure - Intangible Assets and Goodwill (Tables) Sheet http://www.celgene.com/role/IntangibleAssetsAndGoodwillTables Intangible Assets and Goodwill (Tables) false false R42.htm 2311301 - Disclosure - Debt (Tables) Sheet http://www.celgene.com/role/DebtTables Debt (Tables) false false R43.htm 2312301 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.celgene.com/role/StockholdersEquityTables Stockholders' Equity (Tables) false false R44.htm 2313301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.celgene.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) false false R45.htm 2314301 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.celgene.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) false false R46.htm 2316301 - Disclosure - Income Taxes (Tables) Sheet http://www.celgene.com/role/IncomeTaxesTables Income Taxes (Tables) false false R47.htm 2317301 - Disclosure - Collaboration Agreements (Tables) Sheet http://www.celgene.com/role/CollaborationAgreementsTables Collaboration Agreements (Tables) false false R48.htm 2318301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.celgene.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R49.htm 2319301 - Disclosure - Geographic and Product Information (Tables) Sheet http://www.celgene.com/role/GeographicAndProductInformationTables Geographic and Product Information (Tables) false false R50.htm 2320301 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables) Sheet http://www.celgene.com/role/QuarterlyResultsOfOperationsUnauditedTables Quarterly Results of Operations (Unaudited) (Tables) false false R51.htm 2401403 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies (Details) Sheet http://www.celgene.com/role/NatureOfBusinessAndBasisAndSummaryOfSignificantAccountingPoliciesDetails Nature of Business and Basis and Summary of Significant Accounting Policies (Details) false false R52.htm 2401404 - Disclosure - Nature of Business and Basis and Summary of Significant Accounting Policies (Details 2) Sheet http://www.celgene.com/role/NatureOfBusinessAndBasisAndSummaryOfSignificantAccountingPoliciesDetails2 Nature of Business and Basis and Summary of Significant Accounting Policies (Details 2) false false R53.htm 2402402 - Disclosure - Acquisitions and Divestitures (Details) Sheet http://www.celgene.com/role/AcquisitionsAndDivestituresDetails Acquisitions and Divestitures (Details) false false R54.htm 2402403 - Disclosure - Acquisitions and Divestitures (Details 2) Sheet http://www.celgene.com/role/AcquisitionsAndDivestituresDetails2 Acquisitions and Divestitures (Details 2) false false R55.htm 2403402 - Disclosure - Earnings Per Share (Details) Sheet http://www.celgene.com/role/EarningsPerShareDetails Earnings Per Share (Details) false false R56.htm 2404402 - Disclosure - Financial Instruments and Fair Value Measurement (Details) Sheet http://www.celgene.com/role/FinancialInstrumentsAndFairValueMeasurementDetails Financial Instruments and Fair Value Measurement (Details) false false R57.htm 2404403 - Disclosure - Financial Instruments and Fair Value Measurement (Details 2) Sheet http://www.celgene.com/role/FinancialInstrumentsAndFairValueMeasurementDetails2 Financial Instruments and Fair Value Measurement (Details 2) false false R58.htm 2405402 - Disclosure - Derivative Instruments and Hedging Activities (Details) Sheet http://www.celgene.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails Derivative Instruments and Hedging Activities (Details) false false R59.htm 2405403 - Disclosure - Derivative Instruments and Hedging Activities (Details 2) Sheet http://www.celgene.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails2 Derivative Instruments and Hedging Activities (Details 2) false false R60.htm 2405404 - Disclosure - Derivative Instruments and Hedging Activities (Details 3) Sheet http://www.celgene.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails3 Derivative Instruments and Hedging Activities (Details 3) false false R61.htm 2406402 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details) Sheet http://www.celgene.com/role/CashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetails Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details) false false R62.htm 2406403 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details 2) Sheet http://www.celgene.com/role/CashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetails2 Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details 2) false false R63.htm 2406404 - Disclosure - Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details 3) Sheet http://www.celgene.com/role/CashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetails3 Cash, Cash Equivalents and Marketable Securities Available-for-Sale (Details 3) false false R64.htm 2407402 - Disclosure - Inventory (Details) Sheet http://www.celgene.com/role/InventoryDetails Inventory (Details) false false R65.htm 2408402 - Disclosure - Property, Plant and Equipment (Details) Sheet http://www.celgene.com/role/PropertyPlantAndEquipmentDetails Property, Plant and Equipment (Details) false false R66.htm 2409402 - Disclosure - Other Financial Information (Details) Sheet http://www.celgene.com/role/OtherFinancialInformationDetails Other Financial Information (Details) false false R67.htm 2410402 - Disclosure - Intangible Assets and Goodwill (Details) Sheet http://www.celgene.com/role/IntangibleAssetsAndGoodwillDetails Intangible Assets and Goodwill (Details) false false R68.htm 2411402 - Disclosure - Debt (Details) Sheet http://www.celgene.com/role/DebtDetails Debt (Details) false false R69.htm 2411403 - Disclosure - Debt (Details 2) Sheet http://www.celgene.com/role/DebtDetails2 Debt (Details 2) false false R70.htm 2412402 - Disclosure - Stockholders' Equity (Details) Sheet http://www.celgene.com/role/StockholdersEquityDetails Stockholders' Equity (Details) false false R71.htm 2413402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.celgene.com/role/AccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) (Details) false false R72.htm 2413403 - Disclosure - Accumulated Other Comprehensive Income (Loss) Reclassification Out of Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.celgene.com/role/AccumulatedOtherComprehensiveIncomeLossReclassificationOutOfAccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) Reclassification Out of Accumulated Other Comprehensive Income (Loss) (Details) false false R73.htm 2414402 - Disclosure - Share-Based Compensation (Details) Sheet http://www.celgene.com/role/ShareBasedCompensationDetails Share-Based Compensation (Details) false false R74.htm 2414403 - Disclosure - Share-Based Compensation (Details 2) Sheet http://www.celgene.com/role/ShareBasedCompensationDetails2 Share-Based Compensation (Details 2) false false R75.htm 2414404 - Disclosure - Share-Based Compensation (Details 3) Sheet http://www.celgene.com/role/ShareBasedCompensationDetails3 Share-Based Compensation (Details 3) false false R76.htm 2414405 - Disclosure - Share-Based Compensation (Details 4) Sheet http://www.celgene.com/role/ShareBasedCompensationDetails4 Share-Based Compensation (Details 4) false false R77.htm 2414406 - Disclosure - Share-Based Compensation (Details 5) Sheet http://www.celgene.com/role/ShareBasedCompensationDetails5 Share-Based Compensation (Details 5) false false R78.htm 2415401 - Disclosure - Employee Benefit Plans (Details) Sheet http://www.celgene.com/role/EmployeeBenefitPlansDetails Employee Benefit Plans (Details) false false R79.htm 2415402 - Disclosure - Employee Benefit Plans (Details 2) Sheet http://www.celgene.com/role/EmployeeBenefitPlansDetails2 Employee Benefit Plans (Details 2) false false R80.htm 2416402 - Disclosure - Income Taxes (Details) Sheet http://www.celgene.com/role/IncomeTaxesDetails Income Taxes (Details) false false R81.htm 2416403 - Disclosure - Income Taxes (Details 2) Sheet http://www.celgene.com/role/IncomeTaxesDetails2 Income Taxes (Details 2) false false R82.htm 2417402 - Disclosure - Collaboration Agreements (Details) Sheet http://www.celgene.com/role/CollaborationAgreementsDetails Collaboration Agreements (Details) false false R83.htm 2417403 - Disclosure - Collaboration Agreements (Details 2) Sheet http://www.celgene.com/role/CollaborationAgreementsDetails2 Collaboration Agreements (Details 2) false false R84.htm 2418402 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.celgene.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R85.htm 2418403 - Disclosure - Commitments and Contingencies (Details 2) Sheet http://www.celgene.com/role/CommitmentsAndContingenciesDetails2 Commitments and Contingencies (Details 2) false false R86.htm 2418404 - Disclosure - Commitments and Contingencies Manufacturing Facility Payment Obligation (Details) Sheet http://www.celgene.com/role/CommitmentsAndContingenciesManufacturingFacilityPaymentObligationDetails Commitments and Contingencies Manufacturing Facility Payment Obligation (Details) false false R87.htm 2419402 - Disclosure - Geographic and Product Information (Details) Sheet http://www.celgene.com/role/GeographicAndProductInformationDetails Geographic and Product Information (Details) false false R88.htm 2419403 - Disclosure - Geographic and Product Information (Details 2) Sheet http://www.celgene.com/role/GeographicAndProductInformationDetails2 Geographic and Product Information (Details 2) false false R89.htm 2419404 - Disclosure - Geographic and Product Information (Details 3) Sheet http://www.celgene.com/role/GeographicAndProductInformationDetails3 Geographic and Product Information (Details 3) false false R90.htm 2420402 - Disclosure - Quarterly Results of Operations (Unaudited) (Details) Sheet http://www.celgene.com/role/QuarterlyResultsOfOperationsUnauditedDetails Quarterly Results of Operations (Unaudited) (Details) false false R91.htm 2421401 - Disclosure - Subsequent Events (Details) Sheet http://www.celgene.com/role/SubsequentEventsDetails Subsequent Events (Details) false false R92.htm 2422401 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) Sheet http://www.celgene.com/role/ScheduleIiValuationAndQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts (Details) false false All Reports Book All Reports Element celg_AdditionalEquityInvestmentsMade had a mix of decimals attribute values: -5 -2. Element celg_AmortizationofPrepaidResearchandDevelopment had a mix of decimals attribute values: -5 -3. Element celg_ContingentMilestonePaymentstobeMade had a mix of decimals attribute values: -5 0. Element celg_ExtensionofAgreementPaymentMade had a mix of decimals attribute values: -5 -3. Element celg_MilestonePaymentsMade had a mix of decimals attribute values: -5 -3. Element celg_PotentialMilestonesPayment had a mix of decimals attribute values: -5 0. Element celg_UpfrontPaymentsMade had a mix of decimals attribute values: -5 -2. Element invest_DerivativeNotionalAmount had a mix of decimals attribute values: -6 -5. Element us-gaap_EquityMethodInvestments had a mix of decimals attribute values: -5 -2. Element us-gaap_IntangibleAssetsNetExcludingGoodwill had a mix of decimals attribute values: -5 -3. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod had a mix of decimals attribute values: -6 -5. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod had a mix of decimals attribute values: -6 -5. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber had a mix of decimals attribute values: -6 -5. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod had a mix of decimals attribute values: -6 -5. 'Shares' elements on report '2403402 - Disclosure - Earnings Per Share (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2403402 - Disclosure - Earnings Per Share (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2405402 - Disclosure - Derivative Instruments and Hedging Activities (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2410402 - Disclosure - Intangible Assets and Goodwill (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2411402 - Disclosure - Debt (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2411403 - Disclosure - Debt (Details 2)' had a mix of different decimal attribute values. 'Shares' elements on report '2414402 - Disclosure - Share-Based Compensation (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2417402 - Disclosure - Collaboration Agreements (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2417403 - Disclosure - Collaboration Agreements (Details 2)' had a mix of different decimal attribute values. 'Monetary' elements on report '2418402 - Disclosure - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2418403 - Disclosure - Commitments and Contingencies (Details 2)' had a mix of different decimal attribute values. Process Flow-Through: 1001000 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 1002000 - Statement - CONSOLIDATED STATEMENTS OF INCOME Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: 1003000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Process Flow-Through: 1003501 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Process Flow-Through: 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS celg-20131231.xml celg-20131231.xsd celg-20131231_cal.xml celg-20131231_def.xml celg-20131231_lab.xml celg-20131231_pre.xml true true XML 112 R74.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Details 2) (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Stock-Based Compensation      
Total share-based compensation expense $ 325.8 $ 231.0 $ 217.2
Tax benefit related to share-based compensation expense 94.5 61.3 55.9
Reduction in income 231.3 169.7 161.3
Inventory
      
Stock-Based Compensation      
Total share-based compensation expense 1.8 1.2  
Non-qualified stock options
      
Stock-Based Compensation      
Total share-based compensation expense 197.6 155.2 154.4
Cost of goods sold
      
Stock-Based Compensation      
Total share-based compensation expense 18.5 12.4 9.8
Research and development
      
Stock-Based Compensation      
Total share-based compensation expense 144.7 102.4 104.7
Selling, general and administrative
      
Stock-Based Compensation      
Total share-based compensation expense $ 162.6 $ 116.2 $ 102.7
XML 113 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventory (Tables)
 12 Months Ended
Dec. 31, 2013
Inventory Disclosure [Abstract]  
Summary of inventories by major category
 
 
2013
 
2012
Raw materials
 
$
147.4

 
$
79.2

Work in process
 
99.6

 
86.5

Finished goods
 
93.4

 
93.8

Total
 
$
340.4

 
$
259.5
XML 114 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity
 12 Months Ended
Dec. 31, 2013
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
Stockholders' Equity
Preferred Stock:    Our Board of Directors is authorized to issue, at any time, without further stockholder approval, up to 5.0 million shares of preferred stock, and to determine the price, rights, privileges, and preferences of such shares.
Common Stock:    At December 31, 2013, we were authorized to issue up to 575.0 million shares of common stock of which shares of common stock issued totaled 511.2 million.
Treasury Stock:    During the period of April 2009 through December 2013, our Board of Directors has approved repurchases of up to an aggregate $9.500 billion of our common stock, including the June 2013 authorization to repurchase an additional $3.000 billion of our common stock. We repurchased $2.769 billion, $2.050 billion, and $2.220 billion of treasury stock under the program in 2013, 2012 and 2011, respectively, excluding transaction fees. As of December 31, 2013 an aggregate 96.8 million common shares were repurchased under the program at an average price of $76.80 per common share and total cost of $7.432 billion.
Other: When employee awards of RSUs vest and are settled net in order to fulfill minimum statutory tax withholding requirements, the shares withheld are reflected as treasury stock.
A summary of changes in common stock issued and treasury stock is presented below:
 
 
Common Stock
 
Common Stock
in Treasury
December 31, 2010
 
482.2

 
(11.8
)
Exercise of stock options, warrants and conversion of restricted stock units
 
5.2

 
—

Issuance of common stock for employee benefit plans
 
—

 
0.2

Shares repurchased under share repurchase program
 
—

 
(38.3
)
December 31, 2011
 
487.4

 
(49.9
)
Exercise of stock options, warrants and conversion of restricted stock units
 
10.7

 
(0.2
)
Issuance of common stock for employee benefit plans
 
0.3

 
—

Shares repurchased under share repurchase program
 
—

 
(28.6
)
December 31, 2012
 
498.4

 
(78.7
)
Exercise of stock options and conversion of restricted stock units
 
12.5

 
(0.5
)
Issuance of common stock for employee benefit plans
 
0.3

 
—

Shares repurchased under share repurchase program
 
—

 
(22.3
)
December 31, 2013
 
511.2

 
(101.5
)